PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bockhorst, JP; Conroy, JM; Agarwal, S; O'Leary, DP; Yu, H				Bockhorst, Joseph P.; Conroy, John M.; Agarwal, Shashank; O'Leary, Dianne P.; Yu, Hong			Beyond Captions: Linking Figures with Abstract Sentences in Biomedical Articles	PLOS ONE			English	Article							AUTOMATED INTERPRETATION; LOCATION; PROTEOMICS; PATTERNS; DATABASE; SEARCH; ENGINE	Although figures in scientific articles have high information content and concisely communicate many key research findings, they are currently under utilized by literature search and retrieval systems. Many systems ignore figures, and those that do not typically only consider caption text. This study describes and evaluates a fully automated approach for associating figures in the body of a biomedical article with sentences in its abstract. We use supervised methods to learn probabilistic language models, hidden Markov models, and conditional random fields for predicting associations between abstract sentences and figures. Three kinds of evidence are used: text in abstract sentences and figures, relative positions of sentences and figures, and the patterns of sentence/figure associations across an article. Each information source is shown to have predictive value, and models that use all kinds of evidence are more accurate than models that do not. Our most accurate method has an F1-score of 69% on a cross-validation experiment, is competitive with the accuracy of human experts, has significantly better predictive accuracy than state-of-the-art methods and enables users to access figures associated with an abstract sentence with an average of 1.82 fewer mouse clicks. A user evaluation shows that human users find our system beneficial. The system is available at http://FigureItOut.askHERMES.org.	[Bockhorst, Joseph P.; Yu, Hong] Univ Wisconsin, Dept Comp Sci, Milwaukee, WI 53201 USA; [Conroy, John M.] IDA Ctr Comp Sci, Bowie, MD USA; [Agarwal, Shashank; Yu, Hong] Univ Wisconsin, Dept Hlth Sci, Milwaukee, WI 53201 USA; [O'Leary, Dianne P.] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [O'Leary, Dianne P.] Univ Maryland, UMIACS, College Pk, MD 20742 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Bockhorst, JP (corresponding author), Univ Wisconsin, Dept Comp Sci, Milwaukee, WI 53201 USA.	joebock@uwm.edu; hongyu@uwm.edu		O'Leary, Dianne/0000-0001-9809-5180	National Institutes of Health [5R01LM009836, 5R21RR024933]; Research Growth Initiative (RGI) from University of Wisconsin-Milwaukee; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095476] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Growth Initiative (RGI) from University of Wisconsin-Milwaukee; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by National Institutes of Health grants 5R01LM009836 and 5R21RR024933 and the Research Growth Initiative (RGI) from University of Wisconsin-Milwaukee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Blake JA, 1999, NUCLEIC ACIDS RES, V27, P95, DOI 10.1093/nar/27.1.95; ChengXiang Zhai, 2008, Foundations and Trends in Information Retrieval, V2, P137, DOI 10.1561/1500000008; DAGAN I, 1995, COMPUT SPEECH LANG, V9, P123, DOI 10.1006/csla.1995.0008; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Durbin R., 1998, BIOL SEQUENCE ANAL P; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hearst MA, 2007, BIOL TRANSLATIONAL C, P73; Hearst MA, 2007, BIOINFORMATICS, V23, P2196, DOI 10.1093/bioinformatics/btm301; Hiemstra D, 2001, THESIS U TWENTE; Hoffmann R, 2005, BIOINFORMATICS S, P258; Jing H., 2000, P 1 N AM CHAPT ASS C, P178; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Lee Minsuk, 2006, AMIA Annu Symp Proc, P469; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Murphy R. F., 2004, P IASTED INT C KNOWL, P109; Murphy RF, 2005, BIOCHEM SOC T, V33, P535, DOI 10.1042/BST0330535; Murphy RF, 2005, CYTOM PART A, V67A, P1, DOI 10.1002/cyto.a.20179; Murphy RF, 2004, ANN NY ACAD SCI, V1020, P124, DOI 10.1196/annals.1310.013; Murphy RF, 2001, 2ND ANNUAL IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P119, DOI 10.1109/BIBE.2001.974420; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rafkind B., 2006, P BIONLP WORKSH LINK, P73; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Shatkay H, 2006, BIOINFORMATICS, V22, pE446, DOI 10.1093/bioinformatics/btl235; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Xu SH, 2008, BIOINFORMATICS, V24, P1968, DOI 10.1093/bioinformatics/btn340; Yu H, 2006, BIOINFORMATICS, V22, pE547, DOI 10.1093/bioinformatics/btl261; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012983; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	32	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e39618	10.1371/journal.pone.0039618	http://dx.doi.org/10.1371/journal.pone.0039618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815711	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900011
J	Lenartowicz, M; Krzeptowski, W; Koteja, P; Chrzascik, K; Moller, LB				Lenartowicz, Malgorzata; Krzeptowski, Wojciech; Koteja, Pawel; Chrzascik, Katarzyna; Moller, Lisbeth Birk			Prenatal Treatment of Mosaic Mice (Atp7a mo-ms) Mouse Model for Menkes Disease, with Copper Combined by Dimethyldithiocarbamate (DMDTC)	PLOS ONE			English	Article							MACULAR MUTANT MOUSE; GENE-EXPRESSION; ANIMAL-MODEL; METALLOTHIONEIN; THERAPY; FETAL; MANIFESTATIONS; METABOLISM; TRANSPORT; ATPASES	Menkes disease is a fatal neurodegenerative disorder in infants caused by mutations in the gene ATP7A which encodes a copper (Cu) transporter. Defects in ATP7A lead to accumulated copper in the small intestine and kidneys and to copper deficiencies in the brain and the liver. The copper level in the kidney in postnatal copper-treated Menkes patients may reach toxic levels. The mouse model, mosaic Atp7a(mo-ms) recapitulates the Menkes phenotype and die about 15.75 +/- 1.5 days of age. In the present study we found that prenatal treatment of mosaic murine fetuses throughout gestation days 7, 11, 15 and 18 with a combination of CuCl2 (50 mg/kg) and dimethyldithiocarbamate (DMDTC) (280 mg/kg) leads to an increase in survival to about 76 +/- 25.3 days, whereas treatment with CuCl2 alone (50 mg/kg) only leads to survival for about 21 days 65 days. These copper-DMDTC treated mutants showed an improved locomotor activity performance and a gain in body mass. In contrast to treatment with CuCl2 alone, a significant increase in the amount of copper was observed in the brain after prenatal copper-DMDTC treatment as well as a decrease in the amount of accumulated copper in the kidney, both leading towards a normalization of the copper level. Although copper-DMDTC prenatal treatment only leads to a small increase in the sub-normal copper concentration in the liver and to an increase of copper in the already overloaded small intestine, the combined results suggest that prenatal copper-DMDTC treatment also should be considered for humans.	[Lenartowicz, Malgorzata] Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, PL-30060 Krakow, Poland; [Krzeptowski, Wojciech] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland; [Koteja, Pawel; Chrzascik, Katarzyna] Inst Environm Sci, Krakow, Poland; [Moller, Lisbeth Birk] Kennedy Ctr, Ctr Appl Human Genet, Glostrup, Denmark	Jagiellonian University; Jagiellonian University	Lenartowicz, M (corresponding author), Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, PL-30060 Krakow, Poland.	malgorzata.lenartowicz@gmail.com	Koteja, Paweł/O-4039-2015; Koteja, Paweł/AAF-7903-2019	Koteja, Paweł/0000-0003-0077-4957; Koteja, Paweł/0000-0003-0077-4957; Moller, Lisbeth/0000-0002-9524-4301				Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; Grimes A, 1997, HUM MOL GENET, V6, P1037, DOI 10.1093/hmg/6.7.1037; Gybina AA, 2006, GENES NUTR, V1, P51, DOI 10.1007/BF02829936; Hardman B, 2007, CELL PHYSIOL BIOCHEM, V20, P1073, DOI 10.1159/000110718; Harris ED, 2000, ANNU REV NUTR, V20, P291, DOI 10.1146/annurev.nutr.20.1.291; Heydorn K, 1995, J TRACE ELEM EXP MED, V8, P241; Iwase T, 1996, ACTA NEUROPATHOL, V91, P482, DOI 10.1007/s004010050455; JASIM S, 1985, ACTA PHARMACOL TOX, V57, P262; Kaler SG, 2008, NEW ENGL J MED, V358, P605, DOI 10.1056/NEJMoa070613; KASAMA T, 1989, J NUTR SCI VITAMINOL, V35, P627, DOI 10.3177/jnsv.35.627; Kirby BJ, 1998, J INORG BIOCHEM, V71, P189, DOI 10.1016/S0162-0134(98)10053-3; KLEIN D, 1991, TOXICOL LETT, V56, P61, DOI 10.1016/0378-4274(91)90090-S; Kodama H, 2005, J INHERIT METAB DIS, V28, P971, DOI 10.1007/s10545-005-0150-6; Kodama H, 1999, PEDIATR INT, V41, P423, DOI 10.1046/j.1442-200x.1999.01095.x; Kowal M, 2010, SYST BIOL REPROD MED, V56, P431, DOI 10.3109/19396361003734624; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lenartowicz M, 2001, FOLIA HISTOCHEM CYTO, V39, P275; Lenartowicz M., 2000, NUTR RES, V10, P1519, DOI [10.1016/S0271-5317(00)00230-X, DOI 10.1016/S0271-5317(00)00230-X]; Lenartowicz M, 2011, GENE EXPR PATTERNS, V11, P41, DOI 10.1016/j.gep.2010.09.001; Lenartowicz M, 2010, BIOL TRACE ELEM RES, V136, P204, DOI 10.1007/s12011-009-8533-4; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MCARDLE HJ, 1991, J NUTR, V121, P208, DOI 10.1093/jn/121.2.208; MENKES JH, 1962, PEDIATRICS, V29, P764; MERCER JFB, 1992, J NUTR, V122, P1254, DOI 10.1093/jn/122.6.1254; Mercer JFB, 1998, AM J CLIN NUTR, V67, p1022S, DOI 10.1093/ajcn/67.5.1022S; NAKAGAWA S, 1993, ZOOL SCI, V10, P653; Nelson KT, 2009, BRIT J NUTR, V102, P18, DOI 10.1017/S0007114508162961; Oshio T, 1997, J PEDIATR SURG, V32, P782, DOI 10.1016/S0022-3468(97)90035-X; PHILLIPS M, 1991, BIOL TRACE ELEM RES, V29, P11, DOI 10.1007/BF03032670; Prohaska JR, 2006, COMP BIOCHEM PHYS B, V143, P360, DOI 10.1016/j.cbpb.2005.12.010; Qian YC, 1997, MOL BRAIN RES, V48, P60, DOI 10.1016/S0169-328X(97)00083-1; Reed V, 1997, HUM MOL GENET, V6, P417, DOI 10.1093/hmg/6.3.417; SHIRAISHI N, 1988, BIOL NEONATE, V54, P173; STYRNA J, 1977, GENET POL, V18, P61; SuzukiKurasaki M, 1997, J HISTOCHEM CYTOCHEM, V45, P1493, DOI 10.1177/002215549704501106; TANAKA K, 1990, RES COMMUN CHEM PATH, V69, P217; Tilton F, 2006, TOXICOL APPL PHARM, V216, P55, DOI 10.1016/j.taap.2006.04.014; XU GQ, 1994, BIOL NEONATE, V66, P302; Zaffanello M, 2006, ACTA PAEDIATR, V95, P785, DOI 10.1080/08035250500538957; Zhu D, 2011, J ANIM FEED SCI, V20, P60, DOI 10.22358/jafs/66158/2011	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40400	10.1371/journal.pone.0040400	http://dx.doi.org/10.1371/journal.pone.0040400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815746	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900024
J	Popov, T; Rockstroh, B; Weisz, N; Elbert, T; Miller, GA				Popov, Tzvetan; Rockstroh, Brigitte; Weisz, Nathan; Elbert, Thomas; Miller, Gregory A.			Adjusting Brain Dynamics in Schizophrenia by Means of Perceptual and Cognitive Training	PLOS ONE			English	Article							GRAY-MATTER LOSS; CORTICAL NETWORKS; PLASTICITY; OSCILLATIONS; RESPONSES; CORTEX; ONSET; DEFICITS; MEMORY; REORGANIZATION	Background: In a previous report we showed that cognitive training fostering auditory-verbal discrimination and working memory normalized magnetoencephalographic (MEG) M50 gating ratio in schizophrenia patients. The present analysis addressed whether training effects on M50 ratio and task performance are mediated by changes in brain oscillatory activity. Such evidence should improve understanding of the role of oscillatory activity in phenomena such as M50 ratio, the role of dysfunctional oscillatory activity in processing abnormalities in schizophrenia, and mechanisms of action of cognitive training. Methodology/Principal Findings: Time-locked and non-time-locked oscillatory activity was measured together with M50 ratio in a paired-click design before and after a 4-week training of 36 patients randomly assigned to specific cognitive exercises (CE) or standard (comparison) cognitive training (CP). Patient data were compared to those of 15 healthy controls who participated in two MEG measurements 4 weeks apart without training. Training led to more time-locked gamma-band response and more non-time-locked alpha-band desynchronization, moreso after CE than after CP. Only after CE, increased alpha desynchronization was associated with normalized M50 ratio and with improved verbal memory performance. Thus, both types of cognitive training normalized gamma activity, associated with improved stimulus encoding. More targeted training of auditory-verbal discrimination and memory additionally normalized alpha desynchronization, associated with improved elaborative processing. The latter presumably contributes to improved auditory gating and cognitive function. Conclusions/Significance: Results suggest that dysfunctional interplay of ocillatory activity that may contribute to auditory processing disruption in schizophrenia can be modified by targeted training.	[Popov, Tzvetan; Rockstroh, Brigitte; Weisz, Nathan; Elbert, Thomas; Miller, Gregory A.] Univ Konstanz, Dept Psychol, Constance, Germany; [Miller, Gregory A.] Univ Delaware, Dept Psychol, Newark, DE USA; [Miller, Gregory A.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA	University of Konstanz; University of Delaware; University of Illinois System; University of Illinois Urbana-Champaign	Popov, T (corresponding author), Univ Konstanz, Dept Psychol, Constance, Germany.	Tzvetan.Popov@uni-konstanz.de	Elbert, Thomas/C-8556-2009; Weisz, Nathan/K-3325-2015	Elbert, Thomas/0000-0003-1332-4939; Weisz, Nathan/0000-0001-7816-0037	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Research was based on a grant to BR by the Deutsche Forschungsgemeinschaft (DFG), but the DFG had no further role in study design, in the collection, analysis, and interpretation of the data, in the writing of the report, and in the decision to submit the paper for publication.	Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chang WP, 2011, PSYCHOPHYSIOLOGY, V48, P980, DOI 10.1111/j.1469-8986.2010.01168.x; Daskalakis ZJ, 2008, ARCH GEN PSYCHIAT, V65, P378, DOI 10.1001/archpsyc.65.4.378; Debener S, 2003, NEUROREPORT, V14, P683, DOI 10.1097/00001756-200304150-00005; Eack SM, 2010, ARCH GEN PSYCHIAT, V67, P674, DOI 10.1001/archgenpsychiatry.2010.63; Edgar JC, 2008, PSYCHOPHYSIOLOGY, V45, P812, DOI 10.1111/j.1469-8986.2008.00682.x; Elbert T, 2004, NEUROSCIENTIST, V10, P129, DOI 10.1177/1073858403262111; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Fitzgerald PB, 2004, SCHIZOPHR RES, V71, P17, DOI 10.1016/j.schres.2004.01.018; Gallinat J, 2004, CLIN NEUROPHYSIOL, V115, P1863, DOI 10.1016/j.clinph.2004.03.013; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Genevsky Alexander, 2010, Dialogues Clin Neurosci, V12, P416; Gold JM, 2004, SCHIZOPHR RES, V72, P21, DOI 10.1016/j.schres.2004.09.008; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Hasan A, 2011, BEHAV BRAIN RES, V224, P15, DOI 10.1016/j.bbr.2011.05.017; Haut KM, 2010, NEUROPSYCHOPHARMACOL, V35, P1850, DOI 10.1038/npp.2010.52; Helmstaedter L, 2001, VLTM VERBALER LERN M; Higashima M, 2007, INT J PSYCHOPHYSIOL, V65, P95, DOI 10.1016/j.ijpsycho.2007.03.008; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; Ikezawa K, 2011, NEUROSCI RES, V71, P235, DOI 10.1016/j.neures.2011.07.1819; Jay TM, 2004, NEUROTOX RES, V6, P233, DOI 10.1007/BF03033225; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knyazeva MG, 2008, ACTA PSYCHIAT SCAND, V118, P188, DOI 10.1111/j.1600-0447.2008.01227.x; Koh Y, 2011, SCHIZOPHR RES, V126, P36, DOI 10.1016/j.schres.2010.10.001; Krause CM, 2006, PROG BRAIN RES, V159, P197, DOI 10.1016/S0079-6123(06)59013-2; Leicht G, 2010, BIOL PSYCHIAT, V67, P224, DOI 10.1016/j.biopsych.2009.07.033; Li SC, 2002, BEHAV BRAIN SCI, V25, P761, DOI 10.1017/S0140525X02330139; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Popov T, 2011, NEUROIMAGE, V56, P307, DOI 10.1016/j.neuroimage.2011.02.016; Popov T, 2011, BIOL PSYCHIAT, V69, P465, DOI 10.1016/j.biopsych.2010.09.028; Pulvermuller F, 1999, TRENDS COGN SCI, V3, P250, DOI 10.1016/S1364-6613(99)01344-3; Rutter L, 2009, HUM BRAIN MAPP, V30, P3254, DOI 10.1002/hbm.20746; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Thoma RJ, 2003, AM J PSYCHIAT, V160, P1595, DOI 10.1176/appi.ajp.160.9.1595; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; White TP, 2010, CLIN NEUROPHYSIOL, V121, P1427, DOI 10.1016/j.clinph.2010.03.024; Woo TUW, 2010, HARVARD REV PSYCHIAT, V18, P173, DOI 10.3109/10673221003747609; Yee CM, 2010, J ABNORM PSYCHOL, V119, P31, DOI 10.1037/a0018265	52	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e39051	10.1371/journal.pone.0039051	http://dx.doi.org/10.1371/journal.pone.0039051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815697	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900008
J	Yan, FD; Yao, YY; Chen, LJ; Li, YF; Sheng, ZL; Ma, GS				Yan, Fengdi; Yao, Yuyu; Chen, Lijuan; Li, Yefei; Sheng, Zulong; Ma, Genshan			Hypoxic Preconditioning Improves Survival of Cardiac Progenitor Cells: Role of Stromal Cell Derived Factor-1 alpha-CXCR4 Axis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CHEMOKINE RECEPTOR CXCR4; MYOCARDIAL-INFARCTION; INDUCED APOPTOSIS; TRANSPLANTATION; REGENERATION; HEART; GROWTH; EXPRESSION; PROMOTES	Background: Cardiac progenitor cells (CPCs) have been shown to be suitable in stem cell therapy for resurrecting damaged myocardium, but poor retention of transplanted cells in the ischemic myocardium causes ineffective cell therapy. Hypoxic preconditioning of cells can increase the expression of CXCR4 and pro-survival genes to promote better cell survival; however, it is unknown whether hypoxia preconditioning will influence the survival and retention of CPCs via the SDF-1 alpha/CXCR4 axis. Methods and Results: CPCs were isolated from adult mouse hearts and purified by magnetic activated cell sorting using c-kit magnetic beads. These cells were cultured at various times in either normoxic or hypoxic conditions, and cell survival was analyzed using flow cytometry and the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha), CXCR4, phosphorylated Akt and Bcl-2 were measured by Western blot. Results showed that the expression of pro-survival genes significantly increased after hypoxia treatment, especially in cells cultured in hypoxic conditions for six hours. Upon completion of hypoxia preconditioning from c-kit+ CPCs for six hours, the anti-apoptosis, migration and cardiac repair potential were evaluated. Results showed a significant enhancement in anti-apoptosis and migration in vitro, and better survival and cardiac function after being transplanted into acute myocardial infarction (MI) mice in vivo. The beneficial effects induced by hypoxia preconditioning of c-kit+ CPCs could largely be blocked by the addition of CXCR4 selective antagonist AMD3100. Conclusions: Hypoxic preconditioning may improve the survival and retention of c-kit+ CPCs in the ischemic heart tissue through activating the SDF-1 alpha/CXCR4 axis and the downstream anti-apoptosis pathway. Strategies targeting this aspect may enhance the effectiveness of cell-based cardiac regenerative therapy.	[Yan, Fengdi; Yao, Yuyu; Chen, Lijuan; Li, Yefei; Sheng, Zulong; Ma, Genshan] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Yan, FD (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	magenshan@hotmail.com			National Natural Science Foundation of China [81070083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81070083, to GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297; Khan M, 2010, LIFE SCI, V87, P269, DOI 10.1016/j.lfs.2010.06.013; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Peterson KM, 2011, LIFE SCI, V88, P65, DOI 10.1016/j.lfs.2010.10.023; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stamatopoulos B, 2011, HAEMATOLOGICA; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546; Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x; Wu JC, 2003, CIRCULATION, V108, P1302, DOI 10.1161/01.CIR.0000091252.20010.6E; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	39	54	62	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e37948	10.1371/journal.pone.0037948	http://dx.doi.org/10.1371/journal.pone.0037948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815687	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900005
J	Huettl, RE; Haehl, T; Huber, AB				Huettl, Rosa-Eva; Haehl, Teresa; Huber, Andrea B.			Fasciculation and Guidance of Spinal Motor Axons in the Absence of FGFR2 Signaling	PLOS ONE			English	Article							FACTOR RECEPTOR 2; GROWTH-FACTOR RECEPTORS; MESODERM FORMATION; NEURON POOL; EXPRESSION; LIMB; MAINTENANCE; SEMAPHORIN; FGF10; GENERATION	During development, fibroblast growth factors (FGF) are essential for early patterning events along the anterior-posterior axis, conferring positional identity to spinal motor neurons by activation of different Hox codes. In the periphery, signaling through one of four fibroblast growth factor receptors supports the development of the skeleton, as well as induction and maintenance of extremities. In previous studies, FGF receptor 2 (FGFR2) was found to interact with axon bound molecules involved in axon fasciculation and extension, thus rendering this receptor an interesting candidate for the promotion of proper peripheral innervation. However, while the involvement of FGFR2 in limb bud induction has been extensively studied, its role during axon elongation and formation of distinct nervous projections has not been addressed so far. We show here that motor neurons in the spinal cord express FGFR2 and other family members during the establishment of motor connections to the forelimb and axial musculature. Employing a conditional genetic approach to selectively ablate FGFR2 from motor neurons we found that the patterning of motor columns and the expression patterns of other FGF receptors and Sema3A in the motor columns of mutant embryos are not altered. In the absence of FGFR2 signaling, pathfinding of motor axons is intact, and also fasciculation, distal advancement of motor nerves and gross morphology and positioning of axonal projections are not altered. Our findings therefore show that FGFR2 is not required cell-autonomously in motor neurons during the formation of initial motor projections towards limb and axial musculature.	[Huettl, Rosa-Eva; Haehl, Teresa; Huber, Andrea B.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Huber, AB (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	andrea.huber@helmholtz-muenchen.de		Huettl, Rosa-Eva/0000-0001-8196-9865	Deutsche Forschungsgemeinschaft (DFG); Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	The authors gratefully acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG, to ABH) and the Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2010, DEV DYNAM, V239, P987, DOI 10.1002/dvdy.22218; Altmann CR, 2001, INT REV CYTOL, V203, P447; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Belluardo N, 1997, J COMP NEUROL, V379, P226; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Blak AA, 2007, DEV BIOL, V303, P231, DOI 10.1016/j.ydbio.2006.11.008; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Ferhat L, 1997, EUR J NEUROSCI, V9, P1282, DOI 10.1111/j.1460-9568.1997.tb01483.x; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Furusho M, 2011, J NEUROSCI, V31, P5055, DOI 10.1523/JNEUROSCI.4800-10.2011; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Haupt C, 2008, FRONT BIOSCI-LANDMRK, V13, P3136, DOI 10.2741/2915; Hebert JM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00133; Hehr U, 1999, MOL GENET METAB, V68, P139, DOI 10.1006/mgme.1999.2915; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huettl RE, 2011, DEV BIOL; Huettl RE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001020; ISAACS HV, 1992, DEVELOPMENT, V114, P711; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kettunen P, 2007, MECH DEVELOP, V124, P868, DOI 10.1016/j.mod.2007.09.003; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lizarraga G, 1999, DEV GENET, V25, P331, DOI 10.1002/(SICI)1520-6408(1999)25:4<331::AID-DVG7>3.0.CO;2-U; Lom B, 1998, J NEUROBIOL, V37, P633, DOI 10.1002/(SICI)1097-4695(199812)37:4<633::AID-NEU11>3.0.CO;2-L; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Moret F, 2007, DEVELOPMENT, V134, P4491, DOI 10.1242/dev.011452; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Ornitz DM, 2001, GENOME BIOL, V2; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Sahay A, 2003, J NEUROSCI, V23, P6671; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shi P, 2010, LAB CHIP, V10, P1005, DOI 10.1039/b922143c; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; SuterCrazzolara C, 1996, MOL BRAIN RES, V41, P175, DOI 10.1016/0169-328X(96)00089-7; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; THISSE B, 1995, DEV DYNAM, V203, P377, DOI 10.1002/aja.1002030309; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Vesterlund L, 2011, INT J DEV BIOL, V55, P313, DOI 10.1387/ijdb.103240lv; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xu XL, 1998, DEVELOPMENT, V125, P753; Zhang F, 2002, NEUROSCIENCE, V114, P837, DOI 10.1016/S0306-4522(02)00321-4; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	66	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41095	10.1371/journal.pone.0041095	http://dx.doi.org/10.1371/journal.pone.0041095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815929	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000065
J	Alvarez-Cubero, MJ; Guinaldo, MS; Martinez-Gonzalez, LJ; Merino, JCA; Olmo, JMC; Acosta, JAL				Jesus Alvarez-Cubero, Maria; Saiz Guinaldo, Maria; Javier Martinez-Gonzalez, Luis; Alvarez Merino, Juan Carlos; Cozar Olmo, Jose Manuel; Lorente Acosta, Jose Antonio			Mitochondrial Haplogroups and Polymorphisms Reveal No Association with Sporadic Prostate Cancer in a Southern European Population	PLOS ONE			English	Article							CONTROL-REGION SEQUENCES; DNA MUTATIONS; SOMATIC MUTATIONS; SUSCEPTIBILITY GENES; BREAST-CANCER; LINKAGE SCAN; GENOME; GENETICS; RISK; TUMORS	Background: It is known that mitochondria play an important role in certain cancers (prostate, renal, breast, or colorectal) and coronary disease. These organelles play an essential role in apoptosis and the production of reactive oxygen species; in addition, mtDNA also reveals the history of populations and ancient human migration. All these events and variations in the mitochondrial genome are thought to cause some cancers, including prostate cancer, and also help us to group individuals into common origin groups. The aim of the present study is to analyze the different haplogroups and variations in the sequence in the mitochondrial genome of a southern European population consisting of subjects affected (n = 239) and non-affected (n = 150) by sporadic prostate cancer. Methodology and Principal Findings: Using primer extension analysis and DNA sequencing, we identified the nine major European haplogroups and CR polymorphisms. The frequencies of the haplogroups did not differ between patients and control cohorts, whereas the CR polymorphism T16356C was significantly higher in patients with PC compared to the controls (p = 0.029). PSA, staging, and Gleason score were associated with none of the nine major European haplogroups. The CR polymorphisms G16129A (p = 0.007) and T16224C (p = 0.022) were significantly associated with Gleason score, whereas T16311C (p = 0.046) was linked with T-stage. Conclusions and Significance: Our results do not suggest that mtDNA haplogroups could be involved in sporadic prostate cancer etiology and pathogenesis as previous studies performed in middle Europe population. Although some significant associations have been obtained in studying CR polymorphisms, further studies should be performed to validate these results.	[Jesus Alvarez-Cubero, Maria; Saiz Guinaldo, Maria; Alvarez Merino, Juan Carlos; Lorente Acosta, Jose Antonio] Univ Granada, Fac Med, Legal Med & Toxicol Dept, Lab Genet Identificat, Granada, Spain; [Javier Martinez-Gonzalez, Luis; Alvarez Merino, Juan Carlos; Lorente Acosta, Jose Antonio] Univ Granada, Pfizer, Andalusian Govt Ctr Genom & Oncol Res, GENYO, Granada, Spain; [Cozar Olmo, Jose Manuel] Univ Hosp Virgen Nieves, Serv Urol, Granada, Spain	University of Granada; Pfizer; University of Granada; Hospital Universitario Virgen de las Nieves	Alvarez-Cubero, MJ (corresponding author), Univ Granada, Fac Med, Legal Med & Toxicol Dept, Lab Genet Identificat, Granada, Spain.	luisjavier.martinez@genyo.es	Martinez-Gonzalez, Luis Javier/L-6136-2014; Alvarez, Juan/GSD-7155-2022; Alvarez, J. Carlos/R-9722-2019; Cubero, Maria Jesus Alvarez/M-2892-2015; LORENTE, JOSE A./B-8372-2008	Martinez-Gonzalez, Luis Javier/0000-0003-2202-0662; Alvarez, J. Carlos/0000-0002-5884-9918; Cubero, Maria Jesus Alvarez/0000-0002-5492-9355; LORENTE, JOSE A./0000-0002-9892-7386				Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99; Alberti C, 2010, EUR REV MED PHARMACO, V14, P31; Alvarez J. Carlos, 2007, Legal Medicine, V9, P293, DOI 10.1016/j.legalmed.2007.05.005; Alvarez-Cubero MJ, 2011, PROSTATE CANC PROSTA; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], MANUAL UROLOGIA ESEN; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Bailar J C 3rd, 1966, Cancer Chemother Rep, V50, P129; Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Chang BL, 2006, HUM GENET, V118, P716, DOI 10.1007/s00439-005-0099-4; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen JJZ, 2004, J ENVIRON SCI HEAL C, V22, P1, DOI 10.1081/GNC-120037931; Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Ferlay J, 2001, IARC CANCERBASE; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Gomez-Zaera M, 2006, MUTAT RES-FUND MOL M, V595, P42, DOI 10.1016/j.mrfmmm.2005.10.012; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Hulgan T, 2011, AIDS, V25, P37, DOI 10.1097/QAD.0b013e32833f9d02; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Isaacs WB, 2007, LINKAGE STUDIES PROS; Jeronimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646; Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X; Kim W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002211; Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375; Kloss-Brandstatter A, 2010, AM J HUM GENET, V87, P802, DOI 10.1016/j.ajhg.2010.11.001; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kumar V, 2010, CHEMOSPHERE, V81, P464, DOI 10.1016/j.chemosphere.2010.07.067; Kurtz A, 2004, MOL CANCER RES, V2, P433; Lee HY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-483; Liu S., 2011, EUR ARCH OTO-RHINO-L, P1; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; O'Dowd GJ, 2001, PCRI INSIGHTS, V4; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Quaglia A, 2003, EUR J CANCER, V39, P654, DOI 10.1016/S0959-8049(02)00872-9; Ray Katrina, 2011, Nat Rev Urol, V8, P119, DOI 10.1038/nrurol.2011.14; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Shaik NA, 2011, GENET TEST MOL BIOMA, V15, P537, DOI 10.1089/gtmb.2010.0255; Snall N, 2002, HUM BIOL, V74, P253, DOI 10.1353/hub.2002.0024; Tan DJ, 2002, CANCER RES, V62, P972; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tseng LM, 2011, GENE CHROMOSOME CANC, V50, P800, DOI 10.1002/gcc.20901; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Wang L, 2007, CANCER EPIDEM BIOMAR, V16, P1455, DOI 10.1158/1055-9965.EPI-07-0119; Wang L, 2008, CANCER EPIDEM BIOMAR, V17, P3558, DOI 10.1158/1055-9965.EPI-08-0434; Wiesbauer M, 2006, MITOCHONDRION, V6, P263; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Yu JJ, 2010, AGING MALE, V13, P159, DOI 10.3109/13685530903536668	56	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41201	10.1371/journal.pone.0041201	http://dx.doi.org/10.1371/journal.pone.0041201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815971	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000078
J	Swanson, MM; Reavy, B; Makarova, KS; Cock, PJ; Hopkins, DW; Torrance, L; Koonin, EV; Taliansky, M				Swanson, Maud M.; Reavy, Brian; Makarova, Kira S.; Cock, Peter J.; Hopkins, David W.; Torrance, Lesley; Koonin, Eugene V.; Taliansky, Michael			Novel Bacteriophages Containing a Genome of Another Bacteriophage within Their Genomes	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MARINE VIRUSES; SEQUENCE; DIVERSITY; FRAMESHIFT; GENERATION; EVOLUTION; ABUNDANCE; ELEMENTS; PHAGES	A novel bacteriophage infecting Staphylococus pasteuri was isolated during a screen for phages in Antarctic soils. The phage named SpaA1 is morphologically similar to phages of the family Siphoviridae. The 42,784 bp genome of SpaA1 is a linear, double-stranded DNA molecule with 39 protruding cohesive ends. The SpaA1 genome encompasses 63 predicted protein-coding genes which cluster within three regions of the genome, each of apparently different origin, in a mosaic pattern. In two of these regions, the gene sets resemble those in prophages of Bacillus thuringiensis kurstaki str. T03a001 (genes involved in DNA replication/transcription, cell entry and exit) and B. cereus AH676 (additional regulatory and recombination genes), respectively. The third region represents an almost complete genome (except for the short terminal segments) of a distinct bacteriophage, MZTP02. Nearly the same gene module was identified in prophages of B. thuringiensis serovar monterrey BGSC 4AJ1 and B. cereus Rock4-2. These findings suggest that MZTP02 can be shuttled between genomes of other bacteriophages and prophages, leading to the formation of chimeric genomes. The presence of a complete phage genome in the genome of other phages apparently has not been described previously and might represent a 'fast track' route of virus evolution and horizontal gene transfer. Another phage (BceA1) nearly identical in sequence to SpaA1, and also including the almost complete MZTP02 genome within its own genome, was isolated from a bacterium of the B. cereus/B. thuringiensis group. Remarkably, both SpaA1 and BceA1 phages can infect B. cereus and B. thuringiensis, but only one of them, SpaA1, can infect S. pasteuri. This finding is best compatible with a scenario in which MZTP02 was originally contained in BceA1 infecting Bacillus spp, the common hosts for these two phages, followed by emergence of SpaA1 infecting S. pasteuri.	[Swanson, Maud M.; Reavy, Brian; Cock, Peter J.; Hopkins, David W.; Torrance, Lesley; Taliansky, Michael] James Hutton Inst, Dundee, Scotland; [Makarova, Kira S.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	James Hutton Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Swanson, MM (corresponding author), James Hutton Inst, Dundee, Scotland.	Brian.Reavy@hutton.ac.uk	Swanson, Maud/L-4429-2013; GenePool, The/D-8812-2012; Taliansky, Michael/H-8483-2013; Cock, Peter J A/D-8730-2013	Cock, Peter J A/0000-0001-9513-9993; Torrance, Lesley/0000-0001-8327-1276; Hopkins, David/0000-0003-0953-8643	Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division; United States Department of Health and Human Services (National Library of Medicine, National Institutes of Health); BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish; NATIONAL LIBRARY OF MEDICINE [ZIALM000073] Funding Source: NIH RePORTER	Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division; United States Department of Health and Human Services (National Library of Medicine, National Institutes of Health); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work of authors MMS, BR, PJC, DH, LT and MT was funded by the Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division. KSM and EVK are supported by the intramural funds of the United States Department of Health and Human Services (National Library of Medicine, National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; [Anonymous], 2011, VIRUS TAXONOMY; Ashelford KE, 2003, APPL ENVIRON MICROB, V69, P285, DOI 10.1128/AEM.69.1.285-289.2003; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Briani F, 2001, PLASMID, V45, P1, DOI 10.1006/plas.2000.1497; Brussow H, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P129; Calendar R., 2006, BACTERIOPHAGES; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; CHESNEAU O, 1993, INT J SYST BACTERIOL, V43, P237, DOI 10.1099/00207713-43-2-237; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; CHRISTIE GE, 1990, ANNU REV GENET, V24, P465, DOI 10.1146/annurev.ge.24.120190.002341; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Elberling B, 2006, SOIL BIOL BIOCHEM, V38, P3095, DOI 10.1016/j.soilbio.2005.12.011; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Fouts DE, 2006, J BACTERIOL, V188, P3402, DOI 10.1128/JB.188.9.3402-3408.2006; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Haaber J, 2009, ISME J, V3, P430, DOI 10.1038/ismej.2008.125; Hasegawa, 1992, COMPUTER SCI MONOGRA, V27; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hopkins DW, 2006, SOIL BIOL BIOCHEM, V38, P3130, DOI 10.1016/j.soilbio.2006.01.012; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D; Klumpp J, 2010, VIRUSES-BASEL, V2, P961, DOI 10.3390/v2040961; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Kutter E., 2005, BACTERIOPHAGES BIOL; Liao W, 2008, ARCH VIROL, V153, P1855, DOI 10.1007/s00705-008-0201-z; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; McGrath S., 2007, BACTERIOPHAGE GENETI; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Omelchenko MV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r55; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Pritchard L, 2006, BIOINFORMATICS, V22, P616, DOI 10.1093/bioinformatics/btk021; PRUSS G, 1974, P NATL ACAD SCI USA, V71, P2367, DOI 10.1073/pnas.71.6.2367; Ravin NV, 2011, PLASMID, V65, P102, DOI 10.1016/j.plasmid.2010.12.004; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Romero P, 2004, VIROLOGY, V322, P239, DOI 10.1016/j.virol.2004.01.029; SHORE D, 1978, P NATL ACAD SCI USA, V75, P400, DOI 10.1073/pnas.75.1.400; Sobecky Patricia A., 2009, V532, P435, DOI 10.1007/978-1-60327-853-9_25; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Theis C, 2008, NUCLEIC ACIDS RES, V36, P6013, DOI 10.1093/nar/gkn578; Thurber RV, 2009, CURR OPIN MICROBIOL, V12, P582, DOI 10.1016/j.mib.2009.08.008; Verheust C, 2003, MICROBIOL-SGM, V149, P2083, DOI 10.1099/mic.0.26307-0; Wang YQ, 2010, APPL ENVIRON MICROB, V76, P7861, DOI 10.1128/AEM.01270-10; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006	62	35	35	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40683	10.1371/journal.pone.0040683	http://dx.doi.org/10.1371/journal.pone.0040683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815791	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000025
J	Evans, AL; Sahlen, V; Stoen, OG; Fahlman, A; Brunberg, S; Madslien, K; Frobert, O; Swenson, JE; Arnemo, JM				Evans, Alina L.; Sahlen, Veronica; Stoen, Ole-Gunnar; Fahlman, Asa; Brunberg, Sven; Madslien, Knut; Frobert, Ole; Swenson, Jon E.; Arnemo, Jon M.			Capture, Anesthesia, and Disturbance of Free-Ranging Brown Bears (Ursus arctos) during Hibernation	PLOS ONE			English	Article							BLACK BEARS; AMERICANUS; HYDROCHLORIDE; MEDETOMIDINE; PHYSIOLOGY; TILETAMINE; WELFARE	We conducted thirteen immobilizations of previously collared hibernating two-to four-year-old brown bears (Ursus arctos) weighing 21-66 kg in central Sweden in winter 2010 and 2011 for comparative physiology research. Here we report, for the first time, an effective protocol for the capture and anesthesia of free-ranging brown bears during hibernation and an assessment of the disturbance the captures caused. Bears were darted in anthill, soil, or uprooted tree dens on eleven occasions, but two bears in rock dens fled and were darted outside the den. We used medetomidine at 0.02-0.06 mg/kg and zolazepam-tiletamine at 0.9-2.8 mg/kg for anesthesia. In addition, ketamine at 1.5 mg/kg was hand-injected intramuscularly in four bears and in six it was included in the dart at 1.1-3.0 mg/kg. Once anesthetized, bears were removed from the dens. In nine bears, arterial blood samples were analyzed immediately with a portable blood gas analyzer. We corrected hypoxemia in seven bears (PaO2 57-74 mmHg) with supplemental oxygen. We placed the bears back into the dens and antagonized the effect of medetomidine with atipamezole. Capturing bears in the den significantly increased the risk of den abandonment. One of twelve collared bears that were captured remained at the original den until spring, and eleven, left their dens (mean +/- standard deviation) 3.2 +/- 3.6 (range 0.5-10.5) days after capture. They used 1.9 +/- 0.9 intermediate resting sites, during 6.2 +/- 7.8 days before entering a new permanent den. The eleven new permanent dens were located 730 +/- 589 m from the original dens. We documented that it was feasible and safe to capture hibernating brown bears, although they behaved differently than black bears. When doing so, researchers should use 25% of the doses used for helicopter darting during the active period and should consider increased energetic costs associated with den abandonment.	[Evans, Alina L.; Arnemo, Jon M.] Hedmark Univ Coll, Dept Forestry & Wildlife Management, Elverum, Norway; [Evans, Alina L.] Norwegian Sch Vet Sci, Sect Arctic Vet Med, Tromso, Norway; [Sahlen, Veronica; Stoen, Ole-Gunnar; Brunberg, Sven; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Fahlman, Asa] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Sect Anesthesiol, Uppsala, Sweden; [Fahlman, Asa] Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada; [Madslien, Knut] Natl Vet Inst, Sect Wildlife Hlth, Oslo, Norway; [Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Stoen, Ole-Gunnar; Arnemo, Jon M.] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Inland Norway University of Applied Sciences; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; University of Calgary; Norwegian Veterinary Institute; Orebro University; Norwegian Institute Nature Research; Swedish University of Agricultural Sciences	Evans, AL (corresponding author), Hedmark Univ Coll, Dept Forestry & Wildlife Management, Campus Evenstad, Elverum, Norway.	alina.evans@hihm.com	Støen, Ole-Gunnar/AAY-6457-2020; Swenson, Jon/E-2883-2013; Evans, Alina/AAH-8881-2019; Swenson, Jon/AAE-2890-2019; Fahlman, Asa/AAL-2583-2021	Fahlman, Asa/0000-0003-1246-0197; Frobert, Ole/0000-0002-5846-345X; Fahlman, Asa/0000-0001-9092-5514	Norwegian Directorate for Nature Management; Swedish Environmental Protection Agency; Research Council of Norway; WWF Sweden; Norwegian-American Fulbright Commission; American Scandinavian Foundation; Morris Animal Foundation	Norwegian Directorate for Nature Management; Swedish Environmental Protection Agency; Research Council of Norway(Research Council of Norway); WWF Sweden; Norwegian-American Fulbright Commission; American Scandinavian Foundation; Morris Animal Foundation	The Scandinavian Brown Bear Project is supported by the Norwegian Directorate for Nature Management, the Swedish Environmental Protection Agency, the Research Council of Norway, and WWF Sweden. The Norwegian Directorate for Nature Management, Norwegian-American Fulbright Commission, the American Scandinavian Foundation and the Morris Animal Foundation provided salary and stipend support for Dr. Evans during the study and writing periods. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON EM, 1979, J WILDLIFE DIS, V15, P253, DOI 10.7589/0090-3558-15.2.253; Arinell K, 2012, CTS-CLIN TRANSL SCI, V5, P269, DOI 10.1111/j.1752-8062.2011.00370.x; Arnemo J.M., 2011, BIOMEDICAL PROTOCOL; Asano M, 2007, J VET MED SCI, V69, P433, DOI 10.1292/jvms.69.433; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; DoanCrider DL, 1996, J WILDLIFE MANAGE, V60, P398, DOI 10.2307/3802242; Elfstrom M, 2009, URSUS, V20, P85, DOI 10.2192/09GR005.1; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; Fahlman A, 2011, J ZOO WILDLIFE MED, V42, P1, DOI 10.1638/2008-0117.1; Fahlman A, 2010, J ZOO WILDLIFE MED, V41, P161, DOI 10.1638/2009-0036.1; Fink T, 2011, STEM CELL RES, V7, P89, DOI 10.1016/j.scr.2011.03.003; Friebe A, 2001, URSUS-SERIES, V12, P37; Frobert O, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-11; Gervasi V, 2006, WILDLIFE SOC B, V34, P1314, DOI 10.2193/0091-7648(2006)34[1314:AIMTMA]2.0.CO;2; Hall LW, 2003, VET ANESTHESIA; Harlow HJ, 2002, J MAMMAL, V83, P1020, DOI 10.1644/1545-1542(2002)083&lt;1020:BMALCB&gt;2.0.CO;2; HISSA R, 1994, COMP BIOCHEM PHYS A, V109, P781, DOI 10.1016/0300-9629(94)90222-4; Hissa R, 1997, ANN ZOOL FENN, V34, P267; JALANKA HH, 1990, J ZOO WILDLIFE MED, V21, P259; Johnson RA, 2006, FLUID ELECTROLYTE AC; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Matthews NS, 2003, VET ANAESTH ANALG, V30, P3, DOI 10.1046/j.1467-2995.2003.00121.x; Mortenson J, 2001, J ZOO WILDLIFE MED, V32, P217, DOI 10.1638/1042-7260(2001)032[0217:CCUAAO]2.0.CO;2; Nelson OL, 2010, J COMP PHYSIOL B, V180, P465, DOI 10.1007/s00360-009-0421-x; Powell RA, 2005, J MAMMAL, V86, P1171, DOI 10.1644/05-MAMM-A-014R2.1; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Seryodkin Ivan V., 2003, Ursus (Knoxville), V14, P153; Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829; Swenson JE, 1997, WILDLIFE BIOL, V3, P35, DOI 10.2981/wlb.1997.005; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; Tsiouris JA, 2004, CAN J ZOOL, V82, P1468, DOI [10.1139/z04-122, 10.1139/Z04-122]; Vestergaard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021483	33	54	58	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40520	10.1371/journal.pone.0040520	http://dx.doi.org/10.1371/journal.pone.0040520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815757	Green Published, gold			2022-12-27	WOS:000306466100039
J	Lu, SL; Mukkada, VA; Mangray, S; Cleveland, K; Shillingford, N; Schorl, C; Brodsky, AS; Resnick, MB				Lu, Shaolei; Mukkada, Vincent A.; Mangray, Shamlal; Cleveland, Kelly; Shillingford, Nick; Schorl, Christoph; Brodsky, Alexander S.; Resnick, Murray B.			MicroRNA Profiling in Mucosal Biopsies of Eosinophilic Esophagitis Patients Pre and Post Treatment with Steroids and Relationship with mRNA Targets	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ALLERGIC AIRWAYS DISEASE; ARACHIDONATE 15-LIPOXYGENASE; EXPRESSION; CELLS; GLUCOCORTICOIDS; REVERSIBILITY; INFLAMMATION; ANTAGONISM; LEUKOCYTES	Background: The characterization of miRNAs and their target mRNAs involved in regulation of the immune process is an area of intense research and relatively little is known governing these processes in allergic inflammation. Here we present novel findings defining the miRNA and mRNA transcriptome in eosinophilic esophagitis (EoE), an increasing recognized allergic disorder. Methods: Esophageal epithelial miRNA and mRNA from five paired biopsies pre- and post-treatment with glucocorticosteroids were profiled using Taqman and Affymetrix arrays. Validation was performed on additional paired biopsies, untreated EoE specimens and normal controls. Differentially regulated miRNAs and mRNAs were generated, within which miRNA-mRNA target pairs with high predicted confidence were identified. Results: Compared to the post-glucocorticoid treated esophageal mucosa, of all the 377 miRNA sequences examined, 32 miRNAs were significantly upregulated and four downregulated in the pre-treated biopsies. MiR-214 was the most upregulated (150 fold) and miR-146b-5b, 146a, 145, 142-3p and 21 were upregulated by at least 10 fold. Out of 12 miRNAs chosen for validation by qRT-PCR, five (miR-214, 146b-5p, 146a, 142-3p and 21) were confirmed and 11 shared the same trend. When the expression of the 12 miRNAs in the EoE mucosa was compared to unrelated normal mucosa, six (miR-214, 146b-5p, 146a, 21, 203, and 489) showed similar significant changes as in the paired samples and 10 of them shared the same trend. In the same five pairs of samples used to profile miRNA, 311 mRNAs were down-regulated and 35 were upregulated in pre-treated EoE mucosa. Among them, 164 mRNAs were identified as potential targets of differentially regulated miRNAs. Further analysis revealed that immune-related genes, targeted and non-targeted by miRNAs, were among the most important genes involved in the pathogenesis of EoE. Conclusions: Our findings add to the accumulating body of data defining a regulatory role for miRNA in immune and allergic processes.	[Lu, Shaolei; Mangray, Shamlal; Cleveland, Kelly; Shillingford, Nick; Resnick, Murray B.] Brown Univ, Rhode Isl Hosp, Dept Pathol & Lab Med, Alpert Sch Med, Providence, RI 02903 USA; [Mukkada, Vincent A.] Hasbro Childrens Hosp, Dept Pediat, Providence, RI USA; [Schorl, Christoph; Brodsky, Alexander S.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Hasbro Children's Hospital; Brown University	Lu, SL (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pathol & Lab Med, Alpert Sch Med, Providence, RI 02903 USA.	mresnick@lifespan.org	Mukkada, Vincent/AAF-6995-2019; Resnick, Murray/U-2986-2019	Mukkada, Vincent/0000-0003-4225-5506; Lu, Shaolei/0000-0003-2870-5793; Shillingford, Nick/0000-0001-9636-9977	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103421]; National Center for Research Resources (NCRR) [P20RR017695]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103421] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Molecular Pathology Core of the COBRE Center for Cancer Research Development, funded by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103421. The previous segment of this project was supported by the National Center for Research Resources (NCRR) under P20RR017695. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2012, ANNU REV MED, V63, P421, DOI 10.1146/annurev-med-041610-134138; Aceves SS, 2007, J ALLERGY CLIN IMMUN, V119, P206, DOI 10.1016/j.jaci.2006.10.016; Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Chehade M, 2007, J PEDIATR GASTR NUTR, V45, P319, DOI 10.1097/MPG.0b013e31806ab384; Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Collison A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-29; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kagalwalla AF, 2012, J ALLERGY CLIN IMMUN, V129, P1387, DOI 10.1016/j.jaci.2012.03.005; Kan T, 2009, CURR OPIN PHARMACOL, V9, P727, DOI 10.1016/j.coph.2009.08.009; Li N, 2012, MOL BIOL REP, V39, P4655, DOI 10.1007/s11033-011-1257-5; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lu TX, 2012, J ALLERGY CLIN IMMUN, V129, P1064, DOI 10.1016/j.jaci.2012.01.060; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; MACMILLAN DK, 1994, J BIOL CHEM, V269, P26663; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; NADEL JA, 1991, J CLIN INVEST, V87, P1139, DOI 10.1172/JCI115110; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Persad R, 2012, J PEDIAT GASTROENTER; Pietzsch J, 2009, AMINO ACIDS, V36, P381, DOI 10.1007/s00726-008-0097-7; Resnick MB, 2006, GUT, V55, P1717, DOI 10.1136/gut.2006.095646; Sato N, 2002, ANAT REC, V267, P60, DOI 10.1002/ar.10085; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V150, P376, DOI 10.1016/0006-291X(88)90531-1; Straumann A, 2003, GASTROENTEROLOGY, V125, P1660, DOI 10.1053/j.gastro.2003.09.024; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhong H, 2011, INT J HEMATOL, V94, P224, DOI 10.1007/s12185-011-0923-7	38	40	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40676	10.1371/journal.pone.0040676	http://dx.doi.org/10.1371/journal.pone.0040676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815788	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100053
J	Roder, IV; Strack, S; Reischl, M; Dahley, O; Khan, MM; Kassel, O; Zaccolo, M; Rudolf, R				Roeder, Ira Verena; Strack, Siegfried; Reischl, Markus; Dahley, Oliver; Khan, Muzamil Majid; Kassel, Olivier; Zaccolo, Manuela; Rudolf, Ruediger			Participation of Myosin Va and Pka Type I in the Regeneration of Neuromuscular Junctions	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; PROTEIN-KINASE-A; UNCONVENTIONAL MYOSIN; DYSTROPHIC MUSCLE; SKELETAL-MUSCLE; HEAVY-CHAIN; END-PLATE; RI-ALPHA; MOUSE; EXPRESSION	Background: The unconventional motor protein, myosin Va, is crucial for the development of the mouse neuromuscular junction (NMJ) in the early postnatal phase. Furthermore, the cooperative action of protein kinase A (PKA) and myosin Va is essential to maintain the adult NMJ. We here assessed the involvement of myosin Va and PKA in NMJ recovery during muscle regeneration. Methodology/Principal Findings: To address a putative role of myosin Va and PKA in the process of muscle regeneration, we used two experimental models the dystrophic mdx mouse and Notexin-induced muscle degeneration/regeneration. We found that in both systems myosin Va and PKA type I accumulate beneath the NMJs in a fiber maturation-dependent manner. Morphologically intact NMJs were found to express stable nicotinic acetylcholine receptors and to accumulate myosin Va and PKA type I in the subsynaptic region. Subsynaptic cAMP signaling was strongly altered in dystrophic muscle, particularly in fibers with severely subverted NMJ morphology. Conclusions/Significance: Our data show a correlation between the subsynaptic accumulation of myosin Va and PKA type I on the one hand and NMJ regeneration status and morphology, AChR stability and specificity of subsynaptic cAMP handling on the other hand. This suggests an important role of myosin Va and PKA type I for the maturation of NMJs in regenerating muscle.	[Roeder, Ira Verena; Strack, Siegfried; Dahley, Oliver; Khan, Muzamil Majid; Kassel, Olivier; Rudolf, Ruediger] Karlsruhe Inst Technol, Inst Toxikol & Genet, Eggenstein Leopoldshafen, Germany; [Reischl, Markus] Karlsruhe Inst Technol, Inst Angew Informat, Eggenstein Leopoldshafen, Germany; [Zaccolo, Manuela] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Rudolf, Ruediger] Hsch Mannheim, Heidelberg, Germany; [Rudolf, Ruediger] Heidelberg Univ, Inst Med Technol, Heidelberg, Germany; [Rudolf, Ruediger] Hsch Mannheim, Inst Mol & Zellbiol, Mannheim, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Glasgow; Ruprecht Karls University Heidelberg	Roder, IV (corresponding author), Karlsruhe Inst Technol, Inst Toxikol & Genet, Eggenstein Leopoldshafen, Germany.	ruediger.rudolf@kit.edu	Khan, Muzamil Maijd/O-2444-2019; Kassel, Olivier/H-2117-2013; Rudolf, Rüdiger/A-6476-2009; Reischl, Markus/H-6970-2013; Zaccolo, Manuela/AAP-6706-2020; Majid Khan, Muzamil/P-7813-2014	Kassel, Olivier/0000-0002-8616-3091; Rudolf, Rüdiger/0000-0002-0833-1053; Reischl, Markus/0000-0002-7780-6374; Zaccolo, Manuela/0000-0002-0934-3662; Majid Khan, Muzamil/0000-0002-8188-0251	Deutsche Forschungsgemeinschaft [RU923/3-1]; Association Francaise contre les Myopathies [12056]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	RR was supported by the Deutsche Forschungsgemeinschaft (grant RU923/3-1; www.dfg.de). MZ and RR were supported by the Association Francaise contre les Myopathies (grant 12056; www.afm-telethon.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Barradeau S, 2001, P NATL ACAD SCI USA, V98, P5037, DOI 10.1073/pnas.081393598; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Choi KR, 2012, J CELL SCI, V125, P714, DOI 10.1242/jcs.092361; CLEMENTI F, 1983, EUR J CELL BIOL, V29, P274; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Fambrough D M, 1979, Prog Brain Res, V49, P325; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FUMAGALLI G, 1982, J NEUROPATH EXP NEUR, V41, P567, DOI 10.1097/00005072-198211000-00001; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Guo WXA, 1996, FEBS LETT, V398, P259; HARRIS JB, 1974, BRIT J PHARMACOL, V52, pP152; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Lanuza MA, 2002, J NEUROSCI RES, V67, P607, DOI 10.1002/jnr.10122; Li MX, 2001, NAT NEUROSCI, V4, P871, DOI 10.1038/nn0901-871; LYONS PR, 1991, J NEUROCYTOL, V20, P969, DOI 10.1007/BF01187915; Marchand S, 2002, J NEUROSCI, V22, P8891; Marchand S, 2000, J NEUROSCI, V20, P521, DOI 10.1523/JNEUROSCI.20-02-00521.2000; Valenzuela IMPY, 2011, J NEUROSCI, V31, P15586, DOI 10.1523/JNEUROSCI.4038-11.2011; Nelson PG, 2003, J NEUROCYTOL, V32, P803, DOI 10.1023/B:NEUR.0000020625.70284.a6; Pilgram GSK, 2010, MOL NEUROBIOL, V41, P1, DOI 10.1007/s12035-009-8089-5; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; RAMSAY DA, 1992, BRAIN RES, V581, P198, DOI 10.1016/0006-8993(92)90709-I; Reutenauer-Patte J, 2012, AM J PATHOL, V180, P749, DOI 10.1016/j.ajpath.2011.10.038; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Roder IV, 2009, CELL SIGNAL, V21, P819, DOI 10.1016/j.cellsig.2009.01.029; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; SCHIAFFINO S, 1986, EXP CELL RES, V163, P211, DOI 10.1016/0014-4827(86)90574-4; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; STANLEY EF, 1983, SCIENCE, V222, P67, DOI 10.1126/science.6623057; STANLEY EF, 1981, EXP NEUROL, V73, P390, DOI 10.1016/0014-4886(81)90274-0; Strack S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020524; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Xu RF, 1997, J NEUROSCI, V17, P8194; Yampolsky P, 2010, J BIOL CHEM, V285, P34589, DOI 10.1074/jbc.M110.168880	48	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40860	10.1371/journal.pone.0040860	http://dx.doi.org/10.1371/journal.pone.0040860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815846	Green Published, gold			2022-12-27	WOS:000306466100084
J	Ma, YG; Zhang, XW; Bao, HY; Mi, S; Cai, WF; Yan, HM; Wang, QQ; Wang, ZY; Yan, J; Fan, GC; Lindsey, ML; Hu, ZW				Ma, Yonggang; Zhang, Xiaowei; Bao, Huayan; Mi, Su; Cai, Wenfeng; Yan, Huimin; Wang, Qingqing; Wang, Ziyan; Yan, Jun; Fan, Guochang; Lindsey, Merry L.; Hu, Zhuowei			Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; PULMONARY INFLAMMATION; INDUCED CARDIOTOXICITY; IMMUNE MICROENVIRONMENT; CARDIAC DYSFUNCTION; OXIDATIVE STRESS; INNATE IMMUNITY; HEART-FAILURE; KAPPA-B; FIBROSIS	Recent evidence indicates that toll-like receptor (TLR) 2 and 4 are involved in the pathogenesis of dilated cardiomyopathy (DCM), but the exact mechanisms of their actions have not been elucidated. We explored the therapeutic potential of blocking TLRs in mice with established cardiomyopathy. Cardiomyopathy was generated by a single intraperitoneal injection of doxorubicin (10 mg/kg). Two weeks later, the mice were treated with TLR2 or TLR4 neutralizing antibody. Blocking TLR2, but not TLR4, activity not only reduced mortality, but also attenuated doxorubicin-induced cardiac dysfunction by 20% and inhibited myocardial fibrosis. To determine the differential effects of blocking TLR2 and TLR4 in chronic cardiomyopathy, mice were injected with doxorubicin (3.5 mg/kg) once a week for 8 weeks, followed by treatment with TLR2 or TLR4 neutralizing antibody for 40 days. Blocking TLR2 activity blunted cardiac dysfunction by 13% and inhibited cardiac fibrosis, which was associated with a significant suppression of myocardial inflammation. The underlying mechanism involved interrupting the interaction of TLR2 with its endogenous ligands, resulting in attenuation of inflammation and fibrosis. In contrast, blocking TLR4 exacerbated cardiac dysfunction and fibrosis by amplifying inflammation and suppressing autophagy. Our studies demonstrate that TLR2 and TLR4 play distinct roles in the progression of doxorubicin-induced DCM. TLR4 activity is crucial for the resolution of inflammation and cardiac fibrosis, while blocking TLR2 activity has therapeutic potential for the treatment of DCM.	[Ma, Yonggang; Zhang, Xiaowei; Bao, Huayan; Mi, Su; Cai, Wenfeng; Yan, Huimin; Wang, Qingqing; Wang, Ziyan; Yan, Jun; Hu, Zhuowei] Chinese Acad Med Sci, Mol Immunol & Pharmacol Grp, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Ma, Yonggang; Zhang, Xiaowei; Bao, Huayan; Mi, Su; Cai, Wenfeng; Yan, Huimin; Wang, Qingqing; Wang, Ziyan; Yan, Jun; Hu, Zhuowei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Yonggang; Lindsey, Merry L.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio Cardiovasc Prote Ctr, San Antonio, TX 78229 USA; [Ma, Yonggang; Lindsey, Merry L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Geriatr Gerontol & Palliat Med, San Antonio, TX 78229 USA; [Fan, Guochang] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45221 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University System of Ohio; University of Cincinnati	Ma, YG (corresponding author), Chinese Acad Med Sci, Mol Immunol & Pharmacol Grp, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China.	huzhuowei@imm.ac.cn	Wang, Ziyan/HII-8458-2022; Lindsey, Merry L/B-2650-2012; Fan, Guo-Chang/E-1153-2012	Lindsey, Merry L/0000-0002-4090-0391; Fan, Guo-Chang/0000-0002-0439-8277	National Heart Lung and Blood Institute [HHSN268201000036C (N01-HV-00244), R01 HL-075360]; National Major Basic Research Program of China [2006CB503808]; State Key Program of National Natural Science of China [81030056]; Creation of major new drugs [2009ZX09301-003-13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075360] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Major Basic Research Program of China(National Basic Research Program of China); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Creation of major new drugs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge funding from National Heart Lung and Blood Institute HHSN268201000036C (N01-HV-00244) for the San Antonio Cardiovascular Proteomics Center and R01 HL-075360 (to MLL); and the National Major Basic Research Program of China [2006CB503808], the State Key Program of National Natural Science of China [81030056], and Creation of major new drugs [2009ZX09301-003-13] (to ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Birks EJ, 2004, J HEART LUNG TRANSPL, V23, P228, DOI 10.1016/S1053-2498(03)00106-2; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Bruynzeel AME, 2007, BRIT J CANCER, V96, P937, DOI 10.1038/sj.bjc.6603640; Chong AJ, 2004, J THORAC CARDIOV SUR, V128, P170, DOI 10.1016/j.jtcvs.2003.11.036; Delgado RM, 2004, CIRCULATION, V109, P1428, DOI 10.1161/01.CIR.0000121354.34067.48; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Fan GC, 2008, CIRC RES, V103, P1270, DOI 10.1161/CIRCRESAHA.108.182832; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Kaczmarek A, 2012, J PATHOL, V226, P598, DOI 10.1002/path.3009; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Klein G, 2005, CIRC RES, V96, P748, DOI 10.1161/01.RES.0000161999.86198.1e; Knuefermann P, 2002, CHEST, V121, P1329, DOI 10.1378/chest.121.4.1329; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Liu YY, 2008, J IMMUNOL, V180, P7349, DOI 10.4049/jimmunol.180.11.7349; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Olson LE, 2003, CANCER RES, V63, P6602; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Ren J, 2006, FRONT BIOSCI-LANDMRK, V11, P15, DOI 10.2741/1776; Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sakata Y, 2007, AM J PHYSIOL-HEART C, V292, pH503, DOI 10.1152/ajpheart.00642.2006; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Seeland U, 2009, EUR J CLIN INVEST, V39, P851, DOI 10.1111/j.1365-2362.2009.02183.x; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Turakhia S, 2007, AM J PHYSIOL-HEART C, V293, pH3111, DOI 10.1152/ajpheart.00328.2007; Vallejo JG, 2011, CLIN SCI, V121, P1, DOI 10.1042/CS20100539; Wexler R, 2009, AM FAM PHYSICIAN, V79, P778; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019; Yang HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006520; Yang HZ, 2009, J IMMUNOL, V182, P692, DOI 10.4049/jimmunol.182.1.692; Yi XM, 2006, AM J PHYSIOL-HEART C, V290, pH1098, DOI 10.1152/ajpheart.00832.2005	39	75	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40763	10.1371/journal.pone.0040763	http://dx.doi.org/10.1371/journal.pone.0040763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808256	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700051
J	Son, EJ; Wu, L; Yoon, H; Kim, S; Choi, JY; Bok, J				Son, Eun Jin; Wu, Ling; Yoon, Heejei; Kim, Sunhee; Choi, Jae Young; Bok, Jinwoong			Developmental Gene Expression Profiling along the Tonotopic Axis of the Mouse Cochlea	PLOS ONE			English	Article							OUTER HAIR-CELLS; MESSENGER-RNA EXPRESSION; INNER-EAR; MAMMALIAN COCHLEA; BASILAR-MEMBRANE; RECEPTOR; MATURATION; GRADIENTS; CHANNEL; PATTERN	The mammalian cochlear duct is tonotopically organized such that the basal cochlea is tuned to high frequency sounds and the apical cochlea to low frequency sounds. In an effort to understand how this tonotopic organization is established, we searched for genes that are differentially expressed along the tonotopic axis during neonatal development. Cochlear tissues dissected from P0 and P8 mice were divided into three equal pieces, representing the base, middle and apex, and gene expression profiles were determined using the microarray technique. The gene expression profiles were grouped according to changes in expression levels along the tonotopic axis as well as changes during neonatal development. The classified groups were further analyzed by functional annotation clustering analysis to determine whether genes associated with specific biological function or processes are particularly enriched in each group. These analyses identified several candidate genes that may be involved in cochlear development and acquisition of tonotopy. We examined the expression domains for a few candidate genes in the developing mouse cochlea. Tnc (tenacin C) and Nov (nephroblastoma overexpressed gene) are expressed in the basilar membrane, with increased expression toward the apex, which may contribute to graded changes in the structure of the basilar membrane along the tonotopic axis. In addition, Fst (Follistatin), an antagonist of TGF-beta/BMP signaling, is expressed in the lesser epithelial ridge and at gradually higher levels towards the apex. The graded expression pattern of Fst is established at the time of cochlear specification and maintained throughout embryonic and postnatal development, suggesting its possible role in the organization of tonotopy. Our data will provide a good resource for investigating the developmental mechanisms of the mammalian cochlea including the acquisition of tonotopy.	[Son, Eun Jin; Wu, Ling; Choi, Jae Young; Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Wu, Ling; Yoon, Heejei; Kim, Sunhee; Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Wu, Ling; Choi, Jae Young; Bok, Jinwoong] Yonsei Univ, Coll Med, Project Med Sci BK21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Son, EJ (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	ejson@yuhs.ac; bokj@yuhs.ac	Bok, Jinwoong/M-2834-2019	Bok, Jinwoong/0000-0003-1958-1872; choi, jae young/0000-0001-9493-3458	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0023589, 2010-0009623]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0023589 to Dr. Son, 2010-0009623 to Dr. Bok). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amma LL, 2003, MOL CELL NEUROSCI, V23, P460, DOI 10.1016/S1044-7431(03)00075-7; Asai Y, 2010, JARO-J ASSOC RES OTO, V11, P27, DOI 10.1007/s10162-009-0193-8; Bok J, 2010, GENES GENOM, V32, P1, DOI 10.1007/s13258-010-0001-1; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Davis RL, 2003, NEUROSCIENTIST, V9, P311, DOI 10.1177/1073858403251986; Davis RL, 2011, HEARING RES, V276, P34, DOI 10.1016/j.heares.2011.01.014; Etournay R, 2010, DEVELOPMENT, V137, P1373, DOI 10.1242/dev.045138; Frucht CS, 2011, JARO-J ASSOC RES OTO, V12, P423, DOI 10.1007/s10162-011-0259-2; Goodyear R, 1997, J NEUROSCI, V17, P6289; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; Hartman BH, 2009, JARO-J ASSOC RES OTO, V10, P321, DOI 10.1007/s10162-009-0162-2; Helms AW, 1998, DEVELOPMENT, V125, P919; Hibino H, 1997, J NEUROSCI, V17, P4711; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang LC, 2006, HISTOCHEM CELL BIOL, V125, P681, DOI 10.1007/s00418-005-0119-4; Jagger Daniel J, 2012, Methods Mol Biol, V839, P239, DOI 10.1007/978-1-61779-510-7_19; Jin ZH, 2003, TOHOKU J EXP MED, V200, P137, DOI 10.1620/tjem.200.137; Kowalik L, 2011, DEV BIOL, V354, P221, DOI 10.1016/j.ydbio.2011.03.031; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; McCallum L, 2009, BLOOD REV, V23, P79, DOI 10.1016/j.blre.2008.07.002; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Morley BJ, 2002, DEV BRAIN RES, V139, P87, DOI 10.1016/S0165-3806(02)00514-X; Morsli H, 1998, J NEUROSCI, V18, P3327; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Rau A, 1999, J COMP NEUROL, V405, P271; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Richter CP, 2007, BIOPHYS J, V93, P2265, DOI 10.1529/biophysj.106.094474; Rio C, 2002, J COMP NEUROL, V442, P156, DOI 10.1002/cne.10085; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; Rozen S, 2000, Methods Mol Biol, V132, P365; SADANAGA M, 1995, HEARING RES, V89, P155, DOI 10.1016/0378-5955(95)00133-X; Sakai Y, 2011, J NEUROSCI RES, V89, P1747, DOI 10.1002/jnr.22713; Sato T, 2009, ACTA OTO-LARYNGOL, V129, P12, DOI 10.1080/00016480902926464; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Whitlon DS, 1999, J COMP NEUROL, V406, P361, DOI 10.1002/(SICI)1096-9861(19990412)406:3<361::AID-CNE5>3.0.CO;2-O	43	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40735	10.1371/journal.pone.0040735	http://dx.doi.org/10.1371/journal.pone.0040735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808246	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400053
J	Leung, C; Shaheen, F; Bernatchez, P; Hackett, TL				Leung, Cleo; Shaheen, Furquan; Bernatchez, Pascal; Hackett, Tillie-Louise			Expression of Myoferlin in Human Airway Epithelium and Its Role in Cell Adhesion and Zonula Occludens-1 Expression	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; TIGHT JUNCTION PROTEIN; DYSFERLIN EXPRESSION; FER-1-LIKE PROTEIN; PLASMA-MEMBRANE; SKELETAL-MUSCLE; SMALL-INTESTINE; HUMAN PLACENTA; GENE; TRANSCRIPTION	Background: Normal airway epithelial barrier function is maintained by cell-cell contacts which require the translocation of adhesion proteins at the cell surface, through membrane vesicle trafficking and fusion events. Myoferlin and dysferlin, members of the multiple-C2-domain Ferlin superfamily, have been implicated in membrane fusion processes through the induction of membrane curvature. The objectives of this study were to examine the expression of dysferlin and myoferlin within the human airway and determine the roles of these proteins in airway epithelial homeostasis. Methods: The expression of dysferlin and myoferlin were evaluated in normal human airway sections by immunohistochemistry, and primary human airway epithelial cells and fibroblasts by immuno blot. Localization of dysferlin and myoferlin in epithelial cells were determined using confocal microscopy. Functional outcomes analyzed included cell adhesion, protein expression, and cell detachment following dysferlin and myoferlin siRNA knock-down, using the human bronchial epithelial cell line, 16HBE. Results: Primary human airway epithelial cells express both dysferlin and myoferlin whereas fibroblasts isolated from bronchi and the parenchyma only express myoferlin. Expression of dysferlin and myoferlin was further localized within the Golgi, cell cytoplasm and plasma membrane of 16HBE cells using confocal micrscopy. Treatment of 16HBE cells with myoferlin siRNA, but not dysferlin siRNA, resulted in a rounded cell morphology and loss of cell adhesion. This cell shedding following myoferlin knockdown was associated with decreased expression of tight junction molecule, zonula occludens-1 (ZO-1) and increased number of cells positive for apoptotic markers Annexin V and propidium iodide. Cell shedding was not associated with release of the innate inflammatory cytokines IL-6 and IL-8. Conclusions/Significance: This study demonstrates the heterogeneous expression of myoferlin within epithelial cells and fibroblasts of the respiratory airway. The effect of myoferlin on the expression of ZO-1 in airway epithelial cells indicates its role in membrane fusion events that regulate cell detachment and apoptosis within the airway epithelium.	[Leung, Cleo; Shaheen, Furquan; Bernatchez, Pascal; Hackett, Tillie-Louise] St Pauls Hosp, James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; [Leung, Cleo; Bernatchez, Pascal; Hackett, Tillie-Louise] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Leung, C (corresponding author), St Pauls Hosp, James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada.	Tillie.Hackett@hli.ubc.ca			Canadian Lung Association; Klosterfrau Foundation; Canadian Institutes for Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Canadian Foundation for Innovation; CIHR-Institute of community	Canadian Lung Association; Klosterfrau Foundation; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Foundation for Innovation(Canada Foundation for Innovation); CIHR-Institute of community(Canadian Institutes of Health Research (CIHR))	This work is supported by grants from Canadian Lung Association and Klosterfrau Foundation (for TLH), Canadian Institutes for Health Research (CIHR), Michael Smith Foundation for Health Research (MSFHR) and Canadian Foundation for Innovation (for PB). CL is a recipient of a CIHR-Institute of community support award. TLH is a recipient of a CIHR/Canadian Lung Association/GSK, IMPACT strategic training, Michael Smith Foundation for Health Research (MSFHR) and Parker B. Francis Foundation salary awards. PB is a recipient of CIHR and MSFHR salary awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1989, J CELL BIOL, V109, P1047, DOI 10.1083/jcb.109.3.1047; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Arakawa Y, 2004, BIOCHEM BIOPH RES CO, V322, P297, DOI 10.1016/j.bbrc.2004.04.208; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; BARON DA, 1990, J ELECTRON MICR TECH, V16, P15, DOI 10.1002/jemt.1060160104; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Britton S, 2000, GENOMICS, V68, P313, DOI 10.1006/geno.2000.6290; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Fosch H, 2008, CURR OPIN CELL BIOL, V20, P208, DOI 10.1016/j.ceb.2008.01.003; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hochmeister S, 2006, J NEUROPATH EXP NEUR, V65, P855, DOI 10.1097/01.jnen.0000235119.52311.16; Izzedine H, 2006, AM J KIDNEY DIS, V48, P143, DOI 10.1053/j.ajkd.2006.04.074; JINGUJI Y, 1992, CELL STRUCT FUNCT, V17, P27, DOI 10.1247/csf.17.27; Keller P, 1997, J CELL SCI, V110, P3001; Kuru Satoshi, 2004, Rinsho Shinkeigaku, V44, P375; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Patel P, 2008, J MOL BIOL, V379, P981, DOI 10.1016/j.jmb.2008.04.046; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; Posey AD, 2011, J BIOL CHEM, V286, P7379, DOI 10.1074/jbc.M110.157222; Robinson JM, 2009, BIOL REPROD, V81, P33, DOI 10.1095/biolreprod.108.074591; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Selcen D, 2001, NEUROLOGY, V56, P1472, DOI 10.1212/WNL.56.11.1472; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Vandre DD, 2007, BIOL REPROD, V77, P533, DOI 10.1095/biolreprod.107.062190; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247	54	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40478	10.1371/journal.pone.0040478	http://dx.doi.org/10.1371/journal.pone.0040478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808170	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500046
J	Akesson, S; Klaassen, R; Holmgren, J; Fox, JW; Hedenstrom, A				Akesson, Susanne; Klaassen, Raymond; Holmgren, Jan; Fox, James W.; Hedenstrom, Anders			Migration Routes and Strategies in a Highly Aerial Migrant, the Common Swift Apus apus, Revealed by Light-Level Geolocators	PLOS ONE			English	Article							SEASONAL DIFFERENCES; FLIGHT; PERFORMANCE; STOPOVER; BEHAVIOR; TRACKING; BIRDS; TIME	The tracking of small avian migrants has only recently become possible by the use of small light-level geolocators, allowing the reconstruction of whole migration routes, as well as timing and speed of migration and identification of wintering areas. Such information is crucial for evaluating theories about migration strategies and pinpointing critical areas for migrants of potential conservation value. Here we report data about migration in the common swift, a highly aerial and long-distance migrating species for which only limited information based on ringing recoveries about migration routes and wintering areas is available. Six individuals were successfully tracked throughout a complete migration cycle from Sweden to Africa and back. The autumn migration followed a similar route in all individuals, with an initial southward movement through Europe followed by a more southwest-bound course through Western Sahara to Sub-Saharan stopovers, before a southeastward approach to the final wintering areas in the Congo basin. After approximately six months at wintering sites, which shifted in three of the individuals, spring migration commenced in late April towards a restricted stopover area in West Africa in all but one individual that migrated directly towards north from the wintering area. The first part of spring migration involved a crossing of the Gulf of Guinea in those individuals that visited West Africa. Spring migration was generally wind assisted within Africa, while through Europe variable or head winds were encountered. The average detour at about 50% could be explained by the existence of key feeding sites and wind patterns. The common swift adopts a mixed fly-and-forage strategy, facilitated by its favourable aerodynamic design allowing for efficient use of fuel. This strategy allowed swifts to reach average migration speeds well above 300 km/day in spring, which is higher than possible for similar sized passerines. This study demonstrates that new technology may drastically change our views about migration routes and strategies in small birds, as well as showing the unexpected use of very limited geographical areas during migration that may have important consequences for conservation strategies for migrants.	[Akesson, Susanne; Klaassen, Raymond; Holmgren, Jan; Hedenstrom, Anders] Lund Univ, Dept Biol, Lund, Sweden; [Fox, James W.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Lund University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Akesson, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	anders.hedenstrom@biol.lu.se	Hedenström, Anders/F-5377-2010; Akesson, Susanne/F-3175-2015; Klaassen, Raymond/K-3027-2013	Hedenström, Anders/0000-0002-1757-0945; Akesson, Susanne/0000-0001-9039-2180; 	Swedish Research Council [349-2007-8690, 621-2007-5930]; Lund University; Carl Tryggers Foundation; Natural Environment Research Council [bas010013] Funding Source: researchfish; NERC [bas010013] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University; Carl Tryggers Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was financed by a Linnaeus grant (349-2007-8690) to the Centre for Animal Movement Research (CAnMove) from the Swedish Research Council and Lund University, and research grants from the Swedish Research Council (621-2007-5930) and the Carl Tryggers Foundation to S. Akesson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Backman J, 2001, P ROY SOC B-BIOL SCI, V268, P1081, DOI 10.1098/rspb.2001.1622; BAS, 2010, GEOL MAN V8; CURRY PJ, 1979, IBIS, V121, P20, DOI 10.1111/j.1474-919X.1979.tb05012.x; De Roo A., 1966, Gerfaut, V56, P113; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Elgood, 1982, BIRDS NIGERIA; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; GATTER W, 1987, Vogelwarte, V34, P80; Gatter W., 1997, BIRDS LIBERIA; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; GLADWIN T. W., 1964, BRIT BIRDS, V57, P344; Grimes L, 1987, BIRDS GHANA; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hall-Karlsson S., 2008, SWEDISH BIRD RINGING, V2; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hedenstrom A, 1998, J AVIAN BIOL, V29, P424, DOI 10.2307/3677161; Hedenstrom A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000362; Henningsson P, 2011, J R SOC INTERFACE, V8, P807, DOI 10.1098/rsif.2010.0533; Henningsson P, 2011, J EXP BIOL, V214, P382, DOI 10.1242/jeb.050609; Henningsson P, 2009, P ROY SOC B-BIOL SCI, V276, P2395, DOI 10.1098/rspb.2009.0195; Holmgren J, 2004, IBIS, V146, P404, DOI 10.1111/j.1474-919X.2004.00274.x; Kemp MU, 2010, J AVIAN BIOL, V41, P672, DOI 10.1111/j.1600-048X.2010.05053.x; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Lack D., 1956, SWIFTS TOWER; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Lockley RM, 1970, OSTRICH S, V8, P265; Magnusson M., 1948, Var Fagelvarld, V7, P129; Moreau R., 1972, PALAEARCTIC AFRICAN; PERRINS C, 1971, BIRD STUDY, V18, P61, DOI 10.1080/00063657109476297; Perrins C, 2005, MIGRATION ATLAS MOVE, P443; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; Putz K, 2002, CONDOR, V104, P528, DOI 10.1650/0010-5422(2002)104[0528:SATVIT]2.0.CO;2; RAPPOLE JH, 1976, OECOLOGIA, V26, P193, DOI 10.1007/BF00345289; SERLE W, 1950, IBIS, V92, P602, DOI 10.1111/j.1474-919X.1950.tb01768.x; Speek BJ, 1984, THIEMES VOGELTREKATL; Strandberg R, 2007, BEHAV ECOL SOCIOBIOL, V61, P1865, DOI 10.1007/s00265-007-0426-y; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; WEITNAUER E, 1975, Ornithologische Beobachter, V72, P87; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	49	111	125	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41195	10.1371/journal.pone.0041195	http://dx.doi.org/10.1371/journal.pone.0041195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815968	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000306548900096
J	Al-Aqeedi, R; Asaad, N; Al-Qahtani, A; Singh, R; Al Binali, HA; Al Mulla, AW; Al Suwaidi, J				Al-Aqeedi, Rafid; Asaad, Nidal; Al-Qahtani, Awad; Singh, Rajvir; Al Binali, Hajar A.; Al Mulla, Abdul Wahid; Al Suwaidi, Jassim			Acute Coronary Syndrome in Patients with Prior Coronary Artery Bypass Surgery: Observations from a 20-Year Registry in a Middle-Eastern Country	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; GRAFT-SURGERY; THROMBOLYTIC THERAPY; GLOBAL REGISTRY; FOLLOW-UP; OUTCOMES; TRIAL; MORTALITY; SURVIVAL	Objectives: Clinical characteristics and trends in the outcome of acute coronary syndrome (ACS) in patients with prior coronary artery bypass graft surgery (CABG) are unclear. The aim of this study was to evaluate clinical characteristics, in-hospital treatment, and outcomes in patients presented with ACS with or without a history of prior CABG over 2 decades. Methods: Data were derived from hospital-based study for collected data from 1991 through 2010 of patients hospitalized with ACS in Doha, Qatar. Data were analyzed according to their history of prior CABG. Baseline clinical characteristics, in-hospital treatment, and outcome were compared. Results: A total 16,750 consecutive patients with ACS were studied, of which 693 (4.1%) had prior CABG. Patients with prior CABG were older (mean 60.5 +/- 11 vs. 53 +/- 12 years; P = 0.001), more likely to be females and have more cardiovascular risk factors than the non-CABG group. Prior CABG patients had larger infarct size, were less likely to receive reperfusion therapy, early invasive therapy and more likely to receive evidence-based therapies when compared to non-CABG patients. Inhospital mortality and stroke rates were comparable between the 2 groups. Over 2 decades, there was reduction in the in-hospital mortality rates and stroke rates in both groups (CABG, death; 13.2% to 4%, stroke; 1.9% to 0.0%, non-CABG, death; 10% to 3.2%, stroke 1.0% to 0.1%; all, p = 0.001). Conclusion: Significant reduction in-hospital morbidity and mortality among ACS patients with prior CABG over a 20-year period.	[Al-Aqeedi, Rafid; Asaad, Nidal; Al-Qahtani, Awad; Singh, Rajvir; Al Binali, Hajar A.; Al Mulla, Abdul Wahid; Al Suwaidi, Jassim] Heart Hosp Hamad Med Corp HMC, Dept Cardiol & Cardiovasc Surg, Doha, Qatar	Hamad Medical Corporation	Al-Aqeedi, R (corresponding author), Heart Hosp Hamad Med Corp HMC, Dept Cardiol & Cardiovasc Surg, Doha, Qatar.	Jha01@hmc.org.qa		al suwaidi, MB, ChB, FACC, FESC, FSCAI, jassim/0000-0002-5299-9106	Medical Research Center, Hamad Medical Corporation	Medical Research Center, Hamad Medical Corporation	This study was supported by the Medical Research Center, Hamad Medical Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2004, INT J CARDIOL, V96, P217, DOI 10.1016/j.ijcard.2003.06.018; Al Suwaidi J, 2001, AM HEART J, V142, P452, DOI 10.1067/mhj.2001.117319; Al-Aqeedi R, 2011, INTERACT CARDIOV TH, V13, P611, DOI 10.1510/icvts.2011.274571; Alanbaei M, 2011, OPEN CARDIOVASC MED, V5, P196, DOI 10.2174/1874192401105010196; Berry C, 2009, EUR HEART J, V30, P1450, DOI 10.1093/eurheartj/ehp102; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Brilakis ES, 2008, AM J CARDIOL, V102, P552, DOI 10.1016/j.amjcard.2008.04.024; Califf RM, 2000, CIRCULATION, V101, P2231, DOI 10.1161/01.CIR.101.19.2231; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; COLLINS R, 1995, LANCET, V345, P669; DAVIS KB, 1992, CIRCULATION, V85, P2100, DOI 10.1161/01.CIR.85.6.2100; DEVITA C, 1994, LANCET, V343, P1115; Elbarasi E, 2010, AM HEART J, V159, P40, DOI 10.1016/j.ahj.2009.09.019; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Goldberg RJ, 2004, AM J CARDIOL, V93, P288, DOI 10.1016/j.amjcard.2003.10.006; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; GRINES CL, 1990, AM J CARDIOL, V65, P1292, DOI 10.1016/0002-9149(90)91315-W; Hadi HAR, 2005, INT J CARDIOL, V102, P249, DOI 10.1016/j.ijcard.2004.05.024; Kim MS, 2010, AM HEART J, V160, P951, DOI 10.1016/j.ahj.2010.07.025; Kleiman NS, 1996, AM J CARDIOL, V77, P227, DOI 10.1016/S0002-9149(97)89383-6; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Kugelmass Aaron D, 2006, Crit Pathw Cardiol, V5, P167, DOI 10.1097/01.hpc.0000236218.07432.a6; Labinaz M, 2002, CIRCULATION, V105, P322, DOI 10.1161/hc0302.102578; Labinaz M, 2001, AM HEART J, V141, P469, DOI 10.1067/mhj.2001.112779; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Mathew V, 2002, AM HEART J, V144, P463, DOI 10.1067/mhj.2002.124349; MAYNARD C, 1991, CORONARY ARTERY DIS, V2, P443; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Nguyen TT, 2003, AM J CARDIOL, V91, P1250, DOI 10.1016/S0002-9149(03)00277-7; Panduranga P, 2010, ANGIOLOGY, V61, P744, DOI 10.1177/0003319710369794; PEDERSEN TR, 1994, LANCET, V344, P1383; Peterson LR, 1999, AM J CARDIOL, V84, P1287, DOI 10.1016/S0002-9149(99)00559-7; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Servoss SJ, 2004, AM J CARDIOL, V93, P843, DOI 10.1016/j.amjcard.2003.12.021; Stone GW, 2000, J AM COLL CARDIOL, V35, P605, DOI 10.1016/S0735-1097(99)00605-1; Teixeira R, 2010, REV ESP CARDIOL, V63, P554, DOI 10.1016/S0300-8932(10)70117-2; The Society for Cardiothoracic Surgery in Great Britain &amp Ireland, 2008, 6 NAT AD CARD SURG D; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; WATERS DD, 1986, AM J CARDIOL, V58, P465, DOI 10.1016/0002-9149(86)90016-0; Welsh RC, 2010, JACC-CARDIOVASC INTE, V3, P343, DOI 10.1016/j.jcin.2009.12.008; WISEMAN A, 1988, J AM COLL CARDIOL, V12, P873, DOI 10.1016/0735-1097(88)90447-0; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	44	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40571	10.1371/journal.pone.0040571	http://dx.doi.org/10.1371/journal.pone.0040571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815766	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900032
J	Cong, Q; Kinch, LN; Kim, BH; Grishin, NV				Cong, Qian; Kinch, Lisa N.; Kim, Bong-Hyun; Grishin, Nick V.			Predictive Sequence Analysis of the Candidatus Liberibacter asiaticus Proteome	PLOS ONE			English	Article							CITRUS HUANGLONGBING BACTERIUM; SECONDARY STRUCTURE; MEMBRANE-PROTEINS; SIGNAL PEPTIDES; TOPOLOGY; SECRETION; DATABASE; ANNOTATION; VIRULENCE; PATHOGEN	Candidatus Liberibacter asiaticus (Ca. L. asiaticus) is a parasitic Gram-negative bacterium that is closely associated with Huanglongbing (HLB), a worldwide citrus disease. Given the difficulty in culturing the bacterium and thus in its experimental characterization, computational analyses of the whole Ca. L. asiaticus proteome can provide much needed insights into the mechanisms of the disease and guide the development of treatment strategies. In this study, we applied state-of-the-art sequence analysis tools to every Ca. L. asiaticus protein. Our results are available as a public website at http://prodata.swmed.edu/liberibacter_asiaticus/. In particular, we manually curated the results to predict the subcellular localization, spatial structure and function of all Ca. L. asiaticus proteins (http://prodata.swmed.edu/liberibacter_asiaticus/curated/). This extensive information should facilitate the study of Ca. L. asiaticus proteome function and its relationship to disease. Pilot studies based on the information from our website have revealed several potential virulence factors, discussed herein.	[Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Cong, Qian; Kim, Bong-Hyun; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cong, Q (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	grishin@chop.swmed.edu		Cong, Qian/0000-0002-8909-0414; Kinch, Lisa/0000-0003-3041-2615	Citrus Research and Development Foundation; National Institutes of Health [GM094575]; Welch Foundation [I-1505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	Citrus Research and Development Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported by the Citrus Research and Development Foundation and in part by the National Institutes of Health (GM094575 to NVG) and the Welch Foundation (I-1505 to NVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2011, BIOORG MED CHEM LETT, V21, P4183, DOI 10.1016/j.bmcl.2011.05.086; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; BROOMESMITH JK, 1994, MOL MEMBR BIOL, V11, P3, DOI 10.3109/09687689409161023; Cevallos-Cevallos JM, 2009, ELECTROPHORESIS, V30, P1240, DOI 10.1002/elps.200800594; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Collins BS, 2011, DISCOV MED, V11, P7; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P198, DOI 10.1159/000089648; D'Auria G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-14; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Ding F, 2008, PLANT CELL REP, V27, P241, DOI 10.1007/s00299-007-0467-8; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Erdin S, 2011, CURR OPIN STRUC BIOL, V21, P180, DOI 10.1016/j.sbi.2011.02.001; Fan J, 2011, PHYSL PLANT; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Frickey T, 2007, BIOINFORMATICS, V23, P1170, DOI 10.1093/bioinformatics/btm079; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; GOWER JC, 1969, ROY STAT SOC C-APP, V18, P54; Guan K L, 1993, Semin Cell Biol, V4, P389, DOI 10.1006/scel.1993.1046; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hartung JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023289; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kado CI, 2009, MOL PLANT PATHOL, V10, P143, DOI 10.1111/j.1364-3703.2008.00518.x; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Koh EJ, 2011, PROTOPLASMA; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lederberg J, 1997, EMERG INFECT DIS, V3, P417, DOI 10.3201/eid0304.970402; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin H, 2010, J MICROBIOL METH, V81, P17, DOI 10.1016/j.mimet.2010.01.014; Lin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Salavati R, 2010, TRENDS PARASITOL, V26, P225, DOI 10.1016/j.pt.2010.02.001; Sankaran S, 2010, TALANTA, V83, P574, DOI 10.1016/j.talanta.2010.10.008; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Sleator RD, 2010, ARCH MICROBIOL, V192, P151, DOI 10.1007/s00203-010-0549-9; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Tomich M, 2006, J BACTERIOL, V188, P6899, DOI 10.1128/JB.00690-06; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Vahling CM, 2010, J BACTERIOL, V192, P834, DOI 10.1128/JB.01279-09; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	86	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41071	10.1371/journal.pone.0041071	http://dx.doi.org/10.1371/journal.pone.0041071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815919	gold, Green Submitted, Green Published			2022-12-27	WOS:000306548900071
J	Hanson, JL; Hurley, LM				Hanson, Jessica L.; Hurley, Laura M.			Female Presence and Estrous State Influence Mouse Ultrasonic Courtship Vocalizations	PLOS ONE			English	Article							MICE MUS-MUSCULUS; HORMONAL-REGULATION; SEXUAL-BEHAVIOR; MATE CHOICE; ADULT MALE; SONG; FREQUENCY; RESPONSES; PREFERENCE; RATS	The laboratory mouse is an emerging model for context-dependent vocal signaling and reception. Mouse ultrasonic vocalizations are robustly produced in social contexts. In adults, male vocalization during courtship has become a model of interest for signal-receiver interactions. These vocalizations can be grouped into syllable types that are consistently produced by different subspecies and strains of mice. Vocalizations are unique to individuals, vary across development, and depend on social housing conditions. The behavioral significance of different syllable types, including the contexts in which different vocalizations are made and the responses listeners have to different types of vocalizations, is not well understood. We examined the effect of female presence and estrous state on male vocalizations by exploring the use of syllable types and the parameters of syllables during courtship. We also explored correlations between vocalizations and other behaviors. These experimental manipulations produced four main findings: 1) vocalizations varied among males, 2) the production of USVs and an increase in the use of a specific syllable type were temporally related to mounting behavior, 3) the frequency (kHz), bandwidth, and duration of syllables produced by males were influenced by the estrous phase of female partners, and 4) syllable types changed when females were removed. These findings show that mouse ultrasonic courtship vocalizations are sensitive to changes in female phase and presence, further demonstrating the context-sensitivity of these calls.	[Hanson, Jessica L.; Hurley, Laura M.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Hanson, JL (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jeshanso@indiana.edu		Hurley, Laura/0000-0001-6075-2683	National Science Foundation; National Institute of Deafness and Other Communication Disorders [DC-008963]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008963] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a National Science Foundation graduate research fellowship and in part by a National Institute of Deafness and Other Communication Disorders grant (DC-008963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2008, ETHOLOGY, V114, P662, DOI 10.1111/j.1439-0310.2008.01518.x; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Barthelemy M, 2004, NATURWISSENSCHAFTEN, V91, P135, DOI 10.1007/s00114-004-0501-4; BEAN NJ, 1986, HORM BEHAV, V20, P390, DOI 10.1016/0018-506X(86)90002-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Bialy M, 2000, BEHAV NEUROSCI, V114, P983, DOI 10.1037//0735-7044.114.5.983; Blaustein JD, 2008, ANNU REV PSYCHOL, V59, P93, DOI 10.1146/annurev.psych.59.103006.093556; Bosch J, 2001, NATURWISSENSCHAFTEN, V88, P434, DOI 10.1007/s001140100261; BOWERS JM, 1967, SCIENCE, V158, P1208, DOI 10.1126/science.158.3805.1208; BYATT S, 1986, HORM BEHAV, V20, P60, DOI 10.1016/0018-506X(86)90029-2; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Choi H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-104; D'Amato FR, 2001, BEHAV NEUROSCI, V115, P834, DOI 10.1037//0735-7044.115.4.834; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; GEYER LA, 1978, J COMP PHYSIOL PSYCH, V92, P447, DOI 10.1037/h0077487; Goense JBM, 2005, J NEUROBIOL, V65, P22, DOI 10.1002/neu.20172; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hoffmann F, 2012, J ETHOL, P1; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; Holmstrom L, 2007, J NEUROPHYSIOL, V98, P3461, DOI 10.1152/jn.00638.2007; Holmstrom LA, 2010, J NEUROSCI, V30, P802, DOI 10.1523/JNEUROSCI.1964-09.2010; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hurley LM, 2005, J COMP PHYSIOL A, V191, P535, DOI 10.1007/s00359-005-0623-y; Johansen JA, 2008, PHYSIOL BEHAV, V95, P425, DOI 10.1016/j.physbeh.2008.07.004; Kalcounis-Rueppell MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009705; Leong KM, 2003, HORM BEHAV, V43, P433, DOI 10.1016/S0018-506X(03)00025-4; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; McGinnis MY, 2003, PHYSIOL BEHAV, V80, P81, DOI 10.1016/S0031-9384(03)00227-0; Meenderink SWF, 2010, BIOL LETTERS, V6, P278, DOI 10.1098/rsbl.2009.0763; Menuet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025770; Michael J Ryan, 2003, [动物学报, Acta Zoologica Sinica], V49, P713; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Nespor AA, 2000, AVIAN POULT BIOL REV, V11, P45; NUNEZ AA, 1984, PHYSIOL BEHAV, V32, P717, DOI 10.1016/0031-9384(84)90184-7; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2009, NEUROSCIENCE, V162, P486, DOI 10.1016/j.neuroscience.2009.04.056; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; Sacchi R, 2003, BEHAV ECOL SOCIOBIOL, V55, P95, DOI 10.1007/s00265-003-0685-1; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; SALES GD, 1972, J ZOOL, V68, P149; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Shepard KN, 2011, GENES BRAIN BEHAV, V10, P28, DOI 10.1111/j.1601-183X.2010.00580.x; Sisneros JA, 2003, J NEUROSCI, V23, P1049; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Terleph TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002854; Titus RC, 1998, AUK, V115, P386; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; Wagner WE, 2000, ANIM BEHAV, V59, P1219, DOI 10.1006/anbe.1999.1428; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8; WHITE TD, 1992, J ACOUST SOC AM, V92, P1953, DOI 10.1121/1.405243; WHITNEY G, 1979, AM ZOOL, V19, P457; WHITNEY G, 1973, J COMP PHYSIOL PSYCH, V84, P445, DOI 10.1037/h0034899; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	74	101	101	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40782	10.1371/journal.pone.0040782	http://dx.doi.org/10.1371/journal.pone.0040782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815817	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900048
J	Papaleo, E; Casiraghi, N; Arrigoni, A; Vanoni, M; Coccetti, P; De Gioia, L				Papaleo, Elena; Casiraghi, Nicola; Arrigoni, Alberto; Vanoni, Marco; Coccetti, Paola; De Gioia, Luca			Loop 7 of E2 Enzymes: An Ancestral Conserved Functional Motif Involved in the E2-Mediated Steps of the Ubiquitination Cascade	PLOS ONE			English	Article							CONJUGATING ENZYME; POLYUBIQUITIN CHAINS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; PROTEIN FUNCTION; IDENTIFICATION; MECHANISMS; PHOSPHORYLATION; REQUIREMENTS; SPECIFICITY	The ubiquitin (Ub) system controls almost every aspect of eukaryotic cell biology. Protein ubiquitination depends on the sequential action of three classes of enzymes (E1, E2 and E3). E2 Ub-conjugating enzymes have a central role in the ubiquitination pathway, interacting with both E1 and E3, and influencing the ultimate fate of the substrates. Several E2s are characterized by an extended acidic insertion in loop 7 (L7), which if mutated is known to impair the proper E2-related functions. In the present contribution, we show that acidic loop is a conserved ancestral motif in E2s, relying on the presence of alternate hydrophobic and acidic residues. Moreover, the dynamic properties of a subset of family 3 E2s, as well as their binary and ternary complexes with Ub and the cognate E3, have been investigated. Here we provide a model of L7 role in the different steps of the ubiquitination cascade of family 3 E2s. The L7 hydrophobic residues turned out to be the main determinant for the stabilization of the E2 inactive conformations by a tight network of interactions in the catalytic cleft. Moreover, phosphorylation is known from previous studies to promote E2 competent conformations for Ub charging, inducing electrostatic repulsion and acting on the L7 acidic residues. Here we show that these active conformations are stabilized by a network of hydrophobic interactions between L7 and L4, the latter being a conserved interface for E3-recruitment in several E2s. In the successive steps, L7 conserved acidic residues also provide an interaction interface for both Ub and the Rbx1 RING subdomain of the cognate E3. Our data therefore suggest a crucial role for L7 of family 3 E2s in all the E2-mediated steps of the ubiquitination cascade. Its different functions are exploited thank to its conserved hydrophobic and acidic residues in a finely orchestrate mechanism.	[Papaleo, Elena; Casiraghi, Nicola; Arrigoni, Alberto; Vanoni, Marco; Coccetti, Paola; De Gioia, Luca] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy	University of Milano-Bicocca	Papaleo, E (corresponding author), Univ Copenhagen, Struct Biol & NMR Lab, Dept Biol, Copenhagen, Denmark.	elena.papaleo@unimib.it	Coccetti, Paola/Y-2365-2019; Papaleo, Elena/M-6629-2014; Vanoni, Marco/AAA-3699-2021; De Gioia, Luca/K-6439-2016	Coccetti, Paola/0000-0001-5898-5883; Papaleo, Elena/0000-0002-7376-5894; Vanoni, Marco/0000-0002-8690-2587; , Elena/0000-0003-2296-898X	ISCRA-Cineca HPC CLASS-C Grant [HP10COBO3E]; CASPUR Standard HPC Grant	ISCRA-Cineca HPC CLASS-C Grant(CINECA, Italy); CASPUR Standard HPC Grant(CINECA, Italy)	This work was supported by ISCRA-Cineca HPC CLASS-C Grant (HP10COBO3E) to A.A. and E.P., as well as by CASPUR Standard HPC Grant 2011 to E.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arai R, 2006, ACTA CRYSTALLOGR F, V62, P330, DOI 10.1107/S1744309106009006; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Brandman R, 2011, ARCH BIOCHEM BIOPHYS, V509, P127, DOI 10.1016/j.abb.2011.02.020; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Cook WJ, 1997, BIOCHEMISTRY-US, V36, P1621, DOI 10.1021/bi962639e; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dastidar SG, 2011, CELL CYCLE, V10, P82, DOI 10.4161/cc.10.1.14345; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Dikic I, 2009, NAT STRUCT MOL BIOL, V16, P1208, DOI 10.1038/nsmb1209-1209; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duan XY, 2009, ANTI-CANCER AGENT ME, V9, P51, DOI 10.2174/187152009787047716; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Espadaler J, 2006, BIOINFORMATICS, V22, P2237, DOI 10.1093/bioinformatics/btl382; Espinosa A, 2011, J BIOL CHEM, V286, P36478, DOI 10.1074/jbc.M111.241786; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ju TT, 2010, PROTEINS, V78, P1291, DOI 10.1002/prot.22648; Karaca E, 2011, J MOL BIOL, V406, P620, DOI 10.1016/j.jmb.2010.12.044; Kempf JG, 2007, J MOL BIOL, V368, P131, DOI 10.1016/j.jmb.2007.01.074; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lass A, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-7; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li YH, 2011, BIOINFORMATICS, V27, P31, DOI 10.1093/bioinformatics/btq621; Lin HJ, 1999, J BIOL CHEM, V274, P14685, DOI 10.1074/jbc.274.21.14685; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu J, 2011, J BIOL CHEM, V286, P40934, DOI 10.1074/jbc.M111.277236; Liu J, 2010, BIOPHYS J, V99, P736, DOI 10.1016/j.bpj.2010.05.021; Liu J, 2010, J MOL BIOL, V396, P1508, DOI 10.1016/j.jmb.2010.01.022; LIU Y, 1995, MOL CELL BIOL, V15, P5635; Martinez-Noel G, 2001, EUR J BIOCHEM, V268, P5912, DOI 10.1046/j.0014-2956.2001.02541.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Papaleo E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002056; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Raimondo D, 2008, BIOCHEM PHARMACOL, V76, P1620, DOI 10.1016/j.bcp.2008.08.026; RING CS, 1992, J MOL BIOL, V224, P685, DOI 10.1016/0022-2836(92)90553-V; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Satoh T, 2010, BIOCHEM BIOPH RES CO, V400, P329, DOI 10.1016/j.bbrc.2010.08.057; Silvestre-Ryan J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002023; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Tiberti M, 2011, J STRUCT BIOL, V174, P69, DOI 10.1016/j.jsb.2011.01.006; Tozluoglu M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000913; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Widmann J, 2006, MOL CELL PROTEOMICS, V5, P1520, DOI 10.1074/mcp.T600022-MCP200; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Winn PJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3419, DOI 10.2741/2323; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	80	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40786	10.1371/journal.pone.0040786	http://dx.doi.org/10.1371/journal.pone.0040786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815819	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900049
J	Powell, GT; Wright, GJ				Powell, Gareth T.; Wright, Gavin J.			Genomic Organisation, Embryonic Expression and Biochemical Interactions of the Zebrafish Junctional Adhesion Molecule Family of Receptors	PLOS ONE			English	Article							C-DEFICIENT MICE; JAM-C; MYOBLAST FUSION; CELL POLARITY; INTERACTION NETWORK; IMMUNE-RESPONSE; PROTEIN; DROSOPHILA; INTEGRIN; ANGIOGENESIS	The mammalian JAM family is composed of three cell surface receptors. Interactions between the proteins have well-characterised roles in inflammation and tight junction formation, but little is known about their function in early development. Recently, we identified a role for jamb and jamc in zebrafish myocyte fusion. Genome duplication in the teleost lineage raised the possibility that additional JAM family paralogues may also function in muscle development. To address this, we searched the zebrafish genome to identify potential paralogues and confirmed their homology, bringing the total number of zebrafish jam family members to six. We then compared the physical binding properties of each paralogue by surface plasmon resonance and determined the gene expression patterns of all zebrafish jam genes at different stages of development. Our results suggest a significant sub-functionalisation of JAM-B and JAM-C orthologues with respect to binding strength (but not specificity) and gene expression. The paralogous genes, jamb2 and jamc2, were not detected in the somites or myotome of wild-type embryos. We conclude that it is unlikely that the paralogues have a function in primary myogenesis.	[Powell, Gareth T.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Powell, GT (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	gp3@sanger.ac.uk; gw2@sanger.ac.uk		Wright, Gavin/0000-0003-0537-0863; Powell, Gareth/0000-0003-4125-2290	Wellcome Trust [077108/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (www.wellcome.ac.uk; grant number 077108/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Artero RD, 2001, DEVELOPMENT, V128, P4251; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Bazzoni G, 2000, J BIOL CHEM, V275, P30970, DOI 10.1074/jbc.M003946200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bour BA, 2000, GENE DEV, V14, P1498; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Cooke VG, 2006, ARTERIOSCL THROM VAS, V26, P2005, DOI 10.1161/01.ATV.0000234923.79173.99; Cunningham SA, 2000, J BIOL CHEM, V275, P34750, DOI 10.1074/jbc.M002718200; Cunningham SA, 2002, J BIOL CHEM, V277, P27589, DOI 10.1074/jbc.C200331200; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; Fuse C, 2007, J BIOL CHEM, V282, P8276, DOI 10.1074/jbc.M608836200; Gallardo VE, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-120; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Haralalka S, 2010, EXP CELL RES, V316, P3007, DOI 10.1016/j.yexcr.2010.05.018; Imhof BA, 2007, J PATHOL, V212, P198, DOI 10.1002/path.2163; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lamagna C, 2005, MOL BIOL CELL, V16, P4992, DOI 10.1091/mbc.E05-04-0310; Lamagna C, 2005, CANCER RES, V65, P5703, DOI 10.1158/0008-5472.CAN-04-4012; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; Mandell KJ, 2004, J BIOL CHEM, V279, P16254, DOI 10.1074/jbc.M309483200; Mandicourt G, 2007, J BIOL CHEM, V282, P1830, DOI 10.1074/jbc.M605666200; Martin S, 2010, MOL CELL PROTEOMICS, V9, P2654, DOI 10.1074/mcp.M110.004119; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Murakami M, 2010, CANCER RES, V70, P1759, DOI 10.1158/0008-5472.CAN-09-1703; Naik MU, 2003, BLOOD, V102, P2108, DOI 10.1182/blood-2003-04-1114; Naik MU, 2003, ARTERIOSCL THROM VAS, V23, P2165, DOI 10.1161/01.ATV.0000093982.84451.87; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Praetor A, 2009, BLOOD, V113, P1919, DOI 10.1182/blood-2008-06-159574; Prota AE, 2003, P NATL ACAD SCI USA, V100, P5366, DOI 10.1073/pnas.0937718100; Rabquer BJ, 2010, J IMMUNOL, V185, P1777, DOI 10.4049/jimmunol.1000556; Rehder D, 2006, EXP CELL RES, V312, P3389, DOI 10.1016/j.yexcr.2006.07.004; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sakaguchi T, 2006, MOL CELL BIOL, V26, P6557, DOI 10.1128/MCB.00729-06; Santoso S, 2005, J BIOL CHEM, V280, P36326, DOI 10.1074/jbc.M505059200; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; Shao MH, 2008, DEV BIOL, V313, P246, DOI 10.1016/j.ydbio.2007.10.013; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang Y, 2009, ENDOCRINOLOGY, V150, P2404, DOI 10.1210/en.2008-1239; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]; Zimmerli C, 2009, J IMMUNOL, V182, P4728, DOI 10.4049/jimmunol.0803892	63	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40810	10.1371/journal.pone.0040810	http://dx.doi.org/10.1371/journal.pone.0040810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815827	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900052
J	Tiberti, N; Hainard, A; Lejon, V; Courtioux, B; Matovu, E; Enyaru, C; Robin, X; Turck, N; Kristensson, K; Ngoyi, DM; Vatunga, GML; Krishna, S; Buscher, P; Bisser, S; Ndung'u, JM; Sanchez, JC				Tiberti, Natalia; Hainard, Alexandre; Lejon, Veerle; Courtioux, Bertrand; Matovu, Enock; Enyaru, Charles; Robin, Xavier; Turck, Natacha; Kristensson, Krister; Ngoyi, Dieudonne Mumba; Vatunga, Gedeao M. L.; Krishna, Sanjeev; Buescher, Philippe; Bisser, Sylvie; Ndung'u, Joseph Mathu; Sanchez, Jean-Charles			Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; NERVOUS-SYSTEM INVOLVEMENT; DIAGNOSTIC-ACCURACY; FIELD DIAGNOSIS; FOLLOW-UP; ACTIVATION; BIOMARKERS; IGM	Background: Sleeping sickness, or human African trypanosomiasis (HAT), is a protozoan disease that affects rural communities in sub-Saharan Africa. Determination of the disease stage, essential for correct treatment, represents a key issue in the management of patients. In the present study we evaluated the potential of CXCL10, CXCL13, ICAM-1, VCAM-1, MMP-9, B2MG, neopterin and IgM to complement current methods for staging Trypanosoma brucei gambiense patients. Methods and Findings: Five hundred and twelve T. b. gambiense HAT patients originated from Angola, Chad and the Democratic Republic of the Congo (D.R.C.). Their classification as stage 2 (S2) was based on the number of white blood cells (WBC) (>5/mu L) or presence of parasites in the cerebrospinal fluid (CSF). The CSF concentration of the eight markers was first measured on a training cohort encompassing 100 patients (44 S1 and 56 S2). IgM and neopterin were the best in discriminating between the two stages of disease with 86.4% and 84.1% specificity respectively, at 100% sensitivity. When a validation cohort (412 patients) was tested, neopterin (14.3 nmol/L) correctly classified 88% of S1 and S2 patients, confirming its high staging power. On this second cohort, neopterin also predicted both the presence of parasites, and of neurological signs, with the same ability as IgM and WBC, the current reference for staging. Conclusions: This study has demonstrated that neopterin is an excellent biomarker for staging T. b. gambiense HAT patients. A rapid diagnostic test for detecting this metabolite in CSF could help in more accurate stage determination.	[Tiberti, Natalia; Hainard, Alexandre; Robin, Xavier; Turck, Natacha; Sanchez, Jean-Charles] Univ Geneva, Dept Human Prot Sci, Biomed Prote Res Grp, Geneva, Switzerland; [Lejon, Veerle; Buescher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Courtioux, Bertrand; Bisser, Sylvie] INSERM, UMR1094, Limoges, France; [Matovu, Enock] Makerere Univ, Sch Vet Med, Dept Vet Parasitol & Microbiol, Kampala, Uganda; [Enyaru, Charles] Makerere Univ, Coll Nat Sci, Dept Biochem, Kampala, Uganda; [Ngoyi, Dieudonne Mumba] Inst Natl Rech Biomed, Dept Parasitol, Kinshasa, DEM REP CONGO; [Kristensson, Krister] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Vatunga, Gedeao M. L.] Inst Combate Controlo Tripanossomiases, Luanda, Angola; [Krishna, Sanjeev] Univ London, Ctr Infect, Div Cellular & Mol Med, London, England; [Ndung'u, Joseph Mathu] FIND, Geneva, Switzerland; [Courtioux, Bertrand; Bisser, Sylvie] Univ Limoges, Sch Med, CNRS FR 3503 GEIST, Inst Neuroepidemiol & Trop Neurol, Limoges, France	University of Geneva; Institute of Tropical Medicine (ITM); Institut National de la Sante et de la Recherche Medicale (Inserm); Makerere University; Makerere University; Institute Nacional de Recherche Biomedical; Karolinska Institutet; University of London; Foundation For Innovative New Diagnostics; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Franche-Comte; Universite de Limoges	Tiberti, N (corresponding author), Univ Geneva, Dept Human Prot Sci, Biomed Prote Res Grp, Geneva, Switzerland.	Jean-Charles.Sanchez@unige.ch	Lejon, Veerle/AAG-4213-2020; Robin, Xavier/A-1680-2009; Tiberti, Natalia/I-7928-2018; Büscher, Philippe/B-9956-2012; Lejon, Veerle/AAG-5024-2020	Lejon, Veerle/0000-0002-6795-0962; Robin, Xavier/0000-0002-6813-3200; Tiberti, Natalia/0000-0002-2981-5233; Büscher, Philippe/0000-0002-1926-7472; Matovu, Enock/0000-0003-0714-7032; Krishna, Sanjeev/0000-0003-0066-0634	Foundation for Innovative New Diagnostics (FIND); Belgian Directorate General for International Cooperation; European Union [FP6-2004-INCO-DEV-3 032334]	Foundation for Innovative New Diagnostics (FIND); Belgian Directorate General for International Cooperation; European Union(European Commission)	This work was supported by the Foundation for Innovative New Diagnostics (FIND) (http://www.finddiagnostics.org/). The funder assisted in the collection of samples in Angola. DMN received financial support from the Belgian Directorate General for International Cooperation. Part of the specimen collection in DRC was supported by a grant from the European Union [FP6-2004-INCO-DEV-3 032334; NEUROTRYP].	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Amin DN, 2009, J INFECT DIS, V200, P1556, DOI 10.1086/644597; Amin DN, 2010, AM J TROP MED HYG, V82, P983, DOI 10.4269/ajtmh.2010.09-0770; Bisser S, 2002, J NEUROL SCI, V193, P127, DOI 10.1016/S0022-510X(01)00655-4; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Buhrer-Sekula S, 2000, J IMMUNOL METHODS, V238, P55, DOI 10.1016/S0022-1759(00)00148-4; Burri C, 2010, PARASITOLOGY, V137, P1987, DOI 10.1017/S0031182010001137; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Courtioux B, 2009, TROP MED INT HEALTH, V14, P529, DOI 10.1111/j.1365-3156.2009.02263.x; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; Doua F, 1996, AM J TROP MED HYG, V55, P586, DOI 10.4269/ajtmh.1996.55.586; Franco JR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001571; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Hainard A, 2011, TROP MED INT HEALTH, V16, P119, DOI 10.1111/j.1365-3156.2010.02642.x; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; Kennedy PGE, 2008, T ROY SOC TROP MED H, V102, P306, DOI 10.1016/j.trstmh.2007.11.011; Kennedy PGE, 2010, AM J TROP MED HYG, V82, P981, DOI 10.4269/ajtmh.2010.10-0172; Kennedy PG, 2011, J NEUROPARASITOL, V2; Kristensson K, 2010, PROG NEUROBIOL, V91, P152, DOI 10.1016/j.pneurobio.2009.12.001; Lejon V, 1998, B WORLD HEALTH ORGAN, V76, P553; Lejon V, 2003, J NEUROIMMUNOL, V144, P132, DOI 10.1016/j.jneuroim.2003.08.033; Lejon V, 2003, J INFECT DIS, V187, P1475, DOI 10.1086/374645; Lejon V, 2002, TROP MED INT HEALTH, V7, P685, DOI 10.1046/j.1365-3156.2002.00917.x; MacLean L, 2006, T ROY SOC TROP MED H, V100, P270, DOI 10.1016/j.trstmh.2005.03.013; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Miezan TW, 2000, T ROY SOC TROP MED H, V94, P293, DOI 10.1016/S0035-9203(00)90327-4; Moore AC, 2005, J INFECT DIS, V191, P1793, DOI 10.1086/429935; Mugasa CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001438; Ngoyi DM, 2010, J INFECT DIS, V201, P453, DOI 10.1086/649917; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Sucher R, 2010, CANCER LETT, V287, P13, DOI 10.1016/j.canlet.2009.05.008; Tiberti N, 2010, MOL CELL PROTEOMICS, V9, P2783, DOI 10.1074/mcp.M110.001008; Truc P, 1999, B WORLD HEALTH ORGAN, V77, P745; WHO, 2009, MOD LIST ESS MED EML; WHO Expert Comm, 1998, WHO TECH REP SER, V881, P1	38	30	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40909	10.1371/journal.pone.0040909	http://dx.doi.org/10.1371/journal.pone.0040909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815865	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306548900059
J	Zamanian, M; Agbedanu, PN; Wheeler, NJ; McVeigh, P; Kimber, MJ; Day, TA				Zamanian, Mostafa; Agbedanu, Prince N.; Wheeler, Nicolas J.; McVeigh, Paul; Kimber, Michael J.; Day, Tim A.			Novel RNAi-Mediated Approach to G Protein-Coupled Receptor Deorphanization: Proof of Principle and Characterization of a Planarian 5-HT Receptor	PLOS ONE			English	Article							ACTIVATED ADENYLATE-CYCLASE; SCHISTOSOMA-MANSONI; HETEROLOGOUS EXPRESSION; SCHMIDTEA-MEDITERRANEA; EXPORT TRAFFICKING; IDENTIFICATION; SEROTONIN; GENOME; REGENERATION; HOMEOSTASIS	G protein-coupled receptors (GPCRs) represent the largest known superfamily of membrane proteins extending throughout the Metazoa. There exists ample motivation to elucidate the functional properties of GPCRs given their role in signal transduction and their prominence as drug targets. In many target organisms, these efforts are hampered by the unreliable nature of heterologous receptor expression platforms. We validate and describe an alternative loss-of-function approach for ascertaining the ligand and G protein coupling properties of GPCRs in their native cell membrane environment. Our efforts are focused on the phylum Platyhelminthes, given the heavy health burden exacted by pathogenic flatworms, as well as the role of free-living flatworms as model organisms for the study of developmental biology. RNA interference (RNAi) was used in conjunction with a biochemical endpoint assay to monitor cAMP modulation in response to the translational suppression of individual receptors. As proof of principle, this approach was used to confirm the neuropeptide GYIRFamide as the cognate ligand for the planarian neuropeptide receptor GtNPR-1, while revealing its endogenous coupling to G alpha(i/o). The method was then extended to deorphanize a novel G alpha(5)-coupled planarian serotonin receptor, DtSER-1. A bioinformatics protocol guided the selection of receptor candidates mediating 5-HT-evoked responses. These results provide functional data on a neurotransmitter central to flatworm biology, while establishing the great potential of an RNAi-based deorphanization protocol. Future work can help optimize and adapt this protocol for higher-throughput platforms as well as other phyla.	[Zamanian, Mostafa; Kimber, Michael J.; Day, Tim A.] Iowa State Univ, Neurosci Program, Ames, IA 50011 USA; [Zamanian, Mostafa; Agbedanu, Prince N.; Wheeler, Nicolas J.; Kimber, Michael J.; Day, Tim A.] Iowa State Univ, Dept Biomed Sci, Ames, IA USA; [McVeigh, Paul] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	Iowa State University; Iowa State University; Queens University Belfast	Zamanian, M (corresponding author), Iowa State Univ, Neurosci Program, Ames, IA 50011 USA.	mostafaz@iastate.edu	Wheeler, Nic/AAF-1120-2019; Zamanian, Mostafa/B-7993-2013	Wheeler, Nic/0000-0002-5909-4190; Day, Tim/0000-0002-9037-6540; Agbedanu, Prince N./0000-0003-4728-6619; Zamanian, Mostafa/0000-0001-9233-1760	National Institutes of Health [NIH R01 AI49162]; United States Department of Agriculture [IOWV-DAY-411-23-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant from the National Institutes of Health (NIH R01 AI49162) and a grant from the United States Department of Agriculture (IOWV-DAY-411-23-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul S. F., 1990, J MOL BIOL; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Chung S, 2008, BRIT J PHARMACOL, V153, pS339, DOI 10.1038/sj.bjp.0707606; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; CRETI P, 1992, CELL BIOL INT REP, V16, P427, DOI 10.1016/S0309-1651(06)80062-7; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Shehabi F, 2010, INT J PARASITOLOGY; ESTEY SJ, 1987, MOL BIOCHEM PARASIT, V26, P47, DOI 10.1016/0166-6851(87)90129-0; Farrell MS, 2008, BEHAV PHARMACOL, V19, P177, DOI 10.1097/FBP.0b013e3282fe885e; Fitzpatrick JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000543; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hamdan FF, 2002, MOL BIOCHEM PARASIT, V119, P75, DOI 10.1016/S0166-6851(01)00400-5; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Humphries JE, 2004, J BIOL CHEM, V279, P39880, DOI 10.1074/jbc.M405624200; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; KASSCHAU MR, 1982, NATURE, V296, P66, DOI 10.1038/296066a0; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; McCusker EC, 2007, BIOTECHNOL PROGR, V23, P540, DOI 10.1021/bp060349b; McVeigh P, 2005, PARASITOLOGY, V131, pS41, DOI 10.1017/S0031182005008851; McVeigh P, 2009, INT J PARASITOLOGY; Mertens I, 2004, PHARMACOGENOMICS, V5, P657, DOI 10.1517/14622416.5.6.657; Nishimura K, 2009, BIOL PHARM BULL, V32, P1672, DOI 10.1248/bpb.32.1672; Omar HH, 2007, INT J PARASITOL, V37, P725, DOI 10.1016/j.ijpara.2006.12.019; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Retief J D, 2000, Methods Mol Biol, V132, P243; Ribeiro P, 2005, PARASITOLOGY, V131, pS19; RICHARDS JS, 1979, ENDOCRINOLOGY, V104, P765, DOI 10.1210/endo-104-3-765; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Saitoh O, 1996, NEUROREPORT, V8, P173, DOI 10.1097/00001756-199612200-00035; Saitoh O, 1997, GENE, V195, P55, DOI 10.1016/S0378-1119(97)00152-2; Sexton PM, 2001, CELL SIGNAL, V13, P73, DOI 10.1016/S0898-6568(00)00143-1; Taft AS, 2010, EXP PARASITOL, V125, P84, DOI 10.1016/j.exppara.2009.12.021; Taman A, 2009, MOL BIOCH PARASITOL; Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7; Thomsen W, 2005, CURR OPIN BIOTECH, V16, P655, DOI 10.1016/j.copbio.2005.10.008; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wilkie TM, 2000, CURR BIOL, V10, pR853, DOI 10.1016/S0960-9822(00)00823-X; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40787	10.1371/journal.pone.0040787	http://dx.doi.org/10.1371/journal.pone.0040787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815820	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900050
J	Karalija, A; Novikova, LN; Kingham, PJ; Wiberg, M; Novikov, LN				Karalija, Amar; Novikova, Liudmila N.; Kingham, Paul J.; Wiberg, Mikael; Novikov, Lev N.			Neuroprotective Effects of N-Acetyl-Cysteine and Acetyl-L-Carnitine after Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; ISCHEMIA-REPERFUSION INJURY; OLFACTORY ENSHEATHING CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; NEURONAL SURVIVAL; GROWTH-FACTOR; NEUROTROPHIC FACTORS; RUBROSPINAL NEURONS; LIPID-PEROXIDATION	Following the initial acute stage of spinal cord injury, a cascade of cellular and inflammatory responses will lead to progressive secondary damage of the nerve tissue surrounding the primary injury site. The degeneration is manifested by loss of neurons and glial cells, demyelination and cyst formation. Injury to the mammalian spinal cord results in nearly complete failure of the severed axons to regenerate. We have previously demonstrated that the antioxidants N-acetyl-cysteine (NAC) and acetyl-L-carnitine (ALC) can attenuate retrograde neuronal degeneration after peripheral nerve and ventral root injury. The present study evaluates the effects of NAC and ALC on neuronal survival, axonal sprouting and glial cell reactions after spinal cord injury in adult rats. Tibial motoneurons in the spinal cord were pre-labeled with fluorescent tracer Fast Blue one week before lumbar L5 hemisection. Continuous intrathecal infusion of NAC (2.4 mg/day) or ALC (0.9 mg/day) was initiated immediately after spinal injury using Alzet 2002 osmotic minipumps. Neuroprotective effects of treatment were assessed by counting surviving motoneurons and by using quantitative immunohistochemistry and Western blotting for neuronal and glial cell markers 4 weeks after hemisection. Spinal cord injury induced significant loss of tibial motoneurons in L4-L6 segments. Neuronal degeneration was associated with decreased immunostaining for microtubular-associated protein-2 (MAP2) in dendritic branches, synaptophysin in presynaptic boutons and neurofilaments in nerve fibers. Immunostaining for the astroglial marker GFAP and microglial marker OX42 was increased. Treatment with NAC and ALC rescued approximately half of the motoneurons destined to die. In addition, antioxidants restored MAP2 and synaptophysin immunoreactivity. However, the perineuronal synaptophysin labeling was not recovered. Although both treatments promoted axonal sprouting, there was no effect on reactive astrocytes. In contrast, the microglial reaction was significantly attenuated. The results indicate a therapeutic potential for NAC and ALC in the early treatment of traumatic spinal cord injury.	[Karalija, Amar; Novikova, Liudmila N.; Kingham, Paul J.; Wiberg, Mikael; Novikov, Lev N.] Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden; [Wiberg, Mikael] Umea Univ, Sect Hand & Plast Surg, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University	Karalija, A (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden.	lev.novikov@anatomy.umu.se	Novikov, Lev/I-1983-2012	Novikov, Lev/0000-0001-5520-3890; Kingham, Paul/0000-0003-2596-5936	Swedish Medical Research Council; European Union; Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magn. Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Union(European Commission); Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magn. Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	This study was supported by the Swedish Medical Research Council, European Union, Umea University, County of Vasterbotten, Ake Wibergs Stiftelse, Magn. Bergvalls Stiftelse, Clas Groschinskys Minnesfond and the Gunvor and Josef Aner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELUCCI L, 1988, J NEUROSCI RES, V20, P491, DOI 10.1002/jnr.490200413; Arakawa M, 2007, CEREBELLUM, V6, P308, DOI 10.1080/14734220601142878; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; BERNSTEIN JJ, 1984, EXP NEUROL, V83, P548, DOI 10.1016/0014-4886(84)90122-5; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Brooks J O 3rd, 1998, Int Psychogeriatr, V10, P193, DOI 10.1017/S1041610298005304; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cakir O, 2003, CARDIOVASC SURG, V11, P375, DOI 10.1016/S0967-2109(03)00077-2; Calabrese V, 2005, J NEUROSCI RES, V79, P509, DOI 10.1002/jnr.20386; Cullheim S, 2002, BRAIN RES REV, V40, P309, DOI 10.1016/S0165-0173(02)00213-8; CULLHEIM S, 1978, J COMP NEUROL, V178, P537, DOI 10.1002/cne.901780309; CUMMINGS JP, 1988, EXP NEUROL, V100, P381, DOI 10.1016/0014-4886(88)90116-1; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dringen R, 1999, NEUROSCI LETT, V259, P79, DOI 10.1016/S0304-3940(98)00894-5; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Evans JD, 2008, ANN PHARMACOTHER, V42, P1686, DOI 10.1345/aph.1L201; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; FERNANDEZ E, 1995, NEUROL RES, V17, P373, DOI 10.1080/01616412.1995.11740345; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Harkey H Louis 3rd, 2003, Anat Rec B New Anat, V271, P41, DOI 10.1002/ar.b.10012; Hart AM, 2004, NEUROSCIENCE, V125, P91, DOI 10.1016/j.neuroscience.2003.12.040; Hart AM, 2002, EXP BRAIN RES, V145, P182, DOI 10.1007/s00221-002-1100-2; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hawthorne AL, 2011, NEUROTHERAPEUTICS, V8, P252, DOI 10.1007/s13311-011-0032-6; Heard KJ, 2008, NEW ENGL J MED, V359, P285, DOI 10.1056/NEJMct0708278; Hillard VH, 2004, J NEUROTRAUM, V21, P1405, DOI 10.1089/neu.2004.21.1405; Jivan S, 2006, EXP BRAIN RES, V170, P245, DOI 10.1007/s00221-005-0207-7; Kaynar MY, 1998, NEUROSURG REV, V21, P260, DOI 10.1007/BF01105782; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kocogullari CU, 2008, SURG TODAY, V38, P237, DOI 10.1007/s00595-007-3614-5; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; MANFRIDI A, 1992, INT J DEV NEUROSCI, V10, P321, DOI 10.1016/0736-5748(92)90021-Q; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Muneer PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019258; NACIMIENTO W, 1995, ACTA NEUROPATHOL, V90, P552; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Novikova L, 1997, EUR J NEUROSCI, V9, P2774, DOI 10.1111/j.1460-9568.1997.tb01706.x; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; Novikova L, 1996, NEUROSCI LETT, V220, P203, DOI 10.1016/S0304-3940(96)13267-5; Novikova LN, 2011, EXP NEUROL, V229, P132, DOI 10.1016/j.expneurol.2010.09.021; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Novikova LN, 2002, J COMP NEUROL, V452, P255, DOI 10.1002/cne.10381; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Rahman A, 2001, EUR J CARDIO-THORAC, V20, P65, DOI 10.1016/S1010-7940(01)00756-4; Reid AJ, 2010, BRAIN RES, V1310, P1, DOI 10.1016/j.brainres.2009.11.011; Reid AJ, 2009, NEUROSCI RES, V65, P148, DOI 10.1016/j.neures.2009.06.008; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Steencken ACC, 2010, NEUROSCIENCE, V170, P971, DOI 10.1016/j.neuroscience.2010.06.064; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SWETT JE, 1986, EXP NEUROL, V93, P227, DOI 10.1016/0014-4886(86)90161-5; TAGLIALATELA G, 1991, DEV BRAIN RES, V59, P221, DOI 10.1016/0165-3806(91)90102-O; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Wang CC, 2009, J CELL BIOCHEM, V107, P933, DOI 10.1002/jcb.22196; Welin D, 2008, EXP BRAIN RES, V186, P315, DOI 10.1007/s00221-007-1232-5; Welin D, 2009, BRAIN RES, V1287, P58, DOI 10.1016/j.brainres.2009.06.038; Wilson ADH, 2007, J PLAST RECONSTR AES, V60, P114, DOI 10.1016/j.bjps.2006.04.017; Woo MS, 2008, J NEUROCHEM, V106, P770, DOI 10.1111/j.1471-4159.2008.05430.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiao M, 2005, EXP NEUROL, V194, P12, DOI 10.1016/j.expneurol.2005.01.021; Yan CYI, 1998, J NEUROSCI, V18, P4042; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Zanelli SA, 2005, ANN NY ACAD SCI, V1053, P153, DOI 10.1196/annals.1344.013; Zhang CG, 2005, BRIT J PLAST SURG, V58, P765, DOI 10.1016/j.bjps.2005.04.012; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	79	63	66	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41086	10.1371/journal.pone.0041086	http://dx.doi.org/10.1371/journal.pone.0041086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815926	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000063
J	Husson, SJ; Liewald, JF; Schultheis, C; Stirman, JN; Lu, H; Gottschalk, A				Husson, Steven J.; Liewald, Jana F.; Schultheis, Christian; Stirman, Jeffrey N.; Lu, Hang; Gottschalk, Alexander			Microbial Light-Activatable Proton Pumps as Neuronal Inhibitors to Functionally Dissect Neuronal Networks in C. elegans	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; OPTICAL INTERROGATION; OPTOGENETIC ANALYSIS; NERVOUS-SYSTEM; ASH NEURONS; CIRCUIT; CHANNELRHODOPSIN-2; MANIPULATION; AVOIDANCE; BEHAVIORS	Essentially any behavior in simple and complex animals depends on neuronal network function. Currently, the best-defined system to study neuronal circuits is the nematode Caenorhabditis elegans, as the connectivity of its 302 neurons is exactly known. Individual neurons can be activated by photostimulation of Channelrhodopsin-2 (ChR2) using blue light, allowing to directly probe the importance of a particular neuron for the respective behavioral output of the network under study. In analogy, other excitable cells can be inhibited by expressing Halorhodopsin from Natronomonas pharaonis (NpHR) and subsequent illumination with yellow light. However, inhibiting C. elegans neurons using NpHR is difficult. Recently, proton pumps from various sources were established as valuable alternative hyperpolarizers. Here we show that archaerhodopsin-3 (Arch) from Halorubrum sodomense and a proton pump from the fungus Leptosphaeria maculans (Mac) can be utilized to effectively inhibit excitable cells in C. elegans. Arch is the most powerful hyperpolarizer when illuminated with yellow or green light while the action spectrum of Mac is more blue-shifted, as analyzed by light-evoked behaviors and electrophysiology. This allows these tools to be combined in various ways with ChR2 to analyze different subsets of neurons within a circuit. We exemplify this by means of the polymodal aversive sensory ASH neurons, and the downstream command interneurons to which ASH neurons signal to trigger a reversal followed by a directional turn. Photostimulating ASH and subsequently inhibiting command interneurons using two-color illumination of different body segments, allows investigating temporal aspects of signaling downstream of ASH.	[Husson, Steven J.; Liewald, Jana F.; Schultheis, Christian; Gottschalk, Alexander] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Husson, Steven J.; Liewald, Jana F.; Schultheis, Christian; Gottschalk, Alexander] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Stirman, Jeffrey N.; Lu, Hang] Georgia Inst Technol, Sch Chem & Biomol Engn, Interdisciplinary Bioengn Program, Atlanta, GA 30332 USA	Goethe University Frankfurt; Goethe University Frankfurt; University System of Georgia; Georgia Institute of Technology	Husson, SJ (corresponding author), Katholieke Univ Leuven, Funct Genom & Prote, Louvain, Belgium.	steven.husson@bio.kuleuven.be; a.gottschalk@em.uni-frankfurt.de	Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119; Lu, Hang/0000-0002-6881-660X; Stirman, Jeffrey/0000-0003-4761-3341	Human Frontiers Science Program Organization (HFSPO); National Institutes of Health (NIH); Alfred P. Sloan Foundation; Deutsche Forschungsgemeinschaft (DFG) [SFB807-P11, FOR1279-P1, EXC115/1]; European Union Framework Program 7 ("EUTrigTreat''; Schram foundation	Human Frontiers Science Program Organization (HFSPO)(Human Frontier Science Program); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union Framework Program 7 ("EUTrigTreat''; Schram foundation	SJH was supported by the Human Frontiers Science Program Organization (HFSPO; http://www.hfsp.org/). This work was supported by grants from the National Institutes of Health (NIH; http://www.nih.gov/) and the Alfred P. Sloan Foundation (http://www.sloan.org/) to HL, and grants from the Deutsche Forschungsgemeinschaft (DFG: http://www.dfg.de/index.jsp; Grants SFB807-P11, FOR1279-P1; Cluster of Excellence Frankfurt - CEF-MC; EXC115/1), the European Union Framework Program 7 ("EUTrigTreat''; http://www.eutrigtreat.eu/) and the Schram foundation (http://stifterverband.info/stiftungen_und_stifter/aktuelles/2011/2011_03_23_Symposium_Schram-Stiftung_2011/index.html) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGMANN CI, 1990, COLD SH Q B, V55, P529; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatzigeorgiou M, 2011, NEURON, V70, P299, DOI 10.1016/j.neuron.2011.02.046; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kuhara A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1352; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Lindsay TH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1304; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Mahoney TR, 2008, P NATL ACAD SCI USA, V105, P16350, DOI 10.1073/pnas.0803617105; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Stirman JN, 2012, NAT PROTOC, V7, P207, DOI 10.1038/nprot.2011.433; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 1996, J NEUROSCI, V16, P4017; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	39	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40937	10.1371/journal.pone.0040937	http://dx.doi.org/10.1371/journal.pone.0040937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815873	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100096
J	Stockdreher, Y; Venceslau, SS; Josten, M; Sahl, HG; Pereira, IAC; Dahl, C				Stockdreher, Yvonne; Venceslau, Sofia S.; Josten, Michaele; Sahl, Hans-Georg; Pereira, Ines A. C.; Dahl, Christiane			Cytoplasmic Sulfurtransferases in the Purple Sulfur Bacterium Allochromatium vinosum: Evidence for Sulfur Transfer from DsrEFH to DsrC	PLOS ONE			English	Article							DISSIMILATORY SULFITE REDUCTASE; CHROMATIUM-VINOSUM; OXIDATION; PROTEINS; INSIGHTS; PROKARYOTES; THIOSULFATE; COMPLEX; SULFATE; GENES	While the importance of sulfur transfer reactions is well established for a number of biosynthetic pathways, evidence has only started to emerge that sulfurtransferases may also be major players in sulfur-based microbial energy metabolism. Among the first organisms studied in this regard is the phototrophic purple sulfur bacterium Allochromatium vinosum. During the oxidation of reduced sulfur species to sulfate this Gammaproteobacterium accumulates sulfur globules. Low molecular weight organic persulfides have been proposed as carrier molecules transferring sulfur from the periplasmic sulfur globules into the cytoplasm where it is further oxidized via the "Dsr'' (dissimilatory sulfite reductase) proteins. We have suggested earlier that the heterohexameric protein DsrEFH is the direct or indirect acceptor for persulfidic sulfur imported into the cytoplasm. This proposal originated from the structural similarity of DsrEFH with the established sulfurtransferase TusBCD from E. coli. As part of a system for tRNA modification TusBCD transfers sulfur to TusE, a homolog of another crucial component of the A. vinosum Dsr system, namely DsrC. Here we show that neither DsrEFH nor DsrC have the ability to mobilize sulfane sulfur directly from low molecular weight thiols like thiosulfate or glutathione persulfide. However, we demonstrate that DsrEFH binds sulfur specifically to the conserved cysteine residue DsrE-Cys78 in vitro. Sulfur atoms bound to cysteines in DsrH and DsrF were not detected. DsrC was exclusively persulfurated at DsrC-Cys111 in the penultimate position of the protein. Most importantly, we show that persulfurated DsrEFH indeed serves as an effective sulfur donor for DsrC in vitro. The active site cysteines Cys78 of DsrE and Cys20 of DsrH furthermore proved to be essential for sulfur oxidation in vivo supporting the notion that DsrEFH and DsrC are part of a sulfur relay system that transfers sulfur from a persulfurated carrier molecule to the dissimilatory sulfite reductase DsrAB.	[Stockdreher, Yvonne; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, Bonn, Germany; [Venceslau, Sofia S.; Pereira, Ines A. C.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Inst Med Mikrobiol Immunol & Parasitol, Abt Pharmazeut Mikrobiol, Bonn, Germany	University of Bonn; Universidade Nova de Lisboa; University of Bonn	Stockdreher, Y (corresponding author), Univ Bonn, Inst Mikrobiol & Biotechnol, Bonn, Germany.	ChDahl@uni-bonn.de	Venceslau, Sofia/M-2882-2016; Pereira, Inês/C-2748-2009; Dahl, Christiane/H-4786-2019	Venceslau, Sofia/0000-0001-8774-1351; Pereira, Inês/0000-0003-3283-4520; Dahl, Christiane/0000-0001-8288-7546	Duetsche Forschungsgemeinschaft [Da 351/3-5, Da 351/6-1]; Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PTDC/QUI-BIQ/100591/2008, SFRH/BPD/79823/2011]; BONFOR program of the medical Faculty of the University of Bonn	Duetsche Forschungsgemeinschaft; Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); BONFOR program of the medical Faculty of the University of Bonn	This work was supported by the Duetsche Forschungsgemeinschaft (projects Da 351/3-5 and Da 351/6-1 to CD is gratefully acknowledged. Grants PTDC/QUI-BIQ/100591/2008 (to IACP) and fellowship SFRH/BPD/79823/2011 (to SV) funded by Fundacao para a Ciencia e Tecnologia (FCT, Portugal) and FEDER program also contributed to this work. HGS acknowledges financial support by the BONFOR program of the medical Faculty of the University of Bonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch RG, 1996, J BACTERIOL, V178, P4742, DOI 10.1128/jb.178.15.4742-4746.1996; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; CECIL R, 1962, BIOCHEM J, V82, P401, DOI 10.1042/bj0820401; Cort JR, 2008, J MOL BIOL, V382, P692, DOI 10.1016/j.jmb.2008.07.022; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl C., 2008, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0021155, DOI 10.1002/9780470015902.A0021155]; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; EVERETT SA, 1994, FREE RADICAL RES, V20, P387, DOI 10.3109/10715769409145638; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Grein F, 2010, J BACTERIOL, V192, P6369, DOI 10.1128/JB.00849-10; Grimm F, 2010, MICROBIOL-SGM, V156, P764, DOI 10.1099/mic.0.034645-0; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Hipp WM, 1997, MICROBIOL-UK, V143, P2891, DOI 10.1099/00221287-143-9-2891; Hsieh YC, 2010, MOL MICROBIOL, V78, P1101, DOI 10.1111/j.1365-2958.2010.07390.x; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jagov GV, 1994, PRACTICAL GUIDE MEMB; KELLY DP, 1969, ANAL CHEM, V41, P898, DOI 10.1021/ac60276a029; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Klimmek O, 1998, EUR J BIOCHEM, V253, P263, DOI 10.1046/j.1432-1327.1998.2530263.x; Lubbe YJ, 2006, FEMS MICROBIOL LETT, V261, P194, DOI 10.1111/j.1574-6968.2006.00343.x; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Numata T, 2006, STRUCTURE, V14, P357, DOI 10.1016/j.str.2005.11.009; Oliveira TF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00071; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; OVERMANN J, 1992, ARCH MICROBIOL, V157, P329, DOI 10.1007/BF00248677; PATTARAGULWANIT K, 1995, ARCH MICROBIOL, V164, P217, DOI 10.1007/BF02529974; Pfennig N., 1992, PROKARYOTES, P3200; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; Prange A, 2002, MICROBIOL-SGM, V148, P267, DOI 10.1099/00221287-148-1-267; Prieto JL, 1997, J PLANT PHYSIOL, V151, P385, DOI 10.1016/S0176-1617(97)80001-6; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Rethmeier J, 1997, J CHROMATOGR A, V760, P295, DOI 10.1016/S0021-9673(96)00809-6; Riederer BM, 2009, CURR PROTEOMICS, V6, P51, DOI 10.2174/157016409787847448; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Sambrook J., 2002, MOL CLONING LAB MANU; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; SCHEDEL M, 1979, ARCH MICROBIOL, V121, P29, DOI 10.1007/BF00409202; Schiffer A, 2008, J MOL BIOL, V379, P1063, DOI 10.1016/j.jmb.2008.04.027; SORBO B, 1987, METHOD ENZYMOL, V143, P3; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Tajc SG, 2004, J AM CHEM SOC, V126, P10508, DOI 10.1021/ja047929u; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139	43	39	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40785	10.1371/journal.pone.0040785	http://dx.doi.org/10.1371/journal.pone.0040785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815818	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100067
J	Zhou, M; Yan, J; Ma, ZW; Zhou, Y; Abbood, NN; Liu, JF; Su, L; Jia, HB; Guo, AY				Zhou, Mi; Yan, Jun; Ma, Zhaowu; Zhou, Yang; Abbood, Nibras Najm; Liu, Jianfeng; Su, Li; Jia, Haibo; Guo, An-Yuan			Comparative and Evolutionary Analysis of the HES/HEY Gene Family Reveal Exon/Intron Loss and Teleost Specific Duplication Events	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; GENOME DUPLICATION; SIGNALING PATHWAY; BHLH GENES; HEY GENES; NOTCH; EXPRESSION; ENHANCER; HAIRY; REPRESSION	Background: HES/HEY genes encode a family of basic helix-loop-helix (bHLH) transcription factors with both bHLH and Orange domain. HES/HEY proteins are direct targets of the Notch signaling pathway and play an essential role in developmental decisions, such as the developments of nervous system, somitogenesis, blood vessel and heart. Despite their important functions, the origin and evolution of this HES/HEY gene family has yet to be elucidated. Methods and Findings: In this study, we identified genes of the HES/HEY family in representative species and performed evolutionary analysis to elucidate their origin and evolutionary process. Our results showed that the HES/HEY genes only existed in metazoans and may originate from the common ancestor of metazoans. We identified HES/HEY genes in more than 10 species representing the main lineages. Combining the bHLH and Orange domain sequences, we constructed the phylogenetic trees by different methods (Bayesian, ML, NJ and ME) and classified the HES/HEY gene family into four groups. Our results indicated that this gene family had undergone three expansions, which were along with the origins of Eumetazoa, vertebrate, and teleost. Gene structure analysis revealed that the HES/HEY genes were involved in exon and/or intron loss in different species lineages. Genes of this family were duplicated in bony fishes and doubled than other vertebrates. Furthermore, we studied the teleost-specific duplications in zebrafish and investigated the expression pattern of duplicated genes in different tissues by RT-PCR. Finally, we proposed a model to show the evolution of this gene family with processes of expansion, exon/intron loss, and motif loss. Conclusions: Our study revealed the evolution of HES/HEY gene family, the expression and function divergence of duplicated genes, which also provide clues for the research of Notch function in development. This study shows a model of gene family analysis with gene structure evolution and duplication.	[Zhou, Mi; Ma, Zhaowu; Guo, An-Yuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biomed Engn, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Yan, Jun; Liu, Jianfeng; Su, Li; Guo, An-Yuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ,Sino France Lab Drug Screening, Wuhan 430074, Hubei, Peoples R China; [Zhou, Yang; Abbood, Nibras Najm; Jia, Haibo] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Coll Life Sci & Technol, Minist Educ,Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guo, AY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biomed Engn, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China.	haibo.jia@mail.hust.edu.cn; guoay@mail.hust.edu.cn	Yan, Jun/HDN-2389-2022; Ma, Zhaowu/GLN-5157-2022; Guo, An-Yuan/K-3656-2012; Liu, Jianfeng/E-2786-2012	Ma, Zhaowu/0000-0001-7675-1845; 	National Natural Science Foundation of China [31171271]; Young Teachers' Fund for Doctor Stations, Ministry of Education of China [20110142120042]; Scientific Research Fund for the Returned Overseas Chinese Scholars, Ministry of Education of China; State Key Laboratory of Freshwater Ecology and Biotechnology [2012FB02]; NSFC [31171387, 31000640, 81090113]; Hubei National Natural Science Foundation [2010CDB02402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teachers' Fund for Doctor Stations, Ministry of Education of China(Ministry of Education, China); Scientific Research Fund for the Returned Overseas Chinese Scholars, Ministry of Education of China; State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); Hubei National Natural Science Foundation	This work was supported by the following funds to A.Y.G: National Natural Science Foundation of China (31171271), Young Teachers' Fund for Doctor Stations, Ministry of Education of China (20110142120042), the Scientific Research Fund for the Returned Overseas Chinese Scholars, Ministry of Education of China, and fund from the State Key Laboratory of Freshwater Ecology and Biotechnology (2012FB02). This work was also supported by NSFC 31171387, 31000640, 81090113, Hubei National Natural Science Foundation Grant 2010CDB02402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Castro LFC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-132; Cossins J, 2002, DEVELOPMENT, V129, P2195; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Duncan EJ, 2010, GENOME RES, V20, P917, DOI 10.1101/gr.104794.109; Elsworth B, COMMUNICATION   0125; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2002, COLD SPRING HARB SYM, V67, P63, DOI 10.1101/sqb.2002.67.63; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hokamp Karsten, 2003, Journal of Structural and Functional Genomics, V3, P95, DOI 10.1023/A:1022661917301; Hong CC, 2008, CIRC RES, V103, P573, DOI 10.1161/CIRCRESAHA.108.180745; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huminiecki L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-146; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Katoh M, 2007, INT J ONCOL, V31, P461; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; de la Pompa JL, 2009, PEDIATR CARDIOL, V30, P643, DOI 10.1007/s00246-008-9368-z; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Morgenstern B, 1999, MOL BIOL EVOL, V16, P1654, DOI 10.1093/oxfordjournals.molbev.a026079; Mukhopadhyay A, 2009, DEV BIOL, V334, P142, DOI 10.1016/j.ydbio.2009.07.018; Murata J, 2009, J NEUROSCI RES, V87, P3521, DOI 10.1002/jnr.22169; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Ohno S., 1970, P1; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Richards GS, 2008, CURR BIOL, V18, P1156, DOI 10.1016/j.cub.2008.06.074; Rowlinson JM, 2010, BLOOD, V116, P2046, DOI 10.1182/blood-2009-11-252635; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Westerfield M, 1999, TRENDS GENET, V15, P248, DOI 10.1016/S0168-9525(99)01741-2; Wiese C, 2010, PEDIATR CARDIOL, V31, P363, DOI 10.1007/s00246-009-9609-9; Winkler C, 2003, DEV GENES EVOL, V213, P541, DOI 10.1007/s00427-003-0360-6; Xiang F, 2006, AM J PHYSIOL-HEART C, V290, pH1997, DOI 10.1152/ajpheart.01106.2005; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	74	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40649	10.1371/journal.pone.0040649	http://dx.doi.org/10.1371/journal.pone.0040649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808219	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700041
J	Vagasi, CI; Pap, PL; Vincze, O; Benko, Z; Marton, A; Barta, Z				Vagasi, Csongor I.; Pap, Peter L.; Vincze, Orsolya; Benko, Zoltan; Marton, Attila; Barta, Zoltan			Haste Makes Waste but Condition Matters: Molt Rate-Feather Quality Trade-Off in a Sedentary Songbird	PLOS ONE			English	Article							CURRENT REPRODUCTIVE EFFORT; SPARROW PASSER-DOMESTICUS; GREAT TIT; MIGRATORY BEHAVIOR; FLIGHT PERFORMANCE; BODY CONDITION; GROWTH-RATE; MASS; SELECTION; DURATION	Background: The trade-off between current and residual reproductive values is central to life history theory, although the possible mechanisms underlying this trade-off are largely unknown. The 'molt constraint' hypothesis suggests that molt and plumage functionality are compromised by the preceding breeding event, yet this candidate mechanism remains insufficiently explored. Methodology/Principal Findings: The seasonal change in photoperiod was manipulated to accelerate the molt rate. This treatment simulates the case of naturally late-breeding birds. House sparrows Passer domesticus experiencing accelerated molt developed shorter flight feathers with more fault bars and body feathers with supposedly lower insulation capacity (i.e. shorter, smaller, with a higher barbule density and fewer plumulaceous barbs). However, the wing, tail and primary feather lengths were shorter in fast-molting birds if they had an inferior body condition, which has been largely overlooked in previous studies. The rachis width of flight feathers was not affected by the treatment, but it was still condition-dependent. Conclusions/Significance: This study shows that sedentary birds might face evolutionary costs because of the molt rate-feather quality conflict. This is the first study to experimentally demonstrate that (1) molt rate affects several aspects of body feathers as well as flight feathers and (2) the costly effects of rapid molt are condition-specific. We conclude that molt rate and its association with feather quality might be a major mediator of life history trade-offs. Our findings also suggest a novel advantage of early breeding, i.e. the facilitation of slower molt and the condition-dependent regulation of feather growth.	[Vagasi, Csongor I.; Pap, Peter L.; Barta, Zoltan] Univ Debrecen, Dept Evolutionary Zool, H-4012 Debrecen, Hungary; [Vagasi, Csongor I.; Pap, Peter L.; Vincze, Orsolya; Benko, Zoltan; Marton, Attila] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, R-3400 Cluj Napoca, Romania; [Barta, Zoltan] Univ Debrecen, MTA DE Lendulet Behav Ecol Res Grp, H-4012 Debrecen, Hungary	University of Debrecen; Babes Bolyai University from Cluj; University of Debrecen	Vagasi, CI (corresponding author), Univ Debrecen, Dept Evolutionary Zool, H-4012 Debrecen, Hungary.	csongor.vagasi@vocs.unideb.hu	Marton, Attila/D-4023-2012; Vincze, Orsolya/AEQ-1159-2022; Vágási, Csongor I./AAU-4548-2020	Marton, Attila/0000-0002-8768-2248; Vincze, Orsolya/0000-0001-5789-2124; Vágási, Csongor I./0000-0002-8736-2391; Barta, Zoltan/0000-0002-7121-9865	Hungarian Ministry of Education and Culture [FNFRDL060701DN 46/2006]; Hungarian Academy of Sciences [2009A00031E]; OTKA [NF61143, K75696]; Romanian Ministry of Education and Research [PN II-RU TE 291/2010]; TAMOP [4.2.1./B-09/1/KONV-2010-0007]; European Social Fund; European Regional Development Fund	Hungarian Ministry of Education and Culture; Hungarian Academy of Sciences(Hungarian Academy of Sciences); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); TAMOP; European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission)	This work was supported by PhD scholarships from the Hungarian Ministry of Education and Culture (#FNFRDL060701DN 46/2006 to CIV) and the Hungarian Academy of Sciences (#2009A00031E to CIV), OTKA grant (#NF61143 to ZB), and partially supported by a research grant (#PN II-RU TE 291/2010 to PLP and CIV) of the Romanian Ministry of Education and Research and the TAMOP project (#4.2.1./B-09/1/KONV-2010-0007 to Z. Barta) which is implemented through the New Hungary Development Plan, co-financed by the European Social Fund and the European Regional Development Fund. During the preparation of the manuscript Z. Barta was supported by an OTKA grant (K75696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; Andersson Malte, 1994; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Broggi J, 2004, J ANIM ECOL, V73, P967, DOI 10.1111/j.0021-8790.2004.00872.x; Broggi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024942; Carr JM, 2012, BEHAV ECOL, V23, P434, DOI 10.1093/beheco/arr208; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2004, IBIS, V146, P493, DOI 10.1111/j.1474-919x.2004.00290.x; de la Hera I, 2010, J AVIAN BIOL, V41, P609, DOI 10.1111/j.1600-048X.2010.05075.x; de la Hera I, 2010, J AVIAN BIOL, V41, P342, DOI 10.1111/j.1600-048X.2009.04835.x; De La Hera I, 2009, ACTA ORNITHOL, V44, P95, DOI 10.3161/000164509X464939; de la Hera I, 2009, J AVIAN BIOL, V40, P461, DOI 10.1111/j.1600-048X.2008.04689.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; DesRochers DW, 2009, COMP BIOCHEM PHYS A, V152, P46, DOI 10.1016/j.cbpa.2008.08.034; Gienapp P, 2010, J EVOLUTION BIOL, V23, P715, DOI 10.1111/j.1420-9101.2010.01949.x; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Grubb T. C., 2006, PTILOCHRONOLOGY FEAT; Hall KSS, 2000, J AVIAN BIOL, V31, P583, DOI 10.1034/j.1600-048X.2000.310419.x; Helm B, 2005, J ORNITHOL, V146, P348, DOI 10.1007/s10336-005-0009-5; Helm B, 1999, AUK, V116, P589, DOI 10.2307/4089321; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Hinsley SA, 2003, IBIS, V145, P337, DOI 10.1046/j.1474-919X.2003.00167.x; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; Jovani R, 2004, J EVOLUTION BIOL, V17, P294, DOI 10.1111/j.1420-9101.2003.00680.x; Larsson K, 1996, HEREDITY, V76, P100, DOI 10.1038/hdy.1996.13; Legendre P., 2011, LMODEL2 MODEL 2 REGR; LESSELLS CM, 1989, CONDOR, V91, P210, DOI 10.2307/1368167; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Macleod R, 2005, J ANIM ECOL, V74, P292, DOI 10.1111/j.1365-2656.2005.00923.x; Merila J, 2001, J EVOLUTION BIOL, V14, P918, DOI 10.1046/j.1420-9101.2001.00353.x; MOLLER AP, 1995, BEHAV ECOL, V6, P242, DOI 10.1093/beheco/6.3.242; MOLLER AP, 1988, BEHAV ECOL SOCIOBIOL, V22, P373; Moreno-Rueda G, 2010, J EVOLUTION BIOL, V23, P2229, DOI 10.1111/j.1420-9101.2010.02090.x; MORTON GA, 1990, CONDOR, V92, P813, DOI 10.2307/1368717; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Pap PL, 2011, AUK, V128, P330, DOI 10.1525/auk.2011.10142; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Perrins, 1998, COMPLETE BIRDS W PAL; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasband W. S, 2008, IMAGEJ VERSION 1 41; Roff Derek, 2002, pi; Serra L, 2001, J AVIAN BIOL, V32, P377, DOI 10.1111/j.0908-8857.2001.320415.x; SMITH HG, 1991, BEHAV ECOL SOCIOBIOL, V28, P195; Svensson E, 1997, BEHAV ECOL, V8, P92, DOI 10.1093/beheco/8.1.92; Svensson E, 1999, BIOL J LINN SOC, V67, P263, DOI 10.1006/bijl.1998.0302; Swaddle JP, 1996, J AVIAN BIOL, V27, P103, DOI 10.2307/3677139; Swaddle JP, 2003, IBIS, V145, P457, DOI 10.1046/j.1474-919X.2003.00189.x; Vagasi CI, 2011, ARDEA, V99, P53, DOI 10.5253/078.099.0107; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; Wang X, 2012, J EVOLUTION BIOL, V25, P547, DOI 10.1111/j.1420-9101.2011.02449.x; Weber TP, 2005, BIOL LETT-UK, V1, P27, DOI 10.1098/rsbl.2004.0244; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1	65	57	58	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40651	10.1371/journal.pone.0040651	http://dx.doi.org/10.1371/journal.pone.0040651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808221	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400043
J	Wu, LJ; Xi, B; Hou, DQ; Zhao, XY; Liu, JT; Cheng, H; Zhou, X; Shen, Y; Wang, XY; Mi, J				Wu, Lijun; Xi, Bo; Hou, Dongqing; Zhao, Xiaoyuan; Liu, Junting; Cheng, Hong; Zhou, Xin; Shen, Yue; Wang, Xingyu; Mi, Jie			The SNP (rs2230500) in PRKCH Decreases the Risk of Carotid Intima-Media Thickness in a Chinese Young Adult Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PROTEIN-KINASE-C; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; COMPLEMENT C3; ATHEROSCLEROSIS; STROKE; ASSOCIATION; 3RD-COMPONENT; POLYMORPHISMS	Background: The SNP (rs2230500) in PRKCH (the gene encoding protein kinase C g) is associated with ischemic stroke and cerebral hemorrhage in the Chinese population, but the molecular mechanisms are not clear. The aim of the present study is to investigate the association between the SNP and atherosclerosis that is common pathological basis of ischemic stroke and cerebral hemorrhage. Methodology/Principal Findings: We examined the associations of the SNP with carotid intima-media thickness (CIMT), atherosclerosis diagnosed by CIMT, and factors related with inflammation in the Beijing Child Blood Pressure Study. A total of 1190 subjects participated in the follow-up study. The SNP was genotyped by allele-specific real-time PCR assay. The SNP (rs2230500) in PRKCH was significantly associated with CIMT (in far wall of left common carotid arteries, P = 0.016; in far wall of right common carotid arteries, P = 0.012) under a recessive model after adjustment for age, gender, smoking, and hypertension. The SNP was also significantly associated with complement C3 (P = 0.012) under a dominant model after adjustment for age, gender, and high sensitivity C-reactive protein. Conclusions/Significance: Our data provide evidence that the SNP (rs2230500) in PRKCH decreases the risk of CIMT that is a worthwhile predictor of stroke and complement system possibly mediates this process.	[Wu, Lijun; Hou, Dongqing; Zhao, Xiaoyuan; Liu, Junting; Cheng, Hong; Zhou, Xin; Shen, Yue; Mi, Jie] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Xi, Bo] Shandong Univ, Dept Maternal & Child Hlth Care, Sch Publ Hlth, Jinan 250100, Peoples R China; [Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Shandong University; Chinese Hypertension League	Wu, LJ (corresponding author), Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China.	jiemi@vip.163.com			National "Twelfth Five-Year" Plan for Science & Technology Support Program [2012BAI03B03]; Beijing Natural Science Foundation [7112018]; Beijing Key Science and Technology Program [D111100000611002]; National Natural Science Foundation of China [81172746]; Beijing Training Project for the Leading Talents in S T [2011LJ07]	National "Twelfth Five-Year" Plan for Science & Technology Support Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Key Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Training Project for the Leading Talents in S T	This study was supported by grants from the National "Twelfth Five-Year" Plan for Science & Technology Support Program (No. 2012BAI03B03), the Beijing Natural Science Foundation (No. 7112018), the Beijing Key Science and Technology Program (No. D111100000611002), the National Natural Science Foundation of China (No. 81172746), and the Beijing Training Project for the Leading Talents in S & T (No. 2011LJ07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WORLD HLTH STAT 2008; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Dernellis J, 2006, AM J CARDIOL, V97, P245, DOI 10.1016/j.amjcard.2005.08.027; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; Hu DY, 2008, NONINVASIVE DETECTIO, P37; Kastelein JJP, 2008, EUR HEART J, V29, P849, DOI 10.1093/eurheartj/ehn070; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; McGill HC, 1998, AM J CARDIOL, V82, p30T; Millonig G, 2002, ATHEROSCLEROSIS, V160, P441, DOI 10.1016/S0021-9150(01)00596-2; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oksjoki R, 2003, CURR OPIN LIPIDOL, V14, P477, DOI 10.1097/00041433-200310000-00008; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; Pham TNQ, 2003, NITRIC OXIDE-BIOL CH, V9, P123, DOI 10.1016/j.niox.2003.09.006; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scott J, 2004, CURR OPIN GENET DEV, V14, P271, DOI 10.1016/j.gde.2004.04.012; Serizawa M, 2008, ATHEROSCLEROSIS, V199, P340, DOI 10.1016/j.atherosclerosis.2007.11.009; Simon A, 2010, ARTERIOSCL THROM VAS, V30, P182, DOI 10.1161/ATVBAHA.109.196980; Szeplaki G, 2004, ATHEROSCLEROSIS, V177, P383, DOI 10.1016/j.atherosclerosis.2004.07.022; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; WHO Expert Committee, 1995, PHYS STAT UINT ANT; Wu LJ, 2009, STROKE, V40, P2973, DOI 10.1161/STROKEAHA.109.551747; Zureik M, 2003, HYPERTENSION, V41, P519, DOI 10.1161/01.HYP.0000054978.86286.92	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40606	10.1371/journal.pone.0040606	http://dx.doi.org/10.1371/journal.pone.0040606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808203	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400083
J	Wagele, B; Witting, M; Schmitt-Kopplin, P; Suhre, K				Waegele, Brigitte; Witting, Michael; Schmitt-Kopplin, Philippe; Suhre, Karsten			MassTRIX Reloaded: Combined Analysis and Visualization of Transcriptome and Metabolome Data	PLOS ONE			English	Article							MAPS	Systems Biology is a field in biological science that focuses on the combination of several or all "omics"-approaches in order to find out how genes, transcripts, proteins and metabolites act together in the network of life. Metabolomics as analog to genomics, transcriptomics and proteomics is more and more integrated into biological studies and often transcriptomic and metabolomic experiments are combined in one setup. At a first glance both data types seem to be completely different, but both produce information on biological entities, either transcripts or metabolites. Both types can be overlaid on metabolic pathways to obtain biological information on the studied system. For the joint analysis of both data types the MassTRIX webserver was updated. MassTRIX is freely available at www.masstrix.org.	[Waegele, Brigitte; Suhre, Karsten] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Waegele, Brigitte; Witting, Michael] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Witting, Michael; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Analyt BioGeoChem, Neuherberg, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany; [Suhre, Karsten] Educ City Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Wagele, B (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	schmitt-kopplin@helmholtz-muenchen.de	Suhre, Karsten/AAF-1778-2020; Witting, Michael/AAI-1338-2019; Schmitt-Kopplin, Philippe/H-6271-2011	Suhre, Karsten/0000-0001-9638-3912; Witting, Michael/0000-0002-1462-4426; Schmitt-Kopplin, Philippe/0000-0003-0824-2664	The ERA-NET PathoGenoMics (`Pathomics')	The ERA-NET PathoGenoMics (`Pathomics')	This work was supported by The ERA-NET PathoGenoMics (`Pathomics' to B.W. and M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Garcia-Alcalde F, 2011, BIOINFORMATICS, V27, P137, DOI 10.1093/bioinformatics/btq594; Huang N, 1999, J AM SOC MASS SPECTR, V10, P1166, DOI 10.1016/S1044-0305(99)00089-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Leader DP, 2011, RAPID COMMUN MASS SP, V25, P3422, DOI 10.1002/rcm.5245; Shinbo Y, 2006, BIOTECHNOLOGY AGR FO, P165; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810	11	70	71	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39860	10.1371/journal.pone.0039860	http://dx.doi.org/10.1371/journal.pone.0039860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22815716	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800023
J	Congdon, E; Service, S; Wessman, J; Seppanen, JK; Schonauer, S; Miettunen, J; Turunen, H; Koiranen, M; Joukamaa, M; Jarvelin, MR; Peltonen, L; Veijola, J; Mannila, H; Paunio, T; Freimer, NB				Congdon, Eliza; Service, Susan; Wessman, Jaana; Seppanen, Jouni K.; Schonauer, Stefan; Miettunen, Jouko; Turunen, Hannu; Koiranen, Markku; Joukamaa, Matti; Jarvelin, Marjo-Riitta; Peltonen, Leena; Veijola, Juha; Mannila, Heikki; Paunio, Tiina; Freimer, Nelson B.			Early Environment and Neurobehavioral Development Predict Adult Temperament Clusters	PLOS ONE			English	Article							MENTAL-HEALTH; SUBSTANCE USE; RISK-FACTORS; CHILDHOOD; PSYCHOPATHOLOGY; PROFILES; STRESS; BIRTH; DISORDERS; PRESCHOOL	Background: Investigation of the environmental influences on human behavioral phenotypes is important for our understanding of the causation of psychiatric disorders. However, there are complexities associated with the assessment of environmental influences on behavior. Methods/Principal Findings: We conducted a series of analyses using a prospective, longitudinal study of a nationally representative birth cohort from Finland (the Northern Finland 1966 Birth Cohort). Participants included a total of 3,761 male and female cohort members who were living in Finland at the age of 16 years and who had complete temperament scores. Our initial analyses (Wessman et al., in press) provide evidence in support of four stable and robust temperament clusters. Using these temperament clusters, as well as independent temperament dimensions for comparison, we conducted a data-driven analysis to assess the influence of a broad set of life course measures, assessed pre-natally, in infancy, and during adolescence, on adult temperament. Results: Measures of early environment, neurobehavioral development, and adolescent behavior significantly predict adult temperament, classified by both cluster membership and temperament dimensions. Specifically, our results suggest that a relatively consistent set of life course measures are associated with adult temperament profiles, including maternal education, characteristics of the family's location and residence, adolescent academic performance, and adolescent smoking. Conclusions: Our finding that a consistent set of life course measures predict temperament clusters indicate that these clusters represent distinct developmental temperament trajectories and that information about a subset of life course measures has implications for adult health outcomes.	[Congdon, Eliza; Service, Susan; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Wessman, Jaana; Seppanen, Jouni K.; Schonauer, Stefan; Mannila, Heikki] Univ Helsinki, Helsinki Inst Informat Technol, Helsinki, Finland; [Wessman, Jaana; Seppanen, Jouni K.; Schonauer, Stefan; Mannila, Heikki] Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland; [Wessman, Jaana; Turunen, Hannu; Peltonen, Leena; Paunio, Tiina] Natl Inst Hlth & Welf, Helsinki, Finland; [Wessman, Jaana; Turunen, Hannu; Peltonen, Leena; Paunio, Tiina] Inst Mol Med Finland, Helsinki, Finland; [Seppanen, Jouni K.; Veijola, Juha; Mannila, Heikki] Aalto Univ, Espoo, Finland; [Seppanen, Jouni K.; Veijola, Juha; Mannila, Heikki] Helsinki Inst Informat Technol, Espoo, Finland; [Miettunen, Jouko; Paunio, Tiina] Univ Oulu, Dept Psychiat, Oulu, Finland; [Miettunen, Jouko; Paunio, Tiina] Oulu Univ Hosp, Oulu, Finland; [Koiranen, Markku; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Joukamaa, Matti] Tampere Univ Hosp, Dept Psychiat, Tampere, Finland; [Joukamaa, Matti] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland	University of California System; University of California Los Angeles; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Aalto University; Aalto University; University of Helsinki; University of Oulu; University of Oulu; University of Oulu; Tampere University; Tampere University Hospital; Tampere University; Imperial College London; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; University of Helsinki; University of Oulu	Congdon, E (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	econgdon@ucla.edu	Miettunen, Jouko/AAC-4334-2019	Miettunen, Jouko/0000-0003-0575-2669; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	National Institutes of Health (NIH) (NIH Roadmap) [UL1-DE019580, RL1MH083268]; NIH/National Institute of Neurological Disorders and Stroke [T32 NS048004]; National Alliance for Research on Schizophrenia and Depression: Brain and Behavior Research Fund; Academy of Finland [125853]; Medical Research Council [G0801056B] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (NIH Roadmap)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Alliance for Research on Schizophrenia and Depression: Brain and Behavior Research Fund; Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants from the National Institutes of Health (NIH) (NIH Roadmap grants for the Consortium for Neuropsychiatric Phenomics, UL1-DE019580 and RL1MH083268, for EC, SS, NBF; an NIH/National Institute of Neurological Disorders and Stroke training grant T32 NS048004: NBF, PI, for EC); the National Alliance for Research on Schizophrenia and Depression: Brain and Behavior Research Fund (Independent Investigator Award to JM); and a grant from the Academy of Finland (#125853 for JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer JK, 2008, J CHILD PSYCHOL PSYC, V49, P1166, DOI 10.1111/j.1469-7610.2008.01943.x; Bongers IL, 2008, PSYCHOL MED, V38, P989, DOI 10.1017/S0033291707002309; Brenner V, 1998, J GENET PSYCHOL, V159, P251, DOI 10.1080/00221329809596149; Buu A, 2009, J STUD ALCOHOL DRUGS, V70, P489, DOI 10.15288/jsad.2009.70.489; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Chu AT, 2010, ANNU REV CLIN PSYCHO, V6, P469, DOI 10.1146/annurev.clinpsy.121208.131204; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Crockett LJ, 2006, DEV PSYCHOPATHOL, V18, P195, DOI 10.1017/S0954579406060111; Essex MJ, 2006, ARCH GEN PSYCHIAT, V63, P1246, DOI 10.1001/archpsyc.63.11.1246; Flouri E, 2010, EUR CHILD ADOLES PSY, V19, P535, DOI 10.1007/s00787-009-0068-x; Ford T, 2007, SOC PSYCH PSYCH EPID, V42, P953, DOI 10.1007/s00127-007-0272-2; Haapea M, 2008, SCAND J PUBLIC HEALT, V36, P728, DOI 10.1177/1403494808092250; Jansen P.W., 2008, SOCIAL PSYCHIAT PSYC, V44, P87; Janson H, 2008, DEV PSYCHOL, V44, P1314, DOI 10.1037/a0012713; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; KESSLER RC, 1985, ANNU REV PSYCHOL, V36, P531, DOI 10.1146/annurev.ps.36.020185.002531; Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019; Lengua LJ, 1998, CHILD DEV, V69, P164, DOI 10.1111/j.1467-8624.1998.tb06141.x; Miettunen J, 2004, ACTA PSYCHIAT SCAND, V110, P150, DOI 10.1111/j.1600-0047.2004.00344.x; Miettunen J, 2007, COMPR PSYCHIAT, V48, P161, DOI 10.1016/j.comppsych.2006.10.007; Mun EY, 2008, DEV PSYCHOPATHOL, V20, P291, DOI 10.1017/S095457940800014X; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Rettew DC, 2008, J AM ACAD CHILD PSY, V47, P273, DOI 10.1097/chi.0b013e318160b403; Robinson M, 2008, J CHILD PSYCHOL PSYC, V49, P1118, DOI 10.1111/j.1469-7610.2008.01955.x; Saudino KJ, 2005, J DEV BEHAV PEDIATR, V26, P214, DOI 10.1097/00004703-200506000-00010; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shiner R, 2003, J CHILD PSYCHOL PSYC, V44, P2, DOI 10.1111/1469-7610.00101	30	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e38065	10.1371/journal.pone.0038065	http://dx.doi.org/10.1371/journal.pone.0038065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815688	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900006
J	Gautami, B; Fonceka, D; Pandey, MK; Moretzsohn, MC; Sujay, V; Qin, HD; Hong, YB; Faye, I; Chen, XP; BhanuPrakash, A; Shah, TM; Gowda, MVC; Nigam, SN; Liang, XQ; Hoisington, DA; Guo, BZ; Bertioli, DJ; Rami, JF; Varshney, RK				Gautami, Bhimana; Fonceka, Daniel; Pandey, Manish K.; Moretzsohn, Marcio C.; Sujay, Venkataswamy; Qin, Hongde; Hong, Yanbin; Faye, Issa; Chen, Xiaoping; BhanuPrakash, Amindala; Shah, Trushar M.; Gowda, Makanahally V. C.; Nigam, Shyam N.; Liang, Xuanqiang; Hoisington, Dave A.; Guo, Baozhu; Bertioli, David J.; Rami, Jean-Francois; Varshney, Rajeev K.			An International Reference Consensus Genetic Map with 897 Marker Loci Based on 11 Mapping Populations for Tetraploid Groundnut (Arachis hypogaea L.)	PLOS ONE			English	Article							LINKAGE MAP; CULTIVATED PEANUT; RFLP MAP; SSR MARKERS; GENOME; RESISTANCE; BARLEY; MAIZE; TRAIT; QTLS	Only a few genetic maps based on recombinant inbred line (RIL) and backcross (BC) populations have been developed for tetraploid groundnut. The marker density, however, is not very satisfactory especially in the context of large genome size (2800 Mb/1C) and 20 linkage groups (LGs). Therefore, using marker segregation data for 10 RILs and one BC population from the international groundnut community, with the help of common markers across different populations, a reference consensus genetic map has been developed. This map is comprised of 897 marker loci including 895 simple sequence repeat (SSR) and 2 cleaved amplified polymorphic sequence (CAPS) loci distributed on 20 LGs (a01-a10 and b01-b10) spanning a map distance of 3, 863.6 cM with an average map density of 4.4 cM. The highest numbers of markers (70) were integrated on a01 and the least number of markers (21) on b09. The marker density, however, was lowest (6.4 cM) on a08 and highest (2.5 cM) on a01. The reference consensus map has been divided into 20 cM long 203 BINs. These BINs carry 1 (a10_02, a10_08 and a10_09) to 20 (a10_04) loci with an average of 4 marker loci per BIN. Although the polymorphism information content (PIC) value was available for 526 markers in 190 BINs, 36 and 111 BINs have at least one marker with >0.70 and >0.50 PIC values, respectively. This information will be useful for selecting highly informative and uniformly distributed markers for developing new genetic maps, background selection and diversity analysis. Most importantly, this reference consensus map will serve as a reliable reference for aligning new genetic and physical maps, performing QTL analysis in a multi-populations design, evaluating the genetic background effect on QTL expression, and serving other genetic and molecular breeding activities in groundnut.	[Gautami, Bhimana; Pandey, Manish K.; Sujay, Venkataswamy; BhanuPrakash, Amindala; Shah, Trushar M.; Nigam, Shyam N.; Hoisington, Dave A.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru 502324, Andhra Pradesh, India; [Fonceka, Daniel; Rami, Jean-Francois] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR Dev & Ameliorat Plantes, Montpellier, France; [Pandey, Manish K.; Qin, Hongde] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Pandey, Manish K.; Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Moretzsohn, Marcio C.] EMBRAPA Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil; [Sujay, Venkataswamy; Gowda, Makanahally V. C.] Univ Agr Sci UAS D, Dept Genet & Plant Breeding, Dharwad, Karnataka, India; [Qin, Hongde] HAAS, Cash Crop Res Inst, Wuhan, Hubei, Peoples R China; [Hong, Yanbin; Chen, Xiaoping; Liang, Xuanqiang; Varshney, Rajeev K.] GAAS, Crops Res Inst, Guangzhou, Guangdong, Peoples R China; [Faye, Issa] ISRA, CNRA, Bambey, Senegal; [Bertioli, David J.] Univ Brasilia, Dept Genet, Brasilia, DF, Brazil; [Varshney, Rajeev K.] CIMMYT, CGIAR Generat Challenge Programme GCP, Mexico City 06600, DF, Mexico	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CIRAD; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Guangdong Academy of Agricultural Sciences; Universidade de Brasilia; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Gautami, B (corresponding author), Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru 502324, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Moretzsohn, Marcio C/E-5517-2014; Varshney, Rajeev K/C-5295-2014	Moretzsohn, Marcio C/0000-0003-1708-1508; Varshney, Rajeev K/0000-0002-4562-9131; Pandey, Manish/0000-0002-4101-6530; Amindala, BhanuPrakash/0000-0001-8825-1370; Shah, Trushar/0000-0002-0091-7981	Generation Challenge Programme of Consultative Group on International Agricultural Research (CGIAR)	Generation Challenge Programme of Consultative Group on International Agricultural Research (CGIAR)	Financial support from Generation Challenge Programme (http://www.generationcp.org) of Consultative Group on International Agricultural Research (CGIAR) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Bohra A, 2012, THEOR APPL IN PRESS; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Chu Y, 2009, CROP SCI, V49, P2029, DOI 10.2135/cropsci2009.01.0021; Falque M, 2005, GENETICS, V170, P1957, DOI 10.1534/genetics.104.040204; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Feltus FA, 2006, THEOR APPL GENET, V112, P1295, DOI 10.1007/s00122-006-0232-3; Fonceka D., 2009, BMC PLANT BIOL, V12, P26, DOI [10.1186/1471-2229-12-26, DOI 10.1186/1471-2229-12-26]; Fonceka D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-103; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; GOBBI A, 2006, PLANT AN GEN 14 C SA, P679; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; HALWARD T, 1993, THEOR APPL GENET, V87, P379, DOI 10.1007/BF01184927; HAUGE BM, 1993, PLANT J, V3, P745, DOI 10.1111/j.1365-313X.1993.00745.x; Hong YB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-17; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; KIANIAN SF, 1992, THEOR APPL GENET, V84, P544, DOI 10.1007/BF00224150; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANGRIDGE P, 1995, MOL BREEDING, V1, P389, DOI 10.1007/BF01248416; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pandey MK, 2012, PLANT BREEDING, V131, P139, DOI 10.1111/j.1439-0523.2011.01911.x; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Sewell MM, 1999, GENETICS, V151, P321; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu Y, 2008, P LSS COMP SYST BIOI, P285	42	63	73	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41213	10.1371/journal.pone.0041213	http://dx.doi.org/10.1371/journal.pone.0041213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815973	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900099
J	Gekonge, B; Giri, MS; Kossenkov, AV; Nebozyhn, M; Yousef, M; Mounzer, K; Showe, L; Montaner, LJ				Gekonge, Bethsebah; Giri, Malavika S.; Kossenkov, Andrew V.; Nebozyhn, Michael; Yousef, Malik; Mounzer, Karam; Showe, Louise; Montaner, Luis J.			Constitutive Gene Expression in Monocytes from Chronic HIV-1 Infection Overlaps with Acute Toll-Like Receptor Induced Monocyte Activation Profiles	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MACROPHAGES; HUMAN MONOCYTE/MACROPHAGES; DENDRITIC CELLS; REPLICATION; INTERFERON; THERAPY; TARGET; RESTRICTION; RESPONSES	Elevated TLR expression/signalling in monocyte/macrophages has been shown to mediate systemic immune activation, a hallmark of progressive HIV-1 infection. Here we show, via differential gene expression comparisons, the presence of a constitutive in vivo TLR-like gene activation signature in steady-state circulating monocytes from chronically HIV-1 infected subjects. The TLR2-like gene signature was defined as an 82 gene subset of the 376 genes constitutively modulated in in vivo HIV-1 monocytes, based on their overlap with de novo TLR2-induced genes in uninfected subjects' monocytes following acute ex vivo stimulation with Staphylococcus Aureus Cowan (SAC). Additional comparison of in vivo gene networks with available datasets from acute TLR activations in M/M expanded the overlap to 151-gene concordance among the 376 differential genes with emphasis on ERK/MAPK, TNF/IL6 (NF kappa B) and p53 gene networks. TLR2 stimulation of monocytes from HIV-1 infected subjects resulted in further upregulation of inflammatory genes indicative of a sustained transcriptional potential upon stimulation. In summary, our data support the presence of a sustained TLR-like gene activation profile in circulating monocyte from steady-state viremia in HIV-1 infected subjects.	[Gekonge, Bethsebah; Giri, Malavika S.; Kossenkov, Andrew V.; Nebozyhn, Michael; Yousef, Malik; Showe, Louise; Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA USA; [Mounzer, Karam] Philadelphia Field Initiating Grp HIV 1 Trials, Philadelphia, PA USA	The Wistar Institute	Gekonge, B (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	montaner@wistar.org			National Institutes of Health [A1047760]; Philadelphia Foundation; Wistar Institute funds from the Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health CURE program; Wistar Cancer Center Support grant (National Cancer Institute) [P30 CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation; Wistar Institute funds from the Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health CURE program; Wistar Cancer Center Support grant (National Cancer Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grant A1047760, The Philadelphia Foundation, and Wistar Institute funds from the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health CURE program and a Wistar Cancer Center Support grant (National Cancer Institute grant P30 CA010815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Coberley CR, 2004, J VIROL, V78, P11477, DOI 10.1128/JVI.78.21.11477-11486.2004; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; GENDELMAN HE, 1990, J EXP MED, V172, P1433, DOI 10.1084/jem.172.5.1433; GESSANI S, 1994, RES IMMUNOL, V145, P659, DOI 10.1016/S0923-2494(05)80050-1; GESSANI S, 1994, J LEUKOCYTE BIOL, V56, P358, DOI 10.1002/jlb.56.3.358; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Giri MS, 2006, J LEUKOCYTE BIOL, V80, P1031, DOI 10.1189/jlb.0306157; Gorry Paul R, 2005, Methods Mol Biol, V304, P25; Heggelund L, 2004, CLIN EXP IMMUNOL, V138, P116, DOI 10.1111/j.1365-2249.2004.02595.x; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kari L, 2003, J EXP MED, V197, P1477, DOI 10.1084/jem.20021726; MCELRATH MJ, 1989, P NATL ACAD SCI USA, V86, P675, DOI 10.1073/pnas.86.2.675; Meier A, 2007, EXPERT REV ANTI-INFE, V5, P323, DOI 10.1586/14787210.5.3.323; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Papasavvas E, 2009, AIDS, V23, P369, DOI 10.1097/QAD.0b013e32831e9c76; Remer KA, 2006, J IMMUNOL METHODS, V313, P1, DOI 10.1016/j.jim.2005.07.026; Semnani RT, 2006, INFECT IMMUN, V74, P4409, DOI 10.1128/IAI.01106-05; Storey John D, 2003, Methods Mol Biol, V224, P149; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; SZEBENI J, 1991, J VIROL, V65, P6362, DOI 10.1128/JVI.65.11.6362-6364.1991; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Wallet MA, AIDS, V24, P1281; Woelk CH, 2004, AIDS RES HUM RETROV, V20, P1210, DOI 10.1089/aid.2004.20.1210; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	36	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41153	10.1371/journal.pone.0041153	http://dx.doi.org/10.1371/journal.pone.0041153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815948	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900083
J	Nidom, CA; Nakayama, E; Nidom, RV; Alamudi, MY; Daulay, S; Dharmayanti, INLP; Dachlan, YP; Amin, M; Igarashi, M; Miyamoto, H; Yoshida, R; Takada, A				Nidom, Chairul A.; Nakayama, Eri; Nidom, Reviany V.; Alamudi, Mohamad Y.; Daulay, Syafril; Dharmayanti, Indi N. L. P.; Dachlan, Yoes P.; Amin, Mohamad; Igarashi, Manabu; Miyamoto, Hiroko; Yoshida, Reiko; Takada, Ayato			Serological Evidence of Ebola Virus Infection in Indonesian Orangutans	PLOS ONE			English	Article							MARBURG; ECOLOGY; GLYCOPROTEIN; ANTIBODIES; VP40; BATS	Ebola virus (EBOV) and Marburg virus (MARV) belong to the family Filoviridae and cause severe hemorrhagic fever in humans and nonhuman primates. Despite the discovery of EBOV (Reston virus) in nonhuman primates and domestic pigs in the Philippines and the serological evidence for its infection of humans and fruit bats, information on the reservoirs and potential amplifying hosts for filoviruses in Asia is lacking. In this study, serum samples collected from 353 healthy Bornean orangutans (Pongo pygmaeus) in Kalimantan Island, Indonesia, during the period from December 2005 to December 2006 were screened for filovirus-specific IgG antibodies using a highly sensitive enzyme-linked immunosorbent assay (ELISA) with recombinant viral surface glycoprotein (GP) antigens derived from multiple species of filoviruses (5 EBOV and 1 MARV species). Here we show that 18.4% (65/353) and 1.7% (6/353) of the samples were seropositive for EBOV and MARV, respectively, with little cross-reactivity among EBOV and MARV antigens. In these positive samples, IgG antibodies to viral internal proteins were also detected by immunoblotting. Interestingly, while the specificity for Reston virus, which has been recognized as an Asian filovirus, was the highest in only 1.4% (5/353) of the serum samples, the majority of EBOV-positive sera showed specificity to Zaire, Sudan, Cote d'Ivoire, or Bundibugyo viruses, all of which have been found so far only in Africa. These results suggest the existence of multiple species of filoviruses or unknown filovirus-related viruses in Indonesia, some of which are serologically similar to African EBOVs, and transmission of the viruses from yet unidentified reservoir hosts into the orangutan populations. Our findings point to the need for risk assessment and continued surveillance of filovirus infection of human and nonhuman primates, as well as wild and domestic animals, in Asia.	[Nidom, Chairul A.; Nidom, Reviany V.; Alamudi, Mohamad Y.] Airlangga Univ, Avian Influenza Zoonosis Res Ctr, Surabaya, Indonesia; [Nidom, Chairul A.] Airlangga Univ, Fac Vet Med, Surabaya, Indonesia; [Nidom, Chairul A.; Nidom, Reviany V.; Alamudi, Mohamad Y.; Amin, Mohamad] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Nakayama, Eri; Miyamoto, Hiroko; Yoshida, Reiko; Takada, Ayato] Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Daulay, Syafril] Minist Agr, Ctr Diagnost Stand Agr Quarantine, Jakarta, Indonesia; [Dharmayanti, Indi N. L. P.] Indonesian Res Ctr Vet Sci, Minist Agr, Bogor, Indonesia; [Dachlan, Yoes P.] Airlangga Univ, Hosp Trop Dis, Surabaya, Indonesia; [Igarashi, Manabu] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Airlangga University; Airlangga University; Airlangga University; Hokkaido University; Ministry of Agricultire & Rural Development; Ministry of Agricultire & Rural Development; Airlangga University; Hokkaido University	Nidom, CA (corresponding author), Airlangga Univ, Avian Influenza Zoonosis Res Ctr, Surabaya, Indonesia.	nidomca@unair.ac.id; atakada@czc.hokudai.ac.jp	Takada, Ayato/A-6679-2012; Igarashi, Manabu/F-6871-2012; YOSHIDA, Reiko/F-6883-2012		Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Global COE Program from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare Japan; Ministry of Education and Culture, Indonesia	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education and Culture, Indonesia	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and the Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Grant-in-Aid for JSPS Fellows Japan. The work was further supported by a Grant-in-aid from the Ministry of Health, Labor and Welfare Japan, and by Ministry of Education and Culture, Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P49; Appleton BR, 2004, MOL PHYLOGENET EVOL, V31, P431, DOI 10.1016/j.ympev.2003.08.017; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; Corbet GB, 1992, MAMMALS INDO MALAYAN; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584; Feldmann H, 2004, TRENDS MICROBIOL, V12, P433, DOI 10.1016/j.tim.2004.08.009; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Fisher-Hoch SP, 1999, CURR TOP MICROBIOL, V235, P117; Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; MacNeil A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001175; Maryanto Ibnu, 2003, Mammal Study, V28, P111, DOI 10.3106/mammalstudy.28.111; Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281; Nakayama E, 2011, J INFECT DIS, V204, pS978, DOI 10.1093/infdis/jir334; Nakayama E, 2011, J DISASTER RES, V6, P381, DOI 10.20965/jdr.2011.p0381; Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pattnaik P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/rmv.495; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Rima BK, 2005, VIRUS RES, V111, P132, DOI 10.1016/j.virusres.2005.04.005; Takada A, 2003, J VIROL, V77, P1069, DOI 10.1128/JVI.77.2.1069-1074.2003; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Urata S, 2007, J VIROL, V81, P4895, DOI 10.1128/JVI.02829-06; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; WHO, 2009, WHOHSEEPR20092	33	29	35	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40740	10.1371/journal.pone.0040740	http://dx.doi.org/10.1371/journal.pone.0040740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815803	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900041
J	Zhu, ML; Wang, MG; Cao, ZG; He, J; Shi, TY; Xia, KQ; Qiu, LX; Wei, QY				Zhu, Mei-Ling; Wang, Mengyun; Cao, Zhi-Gang; He, Jing; Shi, Ting-Yan; Xia, Kai-Qin; Qiu, Li-Xin; Wei, Qing-Yi			Association between the ERCC5 Asp1104His Polymorphism and Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-G; NONMELANOMA SKIN-CANCER; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; NON-HODGKIN-LYMPHOMA; HUMAN XPG GENE; DNA-REPAIR; LUNG-CANCER; BREAST-CANCER	Background: Excision repair cross complementing group 5 (ERCC5 or XPG) plays an important role in regulating DNA excision repair, removal of bulky lesions caused by environmental chemicals or UV light. Mutations in this gene cause a rare autosomal recessive syndrome, and its functional single nucleotide polymorphisms (SNPs) may alter DNA repair capacity phenotype and cancer risk. However, a series of epidemiological studies on the association between the ERCC5 Asp1104His polymorphism (rs17655, G > C) and cancer susceptibility generated conflicting results. Methodology/Principal Findings: To derive a more precise estimation of the association between the ERCC5 Asp1104His polymorphism and overall cancer risk, we performed a meta-analysis of 44 published case-control studies, in which a total of 23,490 cases and 27,168 controls were included. To provide additional biological plausibility, we also assessed the genotype-gene expression correlation from the HapMap phase II release 23 data with 270 individuals from 4 ethnic populations. When all studies were pooled, we found no statistical evidence for a significantly increased cancer risk in the recessive genetic models (His/His vs. Asp/Asp: OR = 0.99, 95% CI: 0.92-1.06, P = 0.242 for heterogeneity or His/His vs. Asp/His + Asp/Asp: OR = 0.98, 95% CI: 0.93-1.03, P = 0.260 for heterogeneity), nor in further stratified analyses by cancer type, ethnicity, source of controls and sample size. In the genotype-phenotype correlation analysis from 270 individuals, we consistently found no significant correlation of the Asp1104His polymorphism with ERCC5 mRNA expression. Conclusions/Significance: This meta-analysis suggests that it is unlikely that the ERCC5 Asp1104His polymorphism may contribute to individual susceptibility to cancer risk.	[Zhu, Mei-Ling; He, Jing; Shi, Ting-Yan; Xia, Kai-Qin; Qiu, Li-Xin] Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai 200433, Peoples R China; [Zhu, Mei-Ling; Wang, Mengyun; Cao, Zhi-Gang; He, Jing; Shi, Ting-Yan; Xia, Kai-Qin; Qiu, Li-Xin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Zhu, Mei-Ling; Wang, Mengyun; He, Jing; Shi, Ting-Yan; Xia, Kai-Qin; Qiu, Li-Xin; Wei, Qing-Yi] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Cao, Zhi-Gang] Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai 200433, Peoples R China; [Cao, Zhi-Gang] Fudan Univ, Inst Canc, Shanghai 200433, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Zhu, ML (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai 200433, Peoples R China.	mdqiulixin@hotmail.com; weiqingyi@gmail.com	He, Jing/M-5774-2015	He, Jing/0000-0002-1954-2892	"China's Thousand Talents Program" Recruitment at Fudan University; Ministry of Health [201002007]; National Natural Science Foundation of China [81101808]	"China's Thousand Talents Program" Recruitment at Fudan University; Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from "China's Thousand Talents Program" Recruitment at Fudan University, a grant from the Ministry of Health (201002007) and the National Natural Science Foundation of China (81101808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; An J, 2007, CANCER EPIDEM BIOMAR, V16, P1633, DOI 10.1158/1055-9965.EPI-07-0252; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; Bartolucci R, 2009, CLIN LUNG CANCER, V10, P47, DOI 10.3816/CLC.2009.n.007; Berhane N, 2012, MOL BIOL REP, V39, P2471, DOI 10.1007/s11033-011-0998-5; Bessho T, 1999, NUCLEIC ACIDS RES, V27, P979, DOI 10.1093/nar/27.4.979; Biason P, 2011, PHARMACOGENOMICS J; Blankenburg S, 2005, EUR J HUM GENET, V13, P253, DOI 10.1038/sj.ejhg.5201296; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Canbay E, 2011, CURR MED RES OPIN, V27, P1295, DOI 10.1185/03007995.2011.573544; Canbay E, 2010, ANTICANCER RES, V30, P1359; Cao C, 2011, CHINESE MED J-PEKING, V124, P2203, DOI 10.3760/cma.j.issn.0366-6999.2011.14.022; Chang JS, 2008, INT J CANCER, V123, P2095, DOI 10.1002/ijc.23801; Chen B, 2011, J CANCER RES CLIN, V137, P939, DOI 10.1007/s00432-010-0956-y; Chen M, 2007, CARCINOGENESIS, V28, P2160, DOI 10.1093/carcin/bgm167; Cheng L, 2002, CANCER-AM CANCER SOC, V94, P393, DOI 10.1002/cncr.10231; Cheng L, 2000, CARCINOGENESIS, V21, P1527, DOI 10.1093/carcin/21.8.1527; Constantinou A, 1999, J BIOL CHEM, V274, P5637, DOI 10.1074/jbc.274.9.5637; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; Cui Y, 2006, INT J CANCER, V118, P714, DOI 10.1002/ijc.21413; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding DP, 2011, BREAST CANCER RES TR, V129, P203, DOI 10.1007/s10549-011-1447-9; Doherty JA, 2011, CANCER EPIDEM BIOMAR, V20, P1873, DOI 10.1158/1055-9965.EPI-11-0119; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Zein R, 2009, CANCER-AM CANCER SOC, V115, P1651, DOI 10.1002/cncr.24205; Emmert S, 2002, J INVEST DERMATOL, V118, P972, DOI 10.1046/j.1523-1747.2002.01782.x; Emmert S, 2001, NUCLEIC ACIDS RES, V29, P1443, DOI 10.1093/nar/29.7.1443; Fagbemi AF, 2011, DNA REPAIR, V10, P722, DOI 10.1016/j.dnarep.2011.04.022; Figl A, 2010, MUTAT RES-GEN TOX EN, V702, P8, DOI 10.1016/j.mrgentox.2010.06.011; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5; Goncalves FT, 2011, J DERMATOL SCI, V64, P59, DOI 10.1016/j.jdermsci.2011.06.003; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hanawalt PC, 2001, MUTAT RES-DNA REPAIR, V485, P3, DOI 10.1016/S0921-8777(00)00071-9; He XH, 2008, PATHOBIOLOGY, V75, P356, DOI 10.1159/000164220; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Hill DA, 2006, BLOOD, V108, P3161, DOI 10.1182/blood-2005-01-026690; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hongxia M, 2011, PHARMACOGENET GENOM; Hooker S, 2008, PROSTATE CANCER P D, V11, P349, DOI 10.1038/sj.pcan.4501027; Hsu MS, 2010, ANN SURG ONCOL, V17, P760, DOI 10.1245/s10434-009-0802-0; Hung RJ, 2008, CANCER EPIDEM BIOMAR, V17, P3081, DOI 10.1158/1055-9965.EPI-08-0411; Hung RJ, 2007, CANCER EPIDEM BIOMAR, V16, P2736, DOI 10.1158/1055-9965.EPI-07-0494; Hussain SK, 2009, CANCER EPIDEM BIOMAR, V18, P2304, DOI 10.1158/1055-9965.EPI-09-0233; Ibarrola-Villava M, 2011, EUR J CANCER; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Jeon HS, 2003, CARCINOGENESIS, V24, P1677, DOI 10.1093/carcin/bgg120; Jorgensen TJ, 2007, BREAST CANCER RES TR, V101, P65, DOI 10.1007/s10549-006-9263-3; Joshi AD, 2009, CARCINOGENESIS, V30, P472, DOI 10.1093/carcin/bgn260; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiyohara C, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701760; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Koeppel F, 2004, CLIN CANCER RES, V10, P5604, DOI 10.1158/1078-0432.CCR-04-0442; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; Kumar R, 2003, INT J CANCER, V103, P671, DOI 10.1002/ijc.10870; Le Morvan V, 2006, INT J CANCER, V119, P1732, DOI 10.1002/ijc.22009; Lee SK, 2002, CELL, V109, P823, DOI 10.1016/S0092-8674(02)00795-X; Li CX, 2010, MOL BIOL REP, V37, P301, DOI 10.1007/s11033-009-9693-1; Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672; Li Long-man, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P271, DOI 10.3760/cma.j.issn.1007-3418.2010.04.009; Li YC, 2007, EUR J HUM GENET, V15, P967, DOI 10.1038/sj.ejhg.5201855; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; Mechanic LE, 2006, CARCINOGENESIS, V27, P1377, DOI 10.1093/carcin/bgi330; Michiels S, 2007, CARCINOGENESIS, V28, P1731, DOI 10.1093/carcin/bgm111; Mocellin S, 2009, CARCINOGENESIS, V30, P1735, DOI 10.1093/carcin/bgp207; Mort R, 2003, BRIT J CANCER, V89, P333, DOI 10.1038/sj.bjc.6601061; Narter KF, 2009, ANTICANCER RES, V29, P1389; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Pabalan N, 2010, BREAST CANCER RES TR, V124, P531, DOI 10.1007/s10549-010-0863-6; Pan J, 2009, CARCINOGENESIS, V30, P785, DOI 10.1093/carcin/bgp058; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257; Qian BY, 2011, LUNG CANCER, V73, P138, DOI 10.1016/j.lungcan.2010.11.018; Qiu L, 2008, EUR J CANCER, V44, P2241, DOI 10.1016/j.ejca.2008.06.024; Qiu LX, 2010, BREAST CANCER RES TR, V124, P229, DOI 10.1007/s10549-010-0813-3; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rajaraman P, 2008, INT J CANCER, V123, P2713, DOI 10.1002/ijc.23779; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Rouissi K., 2011, Pathology & Oncology Research, V17, P879, DOI 10.1007/s12253-011-9398-3; Rouissi K, 2011, PATHOL ONCOL RES, V17, P879, DOI 10.1007/s12253-011-9398-3; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Sanyal S, 2004, CARCINOGENESIS, V25, P729, DOI 10.1093/carcin/bgh058; Scharer OD, 2008, DNA REPAIR, V7, P339, DOI 10.1016/j.dnarep.2007.10.007; SCHERLY D, 1993, NATURE, V363, P182, DOI 10.1038/363182a0; Shen J, 2006, CANCER EPIDEM BIOMAR, V15, P1614, DOI 10.1158/1055-9965.EPI-06-0218; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Shen M, 2007, HAEMATOLOGICA, V92, P1180, DOI 10.3324/haematol.11324; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stern MC, 2009, CANCER RES, V69, P6857, DOI 10.1158/0008-5472.CAN-09-1091; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; Thirumaran RK, 2006, CARCINOGENESIS, V27, P1676, DOI 10.1093/carcin/bgi381; Thorel F, 2004, MOL CELL BIOL, V24, P10670, DOI 10.1128/MCB.24.24.10670-10680.2004; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Vodicka P, 2007, CARCINOGENESIS, V28, P657, DOI 10.1093/carcin/bgl187; Wakasugi M, 1997, J BIOL CHEM, V272, P16030, DOI 10.1074/jbc.272.25.16030; Walsh CS, 2008, J CLIN ONCOL, V26, P2952, DOI 10.1200/JCO.2007.13.5806; Wang F, 2008, CANCER EPIDEM BIOMAR, V17, P507, DOI 10.1158/1055-9965.EPI-07-2507; Wang LE, 2007, CLIN CANCER RES, V13, P6532, DOI 10.1158/1078-0432.CCR-07-0969; Weiss JM, 2005, CANCER EPIDEM BIOMAR, V14, P2524, DOI 10.1158/1055-9965.EPI-05-0414; Weiss JM, 2006, GYNECOL ONCOL, V103, P891, DOI 10.1016/j.ygyno.2006.05.020; Wen H, 2009, INT UROL NEPHROL, V41, P855, DOI 10.1007/s11255-009-9560-y; Wen Shu-xin, 2006, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V28, P703; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; Wu XF, 2006, AM J HUM GENET, V78, P464, DOI 10.1086/500848; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yuan L, 2011, WORLD J GASTROENTERO, V17, P2343, DOI 10.3748/wjg.v17.i18.2343; Zheng W, 2011, BREAST CANCER RES TR, V128, P811, DOI 10.1007/s10549-011-1369-6	120	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e36293	10.1371/journal.pone.0036293	http://dx.doi.org/10.1371/journal.pone.0036293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815677	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900002
J	Daadi, MM; Grueter, BA; Malenka, RC; Redmond, DE; Steinberg, GK				Daadi, Marcel M.; Grueter, Brad A.; Malenka, Robert C.; Redmond, D. Eugene, Jr.; Steinberg, Gary K.			Dopaminergic Neurons from Midbrain-Specified Human Embryonic Stem Cell-Derived Neural Stem Cells Engrafted in a Monkey Model of Parkinson's Disease	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; SERUM-FREE SUSPENSION; IN-VITRO; ES CELLS; FUNCTIONAL ENGRAFTMENT; ADHERENT CULTURE; DIFFERENTIATION; PRECURSORS; GENERATION; GRAFTS	The use of human embryonic stem cells (hESCs) to repair diseased or injured brain is promising technology with significant humanitarian, societal and economic impact. Parkinson's disease (PD) is a neurological disorder characterized by the loss of midbrain dopaminergic (DA) neurons. The generation of this cell type will fulfill a currently unmet therapeutic need. We report on the isolation and perpetuation of a midbrain-specified self-renewable human neural stem cell line (hNSCs) from hESCs. These hNSCs grew as a monolayer and uniformly expressed the neural precursor markers nestin, vimentin and a radial glial phenotype. We describe a process to direct the differentiation of these hNSCs towards the DA lineage. Glial conditioned media acted synergistically with fibroblastic growth factor and leukemia inhibitory factor to induce the expression of the DA marker, tyrosine hydroxylase (TH), in the hNSC progeny. The glial-derived neurotrophic factor did not fully mimic the effects of conditioned media. The hNSCs expressed the midbrain-specific transcription factors Nurr1 and Pitx3. The inductive effects did not modify the level of the glutamic acid decarboxylase (GAD) transcript, a marker for GABAergic neurons, while the TH transcript increased 10-fold. Immunocytochemical analysis demonstrated that the TH-expressing cells did not co-localize with GAD. The transplantation of these DA-induced hNSCs into the non-human primate MPTP model of PD demonstrated that the cells maintain their DA-induced phenotype, extend neurite outgrowths and express synaptic markers.	[Daadi, Marcel M.; Steinberg, Gary K.] Stanford Sch Med, Dept Neurosurg, Stanford, CA USA; [Daadi, Marcel M.; Grueter, Brad A.; Malenka, Robert C.; Steinberg, Gary K.] Stanford Sch Med, Stanford Inst Neuro Innovat & Translat Neurosci, Stanford, CA USA; [Daadi, Marcel M.] Mol Med Res Inst, Sunnyvale, CA USA; [Redmond, D. Eugene, Jr.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Redmond, D. Eugene, Jr.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA	Stanford University; Stanford University; Yale University; Yale University	Daadi, MM (corresponding author), Stanford Sch Med, Dept Neurosurg, Stanford, CA USA.	mdaadi@stanford.edu		Steinberg, Gary/0000-0001-6374-1058; Grueter, Brad/0000-0002-4224-3866	William Randolph Hearst Foundation; Edward G. Hills Fund; Axion Research Foundation; St Kitts Biomedical Research Foundation; State of Connecticut under the Connecticut Stem Cell Research Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS040822] Funding Source: NIH RePORTER	William Randolph Hearst Foundation; Edward G. Hills Fund; Axion Research Foundation; St Kitts Biomedical Research Foundation; State of Connecticut under the Connecticut Stem Cell Research Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Russell and Elizabeth Siegelman, Bernard and Ronni Lacroute, William Randolph Hearst Foundation, Edward G. Hills Fund, Axion Research Foundation, St Kitts Biomedical Research Foundation and by the State of Connecticut under the Connecticut Stem Cell Research Grants Program. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the State of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Buytaert-Hoefen KA, 2004, STEM CELLS, V22, P669, DOI 10.1634/stemcells.22-5-669; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Daadi M, 1998, NEUROSCIENCE, V86, P867, DOI 10.1016/S0306-4522(98)00102-X; Daadi Marcel M, 2002, Methods Mol Biol, V198, P149; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Daadi Marcel M, 2011, Regen Med, V6, P25, DOI 10.2217/rme.11.85; Daadi MM, 2009, REGEN MED, V4, P251, DOI 10.2217/17460751.4.2.251; Daadi MM, 1999, J NEUROSCI, V19, P4484; Daadi MM, 2002, CONT NEUROS, P203; Dunnett SB, 2001, NAT REV NEUROSCI, V2, P365, DOI 10.1038/35072572; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hayashi H, 2008, EUR J NEUROSCI, V27, P261, DOI 10.1111/j.1460-9568.2008.06027.x; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Iacovitti L, 2007, BRAIN RES, V1127, P19, DOI 10.1016/j.brainres.2006.10.022; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Ko JY, 2009, MOL THER, V17, P1761, DOI 10.1038/mt.2009.148; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindvall O, 2003, PHARMACOL RES, V47, P279, DOI 10.1016/S1043-6618(03)00037-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; REDMOND DE, 1986, LANCET, V1, P1125; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Sladek JR, 2008, CELL TRANSPLANT, V17, P427; SLADEK JR, 1993, EXP NEUROL, V122, P16, DOI 10.1006/exnr.1993.1103; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Taylor JR, 1997, NEUROSCIENCE, V81, P745, DOI 10.1016/S0306-4522(97)00214-5; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	53	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41120	10.1371/journal.pone.0041120	http://dx.doi.org/10.1371/journal.pone.0041120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815935	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000069
J	Liu, WN; Fu, KL; Gao, HY; Shang, YY; Wang, ZH; Jiang, GH; Zhang, Y; Zhang, W; Zhong, M				Liu, Wen-Nan; Fu, Kai-Li; Gao, Hai-Yang; Shang, Yuan-Yuan; Wang, Zhi-Hao; Jiang, Gui-Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming			beta 1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to beta-Blocker Therapy and Prognosis	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; BETA(1)-ADRENERGIC RECEPTOR; ARG389GLY POLYMORPHISM; GENE POLYMORPHISMS; TASK-FORCE; ASSOCIATION; IMPROVEMENT; RISK; DESENSITIZATION; CARDIOMYOPATHY	Aims: The risk stratification of patients for heart failure (HF) remains a challenge, as well as the anticipation of the response to beta-blocker therapy. Since the pivotal role of beta 1 adrenergic receptor (beta 1-AR) in HF, many publications have studied the associations between the beta 1-AR polymorphisms (Ser49Gly and Arg389Gly) and HF, with inconsistent results. Thus, we performed a meta-analysis of studies to evaluate the impact of beta 1-AR polymorphisms on susceptibility to HF, the response to beta-blocker therapy and the prognosis of HF. Methods and Results: Electronic databases were systematically searched before August 2011. We extracted data sets and performed meta-analysis with standardized methods. A total of 27 studies met our inclusion criteria. It was found that in East Asians, the Gly389 allele and Gly389 homozygotes significantly increased the HF risk, while the Gly389 allele and Gly389 homozygotes trended to decrease the risk of HF in whites. With the similar reduction of heart rate, overall, the Arg389 homozygotes showed a better response to beta-blocker therapy. Furthermore, the Arg389 homozygotes were significantly associated with better LVEF improvement in East Asians and a mixed population. And in white people, the Arg389 homozygotes made a greater LVESd/v improvement and trended to be associated with better LVEDd/v improvement. However, the prognosis of Arg389 homozygotes HF patients was similar to those with Gly389 carriers. The Ser49Gly polymorphism did not impact the risk or prognosis of HF. Conclusion: Based on our meta-analysis, the Gly389 allele and Gly389 homozygotes were risk factors in East Asians while trending to protect whites against HF. Furthermore, Arg389 homozygote is significantly associated with a favorable response to beta-blocker treatment in HF patients. However, neither of the two polymorphisms is an independent predictor of the prognosis of HF.	[Liu, Wen-Nan; Fu, Kai-Li; Gao, Hai-Yang; Shang, Yuan-Yuan; Wang, Zhi-Hao; Jiang, Gui-Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Liu, Wen-Nan; Fu, Kai-Li; Gao, Hai-Yang; Shang, Yuan-Yuan; Wang, Zhi-Hao; Jiang, Gui-Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Chinese Minist Publ Hlth, Jinan, Peoples R China; [Liu, Wen-Nan; Fu, Kai-Li; Gao, Hai-Yang; Shang, Yuan-Yuan; Wang, Zhi-Hao; Jiang, Gui-Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan 250100, Peoples R China	Shandong University	Liu, WN (corresponding author), Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China.	zhongmingzm@gmail.com			Key Technologies Research and Development Program of Shandong Province [2006GG2202020, 2010G0020262]; Natural Science Foundation of Shandong Province [Y2005C11, ZR2009CM022, ZR2009CM025, BS2009YY026]; National Natural Science Foundation of China [30871038, 30971215, 81070192, 81070141, 81100605]; National Basic Research Program of China (973 Program) [2009CB521904]	Key Technologies Research and Development Program of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the research grants from Key Technologies Research and Development Program of Shandong Province (2006GG2202020 and 2010G0020262), the Natural Science Foundation of Shandong Province (Y2005C11, ZR2009CM022, ZR2009CM025 and BS2009YY026), the National Natural Science Foundation of China (30871038, 30971215, 81070192, 81070141 and 81100605) and the National Basic Research Program of China (973 Program, Grant No.: 2009CB521904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo ER, 2001, CIRCULATION, V104, P2194, DOI 10.1161/hc4301.098282; Biolo A, 2008, AM J CARDIOL, V102, P726, DOI 10.1016/j.amjcard.2008.04.070; BRODDE OE, 1991, PHARMACOL REV, V43, P203; Chen L, 2007, PHARMACOGENET GENOM, V17, P941, DOI 10.1097/FPC.0b013e3282ef7354; Covolo L, 2004, EUR HEART J, V25, P1534, DOI 10.1016/j.ehj.2004.06.015; Cresci S, 2009, J AM COLL CARDIOL, V54, P432, DOI 10.1016/j.jacc.2009.05.009; de Groote P, 2005, PHARMACOGENET GENOM, V15, P137, DOI 10.1097/01213011-200503000-00001; de Groote P, 2007, AM HEART J, V154, P589, DOI 10.1016/j.ahj.2007.05.013; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Forleo C, 2004, AM J MED, V117, P451, DOI 10.1016/j.amjmed.2004.04.012; Forleo C, 2007, J CARDIOVASC MED, V8, P589, DOI 10.2459/01.JCM.0000281710.51304.03; Fragoso JM, 2006, EXP MOL PATHOL, V80, P279, DOI 10.1016/j.yexmp.2005.12.005; Francis GS, 2003, AM HEART J, V145, P200, DOI 10.1067/mhj.2003.106; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; in B, 2011, MOL BIOL REP, V39, P563; Iwai C, 2002, CIRC J, V66, P723, DOI 10.1253/circj.66.723; Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014; Leineweber K, 2010, N-S ARCH PHARMACOL, V382, P357, DOI 10.1007/s00210-010-0548-z; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Li Ya-jie, 2011, Zhonghua Yi Xue Za Zhi, V91, P3115; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Liggett Stephen B, 2010, Heart Fail Clin, V6, P27, DOI 10.1016/j.hfc.2009.08.011; Liu J, 2003, CLIN PHARMACOL THER, V74, P372, DOI 10.1016/S0009-9236(03)00224-8; Lohse MJ, 2004, TRENDS MOL MED, V10, P55, DOI 10.1016/j.molmed.2003.12.004; Luo M, 2007, CHINESE MED J-PEKING, V120, P1720, DOI 10.1097/00029330-200710010-00016; Magnusson Y, 2005, CLIN PHARMACOL THER, V78, P221, DOI 10.1016/j.clpt.2005.06.004; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; McLean RC, CARDIOVASC DRUGS THE, V25, P251; Metra M, 2003, AM HEART J, V145, P292, DOI 10.1067/mhj.2003.105; Metra M, 2010, CARDIOVASC DRUG THER, V24, P49, DOI 10.1007/s10557-010-6220-5; Muthumala A, 2008, EUR J HEART FAIL, V10, P3, DOI 10.1016/j.ejheart.2007.11.008; Nonen S, 2005, BRIT J CLIN PHARMACO, V60, P414, DOI 10.1111/j.1365-2125.2005.02447.x; O'Connor CM, 2011, J AM COLL CARDIOL, V58, P915, DOI 10.1016/j.jacc.2011.03.057; Paczkowska A, 2009, KARDIOL POL, V67, P235; Perez JM, 2003, NAT MED, V9, P1300, DOI 10.1038/nm930; Petersen M, 2011, BRIT J CLIN PHARMACO, V71, P556, DOI 10.1111/j.1365-2125.2010.03868.x; Podlowski S, 2000, J MOL MED-JMM, V78, P87, DOI 10.1007/s001090000080; Rathz DA, 2003, J BIOL CHEM, V278, P10784, DOI 10.1074/jbc.M206054200; Seghatol FF, 2004, AM J CARDIOL, V93, P854, DOI 10.1016/j.amjcard.2003.12.023; Shin J, 2007, AM J CARDIOL, V99, P250, DOI 10.1016/j.amjcard.2006.08.020; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Terra Steven G, 2005, Pharmacogenet Genomics, V15, P227, DOI 10.1097/01213011-200504000-00006; Tesson F, 1999, J MOL CELL CARDIOL, V31, P1025, DOI 10.1006/jmcc.1999.0947; Wang LJ, 2010, J CARD FAIL, V16, P36, DOI 10.1016/j.cardfail.2009.08.003; Weir B.S., 1990, GENETIC DATA ANAL ME; White HL, 2003, EUR J HEART FAIL, V5, P463, DOI 10.1016/S1388-9842(03)00044-8; Woodiwiss AJ, 2008, CARDIOVASC J AFR, V19, P188; Yu Wen-ping, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P776	52	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e37659	10.1371/journal.pone.0037659	http://dx.doi.org/10.1371/journal.pone.0037659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815685	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000003
J	Yuan, P; Meng, K; Wang, YR; Luo, HY; Huang, HQ; Shi, PJ; Bai, YG; Yang, PL; Yao, B				Yuan, Peng; Meng, Kun; Wang, Yaru; Luo, Huiying; Huang, Huoqing; Shi, Pengjun; Bai, Yingguo; Yang, Peilong; Yao, Bin			Abundance and Genetic Diversity of Microbial Polygalacturonase and Pectate Lyase in the Sheep Rumen Ecosystem	PLOS ONE			English	Article							FIBROBACTER-SUCCINOGENES; BACTERIAL DIVERSITY; MOLECULAR DIVERSITY; PROTEIN; FIBER; IDENTIFICATION; TRANSITION; METAGENOME; RUMINICOLA; DISCOVERY	Background: Efficient degradation of pectin in the rumen is necessary for plant-based feed utilization. The objective of this study was to characterize the diversity, abundance, and functions of pectinases from microorganisms in the sheep rumen. Methodology/Principal Findings: A total of 103 unique fragments of polygalacturonase (PF00295) and pectate lyase (PF00544 and PF09492) genes were retrieved from microbial DNA in the rumen of a Small Tail Han sheep, and 66% of the sequences of these fragments had low identities (<65%) with known sequences. Phylogenetic tree building separated the PF00295, PF00544, and PF09492 sequences into five, three, and three clades, respectively. Cellulolytic and noncellulolytic Butyrivibrio, Prevotella, and Fibrobacter species were the major sources of the pectinases. The two most abundant pectate lyase genes were cloned, and their protein products, expressed in Escherichia coli, were characterized. Both enzymes probably act extracellularly as their nucleotide sequences contained signal sequences, and they had optimal activities at the ruminal physiological temperature and complementary pH-dependent activity profiles. Conclusion/Significance: This study reveals the specificity, diversity, and abundance of pectinases in the rumen ecosystem and provides two additional ruminal pectinases for potential industrial use under physiological conditions.	[Yuan, Peng; Meng, Kun; Wang, Yaru; Luo, Huiying; Huang, Huoqing; Shi, Pengjun; Bai, Yingguo; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Yuan, P (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	binyao@caas.net.cn			National Science and Technology Support program [2011BADB02]; China Modern Agriculture Research System [CARS-42]; national "948" project [2011-G7-4]	National Science and Technology Support program; China Modern Agriculture Research System; national "948" project	This research was supported by the National Science and Technology Support program (2011BADB02) and the China Modern Agriculture Research System (CARS-42) and the national "948" project (2011-G7-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, J BIOL CHEM, V282, P35328, DOI 10.1074/jbc.M705511200; AKIN DE, 1990, J DAIRY SCI, V73, P3023, DOI 10.3168/jds.S0022-0302(90)78989-8; AVGUSTIN G, 1994, INT J SYST BACTERIOL, V44, P246, DOI 10.1099/00207713-44-2-246; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bohannan BJM, 2003, CURR OPIN MICROBIOL, V6, P282, DOI 10.1016/S1369-5274(03)00055-9; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cai SC, 2010, APPL ENVIRON MICROB, V76, P3818, DOI 10.1128/AEM.03124-09; COLLMER A, 1988, METHOD ENZYMOL, V161, P329; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Dehority BA, 2000, APPL ENVIRON MICROB, V66, P2921, DOI 10.1128/AEM.66.7.2921-2927.2000; DEHORITY BA, 1969, J BACTERIOL, V99, P189, DOI 10.1128/JB.99.1.189-196.1969; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Dubey Amit Kumar, 2010, Enzyme Res, V2010, P950230, DOI 10.4061/2010/950230; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Galbraith EA, 2004, ENVIRON MICROBIOL, V6, P928, DOI 10.1111/j.1462-2920.2004.00575.x; Hespell RB, 1996, GASTROINTESTINAL MIC, P59; HOWARD BH, 1961, P NUTR SOC, V20, pR29; Huang HQ, 2011, ENVIRON MICROBIOL, V13, P747, DOI 10.1111/j.1462-2920.2010.02379.x; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kocherginskaya SA, 2001, ANAEROBE, V7, P119, DOI 10.1006/anae.2001.0378; LAGOWSKI JM, 1958, ARCH BIOCHEM BIOPHYS, V76, P306, DOI 10.1016/0003-9861(58)90156-5; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MATTE A, 1992, APPL ENVIRON MICROB, V58, P157, DOI 10.1128/AEM.58.1.157-168.1992; MICHAUX A, 1951, CR HEBD ACAD SCI, V232, P121; Mohamed SA, 2006, J BIOTECHNOL, V127, P54, DOI 10.1016/j.jbiotec.2006.06.009; Monteiro AC., 2009, OPEN BIOTECHNOL J, V3, P9, DOI [10.2174/1874070700903010009, DOI 10.2174/1874070700903010009]; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samsudin AA, 2011, ENVIRON MICROBIOL, V13, P3024, DOI 10.1111/j.1462-2920.2011.02579.x; Sawada K, 2001, BBA-GEN SUBJECTS, V1568, P162, DOI 10.1016/S0304-4165(01)00213-6; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shin EC, 2004, ANAEROBE, V10, P313, DOI 10.1016/j.anaerobe.2004.08.002; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Tajima K, 2000, ANAEROBE, V6, P273, DOI 10.1006/anae.2000.0353; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tuffin Marla, 2009, Biotechnology Journal, V4, P1671, DOI 10.1002/biot.200900235; VANGYLSWYK NO, 1990, FEMS MICROBIOL ECOL, V73, P243, DOI 10.1016/0378-1097(90)90737-B; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Wang GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016731; WELLS JE, 1995, APPL ENVIRON MICROB, V61, P1757, DOI 10.1128/AEM.61.5.1757-1762.1995; WILLIAMS AG, 1982, J APPL BACTERIOL, V52, P377, DOI 10.1111/j.1365-2672.1982.tb05068.x; WOJCIECHOWICZ M, 1979, APPL ENVIRON MICROB, V37, P136, DOI 10.1128/AEM.37.1.136-142.1979; Wright ADG, 2004, APPL ENVIRON MICROB, V70, P1263, DOI 10.1128/AEM.70.3.1263-1270.2004; Yuan P, 2011, PROCESS BIOCHEM, V46, P1921, DOI 10.1016/j.procbio.2011.06.023	52	17	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40940	10.1371/journal.pone.0040940	http://dx.doi.org/10.1371/journal.pone.0040940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815874	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000045
J	Cote, HCF; Soudeyns, H; Thorne, A; Alimenti, A; Lamarre, V; Maan, EJ; Sattha, B; Singer, J; Lapointe, N; Money, DM; Forbes, J				Cote, Helene C. F.; Soudeyns, Hugo; Thorne, Anona; Alimenti, Ariane; Lamarre, Valerie; Maan, Evelyn J.; Sattha, Beheroze; Singer, Joel; Lapointe, Normand; Money, Deborah M.; Forbes, John		CIHR Emerging Team HIV Therapy	Leukocyte Telomere Length in HIV-Infected and HIV-Exposed Uninfected Children: Shorter Telomeres with Uncontrolled HIV Viremia	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; QUANTITATIVE PCR; EROSION DYNAMICS; PATERNAL AGE; MAINTENANCE; DISEASE; CELLS; IMMUNOSENESCENCE; SENESCENCE; THERAPY	Objectives: Nucleoside reverse transcriptase inhibitors (NRTIs) used in HIV antiretroviral therapy can inhibit human telomerase reverse transcriptase. We therefore investigated whether in utero or childhood exposure to NRTIs affects leukocyte telomere length (LTL), a marker of cellular aging. Methods: In this cross-sectional CARMA cohort study, we investigated factors associated with LTL in HIV -1-infected (HIV+) children (n = 94), HIV-1-exposed uninfected (HEU) children who were exposed to antiretroviral therapy (ART) perinatally (n = 177), and HIV-unexposed uninfected (HIV-) control children (n = 104) aged 0-19 years. Univariate followed by multivariate linear regression models were used to examine relationships of explanatory variables with LTL for: a) all subjects, b) HIV+/HEU children only, and c) HIV+ children only. Results: After adjusting for age and gender, there was no difference in LTL between the 3 groups, when considering children of all ages together. In multivariate models, older age and male gender were associated with shorter LTL. For the HIV+ group alone, having a detectable HIV viral load was also strongly associated with shorter LTL (p = 0.007). Conclusions: In this large study, group rates of LTL attrition were similar for HIV+, HEU and HIV- children. No associations between children's LTL and their perinatal ART exposure or HIV status were seen in linear regression models. However, the association between having a detectable HIV viral load and shorter LTL suggests that uncontrolled HIV viremia rather than duration of ART exposure may be associated with acceleration of blood telomere attrition.	[Cote, Helene C. F.; Sattha, Beheroze; Singer, Joel] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Cote, Helene C. F.; Money, Deborah M.] Womens Hlth Res Inst, Vancouver, BC, Canada; [Cote, Helene C. F.] Ctr Blood Res, Vancouver, BC, Canada; [Soudeyns, Hugo] CHU St Justine, Ctr Rech, Unite Immunopathol Virale, Montreal, PQ, Canada; [Soudeyns, Hugo] Univ Montreal, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Soudeyns, Hugo; Lamarre, Valerie; Lapointe, Normand] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Thorne, Anona; Singer, Joel] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada; [Alimenti, Ariane; Forbes, John] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC, Canada; [Alimenti, Ariane; Maan, Evelyn J.; Forbes, John] Childrens & Womens Hlth Ctr BC, Vancouver, BC, Canada; [Lamarre, Valerie] CHU St Justine, Serv Malad Infect, Montreal, PQ, Canada; [Lapointe, Normand] CHU St Justine, Ctr Maternel & Infantile SIDA, Montreal, PQ, Canada; [Money, Deborah M.] BC Womens Hosp, Vancouver, BC, Canada; [Money, Deborah M.] Univ British Columbia, Fac Med, Dept Obstet & Gynaecol, Vancouver, BC, Canada	University of British Columbia; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; University of British Columbia; BC Women's Hospital & Health Centre; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of British Columbia; University of British Columbia	Cote, HCF (corresponding author), Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada.	helene.cote@ubc.ca	Montaner, Julio/K-7621-2012; Cote, Helene/K-7896-2012	Alimenti, Ariane/0000-0003-4999-8230	Canadian Institutes of Health Research (CIHR) operating grant [MOP-79331]; CIHR emerging team grant in HIV therapy and aging [HET-85515]; Reseau SIDA et maladies infectieuses, Fonds de la recherche en sante du Quebec (FRSQ); Michael Smith Foundation for Health Research (MSFHR) Scholar award [CI-SCH-50(02-1)]; CIHR New Investigator award [YSH-80511]; Canadian Foundation for Innovation (CFI)-New Opportunity award [10427]	Canadian Institutes of Health Research (CIHR) operating grant(Canadian Institutes of Health Research (CIHR)); CIHR emerging team grant in HIV therapy and aging(Canadian Institutes of Health Research (CIHR)); Reseau SIDA et maladies infectieuses, Fonds de la recherche en sante du Quebec (FRSQ); Michael Smith Foundation for Health Research (MSFHR) Scholar award(Michael Smith Foundation for Health Research); CIHR New Investigator award(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)-New Opportunity award	This research was supported in part by a Canadian Institutes of Health Research (CIHR) operating grant [MOP-79331] to HCFC, a CIHR emerging team grant in HIV therapy and aging [HET-85515] to HCFC, JF, DMM, NL, AA, and HS, and an infrastructure grant from the Reseau SIDA et maladies infectieuses, Fonds de la recherche en sante du Quebec (FRSQ) to HS. HCFC was partially supported by a Michael Smith Foundation for Health Research (MSFHR) Scholar award [CI-SCH-50(02-1)], a CIHR New Investigator award [YSH-80511] and a Canadian Foundation for Innovation (CFI)-New Opportunity award [10427]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo, 2011, REC US ANT DRUGS PRE; Aviv A, 2002, J MOL MED, V80, P689, DOI 10.1007/s00109-002-0377-8; Bazarbachi A, 2010, J CLIN ONCOL, V28, P4177, DOI 10.1200/JCO.2010.28.0669; Bestilny LJ, 2000, AIDS, V14, P771, DOI 10.1097/00002030-200005050-00002; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown T, 2003, ANN SURG ONCOL, V10, P910, DOI 10.1245/ASO.2003.03.032; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chappuy H, 2004, ANTIMICROB AGENTS CH, V48, P4332, DOI 10.1128/AAC.48.11.4332-4336.2004; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Datta A, 2006, BLOOD, V108, P1021, DOI 10.1182/blood-2006-01-0067; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; De Meyer T, 2011, AGEING RES REV, V10, P297, DOI 10.1016/j.arr.2010.11.001; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dock JN, 2011, AGING DIS, V2, P382; Effros RB, 2011, EXP GERONTOL, V46, P135, DOI 10.1016/j.exger.2010.08.027; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; Forbes JC, 2012, AIDS, V26, P757, DOI 10.1097/QAD.0b013e328350995c; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Gray GE, 2007, BRIT MED J, V334, P950, DOI 10.1136/bmj.39176.674977.AD; Hukazelie KC, 2011, CAN J INFECT DIS MED, p45B; Hunt PW, 2012, CURR HIV AIDS REP; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Liu XH, 2007, NUCLEIC ACIDS RES, V35, P7140, DOI 10.1093/nar/gkm859; Majerska J, 2011, MOL BIOSYST, V7, P1013, DOI 10.1039/c0mb00268b; Mayer S, 2006, CYTOGENET GENOME RES, V112, P194, DOI 10.1159/000089870; Moller P, 2009, AGING-US, V1, P733; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Oliveira LSB, 2010, CAN J INFECT DIS MED, V21, p32B; Olivero OA, 2002, J ACQ IMMUN DEF SYND, V29, P323; Pawelec G, 2004, TRENDS IMMUNOL, V25, P406, DOI 10.1016/j.it.2004.05.006; Peng Y, 2001, MOL CELL, V7, P1201, DOI 10.1016/S1097-2765(01)00268-4; Rickabaugh TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016459; Sanders J, 2011, J GERONTOL A; STRAHL C, 1994, NUCLEIC ACIDS RES, V22, P893, DOI 10.1093/nar/22.6.893; Strahl C, 1996, MOL CELL BIOL, V16, P53; Trudeau M. A., 2010, Current Pharmacogenomics & Personalized Medicine, V8, P7; van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; World Health Organization, 2021, ANT DRUGS TREAT PREG; Wright WE, 1996, DEV GENET, V18, P173; Yamaguchi T, 2001, Nucleic Acids Res Suppl, P211; Zeichner SL, 1999, BLOOD, V93, P2824; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	49	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39266	10.1371/journal.pone.0039266	http://dx.doi.org/10.1371/journal.pone.0039266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815702	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100017
J	Razafimandimbison, SG; Ekman, S; McDowell, TD; Bremer, B				Razafimandimbison, Sylvain G.; Ekman, Stefan; McDowell, Timothy D.; Bremer, Birgitta			Evolution of Growth Habit, Inflorescence Architecture, Flower Size, and Fruit Type in Rubiaceae: Its Ecological and Evolutionary Implications	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; BAYESIAN-ESTIMATION; L. RUBIACEAE; MORINDA L.; S. L.; PHYLOGENY; DIOECY; BIOMECHANICS; RUBIOIDEAE; INFERENCE	During angiosperm evolution, innovations in vegetative and reproductive organs have resulted in tremendous morphological diversity, which has played a crucial role in the ecological success of flowering plants. Morindeae (Rubiaceae) display considerable diversity in growth form, inflorescence architecture, flower size, and fruit type. Lianescent habit, head inflorescence, small flower, and multiple fruit are the predominant states, but arborescent habit, non-headed inflorescence, large flower, and simple fruit states occur in various genera. This makes Morindeae an ideal model for exploring the evolutionary appearances and transitions between the states of these characters. We reconstructed ancestral states for these four traits using a Bayesian approach and combined nuclear/chloroplast data for 61 Morindeae species. The aim was to test three hypotheses: 1) self-supporting habit is generally ancestral in clades comprising both lianescent and arborescent species; 2) changes from lianescent to arborescent habit are uncommon due to "a high degree of specialization and developmental burden''; 3) head inflorescences and multiple fruits in Morindeae evolved from non-headed inflorescences and simple fruits, respectively. Lianescent habit, head inflorescence, large flower, and multiple fruit are inferred for Morindeae, making arborescent habit, non-headed inflorescence, small flower, and simple fruit derived within the tribe. The rate of change from lianescent to arborescent habit is much higher than the reverse change. Therefore, evolutionary changes between lianescent and arborescent forms can be reversible, and their frequency and trends vary between groups. Moreover, these changes are partly attributed to a scarcity of host trees for climbing plants in more open habitats. Changes from large to small flowers might have been driven by shifts to pollinators with progressively shorter proboscis, which are associated with shifts in breeding systems towards dioecy. A single origin of dioecy from hermaphroditism is supported.	[Razafimandimbison, Sylvain G.; Bremer, Birgitta] Stockholm Univ, Bergius Fdn, Royal Swedish Acad Sci, S-10691 Stockholm, Sweden; [Razafimandimbison, Sylvain G.; Bremer, Birgitta] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Ekman, Stefan] Uppsala Univ, Museum Evolut, Uppsala, Sweden; [McDowell, Timothy D.] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA	Royal Swedish Academy of Sciences; Stockholm University; Stockholm University; Uppsala University; East Tennessee State University	Razafimandimbison, SG (corresponding author), Stockholm Univ, Bergius Fdn, Royal Swedish Acad Sci, S-10691 Stockholm, Sweden.	sylvain.razafimandimbison@bergianska.se	Razafimandimbison, Sylvain G./AAD-3437-2021		Swedish Research Council; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was supported by grants from the Swedish Research Council and the Knut and Alice Wallenberg Foundation to Birgitta Bremer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAWA KS, 1994, AM J BOT, V81, P456, DOI 10.2307/2445495; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; BAWA KS, 1975, EVOLUTION, V29, P167, DOI [10.2307/2407150, 10.1111/j.1558-5646.1975.tb00824.x]; BAWA KS, 1982, AM NAT, V119, P866, DOI 10.1086/283960; Burck MW, 1883, ANN JARD BOT BUITENZ, V3, P109; Burger W., 1993, FIELDIANA BOT, V33, P1, DOI DOI 10.5962/BHL.TITLE.2550; Corlett RT, 1998, BIOL REV, V73, P413, DOI 10.1017/S0006323198005234; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Endress P. K., 1994, DIVERSITY EVOLUTIONA; Endress PK, 2010, J SYST EVOL, V48, P225, DOI 10.1111/j.1759-6831.2010.00087.x; EYDE RH, 1985, ARNOLDIA, V45, P2; Feng CM, 2011, NEW PHYTOL, V191, P850, DOI 10.1111/j.1469-8137.2011.03716.x; Halford D. A., 2009, Austrobaileya, V8, P69; Halford D. A., 2009, Austrobaileya, V8, P81; HOLMGREN PK, 1990, INDEX HERBARIUM 1; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Johansson J.T., 1994, OPERA BOT, V122, P5; JOHANSSON JT, 1988, BLUMEA, V33, P265; Lahaye R, 2005, AM J BOT, V92, P1381, DOI 10.3732/ajb.92.8.1381; Liu Y, 2012, PLANT SYST EVOL, V298, P775, DOI 10.1007/s00606-011-0588-y; Maddison D., 1992, MACCLADE ANAL PHYLOG; MADDISON DR, 2007, MESQUITE MODULAR SYS; MUENCHOW GE, 1987, AM J BOT, V74, P287, DOI 10.2307/2444031; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Ortiz RDC, 2007, AM J BOT, V94, P1425, DOI 10.3732/ajb.94.8.1425; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Raju A. J. Solomon, 2004, Zoos' Print Journal, V19, P1595; Rambaut A., 2009, TRACER VERSION 1 5; Razafimandimbison SG, 2002, AM J BOT, V89, P1027, DOI 10.3732/ajb.89.7.1027; Razafimandimbison SG, 2002, ANN MO BOT GARD, V89, P1, DOI 10.2307/3298655; Razafimandimbison SG, 2008, MOL PHYLOGENET EVOL, V48, P207, DOI 10.1016/j.ympev.2008.03.034; Razafimandimbison SG, 2011, ADANSONIA, V33, P283, DOI 10.5252/a2011n2a13; Razafimandimbison Sylvain G., 2001, Systematics and Geography of Plants, V71, P515, DOI 10.2307/3668697; Razafimandimbison SG, 2010, J BIOGEOGR, V37, P520, DOI 10.1111/j.1365-2699.2009.02229.x; Razafimandimbison SG, 2009, MOL PHYLOGENET EVOL, V52, P879, DOI 10.1016/j.ympev.2009.04.007; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; RoBBRECHT E., 1988, OPERA BOT BELG, V1, P13, DOI DOI 10.2307/4110534; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Rowe N, 2005, NEW PHYTOL, V166, P61, DOI 10.1111/j.1469-8137.2004.01309.x; Speck T, 2003, REGNUM VEG, V141, P241; Tao C, 2011, FL CHINA, V19, P220; Taylor CM, 2010, NOVON, V20, P95, DOI 10.3417/2008085; Tetsuto A, 2006, ANN BOT, V98, P317; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Weller SG, 1999, ANNU REV ECOL SYST, V30, P167, DOI 10.1146/annurev.ecolsys.30.1.167; Whitlock BA, 2011, SYST BOT, V36, P129, DOI 10.1600/036364411X553216; WONG K M, 1984, Malayan Nature Journal, V38, P89; Xiang QY, 2008, J SYST EVOL, V46, P349, DOI 10.3724/SP.J.1002.2008.08056; [No title captured]	53	21	21	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40851	10.1371/journal.pone.0040851	http://dx.doi.org/10.1371/journal.pone.0040851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815842	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100082
J	Doss, MX; Di Diego, JM; Goodrow, RJ; Wu, YS; Cordeiro, JM; Nesterenko, VV; Barajas-Martinez, H; Hu, D; Urrutia, J; Desai, M; Treat, JA; Sachinidis, A; Antzelevitch, C				Doss, Michael Xavier; Di Diego, Jose M.; Goodrow, Robert J.; Wu, Yuesheng; Cordeiro, Jonathan M.; Nesterenko, Vladislav V.; Barajas-Martinez, Hector; Hu, Dan; Urrutia, Janire; Desai, Mayurika; Treat, Jacqueline A.; Sachinidis, Agapios; Antzelevitch, Charles			Maximum Diastolic Potential of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Depends Critically on I-Kr	PLOS ONE			English	Article							CARDIOVASCULAR PROGENITOR CELLS; CARDIAC MYOCYTES; DYNAMIC-MODEL; K+ CURRENTS; RABBIT; CHANNEL; DEVELOP; BARIUM	Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) hold promise for therapeutic applications. To serve these functions, the hiPSC-CM must recapitulate the electrophysiologic properties of native adult cardiomyocytes. This study examines the electrophysiologic characteristics of hiPSC-CM between 11 and 121 days of maturity. Embryoid bodies (EBs) were generated from hiPS cell line reprogrammed with Oct4, Nanog, Lin28 and Sox2. Sharp microelectrodes were used to record action potentials (AP) from spontaneously beating clusters (BC) micro-dissected from the EBs (n = 103; 37 degrees C) and to examine the response to 5 mu M E-4031 (n = 21) or BaCl2 (n = 22). Patch-clamp techniques were used to record I-Kr and I-K1 from cells enzymatically dissociated from BC (n = 49; 36 degrees C). Spontaneous cycle length (CL) and AP characteristics varied widely among the 103 preparations. E-4031 (5 mu M; n = 21) increased Bazett-corrected AP duration from 291.8 +/- 81.2 to 426.4 +/- 120.2 msec (p < 0.001) and generated early afterdepolarizations in 8/21 preparations. In 13/21 BC, E-4031 rapidly depolarized the clusters leading to inexcitability. BaCl2, at concentrations that selectively block I-K1 (50-100 mu M), failed to depolarize the majority of clusters (13/22). Patch-clamp experiments revealed very low or negligible I-K1 in 53% (20/38) of the cells studied, but presence of I-Kr in all (11/11). Consistent with the electrophysiological data, RT-PCR and immunohistochemistry studies showed relatively poor mRNA and protein expression of I-K1 in the majority of cells, but robust expression of I-Kr. In contrast to recently reported studies, our data point to major deficiencies of hiPSC-CM, with remarkable diversity of electrophysiologic phenotypes as well as pharmacologic responsiveness among beating clusters and cells up to 121 days post-differentiation (dpd). The vast majority have a maximum diastolic potential that depends critically on I-Kr due to the absence of I-K1. Thus, efforts should be directed at producing more specialized and mature hiPSC-CM for future therapeutic applications.	[Doss, Michael Xavier; Di Diego, Jose M.; Goodrow, Robert J.; Wu, Yuesheng; Cordeiro, Jonathan M.; Nesterenko, Vladislav V.; Barajas-Martinez, Hector; Hu, Dan; Urrutia, Janire; Desai, Mayurika; Treat, Jacqueline A.; Antzelevitch, Charles] Masonic Med Res Lab, Utica, NY USA; [Sachinidis, Agapios] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany	Masonic Medical Research Laboratory; University of Cologne	Doss, MX (corresponding author), Masonic Med Res Lab, Utica, NY USA.	didiego@mmrl.edu; ca@mmrl.edu	Sachinidis, Agapios/AAD-4178-2020; Urrutia, Janire/F-3089-2016; Sachinidis, Agapios/AAM-7988-2020; Jesudoss, Michael Xavier Doss/D-1983-2015	Urrutia, Janire/0000-0002-8546-292X; Antzelevitch, Charles/0000-0001-7349-1582; Cordeiro, Jonathan/0000-0002-4311-4599; Hu, Dan/0000-0002-0994-8434; Antzelevitch, Charles/0000-0001-5215-4667; Jesudoss, Michael Xavier Doss/0000-0001-6339-9782	New York Stem Cell Science (NYSTEM) [C026424]; National Institutes of Health (NIH) [HL47678]; American Heart Association (AHA) [11SDG5410034, 10GRNT4210016]; New York State and Florida Masons; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047678, R55HL047678] Funding Source: NIH RePORTER	New York Stem Cell Science (NYSTEM); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); New York State and Florida Masons; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by New York Stem Cell Science (NYSTEM) grant C026424 (CA), National Institutes of Health (NIH) grant HL47678 (CA), American Heart Association (AHA) grants 11SDG5410034 (MXD) and 10GRNT4210016 (JDD) and New York State and Florida Masons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chun KRJ, 2004, EXP MOL MED, V36, P367, DOI 10.1038/emm.2004.48; Cordeiro JM, 1998, J PHYSIOL-LONDON, V508, P811, DOI 10.1111/j.1469-7793.1998.811bp.x; Dumaine R, 2007, J MOL CELL CARDIOL, V42, P378, DOI 10.1016/j.yjmcc.2006.10.019; GILES WR, 1988, J PHYSIOL-LONDON, V405, P123, DOI 10.1113/jphysiol.1988.sp017325; Gunaseeli I, 2010, CURR MED CHEM, V17, P759, DOI 10.2174/092986710790514480; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; HIRANO Y, 1988, J PHYSIOL-LONDON, V395, P455, DOI 10.1113/jphysiol.1988.sp016929; IMOTO Y, 1987, AM J PHYSIOL, V252, pH325, DOI 10.1152/ajpheart.1987.252.2.H325; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; KOUMI S, 1995, CIRCULATION, V92, P164, DOI 10.1161/01.CIR.92.2.164; LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Pekkanen-Mattila M, 2010, EXP BIOL MED, V235, P522, DOI 10.1258/ebm.2010.009345; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu MH, 1999, EUROPACE, V1, P85, DOI 10.1053/eupc.1998.0022; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	25	111	114	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40288	10.1371/journal.pone.0040288	http://dx.doi.org/10.1371/journal.pone.0040288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22815737	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300048
J	Maille, A; Engelhart, L; Bourjade, M; Blois-Heulin, C				Maille, Audrey; Engelhart, Lucie; Bourjade, Marie; Blois-Heulin, Catherine			To Beg, or Not to Beg? That Is the Question: Mangabeys Modify Their Production of Requesting Gestures in Response to Human's Attentional States	PLOS ONE			English	Article							CERCOCEBUS-TORQUATUS-TORQUATUS; CHIMPANZEES PAN-TROGLODYTES; SOCIAL VISUAL-ATTENTION; RHESUS-MONKEYS; YOUNG CHIMPANZEES; CONTINGENCY TASK; DIFFERENTIAL USE; GORILLA-GORILLA; PONGO-PYGMAEUS; COMMUNICATION	Background: Although gestural communication is widespread in primates, few studies focused on the cognitive processes underlying gestures produced by monkeys. Methodology/Principal Findings: The present study asked whether red-capped mangabeys (Cercocebus torquatus) trained to produce visually based requesting gestures modify their gestural behavior in response to human's attentional states. The experimenter held a food item and displayed five different attentional states that differed on the basis of body, head and gaze orientation; mangabeys had to request food by extending an arm toward the food item (begging gesture). Mangabeys were sensitive, at least to some extent, to the human's attentional state. They reacted to some postural cues of a human recipient: they gestured more and faster when both the body and the head of the experimenter were oriented toward them than when they were oriented away. However, they did not seem to use gaze cues to recognize an attentive human: monkeys begged at similar levels regardless of the experimenter's eyes state. Conclusions/Significance: These results indicate that mangabeys lowered their production of begging gestures when these could not be perceived by the human who had to respond to it. This finding provides important evidence that acquired begging gestures of monkeys might be used intentionally.	[Maille, Audrey; Engelhart, Lucie; Blois-Heulin, Catherine] Univ Rennes 1, CNRS, UMR Ethos Ethol Anim & Humaine 6552, Biol Stn, Paimpont, France; [Bourjade, Marie] Aix Marseille Univ, Res Ctr Psychol Cognit Language & Emot, Aix En Provence, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; UDICE-French Research Universities; Aix-Marseille Universite	Maille, A (corresponding author), Univ Rennes 1, CNRS, UMR Ethos Ethol Anim & Humaine 6552, Biol Stn, Paimpont, France.	audrey.maille@univ-rennes1.fr		Bourjade, Marie/0000-0002-3216-8284	French National Research Agency [ANR-08-BLAN-0011_01]; French Ministery of Research	French National Research Agency(French National Research Agency (ANR)); French Ministery of Research(Ministry of Research, France)	This research was supported by a grant of the French National Research Agency (ANR-08-BLAN-0011_01) to Catherine Blois-Heulin, and a grant of the French Ministery of Research to Audrey Maille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiach-Serrano A, 2007, ANIM COGN, V10, P387, DOI 10.1007/s10071-007-0076-5; Anderson JR, 2010, AM J PRIMATOL, V72, P707, DOI 10.1002/ajp.20827; Anderson JR, 1996, BEHAV PROCESS, V37, P47, DOI 10.1016/0376-6357(95)00074-7; Anderson JR, 2001, J COMP PSYCHOL, V115, P282, DOI 10.1037/0735-7036.115.3.282; Arbib MA, 2008, CURR ANTHROPOL, V49, P1052, DOI 10.1086/593015; BLASCHKE M, 1987, ANIM BEHAV, V35, P1520, DOI 10.1016/S0003-3472(87)80023-4; Blois-Heulin C, 1999, FOLIA PRIMATOL, V70, P264, DOI 10.1159/000021705; Blois-Heulin C, 1999, FOLIA PRIMATOL, V70, P180, DOI 10.1159/000021695; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Call J., 2007, GESTURAL COMMUNICATI; Call Josep, 2007, P197; CAMPBELL R, 1990, NEUROPSYCHOLOGIA, V28, P1123, DOI 10.1016/0028-3932(90)90050-X; COUSSIKORBEL S, 1994, J COMP PSYCHOL, V108, P164, DOI 10.1037/0735-7036.108.2.164; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Gomez J, 2005, GESTURE, V5, P91, DOI [10.1075/gest.5.1-2.08gom, DOI 10.1075/GEST.5.1.08GOM, DOI 10.1075/GEST.5.1-2.08GOM]; Gomez Juan Carlos, 1996, P131; Gomez JC, 2007, CHILD DEV, V78, P729, DOI 10.1111/j.1467-8624.2007.01027.x; Hattori Y, 2007, ANIM COGN, V10, P141, DOI 10.1007/s10071-006-0049-0; Hattori Y, 2010, ANIM COGN, V13, P87, DOI 10.1007/s10071-009-0248-6; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; Kaminski J, 2004, ANIM COGN, V7, P216, DOI 10.1007/s10071-004-0214-2; Leavens DA, 1996, J COMP PSYCHOL, V110, P346, DOI 10.1037/0735-7036.110.4.346; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens David A., 2004, Interaction Studies, V5, P387, DOI 10.1075/is.5.3.05lea; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal K, 2012, PHILOS T R SOC B, V367, P118, DOI 10.1098/rstb.2011.0044; Liebal Katja, 2007, P69; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Mitchell RW, 1997, J COMP PSYCHOL, V111, P351, DOI 10.1037/0735-7036.111.4.351; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; Povinelli DJ, 1996, J COMP PSYCHOL, V110, P336, DOI 10.1037/0735-7036.110.4.336; Povinelli DJ, 2003, ANIM BEHAV, V66, P71, DOI 10.1006/anbe.2003.2195; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Sankey C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018331; Tempelmann S, 2011, ANIM COGN, V14, P433, DOI 10.1007/s10071-011-0378-5; Theall Laura A., 1999, Animal Cognition, V2, P207, DOI 10.1007/s100710050041; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; TOMASELLO M, 1985, J HUM EVOL, V14, P175, DOI 10.1016/S0047-2484(85)80005-1; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; WOODRUFF G, 1979, COGNITION, V7, P333, DOI 10.1016/0010-0277(79)90021-0	48	34	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41197	10.1371/journal.pone.0041197	http://dx.doi.org/10.1371/journal.pone.0041197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815969	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900097
J	Smart, CE; Amiri, MEA; Wronski, A; Dinger, ME; Crawford, J; Ovchinnikov, DA; Vargas, AC; Reid, L; Simpson, PT; Song, S; Wiesner, C; French, JD; Dave, RK; da Silva, L; Purdon, A; Andrew, M; Mattick, JS; Lakhani, SR; Brown, MA; Kellie, S				Smart, Chanel E.; Amiri, Marjan E. Askarian; Wronski, Ania; Dinger, Marcel E.; Crawford, Joanna; Ovchinnikov, Dmitry A.; Vargas, Ana Cristina; Reid, Lynne; Simpson, Peter T.; Song, Sarah; Wiesner, Christiane; French, Juliet D.; Dave, Richa K.; da Silva, Leonard; Purdon, Amy; Andrew, Megan; Mattick, John S.; Lakhani, Sunil R.; Brown, Melissa A.; Kellie, Stuart			Expression and Function of the Protein Tyrosine Phosphatase Receptor J (PTPRJ) in Normal Mammary Epithelial Cells and Breast Tumors	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; GENE-EXPRESSION; NONCODING RNA; CANCER; GROWTH; DEP-1; SURVIVAL; BRCA1; CD148; SUBTYPES	The protein tyrosine phosphatase receptor J, PTPRJ, is a tumor suppressor gene that has been implicated in a range of cancers, including breast cancer, yet little is known about its role in normal breast physiology or in mammary gland tumorigenesis. In this paper we show that PTPRJ mRNA is expressed in normal breast tissue and reduced in corresponding tumors. Meta-analysis revealed that the gene encoding PTPRJ is frequently lost in breast tumors and that low expression of the transcript associated with poorer overall survival at 20 years. Immunohistochemistry of PTPRJ protein in normal human breast tissue revealed a distinctive apical localisation in the luminal cells of alveoli and ducts. Qualitative analysis of a cohort of invasive ductal carcinomas revealed retention of normal apical PTPRJ localization where tubule formation was maintained but that tumors mostly exhibited diffuse cytoplasmic staining, indicating that dysregulation of localisation associated with loss of tissue architecture in tumorigenesis. The murine ortholog, Ptprj, exhibited a similar localisation in normal mammary gland, and was differentially regulated throughout lactational development, and in an in vitro model of mammary epithelial differentiation. Furthermore, ectopic expression of human PTPRJ in HC11 murine mammary epithelial cells inhibited dome formation. These data indicate that PTPRJ may regulate differentiation of normal mammary epithelia and that dysregulation of protein localisation may be associated with tumorigenesis.	[Smart, Chanel E.; Wronski, Ania; Wiesner, Christiane; French, Juliet D.; Purdon, Amy; Andrew, Megan; Brown, Melissa A.; Kellie, Stuart] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Smart, Chanel E.; Vargas, Ana Cristina; Reid, Lynne; Simpson, Peter T.; Song, Sarah; da Silva, Leonard; Lakhani, Sunil R.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Smart, Chanel E.; Vargas, Ana Cristina; Reid, Lynne; Simpson, Peter T.; da Silva, Leonard; Lakhani, Sunil R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Amiri, Marjan E. Askarian; Dinger, Marcel E.; Crawford, Joanna; Ovchinnikov, Dmitry A.; Song, Sarah; Dave, Richa K.; Purdon, Amy; Mattick, John S.; Kellie, Stuart] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, Dept Anat Pathol, Brisbane, Qld, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Queensland	Smart, CE (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	s.kellie@uq.edu.au	Vargas, Ana/GSE-1963-2022; Simpson, Peter/F-1225-2010; Mattick, John S/I-7789-2012; Da Silva, Leonard M/C-4562-2017; Askarian-Amiri, Marjan E./F-7910-2010; Ovchinnikov, Dmitry/J-7963-2014; Kellie, Stuart/A-6036-2010; French, Juliet/AAV-4435-2020; Lakhani, Sunil R/I-1970-2018; Mattick, John/ABH-6130-2020; Smart, Chanel E/C-9583-2011; French, Juliet D/A-4982-2011; Dinger, Marcel/N-1398-2019; Crawford, Joanna/F-9135-2013; Brown, Melissa A/F-1451-2010	Simpson, Peter/0000-0002-4816-8289; Mattick, John S/0000-0002-7680-7527; Da Silva, Leonard M/0000-0001-6751-6819; Askarian-Amiri, Marjan E./0000-0003-3524-9626; Ovchinnikov, Dmitry/0000-0001-9603-8385; French, Juliet/0000-0002-9770-0198; Lakhani, Sunil R/0000-0003-4067-2760; Mattick, John/0000-0002-7680-7527; Crawford, Joanna/0000-0003-0786-6889; Dinger, Marcel/0000-0003-4423-934X; Brown, Melissa/0000-0002-2830-9259; Kellie, Stuart/0000-0002-8163-1474	Queensland Cancer Fund project grant; National Breast Cancer Foundation; NHMRC	Queensland Cancer Fund project grant; National Breast Cancer Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a Queensland Cancer Fund project grant awarded to SK and MAB; a National Breast Cancer Foundation postdoctoral fellowship (JF) and an NHMRC Dora Lush scholarship (RKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bowen TJ, 2005, CANCER RES, V65, P8736, DOI 10.1158/0008-5472.CAN-05-1598; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Brown MA, 2002, TRANSGENIC RES, V11, P467, DOI 10.1023/A:1020348025139; Dave RK, 2009, EXP CELL RES, V315, P1734, DOI 10.1016/j.yexcr.2009.02.023; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Guddo F, 1998, J CLIN PATHOL, V51, P667, DOI 10.1136/jcp.51.9.667; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Iuliano R, 2004, ONCOGENE, V23, P8432, DOI 10.1038/sj.onc.1207766; Iuliano R, 2009, J BIOCHEM, V145, P377, DOI 10.1093/jb/mvn175; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Karagyozov L, 2008, NUCLEIC ACIDS RES, V36, P4443, DOI 10.1093/nar/gkn391; Keane MM, 1996, CANCER RES, V56, P4236; Kellie S, 2004, J CELL SCI, V117, P609, DOI 10.1242/jcs.00879; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Kroschewski R, 2004, NEWS PHYSIOL SCI, V19, P61, DOI 10.1152/nips.01501.2003; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Martelli ML, 1998, EXP CELL RES, V245, P195, DOI 10.1006/excr.1998.4257; Massa A, 2004, J BIOL CHEM, V279, P29004, DOI 10.1074/jbc.M403573200; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Omerovic J, 2010, BIOCHEM J, V426, P65, DOI 10.1042/BJ20091413; Osborne JM, 1998, J LEUKOCYTE BIOL, V64, P692, DOI 10.1002/jlb.64.5.692; Ostrovnaya I, 2010, STAT MED, V29, P1608, DOI 10.1002/sim.3866; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Sallee JL, 2009, J BIOL CHEM, V284, P14997, DOI 10.1074/jbc.M901901200; Saunus JM, 2007, FEBS LETT, V581, P3435, DOI 10.1016/j.febslet.2007.06.046; Smart CE, 2011, ONCOGENE, V30, P1597, DOI 10.1038/onc.2010.538; SMITH PJ, 1981, J AM STAT ASSOC, V76, P737, DOI 10.2307/2287541; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stepanek O, 2011, J BIOL CHEM, V286, P22101, DOI 10.1074/jbc.M110.196733; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; TAVERNA D, 1994, INT J CANCER, V56, P522, DOI 10.1002/ijc.2910560411; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Trapasso F, 2006, DNA CELL BIOL, V25, P376, DOI 10.1089/dna.2006.25.376; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yandell BS, 1997, PRACTICAL DATA ANAL; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	65	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40742	10.1371/journal.pone.0040742	http://dx.doi.org/10.1371/journal.pone.0040742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815804	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000029
J	Donier, E; Gomez-Sanchez, JA; Grijota-Martinez, C; Lakoma, J; Baars, S; Garcia-Alonso, L; Cabedo, H				Donier, Emanuelle; Antonio Gomez-Sanchez, Jose; Grijota-Martinez, Carmen; Lakoma, Jarmila; Baars, Sigrid; Garcia-Alonso, Luis; Cabedo, Hugo			L1CAM Binds ErbB Receptors through Ig-Like Domains Coupling Cell Adhesion and Neuregulin Signalling	PLOS ONE			English	Article							SENSORY AXON GUIDANCE; HUMAN L1-CAM; ACTIVATION; DROSOPHILA; MOLECULES; L1; SUPERFAMILY; KINASE; FAMILY; HER3	During nervous system development different cell-to-cell communication mechanisms operate in parallel guiding migrating neurons and growing axons to generate complex arrays of neural circuits. How such a system works in coordination is not well understood. Cross-regulatory interactions between different signalling pathways and redundancy between them can increase precision and fidelity of guidance systems. Immunoglobulin superfamily proteins of the NCAM and L1 families couple specific substrate recognition and cell adhesion with the activation of receptor tyrosine kinases. Thus it has been shown that L1CAM-mediated cell adhesion promotes the activation of the EGFR (erbB1) from Drosophila to humans. Here we explore the specificity of the molecular interaction between L1CAM and the erbB receptor family. We show that L1CAM binds physically erbB receptors in both heterologous systems and the mammalian developing brain. Different Ig-like domains located in the extracellular part of L1CAM can support this interaction. Interestingly, binding of L1CAM to erbB enhances its response to neuregulins. During development this may synergize with the activation of erbB receptors through L1CAM homophilic interactions, conferring diffusible neuregulins specificity for cells or axons that interact with the substrate through L1CAM.	[Donier, Emanuelle; Antonio Gomez-Sanchez, Jose; Grijota-Martinez, Carmen; Lakoma, Jarmila; Baars, Sigrid; Garcia-Alonso, Luis; Cabedo, Hugo] Univ Miguel Hernandez, Spanish Natl Res Council, Inst Neurociencias Alicante, Alacant, Spain; [Antonio Gomez-Sanchez, Jose; Cabedo, Hugo] Hosp Gen Univ Alicante, Fdn Comunidad Valenciana Invest, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); General University Hospital of Alicante	Donier, E (corresponding author), Univ Miguel Hernandez, Spanish Natl Res Council, Inst Neurociencias Alicante, Alacant, Spain.	lgalonso@umh.es; hugo.cabedo@umh.es	Sanchez, Jose Antonio Gomez/O-7034-2019; Cabedo, Hugo/F-9404-2016; Garcia-Alonso, Luis A/A-3403-2008; Gomez-Sanchez, Jose Antonio/M-6022-2015; Grijota-Martinez, Carmen/P-5093-2017	Sanchez, Jose Antonio Gomez/0000-0002-6746-1800; Cabedo, Hugo/0000-0002-1322-6290; Garcia-Alonso, Luis A/0000-0001-5866-3542; Gomez-Sanchez, Jose Antonio/0000-0002-6746-1800; Grijota-Martinez, Carmen/0000-0003-2656-9062	Conselleria Educacio Generalitat Valenciana [PROMETEO 2008/134]; Spanish MICINN [SAF2008-04106]; Junta para la Ampliacion de Estudios (JAE) Programme/Spanish National Research Council (CSIC) pre-doctoral fellowship	Conselleria Educacio Generalitat Valenciana; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta para la Ampliacion de Estudios (JAE) Programme/Spanish National Research Council (CSIC) pre-doctoral fellowship	This work has been funded by grants PROMETEO 2008/134 (Conselleria Educacio Generalitat Valenciana) to LGA and HC and SAF2008-04106 (Spanish MICINN) to HC. JL holds a Junta para la Ampliacion de Estudios (JAE) Programme/Spanish National Research Council (CSIC) pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2008, EMBO J, V27, P1549, DOI 10.1038/emboj.2008.86; Bechara A, 2007, ADV EXP MED BIOL, V600, P61; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Cabedo H, 2002, J BIOL CHEM, V277, P19905, DOI 10.1074/jbc.M201587200; CHAN SDH, 1995, J BIOL CHEM, V270, P22608, DOI 10.1074/jbc.270.38.22608; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Herron LR, 2009, BIOCHEM J, V419, P519, DOI 10.1042/BJ20082284; HO WH, 1995, J BIOL CHEM, V270, P26722; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Morante-Oria J, 2003, P NATL ACAD SCI USA, V100, P12468, DOI 10.1073/pnas.1633692100; Nagaraj K, 2009, HUM MOL GENET, V18, P3822, DOI 10.1093/hmg/ddp325; Pertusa M, 2007, J BIOL CHEM, V282, P28768, DOI 10.1074/jbc.M701878200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stein RA, 2000, J MOL EVOL, V50, P397, DOI 10.1007/s002390010043; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	26	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40674	10.1371/journal.pone.0040674	http://dx.doi.org/10.1371/journal.pone.0040674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815787	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100052
J	Li, XL; Montgomery, J; Cheng, W; Noh, JH; Hyde, DR; Li, L				Li, Xinle; Montgomery, Jake; Cheng, Wesley; Noh, Jung Hyun; Hyde, David R.; Li, Lei			Pineal Photoreceptor Cells Are Required for Maintaining the Circadian Rhythms of Behavioral Visual Sensitivity in Zebrafish	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; EMBRYONIC ZEBRAFISH; SPECTRAL SENSITIVITY; CONE PHOTORECEPTOR; ADULT ZEBRAFISH; ABLATION; RETINA; CLOCK; NITROREDUCTASE; ACHROMATOPSIA	In non-mammalian vertebrates, the pineal gland functions as the central pacemaker that regulates the circadian rhythms of animal behavior and physiology. We generated a transgenic zebrafish line [Tg(Gnat2:gal4-VP16/UAS:nfsB-mCherry)] in which the E. coli nitroreductase is expressed in pineal photoreceptor cells. In developing embryos and young adults, the transgene is expressed in both retinal and pineal photoreceptor cells. During aging, the expression of the transgene in retinal photoreceptor cells gradually diminishes. By 8 months of age, the Gnat2 promoter-driven nitroreductase is no longer expressed in retinal photoreceptor cells, but its expression in pineal photoreceptor cells persists. This provides a tool for selective ablation of pineal photoreceptor cells, i.e., by treatments with metronidazole. In the absence of pineal photoreceptor cells, the behavioral visual sensitivity of the fish remains unchanged; however, the circadian rhythms of rod and cone sensitivity are diminished. Brief light exposures restore the circadian rhythms of behavioral visual sensitivity. Together, the data suggest that retinal photoreceptor cells respond to environmental cues and are capable of entraining the circadian rhythms of visual sensitivity; however, they are insufficient for maintaining the rhythms. Cellular signals from the pineal photoreceptor cells may be required for maintaining the circadian rhythms of visual sensitivity.	[Li, Xinle; Montgomery, Jake; Cheng, Wesley; Noh, Jung Hyun; Hyde, David R.; Li, Lei] Univ Notre Dame, Dept Biol Sci, Ctr Zebrafish Res, Notre Dame, IN 46556 USA; [Li, Xinle; Li, Lei] Nankai Univ, Tianjin Key Lab Anim Models & Degenerat Neurol Di, Tianjin 300071, Peoples R China	University of Notre Dame; Nankai University	Li, XL (corresponding author), Univ Notre Dame, Dept Biol Sci, Ctr Zebrafish Res, Notre Dame, IN 46556 USA.	Li.78@nd.edu	Li, Lei/F-5722-2015	Li, Lei/0000-0001-9703-2102; Montgomery, Jacob/0000-0002-0178-982X	National Institutes of Health [R01EY013147]; National Natural Science Foundation of China [30970941, 81171066]; Tianjin Science and Technology Committee [08ZCKFSH04600, 12JCYBJC24000]; NATIONAL EYE INSTITUTE [R01EY013147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Committee; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health (R01EY013147), National Natural Science Foundation of China (30970941, 81171066), Tianjin Science and Technology Committee (08ZCKFSH04600, 12JCYBJC24000). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwardt BA, 2001, J NEUROCYTOL, V30, P493, DOI 10.1023/A:1015689116620; Bilotta J, 2001, DEV DYNAM, V222, P564, DOI 10.1002/dvdy.1188; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; Bridgewater JA, 1997, HUM GENE THER, V8, P709, DOI 10.1089/hum.1997.8.6-709; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Cameron DA, 2002, VISUAL NEUROSCI, V19, P365, DOI 10.1017/S0952523802192121; Cameron DA, 1997, J NEUROSCI, V17, P917; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; EDWARDS DI, 1993, J ANTIMICROB CHEMOTH, V31, P9, DOI 10.1093/jac/31.1.9; Emran F, 2010, P NATL ACAD SCI USA, V107, P6034, DOI 10.1073/pnas.0914718107; Falcon J, 1999, PROG NEUROBIOL, V58, P121, DOI 10.1016/S0301-0082(98)00078-1; Forsell J, 2001, J EXP BIOL, V204, P2517; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Kawakami K, 1998, GENE, V225, P17, DOI 10.1016/S0378-1119(98)00537-X; Kennedy BN, 2007, INVEST OPHTH VIS SCI, V48, P522, DOI 10.1167/iovs.06-0975; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kojima D, 2008, PHOTOCHEM PHOTOBIOL, V84, P1011, DOI 10.1111/j.1751-1097.2008.00363.x; LARISON KD, 1990, DEVELOPMENT, V109, P567; Li L, 1997, P NATL ACAD SCI USA, V94, P11645, DOI 10.1073/pnas.94.21.11645; Li L, 1998, VISUAL NEUROSCI, V15, P851, DOI 10.1017/S0952523898155050; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; Li P, 2008, J BIOL CHEM, V283, P31673, DOI 10.1074/jbc.M803875200; LINDMARK DG, 1976, ANTIMICROB AGENTS CH, V10, P476, DOI 10.1128/AAC.10.3.476; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Moss JB, 2009, DIABETES, V58, P1844, DOI 10.2337/db08-0628; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Ren JQ, 2004, VISION RES, V44, P2147, DOI 10.1016/j.visres.2004.03.022; ROBERTS JJ, 1986, BIOCHEM BIOPH RES CO, V140, P1073, DOI 10.1016/0006-291X(86)90744-8; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Saszik S, 1999, VISION RES, V39, P1051, DOI 10.1016/S0042-6989(98)00237-5; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Westerfield M, 1995, ZEBRAFISH BOOK; WILSON SW, 1991, DEVELOPMENT, V112, P723; WITKOVSKY P, 1992, PROGR RETINAL RES, V11, P247; Yu CJ, 2007, J EXP BIOL, V210, P676, DOI 10.1242/jeb.02694	39	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40508	10.1371/journal.pone.0040508	http://dx.doi.org/10.1371/journal.pone.0040508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815753	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100038
J	Ortiz-Sanchez, JM; Nichols, SE; Sayyah, J; Brown, JH; McCammon, A; Grant, BJ				Ortiz-Sanchez, Juan Manuel; Nichols, Sara E.; Sayyah, Jacqueline; Brown, Joan Heller; McCammon, Andrew; Grant, Barry J.			Identification of Potential Small Molecule Binding Pockets on Rho Family GTPases	PLOS ONE			English	Article							THROMBIN RECEPTOR; G-PROTEINS; KINASE; SIMULATION; DYNAMICS; TARGETS; RAS; TRANSFORMATION; ACTIVATION; EFFECTORS	Rho GTPases are conformational switches that control a wide variety of signaling pathways critical for eukaryotic cell development and proliferation. They represent attractive targets for drug design as their aberrant function and deregulated activity is associated with many human diseases including cancer. Extensive high-resolution structures (>100) and recent mutagenesis studies have laid the foundation for the design of new structure-based chemotherapeutic strategies. Although the inhibition of Rho signaling with drug-like compounds is an active area of current research, very little attention has been devoted to directly inhibiting Rho by targeting potential allosteric non-nucleotide binding sites. By avoiding the nucleotide binding site, compounds may minimize the potential for undesirable off-target interactions with other ubiquitous GTP and ATP binding proteins. Here we describe the application of molecular dynamics simulations, principal component analysis, sequence conservation analysis, and ensemble small-molecule fragment mapping to provide an extensive mapping of potential small-molecule binding pockets on Rho family members. Characterized sites include novel pockets in the vicinity of the conformationaly responsive switch regions as well as distal sites that appear to be related to the conformations of the nucleotide binding region. Furthermore the use of accelerated molecular dynamics simulation, an advanced sampling method that extends the accessible time-scale of conventional simulations, is found to enhance the characterization of novel binding sites when conformational changes are important for the protein mechanism.	[Ortiz-Sanchez, Juan Manuel; Nichols, Sara E.; McCammon, Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ortiz-Sanchez, Juan Manuel; Nichols, Sara E.; McCammon, Andrew] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Nichols, Sara E.; Sayyah, Jacqueline; Brown, Joan Heller; McCammon, Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [McCammon, Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Grant, Barry J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Ortiz-Sanchez, JM (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	juanma@ucsd.edu; bjgrant@umich.edu	McCammon, J. Andrew/AAG-1832-2021; Ortiz Sanchez, Juan Manuel/C-9311-2016	Grant, Barry/0000-0002-2215-4196; Ortiz Sanchez, Juan Manuel/0000-0003-1217-5740	National Institutes of Health; National Science Foundation; Howard Hughes Medical Institute; Center for Theoretical Biological Physics; Fulbright Commission; Generalitat de Catalunya; Direct For Mathematical & Physical Scien [1308264] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Center for Theoretical Biological Physics; Fulbright Commission; Generalitat de Catalunya(Generalitat de Catalunya); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health, National Science Foundation, Howard Hughes Medical Institute and the Center for Theoretical Biological Physics. JMOS acknowledges the Fulbright Commission and the Generalitat de Catalunya for a Fulbright and a Beatriu de Pinos postdoctoral grant, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abseher R, 1998, PROTEINS, V31, P370; Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Caves LSD, 1991, MOL DYNAMICS APPL MO, P27; Chen YT, 2008, BIOORG MED CHEM LETT, V18, P6406, DOI 10.1016/j.bmcl.2008.10.080; Deng J, 2011, J MED CHEM, V54, P4508, DOI 10.1021/jm200161c; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Elsawy KM, 2005, NUCLEIC ACIDS RES, V33, P5749, DOI 10.1093/nar/gki888; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang XG, 2010, J MED CHEM, V53, P5727, DOI 10.1021/jm100579r; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Grant BJ, 2010, BIOPHYS J, V99, pL87, DOI 10.1016/j.bpj.2010.10.020; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Grant BJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000325; Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hamelberg D, 2007, J CHEM PHYS, V127; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kitaoka Y, 2004, BRAIN RES, V1018, P111, DOI 10.1016/j.brainres.2004.05.070; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Lu Q, 2009, CURR MED CHEM, V16, P1355, DOI 10.2174/092986709787846569; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Post GR, 1996, MOL BIOL CELL, V7, P1679, DOI 10.1091/mbc.7.11.1679; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; Riganti C, 2008, MINI-REV MED CHEM, V8, P609, DOI 10.2174/138955708784534436; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schirok H, 2008, CHEMMEDCHEM, V3, P1893, DOI 10.1002/cmdc.200800211; Sebti SM, 2005, CANCER CELL, V7, P297, DOI 10.1016/j.ccr.2005.04.005; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Sun HW, 2007, WORLD J GASTROENTERO, V13, P3517, DOI 10.3748/wjg.v13.i25.3517; vanAalten DMF, 1997, BIOPHYS J, V73, P2891, DOI 10.1016/S0006-3495(97)78317-6; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527	65	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40809	10.1371/journal.pone.0040809	http://dx.doi.org/10.1371/journal.pone.0040809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815826	gold, Green Published			2022-12-27	WOS:000306466100071
J	Pettikiriarachchi, A; Gong, L; Perugini, MA; Devenish, RJ; Prescott, M				Pettikiriarachchi, Anne; Gong, Lan; Perugini, Matthew A.; Devenish, Rodney J.; Prescott, Mark			Ultramarine, a Chromoprotein Acceptor for Forster Resonance Energy Transfer	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; POCILLOPORIN PIGMENT; CRYSTAL-STRUCTURE; CELL-DEATH; BIOSENSORS; GFP; DYNAMICS; FRET	We have engineered a monomeric blue non-fluorescent chromoprotein called Ultramarine (fluorescence quantum yield, 0.001; epsilon (585) (nm), 64,000 M-1. cm(-1)) for use as a Forster resonance energy transfer acceptor for a number of different donor fluorescent proteins. We show its use for monitoring activation of caspase 3 in live cells using fluorescence lifetime imaging. Ultramarine has the potential to increase the number of cellular parameters that can be imaged simultaneously.	[Pettikiriarachchi, Anne; Gong, Lan; Devenish, Rodney J.; Prescott, Mark] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gong, Lan; Devenish, Rodney J.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Perugini, Matthew A.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic, Australia	Monash University; Monash University; La Trobe University	Pettikiriarachchi, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	Mark.Prescott@monash.edu	Gong, Lan/J-6368-2016; Gong, Lan/O-7886-2019	Gong, Lan/0000-0003-3136-1565; Gong, Lan/0000-0003-3136-1565; Perugini, Matthew/0000-0001-8052-5584				Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Battad JM, 2007, J MOL BIOL, V368, P998, DOI 10.1016/j.jmb.2007.02.007; Beddoe T, 2003, ACTA CRYSTALLOGR D, V59, P597, DOI 10.1107/S0907444902023466; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ding YD, 2011, ANAL CHEM, V83, P9687, DOI 10.1021/ac202595g; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Higgins GC, 2009, CELL MOL LIFE SCI, V66, P2773, DOI 10.1007/s00018-009-0079-2; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCN; Lalonde S, 2005, CURR OPIN PLANT BIOL, V8, P574, DOI 10.1016/j.pbi.2005.09.015; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Luo KQ, 2001, BIOCHEM BIOPH RES CO, V283, P1054, DOI 10.1006/bbrc.2001.4896; Mijaljica D, 2011, BIOSENSORS - EMERGING MATERIALS AND APPLICATIONS, P383; Miyawaki A, 2002, CELL STRUCT FUNCT, V27, P343, DOI 10.1247/csf.27.343; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Prescott M, 2003, J BIOL CHEM, V278, P251, DOI 10.1074/jbc.M204556200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2002, J BIOL CHEM, V277, P34168, DOI 10.1074/jbc.M112478200; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	28	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41028	10.1371/journal.pone.0041028	http://dx.doi.org/10.1371/journal.pone.0041028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815901	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100110
J	Selvarajah, S; Fong, AYY; Selvaraj, G; Haniff, J; Uiterwaal, CSPM; Bots, ML				Selvarajah, Sharmini; Fong, Alan Yean Yip; Selvaraj, Gunavathy; Haniff, Jamaiyah; Uiterwaal, Cuno S. P. M.; Bots, Michiel L.			An Asian Validation of the TIMI Risk Score for ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; FOLLOW-UP; STRATIFICATION; MANAGEMENT; THERAPY; STEMI; THROMBOLYSIS; MORTALITY; ADMISSION	Background: Risk stratification in ST-elevation myocardial infarction (STEMI) is important, such that the most resource intensive strategy is used to achieve the greatest clinical benefit. This is essential in developing countries with wide variation in health care facilities, scarce resources and increasing burden of cardiovascular diseases. This study sought to validate the Thrombolysis In Myocardial Infarction (TIMI) risk score for STEMI in a multi-ethnic developing country. Methods: Data from a national, prospective, observational registry of acute coronary syndromes was used. The TIMI risk score was evaluated in 4701 patients who presented with STEMI. Model discrimination and calibration was tested in the overall population and in subgroups of patients that were at higher risk of mortality; i.e., diabetics and those with renal impairment. Results: Compared to the TIMI population, this study population was younger, had more chronic conditions, more severe index events and received treatment later. The TIMI risk score was strongly associated with 30-day mortality. Discrimination was good for the overall study population (c statistic 0.785) and in the high risk subgroups; diabetics (c statistic 0.764) and renal impairment (c statistic 0.761). Calibration was good for the overall study population and diabetics, with chi(2) goodness of fit test p value of 0.936 and 0.983 respectively, but poor for those with renal impairment, chi(2) goodness of fit test p value of 0.006. Conclusions: The TIMI risk score is valid and can be used for risk stratification of STEMI patients for better targeted treatment.	[Selvarajah, Sharmini; Haniff, Jamaiyah] Kuala Lumpur Hosp, Clin Res Ctr, Clin Epidemiol Unit, Kuala Lumpur, Malaysia; [Selvarajah, Sharmini; Uiterwaal, Cuno S. P. M.; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Selvarajah, Sharmini] Univ Malaya, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Fong, Alan Yean Yip] Sarawak Gen Hosp, Clin Res Ctr, Kuching, Sarawak, Malaysia; [Fong, Alan Yean Yip] Sarawak Gen Hosp, Ctr Heart, Dept Cardiol, Kuching, Sarawak, Malaysia; [Selvaraj, Gunavathy] Natl Heart Assoc Malaysia, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Utrecht University; Utrecht University Medical Center; Universiti Malaya	Selvarajah, S (corresponding author), Kuala Lumpur Hosp, Clin Res Ctr, Clin Epidemiol Unit, Kuala Lumpur, Malaysia.	s.selvarajah@umcutrecht.nl	Selvarajah, Sharmini/I-1303-2014		University of Malaya/Ministry of Higher Education, Malaysia (UM/MOHE) High Impact Research Grant [E000014-20001]	University of Malaya/Ministry of Higher Education, Malaysia (UM/MOHE) High Impact Research Grant	This work was supported by a University of Malaya/Ministry of Higher Education, Malaysia (UM/MOHE) High Impact Research Grant (Grant number E000014-20001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Aragam KG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007947; Bazzino O, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.07.029; Braunwald E, 2000, EUR HEART J, V21, P2005; Cannon CP, 2002, CIRCULATION, V106, P1588, DOI 10.1161/01.CIR.0000030416.80014.F4; Danchin N, 2009, JACC-CARDIOVASC INTE, V2, P901, DOI 10.1016/j.jcin.2009.05.025; Danchin N, 2009, EUR HEART J SUPPL, V11, pC25, DOI 10.1093/eurheartj/sup007; de Boer SPM, 2011, AM HEART J, V161, P500, DOI 10.1016/j.ahj.2010.11.022; De Luca G, 2009, ATHEROSCLEROSIS, V207, P181, DOI 10.1016/j.atherosclerosis.2009.03.042; De Luca G, 2009, AM J EMERG MED, V27, P712, DOI 10.1016/j.ajem.2008.04.026; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fitchett D, 2001, CAN MED ASSOC J, V164, P1309; Foussas SG, 2005, AM J CARDIOL, V96, P533, DOI 10.1016/j.amjcard.2005.04.015; Frossard M, 2004, CIRCULATION, V110, P1392, DOI 10.1161/01.CIR.0000141575.92958.9C; Giraldez RR, 2009, AM HEART J, V157, P517, DOI 10.1016/j.ahj.2008.10.021; Go J, 2011, CORONARY ARTERY DIS, V22, P411, DOI 10.1097/MCA.0b013e3283487de2; Green S, 2009, ACCESS CARDIAC CARE; Institute for Public Health, 2008, 3 NAT HLTH MORB SURV; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Knol MJ, 2010, J CLIN EPIDEMIOL, V63, P728, DOI 10.1016/j.jclinepi.2009.08.028; Koyanagi R, 2008, CIRC J, V72, P1391, DOI 10.1253/circj.CJ-07-0712; Kozieradzka A, 2007, KARDIOL POL, V65, P788; Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-0; Lev EI, 2008, AM J CARDIOL, V102, P6, DOI 10.1016/j.amjcard.2008.02.088; Ministry of Health, 2008, CLIN PRACT GUID MAN; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; Valente S, 2009, INT J CARDIOL, V132, P84, DOI 10.1016/j.ijcard.2007.10.045; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; van Leeuwen M, 2009, DIABETES RES CLIN PR, V85, P96, DOI 10.1016/j.diabres.2009.04.025; Wan Ahmad WA, 2006, ANN REPORT NCVD ACS; Wan Ahmad WA, 2010, ANN REPORT NCVD ACS; Zhao L, 2009, J INVASIVE CARDIOL, V21, P493	34	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40249	10.1371/journal.pone.0040249	http://dx.doi.org/10.1371/journal.pone.0040249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815733	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100032
J	Xie, C; Song, LB; Wu, JH; Li, J; Yun, JP; Lai, JM; Xie, DY; Lin, BL; Yuan, YF; Li, MF; Gao, ZL				Xie, Chan; Song, Li-bing; Wu, Jue-heng; Li, Jun; Yun, Jing-ping; Lai, Jia-ming; Xie, Dong-ying; Lin, Bing-liang; Yuan, Yun-fei; Li, Mengfeng; Gao, Zhi-liang			Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3a	PLOS ONE			English	Article							X ANTIGEN EFFECTOR; STAGING SYSTEM; CANCER CELLS; HEPATITIS; EXPRESSION; ACTIVATION; SURVIVAL; GROWTH; RISK; GENE	Objective: The goal of the present study was to investigate the potential correlation between the expression level of upregulator of cell proliferation (URGCP/URG4) and the prognosis of hepatocellular carcinoma (HCC), and to examine the biological function of URGCP/URG4 in the progression of HCC, to better understand its underlying molecular mechanism in hepatic tumorigenesis. Design: URGCP/URG4 expression was analyzed in 15 HCC cell lines, in 278 archived paraffin-embedded HCC sections, and in 10 pairs of fresh HCC tumor and para-tumor non-cancerous tissues using immunohistochemistry (IHC) and Western blotting analysis (WB). The effect of URGCP/URG4 on cell proliferation and tumorigenesis was examined in vitro and in vivo. WB and luciferase reporter analyses were performed to identify the effects of URGCP/URG4-overexpression or -knockdown on expression of cell cycle regulators and transcriptional activity of FOXO3a. Results: IHC results revealed an upregulation of URGCP/URG4 in all HCC cell lines and fresh HCC samples as compared with normal liver cells and para-tumor tissues, respectively. URGCP/URG4 was also expressed at a high level in 122 of the 278 (43.8%) archived HCC specimens. The expression level of URGCP/URG4 was significantly correlated with clinical staging and poor patient survival of HCC in the study cohort, and in various clinical subgroups. Strikingly, ectopic expression of URGCP/URG4 induced proliferation and anchorage-independent growth of HCC cells, while silencing of URGCP/URG4 had the opposite effect. Furthermore, URGCP/URG4 overexpression in HCC cells increased cellular entry into the G1/S transitional phase, associated with downregulation of p27(Kip1) and p21(Cip1) and upregulation of cyclin D1. These effects were accompanied by enhanced Akt activity and reduced FOXO3a transcriptional activity. Conclusions: URGCP/URG4 plays an important role in promoting proliferation and tumorigenesis of HCC and may represent a novel prognostic biomarker and therapeutic target for this disease.	[Xie, Chan; Xie, Dong-ying; Lin, Bing-liang; Gao, Zhi-liang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Song, Li-bing] Sun Yat Sen Univ, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jue-heng] Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Li, Jun] Zhongshan Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Yun, Jing-ping] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Lai, Jia-ming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Yuan, Yun-fei] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Chan; Li, Mengfeng; Gao, Zhi-liang] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xie, C (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	limf@mail.sysu.edu.cn; gaozl@yahoo.com.cn	meng, li/GVT-2063-2022; Song, LB/AAL-1968-2020	Yuan, Yunfei/0000-0003-2467-3683	National Grand Program on Key Infectious Disease in the Treatment and Prevention of Infectious Diseases of AIDS and viral hepatitis, China [2012ZX10002007]; National Program on Key Basic Research Project (973 Program) [2011CB11305, 2012CB519003]; Natural Science Foundation of China [81101864, 81071647]; Key Science and Technique Research Project of Guangdong Province [2010B030600003]; National Science and Technique Major Project [201005022-2]	National Grand Program on Key Infectious Disease in the Treatment and Prevention of Infectious Diseases of AIDS and viral hepatitis, China; National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technique Research Project of Guangdong Province; National Science and Technique Major Project	This work was supported by the National Grand Program on Key Infectious Disease in the Treatment and Prevention of Infectious Diseases of AIDS and viral hepatitis, China (No. 2012ZX10002007); the National Program on Key Basic Research Project (973 Program, No. 2011CB11305, No. 2012CB519003); Natural Science Foundation of China(No. 81101864; No. 81071647); The Key Science and Technique Research Project of Guangdong Province (No. 2010B030600003); National Science and Technique Major Project (No. 201005022-2).] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2008, ANN ONCOL, V19, P315, DOI 10.1093/annonc/mdm429; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Brognard J, 2001, CANCER RES, V61, P3986; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Du R, 2010, BIOCHEM BIOPH RES CO, V391, P135, DOI 10.1016/j.bbrc.2009.11.019; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Fan R, 2011, INT J CANCER, V128, P2980, DOI 10.1002/ijc.25624; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang JH, 2009, PATHOLOGY, V41, P149, DOI 10.1080/00313020802436808; Ito Y, 1999, HEPATOLOGY, V30, P90, DOI 10.1002/hep.510300114; Kaseb AO, 2011, CANCER-AM CANCER SOC, V117, P2478, DOI 10.1002/cncr.25791; Kim BC, 2008, BMB REP, V41, P728, DOI 10.5483/BMBRep.2008.41.10.728; Kinugasa H, 2012, J GASTROENTEROL, V47, P421, DOI 10.1007/s00535-011-0492-9; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; Krasilnikov M, 2003, ONCOGENE, V22, P4092, DOI 10.1038/sj.onc.1206598; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Lian ZR, 2006, HEPATOLOGY, V43, P415, DOI 10.1002/hep.21053; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lu MD, 2009, PATHOL ONCOL RES, V15, P679, DOI 10.1007/s12253-009-9171-z; Manghisi G, 1998, HEPATOLOGY, V28, P751; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Nie Y, 2011, J HEPATOL, V54, pS441, DOI 10.1016/S0168-8278(11)61117-3; Pan JB, 2007, J GEN VIROL, V88, P3275, DOI 10.1099/vir.0.83214-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng SY, 1998, J HEPATOL, V29, P281, DOI 10.1016/S0168-8278(98)80014-7; Qiu JL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-166; Sasaki Y, 2006, ANN SURG, V244, P771, DOI 10.1097/01.sla.0000225126.56483.b3; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Song JG, 2006, NEOPLASIA, V8, P995, DOI 10.1593/neo.06592; Sonoda Y, 2001, CANCER RES, V61, P6674; Tufan NLS, 2002, NEOPLASIA, V4, P355, DOI 10.1038/sj.neo.7900241; Wang JH, 2008, EUR J CANCER, V44, P1000, DOI 10.1016/j.ejca.2008.02.018; WANG WL, 1991, HEPATOLOGY, V14, P29, DOI 10.1002/hep.1840140106	42	28	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40607	10.1371/journal.pone.0040607	http://dx.doi.org/10.1371/journal.pone.0040607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815774	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100045
J	Biasiolo, A; Tono, N; Ruvoletto, M; Quarta, S; Turato, C; Villano, G; Beneduce, L; Fassina, G; Merkel, C; Gatta, A; Pontisso, P				Biasiolo, Alessandra; Tono, Natascia; Ruvoletto, Mariagrazia; Quarta, Santina; Turato, Cristian; Villano, Gianmarco; Beneduce, Luca; Fassina, Giorgio; Merkel, Carlo; Gatta, Angelo; Pontisso, Patrizia			IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN-M; IMMUNE-COMPLEXES; CERVICAL-CANCER; SCC ANTIGEN; INHIBITOR; EXPRESSION; APOPTOSIS	Background: Epidemiological studies indicate that a growing number of cirrhotic patients will develop hepatocellular carcinoma (HCC) in the next decade. Recent findings have demonstrated that Squamous cell carcinoma antigen 1 (SCCA1) and 2 (SCCA2) isoforms, now classified as serpinB3 and serpinB4, are over-expressed in HCC, but not in normal liver. As reported, high levels of circulating SCCA-IgM immunocomplexes in patients with cirrhosis are significantly associated with HCC development. Aim: To ascertain whether IgM-linked SCCA isoforms circulate in patients with chronic liver disease, compared to total SCCA-IgM levels. Methodology and Findings: 79 patients with chronic liver disease were studied, including 17 patients with chronic hepatitis, 36 patients with cirrhosis and 26 with HCC. 28 blood donors were used as control. Monoclonal antibodies against serpinB3 and serpinB4 were used as catcher antibodies to set up specific ELISA assays, while total SCCA-IgM immunocomplexes were detected by commercially available ELISA assay. Overall, the results revealed a better diagnostic sensitivity of total SCCA-IgM assay, compared to both serpinB3 and serpinB4 IgM-linked assays. SerpinB4-IgM median values obtained with SCC103 antibody were moderately higher in patients with cirrhosis than in those with HCC, median values: 0.168 (IQR 0.140-0.427) vs. 0.140 (IQR 0.140-0.278), (p = 0.177). A trend toward decreasing serpinB4-IgM/serpinB3-IgM median ratio was observed in patients with advanced liver disease, being 1.08 in patients with HCC, 1.10 in patients with cirrhosis and 1.40 in patients with chronic hepatitis (p = 0.079). Conclusions: IgM-linked SCCA isoforms in serum of patients with chronic liver diseases were quantified for the first time. Although the number of patients was limited, this preliminary study reveals that the relative balance of the two serpin isoforms is altered in HCC and it is characterized by a lower serpinB4-IgM/serpinB3-IgM ratio, determined by lower serpinB4 levels.	[Biasiolo, Alessandra; Ruvoletto, Mariagrazia; Quarta, Santina; Villano, Gianmarco; Merkel, Carlo; Gatta, Angelo; Pontisso, Patrizia] Univ Padua, Dept Med, Padua, Italy; [Tono, Natascia; Turato, Cristian] IRCCS, IOV, Padua, Italy; [Beneduce, Luca; Fassina, Giorgio] Xeptagen SpA, Venice, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV)	Biasiolo, A (corresponding author), Univ Padua, Dept Med, Padua, Italy.	patrizia@unipd.it	Turato, Cristian/F-3262-2010; MERKEL, CARLO/B-6278-2013; Fassina, Giorgio/I-7127-2012; Turato, Cristian/M-4685-2019; PONTISSO, PATRIZIA/K-3574-2018	Turato, Cristian/0000-0001-7086-0792; MERKEL, CARLO/0000-0003-0185-4166; Fassina, Giorgio/0000-0003-1845-2657; Turato, Cristian/0000-0001-7086-0792; PONTISSO, PATRIZIA/0000-0003-2077-9202; Quarta, Santina/0000-0002-9348-1485	National Ministry of Education, University and Research (FIRB) [Prot. RBLA03S4SP_005]; Associazione Italiana per la Ricerca sul Cancro (AIRC)	National Ministry of Education, University and Research (FIRB); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work is supported in part by a grant from the National Ministry of Education, University and Research (FIRB Project Prot. RBLA03S4SP_005) and by a research grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Barnes RC, 2000, GYNECOL ONCOL, V78, P62, DOI 10.1006/gyno.2000.5818; Beneduce L, 2008, EUR J CLIN INVEST, V38, P571, DOI 10.1111/j.1365-2362.2008.01985.x; Beneduce L, 2005, CANCER-AM CANCER SOC, V103, P2558, DOI 10.1002/cncr.21106; Beneduce L, 2004, INT J BIOL MARKER, V19, P155, DOI 10.1177/172460080401900211; Beneduce L, 2007, CANCER DETECT PREV, V31, P402, DOI 10.1016/j.cdp.2007.10.005; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Biasiolo A, 2008, J VIRAL HEPATITIS, V15, P246, DOI 10.1111/j.1365-2893.2007.00935.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Castaldi F, 2005, INT J BIOL MARKER, V20, P204, DOI 10.1177/172460080502000402; Cataltepe S, 2000, CLIN CHIM ACTA, V295, P107, DOI 10.1016/S0009-8981(00)00197-2; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; CROMBACH G, 1989, CANCER, V63, P1337, DOI 10.1002/1097-0142(19890401)63:7<1337::AID-CNCR2820630719>3.0.CO;2-J; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Giannelli G, 2005, INT J CANCER, V116, P579, DOI 10.1002/ijc.20847; Guido M, 2008, J CLIN PATHOL, V61, P445, DOI 10.1136/jcp.2007.051383; Hsu KF, 2007, INT J GYNECOL CANCER, V17, P174, DOI 10.1111/j.1525-1438.2006.00663.x; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; KATO H, 1987, JPN J CANCER RES, V78, P1246; Kato H, 1996, ANTICANCER RES, V16, P2149; KATO H, 1984, GANN, V75, P433; Murakami A, 2000, TUMOR BIOL, V21, P224, DOI 10.1159/000030128; Nustad K, 2009, TUMOR BIOL, V30, P26, DOI 10.1159/000199448; Pak SC, 2004, J BIOL CHEM, V279, P15448, DOI 10.1074/jbc.M400261200; Pontisso P, 2004, BRIT J CANCER, V90, P833, DOI 10.1038/sj.bjc.6601543; Pontisso P, 2006, INT J CANCER, V119, P735, DOI 10.1002/ijc.21908; Quarta S, 2010, J PATHOL, V221, P343, DOI 10.1002/path.2708; Roijer E, 2006, TUMOR BIOL, V27, P142, DOI 10.1159/000092775; Sakata Y, 2004, BIOCHEM BIOPH RES CO, V324, P1340, DOI 10.1016/j.bbrc.2004.09.204; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; Stenman J, 2001, INT J CANCER, V95, P39, DOI 10.1002/1097-0215(20010120)95:1<39::AID-IJC1007>3.0.CO;2-N; Suminami Y, 2000, BRIT J CANCER, V82, P981, DOI 10.1054/bjoc.1999.1028; Suminami Y, 1998, TUMOR BIOL, V19, P488, DOI 10.1159/000030042; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; Suminami Y, 2001, CANCER RES, V61, P1776; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Takeda A, 2002, BIOL CHEM, V383, P1231, DOI 10.1515/BC.2002.136; TAKEDA A, 1995, FEBS LETT, V359, P78, DOI 10.1016/0014-5793(94)01456-B; Torre GC, 1998, TUMOR BIOL, V19, P517, DOI 10.1159/000030045; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011; Vollmers HP, 2007, J AUTOIMMUN, V29, P295, DOI 10.1016/j.jaut.2007.07.013; Zuin J, 2010, CLIN CHEM LAB MED, V48, P217, DOI 10.1515/CCLM.2010.044	46	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40658	10.1371/journal.pone.0040658	http://dx.doi.org/10.1371/journal.pone.0040658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808225	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700043
J	Kim, YM; Kim, J; Heo, SC; Shin, SH; Do, EK; Suh, DS; Kim, KH; Yoon, MS; Lee, TG; Kim, JH				Kim, Young Mi; Kim, Jaeyoon; Heo, Soon Chul; Shin, Sang Hun; Do, Eun Kyoung; Suh, Dong-Soo; Kim, Ki-Hyung; Yoon, Man-Soo; Lee, Taehoon G.; Kim, Jae Ho			Proteomic Identification of ADAM12 as a Regulator for TGF-beta 1-Induced Differentiation of Human Mesenchymal Stem Cells to Smooth Muscle Cells	PLOS ONE			English	Article							METALLOPROTEASE-DISINTEGRIN ADAM12; LIPID RAFTS; CHOLESTEROL DEPLETION; DEPENDENT MECHANISM; CYTOKINE REGULATION; MASS-SPECTROMETRY; SHEDDING ACTIVITY; PROGENITOR CELLS; STELLATE CELLS; LABEL-FREE	Background: Transforming growth factor-beta 1 (TGF-beta 1) induces the differentiation of human adipose tissue-derived mesenchymal stem cells (hASCs) into smooth muscle cells. Lipid rafts are cholesterol-rich microdomains in cell membranes that reportedly play a key role in receptor-mediated signal transduction and cellular responses. In order to clarify whether lipid rafts are involved in TGF-beta 1-induced differentiation of hASCs into smooth muscle cells, we analyzed the lipid raft proteome of hASCs. Methods and Results: Pretreatment of hASCs with the lipid raft disruptor methyl-beta-cyclodextrin abrogated TGF-beta 1-induced expression of alpha-smooth muscle actin, a smooth muscle cell marker, suggesting a pivotal role of lipid rafts in TGF-beta 1-induced differentiation of hASCs to smooth muscle cells. Sucrose density gradient centrifugation along with a shotgun proteomic strategy using liquid chromatography-tandem mass spectrometry identified 1002 individual proteins as the lipid raft proteome, and 242 of these were induced by TGF-beta 1 treatment. ADAM12, a disintegrin and metalloproteases family member, was identified as the most highly up-regulated protein in response to TGF-beta 1 treatment. TGF-beta 1 treatment of hASCs stimulated the production of both ADAM12 protein and mRNA. Silencing of endogenous ADAM12 expression using lentiviral small hairpin RNA or small interfering RNA abrogated the TGF-beta 1-induced differentiation of hASCs into smooth muscle cells. Conclusions: These results suggest a pivotal role for lipid raft-associated ADAM12 in the TGF-beta 1-induced differentiation of hASCs into smooth muscle cells.	[Kim, Young Mi; Heo, Soon Chul; Shin, Sang Hun; Do, Eun Kyoung; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Med Res Ctr Ischem Tissue Regenerat, Yangsan, South Korea; [Kim, Young Mi; Heo, Soon Chul; Shin, Sang Hun; Kim, Jae Ho] Pusan Natl Univ, Dept Physiol, Sch Med, Yangsan, South Korea; [Suh, Dong-Soo; Kim, Ki-Hyung; Yoon, Man-Soo] Pusan Natl Univ, Dept Obstet & Gynecol, Sch Med, Yangsan, South Korea; [Kim, Jaeyoon; Lee, Taehoon G.] NovaCell Technol Inc, Pohang, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Kim, YM (corresponding author), Pusan Natl Univ, Sch Med, Med Res Ctr Ischem Tissue Regenerat, Yangsan, South Korea.	jhkimst@pusan.ac.kr		Kim, Jae Ho/0000-0003-4323-4790	National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2010-0020274, 2010-0014876]; Medical Research Center program [2011-0006193]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Medical Research Center program	This research was supported by National Research Foundation of Korea (NRF) programs funded by the Ministry of Education, Science, and Technology (2010-0020274, 2010-0014876), and by the Medical Research Center program (2011-0006193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cai XX, 2011, BIOL CELL, V103, P435, DOI 10.1042/BC20110033; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gojo S, 2003, EXP CELL RES, V288, P51, DOI 10.1016/S0014-4827(03)00132-0; Griffin NM, 2010, NAT BIOTECHNOL, V28, P83, DOI 10.1038/nbt.1592; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Jacobsen J, 2009, CURR PHARM DESIGN, V15, P2300, DOI 10.2174/138161209788682389; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jeon ES, 2008, CIRC RES, V103, P635, DOI 10.1161/CIRCRESAHA.108.180885; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Liu CS, 2004, TRENDS CARDIOVAS MED, V14, P288, DOI 10.1016/j.tcm.2004.08.002; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Ruan XZ, 1998, NEPHROL DIAL TRANSPL, V13, P1391, DOI 10.1093/ndt/13.6.1391; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Worapamorn W, 2002, J PERIODONTAL RES, V37, P273, DOI 10.1034/j.1600-0765.2002.01610.x; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zhang T, 2010, J MOL BIOL, V402, P761, DOI 10.1016/j.jmb.2010.08.014; Zheng YZ, 2009, J LIPID RES, V50, P1976, DOI 10.1194/jlr.R900018-JLR200; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079	52	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40820	10.1371/journal.pone.0040820	http://dx.doi.org/10.1371/journal.pone.0040820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808268	gold, Green Submitted, Green Published			2022-12-27	WOS:000306406700058
J	Madalozzo, R				Madalozzo, Regina			Transitions in Fertility for Brazilian Women: An Analysis of Impact Factors	PLOS ONE			English	Article							EDUCATION	The labor participation of Brazilian women has increased during the last few decades. According to the World Bank, the percentage of Brazilian women participating in the labor market rose from 20% in the early 1970s to 65% (for women between 16 and 64 years of age) in 2009. The fertility profile has also changed, the fertility rate has decreased from 6.2 in 1960 to 1.9 in 2009, below the replacement rate, according to the World Bank. This paper will present Brazilian fertility trends during the previous (20th) and present (21st) centuries and, emphasize the importance of individual profiles for fertility decisions. This work uses Brazilian data from PNAD (Pesquisa Nacional de Amostra por Domicilios) to understand the cause of this relationship and to predict the consequences of these choices on women's economic development.	Insper Inst Educ & Res, Dept Econ, Sao Paulo, Brazil	Insper	Madalozzo, R (corresponding author), Insper Inst Educ & Res, Dept Econ, Sao Paulo, Brazil.	reginam@insper.edu.br						Alvis-Guzmán Nelson, 2010, Rev. Gerenc. Polit. Salud, V9, P90; Avelino Ricardo, 2003, Estud. Econ., V33, P639, DOI 10.1590/S0101-41612003000400002; Beltrão Kaizô Iwakami, 2009, Cad. Pesqui., V39, P125, DOI 10.1590/S0100-15742009000100007; Bruschini C, 1989, UNIFIED TRISERVICES; Bruschini C, 1998, UNIFIED TRISERVICES; Dreze J, 2001, POPUL DEV REV, V27, P33, DOI 10.1111/j.1728-4457.2001.00033.x; Fukuda Mosel, 2006, REV ECON HOUSEHOLD, V3, P379, DOI DOI 10.1007/s11150-006-0013-4; Hatton TJ, 2010, EXPLOR ECON HIST, V47, P505, DOI 10.1016/j.eeh.2010.05.003; Macunovich D, 1998, J SOCIOECONOMICS, V27, P365; Nanfosso R. A. T., 2010, INT BUSINESS RES, V3, P136; Osili UO, 2008, J DEV ECON, V87, P57, DOI 10.1016/j.jdeveco.2007.10.003; Pazello Elaine Toldo, 2006, Estud. Econ., V36, P507, DOI 10.1590/S0101-41612006000300004; Ponczek V, 2011, J DEV ECON, V94, P242, DOI 10.1016/j.jdeveco.2010.01.011; Potter JE, 2002, DEMOGRAPHY, V39, P739, DOI 10.1353/dem.2002.0039; Secretaria de Politicas para as Mulheres, 2011, TERC C NAC POL MULH; Soares RR, 2008, J POLIT ECON, V116, P1058, DOI 10.1086/596102; World Bank, 2012, DAT	17	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40756	10.1371/journal.pone.0040756	http://dx.doi.org/10.1371/journal.pone.0040756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808252	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700050
J	Murphy, SK; Huang, ZQ; Hoyo, C				Murphy, Susan K.; Huang, Zhiqing; Hoyo, Cathrine			Differentially Methylated Regions of Imprinted Genes in Prenatal, Perinatal and Postnatal Human Tissues	PLOS ONE			English	Article							FOLIC-ACID USE; DNA METHYLATION; CHINESE FAMINE; MATERNAL-BEHAVIOR; BREAST-CANCER; DUTCH FAMINE; EARLY-LIFE; IGF2 GENE; EXPOSURE; EXPRESSION	Epigenetic plasticity in relation to in utero exposures may mechanistically explain observed differences in the likelihood of developing common complex diseases including hypertension, diabetes and cardiovascular disease through the cumulative effects of subtle alterations in gene expression. Imprinted genes are essential mediators of growth and development and are characterized by differentially methylated regulatory regions (DMRs) that carry parental allele-specific methylation profiles. This theoretical 50% level of methylation provides a baseline from which endogenously-or exogenously-induced deviations in methylation can be detected. We quantified DNA methylation at imprinted gene DMRs in a large panel of human conceptal tissues, in matched buccal cell specimens collected at birth and at one year of age, and in the major cell fractions of umbilical cord blood to assess the stability of methylation at these regions. DNA methylation was measured using validated pyrosequencing assays at seven DMRs regulating the IGF2/H19, DLK1/MEG3, MEST, NNAT and SGCE/PEG10 imprinted domains. DMR methylation did not significantly differ for the H19, MEST and SGCE/PEG10 DMRs across all conceptal tissues analyzed (ANOVA p > 0.10). Methylation differences at several DMRs were observed in tissues from brain (IGF2 and MEG3-IG DMRs), liver (IGF2 and MEG3 DMRs) and placenta (both DLK1/MEG3 DMRs and NNAT DMR). In most infants, methylation profiles in buccal cells at birth and at one year of age were comparable, as was methylation in the major cell fractions of umbilical cord blood. Several infants showed temporal deviations in methylation at multiple DMRs. Similarity of inter-individual and intra-individual methylation at some, but not all of the DMRs analyzed supports the possibility that methylation of these regions can serve as useful biosensors of exposure.	[Murphy, Susan K.; Huang, Zhiqing; Hoyo, Cathrine] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Duke University	Murphy, SK (corresponding author), Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA.	susan.murphy@duke.edu	Murphy, Susan/R-3903-2019	Murphy, Susan/0000-0001-8298-7272	United States National Institutes of Health [R21ES014947, R01ES016772, R01DK085173]; Duke Comprehensive Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014947, R01ES016772] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Comprehensive Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by United States National Institutes of Health grants R21ES014947, R01ES016772, R01DK085173 and by funding from the Duke Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Coolen MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025590; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gong L, 2010, EPIGENETICS-US, V5, P619, DOI 10.4161/epi.5.7.12882; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Hoyo C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-46; Hoyo C, 2009, J EPIDEMIOL COMMUN H, V63, P683, DOI 10.1136/jech.2009.090803; Huang C, 2010, J NUTR, V140, P1874, DOI 10.3945/jn.110.121293; Hughes S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-91; Hulshoff HE, 2000, AM J PSYCHIAT, V157, P1170, DOI 10.1176/appi.ajp.157.7.1170; Isles AR, 2000, TRENDS COGN SCI, V4, P309, DOI 10.1016/S1364-6613(00)01504-7; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lee PS, 2010, INT J CANCER, V126, P1378, DOI 10.1002/ijc.24797; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385; Liu TL, 2010, EPIDEMIOLOGY, V21, P736, DOI 10.1097/EDE.0b013e3181e9c118; Lumey L H, 1993, Paediatr Perinat Epidemiol, V7, P354, DOI 10.1111/j.1365-3016.1993.tb00415.x; Ma D, 2004, J CLIN INVEST, V114, P339, DOI 10.1172/jci200419876; Mathers JC, 2008, P NUTR SOC, V67, P390, DOI 10.1017/S0029665108008744; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Nomura Y, 2010, J NERV MENT DIS, V198, P672, DOI 10.1097/NMD.0b013e3181ef3489; Painter RC, 2006, AM J HUM BIOL, V18, P853, DOI 10.1002/ajhb.20564; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Reed K, 2010, ANAL BIOCHEM, V397, P96, DOI 10.1016/j.ab.2009.10.021; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Sciberras E, 2011, J ABNORM CHILD PSYCH, V39, P1025, DOI 10.1007/s10802-011-9504-8; Soubry A, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-2; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Susser E, 2008, ANN NY ACAD SCI, V1136, P185, DOI 10.1196/annals.1425.024; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Uribe-Lewis S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001717; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang YH, 2010, OBESITY, V18, P588, DOI 10.1038/oby.2009.296; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Wong HL, 2006, BIOTECHNIQUES, V41, P734, DOI 10.2144/000112305; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Xu MQ, 2009, SCHIZOPHRENIA BULL, V35, P568, DOI 10.1093/schbul/sbn168; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	63	135	135	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40924	10.1371/journal.pone.0040924	http://dx.doi.org/10.1371/journal.pone.0040924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808284	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700069
J	Plot, V; Criscuolo, F; Zahn, S; Georges, JY				Plot, Virginie; Criscuolo, Francois; Zahn, Sandrine; Georges, Jean-Yves			Telomeres, Age and Reproduction in a Long-Lived Reptile	PLOS ONE			English	Article							LEATHERBACK TURTLES; LIFE-SPAN; DERMOCHELYS-CORIACEA; SEA-TURTLE; OXIDATIVE STRESS; QUANTITATIVE PCR; TRADE-OFF; BODY-MASS; LENGTH; GROWTH	A major interest has recently emerged in understanding how telomere shortening, mechanism triggering cell senescence, is linked to organism ageing and life history traits in wild species. However, the links between telomere length and key history traits such as reproductive performances have received little attention and remain unclear to date. The leatherback turtle Dermochelys coriacea is a long-lived species showing rapid growth at early stages of life, one of the highest reproductive outputs observed in vertebrates and a dichotomised reproductive pattern related to migrations lasting 2 or 3 years, supposedly associated with different environmental conditions. Here we tested the prediction of blood telomere shortening with age in this species and investigated the relationship between blood telomere length and reproductive performances in leatherback turtles nesting in French Guiana. We found that blood telomere length did not differ between hatchlings and adults. The absence of blood telomere shortening with age may be related to an early high telomerase activity. This telomere-restoring enzyme was formerly suggested to be involved in preventing early telomere attrition in early fast-growing and long-lived species, including squamate reptiles. We found that within one nesting cycle, adult females having performed shorter migrations prior to the considered nesting season had shorter blood telomeres and lower reproductive output. We propose that shorter blood telomeres may result from higher oxidative stress in individuals breeding more frequently (i.e., higher costs of reproduction) and/or restoring more quickly their body reserves in cooler feeding areas during preceding migration (i.e., higher foraging costs). This first study on telomeres in the giant leatherback turtle suggests that blood telomere length predicts not only survival chances, but also reproductive performances. Telomeres may therefore be a promising new tool to evaluate individual reproductive quality which could be useful in such species of conservation concern.	[Plot, Virginie; Criscuolo, Francois; Zahn, Sandrine; Georges, Jean-Yves] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Plot, Virginie; Criscuolo, Francois; Zahn, Sandrine; Georges, Jean-Yves] CNRS, UMR 7178, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Plot, V (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	virginie.plot@iphc.cnrs.fr		GEORGES, Jean Yves/0000-0003-1161-2275	French Ministry of Research; Agence Nationale pour la Recherche [ANR-07-JCJC-0122]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	VP was supported by a studentship from the French Ministry of Research. The study was conducted during the MIRETTE project (http://projetmirette.fr) led by JYG and supported by the Agence Nationale pour la Recherche (ANR-07-JCJC-0122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Broderick AC, 2003, J EXP MAR BIOL ECOL, V288, P95, DOI 10.1016/S0022-0981(03)00003-0; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Crawley M.J., 2007, R BOOK; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Foote CG, 2011, BEHAV ECOL, V22, P156, DOI 10.1093/beheco/arq178; Fossette S, 2008, J EXP MAR BIOL ECOL, V356, P69, DOI 10.1016/j.jembe.2007.12.024; FRAZER NB, 1985, HERPETOLOGICA, V41, P246; Geiger S, 2012, MOL ECOL, V21, P1500, DOI 10.1111/j.1365-294X.2011.05331.x; Georges JY, 2006, MAR ECOL PROG SER, V318, P255, DOI 10.3354/meps318255; Girondot Marc, 1996, Chelonian Conservation and Biology, V2, P204; Gomes NMV, 2010, FEBS LETT, V584, P3741, DOI 10.1016/j.febslet.2010.07.031; Hatase H, 2008, GENES GENET SYST, V83, P423, DOI 10.1266/ggs.83.423; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Haussmann MF, 2002, OECOLOGIA, V130, P325, DOI 10.1007/s00442-001-0827-y; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Miller Jeffrey D., 1997, P51; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2010, ANN NY ACAD SCI, V1206, P130, DOI 10.1111/j.1749-6632.2010.05705.x; Olsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017473; Olsson M, 2011, MOL ECOL, V20, P2085, DOI 10.1111/j.1365-294X.2011.05085.x; Olsson M, 2010, BIOL LETTERS, V6, P651, DOI 10.1098/rsbl.2010.0126; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Plot V, ARE LEATHERBAC UNPUB; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rivalan P, 2006, MAR ECOL PROG SER, V317, P285, DOI 10.3354/meps317285; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Seluanov A, 2007, AGING CELL, V6, P45, DOI 10.1111/j.1474-9726.2006.00262.x; Smith S, 2011, HEREDITY, V107, P372, DOI 10.1038/hdy.2011.14; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Ujvari B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007493; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002	48	54	54	1	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40855	10.1371/journal.pone.0040855	http://dx.doi.org/10.1371/journal.pone.0040855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808278	gold, Green Submitted, Green Published			2022-12-27	WOS:000306406700065
J	Schweitzer, CJ; Matthews, JM; Madson, CJ; Donnellan, MR; Cerny, RL; Belshan, M				Schweitzer, Cameron J.; Matthews, John M.; Madson, Christian J.; Donnellan, Meghan R.; Cerny, Ronald L.; Belshan, Michael			Knockdown of the Cellular Protein LRPPRC Attenuates HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR-LOCALIZATION SIGNAL; VIRAL MATRIX PROTEIN; PREINTEGRATION COMPLEXES; REVERSE TRANSCRIPTION; IN-VIVO; GAG POLYPROTEIN; MESSENGER-RNA; MASS-SPECTROMETRY; NONDIVIDING CELLS	HIV-1 exploits numerous host cellular pathways for productive infection. To identify novel factors involved in HIV-1 replication, HIV-1 integrase and matrix protein complexes were captured at 4 hours post infection for proteomic analysis using an affinity purification system. Leucine-rich PPR-motif containing (LRPPRC) protein, a cellular protein involved in mitochondrial function, cell metabolism, and cell-cycle progression was identified as one of the candidate HIV-1 factors. Co-immunoprecipitation RT-PCR experiments confirmed that LRPPRC associated with HIV-1 nucleic acids during the early steps of virus infection. To establish if LRPPRC was critical for HIV-1 infection, three independent LRPPRC knockdown cell lines were constructed (2.7, 3.6, and 4.1). Subcellular fractionation of these cell lines revealed differential knockdown of LRPPRC in subcellular compartments. LRPPRC was knocked down in the insoluble/cytoskeletal fractions of all three cell lines, but the 3.6 and 4.1 cells also showed a reduction in nuclear LRPPRC. Additionally, several cellular factors were downregulated and/or disrupted by loss of LRPPRC. HIV-1 infection was reduced in all three cell lines, but virus production and RNA encapsidation were unaffected, suggesting that LRPPRC was critical for the afferent stage of virus replication. Two of the three cell lines (3.6, 4.1) were refractory for murine leukemia virus infection, a virus dependent on cellular proliferation for productive infection. Consistent with this, these two cell lines exhibited reduced cellular growth with no loss of cellular viability or change in cell cycle phenotype. The early steps of virus infection were also differentially affected among the cell lines. A reduced level of preintegration complex formation was observed in all three cell lines, but viral DNA nuclear import was reduced only in the 3.6 and 4.1 cells. Combined, these data identify LRPPRC as a HIV-1 factor that is involved in HIV-1 replication through more than one mechanism.	[Schweitzer, Cameron J.; Matthews, John M.; Madson, Christian J.; Donnellan, Meghan R.; Belshan, Michael] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Cerny, Ronald L.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Cerny, Ronald L.; Belshan, Michael] Nebraska Ctr Virol, Lincoln, NE USA	Creighton University; University of Nebraska System; University of Nebraska Lincoln	Schweitzer, CJ (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA.	michaelbelshan@creighton.edu			NIH [P20 RR15635, 1RO1AI080348, RR015468-01]; Creighton University Health Futures Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015468, P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080348] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creighton University Health Futures Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant P20 RR15635, 1RO1AI080348, NIH grant RR015468-01, and the Creighton University Health Futures Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; ALLEN P, 1995, VIROLOGY, V209, P327, DOI 10.1006/viro.1995.1264; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Belshan M, 2009, J VIROL METHODS, V159, P178, DOI 10.1016/j.jviromet.2009.03.017; BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briones MS, 2010, J VIROL, V84, P5181, DOI 10.1128/JVI.02382-09; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; Buckman JS, 2003, J VIROL, V77, P1469, DOI 10.1128/JVI.77.2.1469-1480.2003; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; Chan EY, 2009, J VIROL, V83, P9283, DOI 10.1128/JVI.00814-09; Cimarelli A, 1999, J VIROL, V73, P5388, DOI 10.1128/JVI.73.7.5388-5401.1999; Colgan J, 1996, J VIROL, V70, P4299, DOI 10.1128/JVI.70.7.4299-4310.1996; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; Dvorin JD, 2002, J VIROL, V76, P12087, DOI 10.1128/JVI.76.23.12087-12096.2002; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Gallo DE, 2012, VIROLOGY, V422, P13, DOI 10.1016/j.virol.2011.09.015; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hamamoto S, 2006, J VIROL, V80, P5670, DOI 10.1128/JVI.02471-05; Hammerschmid F, 1996, ANN NY ACAD SCI, V782, P456, DOI 10.1111/j.1749-6632.1996.tb40583.x; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; HENDERSON LE, 1988, J VIROL, V62, P2587, DOI 10.1128/JVI.62.8.2587-2595.1988; HOU JZ, 1994, IN VITRO CELL DEV-AN, V30A, P111; Inayoshi Y, 2010, J VIROL, V84, P8250, DOI 10.1128/JVI.02681-09; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kootstra NA, 1999, VIROLOGY, V253, P170, DOI 10.1006/viro.1998.9482; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Labialle S, 2004, NUCLEIC ACIDS RES, V32, P3864, DOI 10.1093/nar/gkh722; Lama J, 1998, J VIROL, V72, P1671, DOI 10.1128/JVI.72.2.1671-1676.1998; LAPADATTAPOLSKY M, 1993, NUCLEIC ACIDS RES, V21, P831, DOI 10.1093/nar/21.4.831; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Limon A, 2002, J VIROL, V76, P10598, DOI 10.1128/JVI.76.21.10598-10607.2002; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Mulder LCF, 2002, J BIOL CHEM, V277, P27489, DOI 10.1074/jbc.M203061200; Nishitsuji H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007825; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; Rain JC, 2009, METHODS, V47, P291, DOI 10.1016/j.ymeth.2009.02.002; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Topisirovic I, 2009, EMBO J, V28, P1087, DOI 10.1038/emboj.2009.53; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Valente Susana T., 2009, V485, P235, DOI 10.1007/978-1-59745-170-3_17; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Wang Jaang-Jiun, 2001, Proceedings of the National Science Council Republic of China Part B Life Sciences, V25, P50; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Zheng YF, 2011, J BIOL CHEM, V286, P17722, DOI 10.1074/jbc.M110.184739; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	78	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40537	10.1371/journal.pone.0040537	http://dx.doi.org/10.1371/journal.pone.0040537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808186	gold, Green Published			2022-12-27	WOS:000306366400033
J	Zhu, W; Fang, JA; Tang, Y; Zhang, WB; Du, W				Zhu, Wu; Fang, Jian-an; Tang, Yang; Zhang, Wenbing; Du, Wei			Digital IIR Filters Design Using Differential Evolution Algorithm with a Controllable Probabilistic Population Size	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CLASSIFIER; PROTEINS; SINGLE; PARAMETERS	Design of a digital infinite-impulse-response (IIR) filter is the process of synthesizing and implementing a recursive filter network so that a set of prescribed excitations results a set of desired responses. However, the error surface of IIR filters is usually non-linear and multi-modal. In order to find the global minimum indeed, an improved differential evolution (DE) is proposed for digital IIR filter design in this paper. The suggested algorithm is a kind of DE variants with a controllable probabilistic (CPDE) population size. It considers the convergence speed and the computational cost simultaneously by nonperiodic partial increasing or declining individuals according to fitness diversities. In addition, we discuss as well some important aspects for IIR filter design, such as the cost function value, the influence of (noise) perturbations, the convergence rate and successful percentage, the parameter measurement, etc. As to the simulation result, it shows that the presented algorithm is viable and comparable. Compared with six existing State-of-the-Art algorithms-based digital IIR filter design methods obtained by numerical experiments, CPDE is relatively more promising and competitive.	[Zhu, Wu; Fang, Jian-an; Tang, Yang; Zhang, Wenbing] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China; [Tang, Yang] Harbin Inst Technol, Res Inst Intelligent Control & Syst, Harbin 150006, Peoples R China; [Tang, Yang] Humboldt Univ, Inst Phys, D-10099 Berlin, Germany; [Tang, Yang] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Zhang, Wenbing; Du, Wei] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China	Donghua University; Harbin Institute of Technology; Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung; Hong Kong Polytechnic University	Zhu, W (corresponding author), Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China.	tangtany@gmail.com			Alexander von Humboldt Foundation of Germany; China Postdoctoral Science Foundation [2011M501040]	Alexander von Humboldt Foundation of Germany(Alexander von Humboldt Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This paper was supported by the Alexander von Humboldt Foundation of Germany and the China Postdoctoral Science Foundation (2011M501040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bostani N, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011901; Brest J, 2006, IEEE T EVOLUT COMPUT, V10, P646, DOI 10.1109/TEVC.2006.872133; Brest J, 2011, SOFT COMPUT, V15, P2157, DOI 10.1007/s00500-010-0644-5; Chakraborty U.K., 2008, ADV DIFFERENTIAL EVO; Chang XA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012126; Chen S, 2001, DIGIT SIGNAL PROCESS, V11, P241, DOI 10.1006/dspr.2001.0384; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Dai CH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036203; Dai CH, 2010, IEEE T IND ELECTRON, V57, P1710, DOI 10.1109/TIE.2009.2031194; Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; du Plessis MC, 2012, EUR J OPER RES, V218, P7, DOI 10.1016/j.ejor.2011.08.031; Garcia-Martinez C, 2008, EUR J OPER RES, V185, P1088, DOI 10.1016/j.ejor.2006.06.043; Ghosh S, 2012, IEEE T SYST MAN CY B, V42, P107, DOI 10.1109/TSMCB.2011.2160625; Hansen N, 2001, EVOL COMPUT, V9, P159, DOI 10.1162/106365601750190398; Karaboga N, 2005, EURASIP J APPL SIG P, V2005, P1269, DOI 10.1155/ASP.2005.1269; Karaboga N, 2004, ENG APPL ARTIF INTEL, V17, P301, DOI 10.1016/j.engappai.2004.02.009; Karaboga N, 2011, TURK J ELECTR ENG CO, V19, P175, DOI 10.3906/elk-0912-344; Karaboga N, 2009, J FRANKLIN I, V346, P328, DOI 10.1016/j.jfranklin.2008.11.003; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Krusienski DJ, 2004, C EV COMP, P2805; Li Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006243; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu YH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036301; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Luque SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015850; Luukko J, 2008, IEEE T IND ELECTRON, V55, P910, DOI 10.1109/TIE.2007.909738; Mallipeddi R, 2011, APPL SOFT COMPUT, V11, P1679, DOI 10.1016/j.asoc.2010.04.024; Merlin JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032630; Pajevic S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000271; Peng HP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036202; Price KV, 2008, STUD COMPUT INTELL, V143, P33; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Ralph JF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.260503; Schumann-Bischoff J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056214; Storn R., 1995, TECH REP; Stutzle T, 2004, ANT COLONY OPTIMIZAT; Tang Y, 2012, IEEE T IND INFORM, V8, P828, DOI 10.1109/TII.2012.2187911; Tang Y, 2011, APPL SOFT COMPUT, V11, P4713, DOI 10.1016/j.asoc.2011.07.012; Tang Y, 2009, CHAOS, V19, DOI 10.1063/1.3068350; Teng NS, 2009, SOFT COMPUT, V13, P709, DOI 10.1007/s00500-008-0344-6; Tumminello M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031123; van Dijk ADJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030591; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Yu DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024333; Yu DC, 2010, AUTOMATICA, V46, P2035, DOI 10.1016/j.automatica.2010.08.010; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	56	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40549	10.1371/journal.pone.0040549	http://dx.doi.org/10.1371/journal.pone.0040549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808191	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400070
J	Stone, A; Valdes-Mora, F; Gee, JMW; Farrow, L; McClelland, RA; Fiegl, H; Dutkowski, C; McCloy, RA; Sutherland, RL; Musgrove, EA; Nicholson, RI				Stone, Andrew; Valdes-Mora, Fatima; Gee, Julia M. W.; Farrow, Lynne; McClelland, Richard A.; Fiegl, Heidi; Dutkowski, Carol; McCloy, Rachael A.; Sutherland, Robert L.; Musgrove, Elizabeth A.; Nicholson, Robert I.			Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer	PLOS ONE			English	Article							BETA SUPERFAMILY MEMBER; GENOME-WIDE ANALYSIS; GROWTH-FACTOR-BETA; ENDOCRINE RESISTANCE; APOPTOTIC RESPONSE; DNA METHYLATION; TARGET GENE; RECEPTOR; CELLS; EXPRESSION	In the present study, we have taken the novel approach of using an in vitro model representative of tamoxifen-withdrawal subsequent to clinical relapse to achieve a greater understanding of the mechanisms that serve to maintain the resistant-cell phenotype, independent of any agonistic impact of tamoxifen, to identify potential novel therapeutic approaches for this disease state. Following tamoxifen withdrawal, tamoxifen-resistant MCF-7 cells conserved both drug resistance and an increased basal rate of proliferation in an oestrogen deprived environment, despite reduced epidermal growth-factor receptor expression and reduced sensitivity to gefitinib challenge. Although tamoxifen-withdrawn cells retained ER expression, a sub-set of ER-responsive genes, including pS2 and progesterone receptor (PgR), were down-regulated by promoter DNA methylation, as confirmed by clonal bisulphite sequencing experiments. Following promoter demethylation with 5-Azacytidine (5-Aza), the co-addition of oestradiol (E2) restored gene expression in these cells. In addition, 5-Aza/E2 co-treatment induced a significant anti-proliferative effect in the tamoxifen-withdrawn cells, in-contrast to either agent used alone. Microarray analysis was undertaken to identify genes specifically up regulated by this co-treatment. Several anti-proliferative gene candidates were identified and their promoters were confirmed as more heavily methylated in the tamoxifen resistant vs sensitive cells. One such gene candidate, growth differentiation factor 15 (GDF15), was carried forward for functional analysis. The addition of 5-Aza/E2 was sufficient to de-methylate and activate GDF15 expression in the tamoxifen resistant cell-lines, whilst in parallel, treatment with recombinant GDF15 protein decreased cell survival. These data provide evidence to support a novel concept that long-term tamoxifen exposure induces epigenetic silencing of a cohort of oestrogen-responsive genes whose function is associated with negative proliferation control. Furthermore, reactivation of such genes using epigenetic drugs could provide a potential therapeutic avenue for the management of tamoxifen-resistant breast cancer.	[Stone, Andrew; Gee, Julia M. W.; Farrow, Lynne; McClelland, Richard A.; Dutkowski, Carol; Nicholson, Robert I.] Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales; [Stone, Andrew; McCloy, Rachael A.; Sutherland, Robert L.; Musgrove, Elizabeth A.] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Stone, Andrew; McCloy, Rachael A.; Sutherland, Robert L.; Musgrove, Elizabeth A.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Valdes-Mora, Fatima] Garvan Inst Med Res, Dept Epigenet, Sydney, NSW, Australia; [Fiegl, Heidi] Innsbruck Med Univ, Dept Obstet & Gynaecol, Innsbruck, Austria; [Sutherland, Robert L.; Musgrove, Elizabeth A.] Univ New S Wales, St Vincents Clin Sch, Fac Med, St Vincents Hosp, Sydney, NSW, Australia	Cardiff University; Garvan Institute of Medical Research; Garvan Institute of Medical Research; Garvan Institute of Medical Research; Medical University of Innsbruck; St Vincents Hospital Sydney; University of New South Wales Sydney	Stone, A (corresponding author), Cardiff Univ, Welsh Sch Pharm, Redwood Bldg, Cardiff, S Glam, Wales.	a.stone@garvan.org.au	Mora, Fatima Valdes/AAB-9728-2021; Gee, Julia MW/N-3995-2014; Fiegl, Heidi/K-4445-2017	Mora, Fatima Valdes/0000-0001-7490-0114; Gee, Julia MW/0000-0001-6483-2015; McCloy, Rachael/0000-0001-7791-4044; Fiegl, Heidi/0000-0002-1236-6806	AstraZeneca; Breast Cancer Campaign; National Health and Medical Research Council Australia; Cancer Institute New South Wales; RT Hall Trust; Petre Foundation; Australian Cancer Research Foundation; Prostate Cancer Foundation of Australia; FWF Austrian Science Fund [V33-B13]	AstraZeneca(AstraZeneca); Breast Cancer Campaign; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; RT Hall Trust; Petre Foundation; Australian Cancer Research Foundation; Prostate Cancer Foundation of Australia; FWF Austrian Science Fund(Austrian Science Fund (FWF))	Julia M. W. Gee and Robert I. Nicholson were in receipt of funding from AstraZeneca. Julia M. W. Gee was also in receipt of funding from Breast Cancer Campaign. Robert L. Sutherland and Elizabeth A. Musgrove were in receipt of funding from the National Health and Medical Research Council Australia, Cancer Institute New South Wales, RT Hall Trust, Petre Foundation and the Australian Cancer Research Foundation. Fatima Valdes-Mora was in receipt of funding from the Prostate Cancer Foundation of Australia. Heidi Fiegl was funded by the FWF Austrian Science Fund (V33-B13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; Aung CS, 2009, CARCINOGENESIS; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Badia E, 2000, CANCER RES, V60, P4130; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; BRUNNER N, 1993, CANCER RES, V53, P3229; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; El-Aziz SHA, 2007, CANCER SCI, V98, P1330, DOI 10.1111/j.1349-7006.2007.00547.x; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gee JMW, 2006, ENDOCR-RELAT CANCER, V13, pS77, DOI 10.1677/erc.1.01274; Graichen R, 2002, J BIOL CHEM, V277, P26662, DOI 10.1074/jbc.M109931200; Gupta M, 1998, J STEROID BIOCHEM, V67, P413, DOI 10.1016/S0960-0760(98)00135-6; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Gutteridge E, 2010, INT J CANCER, V126, P1806, DOI 10.1002/ijc.24884; Hostanska K, 2004, BREAST CANCER RES TR, V84, P151, DOI 10.1023/B:BREA.0000018413.98636.80; Hutcheson IR, 2003, BREAST CANCER RES TR, V81, P81, DOI 10.1023/A:1025484908380; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; LEVENSON AS, 1994, J STEROID BIOCHEM, V51, P229, DOI 10.1016/0960-0760(94)90035-3; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Licznar A, 2003, FEBS LETT, V553, P445, DOI 10.1016/S0014-5793(03)01090-1; Lim HW, 2010, J REPROD DEVELOP, V56, P86, DOI 10.1262/jrd.20247; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mossman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023127; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; Nicholson RI, 2007, REV ENDOCR METAB DIS, V8, P241, DOI 10.1007/s11154-007-9033-5; Norris JD, 2002, MOL ENDOCRINOL, V16, P459, DOI 10.1210/me.16.3.459; Oesterreich S, 2000, MOL ENDOCRINOL, V14, P369, DOI 10.1210/me.14.3.369; Patterson K, 2011, JOVE-J VIS EXP, DOI 10.3791/3170; Peethambaram PP, 1999, BREAST CANCER RES TR, V54, P117, DOI 10.1023/A:1006185805079; Reisner PD, 1997, CELL CALCIUM, V21, P53, DOI 10.1016/S0143-4160(97)90096-8; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Robertson JFR, 2001, BRIT J CANCER, V85, P11, DOI 10.1054/bjoc.2001.1982; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sadikovic B, 2004, BREAST CANCER RES, V6, pR329, DOI 10.1186/bcr799; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Song RXD, 2001, J NATL CANCER I, V93, P1714, DOI 10.1093/jnci/93.22.1714; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Treeck O, 2004, ANTI-CANCER DRUG, V15, P787, DOI 10.1097/00001813-200409000-00008; VANAGTHOVEN T, 1994, MOL ENDOCRINOL, V8, P1474, DOI 10.1210/me.8.11.1474; Wu LY, 2003, J BIOL CHEM, V278, P15192, DOI 10.1074/jbc.M212332200; Wu MH, 2007, MOL CANCER RES, V5, P1285, DOI 10.1158/1541-7786.MCR-07-0126; Zhang L, 2009, J GASTROENTEROL, V44, P305, DOI 10.1007/s00535-009-0027-9	61	48	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40466	10.1371/journal.pone.0040466	http://dx.doi.org/10.1371/journal.pone.0040466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808167	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500044
J	Caplen, G; Hothersall, B; Murrell, JC; Nicol, CJ; Waterman-Pearson, AE; Weeks, CA; Colborne, GR				Caplen, Gina; Hothersall, Becky; Murrell, Joanna C.; Nicol, Christine J.; Waterman-Pearson, Avril E.; Weeks, Claire A.; Colborne, G. Robert			Kinematic Analysis Quantifies Gait Abnormalities Associated with Lameness in Broiler Chickens and Identifies Evolutionary Gait Differences	PLOS ONE			English	Article							BIPEDAL LOCOMOTION; LEG WEAKNESS; FORCE PLATE; DISORDERS; WALKING; GROWTH; BIRDS; PREVALENCE; MECHANICS; SELECTION	This is the first time that gait characteristics of broiler (meat) chickens have been compared with their progenitor, jungle fowl, and the first kinematic study to report a link between broiler gait parameters and defined lameness scores. A commercial motion-capturing system recorded three-dimensional temporospatial information during walking. The hypothesis was that the gait characteristics of non-lame broilers (n = 10) would be intermediate to those of lame broilers (n = 12) and jungle fowl (n = 10, tested at two ages: immature and adult). Data analysed using multi-level models, to define an extensive range of baseline gait parameters, revealed inter-group similarities and differences. Natural selection is likely to have made jungle fowl walking gait highly efficient. Modern broiler chickens possess an unbalanced body conformation due to intense genetic selection for additional breast muscle (pectoral hypertrophy) and whole body mass. Together with rapid growth, this promotes compensatory gait adaptations to minimise energy expenditure and triggers high lameness prevalence within commercial flocks; lameness creating further disruption to the gait cycle and being an important welfare issue. Clear differences were observed between the two lines (short stance phase, little double-support, low leg lift, and little back displacement in adult jungle fowl; much double-support, high leg lift, and substantial vertical back movement in sound broilers) presumably related to mass and body conformation. Similarities included stride length and duration. Additional modifications were also identified in lame broilers (short stride length and duration, substantial lateral back movement, reduced velocity) presumably linked to musculo-skeletal abnormalities. Reduced walking velocity suggests an attempt to minimise skeletal stress and/or discomfort, while a shorter stride length and time, together with longer stance and double-support phases, are associated with instability. We envisage a key future role for this highly quantitative methodology in pain assessment (associated with broiler lameness) including experimental examination of therapeutic agent efficacy.	[Caplen, Gina; Hothersall, Becky; Murrell, Joanna C.; Nicol, Christine J.; Waterman-Pearson, Avril E.; Weeks, Claire A.; Colborne, G. Robert] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Colborne, G. Robert] Univ Bristol, Ctr Comparat & Clin Anat, Bristol, Avon, England	University of Bristol; University of Bristol	Caplen, G (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	gina.caplen@bristol.ac.uk	Nicol, Christine J/B-4841-2011; Weeks, Claire/C-9136-2012	Nicol, Christine J/0000-0001-6734-2177; Weeks, Claire/0000-0002-4280-9604	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G000921/1]; BBSRC [BB/G000921/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G000921/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by Biotechnology and Biological Sciences Research Council (BBSRC) (BB/G000921/1). Additional support was provided via a BBSRC vacation scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOURACHID A, 1991, BRIT POULTRY SCI, V32, P271, DOI 10.1080/00071669108417350; Abourachid A, 2001, COMP BIOCHEM PHYS A, V131, P113, DOI 10.1016/S1095-6433(01)00471-8; ABOURACHID A, 1993, BRIT POULTRY SCI, V34, P887, DOI 10.1080/00071669308417649; Bradshaw RH, 2002, AVIAN POULT BIOL REV, V13, P45, DOI 10.3184/147020602783698421; Clayton HM, 2001, SCI LAMENESS, P29; Colborne GR, 2011, AM J VET RES, V72, P336, DOI 10.2460/ajvr.72.3.336; Corr SA, 2003, ANIM WELFARE, V12, P159; Corr SA, 2003, AM J VET RES, V64, P76, DOI 10.2460/ajvr.2003.64.76; Corr SA, 1998, RES VET SCI, V65, P233, DOI 10.1016/S0034-5288(98)90149-7; Corr SA, 2007, J BIOMECH, V40, P2037, DOI 10.1016/j.jbiomech.2006.09.014; Emmerson DA, 1997, POULTRY SCI, V76, P1121, DOI 10.1093/ps/76.8.1121; FARAGEELAWAR M, 1989, J TOXICOL ENV HEALTH, V26, P119, DOI 10.1080/15287398909531237; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Hutchinson JR, 2001, ELS, DOI [10.1038/npg.els.0001869, DOI 10.1038/NPG.ELS.0001869]; Jackson S, 1996, EVOLUTION, V50, P1638, DOI [10.2307/2410900, 10.1111/j.1558-5646.1996.tb03936.x]; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kestin SC, 2001, VET REC, V148, P195, DOI 10.1136/vr.148.7.195; Knowles TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001545; Mc Geown D, 1999, VET REC, V144, P668, DOI 10.1136/vr.144.24.668; McNamee PT, 1998, VET REC, V143, P131, DOI 10.1136/vr.143.5.131; Mench J., 2004, Measuring and auditing broiler welfare, P3, DOI 10.1079/9780851998053.0003; Muir GD, 1996, J PHYSIOL-LONDON, V493, P589, DOI 10.1113/jphysiol.1996.sp021406; Muir GD, 1998, EXP BRAIN RES, V122, P275, DOI 10.1007/s002210050515; Muir GD, 2002, J NEUROPHYSIOL, V88, P117, DOI 10.1152/jn.2002.88.1.117; Naas ID, 2010, SCI AGR, V67, P129; Oviedo-Rondon EO, 2007, P 34 ANN CAR POULT N, P78; Reiter K, 1997, Equine Vet J Suppl, P110; RESCHMAGRAS C, 1993, VET RES, V24, P5; Rogers LJ, 2008, BRAIN RES BULL, V76, P235, DOI 10.1016/j.brainresbull.2008.02.001; Sandilands V, 2011, Vet Rec, V168, P77, DOI 10.1136/vr.c5978; Schmidt CJ, 2009, POULTRY SCI, V88, P2610, DOI 10.3382/ps.2009-00055; THORP BH, 1994, AVIAN PATHOL, V23, P203, DOI 10.1080/03079459408418991; Vestergaard KS, 1999, VET REC, V144, P205; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Whittle M. W., 2007, GAIT ANAL INTRO	37	35	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40800	10.1371/journal.pone.0040800	http://dx.doi.org/10.1371/journal.pone.0040800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815823	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000031
J	Glaze, CM; Troyer, TW				Glaze, Christopher M.; Troyer, Todd W.			A Generative Model for Measuring Latent Timing Structure in Motor Sequences	PLOS ONE			English	Article							BASAL GANGLIA CIRCUIT; SONG; COVARIANCE; ALGORITHMS; MECHANISMS; DRIFT; CODE	Motor variability often reflects a mixture of different neural and peripheral sources operating over a range of timescales. We present a statistical model of sequence timing that can be used to measure three distinct components of timing variability: global tempo changes that are spread across the sequence, such as might stem from neuromodulatory sources with widespread influence; fast, uncorrelated timing noise, stemming from noisy components within the neural system; and timing jitter that does not alter the timing of subsequent elements, such as might be caused by variation in the motor periphery or by measurement error. In addition to quantifying the variability contributed by each of these latent factors in the data, the approach assigns maximum likelihood estimates of each factor on a trial-to-trial basis. We applied the model to adult zebra finch song, a temporally complex behavior with rich structure on multiple timescales. We find that individual song vocalizations (syllables) contain roughly equal amounts of variability in each of the three components while overall song length is dominated by global tempo changes. Across our sample of syllables, both global and independent variability scale with average length while timing jitter does not, a pattern consistent with the Wing and Kristofferson (1973) model of sequence timing. We also find significant day-to-day drift in all three timing sources, but a circadian pattern in tempo only. In tests using artificially generated data, the model successfully separates out the different components with small error. The approach provides a general framework for extracting distinct sources of timing variability within action sequences, and can be applied to neural and behavioral data from a wide array of systems.	[Glaze, Christopher M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Troyer, Todd W.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Pennsylvania; University of Texas System; University of Texas at San Antonio (UTSA)	Glaze, CM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	cglaze@sas.upenn.edu	Troyer, Todd W/C-2817-2011	Troyer, Todd W/0000-0002-2037-219X	National Institutes of Health [5R21MH 066047-02]; National Science Foundation [IOS-0951310]; Center for the Comparative Biology and Evolution of Hearing (C-CEBH); NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066047] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0951310] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Center for the Comparative Biology and Evolution of Hearing (C-CEBH); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by National Institutes of Health grant 5R21MH 066047-02, National Science Foundation grant IOS-0951310 and a fellowship for CMG from the Center for the Comparative Biology and Evolution of Hearing (C-CEBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andalman AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025461; Bentler PM, 1996, ANNU REV PSYCHOL, V47, P563, DOI 10.1146/annurev.psych.47.1.563; Bishop C. M, 2006, PATTERN RECOGNITION; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Collier GL, 2004, J EXP PSYCHOL HUMAN, V30, P853, DOI 10.1037/0096-1523.30.5.853; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devore J.L., 2004, PROBABILITY STAT ENG; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; GENTNER DR, 1987, PSYCHOL REV, V94, P255, DOI 10.1037/0033-295X.94.2.255; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HEUER H, 1988, PSYCHOL REV, V95, P552, DOI 10.1037/0033-295X.95.4.552; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; JORESKOG KG, 1978, PSYCHOMETRIKA, V43, P443, DOI 10.1007/BF02293808; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Lemoine L, 2009, Q J EXP PSYCHOL, V62, P585, DOI 10.1080/17470210802131896; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Ogden RT, 2002, J NONPARAMETR STAT, V14, P409, DOI 10.1080/10485250290024521; Roweis S, 1999, NEURAL COMPUT, V11, P305, DOI 10.1162/089976699300016674; RUBIN DB, 1982, PSYCHOMETRIKA, V47, P69, DOI 10.1007/BF02293851; Saar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001461; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Schmidt MF, 2008, NEUROSCIENCE BIRDSON, P115; Schoppik D, 2008, NEURON, V58, P248, DOI 10.1016/j.neuron.2008.02.015; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Stepanek L, 2010, J NEUROPHYSIOL, V104, P2474, DOI 10.1152/jn.00977.2009; Thompson J, 2011, J NEUROSCI, V31, P5967; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008; Zarco W, 2009, J NEUROPHYSIOL, V102, P3191, DOI 10.1152/jn.00066.2009	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e37616	10.1371/journal.pone.0037616	http://dx.doi.org/10.1371/journal.pone.0037616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815683	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100006
J	Konig, S; Probst-Kepper, M; Reinl, T; Jeron, A; Huehn, J; Schraven, B; Jansch, L				Koenig, Sebastian; Probst-Kepper, Michael; Reinl, Tobias; Jeron, Andreas; Huehn, Jochen; Schraven, Burkhart; Jaensch, Lothar			First Insight into the Kinome of Human Regulatory T Cells	PLOS ONE			English	Article							PROTEIN-KINASE-II; CYCLE PROGRESSION; SUPPRESSIVE FUNCTION; CD28 COSTIMULATION; PROTEOMICS ANALYSIS; FOXP3 EXPRESSION; DOWN-REGULATION; ACTIVATION; RECEPTOR; LYMPHOCYTES	Regulatory T cells (Tregs) are essential for controlling peripheral tolerance by the active suppression of various immune cells including conventional T effector cells (Teffs). Downstream of the T cell receptor (TCR), more than 500 protein kinases encoded by the human genome have to be considered in signaling cascades regulating the activation of Tregs and Teffs, respectively. Following TCR engagement, Tregs posses a number of unique attributes, such as constitutive expression of Foxp3, hyporesponsiveness and poor cytokine production. Furthermore, recent studies showed that altered regulation of protein kinases is important for Treg function. These data indicate that signaling pathways in Tregs are distinctly organized and alterations at the level of protein kinases contribute to the unique Treg phenotype. However, kinase-based signaling networks in Tregs are poorly understood and necessitate further systematic characterization. In this study, we analyzed the differential expression of kinases in Tregs and Teffs by using a kinase-selective proteome strategy. In total, we revealed quantitative information on 185 kinases expressed in the human CD4(+) T cell subsets. The majority of kinases was equally abundant in both T cell subsets, but 11 kinases were differentially expressed in Tregs. Most strikingly, Tregs showed an altered expression of cell cycle kinases including CDK6. Quantitative proteomics generates first comparative insight into the kinase complements of the CD4(+) Teff and Treg subset. Treg-specific expression pattern of 11 protein kinases substantiate the current opinion that TCR-mediated signaling cascades are altered in Tregs and further suggests that Tregs exhibit significant specificities in cell-cycle control and progression.	[Koenig, Sebastian; Jeron, Andreas; Jaensch, Lothar] Helmholtz Zentrum Infekt Forsch, Dept Mol Struct Biol, Braunschweig, Germany; [Probst-Kepper, Michael] Stadt Klinikum Braunschweig gGmbH, Inst Microbiol Immunol & Hyg, Braunschweig, Germany; [Huehn, Jochen] Helmholtz Zentrum Infekt Forsch, Dept Expt Immunol, Braunschweig, Germany; [Schraven, Burkhart] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University	Konig, S (corresponding author), Helmholtz Zentrum Infekt Forsch, Dept Mol Struct Biol, Braunschweig, Germany.	lothar.jaensch@helmholtz-hzi.de			ForSys partner project TcellTalk; BMBF (Bundesministerium fur Bildung und Forschung); International Research Training Group 1273; German Research Foundation (DFG);  [SFB854]	ForSys partner project TcellTalk; BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); International Research Training Group 1273; German Research Foundation (DFG)(German Research Foundation (DFG)); 	This work was supported by the ForSys partner project TcellTalk funded by BMBF (Bundesministerium fur Bildung und Forschung), the International Research Training Group 1273 and SFB854 funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Alfaro D, 2008, IMMUNOLOGY, V125, P131, DOI 10.1111/j.1365-2567.2008.02828.x; Alfaro D, 2007, EUR J IMMUNOL, V37, P2596, DOI 10.1002/eji.200737097; Appleman LJ, 2002, J IMMUNOL, V168, P2729, DOI 10.4049/jimmunol.168.6.2729; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Belkaid Y, 2006, CURR OPIN IMMUNOL, V18, P406, DOI 10.1016/j.coi.2006.05.014; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; BRANCH DR, 1995, J IMMUNOL, V154, P3678; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Cantrell DA, 2002, IMMUNOLOGY, V105, P369, DOI 10.1046/j.1365-2567.2002.01391.x; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Endo J, 2000, FEBS LETT, V468, P234, DOI 10.1016/S0014-5793(00)01219-9; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Goh YM, 2003, J BIOL CHEM     1224, V285, P10122; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Grossel MJ, 1999, J BIOL CHEM, V274, P29960, DOI 10.1074/jbc.274.42.29960; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hancock WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007890; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Holen HL, J LEUKOC BIOL, V87, P1059; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; Hundertmark C, 2009, BIOINFORMATICS, V25, P1004, DOI 10.1093/bioinformatics/btn551; Ishiguro K, 2007, MOL IMMUNOL, V44, P2095, DOI 10.1016/j.molimm.2006.09.012; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Munoz JJ, 2009, ANN NY ACAD SCI, V1153, P14, DOI 10.1111/j.1749-6632.2008.03965.x; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kim JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006580; Kitamura T, 2008, AM J PHYSIOL-CELL PH, V294, pC189, DOI 10.1152/ajpcell.00314.2007; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Konig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029672; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Ocklenburg F, 2006, LAB INVEST, V86, P724, DOI 10.1038/labinvest.3700432; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; Reed SI, 1997, CANCER SURV, V29, P7; Reinl T, 2009, MOL CELL PROTEOMICS, V8, P2778, DOI 10.1074/mcp.M800521-MCP200; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sharfe N, 2008, MOL IMMUNOL, V45, P1208, DOI 10.1016/j.molimm.2007.09.019; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Solstad T, 2011, BLOOD, V118, P5141, DOI 10.1182/blood-2011-02-339242; Song JX, 2008, CELL MOL IMMUNOL, V5, P239, DOI 10.1038/cmi.2008.30; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su L, 2004, J IMMUNOL, V173, P4994, DOI 10.4049/jimmunol.173.8.4994; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tao L, 2002, BIOCHEM J, V363, P175, DOI 10.1042/0264-6021:3630175; Toda A, 2006, J LEUKOCYTE BIOL, V80, P458, DOI 10.1189/jlb.0206095; Tsang JYS, 2006, J LEUKOCYTE BIOL, V80, P145, DOI 10.1189/jlb.0605344; Vang KB, 1928, J IMMUNOL, V184, P4074; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wissing J, 2007, MOL CELL PROTEOMICS, V6, P537, DOI 10.1074/mcp.T600062-MCP200; Yang ZM, 2009, BIOCHEM BIOPH RES CO, V386, P146, DOI 10.1016/j.bbrc.2009.05.139; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Zanin-Zhorov A, SCIENCE, V328, P372; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	88	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40896	10.1371/journal.pone.0040896	http://dx.doi.org/10.1371/journal.pone.0040896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815858	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100089
J	Kuang, YQ; Charette, N; Frazer, J; Holland, PJ; Attwood, KM; Dellaire, G; Dupre, DJ				Kuang, Yi-Qun; Charette, Nicholle; Frazer, Jennifer; Holland, Patrick J.; Attwood, Kathleen M.; Dellaire, Graham; Dupre, Denis J.			Dopamine Receptor-Interacting Protein 78 Acts as a Molecular Chaperone for CCR5 Chemokine Receptor Signaling Complex Organization	PLOS ONE			English	Article							GABA(B) RECEPTOR; TRAFFICKING; HETERODIMERIZATION; HIV-1; OLIGOMERIZATION; INTERNALIZATION; CCR5-DELTA-32; RESISTANCE; INFECTION; TYPE-1	Chemokine receptors are members of the G protein-coupled receptor (GPCR) family. CCR5 and CXCR4 act as co-receptors for human immunodeficiency virus (HIV) and several efforts have been made to develop ligands to inhibit HIV infection by blocking those receptors. Removal of chemokine receptors from the cell surface using polymorphisms or other means confers some levels of immunity against HIV infection. Up to now, very limited success has been obtained using ligand therapies so we explored potential avenues to regulate chemokine receptor expression at the plasma membrane. We identified a molecular chaperone, DRiP78, that interacts with both CXCR4 and CCR5, but not the heterodimer formed by these receptors. We further characterized the effects of DRiP78 on CCR5 function. We show that the molecular chaperone inhibits CCR5 localization to the plasma membrane. We identified the interaction region on the receptor, the F(x) 6LL motif, and show that upon mutation of this motif the chaperone cannot interact with the receptor. We also show that DRiP78 is involved in the assembly of CCR5 chemokine signaling complex as a homodimer, as well as with the G alpha i protein. Finally, modulation of DRiP78 levels will affect receptor functions, such as cell migration in cells that endogenously express CCR5. Our results demonstrate that modulation of the functions of a chaperone can affect signal transduction at the cell surface.	[Kuang, Yi-Qun; Charette, Nicholle; Frazer, Jennifer; Holland, Patrick J.; Dupre, Denis J.] Dalhousie Univ, Dept Pharmacol, Fac Med, Halifax, NS B3H 4H7, Canada; [Attwood, Kathleen M.; Dellaire, Graham] Dalhousie Univ, Fac Med, Dept Pathol Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Kuang, YQ (corresponding author), Dalhousie Univ, Dept Pharmacol, Fac Med, Halifax, NS B3H 4H7, Canada.	denis.dupre@dal.ca	Kuang, Yi-Qun/K-6161-2013; Dupre, Denis J/AAI-2631-2021; Dellaire, Graham/L-9948-2014; Kuang, Yi-Qun/AAW-4884-2021	Dupre, Denis J/0000-0001-6401-6157; Dellaire, Graham/0000-0002-3466-6316; Kuang, Yi-Qun/0000-0002-1452-4388	Natural Science and Engineering Research Council (NSERC) [RGPIN/355310-2008, EQPEQ-3591097-2008, RGPIN/386049-2010, EQPEQ-389803-2010]; Canada Foundation for Innovation; Beatrice Hunter Cancer Research Institute (BHCRI); Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR); Alexander Graham Bell Canada Graduate Scholarship from NSERC; CIHR; Dalhousie Medical Research Foundation	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Beatrice Hunter Cancer Research Institute (BHCRI); Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alexander Graham Bell Canada Graduate Scholarship from NSERC; CIHR(Canadian Institutes of Health Research (CIHR)); Dalhousie Medical Research Foundation	This work was supported by grants from the Natural Science and Engineering Research Council (NSERC) to DJD (RGPIN/355310-2008, EQPEQ-3591097-2008) and GD (RGPIN/386049-2010, EQPEQ-389803-2010), as well as the Canada Foundation for Innovation (DJD). K. M. A. was supported by the Beatrice Hunter Cancer Research Institute (BHCRI) with funds provided by The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR), and is currently supported by a Alexander Graham Bell Canada Graduate Scholarship from NSERC. G. D. is a Senior Scientist of the BHCRI and both DJD and GD are recipients of the CIHR New Investigator Award. DJD is also a recipient of the Dalhousie Medical Research Foundation New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Blanpain C, 2002, RECEPTOR CHANNEL, V8, P19, DOI 10.1080/10606820212135; Calebiro D, 2005, HUM MOL GENET, V14, P2991, DOI 10.1093/hmg/ddi329; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hu CD., 2005, CURRENT PROTOCOLS PR, V19, DOI [10.1002/0471140864.ps1910s41, DOI 10.1002/0471140864.PS1910S41, 10.1002/0471143030.cb2103s26]; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; LeClerc PC, 2002, ENDOCRINOLOGY, V143, P4702, DOI 10.1210/en.2002-220679; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255	29	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40522	10.1371/journal.pone.0040522	http://dx.doi.org/10.1371/journal.pone.0040522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815758	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100040
J	Onwujekwe, O; Hanson, K; Uzochukwu, B				Onwujekwe, Obinna; Hanson, Kara; Uzochukwu, Benjamin			Examining Inequities in Incidence of Catastrophic Health Expenditures on Different Healthcare Services and Health Facilities in Nigeria	PLOS ONE			English	Article							MANAGEMENT; MALARIA; COSTS	Objective: There is limited evidence about levels of socio-economic and other differences in catastrophic health spending in Nigeria and in many sub-Saharan African countries. The study estimated the level of catastrophic healthcare expenditures for different healthcare services and facilities and their distribution across socioeconomic status (SES) groups. Methods: The study took place in four Local Government Areas in southeast Nigeria. Data were collected using interviewer-administered questionnaires administered to 4873 households. Catastrophic health expenditures (CHE) were measured using a threshold of 40% of monthly non-food expenditure. We examined both total monthly health expenditure and disaggregated expenditure by source and type of care. Results: The average total household health expenditure per month was 2354 Naira ($19.6). For outpatient services, average monthly expenditure was 1809 Naira ($15.1), whilst for inpatient services it was 610 Naira ($5.1). Higher health expenditures were incurred by urban residents and the better-off SES groups. Overall, 27% of households incurred CHE, higher for poorer socioeconomic groups and for rural residents. Only 1.0% of households had a member that was enrolled in a health insurance scheme. Conclusion: The worse-off households (the poorest SES and rural dwellers) experienced the highest burden of health expenditure. There was almost a complete lack of financial risk protection. Health reform mechanisms are needed to ensure universal coverage with financial risk protection mechanisms.	[Onwujekwe, Obinna; Uzochukwu, Benjamin] Univ Nigeria, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu, Nigeria; [Onwujekwe, Obinna; Uzochukwu, Benjamin] Univ Nigeria, Dept Hlth Adm & Management, Enugu, Nigeria; [Hanson, Kara] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Uzochukwu, Benjamin] Univ Nigeria, Dept Community Med, Coll Med, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of London; London School of Hygiene & Tropical Medicine; University of Nigeria	Onwujekwe, O (corresponding author), Univ Nigeria, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu Campus, Enugu, Nigeria.	Obinna.Onwujekwe@unn.edu.ng	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285	UK Aid from the UK Department for International Development (DFID)	UK Aid from the UK Department for International Development (DFID)	This document is an output from the Consortium for Research on Equitable Health Systems funded by UK Aid from the UK Department for International Development (DFID) for the benefit of developing countries. However, the views expressed and information contained in it are not necessarily those of or endorsed by DFID, which can accept no responsibility for such views or information or for any reliance placed on them. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Health Economics and Policy Association (AFHEA), 2011, KEY ISS 2011 AFHEA C; Castillo-Riquelme M, 2008, TROP MED INT HEALTH, V13, P108, DOI 10.1111/j.1365-3156.2007.01979.x; FEDER J, 1987, HEALTH AFFAIR, V6, P5, DOI 10.1377/hlthaff.6.4.5; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Goudge J, 2009, J INT DEV, V21, P159, DOI 10.1002/jid.1551; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Ichoku EH, 2009, J INSUR RISK MANAG, V4, P47; Ichoku H. E., 2006, 200617 PEP U LAV; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; National Bureau for Statistics (NBS), 2004, 2004 NAT LIV STAND S; National Health Insurance Scheme (NHIS), 2011, ROAD MAP IMPL COMM B; National Population Commission (NPC) [Nigeria] and ICF International, 2009, NIG DEM HLTH SURV 20; Nguyen HTH, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-4; ODONNELL O, 2005, 5 EQUITAP PROJ U MAC; Ogunbekun I, 1996, HEALTH POLICY PLANN, V11, P369, DOI 10.1093/heapol/11.4.369; Onoka CA, 2011, TROP MED INT HEALTH, V16, P1334, DOI 10.1111/j.1365-3156.2011.02836.x; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Onwujekwe O, 2009, HEALTH POLICY, V90, P223, DOI 10.1016/j.healthpol.2008.10.006; Organisation of African Unity (OAU), 2001, ABUJ DECL HIV AIDS T; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; Preker AS, 2005, FEASIBILITY MANDATOR; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Sadoh WE, 2011, NIGER J CLIN PRACT, V14, P65, DOI 10.4103/1119-3077.79255; Saksena P, 2011, HEALTH POLICY, V99, P203, DOI 10.1016/j.healthpol.2010.09.009; Shahrawat R, 2011, HLTH POLICY PLAN; Soyibo A, 2005, NATL HLTH ACCO UNPUB; Soyibo A, 2001, NATL HLTH ACCOUNTS N; Uzochukwu BS, 2002, HEALTH POLICY PLANN, V17, P378, DOI 10.1093/heapol/17.4.378; Velenyi E, 2005, PURSUIT MORE BETTER; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; World Bank, 2003, WORLD DEV IND; World Health Organization, 2001, MACR HLTH INV HLTH E; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006	34	55	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40811	10.1371/journal.pone.0040811	http://dx.doi.org/10.1371/journal.pone.0040811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974VS	22815828	gold, Green Published, Green Accepted			2022-12-27	WOS:000306466100072
J	Owens, BMJ; Moore, JWJ; Kaye, PM				Owens, Benjamin M. J.; Moore, John W. J.; Kaye, Paul M.			IRF7 Regulates TLR2-Mediated Activation of Splenic CD11c hi Dendritic Cells	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; I INTERFERON; UP-REGULATION; T-CELLS; EXPRESSION; MATURATION; IL-12	Members of the Interferon Regulatory Factor (IRF) family of transcription factors play an essential role in the development and function of the immune system. Here we investigated the role of IRF7 in the functional activation of conventional CD11c(hi) splenic dendritic cells (cDCs) in vitro and in vivo. Using mice deficient in IRF7, we found that this transcription factor was dispensable for the in vivo development of cDC subsets in the spleen. However, IRF7-deficient cDCs showed enhanced activation in response to microbial stimuli, characterised by exaggerated expression of CD80, CD86 and MHCII upon TLR2 ligation in vitro. The hyper-responsiveness of Irf7(-/-) cDC to TLR ligation could not be reversed with exogenous IFN alpha, nor by co-culture with wild-type cDCs, suggesting an intrinsic defect due to IRF7-deficiency. Irf7(-/-) cDCs also had impaired capacity to produce IL-12p70 when stimulated ex vivo, instead producing elevated levels of IL-10 that impaired their capacity to drive Th1 responses. Finally, analysis of bone marrow microchimeric mice revealed that cDCs deficient in IRF7 were also hyper-responsive to TLR2-mediated activation in vivo. Our data suggest a previously unknown function for IRF7 as a component of the regulatory network associated with cDC activation and adds to the wide variety of situations in which these transcription factors play a role.	Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Owens, BMJ (corresponding author), Univ Oxford, Gastroenterol Unit, Div Expt Med, Nuffield Dept Med, Oxford, England.	paul.kaye@york.ac.uk		Owens, Benjamin/0000-0003-4710-6841; Kaye, Paul/0000-0002-8796-4755	UK Medical Research Council; MRC Doctoral Training Award studentship; Medical Research Council [G1000230, G0400786] Funding Source: researchfish; MRC [G1000230, G0400786] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Doctoral Training Award studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (P.M.K.) and by an MRC Doctoral Training Award studentship (B.M.J.O.); http://www.mrc.ac.uk/index.ht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Bauvois B, 2009, BIOCHEM PHARMACOL, V78, P514, DOI 10.1016/j.bcp.2009.05.005; Beattie L, 2011, INFECT IMMUN, V79, P1057, DOI 10.1128/IAI.00633-10; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Gabriele L, 2006, J LEUKOCYTE BIOL, V80, P1500, DOI 10.1189/jlb.0406246; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kemball CC, 2005, J IMMUNOL, V174, P7950, DOI 10.4049/jimmunol.174.12.7950; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lim W, 2005, J IMMUNOL, V175, P5690, DOI 10.4049/jimmunol.175.9.5690; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Marckmann S, 2004, CLIN EXP IMMUNOL, V138, P499, DOI 10.1111/j.1365-2249.2004.02624.x; Maroof A, 2008, INFECT IMMUN, V76, P239, DOI 10.1128/IAI.00643-07; Marre ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012871; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Penninger JM, 1997, IMMUNITY, V7, P243, DOI 10.1016/S1074-7613(00)80527-0; Petrasek J, 2010, GASTROENTEROLOGY; Phillips R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000813; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Salkowski CA, 2000, J IMMUNOL, V165, P3970, DOI 10.4049/jimmunol.165.7.3970; Salkowski CA, 1999, J IMMUNOL, V163, P1529; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Sgarbanti M, 2007, ANN NY ACAD SCI, V1095, P325, DOI 10.1196/annals.1397.036; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Steinberg C, 2009, EUR J IMMUNOL, V39, P1007, DOI 10.1002/eji.200838814; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Taki S, 2005, J IMMUNOL, V174, P6005, DOI 10.4049/jimmunol.174.10.6005; Tam MA, 2009, IMMUNOLOGY, V128, P429, DOI 10.1111/j.1365-2567.2009.03128.x; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9; Zhao ZD, 2003, J IMMUNOL, V170, P5674, DOI 10.4049/jimmunol.170.11.5674	58	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41050	10.1371/journal.pone.0041050	http://dx.doi.org/10.1371/journal.pone.0041050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815909	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100112
J	Pini, M; Rhodes, DH; Castellanos, KJ; Cabay, RJ; Grady, EF; Fantuzzi, G				Pini, Maria; Rhodes, Davina H.; Castellanos, Karla J.; Cabay, Robert J.; Grady, Eileen F.; Fantuzzi, Giamila			Rosiglitazone Improves Survival and Hastens Recovery from Pancreatic Inflammation in Obese Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; DIET-INDUCED OBESITY; HIGH-FAT DIET; PPAR-GAMMA; INSULIN SENSITIVITY; ADIPOSE-TISSUE; PIOGLITAZONE; SEVERITY; CERULEIN; ADIPONECTIN	Obesity increases severity of acute pancreatitis (AP) by unclear mechanisms. We investigated the effect of the PPAR-gamma agonist rosiglitazone (RGZ, 0.01% in the diet) on severity of AP induced by administration of IL-12+ IL-18 in male C57BL6 mice fed a low fat (LFD) or high fat diet (HFD), under the hypothesis that RGZ would reduce disease severity in HFD-fed obese animals. In both LFD and HFD mice without AP, RGZ significantly increased body weight and % fat mass, with significant upregulation of adiponectin and suppression of erythropoiesis. In HFD mice with AP, RGZ significantly increased survival and hastened recovery from pancreatic inflammation, as evaluated by significantly improved pancreatic histology, reduced saponification of visceral adipose tissue and less severe suppression of erythropoiesis at Day 7 post-AP. This was associated with significantly lower circulating and pancreas-associated levels of IL-6, Galectin-3, osteopontin and TIMP-1 in HFD + RGZ mice, particularly at Day 7 post-AP. In LFD mice with AP, RGZ significantly worsened the degree of intrapancreatic acinar and fat necrosis as well as visceral fat saponification, without affecting other parameters of disease severity or inflammation. Induction of AP lead to major suppression of adiponectin levels at Day 7 in both HFD and HFD + RGZ mice. In conclusion, RGZ prevents development of severe AP in obese mice even though it significantly increases adiposity, indicating that obesity can be dissociated from AP severity by improving the metabolic and inflammatory milieu. However, RGZ worsens selective parameters of AP severity in LFD mice.	[Pini, Maria; Rhodes, Davina H.; Castellanos, Karla J.; Fantuzzi, Giamila] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA; [Cabay, Robert J.] Univ Illinois, Dept Pathol, Chicago, IL USA; [Grady, Eileen F.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco	Pini, M (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA.	giamila@uic.edu	Cabay, Robert J./AAP-9570-2021; Castellanos, Karla/D-1164-2018; Pini, Maria/O-8620-2019; Fantuzzi, Giamila/A-1758-2009; Pini, Maria/AAC-2530-2021; Pini, Maria/T-6292-2018	Cabay, Robert J./0000-0001-8473-296X; Castellanos, Karla/0000-0002-8723-6475; Pini, Maria/0000-0002-9995-5370; Fantuzzi, Giamila/0000-0001-5334-0082; Pini, Maria/0000-0002-9995-5370	National Institues of Health [DK083328, DK080787-03S3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080787, R01DK083328] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institues of Health grants DK083328 to GF and DK080787-03S3 to EFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azzawi HH, 2011, J GASTROINTEST SURG, V15, P1394, DOI 10.1007/s11605-011-1583-x; [Anonymous], BIOCH BIOPHYS ACTA; Araki H, 2008, GUT, V57, P1431, DOI 10.1136/gut.2007.135665; Bao B, 2011, BBA-REV CANCER, V1815, P135, DOI 10.1016/j.bbcan.2010.11.003; Basu A, 2006, DIABETES CARE, V29, P510, DOI 10.2337/diacare.29.03.06.dc05-2004; Berria R, 2007, CLIN PHARMACOL THER, V82, P275, DOI 10.1038/sj.clpt.6100146; Celinski K, 2009, MED SCI MONITOR, V15, pBR21; Chen C, 2009, ARCH MED RES, V40, P79, DOI 10.1016/j.arcmed.2008.11.004; Chilcott J, 2001, CLIN THER, V23, P1792, DOI 10.1016/S0149-2918(00)80078-8; Cuzzocrea S, 2004, INTENS CARE MED, V30, P951, DOI 10.1007/s00134-004-2180-1; Evans A C, 2010, Minerva Gastroenterol Dietol, V56, P169; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Fernandes-Santos C, 2009, PANCREAS, V38, pE80, DOI 10.1097/MPA.0b013e3181987d9d; Folch-Puy E, 2006, WORLD J GASTROENTERO, V12, P6458, DOI 10.3748/wjg.v12.i40.6458; Foryst-Ludwig A, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-64; Frommer KW, 2011, ANN RHEUM DIS; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Ivashchenko CY, 2007, AM J PHYSIOL-GASTR L, V293, pG319, DOI 10.1152/ajpgi.00056.2007; Jha RK, 2009, MED SCI MONITOR, V15, pRA147; Konturek PC, 2005, WORLD J GASTROENTERO, V11, P6322, DOI 10.3748/wjg.v11.i40.6322; Liu LF, 2007, AM J PHYSIOL-GASTR L, V292, P1671, DOI 10.1152/ajpgi.00523.2006; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Papachristou GI, 2008, WORLD J GASTROENTERO, V14, P6273, DOI 10.3748/wjg.14.6273; Pini M, 2012, J LEUKOCYTE BIOL, V91, P957, DOI 10.1189/jlb.1211627; Pini M, 2011, CYTOKINE, V56, P708, DOI 10.1016/j.cyto.2011.09.015; Pini M, 2010, OBESITY, V18, P476, DOI 10.1038/oby.2009.263; Rhodes DH, 2012, OBESITY IN PRESS; Schaffler A, 2010, AM J GASTROENTEROL, V105, P2474, DOI 10.1038/ajg.2010.278; Sennello JA, 2008, P NATL ACAD SCI USA, V105, P8085, DOI 10.1073/pnas.0804091105; Sharma A, 2009, PANCREAS, V38, P907, DOI 10.1097/MPA.0b013e3181b65bbe; Sidhu S, 2011, FUND CLIN PHARMACOL, V25, P237, DOI 10.1111/j.1472-8206.2010.00827.x; Steer M, 2002, GASTROENTEROLOGY, V122, P1168, DOI 10.1053/gast.2002.32761; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wilding J, 2006, INT J CLIN PRACT, V60, P1272, DOI 10.1111/j.1742-1241.2006.01128.x; Xu P, 2007, WORLD J GASTROENTERO, V13, P1983, DOI 10.3748/wjg.v13.i13.1983; Zyromski NJ, 2008, AM J PHYSIOL-GASTR L, V295, pG552, DOI 10.1152/ajpgi.90278.2008; Zyromski NJ, 2009, PANCREATOLOGY, V9, P410, DOI 10.1159/000199436	40	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40944	10.1371/journal.pone.0040944	http://dx.doi.org/10.1371/journal.pone.0040944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815875	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100097
J	Taylor, S; Kumar, L				Taylor, Subhashni; Kumar, Lalit			Sensitivity Analysis of CLIMEX Parameters in Modelling Potential Distribution of Lantana camara L.	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; GEOGRAPHICAL-DISTRIBUTION; CLIMATE-CHANGE; ALIEN PLANT; FIRE ANT; NICHE; INVASIONS; RANGE; CONSERVATION; ERROR	A process-based niche model of L. camara L. (lantana), a highly invasive shrub species, was developed to estimate its potential distribution using CLIMEX. Model development was carried out using its native and invasive distribution and validation was carried out with the extensive Australian distribution. A good fit was observed, with 86.7% of herbarium specimens collected in Australia occurring within the suitable and highly suitable categories. A sensitivity analysis was conducted to identify the model parameters that had the most influence on lantana distribution. The changes in suitability were assessed by mapping the regions where the distribution changed with each parameter alteration. This allowed an assessment of where, within Australia, the modification of each parameter was having the most impact, particularly in terms of the suitable and highly suitable locations. The sensitivity of various parameters was also evaluated by calculating the changes in area within the suitable and highly suitable categories. The limiting low temperature (DV0), limiting high temperature (DV3) and limiting low soil moisture (SM0) showed highest sensitivity to change. The other model parameters were relatively insensitive to change. Highly sensitive parameters require extensive research and data collection to be fitted accurately in species distribution models. The results from this study can inform more cost effective development of species distribution models for lantana. Such models form an integral part of the management of invasive species and the results can be used to streamline data collection requirements for potential distribution modelling.	[Taylor, Subhashni; Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New England	Taylor, S (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	btaylo36@une.edu.au	Kumar, Lalit/A-6397-2011; Taylor, Subhashni/Q-6338-2018	Kumar, Lalit/0000-0002-9205-756X; Taylor, Subhashni/0000-0002-1624-0901	National Climate Change Adaptation Research Facility (NCCARF)	National Climate Change Adaptation Research Facility (NCCARF)	The National Climate Change Adaptation Research Facility (NCCARF) kindly provided a grant that allowed the main author to purchase the CLIMEX software as well as attend a training workshop for CLIMEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Australian Climate Change Science Program, 2012, CLIM CHANG AUSTR; Barney JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017222; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bhuju DR, 2006, NEPAL J SCI TECHNOLO, V7, P35; Biswas K., 1934, INDIAN FOR, V60, P861; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Buddenhagen CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005261; Burgman MA, 2005, ECOLOGY, V86, P2007, DOI 10.1890/04-0906; Chejara VK, 2010, WEED RES, V50, P174, DOI 10.1111/j.1365-3180.2010.00765.x; CILLIERS C J, 1983, Journal of the Entomological Society of Southern Africa, V46, P131; CILLIERS CJ, 1991, AGR ECOSYST ENVIRON, V37, P57, DOI 10.1016/0167-8809(91)90139-O; Crozier L, 2006, AM NAT, V167, P853, DOI 10.1086/504848; Daehler CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004462; Danin A., 2000, Willdenowia, V30, P305, DOI 10.3372/wi.30.30209; Day MD, 2003, LANTANA CURRENT MANA; Department of Primary Industries Parks Water and Environment (DPIPWE), 2003, LANT STAT WEED MAN P; DERM, 2010, MAPP LANT US LANDS R; Dunlop EA, 2006, WEED RES, V46, P404, DOI 10.1111/j.1365-3180.2006.00524.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Garibaldi A, 2008, PLANT DIS, V92, P1369, DOI 10.1094/PDIS-92-9-1369B; Global Biodiversity Information Facility, 2010, GBIF DAT PORT; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hallgren WS, 2000, GLOBAL CHANGE BIOL, V6, P483, DOI 10.1046/j.1365-2486.2000.00325.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hearne Scientific Software, 2007, CLIMEX SOFTW VERS 3; Hulme PE, 2003, ORYX, V37, P178, DOI 10.1017/S003060530300036X; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Johnson CJ, 2008, ECOL MODEL, V213, P143, DOI 10.1016/j.ecolmodel.2007.11.013; Johnson K, 2009, LANTANA CAMARA STRAT; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos DJ, 2011, WEED RES, V51, P85, DOI 10.1111/j.1365-3180.2010.00827.x; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Merow C, 2011, AM NAT, V178, P30, DOI 10.1086/660295; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Olfert O, 2006, ENTOMOL EXP APPL, V120, P221, DOI 10.1111/j.1570-7458.2006.00445.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2003, ECOL LETT, V6, P774, DOI 10.1046/j.1461-0248.2003.00502.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Poutsma J, 2008, BIOCONTROL, V53, P103, DOI 10.1007/s10526-007-9140-y; Robertson MP, 2004, DIVERS DISTRIB, V10, P461, DOI 10.1111/j.1366-9516.2004.00108.x; Rouget M, 2004, DIVERS DISTRIB, V10, P475, DOI 10.1111/j.1366-9516.2004.00118.x; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; South African Plant Invaders Atlas, 2006, MON EM SPREAD INV AL; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Sutherst RW, 2007, CLIMEX VERS 3 US GUI; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Thakur M. L., 1992, Indian Forester, V118, P466; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; van Klinken RD, 2009, GLOBAL ECOL BIOGEOGR, V18, P688, DOI 10.1111/j.1466-8238.2009.00483.x; Vera MT, 2002, ENVIRON ENTOMOL, V31, P1009, DOI 10.1603/0046-225X-31.6.1009; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wharton TN, 2004, DIVERS DISTRIB, V10, P253, DOI 10.1111/j.1366-9516.2004.00090.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; WINDER JA, 1982, B ENTOMOL RES, V72, P599, DOI 10.1017/S0007485300008634; Winder JA, 1980, FACTORS AFFECTING GR	67	27	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40969	10.1371/journal.pone.0040969	http://dx.doi.org/10.1371/journal.pone.0040969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815881	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100100
J	Tse, LA; Yu, ITS; Wang, XR; Qiu, H; Au, JSK				Tse, Lap Ah; Yu, Ignatius Tak-sun; Wang, Xiao-rong; Qiu, Hong; Au, Joseph Siu Kie			Synergistic Effect between Alcohol Consumption and Familial Susceptibility on Lung Cancer Risk among Chinese Men	PLOS ONE			English	Article							CIGARETTE-SMOKING; CASE-REFERENT; HISTORY; COHORT; TWINS	We aimed to examine the effect of alcohol consumption on lung cancer risk stratified by smoking, and to explore whether the impact of alcohol was modified by familial susceptibility to cancer. We recruited 1208 male lung cancer incident cases and 1069 community referents during 2004-2006 and collected their lifetime history of alcohol consumption, cigarette smoking, and family cancer history. Unconditional multivariate logistic regression analysis was performed to estimate the adjusted odds ratio (OR). We tested multiplicative-scale interaction between exposures of interest and examined the additive-scale interaction using synergy index. A moderate association between frequent alcohol consumption and lung cancer was observed among men who had family cancer history (OR = 4.22, 95%CI: 2.46-7.23) after adjustment of smoking and other confounders, while the alcohol effect among men without family history was weak (OR = 1.24, 95%CI: 0.95-1.63) and it became no excess in the never smokers. We observed a consistent synergistic effect between alcohol drinking and family cancer history for all lung cancers and the adenocarcinoma, while there was no multiplicative-scale interaction between the exposures of interest (likelihood ratio test for interaction, p>0.05). Our study revealed a possible synergistic effect between alcohol consumption and familial susceptibility for lung cancer risk; however, this observed possible association needs to be confirmed by future larger analytic studies with more never smoking cases.	[Tse, Lap Ah; Yu, Ignatius Tak-sun; Wang, Xiao-rong; Qiu, Hong] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Occupat & Environm Hlth, Hong Kong, Hong Kong, Peoples R China; [Au, Joseph Siu Kie] Queen Elizabeth Hosp, Dept Clin Oncol, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong	Tse, LA (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Occupat & Environm Hlth, Hong Kong, Hong Kong, Peoples R China.	iyu@cuhk.edu.hk	Yu, Ignatius Tak Sun/A-9936-2008; Qiu, Hong/K-2047-2013	Tse, Lap Ah/0000-0003-0355-6218	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK4460/03M]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China; Project No. CUHK4460/03M. The funding source had no role in the study design, data collection, data analysis, or interpretation of the findings.	Ahrendt SA, 2000, CANCER RES, V60, P3155; Bagnardi V, 2010, AM J EPIDEMIOL, V171, P36, DOI 10.1093/aje/kwp332; Bandera EV, 2001, CANCER EPIDEM BIOMAR, V10, P813; BRAUN MM, 1994, LANCET, V344, P440, DOI 10.1016/S0140-6736(94)91770-1; Carreon-Valencia T, ACETALDEHYDE; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Freudenheim JL, 2005, AM J CLIN NUTR, V82, P657, DOI 10.1093/ajcn/82.3.657; Hong Kong Government, 1997, TERR WID IND RAD FOL; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; *IARC, 1998, IARC MON EV CARC RIS, V44; IRVINE HD, 1993, BMJ-BRIT MED J, V306, P1503, DOI 10.1136/bmj.306.6891.1503; KETCHAM AS, 1963, CANCER RES, V23, P667; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; Lissowska J, 2010, CANCER CAUSE CONTROL, V21, P1091, DOI 10.1007/s10552-010-9537-2; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Schwartz AG, 1996, AM J EPIDEMIOL, V144, P554, DOI 10.1093/oxfordjournals.aje.a008965; SELLERS TA, 1991, GENET EPIDEMIOL, V8, P199, DOI 10.1002/gepi.1370080306; Shah PP, 2008, MUTAT RES-FUND MOL M, V639, P1, DOI 10.1016/j.mrfmmm.2007.10.006; Simonato L, 2001, INT J CANCER, V91, P876, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1139>3.0.CO;2-7; Tse LA, 2011, BRIT J CANCER, V104, P208, DOI 10.1038/sj.bjc.6606006; Tse LA, 2012, CANCER CAUSE CONTROL, V23, P121, DOI 10.1007/s10552-011-9861-1; Tse LA, 2011, ENVIRON HEALTH PERSP, V119, P1641, DOI 10.1289/ehp.1002790; Tse LA, 2011, J THORAC ONCOL, V6, P1670, DOI 10.1097/JTO.0b013e3182217bd4; Tse LA, 2009, AM J EPIDEMIOL, V169, P533, DOI 10.1093/aje/kwn385; Yu ITS, 2006, CANCER RES, V66, P4961, DOI 10.1158/0008-5472.CAN-05-2932; Yu ITS, 2007, INT J CANCER, V120, P133, DOI 10.1002/ijc.22133; Yun YH, 2005, CANCER EPIDEM BIOMAR, V14, P2125, DOI 10.1158/1055-9965.EPI-05-0236	30	5	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40647	10.1371/journal.pone.0040647	http://dx.doi.org/10.1371/journal.pone.0040647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815780	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100049
J	Vastermark, A; Krishnan, A; Houle, ME; Fredriksson, R; Cerda-Reverter, JM; Schioth, HB				Vastermark, Ake; Krishnan, Arunkumar; Houle, Michael E.; Fredriksson, Robert; Miguel Cerda-Reverter, Jose; Schioth, Helgi B.			Identification of Distant Agouti-Like Sequences and Re-Evaluation of the Evolutionary History of the Agouti-Related Peptide (AgRP)	PLOS ONE			English	Article							ELEPHANT SHARK; MELANOCORTIN RECEPTORS; TISSUE DISTRIBUTION; GENOME DUPLICATION; SIGNALING PEPTIDE; PROTEIN AGRP; GENE; FAMILY; FISH; ANTAGONIST	The Agouti-like peptides including AgRP, ASIP and the teleost-specific A2 (ASIP2 and AgRP2) peptides have potent and diverse functional roles in feeding, pigmentation and background adaptation mechanisms. There are contradictory theories about the evolution of the Agouti-like peptide family as well the nomenclature. Here we performed comprehensive mining and annotation of vertebrate Agouti-like sequences. We identified A2 sequences from salmon, trout, seabass, cod, cichlid, tilapia, gilt-headed sea bream, Antarctic toothfish, rainbow smelt, common carp, channel catfish and interestingly also in lobe-finned fish. Moreover, we surprisingly found eight novel homologues from the kingdom of arthropods and three from fungi, some sharing the characteristic C-x(6)-C-C motif which are present in the Agouti-like sequences, as well as approximate sequence length (130 amino acids), positioning of the motif sequence and sharing of exon-intron structures that are similar to the other Agouti-like peptides providing further support for the common origin of these sequences. Phylogenetic analysis shows that the AgRP sequences cluster basally in the tree, suggesting that these sequences split from a cluster containing both the ASIP and the A2 sequences. We also used a novel approach to determine the statistical evidence for synteny, a sinusoidal Hough transform pattern recognition technique. Our analysis shows that the teleost AgRP2 resides in a chromosomal region that has synteny with Hsa 8, but we found no convincing synteny between the regions that A2, AgRP and ASIP reside in, which would support that the Agouti-like peptides were formed by whole genome tetraplodization events. Here we suggest that the Agouti-like peptide genes were formed through classical subsequent gene duplications where the AgRP is the most distantly related to the three other members of that group, first splitting from a common ancestor to ASIP and A2, and then later the A2 split from ASIP followed by a split resulting in ASIP2 and AgRP2.	[Vastermark, Ake; Krishnan, Arunkumar; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Houle, Michael E.] Res Org Informat & Syst, Natl Inst Informat, Tokyo, Japan; [Miguel Cerda-Reverter, Jose] CSIC, Inst Acuicultura Torre de la Sal, Castellon de La Plana, Spain	Uppsala University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Vastermark, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	ake.vastermark@neuro.uu.se	Cerda-Reverter, Jose Miguel/K-4934-2014; Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020	Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Fredriksson, Robert/0000-0002-2810-3226; Houle, Michael/0000-0001-8486-8015; Krishnan, Arunkumar/0000-0002-9677-9092	Swedish Research Council; Recursos y Tecnologias Agroalimentarias (AGL) [2010-22247-C03-01/Incite09402193PR/CSD 2007-00002]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Recursos y Tecnologias Agroalimentarias (AGL)	The studies were supported by the Swedish Research Council to HS and by Recursos y Tecnologias Agroalimentarias (AGL) 2010-22247-C03-01/Incite09402193PR/CSD 2007-00002 to JMCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braasch I, 2011, P NATL ACAD SCI USA, V108, pE47, DOI 10.1073/pnas.1101594108; Braasch I, 2009, MOL BIOL EVOL, V26, P783, DOI 10.1093/molbev/msp015; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daza DO, 2011, ENDOCRINOLOGY, V152, P2278, DOI 10.1210/en.2011-0047; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Haitina T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-101; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Klovins J, 2005, ANN NY ACAD SCI, V1040, P363, DOI 10.1196/annals.1327.063; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Kurokawa T, 2006, PEPTIDES, V27, P3165, DOI 10.1016/j.peptides.2006.09.013; Larsson TA, 2009, GENOMICS, V93, P254, DOI 10.1016/j.ygeno.2008.10.001; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lynch VJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000349; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Murashita K, 2009, GEN COMP ENDOCR, V162, P160, DOI 10.1016/j.ygcen.2009.03.015; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ravi V, 2009, P NATL ACAD SCI USA, V106, P16327, DOI 10.1073/pnas.0907914106; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Saunders R, 2010, PROTEINS, V78, P1282, DOI 10.1002/prot.22646; Schioth HB, 2005, PEPTIDES, V26, P1886, DOI 10.1016/j.peptides.2004.11.034; Schioth HB, 2011, P NATL ACAD SCI USA, V108, pE49, DOI 10.1073/pnas.1102120108; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Song Y, 2003, ENDOCRINE, V22, P257, DOI 10.1385/ENDO:22:3:257; Vastermark A, 2011, EUR J PHARMACOL, V660, P61, DOI 10.1016/j.ejphar.2010.10.106; Widmark J, 2011, MOL BIOL EVOL, V28, P859, DOI 10.1093/molbev/msq257; Zhang C, 2010, P NATL ACAD SCI USA, V107, P20164, DOI 10.1073/pnas.1014941107; Zhao H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-256	34	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40982	10.1371/journal.pone.0040982	http://dx.doi.org/10.1371/journal.pone.0040982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815886	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100103
J	Grover, A; Izzo, AA				Grover, Ajay; Izzo, Angelo A.			BAT3 Regulates Mycobacterium tuberculosis Protein ESAT-6-Mediated Apoptosis of Macrophages	PLOS ONE			English	Article							B-ASSOCIATED TRANSCRIPT-3; GROWTH-FACTOR-BETA; CELL-DEATH; TGF-BETA; BCL-2-BINDING PROTEIN; DENDRITIC CELLS; SCYTHE; EXPRESSION; ANTIGENS; SUPPRESSION	HLA-B-associated transcript 3 (BAT3), also known as Scythe or BAG6, is a nuclear protein implicated in the control of apoptosis and natural killer (NK) cell-dendritic cell (DC) interaction. We demonstrate that BAT3 modulates the immune response by regulating the function of macrophages. BAT3 is released by macrophages in vitro and it down-regulates nitric oxide and proinflammatory cytokines release in IFN-gamma and LPS stimulated macrophages. Furthermore, Mycobacterium tuberculosis-derived protein ESAT-6 (Rv3875) induced transient increase in the expression and release of BAT3 in macrophages. We show that induction of apoptosis by ESAT-6 is dependent on the cleavage of BAT3 by caspase-3 and proteasomal degradation. Our results also indicate that BAT3 regulates ESAT-6-induced apoptosis by interacting with antiapoptotic protein BCL-2. Taken together, the data suggest that BAT3 plays a role in the early immune response to M. tuberculosis infection and may be a key protein associated with the fate of antigen presenting cells during infection.	[Grover, Ajay] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Immunol, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Pathol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Grover, A (corresponding author), Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA.	ajay.grover@colostate.edu	Izzo, Angelo A/F-1229-2017	Izzo, Angelo A/0000-0003-3208-2330	NIH [AI40091]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This Study was supported by NIH AI40091 Funding (A.A.I.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Delgado M, 2004, J LEUKOCYTE BIOL, V75, P1122, DOI 10.1189/jlb.1203626; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Dietrich J, 2006, VET MICROBIOL, V112, P163, DOI 10.1016/j.vetmic.2005.11.030; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Kalra M, 2010, DIAGN MICR INFEC DIS, V66, P153, DOI 10.1016/j.diagmicrobio.2009.09.005; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Minami R, 2007, BIOCHEM J, V405, P495, DOI 10.1042/BJ20061886; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Mustafa AS, 2002, MOL IMMUNOL, V39, P113, DOI 10.1016/S0161-5890(02)00048-2; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Ozaki T, 1999, DNA CELL BIOL, V18, P503, DOI 10.1089/104454999315222; Sasaki T, 2008, J CELL BIOL, V182, P449, DOI 10.1083/jcb.200802113; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Shen ZH, 1997, J IMMUNOL, V158, P2723; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Virador VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005136; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Xiao YQ, 2006, J IMMUNOL, V176, P1209, DOI 10.4049/jimmunol.176.2.1209	36	29	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40836	10.1371/journal.pone.0040836	http://dx.doi.org/10.1371/journal.pone.0040836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808273	Green Submitted, gold, Green Published			2022-12-27	WOS:000306406700061
J	Secor, PR; Jennings, LK; James, GA; Kirker, KR; Pulcini, ED; McInnerney, K; Gerlach, R; Livinghouse, T; Hilmer, JK; Bothner, B; Fleckman, P; Olerud, JE; Stewart, PS				Secor, Patrick R.; Jennings, Laura K.; James, Garth A.; Kirker, Kelly R.; Pulcini, Elinor deLancey; McInnerney, Kate; Gerlach, Robin; Livinghouse, Tom; Hilmer, Jonathan K.; Bothner, Brian; Fleckman, Philip; Olerud, John E.; Stewart, Philip S.			Phevalin (aureusimine B)Production by Staphylococcus aureus Biofilm and Impacts on Human Keratinocyte Gene Expression	PLOS ONE			English	Article							CALPAIN CLEAVAGE; FAMILY; PHOSPHORYLATION; SPECIFICITY; ACTIVATION; APOPTOSIS; CELLS; LISTS; SKIN; P73	Staphylococcus aureus biofilms are associated with chronic skin infections and are orders of magnitude more resistant to antimicrobials and host responses. S. aureus contains conserved nonribosomal peptide synthetases that produce the cyclic dipeptides tyrvalin and phevalin (aureusimine A and B, respectively). The biological function of these compounds has been speculated to be involved in virulence factor gene expression in S. aureus, protease inhibition in eukaryotic cells, and interspecies bacterial communication. However, the exact biological role of these compounds is unknown. Here, we report that S. aureus biofilms produce greater amounts of phevalin than their planktonic counterparts. Phevalin had no obvious impact on the extracellular metabolome of S. aureus as measured by high-performance liquid chromatography-mass spectrometry and nuclear magnetic resonance. When administered to human keratinocytes, phevalin had a modest effect on gene expression. However, conditioned medium from S. aureus spiked with phevalin amplified differences in keratinocyte gene expression compared to conditioned medium alone. Phevalin may be exploited as potential biomarker and/or therapeutic target for chronic, S. aureus biofilm-based infections.	[Secor, Patrick R.; James, Garth A.; Kirker, Kelly R.; Pulcini, Elinor deLancey; Gerlach, Robin; Stewart, Philip S.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Secor, Patrick R.; Jennings, Laura K.; Livinghouse, Tom; Hilmer, Jonathan K.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [McInnerney, Kate] Montana State Univ, Funct Genom Core Facil, Bozeman, MT 59717 USA; [Fleckman, Philip; Olerud, John E.] Univ Washington, Div Dermatol, Seattle, WA 98195 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Washington; University of Washington Seattle	Secor, PR (corresponding author), Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA.	psecor@uw.edu	Gerlach, Robin/A-9474-2012; Olerud, John/AAA-4762-2021	Olerud, John/0000-0002-2727-4680; Stewart, Philip/0000-0001-7773-8570; Hilmer, Jonathan/0000-0002-1494-6353	National Institute of General Medical Sciences (NIGMS) [1P20GM078445-01]; National Science Foundation [MCB 1022481]; NCRR INBRE award [P20 RR016455]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026659, P20RR016455, S10RR013878, S10RR002437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078445] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NCRR INBRE award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (1P20GM078445-01) from the National Institute of General Medical Sciences (NIGMS). The contents of this project are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS. BB is funded in part by MCB 1022481 from the National Science Foundation. We would like to thank the Murdock Charitable Trust and United States National Institutes of Health Cobre (5P20RR02437-03) and DoD (DURIP - W911NF0510255) for support of the Mass Spectrometry Facilities at MSU. Support for the Genomics Core Facility was provided by NCRR INBRE award P20 RR016455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ ME, 1995, J ANTIBIOT, V48, P1165, DOI 10.7164/antibiotics.48.1165; CARILLO S, 1994, ONCOGENE, V9, P1679; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Farkas A, 2003, ARCH DERMATOL RES, V295, P56, DOI 10.1007/s00403-003-0399-2; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Kamei M, 1998, GENOMICS, V51, P197, DOI 10.1006/geno.1998.5395; Kirker KR, 2009, WOUND REPAIR REGEN, V17, P690, DOI 10.1111/j.1524-475X.2009.00523.x; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lipp C, 2010, J WOUND CARE, V19, P220, DOI 10.12968/jowc.2010.19.6.48468; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P346, DOI 10.1111/1523-1747.ep12285556; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Niapour M, 2008, J BIOL CHEM, V283, P21371, DOI 10.1074/jbc.M801462200; POTTS AJ, 1994, EXP CELL RES, V212, P2, DOI 10.1006/excr.1994.1111; Roongsawang N, 2011, INT J MOL SCI, V12, P141, DOI 10.3390/ijms12010141; Secor PR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-143; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Soong G, 2011, J BIOL CHEM; Soriano A, 2000, CLIN INFECT DIS, V30, P368, DOI 10.1086/313650; Sun F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015703; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Wilson ID, 2005, J CHROMATOGR B, V817, P67, DOI 10.1016/j.jchromb.2004.07.045; Wyatt MA, 2011, SCIENCE, V333, P1381; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Zeng YB, 2005, BIOORG MED CHEM LETT, V15, P3034, DOI 10.1016/j.bmcl.2005.04.031; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zhang J, 1997, ORAL MICROBIOL IMMUN, V12, P345, DOI 10.1111/j.1399-302X.1997.tb00736.x; Zimmermann M, 2010, CHEM BIOL, V17, P925, DOI 10.1016/j.chembiol.2010.08.006	35	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40973	10.1371/journal.pone.0040973	http://dx.doi.org/10.1371/journal.pone.0040973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808288	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700072
J	Shutova, M; Yang, CS; Vasiliev, JM; Svitkina, T				Shutova, Maria; Yang, Changsong; Vasiliev, Jury M.; Svitkina, Tatyana			Functions of Nonmuscle Myosin II in Assembly of the Cellular Contractile System	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; SMOOTH-MUSCLE MYOSIN; FOCAL ADHESIONS; STRESS FIBERS; ACTIN-FILAMENTS; MIGRATING CELLS; ELECTRON-MICROSCOPY; RETROGRADE FLOW; CULTURED FIBROBLASTS; EMBRYO FIBROBLASTS	The contractile system of nonmuscle cells consists of interconnected actomyosin networks and bundles anchored to focal adhesions. The initiation of the contractile system assembly is poorly understood structurally and mechanistically, whereas system's maturation heavily depends on nonmuscle myosin II (NMII). Using platinum replica electron microscopy in combination with fluorescence microscopy, we characterized the structural mechanisms of the contractile system assembly and roles of NMII at early stages of this process. We show that inhibition of NMII by a specific inhibitor, blebbistatin, in addition to known effects, such as disassembly of stress fibers and mature focal adhesions, also causes transformation of lamellipodia into unattached ruffles, loss of immature focal complexes, loss of cytoskeleton-associated NMII filaments and peripheral accumulation of activated, but unpolymerized NMII. After blebbistatin washout, assembly of the contractile system begins with quick and coordinated recovery of lamellipodia and focal complexes that occurs before reappearance of NMII bipolar filaments. The initial formation of focal complexes and subsequent assembly of NMII filaments preferentially occurred in association with filopodial bundles and concave actin bundles formed by filopodial roots at the lamellipodial base. Over time, accumulating NMII filaments help to transform the precursor structures, focal complexes and associated thin bundles, into stress fibers and mature focal adhesions. However, semi-sarcomeric organization of stress fibers develops at much slower rate. Together, our data suggest that activation of NMII motor activity by light chain phosphorylation occurs at the cell edge and is uncoupled from NMII assembly into bipolar filaments. We propose that activated, but unpolymerized NMII initiates focal complexes, thus providing traction for lamellipodial protrusion. Subsequently, the mechanical resistance of focal complexes activates a load-dependent mechanism of NMII polymerization in association with attached bundles, leading to assembly of stress fibers and maturation of focal adhesions.	[Shutova, Maria; Yang, Changsong; Svitkina, Tatyana] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Shutova, Maria; Vasiliev, Jury M.] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia	University of Pennsylvania; Russian Academy of Medical Sciences	Shutova, M (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	svitkina@sas.upenn.edu		Shutova, Maria/0000-0003-2340-6102	University of Pennsylvania Research Foundation; National Institutes of Health [GM70898]; Russian Foundation for Basic Research [11-04-01473-a]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070898] Funding Source: NIH RePORTER	University of Pennsylvania Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Pennsylvania Research Foundation, the National Institutes of Health grant #GM70898 and the Russian Foundation for Basic Research grant #11-04-01473-a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Aratyn-Schaus Y, 2011, MOL BIOL CELL, V22, P1330, DOI 10.1091/mbc.E10-11-0891; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; Dahan I, 2012, MOL BIOL CELL, V23, P591, DOI 10.1091/mbc.E11-01-0015; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; HEATH JP, 1981, CELL BIOL INT REP, V5, P975, DOI 10.1016/0309-1651(81)90214-9; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; IKEBE M, 1986, J BIOL CHEM, V261, P36; Iwasaki T, 2008, BIOPHYS J, V94, pL35, DOI 10.1529/biophysj.107.124479; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kim EJ, 2003, J BIOL CHEM, V278, P30063, DOI 10.1074/jbc.M304909200; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kondo T, 2011, BIOCHEM J, V435, P569, DOI 10.1042/BJ20100837; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Lee CS, 2010, J CELL BIOL, V190, P663, DOI 10.1083/jcb.201003057; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Luo TZ, 2012, BIOPHYS J, V102, P238, DOI 10.1016/j.bpj.2011.12.020; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Morimura S, 2011, BIOCHEM BIOPH RES CO, V404, P834, DOI 10.1016/j.bbrc.2010.12.069; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rosado LAR, 2011, J CELL SCI, V124, P483, DOI 10.1242/jcs.074211; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Sanborn KB, 2011, BLOOD, V118, P5862, DOI 10.1182/blood-2011-03-344846; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Sandquist JC, 2008, MOL BIOL CELL, V19, P5156, DOI 10.1091/mbc.E08-05-0533; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Schaub S, 2007, MOL BIOL CELL, V18, P3723, DOI 10.1091/mbc.E06-09-0859; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Shutova MS, 2008, CELL MOTIL CYTOSKEL, V65, P734, DOI 10.1002/cm.20295; SINARD JH, 1989, J CELL BIOL, V109, P1537, DOI 10.1083/jcb.109.4.1537; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sun SX, 2010, CURR BIOL, V20, pR649, DOI 10.1016/j.cub.2010.07.004; Svitkina T, 2007, METHOD CELL BIOL, V79, P295, DOI 10.1016/S0091-679X(06)79012-4; Svitkina T, 2009, METHODS MOL BIOL, V586, P187, DOI 10.1007/978-1-60761-376-3_10; SVITKINA TM, 1989, CELL MOTIL CYTOSKEL, V12, P150, DOI 10.1002/cm.970120304; SVITKINA TM, 1984, EUR J CELL BIOL, V34, P64; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; SVITKINA TM, 2006, CELL BIOL LAB HDB, V3, P277; Takacs B, 2010, P NATL ACAD SCI USA, V107, P6799, DOI 10.1073/pnas.0907585107; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Uyeda TQP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026200; VERKHOVSKY AB, 1987, EXP CELL RES, V173, P244, DOI 10.1016/0014-4827(87)90349-1; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe M, 2010, AM J PHYSIOL-CELL PH, V298, pC1118, DOI 10.1152/ajpcell.00269.2009; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	93	81	82	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40814	10.1371/journal.pone.0040814	http://dx.doi.org/10.1371/journal.pone.0040814			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808267	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700057
J	Ssematimba, A; Elbers, ARW; Hagenaars, TJ; de Jong, MCM				Ssematimba, Amos; Elbers, Armin R. W.; Hagenaars, Thomas J.; de Jong, Mart C. M.			Estimating the Per-Contact Probability of Infection by Highly Pathogenic Avian Influenza (H7N7) Virus during the 2003 Epidemic in The Netherlands	PLOS ONE			English	Article							POULTRY FARMS; A VIRUS; TRANSMISSION; HISTORY	Estimates of the per-contact probability of transmission between farms of Highly Pathogenic Avian Influenza virus of H7N7 subtype during the 2003 epidemic in the Netherlands are important for the design of better control and biosecurity strategies. We used standardized data collected during the epidemic and a model to extract data for untraced contacts based on the daily number of infectious farms within a given distance of a susceptible farm. With these data, we used a maximum likelihood estimation approach to estimate the transmission probabilities by the individual contact types, both traced and untraced. The estimated conditional probabilities, conditional on the contact originating from an infectious farm, of virus transmission were: 0.000057 per infectious farm within 1 km per day, 0.000413 per infectious farm between 1 and 3 km per day, 0.0000895 per infectious farm between 3 and 10 km per day, 0.0011 per crisis organisation contact, 0.0414 per feed delivery contact, 0.308 per egg transport contact, 0.133 per other-professional contact and, 0.246 per rendering contact. We validate these outcomes against literature data on virus genetic sequences for outbreak farms. These estimates can be used to inform further studies on the role that improved biosecurity between contacts and/or contact frequency reduction can play in eliminating between-farm spread of the virus during future epidemics. The findings also highlight the need to; 1) understand the routes underlying the infections without traced contacts and, 2) to review whether the contact-tracing protocol is exhaustive in relation to all the farm's day-to-day activities and practices.	[Ssematimba, Amos; Elbers, Armin R. W.; Hagenaars, Thomas J.] Univ Wageningen & Res Ctr, CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands; [Ssematimba, Amos; de Jong, Mart C. M.] Wageningen Univ, Dept Anim Sci, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Ssematimba, A (corresponding author), Univ Wageningen & Res Ctr, CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands.	amos.ssematimba@wur.nl	de Jong, Mart C.M./GQQ-0825-2022; Ssematimba, Amos/S-3217-2019	de Jong, Mart C.M./0000-0002-5339-1995; Ssematimba, Amos/0000-0002-5407-2478	Foundation for Economic Structure Strengthening (FES) in the Netherlands, FES Program on Avian Influenza	Foundation for Economic Structure Strengthening (FES) in the Netherlands, FES Program on Avian Influenza	This work was supported by the Foundation for Economic Structure Strengthening (FES) in the Netherlands, FES Program on Avian Influenza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bataille A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002094; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Capua I, 2003, VET RES COMMUN, V27, P123, DOI 10.1023/B:VERC.0000014128.68876.31; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; de Jong MCM, 2009, REV SCI TECH OIE, V28, P371; Diekmann O, 1998, J APPL PROBAB, V35, P448, DOI 10.1017/S0021900200015072; Elbers ARW, 2005, AVIAN PATHOL, V34, P181, DOI 10.1080/03079450500096497; Elbers ARW, 2004, AVIAN DIS, V48, P691, DOI 10.1637/7149; Kandun IN, 2010, ZOONOSES PUBLIC HLTH, V57, P285, DOI 10.1111/j.1863-2378.2009.01246.x; KOOPMAN JS, 1994, AM J PUBLIC HEALTH, V84, P836, DOI 10.2105/AJPH.84.5.836; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Lupiani B, 2009, COMP IMMUNOL MICROB, V32, P311, DOI 10.1016/j.cimid.2008.01.004; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031114; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; te Beest DE, 2011, ZOONOSES PUBLIC HLTH, V58, P493, DOI 10.1111/j.1863-2378.2010.01388.x; Thomas ME, 2005, PREV VET MED, V69, P1, DOI 10.1016/j.prevetmed.2004.12.001; van Asseldonk M. A. P. M., 2005, PREVENTION CONTROL F; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; Woods A, 2004, J AGR ENVIRON ETHIC, V17, P341, DOI 10.1007/s10806-004-5185-4; Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913	25	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40929	10.1371/journal.pone.0040929	http://dx.doi.org/10.1371/journal.pone.0040929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808285	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700070
J	Rivara, MB; Bajwa, EK; Januzzi, JL; Gong, MN; Thompson, BT; Christiani, DC				Rivara, Matthew B.; Bajwa, Ednan K.; Januzzi, James L.; Gong, Michelle N.; Thompson, B. Taylor; Christiani, David C.			Prognostic Significance of Elevated Cardiac Troponin-T Levels in Acute Respiratory Distress Syndrome Patients	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE COR-PULMONALE; TRANSTHORACIC ECHOCARDIOGRAPHY; MYOCARDIAL-INFARCTION; SYSTOLIC PRESSURE; RISK-FACTOR; MORTALITY; BIOMARKER; HYPERTENSION; EMBOLISM	Background: Elevated levels of biochemical markers of myocardial necrosis have been associated with worsened outcomes in Acute Respiratory Distress Syndrome (ARDS), but there are few prospective data on this relationship. We investigated elevated cardiac troponin T (cTnT) levels and their relationship with outcome in patients with ARDS. Methods: A prospective cohort study of patients with ARDS was conducted at a tertiary-care academic medical center. Patients had blood taken within 48 hours of ARDS onset and assayed for cTnT. Patients were followed for the outcomes of 60-day mortality, number of organ failures, and days free of mechanical ventilation. Echocardiographic and electrocardiographic (ECG) data were analyzed for signs of myocardial ischemia, infarction, or other myocardial dysfunction. Results: 177 patients were enrolled, 70 of whom died (40%). 119 patients had detectable cTnT levels (67%). Median cTnT level was 0.03 ng/mL, IQR 0-0.10 ng/mL, and levels were higher among non-survivors (P = .008). Increasing cTnT level was significantly associated with increasing mortality (P = .008). The association between increasing cTnT level and mortality remained significant after adjustment in a multivariate model (HRadj = 1.45, 95% CI 1.17-1.81, P = .001). Elevated cTnT level was also associated with increased number of organ failures (P = .002), decreased number of days free of mechanical ventilation (P = .03), echocardiographic wall motion abnormalities (P = 0.001), and severity of tricuspid regurgitation (P = .04). There was no association between ECG findings of myocardial ischemia or infarction and elevated cTnT. Conclusions: Elevated cTnT levels are common in patients with ARDS, and are associated with worsened clinical outcomes and certain echocardiographic abnormalities. No association was seen between cTnT levels and ECG evidence of coronary ischemia.	[Rivara, Matthew B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Bajwa, Ednan K.; Thompson, B. Taylor; Christiani, David C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pulm & Crit Care Unit, Boston, MA USA; [Januzzi, James L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiol Unit, Boston, MA USA; [Gong, Michelle N.] Montefiore Med Ctr, Albert Einstein Coll Med, Crit Care Div, Bronx, NY 10467 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Rivara, MB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	ebajwa@partners.org	Januzzi, James/Y-2436-2019	Bajwa, Ednan/0000-0001-9026-1009	National Institutes of Health/National Heart, Lung, and Blood Institute [HL60710, HL67197, HL07874]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL067197, R01HL060710, T32HL007874] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Heart, Lung, and Blood Institute grants HL60710, HL67197, and HL07874. Reagents for troponin assays were donated by Roche Diagnostics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Ammann P, 2003, J AM COLL CARDIOL, V41, P2004, DOI 10.1016/S0735-1097(03)00421-2; Attaran RR, 2009, TRANSPL P, V41, P3827, DOI 10.1016/j.transproceed.2009.06.201; Bajwa EK, 2007, CRIT CARE MED, V35, P2484, DOI 10.1097/01.CCM.0000281852.36573.22; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Cheng IW, 2003, CRIT CARE MED, V31, P20, DOI 10.1097/00003246-200301000-00003; Collinson PO, 2006, ANN CLIN BIOCHEM, V43, P273, DOI 10.1258/000456306777695555; Court O, 2002, CRIT CARE, V6, P500, DOI 10.1186/cc1822; CUNNION RE, 1986, CIRCULATION, V73, P637, DOI 10.1161/01.CIR.73.4.637; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Flierl MA, 2008, MOL MED, V14, P327, DOI 10.2119/2007-00130.Flierl; Fromm RE, 2007, CRIT CARE MED, V35, P584, DOI 10.1097/01.CCM.0000254349.10953.BE; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Greene R, 1986, J Thorac Imaging, V1, P31, DOI 10.1097/00005382-198607000-00006; Joseph MX, 2004, CHEST, V126, P1592, DOI 10.1378/chest.126.5.1592; Lim W, 2006, CRIT CARE MED, V34, P1338, DOI 10.1097/01.CCM.0000214679.23957.90; Lim W, 2006, AM J CRIT CARE, V15, P280; Lim W, 2006, ARCH INTERN MED, V166, P2446, DOI 10.1001/archinte.166.22.2446; Luecke T, 2004, INTENS CARE MED, V30, P119, DOI 10.1007/s00134-003-1993-7; Martin G R, 1988, J Am Soc Echocardiogr, V1, P257; McClintock DE, 2007, AM J RESP CRIT CARE, V175, P256, DOI 10.1164/rccm.200607-947OC; Metra M, 2007, EUR J HEART FAIL, V9, P776, DOI 10.1016/j.ejheart.2007.05.007; Monchi M, 1998, AM J RESP CRIT CARE, V158, P1076, DOI 10.1164/ajrccm.158.4.9802009; Nathan SD, 2008, RESP MED, V102, P1305, DOI 10.1016/j.rmed.2008.03.022; Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835; Parsons PE, 2005, AM J PHYSIOL-LUNG C, V288, pL426, DOI 10.1152/ajplung.00302.2004; Puchalski Michael D, 2007, Congenit Heart Dis, V2, P27, DOI 10.1111/j.1747-0803.2007.00068.x; Salem R, 2008, CURR OPIN CRIT CARE, V14, P561, DOI 10.1097/MCC.0b013e32830e6d81; Stawicki SP, 2008, J AM COLL SURGEONS, V206, P42, DOI 10.1016/j.jamcollsurg.2007.06.293; SUZUKI Y, 1986, AM J CARDIOL, V57, P811, DOI 10.1016/0002-9149(86)90619-3; Testani JM, 2010, AM J CARDIOL, V105, P1192, DOI 10.1016/j.amjcard.2009.11.048; Vieillard-Baron A, 2002, AM J RESP CRIT CARE, V166, P1310, DOI 10.1164/rccm.200202-146CC; Vieillard-Baron A, 2001, CRIT CARE MED, V29, P1551, DOI 10.1097/00003246-200108000-00009; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Wu AHB, 2008, AM HEART J, V155, P208, DOI 10.1016/j.ahj.2007.10.016; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ZAPOL WM, 1977, NEW ENGL J MED, V296, P476, DOI 10.1056/NEJM197703032960903	40	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40515	10.1371/journal.pone.0040515	http://dx.doi.org/10.1371/journal.pone.0040515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808179	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400030
J	Bair, WN; Kiemel, T; Jeka, JJ; Clark, JE				Bair, Woei-Nan; Kiemel, Tim; Jeka, John J.; Clark, Jane E.			Development of Multisensory Reweighting Is Impaired for Quiet Stance Control in Children with Developmental Coordination Disorder (DCD)	PLOS ONE			English	Article							POSTURAL CONTROL; CLUMSY CHILDREN; SENSORY INTEGRATION; MOTION COHERENCE; YOUNG-CHILDREN; VISUAL-MOTION; INFORMATION; BALANCE; VISION; TOUCH	Background: Developmental Coordination Disorder (DCD) is a leading movement disorder in children that commonly involves poor postural control. Multisensory integration deficit, especially the inability to adaptively reweight to changing sensory conditions, has been proposed as a possible mechanism but with insufficient characterization. Empirical quantification of reweighting significantly advances our understanding of its developmental onset and improves the characterization of its difference in children with DCD compared to their typically developing (TD) peers. Methodology/Principal Findings: Twenty children with DCD (6.6 to 11.8 years) were tested with a protocol in which visual scene and touch bar simultaneously oscillateded medio-laterally at different frequencies and various amplitudes. Their data were compared to data on TD children (4.2 to 10.8 years) from a previous study. Gains and phases were calculated for medio-lateral responses of the head and center of mass to both sensory stimuli. Gains and phases were simultaneously fitted by linear functions of age for each amplitude condition, segment, modality and group. Fitted gains and phases at two comparison ages (6.6 and 10.8 years) were tested for reweighting within each group and for group differences. Children with DCD reweight touch and vision at a later age (10.8 years) than their TD peers (4.2 years). Children with DCD demonstrate a weak visual reweighting, no advanced multisensory fusion and phase lags larger than those of TD children in response to both touch and vision. Conclusions/Significance: Two developmental perspectives, postural body scheme and dorsal stream development, are provided to explain the weak vision reweighting. The lack of multisensory fusion supports the notion that optimal multisensory integration is a slow developmental process and is vulnerable in children with DCD.	[Bair, Woei-Nan] Univ Maryland, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA; [Kiemel, Tim; Jeka, John J.; Clark, Jane E.] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA; [Jeka, John J.; Clark, Jane E.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Bair, WN (corresponding author), Univ Maryland, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA.	wnbair@gmail.com		Jeka, John/0000-0001-5942-3209; Bair, Woei-Nan/0000-0003-3517-3123	National Institutes of Health [5R01HD042527-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by National Institutes of Health 5R01HD042527-05 to Dr. Jane E. Clark. The URL for the project in NIH, RePORT system is http://projectreporter.nih.gov/project_info_description.cfm?aid = 7077646&icde = 10721156&ddparam = &ddvalue = &ddsub =. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison LK, 2006, EXP BRAIN RES, V175, P342, DOI 10.1007/s00221-006-0559-7; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Bair WN, 2011, GAIT POSTURE, V34, P183, DOI 10.1016/j.gaitpost.2011.04.007; Bensmaia SJ, 2006, J NEUROPHYSIOL, V96, P1625, DOI 10.1152/jn.00192.2006; Bo J, 2008, J MOTOR BEHAV, V40, P391, DOI 10.3200/JMBR.40.5.391-399; Bockowski L, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P87; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Carver S, 2006, BIOL CYBERN, V95, P123, DOI 10.1007/s00422-006-0069-5; Cherng RJ, 2007, HUM MOVEMENT SCI, V26, P913, DOI 10.1016/j.humov.2007.05.006; Deconinck FJA, 2008, ADAPT PHYS ACT Q, V25, P17, DOI 10.1123/apaq.25.1.17; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Ernst MO, 2008, CURR BIOL, V18, pR519, DOI 10.1016/j.cub.2008.05.002; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Fox J., 2019, R COMPANION APPL REG, V.; Geuze RH, 2003, HUM MOVEMENT SCI, V22, P527, DOI 10.1016/j.humov.2003.09.008; Geuze RH, 2001, HUM MOVEMENT SCI, V20, P7, DOI 10.1016/S0167-9457(01)00027-6; GEUZE RH, 1987, J HUM MOVEMENT STUD, V13, P421; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Grinter EJ, 2010, BRAIN RES BULL, V82, P147, DOI 10.1016/j.brainresbull.2010.02.016; Grove CR, 2007, HUM MOVEMENT SCI, V26, P457, DOI 10.1016/j.humov.2007.01.014; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Henderson S., 1992, MOVEMENT ASSESSMENT; Ho AK, 2010, HUM MOVEMENT SCI, V29, P605, DOI 10.1016/j.humov.2010.01.007; Hochberg Y., 1987, MULTIPLE COMP PROCED; Horak FB, 1996, EX REG INT MULT SYST; HULME C, 1982, DEV MED CHILD NEUROL, V24, P461; Kashiwagi M, 2009, NEUROREPORT, V20, P1319, DOI 10.1097/WNR.0b013e32832f4d87; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Kiemel T, 2009, ENCY NEUROSCIENCE, P2381, DOI 10.1007/978-3-540-29678-2_3534; Kim SJ, 2004, USE VISION CHILDRENS; Konkle T, 2009, CURR BIOL, V19, P745, DOI 10.1016/j.cub.2009.03.035; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Langaas T, 1998, VISION RES, V38, P1817, DOI 10.1016/S0042-6989(97)00399-4; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; LUNDYEKMAN L, 1991, J COGNITIVE NEUROSCI, V3, P367, DOI 10.1162/jocn.1991.3.4.367; Magnee MJCM, 2008, J CHILD PSYCHOL PSYC, V49, P995, DOI 10.1111/j.1469-7610.2008.01902.x; Manley BFJ., 1997, RANDOMIZATION BOOTST; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Miller LJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.022.2009; Miyahara M, 1995, NEUROPSYCHOL REV, V5, P245, DOI 10.1007/BF02214648; Mon-Williams MA, 1999, DEV MED CHILD NEUROL, V41, P247, DOI 10.1017/S0012162299000523; MonWilliams MA, 1996, OPHTHAL PHYSL OPT, V16, P178, DOI 10.1016/0275-5408(95)00036-4; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; NEWHAM C, 1993, PERCEPTION, V22, P1061, DOI 10.1068/p221061; O'Brien J, 2002, NEUROREPORT, V13, P1399, DOI 10.1097/00001756-200208070-00010; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Peterka R J, 1990, J Vestib Res, V1, P73; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterka RJ, 2009, J PHYSIOL-PARIS, V103, P149, DOI 10.1016/j.jphysparis.2009.08.001; Piek JP, 1995, DEV MED CHILD NEUROL, V37, P976; Riley MA, 1997, EXP BRAIN RES, V117, P165, DOI 10.1007/s002210050211; Ronsse R, 2009, J NEUROSCI, V29, P8419, DOI 10.1523/JNEUROSCI.5734-08.2009; Seber G. A. F., 2003, NONLINEAR REGRESSION; Shams L, 2010, PHYS LIFE REV, V7, P269, DOI 10.1016/j.plrev.2010.04.006; Shirai N, 2010, JPN PSYCHOL RES, V52, P78, DOI 10.1111/j.1468-5884.2010.00426.x; Sigmundsson H, 1997, EXP BRAIN RES, V114, P492, DOI 10.1007/PL00005658; Sigmundsson H, 2003, BEHAV BRAIN RES, V139, P123, DOI 10.1016/S0166-4328(02)00110-9; Smits-Engelsman BCM, 2001, HUM MOVEMENT SCI, V20, P161, DOI 10.1016/S0167-9457(01)00033-1; Smits-Engelsman BCM, 2008, HUM MOVEMENT SCI, V27, P296, DOI 10.1016/j.humov.2008.02.005; Soto-Faraco S, 2003, NEUROPSYCHOLOGIA, V41, P1847, DOI 10.1016/S0028-3932(03)00185-4; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Steinman KJ, 2010, J CHILD NEUROL, V25, P71, DOI 10.1177/0883073809342591; Utley Andrea, 2007, Physiotherapy Theory and Practice, V23, P65, DOI 10.1080/09593980701211838; Van der Kooij H, 2001, BIOL CYBERN, V84, P103, DOI 10.1007/s004220000196; Wann JP, 1998, HUM MOVEMENT SCI, V17, P491, DOI 10.1016/S0167-9457(98)00011-6; Whitall J, 2008, HUM MOVEMENT SCI, V27, P914, DOI 10.1016/j.humov.2007.11.007; Wilson PH, 1998, J CHILD PSYCHOL PSYC, V39, P829, DOI 10.1111/1469-7610.00384; Winter D, 2005, BIOMECHANICS MOTOR C; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T; Zwicker JG, 2010, PEDIATRICS, V126, pE678, DOI 10.1542/peds.2010-0059	79	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40932	10.1371/journal.pone.0040932	http://dx.doi.org/10.1371/journal.pone.0040932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815872	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900061
J	Strom, MA; Zebrowitz, LA; Zhang, SN; Bronstad, PM; Lee, HK				Strom, Michael A.; Zebrowitz, Leslie A.; Zhang, Shunan; Bronstad, P. Matthew; Lee, Hoon Koo			Skin and Bones: The Contribution of Skin Tone and Facial Structure to Racial Prototypicality Ratings	PLOS ONE			English	Article							TRAIT IMPRESSIONS; AFRICAN-AMERICAN; ASIAN-AMERICANS; RACE; PERCEPTION; RECOGNITION; APPEARANCE; FEATURES; ATTRACTIVENESS; STEREOTYPES	Previous research reveals that a more 'African' appearance has significant social consequences, yielding more negative first impressions and harsher criminal sentencing of Black or White individuals. This study is the first to systematically assess the relative contribution of skin tone and facial metrics to White, Black, and Korean perceivers' ratings of the racial prototypicality of faces from the same three groups. Our results revealed that the relative contribution of metrics and skin tone depended on both perceiver race and face race. White perceivers' racial prototypicality ratings were less responsive to variations in skin tone than were Black or Korean perceivers' ratings. White perceivers ratings' also were more responsive to facial metrics than to skin tone, while the reverse was true for Black perceivers. Additionally, across all perceiver groups, skin tone had a more consistent impact than metrics on racial prototypicality ratings of White faces, with the reverse for Korean faces. For Black faces, the relative impact varied with perceiver race: skin tone had a more consistent impact than metrics for Black and Korean perceivers, with the reverse for White perceivers. These results have significant implications for predicting who will experience racial prototypicality biases and from whom.	[Strom, Michael A.; Zebrowitz, Leslie A.; Zhang, Shunan; Bronstad, P. Matthew] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Lee, Hoon Koo] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea	Brandeis University; Yonsei University	Strom, MA (corresponding author), Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA.	zebrowitz@brandeis.edu			NIH [MH066836, K02MH72603]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH072603, R01MH066836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH Grants MH066836 and K02MH72603 to the first author (http://www.nimh.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BP, 1996, J APPL SOC PSYCHOL, V26, P884, DOI 10.1111/j.1559-1816.1996.tb01116.x; Averhart CJ, 1997, J EXP CHILD PSYCHOL, V67, P363, DOI 10.1006/jecp.1997.2413; Balas B, 2010, NEUROPSYCHOLOGIA, V48, P498, DOI 10.1016/j.neuropsychologia.2009.10.007; Bar-Haim Y, 2009, PERCEPTION, V38, P145, DOI 10.1068/p6307; Blair IV, 2004, J PERS SOC PSYCHOL, V87, P763, DOI 10.1037/0022-3514.87.6.763; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Brooks KR, 2010, PERCEPTION, V39, P1142, DOI 10.1068/p6703; Brown TD, 1998, J SOC BEHAV PERS, V13, P295; Dixon TL, 2005, J APPL SOC PSYCHOL, V35, P1555, DOI 10.1111/j.1559-1816.2005.tb02184.x; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Hancock KJ, 2008, BRIT J PSYCHOL, V99, P45, DOI 10.1348/000712607X199981; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Ho C, 2001, J APPL SOC PSYCHOL, V31, P1553, DOI 10.1111/j.1559-1816.2001.tb02742.x; Hugenberg K, 2003, PSYCHOL SCI, V14, P640, DOI 10.1046/j.0956-7976.2003.psci_1478.x; Jarvis B. G., 2004, MEDIALAB VERSION 200; JUDD CM, 1995, J PERS SOC PSYCHOL, V69, P460, DOI 10.1037/0022-3514.69.3.460; Kawai Y, 2005, HOWARD J COMMUN, V16, P109, DOI 10.1080/10646170590948974; Komori M, 2011, J EXP PSYCHOL HUMAN, V37, P626, DOI 10.1037/a0020369; Livingston RW, 2002, J PERS SOC PSYCHOL, V82, P5, DOI 10.1037//0022-3514.82.1.5; Maddox KB, 2004, PERS SOC PSYCHOL REV, V8, P383, DOI 10.1207/s15327957pspr0804_4; Maddox KB, 2002, PERS SOC PSYCHOL B, V28, P250, DOI 10.1177/0146167202282010; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Martinez A., 1998, AR FACE DATABASE CVC; Ronquillo J, 2007, SOC COGN AFFECT NEUR, V2, P39, DOI 10.1093/scan/nsl043; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Russell R, 2007, VISION RES, V47, P157, DOI 10.1016/j.visres.2006.11.002; Russell R, 2006, PERCEPTION, V35, P749, DOI 10.1068/p5490; Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278; Sparko AL, 2011, J NONVERBAL BEHAV, V35, P243, DOI 10.1007/s10919-011-0111-8; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Young SG, 2012, SOC PSYCHOL PERS SCI, V3, P80, DOI 10.1177/1948550611409759; Zebrowitz L, 1999, PERS SOC PSYCHOL B, V25, P569; Zebrowitz L. A., 1997, READING FACES WINDOW; Zebrowitz LA, 2003, PERS SOC PSYCHOL REV, V7, P194, DOI 10.1207/S15327957PSPR0703_01; Zebrowitz LA, 1998, J PERS SOC PSYCHOL, V75, P1300, DOI 10.1037/0022-3514.75.5.1300; Zebrowitz LA, 2007, PERS SOC PSYCHOL B, V33, P648, DOI 10.1177/0146167206297399; Zebrowitz LA, 2007, SOC COGNITION, V25, P306, DOI 10.1521/soco.2007.25.2.306; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990; ZEBROWITZMCARTHUR L, 1989, J NONVERBAL BEHAV, V13, P189, DOI 10.1007/BF00987049	42	29	29	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41193	10.1371/journal.pone.0041193	http://dx.doi.org/10.1371/journal.pone.0041193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815966	Green Published, gold			2022-12-27	WOS:000306548900094
J	Guzik, MT; Adams, MA; Murphy, NP; Cooper, SJB; Austin, AD				Guzik, Michelle T.; Adams, Mark A.; Murphy, Nicholas P.; Cooper, Steven J. B.; Austin, Andrew D.			Desert Springs: Deep Phylogeographic Structure in an Ancient Endemic Crustacean (Phreatomerus latipes)	PLOS ONE			English	Article							GREAT-ARTESIAN BASIN; MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; AUSTRALIAN ARID ZONE; SUBTERRANEAN ARCHIPELAGO; BEETLES COLEOPTERA; SOUTH-AUSTRALIA; LAKE EYRE; EVOLUTION; DISPERSAL; SYSTEMATICS	Desert mound springs of the Great Artesian Basin in central Australia maintain an endemic fauna that have historically been considered ubiquitous throughout all of the springs. Recent studies, however, have shown that several endemic invertebrate species are genetically highly structured and contain previously unrecognised species, suggesting that individuals may be geographically 'stranded in desert islands'. Here we further tested the generality of this hypothesis by conducting genetic analyses of the obligate aquatic phreatoicid isopod Phreatomerus latipes. Phylogenetic and phylogeographic relationships amongst P. latipes individuals were examined using a multilocus approach comprising allozymes and mtDNA sequence data. From the Lake Eyre region in South Australia we collected data for 476 individuals from 69 springs for the mtDNA gene COI; in addition, allozyme electrophoresis was conducted on 331 individuals from 19 sites for 25 putative loci. Phylogenetic and population genetic analyses showed three major clades in both allozyme and mtDNA data, with a further nine mtDNA sub-clades, largely supported by the allozymes. Generally, each of these sub-clades was concordant with a traditional geographic grouping known as spring complexes. We observed a coalescent time between similar to 2-15 million years ago for haplotypes within each of the nine mtDNA sub-clades, whilst an older total time to coalescence (>15 mya) was observed for the three major clades. Overall we observed that multiple layers of phylogeographic history are exemplified by Phreatomerus, suggesting that major climate events and their impact on the landscape have shaped the observed high levels of diversity and endemism. Our results show that this genus reflects a diverse fauna that existed during the early Miocene and appears to have been regionally restricted. Subsequent aridification events have led to substantial contraction of the original habitat, possibly over repeated Pleistocene ice age cycles, with P. latipes populations becoming restricted in the distribution to desert springs.	[Guzik, Michelle T.; Adams, Mark A.; Cooper, Steven J. B.; Austin, Andrew D.] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Adams, Mark A.; Cooper, Steven J. B.] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia; [Murphy, Nicholas P.] La Trobe Univ, Dept Genet, Sch Mol Sci, Bundoora, Vic, Australia	University of Adelaide; La Trobe University	Guzik, MT (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Evolutionary Biol & Biodivers, North Terrace, Adelaide, SA, Australia.	michelle.guzik@adelaide.edu.au	Guzik, Michelle/AAV-8196-2021; Murphy, Nick/J-9883-2019; Cooper, Steven JB/I-6291-2012	Murphy, Nick/0000-0002-0907-4642; 	Australian Research Council [DP0770979, LP0669062]; Department of Environment and Heritage (SA); BHP Billiton; Nature Foundation SA; South Australian Museum; National Water Initiative; SAALNRM; BHP Billiton corporation	Australian Research Council(Australian Research Council); Department of Environment and Heritage (SA); BHP Billiton; Nature Foundation SA; South Australian Museum; National Water Initiative; SAALNRM; BHP Billiton corporation	Funding for this work was obtained from the Australian Research Council Discovery (DP0770979) and Linkage (LP0669062) grant programs with research partners (The Department of Environment and Heritage (SA), BHP Billiton, Nature Foundation SA, the South Australian Museum) and also the National Water Initiative and the SAALNRM for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was partly funded by the BHP Billiton corporation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abrams KM, 2012, MOL PHYLOGENET EVOL, V64, P130, DOI 10.1016/j.ympev.2012.03.010; Adams M., 1986, HDB ANIMAL SYSTEMATI; Alley NF, 1998, PALAEOGEOGR PALAEOCL, V144, P239, DOI 10.1016/S0031-0182(98)00120-5; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bowler Jim M., 2006, Proceedings of the Royal Society of Victoria, V118, P161; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Callen RA., 1977, J GEOL SOC AUST, V24, P151, DOI [10.1080/00167617708728976, DOI 10.1080/00167617708728976]; Chapple DG, 2004, BIOL J LINN SOC, V83, P157, DOI 10.1111/j.1095-8312.2004.00378.x; Chilton C., 1922, Transactions of the Royal Society of South Australia, V46, P23; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper SJB, 2002, INVERTEBR SYST, V16, P589, DOI 10.1071/IT01039; Cooper SJB, 2008, INVERTEBR SYST, V22, P195, DOI 10.1071/IS07039; Cooper SJB, 2007, MOL ECOL, V16, P1533, DOI 10.1111/j.1365-294X.2007.03261.x; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; COYNE JA, 2004, SPECIATION SUNDERLAN; De Deckker P, 1979, P ROYAL SOC S AUSTR, V103, P155; DRUMMOND A. J., 2007, BEAST BAYESIAN EVOLU; Excoffier L, 2005, ARLEQUIN VERSION 3 1; Fensham RJ, 2004, BIOL CONSERV, V119, P41, DOI 10.1016/j.biocon.2003.10.019; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Fujioka T, 2005, GEOLOGY, V33, P993, DOI 10.1130/G21746.1; Fujioka T, 2009, GEOLOGY, V37, P51, DOI 10.1130/G25042A.1; Gotch TB, 2008, INVERTEBR SYST, V22, P151, DOI 10.1071/IS07045; Gouws G, 2007, HYDROBIOLOGIA, V589, P249, DOI 10.1007/s10750-007-0742-2; Green AJ, 2008, FRESHWATER BIOL, V53, P380, DOI 10.1111/j.1365-2427.2007.01901.x; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Guzik MT, 2011, HEREDITY, V107, P215, DOI 10.1038/hdy.2011.6; Habel JC, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P1, DOI 10.1007/978-3-540-92160-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARRIS CR, 1992, RANGELAND J, V14, P157, DOI DOI 10.1071/RJ9920157; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Hill R. S., 1994, HIST AUSTR VEGETATIO, P390; Horner Paul, 2007, Beagle, P1; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; King RA, 2009, ZOOTAXA, P35, DOI 10.11646/zootaxa.2293.1.2; KODRICBROWN A, 1993, ECOLOGY, V74, P1847, DOI 10.2307/1939942; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Leys R, 2008, INVERTEBR SYST, V22, P217, DOI 10.1071/IS07034; Magee JW, 2004, GEOLOGY, V32, P885, DOI 10.1130/G20672.1; MAGEE JW, 1995, PALAEOGEOGR PALAEOCL, V113, P3, DOI 10.1016/0031-0182(95)00060-Y; MILLER PJ, 1987, J NAT HIST, V21, P687, DOI 10.1080/00222938700770391; Mitchell BD, 1985, S AUSTR MOUND SPRING; Murphy NP, 2010, FRESHWATER BIOL, V55, P2499, DOI 10.1111/j.1365-2427.2010.02479.x; Murphy NP, 2009, MOL ECOL, V18, P109, DOI 10.1111/j.1365-294X.2008.04007.x; Murphy NP, J BIOGEOGRA IN PRESS; Myers MJ, 2001, J INSECT CONSERV, V5, P207, DOI 10.1023/A:1017998513721; Pianka E.R., 1981, Monographiae Biologicae, V41, P1375; PONDER WF, 1989, MALACOLOGIA, V31, P1; Ponder WF, 1995, BIOL J LINN SOC, V56, P553; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prescott JR, 2008, AUST J EARTH SCI, V55, P167, DOI 10.1080/08120090701689340; R Schodde, 1982, ORIGIN ADAPTATION EV; Rambaut A., 2007, TRACE 1 4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schneider S, 1999, GENETICS, V152, P1079; Schultz MB, 2008, MOL ECOL, V17, P5291, DOI 10.1111/j.1365-294X.2008.03996.x; Shattuck SO, 2006, AUSTR ANTS THEIR BIO; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timms Brian V., 2001, Lakes and Reservoirs Research and Management, V6, P183, DOI 10.1046/j.1440-1770.2001.00132.x; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; Wilmer JW, 2008, MOL ECOL, V17, P3733, DOI 10.1111/j.1365-294X.2008.03861.x; Wilson GDF, 2003, J PALEONTOL, V77, P454, DOI 10.1666/0022-3360(2003)077<0454:TTIPWC>2.0.CO;2; Wilson GDF, 2008, HYDROBIOLOGIA, V595, P231, DOI 10.1007/s10750-007-9019-z; Wilson GDF, 2009, MOL PHYLOGENET EVOL, V51, P349, DOI 10.1016/j.ympev.2009.02.001	73	32	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e37642	10.1371/journal.pone.0037642	http://dx.doi.org/10.1371/journal.pone.0037642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815684	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000002
J	Korzyukov, O; Sattler, L; Behroozmand, R; Larson, CR				Korzyukov, Oleg; Sattler, Lindsey; Behroozmand, Roozbeh; Larson, Charles R.			Neuronal Mechanisms of Voice Control Are Affected by Implicit Expectancy of Externally Triggered Perturbations in Auditory Feedback	PLOS ONE			English	Article							PITCH FEEDBACK; CORTEX; RESPONSES; BRAIN; ERP; PERCEPTION; PREDICTION; COMPONENTS; SPEECH; SOUNDS	Accurate vocal production relies on several factors including sensory feedback and the ability to predict future challenges to the control processes. Repetitive patterns of perturbations in sensory feedback by themselves elicit implicit expectations in the vocal control system regarding the timing, quality and direction of perturbations. In the present study, the predictability of voice pitch-shifted auditory feedback was experimentally manipulated. A block of trials where all pitch-shift stimuli were upward, and therefore predictable was contrasted against an unpredictable block of trials in which the stimulus direction was randomized between upward and downward pitch-shifts. It was found that predictable perturbations in voice auditory feedback led to a reduction in the proportion of compensatory vocal responses, which might be indicative of a reduction in vocal control. The predictable perturbations also led to a reduction in the magnitude of the N1 component of cortical Event Related Potentials (ERP) that was associated with the reflexive compensations to the perturbations. We hypothesize that formation of expectancy in our study is accompanied by involuntary allocation of attentional resources occurring as a result of habituation or learning, that in turn trigger limited and controlled exploration-related motor variability in the vocal control system.	[Korzyukov, Oleg; Sattler, Lindsey; Behroozmand, Roozbeh; Larson, Charles R.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA	Northwestern University	Korzyukov, O (corresponding author), Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA.	o-korzyukov@northwestern.edu			National Institutes of Health [1R01DC006243]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by a grant from National Institutes of Health, Grant No. 1R01DC006243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIPOURHAGHIGHI F, 1991, ANN OTO RHINOL LARYN, V100, P626, DOI 10.1177/000348949110000805; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; Baess P, 2011, PSYCHOPHYSIOLOGY, V48, P1276, DOI 10.1111/j.1469-8986.2011.01196.x; Behroozmand R, 2011, CLIN NEUROPHYSIOL, V122, P2408, DOI 10.1016/j.clinph.2011.04.019; Behroozmand R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-54; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; Boersma Paul, 2002, GLOT INT, V5, P341; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Burkard RF., 2007, AUDITORY EVOKED POTE; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Chait M, 2004, NEUROREPORT, V15, P2455, DOI 10.1097/00001756-200411150-00004; Conley EM, 1999, CLIN NEUROPHYSIOL, V110, P2086, DOI 10.1016/S1388-2457(99)00183-2; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Deroost N, 2006, PSYCHOL RES-PSYCH FO, V70, P88, DOI 10.1007/s00426-004-0196-3; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Ford JM, 2001, BIOL PSYCHIAT, V50, P540, DOI 10.1016/S0006-3223(01)01166-0; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Ghajar J, 2009, NEUROSCIENTIST, V15, P232, DOI 10.1177/1073858408326429; GIARD MH, 1994, ELECTROEN CLIN NEURO, V92, P238, DOI 10.1016/0168-5597(94)90067-1; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Kawahara H., 1994, Journal of the Acoustical Society of Japan (E), V15, P201, DOI 10.1250/ast.15.201; Korzyukov O, 2012, INT J PSYCHOPHYSIOL, V83, P71, DOI 10.1016/j.ijpsycho.2011.10.006; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Larson CR, 2007, J ACOUST SOC AM, V121, P2862, DOI 10.1121/1.2715657; LARSON CR, 1987, J SPEECH HEAR RES, V30, P552, DOI 10.1044/jshr.3004.552; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Ludlow CL, 1996, VOCAL FOLD, P201; Mandelblat-Cerf Y, 2009, J NEUROSCI, V29, P15053, DOI 10.1523/JNEUROSCI.3011-09.2009; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pavlov I.P., 1955, SELECTED WORKS; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Roberts TPL, 2000, J CLIN NEUROPHYSIOL, V17, P114, DOI 10.1097/00004691-200003000-00002; Rodel RMW, 2004, LARYNGOSCOPE, V114, P918; SIDDLE DAT, 1991, PSYCHOPHYSIOLOGY, V28, P245, DOI 10.1111/j.1469-8986.1991.tb02190.x; Sokolov EN, 1963, PERCEPTION CONDITION, Vx; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wright BA, 2004, PERCEPT PSYCHOPHYS, V66, P508, DOI 10.3758/BF03194897	55	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41216	10.1371/journal.pone.0041216	http://dx.doi.org/10.1371/journal.pone.0041216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JG	22815974	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000080
J	Bigford, GE; Bracchi-Ricard, VC; Nash, MS; Bethea, JR				Bigford, Gregory E.; Bracchi-Ricard, Valerie C.; Nash, Mark S.; Bethea, John R.			Alterations in Mouse Hypothalamic Adipokine Gene Expression and Leptin Signaling following Chronic Spinal Cord Injury and with Advanced Age	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE RISK; UNFOLDED PROTEIN RESPONSE; FATTY-ACID OXIDATION; SYMPATHETIC-NERVOUS-SYSTEM; INDUCED ADIPOSE FACTOR; BODY-WEIGHT; PITUITARY-GLAND; PLASMA LEPTIN	Chronic spinal cord injury (SCI) results in an accelerated trajectory of several cardiovascular disease (CVD) risk factors and related aging characteristics, however the molecular mechanisms that are activated have not been explored. Adipokines and leptin signaling are known to play a critical role in neuro-endocrine regulation of energy metabolism, and are now implicated in central inflammatory processes associated with CVD. Here, we examine hypothalamic adipokine gene expression and leptin signaling in response to chronic spinal cord injury and with advanced age. We demonstrate significant changes in fasting-induced adipose factor (FIAF), resistin (Rstn), long-form leptin receptor (LepRb) and suppressor of cytokine-3 (SOCS3) gene expression following chronic SCI and with advanced age. LepRb and Jak2/stat3 signaling is significantly decreased and the leptin signaling inhibitor SOCS3 is significantly elevated with chronic SCI and advanced age. In addition, we investigate endoplasmic reticulum (ER) stress and activation of the uncoupled protein response (UPR) as a biological hallmark of leptin resistance. We observe the activation of the ER stress/UPR proteins IRE1, PERK, and eIF2alpha, demonstrating leptin resistance in chronic SCI and with advanced age. These findings provide evidence for adipokine-mediated inflammatory responses and leptin resistance as contributing to neuro-endocrine dysfunction and CVD risk following SCI and with advanced age. Understanding the underlying mechanisms contributing to SCI and age related CVD may provide insight that will help direct specific therapeutic interventions.	[Bigford, Gregory E.; Bracchi-Ricard, Valerie C.; Nash, Mark S.; Bethea, John R.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Nash, Mark S.; Bethea, John R.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Nash, Mark S.] Univ Miami, Miller Sch Med, Dept Rehabil Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Bigford, GE (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	gbigford@med.miami.edu	Bigford, Gregory/GMW-4031-2022		Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051709] Funding Source: NIH RePORTER	Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the Miami Project to Cure Paralysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, DIABETES, V55, pS145, DOI 10.2337/db06-S018; Ahima RS, 2006, PROG BRAIN RES, V153, P155, DOI 10.1016/S0079-6123(06)53009-2; Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahn H, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E15; Atkinson LL, 2002, J BIOL CHEM, V277, P29424, DOI 10.1074/jbc.M203813200; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Bauman W A, 2001, J Spinal Cord Med, V24, P266; Bauman W A, 2001, J Spinal Cord Med, V24, P81; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; BAUMAN WA, 1992, MT SINAI J MED, V59, P163; BAUMAN WA, 1992, PARAPLEGIA, V30, P697, DOI 10.1038/sc.1992.136; Bauman WA, 1999, ASSIST TECHNOL, V11, P88, DOI 10.1080/10400435.1999.10131993; Bauman WA, 1999, SPINAL CORD, V37, P601, DOI 10.1038/sj.sc.3100911; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; BRENES G, 1986, ARCH PHYS MED REHAB, V67, P445; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Brown R, 2007, NEUROENDOCRINOLOGY, V85, P232, DOI 10.1159/000104248; Brown R, 2009, J NEUROIMMUNOL, V209, P96, DOI 10.1016/j.jneuroim.2009.02.001; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Chan JL, 2008, J CLIN ENDOCR METAB, V93, P2819, DOI 10.1210/jc.2008-0056; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Charlifue S, 2010, PHYS MED REH CLIN N, V21, P383, DOI 10.1016/j.pmr.2009.12.002; Cheville A L, 1995, J Spinal Cord Med, V18, P227; Ciccone M, 2001, INT J OBESITY, V25, P805, DOI 10.1038/sj.ijo.0801623; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dampney RAL, 2002, CLIN EXP PHARMACOL P, V29, P261, DOI 10.1046/j.1440-1681.2002.03640.x; Demirel S, 2001, SPINAL CORD, V39, P134, DOI 10.1038/sj.sc.3101135; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Gorgey AS, 2011, PM&R, V3, P440, DOI 10.1016/j.pmrj.2011.01.011; Grigorean Valentin Titus, 2009, J Med Life, V2, P133; Grill HJ, 2010, FRONT NEUROENDOCRIN, V31, P61, DOI 10.1016/j.yfrne.2009.10.005; Groah SL, 2001, SPINAL CORD, V39, P310, DOI 10.1038/sj.sc.3101162; Groah SL, 2012, AM J PHYS MED REHAB, V91, P80, DOI 10.1097/PHM.0b013e31821f70bc; Groah SL, 2011, J CARDIOPULM REHABIL, V31, P73, DOI 10.1097/HCR.0b013e3181f68aba; Groah SL, 2009, J SPINAL CORD MED, V32, P25, DOI 10.1080/10790268.2009.11760749; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Harris RBS, 1998, AM J PHYSIOL-REG I, V275, pR1928, DOI 10.1152/ajpregu.1998.275.6.R1928; Hitzig SL, 2011, SPINAL CORD, V49, P684, DOI 10.1038/sc.2010.178; Hof PR., 2000, COMP CYTOARCHITECTON; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Jacobs WB, 2003, NEUROSURGERY, V53, P943, DOI 10.1227/01.NEU.0000083592.74383.B1; KARLSSON AK, 1995, METABOLISM, V44, P52, DOI 10.1016/0026-0495(95)90289-9; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kelesidis T, 2011, INT J INFECT DIS, V15, pE2, DOI 10.1016/j.ijid.2010.03.025; Kemp BJ, 2005, PHYS MED REH CLIN N, V16, pvii; Kemp Bryan J, 2005, Phys Med Rehabil Clin N Am, V16, P1, DOI 10.1016/j.pmr.2004.06.009; Kim HK, 2010, DIABETES, V59, P2772, DOI 10.2337/db10-0145; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Koyanagi I, 2000, J NEUROSURG, V93, P15, DOI 10.3171/spi.2000.93.1.0015; LaVela SL, 2006, J SPINAL CORD MED, V29, P387, DOI 10.1080/10790268.2006.11753887; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liang H, 2007, ARCH PHYS MED REHAB, V88, P1198, DOI 10.1016/j.apmr.2007.05.023; MAKI KC, 1995, PARAPLEGIA, V33, P102, DOI 10.1038/sc.1995.24; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; McGlinchey-Berroth R, 1995, J Spinal Cord Med, V18, P183; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Nash MS, 2007, ARCH PHYS MED REHAB, V88, P751, DOI 10.1016/j.apmr.2007.02.031; Nash MS, 2011, ARCH PHYS MED REHAB, V92, P399, DOI 10.1016/j.apmr.2010.06.029; Nickola MW, 2000, HYPERTENSION, V36, P501, DOI 10.1161/01.HYP.36.4.501; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oswal A, 2010, OBESITY, V18, P221, DOI 10.1038/oby.2009.228; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Reilly MP, 2004, J CLIN ENDOCR METAB, V89, P3872, DOI 10.1210/jc.2003-031676; Robertson SA, 2008, PHYSIOL BEHAV, V94, P637, DOI 10.1016/j.physbeh.2008.04.005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosado-Rivera D, 2011, J SPINAL CORD MED, V34, P395, DOI 10.1179/2045772311Y.0000000019; SaKM G, 2010, TOP SPINAL CORD INJ, V15, P1; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Shetty GK, 2004, DIABETES CARE, V27, P2450, DOI 10.2337/diacare.27.10.2450; SHETTY KR, 1993, AM J MED SCI, V305, P95, DOI 10.1097/00000441-199302000-00006; Singhal A, 2002, CIRCULATION, V106, P1919, DOI 10.1161/01.CIR.0000033219.24717.52; Sloan C, 2011, DIABETES, V60, P1424, DOI 10.2337/db10-1106; Spungen AM, 2003, J APPL PHYSIOL, V95, P2398, DOI 10.1152/japplphysiol.00729.2002; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; TSITOURAS PD, 1995, HORM METAB RES, V27, P287, DOI 10.1055/s-2007-979961; Valentine RJ, 2009, MENOPAUSE, V16, P84, DOI 10.1097/gme.0b013e31817fcb8f; Valentine RJ, 2009, BRAIN BEHAV IMMUN, V23, P643, DOI 10.1016/j.bbi.2008.12.003; van den Berg MEL, 2010, J NEUROTRAUM, V27, P1517, DOI 10.1089/neu.2009.1138; Verberne AJM, 1997, CLIN EXP PHARMACOL P, V24, P748, DOI 10.1111/j.1440-1681.1997.tb02126.x; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Wahman K, 2011, J REHABIL MED, V43, P237, DOI 10.2340/16501977-0658; Wang TD, 2007, J FORMOS MED ASSOC, V106, P919, DOI 10.1016/S0929-6646(08)60062-5; WANG YH, 1992, AM J PHYS MED REHAB, V71, P328, DOI 10.1097/00002060-199212000-00004; Washburn RA, 1999, SPINAL CORD, V37, P685, DOI 10.1038/sj.sc.3100917; White David W., 1996, Cytokine and Growth Factor Reviews, V7, P303, DOI 10.1016/S1359-6101(96)00040-8; Wiesner G, 2004, J ENDOCRINOL, V180, pR1, DOI 10.1677/joe.0.180R001; Wiesner G, 2006, NEUROREPORT, V17, P1195, DOI 10.1097/01.wnr.0000224776.12647.ba; Wilkinson M, 2005, NEUROENDOCRINOLOGY, V81, P19, DOI 10.1159/000084871; Wilkinson M, 2007, NEUROENDOCRINOLOGY, V86, P191, DOI 10.1159/000108635; Wolk R, 2004, J AM COLL CARDIOL, V44, P1819, DOI 10.1016/j.jacc.2004.07.050; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zlotolow S P, 1992, J Am Paraplegia Soc, V15, P158	123	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41073	10.1371/journal.pone.0041073	http://dx.doi.org/10.1371/journal.pone.0041073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815920	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100118
J	Chen, HY; Lin, CC; Chiu, YL; Hsu, SP; Pai, MF; Yang, JY; Peng, YS				Chen, Hung-Yuan; Lin, Chien-Chu; Chiu, Yen-Lin; Hsu, Shih-Ping; Pai, Mei-Fen; Yang, Ju-Yeh; Peng, Yu-Sen			Serum Fetuin A and Chemerin Levels Correlate with Hepatic Steatosis and Regional Adiposity in Maintenance Hemodialysis Patients	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TYPE-2 DIABETES-MELLITUS; CHRONIC-KIDNEY-DISEASE; METABOLIC SYNDROME; WEIGHT-LOSS; A LEVELS; INSULIN-RESISTANCE; DIALYSIS PATIENTS; OBESITY; CALCIFICATION	Background: A deficiency of fetuin A is linked to cardiovascular calcification and mortality in dialysis patients. But, high levels of fetuin A and chemerin correlate with hepatic steatosis and regional adiposity in general population. The association between hepatic steatosis and fetuin A/chemerin levels in hemodialysis (HD) remains unclear. Methods: We performed a cross-sectional, observational study; 216 prevalent HD patients from a single center were enrolled. Baseline serum fetuin A, chemerin levels, conicity index and anthropometric parameters were checked. Presence of hepatic steatosis was qualified by liver ultrasound and quantified by the hepato-renal index (HRI); central obesity defined by waist circumference (WC). ROC analyses and multivariate logistic regression analyses for prediction of hepatic steatosis and central obesity on the basis of fetuin A/chemerin levels, anthropometric parameters, and other relevant covariates were performed. Results: Data from 103 women and 113 men (mean age 60+/-12 years) were analyzed. Eighty subjects had hepatic steatosis and their HRIs were significantly higher than those without hepatic steatosis (P<0.001). Serum fetuin A levels were positively associated with HRIs (P<0.001) and chemerin levels (P<0.001). Fetuin A, chemerin and WC were predictors for hepatic steatosis and central obesity by ROC curve. In multivariate logistic regression analysis, fetuin A and WC independently predicted hepatic steatosis defined by HRIs. And chemerin predicted central obesity and regional adiposity after covariate adjustments (all P<0.05). Conclusions: Serum fetuin A levels were higher in prevalent HD patients with hepatic steatosis, and positively correlated with chemerin levels. Chemerin levels predicted central obesity as well as regional adiposity in the HD patients.	[Chen, Hung-Yuan; Chiu, Yen-Lin; Hsu, Shih-Ping; Pai, Mei-Fen; Yang, Ju-Yeh; Peng, Yu-Sen] Far Eastern Mem Hosp, Dept Internal Med, Div Nephrol, New Taipei City, Taiwan; [Chen, Hung-Yuan; Chiu, Yen-Lin; Hsu, Shih-Ping; Pai, Mei-Fen; Yang, Ju-Yeh; Peng, Yu-Sen] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Chen, Hung-Yuan; Chiu, Yen-Lin; Hsu, Shih-Ping; Pai, Mei-Fen; Yang, Ju-Yeh; Peng, Yu-Sen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Chien-Chu] Far Eastern Mem Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, New Taipei City, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital	Chen, HY (corresponding author), Far Eastern Mem Hosp, Dept Internal Med, Div Nephrol, New Taipei City, Taiwan.	taan70@yahoo.com.tw	peng, yu/GXW-2071-2022	Yang, Ju-Yeh/0000-0003-3034-021X	Far Eastern Memorial Hospital (FEMH), Taiwan [FEMH-2011-C-006]; Ta-Tung Kidney Foundation; Mrs. Hsin-Chin Lee Kidney Research Fund	Far Eastern Memorial Hospital (FEMH), Taiwan; Ta-Tung Kidney Foundation; Mrs. Hsin-Chin Lee Kidney Research Fund	This study was supported by grant from the Far Eastern Memorial Hospital (FEMH) (FEMH-2011-C-006), Taiwan. The authors would like to express their thanks to the Ta-Tung Kidney Foundation and to Mrs. Hsin-Chin Lee Kidney Research Fund for supporting this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J, 2008, AM J NEPHROL, V28, P669, DOI 10.1159/000121358; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chan DC, 2010, DIABETES CARE, V33, P1134, DOI 10.2337/dc09-1765; Chen HY, 2009, EUR J ENDOCRINOL, V160, P777, DOI 10.1530/EJE-08-0813; Heng D, 2006, ATHEROSCLEROSIS, V186, P367, DOI 10.1016/j.atherosclerosis.2005.07.020; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Ix JH, 2009, J CLIN ENDOCR METAB, V94, P4492, DOI 10.1210/jc.2009-0916; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Ketteler M, 2005, CURR OPIN NEPHROL HY, V14, P337, DOI 10.1097/01.mnh.0000172719.26606.6f; Lin X, 1998, LIFE SCI, V63, P145, DOI 10.1016/S0024-3205(98)00250-1; Mori K, 2008, METABOLISM, V57, P1248, DOI 10.1016/j.metabol.2008.04.019; Nguyen-Duy TB, 2003, AM J PHYSIOL-ENDOC M, V284, pE1065, DOI 10.1152/ajpendo.00442.2002; Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schlieper G, 2010, J AM SOC NEPHROL, V21, P689, DOI 10.1681/ASN.2009080829; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Soder RB, 2009, AM J ROENTGENOL, V192, pW201, DOI 10.2214/AJR.08.2061; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032; VALDEZ R, 1991, J CLIN EPIDEMIOL, V44, P955, DOI 10.1016/0895-4356(91)90059-I; Webb M, 2009, AM J ROENTGENOL, V192, P909, DOI 10.2214/AJR.07.4016; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Westenfeld R, 2009, J AM SOC NEPHROL, V20, P1264, DOI 10.1681/ASN.2008060572; Yamamoto T, 2010, NEPHROL DIAL TRANSPL, V25, P4017, DOI 10.1093/ndt/gfq329	30	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e38415	10.1371/journal.pone.0038415	http://dx.doi.org/10.1371/journal.pone.0038415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815691	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100010
J	Chowell, G; Echevarria-Zuno, S; Viboud, C; Simonsen, L; Miller, MA; Fernandez-Garate, I; Gonzalez-Bonilla, C; Borja-Aburto, VH				Chowell, Gerardo; Echevarria-Zuno, Santiago; Viboud, Cecile; Simonsen, Lone; Miller, Mark A.; Fernandez-Garate, Irma; Gonzalez-Bonilla, Cesar; Borja-Aburto, Victor H.			Epidemiological Characteristics and Underlying Risk Factors for Mortality during the Autumn 2009 Pandemic Wave in Mexico	PLOS ONE			English	Article							INFLUENZA-A H1N1; VIRUS-INFECTION; CLINICAL CHARACTERISTICS; ANTIBODY-RESPONSES; VACCINE; HOSPITALIZATION; A(H1N1); DEATH; OUTCOMES; OBESITY	Background: Elucidating the role of the underlying risk factors for severe outcomes of the 2009 A/H1N1 influenza pandemic could be crucial to define priority risk groups in resource-limited settings in future pandemics. Methods: We use individual-level clinical data on a large series of ARI (acute respiratory infection) hospitalizations from a prospective surveillance system of the Mexican Social Security medical system to analyze clinical features at presentation, admission delays, selected comorbidities and receipt of seasonal vaccine on the risk of A/H1N1-related death. We considered ARI hospitalizations and inpatient-deaths, and recorded demographic, geographic, and medical information on individual patients during August-December, 2009. Results: Seasonal influenza vaccination was associated with a reduced risk of death among A/H1N1 inpatients (OR = 0.43 (95% CI: 0.25, 0.74)) after adjustment for age, gender, geography, antiviral treatment, admission delays, comorbidities and medical conditions. However, this result should be interpreted with caution as it could have been affected by factors not directly measured in our study. Moreover, the effect of antiviral treatment against A/H1N1 inpatient death did not reach statistical significance (OR = 0.56 (95% CI: 0.29, 1.10)) probably because only 8.9% of A/H1N1 inpatients received antiviral treatment. Moreover, diabetes (OR = 1.6) and immune suppression (OR = 2.3) were statistically significant risk factors for death whereas asthmatic persons (OR = 0.3) or pregnant women (OR = 0.4) experienced a reduced fatality rate among A/H1N1 inpatients. We also observed an increased risk of death among A/H1N1 inpatients with admission delays >2 days after symptom onset (OR = 2.7). Similar associations were also observed for A/H1N1-negative inpatients. Conclusions: Geographical variation in identified medical risk factors including prevalence of diabetes and immune suppression may in part explain between-country differences in pandemic mortality burden. Furthermore, access to care including hospitalization without delay and antiviral treatment and are also important factors, as well as vaccination coverage with the 2008-09 trivalent inactivated influenza vaccine.	[Chowell, Gerardo; Viboud, Cecile; Simonsen, Lone; Miller, Mark A.] NIH, Div Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Chowell, Gerardo] Arizona State Univ, Math Computat & Modeling Sci Ctr, Sch Human Evolut & Social Change, Tempe, AZ USA; [Echevarria-Zuno, Santiago; Fernandez-Garate, Irma] Inst Mexicano Seguro Social, Direcc Prestac Med, Coordinac Programas Integrados Salud, Mexico City, DF, Mexico; [Simonsen, Lone] George Washington Univ, Dept Global Hlth, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Gonzalez-Bonilla, Cesar; Borja-Aburto, Victor H.] Inst Mexicano Seguro Social, Coordinac Vigilancia Epidemiol & Apoyo Contigenci, Mexico City, DF, Mexico	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Arizona State University; Arizona State University-Tempe; Instituto Mexicano del Seguro Social; George Washington University; Instituto Mexicano del Seguro Social	Chowell, G (corresponding author), NIH, Div Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	gchowell@asu.edu	Chowell, Gerardo/F-5038-2012; Simonsen, Lone/K-4531-2014	Chowell, Gerardo/0000-0003-2194-2251; Simonsen, Lone/0000-0003-1535-8526; Gonzalez Bonilla, Cesar/0000-0002-2225-5069	International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services; RAPIDD (Research and Policy for Infectious Disease Dynamics) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center	International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services; RAPIDD (Research and Policy for Infectious Disease Dynamics) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was conducted in the context of the MISMS (Multinational Influenza Seasonal Mortality Study), an ongoing international collaborative effort to understand influenza epidemiological and evolutionary patterns, led by the Fogarty International Center, National Institutes of Health (http://www.origem.info/misms/index.php). The MISMS study is funded by the International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services. LS acknowledges support from the RAPIDD (Research and Policy for Infectious Disease Dynamics) program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Carcione D, 2010, EURO SURVEILL, V15, P19616; Center for Disease Control and Prevention, 2010, UPD INT REC US ANT M; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Charu V, 2011, CLIN INFECT DIS; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chowell G, 2012, COMPUTATION IN PRESS; Chowell G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-97; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Garcia MC, 2012, J INFECTION, V64, P218, DOI 10.1016/j.jinf.2011.11.022; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gilca R, 2011, INFLUENZA OTHER RESP, V5, P247, DOI 10.1111/j.1750-2659.2011.00204.x; Glezen WP, 2010, CLIN INFECT DIS, V51, P1380, DOI 10.1086/657312; Gonzalez-Candelas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033139; Guia de Referencia Rapida, 2009, GUIA REF RAP PREV DI; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Instituto Mexicano del Seguro Social (IMSS), 2008, COORD PROGR INT SAL; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jain S, 2009, N ENGL J MED; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kreijtz JH, 2011, VIRUS RES; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Larrauri A, 2011, GAC SANIT, V25, P23, DOI 10.1016/j.gaceta.2010.06.010; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Martin-Loeches I, 2011, CRIT CARE, V15, DOI 10.1186/cc10573; Martin-Loeches I, 2011, RESPIROLOGY, V16, P78, DOI 10.1111/j.1440-1843.2010.01874.x; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Muscatello DJ, 2011, EMERG INFECT DIS, V17, P1240, DOI 10.3201/eid1707.101173; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Pebody R, 2011, VACCINE, V29, P2613, DOI 10.1016/j.vaccine.2011.01.046; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Rodriguez-Alvarez M, 2009, ARCH MED RES, V40, P687, DOI 10.1016/j.arcmed.2009.12.002; Rolland-Harris E, 2011, EPIDEMIOL INFECT, V16, P1; Sachedina N, 2010, LANCET, V376, P1846, DOI 10.1016/S0140-6736(10)61195-6; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Takayama K, 2011, J INFECT CHEMOTHER, V17, P401, DOI 10.1007/s10156-010-0187-9; Truelove SA, 2011, J INFECT DIS, V203, P828, DOI 10.1093/infdis/jiq117; Uyeki Tim, 2009, N Engl J Med, V361, pe110, DOI 10.1056/NEJMopv0910738; VAILLANT L, 2009, EURO SURVEILL, V14; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Viboud C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000259; Vidal P, 2011, ARCH MED RES; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wei JY, 2010, LEUKEMIA LYMPHOMA, V51, P2079, DOI 10.3109/10428194.2010.508823; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4779; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884; Zepeda-Lopez HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013256	74	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41069	10.1371/journal.pone.0041069	http://dx.doi.org/10.1371/journal.pone.0041069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815917	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100116
J	Dekker, GA; Lee, SY; North, RA; McCowan, LM; Simpson, NAB; Roberts, CT				Dekker, Gustaaf Albert; Lee, Shalem Y.; North, Robyn A.; McCowan, Lesley M.; Simpson, Nigel A. B.; Roberts, Claire T.			Risk Factors for Preterm Birth in an International Prospective Cohort of Nulliparous Women	PLOS ONE			English	Article							PARTURITION SYNDROME; PREGNANCY OUTCOMES; PREMATURE RUPTURE; GESTATION; LABOR; MEMBRANES; CERVIX; PREVENTION; DELIVERY; DOPPLER	Objectives: To identify risk factors for spontaneous preterm birth (birth <37 weeks gestation) with intact membranes (SPTB-IM) and SPTB after prelabour rupture of the membranes (SPTB-PPROM) for nulliparous pregnant women. Design: Prospective international multicentre cohort. Participants: 3234 healthy nulliparous women with a singleton pregnancy, follow up was complete in 3184 of participants (98.5%). Results: Of the 3184 women, 156 (4.9%) had their pregnancy complicated by SPTB; 96 (3.0%) and 60 (1.9%) in the SPTB-IM and SPTB-PPROM categories, respectively. Independent risk factors for SPTB-IM were shorter cervical length, abnormal uterine Doppler flow, use of marijuana pre-pregnancy, lack of overall feeling of well being, being of Caucasian ethnicity, having a mother with diabetes and/or a history of preeclampsia, and a family history of low birth weight babies. Independent risk factors for SPTB-PPROM were shorter cervical length, short stature, participant's not being the first born in the family, longer time to conceive, not waking up at night, hormonal fertility treatment (excluding clomiphene), mild hypertension, family history of recurrent gestational diabetes, and maternal family history of any miscarriage (risk reduction). Low BMI (<20) nearly doubled the risk for SPTB-PPROM (odds ratio 2.64; 95% CI 1.07-6.51). The area under the receiver operating characteristics curve (AUC), after internal validation, was 0.69 for SPTB-IM and 0.79 for SPTB-PPROM. Conclusion: The ability to predict PTB in healthy nulliparous women using clinical characteristics is modest. The dissimilarity of risk factors for SPTB-IM compared with SPTB-PPROM indicates different pathophysiological pathways underlie these distinct phenotypes.	[Dekker, Gustaaf Albert] Lyell McEwin Hosp, Adelaide, SA, Australia; [Dekker, Gustaaf Albert; Lee, Shalem Y.; Roberts, Claire T.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [North, Robyn A.] Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr, London WC2R 2LS, England; [North, Robyn A.] Kings Hlth Partners, London, England; [McCowan, Lesley M.] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand; [Simpson, Nigel A. B.] Univ Leeds, Acad Dept Obstet & Gynaecol, Leeds, W Yorkshire, England	Lyell McEwin Hospital; Robinson Research Institute; University of Adelaide; University of London; King's College London; University of London; King's College London; University of Auckland; University of Leeds	Dekker, GA (corresponding author), Lyell McEwin Hosp, Adelaide, SA, Australia.	gustaaf.dekker@adelaide.edu.au	Roberts, Claire/A-1205-2007	Roberts, Claire/0000-0002-9250-2192; McCowan, Lesley/0000-0001-9915-7873	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council [04/198]; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government	This study was funded by New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council (04/198); Evelyn Bond Fund, Auckland District Health Board Charitable Trust; and the Premier's Science and Research Fund, South Australian Government. The study sponsors had no role in study design, data analysis or writing this report.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander BT, 2012, HYPERTENSION, V59, P189, DOI 10.1161/HYPERTENSIONAHA.111.186551; Arias F, 1997, OBSTET GYNECOL, V89, P265, DOI 10.1016/S0029-7844(96)00451-6; Bada Henrietta S, 2005, J Perinatol, V25, P631, DOI 10.1038/sj.jp.7211378; Bardin C, 2004, SEMIN PERINATOL, V28, P288, DOI 10.1053/j.semperi.2004.08.006; Berghella V, 2003, CLIN OBSTET GYNECOL, V46, P947, DOI 10.1097/00003081-200312000-00026; Chan BCP, 2009, AUST NZ J OBSTET GYN, V49, P388, DOI 10.1111/j.1479-828X.2009.01006.x; Christensen LB, 2003, J CLIN PERIODONTOL, V30, P949, DOI 10.1034/j.1600-051X.2003.00404.x; Corbella S, 2011, ODONTOLOGY; Craig ED, 2004, AUST NZ J OBSTET GYN, V44, P545, DOI 10.1111/j.1479-828X.2004.00312.x; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Gagel CK, 2010, AM J PERINAT, V27, P691, DOI 10.1055/s-0030-1253100; Glover J, 2005, CENTRAL NO ADELAIDE; GOMEZ R, 1994, AM J OBSTET GYNECOL, V171, P956, DOI 10.1016/0002-9378(94)90014-0; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Green NS, 2005, AM J OBSTET GYNECOL, V193, P626, DOI 10.1016/j.ajog.2005.02.106; Groom KM, 2009, OBSTET GYNECOL, V113, P332, DOI 10.1097/AOG.0b013e318195b223; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Iams JD, 2001, AM J OBSTET GYNECOL, V184, P652, DOI 10.1067/mob.2001.111248; Kho EM, 2009, BJOG-INT J OBSTET GY, V116, P1300, DOI 10.1111/j.1471-0528.2009.02266.x; Kho EM, 2009, J REPROD IMMUNOL, V82, P66, DOI 10.1016/j.jri.2009.04.011; Kovo M, 2011, J PERINAT MED, V39, P423, DOI [10.1515/JPM.2011.038, 10.1515/jpm.2011.038]; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Mason SM, 2010, AM J EPIDEMIOL, V172, P800, DOI 10.1093/aje/kwq209; Mathews T J, 2011, Natl Vital Stat Rep, V59, P1; McCowan L, 2007, ACTRN12607000551493; Menon R, 2011, REPROD SCI, V18, P1046, DOI 10.1177/1933719111415548; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P56, DOI 10.1016/S1470-0328(03)00031-4; Palomba S, 2010, BJOG-INT J OBSTET GY, V117, P711, DOI 10.1111/j.1471-0528.2010.02525.x; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Population health in South Australia, 2005, BURD DIS INJ EST 199; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2011, BEST PRACT RES CL OB, V25, P313, DOI 10.1016/j.bpobgyn.2011.02.006; Roy-Matton N, 2011, J OBSTET GYNAECOL CA, V33, P344, DOI 10.1016/S1701-2163(16)34852-6; SHIONO PH, 1995, AM J OBSTET GYNECOL, V172, P19, DOI 10.1016/0002-9378(95)90078-0; Skarzinski G, 2009, PLACENTA, V30, P898, DOI 10.1016/j.placenta.2009.07.014; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; van Gelder MMHJ, 2010, DRUG ALCOHOL DEPEN, V109, P243, DOI 10.1016/j.drugalcdep.2010.01.007; Werner EF, 2011, ULTRASOUND OBSTET GY, V38; White CRH, 2012, J MATERN-FETAL NEO M, V25, P587, DOI 10.3109/14767058.2011.596959; Wijesiriwardana A, 2006, OBSTET GYNECOL, V107, P557, DOI 10.1097/01.AOG.0000199952.82151.de; ZWEIG MH, 1993, CLIN CHEM, V39, P561	45	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39154	10.1371/journal.pone.0039154	http://dx.doi.org/10.1371/journal.pone.0039154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815699	Green Published, gold			2022-12-27	WOS:000306466100015
J	Dou, W; Mukherjee, S; Li, H; Venkatesh, M; Wang, HW; Kortagere, S; Peleg, A; Chilimuri, SS; Wang, ZT; Feng, Y; Fearon, ER; Mani, S				Dou, Wei; Mukherjee, Subhajit; Li, Hao; Venkatesh, Madhukumar; Wang, Hongwei; Kortagere, Sandhya; Peleg, Ariel; Chilimuri, Sridhar S.; Wang, Zheng-Tao; Feng, Ying; Fearon, Eric R.; Mani, Sridhar			Alleviation of Gut Inflammation by Cdx2/Pxr Pathway in a Mouse Model of Chemical Colitis	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; NUCLEAR RECEPTOR; SCUTELLARIA-BAICALENSIS; DRUG DEVELOPMENT; GENE-EXPRESSION; BINDING-SITES; KAPPA-B; RATS; BAICALIN; PXR	Pregnane X Receptor (PXR), a master regulator of drug metabolism and inflammation, is abundantly expressed in the gastrointestinal tract. Baicalein and its O-glucuronide baicalin are potent anti-inflammatory and anti-cancer herbal flavonoids that undergo a complex cycle of interconversion in the liver and gut. We sought to investigate the role these flavonoids play in inhibiting gut inflammation by an axis involving PXR and other potential factors. The consequences of PXR regulation and activation by the herbal flavonoids, baicalein and baicalin were evaluated in vitro in human colon carcinoma cells and in vivo using wild-type, Pxr-null, and humanized (hPXR) PXR mice. Baicalein, but not its glucuronidated metabolite baicalin, activates PXR in a Cdx2-dependent manner in vitro, in human colon carcinoma LS174T cells, and in the murine colon in vivo. While both flavonoids abrogate dextran sodium sulfate (DSS)-mediated colon inflammation in vivo, oral delivery of a potent bacterial beta-glucuronidase inhibitor eliminates baicalin's effect on gastrointestinal inflammation by preventing the microbial conversion of baicalin to baicalien. Finally, reduction of gastrointestinal inflammation requires the binding of Cdx2 to a specific proximal site on the PXR promoter. Pharmacological targeting of intestinal PXR using natural metabolically labile ligands could serve as effective and potent therapeutics for gut inflammation that avert systemic drug interactions.	[Dou, Wei; Mukherjee, Subhajit; Li, Hao; Venkatesh, Madhukumar; Wang, Hongwei; Peleg, Ariel; Mani, Sridhar] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Dou, Wei; Mukherjee, Subhajit; Li, Hao; Venkatesh, Madhukumar; Wang, Hongwei; Peleg, Ariel; Mani, Sridhar] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Dou, Wei; Wang, Zheng-Tao] Shanghai Univ TCM, Inst Chinese Mat Med, Shanghai Key Lab Formulated Chinese Med, Shanghai, Peoples R China; [Dou, Wei; Wang, Zheng-Tao] Shanghai Univ TCM, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China; [Kortagere, Sandhya] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Chilimuri, Sridhar S.] Bronx Lebanon Hosp Ctr, Dept Med, Bronx, NY 10457 USA; [Feng, Ying] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI USA; [Fearon, Eric R.] Univ Michigan, Sch Med, Dept Internal Med Human Genet & Pathol, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	Yeshiva University; Yeshiva University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Drexel University; BronxCare Health System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dou, W (corresponding author), Albert Einstein Coll Med, Dept Med, New York, NY USA.	wangzht@shutcm.edu.cn; sridhar.mani@einstein.yu.edu	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	Damon Runyon Clinical Investigator Award [CI15-02]; PSC Partners Seeking a Cure Award; National Institutes of Health [R01CA161879]; Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China [IRT1071]; Institute of Chinese Materia Medica, Shanghai University of TCM, Shanghai, China; NATIONAL CANCER INSTITUTE [R01CA222469, R01CA161879, R01CA082223] Funding Source: NIH RePORTER	Damon Runyon Clinical Investigator Award; PSC Partners Seeking a Cure Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)Ministry of Education, China); Institute of Chinese Materia Medica, Shanghai University of TCM, Shanghai, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by The Damon Runyon Clinical Investigator Award CI15-02, PSC Partners Seeking a Cure Award and National Institutes of Health Grant R01CA161879 to SM and a Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China (IRT1071). Postdoctoral Fellowship to WD from the Institute of Chinese Materia Medica, Shanghai University of TCM, Shanghai, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HC, 2001, MOL CELLS, V12, P127; Aoki K, 2011, CANCER RES, V71, P593, DOI 10.1158/0008-5472.CAN-10-2842; Aouabdi S, 2006, DRUG METAB DISPOS, V34, P138, DOI 10.1124/dmd.105.006064; Beck F, 2010, BIOCHEM SOC T, V38, P353, DOI 10.1042/BST0380353; Biswas A, 2009, PHARM RES-DORDR, V26, P1807, DOI 10.1007/s11095-009-9901-7; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; CHANG WS, 1993, ANTICANCER RES, V13, P2165; Cheng J, 2010, J PHARMACOL EXP THER, V335, P32, DOI 10.1124/jpet.110.170225; Coskun M, 2011, BBA-MOL BASIS DIS, V1812, P283, DOI 10.1016/j.bbadis.2010.11.008; De AK, 2011, ACTA POL PHARM, V68, P735; Ekins S, 2007, MOL PHARMACOL, V72, P592, DOI 10.1124/mol.107.038398; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Glas J, 2010, INFLAMM BOWEL DIS; Gong HB, 2006, MOL ENDOCRINOL, V20, P279, DOI 10.1210/me.2005-0205; Gregory PA, 2004, TOXICOL APPL PHARM, V199, P354, DOI 10.1016/j.taap.2004.01.008; Guo XY, 2011, J ASIAN NAT PROD RES, V13, P861, DOI 10.1080/10286020.2011.599321; Hong T, 2002, PLANTA MED, V68, P268, DOI 10.1055/s-2002-23143; Hou YC, 2011, PLANTA MED, V77, P455, DOI 10.1055/s-0030-1250433; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Kawashima K, 2004, BIOL PHARM BULL, V27, P1599, DOI 10.1248/bpb.27.1599; Kim DH, 1997, BIOL PHARM BULL, V20, P834, DOI 10.1248/bpb.20.834; Kim HS, 2009, J MICROBIOL BIOTECHN, V19, P1650, DOI 10.4014/jmb.0904.04053; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kliewer SA, 2003, J NUTR, V133, p2444S, DOI 10.1093/jn/133.7.2444S; Li Y, 2010, EUR J PHARMACOL, V640, P46, DOI 10.1016/j.ejphar.2010.05.017; Liu L, 2010, PLANTA MED, V76, P70, DOI 10.1055/s-0029-1185946; Liu YH, 2011, XENOBIOTICA, V41, P259, DOI 10.3109/00498254.2010.537395; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Mencarelli A, 2010, BIOCHEM PHARMACOL, V80, P1700, DOI 10.1016/j.bcp.2010.08.022; Mu Y, 2006, J PHARMACOL EXP THER, V316, P1369, DOI 10.1124/jpet.105.094342; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Neves MP, 2011, EUR J MED CHEM, V46, P2562, DOI 10.1016/j.ejmech.2011.03.047; Park S, 2010, J CELL BIOCHEM, V110, P1376, DOI 10.1002/jcb.22654; Qualtrough D, 2002, GUT, V51, P184, DOI 10.1136/gut.51.2.184; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Sasaki K, 2000, J BIOL CHEM, V275, P27466; Sepe V, 2011, J MED CHEM, V54, P4590, DOI 10.1021/jm200241s; Shimizu I, 2000, J GASTROEN HEPATOL, V15, pD84, DOI 10.1046/j.1440-1746.2000.02138.x; Shin SC, 2009, PHARMAZIE, V64, P579, DOI 10.1691/ph.2009.9589; Srinivas NR, 2010, XENOBIOTICA, V40, P357, DOI 10.3109/00498251003663724; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Takakura Y, 2010, CANCER RES, V70, P6767, DOI 10.1158/0008-5472.CAN-09-4701; TAKASUNA K, 1995, JPN J CANCER RES, V86, P978, DOI 10.1111/j.1349-7006.1995.tb03010.x; Tian H, 2009, INFLAMMATION, V32, P191, DOI 10.1007/s10753-009-9120-8; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wallace K, 2010, J STEROID BIOCHEM, V120, P137, DOI 10.1016/j.jsbmb.2010.04.012; Wang HW, 2011, J CLIN INVEST, V121, P3220, DOI 10.1172/JCI41514; Wipf P, 2007, MINI-REV MED CHEM, V7, P617; Wu YL, 2010, CHEM-BIOL INTERACT, V188, P526, DOI 10.1016/j.cbi.2010.09.008; Zhang HY, 2010, TRENDS PHARMACOL SCI, V31, P443, DOI 10.1016/j.tips.2010.07.003; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283	52	65	72	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e36075	10.1371/journal.pone.0036075	http://dx.doi.org/10.1371/journal.pone.0036075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815676	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100003
J	Liang, DP; Han, GC; Feng, XM; Sun, JY; Duan, Y; Lei, HX				Liang, Dapeng; Han, Guangchun; Feng, Xuemei; Sun, Jiya; Duan, Yong; Lei, Hongxing			Concerted Perturbation Observed in a Hub Network in Alzheimer's Disease	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; GENE-EXPRESSION PROFILES; MESSENGER-RNA EXPRESSION; LONG-TERM-MEMORY; NEUROFIBRILLARY TANGLES; BETA-SECRETASE; BRAIN-REGIONS; TRANSCRIPTIONAL REGULATION; TAU PHOSPHORYLATION	Alzheimer's disease (AD) is a progressive neurodegenerative disease involving the alteration of gene expression at the whole genome level. Genome-wide transcriptional profiling of AD has been conducted by many groups on several relevant brain regions. However, identifying the most critical dys-regulated genes has been challenging. In this work, we addressed this issue by deriving critical genes from perturbed subnetworks. Using a recent microarray dataset on six brain regions, we applied a heaviest induced subgraph algorithm with a modular scoring function to reveal the significantly perturbed subnetwork in each brain region. These perturbed subnetworks were found to be significantly overlapped with each other. Furthermore, the hub genes from these perturbed subnetworks formed a connected hub network consisting of 136 genes. Comparison between AD and several related diseases demonstrated that the hub network was robustly and specifically perturbed in AD. In addition, strong correlation between the expression level of these hub genes and indicators of AD severity suggested that this hub network can partially reflect AD progression. More importantly, this hub network reflected the adaptation of neurons to the AD-specific microenvironment through a variety of adjustments, including reduction of neuronal and synaptic activities and alteration of survival signaling. Therefore, it is potentially useful for the development of biomarkers and network medicine for AD.	[Liang, Dapeng; Han, Guangchun; Feng, Xuemei; Sun, Jiya; Lei, Hongxing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Liang, Dapeng; Han, Guangchun; Sun, Jiya] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Duan, Yong; Lei, Hongxing] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Duan, Yong; Lei, Hongxing] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis; University of California System; University of California Davis	Liang, DP (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	duan@ucdavis.edu; leihx@big.ac.cn	Han, Guangchun/AAU-8230-2021; Duan, Yong/D-3475-2013	Duan, Yong/0000-0003-3793-5099	National Institutes of Health [GM79383, GM67168]; National Science Foundation of China [30870474]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079383, R01GM067168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (Grants GM79383 and GM67168 to YD) National Science Foundation of China (Grant 30870474 to HL). Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSENOVA MV, 1991, FEBS LETT, V279, P55, DOI 10.1016/0014-5793(91)80249-3; ANDERSON AJ, 1994, EXP NEUROL, V125, P286, DOI 10.1006/exnr.1994.1031; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Caltagarone J, 2007, BBA-MOL BASIS DIS, V1772, P438, DOI 10.1016/j.bbadis.2006.11.007; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Casci T, 2006, NAT REV GENET, V7, P664, DOI 10.1038/nrg1949; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen KD, 2011, NEUROBIOL DIS, V43, P698, DOI 10.1016/j.nbd.2011.05.023; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chun J, 2004, MOL CELLS, V18, P360; Cohen-Matsliah SI, 2008, LEARN MEMORY, V15, P756, DOI 10.1101/lm.1127008; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Docagne F, 2004, BIOCHEM J, V383, P393, DOI 10.1042/BJ20040682; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Dunckley T, 2006, NEUROBIOL AGING, V27, P1359, DOI 10.1016/j.neurobiolaging.2005.08.013; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Engidawork E, 2001, BIOCHEM BIOPH RES CO, V281, P84, DOI 10.1006/bbrc.2001.4306; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Fehlbaum-Beurdeley P, 2010, ALZHEIMERS DEMENT, V6, P25, DOI 10.1016/j.jalz.2009.07.001; Ferrer I, 1996, NEUROPATH APPL NEURO, V22, P521, DOI 10.1111/j.1365-2990.1996.tb01130.x; Figgins JA, 2009, AM J MED GENET B, V150B, P520, DOI 10.1002/ajmg.b.30851; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Giedraitis V, 2009, DEMENT GERIATR COGN, V27, P59, DOI 10.1159/000191203; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hamilton G, 2007, AM J MED GENET B, V144B, P508, DOI 10.1002/ajmg.b.30503; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Heicklen-Klein A, 2000, J NEUROCHEM, V75, P1408, DOI 10.1046/j.1471-4159.2000.0751408.x; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hou XY, 2002, BRAIN RES, V955, P123, DOI 10.1016/S0006-8993(02)03376-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Kato K, 1998, CELL STRESS CHAPERON, V3, P152, DOI 10.1379/1466-1268(1998)003<0152:SOTSIE>2.3.CO;2; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kitamura Y, 1997, NEUROSCI LETT, V237, P17, DOI 10.1016/S0304-3940(97)00797-0; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Lebouvier T, 2008, BBA-MOL CELL RES, V1783, P188, DOI 10.1016/j.bbamcr.2007.11.005; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lei HX, 2010, PROTEIN CELL, V1, P312, DOI 10.1007/s13238-010-0046-6; Lei HX, 2006, J MOL BIOL, V356, P1049, DOI 10.1016/j.jmb.2005.11.087; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li T, 2007, NEUROSCI LETT, V414, P203, DOI 10.1016/j.neulet.2006.11.073; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liu ZP, 2011, MOL BIOSYST, V7, P1441, DOI 10.1039/c0mb00325e; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17; Mateo I, 2008, EUR J NEUROL, V15, P219, DOI 10.1111/j.1468-1331.2008.02059.x; Mateo I, 2008, DEMENT GERIATR COGN, V25, P317, DOI 10.1159/000119123; Matsui T, 2006, J NEUROPATH EXP NEUR, V65, P508, DOI 10.1097/01.jnen.0000229238.05748.12; Maurice T, 2008, NEUROPSYCHOPHARMACOL, V33, P1584, DOI 10.1038/sj.npp.1301551; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; Mei M, 2006, J NEUROCHEM, V99, P1377, DOI 10.1111/j.1471-4159.2006.04174.x; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Min Ming-Yuan, 2011, Commun Integr Biol, V4, P394, DOI 10.4161/cib.4.4.15694; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Pan R, 2008, CHINESE MED J-PEKING, V121, P832, DOI 10.1097/00029330-200805010-00015; Pearson AG, 2006, NEUROSCI LETT, V398, P246, DOI 10.1016/j.neulet.2006.01.031; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Perez-Capote K, 2006, NEUROSCI LETT, V410, P25, DOI 10.1016/j.neulet.2006.09.078; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ray M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r148; Ray M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-136; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; SECKL JR, 1991, BRAIN RES, V561, P332, DOI 10.1016/0006-8993(91)91612-5; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Sugimori K, 2007, PSYCHIAT CLIN NEUROS, V61, P159, DOI 10.1111/j.1440-1819.2007.01631.x; Sun JY, 2012, J ALZHEIMERS DIS, V28, P389, DOI 10.3233/JAD-2011-111313; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; Tsugu Y, 1998, EUR J NEUROL, V5, P561, DOI 10.1046/j.1468-1331.1998.560561.x; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang L, 2008, NEUROBIOL AGING, V29, P357, DOI 10.1016/j.neurobiolaging.2006.11.001; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Wilmot B, 2008, NEUROBIOL AGING, V29, P524, DOI 10.1016/j.neurobiolaging.2006.11.008; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Wu ZL, 2006, NEUROBIOL AGING, V27, P377, DOI 10.1016/j.neurobiolaging.2005.02.010; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhang Y, 2004, J NEUROSCI, V24, P5315, DOI 10.1523/JNEUROSCI.0913-04.2004; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	143	58	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40498	10.1371/journal.pone.0040498	http://dx.doi.org/10.1371/journal.pone.0040498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815752	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100037
J	Lu, CH; Petzold, A; Kalmar, B; Dick, J; Malaspina, A; Greensmith, L				Lu, Ching-Hua; Petzold, Axel; Kalmar, Bernadett; Dick, James; Malaspina, Andrea; Greensmith, Linda			Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1(G93A) Mice that Model ALS	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MOUSE MODEL; DIFFERENTIAL-DIAGNOSIS; SCLEROSIS; SUBUNIT; ARIMOCLOMOL; PROTEINS; CSF; PHOSPHORYLATION; DEGENERATION	Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder characterised by progressive degeneration of motor neurons leading to death, typically within 3-5 years of symptom onset. The diagnosis of ALS is largely reliant on clinical assessment and electrophysiological findings. Neither specific investigative tools nor reliable biomarkers are currently available to enable an early diagnosis or monitoring of disease progression, hindering the design of treatment trials. Methodology/Principal Findings: In this study, using the well-established SOD1(G9-A) mouse model of ALS and a new in-house ELISA method, we have validated that plasma neurofilament heavy chain protein (NfH) levels correlate with both functional markers of late stage disease progression and treatment response. We detected a significant increase in plasma levels of phosphorylated NfH during disease progression in SOD1(G9-A) mice from 105 days onwards. Moreover, increased plasma NfH levels correlated with the decline in muscle force, motor unit survival and, more significantly, with the loss of spinal motor neurons in SOD1 mice during this critical period of decline. Importantly, mice treated with the disease modifying compound arimoclomol had lower plasma NfH levels, suggesting plasma NfH levels could be validated as an outcome measure for treatment trials. Conclusions/Significance: These results show that plasma NfH levels closely reflect later stages of disease progression and therapeutic response in the SOD1(G9-A) mouse model of ALS and may potentially be a valuable biomarker of later disease progression in ALS.	[Lu, Ching-Hua; Kalmar, Bernadett; Dick, James; Greensmith, Linda] UCL, Sobell Dept Motor Neurosci & Movement Disorders, MRC Ctr Neuromuscular Disorders, UCL Inst Neurol, London, England; [Petzold, Axel] UCL, Dept Neuroinflammat, UCL Inst Neurol, London, England; [Petzold, Axel] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Lu, Ching-Hua; Malaspina, Andrea] Queen Mary Univ London, Trauma & Neurosci Ctr, Blizard Inst, Barts & Sch Med & Dent, London, England; [Malaspina, Andrea] NE London & Essex MND Care & Res Ctr, London, England	University of London; University College London; University of London; University College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; Queen Mary University London	Lu, CH (corresponding author), UCL, Sobell Dept Motor Neurosci & Movement Disorders, MRC Ctr Neuromuscular Disorders, UCL Inst Neurol, London, England.	l.greensmith@ucl.ac.uk	Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749; Kalmar, Bernadett/0000-0003-3747-4843	Motor Neuron Disease Association; Brain Research Trust; European Community	Motor Neuron Disease Association; Brain Research Trust; European Community(European Commission)	This project was funded by the Motor Neuron Disease Association. LG is the Graham Watts Senior Research Fellow, funded by The Brain Research Trust and the European Community's Seventh Framework Programme (FP7/2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Bromberg MB, 2007, CLIN NEUROPHYSIOL, V118, P1, DOI 10.1016/j.clinph.2006.07.304; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P205, DOI 10.1016/j.parkreldis.2008.05.001; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Cudkowicz ME, 2008, MUSCLE NERVE, V38, P837, DOI 10.1002/mus.21059; Cudkowicz ME, 2010, AMYOTROPH LATERAL SC, V11, P259, DOI 10.3109/17482960903358865; De Carvalho M, 2009, AMYOTROPH LATERAL SC, V10, P53, DOI 10.1080/17482960802521126; de Jong D, 2007, J NEUROL NEUROSUR PS, V78, P936, DOI 10.1136/jnnp.2006.107326; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Ganesalingam I, 2010, BIOMARK MED, V4, P281, DOI [10.2217/BMM.09.71, 10.2217/bmm.09.71]; Ganesalingam J, 2011, J NEUROCHEM, V117, P528, DOI 10.1111/j.1471-4159.2011.07224.x; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Gnanapavan S, 2012, AUTOIMMUNITY EARLY O, P1; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Kalmar B, 2008, J NEUROCHEM, V107, P339, DOI 10.1111/j.1471-4159.2008.05595.x; Kalmar B, 2012, AMYOTROPH LATERAL SC, V13, P378, DOI 10.3109/17482968.2012.660953; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Lanka V, 2009, EXPERT OPIN INV DRUG, V18, P1907, DOI 10.1517/13543780903357486; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Lu CH, 2011, J NEUROSCI METH, V195, P143, DOI 10.1016/j.jneumeth.2010.11.026; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Otto M, 2012, AMYOTROPH LATERAL SC, V13, P1, DOI 10.3109/17482968.2011.627589; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2010, ANN NEUROL, V68, P806, DOI 10.1002/ana.22169; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Sussmuth SD, 2008, CURR MED CHEM, V15, P1788, DOI 10.2174/092986708785133031; van Eijk JJJ, 2010, J ALZHEIMERS DIS, V21, P569, DOI 10.3233/JAD-2010-090649; Winhammar JMC, 2005, LANCET NEUROL, V4, P229, DOI 10.1016/S1474-4422(05)70042-9; Wolfensohn S, 2003, HDB LAB ANIMAL MANAG, P164; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x; Zoing MC, 2006, J CLIN NEUROSCI, V13, P78, DOI 10.1016/j.jocn.2004.04.011	51	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40998	10.1371/journal.pone.0040998	http://dx.doi.org/10.1371/journal.pone.0040998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815892	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100107
J	Luo, RT; Piovoso, MJ; Martinez-Picado, J; Zurakowski, R				Luo, Rutao; Piovoso, Michael J.; Martinez-Picado, Javier; Zurakowski, Ryan			HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; T-CELLS; IN-VIVO; COMBINATION THERAPY; NONLINEAR-SYSTEMS; TYPE-1 RNA; INFECTION; RESISTANCE; PLASMA	Mathematical models based on ordinary differential equations (ODE) have had significant impact on understanding HIV disease dynamics and optimizing patient treatment. A model that characterizes the essential disease dynamics can be used for prediction only if the model parameters are identifiable from clinical data. Most previous parameter identification studies for HIV have used sparsely sampled data from the decay phase following the introduction of therapy. In this paper, model parameters are identified from frequently sampled viral-load data taken from ten patients enrolled in the previously published AutoVac HAART interruption study, providing between 69 and 114 viral load measurements from 3-5 phases of viral decay and rebound for each patient. This dataset is considerably larger than those used in previously published parameter estimation studies. Furthermore, the measurements come from two separate experimental conditions, which allows for the direct estimation of drug efficacy and reservoir contribution rates, two parameters that cannot be identified from decay-phase data alone. A Markov-Chain Monte-Carlo method is used to estimate the model parameter values, with initial estimates obtained using nonlinear least-squares methods. The posterior distributions of the parameter estimates are reported and compared for all patients.	[Luo, Rutao; Zurakowski, Ryan] Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; [Piovoso, Michael J.] Penn State Univ Great Valley, Dept Elect Engn, Malvern, PA USA; [Martinez-Picado, Javier] IrsiCaixa, Inst Recerca Sindrome Inmunodeficencia Adquirida, Badalona, Spain; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avanats, Barcelona, Spain	University of Delaware; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Luo, RT (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.	ryanz@udel.edu	Martinez-Picado, Javier/G-5507-2012	Martinez-Picado, Javier/0000-0002-4916-2129; Zurakowski, Ryan/0000-0003-3726-3114	National Institute Of Allergy And Infectious Diseases [R21AI078842]; GlaxoSmithKline; Merck; Roche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078842] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Roche(Roche Holding); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	The project described was supported by Award Number R21AI078842 from the National Institute Of Allergy And Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Allergy And Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JMP has received research funding, consultancy fees, or lecture sponsorships from GlaxoSmithKline, Merck and Roche. There are no other conflicts to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bortz DM, 2006, B MATH BIOL, V68, P2005, DOI 10.1007/s11538-006-9084-x; Cardozo EF, 2012, BIOMEDICAL IN PRESS, V59, DOI [10.1109/TBME.2012.2201479, DOI 10.1109/TBME.2012.2201479]; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Ferreira J, 2011, COMPUT METH PROG BIO, V104, P50, DOI 10.1016/j.cmpb.2011.07.011; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864; Hernandez-Vargas E, 2011, INT J ROBUST NONLIN, V21, P1093, DOI 10.1002/rnc.1628; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang YX, 2008, COMPUT STAT DATA AN, V52, P3765, DOI 10.1016/j.csda.2007.12.016; Huang YX, 2006, BIOMETRICS, V62, P413, DOI 10.1111/j.1541-0420.2005.00447.x; Huang YX, 2010, BIOMETRICAL J, V52, P470, DOI 10.1002/bimj.200900173; Liang H, 2010, ANN APPL STAT, V4, P460, DOI 10.1214/09-AOAS290; LJUNG L, 1994, AUTOMATICA, V30, P265, DOI 10.1016/0005-1098(94)90029-9; Luo R, 2008, P AMER CONTR CONF, P2112, DOI 10.1109/ACC.2008.4586804; Luo RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027047; Luo RT, 2011, J PROCESS CONTR, V21, P367, DOI 10.1016/j.jprocont.2010.11.010; Luo RT, 2009, P AMER CONTR CONF, P2295, DOI 10.1109/ACC.2009.5160358; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Martinez-Cajas JL, 2008, DRUGS, V68, P43, DOI 10.2165/00003495-200868010-00004; Miao HY, 2009, BIOMETRICS, V65, P292, DOI 10.1111/j.1541-0420.2008.01059.x; NELSON GW, 1995, MATH BIOSCI, V125, P127, DOI 10.1016/0025-5564(94)00021-Q; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Putter H, 2002, STAT MED, V21, P2199, DOI 10.1002/sim.1211; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Ritt J.F., 1950, AM MATH SOC COLLOQ P, VXXXIII; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Ruiz L, 2001, AIDS, V15, pF19, DOI 10.1097/00002030-200106150-00001; Saccomani MP, 2010, COMPUT BIOL MED, V40, P402, DOI 10.1016/j.compbiomed.2010.02.004; Saccomani MP, 2003, AUTOMATICA, V39, P619, DOI 10.1016/S0005-1098(02)00302-3; Schrager LK, 1998, JAMA-J AM MED ASSOC, V280, P67, DOI 10.1001/jama.280.1.67; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith DM, 2007, J INFECT DIS, V196, P356, DOI 10.1086/519164; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wu HL, 2005, JAIDS-J ACQ IMM DEF, V39, P272, DOI 10.1097/01.qai.0000165907.04710.da; Wu HL, 2008, B MATH BIOL, V70, P785, DOI 10.1007/s11538-007-9279-9; Xia X, 2003, IEEE T AUTOMAT CONTR, V48, P330, DOI 10.1109/TAC.2002.808494	47	49	49	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40198	10.1371/journal.pone.0040198	http://dx.doi.org/10.1371/journal.pone.0040198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815727	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100029
J	Raisanen, S; Vehvilainen-Julkunen, K; Gissler, M; Heinonen, S				Raisanen, Sari; Vehvilainen-Julkunen, Katri; Gissler, Mika; Heinonen, Seppo			Smoking during Pregnancy Is Associated with a Decreased Incidence of Obstetric Anal Sphincter Injuries in Nulliparous Women	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; RISK-FACTORS; URINARY-INCONTINENCE; FORCEPS DELIVERY; EPISIOTOMY; METAANALYSIS; PROTECTS; RUPTURES; FINLAND; TRENDS	Background: Smoking is a modifiable lifestyle factor that has been shown to be associated with adverse perinatal outcomes and to have adverse health and dose-dependent connective tissue effects. The objective of this study was to examine whether smoking during pregnancy was associated with the incidence of obstetric anal sphincter injuries (OASIS) among six birthweight groups in singleton vaginal deliveries, considering nulliparous and multiparous women separately between 1997 and 2007 in Finland. Methodology: A retrospective population-based register study. Populations included women with spontaneous singleton vaginal deliveries, consisting of all 213,059 nulliparous and all 288,391 multiparous women. Incidence of OASIS (n = 2,787) between smoking status groups was adjusted using logistic regression analyses. Principal Findings: Of the nulliparous women, 13.1% were smokers, 3.6% had given up smoking during the first trimester of their pregnancy and 81.1% were non-smokers. Among these groups 0.7%, 0.9% and 1.1%, respectively suffered OASIS (p <= 0.001). Nulliparous women who smoked had a 28% (95% CI 16-38%, p <= 0.001) lower risk of OASIS compared to nonsmokers, when adjusting for background variables. In multiparous women, the overall frequencies of OASIS were much lower (0.0-0.2%). A similar inverse relationship between OASIS rates and smoking was significant in pooled univariate analysis of multiparous women, but multivariate analysis revealed statistically insignificant results between non-smokers and smokers. Conclusions: Nulliparous women who were smokers had a 28% lower incidence of OASIS. However, smoking during pregnancy cannot be recommended since it has shown to be associated with other adverse pregnancy outcomes and adverse health effects. The observed association warrants clinical repetition studies and, if confirmed, also in vitro studies focusing on connective tissue properties at a molecular and cellular level.	[Raisanen, Sari] Savonia Univ Appl Sci, Dept Nursing, Iisalmi, Finland; [Vehvilainen-Julkunen, Katri] Univ Eastern Finland, Dept Nursing Sci, Kuopio, Finland; [Vehvilainen-Julkunen, Katri] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Welf & Hlth Data Resources Unit, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynecol, SF-70210 Kuopio, Finland; [Heinonen, Seppo] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland	Savonia University of Applied Sciences; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Raisanen, S (corresponding author), Savonia Univ Appl Sci, Dept Nursing, Iisalmi, Finland.	sari.raisanen@savonia.fi		Gissler, Mika/0000-0001-8254-7525				Baghestan E, 2010, OBSTET GYNECOL, V116, P25, DOI 10.1097/AOG.0b013e3181e2f50b; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Bulmanski Z, 2011, J PERIODONT IN PRESS; Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2; Christianson LM, 2003, AM J OBSTET GYNECOL, V189, P255, DOI 10.1067/mob.2003.547; de Leeuw JW, 2001, BRIT J OBSTET GYNAEC, V108, P383, DOI 10.1016/S0306-5456(00)00090-5; Dudding TC, 2008, ANN SURG, V247, P224, DOI 10.1097/SLA.0b013e318142cdf4; *EURO PERISTAT PRO, 2008, EUR PER HLTH REP; Frankman EA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.022; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Green AC, 2011, DERMATOLOGY, V222, P74, DOI 10.1159/000322623; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Hudelist G, 2005, AM J OBSTET GYNECOL, V192, P875, DOI 10.1016/j.ajog.2004.09.035; Jaakkola N, 2001, AM J PUBLIC HEALTH, V91, P284, DOI 10.2105/AJPH.91.2.284; Kalis V, 2012, BJOG-INT J OBSTET GY, V119, P522, DOI 10.1111/j.1471-0528.2011.03268.x; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Kim CM, 2007, INT J GYNECOL OBSTET, V98, P248, DOI 10.1016/j.ijgo.2007.02.019; Laine K, 2009, EUR J OBSTET GYN R B, V146, P71, DOI 10.1016/j.ejogrb.2009.04.033; Lewis C, 2008, INT UROGYNECOL J, V19, P41, DOI 10.1007/s00192-007-0402-0; Lowder JL, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.893; Mehendale R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.025; Mendelsohn C, 2011, AUST FAM PHYSICIAN, V40, P403; Millar J, 2004, SELECTION INDICATORS; Nordisk Ministerrad, 2010, NORD KVAL SUNDH; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; PEARSE WH, 1963, AM J OBSTET GYNECOL, V86, P43, DOI 10.1016/0002-9378(63)90075-9; Power D, 2006, J FAM PRACTICE, V55, P193; Raatikainen K, 2007, PREV MED, V44, P59, DOI 10.1016/j.ypmed.2006.07.017; Raisanen S, 2011, SCAND J PUBLIC HEALT, V39, P457, DOI 10.1177/1403494811404276; Raisanen SH, 2009, ACTA OBSTET GYN SCAN, V88, P1365, DOI 10.3109/00016340903295626; Schaffer JI, 2005, CLIN OBSTET GYNECOL, V48, P639, DOI 10.1097/01.grf.0000170428.45819.4e; Sultan AH, 1999, CLIN RISK, V5, P193, DOI [DOI 10.1177/135626229900500601, 10.1177/135626229900500601]; Tahtinen RM, 2011, OBSTET GYNECOL, V118, P643, DOI 10.1097/AOG.0b013e318227b7ac; Torrungruang K, 2012, J INVESTIG CLIN DENT, V3, P135, DOI 10.1111/j.2041-1626.2011.00105.x; Ward KD, 2001, CALCIFIED TISSUE INT, V68, P259, DOI 10.1007/BF02390832	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41014	10.1371/journal.pone.0041014	http://dx.doi.org/10.1371/journal.pone.0041014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815899	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100109
J	Dai, X; Zhu, YX; Luo, YF; Song, L; Liu, D; Liu, L; Chen, FR; Wang, M; Li, JB; Zeng, XW; Dong, ZY; Hu, SN; Li, LY; Xu, J; Huang, L; Dong, XZ				Dai, Xin; Zhu, Yaxin; Luo, Yingfeng; Song, Lei; Liu, Di; Liu, Li; Chen, Furong; Wang, Min; Li, Jiabao; Zeng, Xiaowei; Dong, Zhiyang; Hu, Songnian; Li, Lingyan; Xu, Jian; Huang, Li; Dong, Xiuzhu			Metagenomic Insights into the Fibrolytic Microbiome in Yak Rumen	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; BACTERIAL; GENOME; GENES; DEGRADATION; DIVERSITY; DISCOVERY; CELLULOSE; SEQUENCE; STARCH	The rumen hosts one of the most efficient microbial systems for degrading plant cell walls, yet the predominant cellulolytic proteins and fibrolytic mechanism(s) remain elusive. Here we investigated the cellulolytic microbiome of the yak rumen by using a combination of metagenome-based and bacterial artificial chromosome (BAC)-based functional screening approaches. Totally 223 fibrolytic BAC clones were pyrosequenced and 10,070 ORFs were identified. Among them 150 were annotated as the glycoside hydrolase (GH) genes for fibrolytic proteins, and the majority (69%) of them were clustered or linked with genes encoding related functions. Among the 35 fibrolytic contigs of >10 Kb in length, 25 were derived from Bacteroidetes and four from Firmicutes. Coverage analysis indicated that the fibrolytic genes on most Bacteroidetes-contigs were abundantly represented in the metagenomic sequences, and they were frequently linked with genes encoding SusC/SusD-type outer-membrane proteins. GH5, GH9, and GH10 cellulase/hemicellulase genes were predominant, but no GH48 exocellulase gene was found. Most (85%) of the cellulase and hemicellulase proteins possessed a signal peptide; only a few carried carbohydrate-binding modules, and no cellulosomal domains were detected. These findings suggest that the SucC/SucD-involving mechanism, instead of one based on cellulosomes or the free-enzyme system, serves a major role in lignocellulose degradation in yak rumen. Genes encoding an endoglucanase of a novel GH5 subfamily occurred frequently in the metagenome, and the recombinant proteins encoded by the genes displayed moderate Avicelase in addition to endoglucanase activities, suggesting their important contribution to lignocellulose degradation in the exocellulase-scarce rumen.	[Dai, Xin; Zhu, Yaxin; Song, Lei; Chen, Furong; Wang, Min; Li, Jiabao; Dong, Zhiyang; Li, Lingyan; Huang, Li; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Luo, Yingfeng; Hu, Songnian] Chinese Acad Sci, Beijing Inst Gen, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Liu, Di; Liu, Li] Chinese Acad Sci, Inst Microbiol, Bioinformat Ctr, Beijing, Peoples R China; [Zeng, Xiaowei; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioprocess Technol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Dong, XZ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	xujian@qibebt.ac.cn; huangl@sun.im.ac.cn; dongxz@im.ac.cn	li, jia/GVT-7587-2022; Xu, Jian/G-8430-2012; Liu, Di/G-6135-2014; Liu, Jia-Bao/C-7850-2015; Liu, Di/ABD-2729-2021; Hu, Songnian/C-6509-2013	Xu, Jian/0000-0002-0548-8477; Liu, Di/0000-0003-3693-2726; Liu, Jia-Bao/0000-0002-9620-7692; Liu, Di/0000-0003-3693-2726; ying feng, luo/0000-0003-1950-9045; Hu, Songnian/0000-0003-3966-3111	Chinese Academy of Sciences [KSCX1-YW-11B1]; National High Technology Program (863) of China [2007AA021301]; China National Natural Science Foundation [30770053]	Chinese Academy of Sciences(Chinese Academy of Sciences); National High Technology Program (863) of China(National High Technology Research and Development Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences (KSCX1-YW-11B1), National High Technology Program (863) of China (2007AA021301), and the China National Natural Science Foundation (30770053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; An DD, 2005, ANAEROBE, V11, P207, DOI 10.1016/j.anaerobe.2005.02.001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Brumm P, 2011, APPL BIOCHEM BIOTECH, V163, P649, DOI 10.1007/s12010-010-9070-5; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Dodd D, 2011, MOL MICROBIOL, V79, P292, DOI 10.1111/j.1365-2958.2010.07473.x; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Eddy Sean R, 2009, Genome Inform, V23, P205; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Irwin DC, 2000, EUR J BIOCHEM, V267, P4988, DOI 10.1046/j.1432-1327.2000.01546.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Peer A, 2009, FEMS MICROBIOL LETT, V291, P1, DOI 10.1111/j.1574-6968.2008.01420.x; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990; Steenbakkers PJM, 2002, DNA SEQUENCE, V13, P313, DOI 10.1080/1042517021000024191; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636; Walter J, 2005, APPL ENVIRON MICROB, V71, P2347, DOI 10.1128/AEM.71.5.2347-2354.2005; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	37	67	82	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40430	10.1371/journal.pone.0040430	http://dx.doi.org/10.1371/journal.pone.0040430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808161	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700028
J	Holz, J; Piosczyk, H; Landmann, N; Feige, B; Spiegelhalder, K; Riemann, D; Nissen, C; Voderholzer, U				Holz, Johannes; Piosczyk, Hannah; Landmann, Nina; Feige, Bernd; Spiegelhalder, Kai; Riemann, Dieter; Nissen, Christoph; Voderholzer, Ulrich			The Timing of Learning before Night-Time Sleep Differentially Affects Declarative and Procedural Long-Term Memory Consolidation in Adolescents	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; MOTOR MEMORY; TIME-COURSE; NEUROSCIENCE; EXPRESSION; SYSTEMS; RECONSOLIDATION; POTENTIATION; HIPPOCAMPUS; HOMEOSTASIS	Sleep after learning has been shown to foster the consolidation of new memories. However, fundamental questions on the best timing of learning before night-time sleep persist. We tested the hypothesis that learning directly prior to night-time sleep compared to 7.5 hrs prior to night-time sleep provides better conditions for the consolidation of declarative and procedural memories. Fifty healthy female adolescents (aged 16-17 years) were trained on a declarative word-pair and a procedural finger-tapping task at 3 PM (afternoon group, n = 25) or at 9 PM (evening group, n = 25), followed by a sleep laboratory night. Retrieval was assessed 24 hours and 7 days after initial training. Subjects trained in the afternoon showed a significantly elevated retention rate of word-pairs compared to subjects trained in the evening after 24 hours, but not after 7 days. In contrast, off-line gains in finger-tapping performance were significantly higher in subjects trained in the evening compared to those trained in the afternoon after both retention intervals. The observed enhanced consolidation of procedural memories after training in the evening fits to current models of sleep-related memory consolidation. In contrast, the higher retention of declarative memories after encoding in the afternoon is surprising, appeared to be less robust and needs further investigation.	[Holz, Johannes; Piosczyk, Hannah; Landmann, Nina; Feige, Bernd; Spiegelhalder, Kai; Riemann, Dieter; Nissen, Christoph; Voderholzer, Ulrich] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Voderholzer, Ulrich] Schoen Clin Roseneck, Prien Am Chiemsee, Germany	University of Freiburg	Holz, J (corresponding author), Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany.	christoph.nissen@uniklinik-freiburg.de; UVoderholzer@Schoen-Kliniken.de	Nissen, Christoph/C-7642-2015; Spiegelhalder, Kai/B-7861-2019; Feige, Bernd/C-6690-2012; Riemann, Dieter/R-4013-2019	Nissen, Christoph/0000-0001-9809-0275; Feige, Bernd/0000-0002-9436-1258; Riemann, Dieter/0000-0002-1968-6220	German Research Foundation [542/8-1]	German Research Foundation(German Research Foundation (DFG))	This is not an industry supported study. The study was supported by a research grant provided by the German Research Foundation to Ulrich Voderholzer, (Vo 542/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brown RM, 2007, NAT NEUROSCI, V10, P148, DOI 10.1038/nn1836; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Heller K. A., 1998, MATRIZEN TEST MANUAL, V1; Holz J, 2012, J SLEEP RES     0516; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kloepfer C, 2009, J CLIN SLEEP MED, V5, P540; Kopasz M, 2010, SLEEP MED REV, V14, P167, DOI 10.1016/j.smrv.2009.10.006; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; Nissen C, 2011, J SLEEP RES, V20, P129, DOI 10.1111/j.1365-2869.2010.00872.x; OECD, 2006, PISA 2006 SCI COMP T; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Spinath B., 2002, SKALEN ERFASSUNG LER; Squire LR, 2009, NEURON, V61, P6, DOI 10.1016/j.neuron.2008.12.023; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tewes U, 1994, HAMBURG WECHSLER INT, V2; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; Voderholzer U, 2011, SLEEP MED, V12, P170, DOI 10.1016/j.sleep.2010.07.017; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Zimmermann P, 2007, TESTBATTERIE AUFMERK	51	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40963	10.1371/journal.pone.0040963	http://dx.doi.org/10.1371/journal.pone.0040963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973NH	22808287	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400064
J	Joos, K; Vanneste, S; De Ridder, D				Joos, Kathleen; Vanneste, Sven; De Ridder, Dirk			Disentangling Depression and Distress Networks in the Tinnitus Brain	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; MOOD DISORDERS; CHRONIC PAIN; MECHANISMS; EMOTION; ASYMMETRY; REORGANIZATION	Tinnitus is the continuous perception of an internal auditory stimulus. This permanent sound often affects a person's emotional state inducing distress and depressive feelings changes in 6-25% of the affected population. Distress and depression are two distinct emotional states. Whereas distress describes a transient aversive state, interfering with a person's ability to adequately adapt to stressors, depressive feelings should rather be considered as a more constant emotional state. Based on previous observations in chronic pain, posttraumatic stress disorder and depression, we assume that both states are related to separate neural circuits. We used the Dutch version of the Tinnitus Questionnaire to assess the global index of distress together with the Beck Depression Inventory to evaluate the depressive symptoms accompanying tinnitus. Furthermore sLORETA analysis was performed to correlate current density distribution with distress and depression scores, revealing a lateralization effect of depression versus distress. Distress is mainly correlated with alpha 2, beta 1 and beta 2 activity of the right frontopolar cortex and orbitofrontal cortex in combination with beta 2 activation of the anterior cingulate cortex. In contrast, the more permanent depressive alterations induced by tinnitus are associated with activity of alpha 2 activity in the left frontopolar and orbitofrontal cortex. These specific neural circuits are embedded in a greater neural network, with the parahippocampal region functioning as a crucial linkage between both tinnitus related pathways.	[Joos, Kathleen; Vanneste, Sven; De Ridder, Dirk] Univ Antwerp Hosp, Tinnitus Res Initiat Clin Antwerp, Dept Neurosurg, Brai2n, Antwerp, Belgium	University of Antwerp	Joos, K (corresponding author), Univ Antwerp Hosp, Tinnitus Res Initiat Clin Antwerp, Dept Neurosurg, Brai2n, Antwerp, Belgium.	sven.vanneste@ua.ac.be		Vanneste, Sven/0000-0003-1513-5752				Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Ahmad N, 2004, DRUG AGING, V21, P297, DOI 10.2165/00002512-200421050-00002; Allen JJB, 2004, BIOL PSYCHOL, V67, P1, DOI 10.1016/j.biopsycho.2004.03.001; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Andersson G, 2003, AURIS NASUS LARYNX, V30, P129, DOI 10.1016/S0385-8146(03)00008-7; Angrilli A, 2008, NEUROPSYCHOLOGIA, V46, P1179, DOI 10.1016/j.neuropsychologia.2007.10.018; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Begic D, 2001, INT J PSYCHOPHYSIOL, V40, P167, DOI 10.1016/S0167-8760(00)00153-7; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; BOUMAN TK, 1985, GEDRAG GEZOND, V13, P13; Boutros N, 2005, BIOL PSYCHIAT, V57, P597; Boutros NN, 2008, HIPPOCAMPUS, V18, P310, DOI 10.1002/hipo.20388; Brown GW, 1989, DEPRESSION; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Cramer D, 2003, J PSYCHOL, V137, P507, DOI 10.1080/00223980309600632; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Davidson RJ, 1998, PSYCHOPHYSIOLOGY, V35, P607, DOI 10.1017/S0048577298000134; De Ridder D, 2007, PROG BRAIN RES, V166, P377, DOI 10.1016/S0079-6123(07)66036-1; De Ridder D, 2007, ELECT STIMULATION AU; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2007, ORBITOFRONTAL CORTEX; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Fales CL, 2009, J AFFECT DISORDERS, V112, P206, DOI 10.1016/j.jad.2008.04.027; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; GOEBEL G, 1994, HNO, V42, P166; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Grunwald T, 2003, BIOL PSYCHIAT, V53, P511, DOI 10.1016/S0006-3223(02)01673-6; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kemp AH, 2010, BIOL PSYCHOL, V85, P350, DOI 10.1016/j.biopsycho.2010.08.001; Kennedy SH, 1997, CAN J PSYCHIAT, V42, P467, DOI 10.1177/070674379704200502; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Korzyukov O, 2007, NEUROIMAGE, V35, P814, DOI 10.1016/j.neuroimage.2006.12.011; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Lazarus R.S., 1984, EMOTION ADAPTATION; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Lim JJBH, 2010, SINGAP MED J, V51, P551; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Meeus O, 2007, B-ENT, P11; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; MOBASCHER A, 2009, NEUROIMAGE; Moller AR, 1997, AM J OTOL, V18, P577; Moller AR, 2010, J AM ACAD AUDIOL, V11, P115; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Novatech EEG Inc, EUREKAL VERS 3 0 COM; Onozawa K, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-115; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Plewnia C, 2007, J NEUROL NEUROSUR PS, V78, P152, DOI 10.1136/jnnp.2006.095612; Powell HWR, 2004, NEUROIMAGE, V22, P740, DOI 10.1016/j.neuroimage.2004.01.011; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schweinhardt P, 2008, NEUROIMAGE, V40, P759, DOI 10.1016/j.neuroimage.2007.12.016; Shin LM, 2007, J TRAUMA STRESS, V20, P701, DOI 10.1002/jts.20231; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; TONNDORF J, 1987, HEARING RES, V28, P271, DOI 10.1016/0378-5955(87)90054-2; Tulving E, 1997, CURR OPIN NEUROBIOL, V7, P209, DOI 10.1016/S0959-4388(97)80009-8; Vanneste S, 2012, PLOS ONE, P7; Vanneste S, 2010, B ENT; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt T, 2010, NEUROSCIENCE LETT; Volz KG, 2009, PROG BRAIN RES, V174, P61, DOI 10.1016/S0079-6123(09)01306-5; Waliczek TM, 1996, PRIMER PARTIAL CORRE; WHEELER RE, 1993, PSYCHOPHYSIOLOGY, V30, P82, DOI 10.1111/j.1469-8986.1993.tb03207.x; Zald DH, 2002, P NATL ACAD SCI USA, V99, P2450, DOI 10.1073/pnas.042457199; Zoger S, 2001, AUDIOLOGY, V40, P133	87	57	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40544	10.1371/journal.pone.0040544	http://dx.doi.org/10.1371/journal.pone.0040544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808188	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400034
J	Rosenfeld, JA; Mason, CE; Smith, TM				Rosenfeld, Jeffrey A.; Mason, Christopher E.; Smith, Todd M.			Limitations of the Human Reference Genome for Personalized Genomics	PLOS ONE			English	Article							LOSS-OF-FUNCTION; WHOLE-GENOME; NUCLEOTIDE POLYMORPHISMS; GENETIC EPIDEMIOLOGY; DISEASE GENES; HAPLOTYPE; VARIANTS; SNPS; BRCA1; ASSOCIATION	Data from the 1000 genomes project (1KGP) and Complete Genomics (CG) have dramatically increased the numbers of known genetic variants and challenge several assumptions about the reference genome and its uses in both clinical and research settings. Specifically, 34% of published array-based GWAS studies for a variety of diseases utilize probes that overlap unanticipated single nucleotide polymorphisms (SNPs), indels, or structural variants. Linkage disequilibrium (LD) block length depends on the numbers of markers used, and the mean LD block size decreases from 16 kb to 7 kb, when HapMap-based calculations are compared to blocks computed from 1KGP data. Additionally, when 1KGP and CG variants are compared, 19% of the single nucleotide variants (SNVs) reported from common genomes are unique to one dataset; likely a result of differences in data collection methodology, alignment of reads to the reference genome, and variant-calling algorithms. Together these observations indicate that current research resources and informatics methods do not adequately account for the high level of variation that already exists in the human population and significant efforts are needed to create resources that can accurately assess personal genomics for health, disease, and predict treatment outcomes.	[Rosenfeld, Jeffrey A.] Univ Med & Dent New Jersey, Div High Performance & Res Comp, Newark, NJ 07103 USA; [Rosenfeld, Jeffrey A.] Sackler Inst Comparat Gen, Amer Museum Nat Hist, New York, NY USA; [Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Smith, Todd M.] PerkinElmer, Seattle, WA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; American Museum of Natural History (AMNH); Cornell University; Cornell University	Rosenfeld, JA (corresponding author), Univ Med & Dent New Jersey, Div High Performance & Res Comp, Newark, NJ 07103 USA.	todd.smith@perkinelmer.com	Mason, Christopher/HCH-3977-2022		National Human Genome Research Institute [2R44HG005297]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG005297] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Award Number 2R44HG005297 from the National Human Genome Research Institute supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aach J, 2001, NATURE, V409, P856, DOI 10.1038/35057055; Ajmal M, 2011, GENET TEST MOL BIOMA, V15, P601, DOI 10.1089/gtmb.2010.0184; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balasubramanian S, 2011, GENE DEV, V25, P1, DOI 10.1101/gad.1968411; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; BARRETT J, 2009, COLD SPRING HARBOR P; Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Cox DG, 2005, BREAST CANCER RES, V7, pR171, DOI 10.1186/bcr973; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Freedman ML, 2005, CANCER RES, V65, P7516, DOI 10.1158/0008-5472.CAN-05-0132; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huebner C, 2007, CANCER EPIDEM BIOMAR, V16, P1185, DOI 10.1158/1055-9965.EPI-06-0759; Im KM, 2011, HUM GENET, V130, P685, DOI 10.1007/s00439-011-1003-z; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koboldt DC, 2006, HUM MUTAT, V27, P249, DOI 10.1002/humu.20286; Lemos R, 2012, J MOL NEUROSCI, P1; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Morita A, 2007, MOL CELL PROBE, V21, P171, DOI 10.1016/j.mcp.2006.10.005; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olivier M, 2003, PHYSIOL GENOMICS, V13, P3, DOI 10.1152/physiolgenomics.00178.2002; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Pardanani A, 2010, LEUKEMIA, V24, P110, DOI 10.1038/leu.2009.226; Pereira LHM, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-68; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosenfeld JA, 2010, NUCLEIC ACIDS RES, V38, P6102, DOI 10.1093/nar/gkq408; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Tong MY, 2011, BIOINFORMATICS, V27, P891, DOI 10.1093/bioinformatics/btr029; Wellcome Trust, 2003, SHAR DAT LARG SCAL B; Westphal V, 2000, MOL GENET METAB, V70, P219, DOI 10.1006/mgme.2000.3017; Xu ZL, 2007, BIOINFORMATICS, V23, P3254, DOI 10.1093/bioinformatics/btm426	51	48	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40294	10.1371/journal.pone.0040294	http://dx.doi.org/10.1371/journal.pone.0040294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22811759	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400039
J	Hussain, S; Lawrence, MG; Taylor, RA; Lo, CYW; BioResource, APC; Frydenberg, M; Ellem, SJ; Furic, L; Risbridger, GP				Hussain, Shirin; Lawrence, Mitchell G.; Taylor, Renea A.; Lo, Camden Yeung-Wah; BioResource, A. P. C.; Frydenberg, Mark; Ellem, Stuart J.; Furic, Luc; Risbridger, Gail P.			Estrogen Receptor beta Activation Impairs Prostatic Regeneration by Inducing Apoptosis in Murine and Human Stem/Progenitor Enriched Cell Populations	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; METASTATIC CARCINOMA; CANCER INITIATION; VENTRAL PROSTATE; SELF-RENEWAL; RAT PROSTATE; BASAL-CELLS; IN-VITRO; ANDROGEN; ALPHA	Androgen depletion is the primary treatment for prostate disease; however, it fails to target residual castrate-resistant cells that are regenerative and cells of origin of prostate cancer. Estrogens, like androgens, regulate survival in prostatic cells, and the goal of this study was to determine the advantages of selective activation of estrogen receptor beta (ER beta) to induce cell death in stem cells that are castrate-resistant. Here we show two cycles of short-term ER beta agonist (8 beta-VE2) administration this treatment impairs regeneration, causing cystic atrophy that correlates with sustained depletion of p63+ basal cells. Furthermore, agonist treatment attenuates clonogenicity and self-renewal of murine prostatic stem/progenitor cells and depletes both murine (Lin(-)Sca1(+)CD49f(hi)) and human (CD49f(hi)Trop2(hi)) prostatic basal cells. Finally, we demonstrate the combined added benefits of selective stimulation of ER beta, including the induction of cell death in quiescent post-castration tissues. Subsequent to castration ER beta-induces further apoptosis in basal, luminal and intermediate cells. Our results reveal a novel benefit of ER beta activation for prostate disease and suggest that combining selective activation of ER beta with androgen-deprivation may be a feasible strategy to target stem cells implicated in the origin of prostatic disease.	[Hussain, Shirin; Lawrence, Mitchell G.; Taylor, Renea A.; Ellem, Stuart J.; Furic, Luc; Risbridger, Gail P.] Monash Univ, Prostate & Breast Canc Res Program, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Lo, Camden Yeung-Wah] Monash Hlth Translat Precinct, Monash Micro Imaging, Clayton, Vic, Australia; [Frydenberg, Mark] Monash Univ, Dept Surg, Fac Med, Clayton, Vic, Australia	Monash University; Monash University	Hussain, S (corresponding author), Monash Univ, Prostate & Breast Canc Res Program, Dept Anat & Dev Biol, Clayton, Vic, Australia.	gail.risbridger@monash.edu	Lawrence, Mitchell/B-8082-2014; Furic, Luc/F-4886-2012; Taylor, Renea A/A-5022-2009; Risbridger, Gail P/B-8655-2008; Ellem, Stuart/A-5302-2009	Lawrence, Mitchell/0000-0001-9520-3000; Furic, Luc/0000-0002-1893-9812; Taylor, Renea A/0000-0003-2609-2380; Risbridger, Gail P/0000-0003-3089-4028; Ellem, Stuart/0000-0001-5874-6524	Australian National Health and Medical Research Council [614296, 1002648, 545931, 1035721]; Prostate Cancer Foundation of Australia; Movember Young Investigator Grants [PG0709]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia; Movember Young Investigator Grants	Funding was obtained from the Australian National Health and Medical Research Council (www.nhmrc.gov.au) (Enabling Grant to APCB: 614296, Fellowship to GR: 1002648, Project Grant: 545931, Fellowship to ML: 1035721), and the Prostate Cancer Foundation of Australia (www.prostate.org.au) (Project Grant: PG0709, Movember Young Investigator Grants to RT, ML, LF and SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco JJ, 2002, ENDOCRINOLOGY, V143, P4922, DOI 10.1210/en.2002-220493; Bianco JJ, 2006, AM J PATHOL, V168, P1869, DOI 10.2353/ajpath.2006.050623; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; De Marzo AM, 1998, J UROLOGY, V160, P2381, DOI 10.1016/S0022-5347(01)62196-7; ENGLISH HF, 1985, PROSTATE, V7, P41, DOI 10.1002/pros.2990070106; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; GOLDENBERG SL, 1983, UROLOGY, V22, P130, DOI 10.1016/0090-4295(83)90492-2; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Harris HA, 2006, MOL ENDOCRINOL; Hillisch A, 2004, MOL ENDOCRINOL, V18, P1599, DOI 10.1210/me.2004-0050; Huggins C, 1941, CANCER RES, V1, P293; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Isaacs J, 1987, NIH PUBLICATION, P88; Isaacs J.T., 1987, NIH PUBLICATION, P85; ISAACS JT, 1984, PROSTATE, V5, P545, DOI 10.1002/pros.2990050510; Jefferson WN, 2000, BIOL REPROD, V62, P310, DOI 10.1095/biolreprod62.2.310; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liu J, 2011, MOL ENDOCRINOLOGY; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; McPherson SJ, 2001, ENDOCRINOLOGY, V142, P2458, DOI 10.1210/en.142.6.2458; McPherson SJ, 2007, ENDOCRINOLOGY, V148, P566, DOI 10.1210/en.2006-0906; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Pelletier G, 2000, J ENDOCRINOL, V165, P359, DOI 10.1677/joe.0.1650359; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Risbridger GP, 2010, DEGROOTS TXB ENDOCRI; Schleipen B, 2011, CARCINOGENESIS, V32, P1675, DOI 10.1093/carcin/bgr188; Taylor RA, 2010, ENDOCR RELAT CANC; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zhou Q, 2002, J ANDROL, V23, P870	44	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40732	10.1371/journal.pone.0040732	http://dx.doi.org/10.1371/journal.pone.0040732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808245	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500075
J	Reinhart, KO; Johnson, D; Clay, K				Reinhart, Kurt O.; Johnson, Daniel; Clay, Keith			Conspecific Plant-Soil Feedbacks of Temperate Tree Species in the Southern Appalachians, USA	PLOS ONE			English	Article							SHADE-INTOLERANT TREE; PRUNUS-SEROTINA; TROPICAL TREE; SEEDLING ESTABLISHMENT; DISPERSAL DISTANCE; SPATIAL-PATTERNS; FUNGAL PATHOGENS; DISEASE; MORTALITY; FOREST	Many tree species have seedling recruitment patterns suggesting that they are affected by non-competitive distance-dependent sources of mortality. We conducted an experiment, with landscape-level replication, to identify cases of negative distance-dependent effects and whether variation in these effects corresponded with tree recruitment patterns in the southern Appalachian Mountains region. Specifically, soil was collected from 14 sites and used as inocula in a 62 day growth chamber experiment determining whether tree seedling growth was less when interacting with soil from conspecific (like) than heterospecific (other) tree species. Tests were performed on six tree species. Three of the tree species had been previously described as having greater recruitment around conspecifics (i.e. facilitator species group) compared to the other half (i.e. inhibitor species group). We were then able to determine whether variation in negative distance-dependent effects corresponded with recruitment patterns in the field. Across the six species, none were negatively affected by soil inocula from conspecific relative to heterospecific sources. Most species (four of six) were unaffected by soil source. Two species (Prunus serotina and Tsuga canadensis) had enhanced growth in pots inoculated with soil from conspecific trees vs. heterospecifics. Species varied in their susceptibility to soil pathogens, but trends across all species revealed that species classified as inhibitors were not more negatively affected by conspecific than heterospecific soil inocula or more susceptible to pathogenic effects than facilitators. Although plant-soil biota interactions may be important for individual species and sites, it may be difficult to scale these interactions over space or levels of ecological organization. Generalizing the importance of plant-soil feedbacks or other factors across regional scales may be especially problematic for hyperdiverse temperate forests where interactions may be spatially variable.	[Reinhart, Kurt O.] USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT USA; [Johnson, Daniel; Clay, Keith] Indiana Univ, Dept Biol, Bloomington, IN USA	United States Department of Agriculture (USDA); Indiana University System; Indiana University Bloomington	Reinhart, KO (corresponding author), USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT USA.	kurt.reinhart@ars.usda.gov	Clay, Keith/C-8730-2012; Johnson, Daniel J./L-4899-2019; Johnson, Daniel/K-8661-2012; Reinhart, Kurt O./A-6730-2010	Johnson, Daniel J./0000-0002-8585-2143; Reinhart, Kurt O./0000-0002-7985-6738	Highlands Biological Station; National Parks Ecological Research Fellowship Program, a partnership between the National Parks Ecological Research Fellowship Program; Andrew W. Mellon Foundation helping form a partnership between the National Park Service; Ecological Society of America and the National Park Foundation	Highlands Biological Station; National Parks Ecological Research Fellowship Program, a partnership between the National Parks Ecological Research Fellowship Program; Andrew W. Mellon Foundation helping form a partnership between the National Park Service; Ecological Society of America and the National Park Foundation	Funding for this work included a grant-in-aid to KOR from Highlands Biological Station and to KOR from the National Parks Ecological Research Fellowship Program, a partnership between the National Parks Ecological Research Fellowship Program, funded through a grant from the Andrew W. Mellon Foundation helping form a partnership between the National Park Service, the Ecological Society of America and the National Park Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRIOS GN, 1997, PLANT PATHOLOGY; Augspurger C. K., 1990, Pests, pathogens and plant communities., P131; Augspurger CK, 2007, BIOTROPICA, V39, P702, DOI 10.1111/j.1744-7429.2007.00326.x; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; BAKER F. S., 1949, JOUR FOREST, V47, P179; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; BEUTE MK, 1979, ANNU REV PHYTOPATHOL, V17, P485, DOI 10.1146/annurev.py.17.090179.002413; CONNELL J H, 1971, P298; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; GRIME JP, 1965, J ECOL, V53, P621, DOI 10.2307/2257624; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Hood LA, 2004, J ECOL, V92, P816, DOI 10.1111/j.0022-0477.2004.00917.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Konno M, 2011, J ECOL, V99, P1394, DOI 10.1111/j.1365-2745.2011.01869.x; Littell RC, 2002, SAS LINEAR MODELS; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; O'Hanlon-Manners DL, 2006, PLANT ECOL, V187, P49, DOI 10.1007/s11258-006-9132-5; O'Hanlon-Manners DL, 2004, OECOLOGIA, V140, P650, DOI 10.1007/s00442-004-1625-0; O'Hanlon-Manners DL, 2004, ECOLOGY, V85, P284, DOI 10.1890/03-3030; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Reinhart KO, 2005, J ECOL, V93, P890, DOI 10.1111/j.1365-2745.2005.01028.x; Reinhart KO, 2012, FOREST ECOL MANAG, V263, P268, DOI 10.1016/j.foreco.2011.09.038; Reinhart KO, 2010, ACTA OECOL, V36, P530, DOI 10.1016/j.actao.2010.07.006; Reinhart KO, 2010, NEW PHYTOL, V186, P484, DOI 10.1111/j.1469-8137.2009.03159.x; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163	33	8	8	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40680	10.1371/journal.pone.0040680	http://dx.doi.org/10.1371/journal.pone.0040680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808231	Green Submitted, gold, Green Published			2022-12-27	WOS:000306355500071
J	Rositch, AF; Gatuguta, A; Choi, RY; Guthrie, BL; Mackelprang, RD; Bosire, R; Manyara, L; Kiarie, JN; Smith, JS; Farquhar, C				Rositch, Anne F.; Gatuguta, Ann; Choi, Robert Y.; Guthrie, Brandon L.; Mackelprang, Romel D.; Bosire, Rose; Manyara, Lucy; Kiarie, James N.; Smith, Jennifer S.; Farquhar, Carey			Knowledge and Acceptability of Pap Smears, Self-Sampling and HPV Vaccination among Adult Women in Kenya	PLOS ONE			English	Article							CERVICAL-CANCER; HUMAN-PAPILLOMAVIRUS; YOUNG-ADULTS; ACCEPTANCE; ATTITUDES; NEOPLASIA; BELIEFS; LESIONS; HIV	Objectives: Our study aimed to assess adult women's knowledge of human papillomavirus (HPV) and cervical cancer, and characterize their attitudes towards potential screening and prevention strategies. Methods: Women were participants of an HIV-discordant couples cohort in Nairobi, Kenya. An interviewer-administered questionnaire was used to obtain information on sociodemographic status, and sexual and medical history at baseline and on knowledge and attitudes towards Pap smears, self-sampling, and HPV vaccination at study exit. Results: Only 14% of the 409 women (67% HIV-positive; median age 29 years) had ever had a Pap smear prior to study enrollment and very few women had ever heard of HPV (18%). Although most women knew that Pap smears detect cervical cancer (69%), very few knew that routine Pap screening is the main way to prevent ICC (18%). Most women reported a high level of cultural acceptability for Pap smear screening and a low level of physical discomfort during Pap smear collection. In addition, over 80% of women reported that they would feel comfortable using a self-sampling device (82%) and would prefer at-home sample collection (84%). Nearly all women (94%) reported willingness to be vaccinated to prevent cervical cancer if offered at no or low cost. Conclusions: These findings highlight the need to educate women on routine use of Pap smears in the prevention of cervical cancer and demonstrate that vaccination and self-sampling would be acceptable modalities for cervical cancer prevention and screening.	[Rositch, Anne F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gatuguta, Ann] Kenyatta Univ, Dept Community Hlth, Nairobi, Kenya; [Choi, Robert Y.; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA USA; [Guthrie, Brandon L.; Mackelprang, Romel D.; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Mackelprang, Romel D.; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Bosire, Rose] Kenya Govt Med Res Ctr, Ctr Publ Hlth Res, Nairobi, Kenya; [Manyara, Lucy] Kenya Med Training Coll, Nairobi, Kenya; [Kiarie, James N.] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kenyatta University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Nairobi; University of North Carolina; University of North Carolina Chapel Hill	Rositch, AF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	arositch@jhsph.edu		Rositch, Anne/0000-0002-0403-8482; kiarie, james/0000-0003-4180-7858	US National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01 AI068431]; University of Washington Center for AIDS Research [P30 AI027757]; Fogarty International Clinical Research Scholars/Fellows program; NIH Fogarty International Center [R24 TW007988]; Institutional Research Cancer Epidemiology Fellowship; NIH National Cancer Institute [T32 CA0009314]; GSK; Merck Corporation; FOGARTY INTERNATIONAL CENTER [D43TW000007, R24TW007988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, R01AI068431, P30AI027757, K24AI087399] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; University of Washington Center for AIDS Research; Fogarty International Clinical Research Scholars/Fellows program; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Institutional Research Cancer Epidemiology Fellowship; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); GSK(GlaxoSmithKline); Merck Corporation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by US National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (R01 AI068431) and the University of Washington Center for AIDS Research (P30 AI027757). Dr. Rositch and Dr. Gatuguta were supported by the Fogarty International Clinical Research Scholars/Fellows program funded by the NIH Fogarty International Center grant (R24 TW007988) and Dr. Rositch by the Institutional Research Cancer Epidemiology Fellowship funded by the NIH National Cancer Institute (T32 CA0009314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Smith has received consultancy and research grants from GSK and Merck Corporation over the past five years. The remaining authors have no competing interests to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ali SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011059; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Blumenthal PD, 2001, INT J GYNECOL OBSTET, V72, P47, DOI 10.1016/S0020-7292(00)00329-5; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Brown DR, 2011, J NATL MED ASSOC, V103, P719, DOI 10.1016/S0027-9684(15)30411-9; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Coughlin SS, 2002, PREV MED, V34, P242, DOI 10.1006/pmed.2001.0984; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Dursun P, 2009, AUST NZ J OBSTET GYN, V49, P202, DOI 10.1111/j.1479-828X.2009.00947.x; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Ferlay J, 2010, GLOBOCAN 2008; Gichangi P, 2003, INT J GYNECOL CANCER, V13, P827, DOI 10.1111/j.1525-1438.2003.13612.x; Hoque Monjurul, 2008, East Afr J Public Health, V5, P111; Hsu Yu-Yun, 2011, Oncol Nurs Forum, V38, pE297, DOI 10.1188/11.ONF.E297-E304; Kivistik A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-43; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Lazcano-Ponce E, 2011, LANCET, V378, P1868, DOI 10.1016/S0140-6736(11)61522-5; Lenselink CH, 2008, PUBLIC HEALTH, V122, P1295, DOI 10.1016/j.puhe.2008.02.010; Mahmud SM, 2012, GYNECOL ONCOL, V124, P286, DOI 10.1016/j.ygyno.2011.10.031; Makwe CC, 2011, INT J WOMENS HEALTH, V3, P313, DOI 10.2147/IJWH.S22792; Marlow LAV, 2011, BRIT J CANCER, V105, P486, DOI 10.1038/bjc.2011.272; Mitchell S, 2011, INT J GYNECOL OBSTET, V114, P111, DOI 10.1016/j.ijgo.2011.01.028; [National Cervical Cancer Prevention Program Services KMoPHaSaMoM], 2012, NAT CERV CANC PREV P; Program NASC, 2011, GUID ANT THER KEN; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Sait KH, 2011, SAUDI MED J, V32, P1155; Schmeink CE, 2011, EUR J GYNAECOL ONCOL, V32, P481; SEOW A, 1995, PREV MED, V24, P134, DOI 10.1006/pmed.1995.1026; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wellensiek N, 2002, INT J GYNECOL CANCER, V12, P376, DOI 10.1046/j.1525-1438.2002.01114.x; World Health Organization. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, HUM PAP REL CANC KEN; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	35	63	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40766	10.1371/journal.pone.0040766	http://dx.doi.org/10.1371/journal.pone.0040766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808257	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500079
J	Bryan, SE; Cook, AG; Evans, JP; Hebden, K; Hurrey, L; Colls, P; Jell, JS; Weatherley, D; Firn, J				Bryan, Scott E.; Cook, Alex G.; Evans, Jason P.; Hebden, Kerry; Hurrey, Lucy; Colls, Peter; Jell, John S.; Weatherley, Dion; Firn, Jennifer			Rapid, Long-Distance Dispersal by Pumice Rafting	PLOS ONE			English	Article							PROPAGULE DISPERSAL; MARINE POPULATIONS; LARVAL DISPERSAL; REEF CORALS; MODEL; CONNECTIVITY; RECRUITMENT; ENVIRONMENT; ORGANISMS; COMMUNITY	Pumice is an extremely effective rafting agent that can dramatically increase the dispersal range of a variety of marine organisms and connect isolated shallow marine and coastal ecosystems. Here we report on a significant recent pumice rafting and long-distance dispersal event that occurred across the southwest Pacific following the 2006 explosive eruption of Home Reef Volcano in Tonga. We have constrained the trajectory, and rate, biomass and biodiversity of transfer, discovering more than 80 species and a substantial biomass underwent >5000 km journey in 7-8 months. Differing microenvironmental conditions on the pumice, caused by relative stability of clasts at the sea surface, promoted diversity in biotic recruitment. Our findings emphasise pumice rafting as an important process facilitating the distribution of marine life, which have implications for colonisation processes and success, the management of sensitive marine environments, and invasive pest species.	[Bryan, Scott E.; Hebden, Kerry] Kingston Univ, Sch Geog Geol & Environm, Kingston upon Thames KT1 2EE, Surrey, England; [Bryan, Scott E.; Firn, Jennifer] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Cook, Alex G.] Queensland Museum, Brisbane, Qld, Australia; [Evans, Jason P.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Evans, Jason P.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Hurrey, Lucy] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Colls, Peter; Jell, John S.] Univ Queensland, Sch Earth Sci, St Lucia, Qld, Australia; [Colls, Peter] Petrog Int, Clontarf, Qld, Australia; [Weatherley, Dion] Univ Queensland, WH Bryan Min & Geol Res Ctr, St Lucia, Qld, Australia	Kingston University; Queensland University of Technology (QUT); Queensland Museum; Yale University; University of New South Wales Sydney; University of Queensland; University of Queensland; University of Queensland	Bryan, SE (corresponding author), Kingston Univ, Sch Geog Geol & Environm, Kingston upon Thames KT1 2EE, Surrey, England.	scott.bryan@qut.edu.au	Weatherley, Dion/AAB-9499-2021; Evans, Jason P./F-3716-2011; Bryan, Scott E/J-1297-2012	Weatherley, Dion/0000-0002-1763-3408; Evans, Jason P./0000-0003-1776-3429; Bryan, Scott E/0000-0001-9022-1496; Hurrey, Lucy/0000-0002-4320-6012; Firn, Jennifer/0000-0001-6026-8912	Natural Environment Research Council [NE/E019277/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by Natural Environment Research Council (http://www.nerc.ac.uk/) Award NE/E019277/1 to SB. The amount of the award was 60,750 GBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, NGDC24 NOAA NESDIS; [Anonymous], 2007, B GLOB VOLC NETW, V32, P4; Bonjean F, 2002, J PHYS OCEANOGR, V32, P2938, DOI 10.1175/1520-0485(2002)032<2938:DMAAOT>2.0.CO;2; Bravo M, 2011, MAR ECOL PROG SER, V439, P1, DOI 10.3354/meps09344; Bryan SE, 2004, EARTH PLANET SC LETT, V227, P135, DOI 10.1016/j.epsl.2004.08.009; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Clarke RR, 1994, APPR STAT ANAL INTER; COEROLI M, 1984, AQUACULTURE, V39, P45, DOI 10.1016/0044-8486(84)90258-8; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; Donovan Stephen K., 1999, Caribbean Journal of Science, V35, P323; EVANS F, 1958, NATURE, V182, P1245, DOI 10.1038/1821245b0; Ewart A, 1998, J PETROL, V39, P331, DOI 10.1093/petrology/39.3.331; Fierstein J, 1997, J VOLCANOL GEOTH RES, V76, P215, DOI 10.1016/S0377-0273(96)00081-9; Houghton BF, 2004, B VOLCANOL, V66, P95, DOI 10.1007/s00445-003-0297-7; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; JOKIEL PL, 1990, NATURE, V347, P665, DOI 10.1038/347665a0; JOKIEL PL, 1990, ENDEAVOUR, V14, P66, DOI 10.1016/0160-9327(90)90074-2; JOKIEL PL, 1989, MAR BIOL, V101, P483, DOI 10.1007/BF00541650; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Marshall DJ, 2009, ECOL STUD-ANAL SYNTH, V206, P165, DOI 10.1007/978-3-540-92704-4_11; Molis M, 2003, MAR ECOL PROG SER, V263, P113, DOI 10.3354/meps263113; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Pouvreau S, 2000, AQUACULTURE, V184, P133, DOI 10.1016/S0044-8486(99)00319-1; RICHARDS AF, 1958, DEEP-SEA RES, V5, P29, DOI 10.1016/S0146-6291(58)80005-3; Risso C, 2002, MAR GEOL, V186, P413, DOI 10.1016/S0025-3227(02)00190-1; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rodgers S K, 2000, PAC SCI, V54, P31; Shanks AL, 2003, ECOL APPL, V13, pS159; SMITH CM, 1986, PLANT PHYSIOL, V80, P843, DOI 10.1104/pp.80.4.843; Smithsonian Institution, 2006, B GLOBAL VOLCANISM N, V31, P10; Smithsonian Institution, 1984, SCI EVENT ALERT NETW, P07; Smithsonian Institution, 2008, B GLOBAL VOLCANISM N, V33, P5; Sponaugle S, 2002, B MAR SCI, V70, P341; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thiel M, 2005, OCEANOGR MAR BIOL, V42, P181, DOI DOI 10.1201/9780203507810.CH6; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; Vaughan R., 2007, EOS T AM GEOPHYS UNI, V88, DOI [10.1029/2007EO040002, DOI 10.1029/2007EO040002]; Vaughan R. G., 2007, EOS, V88, P41; Vaughan RG, 2007, EOS T AM GEOPHYS UN, V88, P4; Venzke E., 2002, GLOBAL VOLCANISM PRO; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Whitham A. G., 1986, Bulletin of Volcanology, V48, P209, DOI 10.1007/BF01087675	48	81	84	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40583	10.1371/journal.pone.0040583	http://dx.doi.org/10.1371/journal.pone.0040583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815770	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900035
J	Chen, F; Feng, YM; Zheng, KE; De Keyzer, F; Li, JJ; Feng, YB; Cona, MM; Wang, HJ; Jiang, YS; Yu, J; Marchal, G; Verfaillie, C; De Geest, B; Oyen, R; Ni, YC				Chen, Feng; Feng, Yingmei; Zheng, Kaier; De Keyzer, Frederik; Li, Junjie; Feng, Yuanbo; Cona, Marlein Miranda; Wang, Huaijun; Jiang, Yansheng; Yu, Jie; Marchal, Guy; Verfaillie, Catherine; De Geest, Bart; Oyen, Raymond; Ni, Yicheng			Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; COMBRETASTATIN A-4; CLINICAL MRI; SOLID TUMORS; THALIDOMIDE; THERAPY; CANCER; ANGIOGENESIS; MICROANGIOGRAPHY; NORMALIZATION	A key problem in solid tumor therapy is tumor regrowth from a residual viable rim after treatment with a vascular disrupting agent (VDA). As a potential solution, we studied a combined treatment of a VDA and antiangiogenic. This study was approved by the institutional ethical committee for the use and care of laboratory animals. Rats with implanted liver tumors were randomized into four treatment groups: 1) Zd6126 (Zd); 2) Thalidomide (Tha); 3) Zd in combination with Tha (ZdTha); and 4) controls. Multiparametric MRIs were performed and quantified before and after treatment. Circulating endothelial progenitor cells (EPCs) and plasma stromal cell-derived factor-1 alpha (SDF-1 alpha) were monitored. Tumor apoptosis, necrosis, and microvessels were verified by histopathology. A single use of Zd or Tha did not significantly delay tumor growth. The combined ZdTha showed enhanced antitumor efficacy due to synergistic effects; it induced a cumulative tumor apoptosis or necrosis, which resulted in significant delay in tumor growth and reduction in the viable tumor rim; it also reduced tumor vessel permeability; and it improved tumor hemodynamic indexes, most likely via a transient normalization of tumor vasculature induced by Tha. A stepwise linear regression analysis showed that the apparent diffusion coefficient was an independent predictor of tumor growth. We found no significant increases in Zd-induced circulating EPCs or plasma SDF-1 alpha. ZdTha showed improved therapeutic efficacy in solid tumors compared to either agent alone. The therapeutic effects were successfully tracked in vivo with multiparametric MRI.	[Chen, Feng; De Keyzer, Frederik; Li, Junjie; Feng, Yuanbo; Cona, Marlein Miranda; Wang, Huaijun; Jiang, Yansheng; Yu, Jie; Marchal, Guy; Oyen, Raymond; Ni, Yicheng] Katholieke Univ Leuven, Univ Hosp, Theragnost Lab, Dept Imaging & Pathol, Louvain, Belgium; [Chen, Feng] Southeast Univ, Zhong Da Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Feng, Yingmei; Verfaillie, Catherine] Katholieke Univ Leuven, Interdept Stem Cell Inst, Louvain, Belgium; [Zheng, Kaier] Nanjing Med Univ, Dept Radiol, BenQ Med Ctr, Nanjing, Jiangsu, Peoples R China; [De Geest, Bart] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium	KU Leuven; Southeast University - China; KU Leuven; Nanjing Medical University; KU Leuven	Chen, F (corresponding author), Katholieke Univ Leuven, Univ Hosp, Theragnost Lab, Dept Imaging & Pathol, Louvain, Belgium.	feng.chen@med.kuleuven.be	Wang, Huaijun/F-3219-2015; De Keyzer, Frederik/U-7175-2019; De Geest, Bart/AHB-0394-2022; Ni, Yicheng/O-5887-2017; Verfaillie, Catherine/H-5148-2013	Wang, Huaijun/0000-0003-0078-5592; Ni, Yicheng/0000-0002-8553-7565; De Geest, Bart/0000-0001-5580-686X; Verfaillie, Catherine/0000-0001-7564-4079	National Natural Science Foundation of China (NSFC) [30670603]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (NSFC) project 30670603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansiaux R, 2005, CLIN CANCER RES, V11, P743; Blakey DC, 2002, INT J RADIAT ONCOL, V54, P1497, DOI 10.1016/S0360-3016(02)03922-6; Chen F, 2006, RADIOLOGY, V239, P554, DOI 10.1148/radiol.2392050277; Chen F, 2007, METHODS, V43, P12, DOI 10.1016/j.ymeth.2007.03.007; Chen F, 2011, METHODS MOL BIOL, V771, P489, DOI 10.1007/978-1-61779-219-9_26; Dachs GU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-280; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Dark GG, 1997, CANCER RES, V57, P1829; DENEKAMP J, 1982, BRIT J CANCER, V46, P711, DOI 10.1038/bjc.1982.263; Feng Y, 2008, ARTERIOSCL THROM VAS, V28, P278, DOI 10.1161/ATVBAHA.107.158741; Figg WD, 2007, BJU INT, V99, P1047, DOI 10.1111/j.1464-410X.2007.06763.x; Freter CE, 2008, ABELOFFS CLIN ONCOLO, P449; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kanthou C, 2009, INT J EXP PATHOL, V90, P284, DOI 10.1111/j.1365-2613.2009.00651.x; Kiessling F, 2007, EUR RADIOL, V17, P2136, DOI 10.1007/s00330-006-0566-x; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kivivuori SM, 2011, ACTA PAEDIATR, V100, P134, DOI 10.1111/j.1651-2227.2010.01961.x; Kobayashi H, 2010, LANCET ONCOL, V11, P589, DOI 10.1016/S1470-2045(10)70009-7; Lang P, 1998, RADIOLOGY, V206, P227, DOI 10.1148/radiology.206.1.9423677; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Rajkumar SV, 2000, CANCER TREAT REV, V26, P351, DOI 10.1053/ctrv.2000.0188; Reck M, 2010, NAT REV CLIN ONCOL, V7, P134, DOI 10.1038/nrclinonc.2010.11; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shaked Y, 2009, CANCER RES, V69, P7524, DOI 10.1158/0008-5472.CAN-09-0381; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siemann DW, 2004, INT J RADIAT ONCOL, V60, P1233, DOI 10.1016/j.ijrobp.2004.08.002; Sleijfer S, 2004, EUR J CANCER, V40, P2377, DOI 10.1016/j.ejca.2004.07.023; Thoeny HC, 2005, NEOPLASIA, V7, P779, DOI 10.1593/neo.04748; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; van Heeckeren WJ, 2007, CURR OPIN HEMATOL, V14, P468, DOI 10.1097/MOH.0b013e3282a6457f; Wang HJ, 2009, INVEST RADIOL, V44, P44, DOI 10.1097/RLI.0b013e31818e5ace; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8	37	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41140	10.1371/journal.pone.0041140	http://dx.doi.org/10.1371/journal.pone.0041140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815943	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900079
J	Hogel, M; Laprairie, RB; Denovan-Wright, EM				Hogel, Matthew; Laprairie, Robert B.; Denovan-Wright, Eileen M.			Promoters Are Differentially Sensitive to N-Terminal Mutant Huntingtin-Mediated Transcriptional Repression	PLOS ONE			English	Article							MOUSE MODEL; DISEASE PROTEIN; BINDING PROTEIN; EXPRESSION; CLEAVAGE; NUCLEAR; AGE; LOCALIZATION; DYSFUNCTION; INTERACTS	Huntington's disease (HD) is a neurodegenerative disorder caused by the inheritance of one mutant copy of the huntingtin gene. Mutant huntingtin protein (mHtt) contains an expanded polyglutamine repeat region near the N-terminus. Cleavage of mHtt releases an N-terminal fragment (N-mHtt) which accumulates in the nucleus. Nuclear accumulation of N-mHtt has been directly associated with cellular toxicity. Decreased transcription is among the earliest detected changes that occur in the brains of HD patients, animal and cellular models of HD. Transcriptional dysregulation may trigger many of the perturbations that occur later in disease progression. An understanding of the effects of mHtt may lead to strategies to slow the progression of HD. Current models of N-mHtt-mediated transcriptional dysregulation suggest that abnormal interactions between N-mHtt and transcription factors impair the ability of these transcription factors to associate at N-mHtt-affected promoters and properly regulate gene expression. We tested various aspects of the current models using two N-mHtt-affected promoters in two cell models of HD using overexpression of known N-mHtt-interacting transcription factors, promoter deletion and mutation analyses and in vitro promoter binding assays. Consequently, we proposed a new model of N-mHtt-mediated transcriptional dysregulation centered on the presence of N-mHtt at promoters. In this model, N-mHtt interacts with multiple partners whose presence and affinity for N-mHtt influence the severity of gene dysregulation. We concluded that simultaneous interaction of N-mHtt with multiple binding partners within the transcriptional machinery would explain the gene-specificity of N-mHtt-mediated transcriptional dysregulation, as well as why some genes are affected early in disease progression while others are affected later. Our model explains why alleviating N-mHtt-mediated transcriptional dysregulation through overexpression of N-mHtt-interacting proteins has proven to be difficult and suggests that the most realistic strategy for restoring gene expression across the spectrum of N-mHtt affected genes is by reducing the amount of soluble nuclear N-mHtt.	[Hogel, Matthew; Laprairie, Robert B.; Denovan-Wright, Eileen M.] Dalhousie Univ, Dept Pharmacol, Mol Neurobiol Lab, Halifax, NS B3H 4H7, Canada	Dalhousie University	Hogel, M (corresponding author), Dalhousie Univ, Dept Pharmacol, Mol Neurobiol Lab, Halifax, NS B3H 4H7, Canada.	emdenova@dal.ca		Hogel, Matthew/0000-0002-1193-1746	Nova Scotia Health Research Foundation [42673]; Canadian Institutes of Health Research [42337]; Huntington Society of Canada [42721]	Nova Scotia Health Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Huntington Society of Canada	Funding was provided by the Nova Scotia Health Research Foundation (Grant No. 42673), http://www.nshrf.ca/; the Canadian Institutes of Health Research (Grant No. 42337), http://www.cihr-irsc.gc.ca/e/193.html; and the Huntington Society of Canada (Grant No. 42721), http://www.huntingtonsociety.ca/english/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS P, 1988, AM J HUM GENET, V43, P695; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chiang MC, 2005, J BIOL CHEM, V280, P14331, DOI 10.1074/jbc.M413279200; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Foroud T, 1999, J NEUROL NEUROSUR PS, V66, P52, DOI 10.1136/jnnp.66.1.52; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gomez GT, 2006, MOL CELL NEUROSCI, V31, P661, DOI 10.1016/j.mcn.2005.12.004; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hodges A, 2008, GENES BRAIN BEHAV, V7, P288, DOI 10.1111/j.1601-183X.2007.00350.x; Hu H, 2007, THESIS HALIFAX; Lebedeva LA, 2005, P NATL ACAD SCI USA, V102, P18087, DOI 10.1073/pnas.0509063102; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 2000, HUM MOL GENET, V9, P2859, DOI 10.1093/hmg/9.19.2859; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P375, DOI 10.1111/j.1469-1809.1981.tb00351.x; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x	41	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41152	10.1371/journal.pone.0041152	http://dx.doi.org/10.1371/journal.pone.0041152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815947	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900082
J	Macdonald, IK; Allen, J; Murray, A; Parsy-Kowalska, CB; Healey, GF; Chapman, CJ; Sewell, HF; Robertson, JFR				Macdonald, Isabel K.; Allen, Jared; Murray, Andrea; Parsy-Kowalska, Celine B.; Healey, Graham F.; Chapman, Caroline J.; Sewell, Herbert F.; Robertson, John F. R.			Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection	PLOS ONE			English	Article							LUNG; CANCER; AID	An assay employing a panel of tumor-associated antigens has been validated and is available commercially (EarlyCDT (R)-Lung) to aid the early detection of lung cancer by measurement of serum autoantibodies. The high throughput (HTP) strategy described herein was pursued to identify new antigens to add to the EarlyCDT-Lung panel and to assist in the development of new panels for other cancers. Two ligation-independent cloning vectors were designed and synthesized, producing fusion proteins suitable for the autoantibody ELISA. We developed an abridged HTP version of the validated autoantibody ELISA, determining that results reflected the performance of the EarlyCDT assay, by comparing results on both formats. Once validated this HTP ELISA was utilized to screen multiple fusion proteins prepared on small-scale, by a HTP expression screen. We determined whether the assay performance for these HTP protein batches was an accurate reflection of the performance of R&D or commercial batches. A HTP discovery platform for the identification and optimal production of tumor-associated antigens which detects autoantibodies has been developed and validated. The most favorable conditions for the exposure of immunogenic epitopes were assessed to produce discriminatory proteins for use in a commercial ELISA. This process is rapid and cost-effective compared to standard cloning and screening technologies and enables rapid advancement in the field of autoantibody assay discovery. This approach will significantly reduce timescale and costs for developing similar panels of autoantibody assays for the detection of other cancer types with the ultimate aim of improved overall survival due to early diagnosis and treatment.	[Macdonald, Isabel K.; Allen, Jared; Murray, Andrea; Parsy-Kowalska, Celine B.; Healey, Graham F.; Robertson, John F. R.] City Hosp Nottingham, Oncimmune Ltd, Nottingham, England; [Chapman, Caroline J.; Sewell, Herbert F.; Robertson, John F. R.] Univ Nottingham, Ctr Excellence Autoimmun Canc, Nottingham NG7 2RD, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Macdonald, IK (corresponding author), City Hosp Nottingham, Oncimmune Ltd, Nottingham, England.	andrea.murray@nottingham.ac.uk		Allen, Jared/0000-0002-4061-3704	Oncimmune	Oncimmune	The authors have the following competing interests: IKM, JA, AM, CBP-K and GFH are employed by Oncimmune Ltd. CJC is a consultant for Oncimmune. HFS is on an advisory board for Oncimmune. JFRR is the CSO of Oncimmune and holds shares in Oncimmune. Oncimmune partly funded this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; Chapman CJ, 2012, TUMOR BIOL      0411; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Desmetz C, 2011, J CELL MOL MED, V15, P2013, DOI 10.1111/j.1582-4934.2011.01355.x; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; HOWARD PK, 1985, GENE, V35, P321, DOI 10.1016/0378-1119(85)90011-3; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Li YL, 2005, INT J CANCER, V114, P157, DOI 10.1002/ijc.20715; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Parsy CB, 2007, J CHROMATOGR B, V853, P314, DOI 10.1016/j.jchromb.2007.03.046; Promega Corporation, 2006, PINPOINT XA PROT PUR; Robertson JFR, 2005, J CLIN ONCOL, V23, p16S; Trivers GE, 1996, CLIN CANCER RES, V2, P1767	16	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40759	10.1371/journal.pone.0040759	http://dx.doi.org/10.1371/journal.pone.0040759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815807	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900043
J	Wang, H; Li, Q; Chen, H				Wang, Huan; Li, Qian; Chen, Hong			Genistein Affects Histone Modifications on Dickkopf-Related Protein 1 (DKK1) Gene in SW480 Human Colon Cancer Cell Line	PLOS ONE			English	Article							WNT ANTAGONIST DICKKOPF-1; TUMOR-SUPPRESSOR GENE; VITAMIN-D METABOLISM; COLORECTAL-CANCER; PROSTATE-CANCER; SOY ISOFLAVONE; ORTHOTOPIC GROWTH; CYCLE ARREST; MOUSE COLON; APOPTOSIS	Genistein (GEN) is a plant-derived isoflavone and can block uncontrolled cell growth in colon cancer by inhibiting the WNT signaling pathway. This study aimed to test the hypothesis that the enhanced gene expression of the WNT signaling pathway antagonist, DKK1 by genistein treatment is associated with epigenetic modifications of the gene in colon cancer cells. Genistein treatment induced a concentration-dependent G2 phase arrest in the human colon cancer cell line SW480 and reduced cell proliferation. Results from several other human colon cancer cell lines confirmed the growth inhibitory effects of genistein. Overexpression of DKK1 confirmed its involvement in growth inhibition. Knockdown of DKK1 expression by siRNA slightly induced cell growth. DKK1 gene expression was increased by genistein in SW480 and HCT15 cells. DNA methylation at the DKK1 promoter was not affected by genistein treatment in all the cell lines tested. On the other hand, genistein induced histone H3 acetylation of the DKK1 promoter region in SW480 and HCT15 cells. This indicates that increased histone acetylation is associated with the genistein-induced DKK1 expression. The association between histone acetylation and DKK1 gene expression is confirmed by the histone deacetylase inhibitor trichostatin A (TSA) treatment. In conclusion, genistein treatment decreases cell growth and proliferation in colon cancer cell lines. The effect is associated with the increased DKK1 expression through the induction of histone acetylation at the DKK1 promoter region.	[Wang, Huan; Li, Qian; Chen, Hong] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Wang, H (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.	hongchen@illinois.edu	Chen, Hong/B-4860-2016; Wang, Huan/AAE-9851-2020	Wang, Huan/0000-0003-1115-143X; Li, Qian/0000-0002-5074-9509	NIH/NCI [CA135262]; Illinois Soybean Association; NATIONAL CANCER INSTITUTE [R03CA135262] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Illinois Soybean Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded in part by a NIH/NCI grant to H.C. (CA135262) and the Illinois Soybean Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bises G, 2007, J NUTR, V137, p211S, DOI 10.1093/jn/137.1.211S; Borras C, 2006, FASEB J, V20, P2136, DOI 10.1096/fj.05-5522fje; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Choi YH, 1998, INT J ONCOL, V13, P391; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cross HS, 2006, J NUTR, V136, P561, DOI 10.1093/jn/136.3.561; Cross HS, 2003, RECENT RES CANCER, V164, P413; Day JK, 2002, J NUTR, V132, p2419S, DOI 10.1093/jn/132.8.2419S; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Fan Yu-zhen, 2010, Zhonghua Zhong Liu Za Zhi, V32, P4; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hsu HH, 2006, MOL CELL BIOCHEM, V289, P101, DOI 10.1007/s11010-006-9153-3; Kallay E, 2002, J NUTR, V132, p3490S, DOI 10.1093/jn/132.11.3490S; KENNEDY AR, 1995, J NUTR, V125, pS733, DOI 10.1093/jn/125.3_Suppl.733S; Kikuno N, 2008, INT J CANCER, V123, P552, DOI 10.1002/ijc.23590; Kim EJ, 2005, J MED FOOD, V8, P431, DOI 10.1089/jmf.2005.8.431; King-Batoon A, 2008, ENVIRON MOL MUTAGEN, V49, P36, DOI 10.1002/em.20363; Lee J, 2008, GYNECOL ONCOL, V109, P270, DOI 10.1016/j.ygyno.2008.01.034; Linsalata M, 2005, NUTR CANCER, V52, P84, DOI 10.1207/s15327914nc5201_11; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Majid S, 2010, CANCER-AM CANCER SOC, V116, P66, DOI 10.1002/cncr.24662; Majid S, 2009, CARCINOGENESIS, V30, P662, DOI 10.1093/carcin/bgp042; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Messina M, 1998, BAILLIERE CLIN ENDOC, V12, P707, DOI 10.1016/S0950-351X(98)80012-8; Mikata R, 2006, INT J CANCER, V119, P1616, DOI 10.1002/ijc.21968; Moors M, 2012, TOXICOL SCI, V125, P488, DOI 10.1093/toxsci/kfr304; Oba S, 2007, NUTR CANCER, V57, P151, DOI 10.1080/01635580701274475; Ravindranath MH, 2004, ADV EXP MED BIOL, V546, P121; Rawson JB, 2011, CARCINOGENESIS, V32, P741, DOI 10.1093/carcin/bgr020; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarkar FH, 2002, CANCER METAST REV, V21, P265, DOI 10.1023/A:1021210910821; Sarkar FH, 2003, CANCER INVEST, V21, P744, DOI 10.1081/CNV-120023773; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sikandar S, 2010, ONCOTARGET, V1, P596; Singh AV, 2006, CANCER RES, V66, P1851, DOI 10.1158/0008-5472.CAN-05-1332; Spector D, 2003, NUTR CANCER, V47, P1, DOI 10.1207/s15327914nc4701_1; Wang ZG, 2010, ANTICANCER RES, V30, P4537; Yang G, 2009, AM J CLIN NUTR, V89, P577, DOI 10.3945/ajcn.2008.26742; Zhang YK, 2011, EXP BIOL MED, V236, P714, DOI 10.1258/ebm.2011.010347; Zhou JR, 2002, PROSTATE, V53, P143, DOI 10.1002/pros.10141; Zhou JR, 1998, CANCER RES, V58, P5231; Zhu QL, 2002, NUTR CANCER, V42, P131, DOI 10.1207/S15327914NC421_18	51	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40955	10.1371/journal.pone.0040955	http://dx.doi.org/10.1371/journal.pone.0040955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815877	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900063
J	Weiss, S; Yaski, O; Eilam, D; Portugali, J; Blumenfeld-Lieberthal, E				Weiss, Shahaf; Yaski, Osnat; Eilam, David; Portugali, Juval; Blumenfeld-Lieberthal, Efrat			Network Analysis of Rat Spatial Cognition: Behaviorally-Established Symmetry in a Physically Asymmetrical Environment	PLOS ONE			English	Article							PATH-INTEGRATION; OPEN-FIELD; EXPLORATORY-BEHAVIOR; HIPPOCAMPAL-FORMATION; GEOMETRIC MODULE; LAYOUT GEOMETRY; ANT ODOMETER; NAVIGATION; HOME; LOCOMOTION	Background: We set out to solve two inherent problems in the study of animal spatial cognition (i) What is a "place"?; and (ii) whether behaviors that are not revealed as differing by one methodology could be revealed as different when analyzed using a different approach. Methodology: We applied network analysis to scrutinize spatial behavior of rats tested in either a symmetrical or asymmetrical layout of 4, 8, or 12 objects placed along the perimeter of a round arena. We considered locations as the units of the network (nodes), and passes between locations as the links within the network. Principal Findings: While there were only minor activity differences between rats tested in the symmetrical or asymmetrical object layouts, network analysis revealed substantial differences. Viewing 'location' as a cluster of stopping coordinates, the key locations (large clusters of stopping coordinates) were at the objects in both layouts with 4 objects. However, in the asymmetrical layout with 4 objects, additional key locations were spaced by the rats between the objects, forming symmetry among the key locations. It was as if the rats had behaviorally imposed symmetry on the physically asymmetrical environment. Based on a previous finding that wayfinding is easier in symmetrical environments, we suggest that when the physical attributes of the environment were not symmetrical, the rats established a symmetric layout of key locations, thereby acquiring a more legible environment despite its complex physical structure. Conclusions and Significance: The present study adds a behavioral definition for "location", a term that so far has been mostly discussed according to its physical attributes or neurobiological correlates (e.g. - place and grid neurons). Moreover, network analysis enabled the assessment of the importance of a location, even when that location did not display any distinctive physical properties.	[Weiss, Shahaf; Yaski, Osnat; Eilam, David] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Portugali, Juval] Tel Aviv Univ, Dept Geog & Human Environm, Fac Humanities, IL-69978 Tel Aviv, Israel; [Blumenfeld-Lieberthal, Efrat] Tel Aviv Univ, David Azrieli Sch Architecture, Yolanda & David Katz Fac Arts, IL-69978 Tel Aviv, Israel; [Eilam, David] Univ S Africa, Dept OTANES, ZA-0001 Pretoria, South Africa	Tel Aviv University; Tel Aviv University; Tel Aviv University; University of South Africa	Weiss, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	eilam@post.tau.ac.il	Eilam, David/GOV-6655-2022; Lieberthal, Efrat Blumenfeld/AAW-1116-2021	Eilam, David/0000-0002-4494-6928; Weiss, Shahaf/0000-0001-7455-0556; Blumenfeld-Lieberthal, Efrat/0000-0003-3660-0035	Israel Science Foundation [177/09]	Israel Science Foundation(Israel Science Foundation)	This study was supported by the Israel Science Foundation (http://www.isf.org.il) grant 177/09 to DE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyan SH, 1996, ETHOLOGY, V102, P629; Avni R, 2008, J EXP BIOL, V211, P2817, DOI 10.1242/jeb.019927; Bagler G, 2008, PHYSICA A, V387, P2972, DOI 10.1016/j.physa.2008.01.077; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Ben-Yehoshua D, 2011, ANIM COGN, V14, P341, DOI 10.1007/s10071-010-0368-z; Bremmer F, 1999, EXP BRAIN RES, V127, P33, DOI 10.1007/s002210050771; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 1998, SPATIAL REPRESENTAIO; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Conroy-Dalton R, 2008, SPATIAL COGNITION; EILAM D, 1989, EUR J PHARMACOL, V161, P151, DOI 10.1016/0014-2999(89)90837-6; Eilam D, 2003, BEHAV BRAIN RES, V142, P53, DOI 10.1016/S0166-4328(02)00382-0; Eilam D, 2003, BEHAV BRAIN RES, V141, P73, DOI 10.1016/S0166-4328(02)00322-4; EILAM D, 1989, BEHAV BRAIN RES, V34, P199, DOI 10.1016/S0166-4328(89)80102-0; Etienne AS, 1996, J EXP BIOL, V199, P201; Etienne AS, 1999, WAYFINDING BEHAVIOR, P197; FITZGERALD RE, 1988, TOXICOLOGY, V49, P433, DOI 10.1016/0300-483X(88)90029-7; GALLISTEL CR, 1990, COGNITION, V37, P1, DOI 10.1016/0010-0277(90)90016-D; Gallistel CR, 1990, ORG LEARNING LEARNIN; GOLANI I, 1993, BEHAV BRAIN RES, V53, P21, DOI 10.1016/S0166-4328(05)80263-3; Golledge R., 1999, WAYFINDING BEHAV COG; Golledge RG, 1999, WAYFINDING BEHAVIOR, P5; GOLLEDGE RG, 1993, J ENVIRON PSYCHOL, V13, P293, DOI 10.1016/S0272-4944(05)80252-X; Gould JL, 2009, CURR BIOL, V19, pR338, DOI 10.1016/j.cub.2009.03.001; Guazzelli A, 1998, ADAPT BEHAV, V6, P435, DOI 10.1177/105971239800600305; Hill K., 1998, LOST PERS BEHAV, V116, P1; Hines DJ, 2005, EUR J NEUROSCI, V22, P2363, DOI 10.1111/j.1460-9568.2005.04412.x; Horev G, 2007, GENES BRAIN BEHAV, V6, P30, DOI 10.1111/j.1601-183X.2006.00216.x; Lane ND, 2011, IEEE PERVAS COMPUT, V10, P45, DOI 10.1109/MPRV.2011.70; Lew AR, 2010, DEVELOPMENTAL SCI, V13, P490, DOI 10.1111/j.1467-7687.2009.00904.x; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Lynch K., 1982, IMAGEN CITY; Maaswinkel H, 1999, BEHAV BRAIN RES, V99, P143, DOI 10.1016/S0166-4328(98)00100-4; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mou WM, 2007, J EXP PSYCHOL LEARN, V33, P145, DOI 10.1037/0278-7393.33.1.145; Mou WM, 2006, J EXP PSYCHOL LEARN, V32, P1274, DOI 10.1037/0278-7393.32.6.1274; Mou WM, 2009, J EXP PSYCHOL HUMAN, V35, P83, DOI 10.1037/0096-1523.35.1.83; Nemati F, 2007, BEHAV BRAIN RES, V182, P119, DOI 10.1016/j.bbr.2007.05.016; Niu L, 2008, FRONT STRUCT CIV ENG, V2, P386, DOI 10.1007/s11709-008-0040-8; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; POUCET B, 1993, PSYCHOL REV, V100, P163, DOI 10.1037/0033-295X.100.2.163; Poucet B, 2001, BEHAV PROCESS, V53, P155, DOI 10.1016/S0376-6357(00)00151-0; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rozenfeld HD, 2009, CHEM ENG SCI, V64, P4572, DOI 10.1016/j.ces.2009.02.027; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; SADALLA EK, 1980, J EXP PSYCHOL-HUM L, V6, P516, DOI 10.1037/0278-7393.6.5.516; Shafir S, 2010, P ROY SOC B-BIOL SCI, V277, P1241, DOI 10.1098/rspb.2009.1802; Shettleworth, 2010, COGNITION EVOLUTION; Shettleworth SJ, 2005, BEHAV PROCESS, V69, P147, DOI 10.1016/j.beproc.2005.02.016; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Sovrano VA, 2005, COGNITION, V97, P121, DOI 10.1016/j.cognition.2004.08.003; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; THORNDYKE PW, 1982, COGNITIVE PSYCHOL, V14, P560, DOI 10.1016/0010-0285(82)90019-6; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Twyman AD, 2010, COGNITIVE SCI, V34, P1315, DOI 10.1111/j.1551-6709.2009.01081.x; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Wallace DG, 2002, J NEUROSCI METH, V113, P131, DOI 10.1016/S0165-0270(01)00489-7; Wallace DG, 2002, J NEUROSCI, V22, P10009; Wallace DG, 2008, NATURWISSENSCHAFTEN, V95, P1011, DOI 10.1007/s00114-008-0410-z; Wallace DG, 2006, ANIM COGN, V9, P219, DOI 10.1007/s10071-006-0023-x; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Werner S, 2004, ENVIRON BEHAV, V36, P461, DOI 10.1177/0013916503254829; Whishaw IQ, 2006, BEHAV BRAIN RES, V171, P230, DOI 10.1016/j.bbr.2006.03.037; Whishaw IQ, 2001, BEHAV BRAIN RES, V127, P49, DOI 10.1016/S0166-4328(01)00359-X; Whishaw IQ, 1999, HIPPOCAMPUS, V9, P659, DOI 10.1002/(SICI)1098-1063(1999)9:6<659::AID-HIPO7>3.0.CO;2-E; Wise JM, 2000, CULT STUD, V14, P295, DOI 10.1080/095023800334896; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912; Wittlinger M, 2007, J EXP BIOL, V210, P198, DOI 10.1242/jeb.02657; Yaski O, 2008, BEHAV BRAIN RES, V187, P334, DOI 10.1016/j.bbr.2007.09.027; Yaski O, 2007, ANIM COGN, V10, P415, DOI 10.1007/s10071-007-0073-8; Yaski O, 2012, BEHAV BRAIN RES, V229, P74, DOI 10.1016/j.bbr.2011.12.043; Yaski O, 2011, BEHAV BRAIN RES, V225, P449, DOI 10.1016/j.bbr.2011.07.055; Yaski O, 2011, ANIM COGN, V14, P655, DOI 10.1007/s10071-011-0400-y; Zadicario P, 2005, BEHAV BRAIN RES, V159, P27, DOI 10.1016/j.bbr.2004.09.022; Zadicario P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-23	80	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40760	10.1371/journal.pone.0040760	http://dx.doi.org/10.1371/journal.pone.0040760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815808	Green Published, gold			2022-12-27	WOS:000306548900044
J	Assaiante, C; Mallau, S; Jouve, JL; Bollini, G; Vaugoyeau, M				Assaiante, Christine; Mallau, Sophie; Jouve, Jean-Luc; Bollini, Gerard; Vaugoyeau, Marianne			Do Adolescent Idiopathic Scoliosis (AIS) Neglect Proprioceptive Information in Sensory Integration of Postural Control?	PLOS ONE			English	Article							BALANCE CONTROL; STABILIZATION; ORIENTATION; MATURATION; STRATEGIES; DEFICITS; CHILDREN; HEAD	Introduction: It has been reported that AIS rely much more on ankle proprioception to control the amplitude of the balance control commands as compared to age-matched healthy adolescents. Our hypothesis was that AIS do not neglect proprioceptive information to control posture probably because of their vestibular deficits. We investigated the proprioceptive contribution to postural control in AIS which expresses spinal deformity during a crucial transitional period of ontogenesis. Methods: 10 adolescents with idiopathic scoliosis (AIS) with moderate spinal deformity (10 degrees < Cobb Angle > 35 degrees) and 10 control adolescents (CA) had to maintain vertical stance while very slow oscillations in the frontal plane (below the detection threshold of the semicircular canal system) were applied to the support with the eyes open and closed. Postural orientation and segmental stabilisation were analysed at head, shoulder, trunk and pelvis levels. Results: Scoliosis did not affect vertical orientation control and segmental stabilization strategies. Vision improves postural control in both CA and AIS, which seem more dependent on visual cues than adults. Conclusions: AIS as CA were unable to control efficiently their postural orientation on the basis of the proprioceptive cues, the only sensory information available in the EC situation, whereas in the same condition healthy young adults present no difficulty to achieve the postural control. This suggests that AIS as CA transitory neglect proprioceptive information to control their posture. These results and previous studies suggest the existence of different afferent pathways for proprioceptive information subserving different parts in sensory integration of postural control. We conclude that the static proprioceptive system is not affected by the idiopathic scoliosis, while the dynamic proprioceptive system would be mainly affected.	[Assaiante, Christine; Mallau, Sophie; Vaugoyeau, Marianne] Aix Marseille Univ, CNRS, Lab Neurosci Cognit, Ctr St Charles, Marseille, France; [Jouve, Jean-Luc; Bollini, Gerard] Univ Timone, Ctr Hosp, Serv Chirurg Orthoped Infantile, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Assaiante, C (corresponding author), Aix Marseille Univ, CNRS, Lab Neurosci Cognit, Ctr St Charles, Marseille, France.	christine.assaiante@univ-provence.fr			COTREL foundation	COTREL foundation	This work was supported by the COTREL foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; Assaiante C, 1998, J MOTOR BEHAV, V30, P114, DOI 10.1080/00222899809601329; BARRACK RL, 1984, SPINE, V9, P681, DOI 10.1097/00007632-198410000-00005; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; CLARK FJ, 1985, J NEUROPHYSIOL, V54, P1529, DOI 10.1152/jn.1985.54.6.1529; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; Franchignoni F P, 1985, Minerva Med, V76, P835; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; HERMAN R, 1985, SPINE, V10, P1, DOI 10.1097/00007632-198501000-00001; Mallau S, 2008, J ORTHOP RES, V26, P117, DOI 10.1002/jor.20476; Mallau S, 2007, SPINE, V32, pE14, DOI 10.1097/01.brs.0000251069.58498.eb; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Nadeau S, 2003, GAIT POSTURE, V18, P134, DOI 10.1016/S0966-6362(02)00070-X; Radovanovic S, 2002, EXP BRAIN RES, V143, P276, DOI 10.1007/s00221-001-0994-4; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; SAHLSTRAND T, 1978, ACTA ORTHOP SCAND, V49, P354, DOI 10.3109/17453677809050088; SAHLSTRAND T, 1979, ACTA ORTHOP SCAND, V50, P275, DOI 10.3109/17453677908989768; Simoneau M, 2006, EXP BRAIN RES, V170, P576, DOI 10.1007/s00221-005-0246-0; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; TAYLOR JL, 1990, EXP BRAIN RES, V81, P413; Vaugoyeau M, 2008, GAIT POSTURE, V27, P294, DOI 10.1016/j.gaitpost.2007.04.003; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; Vaugoyeau M, 2011, HUM MOVEMENT SCI, V30, P405, DOI 10.1016/j.humov.2010.10.006; Viel S, 2009, MOTOR CONTROL, V13, P25, DOI 10.1123/mcj.13.1.25; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3	27	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40646	10.1371/journal.pone.0040646	http://dx.doi.org/10.1371/journal.pone.0040646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815779	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000022
J	Davila, J; McNamara, LA; Yang, ZH				Davila, Jose; McNamara, Lucy A.; Yang, Zhenhua			Comparison of the Predicted Population Coverage of Tuberculosis Vaccine Candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a Bioinformatics Approach	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SUBUNIT VACCINE; EFFICIENT PROTECTION; PEPTIDE BINDING; ANTIGEN 85B; ESAT-6; FUSION; SUPERTYPES; INFECTION; RESPONSES	The Bacille-Calmette Guerin (BCG) vaccine does not provide consistent protection against adult pulmonary tuberculosis (TB) worldwide. As novel TB vaccine candidates advance in studies and clinical trials, it will be critically important to evaluate their global coverage by assessing the impact of host and pathogen variability on vaccine efficacy. In this study, we focus on the impact that host genetic variability may have on the protective effect of TB vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f. We use open-source epitope binding prediction programs to evaluate the binding of vaccine epitopes to Class I HLA (A, B, and C) and Class II HLA (DRB1) alleles. Our findings suggest that Mtb72f may be less consistently protective than either Ag85B-ESAT-6 or Ag85B-TB10.4 in populations with a high TB burden, while Ag85B-TB10.4 may provide the most consistent protection. The findings of this study highlight the utility of bioinformatics as a tool for evaluating vaccine candidates before the costly stages of clinical trials and informing the development of new vaccines with the broadest possible population coverage.	[Davila, Jose; McNamara, Lucy A.; Yang, Zhenhua] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [McNamara, Lucy A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davila, J (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	zhenhua@umich.edu		McNamara, Lucy/0000-0001-8240-7493	U.S. National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF))	LAM is supported by a U.S. National Science Foundation Predoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; AERAS, 2012, VACC DEV; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Contini S, 2008, SARCOIDOSIS VASC DIF, V25, P21; Davila J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/208371; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Guan Pingping, 2003, Appl Bioinformatics, V2, P63; Hattotuwagama CK, 2004, J MOL GRAPH MODEL, V22, P195, DOI 10.1016/S1093-3263(03)00160-8; Hebert AM, 2007, INFECT IMMUN, V75, P5798, DOI 10.1128/IAI.00335-07; Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3; Hughes AJ, 2005, CLIN EXP IMMUNOL, V142, P132, DOI 10.1111/j.1365-2249.2005.02884.x; Karosiene E, 2011, IMMUNOGENETICS; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Liu W, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-182; Loffredo JT, 2005, J IMMUNOL, V175, P5986, DOI 10.4049/jimmunol.175.9.5986; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; McNamara LA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-18; Mustafa AS, 2006, INFECT IMMUN, V74, P4566, DOI 10.1128/IAI.01660-05; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Wan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-463; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; World Health Organization, 2009, GLOB TUB CONTR EP ST; Zhang GL, 2011, J IMMUNOL METHODS, V374, P1, DOI 10.1016/j.jim.2011.09.010	39	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40882	10.1371/journal.pone.0040882	http://dx.doi.org/10.1371/journal.pone.0040882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815851	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000037
J	Ni, KF; Zhou, X; Zhao, L; Wang, HL; Ren, YH; Wei, DZ				Ni, Kefeng; Zhou, Xu; Zhao, Li; Wang, Hualei; Ren, Yuhong; Wei, Dongzhi			Magnetic Catechol-Chitosan with Bioinspired Adhesive Surface: Preparation and Immobilization of omega-Transaminase	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; FE3O4-CHITOSAN NANOPARTICLES; CROSS-LINKING; MEMBRANES	The magnetic chitosan nanocomposites have been studied intensively and been used practically in various biomedical and biological applications including enzyme immobilization. However, the loading capacity and the remained activity of immobilized enzyme based on existing approaches are not satisfied. Simpler and more effective immobilization strategies are needed. Here we report a simple catechol modified protocol for preparing a novel catechol-chitosan (CCS) - iron oxide nanoparticles (IONPs) composites carrying adhesive moieties with strong surface affinity. The omega-transaminase (omega-TA) was immobilized onto this magnetic composite via nucleophilic reactions between catechol and omega-TA. Under optimal conditions, 87.5% of the available omega-TA was immobilized on the composite, yielding an enzyme loading capacity as high as 681.7 mg/g. Furthermore, the valuation of enzyme activity showed that omega-TA immobilized on CCS-IONPs displayed enhanced pH and thermal stability compared to free enzyme. Importantly, the immobilized omega-TA retained more than 50% of its initial activity after 15 repeated reaction cycles using magnetic separation and 61.5% of its initial activity after storage at 4 degrees C in phosphate buffered saline (PBS) for 15 days. The results suggested that such adhesive magnetic composites may provide an improved platform technology for bio-macromolecules immobilized.	[Ni, Kefeng; Zhou, Xu; Zhao, Li; Wang, Hualei; Ren, Yuhong; Wei, Dongzhi] E China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ni, KF (corresponding author), E China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	yhren@ecust.edu.cn; dzhwei@ecust.edu.cn	Wei, Dongzhi/AAJ-3404-2021		National Natural Foundation of China [21076079]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of the State Key Laboratory of Bioreactor Engineering	This work was supported by The National Natural Foundation of China (NO.21076079), and Open Funding Project of the State Key Laboratory of Bioreactor Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Desbrieres J, 1996, INT J BIOL MACROMOL, V19, P21, DOI 10.1016/0141-8130(96)01095-1; Orrego CE, 2009, CATAL LETT, V129, P312, DOI 10.1007/s10562-009-9857-6; Ge YQ, 2009, NANOSCALE RES LETT, V4, P287, DOI 10.1007/s11671-008-9239-9; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Jiang YY, 2009, J MOL CATAL B-ENZYM, V58, P103, DOI 10.1016/j.molcatb.2008.12.001; Kaushika A, 2008, BIOSENS BIOELECTRON, V24, P676, DOI 10.1016/j.bios.2008.06.032; Kim JY, 2003, INT J BIOL MACROMOL, V32, P23, DOI 10.1016/S0141-8130(03)00021-7; Koszelewski D, 2010, TRENDS BIOTECHNOL, V28, P324, DOI 10.1016/j.tibtech.2010.03.003; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222; Orrego CE, 2010, CARBOHYD POLYM, V79, P9, DOI 10.1016/j.carbpol.2009.06.015; Orrego CE, 2009, BIOPROC BIOSYST ENG, V32, P197, DOI 10.1007/s00449-008-0237-1; Stepanow S, 2004, J PHYS CHEM B, V108, P19392, DOI 10.1021/jp046766t; Tran HV, 2010, MAT SCI ENG C-MATER, V30, P304, DOI 10.1016/j.msec.2009.11.008; Truppo MD, 2010, ORG PROCESS RES DEV, V14, P234, DOI 10.1021/op900303q; Wu Y, 2009, BIORESOURCE TECHNOL, V100, P3459, DOI 10.1016/j.biortech.2009.02.018; Yi SS, 2007, PROCESS BIOCHEM, V42, P895, DOI 10.1016/j.procbio.2007.01.008; Yuan Q, 2008, ACTA BIOMATER, V4, P1024, DOI 10.1016/j.actbio.2008.02.002; Zhang LY, 2010, CURR APPL PHYS, V10, P828, DOI 10.1016/j.cap.2009.10.002; Zhao DL, 2009, J ALLOY COMPD, V477, P739, DOI 10.1016/j.jallcom.2008.10.104; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhu LZ, 2009, COLLOID SURFACE B, V68, P1, DOI 10.1016/j.colsurfb.2008.07.020	24	27	29	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41101	10.1371/journal.pone.0041101	http://dx.doi.org/10.1371/journal.pone.0041101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815930	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000066
J	Anbazhagan, D; Mansor, M; Yan, GOS; Yusof, MYM; Hassan, H; Sekaran, SD				Anbazhagan, Deepa; Mansor, Marzida; Yan, Gracie Ong Siok; Yusof, Mohd Yasim Md; Hassan, Hamimah; Sekaran, Shamala Devi			Detection of Quorum Sensing Signal Molecules and Identification of an Autoinducer Synthase Gene among Biofilm Forming Clinical Isolates of Acinetobacter spp.	PLOS ONE			English	Article							NOSOCOMIAL PATHOGENS; BAUMANNII INFECTIONS; GLOBAL EPIDEMIOLOGY; EXPRESSION; RESISTANCE; INHIBITION	Background: Quorum sensing is a term that describes an environmental sensing system that allows bacteria to monitor their own population density which contributes significantly to the size and development of the biofilm. Many gram negative bacteria use N-acyl-homoserine lactones as quorum sensing signal molecules. In this study, we sought to find out if the biofilm formation among clinical isolates of Acinetobacter spp. is under the control of autoinducing quorum sensing molecules. Methodology/Principal Findings: Biofilm formation among clinical isolates of Acinetobacter spp. was assessed and the production of signal molecules were detected with Chromobacterium violaceum CV026 biosensor system. Characterisation of autoinducers was carried out by mass spectrometric analysis. We have also reported the identification of an autoinducer synthase gene, abaI among the isolates that produce quorum sensing signal molecules and have reported that the mutation in the abaI gene influences their biofilm forming capabilities. Using a microtitre-plate assay it was shown that 60% of the 50 Acinetobacter spp. isolates significantly formed biofilms. Further detection with the biosensor strain showed that some of these isolates produced long chain signal molecules. Mass spectrometric analysis revealed that five of these isolates produced N-decanoyl homoserine lactone and two isolates produced acyl-homoserine lactone with a chain length equal to C-12. The abaI gene was identified and a tetracycline mutant of the abaI gene was created and the inhibition in biofilm formation in the mutant was shown. Conclusions/Significance: These data are of great significance as the signal molecules aid in biofilm formation which in turn confer various properties of pathogenicity to the clinical isolates including drug resistance. The use of quorum sensing signal blockers to attenuate bacterial pathogenicity is therefore highly attractive, particularly with respect to the emergence of multi antibiotic resistant bacteria.	[Anbazhagan, Deepa; Yusof, Mohd Yasim Md; Hassan, Hamimah; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Mansor, Marzida; Yan, Gracie Ong Siok] Univ Malaya, Fac Med, Dept Anaesthesiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Anbazhagan, D (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Ong, Gracie/B-8554-2010; Devi, Shamala Devi/B-9735-2010; Sekaran, Shamala Devi/B-8482-2008; ong, gracie s/N-7778-2016; MANSOR, MARZIDA/B-8954-2010; Anbazhagan, Deepa/AAP-1564-2020	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Mansor, Marzida/0000-0002-4075-8778	e-Science Grant [12-02-03-2057]; UMRG [225/10 HTM]; PPP vote [PS154/2009B]; HIR [F000009-21001]	e-Science Grant; UMRG; PPP vote; HIR	This project was funded by e-Science Grant No 12-02-03-2057, UMRG 225/10 HTM, PPP vote PS154/2009B and HIR Grant F000009-21001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000432; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boddey JA, 2006, INFECT IMMUN, V74, P5374, DOI 10.1128/IAI.00569-06; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; Bosse JT, 2010, J BACTERIOL, V192, P2414, DOI 10.1128/JB.01513-09; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Emanuel G, 2009, PRACTICAL HDB MICROB, P67; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P117, DOI 10.1111/j.1469-0691.2006.01596.x; FALAGAS ME, 2006, CRIT CARE, V10, pR48; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gonzalez RH, 2001, MICROBIOL RES, V155, P271, DOI 10.1016/S0944-5013(01)80004-5; HARTSTEIN AI, 1988, AM J MED, V85, P624, DOI 10.1016/S0002-9343(88)80233-X; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Kjelleberg S, 2002, CURR OPIN MICROBIOL, V5, P254, DOI 10.1016/S1369-5274(02)00325-9; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; McLean RJC, 1997, FEMS MICROBIOL LETT, V154, P259, DOI 10.1111/j.1574-6968.1997.tb12653.x; Navon-Venezia S, 2007, J ANTIMICROB CHEMOTH, V59, P772, DOI 10.1093/jac/dkm018; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Ravn L, 2001, J MICROBIOL METH, V44, P239, DOI 10.1016/S0167-7012(01)00217-2; Ren DC, 2005, APPL ENVIRON MICROB, V71, P4022, DOI 10.1128/AEM.71.7.4022-4034.2005; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; THROUP J, 1995, BIOLUMINESCENCE CHEM, P89; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Tsakris A, 2006, J ANTIMICROB CHEMOTH, V58, P1097, DOI 10.1093/jac/dkl365; Vidal R, 1997, MICROBIOS, V91, P79; Vidal R, 1996, MICROBIOS, V86, P49; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x	36	63	68	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e36696	10.1371/journal.pone.0036696	http://dx.doi.org/10.1371/journal.pone.0036696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815678	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306466100004
J	Zizlsperger, L; Sauvigny, T; Haarmeier, T				Zizlsperger, Leopold; Sauvigny, Thomas; Haarmeier, Thomas			Selective Attention Increases Choice Certainty in Human Decision Making	PLOS ONE			English	Article							LATERAL INTRAPARIETAL AREA; VISUAL-MOTION COHERENCE; PERFORMANCE; RESPONSES; ALTERS; CONFIDENCE; PERCEPTION; MODULATION; CONTRAST; NEURONS	Choice certainty is a probabilistic estimate of past performance and expected outcome. In perceptual decisions the degree of confidence correlates closely with choice accuracy and reaction times, suggesting an intimate relationship to objective performance. Here we show that spatial and feature-based attention increase human subjects' certainty more than accuracy in visual motion discrimination tasks. Our findings demonstrate for the first time a dissociation of choice accuracy and certainty with a significantly stronger influence of voluntary top-down attention on subjective performance measures than on objective performance. These results reveal a so far unknown mechanism of the selection process implemented by attention and suggest a unique biological valence of choice certainty beyond a faithful reflection of the decision process.	[Zizlsperger, Leopold; Sauvigny, Thomas; Haarmeier, Thomas] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Sauvigny, Thomas] Univ Tubingen, Dept Gen Neurol, Tubingen, Germany	RWTH Aachen University; Eberhard Karls University of Tubingen	Zizlsperger, L (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.	thaarmeier@ukaachen.de		Zizlsperger, Leopold/0000-0002-2396-166X				Anton-Erxleben K, 2010, J VISION, V10, DOI 10.1167/10.11.6; Baldassi S, 2006, PLOS BIOL, V4, P387, DOI 10.1371/journal.pbio.0040056; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Dayan P, 1999, INT C ART NEUR NETW; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Dholakia UM, 2002, J BEHAV DECIS MAKING, V15, P167, DOI 10.1002/bdm.408; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Handel B, 2008, CEREB CORTEX, V18, P2902, DOI 10.1093/cercor/bhn049; Handel B, 2007, CEREB CORTEX, V17, P1542, DOI 10.1093/cercor/bhl063; Henmon VAC, 1911, PSYCHOL REV, V18, P186, DOI 10.1037/h0074579; Herrmann K, 2010, NAT NEUROSCI, V13, P1554, DOI 10.1038/nn.2669; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Jastrow J., 1884, MEMOIRS NATL ACAD SC, V3, P73; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kingdom F, 2009, PALAMEDES MATLAB ROU; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koch C, 2007, NAT NEUROSCI, V10, P140, DOI 10.1038/nn0207-140; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; Liu TS, 2006, PSYCHON B REV, V13, P1091, DOI 10.3758/BF03213931; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	38	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41136	10.1371/journal.pone.0041136	http://dx.doi.org/10.1371/journal.pone.0041136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974VS	22815942	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100121
J	Gallegos, TF; Martovetsky, G; Kouznetsova, V; Bush, KT; Nigam, SK				Gallegos, Thomas F.; Martovetsky, Gleb; Kouznetsova, Valentina; Bush, Kevin T.; Nigam, Sanjay K.			Organic Anion and Cation SLC22 "Drug'' Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; RAT-KIDNEY; GENE-EXPRESSION; MOUSE KIDNEY; TARGETED DISRUPTION; FACTOR 4-ALPHA; MICE; TRANSCRIPTION; MORPHOGENESIS; SYSTEMS	Proper physiological function in the pre- and post-natal proximal tubule of the kidney depends upon the acquisition of selective permeability, apical-basolateral epithelial polarity and the expression of key transporters, including those involved in metabolite, toxin and drug handling. Particularly important are the SLC22 family of transporters, including the organic anion transporters Oat1 (originally identified as NKT) and Oat3 as well as the organic cation transporter Oct1. In ex vivo cultures of metanephric mesenchyme (MM; the embryonic progenitor tissue of the nephron) Oat function was evident before completion of nephron segmentation and corresponded with the maturation of tight junctions as measured biochemically by detergent extractability of the tight junction protein, ZO-1. Examination of available time series microarray data sets in the context of development and differentiation of the proximal tubule (derived from both in vivo and in vitro/ex vivo developing nephrons) allowed for correlation of gene expression data to biochemically and functionally defined states of development. This bioinformatic analysis yielded a network of genes with connectivity biased toward Hnf4 alpha (but including Hnf1 alpha, hyaluronic acid-CD44, and notch pathways). Intriguingly, the Oat1 and Oat3 genes were found to have strong temporal co-expression with Hnf4 alpha in the cultured MM supporting the notion of some connection between the transporters and this transcription factor. Taken together with the ChIP-qPCR finding that Hnf4 alpha occupies Oat1, Oat3, and Oct1 proximal promoters in the in vivo differentiating rat kidney, the data suggest a network of genes with Hnf4 alpha at its center plays a role in regulating the terminal differentiation and capacity for drug and toxin handling by the nascent proximal tubule of the kidney.	[Gallegos, Thomas F.; Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Martovetsky, Gleb] Univ Calif San Diego, Dept Biomed Sci, La Jolla, CA 92093 USA; [Kouznetsova, Valentina; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gallegos, TF (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	snigam@ucsd.edu			National Institutes of Health Institute of Diabetes and Digestive and Kidney Diseases [DK079784]; National Institutes of Health Institute of General Medical Sciences [GM088824]; National Institutes of Health Institute of Child Health and Human Development [HD07160]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088824] Funding Source: NIH RePORTER	National Institutes of Health Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health Institute of Diabetes and Digestive and Kidney Diseases [DK079784], the National Institutes of Health Institute of General Medical Sciences [GM088824], and the National Institutes of Health Institute of Child Health and Human Development [HD07160]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2008, CURR OPIN NEPHROL HY, V17, P499, DOI 10.1097/MNH.0b013e32830b5d5d; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Boj SF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000970; Boj SF, 2009, DIABETES, V58, P1245, DOI 10.2337/db08-0812; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; Chen LH, 2005, AM J PHYSIOL-RENAL, V288, pF939, DOI 10.1152/ajprenal.00369.2004; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Choi Y, 2009, DEVELOPMENT, V136, P4213, DOI 10.1242/dev.037580; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2003, BIOCHEM BIOPH RES CO, V300, P333, DOI 10.1016/S0006-291X(02)02853-X; Gallegos TF, 2012, DEV BIOL; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Hagos Y, 2010, TOXINS, V2, P2055, DOI 10.3390/toxins2082055; Heinz S, 2011, CURR TOP MICROBIOL I; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffmann D, 2010, TOXICOLOGY, V277, P49, DOI 10.1016/j.tox.2010.08.013; Hwang JS, 2010, HISTOL HISTOPATHOL, V25, P33, DOI 10.14670/HH-25.33; Jin L, 2012, J PHARMACOL EXP THER, V340, P648, DOI 10.1124/jpet.111.187161; Jonker JW, 2003, MOL CELL BIOL, V23, P7902, DOI 10.1128/MCB.23.21.7902-7908.2003; Jonker JW, 2001, MOL CELL BIOL, V21, P5471, DOI 10.1128/MCB.21.16.5471-5477.2001; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kanazawa T, 2009, ANAT HISTOL EMBRYOL, V38, P34, DOI 10.1111/j.1439-0264.2008.00889.x; Kanazawa T, 2011, J VET MED SCI, V73, P601, DOI 10.1292/jvms.10-0493; Kanazawa T, 2010, DEV DYNAM, V239, P1145, DOI 10.1002/dvdy.22276; Karbach U, 2000, AM J PHYSIOL-RENAL, V279, pF679, DOI 10.1152/ajprenal.2000.279.4.F679; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LARSSON L, 1975, J ULTRA MOL STRUCT R, V51, P119, DOI 10.1016/S0022-5320(75)80013-X; Lima WR, 2010, J AM SOC NEPHROL, V21, P478, DOI 10.1681/ASN.2009070698; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Maher JM, 2006, BIOCHEM PHARMACOL, V72, P512, DOI 10.1016/j.bcp.2006.03.016; Masereeuw R, 2010, PHARMACOL THERAPEUT, V126, P200, DOI 10.1016/j.pharmthera.2010.02.007; Moore KL, 2008, DEV HUMAN CLIN ORIEN, pxiv; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Nakajima N, 2000, KIDNEY INT, V57, P1608, DOI 10.1046/j.1523-1755.2000.00005.x; Nomura M, 2012, AM J PHYSL RENAL PHY; Ogasawara K, 2007, AM J PHYSIOL-RENAL, V292, pF1819, DOI 10.1152/ajprenal.00017.2007; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Rosines E, 2007, BIOMATERIALS, V28, P4806, DOI 10.1016/j.biomaterials.2007.07.034; Saborowski M, 2006, J PHARMACOL EXP THER, V317, P778, DOI 10.1124/jpet.105.099929; Saji T, 2008, J PHARMACOL EXP THER, V324, P784, DOI 10.1124/jpet.107.128249; Saxen, 1987, ORGANOGENESIS KIDNEY; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Slitt AL, 2002, DRUG METAB DISPOS, V30, P212, DOI 10.1124/dmd.30.2.212; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Surendran K, 2010, DEV BIOL, V337, P386, DOI 10.1016/j.ydbio.2009.11.017; Sweeney DE, 2011, MOL PHARMACOL, V80, P147, DOI 10.1124/mol.110.070680; Sweet DH, 2006, KIDNEY INT, V69, P837, DOI 10.1038/sj.ki.5000170; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Thiagarajan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017286; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Tsigelny IF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1163630; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607	69	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40796	10.1371/journal.pone.0040796	http://dx.doi.org/10.1371/journal.pone.0040796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808265	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700055
J	Sorgi, CA; Rose, S; Court, N; Carlos, D; Paula-Silva, FWG; Assis, PA; Frantz, FG; Ryffel, B; Quesniaux, V; Faccioli, LH				Sorgi, Carlos Arterio; Rose, Stephanie; Court, Nathalie; Carlos, Daniela; Garcia Paula-Silva, Francisco Wanderley; Assis, Patricia Aparecida; Frantz, Fabiani Gai; Ryffel, Bernhard; Quesniaux, Valerie; Faccioli, Lucia Helena			GM-CSF Priming Drives Bone Marrow-Derived Macrophages to a Pro-Inflammatory Pattern and Downmodulates PGE(2) in Response to TLR2 Ligands	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTORS; ARACHIDONIC-ACID RELEASE; INNATE IMMUNE-RESPONSE; ALVEOLAR MACROPHAGE; HUMAN-NEUTROPHILS; PROINFLAMMATORY CYTOKINES; 5-LIPOXYGENASE ACTIVATION; MICROBIAL LIPOPROTEINS; CUTTING EDGE	In response to pathogen recognition by Toll-like receptors (TLRs) on their cell surface, macrophages release lipid mediators and cytokines that are widely distributed throughout the body and play essential roles in host responses. Granulocyte macrophage colony-stimulating factor (GM-CSF) is important for the immune response during infections to improve the clearance of microorganisms. In this study, we examined the release of mediators in response to TLR2 ligands by bone marrow-derived macrophages (BMDMs) primed with GM-CSF. We demonstrated that when stimulated with TLR2 ligands, non-primed BMDMs preferentially produced PGE(2) in greater amounts than LTB4. However, GM-CSF priming shifted the release of lipid mediators by BMDMs, resulting in a significant decrease of PGE(2) production in response to the same stimuli. The decrease of PGE(2) production from primed BMDMs was accompanied by a decrease in PGE-synthase mRNA expression and an increase in TNF-alpha and nitric oxide (NO) production. Moreover, some GM-CSF effects were potentiated by the addition of IFN-gamma. Using a variety of TLR2 ligands, we established that PGE(2) release by GM-CSF-primed BMDMs was dependent on TLR2 co-receptors (TLR1, TLR6), CD14, MyD88 and the nuclear translocation of NF kappa B but was not dependent on peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation. Indeed, GM-CSF priming enhanced TLR2, TLR4 and MyD88 mRNA expression and phospho-I kappa B alpha formation. These findings demonstrate that GM-CSF drives BMDMs to present a profile relevant to the host during infections.	[Sorgi, Carlos Arterio; Carlos, Daniela; Garcia Paula-Silva, Francisco Wanderley; Assis, Patricia Aparecida; Frantz, Fabiani Gai; Faccioli, Lucia Helena] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil; [Rose, Stephanie; Court, Nathalie; Ryffel, Bernhard; Quesniaux, Valerie] CNRS, UMR6218, F-45071 Orleans, France; [Rose, Stephanie; Court, Nathalie; Ryffel, Bernhard; Quesniaux, Valerie] Orleans Univ Mol Immunol & Embryol, Orleans, France	Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS)	Sorgi, CA (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil.	faccioli@fcfrp.usp.br	Lucia, Faccioli/G-8976-2015; Sorgi, Carlos/O-2839-2017; Frantz, Fabiani Gai/B-9204-2016; Assis, Patricia/AAW-8642-2021; Sorgi, Carlos Artério/AAA-6284-2020; Faccioli, Lúcia Helena/AGH-5297-2022; Sorgi, Carlos Arterio/ABE-4246-2020; de Paula e Silva, Francisco Wanderley Garcia Garcia/D-1712-2012	Lucia, Faccioli/0000-0002-4999-8305; Sorgi, Carlos/0000-0001-7528-9935; Frantz, Fabiani Gai/0000-0001-6960-2438; Sorgi, Carlos Artério/0000-0001-7528-9935; Faccioli, Lúcia Helena/0000-0002-4999-8305; de Paula e Silva, Francisco Wanderley Garcia Garcia/0000-0001-8559-532X	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; CNPq - Conselho Nacional de Pesquisa	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Pesquisa(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, and CNPq - Conselho Nacional de Pesquisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brock TG, 1996, J IMMUNOL, V156, P2522; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Clancy R, 2000, J IMMUNOL, V165, P1582, DOI 10.4049/jimmunol.165.3.1582; Coffey MJ, 2000, J IMMUNOL, V165, P3592, DOI 10.4049/jimmunol.165.7.3592; DIPERSIO JF, 1988, J IMMUNOL, V140, P4315; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Flower RJ, 2006, BRIT J PHARMACOL, V147, pS182, DOI 10.1038/sj.bjp.0706506; GASSON JC, 1984, SCIENCE, V226, P1339, DOI 10.1126/science.6390681; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; GOLDSTEIN E, 1974, J CLIN INVEST, V54, P519, DOI 10.1172/JCI107788; Goodwin DC, 1998, J BIOL CHEM, V273, P8903, DOI 10.1074/jbc.273.15.8903; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ikegami R, 2001, J IMMUNOL, V166, P4689, DOI 10.4049/jimmunol.166.7.4689; Jablonska E, 2002, MELANOMA RES, V12, P123; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KRUMP E, 1994, BBA-LIPID LIPID MET, V1213, P135, DOI 10.1016/0005-2760(94)90019-1; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lendemans S, 2006, J ENDOTOXIN RES, V12, P10, DOI 10.1179/096805106X89107; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Maccarrone M, 1996, BIOCHEM BIOPH RES CO, V219, P128, DOI 10.1006/bbrc.1996.0193; Machado ER, 2010, FEMS IMMUNOL MED MIC, V59, P18, DOI 10.1111/j.1574-695X.2010.00656.x; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; MCCOLL SR, 1991, J IMMUNOL, V146, P1204; Means TK, 1999, J IMMUNOL, V163, P6748; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; NATHAN CF, 1984, J EXP MED, V160, P600, DOI 10.1084/jem.160.2.600; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; PETERSGOLDEN M, 1990, J IMMUNOL, V144, P263; Pluddemann A, 2011, IMMUNOL REV, V240, P11, DOI 10.1111/j.1600-065X.2010.00989.x; POULIOT M, 1994, J IMMUNOL, V152, P851; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Randow F, 1997, J IMMUNOL, V158, P2911; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; STADLER J, 1993, J LEUKOCYTE BIOL, V53, P165, DOI 10.1002/jlb.53.2.165; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Yang KK, 2002, J IMMUNOL, V169, P4475, DOI 10.4049/jimmunol.169.8.4475	65	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40523	10.1371/journal.pone.0040523	http://dx.doi.org/10.1371/journal.pone.0040523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808181	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700032
J	Veron, D; Villegas, G; Aggarwal, PK; Bertuccio, C; Jimenez, J; Velazquez, H; Reidy, K; Abrahamson, DR; Moeckel, G; Kashgarian, M; Tufro, A				Veron, Delma; Villegas, Guillermo; Aggarwal, Pardeep Kumar; Bertuccio, Claudia; Jimenez, Juan; Velazquez, Heino; Reidy, Kimberly; Abrahamson, Dale R.; Moeckel, Gilbert; Kashgarian, Michael; Tufro, Alda			Acute Podocyte Vascular Endothelial Growth Factor (VEGF-A) Knockdown Disrupts alpha(V)beta(3) Integrin Signaling in the Glomerulus	PLOS ONE			English	Article							MICE LACKING; EXTRACELLULAR-MATRIX; AFFINITY MODULATION; UROKINASE RECEPTOR; IN-VITRO; ANGIOGENESIS; KIDNEY; EXPRESSION; LETHALITY; CELLS	Podocyte or endothelial cell VEGF-A knockout causes thrombotic microangiopathy in adult mice. To study the mechanism involved in acute and local injury caused by low podocyte VEGF-A we developed an inducible, podocyte-specific VEGF-A knockdown mouse, and we generated an immortalized podocyte cell line (VEGF(KD)) that downregulates VEGF-A upon doxycycline exposure. Tet-O-siVEGF:podocin-rtTA mice express VEGF shRNA in podocytes in a doxycycline-regulated manner, decreasing VEGF-A mRNA and VEGF-A protein levels in isolated glomeruli to similar to 20% of non-induced controls and urine VEGF-A to similar to 30% of control values a week after doxycycline induction. Induced tet-O-siVEGF: podocin-rtTA mice developed acute renal failure and proteinuria, associated with mesangiolysis and microaneurisms. Glomerular ultrastructure revealed endothelial cell swelling, GBM lamination and podocyte effacement. VEGF knockdown decreased podocyte fibronectin and glomerular endothelial alpha(V)beta(3) integrin in vivo. VEGF receptor-2 (VEGFR2) interacts with beta(3) integrin and neuropilin-1 in the kidney in vivo and in VEGF(KD) podocytes. Podocyte VEGF knockdown disrupts alpha(V)beta(3) integrin activation in glomeruli, detected by WOW1-Fab. VEGF silencing in cultured VEGF(KD) podocytes downregulates fibronectin and disrupts alpha(V)beta(3) integrin activation cell-autonomously. Collectively, these studies indicate that podocyte VEGF-A regulates alpha(V)beta(3) integrin signaling in the glomerulus, and that podocyte VEGF knockdown disrupts alpha(V)beta(3) integrin activity via decreased VEGFR2 signaling, thereby damaging the three layers of the glomerular filtration barrier, causing proteinuria and acute renal failure.	[Veron, Delma; Aggarwal, Pardeep Kumar; Bertuccio, Claudia; Tufro, Alda] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Villegas, Guillermo; Reidy, Kimberly] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Velazquez, Heino] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Abrahamson, Dale R.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Moeckel, Gilbert; Kashgarian, Michael] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yale University; University of Kansas; University of Kansas Medical Center; Yale University	Veron, D (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	alda.tufro@yale.edu		Moeckel, Gilbert/0000-0002-6059-0837	National Institutes of Health (NIH) [RO1-DK59333]; NIH George M. O'Brien Kidney Center [P50-DK64236]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064236, P30DK079310, K08DK091507, R01DK059333] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH George M. O'Brien Kidney Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (NIH) RO1-DK59333 (Dr. Tufro), and NIH George M. O'Brien Kidney Center P50-DK64236 (Dr. Velazquez); http://grants.nih.gov/grants/funding/r01.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Bertuccio C, 2011, J BIOL CHEM, V286, P39933, DOI 10.1074/jbc.M111.241620; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Gurevich F, 2009, AM J MED, V122, P322, DOI 10.1016/j.amjmed.2008.11.025; Hafdi Z, 2000, CELL ADHES COMMUN, V7, P441, DOI 10.3109/15419060009040302; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Izzedine H, 2010, EUR J CANCER, V46, P439, DOI 10.1016/j.ejca.2009.11.001; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Persson M, 2012, ATHEROSCLEROSIS, V220, P502, DOI 10.1016/j.atherosclerosis.2011.10.039; Persson M, 2012, NUCL MED BIOL, V39, P560, DOI 10.1016/j.nucmedbio.2011.10.011; Plehm Ralph, 2006, V129, P115; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Robinson SD, 2009, J BIOL CHEM, V284, P33966, DOI 10.1074/jbc.M109.030700; Ruoslahti E, 1996, TUMOR BIOL, V17, P117, DOI 10.1159/000217975; Ruoslahti E, 1994, KIDNEY INT, V44, P17; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z; Veron D, 2010, AM J PATHOL, V177, P2225, DOI 10.2353/ajpath.2010.091146; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Yoon S, 2001, AM J KIDNEY DIS, V38, P1298, DOI 10.1053/ajkd.2001.29228; Yuen PST, 2004, AM J PHYSIOL-RENAL, V286, pF1116, DOI 10.1152/ajprenal.00366.2003	51	46	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40589	10.1371/journal.pone.0040589	http://dx.doi.org/10.1371/journal.pone.0040589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808199	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700035
J	Zhang, W; Dang, E; Shi, XW; Jin, L; Feng, ZZ; Hu, L; Wu, Y; Wang, G				Zhang, Wei; Dang, Erle; Shi, Xiaowei; Jin, Liang; Feng, Zhenzhen; Hu, Lei; Wu, Yan; Wang, Gang			The Pro-Inflammatory Cytokine IL-22 Up-Regulates Keratin 17 Expression in Keratinocytes via STAT3 and ERK1/2	PLOS ONE			English	Article							TH17 T-CELLS; IFN-GAMMA; INTERLEUKIN (IL)-22; PSORIASIS-VULGARIS; MOUSE MODEL; TNF-ALPHA; IL-17; DIFFERENTIATION; PATHOGENESIS; PROLIFERATION	Background: To investigate the regulation of K17 expression by the pro-inflammatory cytokine IL-22 in keratinocytes and its important role in our previously hypothesized "K17/T cell/cytokine autoimmune loop'' in psoriasis. Materials and Methods: K17 expression was examined in the IL-22-treated keratinocytes by real-time quantitative PCR, ELISA, Western blot and Immunofluorescence. In addition, the signaling pathways involved in K17 regulation were investigated with related inhibitors and siRNAs. In addition, K17 expression was examined in the epidermis of IL-22-injected mouse skin. Results: IL-22-induced K17 expression was confirmed in keratinocytes and the epidermis of IL-22-injected mouse skin at both mRNA and protein levels, which is an important complement to the autoimmune loop. We further investigated the regulatory mechanisms and found that both STAT3 and ERK1/2 were involved in the up-regulation of K17 expression induced by IL-22. Conclusion: IL-22 up-regulates K17 expression in keratinocytes in a dose-dependent manner through STAT3- and ERK1/2-dependent mechanisms. These findings indicated that IL-22 was also involved in the K17/T cell/cytokine autoimmune loop and may play an important role in the progression of psoriasis.	[Zhang, Wei; Dang, Erle; Shi, Xiaowei; Jin, Liang; Feng, Zhenzhen; Hu, Lei; Wu, Yan; Wang, Gang] Fourth Mil Med Univ, Dept Dermatol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University	Zhang, W (corresponding author), Fourth Mil Med Univ, Dept Dermatol, Xijing Hosp, Xian 710032, Peoples R China.	xjwgang@fmmu.edu.cn	Wang, Gang/H-6710-2019	Wang, Gang/0000-0002-5842-8080; Dang, Erle/0000-0003-4761-6673	National Natural Science Foundation of China [81171494]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81171494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 1999, J IMMUNOL, V162, P494; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Bockelmanna R, 2005, SKIN PHARMACOL PHYS, V18, P42, DOI 10.1159/000081685; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153; Haider AS, 2008, J IMMUNOL, V180, P1913, DOI 10.4049/jimmunol.180.3.1913; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; JIANG CK, 1994, MOL CELL BIOL, V14, P4759, DOI 10.1128/MCB.14.7.4759; Komine M, 1996, J INVEST DERMATOL, V107, P569, DOI 10.1111/1523-1747.ep12582820; Laatikainen LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024456; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu HJ, 2006, EUR J DERMATOL, V16, P205; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mak RKH, 2009, ACTAS DERMO-SIFILOGR, V100, P2, DOI 10.1016/S0001-7310(09)73372-1; McFadden JP, 2009, BRIT J DERMATOL, V160, P929, DOI 10.1111/j.1365-2133.2009.09102.x; OShea JJ, 1997, J CLIN IMMUNOL, V17, P431, DOI 10.1023/A:1027388508570; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Shen Z, 2005, J DERMATOL SCI, V38, P25, DOI 10.1016/j.jdermsci.2005.01.001; Shen Z, 2006, J AM ACAD DERMATOL, V54, P992, DOI 10.1016/j.jaad.2006.02.033; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	32	48	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40797	10.1371/journal.pone.0040797	http://dx.doi.org/10.1371/journal.pone.0040797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808266	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700056
J	Eisler, MC; Magona, JW; Revie, CW				Eisler, Mark C.; Magona, Joseph W.; Revie, Crawford W.			Diagnosis of Cattle Diseases Endemic to Sub-Saharan Africa: Evaluating a Low Cost Decision Support Tool in Use by Veterinary Personnel	PLOS ONE			English	Article							TRYPANOSOMA-CONGOLENSE; AGROECOLOGICAL ZONE; UGANDA; INFECTIONS; PREVALENCE; DISTRICTS; LIVESTOCK; SYSTEM; CALVES; MBALE	Background: Diagnosis is key to control and prevention of livestock diseases. In areas of sub-Saharan Africa where private practitioners rarely replace Government veterinary services reduced in effectiveness by structural adjustment programmes, those who remain lack resources for diagnosis and might benefit from decision support. Methodology/Principal Findings: We evaluated whether a low-cost diagnostic decision support tool would lead to changes in clinical diagnostic practice by fifteen veterinary and animal health officers undertaking primary animal healthcare in Uganda. The eight diseases covered by the tool included 98% of all bovine diagnoses made before or after its introduction. It may therefore inform proportional morbidity in the area; breed, age and geographic location effects were consistent with current epidemiological understanding. Trypanosomosis, theileriosis, anaplasmosis, and parasitic gastroenteritis were the most common conditions among 713 bovine clinical cases diagnosed prior to introduction of the tool. Thereafter, in 747 bovine clinical cases estimated proportional morbidity of fasciolosis doubled, while theileriosis and parasitic gastroenteritis were diagnosed less commonly and the average number of clinical signs increased from 3.5 to 4.9 per case, with 28% of cases reporting six or more signs compared to 3% beforehand. Anaemia/pallor, weakness and staring coat contributed most to this increase, approximately doubling in number and were recorded in over half of all cases. Finally, although lack of a gold standard hindered objective assessment of whether the tool improved the reliability of diagnosis, informative concordance and misclassification matrices yielded useful insights into its role in the diagnostic process. Conclusions/Significance: The diagnostic decision support tool covered the majority of diagnoses made before or after its introduction, leading to a significant increase in the number of clinical signs recorded, suggesting this as a key beneficial consequence of its use. It may also inform approximate proportional morbidity and represent a useful epidemiological tool in poorly resourced areas.	[Eisler, Mark C.] Univ Bristol, Sch Vet Sci, Fac Med & Vet Med, Bristol BS18 7DU, Avon, England; [Magona, Joseph W.] Bulindi Zonal Agr Res & Dev, Hoima, Uganda; [Revie, Crawford W.] Univ PEI, Atlantic Vet Coll, Charlottetown, PE, Canada	University of Bristol; University of Prince Edward Island	Eisler, MC (corresponding author), Univ Bristol, Sch Vet Sci, Fac Med & Vet Med, Bristol BS18 7DU, Avon, England.	mark.eisler@bristol.ac.uk	Revie, Crawford/B-5002-2011; Eisler, Mark/AAK-1119-2020; guillermo, andres/AAW-4702-2021	Revie, Crawford/0000-0002-5018-0340; Eisler, Mark/0000-0001-6843-3345; 	UK Department for International Development (DFID) under RNRRS [R7597, R8318]	UK Department for International Development (DFID) under RNRRS	The authors would like to thank the UK Department for International Development (DFID) for funding under RNRRS Projects R7597 and R8318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babes V, 1888, CR HEBD ACAD SCI, V107, P692; Bett B, 2004, PREV VET MED, V63, P29, DOI 10.1016/j.prevetmed.2004.02.004; Bruce D, 1910, P R SOC LOND B-CONTA, V82, P256, DOI 10.1098/rspb.1910.0016; Chenyambuga S. W., 2010, Livestock Research for Rural Development, V22, P135; Cowdry EV, 1925, J EXP MED, V42, P231, DOI 10.1084/jem.42.2.231; De Bont J, 1998, ADV PARASIT, V41, P285, DOI 10.1016/S0065-308X(08)60426-1; DWINGER RH, 1994, VET PARASITOL, V54, P353, DOI 10.1016/0304-4017(94)90002-7; Eisler MC, 2007, EPIDEMIOL INFECT, V135, P67, DOI 10.1017/S0950268806006571; Eisler MC, 2003, TRENDS PARASITOL, V19, P341, DOI 10.1016/S1471-4922(03)00164-8; Ely JW, 2011, ACAD MED, V86, P307, DOI 10.1097/ACM.0b013e31820824cd; Fiennes R. N. T.-W., 1970, P729; Ford J, 1976, ATLAS UGANDA, P16; Goossens B, 1997, INT J PARASITOL, V27, P1579, DOI 10.1016/S0020-7519(97)00094-5; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Machila N, 2003, ACTA TROP, V86, P25, DOI 10.1016/S0001-706X(02)00288-7; Magona JW, 2008, VET PARASITOL, V155, P273, DOI 10.1016/j.vetpar.2008.05.022; Magona J. W., 1999, Bulletin of Animal Health and Production in Africa, V47, P9; Magona J. W., 2004, Bulletin of Animal Health and Production in Africa, V52, P130; Magona JW, 2004, J S AFR VET ASSOC, V75, P189; Magona JW, 2004, ANN TROP MED PARASIT, V98, P785, DOI 10.1179/000349804225021532; Magona JW, 2004, ONDERSTEPOORT J VET, V71, P231; Magona JW, 2002, ONDERSTEPOORT J VET, V69, P133; Makundi AE, 1998, VET PARASITOL, V75, P59, DOI 10.1016/S0304-4017(97)00179-9; Norval RAI, 1992, EPIDEMIOLOGY THEILER, V481, P20; Ocaido M., 2005, Livestock Research for Rural Development, V17, P93; Rubaire-Akiiki C, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.8; Rubaire-Akiiki CM, 2006, PREV VET MED, V75, P251, DOI 10.1016/j.prevetmed.2006.04.015; Seidel M, 2003, AGR SYST, V76, P527, DOI 10.1016/S0308-521X(02)00035-5; Uilenberg G., 1981, Diseases of cattle in the tropics, P345; Van den Bossche P, 2000, ACTA TROP, V75, P247, DOI 10.1016/S0001-706X(00)00059-0; WEINBREN B. M., 1960, JOUR COMP PATHOL AND THERAP, V70, P176, DOI 10.1016/S0368-1742(60)80017-3	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40687	10.1371/journal.pone.0040687	http://dx.doi.org/10.1371/journal.pone.0040687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808233	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400047
J	Chakraborty, S				Chakraborty, Sandeep			An Automated Flow for Directed Evolution Based on Detection of Promiscuous Scaffolds Using Spatial and Electrostatic Properties of Catalytic Residues	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; SERINE BETA-LACTAMASES; CRYSTAL-STRUCTURE; IN-VITRO; COMPUTATIONAL DESIGN; NEUTROPHIL ELASTASE; ESCHERICHIA-COLI; ENZYME-ACTIVITY; ACTIVE-SITE; DEACYLATION	The aspiration to mimic and accelerate natural evolution has fueled interest in directed evolution experiments, which endow or enhance functionality in enzymes. Barring a few de novo approaches, most methods take a template protein having the desired activity, known active site residues and structure, and proceed to select a target protein which has a preexisting scaffold congruent to the template motif. Previously, we have established a computational method (CLASP) based on spatial and electrostatic properties to detect active sites, and a method to quantify promiscuity in proteins. We exploit the prospect of promiscuous active sites to serve as the starting point for directed evolution and present a method to select a target protein which possesses a significant partial match with the template scaffold (DECAAF). A library of partial motifs, constructed from the active site residues of the template protein, is used to rank a set of target proteins based on maximal significant matches with the partial motifs, and cull out the best candidate from the reduced set as the target protein. Considering the scenario where this 'incubator' protein lacks activity, we identify mutations in the target protein that will mirror the template motif by superimposing the target and template protein based on the partial match. Using this superimposition technique, we analyzed the less than expected gain of activity achieved by an attempt to induce beta-lactamase activity in a penicillin binding protein (PBP) (PBP-A from T. elongatus), and attributed this to steric hindrance from neighboring residues. We also propose mutations in PBP-5 from E. coli, which does not have similar steric constraints. The flow details have been worked out in an example which aims to select a substitute protein for human neutrophil elastase, preferably related to grapevines, in a chimeric anti-microbial enzyme which bolsters the innate immune defense system of grapevines.	Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sandeepchak@tifr.res.in			Tata Institute of Fundamental Research (Department of Atomic Energy)	Tata Institute of Fundamental Research (Department of Atomic Energy)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Antikainen NM, 2005, BIOORGAN MED CHEM, V13, P2701, DOI 10.1016/j.bmc.2005.01.059; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; BERNICK JJ, 1976, COMP BIOCHEM PHYS B, V54, P51, DOI 10.1016/0305-0491(76)90056-0; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039577; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032011; Chakraborty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028470; Chen CY, 2009, P NATL ACAD SCI USA, V106, P3764, DOI 10.1073/pnas.0900266106; Chesnel L, 2002, EUR J BIOCHEM, V269, P1678, DOI 10.1046/j.1432-1327.2002.02815.x; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; CLIMIE S, 1990, J BIOL CHEM, V265, P18776; Cole MF, 2011, J MOL EVOL, V72, P193, DOI 10.1007/s00239-010-9415-2; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; DePristo MA, 2007, HFSP J, V1, P94, DOI 10.2976/1.2754665; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Faiella M, 2009, NAT CHEM BIOL, V5, P882, DOI 10.1038/nchembio.257; Fernandez C, 1997, J MOL BIOL, V266, P576, DOI 10.1006/jmbi.1996.0772; Georgiev I, 2008, J COMPUT CHEM, V29, P1527, DOI 10.1002/jcc.20909; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; Ghosh AS, 2003, J BACTERIOL, V185, P2178, DOI 10.1128/JB.185.7.2178-2186.2003; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Goddard JP, 2004, CURR OPIN BIOTECH, V15, P314, DOI 10.1016/j.copbio.2004.06.008; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Gumulya Y, 2012, CHEMBIOCHEM, V13, P1060, DOI 10.1002/cbic.201100784; Guntas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035998; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; HALL BG, 1980, P NATL ACAD SCI-BIOL, V77, P3529, DOI 10.1073/pnas.77.6.3529; Harada E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029710; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Johns GC, 2005, J MOL EVOL, V61, P253, DOI 10.1007/s00239-004-0307-1; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Kuhn I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002409; Kunkel M, 2007, CRIT REV IMMUNOL, V27, P233, DOI 10.1615/CritRevImmunol.v27.i3.40; LEWIS EB, 1951, COLD SPRING HARB SYM, V16, P159, DOI 10.1101/SQB.1951.016.01.014; LOBKOVSKY E, 1993, P NATL ACAD SCI USA, V90, P11257, DOI 10.1073/pnas.90.23.11257; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Macdonald SJF, 2002, J MED CHEM, V45, P3878, DOI 10.1021/jm020881f; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Malisi C, 2009, PROTEINS, V77, P74, DOI 10.1002/prot.22418; Matagne A, 1999, NAT PROD REP, V16, P1, DOI 10.1039/a705983c; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Nannemann DP, 2011, FUTURE MED CHEM, V3, P803, DOI [10.4155/FMC.11.48, 10.4155/fmc.11.48]; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2006, CHEM-EUR J, V12, P6031, DOI 10.1002/chem.200600459; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sandstrom AG, 2012, P NATL ACAD SCI USA, V109, P78, DOI 10.1073/pnas.1111537108; Sarkar SK, 2011, MICROBIOL-SGM, V157, P2702, DOI 10.1099/mic.0.046227-0; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015275; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Urbach C, 2008, J BIOL CHEM, V283, P32516, DOI 10.1074/jbc.M805375200; Urbach C, 2009, J MOL BIOL, V386, P109, DOI 10.1016/j.jmb.2008.12.001; Wroe R, 2007, HFSP J, V1, P79, DOI [10.2976/1.2739116, 10.2976/1.2739116/10.2976/1]; YAMAMURA K, 1976, J CHEM SOC CHEM COMM, P830, DOI 10.1039/c39760000830; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	81	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40408	10.1371/journal.pone.0040408	http://dx.doi.org/10.1371/journal.pone.0040408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22811760	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400052
J	Franco, L; Sanchez, C; Bravo, R; Rodriguez, AB; Barriga, C; Romero, E; Cubero, J				Franco, Lourdes; Sanchez, Cristina; Bravo, Rafael; Rodriguez, Ana B.; Barriga, Carmen; Romero, Eulalia; Cubero, Javier			The Sedative Effect of Non-Alcoholic Beer in Healthy Female Nurses	PLOS ONE			English	Article							ESTROGENIC ACTIVITY; FIXED COMBINATION; HOPS; SLEEP; XANTHOHUMOL; EXTRACT; ANGIOGENESIS; CONSUMPTION; EFFICACY; INSOMNIA	Introduction: The hop (Humulus lupulus L.), a component of beer, is a sedative plant whose pharmacological activity is principally due to its bitter resins, in particular to the alpha-acid degradation product 2-methyl-3-buten-2-ol. The mechanism of action of hop resin consists of raising the levels of the neurotransmitter gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter acting in the central nervous system (CNS). Objectives: To analyze the sedative effect of hops as a component of non-alcoholic beer on the sleep/wake rhythm in a work-stressed population. Methods: The experiment was conducted with healthy female nurses (n = 17) working rotating and/or night shifts. Overnight sleep and chronobiological parameters were assessed by actigraphy (Actiwatch (R)) after moderate ingestion of non-alcoholic beer containing hops (333 ml with 0,0% alcohol) with supper for 14 days (treatment). Data were obtained in comparison with her own control group without consumption of beer during supper. Results: Actigraphy results demonstrated improvement of night sleep quality as regards the most important parameters: Sleep Latency diminished (p <= 0.05) in the Treatment group (12.01 +/- 1.19 min) when compared to the Control group (20.50 +/- 4.21 min), as also did Total Activity (p <= 0.05; Treatment group = 5284.78 +/- 836.99 activity pulses vs Control = 7258.78 +/- 898.89 activity pulses). In addition, anxiety as indexed by the State-Trait Anxiety Inventory (STAI) decreased in the Treatment group (State Anxiety 18.09 +/- 3.8 vs Control 20.69 +/- 2.14). Conclusion: The moderate consumption of non-alcoholic beer will favour night-time rest, due in particular to its hop components, in addition to its other confirmed benefits for the organism.	[Franco, Lourdes; Sanchez, Cristina; Bravo, Rafael; Rodriguez, Ana B.; Barriga, Carmen; Cubero, Javier] Univ Extremadura, Dept Physiol, Neuroimmunophysiol & Chrononutr Res Grp, Fac Sci, Badajoz, Spain; [Romero, Eulalia] Hosp Univ Infanta Cristina, SES, Badajoz, Spain; [Cubero, Javier] Univ Extremadura, Lab Hlth Educ, Sci Educ Area, Badajoz, Spain	Universidad de Extremadura; Universidad de Extremadura	Franco, L (corresponding author), Univ Extremadura, Dept Physiol, Neuroimmunophysiol & Chrononutr Res Grp, Fac Sci, Badajoz, Spain.	jcubero@unex.es	Bravo, R./K-8464-2018; Sanchez, Cristina L/C-7615-2009; Rodríguez, Ana/GQR-0554-2022; Rodríguez, Ana B./R-3544-2019; Juánez, Javier Cubero/AAE-2699-2020; Stevens, David/F-4683-2015	Bravo, R./0000-0001-6732-2205; Rodríguez, Ana B./0000-0001-6063-0504; Juánez, Javier Cubero/0000-0003-1658-1041; Sanchez, Cristina L./0000-0001-6380-4282	Proyectos de Iniciacion a la Investigacion y el Desarrollo Tecnologico; Consejeria de Sanidad y Dependencia, Junta de Extremadura; Vicerrectorado de Investigacion, Innovacion e Infraestructura Cientifica, Universidad de Extremadura; Centro de Informacion Cerveza y Salud (CICS)	Proyectos de Iniciacion a la Investigacion y el Desarrollo Tecnologico; Consejeria de Sanidad y Dependencia, Junta de Extremadura; Vicerrectorado de Investigacion, Innovacion e Infraestructura Cientifica, Universidad de Extremadura; Centro de Informacion Cerveza y Salud (CICS)	The authors gratefully acknowledge financial support for this study through the Plan I.D.T.I de la UEx, 2010 Accion VII, Proyectos de Iniciacion a la Investigacion y el Desarrollo Tecnologico; the Consejeria de Sanidad y Dependencia, Junta de Extremadura; the Vicerrectorado de Investigacion, Innovacion e Infraestructura Cientifica, Universidad de Extremadura; and the Centro de Informacion Cerveza y Salud (CICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourashed EA, 2004, PHYTOMEDICINE, V11, P633, DOI 10.1016/j.phymed.2004.03.005; Aoshima H, 2006, J AGR FOOD CHEM, V54, P2514, DOI 10.1021/jf051562a; Bravo L, 1974, Boll Chim Farm, V113, P310; Bravo R, 2011, ANN NUTR METAB; Cornu C, 2010, COMPLEMENT ALTERN ME, V22, P10; Cubero J, 2007, NEUROENDOCRINOL LETT, V28, P360; Cubero J, 2009, NUTR NEUROSCI, V12, P272, DOI 10.1179/147683009X423490; Deeb D, 2010, ANTICANCER RES, V30, P3333; Dimpfel W, 2008, EUR J MED RES, V13, P200; Figard H, 2008, PHYTOMEDICINE, V15, P185, DOI 10.1016/j.phymed.2007.09.016; HANSEL R, 1980, Z NATURFORSCH C, V35, P1096; Hernandez M., 1999, TRATADO NUTR; Klatsky AL, 2007, PHARMACOL RES, V55, P237, DOI 10.1016/j.phrs.2007.01.011; Koetter U, 2007, PHYTOTHER RES, V21, P847, DOI 10.1002/ptr.2167; Kotronoulas G, 2010, HORMONE, V8, P232; Lee K. M., 1993, Planta Medica, V59, pA691, DOI 10.1055/s-2006-959980; Macias MD, 2003, MED CLIN, V120, P138; Magalhaes PJ, 2009, NAT PROD COMMUN, V4, P591; Maldonado MD, 2009, CLIN NUTR, V28, P188, DOI 10.1016/j.clnu.2009.02.001; Meissner O, 2006, PLANTA MED, V72, P656, DOI 10.1055/s-2006-931609; Mellman TA, 2006, PSYCHIAT CLIN N AM, V29, P1047, DOI 10.1016/j.psc.2006.08.005; Milligan S, 2002, REPRODUCTION, V123, P235, DOI 10.1530/rep.0.1230235; Monteiro R, 2008, J CELL BIOCHEM, V104, P1699, DOI 10.1002/jcb.21738; Morin CM, 2005, SLEEP, V28, P1465, DOI 10.1093/sleep/28.11.1465; Negrao R, 2010, J CELL BIOCHEM, V111, P1270, DOI 10.1002/jcb.22850; Pedrera-Zamorano JD, 2009, NUTRITION, V25, P1057, DOI 10.1016/j.nut.2009.02.007; Romeo J, 2007, J PHYSIOL BIOCHEM, V63, P153, DOI 10.1007/BF03168226; Romeo J, 2007, NUTR HOSP, V22, P223; Romeo J, 2007, ANN NUTR METAB, V51, P359, DOI 10.1159/000107679; ROSENBLUM ER, 1993, ALCOHOL CLIN EXP RES, V17, P1207, DOI 10.1111/j.1530-0277.1993.tb05230.x; Ross SM, 2009, HOLIST NURS PRACT, V23, P253, DOI 10.1097/HNP.0b013e3181aed09d; Salter S, 2010, AUST FAM PHYSICIAN, V39, P433; Sanchez CL, 2010, REV ESP NUTR COMUNIT, V16, P160, DOI 10.1016/S1135-3074(10)70034-X; Schellenberg R, 2004, PLANTA MED, V70, P594, DOI 10.1055/s-2004-827180; Schiller H, 2006, PHYTOMEDICINE, V13, P535, DOI 10.1016/j.phymed.2006.05.010; Schmitz M, 1998, Wien Med Wochenschr, V148, P291; Spielberger CD, 2008, STAI CUESTIONARIO AN; Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025; Tucker KL, 2009, AM J CLIN NUTR, V89, P1188, DOI 10.3945/ajcn.2008.26765; Uhde TW, 2009, CURR PSYCHIAT REP, V11, P269, DOI 10.1007/s11920-009-0039-4; VanSomeren EJW, 1997, BIOL PSYCHIAT, V41, P955, DOI 10.1016/S0006-3223(97)89928-3; Vonderheid-Guth B, 2000, Eur J Med Res, V5, P139; Weeks BS, 2009, MED SCI MONITOR, V15, pRA256; WOHLFART R, 1983, PLANTA MED, V48, P120, DOI 10.1055/s-2007-969903; Zanoli P, 2007, J ETHNOPHARMACOL, V109, P87, DOI 10.1016/j.jep.2006.07.008; Zanoli P, 2005, J ETHNOPHARMACOL, V102, P102, DOI 10.1016/j.jep.2005.05.040; Zanoli P, 2008, J ETHNOPHARMACOL, V116, P383, DOI 10.1016/j.jep.2008.01.011	47	28	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e37290	10.1371/journal.pone.0037290	http://dx.doi.org/10.1371/journal.pone.0037290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815680	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900003
J	Santiago, HD; Bennuru, S; Ribeiro, JMC; Nutman, TB				Santiago, Helton da Costa; Bennuru, Sasisekhar; Ribeiro, Jose M. C.; Nutman, Thomas B.			Structural Differences between Human Proteins and Aero- and Microbial Allergens Define Allergenicity	PLOS ONE			English	Article							ASCARIS-LUMBRICOIDES; CHILDHOOD ASTHMA; CROSS-REACTIVITY; HAY-FEVER; IGE; INFECTION; SENSITIZATION; TROPOMYOSIN; MICROARRAY; RESPONSES	The current paradigm suggests that structural homology of allergenic proteins to microbial (particularly helminths) or human proteins underlie their allergenic nature. To examine systematically the structural relationships among allergens and proteins of pathogens (helminths, protozoans, fungi and bacteria) as they relate to allergenicity, we compared the amino acid sequence of 499 molecularly-defined allergens with the predicted proteomes of fifteen known pathogens, including Th2 inducing helminths and Th1-inducing protozoans, and humans using a variety of bioinformatic tools. Allergenicity was assessed based on IgE prevalences using publicly accessible databases and the literature. We found multiple homologues of common allergens among proteins of helminths, protozoans, fungi and humans, but not of bacteria. In contrast, 187 allergens showed no homology with any of the microbial genera studied. Interestingly, allergens without homologues or those with limited levels of sequence conservation were the most allergenic displaying high IgE prevalences in the allergic population. There was an inverse relationship between allergenicity and amino acid conservation levels with either parasite, including helminth, or human proteins. Our results suggest that allergenicity may be associated with the relative "uniqueness" of an antigen, i.e. immunogenicity, while similarity would lead to immunological tolerance.	[Santiago, Helton da Costa; Bennuru, Sasisekhar; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Santiago, HD (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	tnutman@niaid.nih.gov	Santiago, Helton/F-8704-2012; Santiago, Helton/AAA-8558-2021; Ribeiro, Jose/J-7011-2015	Santiago, Helton/0000-0002-5695-8256; Ribeiro, Jose/0000-0002-9107-0818	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000805, ZIAAI000810] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; AAS K, 1978, ALLERGY, V33, P3, DOI 10.1111/j.1398-9995.1978.tb01501.x; Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Capron A, 2002, BRIT MED BULL, V62, P139, DOI 10.1093/bmb/62.1.139; Caraballo Luis, 2011, Front Biosci (Elite Ed), V3, P51, DOI 10.2741/e219; D'Urbano LE, 2010, CLIN EXP ALLERGY, V40, P1561, DOI 10.1111/j.1365-2222.2010.03568.x; Dold S, 1998, J ALLERGY CLIN IMMUN, V102, P414, DOI 10.1016/S0091-6749(98)70129-0; DREBORG S, 1994, CLIN EXP ALLERGY, V24, P610, DOI 10.1111/j.1365-2222.1994.tb00963.x; Emanuelsson C, 2007, MOL IMMUNOL, V44, P3256, DOI 10.1016/j.molimm.2007.01.019; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fernandes JFC, 2010, CLIN IMMUNOL, V136, P148, DOI 10.1016/j.clim.2010.02.019; Fitzsimmons CM, 2009, TRENDS PARASITOL, V25, P447, DOI 10.1016/j.pt.2009.07.004; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; HOFFMAN DR, 1983, J ALLERGY CLIN IMMUN, V71, P481, DOI 10.1016/0091-6749(83)90465-7; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V119, P654, DOI 10.1016/j.jaci.2006.12.609; Karp CL, 2010, J ALLERGY CLIN IMMUN, V125, P955, DOI 10.1016/j.jaci.2010.03.002; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Okano M, 1999, J IMMUNOL, V163, P6712; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P1489, DOI 10.1164/rccm.2107020; Poulsen LK, 2009, CLIN EXP ALLERGY, V39, P623, DOI 10.1111/j.1365-2222.2009.03245.x; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Santiago HC, 2012, J ALLERGY C IN PRESS; Santiago HC, 2011, J ALLERGY CLIN IMMUN, V127, P479, DOI 10.1016/j.jaci.2010.11.007; Santos ABR, 2008, J ALLERGY CLIN IMMUN, V121, P1040, DOI 10.1016/j.jaci.2007.12.1147; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; Shea KM, 2008, J ALLERGY CLIN IMMUN, V122, P443, DOI 10.1016/j.jaci.2008.06.032; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Vercelli D, 2010, CURR OPIN ALLERGY CL; Virtanen T, 1999, IMMUNOL TODAY, V20, P398, DOI 10.1016/S0167-5699(99)01515-7; Yazdanbakhsh M, 2005, CURR OPIN ALLERGY CL, V5, P386, DOI 10.1097/01.all.0000182541.52971.eb; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	43	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40552	10.1371/journal.pone.0040552	http://dx.doi.org/10.1371/journal.pone.0040552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815762	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900030
J	Chan, CWS; Kaplan, W; Parish, CR; Khachigian, LM				Chan, Cecilia W. S.; Kaplan, Warren; Parish, Christopher R.; Khachigian, Levon M.			Reduced Retinal Microvascular Density, Improved Forepaw Reach, Comparative Microarray and Gene Set Enrichment Analysis with c-jun Targeting DNA Enzyme	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; MACULAR DEGENERATION; VISUAL IMPAIRMENT; CHOROIDAL NEOVASCULARIZATION; OCULAR NEOVASCULARIZATION; VASCULAR-PERMEABILITY; UNITED-STATES; PROBE LEVEL; SUPPRESSION	Retinal neovascularization is a critical component in the pathogenesis of common ocular disorders that cause blindness, and treatment options are limited. We evaluated the therapeutic effect of a DNA enzyme targeting c-jun mRNA in mice with preexisting retinal neovascularization. A single injection of Dz13 in a lipid formulation containing N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methyl-sulfate and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine inhibited c-Jun expression and reduced retinal microvascular density. The DNAzyme inhibited retinal microvascular density as effectively as VEGF-A antibodies. Comparative microarray and gene expression analysis determined that Dz13 suppressed not only c-jun but a range of growth factors and matrix-degrading enzymes. Dz13 in this formulation inhibited microvascular endothelial cell proliferation, migration and tubule formation in vitro. Moreover, animals treated with Dz13 sensed the top of the cage in a modified forepaw reach model, unlike mice given a DNAzyme with scrambled RNA-binding arms that did not affect c-Jun expression. These findings demonstrate reduction of microvascular density and improvement in forepaw reach in mice administered catalytic DNA.	[Chan, Cecilia W. S.; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Kaplan, Warren] Garvan Inst Med Res, Peter Wills Bioinformat Ctr, Sydney, NSW, Australia; [Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Ctr Vasc Res, Canberra, ACT 2601, Australia	University of New South Wales Sydney; Garvan Institute of Medical Research; Australian National University; John Curtin School of Medical Research	Chan, CWS (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	L.Khachigian@unsw.edu.au	Chan, Cecilia/E-7450-2013; Khachigian, Levon/AAZ-7458-2020	Parish, Christopher/0000-0001-7740-0430; Khachigian, Levon/0000-0003-3446-0323	Cancer Institute NSW; National Health and Medical Research Council (NHMRC)	Cancer Institute NSW; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from Cancer Institute NSW and the National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Truong A, 2011, J MOL MED, V89, P343, DOI 10.1007/s00109-010-0709-z; Bhindi R, 2007, AM J PATHOL, V171, P1079, DOI 10.2353/ajpath.2007.070120; Buch H, 2001, OPHTHALMOLOGY, V108, P2347, DOI 10.1016/S0161-6420(01)00823-5; Cai H, 2012, SCI TRANSLA IN PRESS; Campochiaro PA, 2003, ONCOGENE, V22, P6537, DOI 10.1038/sj.onc.1206773; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chan CWS, 2009, INTERN MED J, V39, P249, DOI 10.1111/j.1445-5994.2009.01799.x; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Das A, 2003, PROG RETIN EYE RES, V22, P721, DOI 10.1016/j.preteyeres.2003.08.001; de Mestre AM, 2003, J BIOL CHEM, V278, P50377, DOI 10.1074/jbc.M310154200; Dias N, 2002, MOL CANCER THER, V1, P347; Fahmy RG, 2006, NAT BIOTECHNOL, V24, P856, DOI 10.1038/nbt1225; Framme C, 2010, INVEST OPHTH VIS SCI, V51, P1671, DOI 10.1167/iovs.09-4496; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Group CR, 2011, N ENGL J MED; Heier JS, 2011, OPHTHALMOLOGY, V118, P1098, DOI 10.1016/j.ophtha.2011.03.020; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Khachigian LM, 2000, J CLIN INVEST, V106, P1189, DOI 10.1172/JCI11620; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P1660; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Lo R, 2008, LAB CHIP, V8, P1027, DOI 10.1039/b804690e; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4368, DOI 10.1167/iovs.09-3700; Neely KA, 1998, AM J PATHOL, V153, P665, DOI 10.1016/S0002-9440(10)65607-6; Ni Z, 2009, OPHTHALMOLOGICA, V223, P401, DOI 10.1159/000228926; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez J, 2002, OPHTHALMOLOGY, V109, P737, DOI 10.1016/S0161-6420(01)01008-9; Santiago FS, 1999, NAT MED, V5, P1438, DOI 10.1038/71020; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sone H, 1999, LIFE SCI, V65, P2573, DOI 10.1016/S0024-3205(99)00526-3; Spitzer MS, 2007, GRAEF ARCH CLIN EXP, V245, P1837, DOI 10.1007/s00417-007-0568-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tatar O, 2009, ARCH OPHTHALMOL-CHIC, V127, P275, DOI 10.1001/archophthalmol.2008.602; Terry T L, 1942, Trans Am Ophthalmol Soc, V40, P262; Waisbourd M, 2007, DRUG AGING, V24, P643, DOI 10.2165/00002512-200724080-00003; Wong TY, 2007, LANCET, V370, P204, DOI 10.1016/S0140-6736(07)61104-0; Zhang Q, 2009, GRAEF ARCH CLIN EXP, V247, P919, DOI 10.1007/s00417-009-1066-x	49	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e39160	10.1371/journal.pone.0039160	http://dx.doi.org/10.1371/journal.pone.0039160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815700	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000006
J	Jiang, TY; Ci, YP; Chou, WI; Lee, YC; Sun, YJ; Chou, WY; Li, KM; Chang, MDT				Jiang, Ting-Ying; Ci, Yuan-Pei; Chou, Wei-I; Lee, Yuan-Chuan; Sun, Yuh-Ju; Chou, Wei-Yao; Li, Kun-Mou; Chang, Margaret Dah-Tsyr			Two Unique Ligand-Binding Clamps of Rhizopus oryzae Starch Binding Domain for Helical Structure Disruption of Amylose	PLOS ONE			English	Article							ASPERGILLUS-NIGER GLUCOAMYLASE; ATOMIC-FORCE MICROSCOPY; STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURES; BIOLOGICAL ROLES; ALPHA-GLUCAN; CARBOHYDRATE; MODULE; RECOGNITION; PROTEIN	The N-terminal starch binding domain of Rhizopus oryzae glucoamylase (RoSBD) has a high binding affinity for raw starch. RoSBD has two ligand-binding sites, each containing a ligand-binding clamp: a polyN clamp residing near binding site I is unique in that it is expressed in only three members of carbohydrate binding module family 21 (CBM21) members, and a Y32/F58 clamp located at binding site II is conserved in several CBMs. Here we characterized different roles of these sites in the binding of insoluble and soluble starches using an amylose-iodine complex assay, atomic force microscopy, isothermal titration calorimetry, site-directed mutagenesis, and structural bioinformatics. RoSBD induced the release of iodine from the amylose helical cavity and disrupted the helical structure of amylose type III, thereby significantly diminishing the thickness and length of the amylose type III fibrils. A point mutation in the critical ligand-binding residues of sites I and II, however, reduced both the binding affinity and amylose helix disruption. This is the first molecular model for structure disruption of the amylose helix by a non-hydrolytic CBM21 member. RoSBD apparently twists the helical amylose strands apart to expose more ligand surface for further SBD binding. Repeating the process triggers the relaxation and unwinding of amylose helices to generate thinner and shorter amylose fibrils, which are more susceptible to hydrolysis by glucoamylase. This model aids in understanding the natural roles of CBMs in protein-glycan interactions and contributes to potential molecular engineering of CBMs.	[Jiang, Ting-Ying; Ci, Yuan-Pei; Chou, Wei-I; Lee, Yuan-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Jiang, Ting-Ying; Ci, Yuan-Pei; Chou, Wei-I; Lee, Yuan-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chou, Wei-I] Simpson Biotech Co Ltd, Tao Yuan, Taiwan; [Lee, Yuan-Chuan] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Sun, Yuh-Ju; Li, Kun-Mou] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Sun, Yuh-Ju; Li, Kun-Mou] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chou, Wei-I] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan	National Tsing Hua University; National Tsing Hua University; Johns Hopkins University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Jiang, TY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	dtchang@life.nthu.edu.tw			National Tsing Hua University, Taiwan [98N2903E1, 101N2060E1]; National Science Council, Taiwan [100-2628-B-007-003-MY3, 99-2311-B-007-007-MY3, 98-2917-I-007-105]; J.-C. Shen Tsing Hua Fellowship; Simpson Biotech Company, Ltd.	National Tsing Hua University, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); J.-C. Shen Tsing Hua Fellowship; Simpson Biotech Company, Ltd.	This work was funded by National Tsing Hua University, Taiwan (grants 98N2903E1 to M.D.-T.C., and 101N2060E1 to T.-Y.J.), National Science Council, Taiwan (grants 100-2628-B-007-003-MY3 to M.D.-T.C., 99-2311-B-007-007-MY3 to Y.-J.S., and 98-2917-I-007-105 to W.-Y.C.), J.-C. Shen Tsing Hua Fellowship to T.-Y.J., and Simpson Biotech Company, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; BAILEY JM, 1961, J BIOL CHEM, V236, P969; Baker AA, 2001, CARBOHYD RES, V330, P249, DOI 10.1016/S0008-6215(00)00275-5; BHIDE SV, 1976, BIOCHIM BIOPHYS ACTA, V444, P719, DOI 10.1016/0304-4165(76)90319-6; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chou WI, 2006, BIOCHEM J, V396, P469, DOI 10.1042/BJ20051982; Chou WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024814; Chou WY, 2010, BIOINFORMATICS, V26, P1022, DOI 10.1093/bioinformatics/btq084; Cohen R, 2011, J AGR FOOD CHEM, V59, P7932, DOI 10.1021/jf2013277; Coutinho PM, 1997, PROTEINS, V29, P334, DOI [10.1002/(SICI)1097-0134(199711)29:3<334::AID-PROT7>3.0.CO;2-A, 10.1002/(SICI)1097-0134(199711)29:3&lt;334::AID-PROT7&gt;3.0.CO;2-A]; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Frandsen TP, 1999, ENG SPECIFICITY STAB, P189; Giardina T, 2001, J MOL BIOL, V313, P1149, DOI 10.1006/jmbi.2001.5097; Glaring MA, 2011, FEBS J, V278, P1175, DOI 10.1111/j.1742-4658.2011.08043.x; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Heuer WB, 1999, MACROMOL SYMP, V138, P79, DOI 10.1002/masy.19991380109; IMBERTY A, 1988, J MOL BIOL, V201, P365, DOI 10.1016/0022-2836(88)90144-1; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirby AR, 1996, BIOPOLYMERS, V38, P355, DOI 10.1002/(SICI)1097-0282(199603)38:3<355::AID-BIP8>3.0.CO;2-T; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Lin SC, 2009, PROTEIN EXPRES PURIF, V65, P261, DOI 10.1016/j.pep.2009.01.008; Liu YF, 2012, J AGR FOOD CHEM, V60, P4914, DOI 10.1021/jf300957k; Liu YN, 2007, BIOCHEM J, V403, P21, DOI 10.1042/BJ20061312; Machovic M, 2005, FEBS J, V272, P5497, DOI 10.1111/j.1742-4658.2005.04942.x; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; McIntire TM, 1999, INT J BIOL MACROMOL, V26, P303, DOI 10.1016/S0141-8130(99)00097-5; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; Mikkelsen R, 2006, BIOCHEMISTRY-US, V45, P4674, DOI 10.1021/bi051712a; Morris VJ, 2005, STARCH-STARKE, V57, P1, DOI 10.1002/star.200400333; Paldi T, 2003, BIOCHEM J, V372, P905, DOI 10.1042/BJ20021527; Parker R, 2001, J CEREAL SCI, V34, P1, DOI 10.1006/jcrs.2000.0402; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Redel E, 2009, CHEM COMMUN, P2103, DOI 10.1039/b820151j; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Stanley D, 2011, PLANT PHYSIOL, V155, P932, DOI 10.1104/pp.110.168328; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Tung JY, 2008, BIOCHEM J, V416, P27, DOI 10.1042/BJ20080580; Valdez HA, 2008, BIOCHEMISTRY-US, V47, P3026, DOI 10.1021/bi702418h; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Vincent TC, 1999, J POLYM SCI A, V37, P2711; Williamson MP, 1997, BIOCHEMISTRY-US, V36, P7535, DOI 10.1021/bi9702896; Xie HF, 2001, BIOCHEMISTRY-US, V40, P5700, DOI 10.1021/bi010034z; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032; Zabar S, 2009, FOOD HYDROCOLLOID, V23, P1918, DOI 10.1016/j.foodhyd.2009.02.004	58	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41131	10.1371/journal.pone.0041131	http://dx.doi.org/10.1371/journal.pone.0041131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815939	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000070
J	Liu, GX; Zhang, Q; Zhu, H; Hu, ZY				Liu, Guoxiang; Zhang, Qi; Zhu, Huan; Hu, Zhengyu			Massive Trentepohlia-Bloom in a Glacier Valley of Mt. Gongga, China, and a New Variety of Trentepohlia (Chlorophyta)	PLOS ONE			English	Article							PRINTZINA TRENTEPOHLIALES; PHYLOGENY; GROWTH	Trentepohlia is a genus of subaerial green algae which is widespread in tropical, subtropical, and also temperate regions with humid climates. For many years, small-scale Trentepohlia coverage had been found on the rocks of some glacier valleys on the northern slopes of Mt. Gongga, China. However, since 2005, in the Yajiageng river valley, most of the rocks are covered with deep red coloured algal carpets, which now form a spectacular sight and a tourist attraction known as 'Red-Stone-Valley'. Based on morphology and molecular data, we have named this alga as a new variety: Trentepohlia jolithus var. yajiagengensis var. nov., it differs from the type variety in that its end cells of the main filament are often rhizoid, unilateral branches. This new variety only grows on the native rock, both global warming and human activity have provided massive areas of suitable substrata: the rocks surfaces of the Yajiageng river valley floodplain were re-exposed because of heavy debris flows in the summer of 2005; plus human activities such as tourism and road-building have also created a lot of exposed rock! In summer, the glaciers of the northern slopes of Mt. Gongga have brought to the valleys wet and foggy air, ideal for Trentepohlia growth. The cells of the new variety are rich in secondary carotenoids (astaxanthin?), which helps the algal cells resistance to strong ultraviolet radiation at high altitudes (they are only found on rock surfaces at alt. 1900-3900 m); the cells are also rich in oils, which gives them high resistance to cold dry winters.	[Liu, Guoxiang; Zhang, Qi; Zhu, Huan; Hu, Zhengyu] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China; [Zhang, Qi; Zhu, Huan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, GX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China.	liugx@ihb.ac.cn	Liu, Guoxiang/L-7413-2019	Liu, Guoxiang/0000-0001-8565-2363	National Natural Science Foundation of China [30870163, 30970501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant no. 30870163, 30970501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1998, J MAR BIOTECHNOL, V6, P53; Akiyama M, 1961, B SHIMANE U NATURAL, V10, P75; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Bourrelly P, 1966, ALGUES VERTS; Chapman R. L., 1984, SYSTEMATICS GREEN AL, P233; [陈晓清 CHEN Xiaoqing], 2006, [水土保持通报, Bulletin of Soil and Water Conservation], V26, P122; Fischer R., 1922, OSTERR BOT ZEIT, V71, P1; Gildemeister E, 1916, VOLATILE OILS; Google Inc, 2011, GOOGL EARTH VERS 6 0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMBY RK, 1988, PLANT MOL BIOL REP, V6, P175, DOI DOI 10.1007/BF02669591; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huo CF, 2010, J FOREST RES-JPN, V15, P176, DOI 10.1007/s10310-009-0173-1; KJOSEN H, 1972, ACTA CHEM SCAND, V26, P3053, DOI 10.3891/acta.chem.scand.26-3053; Krishnamurthy V, 2000, ALGAE INDIA NEIGHBOU; Li ZX, 2010, QUATERN INT, V218, P166, DOI 10.1016/j.quaint.2008.09.005; Lu XY, 2009, SOIL BIOL BIOCHEM, V41, P1015, DOI 10.1016/j.soilbio.2008.10.028; [吕玉香 LU Yuxiang], 2008, [冰川冻土, Journal of Glaciology and Geocryology], V30, P960; McNeill J., 2006, V146, P1; Mei H, 2007, PLANT SYST EVOL, V265, P179, DOI 10.1007/s00606-007-0523-4; Mukherjee R, 2010, J APPL PHYCOL, V22, P569, DOI 10.1007/s10811-009-9495-9; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prescott GW, 1963, ALGAE OF THE WESTERN; PRINTZ HENRIK, 1964, HYDROBIOLOGIA, V24, P1, DOI 10.1007/BF00170411; PRINTZ HENRIK, 1939, NYTT MAG NATURVIDENSK, V80, P137; Rindi F, 2005, PHYCOLOGIA, V44, P270, DOI 10.2216/0031-8884(2005)44[270:TADOTA]2.0.CO;2; Rindi F, 2002, J PHYCOL, V38, P39, DOI 10.1046/j.1529-8817.2002.01193.x; Rindi F, 2009, MOL PHYLOGENET EVOL, V52, P329, DOI 10.1016/j.ympev.2009.01.009; Sarma P., 1986, NOVA HEDWIGIA, V58, P1; Saxena PN, 1961, B NATL BOT GARDEN; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON RH, 1997, MORPHOLOGY TAXONOMY; Zhong X.H., 1997, RES FOREST ECOSYSTEM	35	11	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e37725	10.1371/journal.pone.0037725	http://dx.doi.org/10.1371/journal.pone.0037725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815686	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100007
J	Meglecz, E; Neve, G; Biffin, E; Gardner, MG				Meglecz, Emese; Neve, Gabriel; Biffin, Ed; Gardner, Michael G.			Breakdown of Phylogenetic Signal: A Survey of Microsatellite Densities in 454 Shotgun Sequences from 154 Non Model Eukaryote Species	PLOS ONE			English	Article							TANDEM REPEATS; ESCHERICHIA-COLI; GENOME DATA; MUTATION; DNA; EVOLUTION; FREQUENCY; INFERENCE; ELEMENTS; LOCI	Microsatellites are ubiquitous in Eukaryotic genomes. A more complete understanding of their origin and spread can be gained from a comparison of their distribution within a phylogenetic context. Although information for model species is accumulating rapidly, it is insufficient due to a lack of species depth, thus intragroup variation is necessarily ignored. As such, apparent differences between groups may be overinflated and generalizations cannot be inferred until an analysis of the variation that exists within groups has been conducted. In this study, we examined microsatellite coverage and motif patterns from 454 shotgun sequences of 154 Eukaryote species from eight distantly related phyla (Cnidaria, Arthropoda, Onychophora, Bryozoa, Mollusca, Echinodermata, Chordata and Streptophyta) to test if a consistent phylogenetic pattern emerges from the microsatellite composition of these species. It is clear from our results that data from model species provide incomplete information regarding the existing microsatellite variability within the Eukaryotes. A very strong heterogeneity of microsatellite composition was found within most phyla, classes and even orders. Autocorrelation analyses indicated that while microsatellite contents of species within clades more recent than 200 Mya tend to be similar, the autocorrelation breaks down and becomes negative or non-significant with increasing divergence time. Therefore, the age of the taxon seems to be a primary factor in degrading the phylogenetic pattern present among related groups. The most recent classes or orders of Chordates still retain the pattern of their common ancestor. However, within older groups, such as classes of Arthropods, the phylogenetic pattern has been scrambled by the long independent evolution of the lineages.	[Meglecz, Emese; Neve, Gabriel] Aix Marseille Univ, CNRS, IRD, IMBE,UMR 7263, Marseille, France; [Meglecz, Emese; Neve, Gabriel; Gardner, Michael G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Biffin, Ed] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Gardner, Michael G.] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Flinders University South Australia; University of Adelaide	Meglecz, E (corresponding author), Aix Marseille Univ, CNRS, IRD, IMBE,UMR 7263, Marseille, France.	emese.meglecz@imbe.fr	Gardner, Michael G/A-8280-2011	Gardner, Michael G/0000-0002-8629-354X	institutional support from the Flinders University; Department of Environment and Natural Resources South Australia	institutional support from the Flinders University; Department of Environment and Natural Resources South Australia	Development of this work was funded by institutional support from the Flinders University and the Department of Environment and Natural Resources South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi P, 2003, GENE, V317, P117, DOI 10.1016/S0378-1119(03)00659-0; Beck NR, 2003, MOL BIOL EVOL, V20, P54, DOI 10.1093/molbev/msg005; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brohede J, 2002, NUCLEIC ACIDS RES, V30, P1997, DOI 10.1093/nar/30.9.1997; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; Duhagon MA, 2011, GENE, V487, P29, DOI 10.1016/j.gene.2011.07.022; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Galindo CL, 2009, MOL BIOL EVOL, V26, P2809, DOI 10.1093/molbev/msp192; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Goldstein D, 1999, MICROSATELLITES EVOL; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Gur-Arie R, 2000, GENOME RES, V10, P62; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Jarne P, 1998, MOL BIOL EVOL, V15, P28, DOI 10.1093/oxfordjournals.molbev.a025844; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kelkar YD, 2010, GENOME BIOL EVOL, V2, P620, DOI 10.1093/gbe/evq046; Kim TS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-31; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kofler R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-612; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Leclercq S, 2010, GENOME BIOL EVOL, V2, P325, DOI 10.1093/gbe/evq023; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Meglecz E, 2007, INSECT MOL BIOL, V16, P175, DOI 10.1111/j.1365-2583.2006.00713.x; Meglecz Emese, 2012, BMC Res Notes, V5, P259; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Merkel A, 2008, BRIEF BIOINFORM, V9, P355, DOI 10.1093/bib/bbn028; Merkel A, 2008, EVOL BIOINFORM, V4, P1; Messier W, 1996, NATURE, V381, P483, DOI 10.1038/381483a0; MOORE SS, 1991, GENOMICS, V10, P654, DOI 10.1016/0888-7543(91)90448-N; Ohashi J, 2003, J HUM GENET, V48, P487, DOI 10.1007/s10038-003-0058-7; Pannebakker BA, 2010, INSECT MOL BIOL, V19, P91, DOI 10.1111/j.1365-2583.2009.00915.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pelizzola M, 2011, FEBS LETT, V585, P1994, DOI 10.1016/j.febslet.2010.10.061; Primmer CR, 1998, MOL BIOL EVOL, V15, P1047, DOI 10.1093/oxfordjournals.molbev.a026003; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Santure AW, 2009, GENETICS, V181, P259, DOI [10.1534/genetics.108.097998, 10.1534/genetics.108.100214]; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Sigwart JD, 2007, P R SOC B, V274, P2413, DOI 10.1098/rspb.2007.0701; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Souames SM, 2003, MOL BIOL EVOL, V20, P1826, DOI 10.1093/molbev/msg194; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Whittaker JC, 2003, GENETICS, V164, P781; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilder J, 2001, MOL BIOL EVOL, V18, P384, DOI 10.1093/oxfordjournals.molbev.a003814; Zhu Y, 2000, GENET RES, V76, P227, DOI 10.1017/S001667230000478X	70	39	44	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40861	10.1371/journal.pone.0040861	http://dx.doi.org/10.1371/journal.pone.0040861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815847	Green Published, gold			2022-12-27	WOS:000306466100085
J	Nishijo, M; Tai, PT; Nakagawa, H; Maruzeni, S; Nguyen, TNA; Luong, HV; Anh, TH; Honda, R; Morikawa, Y; Kido, T; Nishijo, H				Nishijo, Muneko; Pham The Tai; Nakagawa, Hideaki; Maruzeni, Shoko; Nguyen Thi Nguyet Anh; Hoang Van Luong; Tran Hai Anh; Honda, Ryumon; Morikawa, Yuko; Kido, Teruhiko; Nishijo, Hisao			Impact of Perinatal Dioxin Exposure on Infant Growth: A Cross-Sectional and Longitudinal Studies in Dioxin-Contaminated Areas in Vietnam	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; AGENT-ORANGE; ENVIRONMENTAL EXPOSURE; CAMKII PHOSPHORYLATION; HEAD CIRCUMFERENCE; PRENATAL EXPOSURE; MATERNAL EXPOSURE; WASTING SYNDROME; BIRTH-WEIGHT; BREAST-MILK	Dioxin exposure levels remain elevated in residents living around former US Air Force bases in Vietnam, indicating potential adverse impacts on infant growth. In this study, 210 mother-infant pairs in dioxin-contaminated areas in Vietnam were recruited at the infants' birth and followed up for 4 months. Perinatal dioxin exposure levels were estimated by measurement of polychlorinated dibenzo-p-dioxins/furans toxic equivalent (PCDDs/Fs-TEQ) in breast milk. The infants' size was measured at birth and 1 and 4 months after birth, and neurodevelopment was evaluated using the Bayley Scales III at 4 months of age. Among 4 dioxin groups (<25, 25-50, 50-75, >= 75 percentile of PCDDs/Fs-TEQ), cross-sectional comparisons of body size and neurodevelopment scales and comparisons of longitudinally assessed body size were performed respectively. At birth, head circumference of girls in the >= 75 percentile group was significantly larger than those in the <25 and 50-75 percentile groups. At 4 months of age, the weight and body mass index (BMI) of boys in the >= 75 percentile group were significantly lower than those in the other groups. Increase in weight was significantly lower in the >= 75 percentile group in both sexes from birth to 1 month but only in boys at 1-4 months of age. Estimated marginal mean values in a mixed model of weight and BMI during the first 4 months of life were significantly lower in the >= 75 percentile group in boys. In girls, marginal mean values for head circumference were increased with increase in dioxin levels. Only in boys, cognitive, language, and fine motor scores in the >= 75 percentile group were significantly lower than those in the other groups. These results suggested a considerable impact of perinatal dioxin exposure on infant growth, particularly in boys exposed to dioxins at high level of PCDDs/Fs-TEQ.	[Nishijo, Muneko; Pham The Tai; Nakagawa, Hideaki; Maruzeni, Shoko; Nguyen Thi Nguyet Anh] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan; [Pham The Tai; Hoang Van Luong; Tran Hai Anh] Vietnam Mil Med Univ, Biomed & Pharmaceut Res Ctr, Hanoi, Vietnam; [Honda, Ryumon; Morikawa, Yuko] Kanazawa Med Univ, Sch Nursing, Uchinada, Ishikawa 92002, Japan; [Kido, Teruhiko] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Nishijo, Hisao] Toyama Univ, Grad Sch Med, Toyama 930, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa University; University of Toyama	Nishijo, M (corresponding author), Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan.	ni-koei@kanazawa-med.ac.jp			High-Technology Center of Kanazawa Medical University [H2006-9]; Mitsui Co. Ltd. [R07-184]; Japan Society for the promotion of science [22590556, 22240051]; Ministry of Education, Science, Sports and Culture; Grants-in-Aid for Scientific Research [22240051] Funding Source: KAKEN	High-Technology Center of Kanazawa Medical University; Mitsui Co. Ltd.(Mitsui & Co., LTD.); Japan Society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by Project Research from High-Technology Center of Kanazawa Medical University (H2006-9), Mitsui & Co. Ltd. (R07-184), the Japan Society for the promotion of science (Grant-in-Aid for Scientific Research (C) (22590556) and Grant-in-Aid for Scientific Research (A) (22240051)), and JSPS (Japan Society for the Promotion of Science) Asian Core Program, the Ministry of Education, Science, Sports and Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns JS, 2011, PEDIATRICS, V127, pE59, DOI 10.1542/peds.2009-3556; CHEN YCJ, 1992, JAMA-J AM MED ASSOC, V268, P3213, DOI 10.1001/jama.268.22.3213; CHRISTIAN BJ, 1986, TOXICOL APPL PHARM, V82, P239, DOI 10.1016/0041-008X(86)90199-7; Dwernychuk LW, 2005, CHEMOSPHERE, V60, P998, DOI 10.1016/j.chemosphere.2005.01.052; Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828; Eskenazi B, 2010, ENVIRON HEALTH PERSP, V118, P1775, DOI 10.1289/ehp.1002234; Fetissov SO, 2004, REGUL PEPTIDES, V119, P113, DOI 10.1016/j.regpep.2004.01.009; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Guo YLL, 2004, INT ARCH OCC ENV HEA, V77, P153, DOI 10.1007/s00420-003-0487-9; Hatfield Consultants Office of the National Steering Committee 33 MONRE, 2009, COMPR ASS DIOX CONT; Hays LE, 2002, ENVIRON HEALTH PERSP, V110, P369, DOI 10.1289/ehp.02110s3369; Houston CM, 2009, J PHYSIOL-LONDON, V587, P2115, DOI 10.1113/jphysiol.2009.171603; KANNAN K, 1992, ARCH ENVIRON CON TOX, V22, P367, DOI 10.1007/BF00212555; KELLING CK, 1985, FUND APPL TOXICOL, V5, P700, DOI 10.1016/0272-0590(85)90194-0; KoopmanEsseboom C, 1996, PEDIATRICS, V97, P700; Lagiou P, 2005, EUR J NUTR, V44, P52, DOI 10.1007/s00394-004-0491-1; Lindley AA, 2000, AM J EPIDEMIOL, V152, P219, DOI 10.1093/aje/152.3.219; Mai TA, 2007, CHEMOSPHERE, V67, P1802, DOI 10.1016/j.chemosphere.2006.05.086; McKean-Cowdin R, 2006, LANCET ONCOL, V7, P4, DOI 10.1016/S1470-2045(05)70514-3; McLennan JE, 1983, DEV HUMAN BRAIN GROW, P43; Miner P, 2010, BRAIN RES, V1355, P86, DOI 10.1016/j.brainres.2010.07.109; Nakajima S, 2006, ENVIRON HEALTH PERSP, V114, P773, DOI 10.1289/ehp.8614; Nishijo M, 2008, J EXPO SCI ENV EPID, V18, P246, DOI 10.1038/sj.jes.7500589; Nishijo M, 2007, TOXICOL LETT, V173, P41, DOI 10.1016/j.toxlet.2007.06.007; Patandin S, 1999, J PEDIATR-US, V134, P33, DOI 10.1016/S0022-3476(99)70369-0; Patandin S, 1998, PEDIATR RES, V44, P538, DOI 10.1203/00006450-199810000-00012; Tai PT, 2011, ENVIRON SCI TECHNOL, V45, P6625, DOI 10.1021/es201666d; ROGAN WJ, 1988, SCIENCE, V241, P334, DOI 10.1126/science.3133768; Schecter A, 2006, J OCCUP ENVIRON MED, V48, P408, DOI 10.1097/01.jom.0000194153.77646.7d; SCHECTER A, 1995, AM J PUBLIC HEALTH, V85, P516, DOI 10.2105/AJPH.85.4.516; Schecter A, 2002, J OCCUP ENVIRON MED, V44, P218, DOI 10.1097/00043764-200203000-00003; Stellman JM, 2003, NATURE, V422, P681, DOI 10.1038/nature01537; Szajewska H, 2006, AM J CLIN NUTR, V83, P1337, DOI 10.1093/ajcn/83.6.1337; Tawara K., 2003, J KANAZAWA MED U, V28, P17; Tawara Kenji, 2009, Environmental Health and Preventive Medicine, V14, P88, DOI 10.1007/s12199-008-0061-x; Tsukimori K, 2012, ENVIRON INT, V38, P79, DOI 10.1016/j.envint.2011.08.010; TUOMISTO JT, 1995, EUR J PHARM-ENVIRON, V293, P309, DOI 10.1016/0926-6917(95)90050-0; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055	38	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40273	10.1371/journal.pone.0040273	http://dx.doi.org/10.1371/journal.pone.0040273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815734	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100033
J	Shrivastava, N; Nag, JK; Misra-Bhattacharya, S				Shrivastava, Nidhi; Nag, Jeetendra Kumar; Misra-Bhattacharya, Shailja			Molecular Characterization of NAD(+)-Dependent DNA Ligase from Wolbachia Endosymbiont of Lymphatic Filarial Parasite Brugia malayi	PLOS ONE			English	Article							ALPHA-PROTEOBACTERIA; MUTATIONAL ANALYSES; ESCHERICHIA-COLI; INHIBITION; CLONING; EVOLUTION; LIGATION; PROTEINS; DOMAINS; BINDING	The lymphatic filarial parasite, Brugia malayi contains Wolbachia endobacteria that are essential for development, viability and fertility of the parasite. Therefore, wolbachial proteins have been currently seen as the potential antifilarial drug targets. NAD(+)-dependent DNA ligase is characterized as a promising drug target in several organisms due to its crucial, indispensable role in DNA replication, recombination and DNA repair. We report here the cloning, expression and purification of NAD(+)-dependent DNA ligase of Wolbachia endosymbiont of B. malayi (wBm-LigA) for its molecular characterization. wBm-LigA has all the domains that are present in nearly all the eubacterial NAD(+)-dependent DNA ligases such as N-terminal adenylation domain, OB fold, helix-hairpin-helix (HhH) and BRCT domain except zinc-binding tetracysteine domain. The purified recombinant protein (683-amino acid) was found to be biochemically active and was present in its native form as revealed by the circular dichroism and fluorescence spectra. The purified recombinant enzyme was able to catalyze intramolecular strand joining on a nicked DNA as well as intermolecular joining of the cohesive ends of BstEII restricted lamda DNA in an in vitro assay. The enzyme was localized in the various life-stages of B. malayi parasites by immunoblotting and high enzyme expression was observed in Wolbachia within B. malayi microfilariae and female adult parasites along the hypodermal chords and in the gravid portion as evident by the confocal microscopy. Ours is the first report on this enzyme of Wolbachia and these findings would assist in validating the antifilarial drug target potential of wBm-LigA in future studies.	[Shrivastava, Nidhi; Nag, Jeetendra Kumar; Misra-Bhattacharya, Shailja] Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Shrivastava, N (corresponding author), Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India.	shailja_cdri@rediffmail.com			Council for Scientific and Industrial Research Institute, New Delhi, India	Council for Scientific and Industrial Research Institute, New Delhi, India	supported by Council for Scientific and Industrial Research Institute, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PA, 2001, PROTEINS, P39; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brotz-Oesterhelt H, 2003, J BIOL CHEM, V278, P39435, DOI 10.1074/jbc.M306479200; Ciarrocchi G, 1999, ANTIMICROB AGENTS CH, V43, P2766, DOI 10.1128/AAC.43.11.2766; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Ettema TJG, 2009, BIOL LETTERS, V5, P429, DOI 10.1098/rsbl.2008.0793; Ferrer M, 2008, P NATL ACAD SCI USA, V105, P8878, DOI 10.1073/pnas.0800071105; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Georlette D, 2000, EUR J BIOCHEM, V267, P3502, DOI 10.1046/j.1432-1327.2000.01377.x; GOTTESMAN MM, 1973, J MOL BIOL, V77, P531, DOI 10.1016/0022-2836(73)90221-0; Grothe HL, 2009, MOL VIS, V15, P2617; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kaczmarek FS, 2001, J BACTERIOL, V183, P3016, DOI 10.1128/JB.183.10.3016-3024.2001; Keppetipola N, 2005, J BACTERIOL, V187, P6902, DOI 10.1128/JB.187.20.6902-6908.2005; LEHMAN IR, 1974, SCIENCE, V186, P790; Lim JH, 2001, ARCH BIOCHEM BIOPHYS, V388, P253, DOI 10.1006/abbi.2001.2291; LINDAHL T, 1992, ANNU REV BIOCHEM, V61, P251, DOI 10.1146/annurev.bi.61.070192.001343; Lu J, 2004, BBA-PROTEINS PROTEOM, V1701, P37, DOI 10.1016/j.bbapap.2004.06.008; Machala M. K., 2007, ANTIMICROB AGENTS CH, V51, P2888; Muerhoff AS, 2004, J VIROL METHODS, V119, P171, DOI 10.1016/j.jviromet.2004.04.003; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petit MA, 2000, NUCLEIC ACIDS RES, V28, P4642, DOI 10.1093/nar/28.23.4642; Sambrook J, 2000, MOL CLONING LAB MANU, V2, P916; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Seo MS, 2007, J BIOTECHNOL, V128, P519, DOI 10.1016/j.jbiotec.2006.09.024; Singh M, 2009, PARASITOL RES, V104, P753, DOI 10.1007/s00436-008-1251-6; Sriskanda V, 2001, J BIOL CHEM, V276, P36100, DOI 10.1074/jbc.M105643200; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Taylor MJ, 2001, CURR OPIN INFECT DIS, V14, P727, DOI 10.1097/00001432-200112000-00011; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Wilkinson A, 2005, BBA-PROTEINS PROTEOM, V1749, P113, DOI 10.1016/j.bbapap.2005.03.003	35	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41113	10.1371/journal.pone.0041113	http://dx.doi.org/10.1371/journal.pone.0041113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815933	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100120
J	Zhou, CE; Dong, W; Han, L; Wei, JJ; Jia, L; Tan, Y; Zhi, DY; Wang, ZY; Xia, GM				Zhou, Chuanen; Dong, Wei; Han, Lu; Wei, Jiajie; Jia, Li; Tan, Yang; Zhi, Daying; Wang, Zeng-Yu; Xia, Guangmin			Construction of Whole Genome Radiation Hybrid Panels and Map of Chromosome 5A of Wheat Using Asymmetric Somatic Hybridization	PLOS ONE			English	Article							BUPLEURUM-SCORZONERIFOLIUM WILLD; TRITICUM-AESTIVUM L.; SEQUENCE TAG LOCI; ARABIDOPSIS-THALIANA; BIN MAP; PLANT-REGENERATION; BRASSICA-NAPUS; PHYSICAL MAP; GENE; NICOTIANA	To explore the feasibility of constructing a whole genome radiation hybrid (WGRH) map in plant species with large genomes, asymmetric somatic hybridization between wheat (Triticum aestivum L.) and Bupleurum scorzonerifolium Willd. was performed. The protoplasts of wheat were irradiated with ultraviolet light (UV) and gamma-ray and rescued by protoplast fusion using B. scorzonerifolium as the recipient. Assessment of SSR markers showed that the radiation hybrids have the average marker retention frequency of 15.5%. Two RH panels (RHPWI and RHPWII) that contained 92 and 184 radiation hybrids, respectively, were developed and used for mapping of 68 SSR markers in chromosome 5A of wheat. A total of 1557 and 2034 breaks were detected in each panel. The RH map of chromosome 5A based on RHPWII was constructed. The distance of the comprehensive map was 2103 cR and the approximate resolution was estimated to be similar to 501.6 kb/break. The RH panels evaluated in this study enabled us to order the ESTs in a single deletion bin or in the multiple bins cross the chromosome. These results demonstrated that RH mapping via protoplast fusion is feasible at the whole genome level for mapping purposes in wheat and the potential value of this mapping approach for the plant species with large genomes.	[Zhou, Chuanen; Dong, Wei; Han, Lu; Wei, Jiajie; Jia, Li; Zhi, Daying; Xia, Guangmin] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan 250100, Shandong, Peoples R China; [Zhou, Chuanen; Tan, Yang; Wang, Zeng-Yu] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK USA	Shandong University; Noble Research Institute	Zhou, CE (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan 250100, Shandong, Peoples R China.	xiagm@sdu.edu.cn		zhou, chuanen/0000-0001-5667-0255	National Basic Research 973 Program of China [2009CB118305]; National Natural Science Foundation of China [31030053]	National Basic Research 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the funds of the National Basic Research 973 Program of China (2009CB118305) and Major Program of the National Natural Science Foundation of China (No. 31030053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiev EV, 1997, P NATL ACAD SCI USA, V94, P3524, DOI 10.1073/pnas.94.8.3524; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; BATES GW, 1987, THEOR APPL GENET, V74, P718, DOI 10.1007/BF00247548; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DeFilippis L, 1996, PLANT SCI, V121, P39, DOI 10.1016/S0168-9452(96)04505-0; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Fleury D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-382; Forsberg J, 1998, PLANT SCI, V131, P65, DOI 10.1016/S0168-9452(97)00242-2; Forsberg J, 1998, THEOR APPL GENET, V96, P1178, DOI 10.1007/s001220050854; Gao WX, 2006, MOL GENET GENOMICS, V275, P105, DOI 10.1007/s00438-005-0069-5; Gao WX, 2004, GENETICS, V167, P1317, DOI 10.1534/genetics.103.020479; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; Guyon R, 2010, GENOMICS, V96, P228, DOI 10.1016/j.ygeno.2010.07.007; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HINNISDAELS S, 1991, THEOR APPL GENET, V82, P609, DOI 10.1007/BF00226798; Hossain KG, 2004, GENETICS, V168, P687, DOI 10.1534/genetics.104.034850; Hossain KG, 2004, GENETICS, V168, P415, DOI 10.1534/genetics.103.022590; Jones HB, 1996, GENOME RES, V6, P761, DOI 10.1101/gr.6.8.761; Kalavacharla V, 2006, GENETICS, V173, P1089, DOI 10.1534/genetics.106.056481; Kalavacharla V, 2009, ADV AGRON, V102, P201, DOI 10.1016/S0065-2113(09)01006-2; Linkiewicz AM, 2004, GENETICS, V168, P665, DOI 10.1534/genetics.104.034835; Luo MC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-122; Masoudi-Nejad A, 2005, MOL GENET GENOMICS, V274, P589, DOI 10.1007/s00438-005-0052-1; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Park CC, 2008, NAT GENET, V40, P421, DOI 10.1038/ng.113; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; RAMULU KS, 1992, PHYSIOL PLANTARUM, V85, P315, DOI [10.1034/j.1399-3054.1992.850226.x, 10.1111/j.1399-3054.1992.tb04740.x]; Riera-Lizarazu O, 2008, CYTOGENET GENOME RES, V120, P233, DOI 10.1159/000121072; Riera-Lizarazu O, 2000, GENETICS, V156, P327; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; STEWART EA, 1997, GENOME MAPPING, P72; Vitulo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026421; Vlahova M, 1997, THEOR APPL GENET, V94, P184, DOI 10.1007/s001220050398; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; Wang MQ, 2008, PLANT CELL TISS ORG, V92, P121, DOI 10.1007/s11240-007-9308-2; Wang MQ, 2005, PLANT SCI, V168, P593, DOI 10.1016/j.plantsci.2004.09.017; Wardrop J, 2004, THEOR APPL GENET, V108, P343, DOI 10.1007/s00122-003-1434-6; Wardrop J, 2002, PLANT J, V31, P223, DOI 10.1046/j.1365-313X.2002.01351.x; Watanabe TK, 1999, NAT GENET, V22, P27, DOI 10.1038/8737; Xia GM, 1996, PLANT SCI, V120, P197, DOI 10.1016/S0168-9452(96)04492-5; Xia GM, 2003, THEOR APPL GENET, V107, P299, DOI 10.1007/s00122-003-1247-7; XIA GM, 1992, PLANT CELL REP, V11, P155, DOI 10.1007/BF00232170; Xia GM, 2009, J GENET GENOMICS, V36, P547, DOI 10.1016/S1673-8527(08)60146-0; Zhou A, 2001, MOL GENET GENOMICS, V265, P387, DOI 10.1007/s004380000430; Zhou CN, 2006, PLANTA, V223, P714, DOI 10.1007/s00425-005-0127-6; Zubko MK, 2002, THEOR APPL GENET, V105, P822, DOI 10.1007/s00122-002-1037-7	54	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40214	10.1371/journal.pone.0040214	http://dx.doi.org/10.1371/journal.pone.0040214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815731	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100031
J	Shaikh, FY; Utley, TJ; Craven, RE; Rogers, MC; Lapierre, LA; Goldenring, JR; Crowe, JE				Shaikh, Fyza Y.; Utley, Thomas J.; Craven, Ryan E.; Rogers, Meredith C.; Lapierre, Lynne A.; Goldenring, James R.; Crowe, James E., Jr.			Respiratory Syncytial Virus Assembles into Structured Filamentous Virion Particles Independently of Host Cytoskeleton and Related Proteins	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; INFLUENZA-A VIRUS; LIPID-RAFTS; LIQUID-CHROMATOGRAPHY; ACTIN CYTOSKELETON; MATRIX PROTEIN; CELLULAR ACTIN; MORPHOGENESIS; MORPHOLOGY; INFECTION	Respiratory syncytial virus (RSV) is a single-stranded RNA virus that assembles into viral filaments at the cell surface. Virus assembly often depends on the ability of a virus to use host proteins to accomplish viral tasks. Since the fusion protein cytoplasmic tail (FCT) is critical for viral filamentous assembly, we hypothesized that host proteins important for viral assembly may be recruited by the FCT. Using a yeast two-hybrid screen, we found that filamin A interacted with FCT, and mammalian cell experiments showed it localized to viral filaments but did not affect viral replication. Furthermore, we found that a number of actin-associated proteins also were excluded from viral filaments. Actin or tubulin cytoskeletal rearrangement was not necessary for F trafficking to the cell surface or for viral assembly into filaments, but was necessary for optimal viral replication and may be important for anchoring viral filaments. These findings suggest that RSV assembly into filaments occurs independently of actin polymerization and that viral proteins are the principal drivers for the mechanical tasks involved with formation of complex, structured RSV filaments at the host cell plasma membrane.	[Shaikh, Fyza Y.; Utley, Thomas J.; Craven, Ryan E.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Goldenring, James R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Lapierre, Lynne A.; Goldenring, James R.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Lapierre, Lynne A.; Goldenring, James R.] Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, Nashville, TN USA; [Rogers, Meredith C.] Vanderbilt Univ, Med Ctr, Med Scientist Training Program, Nashville, TN USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Shaikh, FY (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079; Rogers, Meredith/0000-0003-1798-6294	Vanderbilt Medical Scientist Training Program NIGMS/NIH [T32 GM007347]; March of Dimes; NIH [R01 DK48370, R01 DK070856, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126, P30CA068485]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070856, P30DK020593, U24DK059637, P60DK020593, R01DK048370, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	Vanderbilt Medical Scientist Training Program NIGMS/NIH; March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	F.Y.S. and M. C. R. were supported by the Vanderbilt Medical Scientist Training Program NIGMS/NIH T32 GM007347. The research was supported by a grant from the March of Dimes (to J.E.C.) and NIH R01 DK48370 and R01 DK070856 (to J.R.G.). Imaging experiments were performed in part through the VUMC (Vanderbilt University Medical Center) Cell Imaging Shared Resources (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The authors acknowledge the support of Dr. Amy Ham and the Mass Spectrometry Research Center Proteomics Core at Vanderbilt and NIH grant P30CA068485 for vesicle protein identification. Flow cytometry experiments were performed in the VMC Flow Cytometry Shared Resource, which is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; BACHI T, 1973, J VIROL, V12, P1173; Batonick M, 2008, J VIROL, V82, P8664, DOI 10.1128/JVI.00827-08; Bitko V, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-9; Bourmakina SV, 2003, J GEN VIROL, V84, P517, DOI 10.1099/vir.0.18803-0; Brock SC, 2005, J VIROL, V79, P12528, DOI 10.1128/JVI.79.19.12528-12535.2005; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; Brown G, 2004, VIROLOGY, V327, P175, DOI 10.1016/j.virol.2004.06.038; Burke E, 2000, J VIROL, V74, P669, DOI 10.1128/JVI.74.2.669-675.2000; Burke E, 1998, VIROLOGY, V252, P137, DOI 10.1006/viro.1998.9471; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Caprioli RM, 2004, ENCY MASS SPECTROM A; CORTES HJ, 1987, J HIGH RES CHROMATOG, V10, P446, DOI 10.1002/jhrc.1240100805; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Fleming EH, 2006, J VIROL, V80, P12160, DOI 10.1128/JVI.00643-06; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; GAUDIN Y, 1995, VIROLOGY, V206, P28, DOI 10.1016/S0042-6822(95)80016-6; Gower TL, 2005, J VIROL, V79, P5326, DOI 10.1128/JVI.79.9.5326-5336.2005; Gower TL, 2001, VIROLOGY, V283, P188, DOI 10.1006/viro.2001.0891; Harpen M, 2009, J VIROL, V83, P10869, DOI 10.1128/JVI.01271-09; Harrison MS, 2010, INT J BIOCHEM CELL B, V42, P1416, DOI 10.1016/j.biocel.2010.04.005; Jeffree CE, 2007, VIROLOGY, V369, P309, DOI 10.1016/j.virol.2007.08.007; Kallewaard NL, 2005, VIROLOGY, V331, P73, DOI 10.1016/j.virol.2004.10.010; Knipe DM., 2006, FIELDS VIROLOGY, V5th ed; Li DS, 2008, J VIROL, V82, P8863, DOI 10.1128/JVI.00343-08; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lindquist ME, 2010, J VIROL, V84, P12274, DOI 10.1128/JVI.00260-10; McCurdy LH, 2003, J VIROL, V77, P1747, DOI 10.1128/JVI.77.3.1747-1756.2003; Mitra R, 2012, J VIROL, V86, P4432, DOI 10.1128/JVI.06744-11; Pasteur I, 1998, FAST EXHAUSTIVE METH; Pasteur I, 2000, FAST EXHAUSTIVE METH; Pasteur I, 2002, FAST EXHAUSTIVE METH; Radhakrishnan A, 2010, MOL CELL PROTEOMICS, V9, P1829, DOI 10.1074/mcp.M110.001651; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Roberts PC, 1998, P NATL ACAD SCI USA, V95, P5746, DOI 10.1073/pnas.95.10.5746; ROBERTS SR, 1995, J VIROL, V69, P2667, DOI 10.1128/JVI.69.4.2667-2673.1995; Shaikh FY, 2012, MBIO, V3, DOI 10.1128/mBio.00270-11; Simpson-Holley M, 2002, VIROLOGY, V301, P212, DOI 10.1006/viro.2002.1595; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Ulloa L, 1998, VIRUS RES, V53, P13, DOI 10.1016/S0168-1702(97)00121-4; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	45	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40826	10.1371/journal.pone.0040826	http://dx.doi.org/10.1371/journal.pone.0040826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808269	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700059
J	Sumaila, UR; Cheung, W; Dyck, A; Gueye, K; Huang, L; Lam, V; Pauly, D; Srinivasan, T; Swartz, W; Watson, R; Zeller, D				Sumaila, Ussif Rashid; Cheung, William; Dyck, Andrew; Gueye, Kamal; Huang, Ling; Lam, Vicky; Pauly, Daniel; Srinivasan, Thara; Swartz, Wilf; Watson, Reginald; Zeller, Dirk			Benefits of Rebuilding Global Marine Fisheries Outweigh Costs	PLOS ONE			English	Article							CLIMATE-CHANGE; CATCHES	Global marine fisheries are currently underperforming, largely due to overfishing. An analysis of global databases finds that resource rent net of subsidies from rebuilt world fisheries could increase from the current negative US$13 billion to positive US$54 billion per year, resulting in a net gain of US$600 to US$1,400 billion in present value over fifty years after rebuilding. To realize this gain, governments need to implement a rebuilding program at a cost of about US$203 (US$130-US$292) billion in present value. We estimate that it would take just 12 years after rebuilding begins for the benefits to surpass the cost. Even without accounting for the potential boost to recreational fisheries, and ignoring ancillary and non-market values that would likely increase, the potential benefits of rebuilding global fisheries far outweigh the costs.	[Sumaila, Ussif Rashid; Dyck, Andrew; Lam, Vicky; Swartz, Wilf] Univ British Columbia, Fisheries Ctr, Fisheries Econ Res Unit, Vancouver, BC V5Z 1M9, Canada; [Cheung, William; Pauly, Daniel; Watson, Reginald; Zeller, Dirk] Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V5Z 1M9, Canada; [Gueye, Kamal] United Nations Environm Programme, Geneva, Switzerland; [Huang, Ling] Univ Connecticut, Dept Econ, Storrs, CT USA; [Srinivasan, Thara] Pacific Ecoinformat & Computat Ecol Lab, Berkeley, CA USA	University of British Columbia; University of British Columbia; University of Connecticut	Sumaila, UR (corresponding author), Univ British Columbia, Fisheries Ctr, Fisheries Econ Res Unit, Vancouver, BC V5Z 1M9, Canada.	r.sumaila@fisheries.ubc.ca	Watson, Reg A/F-4850-2012; Cheung, William/F-5104-2013; Pauly, Daniel Marc/AAY-2316-2021; Sumaila, U. Rashid/ABE-6475-2020; Lam, Vicky/AAX-1684-2020	Watson, Reg A/0000-0001-7201-8865; Cheung, William/0000-0003-3626-1045; Pauly, Daniel/0000-0003-3756-4793; Zeller, Dirk/0000-0001-7304-4125	Pew Charitable Trusts, Philadelphia	Pew Charitable Trusts, Philadelphia	The Sea Around Us Project and the Global Ocean Economics Project are funded by the Pew Charitable Trusts, Philadelphia (http://www.pewtrusts.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, VONBRANDTS FISH CATC; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Cheung WWL, 2008, MAR ECOL PROG SER, V365, P187, DOI 10.3354/meps07414; Clark C.W., 1990, MATH BIOECONOMICS OP; Costello C, 2012, OECD FOOD AGR FISHER; Cullis-Suzuki S, 2008, COASTAL MANAGEMENT, V38, P113; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Delgado CL, 1997, 18 MTID IFPRI; Dyck Andrew J., 2010, Journal of Bioeconomics, V12, P227, DOI 10.1007/s10818-010-9088-3; European Commission (EC), 2006, 2005 ANN REP; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT WORLD FISH AQ S; Froese R, 2012, MAR BIOL, V159, P1283, DOI 10.1007/s00227-012-1909-6; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Heal G, 2000, ECOSYSTEMS, V3, P24, DOI 10.1007/s100210000006; Lam VWY, 2011, ICES J MAR SCI, V68, P1996, DOI 10.1093/icesjms/fsr121; Mason F, 2002, ELECT GREEN J, V1; Merino G, 2012, GLOBAL ENV IN PRESS; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Plimsoll, 2011, COMM FISH GLOB IND C; PONTECORVO G, 1980, SCIENCE, V208, P1000, DOI 10.1126/science.208.4447.1000; Porter G., 1998, ESTIMATING OVERCAPAC; SCFO, 2005, NO COD FAIL CAN FISH; Srinivasan U. Thara, 2010, Journal of Bioeconomics, V12, P183, DOI 10.1007/s10818-010-9090-9; STERN R, 2006, STERN REV EC CLIMATE; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Sumaila UR, 2004, FISH FISH, V5, P329, DOI 10.1111/j.1467-2679.2004.00166.x; Teh L, 2008, INT J SOC ECON, V35, P380, DOI 10.1108/03068290810861620; United Nations Environment Programme, 2011, GREEN EC PATHW SUST; Watson R, 2006, FISH RES, V79, P97, DOI 10.1016/j.fishres.2006.01.010; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Weitzman ML, 2001, AM ECON REV, V91, P260, DOI 10.1257/aer.91.1.260; World Bank and FAO (Food and Agriculture Organization of the United Nations), 2009, SUNK BILL EC JUST FI; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeller D, 2006, MAR RESOUR ECON, V21, P355, DOI DOI 10.1086/MRE.21.4.42629521; [No title captured]	40	101	104	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40542	10.1371/journal.pone.0040542	http://dx.doi.org/10.1371/journal.pone.0040542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808187	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700034
J	Lee, LA; Huang, CG; Liao, CT; Lee, LY; Hsueh, C; Chen, TC; Lin, CY; Fan, KH; Wang, HM; Huang, SF; Chen, IH; Kang, CJ; Ng, SH; Yang, SL; Tsao, KC; Chang, YL; Yen, TC				Lee, Li-Ang; Huang, Chung-Guei; Liao, Chun-Ta; Lee, Li-Yu; Hsueh, Chuen; Chen, Tse-Ching; Lin, Chien-Yu; Fan, Kang-Hsing; Wang, Hung-Ming; Huang, Shiang-Fu; Chen, I-How; Kang, Chung-Jan; Shu-Hang Ng; Yang, Shu-Li; Tsao, Kuo-Chien; Chang, Yu-Liang; Yen, Tzu-Chen			Human Papillomavirus-16 Infection in Advanced Oral Cavity Cancer Patients Is Related to an Increased Risk of Distant Metastases and Poor Survival	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTOR; TONGUE CANCER; VIRUS HPV; HEAD; PREVALENCE; OROPHARYNX; CISPLATIN; RADIOTHERAPY	Background: Human papillomavirus (HPV) is an oncogenic virus causing oropharyngeal cancers and resulting in a favorable outcome after the treatment. The role of HPV in oral cavity squamous cell carcinoma (OSCC) remains ambiguous. Objective: This study aimed to examine the effect of HPV infection on disease control among patients with OSCC following radical surgery with radiation-based adjuvant therapy. Patients and Method: We prospectively followed 173 patients with advanced OSCC (96% were stage III/IV) who had undergone radical surgery and adjuvant therapy between 2004 and 2006. They were followed between surgery and death or up to 60 months. Surgical specimens were examined using a PCR-based HPV blot test. The primary endpoints were the risk of relapse and the time to relapse; the secondary endpoints were disease-free survival, disease-specific survival, and overall survival. Results: The prevalence of HPV-positive OSCC was 22%; HPV-16 (9%) and HPV-18 (7%) were the genotypes most commonly encountered. Solitary HPV-16 infection was a poor predictor of 5-year distant metastases (hazard ratio, 3.4; 95% confidence interval, 1.4-8.0; P = 0.005), disease-free survival (P = 0.037), disease-specific survival (P = 0.006), and overall survival (P = 0.010), whereas HPV-18 infection had no impact on 5-year outcomes. The rate of 5-year distant metastases was significantly higher in the HPV-16 or level IV/V metastasis group compared with both the extracapsular spread or tumor depth >11-mm group and patients without risk factors (P<0.001). Conclusions: HPV infections in advanced OSCC patients are not uncommon and clinically relevant. Compared with HPV-16-negative advanced OSCC patients, those with a single HPV-16 infection are at higher risk of distant metastases and poor survival despite undergoing radiation-based adjuvant therapy and require a more aggressive adjuvant treatment and a more thorough follow-up.	[Lee, Li-Ang; Huang, Chung-Guei; Liao, Chun-Ta; Lee, Li-Yu; Hsueh, Chuen; Chen, Tse-Ching; Lin, Chien-Yu; Fan, Kang-Hsing; Wang, Hung-Ming; Huang, Shiang-Fu; Chen, I-How; Kang, Chung-Jan; Shu-Hang Ng; Yang, Shu-Li; Tsao, Kuo-Chien; Chang, Yu-Liang; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Tao Yuan, Taiwan; [Lee, Li-Ang; Huang, Chung-Guei; Liao, Chun-Ta; Lee, Li-Yu; Hsueh, Chuen; Chen, Tse-Ching; Lin, Chien-Yu; Fan, Kang-Hsing; Wang, Hung-Ming; Huang, Shiang-Fu; Chen, I-How; Kang, Chung-Jan; Shu-Hang Ng; Yang, Shu-Li; Tsao, Kuo-Chien; Chang, Yu-Liang; Yen, Tzu-Chen] Chang Gung Univ, Tao Yuan, Taiwan; [Lee, Li-Ang; Liao, Chun-Ta; Huang, Shiang-Fu; Chen, I-How; Kang, Chung-Jan] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Huang, Chung-Guei; Lee, Li-Yu; Hsueh, Chuen; Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Lin, Chien-Yu; Fan, Kang-Hsing] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Shu-Hang Ng] Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan; [Yang, Shu-Li; Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Chang, Yu-Liang] Chang Gung Mem Hosp, Dept Oral & Maxillofacial Surg, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lee, LA (corresponding author), Chang Gung Mem Hosp, Head & Neck Oncol Grp, Tao Yuan, Taiwan.	liaoct@adm.cgmh.org.tw; yen1110@adm.cgmh.org.tw	Li-Ang, Lee/AAO-6876-2020; Fan, K/GXH-3734-2022; Li-yu, Lee/G-5055-2010	Li-Ang, Lee/0000-0001-8414-595X; Fan, Kang-Hsing/0000-0002-0910-7803; Hsueh, Chuen/0000-0001-7860-5964	Department of Health, Taiwan [DOH100-TD-C-111-006]; Chang Gung Memorial Hospital in Linkou, Taoyuan, Taiwan [CMRPG391431/391432]	Department of Health, Taiwan; Chang Gung Memorial Hospital in Linkou, Taoyuan, Taiwan	This work was supported by grant DOH100-TD-C-111-006 (http://www.doh.gov.tw/) from the Department of Health, Taiwan and by grant CMRPG391431/391432 (http://www.cgmh.org.tw/) from the Chang Gung Memorial Hospital in Linkou, Taoyuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachaud JM, 1996, INT J RADIAT ONCOL, V36, P999, DOI 10.1016/S0360-3016(96)00430-0; Baghi M, 2006, ANTICANCER RES, V26, P559; Chien CY, 2008, ORAL ONCOL, V44, P174, DOI 10.1016/j.oraloncology.2007.01.018; Dahlgren L, 2004, INT J CANCER, V112, P1015, DOI 10.1002/ijc.20490; Friesland S, 2001, ANTICANCER RES, V21, P529; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hong AM, 2010, BRIT J CANCER, V103, P1510, DOI 10.1038/sj.bjc.6605944; Huang SL, 2006, J CLIN MICROBIOL, V44, P1733, DOI 10.1128/JCM.44.5.1733-1739.2006; Jo S, 2009, ANTICANCER RES, V29, P1467; Joo YH, 2012, HEAD NECK-J SCI SPEC, V34, P10, DOI 10.1002/hed.21697; Klozar J, 2008, EUR ARCH OTO-RHINO-L, V265, pS75, DOI 10.1007/s00405-007-0557-9; Laco J, 2011, VIRCHOWS ARCH, V458, P179, DOI 10.1007/s00428-010-1037-y; Lee SY, 2010, INT J ORAL MAX SURG, V39, P678, DOI 10.1016/j.ijom.2010.03.014; Liang XH, 2008, J ORAL MAXIL SURG, V66, P1875, DOI 10.1016/j.joms.2008.04.009; Liao CT, 2008, ANN SURG ONCOL, V15, P915, DOI 10.1245/s10434-007-9761-5; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Lin CY, 2007, J VIROL METHODS, V140, P1, DOI 10.1016/j.jviromet.2006.10.004; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Luo CW, 2007, INT J ORAL MAX SURG, V36, P153, DOI 10.1016/j.ijom.2006.09.005; Machado J, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-6; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Maxwell JH, 2010, CLIN CANCER RES, V16, P1226, DOI 10.1158/1078-0432.CCR-09-2350; Na II, 2007, EUR J CANCER, V43, P520, DOI 10.1016/j.ejca.2006.09.025; Pathare SM, 2011, ONCOL LETT, V2, P445, DOI 10.3892/ol.2011.271; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; Rosenthal DI, 2009, J CLIN ONCOL, V27, P4727, DOI 10.1200/JCO.2008.21.4197; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; Shima K, 2000, BRIT J ORAL MAX SURG, V38, P445, DOI 10.1054/bjom.2000.0162; Smith EM, 2012, J ONCOL, V2012, DOI 10.1155/2012/571862; St Guily JL, 2011, J CLIN VIROL, V51, P100, DOI 10.1016/j.jcv.2011.03.003; Sugiyama M, 2007, BRIT J ORAL MAX SURG, V45, P116, DOI 10.1016/j.bjoms.2006.04.012; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Zhao D, 2009, INT J ORAL SCI, V1, P119, DOI 10.4248/IJOS.09015	34	75	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40767	10.1371/journal.pone.0040767	http://dx.doi.org/10.1371/journal.pone.0040767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808258	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400057
J	Fort, J; Beaugrand, G; Gremillet, D; Phillips, RA				Fort, Jerome; Beaugrand, Gregory; Gremillet, David; Phillips, Richard A.			Biologging, Remotely-Sensed Oceanography and the Continuous Plankton Recorder Reveal the Environmental Determinants of a Seabird Wintering Hotspot	PLOS ONE			English	Article							NORTH-ATLANTIC; CLIMATE; TRACKING; ECOLOGY; BIODIVERSITY; METABOLISM; MOVEMENTS; SHIFTS	Marine environments are greatly affected by climate change, and understanding how this perturbation affects marine vertebrates is a major issue. In this context, it is essential to identify the environmental drivers of animal distribution. Here, we focused on the little auk (Alle alle), one of the world's most numerous seabirds and a major component in Arctic food webs. Using a multidisciplinary approach, we show how little auks adopt specific migratory strategies and balance environmental constraints to optimize their energy budgets. Miniature electronic loggers indicate that after breeding, birds from East Greenland migrate >2000 km to overwinter in a restricted area off Newfoundland. Synoptic data available from the Continuous Plankton Recorder (CPR) indicate that this region harbours some of the highest densities of the copepod Calanus finmarchicus found in the North Atlantic during winter. Examination of large-scale climatic and oceanographic data suggests that little auks favour patches of high copepod abundance in areas where air temperature ranges from 0 degrees C to 5 degrees C. These results greatly advance our understanding of animal responses to extreme environmental constraints, and highlight that information on habitat preference is key to identifying critical areas for marine conservation.	[Fort, Jerome] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Beaugrand, Gregory] Univ Sci & Technol Lille 1, CNRS, UMR 8087, Lab Oceanol & Geosci,Stn Marine, Wimereux, France; [Beaugrand, Gregory] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Gremillet, David] CNRS, UMR 5175, Ctr Ecol Fonct & Evolut, Montpellier, France; [Gremillet, David] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Aarhus University; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Fort, J (corresponding author), Aarhus Univ, Dept Biosci, Roskilde, Denmark.	fort.jerome@gmail.com	Gremillet, David/W-1946-2018; Fort, Jerome/F-1157-2016	Gremillet, David/0000-0002-7711-9398; Fort, Jerome/0000-0002-0860-6707; BEAUGRAND, GREGORY/0000-0002-0712-5223	French Polar Institute [388]; Fyssen Foundation; European Commission [273061]; NERC [bas0100025, SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001, bas0100025] Funding Source: researchfish	French Polar Institute; Fyssen Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the French Polar Institute Paul Emile Victor (Grant 388 to D. G. and J.F.) and grants from the Fyssen Foundation (to J.F.) and the European Commission (Marie Curie Intra European Fellowship to J.F.; Project 273061), and also represents a contribution to the British Antarctic Survey Ecosystems programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2010, P NATL ACAD SCI USA, V107, P10120, DOI 10.1073/pnas.0913855107; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boertmann D, 2004, BIRD CONSERV INT, V14, P87, DOI 10.1017/S0959270904000127; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Falk-Petersen S, 2009, MAR BIOL RES, V5, P18, DOI 10.1080/17451000802512267; Fort J, 2010, MAR ECOL PROG SER, V414, P293, DOI 10.3354/meps08721; Fort J, 2010, BIOL LETTERS, V6, P682, DOI 10.1098/rsbl.2010.0082; Fort J, 2009, J EXP BIOL, V212, P2483, DOI 10.1242/jeb.032300; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; GABRIELSEN GW, 1991, AUK, V108, P71; Gaston A.J., 1998, THE AUKS ALCIDAE; Gaston AJ, 2011, MAR BIOL, V158, P1929, DOI 10.1007/s00227-011-1704-9; Harding AMA, 2008, POLAR BIOL, V31, P725, DOI 10.1007/s00300-008-0413-4; Harding AMA, 2011, OECOLOGIA, V167, P49, DOI 10.1007/s00442-011-1971-7; Helaouet P, 2011, PROG OCEANOGR, V91, P217, DOI 10.1016/j.pocean.2010.11.003; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; KAMPP K, 1987, Dansk Ornitologisk Forenings Tidsskrift, V81, P129; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Lake S, 2006, POLAR BIOL, V29, P270, DOI 10.1007/s00300-005-0050-0; Montevecchi W, 2012, BIOL LETTERS, V8, P218, DOI 10.1098/rsbl.2011.0880; Mosbech A, 2012, POLAR BIOL, V35, P305, DOI 10.1007/s00300-011-1064-4; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Oro D, 2002, ECOLOGY, V83, P2516; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Planque B, 1997, DEEP-SEA RES PT I, V44, P315, DOI 10.1016/S0967-0637(96)00100-8; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Reygondeau G, 2011, GLOBAL CHANGE BIOL, V17, P756, DOI 10.1111/j.1365-2486.2010.02310.x; Richman SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P316, DOI 10.1086/660008; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Shaffer SA, 2011, COMP BIOCHEM PHYS A, V158, P315, DOI 10.1016/j.cbpa.2010.07.012; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stempniewicz L, 2001, J BIRDS W PALEARCTIC, V3, P175; Wilson RP, 1992, WILDLIFE TELEMETRY R	37	29	31	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41194	10.1371/journal.pone.0041194	http://dx.doi.org/10.1371/journal.pone.0041194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815967	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306548900095
J	Liu, YC; Han, YH; Huang, WR; Duan, YG; Mou, LS; Jiang, ZM; Fa, PP; Xie, J; Diao, RY; Chen, YB; Ye, YW; Yang, RL; Chen, J; Sun, XJ; Li, ZS; Tang, AF; Gui, YT; Cai, ZM				Liu, Yuchen; Han, Yonghua; Huang, Weiren; Duan, Yonggang; Mou, Lisha; Jiang, Zhimao; Fa, Pingping; Xie, Jun; Diao, Ruiying; Chen, Yuanbin; Ye, Yiwang; Yang, Ruilin; Chen, Jing; Sun, Xiaojuan; Li, Zesong; Tang, Aifa; Gui, Yaoting; Cai, Zhiming			Whole-Genome Synthesis and Characterization of Viable S13-Like Bacteriophages	PLOS ONE			English	Article							FUNCTIONAL-RELATIONSHIP; NUCLEOTIDE-SEQUENCE; EVOLUTION; PHI-X174; PHIX174; BIOLOGY; PHAGES; G4; GENERATION; ADAPTATION	Background: Unprecedented progresses in high-throughput DNA sequencing and de novo gene synthesis technologies have allowed us to create living organisms in the absence of natural template. Methodology/Principal Findings: The sequence of wild-type S13 phage genome was downloaded from GenBank. Two synonymous mutations were introduced into wt-S13 genome to generate m1-S13 genome. Another mutant, m2-S13 genome, was obtained by engineering two nonsynonymous mutations in the capsid protein coding region of wt-S13 genome. A chimeric phage genome was designed by replacing the F capsid protein open reading frame (ORF) from phage S13 with the F capsid protein ORF from phage G4. The whole genomes of all four phages were assembled from a series of chemically synthesized short overlapping oligonucleotides. The linear synthesized genomes were circularized and electroporated into E. coli C, the standard laboratory host of S13 phage. All four phages were recovered and plaques were visualized. The results of sequencing showed the accuracy of these synthetic genomes. The synthetic phages were capable of lysing their bacterial host and tolerating general environmental conditions. While no phenotypic differences among the variant strains were observed when grown in LB medium with CaCl2, the S13/G4 chimera was found to be much more sensitive to the absence of calcium and to have a lower adsorption rate under calcium free condition. Conclusions/Significance: The bacteriophage S13 and its variants can be chemically synthesized. The major capsid gene of phage G4 is functional in the phage S13 life cycle. These results support an evolutional hypothesis which has been proposed that a homologous recombination event involving gene F of quite divergent ancestral lineages should be included in the history of the microvirid family.	[Liu, Yuchen; Han, Yonghua; Huang, Weiren; Duan, Yonggang; Mou, Lisha; Jiang, Zhimao; Fa, Pingping; Xie, Jun; Diao, Ruiying; Chen, Yuanbin; Ye, Yiwang; Yang, Ruilin; Chen, Jing; Sun, Xiaojuan; Li, Zesong; Tang, Aifa; Gui, Yaoting; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Shenzhen PKUHKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Liu, Yuchen] Shantou Univ, Coll Med, Shantou, Peoples R China; [Cai, Zhiming] Shenzhen Univ, Inst Urogenital Dis, Shenzhen, Peoples R China; [Huang, Weiren; Cai, Zhiming] Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China	Peking University; Shantou University; Shenzhen University; Second People's Hospital of Shenzhen	Liu, YC (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen PKUHKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China.	guiyaoting2007@yahoo.com.cn; caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022; Mou, Lisha/I-4739-2012; Duan, Yong-Gang/AAH-1061-2019; liu, yuchen/GYQ-6286-2022	Mou, Lisha/0000-0001-6232-8341; Duan, Yong-Gang/0000-0002-5350-892X; 	National Natural Science Foundation of China [81100460]; Postdoctoral Science Foundation of China [20100480776]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A]; Ph.D. Programs Foundation of Ministry of Education of China [200800010106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Promotion Program for Shenzhen Key Laboratory, Shenzhen, China; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was funded by the National Natural Science Foundation of China [81100460]; the Postdoctoral Science Foundation of China [20100480776]; the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A to ZC); and the Ph.D. Programs Foundation of Ministry of Education of China (200800010106 to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Bernal RA, 2003, J MOL BIOL, V325, P11, DOI 10.1016/S0022-2836(02)01201-9; BORRIAS WE, 1979, J VIROL, V31, P288, DOI 10.1128/JVI.31.2.288-298.1979; Bull JJ, 2004, EVOLUTION, V58, P692; Burnet FM, 1927, BRIT J EXP PATHOL, V8, P121; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Crill WD, 2000, GENETICS, V154, P27; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; FANE BA, 1992, J BACTERIOL, V174, P2717, DOI 10.1128/jb.174.8.2717-2719.1992; FUJIMURA R, 1962, BIOPHYS J, V2, P433, DOI 10.1016/S0006-3495(62)86866-0; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GODSON GN, 1974, VIROLOGY, V58, P272, DOI 10.1016/0042-6822(74)90161-5; GODSON GN, 1978, NATURE, V276, P236, DOI 10.1038/276236a0; Hayashi M., 1988, BACTERIOPHAGES, V2, P1; JENG Y, 1970, J MOL BIOL, V49, P521, DOI 10.1016/0022-2836(70)90262-7; KAPTEIN JS, 1978, BIOCHEMISTRY-US, V17, P841, DOI 10.1021/bi00598a015; LAU PCK, 1985, GENE, V40, P273, DOI 10.1016/0378-1119(85)90050-2; McKenna R, 1996, J MOL BIOL, V256, P736, DOI 10.1006/jmbi.1996.0121; Mueller S, 2009, CHEM BIOL, V16, P337, DOI 10.1016/j.chembiol.2009.03.002; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rokyta DR, 2009, MOL BIOL EVOL, V26, P2831, DOI 10.1093/molbev/msp199; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; STOREY CC, 1989, J GEN VIROL, V70, P1321, DOI 10.1099/0022-1317-70-6-1321; TESSMAN ES, 1963, VIROLOGY, V19, P239, DOI 10.1016/0042-6822(63)90015-1; THOMPSON BJ, 1978, VIROLOGY, V87, P212, DOI 10.1016/0042-6822(78)90175-7; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593	30	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41124	10.1371/journal.pone.0041124	http://dx.doi.org/10.1371/journal.pone.0041124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815936	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900076
J	Esclassan, F; Courtiol, E; Thevenet, M; Garcia, S; Buonviso, N; Litaudon, P				Esclassan, Frederic; Courtiol, Emmanuelle; Thevenet, Marc; Garcia, Samuel; Buonviso, Nathalie; Litaudon, Philippe			Faster, Deeper, Better: The Impact of Sniffing Modulation on Bulbar Olfactory Processing	PLOS ONE			English	Article							EXTERNAL TUFTED CELLS; RECEPTOR NEURON INPUT; TEMPORAL STRUCTURE; FLOW-RATE; RATS; REPRESENTATION; FREQUENCY; RESPONSES; DYNAMICS; DISCRIMINATION	A key feature of mammalian olfactory perception is that sensory input is intimately related to respiration. Different authors have considered respiratory dynamics not only as a simple vector for odor molecules but also as an integral part of olfactory perception. Thus, rats adapt their sniffing strategy, both in frequency and flow rate, when performing odor-related tasks. The question of how frequency and flow rate jointly impact the spatio-temporal representation of odor in the olfactory bulb (OB) has not yet been answered. In the present paper, we addressed this question using a simulated nasal airflow protocol on anesthetized rats combined with voltage-sensitive dye imaging (VSDi) of odor-evoked OB glomerular maps. Glomerular responses displayed a tonic component during odor stimulation with a superimposed phasic component phase-locked to the sampling pattern. We showed that a high sniffing frequency (10 Hz) retained the ability to shape OB activity and that the tonic and phasic components of the VSDi responses were dependent on flow rate and inspiration volume, respectively. Both sniffing parameters jointly affected OB responses to odor such that the reduced activity level induced by a frequency increase was compensated by an increased flow rate.	[Esclassan, Frederic; Courtiol, Emmanuelle; Thevenet, Marc; Garcia, Samuel; Buonviso, Nathalie; Litaudon, Philippe] Univ Lyon 1, UMR 5292, CNRS, CRNL,INSERM,Equipe Olfact Codage Memoire,U1028, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Esclassan, F (corresponding author), Univ Lyon 1, UMR 5292, CNRS, CRNL,INSERM,Equipe Olfact Codage Memoire,U1028, F-69365 Lyon, France.	litaudon@olfac.univ-lyon1.fr	Buonviso, Nathalie/G-8467-2017; Courtiol, Emmanuelle/N-9316-2017; Litaudon, Philippe/R-9578-2019; Litaudon, Philippe/M-6421-2014	Buonviso, Nathalie/0000-0002-0018-1695; Courtiol, Emmanuelle/0000-0002-7197-1117; Litaudon, Philippe/0000-0002-1482-5025; Litaudon, Philippe/0000-0002-1482-5025; GARCIA, Samuel/0000-0001-6389-9779	French National Research Agency [ANR-07-NEURO-030]	French National Research Agency(French National Research Agency (ANR))	This work was supported by a grant from the French National Research Agency (grant number ANR-07-NEURO-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; AMBROSINGERSON J, 1990, SCIENCE, V247, P1344, DOI 10.1126/science.2315702; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Buonviso N, 2006, CHEM SENSES, V31, P145, DOI 10.1093/chemse/bjj010; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Courtiol E, 2011, J NEUROPHYSIOL, V106, P2813, DOI 10.1152/jn.00672.2011; Courtiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016445; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Fletcher ML, 2009, J NEUROPHYSIOL, V102, P817, DOI 10.1152/jn.00020.2009; FREEMAN WJ, 1983, J COMP PSYCHOL, V97, P12, DOI 10.1037/0735-7036.97.1.12; Garcia Samuel, 2009, Front Neuroinform, V3, P14, DOI 10.3389/neuro.11.014.2009; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hegoburu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00025; HUDSON R, 1987, BRAIN RES, V421, P85, DOI 10.1016/0006-8993(87)91278-9; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; Kay LM, 2005, P NATL ACAD SCI USA, V102, P3863, DOI 10.1073/pnas.0407920102; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; KOMISARU.BR, 1970, J COMP PHYSIOL PSYCH, V70, P482, DOI 10.1037/h0028709; Litalidon P, 2008, NEUROSCIENCE, V156, P781, DOI 10.1016/j.neuroscience.2008.07.077; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Martin C, 2007, NEUROIMAGE, V36, P1288, DOI 10.1016/j.neuroimage.2007.04.029; Oka Y, 2009, J NEUROSCI, V29, P12070, DOI 10.1523/JNEUROSCI.1415-09.2009; Roux SG, 2006, J NEUROSCI METH, V152, P173, DOI 10.1016/j.jneumeth.2005.09.004; Rubin BD, 2001, NAT NEUROSCI, V4, P355, DOI 10.1038/85997; Schoenfeld TA, 2006, CHEM SENSES, V31, P131, DOI 10.1093/chemse/bjj015; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SLOTNICK BM, 1987, BRAIN RES, V417, P343, DOI 10.1016/0006-8993(87)90460-4; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Walker JKL, 1997, RESP PHYSIOL, V107, P241, DOI 10.1016/S0034-5687(96)02520-0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	50	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40927	10.1371/journal.pone.0040927	http://dx.doi.org/10.1371/journal.pone.0040927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815871	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000044
J	Heitner, J; Bhumireddy, GP; Crowley, AL; Weinsaft, J; Haq, SA; Klem, I; Kim, RJ; Jollis, JG				Heitner, John; Bhumireddy, Geetha P.; Crowley, Anna Lisa; Weinsaft, Jonathan; Haq, Salman A.; Klem, Igor; Kim, Raymond J.; Jollis, James G.			Clinical Application of Cine-MRI in the Visual Assessment of Mitral Regurgitation Compared to Echocardiography and Cardiac Catheterization	PLOS ONE			English	Article							DOPPLER-ECHOCARDIOGRAPHY; VALVULAR REGURGITATION; SEVERITY; FLOW	Background: Detecting and quantifying the severity of mitral regurgitation is essential for risk stratification and clinical decision-making regarding timing of surgery. Our objective was to assess specific visual parameters by cine-magnetic resonance imaging (MRI) in the determination of the severity of mitral regurgitation and to compare it to previously validated imaging modalities: echocardiography and cardiac ventriculography. Methods: The study population consisted of 68 patients who underwent a cardiac MRI followed by an echocardiogram within a median time of 2.0 days and 49 of these patients who had a cardiac catheterization, median time of 2.0 days. The inter-rater agreement statistic (Kappa) was used to evaluate the agreement. Results: There was moderate agreement between cine MRI and Doppler echocardiography in assessing mitral regurgitation severity, with a kappa value of 0.47, confidence interval (CI) 0.29-0.65. There was also fair agreement between cine MRI and cardiac catheterization with a kappa value of 0.36, CI of 0.17-0.55. Conclusion: Cine MRI offers a reasonable alternative to both Doppler echocardiography and, to a lesser extent, cardiac catheterization for visually assessing the severity of mitral regurgitation with specific visual parameters during routine clinical cardiac MRI.	[Heitner, John; Bhumireddy, Geetha P.; Haq, Salman A.] New York Methodist Hosp, Div Cardiol, Dept Med, Brooklyn, NY USA; [Crowley, Anna Lisa; Weinsaft, Jonathan; Klem, Igor; Kim, Raymond J.; Jollis, James G.] Duke Med Ctr, Cardiovasc Magnet Resonance Ctr, Durham, NC USA	NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; Duke University	Heitner, J (corresponding author), New York Methodist Hosp, Div Cardiol, Dept Med, Brooklyn, NY USA.	John.Heitner@gmail.com	Kim, Raymond J/B-1426-2008					ALTMAN DG, 1991, STAT MED, V10, P1897, DOI 10.1002/sim.4780101206; CASTELLO R, 1992, J AM COLL CARDIOL, V19, P1516, DOI 10.1016/0735-1097(92)90612-Q; Flachskampf FA, 1998, J AM SOC ECHOCARDIOG, V11, P882, DOI 10.1016/S0894-7317(98)70008-2; Fujita N, 1994, J AM COLL CARDIOL, V23, P959; Grigioni F, 1999, J AM COLL CARDIOL, V34, P2078, DOI 10.1016/S0735-1097(99)00474-X; Grigioni F, 2002, J AM COLL CARDIOL, V40, P84, DOI 10.1016/S0735-1097(02)01922-8; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; Grossman W, 1980, CARDIAC CATHETERIZAT, P305; HIGGINS CB, 1991, CIRCULATION, V84, pI198; HUNDLEY WG, 1995, CIRCULATION, V92, P1151, DOI 10.1161/01.CIR.92.5.1151; MANN H, 1994, ARCH MAL COEUR VAISS, V87, P331; MANNING WJ, 2002, CARDIOVASCULAR MAGNE; Mego D M, 1995, J Am Soc Echocardiogr, V8, P897, DOI 10.1016/S0894-7317(05)80014-8; NEUHOLD A, 1990, ROFO FORTSCHR RONTG, V153, P627, DOI 10.1055/s-2008-1033454; Quere Jean Paul, 2003, Curr Cardiol Rep, V5, P110, DOI 10.1007/s11886-003-0077-1; ROGERS WJ, 1982, AM HEART J, V103, P185, DOI 10.1016/0002-8703(82)90491-4; Soblega A, 2012, INT J CARDIOVAS IMAG, V28, P59; SPAIN MG, 1989, J AM COLL CARDIOL, V13, P585, DOI 10.1016/0735-1097(89)90597-4; Tabata T, 2003, J AM COLL CARDIOL, V41, P1243, DOI 10.1016/S0735-1097(03)00126-8; Yamachika S, 1997, J AM SOC ECHOCARDIOG, V10, P159, DOI 10.1016/S0894-7317(97)70089-0; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	21	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40491	10.1371/journal.pone.0040491	http://dx.doi.org/10.1371/journal.pone.0040491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815751	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000016
J	Kim, SW; Zhang, HZ; Guo, L; Kim, JM; Kim, MH				Kim, Sung-Whan; Zhang, Hong-Zhe; Guo, Longzhe; Kim, Jong-Min; Kim, Moo Hyun			Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities	PLOS ONE			English	Article							CARDIAC-FUNCTION; SKIN; DIFFERENTIATION; FIBROBLASTS; MYOCARDIUM; APOPTOSIS; DISEASE; FOOT; CARDIOMYOCYTES; PROLIFERATION	Although human amniotic mesenchymal stem cells (AMMs) have been recognised as a promising stem cell resource, their therapeutic potential for wound healing has not been widely investigated. In this study, we evaluated the therapeutic potential of AMMs using a diabetic mouse wound model. Quantitative real-time PCR and ELISA results revealed that the angiogenic factors, IGF-1, EGF and IL-8 were markedly upregulated in AMMs when compared with adipose-derived mesenchymal stem cells (ADMs) and dermal fibroblasts. In vitro scratch wound assays also showed that AMM-derived conditioned media (CM) significantly accelerated wound closure. Diabetic mice were generated using streptozotocin and wounds were created by skin excision, followed by AMM transplantation. AMM transplantation significantly promoted wound healing and increased re-epithelialization and cellularity. Notably, transplanted AMMs exhibited high engraftment rates and expressed keratinocyte-specific proteins and cytokeratin in the wound area, indicating a direct contribution to cutaneous closure. Taken together, these data suggest that AMMs possess considerable therapeutic potential for chronic wounds through the secretion of angiogenic factors and enhanced engraftment/differentiation capabilities.	[Kim, Sung-Whan; Zhang, Hong-Zhe; Guo, Longzhe; Kim, Moo Hyun] Dong A Univ Hosp, Reg Clin Ctr, Pusan, South Korea; [Kim, Sung-Whan; Zhang, Hong-Zhe; Guo, Longzhe; Kim, Moo Hyun] Dong A Univ, Coll Med, Dept Cardiol, Pusan, South Korea; [Kim, Jong-Min] Dong A Univ, Coll Med, Dept Anat & Cell Biol, Pusan, South Korea	Dong A University; Dong A University; Dong A University	Kim, SW (corresponding author), Dong A Univ Hosp, Reg Clin Ctr, Pusan, South Korea.	sungwhk@yahoo.co.kr; kimmh@dau.ac.kr			Ministry of Health & Welfare, Republic of Korea [A070001]; National Research Foundation of Korea (NRF); Korean government (MEST) [2009 0093191]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A070001) and the National Research Foundation of Korea (NRF) Grant funded by the Korean government (MEST) (2009 0093191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Campbell WB, 2000, EUR J VASC ENDOVASC, V19, P174, DOI 10.1053/ejvs.1999.1006; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Desbois-Mouthon C, 2006, FASEB J, V20, P773, DOI 10.1096/fj.05-4704fje; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509; Gao Feng, 2007, Zhongguo Zhen Jiu, V27, P645; Kim MH, 2011, INT J CARDIOL; Kim SW, 2006, STEM CELLS, V24, P1620, DOI 10.1634/stemcells.2005-0365; Kim SW, 2012, CARDIOVASC RES, V93, P525, DOI 10.1093/cvr/cvr328; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lamme EN, 2002, WOUND REPAIR REGEN, V10, P152, DOI 10.1046/j.1524-475X.2002.10901.x; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Loomans CJM, 2005, ANTIOXID REDOX SIGN, V7, P1468, DOI 10.1089/ars.2005.7.1468; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Medina RJ, 2006, INT J MOL MED, V17, P721; MICHEL G, 1992, FEBS LETT, V305, P241, DOI 10.1016/0014-5793(92)80677-9; Moulik PK, 2003, DIABETES CARE, V26, P491, DOI 10.2337/diacare.26.2.491; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Perks CM, 2000, J CELL BIOCHEM, V80, P248; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Sumpio Bauer E, 2003, Clin Podiatr Med Surg, V20, P689, DOI 10.1016/S0891-8422(03)00088-0; Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260; TUSCHIL A, 1992, J INVEST DERMATOL, V99, P294, DOI 10.1111/1523-1747.ep12616634; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; Wu JI, 2007, INT J OBSTET ANESTH, V16, P122, DOI 10.1016/j.ijoa.2006.11.004; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65; Wu Y, STEM CELLS, V905-915; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhao P, 2005, TRANSPLANTATION, V79, P528, DOI 10.1097/01.TP.0000149503.92433.39; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	45	100	113	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41105	10.1371/journal.pone.0041105	http://dx.doi.org/10.1371/journal.pone.0041105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815931	Green Published, gold			2022-12-27	WOS:000306507000067
J	Caleo, M; Restani, L; Vannini, E; Siskova, Z; Al-Malki, H; Morgan, R; O'Connor, V; Perry, VH				Caleo, Matteo; Restani, Laura; Vannini, Eleonora; Siskova, Zuzana; Al-Malki, Hussain; Morgan, Ruth; O'Connor, Vincent; Perry, V. Hugh			The Role of Activity in Synaptic Degeneration in a Protein Misfolding Disease, Prion Disease	PLOS ONE			English	Article							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; BOTULINUM-TOXIN-A; AMYLOID-BETA; IN-VIVO; CHRONIC NEURODEGENERATION; PRESYNAPTIC DEGENERATION; INFLAMMATORY RESPONSE; ALZHEIMERS-DISEASE; TRANSGENIC MICE	In chronic neurodegenerative diseases associated with aggregates of misfolded proteins (such as Alzheimer's, Parkinson's and prion disease), there is an early degeneration of presynaptic terminals prior to the loss of the neuronal somata. Identifying the mechanisms that govern synapse degeneration is of paramount importance, as cognitive decline is strongly correlated with loss of presynaptic terminals in these disorders. However, very little is known about the processes that link the presence of a misfolded protein to the degeneration of synapses. It has been suggested that the process follows a simple linear sequence in which terminals that become dysfunctional are targeted for death, but there is also evidence that high levels of activity can speed up degeneration. To dissect the role of activity in synapse degeneration, we infused the synaptic blocker botulinum neurotoxin A (BoNT/A) into the hippocampus of mice with prion disease and assessed synapse loss at the electron microscopy level. We found that injection of BoNT/A in naive mice caused a significant enlargement of excitatory presynaptic terminals in the hippocampus, indicating transmission impairment. Long-lasting blockade of activity by BoNT/A caused only minimal synaptic pathology and no significant activation of microglia. In mice with prion disease infused with BoNT/A, rates of synaptic degeneration were indistinguishable from those observed in control diseased mice. We conclude that silencing synaptic activity neither prevents nor enhances the degree of synapse degeneration in prion disease. These results challenge the idea that dysfunction of synaptic terminals dictates their elimination during prion-induced neurodegeneration.	[Caleo, Matteo; Restani, Laura] CNR, Neurosci Inst, Pisa, Italy; [Vannini, Eleonora] Scuola Normale Super Pisa, Pisa, Italy; [Siskova, Zuzana; Al-Malki, Hussain; Morgan, Ruth; O'Connor, Vincent; Perry, V. Hugh] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England	Consiglio Nazionale delle Ricerche (CNR); Scuola Normale Superiore di Pisa; University of Southampton	Caleo, M (corresponding author), CNR, Neurosci Inst, Pisa, Italy.	caleo@in.cnr.it	Perry, V. Hugh/Y-2935-2019; Vannini, Eleonora/P-2303-2018; Restani, Laura/ABH-1733-2020; Restani, Laura/AAY-5659-2020	Vannini, Eleonora/0000-0002-1337-3901; RESTANI, LAURA/0000-0002-8295-8452; O'Connor, Vincent/0000-0003-3185-5709; CALEO, MATTEO/0000-0002-4333-6378	Italian Ministry of Health (Progetti di Rilevante Interesse Nazionale); Tuscany region (Health Research Program); Medical Research Council, United Kingdom [G0501636]; Ministry of Education, Kingdom of Saudi Arabia; MRC [G0501636] Funding Source: UKRI; Medical Research Council [G0501636] Funding Source: researchfish	Italian Ministry of Health (Progetti di Rilevante Interesse Nazionale); Tuscany region (Health Research Program); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Kingdom of Saudi Arabia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Italian Ministry of Health (Progetti di Rilevante Interesse Nazionale - 2008; MC) the Tuscany region (Health Research Program 2009; MC) and the Medical Research Council, United Kingdom (G0501636). HAM was supported by the Ministry of Education, Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Betmouni S, 1999, NEUROPATH APPL NEURO, V25, P20, DOI 10.1046/j.1365-2990.1999.00153.x; Bozzi Y, 2006, NEUROTOX RES, V9, P197, DOI 10.1007/BF03033939; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; Capogna M, 1997, J NEUROSCI, V17, P7190; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dickey CA, 2003, J NEUROSCI, V23, P5219; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; KAO I, 1976, SCIENCE, V193, P1256, DOI 10.1126/science.785600; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Matak I, 2011, NEUROSCIENCE, V186, P201, DOI 10.1016/j.neuroscience.2011.04.026; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Restani L, 2011, J NEUROSCI, V31, P15650, DOI 10.1523/JNEUROSCI.2618-11.2011; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; Siskova Z, 2010, BIOCHEM SOC T, V38, P471, DOI 10.1042/BST0380471; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; SUMNER BEH, 1977, EXP BRAIN RES, V30, P313; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Wree A, 2011, NEUROBIOL DIS, V41, P291, DOI 10.1016/j.nbd.2010.09.017	52	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41182	10.1371/journal.pone.0041182	http://dx.doi.org/10.1371/journal.pone.0041182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815961	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100125
J	Rathore, CS; Dubey, Y; Shrivastava, A; Pathak, P; Patil, V				Rathore, Chinmaya S.; Dubey, Yogesh; Shrivastava, Anurag; Pathak, Prasad; Patil, Vinayak			Opportunities of Habitat Connectivity for Tiger (Panthera tigris) between Kanha and Pench National Parks in Madhya Pradesh, India	PLOS ONE			English	Article							NATURE-BASED TOURISM; CONSERVATION; DISPERSAL; LANDSCAPE; CORRIDORS; COMMUNITIES; DIVERSITY; COUGARS	The Tiger (Panthera tigris) population in India has undergone a sharp decline during the last few years. Of the number of factors attributed to this decline, habitat fragmentation has been the most worrisome. Wildlife corridors have long been a subject of discussion amongst wildlife biologists and conservationists with contrasting schools of thought arguing their merits and demerits. However, it is largely believed that wildlife corridors can help minimize genetic isolation, offset fragmentation problems, improve animal dispersal, restore ecological processes and reduce man animal conflict. This study attempted to evaluate the possibilities of identifying a suitable wildlife corridor between two very important wildlife areas of central India - the Kanha National Park and the Pench National Park - with tiger as the focal species. Geographic Information System (GIS) centric Least Cost Path modeling was used to identify likely routes for movement of tigers. Habitat suitability, perennial water bodies, road density, railway tracks, human settlement density and total forest edge were considered as key variables influencing tiger movement across the Kanha-Pench landscape. Each of these variables was weighted in terms of relative importance through an expert consultation process. Using different importance scenarios, three alternate corridor routes were generated of which one was identified as the most promising for tiger dispersal. Weak links - where cover and habitat conditions are currently sub-optimal - were flagged on the corridor route. Interventions aimed at augmenting the identified corridor route have been suggested using accepted wildlife corridor design principles. The involvement of local communities through initiatives such as ecotourism has been stressed as a crucial long term strategy for conservation of the Kanha-Pench wildlife corridor. The results of the study indicate that restoration of the identified wildlife corridors between the two protected areas is technically feasible.	[Rathore, Chinmaya S.; Dubey, Yogesh; Pathak, Prasad; Patil, Vinayak] Indian Inst Forest Management, Bhopal, India; [Shrivastava, Anurag] Madhya Pradesh Forest Dept, Bhopal, India	Indian Institute of Forest Management	Rathore, CS (corresponding author), Indian Inst Forest Management, Bhopal, India.	csr@iifm.ac.in		Patil, Vinayak/0000-0002-3489-4431	Department of Information Technology, Biodiversity & Biotechnology, Government of Madhya Pradesh, Madhya Pradesh, India; Government of Madhya Pradesh	Department of Information Technology, Biodiversity & Biotechnology, Government of Madhya Pradesh, Madhya Pradesh, India; Government of Madhya Pradesh	The funding source of the research was Department of Information Technology, Biodiversity & Biotechnology, Government of Madhya Pradesh, Madhya Pradesh, India funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication is the outcome of the research project initiated by Indian Institute of Forest Management Bhopal, India, in collaboration with Department of Information Technology, Biodiversity & Biotechnology, Government of Madhya Pradesh. We are thankful to Government of Madhya Pradesh for providing funding to carry out this study. We are extremely grateful to Mr. Parsuram, Principal Secretary, Department of Information Technology, Biodiversity & Biotechnology, Government of Madhya Pradesh for his kind help and support. We are extremely grateful to Director, Indian Institute of Forest Management for his encouragement and support.	Alfred JRB, 1998, FAUNAL DIVERSITY IND, p[I, 1]; Barnes R.F.W., 1987, TECH B, V1, P1; Bates W., 2007, LEAST COST COR UNPUB; BEIER P, 1992, WILDLIFE SOC B, V20, P434; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier P., 2007, CONCEPTUAL STEPS DES; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bhatnagar Y.V., 1997, THESIS SAURASHTRA U; Bond Monica, 2003, PRINCIPLES WILDLIFE; Bookbinder MP, 1998, CONSERV BIOL, V12, P1399, DOI 10.1046/j.1523-1739.1998.97229.x; Borah J, 2009, MAMMALIA, V73, P85, DOI 10.1515/MAMM.2009.024; Calix M., 2018, EUROPEAN RED LIST SA; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Craighead L, 1996, METAPOPULATIONS WILD, P325; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fragstats, 2006, SPATIAL PATTERN ANAL; Ghanekar NM, 2011, HINDUSTAN TIMES 1129; Gujarat Forest Department, 2012, WILDL CENS; HARRISON RL, 1992, CONSERV BIOL, V6, P293, DOI 10.1046/j.1523-1739.1992.620293.x; Hilty JA, 2006, CORRIDOR ECOLOGY SCI, P206; Huck M, 2011, ACTA THERIOL, V56, P91, DOI 10.1007/s13364-010-0006-9; IUCN, 2011, IUCN RED LIST CUON A; JOHNSINGH A J T, 1983, Journal of the Bombay Natural History Society, V80, P1; Joshi Ritesh, 2008, Journal of American Science, V4, P63; Karanth K. Ullas, 2003, Journal of the Bombay Natural History Society, V100, P169; Karanth KK, 2011, CONSERV LETT, V4, P137, DOI 10.1111/j.1755-263X.2010.00154.x; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; KARANTH U.K., 1995, J ANIM ECOL, V64, P439; KOSTER SH, 1988, AFR J ECOL, V26, P117, DOI 10.1111/j.1365-2028.1988.tb00962.x; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Lomolino MV, 2000, ECOLOGY, V81, P1517, DOI 10.2307/177303; Majka D, 2010, NEW TOOLS AVAILABLE; Manjrekar N, 1997, THESIS SAURASHTRA U; McEuen A, 1993, WILDLIFE CORRIDOR CO, V10; McKenzie E, 1995, IMPORTANT CRITERIA P; Meneguzzo DM, 2006, P 8 ANN FOR INV AN S; Menke K, 2008, LOCATING POTENTIAL C; Ministry of Tourism, 2012, ECOTOURISM; Miquelle Dale G., 1999, P71; NOSS R F, 1987, Natural Areas Journal, V7, P2; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Noss RF, 2004, NAT AREA J, V24, P223; NOSS RF, 1986, ENVIRON MANAGE, V10, P299, DOI 10.1007/BF01867252; NOSS RF, 1983, BIOSCIENCE, V33, P700, DOI 10.2307/1309350; NTCA, 2008, REV GUID ONG CENTR S; Osborn FV, 2003, AFR J ECOL, V41, P68, DOI 10.1046/j.1365-2028.2003.00413.x; Paetkau D, 1997, DRAMATIC VARIATION G; Parks Canada, 2003, ELK MAN BANFF NAT PA; QUINBY P, 2000, WILD EARTH, V10, P75; Rathore CS, 2008, TOURISM DEV J, V5; Sale JB, 1990, PRELIMINARY TR UNPUB; Sandbrook CG, 2010, CONSERV LETT, V3, P21, DOI 10.1111/j.1755-263X.2009.00085.x; Sankar K., 1994, THESIS U RAJASTHAN J; Sathyakumar S., 1994, THESIS SAURASHTRA U; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schadt S, 2002, ECOL APPL, V12, P1469; Scheyvens R, 1999, TOURISM MANAGE, V20, P245, DOI 10.1016/S0261-5177(98)00069-7; Seidensticker J, 1999, TIGER CONSERVATION H; Seidensticker J, 2010, TIGER POPULATIONS HA; Seidensticker John, 1993, Symposia of the Zoological Society of London, V65, P105; SIMBERLOFF D, 1987, Conservation Biology, V1, P63, DOI 10.1111/j.1523-1739.1987.tb00010.x; SIMBERLOFF DS, 1976, SCIENCE, V191, P285, DOI 10.1126/science.191.4224.285; Simberloff S, 1992, CONSERV BIOL, V1, P63; Sinha PR, 2011, 2011003 TR NAT TIG C, P302; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Trombulak SC, 2010, LANDSCAPE-SCALE CONSERVATION PLANNING, P281, DOI 10.1007/978-90-481-9575-6_13; UFL, 2005, BIRDS US WILDL CORR; Varman KS, 1988, THESIS BHARATHIDASAN; Varman KS, 1995, P INT WORKSH CONS AS; Walker R, 1997, P ESRI US C REDL US; Walker R, 1997, P ENV SYST RES I INT; Wiess M, 2006, THEORY ISLAND BIOGEO; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wilson E.O., 1975, P522; WWF International, 2001, GUID COMM BAS EC DEV; Zeng H., 2005, COMPUT ENVIRON URBAN, V29, P159, DOI [DOI 10.1016/j.compenvurbsys.2003.09.002, 10.1016/j.compenvurbsys.2003.09.002, DOI 10.1016/J.COMPENVURBSYS.2003.09.002]	77	25	26	3	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39996	10.1371/journal.pone.0039996	http://dx.doi.org/10.1371/journal.pone.0039996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815720	gold, Green Published			2022-12-27	WOS:000306466100024
J	Wang, HM; Hsiao, CL; Hsieh, AR; Lin, YC; Fann, CSJ				Wang, Hui-Min; Hsiao, Ching-Lin; Hsieh, Ai-Ru; Lin, Ying-Chao; Fann, Cathy S. J.			Constructing Endophenotypes of Complex Diseases Using Non-Negative Matrix Factorization and Adjusted Rand Index	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRINCIPAL COMPONENT ANALYSIS; GENE-EXPRESSION; MICROARRAY DATA; CLASS DISCOVERY; BREAST-CANCER; ERYTHROPOIETIN; PATHWAY; GASTRIN; VISUALIZATION	Complex diseases are typically caused by combinations of molecular disturbances that vary widely among different patients. Endophenotypes, a combination of genetic factors associated with a disease, offer a simplified approach to dissect complex trait by reducing genetic heterogeneity. Because molecular dissimilarities often exist between patients with indistinguishable disease symptoms, these unique molecular features may reflect pathogenic heterogeneity. To detect molecular dissimilarities among patients and reduce the complexity of high-dimension data, we have explored an endophenotype-identification analytical procedure that combines non-negative matrix factorization (NMF) and adjusted rand index (ARI), a measure of the similarity of two clusterings of a data set. To evaluate this procedure, we compared it with a commonly used method, principal component analysis with k-means clustering (PCA-K). A simulation study with gene expression dataset and genotype information was conducted to examine the performance of our procedure and PCA-K. The results showed that NMF mostly outperformed PCA-K. Additionally, we applied our endophenotype-identification analytical procedure to a publicly available dataset containing data derived from patients with late-onset Alzheimer's disease (LOAD). NMF distilled information associated with 1,116 transcripts into three metagenes and three molecular subtypes (MS) for patients in the LOAD dataset: MS1 (n(1) = 80), MS2 (n(2) = 73), and MS3 (n(3) = 23). ARI was then used to determine the most representative transcripts for each metagene; 123, 89, and 71 metagene-specific transcripts were identified for MS1, MS2, and MS3, respectively. These metagene-specific transcripts were identified as the endophenotypes. Our results showed that 14, 38, 0, and 28 candidate susceptibility genes listed in AlzGene database were found by all patients, MS1, MS2, and MS3, respectively. Moreover, we found that MS2 might be a normal-like subtype. Our proposed procedure provides an alternative approach to investigate the pathogenic mechanism of disease and better understand the relationship between phenotype and genotype.	[Wang, Hui-Min] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hsiao, Ching-Lin; Hsieh, Ai-Ru; Lin, Ying-Chao; Fann, Cathy S. J.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Wang, HM (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	csjfann@ibms.sinica.edu.tw	wang, huimin/HDM-8421-2022; Fann, Cathy SJ/F-9410-2010	Fann, Cathy SJ/0000-0001-9025-2276; HSIEH, AIRU/0000-0003-3900-9101	National Science Council; Institute of Biomedical Sciences Academia Sinica of Taiwan; National Science Council of Taiwan [98-2628-B-001-008]	National Science Council(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences Academia Sinica of Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We would like to thank the reviewers, for their valuable and constructive comments and suggestions which have helped to improve the manuscript greatly. We also thank Dr. Ie-Bin. Lian (Department of Mathematics, National Changhua University of Education, Taiwan) and Dr. Yuh-Shan Jou (Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan) for their suggestions on data and pathway analyses. We are grateful to National Science Council and Institute of Biomedical Sciences Academia Sinica of Taiwan for their supports.; This research was supported by National Science Council grants (98-2628-B-001-008) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Anguiano A, 2009, J CLIN ONCOL, V27, P4197, DOI 10.1200/JCO.2008.19.1916; Beazely MA, 2006, J NEUROCHEM, V98, P1657, DOI 10.1111/j.1471-4159.2006.04064.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bieber E, 2001, J REPROD MED, V46, P521; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Boone PM, 2011, HUM GENET, V130, P103, DOI 10.1007/s00439-011-1001-1; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; CARMONASAEZ P, 2006, BMC BIOINFORMATICS, V7; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Cupples LA, 2007, BMC MED GENETICS, P8; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Ekins S, 2007, METH MOL B, V356, P319; Fan HT, 2005, CURR MOL MED, V5, P3, DOI 10.2174/1566524053152861; Ferrand A, 2006, CANCER LETT, V238, P15, DOI 10.1016/j.canlet.2005.06.025; Florez JC, 2007, DIABETES, V56, pA94; Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Goodnough LT, 2000, BLOOD, V96, P823, DOI 10.1182/blood.V96.3.823.015k49_823_833; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Grabowska AM, 2007, CANCER LETT, V257, P1, DOI 10.1016/j.canlet.2007.06.017; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Hollingworth P., 2011, MOL PSYCHIAT; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Huber KE, 2009, SEMIN RADIAT ONCOL, V19, P204, DOI 10.1016/j.semradonc.2009.05.004; Jonsson G, 2010, BREAST CANC RES, P12; Kamboh MI, 2004, ANN HUM GENET, V68, P381, DOI 10.1046/j.1529-8817.2004.00110.x; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kong W, 2008, BIOTECHNIQUES, V45, P501, DOI 10.2144/000112950; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li H, 2010, GENETICA, V138, P915, DOI 10.1007/s10709-010-9480-x; Linseman DA, 2002, J BIOL CHEM, V277, P24546, DOI 10.1074/jbc.M201098200; Liu WX, 2008, J BIOMED INFORM, V41, P602, DOI 10.1016/j.jbi.2007.12.003; Lohmann G, 2007, NEUROIMAGE, V37, P1148, DOI 10.1016/j.neuroimage.2007.05.031; Lynn KS, 2009, BIOINFORMATICS, V25, P981, DOI 10.1093/bioinformatics/btp106; McCarthy MI, 2008, HUM MOL GENET, V17, pR100, DOI 10.1093/hmg/ddn298; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mosca L, 2010, CLIN CANCER RES, V16, P5641, DOI 10.1158/1078-0432.CCR-10-0151; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Pan WH, 2006, GENET EPIDEMIOL, V30, P143, DOI 10.1002/gepi.20136; R Development Core Team R. R, 2011, LANG ENV STAT COMP; Roesler Rafael, 2007, Recent Pat CNS Drug Discov, V2, P125; Ross DA, 2006, J MACH LEARN RES, V7, P2369; Salma J, 2012, J NEUROSCI, V32, P2790, DOI 10.1523/JNEUROSCI.3609-11.2012; Smesny S, 2007, PROSTAG LEUKOTR ESS, V77, P79, DOI 10.1016/j.plefa.2007.08.006; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Williams RBH, 2007, GENOME RES, V17, P1707, DOI 10.1101/gr.6981507; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Zhang WS, 2006, BIOINFORMATICS, V22, P317, DOI 10.1093/bioinformatics/bti738; Zou F, 2010, NEUROLOGY, V74, P480, DOI 10.1212/WNL.0b013e3181d07654	76	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40996	10.1371/journal.pone.0040996	http://dx.doi.org/10.1371/journal.pone.0040996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815890	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100105
J	Abdulmalik, O; Lombardi, AA; Russell, JE				Abdulmalik, Osheiza; Lombardi, Alyssa A.; Russell, J. Eric			A Reverse Time-Course Method for Transcriptional Chase Analyses of mRNA Half-Lives in Cultured Cells	PLOS ONE			English	Article							GENE-EXPRESSION; STABILITY; REGION; TURNOVER; SEQUENCE	Standard methods for assessing mRNA stabilities in intact cells are labor-intensive and can generate half-life (t(1/2)) measures that are both imprecise and inaccurate. We describe modifications to a conventional tetracycline-conditional transcriptional chase method for analyzing mRNA stability that significantly simplify its conduct, while generating highly reproducible and accurate t(1/2) values. The revised method-which is conducted as a reverse time course, and which accounts for interval expansion in the number of cultured cells-is validated for the analyses of mRNAs with both short and long half-lives. This approach facilitates accurate assessment of mRNA metabolism, providing a user-friendly tool for detailed investigations into their structures and functions, as well as the processes that contribute to their post-transcriptional regulation.	[Abdulmalik, Osheiza; Russell, J. Eric] Univ Penn, Sch Med, Dept Pediat Hematol, Philadelphia, PA 19104 USA; [Abdulmalik, Osheiza; Lombardi, Alyssa A.; Russell, J. Eric] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Lombardi, Alyssa A.; Russell, J. Eric] Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Abdulmalik, O (corresponding author), Univ Penn, Sch Med, Dept Pediat Hematol, Philadelphia, PA 19104 USA.	abdulmalik@email.chop.edu		abdulmalik, osheiza/0000-0003-2497-4291	UNICO Foundation;  [R01-HL082754];  [R01-HL061399];  [K01-HL103186]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103186, R01HL082754, R01HL061399] Funding Source: NIH RePORTER	UNICO Foundation; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants R01-HL082754 and R01-HL061399 (JER), K01-HL103186 (OA), and through an award from the UNICO Foundation (OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheadle C, 2005, ANN NY ACAD SCI, V1058, P196, DOI 10.1196/annals.1359.026; Chowdhury B, 2005, J BIOL CHEM, V280, P18959, DOI 10.1074/jbc.M501048200; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; LEBWOHL DE, 1994, ONCOGENE, V9, P1925; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Liu X, 2010, J THROMB HAEMOST, V8, P2580, DOI 10.1111/j.1538-7836.2010.04026.x; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Nirunsuksiri W, 1998, J INVEST DERMATOL, V110, P854, DOI 10.1046/j.1523-1747.1998.00208.x; PasmanikChor M, 1997, HUM MOL GENET, V6, P887, DOI 10.1093/hmg/6.6.887; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558	15	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40827	10.1371/journal.pone.0040827	http://dx.doi.org/10.1371/journal.pone.0040827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808270	Green Submitted, gold, Green Published			2022-12-27	WOS:000306406700060
J	Goc, A; Abdalla, M; Al-Azayzih, A; Somanath, PR				Goc, Anna; Abdalla, Maha; Al-Azayzih, Ahmad; Somanath, Payaningal R.			Rac1 Activation Driven by 14-3-3 zeta Dimerization Promotes Prostate Cancer Cell-Matrix Interactions, Motility and Transendothelial Migration	PLOS ONE			English	Article							ONCOGENIC TRANSFORMATION; PROTEIN; 14-3-3-SIGMA; 14-3-3-PROTEINS; EXPRESSION; PROTEOMICS; REDUCTION; INHIBITOR; SLINGSHOT; BINDING	14-3-3 proteins are ubiquitously expressed dimeric adaptor proteins that have emerged as key mediators of many cell signaling pathways in multiple cell types. Its effects are mainly mediated by binding to selective phosphoserine/threonine proteins. The importance of 14-3-3 proteins in cancer have only started to become apparent and its exact role in cancer progression as well as the mechanisms by which 14-3-3 proteins mediate cancer cell function remain unknown. While protein 14-3-3 sigma is widely accepted as a tumor suppressor, 14-3-3 zeta, beta and gamma isoforms have been shown to have tumor promoting effects. Despite the importance of 14-3-3 family in mediating various cell processes, the exact role and mechanism of 14-3-3 zeta remain unexplored. In the current study, we investigated the role of protein 14-3-3 zeta in prostate cancer cell motility and transendothelial migration using biochemical, molecular biology and electric cell-substrate impedance sensing approaches as well as cell based functional assays. Our study indicated that expression with wild-type protein 14-3-3 zeta significantly enhanced Rac activity in PC3 cells. In contrast, expression of dimer-resistant mutant of protein 14-3-3 zeta (DM-14-3-3) inhibited Rac activity and associated phosphorylation of p21 activated kinase-1 and 2. Expression with wild-type 14-3-3 zeta or constitutively active Rac1 enhanced extracellular matrix recognition, lamellipodia formation, cell migration and trans-endothelial migration by PC3 cells. In contrast, expression with DM 14-3-3 zeta or DN-Rac1 in PC3 cells significantly inhibited these cell functions. Our results demonstrate for the first time that 14-3-3 zeta enhances prostate cancer cell-matrix interactions, motility and transendothelial migration in vitro via activation of Rac1-GTPase and is an important target for therapeutic interventions for prostate cancer.	[Goc, Anna; Abdalla, Maha; Al-Azayzih, Ahmad; Somanath, Payaningal R.] Univ Georgia, Coll Pharm, Augusta, GA USA; [Goc, Anna; Abdalla, Maha; Al-Azayzih, Ahmad; Somanath, Payaningal R.] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Somanath, Payaningal R.] Georgia Hlth Sci Univ, Dept Med, Augusta, GA USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University	Goc, A (corresponding author), Univ Georgia, Coll Pharm, Augusta, GA USA.	sshenoy@georgiahealth.edu		Abdalla, Maha/0000-0002-5644-3383; Rammohan Shenoy, Somanath/0000-0003-3017-0230	University of Georgia Research Foundation; Wilson Pharmacy Foundation; UGA College of Pharmacy; National Institutes of Health [R01HL103952]; American Heart Association [0830326N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103952] Funding Source: NIH RePORTER	University of Georgia Research Foundation; Wilson Pharmacy Foundation; UGA College of Pharmacy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funds were provided by the University of Georgia Research Foundation, Wilson Pharmacy Foundation and UGA College of Pharmacy through intramural grants to PRS, and in part by the National Institutes of Health grant (R01HL103952) and American Heart Association Scientist Development Grant (0830326N) to PRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiya AA, 2011, INT J ONCOL, V38, P1047, DOI 10.3892/ijo.2011.937; Bialkowska K, 2003, J BIOL CHEM, V278, P33342, DOI 10.1074/jbc.M301217200; Cao WD, 2006, J NEURO-ONCOL, V77, P125, DOI 10.1007/s11060-005-9027-7; Chatterjee D, 2004, INT J ONCOL, V25, P503; Cheng L, 2004, CLIN CANCER RES, V10, P3064, DOI 10.1158/1078-0432.CCR-03-0652; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Goc A, 2011, INT J ONCOL, V38, P267, DOI 10.3892/ijo_00000847; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hong HY, 2010, MOL CELLS, V29, P305, DOI 10.1007/s10059-010-0037-8; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Lee CH, 2012, P NATL ACAD SCI USA, V109, P929, DOI 10.1073/pnas.1115528109; Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445; Masters SC, 2002, BIOCHEM SOC T, V30, P360, DOI 10.1042/bst0300360; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Maxwell SA, 2009, J BIOL CHEM, V284, P22379, DOI 10.1074/jbc.M109.022418; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Nakanishi Kozo, 1997, Human Antibodies, V8, P189; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Qi WQ, 2003, RADIAT RES, V160, P217, DOI 10.1667/RR3038; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Ravi D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015864; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Somanath PR, 2009, ONCOGENE, V28, P2365, DOI 10.1038/onc.2009.114; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang X, 2012, CANCER GENE THER, V19, P153, DOI 10.1038/cgt.2011.85; Zhao J, 2011, P NATL ACAD SCI USA, V108, P16212, DOI 10.1073/pnas.1100012108; Zhou QQ, 2010, CURR BIOL, V20, P1881, DOI 10.1016/j.cub.2010.09.048	38	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40594	10.1371/journal.pone.0040594	http://dx.doi.org/10.1371/journal.pone.0040594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808202	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700037
J	Zill, P; Baghai, TC; Schule, C; Born, C; Frustuck, C; Buttner, A; Eisenmenger, W; Varallo-Bedarida, G; Rupprecht, R; Moller, HJ; Bondy, B				Zill, Peter; Baghai, Thomas C.; Schuele, Cornelius; Born, Christoph; Fruestueck, Clemens; Buettner, Andreas; Eisenmenger, Wolfgang; Varallo-Bedarida, Gabriella; Rupprecht, Rainer; Moeller, Hans-Juergen; Bondy, Brigitta			DNA Methylation Analysis of the Angiotensin Converting Enzyme (ACE) Gene in Major Depression	PLOS ONE			English	Article							INSERTION/DELETION POLYMORPHISM; EPIGENETIC REGULATION; MATERNAL-CARE; COMT PROMOTER; BRAIN; RECEPTOR; EXPRESSION; SYSTEM; HYPERMETHYLATION; ASSOCIATION	Background: The angiotensin converting enzyme (ACE) has been repeatedly discussed as susceptibility factor for major depression (MD) and the bi-directional relation between MD and cardiovascular disorders (CVD). In this context, functional polymorphisms of the ACE gene have been linked to depression, to antidepressant treatment response, to ACE serum concentrations, as well as to hypertension, myocardial infarction and CVD risk markers. The mostly investigated ACE Ins/Del polymorphism accounts for similar to 40%-50% of the ACE serum concentration variance, the remaining half is probably determined by other genetic, environmental or epigenetic factors, but these are poorly understood. Materials and Methods: The main aim of the present study was the analysis of the DNA methylation pattern in the regulatory region of the ACE gene in peripheral leukocytes of 81 MD patients and 81 healthy controls. Results: We detected intensive DNA methylation within a recently described, functional important region of the ACE gene promoter including hypermethylation in depressed patients (p = 0.008) and a significant inverse correlation between the ACE serum concentration and ACE promoter methylation frequency in the total sample (p = 0.02). Furthermore, a significant inverse correlation between the concentrations of the inflammatory CVD risk markers ICAM-1, E-selectin and P-selectin and the degree of ACE promoter methylation in MD patients could be demonstrated (p = 0.01 - 0.04). Conclusion: The results of the present study suggest that aberrations in ACE promoter DNA methylation may be an underlying cause of MD and probably a common pathogenic factor for the bi-directional relationship between MD and cardiovascular disorders.	[Zill, Peter; Baghai, Thomas C.; Schuele, Cornelius; Born, Christoph; Fruestueck, Clemens; Rupprecht, Rainer; Moeller, Hans-Juergen; Bondy, Brigitta] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Zill, Peter; Bondy, Brigitta] Univ Munich, Div Psychiat Genet & Neurochem, Munich, Germany; [Baghai, Thomas C.; Rupprecht, Rainer] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Buettner, Andreas; Eisenmenger, Wolfgang] Univ Regensburg, Inst Med Legale, Regensburg, Germany; [Buettner, Andreas] Univ Rostock, Inst Med Legale, Rostock, Germany; [Varallo-Bedarida, Gabriella] Univ Rostock, Dept Internal Med Prevent Cardiol, Rostock, Germany	University of Munich; University of Munich; University of Regensburg; University of Regensburg; University of Rostock; University of Rostock	Zill, P (corresponding author), Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany.	Peter.Zill@med.uni-muenchen.de	Büttner, Andreas/I-5974-2014	Büttner, Andreas/0000-0002-6676-4957; Baghai, Thomas C/0000-0002-7873-4130	Deutsche Forschungsgemeinschaft [DFG BA 2309/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The present project was in part supported by a grant from the Deutsche Forschungsgemeinschaft (DFG BA 2309/1-1). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; Angunsri R, 2009, J RENIN-ANGIO-ALDO S, V10, P179, DOI 10.1177/1470320309344151; Arganaraz GA, 2008, EPILEPSIA, V49, P1348, DOI 10.1111/j.1528-1167.2008.01581.x; Arinami T, 1996, BIOL PSYCHIAT, V40, P1122, DOI 10.1016/S0006-3223(95)00597-8; Baghai TC, 2006, MOL PSYCHIATR, V11, P1003, DOI 10.1038/sj.mp.4001884; Baghai TC, 2004, NEUROSCI LETT, V363, P38, DOI 10.1016/j.neulet.2004.03.052; Baghai TC, 2002, NEUROSCI LETT, V328, P299, DOI 10.1016/S0304-3940(02)00527-X; Baghai TC, 2001, MOL PSYCHIATR, V6, P258, DOI 10.1038/sj.mp.4000857; Baghai TC, 2010, J CLIN PSYCHIAT; Baltatu OC, 2011, PEPTIDES, V32, P1083, DOI 10.1016/j.peptides.2011.02.008; Bennett MR, 2011, PROG NEUROBIOL, V93, P468, DOI 10.1016/j.pneurobio.2011.01.006; Bondy Brigitta, 2007, Dialogues Clin Neurosci, V9, P19; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; da Cunha V, 2005, ATHEROSCLEROSIS, V178, P9, DOI 10.1016/j.atherosclerosis.2004.08.023; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; First M. B., 1997, STRUCTURED CLIN INTE; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Grippo AJ, 2002, NEUROSCI BIOBEHAV R, V26, P941, DOI 10.1016/S0149-7634(03)00003-4; Haefher S, 2008, J PSYCHIATR RES, V42, P163, DOI 10.1016/j.jpsychires.2007.02.002; Hamelin BA, 2011, J CLIN PHARMACOL, V51, P1286, DOI 10.1177/0091270010382420; Hamming I, 2008, EXP PHYSIOL, V93, P631, DOI 10.1113/expphysiol.2007.041855; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kinnally EL, 2010, GENES BRAIN BEHAV, V9, P45, DOI 10.1111/j.1601-183X.2009.00533.x; Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117; Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; McKinley MJ, 2001, JPN J PHYSIOL, V51, P281, DOI 10.2170/jjphysiol.51.281; Melki JR, 1999, CANCER RES, V59, P3730; Mendlewicz J, 2005, INT J NEUROPSYCHOPH, V8, P505, DOI 10.1017/S1461145705005444; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Murphy BC, 2005, AM J MED GENET B, V133B, P37, DOI 10.1002/ajmg.b.30134; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nantel P, 2010, CAN J CARDIOL SE, V26, p7E; Nohesara S, 2011, J PSYCHIATR RES, V45, P1432, DOI 10.1016/j.jpsychires.2011.06.013; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Olsson CA, 2010, BIOL PSYCHOL, V83, P159, DOI 10.1016/j.biopsycho.2009.12.003; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Pidsley R, 2011, BIOL PSYCHIAT, V69, P146, DOI 10.1016/j.biopsych.2010.03.029; Poulter MO, 2008, BIOL PSYCHIAT, V64, P645, DOI 10.1016/j.biopsych.2008.05.028; Raleigh SM, 2012, J APPL PHYSIOL, V112, P1082, DOI 10.1152/japplphysiol.00828.2011; Riviere G, 2011, EPIGENETICS-US, V6, P479, DOI 10.4161/epi.6.4.14961; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004; Soehnlein O, 2005, J VASC RES, V42, P399, DOI 10.1159/000087340; Takai Daiya, 2003, In Silico Biology, V3, P235; Tan JH, 2004, AM J PHYSIOL-HEART C, V286, pH1665, DOI 10.1152/ajpheart.00858.2003; Taverne K, 2010, EXPERT OPIN DRUG MET, V6, P439, DOI 10.1517/17425250903571670; TESTUT P, 1993, BIOCHEM J, V293, P843, DOI 10.1042/bj2930843; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsikouris JP, 2003, PHARMACOTHERAPY, V23, P1141, DOI 10.1592/phco.23.10.1141.32763; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; Weaver ICG, 2009, SEMIN FETAL NEONAT M, V14, P143, DOI 10.1016/j.siny.2008.12.002; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010	62	60	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40479	10.1371/journal.pone.0040479	http://dx.doi.org/10.1371/journal.pone.0040479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808171	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700031
J	Nikitidou, L; Kanter-Schlifke, I; Dhondt, J; Carmeliet, P; Lambrechts, D; Kokaia, M				Nikitidou, Litsa; Kanter-Schlifke, Irene; Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether; Kokaia, Merab			VEGF Receptor-2 (Flk-1) Overexpression in Mice Counteracts Focal Epileptic Seizures	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; STIMULATES AXONAL OUTGROWTH; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; IN-VITRO; HIPPOCAMPAL NEUROGENESIS; CELL PROLIFERATION; GENE-EXPRESSION; SEX-DIFFERENCES; NERVOUS-SYSTEM	Vascular endothelial growth factor (VEGF) was first described as an angiogenic agent, but has recently also been shown to exert various neurotrophic and neuroprotective effects in the nervous system. These effects of VEGF are mainly mediated by its receptor, VEGFR-2, which is also referred to as the fetal liver kinase receptor 1 (Flk-1). VEGF is up-regulated in neurons and glial cells after epileptic seizures and counteracts seizure-induced neurodegeneration. In vitro, VEGF administration suppresses ictal and interictal epileptiform activity caused by AP4 and 0 Mg2+ via Flk-1 receptor. We therefore explored whether increased VEGF signaling through Flk-1 overexpression may regulate epileptogenesis and ictogenesis in vivo. To this extent, we used transgenic mice overexpressing Flk-1 postnatally in neurons. Intriguingly, Flk-1 overexpressing mice were characterized by an elevated threshold for seizure induction and a decreased duration of focal after discharges, indicating anti-ictal action. On the other hand, the kindling progression in these mice was similar to wild-type controls. No significant effects on blood vessels or glia cells, as assessed by Glut1 and GFAP immunohistochemistry, were detected. These results suggest that increased VEGF signaling via overexpression of Flk-1 receptors may directly affect seizure activity even without altering angiogenesis. Thus, Flk-1 could be considered as a novel target for developing future gene therapy strategies against ictal epileptic activity.	[Nikitidou, Litsa; Kanter-Schlifke, Irene; Kokaia, Merab] Univ Lund Hosp, Expt Epilepsy Grp, Wallenberg Neurosci Ctr, S-22185 Lund, Sweden; [Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium; [Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium	Lund University; Skane University Hospital; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven	Nikitidou, L (corresponding author), Univ Lund Hosp, Expt Epilepsy Grp, Wallenberg Neurosci Ctr, BMC A-11, S-22185 Lund, Sweden.	Merab.Kokaia@med.lu.se	Carmeliet, Peter/AAQ-5140-2020; Lambrechts, Diether/AAJ-3167-2020; Verdrengh, Evelien/H-4571-2012	Carmeliet, Peter/0000-0001-7961-1821; Lambrechts, Diether/0000-0002-3429-302X; 	Swedish Research Council; EU commission [LSH-037315]; Segerfalk Foundation; Kock foundation; Crafoord Foundation; Long term Structural funding: Methusalem	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU commission(European CommissionEuropean Commission Joint Research Centre); Segerfalk Foundation; Kock foundation; Crafoord Foundation; Long term Structural funding: Methusalem	This study was supported by grants from the Swedish Research Council, EU commission grant (LSH-037315), Segerfalk Foundation, Kock foundation, Crafoord Foundation and Long term Structural funding: Methusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boer K, 2008, ACTA NEUROPATHOL, V115, P683, DOI 10.1007/s00401-008-0354-6; Cammalleri M, 2011, EUR J NEUROSCI, V33, P482, DOI 10.1111/j.1460-9568.2010.07529.x; Cornford E M, 1999, Adv Neurol, V79, P845; Croll SD, 2004, ADV EXP MED BIOL, V548, P57; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; EBERT U, 1994, BRAIN RES, V638, P45, DOI 10.1016/0006-8993(94)90631-9; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fujiki M, 2010, EXP NEUROL, V225, P377, DOI 10.1016/j.expneurol.2010.07.010; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gotzsche CR, 2011, NEUROBIOL DIS; Gronlund KM, 1996, J NEUROPATH EXP NEUR, V55, P832, DOI 10.1097/00005072-199607000-00008; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; LI J, 1995, J BIOL CHEM, V270, P308, DOI 10.1074/jbc.270.1.308; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Newton SS, 2003, J NEUROSCI, V23, P10841; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Nicoletti JN, 2010, EPILEPSY BEHAV, V19, P272, DOI 10.1016/j.yebeh.2010.07.011; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, V33; Peltola J, 2002, SEIZURE-EUR J EPILEP, V11, P44, DOI 10.1053/seiz.2001.0575; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shimakawa S, 2002, BRAIN RES, V956, P67, DOI 10.1016/S0006-8993(02)03482-0; Shimotake J, 2010, STROKE, V41, P343, DOI 10.1161/STROKEAHA.109.564229; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Teskey GC, 1999, CEREB CORTEX, V9, P675, DOI 10.1093/cercor/9.7.675; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Woldbye DPD, 2010, BRAIN, V133, P2778, DOI 10.1093/brain/awq219; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	49	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40535	10.1371/journal.pone.0040535	http://dx.doi.org/10.1371/journal.pone.0040535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808185	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400032
J	Jaubert, AM; Penot, G; Niang, F; Durant, S; Forest, C				Jaubert, Anne-Marie; Penot, Graziella; Niang, Fatoumata; Durant, Sylvie; Forest, Claude			Rapid Nitration of Adipocyte Phosphoenolpyruvate Carboxykinase by Leptin Reduces Glyceroneogenesis and Induces Fatty Acid Release	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ADIPOSE-TISSUE LIPOLYSIS; HORMONE-SENSITIVE LIPASE; INSULIN-RESISTANCE; GENE-EXPRESSION; TYROSINE NITRATION; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; IN-VITRO; PROTEIN	Fatty acid (FA) release from white adipose tissue (WAT) is the result of the balance between triglyceride breakdown and FA re-esterification. The latter relies on the induction of cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C), the key enzyme for glyceroneogenesis. We previously demonstrated that long-term (18 h) leptin treatment of rat epididymal WAT explants reduced glyceroneogenesis through nitric oxide (NO)-induced decrease in PEPCK-C expression. We investigated the effect of a short-term leptin treatment (2 h) on PEPCK-C expression and glyceroneogenesis in relation to NO production. We demonstrate that in WAT explants, leptin-induced NO synthase III (NOS III) phosphorylation was associated with reduced PEPCK-C level and glyceroneogenesis, leading to FA release, while PEPCK-C gene expression remained unaffected. These effects were absent in WAT explants from leptin receptor-deficient Zucker rat. Immunoprecipitation and western blot experiments showed that the leptin-induced decrease in PEPCK-C level was correlated with an increase in PEPCK-C nitration. All these effects were abolished by the NOS inhibitor Nv-nitro-L-arginine methyl ester and mimicked by the NO donor S-nitroso-N-acetyl-DL penicillamine. We propose a mechanism in which leptin activates NOS III and induces NO that nitrates PEPCK-C to reduce its level and glyceroneogenesis, therefore limiting FA re-esterification in WAT.	[Jaubert, Anne-Marie; Penot, Graziella; Niang, Fatoumata; Durant, Sylvie; Forest, Claude] Univ Paris 05, Inst Natl Sante & Rech Med, UMR S 747, Paris, France; [Jaubert, Anne-Marie] Univ Versailles St Quentin Yvelines, Dept Biochim & Biol Mol, Fac Med Paris Ile France Ouest, Versailles, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Jaubert, AM (corresponding author), Univ Paris 05, Inst Natl Sante & Rech Med, UMR S 747, Paris, France.	claude.forest@parisdescartes.fr		Niang, Fatoumata/0000-0001-9048-2194; Forest, Claude/0000-0003-3401-8148	Institut National de la Recherche Medicale (INSERM); Universite Paris Descartes; Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche; Association de Recherche sur le Cancer	Institut National de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Descartes; Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche; Association de Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was financed by the Institut National de la Recherche Medicale (INSERM) and the Universite Paris Descartes. The Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche and the Association de Recherche sur le Cancer have awarded a fellowship to Dr. Niang and Dr. Penot respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTRASFERRY J, 1995, EUR J BIOCHEM, V234, P390, DOI 10.1111/j.1432-1033.1995.390_b.x; ANTRASFERRY J, 1994, BIOCHEM J, V302, P943, DOI 10.1042/bj3020943; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; BELFRAGE P, 1985, INT J OBESITY, V9, P129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadoudal T, 2007, DIABETOLOGIA, V50, P666, DOI 10.1007/s00125-006-0560-5; Charbonneau A, 2010, DIABETES, V59, P861, DOI 10.2337/db09-1238; Chaves VE, 2011, BIOCHIMIE, V93, P1631, DOI 10.1016/j.biochi.2011.05.018; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dighiero P, 1997, INVEST OPHTH VIS SCI, V38, P2045; Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Forest C, 1997, PROSTAG LEUKOTR ESS, V57, P47, DOI 10.1016/S0952-3278(97)90492-0; Forest C, 2003, BIOCHEM SOC T, V31, P1125; Forstermann U, 1995, Adv Pharmacol, V34, P171; Fruhbeck G, 2001, CELL SIGNAL, V13, P827, DOI 10.1016/S0898-6568(01)00211-X; Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716; Gaudiot N, 1998, J BIOL CHEM, V273, P13475, DOI 10.1074/jbc.273.22.13475; Glorian M, 1998, J CELL BIOCHEM, V68, P298, DOI 10.1002/(SICI)1097-4644(19980301)68:3<298::AID-JCB2>3.0.CO;2-P; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kapur S, 1999, AM J PHYSIOL-ENDOC M, V276, pE635, DOI 10.1152/ajpendo.1999.276.4.E635; Kawaji N, 2001, J LIPID RES, V42, P1671; Khazen W, 2007, ENDOCRINOLOGY, V148, P4007, DOI 10.1210/en.2006-1760; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Mehebik N, 2005, AM J PHYSIOL-CELL PH, V289, pC379, DOI 10.1152/ajpcell.00320.2004; MEMON RA, 1992, ENDOCRINOLOGY, V131, P1695, DOI 10.1210/en.131.4.1695; Mitchell RN, 2004, J CLIN INVEST, V114, P762, DOI 10.1172/JCI200422927; Murphy E, 2011, J MOL CELL CARDIOL; Niang F, 2011, J NUTR, V141, P4, DOI 10.3945/jn.110.125765; OBRIEN RM, 1990, DIABETES CARE, V13, P327, DOI 10.2337/diacare.13.3.327; Osoata GO, 2009, BIOCHEM BIOPH RES CO, V384, P366, DOI 10.1016/j.bbrc.2009.04.128; Pilon G, 2000, HORM METAB RES, V32, P480, DOI 10.1055/s-2007-978674; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; PleeGautier E, 1996, BIOCHEM J, V318, P1057, DOI 10.1042/bj3181057; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Raharijaona M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007964; RESHEFF L, 1970, J BIOL CHEM, V245, P5979; Ribiere C, 1996, BIOCHEM BIOPH RES CO, V222, P706, DOI 10.1006/bbrc.1996.0824; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; White PJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE868, DOI 10.1152/ajpendo.00510.2010; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zhang JL, 1997, RES COMMUN MOL PATH, V96, P71; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	52	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40650	10.1371/journal.pone.0040650	http://dx.doi.org/10.1371/journal.pone.0040650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808220	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400090
J	Manabe, T; Iglesias, ALH; Manriquez, MEV; Valadez, ELM; Ramos, LA; Izumi, S; Takasaki, J; Kudo, K				Manabe, Toshie; Higuera Iglesias, Anjarath Lorena; Vazquez Manriquez, Maria Eugenia; Martinez Valadez, Eduarda Leticia; Alfaro Ramos, Leticia; Izumi, Shinyu; Takasaki, Jin; Kudo, Koichiro			Socioeconomic Factors Influencing Hospitalized Patients with Pneumonia Due to Influenza A(H1N1)pdm09 in Mexico	PLOS ONE			English	Article							A H1N1 VIRUS; RETROSPECTIVE ANALYSIS; INFECTION; MORTALITY; DEATH	Background: In addition to clinical aspects and pathogen characteristics, people's health-related behavior and socioeconomic conditions can affect the occurrence and severity of diseases including influenza A(H1N1)pdm09. Methodology and Principal Findings: A face-to-face interview survey was conducted in a hospital in Mexico City at the time of follow-up consultation for hospitalized patients with pneumonia due to influenza virus infection. In all, 302 subjects were enrolled and divided into two groups based on the period of hospitalization. Among them, 211 tested positive for influenza A(H1N1)pdm09 virus by real-time reverse-transcriptase-polymerase-chain-reaction during the pandemic period (Group-pdm) and 91 tested positive for influenza A virus in the post-pandemic period (Group-post). All subjects were treated with oseltamivir. Data on the demographic characteristics, socioeconomic status, living environment, and information relating to A(H1N1)pdm09, and related clinical data were compared between subjects in Group-pdm and those in Group-post. The ability of household income to pay for utilities, food, and health care services as well as housing quality in terms of construction materials and number of rooms revealed a significant difference: Group-post had lower socioeconomic status than Group-pdm. Group-post had lower availability of information regarding H1N1 influenza than Group-pdm. These results indicate that subjects in Group-post had difficulty receiving necessary information relating to influenza and were more likely to be impoverished than those in Group-pdm. Possible factors influencing time to seeking health care were number of household rooms, having received information on the necessity of quick access to health care, and house construction materials. Conclusions: Health-care-seeking behavior, poverty level, and the distribution of information affect the occurrence and severity of pneumonia due to H1N1 virus from a socioeconomic point of view. These socioeconomic factors may explain the different patterns of morbidity and mortality for H1N1 influenza observed among different countries and regions.	[Manabe, Toshie; Izumi, Shinyu; Takasaki, Jin; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Higuera Iglesias, Anjarath Lorena; Alfaro Ramos, Leticia] Natl Inst Resp Dis, Res Inst, Dept Clin Epidemiol Invest, Mexico City, DF, Mexico; [Vazquez Manriquez, Maria Eugenia] Natl Inst Resp Dis, Dept Pathol, Mexico City, DF, Mexico; [Martinez Valadez, Eduarda Leticia] Natl Inst Resp Dis, Dept Epidemiol, Mexico City, DF, Mexico	National Center for Global Health & Medicine - Japan	Manabe, T (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.	kudo@dcc.go.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniji KA, 2011, CRIT CARE, V15, DOI 10.1186/cc10001; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bellon MR, 2005, FOOD POLICY, V30, P476, DOI 10.1016/j.foodpol.2005.09.003; Benner David G., 2010, OPENING GOD0; BLAXTER M, 1987, LANCET, V2, P30; CONEVAL, 2011, SOC GAP IND; Cox CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029301; Dominguez-Cherit G, 2010, JAMA-J AM MED ASSOC, V302, P1880; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Enrique R, 2002, P BAYL U MED CTR, V15, P319; Eugenia-Manjarrez M, 2012, RESP DIS INTECH, P217; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gobierno Federal, MAN VAC 2008 2009; Gozalan A, 2012, JPN J INFECT DIS, V65, P13; Grijalva-Otero I, 2009, ARCH MED RES, V40, P662, DOI 10.1016/j.arcmed.2009.10.010; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; Pelcastre-Villafuerte BE, 2011, CAD SAUDE PUBLICA, V27, P460, DOI 10.1590/S0102-311X2011000300007; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; SALUDE, 2012, SIT ACT EP; SALUDE, 2010, SIT ACT EP; Vasoo S, 2010, EMERG INFECT DIS, V16, P1594, DOI 10.3201/eid1610.091889; Xi XM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-256; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	25	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40529	10.1371/journal.pone.0040529	http://dx.doi.org/10.1371/journal.pone.0040529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808184	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400067
J	de Sassi, C; Tylianakis, JM				de Sassi, Claudio; Tylianakis, Jason M.			Climate Change Disproportionately Increases Herbivore over Plant or Parasitoid Biomass	PLOS ONE			English	Article							NITROGEN DEPOSITION; COMMUNITY STRUCTURE; TUSSOCK GRASSLAND; INSECT HERBIVORY; TROPHIC LEVELS; GLOBAL CHANGE; TEMPERATURE; RESPONSES; IMPACTS; BIODIVERSITY	All living organisms are linked through trophic relationships with resources and consumers, the balance of which determines overall ecosystem stability and functioning. Ecological research has identified a multitude of mechanisms that contribute to this balance, but ecologists are now challenged with predicting responses to global environmental changes. Despite a wealth of studies highlighting likely outcomes for specific mechanisms and subsets of a system (e.g., plants, plant-herbivore or predator-prey interactions), studies comparing overall effects of changes at multiple trophic levels are rare. We used a combination of experiments in a grassland system to test how biomass at the plant, herbivore and natural enemy (parasitoid) levels responds to the interactive effects of two key global change drivers: warming and nitrogen deposition. We found that higher temperatures and elevated nitrogen generated a multitrophic community that was increasingly dominated by herbivores. Moreover, we found synergistic effects of the drivers on biomass, which differed across trophic levels. Both absolute and relative biomass of herbivores increased disproportionately to that of plants and, in particular, parasitoids, which did not show any significant response to the treatments. Reduced parasitism rates mirrored the profound biomass changes in the system. These findings carry important implications for the response of biota to environmental changes; reduced top-down regulation is likely to coincide with an increase in herbivory, which in turn is likely to cascade to other fundamental ecosystem processes. Our findings also provide multitrophic data to support the general concern of increasing herbivore pest outbreaks in a warmer world.	[de Sassi, Claudio; Tylianakis, Jason M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	de Sassi, C (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	cdesassi@gmail.com	Tylianakis, Jason/B-6634-2011	Tylianakis, Jason/0000-0001-7402-5620; De Sassi, Claudio/0000-0002-8811-7347	University of Canterbury Doctoral Scholarship; Hellaby Trust Fellowship; Rutherford Discovery Fellowship; Marsden Fund [UOC-0705]; Miss E.L. Hellaby Indigenous Grassland Research Trust	University of Canterbury Doctoral Scholarship; Hellaby Trust Fellowship; Rutherford Discovery Fellowship; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Miss E.L. Hellaby Indigenous Grassland Research Trust	CdS is supported by a University of Canterbury Doctoral Scholarship and a Hellaby Trust Fellowship. JMT is funded by a Rutherford Discovery Fellowship, administered by the Royal Society of New Zealand. This research was funded by the Marsden Fund (UOC-0705) and the Miss E.L. Hellaby Indigenous Grassland Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2005, AUSTRAL ECOL, V30, P281, DOI 10.1111/j.1442-9993.2005.01464.x; Austin D, 2007, MODELING NITROGEN FE; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barratt BIP, 2005, J ROY SOC NEW ZEAL, V35, P287, DOI 10.1080/03014223.2005.9517785; Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bloor JMG, 2010, ECOSYSTEMS, V13, P888, DOI 10.1007/s10021-010-9363-0; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Currano ED, 2008, P NATL ACAD SCI USA, V105, P1960, DOI 10.1073/pnas.0708646105; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Greenland DE, 1977, WEATHER CLIMATE CASS; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hoover JK, 2004, GLOBAL CHANGE BIOL, V10, P1197, DOI 10.1111/j.1529-8817.2003.00796.x; IPCC, 2007, PHYS SCI BAS; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Kishi D, 2005, FRESHWATER BIOL, V50, P1315, DOI 10.1111/j.1365-2427.2005.01404.x; Laliberte E, 2010, RANGELAND ECOL MANAG, V63, P537, DOI 10.2111/REM-D-09-00156.1; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Millennium Ecosystem Assessment (MEA), 2005, EC HUM WELLB SCEN; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Pickett S.T.A, 1989, SPACE FOR TIME SUBST; Pinheiro J., 2011, NLME LINEAR NONLINEA; Rall BC, 2010, GLOBAL CHANGE BIOL, V16, P2145, DOI 10.1111/j.1365-2486.2009.02124.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Richardson SJ, 2002, J ECOL, V90, P544, DOI 10.1046/j.1365-2745.2002.00681.x; Rose AB, 2004, NEW ZEAL J BOT, V42, P77, DOI 10.1080/0028825X.2004.9512891; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson PL, 2008, ARCT ANTARCT ALP RES, V40, P192, DOI 10.1657/1523-0430(06-105)[THOMPSON]2.0.CO;2; Throop HL, 2005, OIKOS, V111, P91, DOI 10.1111/j.0030-1299.2005.14026.x; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Tscharntke T, 2010, BIOL CONSERV, V143, P2249, DOI 10.1016/j.biocon.2010.03.028; Tuda M, 2006, POPUL ECOL, V48, P59, DOI 10.1007/s10144-005-0243-y; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vatka E, 2011, GLOBAL CHANGE BIOL, V17, P3002, DOI 10.1111/j.1365-2486.2011.02430.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; Wallisdevries MF, 2006, GLOBAL CHANGE BIOL, V12, P1620, DOI 10.1111/j.1365-2486.2006.01202.x; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; WILLIAMS PA, 1995, NEW ZEAL J BOT, V33, P237; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053	53	78	80	1	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40557	10.1371/journal.pone.0040557	http://dx.doi.org/10.1371/journal.pone.0040557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815763	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900031
J	Finetti, F; Terzuoli, E; Bocci, E; Coletta, I; Polenzani, L; Mangano, G; Alisi, MA; Cazzolla, N; Giachetti, A; Ziche, M; Donnini, S				Finetti, Federica; Terzuoli, Erika; Bocci, Elena; Coletta, Isabella; Polenzani, Lorenzo; Mangano, Giorgina; Alisi, Maria Alessandra; Cazzolla, Nicola; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra			Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; E-2 SYNTHASE-1; EGF RECEPTOR; CANCER; CYCLOOXYGENASE-2; 5-LIPOXYGENASE; EXPRESSION; TUMORIGENESIS; PROGRESSION; ACTIVATION	Background: Blockade of Prostaglandin (PG) E-2 production via deletion of microsomal Prostaglandin E synthase-1 (mPGES-1) gene reduces tumor cell proliferation in vitro and in vivo on xenograft tumors. So far the therapeutic potential of the pharmacological inhibition of mPGES-1 has not been elucidated. PGE(2) promotes epithelial tumor progression via multiple signaling pathways including the epidermal growth factor receptor (EGFR) signaling pathway. Methodology/Principal Findings: Here we evaluated the antitumor activity of AF3485, a compound of a novel family of human mPGES-1 inhibitors, in vitro and in vivo, in mice bearing human A431 xenografts overexpressing EGFR. Treatment of the human cell line A431 with interleukin-1beta (IL-1 beta) increased mPGES-1 expression, PGE(2) production and induced EGFR phosphorylation, and vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) expression. AF3485 reduced PGE(2) production, both in quiescent and in cells stimulated by IL-1 beta. AF3485 abolished IL-1 beta-induced activation of the EGFR, decreasing VEGF and FGF-2 expression, and tumor-mediated endothelial tube formation. In vivo, in A431 xenograft, AF3485, administered sub-chronically, decreased tumor growth, an effect related to inhibition of EGFR signalling, and to tumor microvessel rarefaction. In fact, we observed a decrease of EGFR phosphorylation, and VEGF and FGF-2 expression in tumours explanted from treated mice. Conclusion: Our work demonstrates that the pharmacological inhibition of mPGES-1 reduces squamous carcinoma growth by suppressing PGE(2) mediated-EGFR signalling and by impairing tumor associated angiogenesis. These results underscore the potential of mPGES-1 inhibitors as agents capable of controlling tumor growth.	[Finetti, Federica; Terzuoli, Erika; Bocci, Elena; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra] Univ Siena, Dept Biotechnol, Siena, Italy; [Coletta, Isabella; Polenzani, Lorenzo; Mangano, Giorgina; Alisi, Maria Alessandra; Cazzolla, Nicola] Angelini Res Ctr ACRAF SpA, Rome, Italy	University of Siena	Finetti, F (corresponding author), Univ Siena, Dept Biotechnol, Via Aldo Moro 2, Siena, Italy.	marina.ziche@unisi.it; sandra.donnini@unisi.it	Donnini, Sandra/K-9252-2019; Finetti, Federica/J-9089-2016; Coletta, Isabella/L-9262-2019; Terzuoli, Erika/M-7346-2016	Donnini, Sandra/0000-0001-6617-1644; Terzuoli, Erika/0000-0001-9248-4505; Ziche, Marina/0000-0002-9564-214X	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG10731]; Fondazione Italiana per la Ricerca sul Cancro (FIRC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work has received financial support from Associazione Italiana per la Ricerca sul Cancro (AIRC) IG10731 (MZ). Erika Terzuoli was supported by a fellowship from the Fondazione Italiana per la Ricerca sul Cancro (FIRC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT CF, 1993, BIOCHEM J, V289, P33, DOI 10.1042/bj2890033; Bruno A, 2010, BIOCHEM PHARMACOL, V79, P974, DOI 10.1016/j.bcp.2009.11.011; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; De Simone R, 2011, J MED CHEM, V54, P1565, DOI 10.1021/jm101238d; Donnini S, 2012, ONCOGENE, V31, P3457, DOI 10.1038/onc.2011.503; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Golijanin D, 2004, CLIN CANCER RES, V10, P1024, DOI 10.1158/1078-0432.CCR-1032-3; Johns TG, 2003, P NATL ACAD SCI USA, V100, P15871, DOI 10.1073/pnas.2036503100; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Koeberle A, 2008, J MED CHEM, V51, P8068, DOI 10.1021/jm801085s; Lu DD, 2011, GASTROENTEROLOGY, V140, P2084, DOI 10.1053/j.gastro.2011.02.056; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; Mbalaviele G, 2010, BIOCHEM PHARMACOL, V79, P1445, DOI 10.1016/j.bcp.2010.01.003; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Radmark O, 2010, J INTERN MED, V268, P5, DOI 10.1111/j.1365-2796.2010.02246.x; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Siemoneit U, 2011, BRIT J PHARMACOL, V162, P147, DOI 10.1111/j.1476-5381.2010.01020.x; Terzuoli E, 2010, CLIN CANCER RES, V16, P4207, DOI 10.1158/1078-0432.CCR-10-0156; Thoren S, 2000, EUR J BIOCHEM, V267, P6428, DOI 10.1046/j.1432-1327.2000.01735.x; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P2669; ZICHE M, 1982, JNCI-J NATL CANCER I, V69, P475	29	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40576	10.1371/journal.pone.0040576	http://dx.doi.org/10.1371/journal.pone.0040576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815767	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900033
J	Nicholson, E; Collen, B; Barausse, A; Blanchard, JL; Costelloe, BT; Sullivan, KME; Underwood, FM; Burn, RW; Fritz, S; Jones, JPG; McRae, L; Possingham, HP; Milner-Gulland, EJ				Nicholson, Emily; Collen, Ben; Barausse, Alberto; Blanchard, Julia L.; Costelloe, Brendan T.; Sullivan, Kathryn M. E.; Underwood, Fiona M.; Burn, Robert W.; Fritz, Steffen; Jones, Julia P. G.; McRae, Louise; Possingham, Hugh P.; Milner-Gulland, E. J.			Making Robust Policy Decisions Using Global Biodiversity Indicators	PLOS ONE			English	Article							PARTIALLY PROTECTED AREAS; ECOSYSTEM SERVICES; REFERENCE POINTS; MANAGEMENT; CONSERVATION; POPULATIONS; FRAMEWORK; TRACKING; COLLAPSE; BENGUELA	In order to influence global policy effectively, conservation scientists need to be able to provide robust predictions of the impact of alternative policies on biodiversity and measure progress towards goals using reliable indicators. We present a framework for using biodiversity indicators predictively to inform policy choices at a global level. The approach is illustrated with two case studies in which we project forwards the impacts of feasible policies on trends in biodiversity and in relevant indicators. The policies are based on targets agreed at the Convention on Biological Diversity (CBD) meeting in Nagoya in October 2010. The first case study compares protected area policies for African mammals, assessed using the Red List Index; the second example uses the Living Planet Index to assess the impact of a complete halt, versus a reduction, in bottom trawling. In the protected areas example, we find that the indicator can aid in decision-making because it is able to differentiate between the impacts of the different policies. In the bottom trawling example, the indicator exhibits some counter-intuitive behaviour, due to over-representation of some taxonomic and functional groups in the indicator, and contrasting impacts of the policies on different groups caused by trophic interactions. Our results support the need for further research on how to use predictive models and indicators to credibly track trends and inform policy. To be useful and relevant, scientists must make testable predictions about the impact of global policy on biodiversity to ensure that targets such as those set at Nagoya catalyse effective and measurable change.	[Nicholson, Emily; Blanchard, Julia L.; Costelloe, Brendan T.; Sullivan, Kathryn M. E.; Milner-Gulland, E. J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, Berks, England; [Nicholson, Emily] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Collen, Ben; Costelloe, Brendan T.; Sullivan, Kathryn M. E.; McRae, Louise] Zool Soc London, Inst Zool, London NW1 4RY, England; [Barausse, Alberto] Univ Padua, Environm Syst Anal Lab, Padua, Italy; [Blanchard, Julia L.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Underwood, Fiona M.; Burn, Robert W.] Univ Reading, Dept Math & Stat, Reading RG6 2AH, Berks, England; [Fritz, Steffen] IIASA, Laxenburg, Austria; [Jones, Julia P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Possingham, Hugh P.] Univ Queensland, Australian Res Council Ctr Excellence Environm De, St Lucia, Qld, Australia	Imperial College London; University of Melbourne; Zoological Society of London; University of Padua; University of Sheffield; University of Reading; International Institute for Applied Systems Analysis (IIASA); Bangor University; University of Queensland	Nicholson, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, Berks, England.	emily.nicholson@unimelb.edu.au	POSSINGHAM, HUGH/R-8310-2019; Collen, Ben/D-5055-2011; Blanchard, Julia L/E-4919-2010; Jones, Julia P G/ABD-5629-2021; Jones, Julia P G/A-3031-2011; Possingham, Hugh/B-1337-2008; Nicholson, Emily/H-9001-2013; Gatali, Callixte/S-2549-2018; Collen, Ben/F-2543-2016; Underwood, Fiona/O-6072-2016	POSSINGHAM, HUGH/0000-0001-7755-996X; Blanchard, Julia L/0000-0003-0532-4824; Jones, Julia P G/0000-0002-5199-3335; Jones, Julia P G/0000-0002-5199-3335; Possingham, Hugh/0000-0001-7755-996X; Nicholson, Emily/0000-0003-2199-3446; Collen, Ben/0000-0003-2564-4243; Barausse, Alberto/0000-0002-2849-7624; Underwood, Fiona/0000-0001-8701-7136; , Steffen/0000-0003-0420-8549; Milner-Gulland, E.J./0000-0003-0324-2710	NERC Centre for Population Biology; Marie Curie Fellowship; Centenary Fellowship, Faculty of Science, The University of Melbourne; Rufford Foundation; EC; WWF International; Australian Research Council; ARC Centre of Excellence for Environmental Decisions; AEDA; Commonwealth Environmental Research Facility; Royal Society Wolfson Research Merit award	NERC Centre for Population Biology(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marie Curie Fellowship(European Commission); Centenary Fellowship, Faculty of Science, The University of Melbourne; Rufford Foundation; EC(European CommissionEuropean Commission Joint Research Centre); WWF International; Australian Research Council(Australian Research Council); ARC Centre of Excellence for Environmental Decisions(Australian Research Council); AEDA; Commonwealth Environmental Research Facility; Royal Society Wolfson Research Merit award(Royal Society of London)	This paper was a product of a workshop funded by the NERC Centre for Population Biology. EN was funded by a Marie Curie Fellowship, and thanks the Grantham Institute for Climate Change at Imperial College for institutional support. EN is supported by a Centenary Fellowship, Faculty of Science, The University of Melbourne. BC was supported by the Rufford Foundation; AB by the EC FP7 KnowSeas project; JLB by the EU F7 project DEEPFISHMAN; LM by WWF International; HPP by the Australian Research Council, The ARC Centre of Excellence for Environmental Decisions, and AEDA, a Commonwealth Environmental Research Facility; and EJMG by a Royal Society Wolfson Research Merit award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER J, 2007, ECOSYSTEM BASED GLOB, DOI DOI 10.1016/J.ECOLMODEL.2003.09.003; Alder J, 2007, GLOBAL BIODIVERSITY; Arreguin-Sanchez F, 2002, ECOL MODEL, V156, P167, DOI 10.1016/S0304-3800(02)00159-X; BALL IR, 2000, MARXAN VERSION 1 8 3, DOI DOI 10.1016/J.BIOCON.2007.01.001; Barausse A, 2009, ESTUAR COAST SHELF S, V83, P577, DOI 10.1016/j.ecss.2009.05.003; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caro TM, 1999, J APPL ECOL, V36, P205, DOI 10.1046/j.1365-2664.1999.00392.x; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chee YE, 2010, J APPL ECOL, V47, P1169, DOI 10.1111/j.1365-2664.2010.01877.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; CoP10, 2010, AD HOC TECHN EXP GRO; COSTELLOE BT, 2010, POWER GLOBAL BIODIVE, DOI DOI 10.1073/PNAS.0703015105; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Failing L, 2003, J ENVIRON MANAGE, V68, P121, DOI 10.1016/S0301-4797(03)00014-8; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; GIANNI M, 2004, HIGH SEAS BOTTOM TRA, DOI DOI 10.1146/ANNUREV.ECOLYSIS.33.010802.150515; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Heymans S.J.J., 2005, FOODWEB MODELS DATA, V13, P8, DOI DOI 10.1016/J.ECOLMODEL.2003.09.015; Hong J, 2008, ECOL MODEL, V212, P492, DOI 10.1016/j.ecolmodel.2007.10.048; *IUCN, 2008, GUID US IUCN RED LIS, DOI DOI 10.1111/J.1523-1739.2008.01044.X; *IUCN, 2001, IUCN RED LIST CAT CR, DOI DOI 10.1111/J.1523-1739.2005.00204.X; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Jiang H, 2008, ECOSYSTEM MODELLING, V212, P492; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Keith DA, 2011, BIOL CONSERV, V144, P1175, DOI 10.1016/j.biocon.2010.11.022; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; Leadley P, 2010, CONSERVATIO IN PRESS; Leadley P., 2010, BIODIVERSITY SCENARI; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Lindegren M, 2009, P NATL ACAD SCI USA, V106, P14722, DOI 10.1073/pnas.0906620106; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mackinson S, 2007, ECOSYSTEM MODEL N SE; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Margoluis R, 2009, EVAL PROGRAM PLANN, V32, P138, DOI 10.1016/j.evalprogplan.2008.09.007; Milner-Gulland EJ, 2011, P NATL ACAD SCI USA, V108, P1741, DOI 10.1073/pnas.1010533108; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Okey T., 2002, ECOSYSTEM MODEL W FL, VII; Okey TA, 2004, ECOL MODEL, V172, P339, DOI 10.1016/j.ecolmodel.2003.09.015; Okey TA, 2002, THESIS CENTRO INTERD; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pereira HM, 2010, FRONT ECOL ENVIRON, V8, P458, DOI 10.1890/10.WB.23; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Piet GJ, 2004, ICES J MAR SCI, V61, P1305, DOI 10.1016/j.icesjms.2004.08.009; POSSINGHAM HP, 2002, SETTING BIODIVERSITY, DOI DOI 10.1111/J.1523-1739.2008.01124.X; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rochet MJ, 2010, J APPL ECOL, V47, P741, DOI 10.1111/j.1365-2664.2010.01841.x; Rondinini C, 2005, CONSERV BIOL, V19, P1488, DOI 10.1111/j.1523-1739.2005.00204.x; Roux JP, 2004, AFR J MAR SCI, V26, P79, DOI 10.2989/18142320409504051; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; *SECR CBD, 2010, GLOB BIOD OUTL, V3, DOI DOI 10.1126/SCIENCE.1196624; Secretariat of the CBD, 2010, BIOD IND 2010 TARG E; Setsaas TH, 2007, BIOL CONSERV, V136, P563, DOI 10.1016/j.biocon.2007.01.001; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Shea K, 1998, TRENDS ECOL EVOL, V13, P371, DOI 10.1016/S0169-5347(98)01381-0; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; SINCLAIR ARE, 1995, SERENGETI, V2, DOI DOI 10.1016/J.BIOCON.2004.10.007; Sparks TH, 2011, ORYX, V45, P411, DOI 10.1017/S003060531100024X; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; WALTERS CJ, 1986, ADAPTIVE MANAGEMENT, DOI DOI 10.1016/S0301-4797(03)00014-8; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; 2010, C PART CONV BIOL DIV, DOI DOI 10.1126/SCIENCE.1175466	74	63	65	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41128	10.1371/journal.pone.0041128	http://dx.doi.org/10.1371/journal.pone.0041128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815938	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306548900078
J	Weiden, MD; Naveed, B; Kwon, S; Segal, LN; Cho, SJ; Tsukiji, J; Kulkarni, R; Comfort, AL; Kasturiarachchi, KJ; Prophete, C; Cohen, MD; Chen, LC; Rom, WN; Prezant, DJ; Nolan, A				Weiden, Michael D.; Naveed, Bushra; Kwon, Sophia; Segal, Leopoldo N.; Cho, Soo Jung; Tsukiji, Jun; Kulkarni, Rohan; Comfort, Ashley L.; Kasturiarachchi, Kusali J.; Prophete, Colette; Cohen, Mitchell D.; Chen, Lung-Chi; Rom, William N.; Prezant, David J.; Nolan, Anna			Comparison of WTC Dust Size on Macrophage Inflammatory Cytokine Release In vivo and In vitro	PLOS ONE			English	Article							WORLD-TRADE-CENTER; BRONCHIAL EPITHELIAL-CELLS; COLONY-STIMULATING FACTOR; FINE PARTICULATE MATTER; AIR-POLLUTION; PULMONARY INFLAMMATION; GENE-EXPRESSION; LUNG-FUNCTION; FIREFIGHTERS; HEALTH	Background: The WTC collapse exposed over 300,000 people to high concentrations of WTC-PM; particulates up to similar to 50 mm were recovered from rescue workers' lungs. Elevated MDC and GM-CSF independently predicted subsequent lung injury in WTC-PM-exposed workers. Our hypotheses are that components of WTC dust strongly induce GM-CSF and MDC in AM; and that these two risk factors are in separate inflammatory pathways. Methodology/Principal Findings: Normal adherent AM from 15 subjects without WTC-exposure were incubated in media alone, LPS 40 ng/mL, or suspensions of WTC-PM10-53 or WTC-PM2.5 at concentrations of 10, 50 or 100 mu g/mL for 24 hours; supernatants assayed for 39 chemokines/cytokines. In addition, sera from WTC-exposed subjects who developed lung injury were assayed for the same cytokines. In the in vitro studies, cytokines formed two clusters with GM-CSF and MDC as a result of PM10-53 and PM2.5. GM-CSF clustered with IL-6 and IL-12(p70) at baseline, after exposure to WTC-PM10-53 and in sera of WTC dust-exposed subjects (n = 70) with WTC lung injury. Similarly, MDC clustered with GRO and MCP-1. WTC-PM10-53 consistently induced more cytokine release than WTC-PM2.5 at 100 mu g/mL. Individual baseline expression correlated with WTC-PM-induced GM-CSF and MDC. Conclusions: WTC-PM10-53 induced a stronger inflammatory response by human AM than WTC-PM2.5. This large particle exposure may have contributed to the high incidence of lung injury in those exposed to particles at the WTC site. GM-CSF and MDC consistently cluster separately, suggesting a role for differential cytokine release in WTC-PM injury. Subject-specific response to WTC-PM may underlie individual susceptibility to lung injury after irritant dust exposure.	[Weiden, Michael D.; Naveed, Bushra; Kwon, Sophia; Segal, Leopoldo N.; Cho, Soo Jung; Tsukiji, Jun; Kulkarni, Rohan; Comfort, Ashley L.; Kasturiarachchi, Kusali J.; Rom, William N.; Nolan, Anna] NYU, Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA; [Weiden, Michael D.; Prophete, Colette; Cohen, Mitchell D.; Chen, Lung-Chi; Rom, William N.; Nolan, Anna] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Weiden, Michael D.; Prezant, David J.; Nolan, Anna] Bur Hlth Serv, Brooklyn, NY USA; [Weiden, Michael D.; Prezant, David J.; Nolan, Anna] Off Med Affairs, Fire Dept New York, Brooklyn, NY USA; [Prezant, David J.] Montefiore Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA; [Prophete, Colette] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem & Regenerat, Bronx, NY 10467 USA	New York University; New York University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Weiden, MD (corresponding author), NYU, Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA.	anna.nolan@med.nyu.edu	Nolan, Anna/C-2796-2012; Cjem, Lung-Chi/H-5030-2012	Nolan, Anna/0000-0002-0631-1171; Comfort, Ashley/0000-0002-8213-8374; Chen, Lung Chi/0000-0003-1154-2107; Kwon, Sophia/0000-0003-3639-5107; Rom, William/0000-0002-8793-7028; TSUKIJI, JUN/0000-0002-1578-3226; Segal, Leopoldo/0000-0003-3559-9431	National Institutes of Health [K23HL084191, K24A1080298, UL1 RR029893, T32-ES007267, U01CA008617, RO1HL090316, R01OH008280, 1UL1RR029893]; National Institute for Occupational Safety and Health [U10-OH008243, U10-OH008242]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090316, K23HL084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U10OH008243, R01OH008280, U10OH008242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by National Institutes of Health: Grants K23HL084191(AN), K24A1080298(MW), UL1 RR029893, T32-ES007267 (BN), U01CA008617, RO1HL090316 (WNR), R01OH008280 (MDC), and 1UL1RR029893(NYU CTSI); and National Institute for Occupational Safety and Health: Grants U10-OH008243, U10-OH008242. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; [Anonymous], [No title captured]; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Chen LC, 2002, LANCET, V360, pS37, DOI 10.1016/S0140-6736(02)11814-9; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Fujita Andre, 2009, Journal of Bioinformatics and Computational Biology, V7, P663, DOI 10.1142/S0219720009004230; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P971, DOI 10.1289/ehp.111-1241533; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Gold JA, 2004, INFECT IMMUN, V72, P1291, DOI 10.1128/IAI.72.3.1291-1297.2004; Gold JA, 2004, INFECT IMMUN, V72, P645, DOI 10.1128/IAI.72.2.645-650.2004; Hartl D, 2005, J ALLERGY CLIN IMMUN, V115, P728, DOI 10.1016/j.jaci.2004.11.049; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Landrigan PJ, 2001, ENVIRON HEALTH PERSP, V109, pA514, DOI 10.1289/ehp.109-a514; Lioy PJ, 2006, ENVIRON SCI TECHNOL, V40, P6876, DOI 10.1021/es062980e; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; Liu LY, 2004, AM J RESP CRIT CARE, V169, P1118, DOI 10.1164/rccm.200312-1659OC; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Naveed B, 2012, AM J RESP CRIT CARE, V185, P392, DOI 10.1164/rccm.201109-1672OC; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Nolan A, 2011, CHEST; O'Neill LAJ, 2008, SCIENCE, V320, P619, DOI 10.1126/science.1158398; Payne JP, 2004, J OCCUP ENVIRON MED, V46, P420, DOI 10.1097/01.jom.0000126021.25149.64; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Reibman J, 2000, J IMMUNOL, V165, P1618, DOI 10.4049/jimmunol.165.3.1618; Reibman J, 2002, AM J RESP CELL MOL, V27, P455, DOI 10.1165/rcmb.2001-0005OC; Ritter M, 2005, BIOCHEM BIOPH RES CO, V334, P254, DOI 10.1016/j.bbrc.2005.06.084; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Suwa T, 2002, EXP LUNG RES, V28, P1, DOI 10.1080/019021402753355508; THURSTON GD, 1994, ENVIRON RES, V65, P271, DOI 10.1006/enrs.1994.1037; Wang RY, 2008, J MED TOXICOL, V4, P143, DOI 10.1007/BF03160970; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580	41	23	23	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40016	10.1371/journal.pone.0040016	http://dx.doi.org/10.1371/journal.pone.0040016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815721	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900015
J	Gelling, M; Johnson, PJ; Moorhouse, TP; Macdonald, DW				Gelling, Merryl; Johnson, Paul J.; Moorhouse, Tom P.; Macdonald, David W.			Measuring Animal Welfare within a Reintroduction: An Assessment of Different Indices of Stress in Water Voles Arvicola amphibius	PLOS ONE			English	Article							SEASONAL-CHANGES; BODY-WEIGHT; TRANSLOCATION; CONSERVATION; MAMMALS; MELES; REPRODUCTION; METABOLITES; TRANSPORT; HYDRATION	Reintroductions are an increasingly common conservation restoration tool; however, little attention has hitherto been given to different methods for monitoring the stress encountered by reintroduced individuals. We compared ten potential measures of stress within four different categories (neuroendocrine, cell function, body condition and immune system function) as proxies for animal welfare in water voles being reintroduced to the Upper Thames region, Oxfordshire, UK. Captive-bred voles were assessed pre-release, and each month post-release for up to five months. Wild-born voles were captured in the field and assessed from two months post-release. Plasma corticosteroid, hydration and body condition of captive-bred voles differed between their pre-release measures and both their first ("short-term") recapture, and their final recapture ("long-term" release), however only body condition and immunocompetence measured using the Nitroblue Tetrazolium (NBT) test were significantly different post-release between the first and last recaptures. Captive-bred animals had lower fat reserves, higher weight/length ratios and better immunocompetence (NBT) than did wild-born voles. Captive-bred males had higher ectoparasite burdens compared to wild-born males and, as reintroduction site quality decreased, became less hydrated. These observations indicate that some methods can identify changes in the stress response in individuals, highlighting areas of risk in a reintroduction programme. In addition, a single measure may not provide a full picture of the stress experienced; instead, a combination of measures of different physiological systems may give a more complete indication of stress during the reintroduction process. We highlight the need to monitor stress in reintroductions using measures from different physiological systems to inform on possible animal welfare improvements and thus the overall success rate of reintroductions.	[Gelling, Merryl; Johnson, Paul J.; Moorhouse, Tom P.; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney, England	University of Oxford	Gelling, M (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney, England.	merryl.gelling@zoo.ox.ac.uk	Gelling, Merryl/I-8448-2012		Environment Agency; Peoples Trust for Endangered Species (PTES); Holly Hill Trust	Environment Agency; Peoples Trust for Endangered Species (PTES); Holly Hill Trust	M. Gelling was funded by the Environment Agency and Peoples Trust for Endangered Species (PTES) with contributions from D. Gow Consultancies. T. Moorhouse was funded by the Holly Hill Trust and PTES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Bonacic C, 2006, BIOL CONSERV, V129, P543, DOI 10.1016/j.biocon.2005.11.021; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Charbonnel N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P63, DOI 10.1086/523306; Clauss M, 2007, J ANIM PHYSIOL AN N, V91, P187, DOI 10.1111/j.1439-0396.2007.00691.x; DeVries AC, 2002, PSYCHONEUROENDOCRINO, V27, P705, DOI 10.1016/S0306-4530(01)00073-7; Dhabhar FS, 1998, ANN NY ACAD SCI, V840, P359, DOI 10.1111/j.1749-6632.1998.tb09575.x; Disalvo EA, 2008, BBA-BIOMEMBRANES, V1778, P2655, DOI 10.1016/j.bbamem.2008.08.025; Dugdale HL, 2003, ECOLOGY, V84, P40, DOI 10.1890/0012-9658(2003)084[0040:OSRVIT]2.0.CO;2; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fletcher QE, 2006, J ZOOL, V270, P473, DOI 10.1111/j.1469-7998.2006.00153.x; Franceschini MD, 2008, ANIM CONSERV, V11, P263, DOI 10.1111/j.1469-1795.2008.00175.x; Gelling M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009791; Gentle LK, 2001, P ROY SOC B-BIOL SCI, V268, P487, DOI 10.1098/rspb.2000.1405; Hartup BK, 2005, ZOO BIOL, V24, P15, DOI 10.1002/zoo.20033; IUCN, 1998, IUCN GUID REINTR; IUCN, 2012, GUID REINTR OT UNPUB; Kenagy GJ, 2000, GEN COMP ENDOCR, V117, P189, DOI 10.1006/gcen.1999.7397; Lerner IM, 1954, GENETIC HOMEOSTASIS; Macdonald DW, 2002, ECOLOGY, V83, P2056, DOI 10.2307/3071787; Macdonald DW, 2009, REINTRODUCTION TOP O; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Mathews F, 2002, VET REC, V150, P785, DOI 10.1136/vr.150.25.785; Mathews F, 2006, BIOL CONSERV, V131, P338, DOI 10.1016/j.biocon.2006.04.011; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; McLaren Graeme, 2006, P120; McLaren GW, 2004, ANIM WELFARE, V13, P337; McLaren GW, 2003, EXP PHYSIOL, V88, P541, DOI 10.1113/eph8802571; Mendoza SP, 2000, BIOL ANIMAL STRESS; Mian R, 2003, STRESS, V6, P41, DOI 10.1080/1025389031000101349; Mian Rubina, 2005, P61; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Moberg GP, 1999, LAB ANIMAL, V28, P22; MOBERG GP, 1987, J AM VET MED ASSOC, V191, P1207; Montes I, 2004, ANIM WELFARE, V13, P355; Moorhouse TP, 2007, J ZOOL, V271, P19, DOI 10.1111/j.1469-7998.2006.00175.x; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; Moorhouse TP, 2008, J ANIM ECOL, V77, P1288, DOI 10.1111/j.1365-2656.2008.01431.x; Morand S, 2004, PARASITOLOGY, V129, P505, DOI 10.1017/S0031182004005840; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 1997, Z SAUGETIERKD, V62, P192; REDEI E, 1994, NEUROENDOCRINOLOGY, V60, P113, DOI 10.1159/000126741; Ritz P, 2005, NUTR REV, V63, pS6, DOI [10.1301/nr.2005.jun.S6-S13, 10.1111/j.1753-4887.2005.tb00155.x]; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rothschild DM, 2008, J WILDLIFE MANAGE, V72, P138, DOI 10.2193/2005-700; Shutler D, 2004, CAN J ZOOL, V82, P442, DOI [10.1139/z04-016, 10.1139/Z04-016]; Soorae PS, 2011, GLOBAL REINTRODUCTIO; Stevenson RD, 2005, INTEGR COMP BIOL, V45, P1, DOI 10.1093/icb/45.1.1; Stirling I, 2008, J WILDLIFE MANAGE, V72, P568, DOI 10.2193/2007-123; Strachan R, 1993, WATER VOLE ARVICOLA; Strachan R., 2011, WATER VOLE CONSERVAT; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Viswanathan K, 2005, INT IMMUNOL, V17, P1059, DOI 10.1093/intimm/dxh286; Zapata B, 2004, ANIM WELFARE, V13, P439	58	9	10	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41081	10.1371/journal.pone.0041081	http://dx.doi.org/10.1371/journal.pone.0041081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815923	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000062
J	Holtan, SG; Steen, PD; Foster, NR; Erlichman, C; Medeiros, F; Ames, MM; Safgren, SL; Graham, DL; Behrens, RJ; Goetz, MP				Holtan, Shernan G.; Steen, Preston D.; Foster, Nathan R.; Erlichman, Charles; Medeiros, Fabiola; Ames, Matthew M.; Safgren, Stephanie L.; Graham, David L.; Behrens, Robert J.; Goetz, Matthew P.			Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial	PLOS ONE			English	Article							CANCER-RESEARCH-NETWORK; PRIMARY SITE; PROGNOSTIC-FACTORS; ORIGIN; TUMORS; CHEMOTHERAPY; PACLITAXEL	Metastatic carcinoma of unknown primary (CUP) has a very poor prognosis, and no standard first-line therapy currently exists. Here, we report the results of a phase II study utilizing a combination of gemcitabine and irinotecan as first-line therapy. Treatment was with gemcitabine 1000 mg/m(2) and irinotecan 75 mg/m(2) weekly times four on a six week cycle (Cohort I). Due to excessive toxicity, the dose and schedule were modified as follows: gemcitabine 750 mg/m(2) and irinotecan 75 mg/m(2) given weekly times three on a four week cycle (Cohort II). The primary endpoint was the confirmed response rate (CR + PR). Secondary endpoints consisted of adverse events based upon the presence or absence of the UDP glucuronosyltransferase 1 family, polypeptide A1*28 (UGT1A1*28) polymorphism, time to progression, and overall survival. Thirty-one patients were enrolled with a median age of 63 (range: 38-94), and 26 patients were evaluable for efficacy. Significant toxicity was observed in Cohort 1, characterized by 50% (7/14) patients experiencing a grade 4+ adverse event, but not in cohort II. The confirmed response rate including patients from both cohorts was 12% (95% CI: 2-30%), which did not meet the criteria for continued enrollment. Overall median survival was 7.2 months (95% CI: 4.0 to 11.6) for the entire cohort but notably longer in cohort II than in cohort I (9.3 months (95% CI: 4.1 to 12.1) versus 4.0 months (95% CI: 2.2 to 15.6)). Gemcitabine and irinotecan is not an active combination when used as first line therapy in patients with metastatic carcinoma of unknown primary. Efforts into developing novel diagnostic and therapeutic approaches remain important for improving the outlook for this heterogeneous group of patients.	[Holtan, Shernan G.; Foster, Nathan R.; Erlichman, Charles; Medeiros, Fabiola; Ames, Matthew M.; Safgren, Stephanie L.; Goetz, Matthew P.] Mayo Clin Rochester, Rochester, MN 55905 USA; [Steen, Preston D.] Sanford Roger Maris Canc Ctr, Fargo, ND USA; [Graham, David L.] Carle Canc Ctr CCOP, Urbana, IL USA; [Behrens, Robert J.] Iowa Oncol Res Assoc CCOP, Des Moines, IA USA	Mayo Clinic; Sanford Health	Holtan, SG (corresponding author), Mayo Clin Rochester, Rochester, MN 55905 USA.	goetz.matthew@mayo.edu	Goetz, Matthew P/AAH-2333-2020; Holtan, Shernan G./AAA-2456-2022	Holtan, Shernan/0000-0002-5054-9419; Harrington, Jon/0000-0003-1293-5201	Public Health Service [CA-25224, CA-37404, CA-35195, CA-35090, CA-35101, CA-35269, CA-37417, CA-52352, CA-35267, CA-63849, CA-35103, CA-35431]; NATIONAL CANCER INSTITUTE [U10CA037417, P50CA116201, U10CA035101, U10CA063849, U10CA025224, U10CA037404, U10CA035431, U10CA035267, U10CA052352, U10CA035269, U10CA035195, U10CA035103, U10CA035090] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants: CA-25224, CA-37404, CA-35195, CA-35090, CA-35101, CA-35269, CA-37417, CA-52352, CA-35267, CA-63849, CA-35103, CA-35431. No additional external funding received for this study. The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institutes of Health. The funders had no role in data collection and analysis, decision to publish or preparation of the manuscript.	ABBRUZZESE JL, 1995, J CLIN ONCOL, V13, P2094, DOI 10.1200/JCO.1995.13.8.2094; ABBRUZZESE JL, 1994, J CLIN ONCOL, V12, P1272, DOI 10.1200/JCO.1994.12.6.1272; Boyland L, 2008, PALLIATIVE MED, V22, P177, DOI 10.1177/0269216307085341; Briasoulis E, 2000, J CLIN ONCOL, V18, P3101, DOI 10.1200/JCO.2000.18.17.3101; BRIASOULIS E, 2005, ANN ONCOL         S1, V16, P75; GATTER KC, 1985, LANCET, V1, P1302; Greco FA, 2010, ONCOLOGIST, V15, P500, DOI 10.1634/theoncologist.2009-0328; Greco FA, 2009, SEMIN ONCOL, V36, P65, DOI 10.1053/j.seminoncol.2008.10.005; Hainsworth JD, 2000, ONCOLOGY-NY, V14, P563; Hainsworth JD, 2005, CANCER-AM CANCER SOC, V104, P1992, DOI 10.1002/cncr.21416; Hainsworth JD, CANC J, V16, P70; Hainsworth JD, 2011, CLIN COLORECTAL CANC; Hainsworth JD, 2007, J CLIN ONCOL, V25, P1747, DOI 10.1200/JCO.2006.09.3047; Hainsworth JD, 2009, ONCOLOGIST, V14, P1189, DOI 10.1634/theoncologist.2009-0112; Iyer L., 2002, Pharmacogenomics Journal, V2, P43, DOI 10.1038/sj.tpj.6500072; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karavasilis V, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-25; Kaya AO, 2008, ASIAN PAC J CANCER P, V9, P683; Lunn RA, 2005, HEMATOLOGY, V10, P107, DOI 10.1080/10245330400001975; Massard C, 2007, BRIT J CANCER, V97, P857, DOI 10.1038/sj.bjc.6603942; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Palmeri S, 2006, CANCER-AM CANCER SOC, V107, P2898, DOI 10.1002/cncr.22379; Saad ED, 2002, CRIT REV ONCOL HEMAT, V41, P205, DOI 10.1016/S1040-8428(01)00157-3; Sargent DJ, 2001, CONTROL CLIN TRIALS, V22, P117, DOI 10.1016/S0197-2456(00)00115-X; SCHAPIRA DV, 1995, ARCH INTERN MED, V155, P2050, DOI 10.1001/archinte.155.19.2050; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Varadhachary GR, 2008, J CLIN ONCOL, V26, P4442, DOI 10.1200/JCO.2007.14.4378	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e39285	10.1371/journal.pone.0039285	http://dx.doi.org/10.1371/journal.pone.0039285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815703	gold, Green Published			2022-12-27	WOS:000306507000007
J	Matsumoto, H; Takechi, K; Sato, H; Takio, S; Takano, H				Matsumoto, Hiroko; Takechi, Katsuaki; Sato, Hiroshi; Takio, Susumu; Takano, Hiroyoshi			Treatment with Antibiotics that Interfere with Peptidoglycan Biosynthesis Inhibits Chloroplast Division in the Desmid Closterium	PLOS ONE			English	Article							MICROFIBRIL ARRANGEMENT; SYNTHESIS PATHWAY; PLASTID DIVISION; CELL-WALL; EVOLUTION; PLANTS; MOSS; ACEROSUM; COMPLEX; GENES	Charophytes is a green algal group closely related to land plants. We investigated the effects of antibiotics that interfere with peptidoglycan biosynthesis on chloroplast division in the desmid Closterium peracerosum-strigosum-littorale complex. To detect cells just after division, we used colchicine, which inhibits Closterium cell elongation after division. Although normal Closterium cells had two chloroplasts before and after cell division, cells treated with ampicillin, D-cycloserine, or fosfomycin had only one chloroplast after cell division, suggesting that the cells divided without chloroplast division. The antibiotics bacitracin and vancomycin showed no obvious effect. Electron microscopic observation showed that irregular-shaped chloroplasts existed in ampicillin-treated Closterium cells. Because antibiotic treatments resulted in the appearance of long cells with irregular chloroplasts and cell death, we counted cell types in the culture. The results suggested that cells with one chloroplast appeared first and then a huge chloroplast was generated that inhibited cell division, causing elongation followed by cell death.	[Matsumoto, Hiroko; Sato, Hiroshi] Kumamoto Univ, Fac Sci, Kumamoto 860, Japan; [Takechi, Katsuaki; Takio, Susumu; Takano, Hiroyoshi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan; [Takio, Susumu] Kumamoto Univ, Ctr Marine Environm Studies, Kumamoto, Japan; [Takano, Hiroyoshi] Kumamoto Univ, Bioelect Res Ctr, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University	Matsumoto, H (corresponding author), Kumamoto Univ, Fac Sci, Kumamoto 860, Japan.	takano@kumamoto-u.ac.jp		Takano, Hiroyoshi/0000-0003-4720-5057	Japan Society for the Promotion of Science [22570046, 22770044]; Toray Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toray Science Foundation(Toray Industries, Inc.)	This study was supported by Grants-in-Aid for Scientific Research (C) (No. 22570046 to HT and KT) and for Young Scientists (B) (No. 22770044 to KT) from the Japan Society for the Promotion of Science and a grant from the Toray Science Foundation to HT and KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JM, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P19, DOI 10.1007/978-3-642-22380-8_2; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; HOGETSU T, 1978, PLANTA, V140, P7, DOI 10.1007/BF00389373; HOGETSU T, 1978, PLANTA, V140, P15, DOI 10.1007/BF00389374; Homi S, 2009, PLANT CELL PHYSIOL, V50, P2047, DOI 10.1093/pcp/pcp158; Iino M, 2003, J PHYCOL, V39, P561, DOI 10.1046/j.1529-8817.2003.02132.x; Izumi Y, 2008, CYTOLOGIA, V73, P393, DOI 10.1508/cytologia.73.393; KASTEN B, 1997, J PLANT PHYSL, V150, P197; Katayama N, 2003, PLANT CELL PHYSIOL, V44, P776, DOI 10.1093/pcp/pcg096; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Sekimoto H, 2006, PLANT PHYSIOL, V141, P271, DOI 10.1104/pp.106.078048; Steiner JM, 2002, TRENDS PLANT SCI, V7, P72, DOI 10.1016/S1360-1385(01)02179-3; Takano H, 2010, BBA-GEN SUBJECTS, V1800, P144, DOI 10.1016/j.bbagen.2009.07.020; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6	19	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40734	10.1371/journal.pone.0040734	http://dx.doi.org/10.1371/journal.pone.0040734			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815801	gold, Green Submitted, Green Published			2022-12-27	WOS:000306507000028
J	Adzemovic, MZ; Ockinger, J; Zeitelhofer, M; Hochmeister, S; Beyeen, AD; Paulson, A; Gillett, A; Hedreul, MT; Covacu, R; Lassmann, H; Olsson, T; Jagodic, M				Adzemovic, Milena Z.; Ockinger, Johan; Zeitelhofer, Manuel; Hochmeister, Sonja; Beyeen, Amennai Daniel; Paulson, Atul; Gillett, Alan; Hedreul, Melanie Thessen; Covacu, Ruxandra; Lassmann, Hans; Olsson, Tomas; Jagodic, Maja			Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EOSINOPHIL EOTAXIN RECEPTOR; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; CC-CHEMOKINE; MOLECULAR-CLONING; CELLS; LOCUS	Multiple sclerosis (MS) is a polygenic disease characterized by inflammation and demyelination in the central nervous system (CNS), which can be modeled in experimental autoimmune encephalomyelitis (EAE). The Eae18b locus on rat chromosome 10 has previously been linked to regulation of beta-chemokine expression and severity of EAE. Moreover, the homologous chemokine cluster in humans showed evidence of association with susceptibility to MS. We here established a congenic rat strain with Eae18b locus containing a chemokine cluster (Ccl2, Ccl7, Ccl11, Ccl12 and Ccl1) from the EAE-resistant PVG rat strain on the susceptible DA background and utilized myelin oligodendrocyte glycoprotein (MOG)-induced EAE to characterize the mechanisms underlying the genetic regulation. Congenic rats developed a milder disease compared to the susceptible DA strain, and this was reflected in decreased demyelination and in reduced recruitment of inflammatory cells to the brain. The congenic strain also showed significantly increased Ccl11 mRNA expression in draining lymph nodes and spinal cord after EAE induction. In the lymph nodes, macrophages were the main producers of CCL11, whereas macrophages and lymphocytes expressed the main CCL11 receptor, namely CCR3. Accordingly, the congenic strain also showed significantly increased Ccr3 mRNA expression in lymph nodes. In the CNS, the main producers of CCL11 were neurons, whereas CCR3 was detected on neurons and CSF producing ependymal cells. This corresponded to increased levels of CCL11 protein in the cerebrospinal fluid of the congenic rats. Increased intrathecal production of CCL11 in congenic rats was accompanied by a tighter blood brain barrier, reflected by more occludin(+) blood vessels. In addition, the congenic strain showed a reduced antigen specific response and a predominant anti-inflammatory Th2 phenotype. These results indicate novel mechanisms in the genetic regulation of neuroinflammation.	[Adzemovic, Milena Z.; Ockinger, Johan; Zeitelhofer, Manuel; Hochmeister, Sonja; Beyeen, Amennai Daniel; Paulson, Atul; Gillett, Alan; Hedreul, Melanie Thessen; Covacu, Ruxandra; Olsson, Tomas; Jagodic, Maja] Karolinska Inst, Neuroimmunol Unit, Dept Clin Neurosci, Ctr Mol Med, Stockholm, Sweden; [Adzemovic, Milena Z.; Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Dept Neuroimmunol, Vienna, Austria; [Hochmeister, Sonja] Med Univ Graz, Dept Neurol, Graz, Austria	Karolinska Institutet; Medical University of Vienna; Medical University of Graz	Adzemovic, MZ (corresponding author), Karolinska Inst, Neuroimmunol Unit, Dept Clin Neurosci, Ctr Mol Med, Stockholm, Sweden.	Milena.Zeitelhofer-Adzemovic@ki.se; Johan.Ockinger@ki.se	Lassmann, Hans/Z-2269-2019; Öckinger, Johan/F-4543-2010	Lassmann, Hans/0000-0001-8617-5052; Öckinger, Johan/0000-0003-4300-3415; Covacu, Ruxandra/0000-0003-3183-2988; Zeitelhofer, Manuel/0000-0002-4324-2355; Olsson, Tomas/0000-0002-2938-1877	Biogen Idec; Wenner-Gren Foundation; Swedish Research Council; Ragnar Soderberg's Foundation; Bibbi and Niels Jensen's Foundation; Montel William's Foundation; Ake-Wibergs Stiftelse; Swedish Association of Persons with Neurological Disabilities; Swedish Brain Foundation; Multiple Sclerosis Society of Canada; EU [LSHG-CT-2005-019015, LSHM-CT-2005-018637]; Biogen Idec, Inc.	Biogen Idec(Biogen); Wenner-Gren Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg's Foundation; Bibbi and Niels Jensen's Foundation; Montel William's Foundation; Ake-Wibergs Stiftelse; Swedish Association of Persons with Neurological Disabilities; Swedish Brain Foundation; Multiple Sclerosis Society of Canada; EU(European Commission); Biogen Idec, Inc.(Biogen)	This study was supported by grants from Biogen Idec, the Wenner-Gren Foundation, the Swedish Research Council, Ragnar Soderberg's Foundation, Bibbi and Niels Jensen's Foundation, Montel William's Foundation, Ake-Wibergs Stiftelse, the Swedish Association of Persons with Neurological Disabilities, Swedish Brain Foundation, the Multiple Sclerosis Society of Canada and the EU 6TH Framework EURATools (LSHG-CT-2005-019015) and Neuropromise (LSHM-CT-2005-018637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Milena Zeitelhofer-Adzemovic was partly funded by a research grant from Biogen Idec, Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AMOR S, 1994, J IMMUNOL, V153, P4349; Beaulieu S, 2002, J IMMUNOL, V169, P2925, DOI 10.4049/jimmunol.169.6.2925; Bradl M, 2005, AM J PATHOL, V166, P1441, DOI 10.1016/S0002-9440(10)62361-9; Bromley ST, 2008, PHYS CHEM CHEM PHYS, V10, P121, DOI 10.1039/b713688a; Bugeja MJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-64; Correale J, 2004, NEUROLOGY, V63, P2363, DOI 10.1212/01.WNL.0000148481.80152.BF; Dahlman I, 1999, HUM MOL GENET, V8, P2183, DOI 10.1093/hmg/8.12.2183; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Gao JL, 1996, BIOCHEM BIOPH RES CO, V223, P679, DOI 10.1006/bbrc.1996.0955; Hedreul MT, 2009, J NEUROIMMUNOL, V210, P30, DOI 10.1016/j.jneuroim.2009.02.010; Hochmeister S, 2006, J NEUROPATH EXP NEUR, V65, P855, DOI 10.1097/01.jnen.0000235119.52311.16; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Jagodic M, 2001, IMMUNOGENETICS, V53, P410, DOI 10.1007/s002510100342; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Ockinger J, 2010, GENES IMMUN, V11, P142, DOI 10.1038/gene.2009.82; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2008, BRAIN, V131, P3118, DOI 10.1093/brain/awn081; Stevenson NJ, 2009, J LEUKOCYTE BIOL, V85, P289, DOI 10.1189/jlb.0708394; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Teuscher C, 1999, J IMMUNOL, V163, P2262; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Vyshkina T, 2005, HUM GENET, V118, P67, DOI 10.1007/s00439-005-0003-2; Vyshkina T, 2005, EUR J HUM GENET, V13, P240, DOI 10.1038/sj.ejhg.5201295; Wainwright DA, 2009, ASN NEURO, V1, DOI 10.1042/AN20090017; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	34	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39794	10.1371/journal.pone.0039794	http://dx.doi.org/10.1371/journal.pone.0039794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815714	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100022
J	Cheng, FX; Zhou, YD; Li, WH; Liu, GX; Tang, Y				Cheng, Feixiong; Zhou, Yadi; Li, Weihua; Liu, Guixia; Tang, Yun			Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method	PLOS ONE			English	Article							WEB SERVER; DISCOVERY; DRUGS; TARGETS; DESIGN; IDENTIFICATION; BMS-354825; RESPONSES; OPINION; KINOME	Chemical-protein interaction (CPI) is the central topic of target identification and drug discovery. However, large scale determination of CPI is a big challenge for in vitro or in vivo experiments, while in silico prediction shows great advantages due to low cost and high accuracy. On the basis of our previous drug-target interaction prediction via network-based inference (NBI) method, we further developed node-and edge-weighted NBI methods for CPI prediction here. Two comprehensive CPI bipartite networks extracted from ChEMBL database were used to evaluate the methods, one containing 17,111 CPI pairs between 4,741 compounds and 97 G protein-coupled receptors, the other including 13,648 CPI pairs between 2,827 compounds and 206 kinases. The range of the area under receiver operating characteristic curves was 0.73 to 0.83 for the external validation sets, which confirmed the reliability of the prediction. The weak-interaction hypothesis in CPI network was identified by the edge-weighted NBI method. Moreover, to validate the methods, several candidate targets were predicted for five approved drugs, namely imatinib, dasatinib, sertindole, olanzapine and ziprasidone. The molecular hypotheses and experimental evidence for these predictions were further provided. These results confirmed that our methods have potential values in understanding molecular basis of drug polypharmacology and would be helpful for drug repositioning.	[Cheng, Feixiong; Zhou, Yadi; Li, Weihua; Liu, Guixia; Tang, Yun] E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai 200237, Peoples R China	East China University of Science & Technology	Cheng, FX (corresponding author), E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai 200237, Peoples R China.	ytang234@ecust.edu.cn	Cheng, Feixiong/D-9922-2013; LI, Weihua/G-7190-2011	Cheng, Feixiong/0000-0002-1251-3116; Cheng, Feixiong/0000-0002-1736-2847	863 Project [2012AA020308]; National Natural Science Foundation of China [21072059]; 111 Project [B07023]; Fundamental Research Funds for the Central Universities [WY1113007]; Shanghai Committee of Science and Technology [11DZ2260600]	863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the 863 Project (Grant 2012AA020308), the National Natural Science Foundation of China (Grant 21072059), the 111 Project (Grant B07023), the Fundamental Research Funds for the Central Universities (WY1113007), and the Shanghai Committee of Science and Technology (11DZ2260600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitaya T, 2007, BIOMACROMOLECULES, V8, P273, DOI 10.1021/bm060634j; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Baskin Igor, 2008, P1, DOI 10.1039/9781847558879-00001; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Uliana SRB, 2009, SCIENCE, V326, P935, DOI 10.1126/science.326.5955.935-a; Cami A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002774; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chen ZM, 2006, MOL PHARMACOL, V69, P1527, DOI 10.1124/mol.105.020172; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Cheng FX, 2012, MOL BIOSYST IN PRESS, DOI 101039/C2MB25110H; Csermely P, 2004, TRENDS BIOCHEM SCI, V29, P331, DOI 10.1016/j.tibs.2004.05.004; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gleich GJ, 2002, LANCET, V359, P1577, DOI 10.1016/S0140-6736(02)08505-7; Gonzalez-Diaz H, 2011, J PROTEOME RES, V10, P1698, DOI 10.1021/pr101009e; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iskar M, 2012, CURR OPIN BIOTECH, V23, P609, DOI 10.1016/j.copbio.2011.11.010; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jia CX, 2008, PHYSICA A, V387, P5887, DOI 10.1016/j.physa.2008.06.046; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Korcsmaros T, 2007, EXPERT OPIN DRUG DIS, V2, P799, DOI 10.1517/17460441.2.6.799; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Lindstrom E, 2006, EXPERT OPIN PHARMACO, V7, P1825, DOI 10.1517/14656566.7.13.1825; Linyuan L, 2010, EPL, V89; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Quintas-Cardama Alfonso, 2006, Future Oncol, V2, P655, DOI 10.2217/14796694.2.6.655; Sadowski MI, 2009, CURR OPIN STRUC BIOL, V19, P357, DOI 10.1016/j.sbi.2009.03.008; Sawyers CL, 2007, NATURE, V449, P993, DOI 10.1038/449993a; Schilsky RL, 2010, ONCOLOGIST, V15, P484, DOI 10.1634/theoncologist.2010-0079; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Wang F, 2011, J CHEM INF MODEL, V51, P2821, DOI 10.1021/ci200264h; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Yabuuchi H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.5; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007; Zhang JY, 2006, BIOCHEM PHARMACOL, V71, P521, DOI 10.1016/j.bcp.2005.11.007; Zhang SD, 2011, MEDCHEMCOMM, V2, P471, DOI 10.1039/c0md00245c; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008	62	78	80	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41064	10.1371/journal.pone.0041064	http://dx.doi.org/10.1371/journal.pone.0041064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815915	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100114
J	Zhang, S; Yuan, J; Yu, M; Fan, H; Guo, ZQ; Yang, R; Guo, HP; Liao, YH; Wang, M				Zhang, Shuang; Yuan, Jing; Yu, Miao; Fan, Hong; Guo, Zhang-Qiang; Yang, Rui; Guo, He-Ping; Liao, Yu-Hua; Wang, Min			IL-17A Facilitates Platelet Function through the ERK2 Signaling Pathway in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ACTIVATION; DISEASE	Background: Platelet aggregation mediated by inflammation played a critical role in the development of coronary heart diseases (CHD). Our previous clinical researches showed that Th17 cells and their characteristic cytokine IL-17A were associated with the plaque destabilization in patients with acute coronary syndrome (ACS). However, the potent effect of IL-17A on platelets-induced atherothrombosis remains unknown. Methods and Results: In this study, we detected the plasma IL-17A levels and platelet aggregation in patients with stable angina (SA), unstable angina (UA), acute myocardial infarction (AMI) and chest pain syndrome (CPS). In addition, the markers of platelet activation (CD62P/PAC-1) and the mitogen-activated protein kinases (MAPKs) pathway were detected in platelets from ACS patients. We found that plasma IL-17A levels and platelet aggregation in patients with ACS (UA and AMI) were significantly higher than patients with SA and CPS, and the plasma IL-17A levels were positively correlated with the platelet aggregation (R = 0.47, P<0.01). In addition, in patients with ACS, the platelet aggregation, CD62P/PAC-1 and the phosphorylation of ERK2 signaling pathway were obviously elevated in platelets pre-stimulated with IL-17A in vitro. Furthermore, the specific inhibitor of ERK2 could attenuate platelet aggregation and activation triggered by IL-17A. Conclusion: Our experiment firstly proved that IL-17A could promote platelet function in patients with ACS via activating platelets ERK2 signaling pathway and may provide a novel target for antiplatelet therapies in CHD.	[Zhang, Shuang; Yuan, Jing; Yu, Miao; Guo, He-Ping; Liao, Yu-Hua; Wang, Min] Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Inst Cardiol, Union Hosp, Wuhan 430074, Peoples R China; [Fan, Hong] Huazhong Univ Sci & Technol, Dept Emergency Med, Union Hosp, Wuhan 430074, Peoples R China; [Guo, Zhang-Qiang] Huazhong Univ Sci & Technol, Dept Cardiol, Pu Ai Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yang, Rui] Huazhong Univ Sci & Technol, Dept Hematol, Union Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, S (corresponding author), Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Inst Cardiol, Union Hosp, Wuhan 430074, Peoples R China.	liaoyh27@163.com; wm_xmy@whuh.com			National Basic Research Program of China (973 Program) [2007CB512000, 2007CB512005]; National Natural Science Foundation of China [81100158]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by National Basic Research Program of China (973 Program): 2007CB512000, 2007CB512005 and National Natural Science Foundation of China: 81100158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 2008, J THROMB HAEMOST, V6, P2007, DOI 10.1111/j.1538-7836.2008.03169.x; Anderson GF, 2007, NEW ENGL J MED, V356, P209, DOI 10.1056/NEJMp068182; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Cheng XA, 2011, ATHEROSCLEROSIS, V215, P471, DOI 10.1016/j.atherosclerosis.2010.12.034; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lubberts E, 2010, SEMIN IMMUNOPATHOL, V32, P43, DOI 10.1007/s00281-009-0189-9; Maione F, 2011, BIOCHEM BIOPH RES CO, V408, P658, DOI 10.1016/j.bbrc.2011.04.080; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Taleb S, 2010, CURR OPIN LIPIDOL, V21, P404, DOI 10.1097/MOL.0b013e32833dc7f9; von Vietinghoff S, 2010, CYTOKINE GROWTH F R, V21, P463, DOI 10.1016/j.cytogfr.2010.10.003; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yuan J, 2010, J IMMUNOL, V185, P4004, DOI 10.4049/jimmunol.1001718	22	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40641	10.1371/journal.pone.0040641	http://dx.doi.org/10.1371/journal.pone.0040641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808218	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400089
J	Steinestel, K; Bruderlein, S; Steinestel, J; Markl, B; Schwerer, MJ; Arndt, A; Kraft, K; Propper, C; Moller, P				Steinestel, Konrad; Bruederlein, Silke; Steinestel, Julie; Maerkl, Bruno; Schwerer, Michael J.; Arndt, Annette; Kraft, Klaus; Proepper, Christian; Moeller, Peter			Expression of Abelson Interactor 1 (Abi1) Correlates with Inflammation, KRAS Mutation and Adenomatous Change during Colonic Carcinogenesis	PLOS ONE			English	Article							COLORECTAL-CANCER; SERRATED POLYPS; CELL-ADHESION; CARCINOMA; PATHWAY; MIGRATION; COMPLEX; PROTEIN; INVASION; RECEPTOR	Background: Abelson interactor 1 (Abi1) is an important regulator of actin dynamics during cytoskeletal reorganization. In this study, our aim was to investigate the expression of Abi1 in colonic mucosa with and without inflammation, colonic polyps, colorectal carcinomas (CRC) and metastases as well as in CRC cell lines with respect to BRAF/KRAS mutation status and to find out whether introduction of KRAS mutation or stimulation with TNFalpha enhances Abi1 protein expression in CRC cells. Methodology/Principal Findings: We immunohistochemically analyzed Abi1 protein expression in 126 tissue specimens from 95 patients and in 5 colorectal carcinoma cell lines with different mutation status by western immunoblotting. We found that Abi1 expression correlated positively with KRAS, but not BRAF mutation status in the examined tissue samples. Furthermore, Abi1 is overexpressed in inflammatory mucosa, sessile serrated polyps and adenomas, tubular adenomas, invasive CRC and CRC metastasis when compared to healthy mucosa and BRAF-mutated as well as KRAS wild-type hyperplastic polyps. Abi1 expression in carcinoma was independent of microsatellite stability of the tumor. Abi1 protein expression correlated with KRAS mutation in the analyzed CRC cell lines, and upregulation of Abi1 could be induced by TNFalpha treatment as well as transfection of wild-type CRC cells with mutant KRAS. The overexpression of Abi1 could be abolished by treatment with the PI3K-inhibitor Wortmannin after KRAS transfection. Conclusions/Significance: Our results support a role for Abi1 as a downstream target of inflammatory response and adenomatous change as well as oncogenic KRAS mutation via PI3K, but not BRAF activation. Furthermore, they highlight a possible role for Abi1 as a marker for early KRAS mutation in hyperplastic polyps. Since the protein is a key player in actin dynamics, our data encourages further studies concerning the exact role of Abi1 in actin reorganization upon enhanced KRAS/PI3K signalling during colonic tumorigenesis.	[Steinestel, Konrad; Bruederlein, Silke; Moeller, Peter] Univ Ulm, Inst Pathol, Ulm, Germany; [Steinestel, Konrad; Arndt, Annette; Kraft, Klaus] Bundeswehrkrankenhaus Ulm, Dept Pathol, Ulm, Germany; [Steinestel, Julie] Univ Ulm, Dept Urol, Ulm, Germany; [Maerkl, Bruno] Klinikum Augsburg, Inst Pathol, Augsburg, Germany; [Schwerer, Michael J.] German AF Inst Aviat Med, Dept Forens Med Aircraft Accid Invest, Furstenfeldbruck, Germany; [Proepper, Christian] Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany	Ulm University; Ulm University; Military Hospital Ulm; Ulm University; Klinikum Augsburg; Ulm University	Steinestel, K (corresponding author), Univ Ulm, Inst Pathol, Ulm, Germany.	konrad@steinestel.com	Märkl, Bruno/AAT-5038-2020; Maerkl, Bruno/H-6832-2019	Märkl, Bruno/0000-0002-7704-850X; Maerkl, Bruno/0000-0002-7704-850X; Steinestel, Konrad/0000-0002-6549-9848				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Baba RA, 2012, DIS MARKERS, V32, P273, DOI [10.1155/2012/986347, 10.3233/DMA-2011-0881]; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Echarri A, 2004, MOL CELL BIOL, V24, P4979, DOI 10.1128/MCB.24.11.4979-4993.2004; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Fujita K, 2011, AM J SURG PATHOL, V35, P295, DOI 10.1097/PAS.0b013e318205df36; Gay F, 2008, HUM PATHOL, V39, P1420, DOI 10.1016/j.humpath.2008.02.020; German Ethics Counsil, 2010, HUM BIOB RES OPIN, P47; Henderson-Jackson EB, 2010, INT J CLIN EXP PATHO, V3, P768; Huang EH, 2008, TRENDS MOL MED, V14, P503, DOI 10.1016/j.molmed.2008.09.005; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Inokuchi J, 2004, J HUM GENET, V49, P46, DOI 10.1007/s10038-003-0106-3; Iwaya K, 2007, CANCER SCI, V98, P992, DOI 10.1111/j.1349-7006.2007.00488.x; Jass JR, 2006, HISTOPATHOLOGY, V49, P121, DOI 10.1111/j.1365-2559.2006.02466.x; Kim KM, 2011, AM J SURG PATHOL, V35, P1274, DOI 10.1097/PAS.0b013e318224cd2e; Kim KM, 2010, AM J SURG PATHOL, V34, P667, DOI 10.1097/PAS.0b013e3181d40cb2; KORETZ K, 1994, VIRCHOWS ARCH, V425, P229; Kotula L, 2012, FEBS LETT       0519; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Leontovich AA, 2012, INT J ONCOL, V40, P1858, DOI 10.3892/ijo.2012.1407; Li YZ, 2007, J CELL SCI, V120, P1436, DOI 10.1242/jcs.03430; Liebau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018148; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Miller Mark Steven, 2012, Frontiers in Genetics, V2, P100, DOI 10.3389/fgene.2011.00100; MOLLER P, 1994, INT J CANCER, V57, P371, DOI 10.1002/ijc.2910570314; Monticone M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-92; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Pikor LA, 2011, JOVE-J VIS EXP, V49, pe2763, DOI DOI 10.3791/2763; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Proepper C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027045; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ring C, 2011, P NATL ACAD SCI USA, V108, P149, DOI 10.1073/pnas.1012316108; Schmiegel W, 2009, DTSCH ARZTEBL INT, V106, P843, DOI 10.3238/arztebl.2009.0843; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; THOMAS DB, 1987, CANCER RES, V47, P5771; Wang C, 2007, MOL CANCER RES, V5, P1031, DOI 10.1158/1541-7786.MCR-06-0391; Williams DL, 2006, SHOCK, V25, P432, DOI 10.1097/01.shk.0000209542.76305.55; Yen LC, 2010, ANN SURG, V251, P254, DOI 10.1097/SLA.0b013e3181bc9d96; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu WD, 2008, CARCINOGENESIS, V29, P1717, DOI 10.1093/carcin/bgn098; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	53	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40671	10.1371/journal.pone.0040671	http://dx.doi.org/10.1371/journal.pone.0040671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808230	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500070
J	Peter, JG; Theron, G; Muchinga, TE; Govender, U; Dheda, K				Peter, Jonathan G.; Theron, Grant; Muchinga, Tapuwa E.; Govender, Ureshnie; Dheda, Keertan			The Diagnostic Accuracy of Urine-Based Xpert MTB/RIF in HIV-Infected Hospitalized Patients Who Are Smear-Negative or Aputum Scarce	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; METAANALYSIS; AUTOPSY; AFRICA; ASSAY	Background: Hospitals in sub-Saharan Africa are inundated with HIV-infected patients and tuberculosis (TB) is the commonest opportunistic infection in this sub-group. Up to one third of TB-HIV co-infected patients fail to produce a sputum sample (sputum scarce) and diagnosis is thus often delayed or missed. We investigated the sensitivity of urine-based methods (Xpert MTB/RIF, LAM strip test and LAM ELISA) in such patients. Methodology/Principal Findings: 281 HIV-infected hospitalised patients with clinically suspected TB provided a spot urine sample. The reference standard was culture positivity for Mycobacterium tuberculosis on >= 1 sputum or extra-pulmonary sample. MTB/RIF was performed using 1 ml of both unprocessed and, when possible, concentrated urine. Each unconcentrated urine sample was also tested using the Clearview LAM ELISA and Alere LAM strip test. 42% (116/242) of patients had culture-proven TB. 18% (20/54) were sputum scarce. In sputum-scarce patients, the sensitivity of urine MTB/RIF and LAM ELISA was 40% (95% CI: 22-61) and 60% (95% CI: 39-78), respectively. Urine MTB/RIF specificity was 98% (95% CI: 95-100). Combined sensitivity of urine LAM ELISA and MTB/RIF was better than MTB/RIF alone [MTB/RIF and LAM: 70% (95% CI: 48-85) vs. MTB/RIF: 40% (95% CI: 22-61), p = 0.03]. Significant predictors of urine MTB/RIF positivity were CD4<50 cells/ml (p = 0.001), elevated protein-to-creatinine ratio (p < 0.001) and LAM ELISA positivity (p < 0.001). Urine centrifugation and pelleting significantly increased the sensitivity of MTB/RIF over unprocessed urine in paired samples [42% (95% CI: 2658) vs. 8% (95% CI: 0-16), p < 0.001]. Urine MTB/RIF-generated C-T values correlated poorly with markers of bacillary burden (smear grade and time-to-positivity). Conclusions/Significance: This preliminary study indicates that urine-based MTB/RIF, alone or in combination with LAM antigen detection, may potentially aid the diagnosis of TB in HIV-infected patients with advanced immunosuppression when sputum-based diagnosis is not possible. Concentration of urine prior to MTB/RIF-testing significantly improves sensitivity.	[Peter, Jonathan G.; Theron, Grant; Muchinga, Tapuwa E.; Govender, Ureshnie; Dheda, Keertan] Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa; [Peter, Jonathan G.; Theron, Grant; Muchinga, Tapuwa E.; Govender, Ureshnie; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] UCL, Sch Med, Dept Infect, London W1N 8AA, England	University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School	Peter, JG (corresponding author), Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa.	Keertan.Dheda@uct.ac.za	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415; Peter, Jonathan/0000-0002-2658-0723	European and Developing Countries Clinical Trials Partnership (EDCTP)	European and Developing Countries Clinical Trials Partnership (EDCTP)	This project was funded by a grant from the European and Developing Countries Clinical Trials Partnership (EDCTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO REP 2011 GLOB TU; [Anonymous], 2010, ROADM ROLL OUT XPERT; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Bossuyt PM, 2003, CROAT MED J, V44, P639; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Cox JA, 2010, AIDS REV, V12, P183; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Gonzalez-Angulo Y, 2011, EUROPEAN J CLIN MICR; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Lange C, 2012, EUR RESPIR MONOGR, P1; Lawn SD, 2012, J ACQUIRED IMMUNE DE; Lawn SD, 2011, LANCET INFECT DIS; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; STEWART SM, 1953, J CLIN PATHOL, V6, P241, DOI 10.1136/jcp.6.3.241; Theron G, 2011, EUROPEAN RESP J OFFI; Theron G, 2012, CLIN INFECT DIS, V54, P384, DOI 10.1093/cid/cir824; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; World Health Organization, 2011, WHO PUBL	28	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39966	10.1371/journal.pone.0039966	http://dx.doi.org/10.1371/journal.pone.0039966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22815718	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700021
J	Chong, NW; Koekemoer, AL; Ounzain, S; Samani, NJ; Shin, JT; Shaw, SY				Chong, Nelson W.; Koekemoer, Andrea L.; Ounzain, Samir; Samani, Nilesh J.; Shin, Jordan T.; Shaw, Stanley Y.			STARS Is Essential to Maintain Cardiac Development and Function In Vivo via a SRF Pathway	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; STRIATED-MUSCLE ACTIVATOR; HUMAN SKELETAL-MUSCLE; GENE; EXPRESSION; ZEBRAFISH; TRANSCRIPTION; HYPERTROPHY; TARGETS	Background: STARS (STriated muscle Activator of Rho Signaling) is a sarcomeric protein expressed early in cardiac development that acts as an acute stress sensor for pathological remodeling. However the role of STARS in cardiac development and function is incompletely understood. Here, we investigated the role of STARS in heart development and function in the zebrafish model and in vitro. Methodology and Principal Findings: Expression of zebrafish STARS (zSTARS) first occurs in the somites by the 16 somite stage [17 hours post fertilization (hpf)]. zSTARS is expressed in both chambers of the heart by 48 hpf, and also in the developing brain, jaw structures and pectoral fins. Morpholino-induced knockdown of zSTARS alters atrial and ventricular dimensions and decreases ventricular fractional shortening (measured by high-speed video microscopy), with pericardial edema and decreased or absent circulation [abnormal cardiac phenotypes in 126/164 (77%) of morpholino-injected embryos vs. 0/152 (0%) of control morpholino embryos]. Co-injection of zsrf (serum response factor) mRNA rescues the cardiac phenotype of zSTARS knockdown, resulting in improved fractional shortening and ventricular end-diastolic dimensions. Ectopic over-expression of STARS in vitro activates the STARS proximal promoter, which contains a conserved SRF site. Chromatin immunoprecipitation demonstrates that SRF binds to this site in vivo and the SRF inhibitor CCG-1423 completely blocks STARS proximal reporter activity in H9c2 cells. Conclusions/Significance: This study demonstrates for the first time that STARS deficiency severely disrupts cardiac development and function in vivo and revealed a novel STARS-SRF feed-forward autoregulatory loop that could play an essential role in STARS regulation and cardiac function.	[Chong, Nelson W.; Koekemoer, Andrea L.; Ounzain, Samir; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Clin Sci Wing, Leicester, Leics, England; [Shin, Jordan T.] Massachusetts Gen Hosp, Div Cardiol, Cardiovasc Res Ctr, Charlestown, MA USA; [Shin, Jordan T.] Harvard Univ, Sch Med, Charlestown, MA USA; [Shaw, Stanley Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Simches Res Ctr, Boston, MA 02114 USA; [Shaw, Stanley Y.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chong, NW (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Clin Sci Wing, Leicester, Leics, England.	nc69@le.ac.uk			National Institutes of Health/National Heart, Lung, and Blood Institute [K08 HL077186, HL-085280]; Heart Research UK [RG2474/04/07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085280, K08HL077186] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heart Research UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Heart, Lung, and Blood Institute K08 HL077186 (S.Y.S.), HL-085280 (J.T.S.) and the Heart Research UK (RG2474/04/07; N.W.C.). N.J.S. holds a British Heart Foundation Chair of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Becker JR, 2011, DIS MODEL MECH, V4, P400, DOI 10.1242/dmm.006148; Chandrasekaran S, 2009, FASEB J, V23, P3851, DOI 10.1096/fj.09-132415; Chong NW, 2005, HEART, V91, pA44; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Koekemoer AL, 2009, FEBS LETT, V583, P2964, DOI 10.1016/j.febslet.2009.08.011; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Lamon S, 2009, J PHYSIOL-LONDON, V587, P1795, DOI 10.1113/jphysiol.2009.168674; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Mahadeva H, 2002, FEBS LETT, V521, P100, DOI 10.1016/S0014-5793(02)02833-8; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; Ounzain S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-50; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Sakuma K, 2008, BBA-MOL BASIS DIS, V1782, P453, DOI 10.1016/j.bbadis.2008.03.008; Shin JT, 2010, PHYSIOL GENOMICS, V42, P300, DOI 10.1152/physiolgenomics.00206.2009; Stickney HL, 2000, DEV DYNAM, V219, P287; THISSE C, 1993, DEVELOPMENT, V119, P1203; Troidl K, 2009, ARTERIOSCLER THROMB, V29; Wallace MA, 2011, J PHYSIOL-LONDON, V589, P2027, DOI 10.1113/jphysiol.2011.205468; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200	25	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40966	10.1371/journal.pone.0040966	http://dx.doi.org/10.1371/journal.pone.0040966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815879	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900064
J	Hendricks, AE; Dupuis, J; Gupta, M; Logue, MW; Lunetta, KL				Hendricks, Audrey E.; Dupuis, Josee; Gupta, Mayetri; Logue, Mark W.; Lunetta, Kathryn L.			A Comparison of Gene Region Simulation Methods	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; ATRIAL-FIBRILLATION; ALLELE FREQUENCIES; HUMAN GENOME; ASSOCIATION; POPULATION; VARIANTS; TOOL; LD	Background: Accurately modeling LD in simulations is essential to correctly evaluate new and existing association methods. At present, there has been minimal research comparing the quality of existing gene region simulation methods to produce LD structures similar to an existing gene region. Here we compare the ability of three approaches to accurately simulate the LD within a gene region: HapSim (2005), Hapgen (2009), and a minor extension to simple haplotype resampling. Methodology/Principal Findings: In order to observe the variation and bias for each method, we compare the simulated pairwise LD measures and minor allele frequencies to the original HapMap data in an extensive simulation study. When possible, we also evaluate the effects of changing parameters. HapSim produces samples of haplotypes with lower LD, on average, compared to the original haplotype set while both our resampling method and Hapgen do not introduce this bias. The variation introduced across the replicates by our resampling method is quite small and may not provide enough sampling variability to make a generalizable simulation study. Conclusion: We recommend using Hapgen to simulate replicate haplotypes from a gene region. Hapgen produces moderate sampling variation between the replicates while retaining the overall unique LD structure of the gene region.	[Hendricks, Audrey E.; Dupuis, Josee; Gupta, Mayetri; Logue, Mark W.; Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Dupuis, Josee; Gupta, Mayetri] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Logue, Mark W.] Boston Univ, Sch Med, Dept Biomed Genet, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Hendricks, AE (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	baera@bu.edu	Hendricks, Audrey/I-4127-2016	Hendricks, Audrey/0000-0002-7152-0287; Lunetta, Kathryn/0000-0002-9268-810X; Dupuis, Josee/0000-0003-2871-3603; Logue, Mark/0000-0001-9347-7892	Department of Medicine at Boston University School of Medicine and Boston Medical Center	Department of Medicine at Boston University School of Medicine and Boston Medical Center	No direct external funding was received for this study. A portion of this research was conducted using the Linux Clusters for Genetic Analysis (LinGA) computing resource funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center and by contributions from individual investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Carvajal-Rodriguez A, 2008, CURR GENOMICS, V9, P155, DOI 10.2174/138920208784340759; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chen Han, 2011, BMC Proc, V5 Suppl 9, pS113, DOI 10.1186/1753-6561-5-S9-S113; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ellinor PT, 2012, NATURE GENETICS; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; Li C, 2008, BIOINFORMATICS, V24, P140, DOI 10.1093/bioinformatics/btm549; Li N, 2003, GENETICS, V165, P2213; Liu Youfang, 2008, Hum Genomics, V3, P79; McEvoy BP, 2011, GENOME RES, V21, P821, DOI 10.1101/gr.119636.110; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Pagano M., 2018, PRINCIPLES BIOSTATIS; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Team RDC, 2009, R LANG ENV STAT COMP; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Vargha A, 1996, J EDUC BEHAV STAT, V21, P264; Wright FA, 2007, BIOINFORMATICS, V23, P2581, DOI 10.1093/bioinformatics/btm386; WRIGHT S., 1938, Science (Washington), V87, P430; Wright S, 1931, GENETICS, V16, P0097; Zapata C, 1997, AM J HUM GENET, V61, P771; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016739	32	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40925	10.1371/journal.pone.0040925	http://dx.doi.org/10.1371/journal.pone.0040925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815869	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306548900060
J	Carter, DM; Lu, HR; Bloom, CE; Crevar, CJ; Cherry, JL; Lipman, DJ; Ross, TM				Carter, Donald M.; Lu, Hai-Rong; Bloom, Chalise E.; Crevar, Corey J.; Cherry, Joshua L.; Lipman, David J.; Ross, Ted M.			Complex Patterns of Human Antisera Reactivity to Novel 2009 H1N1 and Historical H1N1 Influenza Strains	PLOS ONE			English	Article							ADAMANTANE RESISTANCE; VIRUSES; ORIGIN; ANTIBODIES; IMMUNITY; VACCINE; PROTECTION	Background: During the 2009 influenza pandemic, individuals over the age of 60 had the lowest incidence of infection with approximately 25% of these people having pre-existing, cross-reactive antibodies to novel 2009 H1N1 influenza isolates. It was proposed that older people had pre-existing antibodies induced by previous 1918-like virus infection(s) that cross-reacted to novel H1N1 strains. Methodology/Principal Findings: Using antisera collected from a cohort of individuals collected before the second wave of novel H1N1 infections, only a minority of individuals with 1918 influenza specific antibodies also demonstrated hemagglutination-inhibition activity against the novel H1N1 influenza. In this study, we examined human antisera collected from individuals that ranged between the ages of 1 month and 90 years to determine the profile of seropositive influenza immunity to viruses representing H1N1 antigenic eras over the past 100 years. Even though HAI titers to novel 2009 H1N1 and the 1918 H1N1 influenza viruses were positively associated, the association was far from perfect, particularly for the older and younger age groups. Conclusions/Significance: Therefore, there may be a complex set of immune responses that are retained in people infected with seasonal H1N1 that can contribute to the reduced rates of H1N1 influenza infection in older populations.	[Carter, Donald M.; Lu, Hai-Rong; Bloom, Chalise E.; Crevar, Corey J.; Ross, Ted M.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Ross, Ted M.] Univ Pittsburgh, Sch Med, Grad Program Immunol, Pittsburgh, PA USA; [Ross, Ted M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Cherry, Joshua L.; Lipman, David J.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Carter, DM (corresponding author), Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	tmr15@pitt.edu			National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [GM083602-01]; Oak Ridge Visiting Scientist training program; Pennsylvania Department of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083602] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000077] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oak Ridge Visiting Scientist training program; Pennsylvania Department of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) award GM083602-01 to Ted M. Ross, by an Oak Ridge Visiting Scientist training program award to Donald M Carter. This project was also funded, in part, under a grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The authors have no conflict of interest in the results reported in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; DAVENPORT FM, 1957, T ASSOC AM PHYSICIAN, V70, P81; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; FRANCIS T, 1952, FED PROC, V11, P808; Giles BM, 2011, 1918 INFLUENZA VIRUS; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; JENSEN KE, 1953, J EXP MED, V98, P619, DOI 10.1084/jem.98.6.619; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; McVernon J, 2010, EURO SURVEILL, V15, pii; McVernon J, 2011, INFLUENZA OTHER RESP, V5, P7, DOI 10.1111/j.1750-2659.2010.00172.x; Mitchell JA, 2003, VACCINE, V21, P902, DOI 10.1016/S0264-410X(02)00539-X; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Xu R, 2010, SCI SCI; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	29	8	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e39435	10.1371/journal.pone.0039435	http://dx.doi.org/10.1371/journal.pone.0039435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815705	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306507000009
J	Chen, DH; Liu, XL; Zhang, WP; Shi, YG				Chen, Daohong; Liu, Xiaolei; Zhang, Weiping; Shi, Yuguang			Targeted Inactivation of GPR26 Leads to Hyperphagia and Adiposity by Activating AMPK in the Hypothalamus	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; DIET-INDUCED OBESITY; FOOD-INTAKE; INSULIN-RESISTANCE; METABOLIC SYNDROME; KINASE; MICE; DISRUPTION; RIMONABANT; DEPRESSION	G-protein coupled receptor 26 (GPR26) is a brain-specific orphan GPCR with high expression in the brain region that controls satiety. Depletion of GPR26 has been shown to increase fat storage in C. elegans, whereas GPR26 deficiency in the hypothalamus is associated with high genetic susceptibility to the onset of obesity in mice. However, the metabolic function of GPR26 in mammals remains elusive. Herein, we investigated a role of GPR26 in regulating energy homeostasis by generating mice with targeted deletion of the GPR26 gene. We show that GPR26 deficiency causes hyperphagia and hypometabolism, leading to early onset of diet-induced obesity. Accordingly, GPR26 deficiency also caused metabolic complications commonly associated with obesity, including glucose intolerance, hyperinsulinemia, and dyslipidemia. Moreover, consistent with hyperphagia in GPR26 null mice, GPR26 deficiency significantly increased hypothalamic activity of AMPK, a key signaling event that stimulates appetite. In further support of a regulatory role of GPR26 in satiety, GPR26 knockout mice also demonstrate hypersensitivity to treatment of rimonabant, an endocannabinoid receptor-1 antagonist commonly used to treat obesity by suppressing appetite in humans. Together, these findings identified a key role of GPR26 as a central regulator of energy homeostasis though modulation of hypothalamic AMPK activation.	[Chen, Daohong; Liu, Xiaolei; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA; [Liu, Xiaolei] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China; [Zhang, Weiping] Second Mil Med Univ Shanghai, Dept Pathophysiol, Shanghai, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Central South University; Naval Medical University	Chen, DH (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA.	yus11@psu.edu			National Institutes of Health [DK076685]; National Natural Science Foundation of China [31025013, 81130084]; National Key Basic Research Program of China [2012CB524900]; National "863" Program of China [2007AA02Z173]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK076685, R01DK076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National "863" Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by grants from the National Institutes of Health (DK076685 to YS), National Natural Science Foundation of China (31025013 and 81130084 to WZ), National Key Basic Research Program of China (2012CB524900 to WZ), and National "863" Program of China (2007AA02Z173 to WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Atlantis E, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3868; Bresnick JN, 2003, ASSAY DRUG DEV TECHN, V1, P239, DOI 10.1089/15406580360545053; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2009, NAT REV ENDOCRINOL, V5, P633, DOI 10.1038/nrendo.2009.197; Dong CH, 2003, AM J HUM GENET, V72, P115, DOI 10.1086/345648; Farrigan C, 2002, NAT REV DRUG DISCOV, V1, P257, DOI 10.1038/nrd781; Hardie DG, 2007, CELL METAB, V6, P339, DOI 10.1016/j.cmet.2007.10.001; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Jandacek RJ, 2004, DRUG DISCOV TODAY, V9, P874, DOI 10.1016/S1359-6446(04)03244-1; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; King A, 2010, NAT REV CARDIOL, V7, P297, DOI [10.1038/nrcardio.2010.148, 10.1038/nrcardio.2010.66]; Kola B, 2008, J NEUROENDOCRINOL, V20, P942, DOI 10.1111/j.1365-2826.2008.01745.x; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lee DK, 2000, BBA-GENE STRUCT EXPR, V1490, P311, DOI 10.1016/S0167-4781(99)00241-9; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Xu YL, 2004, EUR J PHARMACOL, V500, P243, DOI 10.1016/j.ejphar.2004.07.029; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40764	10.1371/journal.pone.0040764	http://dx.doi.org/10.1371/journal.pone.0040764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815809	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100063
J	Yates-Binder, CC; Rodgers, M; Jaynes, J; Wells, A; Bodnar, RJ; Turner, T				Yates-Binder, Cecelia C.; Rodgers, Margaret; Jaynes, Jesse; Wells, Alan; Bodnar, Richard J.; Turner, Timothy			An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR3; PROTEIN-KINASE-A; INDUCIBLE PROTEIN-9; CELL MOTILITY; GROWTH-FACTOR; MICE LACKING; WOUND REPAIR; CALPAIN; KERATINOCYTES; ACTIVATION	Angiogenesis plays a critical role in processes such as organ development, wound healing, and tumor growth. It requires well-orchestrated integration of soluble and matrix factors and timely recognition of such signals to regulate this process. Previous work has shown that newly forming vessels express the chemokine receptor CXC receptor 3 (CXCR3) and, activation by its ligand IP-10 (CXCL10), both inhibits development of new vasculature and causes regression of newly formed vessels. To identify and develop new therapeutic agents to limit or reverse pathological angiogenesis, we identified a 21 amino acid fragment of IP-10, spanning the a-helical domain residues 77-98, that mimic the actions of the whole IP-10 molecule on endothelial cells. Treatment of the endothelial cells with the 22 amino acid fragment referred to as IP-10p significantly inhibited VEGF-induced endothelial motility and tube formation in vitro, properties critical for angiogenesis. Using a Matrigel plug assay in vivo, we demonstrate that IP-10p both prevented vessel formation and induced involution of nascent vessels. CXCR3 neutralizing antibody was able to block the inhibitory effects of the IP-10p, demonstrating specificity of the peptide. Inhibition of endothelial function by IP-10p was similar to that described for IP-10, secondary to CXCR3-mediated increase in cAMP production, activation of PKA inhibiting cell migration, and inhibition of VEGF-mediated m-calpain activation. IP-10p provides a novel therapeutic agent that inhibits endothelial cell function thus, allowing for the modulation of angiogenesis.	[Yates-Binder, Cecelia C.; Jaynes, Jesse; Wells, Alan; Turner, Timothy] Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA; [Yates-Binder, Cecelia C.; Wells, Alan; Bodnar, Richard J.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Yates-Binder, Cecelia C.; Rodgers, Margaret; Wells, Alan; Bodnar, Richard J.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Tuskegee University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Yates-Binder, CC (corresponding author), Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA.	cey4@pitt.edu; Rjb8@pitt.edu		Wells, Alan/0000-0002-1637-8150	National Center on Minority Health and Health Disparities, National Institute of General Medical Science of the National Institutes of Health [R01GM063569]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063569] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities, National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by grants from the National Center on Minority Health and Health Disparities, National Institute of General Medical Science of the National Institutes of Health (R01GM063569) and in kind support from the Pittsburgh VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Balestrieri ML, 2008, CARDIOVASC RES, V78, P250, DOI 10.1093/cvr/cvn029; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Dimberg A, 2010, CURR TOP MICROBIOL, V341, P59, DOI 10.1007/82_2010_21; Godessart N, 2001, CURR OPIN IMMUNOL, V13, P670, DOI 10.1016/S0952-7915(01)00277-1; Jouan V, 1999, BLOOD, V94, P984, DOI 10.1182/blood.V94.3.984.415k31_984_993; Kelsen SG, 2004, AM J PHYSIOL-LUNG C, V287, pL584, DOI 10.1152/ajplung.00453.2003; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Ohta K, 2008, J DENT RES, V87, P1160, DOI 10.1177/154405910808701211; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Satish L, 2003, J INVEST DERMATOL, V120, P1110, DOI 10.1046/j.1523-1747.2003.12230.x; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092; Yates CC, 2009, WOUND REPAIR REGEN, V17, P34, DOI 10.1111/j.1524-475X.2008.00439.x	23	60	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40812	10.1371/journal.pone.0040812	http://dx.doi.org/10.1371/journal.pone.0040812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815829	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306466100073
J	Heimesaat, MM; Boelke, S; Fischer, A; Haag, LM; Loddenkemper, C; Kuhl, AA; Gobel, UB; Bereswill, S				Heimesaat, Markus M.; Boelke, Silvia; Fischer, Andre; Haag, Lea-Maxie; Loddenkemper, Christoph; Kuehl, Anja A.; Goebel, Ulf B.; Bereswill, Stefan			Comprehensive Postmortem Analyses of Intestinal Microbiota Changes and Bacterial Translocation in Human Flora Associated Mice	PLOS ONE			English	Article							CROHNS-DISEASE; ESCHERICHIA-COLI; AUTOPSY BACTERIOLOGY; BLOOD CULTURES; INFECTION; IMMUNOPATHOLOGY; OVERGROWTH; KINETICS; MOTILITY; INVASION	Background: Postmortem microbiological examinations are performed in forensic and medical pathology for defining uncertain causes of deaths and for screening of deceased tissue donors. Interpretation of bacteriological data, however, is hampered by false-positive results due to agonal spread of microorganisms, postmortem bacterial translocation, and environmental contamination. Methodology/Principal Findings: We performed a kinetic survey of naturally occurring postmortem gut flora changes in the small and large intestines of conventional and gnotobiotic mice associated with a human microbiota (hfa) applying cultural and molecular methods. Sacrificed mice were kept under ambient conditions for up to 72 hours postmortem. Intestinal microbiota changes were most pronounced in the ileal lumen where enterobacteria and enterococci increased by 3-5 orders of magnitude in conventional and hfa mice. Interestingly, comparable intestinal overgrowth was shown in acute and chronic intestinal inflammation in mice and men. In hfa mice, ileal overgrowth with enterococci and enterobacteria started 3 and 24 hours postmortem, respectively. Strikingly, intestinal bacteria translocated to extra-intestinal compartments such as mesenteric lymphnodes, spleen, liver, kidney, and cardiac blood as early as 5 min after death. Furthermore, intestinal tissue destruction was characterized by increased numbers of apoptotic cells and neutrophils within 3 hours postmortem, whereas counts of proliferative cells as well as T- and B-lymphocytes and regulatory T-cells decreased between 3 and 12 hours postmortem. Conclusions/Significance: We conclude that kinetics of ileal overgrowth with enterobacteria and enterococci in hfa mice can be used as an indicator for compromized intestinal functionality and for more precisely defining the time point of death under defined ambient conditions. The rapid translocation of intestinal bacteria starting within a few minutes after death will help to distinguish between relevant bacteria and secondary contaminants thus providing important informations for routine applications and future studies in applied microbiology, forensic pathology, and criminal medicine.	[Heimesaat, Markus M.; Boelke, Silvia; Fischer, Andre; Haag, Lea-Maxie; Goebel, Ulf B.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Loddenkemper, Christoph; Kuehl, Anja A.] Charite, Dept Pathol, Res Ctr ImmunoSci RCIS, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Haag, Lea Maxie/AAP-9001-2020	Heimesaat, Markus/0000-0001-6399-651X; Kuhl, Anja/0000-0003-2293-5387; Haag, Lea-Maxie/0000-0002-3754-5317	German Research Foundation (DFG) [GO363/12-1, SFB633, TP A7, TP Z1, TP B6]; German Federal Ministery of Education and Research (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to UBG (GO363/12-1, CampyGerm; SFB633, TP A7), SB (SFB633, TP A7), AAK and CL (SFB633, TP Z1), MMH (SFB633, TP B6), LMH (SFB633, Immuco) and from the German Federal Ministery of Education and Research (BMBF) to SB ("Lab in a hanky'' projects TP 1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Burn CG, 1934, J INFECT DIS, V54, P395, DOI 10.1093/infdis/54.3.395; Burn CG, 1934, J INFECT DIS, V54, P388, DOI 10.1093/infdis/54.3.388; CARPENTER H, 1964, ARCH PATHOL, V77, P73; CARTWRIGHT GE, 1964, ANN NY ACAD SCI, V113, P963, DOI 10.1111/j.1749-6632.1964.tb40716.x; CARTWRIGHT GE, 1964, BLOOD, V24, P780, DOI 10.1182/blood.V24.6.780.780; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; DUMOULIN GC, 1985, HUM PATHOL, V16, P539, DOI 10.1016/S0046-8177(85)80102-7; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; FLIEDNER TM, 1964, BLOOD, V24, P402, DOI 10.1182/blood.V24.4.402.402; GILBERT R, 1992, ARCH DIS CHILD, V67, P171, DOI 10.1136/adc.67.2.171; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Jaenisch Stefanie, 2010, Archiv fuer Kriminologie, V225, P99; Kayama S, 2000, J GASTROENTEROL, V35, P15, DOI 10.1007/PL00009970; KELLERMAN GD, 1976, AM J CLIN PATHOL, V66, P911; KONEMAN EW, 1974, AM J CLIN PATHOL, V61, P28; KURTIN JJ, 1958, AM J CLIN PATHOL, V30, P239, DOI 10.1093/ajcp/30.3.239; Leveau P, 1996, INT J PANCREATOL, V20, P119; Lobmaier IVK, 2009, EUR J CLIN MICROBIOL, V28, P1191, DOI 10.1007/s10096-009-0762-0; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183; Morris JA, 2007, CURR DIAGN PATHOL, V13, P65, DOI DOI 10.1016/J.CDIP.2006.07.005; Morris JA, 2007, MED HYPOTHESES, V69, P1032, DOI 10.1016/j.mehy.2007.02.039; Norris C, 1905, J EXP MED, V7, P450, DOI 10.1084/jem.7.5.450; Roberts FJ, 1998, EUR J CLIN MICROBIOL, V17, P821, DOI 10.1007/s100960050200; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; Saegeman V, 2009, EUR J CLIN MICROBIOL, V28, P161, DOI 10.1007/s10096-008-0609-0; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Sartor RB, 2003, CURR OPIN GASTROEN, V19, P358, DOI 10.1097/00001574-200307000-00006; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; SILVER H, 1969, AM J CLIN PATHOL, V52, P433; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tsokos M, 2001, Leg Med (Tokyo), V3, P15, DOI 10.1016/S1344-6223(01)00002-5; Tsokos M, 2001, INT J LEGAL MED, V114, P291, DOI 10.1007/s004140000172; WANG XD, 1994, EUR J SURG, V160, P153; Weber MA, 2010, FORENSIC SCI INT, V198, P121, DOI 10.1016/j.forsciint.2010.02.002; Yang SB, 2011, J LEUKOCYTE BIOL, V89, P85, DOI 10.1189/jlb.0910506; Zhao Dong, 2009, Leg Med (Tokyo), V11 Suppl 1, pS286, DOI 10.1016/j.legalmed.2009.02.014; Zhao Dong, 2009, Leg Med (Tokyo), V11 Suppl 1, pS43, DOI 10.1016/j.legalmed.2009.01.066	45	53	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40758	10.1371/journal.pone.0040758	http://dx.doi.org/10.1371/journal.pone.0040758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808253	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400055
J	Neville, BA; Forde, BM; Claesson, MJ; Darby, T; Coghlan, A; Nally, K; Ross, RP; O'Toole, PW				Neville, B. Anne; Forde, Brian M.; Claesson, Marcus J.; Darby, Trevor; Coghlan, Avril; Nally, Kenneth; Ross, R. Paul; O'Toole, Paul W.			Characterization of Pro-Inflammatory Flagellin Proteins Produced by Lactobacillus ruminis and Related Motile Lactobacilli	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; ESCHERICHIA-COLI; GENOME SEQUENCES; GENE-EXPRESSION; RHAMNOSUS GG; SP NOV.; STRAINS; SURFACE	Lactobacillus ruminis is one of at least twelve motile but poorly characterized species found in the genus Lactobacillus. Of these, only L. ruminis has been isolated from mammals, and this species may be considered as an autochthonous member of the gastrointestinal microbiota of humans, pigs and cows. Nine L. ruminis strains were investigated here to elucidate the biochemistry and genetics of Lactobacillus motility. Six strains isolated from humans were non-motile while three bovine isolates were motile. A complete set of flagellum biogenesis genes was annotated in the sequenced genomes of two strains, ATCC25644 (human isolate) and ATCC27782 (bovine isolate), but only the latter strain produced flagella. Comparison of the L. ruminis and L. mali DSM20444(T) motility loci showed that their genetic content and gene-order were broadly similar, although the L. mali motility locus was interrupted by an 11.8 Kb region encoding rhamnose utilization genes that is absent from the L. ruminis motility locus. Phylogenetic analysis of 39 motile bacteria indicated that Lactobacillus motility genes were most closely related to those of motile carnobacteria and enterococci. Transcriptome analysis revealed that motility genes were transcribed at a significantly higher level in motile L. ruminis ATCC27782 than in non-motile ATCC25644. Flagellin proteins were isolated from L. ruminis ATCC27782 and from three other Lactobacillus species, while recombinant flagellin of aflagellate L. ruminis ATCC25644 was expressed and purified from E. coli. These native and recombinant Lactobacillus flagellins, and also flagellate L. ruminis cells, triggered interleukin-8 production in cultured human intestinal epithelial cells in a manner suppressed by short interfering RNA directed against Toll-Like Receptor 5. This study provides genetic, transcriptomic, phylogenetic and immunological insights into the trait of flagellum-mediated motility in the lactobacilli.	[Neville, B. Anne; Forde, Brian M.; Claesson, Marcus J.; Coghlan, Avril; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Darby, Trevor; Nally, Kenneth; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Ross, R. Paul] TEAGASC, Moorepk Food Res Ctr, Fermoy, Cork, Ireland	University College Cork; University College Cork; Teagasc	Neville, BA (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	pwotoole@ucc.ie	Nally, Ken/AAY-6968-2021; Forde, Brian/GLQ-9491-2022; Ross, Paul/A-7584-2015; O'Toole, Paul W/G-1593-2012; Claesson, Marcus/K-7639-2015; Claesson, Marcus/AAE-4145-2019	Nally, Ken/0000-0002-9833-170X; Forde, Brian/0000-0002-2264-4785; Ross, Paul/0000-0003-4876-8839; O'Toole, Paul W/0000-0001-5377-0824; Claesson, Marcus/0000-0002-5712-0623; Claesson, Marcus/0000-0002-5712-0623; Darby, Trevor/0000-0002-7379-3836; Coghlan, Avril/0000-0002-2775-5951	Principal Investigator Award [07/IN.1/B1780]; Science Foundation Ireland; Irish Research Council for Science Engineering and Technology; Alimentary Pharmabiotic Centre	Principal Investigator Award(Science Foundation Ireland); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Alimentary Pharmabiotic Centre(Science Foundation Ireland)	This work was supported by a Principal Investigator Award (07/IN.1/B1780) from Science Foundation Ireland to PWOT. BAN was the recipient of an Embark studentship from the Irish Research Council for Science Engineering and Technology. TD and KN were supported by the Alimentary Pharmabiotic Centre, funded by Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2003, LETT APPL MICROBIOL, V37, P213, DOI 10.1046/j.1472-765X.2003.01380.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Buron N, 2011, FOOD MICROBIOL, V28, P1243, DOI 10.1016/j.fm.2011.05.001; CARR JG, 1970, J APPL BACTERIOL, V33, P768, DOI 10.1111/j.1365-2672.1970.tb02261.x; CARR JG, 1977, J APPL BACTERIOL, V42, P219, DOI 10.1111/j.1365-2672.1977.tb00688.x; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Coton M, 2010, FOOD MICROBIOL, V27, P1078, DOI 10.1016/j.fm.2010.07.012; Couto JA, 2006, AM J ENOL VITICULT, V57, P166; Dal Bello F, 2006, SYST APPL MICROBIOL, V29, P69, DOI 10.1016/j.syapm.2005.07.002; Delgado S, 2004, EUR J NUTR, V43, P375, DOI 10.1007/s00394-004-0485-z; Dicks LMT, 2009, S AFR J ENOL VITIC, V30, P72; Dommels YEM, 2009, APPL ENVIRON MICROB, V75, P6198, DOI 10.1128/AEM.01054-09; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Forde BM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S13; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Jakava-Viljanen M, 2002, J BACTERIOL, V184, P6786, DOI 10.1128/JB.184.24.6786-6795.2002; Kajikawa A, 2011, APPL ENVIRON MICROB, V77, P6587, DOI 10.1128/AEM.05153-11; Kajikawa A, 2010, VACCINE, V28, P3409, DOI 10.1016/j.vaccine.2010.02.077; Kandler O., 1986, BERGEYS MANUAL SYSTE, P1208; KANEUCHI C, 1988, INT J SYST BACTERIOL, V38, P269, DOI 10.1099/00207713-38-3-269; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kim DS, 2011, J BACTERIOL, V193, P5053, DOI 10.1128/JB.05659-11; Kimura K, 1997, APPL ENVIRON MICROB, V63, P3394, DOI 10.1128/AEM.63.9.3394-3398.1997; Kimura K., 2010, Bioscience and Microflora, V29, P47; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Krause DO, 2003, MICROBIOL-SGM, V149, P57, DOI 10.1099/mic.0.25685-0; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Landete JM, 2007, FOOD CONTROL, V18, P1569, DOI 10.1016/j.foodcont.2006.12.008; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; LERCHE M., 1960, ZENTRALBL BAKT PARASITENK INFEKTIONS KRANKH U HYG, V179, P354; Letran SE, 2011, J IMMUNOL, V186, P5406, DOI 10.4049/jimmunol.1003576; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; de Lucena BTL, 2012, J BACTERIOL, V194, P3018, DOI 10.1128/JB.00446-12; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; McCracken A, 2000, ARCH MICROBIOL, V173, P383, DOI 10.1007/s002030000159; Morishita T, 1999, J DAIRY SCI, V82, P1897, DOI 10.3168/jds.S0022-0302(99)75424-X; Naser SM, 2006, INT J SYST EVOL MICR, V56, P1681, DOI 10.1099/ijs.0.64229-0; PEEL M, 1988, J GEN MICROBIOL, V134, P2171; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rodas AM, 2006, INT J SYST EVOL MICR, V56, P513, DOI 10.1099/ijs.0.63877-0; Saad N, 2009, J MICROBIOL BIOTECHN, V19, P1635, DOI 10.4014/jmb.0902.0102; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Seto A, 2006, APPL MICROBIOL BIOT, V73, P915, DOI 10.1007/s00253-006-0515-2; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Sitaraman SV, 2005, AM J PHYSIOL-GASTR L, V288, pG403, DOI 10.1152/ajpgi.00357.2004; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Snyder LAS, 2009, TRENDS MICROBIOL, V17, P1, DOI 10.1016/j.tim.2008.10.002; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Stsepetova J, 2011, BRIT J NUTR, V105, P1235, DOI 10.1017/S0007114510004770; Sun Z, 2012, APPL MICROBIOL BIOTE; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Tanasupawat S, 2000, INT J SYST EVOL MICR, V50, P1479, DOI 10.1099/00207713-50-4-1479; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Torriani S, 1996, INT J SYST BACTERIOL, V46, P1158, DOI 10.1099/00207713-46-4-1158; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walter J, 2005, PROBIOTICS AND PREBIOTICS: SCIENTIFIC ASPECTS, P51; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Yin QQ, 2005, J BIOSCI BIOENG, V99, P68, DOI 10.1263/jbb.99.68; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Yuan JH, 2010, P NATL ACAD SCI USA, V107, P12846, DOI 10.1073/pnas.1007333107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou KF, 2012, J STRUCT BIOL, V177, P402, DOI 10.1016/j.jsb.2011.12.002	84	48	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40592	10.1371/journal.pone.0040592	http://dx.doi.org/10.1371/journal.pone.0040592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808200	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500062
J	Chen, JW; Shao, PF; Cao, Q; Li, P; Li, J; Cai, HZ; Zhu, J; Wang, ML; Zhang, ZD; Qin, C; Yin, CJ				Chen, Jiawei; Shao, Pengfei; Cao, Qiang; Li, Pu; Li, Jie; Cai, Hongzhou; Zhu, Jian; Wang, Meilin; Zhang, Zhengdong; Qin, Chao; Yin, Changjun			Genetic Variations in a PTEN/AKT/mTOR Axis and Prostate Cancer Risk in a Chinese Population	PLOS ONE			English	Article							ACTIVATED MAMMALIAN TARGET; SIGNALING PATHWAY; CISPLATIN RESISTANCE; 3-KINASE/AKT/MAMMALIAN TARGET; PI3K-AKT-MTOR PATHWAY; OVARIAN-CANCER; RAPAMYCIN; PTEN; AKT; EXPRESSION	Backgroud: Genetic variations in a PTEN/AKT/mTOR signaling axis may influence cellular functions including cell growth, proliferation and apoptosis, and then increase the individual's risk of cancer. Accordingly, we explore the association between single nucleotide polymorphisms (SNPs) of these genes and prostate cancer (PCa) in our Chinese population. Methods: Subjects were recruited from 666 PCa patients and 708 cancer-free controls, and eight SNPs in the PTEN/AKT/mTOR axis were determined by the TaqMan assay. Odds ratios (OR) and 95% confidence intervals (95% CI) were evaluated by logistic regression. Results: We observed significant associations between PCa risk and mTOR rs2295080 [P = 0.027, OR = 0.85, 95% CI = 0.74-0.98], and AKT2 rs7254617 (P = 0.003, OR = 1.35, 95% CI = 1.11-1.64). When estimated these two SNPs together, the combined genotypes with 2-4 risk alleles (rs2295080 T and rs7254617 A alleles) were associated with an increased risk of PCa compared with 0-1 risk alleles, which was more pronounced among subgroups of age >71 years, smokers, drinkers and no family history of cancer. Results of stratified analyses by cliniopathological parameters revealed that the frequencies of the combined genotypes with 2-4 risk alleles in advanced stage were significantly higher than in localized stage(P = 0.022), but there was no significant association in Gleason score and PSA level. Conclusion: Our results indicate, for the first time that the two variants in AKT2 and mTOR, particularly the joint genotypes with 2-4 risk alleles may influence PCa susceptibility and progression in Chinese, and the association appeared to be more strong in the subgroup of smokers and drinkers.	[Chen, Jiawei; Shao, Pengfei; Cao, Qiang; Li, Pu; Li, Jie; Cai, Hongzhou; Zhu, Jian; Qin, Chao; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Chen, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	urology_qinchao@163.com; drcjyin@gmail.com	Cao, Qiang/K-2349-2019; zhang, zheng/HCH-9684-2022	Cai, Hongzhou/0000-0001-6915-564X	Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines; National Natural Science Foundation of China [81171963, 81102089]; Natural Science Foundation of Jiangsu Province [BK2008473, BK2011773]	Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines, by the National Natural Science Foundation of China [grant number 81171963 and 81102089] and Jiangsu Province and the Natural Science Foundation of Jiangsu Province [grant number BK2008473 and BK2011773]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedolla R, 2007, CLIN CANCER RES, V13, P3860, DOI 10.1158/1078-0432.CCR-07-0091; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Campa D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016914; Chen M, 2010, CARCINOGENESIS, V31, P1387, DOI 10.1093/carcin/bgq110; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Chen Wong L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P575, DOI 10.2174/156801105774574649; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cui XJ, 2003, MOL ENDOCRINOL, V17, P575, DOI 10.1210/me.2002-0318; Dai B, 2009, BJU INT, V104, P1009, DOI 10.1111/j.1464-410X.2009.08538.x; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Dianat SS, 2009, BJU INT, V104, P1560, DOI 10.1111/j.1464-410X.2009.08973.x; Faried LS, 2008, MOL CARCINOGEN, V47, P446, DOI 10.1002/mc.20402; Faried LS, 2006, ONCOL REP, V16, P57; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Granville CA, 2006, CLIN CANCER RES, V12, P679, DOI 10.1158/1078-0432.CCR-05-1654; Haiman CA, 2006, CANCER EPIDEM BIOMAR, V15, P1021, DOI 10.1158/1055-9965.EPI-05-0896; Hartmann W, 2009, CLIN CANCER RES, V15, P4538, DOI 10.1158/1078-0432.CCR-08-2878; Hou GQ, 2007, CANCER LETT, V253, P236, DOI 10.1016/j.canlet.2007.01.026; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim JG, 2011, ONCOLOGY, V79, P278; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Lacey JV, 2011, GYNECOL ONCOL, V120, P167, DOI 10.1016/j.ygyno.2010.10.016; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liao YD, 2003, INT J CANCER, V107, P676, DOI 10.1002/ijc.11471; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Shao PF, 2011, PROSTATE, V71, P1122, DOI 10.1002/pros.21328; Shimizu Y, 2007, BJU INT, V100, P685, DOI 10.1111/j.1464-410X.2007.07014.x; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vogiatzi P, 2009, DRUG NEWS PERSPECT, V22, P593, DOI [10.1358/dnp.2009.22.10.1443392, 10.1358/dnp.2009.10.1428872]; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Wang Y, 2008, ONCOGENE, V27, P7106, DOI 10.1038/onc.2008.318; Wu LC, 2005, CANCER RES, V65, P2825, DOI 10.1158/0008-5472.CAN-04-3137; Wu X, 2004, BJU INT, V93, P143, DOI 10.1111/j.1464-410X.2004.04574.x; Xu B, 2011, UROL INT, V85, P401; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zheng J, 2011, PROSTATE; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	53	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40817	10.1371/journal.pone.0040817	http://dx.doi.org/10.1371/journal.pone.0040817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815832	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900053
J	de Souza, DA; Toso, VD; Campos, MRD; Lara, VS; Oliver, C; Jamur, MC				de Souza, Devandir Antonio, Jr.; Toso, Vanina Danuza; de Cassia Campos, Maria Rita; Lara, Vanessa Soares; Oliver, Constance; Jamur, Maria Celia			Expression of Mast Cell Proteases Correlates with Mast Cell Maturation and Angiogenesis during Tumor Progression	PLOS ONE			English	Article							INTEGRIN ALPHA(V)BETA(3); POOR-PROGNOSIS; TRYPTASE; DENSITY; ACTIVATION; PERITONEAL; INDUCTION; CARCINOMA; MEDIATORS; EXHIBIT	Tumor cells are surrounded by infiltrating inflammatory cells, such as lymphocytes, neutrophils, macrophages, and mast cells. A body of evidence indicates that mast cells are associated with various types of tumors. Although role of mast cells can be directly related to their granule content, their function in angiogenesis and tumor progression remains obscure. This study aims to understand the role of mast cells in these processes. Tumors were chemically induced in BALB/c mice and tumor progression was divided into Phases I, II and III. Phase I tumors exhibited a large number of mast cells, which increased in phase II and remained unchanged in phase III. The expression of mouse mast cell protease (mMCP)-4, mMCP-5, mMCP-6, mMCP-7, and carboxypeptidase A were analyzed at the 3 stages. Our results show that with the exception of mMCP-4 expression of these mast cell chymase (mMCP-5), tryptases (mMCP-6 and 7), and carboxypeptidase A (mMC-CPA) increased during tumor progression. Chymase and tryptase activity increased at all stages of tumor progression whereas the number of mast cells remained constant from phase II to III. The number of new blood vessels increased significantly in phase I, while in phases II and III an enlargement of existing blood vessels occurred. In vitro, mMCP-6 and 7 are able to induce vessel formation. The present study suggests that mast cells are involved in induction of angiogenesis in the early stages of tumor development and in modulating blood vessel growth in the later stages of tumor progression.	[de Souza, Devandir Antonio, Jr.; Toso, Vanina Danuza; de Cassia Campos, Maria Rita; Oliver, Constance; Jamur, Maria Celia] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil; [Lara, Vanessa Soares] Univ Sao Paulo, Fac Odontol Bauru, Dept Estomatol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	de Souza, DA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil.	mjamur@fmrp.usp.br	Jamur, Maria Celia/L-5520-2016; Lara, Vanessa S/B-9197-2012	Jamur, Maria Celia/0000-0001-7065-8543; Lara, Vanessa S/0000-0003-1986-0003	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [141722/2007-0, 302778/2008-0]; FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo) [07/54231-2]; FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia)	Funding was provided by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br); pre-doctoral fellowship 141722/2007-0 to DASJ and individual fellowship 302778/2008-0 to MCJ), FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo, http://www.fapesp.br/,; individual grant 07/54231-2 to MCJ) and FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia, http://www.faepa.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2003, INT ARCH ALLERGY IMM, V130, P216, DOI 10.1159/000069515; Bachmann IM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-362; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Brown JK, 2002, AM J PHYSIOL-LUNG C, V282, pL197, DOI 10.1152/ajplung.2002.282.2.L197; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dundar E, 2008, J INT MED RES, V36, P88, DOI 10.1177/147323000803600112; Elpek GO, 2001, J CLIN PATHOL, V54, P940, DOI 10.1136/jcp.54.12.940; FAWCETT DW, 1955, ANAT REC, V121, P29, DOI 10.1002/ar.1091210104; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Fiorucci L, 2004, CELL MOL LIFE SCI, V61, P1278, DOI 10.1007/s00018-004-3400-0; Gasparini G, 1998, CLIN CANCER RES, V4, P2625; GRUBER BL, 1995, BLOOD, V86, P2488; Guidolin D, 2009, CANCER LETT, V273, P80, DOI 10.1016/j.canlet.2008.07.032; HARTVEIT F, 1981, J PATHOL, V134, P7, DOI 10.1002/path.1711340103; Henningsson F, 2005, J CELL SCI, V118, P2035, DOI 10.1242/jcs.02333; Henningsson F, 2003, BIOL CHEM, V384, P1527, DOI 10.1515/BC.2003.169; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Imamura T, 1996, LAB INVEST, V74, P861; Jamur Maria Celia, 2011, Front Biosci (Schol Ed), V3, P1390; Jamur MC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-32; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; Lilla JN, 2010, DEV BIOL, V337, P124, DOI 10.1016/j.ydbio.2009.10.021; Lundequist A, 2004, CELL MOL LIFE SCI; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MENDONCA VO, 1986, CELL TISSUE RES, V243, P635; Nienartowicz A, 2006, MED SCI MONITOR, V12, pRA53; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; Ribatti D, 2000, INT J CANCER, V85, P171, DOI 10.1002/(SICI)1097-0215(20000115)85:2<171::AID-IJC4>3.0.CO;2-W; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Ribatti D, 1999, BRIT J CANCER, V79, P451, DOI 10.1038/sj.bjc.6690070; Ribatti D, 2003, EUR J CLIN INVEST, V33, P420, DOI 10.1046/j.1365-2362.2003.01152.x; Ribatti D, 2001, BRIT J HAEMATOL, V115, P514, DOI 10.1046/j.1365-2141.2001.03202.x; Ribatti D, 2010, BIOCH BIOPHYS ACTA; Ribatti D, 2011, ADV EXP MED BIOL, V716, P270, DOI 10.1007/978-1-4419-9533-9_14; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; Sommerhoff CP, 2001, AM J RESP CRIT CARE, V164, pS52, DOI 10.1164/ajrccm.164.supplement_2.2106058; Stevens RL, 1996, FASEB J, V10; Sundberg JP, 1997, MOL CARCINOGEN, V20, P19, DOI 10.1002/(SICI)1098-2744(199709)20:1<19::AID-MC4>3.0.CO;2-D; Temkin V, 2002, J IMMUNOL, V169, P2662, DOI 10.4049/jimmunol.169.5.2662; Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041; Tomita M, 2000, ANN THORAC SURG, V69, P1686, DOI 10.1016/S0003-4975(00)01160-7; Tuna B, 2006, EUR UROL, V50, P530, DOI 10.1016/j.eururo.2005.12.040; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weller CL, 2011, CLIN SCI, V120, P473, DOI 10.1042/CS20100459; Yano H, 1999, INT J CANCER, V82, P665, DOI 10.1002/(SICI)1097-0215(19990827)82:5&lt;665::AID-IJC8&gt;3.0.CO;2-E	52	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40790	10.1371/journal.pone.0040790	http://dx.doi.org/10.1371/journal.pone.0040790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815822	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900051
J	Flynn, R; Labrie-Dion, E; Bernier, N; Colicos, MA; De Koninck, P; Zamponi, GW				Flynn, Robyn; Labrie-Dion, Etienne; Bernier, Nikolas; Colicos, Michael A.; De Koninck, Paul; Zamponi, Gerald W.			Activity-Dependent Subcellular Cotrafficking of the Small GTPase Rem2 and Ca2+/CaM-Dependent Protein Kinase II alpha	PLOS ONE			English	Article							CALCIUM-CHANNEL ACTIVITY; SYNAPTIC STRENGTH; BINDING PROTEINS; CAMKII; GEM; RAD; CALMODULIN; CYTOSKELETON; FAMILY; BRAIN	Background: Rem2 is a small monomeric GTP-binding protein of the RGK family, whose known functions are modulation of calcium channel currents and alterations of cytoskeletal architecture. Rem2 is the only RGK protein found predominantly in the brain, where it has been linked to synaptic development. We wished to determine the effect of neuronal activity on the subcellular distribution of Rem2 and its interacting partners. Results: We show that Rem2 undergoes activity-and N-Methyl-D-Aspartate Receptor (NMDAR)-dependent translocation in rat hippocampal neurons. This redistribution of Rem2, from a diffuse pattern to one that is highly punctate, is dependent on Ca2+ influx, on binding to calmodulin (CaM), and also involves an auto-inhibitory domain within the Rem2 distal C-terminus region. We found that Rem2 can bind to Ca2+/CaM-dependent protein kinase II alpha (CaMKII) a in Ca2+/CaM-dependent manner. Furthermore, our data reveal a spatial and temporal correlation between NMDAR-dependent clustering of Rem2 and CaMKII in neurons, indicating co-assembly and co-trafficking in neurons. Finally, we show that inhibiting CaMKII aggregation in neurons and HEK cells reduces Rem2 clustering, and that Rem2 affects the baseline distribution of CaMKII in HEK cells. Conclusions: Our data suggest a novel function for Rem2 in co-trafficking with CaMKII, and thus potentially expose a role in neuronal plasticity.	[Flynn, Robyn; Colicos, Michael A.; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Labrie-Dion, Etienne; Bernier, Nikolas; De Koninck, Paul] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	University of Calgary; Laval University; Laval University	Flynn, R (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by operating grants to GWZ, MAC, and PDK from the Canadian Institutes of Health Research (CIHR), and funding from the Heart and Stroke Foundation of Alberta, the Northwest Territories and Nunavut. RF held a studentship award from the Alberta Heritage Foundation for Medical Research (AHFMR). MAC is an AHFMR Scholar, GWZ is and AHFMR Scientist and a Canada Research Chair, and PDK was a CIHR career awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresta S, 2002, BIOCHEM J, V367, P57, DOI 10.1042/BJ20020829; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Bilan PJ, 1998, EXP CELL RES, V242, P391, DOI 10.1006/excr.1998.4092; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Crump SM, 2006, AM J PHYSIOL-HEART C, V291, pH1959, DOI 10.1152/ajpheart.00956.2005; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fan M, 2010, P NATL ACAD SCI US; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Goda Y, 2006, NAT PROTOC, V1, P461, DOI 10.1038/nprot.2006.67; Gutierrez RC, 2009, EUR J NEUROSCI, V30, P2042, DOI 10.1111/j.1460-9568.2009.07007.x; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Jourdain P, 2003, J NEUROSCI, V23, P10645; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Pan JY, 2000, J CELL BIOL, V149, P1107, DOI 10.1083/jcb.149.5.1107; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Piddini E, 2001, EMBO J, V20, P4076, DOI 10.1093/emboj/20.15.4076; Sanabria H, 2009, J BIOL CHEM, V284, P9770, DOI 10.1074/jbc.M809518200; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41185	10.1371/journal.pone.0041185	http://dx.doi.org/10.1371/journal.pone.0041185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815963	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900092
J	Goncalves, RLS; Oliveira, JHM; Oliveira, GA; Andersen, JF; Oliveira, MF; Oliveira, PL; Barillas-Mury, C				Goncalves, Renata L. S.; Oliveira, Jose Henrique M.; Oliveira, Giselle A.; Andersen, John F.; Oliveira, Marcus F.; Oliveira, Pedro L.; Barillas-Mury, Carolina			Mitochondrial Reactive Oxygen Species Modulate Mosquito Susceptibility to Plasmodium Infection	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; ANOPHELES-GAMBIAE; UNCOUPLING PROTEIN-2; HYDROGEN-PEROXIDE; IMMUNE-RESPONSES; MIDGUT CELLS; KAPPA-B; OXIDASE; CARRIER; BERGHEI	Background: Mitochondria perform multiple roles in cell biology, acting as the site of aerobic energy-transducing pathways and as an important source of reactive oxygen species (ROS) that modulate redox metabolism. Methodology/Principal Findings: We demonstrate that a novel member of the mitochondrial transporter protein family, Anopheles gambiae mitochondrial carrier 1 (AgMC1), is required to maintain mitochondrial membrane potential in mosquito midgut cells and modulates epithelial responses to Plasmodium infection. AgMC1 silencing reduces mitochondrial membrane potential, resulting in increased proton-leak and uncoupling of oxidative phosphorylation. These metabolic changes reduce midgut ROS generation and increase A. gambiae susceptibility to Plasmodium infection. Conclusion: We provide direct experimental evidence indicating that ROS derived from mitochondria can modulate mosquito epithelial responses to Plasmodium infection.	[Goncalves, Renata L. S.; Oliveira, Jose Henrique M.; Oliveira, Giselle A.; Andersen, John F.; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Goncalves, Renata L. S.; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Resposta Estresse, Rio De Janeiro, Brazil; [Oliveira, Jose Henrique M.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Artropodes Hematofagos, Rio De Janeiro, Brazil; [Goncalves, Renata L. S.; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Inflamacao & Metab, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Goncalves, RLS (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	cbarillas@niaid.nih.gov	Oliveira, Marcus/G-3158-2011; L. Oliveira, Pedro/A-9438-2010	Oliveira, Marcus/0000-0002-9890-8425; L. Oliveira, Pedro/0000-0003-0307-354X; Oliveira, Giselle/0000-0002-5898-7843; Oliveira, Jose Henrique M./0000-0003-3814-5312	National Institutes of Health, United States of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000947] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the intramural program of the National Institutes of Health, United States of America, there are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2011, FREE RADICAL BIO MED, V50, P609, DOI 10.1016/j.freeradbiomed.2010.12.020; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; CHANCE B, 1955, J BIOL CHEM, V217, P409; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Ishida I, 2002, J IMMUNOL, V169, P2069, DOI 10.4049/jimmunol.169.4.2069; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Jaramillo-Gutierrez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011168; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Oliveira JHM, 2011, INSECT BIOCHEM MOLEC, V41, P349, DOI 10.1016/j.ibmb.2011.02.001; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yu XX, 2001, BIOCHEM J, V353, P369, DOI 10.1042/bj3530369; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	47	24	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41083	10.1371/journal.pone.0041083	http://dx.doi.org/10.1371/journal.pone.0041083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815925	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900074
J	Reichard, M; Spence, R; Bryjova, A; Bryja, J; Smith, C				Reichard, Martin; Spence, Rowena; Bryjova, Anna; Bryja, Josef; Smith, Carl			Female Rose Bitterling Prefer MHC-Dissimilar Males: Experimental Evidence	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATE CHOICE; SEXUAL SELECTION; GOOD GENES; REPRODUCTIVE SUCCESS; EVOLUTION; COMPATIBILITY; POLYANDRY; ZEBRAFISH; CONFLICT	The role of genetic benefits in female mate choice remains a controversial aspect of sexual selection theory. In contrast to "good allele" models of sexual selection, "compatible allele" models of mate choice predict that females prefer mates with alleles complementary to their own rather than conferring additive effects. While correlative results suggest complementary genetic effects to be plausible, direct experimental evidence is scarce. A previous study on the Chinese rose bitterling (Rhodeus ocellatus) demonstrated a positive correlation between female mate choice, offspring growth and survival, and the functional dissimilarity between the Major Histocompatibility Complex (MHC) alleles of males and females. Here we directly tested whether females used cues associated with MHC genes to select genetically compatible males in an experimental framework. By sequentially pairing females with MHC similar and dissimilar males, based on a priori known MHC profiles, we showed that females discriminated between similar and dissimilar males and deposited significantly more eggs with MHC dissimilar males. Notably, the degree of dissimilarity was an important factor for female decision to mate, possibly indicating a potential threshold value of dissimilarity for decision making, or of an indirect effect of the MHC.	[Reichard, Martin; Bryjova, Anna; Bryja, Josef] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Spence, Rowena; Smith, Carl] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of St Andrews	Reichard, M (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic.	reichard@ivb.cz	Bryja, Josef/C-3013-2008; Reichard, Martin/C-6563-2009; Smith, Carl/A-2254-2015	Bryja, Josef/0000-0003-0516-7742; Reichard, Martin/0000-0002-9306-0074; Smith, Carl/0000-0003-3285-0379	Czech Science Foundation [206/08/1163]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by Czech Science Foundation 206/08/1163. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbali M., 2011, THESIS U ST ANDREWS; Agbali M, 2010, EVOLUTION, V64, P1683, DOI 10.1111/j.1558-5646.2010.00961.x; Andersson Malte, 1994; Barton K, 2012, PACKAGE MUMIN 1 7 7; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bryja J, 2005, MOL ECOL NOTES, V5, P173, DOI 10.1111/j.1471-8286.2004.00855.x; Casalini M, 2009, EVOLUTION, V63, P366, DOI 10.1111/j.1558-5646.2008.00555.x; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Crawley M.J., 2007, R BOOK; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Eizaguirre C, 2011, EVOL ECOL, V25, P605, DOI 10.1007/s10682-010-9424-z; Eizaguirre C, 2009, ECOL LETT, V12, P5, DOI 10.1111/j.1461-0248.2008.01247.x; Forsberg LA, 2007, J EVOLUTION BIOL, V20, P1859, DOI 10.1111/j.1420-9101.2007.01380.x; Gerlach G, 2008, P ROY SOC B-BIOL SCI, V275, P2165, DOI 10.1098/rspb.2008.0647; Griggio M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-44; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Kanoh Y, 2000, ENVIRON BIOL FISH, V57, P143, DOI 10.1023/A:1004585405848; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Lenz TL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-269; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Mills SC, 2002, ANIM BEHAV, V63, P1029, DOI 10.1006/anbe.2001.1988; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Oliver M, 2010, MOL ECOL, V19, P4099, DOI 10.1111/j.1365-294X.2010.04812.x; Ottova E, 2005, FISH SHELLFISH IMMUN, V18, P199, DOI 10.1016/j.fsi.2004.07.004; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Pialek J, 2005, TRENDS ECOL EVOL, V20, P63, DOI 10.1016/j.tree.2004.11.018; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Puurtinen M, 2005, TRENDS ECOL EVOL, V20, P157, DOI 10.1016/j.tree.2005.02.005; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Rosenthal GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016994; Sambrook JG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-152; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Santos PSC, 2010, IMMUNOGENETICS, V62, P569, DOI 10.1007/s00251-010-0468-6; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Setchell JM, 2011, P ROY SOC B-BIOL SCI, V278, P274, DOI 10.1098/rspb.2010.0571; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Smith C, 2007, J FISH BIOL, V71, P1841, DOI 10.1111/j.1095-8649.2007.01624.x; Smith C, 2005, P ROY SOC B-BIOL SCI, V272, P1683, DOI 10.1098/rspb.2005.3140; Smith C, 2004, J ZOOL, V262, P107, DOI 10.1017/S0952836903004497; WAKELAND EK, 1990, IMMUNOL RES, V9, P115, DOI 10.1007/BF02918202; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; Yamazaki K, 2007, ADV GENET, V59, P129, DOI 10.1016/S0065-2660(07)59005-X; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	52	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40780	10.1371/journal.pone.0040780	http://dx.doi.org/10.1371/journal.pone.0040780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815816	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900047
J	Wessman, J; Schonauer, S; Miettunen, J; Turunen, H; Parviainen, P; Seppanen, JK; Congdon, E; Service, S; Koiranen, M; Ekelund, J; Laitinen, J; Taanila, A; Tammelin, T; Hintsanen, M; Pulkki-Raback, L; Keltikangas-Jarvinen, L; Viikari, J; Raitakari, OT; Joukamaa, M; Jarvelin, MR; Freimer, N; Peltonen, L; Veijola, J; Mannila, H; Paunio, T				Wessman, Jaana; Schonauer, Stefan; Miettunen, Jouko; Turunen, Hannu; Parviainen, Pekka; Seppanen, Jouni K.; Congdon, Eliza; Service, Susan; Koiranen, Markku; Ekelund, Jesper; Laitinen, Jaana; Taanila, Anja; Tammelin, Tuija; Hintsanen, Mirka; Pulkki-Raback, Laura; Keltikangas-Jarvinen, Liisa; Viikari, Jorma; Raitakari, Olli T.; Joukamaa, Matti; Jarvelin, Marjo-Riitta; Freimer, Nelson; Peltonen, Leena; Veijola, Juha; Mannila, Heikki; Paunio, Tiina			Temperament Clusters in a Normal Population: Implications for Health and Disease	PLOS ONE			English	Article							GENETIC-STRUCTURE; PERSONALITY; DIMENSIONS; CHARACTER; DEPRESSION; DISORDERS; SYMPTOMS; SCHIZOPHRENIA; VALIDATION; PROFILES	Background: The object of this study was to identify temperament patterns in the Finnish population, and to determine the relationship between these profiles and life habits, socioeconomic status, and health. Methods/Principal Findings: A cluster analysis of the Temperament and Character Inventory subscales was performed on 3,761 individuals from the Northern Finland Birth Cohort 1966 and replicated on 2,097 individuals from the Cardiovascular Risk in Young Finns study. Clusters were formed using the k-means method and their relationship with 115 variables from the areas of life habits, socioeconomic status and health was examined. Results: Four clusters were identified for both genders. Individuals from Cluster I are characterized by high persistence, low extravagance and disorderliness. They have healthy life habits, and lowest scores in most of the measures for psychiatric disorders. Cluster II individuals are characterized by low harm avoidance and high novelty seeking. They report the best physical capacity and highest level of income, but also high rate of divorce, smoking, and alcohol consumption. Individuals from Cluster III are not characterized by any extreme characteristic. Individuals from Cluster IV are characterized by high levels of harm avoidance, low levels of exploratory excitability and attachment, and score the lowest in most measures of health and well-being. Conclusions: This study shows that the temperament subscales do not distribute randomly but have an endogenous structure, and that these patterns have strong associations to health, life events, and well-being.	[Wessman, Jaana; Schonauer, Stefan; Parviainen, Pekka] Univ Helsinki, Helsinki Inst Informat Technol, Helsinki, Finland; [Wessman, Jaana; Schonauer, Stefan; Parviainen, Pekka] Univ Helsinki, Dept Comp Sci, Helsinki, Finland; [Wessman, Jaana; Turunen, Hannu; Ekelund, Jesper; Peltonen, Leena; Paunio, Tiina] Inst Mol Med Finland, Helsinki, Finland; [Wessman, Jaana; Turunen, Hannu; Ekelund, Jesper; Peltonen, Leena; Paunio, Tiina] Natl Inst Hlth & Welf, Helsinki, Finland; [Seppanen, Jouni K.; Mannila, Heikki] Aalto Univ, Helsinki Inst Informat Technol, Espoo, Finland; [Seppanen, Jouni K.; Mannila, Heikki] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland; [Congdon, Eliza; Service, Susan; Freimer, Nelson] Univ Calif Los Angeles, Univ Calif Angeles Ctr Neurobehav Genet, Los Angeles, CA USA; [Koiranen, Markku] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Ekelund, Jesper] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland; [Laitinen, Jaana; Tammelin, Tuija] Finnish Inst Occupat Hlth, Helsinki, Finland; [Taanila, Anja] Univ Hosp, Unit Gen Practice, Oulu, Finland; [Tammelin, Tuija] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Hintsanen, Mirka; Pulkki-Raback, Laura; Keltikangas-Jarvinen, Liisa; Jarvelin, Marjo-Riitta] Univ Helsinki, Dept Psychol, Helsinki, Finland; [Viikari, Jorma] Univ Turku, Cent Hosp, Dept Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Cent Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Joukamaa, Matti] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Joukamaa, Matti] Tampere Univ Hosp, Dept Psychiat, Tampere, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Miettunen, Jouko; Veijola, Juha] Univ Oulu, Dept Psychiat, Oulu, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Aalto University; University of Helsinki; Aalto University; University of California System; University of California Los Angeles; University of Oulu; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health; University of Helsinki; University of Turku; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; Imperial College London; Wellcome Trust Sanger Institute; University of Helsinki; University of Oulu	Wessman, J (corresponding author), Univ Helsinki, Helsinki Inst Informat Technol, Helsinki, Finland.	tiina.paunio@thl.fi	Miettunen, Jouko/AAC-4334-2019; Ekelund, Jesper/D-6655-2013; Raitakari, Olli/AAQ-7389-2021; Hintsanen, Mirka/B-6012-2008	Miettunen, Jouko/0000-0003-0575-2669; Hintsanen, Mirka/0000-0003-2673-0901; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	National Institutes of Health (NIH) (NIH Roadmap) [UL1-DE019580, RL1MH083268]; NIH/National Institute of Neurological Disorders and Stroke [T32 NS048004]; Brain & Behavior Research Foundation: Brain and Behavior Research Fund; Academy of Finland [125853]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	National Institutes of Health (NIH) (NIH Roadmap)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Brain & Behavior Research Foundation: Brain and Behavior Research Fund; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by research grants from the National Institutes of Health (NIH) (NIH Roadmap grants for the Consortium for Neuropsychiatric Phenomics, UL1-DE019580 and RL1MH083268, for EC, SS, NBF; an NIH/National Institute of Neurological Disorders and Stroke training grant T32 NS048004: NBF, PI, for EC); the The Brain & Behavior Research Foundation: Brain and Behavior Research Fund (Independent Investigator Award to JM); and a grant from the Academy of Finland (#125853 for JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114; Ando J, 2002, J PERS, V70, P583; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Battaglia M, 1996, COMPR PSYCHIAT, V37, P292, DOI 10.1016/S0010-440X(96)90008-5; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Crockett LJ, 2006, DEV PSYCHOPATHOL, V18, P195, DOI 10.1017/S0954579406060111; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; ECKBLAD M, 1986, J ABNORM PSYCHOL, V95, P214, DOI 10.1037/0021-843X.95.3.214; Elovainio M, 2004, J AFFECT DISORDERS, V83, P227, DOI 10.1016/j.jad.2004.06.005; Engstrom C, 2004, J AFFECT DISORDERS, V82, P131, DOI 10.1016/j.jad.2003.09.004; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Fassino S, 2002, INT J EAT DISORDER, V32, P412, DOI 10.1002/eat.10099; Gillespie NA, 2003, PERS INDIV DIFFER, V35, P1931, DOI 10.1016/S0191-8869(03)00042-4; GOLDEN RR, 1979, J ABNORM PSYCHOL, V88, P217, DOI 10.1037/0021-843X.88.3.217; Haapea M, 2008, SCAND J PUBLIC HEALT, V36, P728, DOI 10.1177/1403494808092250; HEATH AC, 1994, J PERS SOC PSYCHOL, V66, P762, DOI 10.1037/0022-3514.66.4.762; Herbst JH, 2000, AM J PSYCHIAT, V157, P1285, DOI 10.1176/appi.ajp.157.8.1285; Janson H, 2008, DEV PSYCHOL, V44, P1314, DOI 10.1037/a0012713; Joukamaa M, 2001, NORD J PSYCHIAT, V55, P123, DOI 10.1080/08039480151108561; Jylha P, 2006, EUR PSYCHIAT, V21, P389, DOI 10.1016/j.eurpsy.2005.09.003; Keltikangas-Jarvinen L, 1999, ARTERIOSCLER THROMB, V19, P1988; Klump KL, 2004, PSYCHOL MED, V34, P1407, DOI 10.1017/S0033291704002442; Komsi N, 2006, INFANT BEHAV DEV, V29, P494, DOI 10.1016/j.infbeh.2006.05.002; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McLachlan G., 2000, WILEY SER PROB STAT; Meyer TD, 2003, PERS INDIV DIFFER, V35, P785, DOI 10.1016/S0191-8869(02)00283-0; Miettunen J, 2004, ACTA PSYCHIAT SCAND, V110, P150, DOI 10.1111/j.1600-0047.2004.00344.x; Miettunen J, 2008, PSYCHIAT RES, V160, P106, DOI 10.1016/j.psychres.2007.05.003; Miettunen J, 2007, COMPR PSYCHIAT, V48, P161, DOI 10.1016/j.comppsych.2006.10.007; Miettunen J, 2010, PSYCHIAT RES, V178, P408, DOI 10.1016/j.psychres.2008.07.022; Moilanen K, 2003, SOC PSYCH PSYCH EPID, V38, P305, DOI 10.1007/s00127-003-0638-z; Nyman E, 2011, J AFFECT DISORDERS, V131, P393, DOI 10.1016/j.jad.2010.12.008; Oliver JP, 2008, HDB PERSONALITY; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Rettew DC, J AM ACAD CHILD ADOL, V47, P273; Ritsner M, 2004, PSYCHIAT RES, V128, P219, DOI 10.1016/j.psychres.2004.06.007; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sintonen H., 1989, J SOC MED, V26, P85; Smith TW, 2006, ANNU REV CLIN PSYCHO, V2, P435, DOI 10.1146/annurev.clinpsy.2.022305.095257; Sovio U, 2007, J HEALTH PSYCHOL, V12, P371, DOI 10.1177/1359105307074301; Stallings MC, 1996, J PERS SOC PSYCHOL, V70, P127, DOI 10.1037/0022-3514.70.1.127; Veijola J, 2003, NORD J PSYCHIAT, V57, P119, DOI 10.1080/08039480310000941; Wessman J, 2009, BIOL PSYCHIAT, V66, P990, DOI 10.1016/j.biopsych.2009.05.034	50	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e33088	10.1371/journal.pone.0033088	http://dx.doi.org/10.1371/journal.pone.0033088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815673	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900001
J	Chen, CM; Wu, CT; Chiang, CK; Liao, BW; Liu, SH				Chen, Chang-Mu; Wu, Cheng-Tien; Chiang, Chih-Kang; Liao, Bor-Wu; Liu, Shing-Hwa			C/EBP Homologous Protein (CHOP) Deficiency Aggravates Hippocampal Cell Apoptosis and Impairs Memory Performance	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-REGULATED PROTEINS; TRANSCRIPTION FACTORS; DEATH; ACTIVATION; INDUCTION; ER; ADAPTATION; PATHWAY; FAMILY	Neurodegenerative disorders are growing burdens in modern societies because of increased life expectancy. Most neurodegenerative disorders commonly possess a similar neuropathological feature - the accumulation of abnormal protein aggregates or inclusions (misfolded proteins) in the brain. One of the main functions of endoplasmic reticulum (ER) is to initiate proper protein folding to facilitate protein secretion through the induction of unfolded protein response (UPR). C/EBP homologous protein (CHOP) induction has been demonstrated to be a signaling event underlying ER stress-induced cell apoptosis. In this study, we explored the role of CHOP in the hippocampal cell apoptosis and memory performance injury under an induced ER stress condition. Adult male wild type (C57BL/6J) and CHOP knockout (CHOP-/-) mice were intracerebroventricularly injected with tunicamycin. Tunicamycin can induce ER stress and cell apoptosis in mouse hippocampus. Compared with wild type mice, CHOP-/- mice showed an enhanced hippocampal cell apoptosis, worse performance in memory-related behavioral tests, and attenuated IRE-1 expression under tunicamycin treatment. The aggravated cell apoptosis and worse memory performance in CHOP-/- mice might be due to the deficiency of CHOP protein resulted in the impaired adaptive/pathological transcriptional response, the decreased IRE-1 and XBP-1 expressions, and the increased JNK phosphorylation to cope with ER stress. Taken together, these results suggest that CHOP may play a protective role in the hippocampal cell apoptosis and impairment of memory performance.	[Chen, Chang-Mu] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Wu, Cheng-Tien; Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Liao, Bor-Wu] Cardinal Tien Hosp, Yung Ho Branch, Dept Otolaryngol, New Taipei City, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Cardinal Tien Hospital	Chen, CM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan.	cmchen10@ms27.hinet.net; shinghwaliu@ntu.edu.tw	Wu, Cheng-Tien/ABE-9509-2022; Wu, Cheng-Tien/AAF-5177-2019	CHEN, CHANG-MU/0000-0002-7544-3856; LIU, SHING-HWA/0000-0002-9976-1197; CHIANG, CHIH-KANG/0000-0001-9021-4616	National Science Council of Taiwan [NSC97-2314-B-002-052-MY3]; National Taiwan University Hospital/Cardinal Tien Hospital [99-TYN05, 100-TYN05]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital/Cardinal Tien Hospital	This study was supported by grants from the National Science Council of Taiwan (NSC97-2314-B-002-052-MY3) and National Taiwan University Hospital/Cardinal Tien Hospital (99-TYN05) and (100-TYN05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Chen CM, 2010, BEHAV NEUROSCI, V124, P541, DOI 10.1037/a0020050; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lacour P, 2007, J NEUROSCI METH, V166, P24, DOI 10.1016/j.jneumeth.2007.06.019; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Taylor JP, 2002, CAN J DIET PRACT RES, V63, P198, DOI 10.3148/63.4.2002.198; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	27	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40801	10.1371/journal.pone.0040801	http://dx.doi.org/10.1371/journal.pone.0040801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815824	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100069
J	Hughes, AK; Cichacz, Z; Scheck, A; Coons, SW; Johnston, SA; Stafford, P				Hughes, Alexa K.; Cichacz, Zbigniew; Scheck, Adrienne; Coons, Stephen W.; Johnston, Stephen Albert; Stafford, Phillip			Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; GLIOBLASTOMA-MULTIFORME; B-CELLS; OVARIAN; IMMUNOSURVEILLANCE; IDENTIFICATION; RADIOTHERAPY; TEMOZOLOMIDE; METHYLATION; TOOLS	Immunosignaturing shows promise as a general approach to diagnosis. It has been shown to detect immunological signs of infection early during the course of disease and to distinguish Alzheimer's disease from healthy controls. Here we test whether immunosignatures correspond to clinical classifications of disease using samples from people with brain tumors. Blood samples from patients undergoing craniotomies for therapeutically naive brain tumors with diagnoses of astrocytoma (23 samples), Glioblastoma multiforme (22 samples), mixed oligodendroglioma/ astrocytoma (16 samples), oligodendroglioma (18 samples), and 34 otherwise healthy controls were tested by immunosignature. Because samples were taken prior to adjuvant therapy, they are unlikely to be perturbed by non-cancer related affects. The immunosignaturing platform distinguished not only brain cancer from controls, but also pathologically important features about the tumor including type, grade, and the presence or absence of O-6-methyl-guanine-DNA methyltransferase methylation promoter (MGMT), an important biomarker that predicts response to temozolomide in Glioblastoma multiformae patients.	[Hughes, Alexa K.; Cichacz, Zbigniew; Johnston, Stephen Albert; Stafford, Phillip] Arizona State Univ, Ctr Innovat Med, Biodesign Inst, Tempe, AZ 85287 USA; [Scheck, Adrienne; Coons, Stephen W.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA	Arizona State University; Arizona State University-Tempe; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Hughes, AK (corresponding author), Arizona State Univ, Ctr Innovat Med, Biodesign Inst, Tempe, AZ 85287 USA.	Phillip.Stafford@asu.edu	Scheck, Adrienne/AAH-5040-2020	Scheck, Adrienne/0000-0003-3497-1895	State of Arizona	State of Arizona	Funds come from startup to SAJ from the State of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Geijersstam V, 1998, J INFECT DIS, V177, P1710, DOI 10.1086/517428; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Balagurunathan Y, 2008, MOL CANCER THER, V7, P3071, DOI 10.1158/1535-7163.MCT-08-0402; Boltz KW, 2009, ANALYST, V134, P650, DOI 10.1039/b823156g; Brand RE, 2011, CLIN CANCER RES, V17, P805, DOI 10.1158/1078-0432.CCR-10-0248; Brown JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-349; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Chase BA, 2012, CLIN VACCINE IMMUNOL, V19, P352, DOI 10.1128/CVI.05667-11; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Cooperman J, 2004, STEM CELLS, V22, P1111, DOI 10.1634/stemcells.22-6-1111; Desmetz C, 2009, EXPERT REV PROTEOMIC, V6, P377, DOI 10.1586/EPR.09.56; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Fischer E, 2010, J IMMUNOL, V185, P3095, DOI 10.4049/jimmunol.0902166; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Halperin R, 2010, MOL CELLULAR PROTEOM, V28; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; Ishii D, 2007, NEUROL MED-CHIR, V47, P341, DOI 10.2176/nmc.47.341; Jemal A., 2010, CA-CANCER J CLIN, P20073, DOI DOI 10.3322/CAAC.20073; Kijanka G, 2009, J PROTEOMICS, V72, P936, DOI 10.1016/j.jprot.2009.02.006; Legutki JB, 2010, VACCINE, V28, P4529, DOI 10.1016/j.vaccine.2010.04.061; Lutz AM, 2011, RADIOLOGY, V259, P329, DOI 10.1148/radiol.11090563; Merbl Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006053; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Mou ZR, 2009, CANCER LETT, V278, P123, DOI 10.1016/j.canlet.2008.09.009; Nolen BM, 2011, CANCER BIOMARK, V10, P3, DOI 10.3233/CBM-2012-0229; Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8; Oyama T, 2003, CANCER LETT, V202, P219, DOI 10.1016/j.canlet.2003.08.011; Restrepo L, 2011, ANN NEUROL, V70, P286, DOI 10.1002/ana.22405; Smith KA, 2008, J NEUROSURG, V109, P106, DOI 10.3171/JNS/2008/109/12/S17; Sreekumar A, 2004, JNCI-J NATL CANCER I, V96, P834, DOI 10.1093/jnci/djh145; Stafford P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011593; Stafford P, 2011, EXPERT REV MOL DIAGN, V11, P5, DOI [10.1586/erm.10.113, 10.1586/ERM.10.113]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SULZER B, 1993, B MATH BIOL, V55, P1133, DOI 10.1007/BF02460702; Team RDC, 2005, R LANG ENV STAT COMP; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973	42	31	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40201	10.1371/journal.pone.0040201	http://dx.doi.org/10.1371/journal.pone.0040201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815729	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100030
J	Masquillier, C; Wouters, E; Loos, J; Nostlinger, C				Masquillier, Caroline; Wouters, Edwin; Loos, Jasna; Nostlinger, Christiana			Measuring Health-Related Quality of Life of HIV-Positive Adolescents in Resource-Constrained Settings	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CHILDREN; INFECTION; AIDS; DISCLOSURE; HIV/AIDS; SUPPORT; IMPACT	Background and Objectives: Access to antiretroviral treatment among adolescents living with HIV (ALH) is increasing. Health-related quality of life (HRQOL) is relevant for monitoring the impact of the disease on both well-being and treatment outcomes. However, adequate screening tools to assess HRQOL in low-resource settings are scarce. This study aims to fill this research gap, by 1) assessing the psychometric properties and reliability of an Eastern African English version of a European HRQOL scale for adolescents (KIDSCREEN) and 2) determining which version of the KIDSCREEN (52-, 27- and 10-item version) is most suitable for low-resource settings. Methods: The KIDSCREEN was translated into Eastern African English, Luganda (Uganda) and Dholuo (Kenya) according to standard procedures. The reconciled version was administered in 2011 to ALH aged 13-17 in Kenya (n = 283) and Uganda (n = 299). All three KIDSCREEN versions were fitted to the data with confirmatory factor analysis (CFA). After comparison, the most suitable version was adapted based on the CFA outcomes utilizing the results of previous formative research. In order to develop a general HRQOL factor, a second-order measurement model was fitted to the data. Results: The CFA results showed that without adjustments, the KIDSCREEN cannot be used for measuring the HRQOL of HIV-positive adolescents. After comparison, the most suitable version for low-resource settings - the 27-item version - was adapted further. The introduction of a negative wording factor was required for the Dholuo model. The Dholuo (CFI: 0.93; RMSEA: 0.039) and the Luganda model (CFI: 0.90; RMSEA: 0.052) showed a good fit. All cronbach's alphas of the factors were 0.70 or above. The alpha value of the Dholuo and Lugandan HRQOL second-order factor was respectively 0.84 and 0.87. Conclusions: The study showed that the adapted KIDSCREEN-27 is an adequate tool for measuring HRQOL in low-resource settings with high HIV prevalence.	[Masquillier, Caroline; Wouters, Edwin] Univ Antwerp, Res Ctr Longitudinal & Life Course Studies CELLO, Dept Sociol, B-2020 Antwerp, Belgium; [Loos, Jasna; Nostlinger, Christiana] Inst Trop Med, Dept Publ Hlth, ITM HIV AIDS Ctr, B-2000 Antwerp, Belgium	University of Antwerp; Institute of Tropical Medicine (ITM)	Masquillier, C (corresponding author), Univ Antwerp, Res Ctr Longitudinal & Life Course Studies CELLO, Dept Sociol, B-2020 Antwerp, Belgium.	Caroline.Masquillier@ua.ac.be	Loos, Jasna/GVS-6862-2022; Wouters, Edwin/AAE-1649-2021	Wouters, Edwin/0000-0003-2268-3829; Masquillier, Caroline/0000-0003-1748-5967	Dutch AIDS fonds; Belgian Development cooperation	Dutch AIDS fonds; Belgian Development cooperation	The funders, the Dutch AIDS fonds and the Belgian Development cooperation, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Birungi H, 2011, AGE, V15, P3530; Brown LK, 2000, J CHILD PSYCHOL PSYC, V41, P81, DOI 10.1111/1469-7610.00550; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; de Boer-van der Kolk IM, 2010, CLIN INFECT DIS, V50, P255, DOI 10.1086/649216; Garvie PA, 2009, CHILD CARE HLTH DEV, V35, P440, DOI 10.1111/j.1365-2214.2009.00985.x; Guedes Dartagnan Pinto, 2011, Rev. paul. pediatr., V29, P364; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Hong SD, 2007, J KOREAN MED SCI, V22, P446, DOI 10.3346/jkms.2007.22.3.446; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacquet A, 2011, QUALITY LIFE PATIENT; Lam PK, 2007, AIDS PATIENT CARE ST, V21, P20, DOI 10.1089/apc.2006.005; Lee GM, 2006, PEDIATRICS, V117, P273, DOI 10.1542/peds.2005-0323; Loos J, 2010, WE ARE ADOLESCENTS W; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Matza LS, 2004, VALUE HEALTH, V7, P79, DOI 10.1111/j.1524-4733.2004.71273.x; McCarthy EA, 2006, PLOS MED, V3, P989, DOI 10.1371/journal.pmed.0030304; Qidwai W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012914; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Sawyer SM, 2007, LANCET, V369, P1481, DOI 10.1016/S0140-6736(07)60370-5; Skevington SM, 2003, PSYCHOL HEALTH, V18, P331, DOI 10.1080/0887044031000084030; Solans M, 2008, VALUE HEALTH, V11, P742, DOI 10.1111/j.1524-4733.2007.00293.x; Spire B, 2008, J INT AIDS SOC, V11; UAC, 2006, ACC HIV PREV ROADM U; Unicef Unaids Unfpa Ilo Who, 2011, OPP CRIS PREV HIV EA; Vandenhoudt H, 2010, BASELINE STUDY PROCE; Wilson CM, 2010, JAIDS-J ACQ IMM DEF, V54, pS5, DOI 10.1097/QAI.0b013e3181e243a1; Wouters E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034881	31	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40628	10.1371/journal.pone.0040628	http://dx.doi.org/10.1371/journal.pone.0040628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974VS	22815776	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100047
J	She, HC; Jung, TP; Chou, WC; Huang, LY; Wang, CY; Lin, GY				She, Hsiao-Ching; Jung, Tzyy-Ping; Chou, Wen-Chi; Huang, Li-Yu; Wang, Chia-Yu; Lin, Guan-Yu			EEG Dynamics Reflect the Distinct Cognitive Process of Optic Problem Solving	PLOS ONE			English	Article							WORKING-MEMORY TASK; UPPER ALPHA OSCILLATIONS; THETA-OSCILLATIONS; MENTAL ACTIVITY; SYNCHRONIZATION; CORTEX; NEUROSCIENCE	This study explores the changes in electroencephalographic (EEG) activity associated with the performance of solving an optics maze problem. College students (N = 37) were instructed to construct three solutions to the optical maze in a Web-based learning environment, which required some knowledge of physics. The subjects put forth their best effort to minimize the number of convexes and mirrors needed to guide the image of an object from the entrance to the exit of the maze. This study examines EEG changes in different frequency bands accompanying varying demands on the cognitive process of providing solutions. Results showed that the mean power of theta, alpha 1, alpha 2, and beta 1 significantly increased as the number of convexes and mirrors used by the students decreased from solution 1 to 3. Moreover, the mean power of theta and alpha 1 significantly increased when the participants constructed their personal optimal solution (the least total number of mirrors and lens used by students) compared to their non-personal optimal solution. In conclusion, the spectral power of frontal, frontal midline and posterior theta, posterior alpha, and temporal beta increased predominantly as the task demands and task performance increased.	[She, Hsiao-Ching; Chou, Wen-Chi; Huang, Li-Yu; Wang, Chia-Yu] Natl Chiao Tung Univ, Inst Educ, Hsinchu, Taiwan; [Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, San Diego, CA 92103 USA; [Lin, Guan-Yu] Natl Chung Cheng Univ, Chiayi Cty, Taiwan	National Yang Ming Chiao Tung University; University of California System; University of California San Diego; National Chung Cheng University	She, HC (corresponding author), Natl Chiao Tung Univ, Inst Educ, Hsinchu, Taiwan.	hcshe@mail.nctu.edu.tw	Wang, Chia-Yu/ABE-3762-2020	Wang, Chia-Yu/0000-0002-9907-3132	National Science Council, Taiwan, Republic of China [NSC 96-2511-S-009-004-MY3]; I-RICE from the National Science Council, Taiwan, Republic of China [I-RICE NSC99-2911-I-010-101]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); I-RICE from the National Science Council, Taiwan, Republic of China	This work was supported by the National Science Council grant (NSC 96-2511-S-009-004-MY3), Taiwan, Republic of China. The research was also partly supported by the I-RICE (I-RICE NSC99-2911-I-010-101) from the National Science Council, Taiwan, Republic of China. The funders has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Association for the Advancement of Science (AAAS), 1993, BENCHM SCI LIT; Bransford JD., 2000, PEOPLE LEARN; Byrnes JP, 1998, EDUC PSYCHOL REV, V10, P297, DOI 10.1023/A:1022145812276; Davidson J.E., 2003, PSYCHOL PROBLEM SOLV; Fries P, 2002, J NEUROSCI, V22, P3739; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A. S., 2003, THEORETICAL ISSUES E, V4, P113, DOI [DOI 10.1080/14639220210159717, 10.1080/14639220210159717]; Inanaga K, 1998, PSYCHIAT CLIN NEUROS, V52, P555, DOI 10.1046/j.1440-1819.1998.00452.x; ISHIHARA T, 1972, ELECTROEN CLIN NEURO, V33, P71, DOI 10.1016/0013-4694(72)90026-0; Jausovec N, 2000, BIOL PSYCHOL, V55, P137, DOI 10.1016/S0301-0511(00)00076-4; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kim YY, 2005, PSYCHOPHYSIOLOGY, V42, P616, DOI 10.1111/j.1469-8986.2005.00349.x; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kounios J, 2009, CURR DIR PSYCHOL SCI, V18, P210, DOI 10.1111/j.1467-8721.2009.01638.x; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MCDERMOTT LC, 1991, AM J PHYS, V59, P301, DOI 10.1119/1.16539; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miltner WH, 1999, NATURE, V397, P391; Molle M, 2000, BRAIN COGNITION, V44, P547, DOI 10.1006/brcg.2000.1215; Nikolaev AR, 1998, HUM PHYSL, V24, P5; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; REIF F, 1976, AM J PHYS, V44, P212, DOI 10.1119/1.10458; Reif F., 1981, PHYS TEACH, V19, P310; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schack B, 2003, HUM BRAIN MAPP, V19, P18, DOI 10.1002/hbm.10104; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Sternberg RJ., 2003, HDB GIFTED ED, V3, P88; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Watts M., 1994, PROBLEM SOLVING SCI	35	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40731	10.1371/journal.pone.0040731	http://dx.doi.org/10.1371/journal.pone.0040731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815800	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100061
J	Wolff, L; Fernandez, P; Kroy, K				Wolff, Lars; Fernandez, Pablo; Kroy, Klaus			Resolving the Stiffening-Softening Paradox in Cell Mechanics	PLOS ONE			English	Article							RHEOLOGICAL REDUNDANCY; ACTIN; VISCOELASTICITY; ELASTICITY; NETWORKS; POLYMERS; TENSION	Background: Despite their notorious diversity, biological cells are mechanically well characterized by only a few robust and universal laws. Intriguingly, the law characterizing the nonlinear response to stretch appears self-contradictory. Various cell types have been reported to both stiffen and soften, or "fluidize" upon stretch. Within the classical paradigm of cells as viscoelastic bodies, this constitutes a paradox. Principal Findings: Our measurements reveal that minimalistic reconstituted cytoskeletal networks (F-actin/HMM) exhibit a similarly peculiar response. A mathematical model of transiently crosslinked polymer networks, the so-called inelastic glassy wormlike chain (iGWLC) model, can simulate the data and resolve the apparent contradiction. It explains the observations in terms of two antagonistic physical mechanisms, the nonlinear viscoelastic resistance of biopolymers to stretch, and the breaking of weak transient bonds between them. Conclusions: Our results imply that the classical paradigm of cells as viscoelastic bodies has to be replaced by such an inelastic mechanical model.	[Wolff, Lars; Kroy, Klaus] Univ Leipzig, Inst Theoret Phys, Leipzig, Germany; [Fernandez, Pablo] Tech Univ Munich, Dept Phys, D-8046 Garching, Germany	Leipzig University; Technical University of Munich	Wolff, L (corresponding author), Univ Leipzig, Inst Theoret Phys, Leipzig, Germany.	klaus.kroy@uni-leipzig.de			Leipzig School of Natural Sciences "Building with molecules and nano-objects" by German excellence initiative [GSC 185]	Leipzig School of Natural Sciences "Building with molecules and nano-objects" by German excellence initiative	This work was supported through the Leipzig School of Natural Sciences "Building with molecules and nano-objects" (GSC 185) by the German excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Broedersz CP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118103; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fantner GE, 2006, BIOPHYS J, V90, P1411, DOI 10.1529/biophysj.105.069344; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Fernandez P, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/419; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Gardel M, 2006, PHYS REV LETT, V96, P12; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kroy K, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/416; Kroy K, 2009, AIP CONF PROC, V1151, P52; Lee H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011919; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Morse DC, 1999, MACROMOLECULES, V32, P5934, DOI 10.1021/ma970475j; Pourati J, 1998, AM J PHYSIOL-CELL PH, V274, pC1283, DOI 10.1152/ajpcell.1998.274.5.C1283; SCHMIDT CF, 1989, MACROMOLECULES, V22, P3638, DOI 10.1021/ma00199a023; Semmrich C, 2008, SOFT MATTER, V4, P1675, DOI 10.1039/b800989a; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tharmann R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.088103; Trepat X, 2008, SOFT MATTER, V4, P1750, DOI 10.1039/b804866e; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wen Q, 2011, CURR OPIN SOLID ST M, V15, P177, DOI 10.1016/j.cossms.2011.05.002; Wolff L, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053024; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200	39	43	45	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40063	10.1371/journal.pone.0040063	http://dx.doi.org/10.1371/journal.pone.0040063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815724	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100027
J	Hosseini, SMH; Hoeft, F; Kesler, SR				Hosseini, S. M. Hadi; Hoeft, Fumiko; Kesler, Shelli R.			GAT: A Graph-Theoretical Analysis Toolbox for Analyzing Between-Group Differences in Large-Scale Structural and Functional Brain Networks	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HIPPOCAMPAL CELL-PROLIFERATION; LONG-TERM SURVIVORS; AGE-RELATED-CHANGES; SMALL-WORLD; CORTICAL THICKNESS; WHITE-MATTER; MODULAR ORGANIZATION; TOPOLOGICAL PATTERNS; ANATOMICAL NETWORKS	In recent years, graph theoretical analyses of neuroimaging data have increased our understanding of the organization of large-scale structural and functional brain networks. However, tools for pipeline application of graph theory for analyzing topology of brain networks is still lacking. In this report, we describe the development of a graph-analysis toolbox (GAT) that facilitates analysis and comparison of structural and functional network brain networks. GAT provides a graphical user interface (GUI) that facilitates construction and analysis of brain networks, comparison of regional and global topological properties between networks, analysis of network hub and modules, and analysis of resilience of the networks to random failure and targeted attacks. Area under a curve (AUC) and functional data analyses (FDA), in conjunction with permutation testing, is employed for testing the differences in network topologies; analyses that are less sensitive to the thresholding process. We demonstrated the capabilities of GAT by investigating the differences in the organization of regional gray-matter correlation networks in survivors of acute lymphoblastic leukemia (ALL) and healthy matched Controls (CON). The results revealed an alteration in small-world characteristics of the brain networks in the ALL survivors; an observation that confirm our hypothesis suggesting widespread neurobiological injury in ALL survivors. Along with demonstration of the capabilities of the GAT, this is the first report of altered large-scale structural brain networks in ALL survivors.	[Hosseini, S. M. Hadi; Hoeft, Fumiko; Kesler, Shelli R.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Hoeft, Fumiko] Univ Calif San Francisco, Dept Psychiat, Div Child & Adolescent Psychiat, San Francisco, CA USA; [Kesler, Shelli R.] Stanford Canc Ctr, Palo Alto, CA USA	Stanford University; University of California System; University of California San Francisco; Stanford Cancer Institute; Stanford University	Hosseini, SMH (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	hosseiny@stanford.edu	Hosseini, Hadi/AAF-7095-2020	Hosseini, Hadi/0000-0001-5186-7008	National Institutes of Health [1 DP2 OD004445-01, K23 HD054720]; National Cancer Institute [K07 CA134639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD054720] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA134639] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Director's New Innovator Award 1 DP2 OD004445-01 to SK and K23 HD054720 to FH and National Cancer Institute (K07 CA134639 to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aukema EJ, 2009, INT J RADIAT ONCOL, V74, P837, DOI 10.1016/j.ijrobp.2008.08.060; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buizer AI, 2009, PEDIATR BLOOD CANCER, V52, P447, DOI 10.1002/pbc.21869; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campbell LK, 2007, PEDIATR BLOOD CANCER, V49, P65, DOI 10.1002/pbc.20860; Carey ME, 2008, AM J NEURORADIOL, V29, P792, DOI 10.3174/ajnr.A0904; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Dellani PR, 2008, J MAGN RESON IMAGING, V27, P1250, DOI 10.1002/jmri.21364; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Ficek K, 2010, ACTA NEUROCHIR SUPPL, V106, P195, DOI 10.1007/978-3-211-98811-4_36; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P10, DOI 10.1016/B978-012372560-8/50002-4; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Janelsins MC, 2011, SEMIN ONCOL, V38, P431, DOI 10.1053/j.seminoncol.2011.03.014; Jin CW, 2011, NEUROSCI LETT, V503, P105, DOI 10.1016/j.neulet.2011.08.017; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kesler SR, 2010, BRAIN IMAGING BEHAV, V4, P256, DOI 10.1007/s11682-010-9104-1; Leh SE, 2010, NEUROPSYCHOPHARMACOL, V35, P70, DOI 10.1038/npp.2009.88; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Paakko E, 2000, MED PEDIATR ONCOL, V35, P456, DOI 10.1002/1096-911X(20001101)35:5<456::AID-MPO3>3.0.CO;2-1; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Petrella JR, 2011, RADIOLOGY, V259, P317, DOI 10.1148/radiol.11110380; Porto L, 2008, EUR RADIOL, V18, P2691, DOI 10.1007/s00330-008-1038-2; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Reddick WE, 2009, AM J NEURORADIOL, V30, P1947, DOI 10.3174/ajnr.A1733; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Seigers R, 2009, BEHAV BRAIN RES, V201, P279, DOI 10.1016/j.bbr.2009.02.025; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Temming P, 2010, ARCH DIS CHILD, V95, P936, DOI 10.1136/adc.2008.153809; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang LA, 2010, J NEUROSCI, V30, P13171, DOI 10.1523/JNEUROSCI.3514-10.2010; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	92	242	244	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40709	10.1371/journal.pone.0040709	http://dx.doi.org/10.1371/journal.pone.0040709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808240	Green Published, gold			2022-12-27	WOS:000306406700047
J	Orlando, UD; Garona, J; Ripoll, GV; Maloberti, PM; Solano, AR; Avagnina, A; Gomez, DE; Alonso, DF; Podesta, EJ				Orlando, Ulises D.; Garona, Juan; Ripoll, Giselle V.; Maloberti, Paula M.; Solano, Angela R.; Avagnina, Alejandra; Gomez, Daniel E.; Alonso, Daniel F.; Podesta, Ernesto J.			The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target	PLOS ONE			English	Article							COX-2 INHIBITORS; GAMMA AGONISTS; PROTEIN-KINASE; MURINE MODEL; MOUSE MODEL; BREAST; CANCER; EXPRESSION; RAT; 5-LIPOXYGENASE	The acyl-CoA synthetase 4 (ACSL4), which esterify mainly arachidonic acid (AA) into acyl-CoA, is increased in breast, colon and hepatocellular carcinoma. The transfection of MCF-7 cells with ACSL4 cDNA transforms the cells into a highly aggressive phenotype and controls both lipooxygenase-5 (LOX-5) and cyclooxygenase-2 (COX-2) metabolism of AA, suggesting a causal role of ACSL4 in tumorigenesis. We hypothesized that ACSL4, LOX-5 and COX-2 may constitute potential therapeutic targets for the control of tumor growth. Therefore, the aim of this study was to use a tetracycline Tet-Off system of MCF-7 xenograft model of breast cancer to confirm the effect of ACSL4 overexpression on tumor growth in vivo. We also aim to determine whether a combinatorial inhibition of the ACSL4-LOX-COX-2 pathway affects tumor growth in vivo using a xenograft model based on MDA-MB-231 cells, a highly aggressive breast cancer cell line naturally overexpressing ACSL4. The first novel finding is that stable transfection of MCF-7 cells with ACSL4 using the tetracycline Tet-Off system of MCF-7 cells resulted in development of growing tumors when injected into nude mice. Tumor xenograft development measured in animals that received doxycycline resulted in tumor growth inhibition. The tumors presented marked nuclear polymorphism, high mitotic index and low expression of estrogen and progesterone receptor. These results demonstrate the transformational capacity of ACSL4 overexpression. We examined the effect of a combination of inhibitors of ACSL4, LOX-5 and COX-2 on MDA-MB-231 tumor xenografts. This treatment markedly reduced tumor growth in doses of these inhibitors that were otherwise ineffective when used alone, indicating a synergistic effect of the compounds. Our results suggest that these enzymes interact functionally and form an integrated system that operates in a concerted manner to regulate tumor growth and consequently may be potential therapeutic targets for the control of proliferation as well as metastatic potential of cancer cells.	[Orlando, Ulises D.; Maloberti, Paula M.; Solano, Angela R.; Podesta, Ernesto J.] Univ Buenos Aires, Sch Med, Inst Invest Biomed INBIOMED, Dept Human Biochem, Buenos Aires, DF, Argentina; [Garona, Juan; Ripoll, Giselle V.; Gomez, Daniel E.; Alonso, Daniel F.] Quilmes Natl Univ, Mol Oncol Lab, Buenos Aires, DF, Argentina; [Avagnina, Alejandra] Hosp Univ Ctr Estudios Med & Invest Clin CEMIC, Pathol Unit, Buenos Aires, DF, Argentina	University of Buenos Aires; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC)	Orlando, UD (corresponding author), Univ Buenos Aires, Sch Med, Inst Invest Biomed INBIOMED, Dept Human Biochem, Buenos Aires, DF, Argentina.	ernestopodesta@yahoo.com.ar	Maloberti, Paula/AAU-5216-2020; Garona, Juan/Q-2306-2019	Garona, Juan/0000-0002-0389-5546; Alonso, Daniel F./0000-0002-0601-613X; Gomez, Daniel E/0000-0002-8629-0787	CONICET [112-200801-01976]; UBA [M059, 20020090200030]; FONCyT [PICT-2010-0498, PICT 1586]; INC (Resolucion Ministerial) [N 148/12]; UNQ [53/1004]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBA(University of Buenos Aires); FONCyT(FONCyT); INC (Resolucion Ministerial); UNQ	This work was supported by CONICET (112-200801-01976) http://www.conicet.gov.ar/, Podesta; UBA (M059, 20020090200030) Podesta, Maloberti, http://www.uba.ar/homepage.php; FONCyT (PICT-2010-0498) Podesta, http://www.agencia.mincyt.gov.ar/; INC (Resolucion Ministerial (N 148/12)) http://www.msal.gov.ar/inc/novedades-proy-invest.php, Podesta; UNQ (53/1004) http://www.unq.edu.ar/, Gomez; and FONCyT (PICT 1586) http://www.agencia.mincyt.gov.ar/, Alonso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyeke TO, 2011, CANCER BIOL THER, V11, P1046, DOI 10.4161/cbt.11.12.15709; Al-Alem L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016179; Alvarez-Diaz S, 2010, CELL CYCLE, V9, P32, DOI 10.4161/cc.9.1.10266; ANDERSON WA, 1984, J SUBMICR CYTOL PATH, V16, P673; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; Avis I, 2001, FASEB J, V15, P2007, DOI 10.1096/fj.00-0866fje; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cao Y, 2001, CANCER RES, V61, P8429; Cellai I, 2010, BRIT J CANCER, V102, P685, DOI 10.1038/sj.bjc.6605506; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Chen XX, 2004, CLIN CANCER RES, V10, P6703, DOI 10.1158/1078-0432.CCR-04-0838; Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x; Drzewoski J, 2011, POL ARCH MED WEWN, V121, P81, DOI 10.20452/pamw.1029; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Elston C W, 1998, Clin Oncol (R Coll Radiol), V10, P14, DOI 10.1016/S0936-6555(98)80105-2; Fegn L, 2009, J LARYNGOL OTOL, V123, P880, DOI 10.1017/S0022215109004617; Ferlay J, 2008, INT J CANC; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gonzalez-Periz A, 2007, CURR TOP MED CHEM, V7, P297, DOI 10.2174/156802607779941378; Half E, 2002, CANCER RES, V62, P1676; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Huang JW, 2005, MOL PHARMACOL, V67, P1342, DOI 10.1124/mol.104.007732; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Kim KY, 2006, BIOCHEM PHARMACOL, V72, P530, DOI 10.1016/j.bcp.2006.05.009; Koga H, 2001, HEPATOLOGY, V33, P1087, DOI 10.1053/jhep.2001.24024; Kundu N, 2002, CANCER RES, V62, P2343; Kundu N, 2001, INT J CANCER, V93, P681, DOI 10.1002/ijc.1397; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Luconi M, 2010, ENDOCR-RELAT CANCER, V17, P169, DOI 10.1677/ERC-09-0170; Maloberti PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015540; Minami CA, 2011, BREAST CANCER-BASIC, V5, P175, DOI 10.4137/BCBCR.S6562; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Narko K, 2005, PROSTAG OTH LIPID M, V76, P86, DOI 10.1016/j.prostaglandins.2005.01.002; Perera Y, 2008, INT J CANCER, V122, P57, DOI 10.1002/ijc.23013; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Ripoll GV, 2008, ANTICANCER RES, V28, P2607; Robertson FM, 2007, ANTICANCER RES, V27, P719; Scoditti E, 2010, CARDIOVASC RES, V86, P302, DOI 10.1093/cvr/cvp400; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sung YK, 2003, CANCER SCI, V94, P421, DOI 10.1111/j.1349-7006.2003.tb01458.x; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Wei S, 2009, CANCER LETT, V276, P119, DOI 10.1016/j.canlet.2008.08.008; Weng JR, 2006, ENDOCR-RELAT CANCER, V13, P401, DOI 10.1677/erc.1.01182; Yao M, 2005, CLIN CANCER RES, V11, P1618, DOI 10.1158/1078-0432.CCR-04-1696	55	42	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40794	10.1371/journal.pone.0040794	http://dx.doi.org/10.1371/journal.pone.0040794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808264	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700054
J	Massen, JJM; Vermunt, DA; Sterck, EHM				Massen, Jorg J. M.; Vermunt, Dorith A.; Sterck, Elisabeth H. M.			Male Yawning Is More Contagious than Female Yawning among Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							ALTRUISM; EMPATHY; DOGS	Yawn contagion is not restricted to humans and has also been reported for several non-human animal species, including chimpanzees (Pan troglodytes). Contagious yawning may lead to synchronisation of behaviour. However, the function of contagious yawning is relatively understudied. In this study, we investigated the function of contagious yawning by focusing on two types of signal providers: close social associates and leaders. We provided a captive chimpanzee colony with videos of all individuals of their own group that were either yawning, or at rest. Consistent with other studies, we demonstrated that yawning is contagious for chimpanzees, yet we did not find any effect of relationship quality on yawn contagion. However, we show that yawn contagion is significantly higher when the video model is a yawning male than when the video model was a yawning female, and that this effect is most apparent among males. As males are dominant in chimpanzee societies, male signals may be more relevant to the rest of the group than female signals. Moreover, since chimpanzees form male-bonded societies, male signals are especially relevant for other males. Therefore, we suggest that the sex-differences of yawning contagion among chimpanzees reflect the function of yawning in the synchronisation of behaviour.	[Massen, Jorg J. M.; Vermunt, Dorith A.; Sterck, Elisabeth H. M.] Univ Utrecht, Dept Behav Biol, Utrecht, Netherlands; [Massen, Jorg J. M.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Sterck, Elisabeth H. M.] Biomed Primate Res Ctr, Rijswijk, Netherlands	Utrecht University; University of Vienna	Massen, JJM (corresponding author), Univ Utrecht, Dept Behav Biol, Utrecht, Netherlands.	jorgmassen@gmail.com	Sterck, Elisabeth/C-1063-2011; Massen, Jorg/F-1190-2011	Sterck, Elisabeth/0000-0003-1101-6027; Massen, Jorg/0000-0002-1630-9606	Lucy Burgers Foundation for Comparative Behaviour Research, Arnhem, The Netherlands; Austrian Science Foundation (FWF) [M 1351-B17]; Utrecht University; Burgers' Zoo; Austrian Science Fund (FWF) [M 1351] Funding Source: researchfish	Lucy Burgers Foundation for Comparative Behaviour Research, Arnhem, The Netherlands(Netherlands Government); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Utrecht University; Burgers' Zoo; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	JJMM was supported by a research grant of the Lucy Burgers Foundation for Comparative Behaviour Research, Arnhem, The Netherlands. Currently JJMM is financed by Lise Meitner grant of the Austrian Science Foundation (FWF, grantnr.: M 1351-B17). The authors are grateful to Utrecht University (High Potentials grant to SM Reader) for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Burgers' Zoo and the animal caretakers for support throughout the research. We are grateful to Sonja Koski, Tobias Deschner and two anonymous referees for helpful comments on an earlier draft of this manuscript. The experiments comply with the current laws of the country in which they were performed.	Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Bates LA, 2009, BEHAV ECOL SOCIOBIOL, V64, P247, DOI 10.1007/s00265-009-0841-3; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEPUTTE BL, 1994, ETHOLOGY, V98, P221; GIGANTI F, 2009, CURR PSYCHOL LETT, V25, P1; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Harr AL, 2009, ANIM COGN, V12, P833, DOI 10.1007/s10071-009-0233-0; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Helt MS, 2010, CHILD DEV, V81, P1620, DOI 10.1111/j.1467-8624.2010.01495.x; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Koski SE, 2010, EUR J DEV PSYCHOL, V7, P38, DOI 10.1080/17405620902986991; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LEHMANN HE, 1979, B MENNINGER CLIN, V43, P123; Massen JJM, 2011, PRIMATES, V52, P237, DOI 10.1007/s10329-011-0244-8; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Mitani JC, 2002, ANIM BEHAV, V64, P727, DOI 10.1006/anbe.2002.4014; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Paukner A, 2006, BIOL LETTERS, V2, P36, DOI 10.1098/rsbl.2005.0411; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; SAWYER J, 1966, AM J SOCIOL, V71, P407, DOI 10.1086/224129; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Vick SJ, 2010, AM J PRIMATOL, V72, P262, DOI 10.1002/ajp.20781	29	48	48	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40697	10.1371/journal.pone.0040697	http://dx.doi.org/10.1371/journal.pone.0040697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808234	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400092
J	Barbazan, J; Alonso-Alconada, L; Muinelo-Romay, L; Vieito, M; Abalo, A; Alonso-Nocelo, M; Candamio, S; Gallardo, E; Fernandez, B; Abdulkader, I; Casares, MD; Gomez-Tato, A; Lopez-Lopez, R; Abal, M				Barbazan, Jorge; Alonso-Alconada, Lorena; Muinelo-Romay, Laura; Vieito, Maria; Abalo, Alicia; Alonso-Nocelo, Marta; Candamio, Sonia; Gallardo, Elena; Fernandez, Beatriz; Abdulkader, Ihab; de los Angeles Casares, Maria; Gomez-Tato, Antonio; Lopez-Lopez, Rafael; Abal, Miguel			Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer	PLOS ONE			English	Article							MEMBRANE ARRAY; EXPRESSION; SURVIVAL; MARKER; CD9	Metastatic colorectal cancer (mCRC) relies on the detachment of aggressive malignant cells from the primary tumor into the bloodstream and, concordantly, the presence of these Circulating Tumor Cells (CTC) is associated with a poor prognosis. In this work, the molecular characterization of CTC from mCRC patients was approached, with the aim of understanding their biology and improving their clinical utility in the management of colorectal cancer patients. For this, EpCAM-based immunoisolation of CTC was combined with whole transcriptome amplification and hybridization onto cDNA microarrays. Gene expression data from mCRC patients, once the background of unspecific immunoisolation from a group of controls had been subtracted, resulted in 410 genes that characterized the CTC population. Bioinformatics were used for the biological interpretation of the data, revealing that CTC are characterized by genes related to cell movement and adhesion, cell death and proliferation, and cell signalling and interaction. RTqPCR on an independent series of mCRC patients and controls was used for the validation of a number of genes related to the main cellular functions characterizing the CTC population. Comparison between primary carcinomas and lung and liver metastases further involved the CTC-genes in the promotion of metastasis. Moreover, the correlation of CTC-gene expression with clinical parameters demonstrated detection and prognosis significance. In conclusion, the molecular characterization of CTC from mCRC patients and the identification of diagnostic and prognostic biomarkers represent an innovative and promising approach in the clinical management of this type of patients.	[Barbazan, Jorge; Alonso-Alconada, Lorena; Muinelo-Romay, Laura; Vieito, Maria; Abalo, Alicia; Alonso-Nocelo, Marta; Candamio, Sonia; Gallardo, Elena; Lopez-Lopez, Rafael; Abal, Miguel] Univ Santiago de Compostela, SERGAS, Complexo Hosp, Translat Lab,Med Oncol Dept, Santiago De Compostela, Spain; [Fernandez, Beatriz; Abdulkader, Ihab] Univ Santiago de Compostela, SERGAS, Complexo Hosp, Dept Pathol, Santiago De Compostela, Spain; [de los Angeles Casares, Maria; Gomez-Tato, Antonio] Univ Santiago, Sch Math, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Barbazan, J (corresponding author), Univ Santiago de Compostela, SERGAS, Complexo Hosp, Translat Lab,Med Oncol Dept, Santiago De Compostela, Spain.	miguel.abal.posada@sergas.es	Tato, Antonio Gómez/N-3202-2013; Barbazán, Jorge/AAM-3263-2020; Casares de Cal, Maria de los Angeles/E-1767-2018	Tato, Antonio Gómez/0000-0003-2465-3500; Barbazán, Jorge/0000-0002-7165-8497; Lopez Lopez, Rafael/0000-0003-1315-655X; Casares de Cal, Maria de los Angeles/0000-0001-8077-3684; Abal Posada, Miguel/0000-0003-3533-7781; Abalo, Alicia/0000-0002-5075-0251; Vieito, Maria/0000-0001-7531-343X; Alonso-Nocelo, Marta/0000-0001-8838-363X	Spanish Ministry of Health [CP08/00142]; European Commission Program Fondo Europeo de Desarrollo Regional (FEDER); Spanish Ministry of Education and Science; Basque Government (Spain)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Commission Program Fondo Europeo de Desarrollo Regional (FEDER); Spanish Ministry of Education and Science(Spanish Government); Basque Government (Spain)(Basque Government)	This work was in part funded by the Spanish Ministry of Health (CP08/00142) and the European Commission Program Fondo Europeo de Desarrollo Regional (FEDER). No additional external funding received for this study. J. Barbazan and L. Alonso-Alconada are recipients of fellowships from the Spanish Ministry of Education and Science and the Basque Government (Spain), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2010, CURR COLORECT CANC R, V6, P212, DOI 10.1007/s11888-010-0069-7; Barbazan J, 2012, J CELL MOL MED; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Bretthauer M, 2010, BEST PRACT RES CL GA, V24, P417, DOI 10.1016/j.bpg.2010.06.005; Cohen SJ, 2009, ANN ONCOL, V20, P1223, DOI 10.1093/annonc/mdn786; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cohen SJ, 2006, CLIN COLORECTAL CANC, V6, P125, DOI 10.3816/CCC.2006.n.029; Cristofanilli M, 2009, BREAST, V18, pS38, DOI 10.1016/S0960-9776(09)70270-X; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrmann I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013474; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Konigsberg R, 2010, CANCER LETT, V293, P117, DOI 10.1016/j.canlet.2010.01.003; Lin AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016636; Mazzarelli P, 2009, ADV CANCER RES, V105, P45, DOI 10.1016/S0065-230X(09)05003-9; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Oka M, 2002, MOL BIOL CELL, V13, P1274, DOI 10.1091/mbc.02-01-0600; Oppenheimer SB, 2006, ACTA HISTOCHEM, V108, P327, DOI 10.1016/j.acthis.2006.03.008; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; Ricca TI, 2009, TRANSL ONCOL, V2, P329, DOI 10.1593/tlo.09220; Riethdorf S, 2010, ANN NY ACAD SCI, V1210, P66, DOI 10.1111/j.1749-6632.2010.05779.x; Schelter F, 2011, CLIN EXP METASTAS, V28, P793, DOI 10.1007/s10585-011-9410-z; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Yang MJ, 2010, ANN SURG ONCOL, V17, P624, DOI 10.1245/s10434-009-0831-8; Ye L, 2011, FRONT BIOSCI-LANDMRK, V16, P865, DOI 10.2741/3725; Yeh CS, 2006, INT J ONCOL, V28, P411	29	66	72	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40476	10.1371/journal.pone.0040476	http://dx.doi.org/10.1371/journal.pone.0040476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22811761	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500045
J	Gomez-Lievano, A; Youn, H; Bettencourt, LMA				Gomez-Lievano, Andres; Youn, HyeJin; Bettencourt, Luis M. A.			The Statistics of Urban Scaling and Their Connection to Zipf's Law	PLOS ONE			English	Article							DISTRIBUTIONS; CITIES	Urban scaling relations characterizing how diverse properties of cities vary on average with their population size have recently been shown to be a general quantitative property of many urban systems around the world. However, in previous studies the statistics of urban indicators were not analyzed in detail, raising important questions about the full characterization of urban properties and how scaling relations may emerge in these larger contexts. Here, we build a self-consistent statistical framework that characterizes the joint probability distributions of urban indicators and city population sizes across an urban system. To develop this framework empirically we use one of the most granular and stochastic urban indicators available, specifically measuring homicides in cities of Brazil, Colombia and Mexico, three nations with high and fast changing rates of violent crime. We use these data to derive the conditional probability of the number of homicides per year given the population size of a city. To do this we use Bayes' rule together with the estimated conditional probability of city size given their number of homicides and the distribution of total homicides. We then show that scaling laws emerge as expectation values of these conditional statistics. Knowledge of these distributions implies, in turn, a relationship between scaling and population size distribution exponents that can be used to predict Zipf's exponent from urban indicator statistics. Our results also suggest how a general statistical theory of urban indicators may be constructed from the stochastic dynamics of social interaction processes in cities.	[Gomez-Lievano, Andres] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Youn, HyeJin; Bettencourt, Luis M. A.] Santa Fe Inst, Santa Fe, NM 87501 USA	Arizona State University; Arizona State University-Tempe; The Santa Fe Institute	Gomez-Lievano, A (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	agomez26@asu.edu	Gomez-Lievano, Andres/AAA-3208-2019; Bettencourt, Luis/R-9861-2019; Youn, Hyejin/ABD-2997-2020	Gomez-Lievano, Andres/0000-0001-8320-0857; Youn, Hyejin/0000-0002-6190-4412	Rockefeller Foundation; James S. McDonnell Foundation [220020195]; National Science Foundation [103522]; Boeing Company [525993]; John Templeton Foundation [15705]; Direct For Social, Behav & Economic Scie [1035225] Funding Source: National Science Foundation	Rockefeller Foundation; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); Boeing Company; John Templeton Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research is partially supported by the Rockefeller Foundation, the James S. McDonnell Foundation (grant no. 220020195), the National Science Foundation (grant no. 103522), The Boeing Company (purchase contract no. 525993), the John Templeton Foundation (grant no. 15705) and by a generous gift of the Bryan J. and June B. Zwan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSCOMBE FJ, 1950, BIOMETRIKA, V37, P358, DOI 10.1093/biomet/37.3-4.358; Bacon E. N., 1976, DESIGN CITIES; Baek SK, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043004; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Fischer C. S., 1984, URBAN EXPERIENCE; Flanagan W. G., 2010, URBAN SOCIOLOGY IMAG, P101; Frank SA, 2009, J EVOLUTION BIOL, V22, P1563, DOI 10.1111/j.1420-9101.2009.01775.x; Fujita M., 2001, SPATIAL EC CITIES RE; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gaviria A, 2000, J DEV ECON, V61, P1, DOI 10.1016/S0304-3878(99)00059-0; Goertzel T, 2009, HOMICIDE STUD, V13, P398, DOI 10.1177/1088767909348711; Hall P, 1976, CITIES CIVILIZATION; MANDELBROT B, 1961, INFORM CONTROL, V4, P300, DOI 10.1016/S0019-9958(61)80025-9; MONTROLL EW, 1982, P NATL ACAD SCI USA, V79, P3380, DOI 10.1073/pnas.79.10.3380; Mumford L., 1961, CITY HIST ITS ORIGIN, DOI DOI 10.1016/j.jaa.2011.06.005; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Sullivan A, 2006, URBAN EC; Olver F. W., 2010, NIST HDB MATH FUNCTI; Pinker S., 2011, BETTER ANGELS OUR NA; REDNER S, 1990, AM J PHYS, V58, P267, DOI 10.1119/1.16497; Saichev A, 2010, LECT NOTES EC MATH S, V632; SIMON HA, 1955, BIOMETRIKA, V42, P425; Soo KT, 2005, REG SCI URBAN ECON, V35, P239, DOI 10.1016/j.regsciurbeco.2004.04.004; Sornette D., 2006, CRITICAL PHENOMENA N, DOI DOI 10.1007/3-540-33182-4; The World Bank, 2011, VIOL CIT UND SUPP CO; The World Bank, 2011, CON SEC DEV REP; Valle-Jones D, 2011, VIOLENT DEATHS MEXIC	30	83	84	9	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40393	10.1371/journal.pone.0040393	http://dx.doi.org/10.1371/journal.pone.0040393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815745	gold, Green Published			2022-12-27	WOS:000306548900023
J	Rogers, TE; Ataide, SF; Dare, K; Katz, A; Seveau, S; Roy, H; Ibba, M				Rogers, Theresa E.; Ataide, Sandro F.; Dare, Kiley; Katz, Assaf; Seveau, Stephanie; Roy, Herve; Ibba, Michael			A Pseudo-tRNA Modulates Antibiotic Resistance in Bacillus cereus	PLOS ONE			English	Article							REGULATED SMALL RNA; NITRIC-OXIDE; FUNCTIONAL IMPLICATIONS; ESCHERICHIA-COLI; IRON-METABOLISM; BACTERIA; SUBTILIS; GENES; MECHANISM; PROTEINS	Bacterial genomic islands are often flanked by tRNA genes, which act as sites for the integration of foreign DNA into the host chromosome. For example, Bacillus cereus ATCC14579 contains a pathogenicity island flanked by a predicted pseudo-tRNA, tRNA(Other), which does not function in translation. Deletion of tRNA(Other) led to significant changes in cell wall morphology and antibiotic resistance and was accompanied by changes in the expression of numerous genes involved in oxidative stress responses, several of which contain significant complementarities to sequences surrounding tRNA(Other). This suggested that tRNA(Other) might be expressed as part of a larger RNA, and RACE analysis subsequently confirmed the existence of several RNA species that significantly extend both the 39 and 5'-ends of tRNA(Other). tRNA(Other) expression levels were found to be responsive to changes in extracellular iron concentration, consistent with the presence of three putative ferric uptake regulator (Fur) binding sites in the 59 leader region of one of these larger RNAs. Taken together with previous data, this study now suggests that tRNA(Other) may function by providing a tRNA-like structural element within a larger regulatory RNA. These findings illustrate that while integration of genomic islands often leaves tRNA genes intact and functional, in other instances inactivation may generate tRNA-like elements that are then recruited to other functions in the cell.	[Rogers, Theresa E.; Ataide, Sandro F.; Dare, Kiley; Katz, Assaf; Seveau, Stephanie; Roy, Herve; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Roy, Herve] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Ibba, Michael] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; State University System of Florida; University of Central Florida; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Rogers, TE (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu	Katz, Assaf/R-7504-2019; Katz, Assaf/K-7130-2018; Seveau, Stephanie/E-4060-2011	Katz, Assaf/0000-0001-5481-7399; Rogers, Theresa/0000-0002-9741-5768; F Ataide, Sandro/0000-0003-1807-5708	National Institutes of Health [GM 65183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM 65183 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataide SF, 2009, RNA BIOL, V6, P479, DOI 10.4161/rna.6.4.9332; Ataide SF, 2005, EMBO REP, V6, P742, DOI 10.1038/sj.embor.7400474; Banerjee R, 2010, FEBS LETT, V584, P387, DOI 10.1016/j.febslet.2009.11.013; Baron Christian, 1995, P529; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buddha MR, 2004, P NATL ACAD SCI USA, V101, P15881, DOI 10.1073/pnas.0405483101; Cao Y, 2009, BIOINFORMATION, V3, P364, DOI 10.6026/97320630003364; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Dorazi R, 2003, J THEOR BIOL, V225, P383, DOI 10.1016/S0022-5193(03)00268-6; Dreher TW, 2009, VIRUS RES, V139, P217, DOI 10.1016/j.virusres.2008.06.010; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Fechter P, 2001, CELL MOL LIFE SCI, V58, P1547, DOI 10.1007/PL00000795; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Giannouli S, 2009, BIOCHIMIE, V91, P344, DOI 10.1016/j.biochi.2008.10.009; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Haghighat AC, 2010, J IMMUNOL METHODS, V352, P186, DOI 10.1016/j.jim.2009.11.013; Haiser HJ, 2008, NUCLEIC ACIDS RES, V36, P732, DOI 10.1093/nar/gkm1096; Hammond JA, 2009, RNA, V15, P294, DOI 10.1261/rna.1360709; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Hou YM, 1999, TRENDS BIOCHEM SCI, V24, P295, DOI 10.1016/S0968-0004(99)01428-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; LANGENBERGER D, PAC S BIOCOMPUT, P80; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li Y, 2008, NUCLEIC ACIDS RES, V36, P6048, DOI 10.1093/nar/gkn596; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POPHAM DL, 1995, J BACTERIOL, V177, P326, DOI 10.1128/jb.177.2.326-335.1995; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Ryckelynck M, 2005, BIOCHIMIE, V87, P835, DOI 10.1016/j.biochi.2005.02.014; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Steinberg S, 1997, J MOL BIOL, V266, P269, DOI 10.1006/jmbi.1996.0803; STEWART TS, 1971, NATURE, V230, P36, DOI 10.1038/230036a0; Strube K, 2007, J BIOL CHEM, V282, P20292, DOI 10.1074/jbc.M702003200; Taquist H, 2007, NUCLEIC ACIDS RES, V35, pW350, DOI 10.1093/nar/gkm393; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yan L, 2009, SCI CHINA SER C, V52, P245, DOI 10.1007/s11427-009-0039-y	61	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41248	10.1371/journal.pone.0041248	http://dx.doi.org/10.1371/journal.pone.0041248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815980	gold, Green Published			2022-12-27	WOS:000306548900100
J	Aiche, S; Reinert, K; Schutte, C; Hildebrand, D; Schluter, H; Conrad, TOF				Aiche, Stephan; Reinert, Knut; Schuette, Christof; Hildebrand, Diana; Schlueter, Hartmut; Conrad, Tim O. F.			Inferring Proteolytic Processes from Mass Spectrometry Time Series Data Using Degradation Graphs	PLOS ONE			English	Article							CANCER DEVELOPMENT; SERUM PEPTIDOME; PROTEINS; DESIGN; ROLES	Background: Proteases play an essential part in a variety of biological processes. Besides their importance under healthy conditions they are also known to have a crucial role in complex diseases like cancer. In recent years, it has been shown that not only the fragments produced by proteases but also their dynamics, especially ex vivo, can serve as biomarkers. But so far, only a few approaches were taken to explicitly model the dynamics of proteolysis in the context of mass spectrometry. Results: We introduce a new concept to model proteolytic processes, the degradation graph. The degradation graph is an extension of the cleavage graph, a data structure to reconstruct and visualize the proteolytic process. In contrast to previous approaches we extended the model to incorporate endoproteolytic processes and present a method to construct a degradation graph from mass spectrometry time series data. Based on a degradation graph and the intensities extracted from the mass spectra it is possible to estimate reaction rates of the underlying processes. We further suggest a score to rate different degradation graphs in their ability to explain the observed data. This score is used in an iterative heuristic to improve the structure of the initially constructed degradation graph. Conclusion: We show that the proposed method is able to recover all degraded and generated peptides, the underlying reactions, and the reaction rates of proteolytic processes based on mass spectrometry time series data. We use simulated and real data to demonstrate that a given process can be reconstructed even in the presence of extensive noise, isobaric signals and false identifications. While the model is currently only validated on peptide data it is also applicable to proteins, as long as the necessary time series data can be produced.	[Aiche, Stephan; Reinert, Knut; Schuette, Christof; Conrad, Tim O. F.] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Aiche, Stephan] Int Max Planck Res Sch Computat Biol & Sci Comp, Berlin, Germany; [Hildebrand, Diana; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany	Free University of Berlin; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Aiche, S (corresponding author), Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany.	stephan.aiche@fu-berlin.de	Reinert, Knut/V-3327-2019; Schluter, Hartmut/D-1371-2015; Conrad, Tim/N-2742-2014	Reinert, Knut/0000-0003-3078-8129; Schluter, Hartmut/0000-0002-9358-7036; Conrad, Tim/0000-0002-5590-5726; Aiche, Stephan/0000-0001-9601-8229	DFG research center Matheon "Mathematics for key technologies" in Berlin; BMBF [0313694]; Center for Scientific Simulation, Freie Universitat Berlin	DFG research center Matheon "Mathematics for key technologies" in Berlin(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Center for Scientific Simulation, Freie Universitat Berlin	The research described in this paper was partially supported by the DFG research center Matheon "Mathematics for key technologies" in Berlin and the BMBF grant 0313694 A. SA was partially supported by the Center for Scientific Simulation, Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Baumann S, 2005, CLIN CHEM, V51, P973, DOI 10.1373/clinchem.2004.047308; Bielow C, 2011, J PROTEOME RES, V10, P2922, DOI 10.1021/pr200155f; Bock H.G., 2007, REACTIVE FLOWS DIFFU, P117, DOI DOI 10.1007/978-3-540-28396-6_6; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Cleynen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024106; Conrad TOF, 2006, LECT NOTES COMPUT SC, V4216, P119; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Deuhard P, 2004, SPRINGER SERIES COMP, V35; Dierkes T., 2011, 1115 ZIB; Kluge B, 2009, J COMPUT BIOL, V16, P395, DOI 10.1089/cmb.2008.22TT; Lange Eva, 2006, Pac Symp Biocomput, P243, DOI 10.1142/9789812701626_0023; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467; Lorenz S, 2007, J COMPUT CHEM, V28, P1384, DOI 10.1002/jcc.20674; Ludwig T, 2005, BIOESSAYS, V27, P1181, DOI 10.1002/bies.20306; Masaki T, 2001, BRIT J CANCER, V84, P1317, DOI 10.1054/bjoc.2001.1790; Nesvizhskii A.I., 2007, METHODS MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Peccerella T, 2010, CLIN CHEM, V56, P272, DOI 10.1373/clinchem.2009.133462; Schluter H, 2008, ANAL BIOANAL CHEM, V392, P783, DOI 10.1007/s00216-008-2213-7; Seife C, 1997, SCIENCE, V277, P1602, DOI 10.1126/science.277.5332.1602; Steinrucke P, 2000, ANAL BIOCHEM, V286, P26, DOI 10.1006/abio.2000.4780; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Walsh PN, 2002, ESSAYS BIOCHEM, V38, P95, DOI 10.1042/bse0380095; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40656	10.1371/journal.pone.0040656	http://dx.doi.org/10.1371/journal.pone.0040656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815782	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000023
J	Chang, CM; Huang, KY; Hsu, TW; Su, YC; Yang, WZ; Chen, TC; Chou, P; Lee, CC				Chang, Chun-Ming; Huang, Kuang-Yung; Hsu, Ta-Wen; Su, Yu-Chieh; Yang, Wei-Zhen; Chen, Ting-Chang; Chou, Pesus; Lee, Ching-Chih			Multivariate Analyses to Assess the Effects of Surgeon and Hospital Volume on Cancer Survival Rates: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; 5-YEAR SURVIVAL; UNITED-STATES; LUNG-CANCER; OPERATIVE MORTALITY; COLORECTAL-CANCER; PROPENSITY SCORES; SURGICAL VOLUME; ASIAN COUNTRY	Background: Positive results between caseloads and outcomes have been validated in several procedures and cancer treatments. However, there is limited information available on the combined effects of surgeon and hospital caseloads. We used nationwide population-based data to explore the association between surgeon and hospital caseloads and survival rates for major cancers. Methodology: A total of 11677 patients with incident cancer diagnosed in 2002 were identified from the Taiwan National Health Insurance Research Database. Survival analysis, the Cox proportional hazards model, and propensity scores were used to assess the relationship between 5-year survival rates and different caseload combinations. Results: Based on the Cox proportional hazard model, cancer patients treated by low-volume surgeons in low-volume hospitals had poorer survival rates, and hazard ratios ranged from 1.3 in head and neck cancer to 1.8 in lung cancer after adjusting for patients' demographic variables, co-morbidities, and treatment modality. When analyzed using the propensity scores, the adjusted 5-year survival rates were poorer for patients treated by low-volume surgeons in low-volume hospitals, compared to those treated by high-volume surgeons in high-volume hospitals (P<0.005). Conclusions: After adjusting for differences in the case mix, cancer patients treated by low-volume surgeons in low-volume hospitals had poorer 5-year survival rates. Payers may implement quality care improvement in low-volume surgeons.	[Chang, Chun-Ming; Hsu, Ta-Wen] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan; [Chang, Chun-Ming; Huang, Kuang-Yung; Hsu, Ta-Wen; Su, Yu-Chieh; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Yang, Wei-Zhen] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan; [Chen, Ting-Chang] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan; [Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Chang, CM (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan.	hematcd@hotamil.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017				Al-Refaie WB, 2012, J AM COLL SURGEONS, V214, P81, DOI 10.1016/j.jamcollsurg.2011.10.003; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Barker FG, 2003, J CLIN ENDOCR METAB, V88, P4709, DOI 10.1210/jc.2003-030461; Becher EC, 2002, ACAD MED, V77, P953, DOI 10.1097/00001888-200210000-00005; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI DOI 10.1056/NEJMsa035205; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Bureau of Health Promotion Department of Health ROC, 2011, CANC STAT TAIW; Chen CS, 2008, BREAST CANCER RES TR, V110, P349, DOI 10.1007/s10549-007-9715-4; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Cheng SH, 2004, QUAL SAF HEALTH CARE, V13, P98, DOI 10.1136/qshc.2003.006981; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Davoli Marina, 2005, Epidemiol Prev, V29, P3; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gilligan MA, 2007, ARCH SURG-CHICAGO, V142, P17, DOI 10.1001/archsurg.142.1.17; Goodney PP, 2003, ANN SURG, V238, P161, DOI 10.1097/01.SLA.0000081094.66659.c3; Gruen RL, 2009, CA-CANCER J CLIN, V59, P192, DOI 10.3322/caac.20018; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hyndman ME, 2010, CURR OPIN UROL, V20, P211, DOI 10.1097/MOU.0b013e328338405d; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kee F, 1999, BRIT MED J, V318, P1381, DOI 10.1136/bmj.318.7195.1381; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Larsen SR, 2009, J ORAL PATHOL MED, V38, P657, DOI 10.1111/j.1600-0714.2009.00797.x; Lee CC, 2012, ORAL ONCOL, V48, P253, DOI 10.1016/j.oraloncology.2011.10.002; Lee CC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-92; Lien YC, 2007, ANN THORAC SURG, V83, P1837, DOI 10.1016/j.athoracsur.2006.12.008; Lin CC, 2008, SURGERY, V143, P343, DOI 10.1016/j.surg.2007.09.033; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; Mikeljevic JS, 2003, BRIT J CANCER, V89, P487, DOI 10.1038/sj.bjc.6601148; Renzulli P, 2006, SURGERY, V139, P296, DOI 10.1016/j.surg.2005.08.023; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; RUBIN DB, 1993, MED CARE, V31, pYS103, DOI 10.1097/00005650-199305001-00017; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Schrag D, 2006, JNCI-J NATL CANCER I, V98, P163, DOI 10.1093/jnci/djj018; Scott IA, 2008, INTERN MED J, V38, P44, DOI 10.1111/j.1445-5994.2007.01456.x; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; Tai P, 2003, INT J RADIAT ONCOL, V56, P626, DOI 10.1016/S0360-3016(03)00070-1; Taylor CB, 2006, AM J PREV MED, V31, P127, DOI 10.1016/j.amepre.2006.03.025; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; Virnig BA, 2001, ANNU REV PUBL HEALTH, V22, P213, DOI 10.1146/annurev.publhealth.22.1.213; Woolgar JA, 2006, ORAL ONCOL, V42, P229, DOI 10.1016/j.oraloncology.2005.05.008	46	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40590	10.1371/journal.pone.0040590	http://dx.doi.org/10.1371/journal.pone.0040590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JG	22815771	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000020
J	Chrudimsky, T; Husnik, F; Novakova, E; Hypsa, V				Chrudimsky, Tomas; Husnik, Filip; Novakova, Eva; Hypsa, Vaclav			Candidatus Sodalis melophagi sp nov.: Phylogenetically Independent Comparative Model to the Tsetse Fly Symbiont Sodalis glossinidius	PLOS ONE			English	Article							III SECRETION SYSTEMS; SECONDARY ENDOSYMBIONT; INSECT ENDOSYMBIONT; EVOLUTION; FLIES; BACTERIA; ARSENOPHONUS; PHYLOGENIES; COLEOPTERA; INFERENCE	Bacteria of the genus Sodalis live in symbiosis with various groups of insects. The best known member of this group, a secondary symbiont of tsetse flies Sodalis glossinidius, has become one of the most important models in investigating establishment and evolution of insect-bacteria symbiosis. It represents a bacterium in the early/intermediate state of the transition towards symbiosis, which allows for exploring such interesting topics as: usage of secretory systems for entering the host cell, tempo of the genome modification, and metabolic interaction with a coexisting primary symbiont. In this study, we describe a new Sodalis species which could provide a useful comparative model to the tsetse symbiont. It lives in association with Melophagus ovinus, an insect related to tsetse flies, and resembles S. glossinidius in several important traits. Similar to S. glossinidius, it cohabits the host with another symbiotic bacterium, the bacteriome-harbored primary symbiont of the genus Arsenophonus. As a typical secondary symbiont, Candidatus Sodalis melophagi infects various host tissues, including bacteriome. We provide basic morphological and molecular characteristics of the symbiont and show that these traits also correspond to the early/intermediate state of the evolution towards symbiosis. Particularly, we demonstrate the ability of the bacterium to live in insect cell culture as well as in cell-free medium. We also provide basic characteristics of type three secretion system and using three reference sequences (16 S rDNA, groEL and spaPQR region) we show that the bacterium branched within the genus Sodalis, but originated independently of the two previously described symbionts of hippoboscoids. We propose the name Candidatus Sodalis melophagi for this new bacterium.	[Chrudimsky, Tomas; Husnik, Filip; Novakova, Eva; Hypsa, Vaclav] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Husnik, Filip; Novakova, Eva; Hypsa, Vaclav] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Chrudimsky, T (corresponding author), Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	tomas.chrudimsky@gmail.com	Chrudimský, Tomáš/L-5628-2014; Husnik, Filip/U-2851-2017; Hypša, Václav/ABA-1503-2021; Hypsa, Vaclav/G-9847-2014; Novakova, Eva/D-9475-2016	Husnik, Filip/0000-0002-5381-0125; Hypša, Václav/0000-0001-5572-782X; Novakova, Eva/0000-0003-4090-0655	Ministry of Education, Youth and Sports of the Czech Republic [LC06073, MSM6007665801]; Grant agency of the Czech Republic [P505/10/1401]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant agency of the Czech Republic(Grant Agency of the Czech Republic)	The study was supported by grants LC06073 and MSM6007665801 (Ministry of Education, Youth and Sports of the Czech Republic) and grant P505/10/1401 (Grant agency of the Czech Republic). Access to the MetaCentrum computing facilities was provided by "Projects of Large Infrastructure for Research, Development, and Innovations" LM2010005 (Ministry of Education, Youth, and Sports of the Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; AKSOY S, 1995, INT J SYST BACTERIOL, V45, P848, DOI 10.1099/00207713-45-4-848; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belda E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-449; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Burke GR, 2009, APPL ENVIRON MICROB, V75, P5328, DOI 10.1128/AEM.00717-09; CAMPBELL BC, 1992, INSECT BIOCHEM MOLEC, V22, P415, DOI 10.1016/0965-1748(92)90136-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng Q, 1999, INSECT MOL BIOL, V8, P125, DOI 10.1046/j.1365-2583.1999.810125.x; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Coombes BK, 2009, TRENDS MICROBIOL, V17, P89, DOI 10.1016/j.tim.2008.11.006; Dale C, 2006, APPL ENVIRON MICROB, V72, P2997, DOI 10.1128/AEM.72.4.2997-3004.2006; Dale C, 2005, MOL BIOL EVOL, V22, P758, DOI 10.1093/molbev/msi061; Dale C, 1999, INT J SYST BACTERIOL, V49, P267, DOI 10.1016/S0020-7519(01)00151-5; Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Fukatsu T, 2007, APPL ENVIRON MICROB, V73, P6660, DOI 10.1128/AEM.01131-07; Grunwald S, 2010, SYST APPL MICROBIOL, V33, P25, DOI 10.1016/j.syapm.2009.10.002; Gruwell ME, 2010, APPL ENVIRON MICROB, V76, P7521, DOI 10.1128/AEM.01354-10; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Kaiwa N, 2011, ZOOL SCI, V28, P169, DOI 10.2108/zsj.28.169; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KRIEG NR, 1986, ANNU REV MICROBIOL, V40, P107, DOI 10.1146/annurev.micro.40.1.107; Lindh JM, 2011, ANTON LEEUW INT J G, V99, P711, DOI 10.1007/s10482-010-9546-x; Matthew CZ, 2005, FEMS MICROBIOL LETT, V248, P69, DOI 10.1016/j.femsle.2005.05.024; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Novakova E, 2007, FEMS MICROBIOL LETT, V269, P131, DOI 10.1111/j.1574-6968.2006.00620.x; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Pontes MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003541; Pontes MH, 2011, APPL ENVIRON MICROB, V77, P1918, DOI 10.1128/AEM.02166-10; Pontes MH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002349; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rio RVM, 2012, MBIO, V3, DOI 10.1128/mBio.00240-11; Runyen-Janecky LJ, 2010, J BACTERIOL, V192, P3780, DOI 10.1128/JB.00161-10; Sameshima S, 1999, ZOOL SCI, V16, P993, DOI 10.2108/zsj.16.993; Snyder AK, 2011, FEMS MICROBIOL LETT, V317, P143, DOI 10.1111/j.1574-6968.2011.02221.x; Snyder AK, 2010, P ROY SOC B-BIOL SCI, V277, P2389, DOI 10.1098/rspb.2010.0364; Thao ML, 2000, CURR MICROBIOL, V41, P300, DOI 10.1007/s002840010138; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Toju H, 2010, APPL ENVIRON MICROB, V76, P275, DOI 10.1128/AEM.02154-09; Verbarg S, 2008, CURR MICROBIOL, V56, P603, DOI 10.1007/s00284-008-9133-9; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	58	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40354	10.1371/journal.pone.0040354	http://dx.doi.org/10.1371/journal.pone.0040354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815743	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000014
J	O'Donnell, EF; Kopparapu, PR; Koch, DC; Jang, HS; Phillips, JL; Tanguay, RL; Kerkvliet, NI; Kolluri, SK				O'Donnell, Edmond F.; Kopparapu, Prasad Rao; Koch, Daniel C.; Jang, Hyo Sang; Phillips, Jessica Lynne; Tanguay, Robert L.; Kerkvliet, Nancy I.; Kolluri, Siva Kumar			The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells	PLOS ONE			English	Article							DIHYDROOROTATE DEHYDROGENASE; TUMOR-SUPPRESSOR; CYCLE REGULATION; GENE-EXPRESSION; HEPATOMA-CELLS; BREAST-CANCER; AH RECEPTOR; IN-VITRO; PROLIFERATION; INDUCTION	A novel role of the dihydroorotatedehydrogenase (DHODH) inhibitor leflunomide as a potential anti-melanoma therapy was recently reported (Nature 471: 518-22, 2011). We previously reported that leflunomide strongly activates the transcriptional activity of the Aryl Hydrocarbon Receptor (AhR). We therefore tested whether the AhR regulates the anti-proliferative effects of leflunomide in melanoma. We first evaluated the expression of AhR in melanoma cells and found that AhR is highly expressed in A375 melanoma as well as in several other cancer cell types. To evaluate whether AhR plays a role in regulating the growth inhibitory effects of leflunomide in A375 cells, we generated a stable cell line from parental A375 cells expressing a doxycycline (DOX) inducible AhR shRNA. Using these cells in the absence or presence of DOX (normal AhR levels or AhR-knockdown, respectively) we found that the anti-proliferative effects of leflunomide, but not its metabolite A771726, were strongly dependent upon AhR expression. It has been well established that supplementation of cells with exogenous uridine completely rescues the anti-proliferative effects due to DHODH inhibition. Thus, we performed uridine rescue experiments in A375 cells to determine whether the anti-proliferative effects of leflunomide are solely due to DHODH inhibition as previously reported. Interestingly, saturating levels of uridine only modestly rescued A375 cells from the anti-proliferative effects of both leflunomide and A771726, indicating additional mechanism(s), apart from DHODH inhibition are responsible for the anti-proliferative effects of leflunomide in melanoma cells. Uridine also did not rescue MDA-MB-435S melanoma cell proliferation after leflunomide treatment. Our results reveal that the AhR is a molecular target of leflunomide and support the feasibility of the clinical application of leflunomide for treating melanoma. Furthermore, analysis of expression data from 967 cancer cell lines revealed that AhR is expressed in multiple different cancer types supporting the intriguing possibility of targeting the AhR for therapy in a number of cancers.	[O'Donnell, Edmond F.; Kopparapu, Prasad Rao; Koch, Daniel C.; Jang, Hyo Sang; Phillips, Jessica Lynne; Kolluri, Siva Kumar] Oregon State Univ, Canc Res Lab, Corvallis, OR 97331 USA; [O'Donnell, Edmond F.; Kopparapu, Prasad Rao; Koch, Daniel C.; Jang, Hyo Sang; Tanguay, Robert L.; Kerkvliet, Nancy I.; Kolluri, Siva Kumar] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Phillips, Jessica Lynne; Tanguay, Robert L.; Kolluri, Siva Kumar] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Tanguay, Robert L.; Kerkvliet, Nancy I.; Kolluri, Siva Kumar] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	O'Donnell, EF (corresponding author), Oregon State Univ, Canc Res Lab, Corvallis, OR 97331 USA.	Siva.Kolluri@oregonstate.edu		Jang, Hyo Sang/0000-0003-0460-9924; /0000-0001-9516-9690	National Institute of Environmental Health Sciences (NIEHS) [ES016651, ES019000, T32ES07060]; Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS [P30 ES00210]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0160]; NIEHS training grant [T32ES07060]; National Research Service Award pre-doctoral fellowship through the National Cancer Institute [F31CA144571]; NATIONAL CANCER INSTITUTE [F31CA144571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210, R21ES019000, T32ES007060, R01ES016651] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS; Department of Defense Breast Cancer Research Program(United States Department of Defense); NIEHS training grant; National Research Service Award pre-doctoral fellowship through the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Institute of Environmental Health Sciences (NIEHS) grant numbers ES016651 and ES019000, The Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS grant number P30 ES00210. EFO is currently supported by a pre-doctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-10-1-0160) and was previously supported by NIEHS training grant (T32ES07060). DCK is supported by National Research Service Award pre-doctoral fellowship awarded through the National Cancer Institute (F31CA144571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Davis JP, 1996, BIOCHEMISTRY-US, V35, P1270, DOI 10.1021/bi952168g; Denison MS, 2002, CURR PROTOC TOXICOL; DuSell CD, 2010, MOL ENDOCRINOL, V24, P33, DOI 10.1210/me.2009-0339; Fan YX, 2010, CANCER RES, V70, P212, DOI 10.1158/0008-5472.CAN-09-3090; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Ftitz WA, 2009, BIOCHEM PHARMACOL, V77, P1151, DOI 10.1016/j.bcp.2008.12.015; Goodale BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029346; GREENE S, 1995, BIOCHEM PHARMACOL, V50, P861, DOI 10.1016/0006-2952(95)00255-X; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Jin DQ, 2004, NEUROSCI LETT, V363, P69, DOI 10.1016/j.neulet.2004.03.047; Jux B, 2011, J INVEST DERMATOL, V131, P203, DOI 10.1038/jid.2010.269; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kolluri SK, 2001, CANCER RES, V61, P8534; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Nair RV, 1995, IMMUNOL LETT, V48, P77, DOI 10.1016/0165-2478(95)02464-6; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Pang PH, 2008, J CELL PHYSIOL, V215, P161, DOI 10.1002/jcp.21299; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Safe S, 1999, Expert Opin Investig Drugs, V8, P1385, DOI 10.1517/13543784.8.9.1385; Safe S, 2002, INT J ONCOL, V20, P1123; Spodnik JH, 2002, MITOCHONDRION, V2, P163, DOI 10.1016/S1567-7249(02)00045-4; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; WILLIAMSON RA, 1995, J BIOL CHEM, V270, P22467, DOI 10.1074/jbc.270.38.22467; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Zhang S, 2009, ENDOCR-RELAT CANCER, V16, P835, DOI 10.1677/ERC-09-0054; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	39	53	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40926	10.1371/journal.pone.0040926	http://dx.doi.org/10.1371/journal.pone.0040926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815870	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000043
J	Mittal, D; Madhyastha, DA; Grover, A				Mittal, Dheeraj; Madhyastha, Dinesh A.; Grover, Anil			Genome-Wide Transcriptional Profiles during Temperature and Oxidative Stress Reveal Coordinated Expression Patterns and Overlapping Regulons in Rice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; COMPOSITE MODULE ANALYST; HIGH-SALINITY STRESSES; REACTIVE OXYGEN; ABIOTIC STRESS; HYDROGEN-PEROXIDE; GENE-EXPRESSION; COLD STRESS; OVER-EXPRESSION; CDNA MICROARRAY	Genome wide transcriptional changes by cold stress, heat stress and oxidative stress in rice seedlings were analyzed. Heat stress resulted in predominant changes in transcripts of heat shock protein and heat shock transcription factor genes, as well as genes associated with synthesis of scavengers of reactive oxygen species and genes that control the level of sugars, metabolites and auxins. Cold stress treatment caused differential expression of transcripts of various transcription factors including desiccation response element binding proteins and different kinases. Transcripts of genes that are part of calcium signaling, reactive oxygen scavenging and diverse metabolic reactions were differentially expressed during cold stress. Oxidative stress induced by hydrogen peroxide treatment, resulted in significant up-regulation in transcript levels of genes related to redox homeostasis and down-regulation of transporter proteins. ROS homeostasis appeared to play central role in response to temperature extremes. The key transcription factors that may underlie the concerted transcriptional changes of specific components in various signal transduction networks involved are highlighted. Co-ordinated expression pattern and promoter architectures based analysis (promoter models and overrepresented transcription factor binding sites) suggested potential regulons involved in stress responses. A considerable overlap was noted at the level of transcription as well as in regulatory modules of differentially expressed genes.	[Mittal, Dheeraj; Grover, Anil] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Madhyastha, Dinesh A.] BIOBASE Databases India Private Ltd, Bangalore, Karnataka, India	University of Delhi	Mittal, D (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India.	agrover@south.du.ac.in	Grover, Anil/D-4875-2014		Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work is supported by the project grant to AG by Department of Biotechnology, Government of India (http://dbtindia.nic.in/index.asp), Council of Scientific and Industrial Research, Government of India (http://www.csir.res.in/home.asp), provided the fellowship grants to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2005, PLANT SCI, V169, P559, DOI 10.1016/j.plantsci.2005.05.004; Archak Sunil, 2007, Genomics Proteomics & Bioinformatics, V5, P196, DOI 10.1016/S1672-0229(08)60007-8; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Banti V, 2008, PLANT CELL ENVIRON, V31, P1029, DOI 10.1111/j.1365-3040.2008.01816.x; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Carranco R, 2010, P NATL ACAD SCI USA, V107, P21908, DOI 10.1073/pnas.1014856107; Chao DY, 2005, CELL RES, V15, P796, DOI 10.1038/sj.cr.7290349; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Djanaguiraman M, 2006, PLANT SOIL, V284, P363, DOI 10.1007/s11104-006-0043-y; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Ella ES, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr007; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Goswami A, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq023; Haralampidis K, 2002, PLANT PHYSIOL, V129, P1138, DOI 10.1104/pp.004044; He LH, 2009, AFR J BIOTECHNOL, V8, P6151; Hoshida H, 2000, PLANT MOL BIOL, V43, P103, DOI 10.1023/A:1006408712416; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Kant P, 2008, PLANT CELL ENVIRON, V31, P697, DOI 10.1111/j.1365-3040.2008.01779.x; Katiyar-Agarwal S, 2003, PLANT MOL BIOL, V51, P677, DOI 10.1023/A:1022561926676; Kel A, 2006, BIOINFORMATICS, V22, P1190, DOI 10.1093/bioinformatics/btl041; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Lee BH, 2000, GENE, V245, P283, DOI 10.1016/S0378-1119(00)00043-3; Liu DL, 2006, PLANT PHYSIOL BIOCH, V44, P380, DOI 10.1016/j.plaphy.2006.06.011; Locato V, 2008, PLANT CELL ENVIRON, V31, P1606, DOI 10.1111/j.1365-3040.2008.01867.x; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Mahalingam R, 2003, PHYSIOL PLANTARUM, V119, P56, DOI 10.1034/j.1399-3054.2003.00156.x; Marsoni M, 2010, PLANT CELL ENVIRON, V33, P1161, DOI 10.1111/j.1365-3040.2010.02137.x; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Mittal D, 2009, PLANT PHYSIOL BIOCH, V47, P785, DOI 10.1016/j.plaphy.2009.05.003; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Neta-Sharir I, 2005, PLANT CELL, V17, P1829, DOI 10.1105/tpc.105.031914; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Panikulangara TJ, 2004, PLANT PHYSIOL, V136, P3148, DOI 10.1104/pp.104.042606; Paragh G, 2008, EXP DERMATOL, V17, P1004, DOI 10.1111/j.1600-0625.2008.00736.x; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; Pucciariello C, 2012, PLANT PHYSIOL BIOCH, V59, P3, DOI 10.1016/j.plaphy.2012.02.016; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Sabehat A, 1998, PLANT PHYSIOL, V117, P651, DOI 10.1104/pp.117.2.651; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sakamoto A, 1998, PLANT MOL BIOL, V38, P1011, DOI 10.1023/A:1006095015717; Sakata T, 2010, P NATL ACAD SCI USA, V107, P8569, DOI 10.1073/pnas.1000869107; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; SATAKE T, 1978, JPN J CROP SCI, V47, P6, DOI 10.1626/jcs.47.6; Singh Amanjot, 2008, Physiology and Molecular Biology of Plants, V14, P155, DOI 10.1007/s12298-008-0014-2; Singh A, 2012, CELL STRESS CHAPERON, V17, P243, DOI 10.1007/s12192-011-0303-5; Singh A, 2010, PLANT MOL BIOL, V74, P395, DOI 10.1007/s11103-010-9682-8; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-95; SLAFER GA, 1994, AUST J PLANT PHYSIOL, V21, P393, DOI 10.1071/PP9940393; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wahid A, 2008, SEED SCI TECHNOL, V36, P633, DOI 10.15258/sst.2008.36.3.13; Waleev T, 2006, NUCLEIC ACIDS RES, V34, pW541, DOI 10.1093/nar/gkl342; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wojciak JM, 2001, NAT STRUCT BIOL, V8, P568, DOI 10.1038/89582; Xuan Y, 2010, PLANT PHYSIOL, V153, P1895, DOI 10.1104/pp.110.160424; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yokoi S, 1998, MOL BREEDING, V4, P269, DOI 10.1023/A:1009671231614; Yoshida S., 1981, IRRI RES PAPER SERIE, V67, P1; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang W, 2009, PLANT PHYSIOL, V149, P1773, DOI 10.1104/pp.108.133744; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	90	59	70	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40899	10.1371/journal.pone.0040899	http://dx.doi.org/10.1371/journal.pone.0040899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815860	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100091
J	Pilloni, G; Granitsiotis, MS; Engel, M; Lueders, T				Pilloni, Giovanni; Granitsiotis, Michael S.; Engel, Marion; Lueders, Tillmann			Testing the Limits of 454 Pyrotag Sequencing: Reproducibility, Quantitative Assessment and Comparison to T-RFLP Fingerprinting of Aquifer Microbes	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; RIBOSOMAL-RNA; GENERATION; DATABASE; GENES; TOOLS; IRON; BIAS	The characterization of microbial community structure via 16S rRNA gene profiling has been greatly advanced in recent years by the introduction of amplicon pyrosequencing. The possibility of barcoding gives the opportunity to massively screen multiple samples from environmental or clinical sources for community details. However, an on-going debate questions the reproducibility and semi-quantitative rigour of pyrotag sequencing, similar to the early days of community fingerprinting. In this study we demonstrate the reproducibility of bacterial 454 pyrotag sequencing over biological and technical replicates of aquifer sediment bacterial communities. Moreover, we explore the potential of recovering specific template ratios via quantitatively defined template spiking to environmental DNA. We sequenced pyrotag libraries of triplicate sediment samples taken in annual sampling campaigns at a tar oil contaminated aquifer in Dusseldorf, Germany. The abundance of dominating lineages was highly reproducible with a maximal standard deviation of similar to 4% read abundance across biological, and similar to 2% across technical replicates. Our workflow also allows for the linking of read abundances within defined assembled pyrotag contigs to that of specific 'in vivo' fingerprinting signatures. Thus we demonstrate that both terminal restriction fragment length polymorphism (T-RFLP) analysis and pyrotag sequencing are capable of recovering highly comparable community structure. Overall diversity was roughly double in amplicon sequencing. Pyrotag libraries were also capable of linearly recovering increasing ratios (up to 20%) of 16S rRNA gene amendments from a pure culture of Aliivibrio fisheri spiked to sediment DNA. Our study demonstrates that 454 pyrotag sequencing is a robust and reproducible method, capable of reliably recovering template abundances and overall community structure within natural microbial communities.	[Pilloni, Giovanni; Granitsiotis, Michael S.; Lueders, Tillmann] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Groundwater Ecol, Neuherberg, Germany; [Engel, Marion] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Environm Gen, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Pilloni, G (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Groundwater Ecol, Neuherberg, Germany.	tillmann.lueders@helmholtz-muenchen.de	Lueders, Tillmann/B-1486-2013	Lueders, Tillmann/0000-0002-9361-5009; Pilloni, Giovanni/0000-0002-2125-0987; Granitsiotis, Michael S./0000-0002-8634-6103	Deutsche Forschungsgemeinschaft within the Research Unit 'Analysis and Modelling of Diffusion/Dispersion-limited Reactions in Porous Media' [FOR 525, LU 1188/2-2]; Helmholtz Society; 'NanoSan' project; German Federal Ministry of Education and Research (BMBF) [03X0085C]; EU-FP7 GOODWATER ITN [212683]	Deutsche Forschungsgemeinschaft within the Research Unit 'Analysis and Modelling of Diffusion/Dispersion-limited Reactions in Porous Media'; Helmholtz Society(Helmholtz Association); 'NanoSan' project; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU-FP7 GOODWATER ITN	This work was financed by grants from the Deutsche Forschungsgemeinschaft within the Research Unit 'Analysis and Modelling of Diffusion/Dispersion-limited Reactions in Porous Media' (FOR 525) to TL (LU 1188/2-2) as well as by the Helmholtz Society. During writing, GP received funding by the 'NanoSan' project financed by the German Federal Ministry of Education and Research (BMBF; Grant No. 03X0085C). MSG was financed by a fellowship within the EU-FP7 GOODWATER ITN (Grant No. 212683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneser B, 2010, GEOMICROBIOL J, V27, P130, DOI 10.1080/01490450903456723; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Berry D, 2011, APPL ENV MICROBIOL; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Junier P, 2008, APPL ENVIRON MICROB, V74, P6452, DOI 10.1128/AEM.01394-08; Kohlmann A, 2011, LEUKEMIA, V25, P1840, DOI 10.1038/leu.2011.155; Kunapuli U, 2007, ISME J, V1, P643, DOI 10.1038/ismej.2007.73; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Novais RC, 2011, J MICROBIOL METH, V86, P1, DOI 10.1016/j.mimet.2011.04.006; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pilloni G, 2011, FEMS MICROBIOL ECOL, V78, P165, DOI 10.1111/j.1574-6941.2011.01083.x; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winderl C, 2008, APPL ENVIRON MICROB, V74, P792, DOI 10.1128/AEM.01951-07; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	23	126	127	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40467	10.1371/journal.pone.0040467	http://dx.doi.org/10.1371/journal.pone.0040467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808168	Green Published, gold			2022-12-27	WOS:000306366400026
J	Bodai, L; Zsindely, N; Gaspar, R; Kristo, I; Komonyi, O; Boros, IM				Bodai, Laszlo; Zsindely, Nora; Gaspar, Renata; Kristo, Ildiko; Komonyi, Orban; Boros, Imre Miklos			Ecdysone Induced Gene Expression Is Associated with Acetylation of Histone H3 Lysine 23 in Drosophila melanogaster	PLOS ONE			English	Article							ANDROGEN RECEPTOR; INDUCIBLE GENE; EARLY PUFF; METAMORPHOSIS; TRANSCRIPTION; CBP; COACTIVATOR; ENCODES; COMPLEX; BINDING	Posttranslational modification of histones regulates transcription but the exact role that acetylation of specific lysine residues plays in biological processes in vivo is still not clearly understood. To assess the contribution of different histone modifications to transcriptional activation in vivo, we determined the acetylation patterns on the ecdysone induced Eip74EF and Eip75B genes in Drosophila melanogaster larvae by chromatin immunoprecipitation. We found that acetylation of histone H3 lysine 23 is localized to promoters and correlates with endogenous ecdysone induced gene activation. In contrast, acetylation of lysines 8, 12 and 16 of histone H4 and lysine 9 of histone H3 showed minor differences in their distribution on the regulatory and transcribed regions tested, and had limited or no correlation with ecdysone induced transcriptional activity. We found that dCBP, which is encoded by the nejire gene, acetylates H3 lysine 23 in vivo, and silencing of nejire leads to reduced expression of the Eip74EF and Eip75B genes. Our results suggest that acetylation of specific lysine residues of histones contribute specifically to the dynamic regulation of transcription. Furthermore, along with previous studies identify CBP dependent H3 lysine 23 acetylation as an evolutionarily conserved chromatin modification involved in steroid induced gene activation.	[Bodai, Laszlo; Zsindely, Nora; Gaspar, Renata; Kristo, Ildiko; Boros, Imre Miklos] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Zsindely, Nora; Komonyi, Orban; Boros, Imre Miklos] Univ Szeged, Chromatin Res Grp, Hungarian Acad Sci, Szeged, Hungary; [Komonyi, Orban] CNRS, UMR 7104, Inst Genet & Biol Mol & Cellulaire, INSERM,U964, Illkirch Graffenstaden, France; [Boros, Imre Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	Szeged University; Hungarian Academy of Sciences; Szeged University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Bodai, L (corresponding author), Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA.	lbodai@yahoo.com	Bodai, Laszlo/A-9764-2012; Zsindely, Nora/AAG-9738-2021	Bodai, Laszlo/0000-0001-8411-626X; Zsindely, Nora/0000-0002-6189-3100; Gaspar, Renata/0000-0001-9673-4532; Boros, Imre/0000-0001-8504-9687	Hungarian National Science Foundation (OTKA) [PD-72491, 77443]	Hungarian National Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian National Science Foundation (OTKA, http://www.otka.hu) grant PD-72491 to Dr. Bodai and grant 77443 to Dr. Boros. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Anamika K, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-18; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bodai L, 2012, NEURODEGENER DIS, V9, P104, DOI 10.1159/000330505; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Buszczak M, 2000, CURR BIOL, V10, pR830, DOI 10.1016/S0960-9822(00)00792-2; Cakouros D, 2004, J BIOL CHEM, V279, P18467, DOI 10.1074/jbc.M400972200; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; HUET F, 1993, DEVELOPMENT, V118, P613; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Kirilly D, 2011, NEURON, V72, P86, DOI 10.1016/j.neuron.2011.08.003; Kumar JP, 2004, GENETICS, V168, P877, DOI 10.1534/genetics.104.029850; Lilja T, 2003, DEV BIOL, V262, P294, DOI 10.1016/S0012-1606(03)00392-0; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marmorstein R, 2001, STRUCTURE, V9, P1127, DOI 10.1016/S0969-2126(01)00690-6; Miotto B, 2006, GENE DEV, V20, P101, DOI 10.1101/gad.359506; Munshi A, 2009, J GENET GENOMICS, V36, P75, DOI 10.1016/S1673-8527(08)60094-6; Pankotai T, 2005, MOL CELL BIOL, V25, P8215, DOI 10.1128/MCB.25.18.8215-8227.2005; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Sanchez-Pacheco A, 2009, ENDOCRINOLOGY, V150, P5143, DOI 10.1210/en.2009-0117; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scott EK, 2001, CURR BIOL, V11, P99, DOI 10.1016/S0960-9822(01)00020-3; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sheffield JB, 2007, MICROSC MICROANAL, V13, P200, DOI 10.1017/S1431927607076611; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vincent S, 1996, DEVELOPMENT, V122, P131; Xue K, 2010, MOL REPROD DEV, V77, P605, DOI 10.1002/mrd.21190; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Zsindely N, 2009, NUCLEIC ACIDS RES, V37, P6665, DOI 10.1093/nar/gkp722	51	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40565	10.1371/journal.pone.0040565	http://dx.doi.org/10.1371/journal.pone.0040565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808194	gold, Green Published			2022-12-27	WOS:000306355500058
J	Huang, YH; Lin, KH; Liao, CH; Lai, MW; Tseng, YH; Yeh, CT				Huang, Ya-Hui; Lin, Kwang-Huei; Liao, Chen-Hsin; Lai, Ming-Wei; Tseng, Yi-Hsin; Yeh, Chau-Ting			Furin Overexpression Suppresses Tumor Growth and Predicts a Better Postoperative Disease-Free Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; GENE-EXPRESSION; FACTOR-BETA-1-INDUCED APOPTOSIS; CANCER-CELLS; HUMAN HEAD; TGF-BETA; BCL-XL; ACTIVATION; PROGRESSION; TUMORIGENESIS	Furin is a member of the pro-protein convertase family. It processes several growth regulatory proteins into their active forms, which are critical to tumor progression, metastasis, and angiogenesis. Furin over-expression could occur in liver cancer and a previous study showed that over-expression of furin promoted HepG2 cell invasion in tail vein xenograft models. However, the clinical relevance of furin expression in hepatocellular carcinoma (HCC) remained unknown. Surprisingly, in a postoperative survival analysis for HCC patients, it was found that the tumor/non-tumor (T/N) ratio of furin expression >= 3.5 in HCC tissues predicted a better postoperative disease-free survival (DFS) (P = 0.010; log-rank test). Furthermore, subcutaneous xenograft experiments demonstrated a significant suppression effect of tumor growth in the furin-overexpressed xenografts (Huh7-Furin) compared to the mock control. Administration of a synthetic furin inhibitor for inhibition of the pro-protein convertase activity, decanoyl-Arg-Val-Lys-Arg-chloromethylketone (decRVKR-CMK), to the Huh7-Furin xenograft bearing mice restored the repression effect of tumor growth. In contrast, administration of decRVKR-CMK to the mock Huh7 xenograft bearing mice showed no change in growth rate. In conclusion, furin overexpression inhibited HCC tumor growth in a subcutaneous xenograft model and predicted a better postoperative DFS in clinical analysis.	[Huang, Ya-Hui; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan; [Lin, Kwang-Huei; Liao, Chen-Hsin; Tseng, Yi-Hsin] Chang Gung Univ, Dept Biochem, Sch Med, Tao Yuan, Taiwan; [Lai, Ming-Wei] Chang Gung Children Hosp, Dept Pediat Gastroenterol, Tao Yuan, Taiwan; [Yeh, Chau-Ting] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, YH (corresponding author), Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan.	chautingy@gmail.com			Chang Gung Medical Research Council [CMRPG 370692]	Chang Gung Medical Research Council	The study is supported by a grant from Chang Gung Medical Research Council (CMRPG 370692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem E, 2011, TOXICOL PATHOL, V39, P524, DOI 10.1177/0192623310396905; ANGLIKER H, 1993, BIOCHEM J, V293, P75, DOI 10.1042/bj2930075; Bassi DE, 2000, MOL CARCINOGEN, V28, P63, DOI 10.1002/1098-2744(200006)28:2<63::AID-MC1>3.3.CO;2-3; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; Cao J, 2005, J BIOL CHEM, V280, P10974, DOI 10.1074/jbc.M412370200; Chen RN, 2008, ENDOCRINOLOGY, V149, P3817, DOI 10.1210/en.2007-0989; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Chipuk JE, 2001, J BIOL CHEM, V276, P26614, DOI 10.1074/jbc.M100913200; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; de Cicco RL, 2007, MOL CARCINOGEN, V46, P654, DOI 10.1002/mc.20331; De Vos L, 2008, INT J ONCOL, V32, P1073; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; Guo XZ, 2002, WORLD J GASTROENTERO, V8, P1059, DOI 10.3748/wjg.v8.i6.1059; Huang YH, 2010, J CELL PHYSIOL, V222, P347, DOI 10.1002/jcp.21959; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Masaki T, 2000, HEPATOLOGY, V32, P711, DOI 10.1053/jhep.2000.17705; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Page RE, 2007, CELL ONCOL, V29, P289; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; Schnater JM, 2006, J HEPATOL, V45, P377, DOI 10.1016/j.jhep.2006.03.018; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Sun XW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-73; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Yeh CT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-324; Zhang H, 2004, CANCER SCI, V95, P878, DOI 10.1111/j.1349-7006.2004.tb02197.x	39	27	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40738	10.1371/journal.pone.0040738	http://dx.doi.org/10.1371/journal.pone.0040738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808247	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500076
J	Sarma, U; Sareen, A; Maiti, M; Kamat, V; Sudan, R; Pahari, S; Srivastava, N; Roy, S; Sinha, S; Ghosh, I; Chande, AG; Mukhopadhyaya, R; Saha, B				Sarma, Uddipan; Sareen, Archana; Maiti, Moitrayee; Kamat, Vanita; Sudan, Raki; Pahari, Sushmita; Srivastava, Neetu; Roy, Somenath; Sinha, Sitabhra; Ghosh, Indira; Chande, Ajit G.; Mukhopadhyaya, Robin; Saha, Bhaskar			Modeling and Experimental Analyses Reveals Signaling Plasticity in a Bi-Modular Assembly of CD40 Receptor Activated Kinases	PLOS ONE			English	Article							LEISHMANIA-MAJOR INFECTION; NEGATIVE-FEEDBACK; PATHWAY; MAPK; OSCILLATIONS; STRENGTH; CELLS	Depending on the strength of signal dose, CD40 receptor (CD40) controls ERK-1/2 and p38MAPK activation. At low signal dose, ERK-1/2 is maximally phosphorylated but p38MAPK is minimally phosphorylated; as the signal dose increases, ERK-1/2 phosphorylation is reduced whereas p38MAPK phosphorylation is reciprocally enhanced. The mechanism of reciprocal activation of these two MAPKs remains un-elucidated. Here, our computational model, coupled to experimental perturbations, shows that the observed reciprocity is a system-level behavior of an assembly of kinases arranged in two modules. Experimental perturbations with kinase inhibitors suggest that a minimum of two trans-modular negative feedback loops are required to reproduce the experimentally observed reciprocity. The bi-modular architecture of the signaling pathways endows the system with an inherent plasticity which is further expressed in the skewing of the CD40-induced productions of IL-10 and IL-12, the respective anti-inflammatory and pro-inflammatory cytokines. Targeting the plasticity of CD40 signaling significantly reduces Leishmania major infection in a susceptible mouse strain. Thus, for the first time, using CD40 signaling as a model, we show how a bi-modular assembly of kinases imposes reciprocity to a receptor signaling. The findings unravel that the signalling plasticity is inherent to a reciprocal system and that the principle can be used for designing a therapy.	[Sarma, Uddipan; Sareen, Archana; Maiti, Moitrayee; Kamat, Vanita; Sudan, Raki; Pahari, Sushmita; Srivastava, Neetu; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Roy, Somenath] Vidyasagar Univ, Midnapore, W Bengal, India; [Sinha, Sitabhra] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Ghosh, Indira] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Chande, Ajit G.; Mukhopadhyaya, Robin] Tata Mem Hosp, Adv Ctr Training,Res & Educ Canc ACTREC, Navi Mumbai, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Vidyasagar University; Institute of Mathematical Sciences (IMSc) India; Jawaharlal Nehru University, New Delhi; Tata Memorial Centre (TMC); Tata Memorial Hospital	Sarma, U (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	sahab@nccs.res.in	Sudan, Raki/AFK-6979-2022; Srivastava, Neetu/HDM-9431-2022; Chande, Ajit/K-5031-2014; ghosh, indira/H-5008-2019; Srivastava, Neetu/AAM-6596-2021	Chande, Ajit/0000-0003-2210-5180; CHAKRABORTY, SUSHMITA/0000-0002-0255-9532	Department of Biotechnology, Government of India, New Delhi [BT/PR/7521/BRB/10/482/2006]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	The work was funded by the Department of Biotechnology, Government of India, New Delhi [Project no. BT/PR/7521/BRB/10/482/2006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaudhri VK, 2010, J BIOL CHEM, V285, P1296, DOI 10.1074/jbc.M109.055863; Davis JR, 1993, MITOGEN ACTIVATED PR, V268, P14553; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Foey AD, 2001, CYTOKINE, V16, P131, DOI 10.1006/cyto.2001.0954; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goldstein B, 2002, MOL IMMUNOL, V1137, P17; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Purkerson JM, 1998, J IMMUNOL, V160, P2121; Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705; Santhosh CV, 2008, BIOCHEM BIOPH RES CO, V371, P546, DOI 10.1016/j.bbrc.2008.04.106; Segel I. H., 1993, ENZYME KINETICS BEHA; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Srivastava N, 2011, J IMMUNOL, V186, P5863, DOI 10.4049/jimmunol.1003957; Sudan R, 2012, J IMMUNOL, V188, P2328, DOI 10.4049/jimmunol.1101678; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yanagi S, 1996, J BIOL CHEM, V271, P30487, DOI 10.1074/jbc.271.48.30487; Zheng Y, 2006, IEE P SYST BIOL, V153, P201, DOI 10.1049/ip-syb:20050088; Zi ZK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-342	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e39898	10.1371/journal.pone.0039898	http://dx.doi.org/10.1371/journal.pone.0039898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815717	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900013
J	Slopen, N; Glynn, RJ; Buring, JE; Lewis, TT; Williams, DR; Albert, MA				Slopen, Natalie; Glynn, Robert J.; Buring, Julie E.; Lewis, Tene T.; Williams, David R.; Albert, Michelle A.			Job Strain, Job Insecurity, and Incident Cardiovascular Disease in the Women's Health Study: Results from a 10-Year Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PSYCHOSOCIAL FACTORS; WORK STRESS; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; RISK; OCCUPATION; SYMPTOMS; PROFILE	Objectives: Research about work-related stressors and cardiovascular disease (CVD) has produced mixed findings. Moreover, a paucity of data exists regarding the long-term associations between job strain and job insecurity and CVD among women. Methods: We used Cox proportional hazard models to examine the relationship between job strain, job insecurity, and incident CVD over 10 years of follow-up among 22,086 participants in the Women's Health Study (mean age 57 +/- 5 years). Results: During 10 years of follow-up there were 170 myocardial infarctions (MI), 163 ischemic strokes, 440 coronary revascularizations, and 52 CVD deaths. In models adjusted for age, race, education, and income, women with high job strain (high demand, low control) were 38% more likely to experience a CVD event than their counterparts who reported low job strain (low demand, high control; Rate Ratio (RR) = 1.38, 95% Confidence Interval (CI) = 1.08-1.77), and women with active jobs (high demand, high control) were 38% more likely to experience a CVD event relative to women who reported low job strain (95% CI = 1.07-1.77). Outcome-specific analyses revealed that high job strain predicted non-fatal myocardial infarction (RR = 1.67, CI = 1.04-2.70), and coronary revascularization (RR = 1.41, CI = 1.05-1.90). No evidence of an association between job insecurity and long-term CVD risk was observed. Conclusion: High strain and active jobs, but not job insecurity, were related to increased CVD risk among women. Both job strain and job insecurity were significantly related to CVD risk factors. With the increase of women in the workforce, these data emphasize the importance of addressing job strain in CVD prevention efforts among working women.	[Slopen, Natalie; Glynn, Robert J.; Buring, Julie E.; Williams, David R.] Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA; [Slopen, Natalie] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Glynn, Robert J.; Buring, Julie E.; Albert, Michelle A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Prevent Med, Boston, MA 02115 USA; [Lewis, Tene T.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Williams, David R.] Harvard Univ, Dept African & African Amer Studies, Cambridge, MA 02138 USA; [Albert, Michelle A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Slopen, N (corresponding author), Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA.	maalbert@partners.org			National Heart, Lung, and Blood Institute [HL-080467, HL099355, HL-43851, CA-47988]; National Cancer Institute; Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851, RC1HL099355, F32HL143851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Health Study is supported by grants HL-080467, HL099355, HL-43851 and CA-47988 from the National Heart, Lung, and Blood Institute and the National Cancer Institute. Dr. Albert is supported by an H. Richard Nesson Award from the Brigham and Women's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFREDSSON L, 1985, INT J EPIDEMIOL, V14, P378, DOI 10.1093/ije/14.3.378; Backe EM, 2012, INT ARCH OCC ENV HEA, V85, P67, DOI 10.1007/s00420-011-0643-6; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Eaker ED, 2004, AM J EPIDEMIOL, V159, P950, DOI 10.1093/aje/kwh127; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Ferrie JE, 1998, SOC SCI MED, V46, P243, DOI 10.1016/S0277-9536(97)00158-5; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; Griffin JM, 2007, J OCCUP HEALTH PSYCH, V12, P334, DOI 10.1037/1076-8998.12.4.334; HALL EM, 1993, OCCUP MED, V8, P709; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2009, INT J EPIDEMIOL, V38, P1265, DOI 10.1093/ije/dyn373; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Kivimaki M, 2006, PSYCHOSOM MED, V68, P398, DOI 10.1097/01.psy.0000221252.84351.e2; Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752; Kung HC, 2008, NATL VITAL STAT REPO; Kuper H, 2007, STROKE, V38, P27, DOI 10.1161/01.STR.0000251805.47370.91; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lee S, 2004, ANN EPIDEMIOL, V14, P24, DOI 10.1016/S1047-2797(03)00074-7; Lee S, 2002, INT J EPIDEMIOL, V31, P1147, DOI 10.1093/ije/31.6.1147; Lucini D, 2007, HYPERTENSION, V49, P291, DOI 10.1161/01.HYP.0000255034.42285.58; Markovitz JH, 2004, ANN BEHAV MED, V28, P4, DOI 10.1207/s15324796abm2801_2; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005	35	70	70	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40512	10.1371/journal.pone.0040512	http://dx.doi.org/10.1371/journal.pone.0040512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815754	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900027
J	Wang, GY; Rong, YW; Chen, H; Pearson, C; Du, CH; Simha, R; Zeng, C				Wang, Guanyu; Rong, Yongwu; Chen, Hao; Pearson, Carl; Du, Chenghang; Simha, Rahul; Zeng, Chen			Process-Driven Inference of Biological Network Structure: Feasibility, Minimality, and Multiplicity	PLOS ONE			English	Article							REGULATORY NETWORKS; GENE-EXPRESSION; TOPOLOGY; EVOLVABILITY; ALGORITHM; DYNAMICS; MODELS; CELLS	A common problem in molecular biology is to use experimental data, such as microarray data, to infer knowledge about the structure of interactions between important molecules in subsystems of the cell. By approximating the state of each molecule as "on" or "off", it becomes possible to simplify the problem, and exploit the tools of Boolean analysis for such inference. Amongst Boolean techniques, the process-driven approach has shown promise in being able to identify putative network structures, as well as stability and modularity properties. This paper examines the process-driven approach more formally, and makes four contributions about the computational complexity of the inference problem, under the "dominant inhibition" assumption of molecular interactions. The first is a proof that the feasibility problem (does there exist a network that explains the data?) can be solved in polynomial-time. Second, the minimality problem (what is the smallest network that explains the data?) is shown to be NP-hard, and therefore unlikely to result in a polynomial-time algorithm. Third, a simple polynomial-time heuristic is shown to produce near-minimal solutions, as demonstrated by simulation. Fourth, the theoretical framework explains how multiplicity (the number of network solutions to realize a given biological process), which can take exponential-time to compute, can instead be accurately estimated by a fast, polynomial-time heuristic.	[Wang, Guanyu; Chen, Hao; Pearson, Carl; Du, Chenghang; Zeng, Chen] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Rong, Yongwu] George Washington Univ, Dept Math, Washington, DC 20052 USA; [Simha, Rahul] George Washington Univ, Dept Comp Sci, Washington, DC 20052 USA; [Zeng, Chen] Huazhong Univ Sci & Technol, Dept Phys, Wuhan 430074, Peoples R China	George Washington University; George Washington University; George Washington University; Huazhong University of Science & Technology	Wang, GY (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.	chenz@gwu.edu	Pearson, Carl/AAH-8892-2019	Pearson, Carl/0000-0003-0701-7860	National Science Foundation (NSF) [CDI-0941228]; HUST; American Cancer Society [IRG-08-091-01]; Directorate For Engineering [0941228] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); HUST; American Cancer Society(American Cancer Society); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	1. National Science Foundation (NSF) Grant CDI-0941228 (C.Z., R. S., Y.R., G. W.) (http://www.nsf.gov/), 2. Chutian Visiting Professorship at HUST (C.Z.) (http://www.hust.edu.cn/), 3. American Cancer Society grant IRG-08-091-01 (G. W.) (http://www.cancer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2003, THEOR COMPUT SCI, V298, P235, DOI 10.1016/S0304-3975(02)00425-5; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon N, 2006, ACM T ALGORITHMS, V2, P153, DOI 10.1145/1150334.1150336; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; ASPVALL B, 1979, INFORM PROCESS LETT, V8, P121, DOI 10.1016/0020-0190(79)90002-4; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Brassard G., 1996, FUNDAMENTALS ALGORIT; Chandru V., 1990, ANN MATH ARTIF INTEL, V1, P33; Chang CC, 1958, J SYMBOLIC LOGIC, V23, P149; Chowdhury SA, 2010, BIOCOMPUT-PAC SYM, P133; Chvatal V., 1979, Mathematics of Operations Research, V4, P233, DOI 10.1287/moor.4.3.233; Chvatal V, 1979, MATH OPER RES, V4, p[233, 22]; Cook S, 2010, LOGICAL FDN PROOF CO; Cook SA, 1971, P 3 ANN ACM S THEOR, P151, DOI DOI 10.1145/800157.805047; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Dehmer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003079; Doi, 1997, Genome Inform Ser Workshop Genome Inform, V8, P43; Dowling W. F., 1984, Journal of Logic Programming, V1, P267, DOI 10.1016/0743-1066(84)90014-1; Emmert-Streib F, 2007, APPL MATH COMPUT, V190, P1783, DOI 10.1016/j.amc.2007.02.095; Emmert-Streib F, 2011, STRUCTURAL ANALYSIS OF COMPLEX NETWORKS, P1, DOI 10.1007/978-0-8176-4789-6_1; Estrada E., 2012, STRUCTURE COMPLEX NE, DOI DOI 10.1093/ACPROF:OSO/9780199591756.001.0001; Finlayson MR, 2011, MOL BIOL CELL, V22, P3081, DOI 10.1091/mbc.E10-12-1006; Fortuna MA, 2007, J THEOR BIOL, V247, P331, DOI 10.1016/j.jtbi.2007.03.017; Fukagawa D, 2005, INFORM PROCESS LETT, V93, P7, DOI 10.1016/j.ipl.2004.09.017; Garey M. R., 1979, Computers and intractability. A guide to the theory of NP-completeness; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Greenbury SF, 2010, J THEOR BIOL, V267, P48, DOI 10.1016/j.jtbi.2010.08.006; Hogan J M, 2001, Int J Neural Syst, V11, P537, DOI 10.1016/S0129-0657(01)00095-3; Horn A., 1951, J SYMBOLIC LOGIC, V16, P14, DOI DOI 10.2307/2268661; Howes R, 1998, P 47 IEEE C DEC CONT; Ideker T. E., 2000, PAC S BIOC, V5, P302; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Karp R.M., 1972, REDUCIBILITY COMBINA, P85, DOI DOI 10.1007/978-1-4684-2001-29; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kauffman Stuart A., 1993; KEISLER HJ, 1965, T AM MATH SOC, V117, P307, DOI 10.2307/1994209; Kosaraju SR, 1998, J COMPUT BIOL, V5, P9, DOI 10.1089/cmb.1998.5.9; Lau KY, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051907; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Mendelson E, 1997, INTRO MATH LOGIC; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mossel E., 2003, P 35 ACM S THEOR COM, P206; Mukherjee S, 2009, BIOINFORMATICS, V25, P265, DOI 10.1093/bioinformatics/btn611; Needham CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-85; Ning T, 2006, J THEOR BIOL, V240, P592, DOI 10.1016/j.jtbi.2005.10.019; Nochomovitz YD, 2006, P NATL ACAD SCI USA, V103, P4180, DOI 10.1073/pnas.0507032103; Okazaki N, 2008, J THEOR BIOL, V250, P621, DOI 10.1016/j.jtbi.2007.10.030; Perkins TJ, 2010, PHILOS T R SOC A, V368, P4961, DOI 10.1098/rsta.2010.0139; Perkins TJ, 2010, IEEE ACM T COMPUT BI, V7, P118, DOI 10.1109/TCBB.2008.38; Raychaudhuri S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011930; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Saithong T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030232; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; VANBEEK P, 1995, J ACM, V42, P543, DOI 10.1145/210346.210347; Vassilevska V, 2009, ACM S THEORY COMPUT, P455; Wang GY, 2010, P NATL ACAD SCI USA, V107, P10478, DOI 10.1073/pnas.0914180107; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	66	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40330	10.1371/journal.pone.0040330	http://dx.doi.org/10.1371/journal.pone.0040330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815739	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900021
J	Wappler, T; Labandeira, CC; Rust, J; Frankenhauser, H; Wilde, V				Wappler, Torsten; Labandeira, Conrad C.; Rust, Jes; Frankenhaeuser, Herbert; Wilde, Volker			Testing for the Effects and Consequences of Mid Paleogene Climate Change on Insect Herbivory	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; PLANT DIVERSITY; ATMOSPHERIC CO2; ECKFELD EIFEL; EOCENE; ASSOCIATIONS; GERMANY; TEMPERATURE; GENERALIST; SPECIALIST	Background: The Eocene, a time of fluctuating environmental change and biome evolution, was generally driven by exceptionally warm temperatures. The Messel (47.8 Ma) and Eckfeld (44.3 Ma) deposits offer a rare opportunity to take a census of two, deep-time ecosystems occurring during a greenhouse system. An understanding of the long-term consequences of extreme warming and cooling events during this interval, particularly on angiosperms and insects that dominate terrestrial biodiversity, can provide insights into the biotic consequences of current global climatic warming. Methodology/Principal Findings: We compare insect-feeding damage within two middle Eocene fossil floras, Messel and Eckfeld, in Germany. From these small lake deposits, we studied 16,082 angiosperm leaves and scored each specimen for the presence or absence of 89 distinctive and diagnosable insect damage types (DTs), each of which was allocated to a major functional feeding group, including four varieties of external foliage feeding, piercing- and-sucking, leaf mining, galling, seed predation, and oviposition. Methods used for treatment of presence-absence data included general linear models and standard univariate, bivariate and multivariate statistical techniques. Conclusions/Significance: Our results show an unexpectedly high diversity and level of insect feeding than comparable, penecontemporaneous floras from North and South America. In addition, we found a higher level of herbivory on evergreen, rather than deciduous taxa at Messel. This pattern is explained by a ca. 2.5-fold increase in atmospheric CO2 that overwhelmed evergreen antiherbivore defenses, subsequently lessened during the more ameliorated levels of Eckfeld times. These patterns reveal important, previously undocumented features of plant-host and insect-herbivore diversification during the European mid Eocene.	[Wappler, Torsten; Rust, Jes] Univ Bonn, Steinmann Inst, Bonn, Germany; [Labandeira, Conrad C.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Labandeira, Conrad C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Labandeira, Conrad C.] Univ Maryland, BEES Program, College Pk, MD 20742 USA; [Frankenhaeuser, Herbert] Mainz Nat Hist Museum State Collect Nat Hist Rhin, Mainz, Germany; [Wilde, Volker] Senckenberg Forschungsinst, Frankfurt, Germany; [Wilde, Volker] Natl Museum, Frankfurt, Germany	University of Bonn; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Senckenberg Gesellschaft fur Naturforschung (SGN)	Wappler, T (corresponding author), Univ Bonn, Steinmann Inst, Bonn, Germany.	twappler@uni-bonn.de	Wappler, Torsten/P-6831-2019; Wappler, Torsten/D-4287-2011	Wappler, Torsten/0000-0003-1592-0988; Wappler, Torsten/0000-0003-1592-0988	Deutsche Forschungsgemeinschaft (DFG) DFG [RU 665/4-1, RU 665/4-2]	Deutsche Forschungsgemeinschaft (DFG) DFG	Funding was provided from the Deutsche Forschungsgemeinschaft (DFG) DFG project No. RU 665/4-1 and 4-2 (to TW and JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2009, ECOL RES, V24, P1381, DOI 10.1007/s11284-009-0623-4; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Andreasson FP, 2000, GEOL SOC AM BULL, V112, P628, DOI 10.1130/0016-7606(2000)112<628:TSITEM>2.0.CO;2; Archibald SB, 2010, PALEOBIOLOGY, V36, P374, DOI 10.1666/09021.1; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Bijl PK, 2010, SCIENCE, V330, P819, DOI 10.1126/science.1193654; Blondel C, 2001, PALAEOGEOGR PALAEOCL, V168, P125, DOI 10.1016/S0031-0182(00)00252-2; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; CONNELL J H, 1971, P298; Crawley M.J., 2007, R BOOK; Currano ED, 2008, P NATL ACAD SCI USA, V105, P1960, DOI 10.1073/pnas.0708646105; Currano ED, 2010, ECOL MONOGR, V80, P547, DOI 10.1890/09-2138.1; Ellsworth DS, 2012, GLOBAL CHANGE BIOL, V18, P223, DOI 10.1111/j.1365-2486.2011.02505.x; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Frankenhauser H., 1995, ABH STAATL MUS MINER, V41, P97; Franzen Jens Lorenz, 1993, Mainzer Naturwissenschaftliches Archiv, V31, P201; FRANZEN JL, 2005, COURIER FORSCHUNGSIN, V255, P77; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gagne Raymond J., 2008, Memoirs of the American Entomological Society, V48, P1; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Grein M, 2011, PALAEOGEOGR PALAEOCL, V309, P383, DOI 10.1016/j.palaeo.2011.07.008; Grein M, 2011, NEUES JAHRB GEOL P-A, V260, P305, DOI 10.1127/0077-7749/2011/0139; Gruber G, 2007, MESSEL TREASURES ECO; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Harms F.-J., 2003, NAT MUS, V132, P137; Harrell FE, 2009, DESIGN DESIGN PACKAG; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Hughes DP, 2011, BIOL LETTERS, V7, P67, DOI 10.1098/rsbl.2010.0521; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jaramillo C, 2010, SCIENCE, V330, P957, DOI 10.1126/science.1193833; KIMMERER TW, 1987, OECOLOGIA, V71, P548, DOI 10.1007/BF00379295; Knepp RG, 2005, NEW PHYTOL, V167, P207, DOI 10.1111/j.1469-8137.2005.01399.x; Knor S, 2012, PALAEOGEOGR PALAEOCL, V321, P102, DOI 10.1016/j.palaeo.2012.01.023; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Labandeira CC, 1998, ANNU REV EARTH PL SC, V26, P329, DOI 10.1146/annurev.earth.26.1.329; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Labandeira CC, 2007, GUIDE INSECTS OTHER; Labandeira Conrad C., 2011, P95; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lau JA, 2009, OECOLOGIA, V161, P401, DOI 10.1007/s00442-009-1384-z; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Lobo JM, 2000, ANN ENTOMOL SOC AM, V93, P115, DOI 10.1603/0013-8746(2000)093[0115:BAEFAT]2.0.CO;2; Lorenz V, 2004, JAHRESBERICHTE MITTE, V86, P125; Lutz H, 2006, Z DTSCH GES GEOWISS, V157, P433, DOI DOI 10.1127/1860-1804/2006/0157-0433; Lutz H, 2010, ACTA GEOL SIN-ENGL, V84, P984, DOI 10.1111/j.1755-6724.2010.00237.x; Marquis Robert J., 2005, P328, DOI 10.1017/CBO9780511541971.014; MCCOY ED, 1990, OIKOS, V58, P313, DOI 10.2307/3545222; Mertz D.F., 2005, COUR FORSCH I SENCKE, V255, P67; Mertz DF, 2000, NATURWISSENSCHAFTEN, V87, P270, DOI 10.1007/s001140050719; Meyer W, 1994, MAINZER NATURWISS S, V16, P9; Mingram J, 1998, PALAEOGEOGR PALAEOCL, V140, P289, DOI 10.1016/S0031-0182(98)00021-2; Mosbrugger V, 2005, P NATL ACAD SCI USA, V102, P14964, DOI 10.1073/pnas.0505267102; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nicolo MJ, 2007, GEOLOGY, V35, P699, DOI 10.1130/G23648A.1; Niinemets U, 2011, TRENDS ECOL EVOL, V26, P136, DOI 10.1016/j.tree.2010.12.012; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pirrung M., 2001, Z DTSCH GEOLOGISCHEN, V152, P27; Price PW, 1998, J BIOGEOGR, V25, P581, DOI 10.1046/j.1365-2699.1998.2530581.x; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Ribeiro SP, 2007, ECOGRAPHY, V30, P663, DOI 10.1111/j.2007.0906-7590.05083.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Royer DL, 2007, PALEOBIOLOGY, V33, P574, DOI 10.1666/07001.1; Schaal S., 1992, MESSEL INSIGHT HIST; Scheidel U, 2003, ACTA OECOL, V24, P275, DOI 10.1016/j.actao.2003.09.004; Sexton PF, 2011, NATURE, V471, P349, DOI 10.1038/nature09826; Smith DM, 2008, GEOL S AM S, V435, P89; Townsend KEB, 2010, PALAEOGEOGR PALAEOCL, V297, P144, DOI 10.1016/j.palaeo.2010.07.024; Utescher T, 2007, PALAEOGEOGR PALAEOCL, V247, P243, DOI 10.1016/j.palaeo.2006.10.022; Utescher T, 2009, EARTH PLANETARY SCI; Wappler T., 2003, MAINZER NATURWISSENS, V27, P1; Wappler T, 2011, PALAEOGEOGR PALAEOCL, V310, P283, DOI 10.1016/j.palaeo.2011.07.020; Wappler T, 2010, PALAEONTOGR ABT B, V283, P137, DOI 10.1127/palb/283/2010/137; Wappler T, 2010, PALAEONTOGR ABT B, V283, P99, DOI 10.1127/palb/283/2010/99; Wappler T, 2010, PALAEOGEOGR PALAEOCL, V292, P540, DOI 10.1016/j.palaeo.2010.04.029; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Wappler T, 2008, ACTA PALAEONTOL POL, V53, P627, DOI 10.4202/app.2008.0407; Wedmann Sonja, 2005, Courier Forschungsinstitut Senckenberg, V255, P103; Wedmann S, 2009, NATURWISSENSCHAFTEN, V96, P703, DOI 10.1007/s00114-009-0525-x; Wilde V, 1998, REV PALAEOBOT PALYNO, V101, P7, DOI 10.1016/S0034-6667(97)00067-5; Wilde V., 2004, COURIER FORSCHUNGSIN, V252, P109; Wilde V., 1989, COURIER FORSCHUNGSIN, V115, P1; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2005, P NATL ACAD SCI USA, V102, P8944, DOI 10.1073/pnas.0500516102; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Wilf P, 2001, P NATL ACAD SCI USA, V98, P6221, DOI 10.1073/pnas.111069498; Wilf P, 2006, SCIENCE, V313, P1112, DOI 10.1126/science.1129569; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; WOLDA H, 1987, BIOL J LINN SOC, V30, P313, DOI 10.1111/j.1095-8312.1987.tb00305.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	104	51	52	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40744	10.1371/journal.pone.0040744	http://dx.doi.org/10.1371/journal.pone.0040744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815805	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900042
J	Caraiani, P				Caraiani, Petre			Evidence of Multifractality from Emerging European Stock Markets	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; DETRENDED FLUCTUATION ANALYSIS; NONLINEARITY	We test for the presence of multifractality in the daily returns of the three most important stock market indices from Central and Eastern Europe, Czech PX, Hungarian BUX and Polish WIG using the Empirical Mode Decomposition based Multifractal Detrended Fluctuation Analysis. We found that the global Hurst coefficient varies with the q coefficient and that there is multifractality evidenced through the multifractal spectrum. The exercise is replicated for the sample around the high volatility period corresponding to the last global financial crisis. Although no direct link has been found between the crisis and the multifractal spectrum, the crisis was found to influence the overall shape as quantified through the norm of the multifractal spectrum.	Romanian Acad, Inst Econ Forecasting, Bucharest, Romania	Romanian Academy of Sciences	Caraiani, P (corresponding author), Romanian Acad, Inst Econ Forecasting, Bucharest, Romania.	Caraiani@ipe.ro	Caraiani, Petre/A-2963-2009; Caraiani, Petre/E-9082-2018	Caraiani, Petre/0000-0002-7526-580X; Caraiani, Petre/0000-0002-7526-580X	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund; Romanian Government [SOP HRD/89/1.5/S/62988]	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government)	This paper is supported by the Sectorial Operational Programme Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian Government under the contract number SOP HRD/89/1.5/S/62988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett WA, 2000, J ECON DYN CONTROL, V24, P703, DOI 10.1016/S0165-1889(99)00023-8; BARNETT WA, 1995, J ECON BEHAV ORGAN, V27, P301, DOI 10.1016/0167-2681(94)00082-P; Domino K, 2011, PHYSICA A, V390, P98, DOI 10.1016/j.physa.2010.04.015; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Ihlen EAF, 2010, J EXP PSYCHOL GEN, V139, P436, DOI 10.1037/a0019098; Jagric T, 2005, E EUR EC, V43, P85; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kumar S, 2009, PHYSICA A, V388, P1593, DOI 10.1016/j.physa.2008.12.017; Los C. A., 2003, FINANCIAL MARKET RIS; Los C.A., 2006, INT RES J FINANCE EC, V1, P106; MANDELBROT B, 1967, OPER RES, V15, P1057, DOI 10.1287/opre.15.6.1057; Mandelbrot B.B., 1997, WORKING PAPERS YALE; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Oh G, 2010, J KOREAN PHYS SOC, V56, P982, DOI 10.3938/jkps.56.982; Peters E.E., 1994, FRACTAL MARKET ANAL; Qian XY, 2011, PHYSICA A, V390, P4388, DOI 10.1016/j.physa.2011.07.008; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104	21	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40693	10.1371/journal.pone.0040693	http://dx.doi.org/10.1371/journal.pone.0040693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JG	22815792	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000026
J	Szentirmai, E				Szentirmai, Eva			Central but Not Systemic Administration of Ghrelin Induces Wakefulness in Mice	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; SLOW-WAVE SLEEP; STIMULATES LOCOMOTOR-ACTIVITY; MESSENGER-RNA; DEFICIENT MICE; RATS; SECRETION; RECEPTOR; PEPTIDE; APPETITE	Ghrelin is a brain-gut peptide hormone widely known for its orexigenic and growth hormone-releasing activities. Findings from our and other laboratories indicate a role of ghrelin in sleep regulation. The effects of exogenous ghrelin on sleep-wake activity in mice are, however, unknown. The aim of the present study was to determine the sleep-modulating effects of ghrelin after central and systemic administrations in mice. Sleep-wake activity after intracerebroventricular (icv) administration of 0.2, 1 and 5 mu g ghrelin and intraperitoneal injections of 40, 100, and 400 mu g/kg ghrelin prior to light onset were determined in C57BL/6 mice. In addition, body temperature, motor activity and 1-hour food intake was measured after the systemic injections. Sleep effects of systemic ghrelin (40 and 400 mu g/kg) injected before dark onset were also determined. Icv injection of ghrelin increased wakefulness and suppressed non-rapid-eye-movement sleep and electroencephalographic slow-wave activity in the first hour after injections. Rapid-eye-movement sleep was decreased for 2-4 hours after each dose of ghrelin. Sytemic administration of ghrelin did not induce changes in sleep-wake activity in mice at dark or light onset. Motor activity and body temperature remained unaltered and food intake was significantly increased after systemic injections of ghrelin given prior the light period. These findings indicate that the activation of central, but not peripheral, ghrelin-sensitive mechanisms elicits arousal in mice. The results are consistent with the hypothesis that the activation of the hypothalamic neuronal circuit formed by ghrelin, orexin, and neuropeptide Y neurons triggers behavioral sequence characterized by increased wakefulness, motor activity and feeding in nocturnal rodents.	[Szentirmai, Eva] Washington State Univ, Washington Wyoming Alaska Montana & Idaho WWAMI M, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA	Washington State University; Washington State University; Washington State University	Szentirmai, E (corresponding author), Washington State Univ, Washington Wyoming Alaska Montana & Idaho WWAMI M, Spokane, WA USA.	eszentirmai@wsu.edu			Washington State University	Washington State University	This work was supported by a Faculty Seed Grant to Dr. Szentirmai by the Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2006, J NEUROSCI, V26, P11052, DOI 10.1523/JNEUROSCI.2606-06.2006; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Baragli A, 2011, PEPTIDES, V32, P2323, DOI 10.1016/j.peptides.2011.10.024; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Borbely AA, 2001, ARCH ITAL BIOL, V139, P53; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Copinschi G, 1997, NEUROENDOCRINOLOGY, V66, P278, DOI 10.1159/000127249; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Date Y, 2006, CELL METAB, V4, P323, DOI 10.1016/j.cmet.2006.09.004; Dieguez C, 2010, FRONT HORM RES, V38, P196, DOI 10.1159/000318511; Esposito M, 2012, EUR J NEUROSCI, V35, P233, DOI 10.1111/j.1460-9568.2011.07946.x; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frieboes RM, 2004, PSYCHONEUROENDOCRINO, V29, P851, DOI 10.1016/S0306-4530(03)00152-5; FRIEBOES RM, 1995, NEUROENDOCRINOLOGY, V61, P584, DOI 10.1159/000126883; Granata R, 2011, EXP BIOL MED, V236, P505, DOI 10.1258/ebm.2011.010365; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Harrold JA, 2008, BRAIN RES, V1196, P59, DOI 10.1016/j.brainres.2007.12.055; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Jaszberenyi M, 2006, HORM BEHAV, V50, P266, DOI 10.1016/j.yhbeh.2006.03.010; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Kluge M, 2007, PSYCHONEUROENDOCRINO, V32, P1079, DOI 10.1016/j.psyneuen.2007.09.001; Kluge M, 2007, PSYCHONEUROENDOCRINO, V32, P287, DOI 10.1016/j.psyneuen.2006.12.015; Kluge M, 2010, PSYCHONEUROENDOCRINO, V35, P297, DOI 10.1016/j.psyneuen.2009.07.007; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2010, ANN NY ACAD SCI, V1200, P140, DOI 10.1111/j.1749-6632.2010.05516.x; Leite-Moreira AF, 2007, DRUG DISCOV TODAY, V12, P276, DOI 10.1016/j.drudis.2007.02.009; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Moreno-Reyes R, 1998, AM J PHYSIOL-ENDOC M, V274, pE779, DOI 10.1152/ajpendo.1998.274.5.E779; Obal F, 2003, AM J PHYSIOL-REG I, V284, pR131, DOI 10.1152/ajpregu.00361.2002; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Steiger A, 2011, MOL CELL ENDOCRINOL, V340, P88, DOI 10.1016/j.mce.2011.02.013; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Szentirmai E, 2006, AM J PHYSIOL-REG I, V291, pR473, DOI 10.1152/ajpregu.00919.2005; Szentirmai E, 2006, BRAIN RES, V1088, P131, DOI 10.1016/j.brainres.2006.02.072; Szentirmai E, 2007, AM J PHYSIOL-REG I, V293, pR510, DOI 10.1152/ajpregu.00155.2007; Szentirmai E, 2007, AM J PHYSIOL-REG I, V292, pR575, DOI 10.1152/ajpregu.00448.2006; Szentirmai E, 2010, AM J PHYSIOL-REG I, V298, pR467, DOI 10.1152/ajpregu.00557.2009; Szentirmai E, 2009, P NATL ACAD SCI USA, V106, P14069, DOI 10.1073/pnas.0903090106; Tolle V, 2002, ENDOCRINOLOGY, V143, P1353, DOI 10.1210/en.143.4.1353; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Weikel JC, 2003, AM J PHYSIOL-ENDOC M, V284, pE407, DOI 10.1152/ajpendo.00184.2002; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	54	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41172	10.1371/journal.pone.0041172	http://dx.doi.org/10.1371/journal.pone.0041172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815958	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000076
J	Ciarlo, TJ; Mullin, CA; Frazier, JL; Schmehl, DR				Ciarlo, Timothy J.; Mullin, Christopher A.; Frazier, James L.; Schmehl, Daniel R.			Learning Impairment in Honey Bees Caused by Agricultural Spray Adjuvants	PLOS ONE			English	Article							APIS-MELLIFERA L; CLASSICAL CONDITIONED-RESPONSE; COLONY COLLAPSE DISORDER; SILWET L-77; PESTICIDES; TOXICITY; AGROCHEMICALS; PERFORMANCES; INSECTICIDES; TEBUFENOZIDE	Background: Spray adjuvants are often applied to crops in conjunction with agricultural pesticides in order to boost the efficacy of the active ingredient(s). The adjuvants themselves are largely assumed to be biologically inert and are therefore subject to minimal scrutiny and toxicological testing by regulatory agencies. Honey bees are exposed to a wide array of pesticides as they conduct normal foraging operations, meaning that they are likely exposed to spray adjuvants as well. It was previously unknown whether these agrochemicals have any deleterious effects on honey bee behavior. Methodology/Principal Findings: An improved, automated version of the proboscis extension reflex (PER) assay with a high degree of trial-to-trial reproducibility was used to measure the olfactory learning ability of honey bees treated orally with sublethal doses of the most widely used spray adjuvants on almonds in the Central Valley of California. Three different adjuvant classes (nonionic surfactants, crop oil concentrates, and organosilicone surfactants) were investigated in this study. Learning was impaired after ingestion of 20 mu g organosilicone surfactant, indicating harmful effects on honey bees caused by agrochemicals previously believed to be innocuous. Organosilicones were more active than the nonionic adjuvants, while the crop oil concentrates were inactive. Ingestion was required for the tested adjuvant to have an effect on learning, as exposure via antennal contact only induced no level of impairment. Conclusions/Significance: A decrease in percent conditioned response after ingestion of organosilicone surfactants has been demonstrated here for the first time. Olfactory learning is important for foraging honey bees because it allows them to exploit the most productive floral resources in an area at any given time. Impairment of this learning ability may have serious implications for foraging efficiency at the colony level, as well as potentially many social interactions. Organosilicone spray adjuvants may therefore contribute to the ongoing global decline in honey bee health.	[Ciarlo, Timothy J.; Mullin, Christopher A.; Frazier, James L.; Schmehl, Daniel R.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ciarlo, TJ (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	tjc273@psu.edu		Schmehl, Daniel/0000-0003-1591-8722	United States Department of Agriculture - National Institute of Food and Agriculture - Coordinated Agricultural Project and Foundational Award programs; Foundation for the Preservation of Honey Bees; Sigma Xi	United States Department of Agriculture - National Institute of Food and Agriculture - Coordinated Agricultural Project and Foundational Award programs; Foundation for the Preservation of Honey Bees; Sigma Xi	Funding was received from the United States Department of Agriculture - National Institute of Food and Agriculture - Coordinated Agricultural Project and Foundational Award programs, The Foundation for the Preservation of Honey Bees, and Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2004, ENVIRON ENTOMOL, V33, P378, DOI 10.1603/0046-225X-33.2.378; Abramson CI, 1997, PHYSIOL BEHAV, V62, P657, DOI 10.1016/S0031-9384(97)00194-7; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Almond Board of California, 2010, 2010 ALM ALM, P31; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; CDPR (California Department of Pesticide Regulation), 2009, CALPIP CAL PES INF P; Chaffiol A, 2005, J EXP BIOL, V208, P3731, DOI 10.1242/jeb.01796; Cowles RS, 2000, J ECON ENTOMOL, V93, P180, DOI 10.1603/0022-0493-93.2.180; Cox C, 2006, ENVIRON HEALTH PERSP, V114, P1803, DOI 10.1289/ehp.9374; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DEVILLERS J, 2002, HONEY BEES ESTIMATIN; DYER FC, 1981, SCIENCE, V214, P1041, DOI 10.1126/science.214.4524.1041; Frazier J, 2011, AM BEE J, V151, P779; Goodwin R. M., 2000, New Zealand Plant Protection Volume 53, 2000. Proceedings of a conference, Commodore Hotel, Christchurch, New Zealand, 8-10 August 2000, P230; Gould J.L., 1988, HONEY BEE; Green J., 2000, Pesticide Outlook, V11, P196, DOI 10.1039/b008021g; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Hartzler B, 2001, ROLE SPRAY ADJUVANTS; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Hess FD., 1999, P CALIFORNIA WEED SC, V51, P156; KNIGHT H, 1991, PESTIC SCI, V33, P305, DOI 10.1002/ps.2780330305; MAYER DF, 1986, ENVIRON ENTOMOL, V15, P1047, DOI 10.1093/ee/15.5.1047; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Purcell MF, 1996, J ECON ENTOMOL, V89, P1566, DOI 10.1093/jee/89.6.1566; Retnakaran A, 2001, PEST MANAG SCI, V57, P951, DOI 10.1002/ps.377; Sakura M, 2012, P ROY SOC B-BIOL SCI, V279, P535, DOI 10.1098/rspb.2011.0929; Sames WJ, 1990, AM BEE J, V130, P389; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Stark JD, 2003, ENVIRON TOXICOL CHEM, V22, P3056, DOI 10.1897/02-504; Stevens PJ, 1993, PESTIC SCI, V28, P237; STEVENS PJG, 1993, PESTIC SCI, V38, P103, DOI 10.1002/ps.2780380206; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; TAYLOR KS, 1987, APIDOLOGIE, V18, P243, DOI 10.1051/apido:19870304; Tipping C, 2003, J ECON ENTOMOL, V96, P246, DOI 10.1603/0022-0493-96.1.246; VANECK WH, 1979, INSECT BIOCHEM, V9, P295, DOI 10.1016/0020-1790(79)90009-X; vanEngelsdorp D, 2011, PRELIMINARY RESULTS; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONFRISCH K, 1954, NATURWISSENSCHAFTEN, V41, P245, DOI 10.1007/BF00634944; Winston M.L., 1991, BIOL HONEY BEE; Young B, 2010, COMPENDIUM HERBICIDE	46	76	78	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40848	10.1371/journal.pone.0040848	http://dx.doi.org/10.1371/journal.pone.0040848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815841	Green Published, gold			2022-12-27	WOS:000306466100081
J	Urasaki, N; Tarora, K; Shudo, A; Ueno, H; Tamaki, M; Miyagi, N; Adaniya, S; Matsumura, H				Urasaki, Naoya; Tarora, Kazuhiko; Shudo, Ayano; Ueno, Hiroki; Tamaki, Moritoshi; Miyagi, Norimichi; Adaniya, Shinichi; Matsumura, Hideo			Digital Transcriptome Analysis of Putative Sex-Determination Genes in Papaya (Carica papaya)	PLOS ONE			English	Article							PLANT SILENE-LATIFOLIA; PRIMITIVE Y-CHROMOSOME; MALE-SPECIFIC REGION; LINKED GENES; EXPRESSION; EVOLUTION; SUPERSAGE; L.	Papaya (Carica papaya) is a trioecious plant species that has male, female and hermaphrodite flowers on different plants. The primitive sex chromosomes genetically determine the sex of the papaya. Although draft sequences of the papaya genome are already available, the genes for sex determination have not been identified, likely due to the complicated structure of its sex-chromosome sequences. To identify the candidate genes for sex determination, we conducted a transcriptome analysis of flower samples from male, female and hermaphrodite plants using high-throughput SuperSAGE for digital gene expression analysis. Among the short sequence tags obtained from the transcripts, 312 unique tags were specifically mapped to the primitive sex chromosome (X or Y-h) sequences. An annotation analysis revealed that retroelements are the most abundant sequences observed in the genes corresponding to these tags. The majority of tags on the sex chromosomes were located on the X chromosome, and only 30 tags were commonly mapped to both the X and Y-h chromosome, implying a loss of many genes on the Y-h chromosome. Nevertheless, candidate Y-h chromosome-specific female determination genes, including a MADS-box gene, were identified. Information on these sex chromosome-specific expressed genes will help elucidating sex determination in the papaya.	[Urasaki, Naoya; Tarora, Kazuhiko; Shudo, Ayano; Tamaki, Moritoshi; Miyagi, Norimichi] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa, Japan; [Ueno, Hiroki; Matsumura, Hideo] Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan; [Adaniya, Shinichi] Univ Ryukyus, Nishihara, Okinawa 90301, Japan	Shinshu University; University of the Ryukyus	Urasaki, N (corresponding author), Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa, Japan.	hideoma@shinshu-u.ac.jp		Tarora, Kazuhiko/0000-0003-1448-976X; Matsumura, Hideo/0000-0003-4849-1016	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKLE TD, 1984, HORTSCIENCE, V19, P832; Bergero R, 2008, GENETICS, V178, P2045, DOI 10.1534/genetics.107.084566; Bergero R, 2007, GENETICS, V175, P1945, DOI 10.1534/genetics.106.070110; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; HOFMEYR J. D. J., 1938, South African Journal of Science, V35, P300; Irie T, 2003, MOL GENET GENOMICS, V270, P181, DOI 10.1007/s00438-003-0911-6; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; JOHNSON MH, 1982, NATURE, V296, P493, DOI 10.1038/296493a0; Kazama Y, 2009, PLANT CELL PHYSIOL, V50, P1127, DOI 10.1093/pcp/pcp064; Kumar L. S., 1945, INDIAN JOUR AGRIC SCI, V15, P242; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Ming R, 2007, SEMIN CELL DEV BIOL, V18, P401, DOI 10.1016/j.semcdb.2006.11.013; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Porter BW, 2008, PLANT SCI, V174, P38, DOI 10.1016/j.plantsci.2007.09.013; Storey W. B., 1938, Proceedings. American Society for Horticultural Science, 1937, V35, P83; STOREY WB, 1953, J HERED, V44, P70, DOI 10.1093/oxfordjournals.jhered.a106358; Tamaki M, 2011, J JPN SOC HORTIC SCI, V80, P156, DOI 10.2503/jjshs1.80.156; Urasaki N, 2002, THEOR APPL GENET, V104, P281, DOI 10.1007/s001220100693; Yu Q. Y., 2008, Tropical Plant Biology, V1, P49, DOI 10.1007/s12042-007-9005-7; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; Yu QY, 2007, MOL GENET GENOMICS, V278, P177, DOI 10.1007/s00438-007-0243-z; Zhang WL, 2008, GENOME RES, V18, P1938, DOI 10.1101/gr.078808.108; Zluvova J, 2005, EVOL DEV, V7, P327, DOI 10.1111/j.1525-142X.2005.05038.x	32	37	41	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40904	10.1371/journal.pone.0040904	http://dx.doi.org/10.1371/journal.pone.0040904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815863	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100093
J	Van Wynsberge, S; Andrefouet, S; Hamel, MA; Kulbicki, M				Van Wynsberge, Simon; Andrefouet, Serge; Hamel, Melanie A.; Kulbicki, Michel			Habitats as Surrogates of Taxonomic and Functional Fish Assemblages in Coral Reef Ecosystems: A Critical Analysis of Factors Driving Effectiveness	PLOS ONE			English	Article							SELECTION PROCEDURES; SPECIES RICHNESS; MARINE RESERVES; CONSERVATION; BIODIVERSITY; MANAGEMENT; DIVERSITY; PATTERNS; SYSTEMS; EXTENT	Species check-lists are helpful to establish Marine Protected Areas (MPAs) and protect local richness, endemicity, rarity, and biodiversity in general. However, such exhaustive taxonomic lists (i.e., true surrogate of biodiversity) require extensive and expensive censuses, and the use of estimator surrogates (e.g., habitats) is an appealing alternative. In truth, surrogate effectiveness appears from the literature highly variable both in marine and terrestrial ecosystems, making it difficult to provide practical recommendations for managers. Here, we evaluate how the biodiversity reference data set and its inherent bias can influence effectiveness. Specifically, we defined habitats by geomorphology, rugosity, and benthic cover and architecture criteria, and mapped them with satellite images for a New-Caledonian site. Fish taxonomic and functional lists were elaborated from Underwater Visual Censuses, stratified according to geomorphology and exposure. We then tested if MPA networks designed to maximize habitat richness, diversity and rarity could also effectively maximize fish richness, diversity, and rarity. Effectiveness appeared highly sensitive to the fish census design itself, in relation to the type of habitat map used and the scale of analysis. Spatial distribution of habitats (estimator surrogate's distribution), quantity and location of fish census stations (target surrogate's sampling), and random processes in the MPA design all affected effectiveness to the point that one small change in the data set could lead to opposite conclusions. We suggest that previous conclusions on surrogacy effectiveness, either positive or negative, marine or terrestrial, should be considered with caution, except in instances where very dense data sets were used without pseudo-replication. Although this does not rule out the validity of using surrogates of species lists for conservation planning, the critical joint examination of both target and estimator surrogates is needed for every case study.	[Van Wynsberge, Simon; Andrefouet, Serge; Hamel, Melanie A.] IRD, UR CoReUs, Noumea, New Caledonia; [Kulbicki, Michel] IRD, UR CoReUs, Lab Arago, Banyuls Sur Mer, France	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Van Wynsberge, S (corresponding author), IRD, UR CoReUs, Noumea, New Caledonia.	serge.andrefouet@ird.fr	Hamel, Melanie A./B-8409-2009	Hamel, Melanie A./0000-0001-5253-4125; Kulbicki, Michel/0000-0003-1258-5061				Anderson TJ, 2009, J EXP MAR BIOL ECOL, V379, P34, DOI 10.1016/j.jembe.2009.07.033; Andrefouet S, 2008, J SPAT SCI, V53, P113, DOI 10.1080/14498596.2008.9635140; Andrefouet S, 2010, MAR POLLUT BULL, V61, P612, DOI 10.1016/j.marpolbul.2010.06.031; Beger M, 2003, BIOL CONSERV, V111, P53, DOI 10.1016/S0006-3207(02)00249-5; Beger M, 2007, CONSERV BIOL, V21, P1584, DOI 10.1111/j.1523-1739.2007.00795.x; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Caro T., 2010, CONSERVATION PROXIES; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Chabanet P, 2010, MAR POLLUT BULL, V61, P598, DOI 10.1016/j.marpolbul.2010.06.032; Chettri N, 2010, J NAT CONSERV, V18, P75, DOI 10.1016/j.jnc.2009.03.003; Clua E, 2006, J EXP MAR BIOL ECOL, V333, P219, DOI 10.1016/j.jembe.2005.12.010; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Ferrier S, 1997, EVALUATION EFFECTIVE; Freitag S, 1998, P ROY SOC B-BIOL SCI, V265, P1475, DOI 10.1098/rspb.1998.0460; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Guillemot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026735; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; Hess GR, 2006, BIOL CONSERV, V132, P448, DOI 10.1016/j.biocon.2006.04.037; Knudby A, 2010, REMOTE SENS IN PRESS; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M., 2006, THESIS U PERPIGNAN P; Kulbicki M., 2011, MAJOR CORAL REEF FIS; LABROSSE P, 2001, UNDERWATER VISUAL FI; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Malcolm HA, 2010, BIODIVERS CONSERV, V19, P3611, DOI 10.1007/s10531-010-9913-y; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mellin C, 2007, CORAL REEFS, V26, P895, DOI 10.1007/s00338-007-0281-3; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Mellin C, 2009, MAR POLLUT BULL, V58, P11, DOI 10.1016/j.marpolbul.2008.10.010; Moilanen A., 2009, SPATIAL CONSERVATION; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Sokal RR, 1995, BIOMETRY; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Ward TJ, 1999, ECOL APPL, V9, P691; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025; Williams P, 2006, BIOL CONSERV, V128, P253, DOI 10.1016/j.biocon.2005.09.047	47	18	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40997	10.1371/journal.pone.0040997	http://dx.doi.org/10.1371/journal.pone.0040997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815891	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000306466100106
J	Barthe, S; Gugerli, F; Barkley, NA; Maggia, L; Cardi, C; Scotti, I				Barthe, Stephanie; Gugerli, Felix; Barkley, Noelle A.; Maggia, Laurent; Cardi, Celine; Scotti, Ivan			Always Look on Both Sides: Phylogenetic Information Conveyed by Simple Sequence Repeat Allele Sequences	PLOS ONE			English	Article							MICROSATELLITE LOCI; MUTATION MODEL; HOMOPLASY; DISTANCES; PATTERNS; TRANSFERABILITY; DIVERSITY; EVOLUTION; MARKERS; TREES	Simple sequence repeat (SSR) markers are widely used tools for inferences about genetic diversity, phylogeography and spatial genetic structure. Their applications assume that variation among alleles is essentially caused by an expansion or contraction of the number of repeats and that, accessorily, mutations in the target sequences follow the stepwise mutation model (SMM). Generally speaking, PCR amplicon sizes are used as direct indicators of the number of SSR repeats composing an allele with the data analysis either ignoring the extent of allele size differences or assuming that there is a direct correlation between differences in amplicon size and evolutionary distance. However, without precisely knowing the kind and distribution of polymorphism within an allele (SSR and the associated flanking region (FR) sequences), it is hard to say what kind of evolutionary message is conveyed by such a synthetic descriptor of polymorphism as DNA amplicon size. In this study, we sequenced several SSR alleles in multiple populations of three divergent tree genera and disentangled the types of polymorphisms contained in each portion of the DNA amplicon containing an SSR. The patterns of diversity provided by amplicon size variation, SSR variation itself, insertions/deletions (indels), and single nucleotide polymorphisms (SNPs) observed in the FRs were compared. Amplicon size variation largely reflected SSR repeat number. The amount of variation was as large in FRs as in the SSR itself. The former contributed significantly to the phylogenetic information and sometimes was the main source of differentiation among individuals and populations contained by FR and SSR regions of SSR markers. The presence of mutations occurring at different rates within a marker's sequence offers the opportunity to analyse evolutionary events occurring on various timescales, but at the same time calls for caution in the interpretation of SSR marker data when the distribution of within-locus polymorphism is not known.	[Barthe, Stephanie] Univ French W Indies & French Guiana, Unite Mixte Rech Ecol Forets Guyane, Kourou, French Guiana; [Gugerli, Felix] Swiss Fed Res Inst Forest Snow & Landscape Res, Biodivers & Conservat Biol Res Unit, Birmensdorf, Switzerland; [Barkley, Noelle A.] USDA ARS, Plant Genet Resources Conservat Unit, Griffin, GA USA; [Maggia, Laurent] Inst Agron Neocaledonien, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Noumea, New Caledonia; [Cardi, Celine] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Scotti, Ivan] Inst Natl Rech Agron, Unite Mixte Rech Ecol Forets Guyane, Kourou, French Guiana	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; United States Department of Agriculture (USDA); CIRAD; INRAE	Barthe, S (corresponding author), Univ French W Indies & French Guiana, Unite Mixte Rech Ecol Forets Guyane, Kourou, French Guiana.	ivan.scotti@ecofog.gf	Gugerli, Felix/C-9369-2009; Barkley, Noelle/C-5815-2008; Gugerli, Felix/U-7195-2019	Gugerli, Felix/0000-0003-3878-1845; Gugerli, Felix/0000-0003-3878-1845; Anglin, Noelle L./0000-0002-3454-1142	PO-FEDER Guyane "ENERGIRAVI"; European Social Fund	PO-FEDER Guyane "ENERGIRAVI"; European Social Fund(European Social Fund (ESF))	Funding provided by PO-FEDER Guyane "ENERGIRAVI" http://www.europe-guyane.eu/index.php?option = com_content&task = view&id = 14&Itemid = 206. SB's Doctoral program has been partly funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barkley NA, 2009, PLANT SYST EVOL, V282, P71, DOI 10.1007/s00606-009-0208-2; Billotte N., 1999, Fruits (Paris), V54, P277; Brohede J, 1999, P ROY SOC B-BIOL SCI, V266, P825, DOI 10.1098/rspb.1999.0712; Colpaert N, 2005, SILVAE GENET, V54, P265, DOI 10.1515/sg-2005-0038; Colson I, 1999, GENETICS, V152, P617; Cornuet JM, 2006, THEOR POPUL BIOL, V69, P129, DOI 10.1016/j.tpb.2005.07.005; Curtu A-L, 2004, PLANT MOL BIOL REP, p[339, 22]; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; England PR, 2002, MOL ECOL, V11, P967, DOI 10.1046/j.1365-294X.2002.01500.x; Estoup A, 2001, GENETICS, V159, P1671; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Grimaldi MC, 1997, J MOL EVOL, V44, P336, DOI 10.1007/PL00006151; Gugerli F, 2007, ANN BOT-LONDON, V99, P713, DOI 10.1093/aob/mcm006; Gugerli F, 2008, PLANT MOL BIOL REP, V26, P255, DOI 10.1007/s11105-008-0034-7; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Kampfer S, 1998, HEREDITAS, V129, P183, DOI 10.1111/j.1601-5223.1998.00183.x; Kijas JMH, 1997, THEOR APPL GENET, V94, P701, DOI 10.1007/s001220050468; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Lia VV, 2007, THEOR APPL GENET, V115, P981, DOI 10.1007/s00122-007-0625-y; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; McDonald MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000622; Michalakis Y, 1996, GENETICS, V142, P1061; Mogg R, 2002, THEOR APPL GENET, V105, P532, DOI 10.1007/s00122-002-0897-1; Orti G, 1997, P NATL ACAD SCI USA, V94, P10745, DOI 10.1073/pnas.94.20.10745; Payseur BA, 2006, TRENDS GENET, V22, P424, DOI 10.1016/j.tig.2006.06.009; Peakall R, 1998, MOL BIOL EVOL, V15, P1275, DOI 10.1093/oxfordjournals.molbev.a025856; Pons O, 1996, GENETICS, V144, P1237; Primmer CR, 1998, MOL BIOL EVOL, V15, P997, DOI 10.1093/oxfordjournals.molbev.a026015; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Randi E, 2003, MOL ECOL, V12, P2201, DOI 10.1046/j.1365-294X.2003.01899.x; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Rodriguez H, 2000, MOL ECOL, V9, P498, DOI 10.1046/j.1365-294x.2000.00871-7.x; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Shepherd LD, 2005, J HERED, V96, P566, DOI 10.1093/jhered/esi070; Stajner N, 2005, PLANT SCI, V168, P213, DOI 10.1016/j.plantsci.2004.07.031; Symonds VV, 2003, GENETICS, V165, P1475; Takezaki N, 1996, GENETICS, V144, P389; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Xie H, 2006, THEOR APPL GENET, V112, P366, DOI 10.1007/s00122-005-0138-5; Zhivotovsky LA, 1997, MOL BIOL EVOL, V14, P926, DOI 10.1093/oxfordjournals.molbev.a025835	47	29	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40699	10.1371/journal.pone.0040699	http://dx.doi.org/10.1371/journal.pone.0040699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808236	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000306406700046
J	Chen, J; Wang, GY; Lu, CQ; Guo, XD; Hong, WJ; Kang, JH; Wang, JM				Chen, Jie; Wang, Guiying; Lu, Chenqi; Guo, Xudong; Hong, Wujun; Kang, Jiuhong; Wang, Jianmin			Synergetic Cooperation of microRNAs with Transcription Factors in iPS Cell Generation	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; HUMAN FIBROBLASTS; YAMANAKA FACTORS; MOUSE; DNMT3A; METHYLATION; EXPRESSION; INDUCTION; EFFICIENT	Induced pluripotent stem (iPS) cells were first generated by forced expression of transcription factors (TFs) in fibroblasts. Recently, iPS cells have been generated more rapidly and efficiently using miRNAs with or without other transcription factors. However, the specific and collaborative roles of miRNAs and transcription factors in pluripotency acquisition and maintenance remain to be further investigated. Here, based on the miRNA profiling in mouse embryonic fibroblasts (MEFs), MEFs infected with Oct3/4, Sox2, Klf4 and c-Myc (OSKM) for 1, 2, 4, or 8 day, two iPS cell lines and ES cells, representing iPS activation and maintenance steps, we found that two unique miRNA sets are responsible for different steps of iPS generation, and the miRNA expression profiles of iPS cells are very similar to that of ES cells. Furthermore, we searched for transcription factors binding sites at the promoter regions of up-regulated miRNAs, and found that up-regulated miRNAs such as the miR-429-200 and miR-17 clusters are directly activated by exogenous TFs. The GO and pathway enrichment for candidate target gene sets of miRNAs or OSKM provided a clear picture of division and collaboration between miRNAs and OSKM during completion of the iPS process. Compared with the pathways regulated by OSKM, we found that miRNAs play critical roles in regulating iPS-specific pathways, such as the adherens junction and Wnt signaling pathways. Furthermore, we blocked miRNA expression using Dicer knockdown, and found that the level of miRNAs was decreased following this treatment, and the efficiency of iPS generation was significantly repressed. By combining high-throughput analysis, biostatistical analysis and functional experiments, this study provides new ideas for investigating the important roles of miRNAs, the mechanisms of miRNAs and related signaling pathways, and the potential for many more applications of miRNAs in somatic cell reprogramming.	[Chen, Jie; Wang, Jianmin] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China; [Wang, Guiying; Guo, Xudong; Hong, Wujun; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Lu, Chenqi] Fudan Univ, Sch Life Sci, Inst Biostat, Lab Populat & Quantitat Genet, Shanghai 200433, Peoples R China	Naval Medical University; Tongji University; Fudan University	Chen, J (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China.	jhkang@tongji.edu.cn; jmwang@medmail.com.cn	wang, jian/GVS-0711-2022		Ministry of Science and Technology [2011CB965100, 2010CB944900, 2010CB945000, 2011CBA01100, 2011DFA30480]; National Natural Science Foundation of China [90919028, 31071306, 31000378, 31101061, 31171432, 30971451, 81170499]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 11XD1405300]; Ministry of Education [IRT1168, 20110072110039]; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Ministry of Science and Technology (2011CB965100, 2010CB944900, 2010CB945000, 2011CBA01100, and 2011DFA30480), the National Natural Science Foundation of China (90919028, 31071306, 31000378, 31101061, 31171432, 30971451, and 81170499), the Science and Technology Commission of Shanghai Municipality (11ZR1438500, 11XD1405300), and IRT1168 and 20110072110039 from Ministry of Education. The work was also supported by Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Di Stefano B, 2011, STEM CELLS, V29, P1684, DOI 10.1002/stem.726; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JY, 2009, CELL RES, V19, P1127, DOI 10.1038/cr.2009.106; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Liu HY, 2011, MOL BIOL REP, V38, P2155, DOI 10.1007/s11033-010-0343-4; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takada S, 2009, RNA, V15, P1507, DOI 10.1261/rna.1418309; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yang CS, 2011, RNA, V17, P1451, DOI 10.1261/rna.2664111; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	34	17	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40849	10.1371/journal.pone.0040849	http://dx.doi.org/10.1371/journal.pone.0040849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808276	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700063
J	Barboro, P; Repaci, E; D'Arrigo, C; Balbi, C				Barboro, Paola; Repaci, Erica; D'Arrigo, Cristina; Balbi, Cecilia			The Role of Nuclear Matrix Proteins Binding to Matrix Attachment Regions (MARs) in Prostate Cancer Cell Differentiation	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; CHROMATIN LOOPS; GENE-REGULATION; LAMIN SCAFFOLD; SATB1; ORGANIZATION; EXPRESSION; ARCHITECTURE; DOMAINS; PROGNOSIS	In tumor progression definite alterations in nuclear matrix (NM) protein composition as well as in chromatin structure occur. The NM interacts with chromatin via specialized DNA sequences called matrix attachment regions (MARs). In the present study, using a proteomic approach along with a two-dimensional Southwestern assay and confocal laser microscopy, we show that the differentiation of stabilized human prostate carcinoma cells is marked out by modifications both NM protein composition and bond between NM proteins and MARs. Well-differentiated androgen-responsive and slowly growing LNCaP cells are characterized by a less complex pattern and by a major number of proteins binding MAR sequences in comparison to 22Rv1 cells expressing androgen receptor but androgen-independent. Finally, in the poorly differentiated and strongly aggressive androgen-independent PC3 cells the complexity of NM pattern further increases and a minor number of proteins bind the MARs. Furthermore, in this cell line with respect to LNCaP cells, these changes are synchronous with modifications in both the nuclear distribution of the MAR sequences and in the average loop dimensions that significantly increase. Although the expression of many NM proteins changes during dedifferentiation, only a very limited group of MAR-binding proteins seem to play a key role in this process. Variations in the expression of poly (ADP-ribose) polymerase (PARP) and special AT-rich sequence-binding protein-1 (SATB1) along with an increase in the phosphorylation of lamin B represent changes that might trigger passage towards a more aggressive phenotype. These results suggest that elucidating the MAR-binding proteins that are involved in the differentiation of prostate cancer cells could be an important tool to improve our understanding of this carcinogenesis process, and they could also be novel targets for prostate cancer therapy.	[Barboro, Paola; Repaci, Erica; Balbi, Cecilia] IRCCS Azienda Osped Univ San Martino IST, Ist Nazl Ric Canc, Dept Diagnost Technol, Genoa, Italy; [D'Arrigo, Cristina] ISMAC, Ist Studio Macromol, CNR, Sez Genova, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio delle Macromolecole (ISMAC-CNR)	Barboro, P (corresponding author), IRCCS Azienda Osped Univ San Martino IST, Ist Nazl Ric Canc, Dept Diagnost Technol, Genoa, Italy.	cecilia.balbi@istge.it	Barboro, Paola/AAE-7144-2019; Repaci, Erica/H-6576-2017	Barboro, Paola/0000-0001-9074-9290; D'Arrigo, Cristina/0000-0002-5352-5287; Repaci, Erica/0000-0002-6441-9308	Regione Liguria [563/2009]; Compagnia San Paolo [2009.127]; Ministero dell'Universita' e Ricerca Scientifica - MIUR [2005065404-003]	Regione Liguria(Regione Liguria); Compagnia San Paolo(Compagnia di San Paolo); Ministero dell'Universita' e Ricerca Scientifica - MIUR(Ministry of Education, Universities and Research (MIUR))	This work was funded by Regione Liguria (www.regione.liguria.it), grant number 563/2009; Compagnia San Paolo (www.fondazioneintesasanpaoloonlus.org), grant number 2009.127; Ministero dell'Universita' e Ricerca Scientifica - MIUR (www.prin.miur.it) project PRIN, grant number 2005065404-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva-Medina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021360; Aranda-Anzaldo A, 2009, AGING-US, V1, P598, DOI 10.18632/aging.100074; Barboro P, 2005, ANTICANCER RES, V25, P3999; Barboro P, 2002, EXP CELL RES, V279, P202, DOI 10.1006/excr.2002.5605; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Barboro P, 2008, CELL ONCOL, V30, P13; Barboro P, 2011, PROSTATE, V71, P1466, DOI 10.1002/pros.21366; Barboro P, 2010, EXP CELL RES, V316, P992, DOI 10.1016/j.yexcr.2009.12.010; Barboro P, 2009, EXP CELL RES, V315, P226, DOI 10.1016/j.yexcr.2008.10.017; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Coffey DS, 2002, CLIN CANCER RES, V8, P3031; Coradeghini R, 2006, ONCOL REP, V15, P609; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; DWORETZKY SI, 1990, P NATL ACAD SCI USA, V87, P4605, DOI 10.1073/pnas.87.12.4605; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Galande S, 2000, J CELL BIOCHEM, P36; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gluch A., 2008, V186, P67, DOI 10.1007/978-3-540-72843-6_4; Goes ACS, 2011, J CELL BIOCHEM, V112, P2072, DOI 10.1002/jcb.23129; Gotzmann J, 2000, CELL DEATH DIFFER, V7, P425, DOI 10.1038/sj.cdd.4400668; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Leman ES, 2002, J CELL BIOCHEM, V86, P213, DOI 10.1002/jcb.10218; Lever E, 2010, J PATHOL, V220, P114, DOI 10.1002/path.2651; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; Maya-Mendoza A, 2005, MECH AGEING DEV, V126, P767, DOI 10.1016/j.mad.2005.01.011; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Moir RD, 1995, INT REV CYTOL, V162B, P141; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Razin SV, 2001, CELL MOL BIOL LETT, V6, P59; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Selinger CI, 2011, J THORAC ONCOL, V6, P1179, DOI 10.1097/JTO.0b013e31821b4ce0; Seo J, 2005, J BIOL CHEM, V280, P24600, DOI 10.1074/jbc.M414076200; Shi LH, 2008, J BIOL CHEM, V283, P36474, DOI 10.1074/jbc.M805980200; Tan JAT, 2010, MOL CELL BIOL, V30, P2823, DOI 10.1128/MCB.01603-09; Vassetzky YS, 2000, J CELL BIOCHEM, P54; Vidakovic M, 2005, J CELL BIOCHEM, V96, P555, DOI 10.1002/jcb.20516; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Zeng CM, 1998, P NATL ACAD SCI USA, V95, P1585, DOI 10.1073/pnas.95.4.1585	44	38	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40617	10.1371/journal.pone.0040617	http://dx.doi.org/10.1371/journal.pone.0040617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808207	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400085
J	Haag, LM; Fischer, A; Otto, B; Plickert, R; Kuhl, AA; Gobel, UB; Bereswill, S; Heimesaat, MM				Haag, Lea-Maxie; Fischer, Andre; Otto, Bettina; Plickert, Rita; Kuehl, Anja A.; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.			Campylobacter jejuni Induces Acute Enterocolitis in Gnotobiotic IL-10(-/-) Mice via Toll-Like-Receptor-2 and-4 Signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI; DENDRITIC CELLS; MURINE COLITIS; ACTIVATION; COLONIZATION; INFECTION; RESPONSES; C57BL/6; DISEASE	Background: Campylobacter jejuni is a leading cause of foodborne bacterial enterocolitis worldwide. Investigation of immunopathology is hampered by a lack of suitable vertebrate models. We have recently shown that gnotobiotic mice as well as conventional IL-10(-/-) animals are susceptible to C. jejuni infection and develop intestinal immune responses. However, clinical symptoms of C. jejuni infection were rather subtle and did not reflect acute bloody diarrhea seen in human campylobacteriosis. Methodology/Principal Findings: In order to overcome these limitations we generated gnotobiotic IL-10(-/-) mice by quintuple antibiotic treatment starting right after weaning. The early treatment was essential to prevent these animals from chronic colitis. Following oral infection C. jejuni colonized the gastrointestinal tract at high levels and induced acute enterocolitis within 7 days as indicated by bloody diarrhea and pronounced histopathological changes of the colonic mucosa. Immunopathology was further characterized by increased numbers of apoptotic cells, regulatory T-cells, T- and B-lymphocytes as well as elevated TNF-alpha, IFN-gamma, and MCP-1 concentrations in the inflamed colon. The induction of enterocolitis was specific for C. jejuni given that control animals infected with a commensal E. coli strain did not display any signs of disease. Most strikingly, intestinal immunopathology was ameliorated in mice lacking Toll-like-receptors-2 or -4 indicating that C. jejuni lipoproteins and lipooligosaccharide are essential for induction and progression of immunopathology. Conclusion/Significance: Gnotobiotic IL-10(-/-) mice develop acute enterocolitis following C. jejuni infection mimicking severe episodes of human campylobacteriosis and are thus well suited to further dissect mechanisms underlying Campylobacter infections in vivo.	[Haag, Lea-Maxie; Fischer, Andre; Otto, Bettina; Plickert, Rita; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.] Charite, Dept Internal Med, RCIS, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haag, LM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Haag, Lea Maxie/AAP-9001-2020	Haag, Lea-Maxie/0000-0002-3754-5317; Kuhl, Anja/0000-0003-2293-5387; Heimesaat, Markus/0000-0001-6399-651X	German Research Foundation (DFG) [GO363/12-1, SFB633]; German Federal Ministery of Education and Research (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to UBG (GO363/12-1, CampyGerm; SFB633, TP A7), SB (SFB633, TP A7), AK (SFB633, TP Z1), MMH (SFB633, TP B6), LMH and BO (SFB633, Immuco), and from the German Federal Ministery of Education and Research (BMBF) to SB ("Lab in a hanky'' projects TP1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 1997, J INFECT DIS, V176, pS125, DOI 10.1086/513783; Bell JA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-57; Bereswill S, 2011, EUR J MICROBIOL IMMU, V1, P237, DOI 10.1556/EuJMI.1.2011.3.8; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Croinin TO, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00025; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; Friis LM, 2009, INFECT IMMUN, V77, P1553, DOI 10.1128/IAI.00707-08; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hermans D, 2012, VECTOR BORNE ZOONOTI; Hu L, 2005, INFECT IMMUN, V73, P4437, DOI 10.1128/IAI.73.7.4437-4440.2005; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; JESUDASON MV, 1989, INFECT IMMUN, V57, P2279, DOI 10.1128/IAI.57.8.2279-2282.1989; Kist M, 2001, Contrib Microbiol, V8, P150; Lane JA, 2010, INT J FOOD MICROBIOL, V142, P1, DOI 10.1016/j.ijfoodmicro.2010.05.027; Lippert E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007413; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mansfield LS, 2008, MICROB PATHOGENESIS, V45, P241, DOI 10.1016/j.micpath.2008.05.010; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Rathinam VAK, 2008, MICROBES INFECT, V10, P1316, DOI 10.1016/j.micinf.2008.07.030; SAVIDGE TC, 1991, AM J PATHOL, V139, P177; SHROFF KE, 1995, ADV EXP MED BIOL, V371, P441; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Sun XL, 2012, GASTROENTEROLOGY, V142, P86, DOI 10.1053/j.gastro.2011.09.042; Tareen AM, 2010, MICROBIOL-SGM, V156, P3123, DOI 10.1099/mic.0.039438-0; van Mourik A, 2010, J BIOL CHEM, V285, P15828, DOI 10.1074/jbc.M110.102061; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Wohlgemuth S, 2011, GUT MICROBES, V2, P159, DOI 10.4161/gmic.2.3.16104; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; YOUSSEF M, 1987, INFECT IMMUN, V55, P1019, DOI 10.1128/IAI.55.4.1019-1021.1987; YRIOS JW, 1986, INFECT IMMUN, V53, P384, DOI 10.1128/IAI.53.2.384-392.1986	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40761	10.1371/journal.pone.0040761	http://dx.doi.org/10.1371/journal.pone.0040761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808254	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500078
J	Boers, SA; van der Reijden, WA; Jansen, R				Boers, Stefan A.; van der Reijden, Wil A.; Jansen, Ruud			High-Throughput Multilocus Sequence Typing: Bringing Molecular Typing to the Next Level	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; METHICILLIN-RESISTANT; IDENTIFICATION; CLONES; SCHEME; VALIDATION	Multilocus sequence typing (MLST) is a widely used system for typing microorganisms by sequence analysis of housekeeping genes. The main advantage of MLST in comparison to other typing techniques is the unambiguity and transferability of sequence data. However, a main disadvantage is the high cost of DNA sequencing. Here we introduce a high-throughput MLST (HiMLST) method that employs next-generation sequencing (NGS) technology (Roche 454), to generate large quantities of high-quality MLST data at low costs. The HiMLST protocol consists of two steps. In the first step MLST target genes are amplified by PCR in multi-well plates. During this PCR the amplicons of each bacterial isolate are provided with a unique DNA barcode, the multiplex identifier (MID). In the second step all amplicons are pooled and sequenced in a single NGS-run. The MLST profile of each individual isolate can be retrieved easily using its unique MID. With HiMLST we have profiled 575 isolates of Legionella pneumophila, Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pneumoniae in mixed species HiMLST experiments. In conclusion, the introduction of HiMLST paves the way for a broad employment of the MLST as a high-quality and cost-effective method for typing microbial species.	[Boers, Stefan A.; van der Reijden, Wil A.; Jansen, Ruud] Reg Publ Hlth Lab, Dept Mol Biol, Haarlem, Netherlands		Boers, SA (corresponding author), Reg Publ Hlth Lab, Dept Mol Biol, Haarlem, Netherlands.	r.jansen@streeklabhaarlem.nl		Boers, Stefan/0000-0002-1560-6799				Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Dunne EM, 2011, J CLIN MICROBIOL, V49, P3756, DOI 10.1128/JCM.05113-11; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Facklam R, 1999, EMERG INFECT DIS, V5, P247, DOI 10.3201/eid0502.990209; Franco A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023147; Frenay HME, 1996, EUR J CLIN MICROBIOL, V15, P60, DOI 10.1007/BF01586186; Gaia V, 2003, J CLIN MICROBIOL, V41, P2932, DOI 10.1128/JCM.41.7.2932-2939.2003; Haas J, 2011, MOL CELL PROBE, V25, P206, DOI 10.1016/j.mcp.2011.08.005; Hall TA, 2009, J CLIN MICROBIOL, V47, P1733, DOI 10.1128/JCM.02175-08; Jiang Q, 2012, HUM MUTAT, V33, P281, DOI 10.1002/humu.21602; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Neiman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017785; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Singh P, 2012, J MICROBIOL METH, V88, P127, DOI 10.1016/j.mimet.2011.11.004; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Sobral D, 2011, APPL ENVIRON MICROB, V77, P6899, DOI 10.1128/AEM.05556-11; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Van Belkum A, 2002, J MED MICROBIOL, V51, P7, DOI 10.1099/0022-1317-51-1-7	31	72	83	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e39630	10.1371/journal.pone.0039630	http://dx.doi.org/10.1371/journal.pone.0039630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815712	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900012
J	Huang, CY; Chen, JJW; Shen, KY; Chang, LS; Yeh, YC; Chen, IH; Chong, P; Liu, SJ; Leng, CH				Huang, Chiung-Yi; Chen, Jeremy J. W.; Shen, Kuan-Yin; Chang, Li-Sheng; Yeh, Yi-Chen; Chen, I-Hua; Chong, Pele; Liu, Shih-Jen; Leng, Chih-Hsiang			Recombinant Lipidated HPV E7 Induces a Th-1-Biased Immune Response and Protective Immunity against Cervical Cancer in a Mouse Model	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; PSEUDOMONAS-AERUGINOSA; LIPOPEPTIDE VACCINES; LYME-DISEASE; LIPOPROTEIN; ADJUVANT; ONCOPROTEIN; VACCINATION; PROTEIN; IMMUNOGENICITY	The E7 oncoprotein of human papillomavirus (HPV) is an ideal target for developing immunotherapeutic strategies against HPV-associated tumors. However, because protein-based immunogens alone are poor elicitors of the cytotoxic T-lymphocyte (CTL) responses, they have been difficult to exploit for therapeutic purposes. In this study, we report that a recombinant lipoprotein consisting of inactive E7 (E7m) biologically linked to a bacterial lipid moiety (rlipo-E7m) induces the maturation of mouse bone marrow-derived dendritic cells through toll-like receptor 2 (TLR2), skews the immune responses toward the Th1 responses and induces E7-specific CTL responses. We further studied the ability of rlipo-E7m to provide protection against a TC-1 tumor cell challenge in an animal model. Mice prophylactically immunized with two 10-mu g doses of rlipo-E7m were found to be free of TC-1 tumor growth. Experiments in a therapeutic immunization model showed that the tumor volume in mice receiving a single dose of rlipo-E7m was less than 0.01 cm(3) on day 40, whereas the tumor volume in mice treated with rE7m was 2.28 +/- 1.21 cm(3). The tumor volume of the entire control group was over 3 cm(3). In addition, we demonstrated that the CD8+ T cells play a major role in anti-tumor immunity when administration of rlipo-E7m. These results demonstrate that rlipo-E7m could be a promising candidate for treating HPV-associated tumors.	[Huang, Chiung-Yi; Shen, Kuan-Yin; Chang, Li-Sheng; Yeh, Yi-Chen; Chen, I-Hua; Chong, Pele; Liu, Shih-Jen; Leng, Chih-Hsiang] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli, Taiwan; [Huang, Chiung-Yi; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Liu, Shih-Jen; Leng, Chih-Hsiang] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Chung Hsing University; China Medical University Taiwan	Huang, CY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli, Taiwan.	levent@nhri.org.tw; leoleng@nhri.org.tw	Chong, Pele/E-3855-2010; CHANG, LI SHENG/I-5568-2013; Leng, Chih-Hsiang/E-3874-2010; Liu, Shih-Jen/E-3942-2010; Liu, Shih-Jen/AAV-1931-2021	Liu, Shih-Jen/0000-0002-8736-1452; Chen, Jeremy J.W./0000-0003-1049-3825	National Health Research Institutes [VC-098-PP-04, VC-098-PP-06]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by a Research Investigator Award from the National Health Research Institutes (VC-098-PP-04 to S-JL) and (VC-098-PP-06 to C-HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P43; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P35; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; Bettahi I, 2006, VIRAL IMMUNOL, V19, P220, DOI 10.1089/vim.2006.19.220; Chen HW, 2009, VACCINE, V27, P1400, DOI 10.1016/j.vaccine.2008.12.043; Chentoufi AA, 2009, ARCH IMMUNOL THER EX, V57, P409, DOI 10.1007/s00005-009-0049-2; Chiang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023319; Cui ZR, 2005, CANCER IMMUNOL IMMUN, V54, P1180, DOI 10.1007/s00262-005-0685-2; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Fiander A, 1997, BIODRUGS, V8, P331, DOI 10.2165/00063030-199708050-00001; Gartner T, 2007, IMMUNOL LETT, V111, P26, DOI 10.1016/j.imlet.2007.04.010; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hallez S, 2004, CANCER IMMUNOL IMMUN, V53, P642, DOI 10.1007/s00262-004-0501-4; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; InfanteDuarte C, 1997, INFECT IMMUN, V65, P4094, DOI 10.1128/IAI.65.10.4094-4099.1997; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kiura K, 2006, FEMS IMMUNOL MED MIC, V48, P44, DOI 10.1111/j.1574-695X.2006.00119.x; Kwok Y, 2011, PROTEOMICS, V11, P2620, DOI 10.1002/pmic.201000688; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng CH, 2010, MOL IMMUNOL, V47, P2015, DOI 10.1016/j.molimm.2010.04.012; Lin CC, 2004, MOL THER, V10, P290, DOI 10.1016/j.ymthe.2004.05.015; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Oftung F, 1997, SCAND J IMMUNOL, V46, P445, DOI 10.1046/j.1365-3083.1997.d01-150.x; Oldford SA, 2010, J IMMUNOL, V185, P7067, DOI 10.4049/jimmunol.1001137; PATRICK DR, 1994, J BIOL CHEM, V269, P6842; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; Poland GA, 2011, CLIN INFECT DIS, V52, pS253, DOI 10.1093/cid/ciq116; Rau H, 2006, VACCINE, V24, P4757, DOI 10.1016/j.vaccine.2006.03.028; Renaudet O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011216; RESSING ME, 1995, J IMMUNOL, V154, P5934; Schneider C, 2004, GUT, V53, P355, DOI 10.1136/gut.2003.026005; Schwarz TF, 2008, EXPERT REV VACCINES, V7, P1465, DOI 10.1586/14760584.7.10.1465; Shingu K, 2003, AM J RESP CELL MOL, V28, P316, DOI 10.1165/rcmb.2002-0106OC; Speiser DE, 2010, SEMIN IMMUNOL, V22, P144, DOI 10.1016/j.smim.2010.03.004; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Stewart TJ, 2004, VACCINE, V22, P3738, DOI 10.1016/j.vaccine.2004.03.026; Su JH, 2010, BIODRUGS, V24, P109, DOI 10.2165/11532810-000000000-00000; Sung JWC, 2010, VACCINE, V28, P8175, DOI 10.1016/j.vaccine.2010.09.091; Zhu XM, 2004, EUR J IMMUNOL, V34, P3102, DOI 10.1002/eji.200425166	42	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40970	10.1371/journal.pone.0040970	http://dx.doi.org/10.1371/journal.pone.0040970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815882	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900065
J	McGready, R; Boel, M; Rijken, MJ; Ashley, EA; Cho, T; Moo, O; Paw, MK; Pimanpanarak, M; Hkirijareon, L; Carrara, VI; Lwin, KM; Phyo, AP; Turner, C; Chu, CS; van Vugt, M; Price, RN; Luxemburger, C; ter Kuile, FO; Tan, SO; Proux, S; Singhasivanon, P; White, NJ; Nosten, FH				McGready, Rose; Boel, Machteld; Rijken, Marcus J.; Ashley, Elizabeth A.; Cho, Thein; Moo, Oh; Paw, Moo Koh; Pimanpanarak, Mupawjay; Hkirijareon, Lily; Carrara, Verena I.; Lwin, Khin Maung; Phyo, Aung Pyae; Turner, Claudia; Chu, Cindy S.; van Vugt, Michele; Price, Richard N.; Luxemburger, Christine; ter Kuile, Feiko O.; Tan, Saw Oo; Proux, Stephane; Singhasivanon, Pratap; White, Nicholas J.; Nosten, Francois H.			Effect of Early Detection and Treatment on Malaria Related Maternal Mortality on the North-Western Border of Thailand 1986-2010	PLOS ONE			English	Article							FALCIPARUM-MALARIA; PREGNANT-WOMEN; DOUBLE-BLIND; KAREN; EPIDEMIOLOGY; PREVENTION; RATES; AREA; HIV	Introduction: Maternal mortality is high in developing countries, but there are few data in high-risk groups such as migrants and refugees in malaria-endemic areas. Trends in maternal mortality were followed over 25 years in antenatal clinics prospectively established in an area with low seasonal transmission on the north-western border of Thailand. Methods and Findings: All medical records from women who attended the Shoklo Malaria Research Unit antenatal clinics from 12th May 1986 to 31st December 2010 were reviewed, and maternal death records were analyzed for causality. There were 71 pregnancy-related deaths recorded amongst 50,981 women who attended antenatal care at least once. Three were suicide and excluded from the analysis as incidental deaths. The estimated maternal mortality ratio (MMR) overall was 184 (95% CI 150-230) per 100,000 live births. In camps for displaced persons there has been a six-fold decline in the MMR from 499 (95% CI 200-780) in 1986-90 to 79 (40-170) in 2006-10, p<0.05. In migrants from adjacent Myanmar the decline in MMR was less significant: 588 (100-3260) to 252 (150-430) from 1996-2000 to 2006-2010. Mortality from P. falciparum malaria in pregnancy dropped sharply with the introduction of systematic screening and treatment and continued to decline with the reduction in the incidence of malaria in the communities. P. vivax was not a cause of maternal death in this population. Infection (non-puerperal sepsis and P. falciparum malaria) accounted for 39.7 (27/68) % of all deaths. Conclusions: Frequent antenatal clinic screening allows early detection and treatment of falciparum malaria and substantially reduces maternal mortality from P. falciparum malaria. No significant decline has been observed in deaths from sepsis or other causes in refugee and migrant women on the Thai-Myanmar border.	[McGready, Rose; Boel, Machteld; Rijken, Marcus J.; Ashley, Elizabeth A.; Cho, Thein; Moo, Oh; Paw, Moo Koh; Pimanpanarak, Mupawjay; Hkirijareon, Lily; Carrara, Verena I.; Lwin, Khin Maung; Phyo, Aung Pyae; Turner, Claudia; Chu, Cindy S.; van Vugt, Michele; Luxemburger, Christine; ter Kuile, Feiko O.; Tan, Saw Oo; Proux, Stephane; Nosten, Francois H.] Shoklo Malaria Res Unit, Dept Obstet, Mae Sot, Thailand; [McGready, Rose; Ashley, Elizabeth A.; Turner, Claudia; van Vugt, Michele; Singhasivanon, Pratap; White, Nicholas J.; Nosten, Francois H.] Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand; [McGready, Rose; Ashley, Elizabeth A.; Turner, Claudia; Price, Richard N.; White, Nicholas J.; Nosten, Francois H.] Univ Oxford, Ctr Trop Med, Oxford, England; [van Vugt, Michele] Univ Amsterdam, Div Infect Dis, Amsterdam, Netherlands; [Price, Richard N.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of Amsterdam; Charles Darwin University; Menzies School of Health Research; Liverpool School of Tropical Medicine; University of Liverpool	McGready, R (corresponding author), Shoklo Malaria Res Unit, Dept Obstet, Mae Sot, Thailand.	rose@shoklo-unit.com	Kuile, Feiko ter/ABD-6681-2020; Phyo, Aung Pyae/K-2413-2019; McGready, Rose/A-3290-2014; Carrara, Verena/R-6492-2019; Phyo, Aung Pyae/GYU-6181-2022; Chu, Cindy S/E-3135-2014; Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012	Kuile, Feiko ter/0000-0003-3663-5617; Phyo, Aung Pyae/0000-0002-0383-9624; McGready, Rose/0000-0003-1621-3257; Carrara, Verena/0000-0002-2758-0872; Phyo, Aung Pyae/0000-0002-0383-9624; Chu, Cindy S/0000-0001-9465-8214; Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Paw, Moo Kho/0000-0002-4008-3168; Ashley, Elizabeth/0000-0002-7620-4822; Rijken, Marcus/0000-0003-0914-5508; Price, Richard/0000-0003-2000-2874; Singhasivanon, Pratap/0000-0002-9759-1702	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant)	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant)(Wellcome Trust)	This research was a part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant). The funders had no role in the collection, analysis and interpretation of the data, the writing of the article, or in submission of the paper for publication. The views expressed in the paper are those of the authors and do not represent the positions of their respective institutions or that of the funding agencies.	Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Ahmad K, 2006, LANCET INFECT DIS, V6, P14, DOI 10.1016/S1473-3099(05)70315-7; Barnett S, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI DOI 10.1186/1471-2393-8-6; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Belton S, 2007, SOC SCI MED, V65, P1512, DOI 10.1016/j.socscimed.2007.05.046; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; DOLAN G, 1993, T ROY SOC TROP MED H, V87, P620, DOI 10.1016/0035-9203(93)90262-O; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Faiz MA, 2005, LANCET, V366, P717; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Hanvoravongchai P, 2010, HEALTH POLICY PLANN, V25, pi53, DOI 10.1093/heapol/czq059; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Kietinun S, 1993, World Health Forum, V14, P418; Lee TJ, 2006, TROP MED INT HEALTH, V11, P1119, DOI 10.1111/j.1365-3156.2006.01651.x; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; McGready R, 2001, T ROY SOC TROP MED H, V95, P137, DOI 10.1016/S0035-9203(01)90137-3; McGready R, 2010, AM J TROP MED HYG, V83, P1322, DOI 10.4269/ajtmh.2010.10-0332; McGready R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000888; Millennium Development Goals Indicators, OFF UN SIT MDG IND; Moodley J, 2011, BJOG-INT J OBSTET GY, V118, P219, DOI 10.1111/j.1471-0528.2010.02726.x; Mullany LC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000317; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; NOSTEN F, 1994, J INFECT DIS, V169, P595, DOI 10.1093/infdis/169.3.595; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Paxton A, 2011, NEW ENGL J MED, V364, P1990, DOI 10.1056/NEJMp1012860; Plewes K, 2008, INT J STD AIDS, V19, P833, DOI 10.1258/ijsa.2008.008034; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Tangcharoensathien V, 2005, SOC POLICY DEV CONTE, P257; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; White LJ, 2012, J R SOC INTERFACE, V9, P503, DOI 10.1098/rsif.2011.0376; WHO, 2003, ASS MON ANT DRUG EFF, P57; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 1992, INT STAT CLASS DIS R	41	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40244	10.1371/journal.pone.0040244	http://dx.doi.org/10.1371/journal.pone.0040244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815732	Green Accepted, Green Published, gold			2022-12-27	WOS:000306548900018
J	Witt, J; Konrath, F; Sawodny, O; Ederer, M; Kulms, D; Sauter, T				Witt, Johannes; Konrath, Fabian; Sawodny, Oliver; Ederer, Michael; Kulms, Dagmar; Sauter, Thomas			Analysing the Role of UVB-Induced Translational Inhibition and PP2Ac Deactivation in NF-kappa B Signalling Using a Minimal Mathematical Model	PLOS ONE			English	Article							TEMPORAL CONTROL; GENE-EXPRESSION; KINASE-ACTIVITY; ALPHA; DYNAMICS; DEGRADATION; SPECIFICITY; DETERMINES; ACTIVATION; REPRESSION	Activation of nuclear factor kappa B (NF-kappa B) by interleukin-1 beta (IL-1) usually results in an anti-apoptotic activity that is rapidly terminated by a negative feedback loop involving NF-kB dependent resynthesis of its own inhibitor I kappa B alpha. However, apoptosis induced by ultraviolet B radiation (UVB) is not attenuated, but significantly enhanced by co-stimulation with IL-1 in human epithelial cells. Under these conditions NF-kappa B remains constitutively active and turns into a pro-apoptotic factor by selectively repressing anti-apoptotic genes. Two different mechanisms have been separately proposed to explain UV-induced lack of I kappa B alpha recurrence: global translational inhibition as well as deactivation of the Ser/Thr phosphatase PP2Ac. Using mathematical modelling, we show that the systems behaviour requires a combination of both mechanisms, and we quantify their contribution in different settings. A mathematical model including both mechanisms is developed and fitted to various experimental data sets. A comparison of the model results and predictions with model variants lacking one of the mechanisms shows that both mechanisms are present in our experimental setting. The model is successfully validated by the prediction of independent data. Weak constitutive IKK beta phosphorylation is shown to be a decisive process in I kappa B alpha degradation induced by UVB stimulation alone, but irrelevant for (co-) stimulations with IL-1. In silico knockout experiments show that translational inhibition is predominantly responsible for lack of I kappa B alpha recurrence following IL-1+UVB stimulation. In case of UVB stimulation alone, cooperation of both processes causes the observed decrease of I kappa B alpha. This shows that the processes leading to activation of transcription factor NF-kappa B upon stimulation with ultraviolet B radiation with and without interleukin-1 costimulation are more complex than previously thought, involving both a cross talk of UVB induced translational inhibition and PP2Ac deactivation. The importance of each of the mechanisms depends on the specific cellular setting.	[Witt, Johannes; Konrath, Fabian; Sawodny, Oliver; Ederer, Michael; Sauter, Thomas] Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany; [Konrath, Fabian; Kulms, Dagmar] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Sauter, Thomas] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg	University of Stuttgart; University of Stuttgart; University of Luxembourg	Witt, J (corresponding author), Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany.	witt@isys.uni-stuttgart.de; thomas.sauter@uni.lu	Kulms, Dagmar/H-1653-2014	Sauter, Thomas/0000-0001-8225-2954	German Research Foundation [DFG SA1672/1-1, DFG KU 1981/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG SA1672/1-1, DFG KU 1981/1-1 and DFG funding programme Open Access Publishing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barisic S, 2008, CELL DEATH DIFFER, V15, P1681, DOI 10.1038/cdd.2008.98; Blattner C, 2000, MOL CELL BIOL, V20, P3616, DOI 10.1128/MCB.20.10.3616-3625.2000; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Cowan JL, 2004, EUR J BIOCHEM, V271, P3596, DOI 10.1111/j.0014-2956.2004.04306.x; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kothny-Wilkes G, 1999, J BIOL CHEM, V274, P28916, DOI 10.1074/jbc.274.41.28916; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; Mengel B, 2010, CURR OPIN GENET DEV, V20, P656, DOI 10.1016/j.gde.2010.08.008; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Poppelmann B, 2005, J BIOL CHEM, V280, P15635, DOI 10.1074/jbc.M413006200; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Strozyk E, 2006, ONCOGENE, V25, P6239, DOI 10.1038/sj.onc.1209655; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; Warskulat U, 2007, BIOL CHEM, V388, P1345, DOI 10.1515/BC.2007.140; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Witt J, 2007, P SICE ANN C, P1353; Witt J, 2011, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2011-3; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Yang L, 2001, BIOCHEM BIOPH RES CO, V285, P603, DOI 10.1006/bbrc.2001.5205; Zhong JL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1092, DOI 10.1111/j.1751-1097.2011.00963.x	41	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40274	10.1371/journal.pone.0040274	http://dx.doi.org/10.1371/journal.pone.0040274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815735	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900019
J	Katayama, T; Kobayashi, H; Okamura, T; Yamasaki-Katayama, Y; Kibayashi, T; Kimura, H; Ohsawa, K; Kohsaka, S; Minami, M				Katayama, Takahiro; Kobayashi, Hayato; Okamura, Toshiyuki; Yamasaki-Katayama, Yuko; Kibayashi, Tatsuya; Kimura, Hiroshi; Ohsawa, Keiko; Kohsaka, Shinichi; Minami, Masabumi			Accumulating Microglia Phagocytose Injured Neurons in Hippocampal Slice Cultures: Involvement of p38 MAP Kinase	PLOS ONE			English	Article							IN-VIVO; CELLS; CLEARANCE; BRAIN; MODEL	In this study, microglial migration and phagocytosis were examined in mouse organotypic hippocampal slice cultures, which were treated with N-methyl-D-aspartate (NMDA) to selectively injure neuronal cells. Microglial cells were visualized by the expression of enhanced green fluorescent protein. Daily observation revealed microglial accumulation in the pyramidal cell layer, which peaked 5 to 6 days after NMDA treatment. Time-lapse imaging showed that microglia migrated to the pyramidal cell layer from adjacent and/or remote areas. There was no difference in the number of proliferating microglia between control and NMDA-treated slices in both the pyramidal cell layer and stratum radiatum, suggesting that microglial accumulation in the injured areas is mainly due to microglial migration, not to proliferation. Time-lapse imaging also showed that the injured neurons, which were visualized by propidium iodide (PI), disappeared just after being surrounded by microglia. Daily observation revealed that the intensity of PI fluorescence gradually attenuated, and this attenuation was suppressed by pretreatment with clodronate, a microglia toxin. These findings suggest that accumulating microglia phagocytosed injured neurons, and that PI fluorescence could be a useful indicator for microglial phagocytosis. Using this advantage to examine microglial phagocytosis in living slice cultures, we investigated the involvements of mitogen-activated protein (MAP) kinases in microglial accumulation and phagocytosis. p38 MAP kinase inhibitor SB203580, but not MAP kinase/extracellular signal-regulated kinase inhibitor PD98059 or c-Jun N-terminal kinase inhibitor SP600125, suppressed the attenuation of PI fluorescence. On the other hand, microglial accumulation in the injured areas was not inhibited by any of these inhibitors. These data suggest that p38 MAP kinase plays an important role in microglial phagocytosis of injured neurons.	[Katayama, Takahiro; Kobayashi, Hayato; Okamura, Toshiyuki; Kibayashi, Tatsuya; Minami, Masabumi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Okamura, Toshiyuki; Yamasaki-Katayama, Yuko] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Ohsawa, Keiko; Kohsaka, Shinichi] Natl Inst Neurosci, Dept Neurochem, Tokyo, Japan	Hokkaido University; Kyoto University; Osaka University; National Center for Neurology & Psychiatry - Japan	Katayama, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan.	mminami@pharm.hokudai.ac.jp	Kimura, Hiroshi/B-9524-2015; Minami, Masabumi/A-3883-2012	Kimura, Hiroshi/0000-0003-0854-083X; Minami, Masabumi/0000-0002-0144-0679	Ministry of Education, Culture, Sports, Science and Technology of Japan [18053002, 19045001, 21026001]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [23659028] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants for Scientific Research on Priority Areas on the "Elucidation of glia-neuron network-mediated information processing systems" (MM, 18053002) and "Molecular interaction and modal shift of cellular sensor" (MM, 19045001 and MM, 21026001) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Smoking Research Foundation (http://www.srf.or.jp/index.html) (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fujimoto S, 2006, NEUROBIOL DIS, V22, P130, DOI 10.1016/j.nbd.2005.10.008; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Holopainen IE, 2005, NEUROCHEM RES, V30, P1521, DOI 10.1007/s11064-005-8829-5; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Katayama T, 2010, EUR J NEUROSCI, V31, P1359, DOI 10.1111/j.1460-9568.2010.07160.x; Kohl A, 2003, EXP NEUROL, V181, P1, DOI 10.1016/S0014-4886(02)00049-3; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Witting A, 2000, J NEUROCHEM, V75, P1060, DOI 10.1046/j.1471-4159.2000.0751060.x	21	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40813	10.1371/journal.pone.0040813	http://dx.doi.org/10.1371/journal.pone.0040813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815830	Green Published, gold			2022-12-27	WOS:000306507000032
J	Lucas, SJ; Budak, H				Lucas, Stuart J.; Budak, Hikmet			Sorting the Wheat from the Chaff: Identifying miRNAs in Genomic Survey Sequences of Triticum aestivum Chromosome 1AL	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; PLANT MICRORNAS; GENE-EXPRESSION; STRESS; BARLEY; L.; CLASSIFICATION; IDENTIFICATION; BIOGENESIS; PREDICTION	Individual chromosome-based studies of bread wheat are beginning to provide valuable structural and functional information about one of the world's most important crops. As new genome sequences become available, identifying miRNA coding sequences is arguably as important a task as annotating protein coding sequences, but one that is not as well developed. We compared conservation-based identification of conserved miRNAs in 1.5 x coverage survey sequences of wheat chromosome 1AL with a predictive method based on pre-miRNA hairpin structure alone. In total, 42 sequences expected to encode conserved miRNAs were identified on chromosome 1AL, including members of several miRNA families that have not previously been reported to be expressed in T. aestivum. In addition, we demonstrate that a number of sequences previously annotated as novel wheat miRNAs are closely related to transposable elements, particularly Miniature Inverted Terminal repeat Elements (MITEs). Some of these TE-miRNAs may well have a functional role, but separating true miRNA coding sequences from TEs in genomic sequences is far from straightforward. We propose a strategy for annotation to minimize the risk of mis-identifying TE sequences as miRNAs.	[Lucas, Stuart J.; Budak, Hikmet] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Sabanci University	Lucas, SJ (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	budak@sabanciuniv.edu	Lucas, Stuart J./AAW-5615-2020; Budak, Hikmet/F-4708-2010; Budak, Hikmet/U-8517-2019; Budak, Hikmet/S-5835-2017	Lucas, Stuart J./0000-0003-3059-7453; Budak, Hikmet/0000-0002-2556-2478; Budak, Hikmet/0000-0002-2556-2478; Budak, Hikmet/0000-0002-2556-2478				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budak H, 2011, OMICS, V15, P791, DOI 10.1089/omi.2011.0073; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Feldman M., 1995, EVOLUTION CROP PLANT, V2nd, P184; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2010, METHODS MOL BIOL, V592, P19, DOI 10.1007/978-1-60327-005-2_2; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kantar M, 2012, FUNCT INTEG IN PRESS; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kubalakova M, 2002, THEOR APPL GENET, V104, P1362, DOI 10.1007/s00122-002-0888-2; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019212; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lucas SJ, 2012, FUNCT INTEGR GENOMIC, V12, P173, DOI 10.1007/s10142-011-0250-3; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Pantaleo V, 2011, ADV EXP MED BIOL, V722, P39, DOI 10.1007/978-1-4614-0332-6_3; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Unver Turgay, 2009, Int J Plant Genomics, V2009, P262463, DOI 10.1155/2009/262463; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Vitulo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026421; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xuan P, 2011, BIOINFORMATICS, V27, P1368, DOI 10.1093/bioinformatics/btr153; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007	40	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40859	10.1371/journal.pone.0040859	http://dx.doi.org/10.1371/journal.pone.0040859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815845	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000034
J	Weigt, LA; Baldwin, CC; Driskell, A; Smith, DG; Ormos, A; Reyier, EA				Weigt, Lee A.; Baldwin, Carole C.; Driskell, Amy; Smith, David G.; Ormos, Andrea; Reyier, Eric A.			Using DNA Barcoding to Assess Caribbean Reef Fish Biodiversity: Expanding Taxonomic and Geographic Coverage	PLOS ONE			English	Article							FRESH-WATER FISHES; C-OXIDASE-I; NUCLEOTIDE; EXTRACTION; SPECIATION; TELEOSTEI; IDENTIFICATION; DIVERGENCE; DIVERSITY; GENETICS	This paper represents a DNA barcode data release for 3,400 specimens representing 521 species of fishes from 6 areas across the Caribbean and western central Atlantic regions (FAO Region 31). Merged with our prior published data, the combined efforts result in 3,964 specimens representing 572 species of marine fishes and constitute one of the most comprehensive DNA barcoding "coverages" for a region reported to date. The barcode data are providing new insights into Caribbean shorefish diversity, allowing for more and more accurate DNA-based identifications of larvae, juveniles, and unknown specimens. Examples are given correcting previous work that was erroneous due to database incompleteness.	[Weigt, Lee A.; Driskell, Amy; Ormos, Andrea] Smithsonian Inst, Labs Analyt Biol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Baldwin, Carole C.; Smith, David G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Reyier, Eric A.] Kennedy Space Ctr, IHA Environm Serv, Kennedy Space Ctr, FL USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Weigt, LA (corresponding author), Smithsonian Inst, Labs Analyt Biol, Natl Museum Nat Hist, Washington, DC 20560 USA.	weigtl@si.edu			Smithsonian Marine Science Network; Smithsonian DNA Barcoding Initiative at L.A.B.	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); Smithsonian DNA Barcoding Initiative at L.A.B.	Funding was provided by the Smithsonian Marine Science Network and the Smithsonian DNA Barcoding Initiative at L.A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Aranishi F, 2006, CONSERV GENET, V7, P153, DOI 10.1007/s10592-005-5387-y; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Asgharian H, 2011, MOL ECOL RESOUR, V11, P461, DOI 10.1111/j.1755-0998.2011.02989.x; Baldwin CC, 2011, ZOOTAXA, P1; Baldwin CC, 2012, COPEIA, P23, DOI 10.1643/CG-11-035; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Baldwin Carole C., 2009, Smithsonian Contributions to the Marine Sciences, P111; Baldwin CC, 2009, ZOOTAXA, P1; Baldwin CC, 2003, B MAR SCI, V72, P639; BARTLETT SE, 1992, BIOTECHNIQUES, V12, P408; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Cawthorn DM, 2011, MOL ECOL RESOUR, V11, P979, DOI 10.1111/j.1755-0998.2011.03039.x; Chao NL, 2002, AM SOC ICHTHYOLOGIST, V3, P601; Eschmeyer WN, 2010, ZOOTAXA, P19; Eschmeyer WN, 2010, CATALOG FISHES WEBSI; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Handy SM, 2010, J AOAC INT, V94, P1; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Kartavtsev YP, 2011, MITOCHONDR DNA, V22, P55, DOI 10.3109/19401736.2011.588215; Kartavtsev YP, 2011, MAR GENOM, V4, P71, DOI 10.1016/j.margen.2011.02.002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar R, 2007, INDIAN J EXP BIOL, V45, P992; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lucentini L, 2006, CONSERV GENET, V7, P1009, DOI 10.1007/s10592-006-9137-6; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; McBride RS, 2010, ZOOTAXA, P29; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; Olney J.E., 2006, EARLY STAGES ATLANTI, P1019; Palero F, 2010, SCI MAR, V74, P465, DOI 10.3989/scimar.2010.74n3465; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shokralla S, 2010, BIOTECHNIQUES, V48, P233, DOI 10.2144/000113362; Smith KM, 2012, PLOS ONE, V7, P71, DOI 10.1371/journal.pone.0029505; SWOFFORD DL, 2002, PHYLOGENETIC ANAL PA; Tornabene Luke, 2010, Aqua, V16, P141; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Victor BC, 2007, ZOOTAXA, P51; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Wang ZD, 2010, SCI CHINA LIFE SCI, V53, P1025, DOI 10.1007/s11427-010-4034-0; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Weigt LA, 2011, DNA BARCODE IN PRESS; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Yancy H. F., 2008, FDA LAB INFORM B; Zhang J, 2010, MOL ECOL RESOUR, V10, P935, DOI 10.1111/j.1755-0998.2010.2838.x	51	80	86	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41059	10.1371/journal.pone.0041059	http://dx.doi.org/10.1371/journal.pone.0041059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815912	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000059
J	Kraszewski, S; Bianco, A; Tarek, M; Ramseyer, C				Kraszewski, Sebastian; Bianco, Alberto; Tarek, Mounir; Ramseyer, Christophe			Insertion of Short Amino-Functionalized Single-Walled Carbon Nanotubes into Phospholipid Bilayer Occurs by Passive Diffusion	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; TRANSLOCATION MECHANISMS; C-60 FULLERENES; PLASMID DNA; FORCE-FIELD; DELIVERY; TRANSPORTERS; WATER; INTERNALIZATION; MEMBRANES	Carbon nanotubes have been proposed to be efficient nanovectors able to deliver genetic or therapeutic cargo into living cells. However, a direct evidence of the molecular mechanism of their translocation across cell membranes is still needed. Here, we report on an extensive computational study of short (5 nm length) pristine and functionalized single-walled carbon nanotubes uptake by phospholipid bilayer models using all-atom molecular dynamics simulations. Our data support the hypothesis of a direct translocation of the nanotubes through the phospholipid membrane. We find that insertion of neat nanotubes within the bilayer is a "nanoneedle'' like process, which can often be divided in three consecutive steps: landing and floating, penetration of the lipid headgroup area and finally sliding into the membrane core. The presence of functional groups at moderate concentrations does not modify the overall scheme of diffusion mechanism, provided that their deprotonated state favors translocation through the lipid bilayer.	[Kraszewski, Sebastian; Ramseyer, Christophe] Univ Franche Comte, CHU Besancon, Lab Nanomed Imagerie & Therapeut, EA 4662, F-25030 Besancon, France; [Bianco, Alberto] CNRS, Inst Biol Mol & Cellulaire, Lab Immunol & Chim Therapeut, F-67084 Strasbourg, France; [Tarek, Mounir] Univ Lorraine, CNRS, Equipe Chim & Biochim Theor, UMR 7565, Nancy, France	Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine	Kraszewski, S (corresponding author), Univ Franche Comte, CHU Besancon, Lab Nanomed Imagerie & Therapeut, EA 4662, F-25030 Besancon, France.	mounir.tarek@srsmc.uhp-nancy.fr; christophe.ramseyer@univ-fcomte.fr	Kraszewski, Sebastian/ABA-9541-2021; TAREK, Mounir/B-8443-2012; ramseyer, christophe/B-6651-2013	ramseyer, christophe/0000-0002-9197-1835; Kraszewski, Sebastian/0000-0003-3244-7694; TAREK, mounir/0000-0002-9451-3215	CNRS; GENCI-CINES [2009-75136, 2010-75136]	CNRS(Centre National de la Recherche Scientifique (CNRS)); GENCI-CINES	The authors wish to thank CNRS for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was granted access to the HPC resources of a regional computational center the Mesocentre of the University of Franche-Comte. Simulations were also partly performed using HPC resources from GENCI-CINES Grant 2009-75136 and 2010-75136.	Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g; Al-Jamal KT, 2011, NANOSCALE, V3, P2627, DOI 10.1039/c1nr10080g; Antonelli A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/42/425101; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Cheng C, 2009, BIOMATERIALS, V30, P4152, DOI 10.1016/j.biomaterials.2009.04.019; Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311; Da Ros T, 1999, CHEM COMMUN, P663; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foldvari M, 2008, NANOMED-NANOTECHNOL, V4, P183, DOI 10.1016/j.nano.2008.04.003; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Frisch MJ, 2004, GAUSSIAN 03 REV C 02; Gangupomu VK, 2011, J NANOMATER, V2011, DOI 10.1155/2011/830436; Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a; Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432; Hofinger S, 2011, BIOMATERIALS, V32, P7079, DOI 10.1016/j.biomaterials.2011.06.011; Janosi L, 2010, J CHEM THEORY COMPUT, V6, P3267, DOI 10.1021/ct100381g; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kang B, 2010, SMALL, V6, P2362, DOI 10.1002/smll.201001260; Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Kraszewski S, 2011, ACS NANO, V5, P8571, DOI 10.1021/nn201952c; Lacerda L, 2007, NANO TODAY, V2, P38, DOI 10.1016/S1748-0132(07)70172-X; Lacerda L, 2012, BIOMATERIALS, V33, P3334, DOI 10.1016/j.biomaterials.2012.01.024; Li LW, 2007, J PHYS CHEM B, V111, P4067, DOI 10.1021/jp064982r; Li LW, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121647; Li LW, 2006, J PHYS CHEM B, V110, P10509, DOI 10.1021/jp060718m; Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; Makarucha AJ, 2011, EUR BIOPHYS J BIOPHY, V40, P103, DOI 10.1007/s00249-010-0651-6; Menard-Moyon C, 2010, CHEM BIOL, V17, P107, DOI 10.1016/j.chembiol.2010.01.009; Monticelli L, 2009, SOFT MATTER, V5, P4433, DOI 10.1039/b912310e; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Norrby PO, 2001, COORDIN CHEM REV, V212, P79, DOI 10.1016/S0010-8545(00)00296-4; Okabe A, 1992, SPATIAL TESSELLATION; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Partha R, 2009, INT J NANOMED, V4, P261; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pogodin S, 2010, ACS NANO, V4, P5293, DOI 10.1021/nn1016549; Prato M, 1998, ACCOUNTS CHEM RES, V31, P519, DOI 10.1021/ar970210p; Raffa V, 2008, CARBON, V46, P1600, DOI 10.1016/j.carbon.2008.06.053; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; Shi XH, 2008, ACTA MECH SINICA-PRC, V24, P161, DOI 10.1007/s10409-007-0131-0; Shi XH, 2011, NAT NANOTECHNOL, V6, P714, DOI [10.1038/nnano.2011.151, 10.1038/NNANO.2011.151]; Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561; Wallace EJ, 2008, NANO LETT, V8, P2751, DOI 10.1021/nl801217f; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; Yang K, 2010, NAT NANOTECHNOL, V5, P579, DOI [10.1038/NNANO.2010.141, 10.1038/nnano.2010.141]; Yoo J, 2008, BIOPHYS J, V94, pL61, DOI 10.1529/biophysj.107.122945	54	58	58	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40703	10.1371/journal.pone.0040703	http://dx.doi.org/10.1371/journal.pone.0040703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815794	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100057
J	Voloshin, O; Bakhrat, A; Herrmann, S; Raveh, D				Voloshin, Olga; Bakhrat, Anya; Herrmann, Sharon; Raveh, Dina			Transfer of Ho Endonuclease and Ufo1 to the Proteasome by the UbL-UbA Shuttle Protein, Ddi1, Analysed by Complex Formation In Vitro	PLOS ONE			English	Article							SCF UBIQUITIN-LIGASE; F-BOX PROTEINS; CELL-CYCLE; BINDING PROTEINS; STRUCTURAL BASIS; 26S PROTEASOME; DEGRADATION; YEAST; SYSTEM; MOTIF	The F-box protein, Ufo1, recruits Ho endonuclease to the SCFUfo1 complex for ubiquitylation. Both ubiquitylated Ho and Ufo1 are transferred by the UbL-UbA protein, Ddi1, to the 19S Regulatory Particle (RP) of the proteasome for degradation. The Ddi1-UbL domain binds Rpn1 of the 19S RP, the Ddi1-UbA domain binds ubiquitin chains on the degradation substrate. Here we used complex reconstitution in vitro to identify stages in the transfer of Ho and Ufo1 from the SCFUfo1 complex to the proteasome. We report SCFUfo1 complex at the proteasome formed in the presence of Ho. Subsequently Ddi1 is recruited to this complex by interaction between the Ddi1-UbL domain and Ufo1. The core of Ddi1 binds both Ufo1 and Rpn1; this interaction confers specificity of SCFUfo1 for Ddi1. The substrate-shield model predicts that Ho would protect Ufo1 from degradation and we find that Ddi1 binds Ho, Ufo1, and Rpn1 simultaneously forming a complex for transfer of Ho to the 19S RP. In contrast, in the absence of Ho, Rpn1 displaces Ufo1 from Ddi1 indicating a higher affinity of the Ddi1-UbL for the 19S RP. However, at high Rpn1 levels there is synergistic binding of Ufo1 to Ddi1 that is dependent on the Ddi1-UbA domain. Our interpretation is that in the absence of substrate, the Ddi1-UbL binds Rpn1 while the Ddi1-UbA binds ubiquitin chains on Ufo1. This would promote degradation of Ufo1 and disassembly of SCFUfo1 complexes.	[Voloshin, Olga; Bakhrat, Anya; Herrmann, Sharon; Raveh, Dina] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel	Ben Gurion University	Voloshin, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	dina.raveh@gmail.com			FP7 EU [PITN-GA-2008-215148]; Israel Cancer Association	FP7 EU; Israel Cancer Association	This work was supported by FP7 EU contract PITN-GA-2008-215148 and the Israel Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Baranes-Bacher K, 2008, YEAST, V25, P733, DOI 10.1002/yea.1615; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Hanzelmann P, 2010, J BIOL CHEM, V285, P20390, DOI 10.1074/jbc.M110.112532; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Ivantsiv Y, 2006, MOL CELL BIOL, V26, P1579, DOI 10.1128/MCB.26.5.1579-1588.2006; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kaplun L, 2000, P NATL ACAD SCI USA, V97, P10077, DOI 10.1073/pnas.97.18.10077; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kaplun L, 2003, J BIOL CHEM, V278, P48727, DOI 10.1074/jbc.M308671200; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Krylov DM, 2001, CURR BIOL, V11, pR584, DOI 10.1016/S0960-9822(01)00357-8; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Mathias N, 1999, MOL CELL BIOL, V19, P1759; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seibert V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-22; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Voloshin O, 2010, CELL MOL LIFE SCI, V67, P2025, DOI 10.1007/s00018-010-0308-8; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	52	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39210	10.1371/journal.pone.0039210	http://dx.doi.org/10.1371/journal.pone.0039210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815701	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100016
J	Putz, EM; Prchal-Murphy, M; Simma, OA; Forster, F; Koenig, X; Stockinger, H; Piekorz, RP; Freissmuth, M; Muller, M; Sexl, V; Zebedin-Brandl, E				Putz, Eva Maria; Prchal-Murphy, Michaela; Simma, Olivia Annabella; Forster, Florian; Koenig, Xaver; Stockinger, Hannes; Piekorz, Roland P.; Freissmuth, Michael; Mueller, Mathias; Sexl, Veronika; Zebedin-Brandl, Eva			PI3K delta Is Essential for Tumor Clearance Mediated by Cytotoxic T Lymphocytes	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE P110-DELTA; B-CELL DEVELOPMENT; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; CUTTING EDGE; PI3K; P110-GAMMA; ISOFORM; KINASE; INHIBITORS	Background: PI3K delta is a lipid kinase of the phosphoinositide 3-kinase class 1A family and involved in early signaling events of leukocytes regulating proliferation, differentiation and survival. Currently, several inhibitors of PI3K delta are under investigation for the treatment of hematopoietic malignancies. In contrast to the beneficial effect of inhibiting PI3K delta in tumor cells, several studies reported the requirement of PI3K delta for the function of immune cells, such as natural killer and T helper cells. Cytotoxic T lymphocytes (CTLs) are essential for tumor surveillance. The scope of this study is to clarify the potential impact of PI3K delta inhibition on the function of CTLs with emphasis on tumor surveillance. Principal Findings: PI3K delta-deficient mice develop significantly bigger tumors when challenged with MC38 colon adenocarcinoma cells. This defect is accounted for by the fact that PI3K delta controls the secretory perforin-granzyme pathway as well as the death-receptor pathway of CTL-mediated cytotoxicity, leading to severely diminished cytotoxicity against target cells in vitro and in vivo in the absence of PI3K delta expression. PI3K delta-deficient CTLs express low mRNA levels of important components of the cytotoxic machinery, e.g. prf1, grzmA, grzmB, fasl and trail. Accordingly, PI3K delta-deficient tumor-infiltrating CTLs display a phenotype reminiscent of naive T cells (CD69(low)CD62L(high)). In addition, electrophysiological capacitance measurements confirmed a fundamental degranulation defect of PI3K delta-/- CTLs. Conclusion: Our results demonstrate that CTL-mediated tumor surveillance is severely impaired in the absence of PI3K delta and predict that impaired immunosurveillance may limit the effectiveness of PI3K delta inhibitors in long-term treatment.	[Putz, Eva Maria; Sexl, Veronika] Univ Vet Med Vienna, Dept Biomed Sci, Inst Pharmacol & Toxicol, Vienna, Austria; [Prchal-Murphy, Michaela; Mueller, Mathias] Univ Vet Med Vienna, Dept Biomed Sci, Inst Anim Breeding & Genet, Vienna, Austria; [Simma, Olivia Annabella] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan; [Forster, Florian; Stockinger, Hannes] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Vienna, Austria; [Koenig, Xaver] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Neurophysiol & Pharmacol, Vienna, Austria; [Piekorz, Roland P.] Univ Dusseldorf, Univ Hosp & Clin, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Freissmuth, Michael; Zebedin-Brandl, Eva] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Mueller, Mathias] Univ Vet Med Vienna, Biomodels Austria, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Osaka University; Medical University of Vienna; Medical University of Vienna; Heinrich Heine University Dusseldorf; Medical University of Vienna; University of Veterinary Medicine Vienna	Putz, EM (corresponding author), Univ Vet Med Vienna, Dept Biomed Sci, Inst Pharmacol & Toxicol, Vienna, Austria.	eva-maria.zebedin@meduniwien.ac.at	König, Eva Maria/AAF-4041-2019; Stockinger, Hannes/E-5173-2011; Koenig, Xaver/Y-5588-2019; Forster, Florian/J-4300-2012; Sexl, Veronika/B-8657-2016	König, Eva Maria/0000-0002-9990-4477; Stockinger, Hannes/0000-0001-6404-4430; Koenig, Xaver/0000-0002-2423-4966; Sexl, Veronika/0000-0001-9363-0412; Muller, Mathias/0000-0002-7879-3552; Freissmuth, Michael/0000-0001-9398-1765; Zebedin-Brandl, Eva Maria/0000-0001-8479-0158; Putz, Eva Maria/0000-0002-5309-4114	Austrian Academy of Science DOC-fFORTE fellowship; Austrian Science Fund FWF [SFB F28]; GEN-AU program "Austromouse'' of Austrian Federal Ministry of Science and Research	Austrian Academy of Science DOC-fFORTE fellowship; Austrian Science Fund FWF(Austrian Science Fund (FWF)); GEN-AU program "Austromouse'' of Austrian Federal Ministry of Science and Research	This work was supported by the Austrian Academy of Science DOC-fFORTE fellowship (EMP and OAS; http://stipendien.oeaw.ac.at/en), the Austrian Science Fund FWF grant SFB F28 (EMP, MPM, MM, and VS; http://www.fwf.ac.at/en/projects/sfb.html), and the GEN-AU program "Austromouse'' of the Austrian Federal Ministry of Science and Research (MM; http://www.gen-au.at/projekt.jsp?projektId = 110&lang = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2008, J IMMUNOL, V180, P2538, DOI 10.4049/jimmunol.180.4.2538; Beer-Hammer S, 2010, J LEUKOCYTE BIOL, V87, P1083, DOI 10.1189/jlb.0809585; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Burger JA, 2012, CURR HEMATOL MALIG R, V7, P26, DOI 10.1007/s11899-011-0104-z; Castillo JJ, 2011, EXPERT OPINION INVES; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Collins I, 2009, ANTI-CANCER AGENT ME, V9, P32, DOI 10.2174/187152009787047734; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Gadgil A, 2008, INT J CHRONIC OBSTR, V3, P531; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Haylock-Jacobs S, 2011, J AUTOIMMUN, V36, P278, DOI 10.1016/j.jaut.2011.02.006; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Hickey FB, 2006, J BIOL CHEM, V281, P2441, DOI 10.1074/jbc.M511173200; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kerr WG, 2011, J INNATE IMMUN, V3, P249, DOI 10.1159/000323920; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lindsey WB, 2007, CYTOTHERAPY, V9, P123, DOI 10.1080/14653240601182838; Liu D, 2010, J IMMUNOL, V184, P3098, DOI 10.4049/jimmunol.0903177; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Ma S, 2011, CURR OPIN ONCOL, V23, P601, DOI 10.1097/CCO.0b013e32834b8943; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; McHardy T, 2010, J MED CHEM, V53, P2239, DOI 10.1021/jm901788j; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Saudemont A, 2007, BIOCHEM SOC T, V35, P183, DOI 10.1042/BST0350183; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Simma O, 2009, CANCER RES, V69, P203, DOI 10.1158/0008-5472.CAN-08-1705; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Swat W, 2006, BLOOD, V107, P2415, DOI 10.1182/blood-2005-08-3300; Tassi I, 2007, IMMUNITY, V27, P214, DOI 10.1016/j.immuni.2007.07.014; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Ying HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032892; Zebedin E, 2004, AM J PHYSIOL-CELL PH, V287, pC270, DOI 10.1152/ajpcell.00015.2004; Zebedin E, 2008, BLOOD, V112, P4655, DOI 10.1182/blood-2008-02-139105	53	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40852	10.1371/journal.pone.0040852	http://dx.doi.org/10.1371/journal.pone.0040852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808277	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700064
J	Simons, MJP; Briga, M; Koetsier, E; Folkertsma, R; Wubs, MD; Dijkstra, C; Verhulst, S				Simons, Mirre J. P.; Briga, Michael; Koetsier, Egbert; Folkertsma, Remco; Wubs, Matthias D.; Dijkstra, Cor; Verhulst, Simon			Bill Redness Is Positively Associated with Reproduction and Survival in Male and Female Zebra Finches	PLOS ONE			English	Article							SEXUALLY SELECTED TRAITS; TAENIOPYGIA-GUTTATA; PLUMAGE COLORATION; GENETIC-BASIS; SELECTION; CAROTENOIDS; SEX; SIGNALS; BIRDS; METAANALYSIS	Sexual traits can serve as honest indicators of phenotypic quality when they are costly. Brightly coloured yellow to red traits, which are pigmented by carotenoids, are relatively common in birds, and feature in sexual selection. Carotenoids have been linked to immune and antioxidant function, and the trade-off between ornamentation and these physiological functions provides a potential mechanism rendering carotenoid based signals costly. Mutual ornamentation is also common in birds and can be maintained by mutual mate choice for this ornament or by a correlated response in one sex to selection on the other sex. When selection pressures differ between the sexes this can cause intralocus sexual conflict. Sexually antagonistic selection pressures have been demonstrated for few sexual traits, and for carotenoid-dependent traits there is a single example: bill redness was found to be positively associated with survival and reproductive output in male zebra finches, but negatively so in females. We retested these associations in our captive zebra finch population without two possible limitations of this earlier study. Contrary to the earlier findings, we found no evidence for sexually antagonistic selection. In both sexes, individuals with redder bills showed higher survival. This association disappeared among the females with the reddest bills. Furthermore, females with redder bills achieved higher reproductive output. We conclude that bill redness of male and female zebra finches honestly signals phenotypic quality, and discuss the possible causes of the differences between our results and earlier findings.	[Simons, Mirre J. P.; Briga, Michael; Koetsier, Egbert; Folkertsma, Remco; Wubs, Matthias D.; Dijkstra, Cor; Verhulst, Simon] Univ Groningen, Ctr Life Sci, Groningen, Netherlands	University of Groningen	Simons, MJP (corresponding author), Univ Groningen, Ctr Life Sci, Groningen, Netherlands.	mirresimons@gmail.com	Dijkstra, Cor/D-5876-2011; Verhulst, Simon/S-3404-2019; Verhulst, Simon/B-1613-2009	Dijkstra, Cor/0000-0002-7042-8083; Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Simons, Mirre/0000-0001-7406-7708; Briga, Michael/0000-0003-3160-0407	Netherlands Organization of Scientific Research (NWO); Top-talent grant; NWO Vici grant	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Top-talent grant; NWO Vici grant(Netherlands Organization for Scientific Research (NWO))	Funding is by the Netherlands Organization of Scientific Research (NWO, www.nwo.nl), a Top-talent grant to M.J.P.S. and an NWO Vici grant, which also funded E.K., to S.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Birkhead TR, 2006, EVOLUTION, V60, P2389; Birkhead TR, 1998, BEHAV ECOL SOCIOBIOL, V44, P179, DOI 10.1007/s002650050530; Bjorklund M, 2001, J EVOLUTION BIOL, V14, P841, DOI 10.1046/j.1420-9101.2001.00334.x; Bolund E, 2009, P R SOC B, V276, P707, DOI 10.1098/rspb.2008.1251; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; BURLEY N, 1987, ETHOLOGY, V76, P133; Burley NT, 1996, BEHAV ECOL, V7, P218, DOI 10.1093/beheco/7.2.218; Chenoweth SF, 2010, ANNU REV ECOL EVOL S, V41, P81, DOI 10.1146/annurev-ecolsys-102209-144657; Cote J, 2010, J EXP BIOL, V213, P271, DOI 10.1242/jeb.035188; De Coster G, 2011, NATURWISSENSCHAFTEN, V98, P1049, DOI 10.1007/s00114-011-0863-3; Eraud C, 2007, J EXP BIOL, V210, P3571, DOI 10.1242/jeb.005496; Figuerola J, 2007, OIKOS, V116, P636, DOI 10.1111/j.2007.0030-1299.14719.x; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Gautier P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1159, DOI 10.1007/s00265-008-0544-1; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Horak P, 2001, OECOLOGIA, V126, P166, DOI 10.1007/s004420000513; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Koetsier E, 2011, J EXP BIOL, V214, P1225, DOI 10.1242/jeb.050336; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; McGraw KJ, 2003, AUK, V120, P400, DOI 10.1642/0004-8038(2003)120[0400:DPCASC]2.0.CO;2; McGraw KJ, 2004, J AVIAN BIOL, V35, P471, DOI 10.1111/j.0908-8857.2004.03405.x; Nolan PM, 1998, P ROY SOC B-BIOL SCI, V265, P961, DOI 10.1098/rspb.1998.0384; Olson VA, 2005, J EVOLUTION BIOL, V18, P1534, DOI 10.1111/j.1420-9101.2005.00940.x; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; PRICE DK, 1994, AM NAT, V144, P908, DOI 10.1086/285718; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; Schielzeth H, 2012, EVOLUTION, V66, P18, DOI 10.1111/j.1558-5646.2011.01431.x; Simons MJP, 2011, BEHAV ECOL, V22, P755, DOI 10.1093/beheco/arr043; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stigell P., 2007, Pattern Recognition and Image Analysis, V17, P233, DOI 10.1134/S1054661807020101; SUNDBERG J, 1995, BEHAV ECOL SOCIOBIOL, V37, P275, DOI 10.1007/s002650050191; Toomey MB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-3; van Doorn GS, 2009, ANN NY ACAD SCI, V1168, P52, DOI 10.1111/j.1749-6632.2009.04573.x; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	43	23	23	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40721	10.1371/journal.pone.0040721	http://dx.doi.org/10.1371/journal.pone.0040721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808243	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306366400052
J	Grarock, K; Tidemann, CR; Wood, J; Lindenmayer, DB				Grarock, Kate; Tidemann, Christopher R.; Wood, Jeffrey; Lindenmayer, David B.			Is It Benign or Is It a Pariah? Empirical Evidence for the Impact of the Common Myna (Acridotheres tristis) on Australian Birds	PLOS ONE			English	Article							MINERS MANORINA-MELANOPHRYS; ECOSYSTEM; CONSEQUENCES; INVASIONS; BIODIVERSITY; COMPETITION; POPULATION; MANAGEMENT; DIVERSITY; ABUNDANCE	There is widespread concern over the impact of introduced species on biodiversity, but the magnitude of these impacts can be variable. Understanding the impact of an introduced species is essential for effective management. However, empirical evidence of the impact of an introduced species can be difficult to obtain, especially when the impact is through competition. Change in species abundance is often slow and gradual, coinciding with environmental change. As a result, negative impacts on native species through competition are poorly documented. An example of the difficulties associated with obtaining empirical evidence of impact due to competition comes from work on the Common Myna (Acridotheres tristis). The species is listed in the World's top 100 worst invaders, despite a lack of empirical evidence of its negative impacts on native species. We assessed the impact of the Common Myna on native bird abundance, using long-term data both pre and post its invasion. At the outset of our investigation, we postulated that Common Myna establishment would negatively affect the abundance of other cavity-nesting species and bird species that are smaller than it. We found a negative relationship between the establishment of the Common Myna and the long-term abundance of three cavity-nesting species (Sulphur-crested Cockatoo, Crimson Rosella, Laughing Kookaburra) and eight small bird species (Striated Paradoxes, Rufous Whistler, Willie Wagtail, Grey Fantail, Magpie-lark, House Sparrow, Silvereye, Common Blackbird). To the best of our knowledge, this finding has never previously been demonstrated at the population level. We discuss the key elements of our success in finding empirical evidence of a species impact and the implications for prioritisation of introduced species for management. Specifically, prioritization of the Common Myna for management over other species still remains a contentious issue.	[Grarock, Kate; Tidemann, Christopher R.; Wood, Jeffrey; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Coll Med Biol & Environm, Canberra, ACT, Australia; [Grarock, Kate; Lindenmayer, David B.] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia	Australian National University; University of Canberra	Grarock, K (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Coll Med Biol & Environm, Canberra, ACT, Australia.	kate.grarock@gmail.com.au	Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088	Invasive Animals Cooperative Research Centre; Australian National University	Invasive Animals Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian National University(Australian National University)	This work is supported in part by the Invasive Animals Cooperative Research Centre and the Australian National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABC, 2005, WILDW AUSTR SURV; ABS, 2006, CENS POP HOUS AUSTR; ACT Planning and Land Authority, 2011, ACT VEG; Blackburn TM, 2009, GLOBAL CHANGE BIOL, V15, P2852, DOI 10.1111/j.1365-2486.2008.01841.x; Bradshaw CJA, 2007, WILDLIFE RES, V34, P419, DOI 10.1071/WR06056; Brown GP, 2011, ECOLOGY, V92, P422, DOI 10.1890/10-0536.1; Clarke MF, 1999, BIOL CONSERV, V88, P111, DOI 10.1016/S0006-3207(98)00083-4; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cooper CB, 2007, ECOLOGY, V88, P864, DOI 10.1890/06-0855; COUNSILMAN J J, 1974, Emu, V74, P135; COUNSILMAN J J, 1974, Notornis, V21, P318; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Crossman ND, 2007, BIODIVERS CONSERV, V16, P3781, DOI 10.1007/s10531-007-9180-8; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Dhami M. K., 2009, REV BIOL ECOLOGY COM; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; ESRI, 2010, ARCGIS; Feare C, 1998, STARLINGS MYNAS; Gregory-Smith R, 1985, CANBERRA BIRD NOTES, V10, P97; Grey M, 2008, IMPACT NOISY MINER M; Grey MJ, 1997, WILDLIFE RES, V24, P631, DOI 10.1071/WR96080; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Harper MJ, 2005, WILDLIFE RES, V32, P509, DOI 10.1071/WR04106; HONE J, 1978, EMU, V78, P227, DOI 10.1071/MU9780227; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Kemmerer EP, 2008, FOREST ECOL MANAG, V255, P2094, DOI 10.1016/j.foreco.2007.12.035; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kumschick S, 2011, BIOL CONSERV, V144, P2747, DOI 10.1016/j.biocon.2011.08.019; Kumschick S, 2010, BIOL CONSERV, V143, P2757, DOI 10.1016/j.biocon.2010.07.023; Lee Y., 2006, GEN LINEAR MODELS RA; Lindenmayer DB, 2011, BIOL CONSERV, V144, P430, DOI 10.1016/j.biocon.2010.09.029; Long JL, 1981, INTRO BIRDS WORLD; Lowe KA, 2011, J ORNITHOL, V152, P909, DOI 10.1007/s10336-011-0674-5; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Markula A., 2009, PEST ANIMAL RISK ASS; Maron M, 2007, FOREST ECOL MANAG, V240, P24, DOI 10.1016/j.foreco.2006.11.017; Martin WK, 1996, EMU, V96, P166, DOI 10.1071/MU9960166; Meinesz A., 1999, KILLER ALGAE; Montague-Drake RM, 2011, LANDSCAPE ECOL, V26, P1383, DOI 10.1007/s10980-011-9665-4; National Carbon Accounting System, 2011, FOR EXT CHANG VERS 7; Nentwig W, 2010, CONSERV BIOL, V24, P302, DOI 10.1111/j.1523-1739.2009.01289.x; Newton I., 1998, POPULATION LIMITATIO; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Pell AS, 1997, BIOL CONSERV, V79, P145, DOI 10.1016/S0006-3207(96)00112-7; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pizzey G, 2007, FIELD GUIDE BIRDS AU; Pysek Petr, 2007, V193, P97; Ricciardi A, 2003, FRESHWATER BIOL, V48, P972, DOI 10.1046/j.1365-2427.2003.01071.x; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Strubbe D, 2011, BIOL CONSERV, V144, P2748, DOI 10.1016/j.biocon.2011.08.011; Strubbe D, 2011, BIOL CONSERV, V144, P2112, DOI 10.1016/j.biocon.2011.05.001; Taylor RS, 2008, LANDSCAPE ECOL, V23, P377, DOI 10.1007/s10980-008-9196-9; Tindall S. David, 2007, Pacific Conservation Biology, V13, P202; Townsend CR, 2003, CONSERV BIOL, V17, P38, DOI 10.1046/j.1523-1739.2003.02017.x; Tracey J., 2007, MANAGING BIRD DAMAGE; Veerman PA, 2003, CANBERRA BIRDS REPOR; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; VSN International, 2011, GENSTAT 14; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson PR, 1973, ECOLOGY COMMON MYNA	69	56	59	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40622	10.1371/journal.pone.0040622	http://dx.doi.org/10.1371/journal.pone.0040622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808210	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400087
J	Brown, CL; Hardy, AR; Barber, JR; Fristrup, KM; Crooks, KR; Angeloni, LM				Brown, Casey L.; Hardy, Amanda R.; Barber, Jesse R.; Fristrup, Kurt M.; Crooks, Kevin R.; Angeloni, Lisa M.			The Effect of Human Activities and Their Associated Noise on Ungulate Behavior	PLOS ONE			English	Article							PREDATION RISK; GROUP-SIZE; ANTIPREDATOR BEHAVIOR; ANTHROPOGENIC NOISE; WILDLIFE RESPONSES; HUMAN DISTURBANCE; MODEL SELECTION; AIRCRAFT NOISE; BIGHORN SHEEP; TRAFFIC NOISE	Background: The effect of anthropogenic noise on terrestrial wildlife is a relatively new area of study with broad ranging management implications. Noise has been identified as a disturbance that has the potential to induce behavioral responses in animals similar to those associated with predation risk. This study investigated potential impacts of a variety of human activities and their associated noise on the behavior of elk (Cervus elaphus) and pronghorn (Antilocapra americana) along a transportation corridor in Grand Teton National Park. Methodology/Principal Findings: We conducted roadside scan surveys and focal observations of ungulate behavior while concurrently recording human activity and anthropogenic noise. Although we expected ungulates to be more responsive with greater human activity and noise, as predicted by the risk disturbance hypothesis, they were actually less responsive (less likely to perform vigilant, flight, traveling and defensive behaviors) with increasing levels of vehicle traffic, the human activity most closely associated with noise. Noise levels themselves had relatively little effect on ungulate behavior, although there was a weak negative relationship between noise and responsiveness in our scan samples. In contrast, ungulates did increase their responsiveness with other forms of anthropogenic disturbance; they reacted to the presence of pedestrians (in our scan samples) and to passing motorcycles (in our focal observations). Conclusions: These findings suggest that ungulates did not consistently associate noise and human activity with an increase in predation risk or that they could not afford to maintain responsiveness to the most frequent human stimuli. Although reduced responsiveness to certain disturbances may allow for greater investment in fitness-enhancing activities, it may also decrease detections of predators and other environmental cues and increase conflict with humans.	[Brown, Casey L.; Hardy, Amanda R.; Crooks, Kevin R.; Angeloni, Lisa M.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Barber, Jesse R.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Fristrup, Kurt M.] Natl Pk Serv, Nat Sounds & Night Skies Div, Ft Collins, CO USA; [Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Angeloni, Lisa M.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; Idaho; Boise State University; United States Department of the Interior; Colorado State University; Colorado State University	Brown, CL (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	caseylynnbrown@gmail.com			National Park Service; National Science Foundation [DGE-0649876]; Colorado State University; Rocky Mountain Goats Foundation; United States National Park Service (RM-CESU Cooperative) [H1200040001]	National Park Service; National Science Foundation(National Science Foundation (NSF)); Colorado State University; Rocky Mountain Goats Foundation; United States National Park Service (RM-CESU Cooperative)	We would like to thank Grand Teton National Park, including S. Burson, S. Cain, and S. Dewey, for permission to conduct this research and logistical support. The National Park Service Natural Sounds and Night Skies Division and the Cornell Lab of Ornithology provided recording equipment and valuable assistance with acoustical software and analyses. We also thank M. Scott and K. Van Ort for their help with the collection and organization of data. We are grateful to J. Eickoff for providing statistical guidance. The comments of M. Hayward and two anonymous reviewers improved the manuscript considerably. The National Park Service, the National Science Foundation, Colorado State University and the Rocky Mountain Goats Foundation provided support for this project.; This study was funded by the United States National Park Service (RM-CESU Cooperative Agreement # H1200040001). Fellowship support was given to CLB by Colorado State University, Rocky Mountain Goats Foundation, and the National Science Foundation (DGE-0649876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament R, 2008, ENVIRON MANAGE, V42, P480, DOI 10.1007/s00267-008-9112-8; Angeloni L, 2010, ENCY ANIMAL BEHAV, P377; Angeloni L, 2008, ANIM BEHAV, V75, P731, DOI 10.1016/j.anbehav.2007.08.007; Barber JR, 2011, LANDSCAPE ECOL, V26, P1281, DOI 10.1007/s10980-011-9646-7; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Bejder L, 2009, MAR ECOL PROG SER, V395, P177, DOI 10.3354/meps07979; BERGER J, 1983, BIOL CONSERV, V25, P193, DOI 10.1016/0006-3207(83)90036-8; Berger J, 2003, CONSERV BIOL, V17, P1451, DOI 10.1046/j.1523-1739.2003.02467.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Bolger DT, 2008, ECOL LETT, V11, P63; Borkowski JJ, 2006, ECOL APPL, V16, P1911, DOI 10.1890/1051-0761(2006)016[1911:BROBAE]2.0.CO;2; Bradshaw CJA, 1998, CAN J ZOOL, V76, P1319, DOI 10.1139/cjz-76-7-1319; Buchholz R, 2007, TRENDS ECOL EVOL, V22, P401, DOI 10.1016/j.tree.2007.06.002; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; CASSIRER EF, 1992, WILDLIFE SOC B, V20, P375; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Clair CCS, 2009, BEHAVIOUR, V146, P393, DOI 10.1163/156853909X410973; Cleveland SM, 2010, THESIS U MONTANA MIS; Conover M., 2002, RESOLVING HUMAN WILD; CZECH B, 1991, APPL ANIM BEHAV SCI, V29, P269, DOI 10.1016/0168-1591(91)90253-T; D'Angelo GJ, 2007, J WILDLIFE MANAGE, V71, P1238, DOI 10.2193/2006-326; Delaney DK, 1999, J WILDLIFE MANAGE, V63, P60, DOI 10.2307/3802487; Doherty P. F., 2010, J ORNITHOL, V152, pS317; Dooling R.J., 2007, EFFECTS HIGHWAY NOIS; DORRANCE MJ, 1975, J WILDLIFE MANAGE, V39, P563, DOI 10.2307/3800399; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Fahrig L, 2009, ECOL SOC, V14; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fortin D, 2003, WILDLIFE SOC B, V31, P804; Francis CD, 2011, LANDSCAPE ECOL, V26, P1269, DOI 10.1007/s10980-011-9609-z; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; FREDDY DJ, 1986, WILDLIFE SOC B, V14, P63; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Frid A, 2002, CONSERV ECOL, V6; Gavin SD, 2006, CAN J ZOOL, V84, P1775, DOI 10.1139/Z06-175; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Goldstein MI, 2005, WILDLIFE SOC B, V33, P688, DOI 10.2193/0091-7648(2005)33[688:MGRTHO]2.0.CO;2; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Harms CA, 1997, CONDOR, V99, P231, DOI 10.2307/1370247; Henderson D, 1976, EFFECTS NOISE HEARIN; Knight Richard L., 1995, P51; Leighton PA, 2010, BIOL CONSERV, V143, P2156, DOI 10.1016/j.biocon.2010.05.028; Lengagne T, 2008, BIOL CONSERV, V141, P2023, DOI 10.1016/j.biocon.2008.05.017; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIPETZ VE, 1982, Z TIERPSYCHOL, V58, P203; Lynch E, 2011, LANDSCAPE ECOL, V26, P1297, DOI 10.1007/s10980-011-9643-x; Lyon LJ, 1982, ELK N AM ECOLOGY MAN, P442; Maier JAK, 1998, J WILDLIFE MANAGE, V62, P752, DOI 10.2307/3802352; Manor R, 2003, ECOL APPL, V13, P1830, DOI 10.1890/01-5354; Miller SG, 2001, WILDLIFE SOC B, V29, P124; MORRISON JR, 1995, WILDLIFE SOC B, V23, P481; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Owen MA, 2004, ZOO BIOL, V23, P147, DOI 10.1002/zoo.10124; Papouchis CM, 2001, J WILDLIFE MANAGE, V65, P573, DOI 10.2307/3803110; PEDEVILLANO C, 1987, BIOL CONSERV, V39, P1, DOI 10.1016/0006-3207(87)90002-4; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; Quinn JL, 2006, J AVIAN BIOL, V37, P601; Rabin LA, 2006, BIOL CONSERV, V131, P410, DOI 10.1016/j.biocon.2006.02.016; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; ROST GR, 1979, J WILDLIFE MANAGE, V43, P634, DOI 10.2307/3808741; Rowland MM, 2000, J WILDLIFE MANAGE, V64, P672, DOI 10.2307/3802737; Rumble Mark A., 2005, Intermountain Journal of Sciences, V11, P10; Rumble Mark A., 2011, Prairie Naturalist, V43, P3; SCHULTZ RD, 1978, J WILDLIFE MANAGE, V42, P91, DOI 10.2307/3800694; Setsaas TH, 2007, BIOL CONSERV, V136, P563, DOI 10.1016/j.biocon.2007.01.001; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Smith BL, 2007, NORTHWEST SCI, V81, P251, DOI 10.3955/0029-344X-81.4.251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; STOCKWELL CA, 1991, BIOL CONSERV, V56, P317, DOI 10.1016/0006-3207(91)90064-G; Summers PD, 2011, J APPL ECOL, V48, P1527, DOI 10.1111/j.1365-2664.2011.02041.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; Thorpe, 1963, LEARNING INSTINCT AN; TYLER NJC, 1991, BIOL CONSERV, V56, P179, DOI 10.1016/0006-3207(91)90016-3; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; Waynert DF, 1999, APPL ANIM BEHAV SCI, V62, P27, DOI 10.1016/S0168-1591(98)00211-1; Weisenberger ME, 1996, J WILDLIFE MANAGE, V60, P52, DOI 10.2307/3802039; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	89	44	47	4	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40505	10.1371/journal.pone.0040505	http://dx.doi.org/10.1371/journal.pone.0040505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808175	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500048
J	Van Duyne, R; Guendel, I; Klase, Z; Narayanan, A; Coley, W; Jaworski, E; Roman, J; Popratiloff, A; Mahieux, R; Kehn-Hall, K; Kashanchi, F				Van Duyne, Rachel; Guendel, Irene; Klase, Zachary; Narayanan, Aarthi; Coley, William; Jaworski, Elizabeth; Roman, Jessica; Popratiloff, Anastas; Mahieux, Renaud; Kehn-Hall, Kylene; Kashanchi, Fatah			Localization and Sub-Cellular Shuttling of HTLV-1 Tax with the miRNA Machinery	PLOS ONE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-1 TAX; NF-KAPPA-B; RNA SILENCING SUPPRESSOR; CREB BINDING-PROTEIN; PROTEASOME INHIBITOR PS-341; SHORT INTERFERING RNA; HEPATITIS-C VIRUS; I TAX; REX PROTEIN	The innate ability of the human cell to silence endogenous retroviruses through RNA sequences encoding microRNAs, suggests that the cellular RNAi machinery is a major means by which the host mounts a defense response against present day retroviruses. Indeed, cellular miRNAs target and hybridize to specific sequences of both HTLV-1 and HIV-1 viral transcripts. However, much like the variety of host immune responses to retroviral infection, the virus itself contains mechanisms that assist in the evasion of viral inhibition through control of the cellular RNAi pathway. Retroviruses can hijack both the enzymatic and catalytic components of the RNAi pathway, in some cases to produce novel viral miRNAs that can either assist in active viral infection or promote a latent state. Here, we show that HTLV-1 Tax contributes to the dysregulation of the RNAi pathway by altering the expression of key components of this pathway. A survey of uninfected and HTLV-1 infected cells revealed that Drosha protein is present at lower levels in all HTLV-1 infected cell lines and in infected primary cells, while other components such as DGCR8 were not dramatically altered. We show colocalization of Tax and Drosha in the nucleus in vitro as well as coimmunoprecipitation in the presence of proteasome inhibitors, indicating that Tax interacts with Drosha and may target it to specific areas of the cell, namely, the proteasome. In the presence of Tax we observed a prevention of primary miRNA cleavage by Drosha. Finally, the changes in cellular miRNA expression in HTLV-1 infected cells can be mimicked by the add back of Drosha or the addition of antagomiRs against the cellular miRNAs which are downregulated by the virus.	[Van Duyne, Rachel; Guendel, Irene; Narayanan, Aarthi; Jaworski, Elizabeth; Roman, Jessica; Kehn-Hall, Kylene; Kashanchi, Fatah] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Van Duyne, Rachel; Coley, William; Kashanchi, Fatah] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Klase, Zachary] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Popratiloff, Anastas] George Washington Univ, Dept Anat & Regenerat Biol, Washington, DC USA; [Mahieux, Renaud] INSERM U758 Virol Humaine, Retroviral Oncogenesis Team, Lyon, France	George Mason University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Van Duyne, R (corresponding author), George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	fkashanc@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/ABI-2429-2020; Van Duyne, Rachel/I-7365-2019	Van Duyne, Rachel/0000-0003-2914-6874; Roman, Jessica/0000-0003-0454-1974; Kehn-Hall, Kylene/0000-0001-8036-7213; mahieux, renaud/0000-0002-5129-6804	NIH [AI078859, AI074410-01]; National Center for Research Resources [1S10RR025565]; George Mason university funds; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078859, R21AI074410] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); George Mason university funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The confocal images and the GWU CMIA are supported by a grant from the NIH, National Center for Research Resources, 1S10RR025565. Further support came from grants from the George Mason university funds to FK and NIH grants AI078859 and AI074410-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2010, FEBS LETT, V584, P4313, DOI 10.1016/j.febslet.2010.09.031; Abou-Merhi R, 2007, LEUKEMIA, V21, P1792, DOI 10.1038/sj.leu.2404797; Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x; BALLAUN C, 1991, J VIROL, V65, P4408, DOI 10.1128/JVI.65.8.4408-4413.1991; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Basbous J, 2003, J VIROL, V77, P13028, DOI 10.1128/JVI.77.24.13028-13035.2003; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Bennasser Yamina, 2006, V342, P241, DOI 10.1385/1-59745-123-1:241; Bennasser Y, 2006, CURR OPIN HIV AIDS, V1, P208, DOI 10.1097/01.COH.0000221593.49412.56; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; CARON C, 1993, EMBO J, V12, P4269, DOI 10.1002/j.1460-2075.1993.tb06111.x; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chiari E, 2004, J VIROL, V78, P11823, DOI 10.1128/JVI.78.21.11823-11832.2004; Chowdhury IH, 2003, J GEN VIROL, V84, P897, DOI 10.1099/vir.0.18753-0; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Colgin MA, 1998, J VIROL, V72, P9396, DOI 10.1128/JVI.72.11.9396-9399.1998; de Vries W, 2009, J GEN VIROL, V90, P1916, DOI 10.1099/vir.0.008284-0; Delgadillo MO, 2004, J GEN VIROL, V85, P993, DOI 10.1099/vir.0.19735-0; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; Gallo RC, 2005, ONCOGENE, V24, P5926, DOI 10.1038/sj.onc.1208980; Gatza ML, 2006, J VIROL, V80, P6657, DOI 10.1128/JVI.02270-05; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; GOREN I, 1995, J VIROL, V69, P5806, DOI 10.1128/JVI.69.9.5806-5811.1995; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002; Harrod R, 2000, J BIOL CHEM, V275, P11852, DOI 10.1074/jbc.275.16.11852; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Jeong SJ, 2004, BLOOD, V104, P1490, DOI 10.1182/blood-2003-12-4174; Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0; Jiang H, 1999, MOL CELL BIOL, V19, P8136; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Karjee S, 2010, J VIROL, V84, P10395, DOI 10.1128/JVI.00748-10; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Kashanchi F, 1998, J BIOL CHEM, V273, P34646, DOI 10.1074/jbc.273.51.34646; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kusuhara K, 1999, J VIROL, V73, P8112, DOI 10.1128/JVI.73.10.8112-8119.1999; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE WR, 1992, J VIROL, V66, P1799, DOI 10.1128/JVI.66.3.1799-1803.1992; Lemasson I, 2004, MOL CELL BIOL, V24, P6117, DOI 10.1128/MCB.24.14.6117-6126.2004; Lenzmeier BA, 1998, MOL CELL BIOL, V18, P721, DOI 10.1128/MCB.18.2.721; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Mitra-Kaushik S, 2004, BLOOD, V104, P802, DOI 10.1182/blood-2003-11-3967; Narayan M, 2001, J VIROL, V75, P8440, DOI 10.1128/JVI.75.18.8440-8448.2001; Nasr R, 2005, ONCOGENE, V24, P419, DOI 10.1038/sj.onc.1208212; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Nicot C, 2000, ONCOGENE, V19, P2155, DOI 10.1038/sj.onc.1203536; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P6815, DOI 10.1073/pnas.77.11.6815; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034490; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Ruggero K, 2010, MOL ASPECTS MED, V31, P367, DOI 10.1016/j.mam.2010.05.001; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Satou Y, 2004, LEUKEMIA, V18, P1357, DOI 10.1038/sj.leu.2403400; Schnettler E, 2009, EMBO REP, V10, P258, DOI 10.1038/embor.2009.6; SEMMES OJ, 1995, J VIROL, V69, P1827, DOI 10.1128/JVI.69.3.1827-1833.1995; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SMITH MR, 1992, VIROLOGY, V187, P316, DOI 10.1016/0042-6822(92)90320-O; Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; SUZUKI T, 1994, ONCOGENE, V9, P3099; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; Taylor JM, 2008, APOPTOSIS, V13, P733, DOI 10.1007/s10495-008-0208-7; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Xiao GT, 2000, ONCOGENE, V19, P5198, DOI 10.1038/sj.onc.1203894; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; YIN MJ, 1995, J VIROL, V69, P3420, DOI 10.1128/JVI.69.6.3420-3432.1995; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Yoshida K, 2007, EUR HEART J, V28, P2610, DOI 10.1093/eurheartj/ehm441; Zheng ZM, 2010, INT J BIOL SCI, V6, P730	96	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40662	10.1371/journal.pone.0040662	http://dx.doi.org/10.1371/journal.pone.0040662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808228	gold, Green Published			2022-12-27	WOS:000306355500069
J	Carnevali, L; Mastorci, F; Audero, E; Graiani, G; Rossi, S; Macchi, E; Callegari, S; Bartolomucci, A; Nalivaiko, E; Quaini, F; Gross, C; Sgoifo, A				Carnevali, Luca; Mastorci, Francesca; Audero, Enrica; Graiani, Gallia; Rossi, Stefano; Macchi, Emilio; Callegari, Sergio; Bartolomucci, Alessandro; Nalivaiko, Eugene; Quaini, Federico; Gross, Cornelius; Sgoifo, Andrea			Stress-Induced Susceptibility to Sudden Cardiac Death in Mice with Altered Serotonin Homeostasis	PLOS ONE			English	Article							CENTRAL 5-HT RECEPTORS; HEART-RATE-VARIABILITY; KNOCKOUT MICE; CARDIOVASCULAR-RESPONSES; VENTROLATERAL MEDULLA; PSYCHOLOGICAL STRESS; MYOCARDIAL-ISCHEMIA; PSYCHOSOCIAL STRESS; BODY-TEMPERATURE; SOCIAL STRESS	In humans, chronic stressors have long been linked to cardiac morbidity. Altered serotonergic neurotransmission may represent a crucial pathophysiological mechanism mediating stress-induced cardiac disturbances. Here, we evaluated the physiological role of serotonin (5-HT) 1A receptors in the autonomic regulation of cardiac function under acute and chronic stress conditions, using 5-HT1A receptor knockout mice (KOs). When exposed to acute stressors, KO mice displayed a higher tachycardic stress response and a larger reduction of vagal modulation of heart rate than wild type counterparts (WTs). During a protocol of chronic psychosocial stress, 6 out of 22 (27%) KOs died from cardiac arrest. Close to death, they displayed a severe bradycardia, a lengthening of cardiac interval (P wave, PQ and QRS) duration, a notched QRS complex and a profound hypothermia. In the same period, the remaining knockouts exhibited higher values of heart rate than WTs during both light and dark phases of the diurnal rhythm. At sacrifice, KO mice showed a larger expression of cardiac muscarinic receptors (M2), whereas they did not differ for gross cardiac anatomy and the amount of myocardial fibrosis compared to WTs. This study demonstrates that chronic genetic loss of 5-HT1A receptors is detrimental for cardiovascular health, by intensifying acute, stress-induced heart rate rises and increasing the susceptibility to sudden cardiac death in mice undergoing chronic stress.	[Carnevali, Luca; Mastorci, Francesca; Rossi, Stefano; Macchi, Emilio; Sgoifo, Andrea] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Audero, Enrica; Gross, Cornelius] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Graiani, Gallia; Quaini, Federico] Univ Parma, Dept Internal Med, I-43100 Parma, Italy; [Callegari, Sergio] Vaio Hosp, Div Cardiol, Parma, Italy; [Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Nalivaiko, Eugene] Univ Newcastle, Sch Pharm & Biomed Sci, Newcastle, NSW 2300, Australia	University of Parma; European Molecular Biology Laboratory (EMBL); University of Parma; University of Minnesota System; University of Minnesota Twin Cities; University of Newcastle	Carnevali, L (corresponding author), Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy.	andrea.sgoifo@unipr.it	Rossi, Stefano/L-2556-2016; Carnevali, Luca/P-9508-2019; Carnevali, Luca/E-5322-2017; Sgoifo, Andrea/AAC-6278-2022	Rossi, Stefano/0000-0003-0346-8410; Carnevali, Luca/0000-0001-9053-7976; Carnevali, Luca/0000-0001-9053-7976; Sgoifo, Andrea/0000-0002-9428-6198; Quaini, Federico/0000-0003-2377-4810; Audero, Enrica/0000-0002-6138-244X; Nalivaiko, Eugene/0000-0002-6449-8181; Graiani, Gallia/0000-0003-1926-7568	Italian Ministry for Education, University and Research [2007WB35CW_004]; 'Fondi Regionali Ministero della Sanita' - Medicina Rigenerativa - THEAPPL'; EUROPEAN GRANT FP7-NMP [214539-BIOSCENT]	Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); 'Fondi Regionali Ministero della Sanita' - Medicina Rigenerativa - THEAPPL'; EUROPEAN GRANT FP7-NMP	This study was supported by a grant from the Italian Ministry for Education, University and Research (PRIN2007, 2007WB35CW_004), 'Fondi Regionali Ministero della Sanita' - Medicina Rigenerativa 2007- THEAPPL' and 'EUROPEAN GRANT FP7-NMP-2007: No 214539-BIOSCENT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameova A, 2009, CAN J PHYSIOL PHARM, V87, P493, DOI [10.1139/Y09-042, 10.1139/y09-042]; Bago M, 1999, J AUTONOM NERV SYST, V76, P127, DOI 10.1016/S0165-1838(99)00021-1; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; BERNE RM, 1954, CIRC RES, V2, P236, DOI 10.1161/01.RES.2.3.236; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Bouwknecht JA, 2000, EUR J PHARMACOL, V400, P59, DOI 10.1016/S0014-2999(00)00387-3; Costoli T, 2004, AM J PHYSIOL-HEART C, V286, pH2133, DOI 10.1152/ajpheart.00869.2003; DAUCHOT P, 1976, ANESTHESIOLOGY, V44, P501, DOI 10.1097/00000542-197606000-00008; DEANFIELD JE, 1984, AM J CARDIOL, V54, P1195, DOI 10.1016/S0002-9149(84)80066-1; Dhalla NS, 2008, FUTUR CARDIOL, V4, P339, DOI 10.2217/14796678.4.4.339; DODGE HT, 1969, AM J CARDIOL, V23, P528, DOI 10.1016/0002-9149(69)90006-X; FELDMAN T, 1986, AM J CARDIOL, V58, P885, DOI 10.1016/S0002-9149(86)80004-2; Friedman BH, 1998, BIOL PSYCHOL, V49, P303; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gross C, 2000, BIOL PSYCHIAT, V48, P1157, DOI 10.1016/S0006-3223(00)01041-6; GUDELSKY GA, 1986, NEUROPHARMACOLOGY, V25, P1307, DOI 10.1016/0028-3908(86)90101-2; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Helke CJ, 1997, J COMP NEUROL, V379, P261; Holmes DR, 1999, CIRCULATION, V100, P2067, DOI 10.1161/01.CIR.100.20.2067; Jordan D, 2005, EXP PHYSIOL, V90, P175, DOI 10.1113/expphysiol.2004.029058; LOVICK TA, 1989, J AUTONOM NERV SYST, V28, P35, DOI 10.1016/0165-1838(89)90005-2; MARAZZITI D, 1992, PHYSIOL BEHAV, V52, P393, DOI 10.1016/0031-9384(92)90290-I; MCCALL RB, 1994, PHARMACOL REV, V46, P231; Meerlo P, 1999, BEHAV NEUROSCI, V113, P1283, DOI 10.1037/0735-7044.113.6.1283; MICZEK KA, 1979, PSYCHOPHARMACOLOGY, V60, P253, DOI 10.1007/BF00426664; Morrison SF, 2001, ANN NY ACAD SCI, V940, P286; Nalivaiko E, 2005, AM J PHYSIOL-REG I, V289, pR596, DOI 10.1152/ajpregu.00845.2004; Nalivaiko E, 2009, PHYSIOL BEHAV, V96, P320, DOI 10.1016/j.physbeh.2008.10.017; Nalivaiko E, 2009, NEUROSCI BIOBEHAV R, V33, P95, DOI 10.1016/j.neubiorev.2008.05.026; Ngampramuan S, 2008, AM J PHYSIOL-REG I, V294, pR132, DOI 10.1152/ajpregu.00464.2007; NOSJEAN A, 1991, AM J PHYSIOL, V260, pR600, DOI 10.1152/ajpregu.1991.260.3.R600; Olivier B, 1999, Prog Drug Res, V52, P103; Ootsuka Y, 2007, NEUROSCIENCE, V147, P127, DOI 10.1016/j.neuroscience.2007.04.015; Pattij T, 2002, NEUROPSYCHOPHARMACOL, V27, P380, DOI 10.1016/S0893-133X(02)00317-2; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Ramachandruni S, 2004, CURR OPIN CARDIOL, V19, P494, DOI 10.1097/01.hco.0000132321.24004.25; Ramage AG, 2001, BRAIN RES BULL, V56, P425, DOI 10.1016/S0361-9230(01)00612-8; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Samuels BC, 2002, J PHYSIOL-LONDON, V538, P941, DOI 10.1113/jphysiol.2001.013302; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Tiainen M, 2009, CRIT CARE MED, V37, P403, DOI 10.1097/CCM.0b013e31819572c4; van den Buuse M, 2005, EUR J PHARMACOL, V507, P187, DOI 10.1016/j.ejphar.2004.11.048; Zhuang XX, 1999, NEUROPSYCHOPHARMACOL, V21, pS52, DOI 10.1016/S0893-133X(99)00047-0	46	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41184	10.1371/journal.pone.0041184	http://dx.doi.org/10.1371/journal.pone.0041184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815962	gold, Green Published			2022-12-27	WOS:000306548900091
J	Manrubia, SC; Axelsen, JB; Zanette, DH				Manrubia, Susanna C.; Axelsen, Jacob B.; Zanette, Damian H.			Role of Demographic Dynamics and Conflict in the Population-Area Relationship for Human Languages	PLOS ONE			English	Article							SCALE; ABUNDANCE	Many patterns displayed by the distribution of human linguistic groups are similar to the ecological organization described for biological species. It remains a challenge to identify simple and meaningful processes that describe these patterns. The population size distribution of human linguistic groups, for example, is well fitted by a log-normal distribution that may arise from stochastic demographic processes. As we show in this contribution, the distribution of the area size of home ranges of those groups also agrees with a log-normal function. Further, size and area are significantly correlated: the number of speakers p and the area a spanned by linguistic groups follow the allometric relation a proportional to p(z), with an exponent z varying accross different world regions. The empirical evidence presented leads to the hypothesis that the distributions of p and a, and their mutual dependence, rely on demographic dynamics and on the result of conflicts over territory due to group growth. To substantiate this point, we introduce a two-variable stochastic multiplicative model whose analytical solution recovers the empirical observations. Applied to different world regions, the model reveals that the retreat in home range is sublinear with respect to the decrease in population size, and that the population-area exponent z grows with the typical strength of conflicts. While the shape of the population size and area distributions, and their allometric relation, seem unavoidable outcomes of demography and inter-group contact, the precise value of z could give insight on the cultural organization of those human groups in the last thousand years.	[Manrubia, Susanna C.; Axelsen, Jacob B.] Inst Nacl Tecn Aeroespacial, Ctr Astrobiol, Madrid, Spain; [Manrubia, Susanna C.; Axelsen, Jacob B.] CSIC, Madrid, Spain; [Zanette, Damian H.] Consejo Nacl Invest Cient & Tecn, Ctr Atom Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Zanette, Damian H.] Inst Balseiro, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Manrubia, SC (corresponding author), Inst Nacl Tecn Aeroespacial, Ctr Astrobiol, Madrid, Spain.	scmanrubia@cab.inta-csic.es	Manrubia, Susanna/K-4501-2014	Manrubia, Susanna/0000-0003-0134-2785; Zanette, Damian/0000-0003-0681-0592	Spanish The Ministry of Science and Innovation [FIS2011-27569]; Comunidad de Madrid (MODELICO) [S2009/ESP-1691]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 112-200801-76/09]	Spanish The Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Comunidad de Madrid (MODELICO)(Comunidad de Madrid); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors acknowledge financial support from Spanish The Ministry of Science and Innovation (FIS2011-27569), from Comunidad de Madrid (MODELICO, S2009/ESP-1691), and from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP 112-200801-76/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURLANDO B, 1990, J THEOR BIOL, V146, P99, DOI 10.1016/S0022-5193(05)80046-3; Burnside WR, 2012, BIOL REV, V87, P194, DOI 10.1111/j.1469-185X.2011.00192.x; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Currie TE, 2009, P NATL ACAD SCI USA, V106, P7339, DOI 10.1073/pnas.0804698106; Gaston KJ, 2002, P ROY SOC B-BIOL SCI, V269, P1079, DOI 10.1098/rspb.2002.1969; Gomes MAF, 1999, PHYSICA A, V271, P489, DOI 10.1016/S0378-4371(99)00249-6; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P4765, DOI 10.1073/pnas.0611197104; Harte J, 2001, AM NAT, V157, P374, DOI 10.1086/319323; Lyons SK, 2002, ECOLOGY, V83, P47; MACE R, 1995, P ROY SOC B-BIOL SCI, V261, P117, DOI 10.1098/rspb.1995.0125; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; MOSELEY C, 1994, ATLAS WORLDS LANGUAG; Nettle D, 1998, J ANTHROPOL ARCHAEOL, V17, P354, DOI 10.1006/jaar.1998.0328; Pagel M, 2004, NATURE, V428, P275, DOI 10.1038/428275a; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; Pinker S., 2007, HIST VIOLENCE; Pinker S., 2011, BETTER ANGELS OUR NA; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Rapoport E.H., 1982, AREOGRAPHY, P210; Schwammle V, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093006; Sutherland WJ, 2003, NATURE, V423, P276, DOI 10.1038/nature01607; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zanette DH, 2008, INT J MOD PHYS C, V19, P237, DOI 10.1142/S0129183108012042; Zanette Damian H, 2001, ADV COMPLEX SYST, V4, P281; Zanette DH, 1997, PHYS REV LETT, V79, P523, DOI 10.1103/PhysRevLett.79.523	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40137	10.1371/journal.pone.0040137	http://dx.doi.org/10.1371/journal.pone.0040137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815726	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900016
J	Winters, MA; Lloyd, RM; Shafer, RW; Kozal, MJ; Miller, MD; Holodniy, M				Winters, Mark A.; Lloyd, Robert M., Jr.; Shafer, Robert W.; Kozal, Michael J.; Miller, Michael D.; Holodniy, Mark			Development of Elvitegravir Resistance and Linkage of Integrase Inhibitor Mutations with Protease and Reverse Transcriptase Resistance Mutations	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE PATIENTS; HIV-1 INTEGRASE; RALTEGRAVIR RESISTANCE; DRUG-RESISTANCE; DNA RECOMBINATION; TYPE-1 VARIANTS; DOUBLE-BLIND; EVOLUTION; EFFICACY	Failure of antiretroviral regimens containing elvitegravir (EVG) and raltegravir (RAL) can result in the appearance of integrase inhibitor (INI) drug-resistance mutations (DRMs). While several INI DRMs have been identified, the evolution of EVG DRMs and the linkage of these DRMs with protease inhibitor (PI) and reverse transcriptase inhibitor (RTI) DRMs have not been studied at the clonal level. We examined the development of INI DRMs in 10 patients failing EVG-containing regimens over time, and the linkage of INI DRMs with PI and RTI DRMs in these patients plus 6 RAL-treated patients. A one-step RT-nested PCR protocol was used to generate a 2.7 kB amplicon that included the PR, RT, and IN coding region, and standard cloning and sequencing techniques were used to determine DRMs in 1,277 clones (mean 21 clones per time point). Results showed all patients had multiple PI, NRTI, and/or NNRTI DRMs at baseline, but no primary INI DRM. EVG-treated patients developed from 2 to 6 strains with different primary INI DRMs as early as 2 weeks after initiation of treatment, predominantly as single mutations. The prevalence of these strains fluctuated and new strains, and/or strains with new combinations of INI DRMs, developed over time. Final failure samples (weeks 14 to 48) typically showed a dominant strain with multiple mutations or N155H alone. Single N155H or multiple mutations were also observed in RAL-treated patients at virologic failure. All patient strains showed evidence of INI DRM co-located with single or multiple PI and/or RTI DRMs on the same viral strand. Our study shows that EVG treatment can select for a number of distinct INI-resistant strains whose prevalence fluctuates over time. Continued appearance of new INI DRMs after initial INI failure suggests a potent, highly dynamic selection of INI resistant strains that is unaffected by co-location with PI and RTI DRMs.	[Winters, Mark A.; Holodniy, Mark] Vet Affairs Palo Alto Hlth Care Syst, AIDS Res Ctr, Palo Alto, CA USA; [Winters, Mark A.; Shafer, Robert W.; Holodniy, Mark] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Lloyd, Robert M., Jr.] Res ThinkTank Inc, Buford, GA USA; [Kozal, Michael J.] Yale Univ, Sch Med, New Haven, CT USA; [Kozal, Michael J.] Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Miller, Michael D.] Gilead Sci Inc, Foster City, CA 94404 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Gilead Sciences	Winters, MA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, AIDS Res Ctr, Palo Alto, CA USA.	Mark.winters@stanford.edu		, Michael/0000-0002-7719-7396; Kozal, Michael/0000-0002-3100-8254; Holodniy, Mark/0000-0002-6655-7982	Department of Veterans Affairs; Veterans Affairs Merit Award; Merck; Pfizer; Gilead; Abbott; Glaxo Smith Kline; Bristol-Myers Squibb; Stanford University for some HIV diagnostic tests; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068581] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs Merit Award(US Department of Veterans Affairs); Merck(Merck & Company); Pfizer(Pfizer); Gilead(Gilead Sciences); Abbott(Abbott Laboratories); Glaxo Smith Kline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Stanford University for some HIV diagnostic tests; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a research grant from the Department of Veterans Affairs to MH, and a Veterans Affairs Merit Award to MJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: MDM is an employee and stock holder of Gilead Sciences, Inc. RWS is an employee of Research ThinkTank, Inc. MJK serves as principal investigator for studies from which Yale University receives grant support from Merck, Pfizer, Gilead, Abbott, Glaxo Smith Kline and Bristol-Myers Squibb. MJK receives royalties from a patent owned by Stanford University for some HIV diagnostic tests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Baldanti F, 2010, J MED VIROL, V82, P116, DOI 10.1002/jmv.21651; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Canducci F, 2011, CLIN MICROBIOL INFEC, V17, P928, DOI 10.1111/j.1469-0691.2010.03375.x; Canducci F, 2010, J ANTIMICROB CHEMOTH, V65, P425, DOI 10.1093/jac/dkp477; Canducci F, 2009, AIDS, V23, P455, DOI 10.1097/QAD.0b013e328323da60; Codoner FM, 2010, ANTIVIR RES, V88, P281, DOI 10.1016/j.antiviral.2010.09.016; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; da Silva D, 2010, J ANTIMICROB CHEMOTH, V65, P1262, DOI 10.1093/jac/dkq099; Fang GW, 1998, J VIROL METHODS, V76, P139, DOI 10.1016/S0166-0934(98)00133-5; Ferns RB, 2009, AIDS, V23, P2159, DOI 10.1097/QAD.0b013e32832ec4ae; Fransen S, 2009, J VIROL, V83, P11440, DOI 10.1128/JVI.01168-09; Gonzales MJ, 2003, JAIDS-J ACQ IMM DEF, V34, P398, DOI 10.1097/00126334-200312010-00006; Goodman D, 2008, ANTIVIR THER, V13, pA15; Hatano H, 2010, JAIDS-J ACQ IMM DEF, V54, P389, DOI 10.1097/QAI.0b013e3181c42ea4; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ingale Kundan B., 2011, Antiviral Chemistry & Chemotherapy, V22, P95, DOI 10.3851/IMP1740; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Kavlick MF, 1998, J INFECT DIS, V177, P1506, DOI 10.1086/515324; Lataillade M, 2011, ANTIVIR THER, V16, pA34; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Malet I, 2011, J ANTIMICROB CHEMOTH, V66, P2827, DOI 10.1093/jac/dkr389; Malet I, 2009, J ANTIMICROB CHEMOTH, V63, P795, DOI 10.1093/jac/dkp014; Mbisa JL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-31; McColl DJ, 2007, ANTIVIR THER, V12, pS11; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Mukherjee R, 2011, AIDS, V25, P1951, DOI 10.1097/QAD.0b013e32834b34de; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Rangel HR, 2010, AIDS RES HUM RETROV, V26, P923, DOI 10.1089/aid.2010.0039; Reigadas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010311; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Rockstroh JK, 2011, AIDS, V25, P1365, DOI 10.1097/QAD.0b013e328348065a; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shi B, 2010, VIROLOGY, V404, P5, DOI 10.1016/j.virol.2010.04.008; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Soriano Vincent, 2002, HIV Clin Trials, V3, P249; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Towler WI, 2008, AIDS RES HUM RETROV, V24, P1209, DOI 10.1089/aid.2008.0109; van Lunzen J, 2011, LANCET INFECT DIS; Vandenbroucke Ina, 2008, Open Virol J, V2, P8, DOI 10.2174/1874357900802010008; Varghese V, 2010, AIDS RES HUM RETROV, V26, P1323, DOI 10.1089/aid.2010.0123; Yang YL, 1996, AIDS RES HUM RETROV, V12, P303, DOI 10.1089/aid.1996.12.303; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	53	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40514	10.1371/journal.pone.0040514	http://dx.doi.org/10.1371/journal.pone.0040514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815755	Green Submitted, gold, Green Published			2022-12-27	WOS:000306548900028
J	Hung, CF; Chiang, AJ; Tsai, HH; Pomper, MG; Kang, TH; Roden, RR; Wu, TC				Hung, Chien-Fu; Chiang, An Jen; Tsai, Hsiao-Hsuan; Pomper, Martin G.; Kang, Tae Heung; Roden, Richard R.; Wu, T. -C.			Ovarian Cancer Gene Therapy Using HPV-16 Pseudovirion Carrying the HSV-tk Gene	PLOS ONE			English	Article							CYTOSINE DEAMINASE/5-FLUOROCYTOSINE; L2; EXPRESSION; STATISTICS; PROTEIN; CELLS	Ovarian cancer is the leading cause of death from all gynecological cancers and conventional therapies such as surgery, chemotherapy, and radiotherapy usually fail to control advanced stages of the disease. Thus, there is an urgent need for alternative and innovative therapeutic options. We reason that cancer gene therapy using a vector capable of specifically delivering an enzyme-encoding gene to ovarian cancer cells will allow the cancer cell to metabolize a harmless prodrug into a potent cytotoxin, which will lead to therapeutic effects. In the current study, we explore the use of a human papillomavirus (HPV) pseudovirion to deliver a herpes simplex virus thymidine kinase (HSV-tk) gene to ovarian tumor cells. We found that the HPV-16 pseudovirion was able to preferentially infect murine and human ovarian tumor cells when administered intraperitoneally. Furthermore, intraperitoneal injection of HPV-16 pseudovirions carrying the HSV-tk gene followed by treatment with ganciclovir led to significant therapeutic anti-tumor effects in murine ovarian cancer-bearing mice. Our data suggest that HPV pseudovirion may serve as a potential delivery vehicle for ovarian cancer gene therapy.	[Hung, Chien-Fu; Chiang, An Jen; Tsai, Hsiao-Hsuan; Kang, Tae Heung; Roden, Richard R.; Wu, T. -C.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Hung, Chien-Fu; Roden, Richard R.; Wu, T. -C.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Chiang, An Jen] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Chiang, An Jen] Natl Yang Ming Univ, Sch Med, Div Obstet & Gynecol, Taipei 112, Taiwan; [Chiang, An Jen] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Pomper, Martin G.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA; [Roden, Richard R.; Wu, T. -C.] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; National Sun Yat Sen University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Hung, CF (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	chung2@jhmi.edu			National Cancer Institute [P50 CA098252, CA118790, CA122581]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA118790, R01CA122581] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Specialized Programs of Research Excellence (http://trp.cancer.gov/) in Cervical Cancer P50 CA098252, CA118790 (Roden), and CA122581 (Roden). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaner C, 2008, CANCER LETT, V270, P191, DOI 10.1016/j.canlet.2008.04.023; Bridgewater JA, 1995, EUR J CANCER, V31A, P2362, DOI 10.1016/0959-8049(95)00436-X; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Campos SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004463; Cerio R, 2010, 26 INT PAP C MONTR C; Connolly DC, 2003, CANCER RES, V63, P1389; Danks MK, 1998, CANCER RES, V58, P20; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Gambhira R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-176; Gordon SN, 2012, J IMMUNOL, V188, P714, DOI 10.4049/jimmunol.1101404; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Hanna NN, 1997, CANCER RES, V57, P4205; Hung CF, 2001, CANCER RES, V61, P3698; Hung CF, 2007, VACCINE, V25, P127, DOI 10.1016/j.vaccine.2006.06.087; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Lu D, 2009, VACCINE, V27, P4363, DOI 10.1016/j.vaccine.2009.02.041; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Morgan RA, 2012, MOL THER, V20, P11, DOI 10.1038/mt.2011.273; Page RE, 2007, CELL ONCOL, V29, P289; Peng S, 2010, GENE THER, V17, P1453, DOI 10.1038/gt.2010.106; Peng SW, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-26; Pulkkanen KJ, 2005, MOL THER, V12, P585, DOI 10.1016/j.ymthe.2005.07.357; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts JN, 2007, 24 INT PAP C CLIN WO; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rossi JL, 2000, HUM GENE THER, V11, P1165, DOI 10.1089/10430340050015211; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; SORSCHER EJ, 1994, GENE THER, V1, P233; TRINH QT, 1995, CANCER RES, V55, P4808; Waxman DJ, 1999, DRUG METAB REV, V31, P503, DOI 10.1081/DMR-100101933	32	11	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40983	10.1371/journal.pone.0040983	http://dx.doi.org/10.1371/journal.pone.0040983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815887	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000048
J	Kimbler, DE; Shields, J; Yanasak, N; Vender, JR; Dhandapani, KM				Kimbler, Donald E.; Shields, Jessica; Yanasak, Nathan; Vender, John R.; Dhandapani, Krishnan M.			Activation of P2X7 Promotes Cerebral Edema and Neurological Injury after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; SEVERE HEAD-INJURY; CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; ATP-INDUCED RELEASE; SPINAL-CORD-INJURY; CEREBROSPINAL-FLUID; INTRACRANIAL HYPERTENSION; COGNITIVE DYSFUNCTION; AQUAPORIN-4	Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Cerebral edema, the abnormal accumulation of fluid within the brain parenchyma, contributes to elevated intracranial pressure (ICP) and is a common life-threatening neurological complication following TBI. Unfortunately, neurosurgical approaches to alleviate increased ICP remain controversial and medical therapies are lacking due in part to the absence of viable drug targets. In the present study, genetic inhibition (P2X7-/- mice) of the purinergic P2x7 receptor attenuated the expression of the pro-inflammatory cytokine, interleukin-1 beta (IL-1 beta) and reduced cerebral edema following controlled cortical impact, as compared to wild-type mice. Similarly, brilliant blue G (BBG), a clinically non-toxic P2X7 inhibitor, inhibited IL-1 beta expression, limited edemic development, and improved neurobehavioral outcomes after TBI. The beneficial effects of BBG followed either prophylactic administration via the drinking water for one week prior to injury or via an intravenous bolus administration up to four hours after TBI, suggesting a clinically-implementable therapeutic window. Notably, P2X7 localized within astrocytic end feet and administration of BBG decreased the expression of glial fibrillary acidic protein (GFAP), a reactive astrocyte marker, and attenuated the expression of aquaporin-4 (AQP4), an astrocytic water channel that promotes cellular edema. Together, these data implicate P2X7 as a novel therapeutic target to prevent secondary neurological injury after TBI, a finding that warrants further investigation.	[Kimbler, Donald E.; Shields, Jessica; Vender, John R.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA; [Yanasak, Nathan] Georgia Hlth Sci Univ, Dept Radiol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kimbler, DE (corresponding author), Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA.	kdhandapani@georgiahealth.edu	Yanasak, Nathan/CAG-5116-2022	Dhandapani, Krishnan/0000-0001-7044-1117	National Institutes of Health [NS065172]; TriServices Nursing Research Program [HU0001-10-1-TS11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TriServices Nursing Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was provided by grants from the National Institutes of Health (NS065172) and from the TriServices Nursing Research Program (HU0001-10-1-TS11). The content and views expressed herein do not necessarily represent the views of the Department of Defense, the TriServices Nursing Research Program, Uniformed Services University of the Health Sciences, or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], FED REG; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cristofori L, 2005, CLIN BIOCHEM, V38, P97, DOI 10.1016/j.clinbiochem.2004.09.013; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Dhandapani KM, 2003, ENDOCRINE, V21, P59, DOI 10.1385/ENDO:21:1:59; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Kawamata T, 2007, PROG BRAIN RES, V161, P235, DOI 10.1016/S0079-6123(06)61016-9; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kleinschmidt JJ, 2000, NEUROLOGY, V54, P319, DOI 10.1212/WNL.54.2.319; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, CURR OPIN INVEST DR, V10, P664; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Latini S, 1996, NEUROCHEM INT, V28, P113, DOI 10.1016/0197-0186(95)00062-D; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; NEARY JT, 1994, ACTA NEUROPATHOL, V87, P8; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oprica M, 2005, BRAIN BEHAV IMMUN, V19, P223, DOI 10.1016/j.bbi.2004.07.006; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/neu.2004.21.1553; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Pillai A, 2007, NEUROPSYCHOPHARMACOL; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Wakade C, 2009, ANTIOXID REDOX SIGN, V11, P35, DOI 10.1089/ars.2008.2056; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wheaton P., 2011, J PSYCHOPHARMACOL; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	76	112	118	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41229	10.1371/journal.pone.0041229	http://dx.doi.org/10.1371/journal.pone.0041229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815977	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000083
J	Lin, MY; Tavakilian, GL				Lin, Mei-Ying; Tavakilian, Gerard Luc			A New Genus Bifidunguiglenea gen. nov Is Erected for the Species Glenea gestroi Gahan (Cerambycidae: Lamiinae: Saperdini)	PLOS ONE			English	Article								Bifidunguiglenea gen. nov. is erected for the species Glenea gestroi Gahan, 1894. Bifidunguiglenea gestroi (Gahan, 1894) comb. nov. is redescribed. The genitalia descriptions are reported for the first time and it is newly recorded from Thailand.	[Lin, Mei-Ying] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Tavakilian, Gerard Luc] Museum Natl Hist Nat, Antenne IRD, Dept Systemat & Evolut, F-75231 Paris, France	Chinese Academy of Sciences; Institute of Zoology, CAS; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Lin, MY (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.	linmeiying@ioz.ac.cn			Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Natural Science Foundation of China [31000967]	Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant (No. O529YX5105) from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences, and by National Natural Science Foundation of China program 31000967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breuning S., 1966, P659; BREUNING STEPHAN, 1956, ENT ARBEITEN, V7, P1; BREUNING STEPHAN, 1956, ENT ARBEITEN, V7, P671; Gahan C. J., 1894, ANN MUSEO CIVICO STO, V34, P5; Gahan CJ., 1897, ANN MAG NAT HIST, V19, P473, DOI [10.1080/00222939708680567, DOI 10.1080/00222939708680567]; Lin Meiying, 2009, Zootaxa, V2155, P1; Lin Meiying, 2009, Zootaxa, V2137, P1; Lin MY, 2009, ANN SOC ENTOMOL FR, V45, P157, DOI 10.1080/00379271.2009.10697599; PIC MAURICE, 1928, M LANGES EXOTICO ENTOMOLOGIQUES, V51, P1; PIC MAURICE, 1930, MELAN GES EXOTICO ENT, VNo. 55, P1	10	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40768	10.1371/journal.pone.0040768	http://dx.doi.org/10.1371/journal.pone.0040768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815810	gold, Green Submitted, Green Published			2022-12-27	WOS:000306507000030
J	Hohne, K; Schliessmann, SJ; Kirschbaum, A; Plones, T; Muller-Quernheim, J; Tenor, H; Zissel, G				Hoehne, Kerstin; Schliessmann, Stephan J.; Kirschbaum, Andreas; Ploenes, Till; Mueller-Quernheim, Joachim; Tenor, Hermann; Zissel, Gernot			Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II	PLOS ONE			English	Article							SP-A GENE; RESPIRATORY-DISTRESS-SYNDROME; TRANSCRIPTION FACTOR-I; MESSENGER-RNA; PULMONARY-FIBROSIS; PHOSPHODIESTERASE-4 INHIBITOR; PROINFLAMMATORY CYTOKINES; MESENCHYMAL TRANSITION; SP-A2 GENES; LUNG	Surfactant proteins (SPs) are important lipoprotein complex components, expressed in alveolar epithelial cells type II (AECII), and playing an essential role in maintenance of alveolar integrity and host defence. Because expressions of SPs are regulated by cyclic adenosine monophosphate (cAMP), we hypothesized that phosphodiesterase (PDE) inhibitors, influence SP expression and release. Analysis of PDE activity of our AEC-II preparations revealed that PDE4 is the major cAMP hydrolysing PDE in human adult AEC-II. Thus, freshly isolated human AEC-II were stimulated with two different concentrations of the PDE4 inhibitor roflumilast-N-oxide (3 nM and 1 mu M) to investigate the effect on SP expression. SP mRNA levels disclosed a large inter-individual variation. Therefore, the experiments were grouped by the basal SP expression in low and high expressing donors. AEC-II stimulated with Roflumilast-N-oxide showed a minor increase in SP-A1, SP-C and SP-D mRNA mainly in low expressing preparations. To overcome the effects of different basal levels of intracellular cAMP, cyclooxygenase was blocked by indomethacin and cAMP production was reconstituted by prostaglandin E2 (PGE2). Under these conditions SP-A1, SP-A2, SP-B and SP-D are increased by roflumilast-N-oxide in low expressing preparations. Roflumilast-N-oxide fosters the expression of SPs in human AEC-II via increase of intracellular cAMP levels potentially contributing to improved alveolar host defence and enhanced resolution of inflammation.	[Hoehne, Kerstin; Schliessmann, Stephan J.; Mueller-Quernheim, Joachim; Zissel, Gernot] Univ Med Ctr, Dept Pneumol, Div Internal Med, Freiburg, Germany; [Hoehne, Kerstin] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kirschbaum, Andreas; Ploenes, Till] Univ Med Ctr, Dept Thorac Surg, Div Surg, Freiburg, Germany; [Tenor, Hermann] Nycomed GmbH, Nycomed GmbH Global Discovery, Constance, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Nycomed GmbH	Hohne, K (corresponding author), Univ Med Ctr, Dept Pneumol, Div Internal Med, Freiburg, Germany.	gernot.zissel@uniklinik-freiburg.de	Schließmann, Stephan J./B-3756-2012; Zissel, Gernot/B-1208-2010; Plönes, Till/AAK-8208-2021	Schließmann, Stephan J./0000-0002-2546-4173; Zissel, Gernot/0000-0001-8021-9798; Plönes, Till/0000-0003-4839-2130	Nycomed GmbH, Konstanz, Germany	Nycomed GmbH, Konstanz, Germany	This study was supported by a research grant from Nycomed GmbH, Konstanz, Germany. HT is an employee of Nycomed GmbH. GZ is a PLoS ONE Editorial Board member. Roflumilast is the effective component of "Daxas" which is sold by Nycomed for COPD treatment to minimize exacerbations. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ACARREGUI MJ, 1990, ENDOCRINOLOGY, V127, P1105, DOI 10.1210/endo-127-3-1105; Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; BAUER AC, 1980, N-S ARCH PHARMACOL, V311, P193, DOI 10.1007/BF00510259; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bethke TD, 2007, J CLIN PHARMACOL, V47, P26, DOI 10.1177/0091270006294529; Betsuyaku T, 2004, EUR RESPIR J, V24, P964, DOI 10.1183/09031936.04.00064004; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; DiAngelo S, 1999, DIS MARKERS, V15, P269, DOI 10.1155/1999/961430; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Goldmann T, 2002, PATHOL RES PRACT, V198, P91, DOI 10.1078/0344-0338-00192; Gonzales LW, 2001, PEDIATR PATHOL MOL M, V20, P387, DOI 10.1080/15513810109168622; Gower WA, 2011, PAEDIATR RESPIR REV, V12, P223, DOI 10.1016/j.prrv.2011.01.005; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; Hamvas A, 2007, NEONATOLOGY, V91, P311, DOI 10.1159/000101347; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; HONDA Y, 1993, CHEST, V103, P496, DOI 10.1378/chest.103.2.496; Hoover RR, 1998, AM J RESP CELL MOL, V18, P353, DOI 10.1165/ajrcmb.18.3.3035; Ito Y, 2011, AM J RESP CELL MOL, V45, P938, DOI 10.1165/rcmb.2011-0052OC; Kala P, 1998, PEDIATR RES, V43, P169, DOI 10.1203/00006450-199802000-00003; Karinch AM, 1997, BIOCHEM J, V321, P39, DOI 10.1042/bj3210039; KATYAL SL, 1992, AM J RESP CELL MOL, V6, P446, DOI 10.1165/ajrcmb/6.4.446; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kumar AS, 2000, BBA-GENE STRUCT EXPR, V1492, P45, DOI 10.1016/S0167-4781(00)00058-0; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Marcet B, 2007, EUR J PHARMACOL, V566, P167, DOI 10.1016/j.ejphar.2007.04.003; MCCORMICK SM, 1994, AM J PHYSIOL, V266, pL367, DOI 10.1152/ajplung.1994.266.4.L367; MCCORMICK SM, 1994, AM J PHYSIOL, V266, pL354, DOI 10.1152/ajplung.1994.266.4.L354; Pechkovsky DV, 2000, EUR CYTOKINE NETW, V11, P618; RABE KF, 1993, AM J PHYSIOL, V264, pL458, DOI 10.1152/ajplung.1993.264.5.L458; Schliessmann SJ, 2009, IFMBE PROC, V22, P2027; Stoffers M, 2004, Pneumologie, V58, P395, DOI 10.1055/s-2004-818506; TAKAHASHI H, 1995, CLIN CHIM ACTA, V239, P213; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Thompson W J, 1979, Adv Cyclic Nucleotide Res, V10, P69; Vayrynen O, 2002, AM J PHYSIOL-LUNG C, V282, pL803, DOI 10.1152/ajplung.00274.2001; VELETZA SV, 1992, AM J PHYSIOL, V262, pL684, DOI 10.1152/ajplung.1992.262.6.L684; Vlachaki EM, 2010, CHEST, V137, P37, DOI 10.1378/chest.09-1029; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Zhao JS, 2000, J BIOL CHEM, V275, P23992, DOI 10.1074/jbc.M002433200	44	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e38369	10.1371/journal.pone.0038369	http://dx.doi.org/10.1371/journal.pone.0038369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815690	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100009
J	Martin-Granados, C; Prescott, AR; Van Dessel, N; Van Eynde, A; Arocena, M; Klaska, IP; Gornemann, J; Beullens, M; Bollen, M; Forrester, JV; McCaig, CD				Martin-Granados, Cristina; Prescott, Alan R.; Van Dessel, Nele; Van Eynde, Aleyde; Arocena, Miguel; Klaska, Izabela P.; Gornemann, Janina; Beullens, Monique; Bollen, Mathieu; Forrester, John V.; McCaig, Colin D.			A Role for PP1/NIPP1 in Steering Migration of Human Cancer Cells	PLOS ONE			English	Article							PHYSIOLOGICAL ELECTRIC-FIELD; MICROTUBULE-ORGANIZING CENTER; CORNEAL EPITHELIAL-CELLS; PROTEIN PHOSPHATASE-1; DIRECTIONAL MIGRATION; RHO-GTPASES; BREAST-CANCER; INHIBITORY POLYPEPTIDES; DIRECTED MIGRATION; NUCLEAR INHIBITOR	Electrical gradients are present in many developing and regenerating tissues and around tumours. Mimicking endogenous electric fields in vitro has profound effects on the behaviour of many cell types. Intriguingly, specific cell types migrate cathodally, others anodally and some polarise with their long axis perpendicular to the electric vector. These striking phenomena are likely to have in vivo relevance since one of the determining factors during cancer metastasis is the ability to switch between attractive and repulsive migration in response to extracellular guidance stimuli. We present evidence that the cervical cancer cell line HeLa migrates cathodally in a direct current electric field of physiological intensity, while the strongly metastatic prostate cancer cell line PC-3-M migrates anodally. Notably, genetic disruption of protein serine/threonine phosphatase-1 (PP1) and its regulator NIPP1 decrease directional migration in these cell lines. Conversely, the inducible expression of NIPP1 switched the directional response of HeLa cells from cathodal to slightly anodal in a PP1-dependent manner. Remarkably, induction of a hyperactive PP1/NIPP1 holoenzyme, further shifted directional migration towards the anode. We show that PP1 association with NIPP1 upregulates signalling by the GTPase Cdc42 and demonstrate that pharmacological inhibition of Cdc42 in cells overexpressing NIPP1 recovered cathodal migration. Taken together, we provide the first evidence for regulation of directional cell migration by NIPP1. In addition, we identify PP1/NIPP1 as a novel molecular compass that controls directed cell migration via upregulation of Cdc42 signalling and suggest a way by which PP1/NIPP1 may contribute to the migratory properties of cancer cells.	[Martin-Granados, Cristina; Klaska, Izabela P.; Forrester, John V.; McCaig, Colin D.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Prescott, Alan R.; Arocena, Miguel] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Van Dessel, Nele; Van Eynde, Aleyde; Gornemann, Janina; Beullens, Monique; Bollen, Mathieu] Univ Leuven, Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, Louvain, Belgium	University of Aberdeen; University of Dundee; KU Leuven	Martin-Granados, C (corresponding author), Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.	c.martin@abdn.ac.uk; c.mccaig@abdn.ac.uk	Prescott, Alan/Y-5956-2018	Prescott, Alan/0000-0002-0747-7317; Gornemann, Janina/0000-0001-6246-6904	Wellcome Trust [079518/z/06/z]; Development Trust of the University of Aberdeen	Wellcome Trust(Wellcome TrustEuropean Commission); Development Trust of the University of Aberdeen	This work was funded by a Wellcome Trust grant 079518/z/06/z to CDM and by the Development Trust of the University of Aberdeen to JVF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; BEULLENS M, 1993, J BIOL CHEM, V268, P13172; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; CARNEY PR, 1989, ANAT REC, V225, P156, DOI 10.1002/ar.1092250211; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; COAN DE, 1993, J CELL SCI, V104, P1145; Cohen PTW, 2002, J CELL SCI, V115, P241; Cuzick J, 1998, LANCET, V352, P359, DOI 10.1016/S0140-6736(97)10002-2; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; EUTENEUER U, 1992, J CELL BIOL, V116, P1157, DOI 10.1083/jcb.116.5.1157; Fang KS, 1999, J CELL SCI, V112, P1967; Faupel M, 1997, EUR J RADIOL, V24, P33, DOI 10.1016/S0720-048X(96)01113-8; Fukuda M, 1996, JPN J CANCER RES, V87, P1092, DOI 10.1111/j.1349-7006.1996.tb03115.x; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han J, 2011, OPHTHALMIC RES, V45, P15, DOI 10.1159/000313552; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Huang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025928; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kim SE, 2000, INT J ONCOL, V16, P751; Kimura K, 2006, INVEST OPHTH VIS SCI, V47, P4323, DOI 10.1167/iovs.05-1508; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; MACDOUGALL LK, 1989, BIOCHIM BIOPHYS ACTA, V1010, P218, DOI 10.1016/0167-4889(89)90164-X; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; MARINO AA, 1994, TUMOR BIOL, V15, P147; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Nabi IR, 1999, J CELL SCI, V112, P1803; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P941; NEMERE I, 1985, CELL MOTIL CYTOSKEL, V5, P17, DOI 10.1002/cm.970050103; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nuccitelli R, 2008, WOUND REPAIR REGEN, V16, P432, DOI 10.1111/j.1524-475X.2008.00389.x; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Pu J, 2005, J CELL SCI, V118, P1117, DOI 10.1242/jcs.01646; Pullar CE, 2011, BIOL EFF ELECTROMAGN, P1; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rajnicek AM, 2007, DEV BIOL, V312, P448, DOI 10.1016/j.ydbio.2007.09.051; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; Rakic P, 2000, ADV NEUROL, V84, P1; Reid B, 2007, NAT PROTOC, V2, P661, DOI 10.1038/nprot.2007.91; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; Surviladze Z., 2010, PROBE REPORTS NIH MO; Szatkowski M, 2000, BJU INT, V86, P1068, DOI 10.1046/j.1464-410x.2000.00889.x; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Van Eynde A, 1995, J BIOL CHEM, V270, P28068, DOI 10.1074/jbc.270.47.28068; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Zhang Y, 2012, GENE DEV, V26, P69, DOI 10.1101/gad.179283.111; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 1996, J CELL SCI, V109, P1405; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zyss D, 2011, J CELL BIOL, V195, P781, DOI 10.1083/jcb.201106025	69	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40769	10.1371/journal.pone.0040769	http://dx.doi.org/10.1371/journal.pone.0040769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815811	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100064
J	Mouzaki, A; Panagoulias, I; Raptis, G; Farri-Kostopoulou, E				Mouzaki, Athanasia; Panagoulias, Ioannis; Raptis, George; Farri-Kostopoulou, Evagellia			Cord Blood Leptin Levels of Healthy Neonates Are Associated with IFN-gamma Production by Cord Blood T-Cells	PLOS ONE			English	Article							INTERFERON-GAMMA; GROWTH RESTRICTION; MEDIATED-IMMUNITY; PONDERAL INDEX; TH1 CYTOKINE; BODY-WEIGHT; FEMALE MICE; RECEPTOR; EXPRESSION; ADIPONECTIN	Leptin is a hormone synthesized by adipocytes and other tissues, including the placenta, and it regulates food intake and energy expenditure, reproductive and immune functions. To investigate the role of leptin in neonatal immunity, we measured serum leptin and cytokine (IFN-gamma, TNF-alpha, IL-2, IL-4, IL-10, IL-12) levels in the cord blood (cb) of 510 healthy neonates, 14 small for gestational age (SGA), 312 appropriately grown for gestational age (AGA) and 184 large for gestational age (LGA). Median serum leptin concentration in the whole sample was 11 ng/ml. In 11.2% neonates (1 SGA, 32 AGA, 24 LGA), leptin levels were >90th percentile (median 39 ng/ml). In 33.3% of those (3.72% of total sample) with the highest leptin levels (median 46 ng/ml), significantly elevated levels of serum IFN-gamma were also found (mean 27.11 pg/ml, range 17.5-38.5 pg/ml). In neonates with leptin levels similar to 50th percentile (median 12 ng/ml) or <10th percentile (median 1 ng/ml), serum IFN-gamma levels were negligible. All other cytokines measured, were < the assays' detection limits. To investigate whether leptin can independently influence cytokine gene expression by cb T-cells and monocytes (Mc), we cultured cb T-cells or Mc, isolated from randomly selected AGA neonates or adult peripheral blood, with leptin. This resulted in upregulation of IL-2, IFN-gamma and IL-4 gene expression in cb and adult T-cells and IL-10 expression mainly in cb-Mc. Significantly higher expression of IFN-gamma occurred in female cb-T-cells cultured with leptin, compared with male cb-T-cells. In conclusion, the concurrent presence of high concentrations in both leptin and IFN-gamma in cb of healthy infants, and leptin's ability to directly upregulate cytokine gene expression in cb T and Mc cells, indicate that abnormally high leptin levels can independently influence the immune system of healthy newborns, and may mediate gender differences in the development of a Th1 polarized immune response.	[Mouzaki, Athanasia; Panagoulias, Ioannis] Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece; [Raptis, George] Royal Oldham Hosp, Dept Child Hlth, Oldham, England; [Farri-Kostopoulou, Evagellia] St Andrews Gen Hosp Patras, Neonatal Intens Care Unit, Patras, Greece	University of Patras	Mouzaki, A (corresponding author), Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece.	mouzaki@upatras.gr	panagoulias, ioannis/ABA-7915-2020					Bao M, 2002, J IMMUNOL, V168, P5369, DOI 10.4049/jimmunol.168.10.5369; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Canto E, 2003, J LEUKOCYTE BIOL, V74, P998, DOI 10.1189/jlb.0303098; CHANDRA RK, 1980, PEDIATR RES, V14, P544, DOI 10.1093/ajcn/33.1.13; Chatzantoni K, 2004, J AUTOIMMUN, V23, P169, DOI 10.1016/j.jaut.2004.05.007; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; Conde J, 2010, EXPERT REV CLIN IMMU, V6, P801, DOI [10.1586/eci.10.48, 10.1586/ECI.10.48]; Considine R V, 2001, Rev Endocr Metab Disord, V2, P357, DOI 10.1023/A:1011896331159; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Dunn SE, 2007, J EXP MED, V204, P321, DOI 10.1084/jem.20061839; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Forhead AJ, 2009, J PHYSIOL-LONDON, V587, P1145, DOI 10.1113/jphysiol.2008.167072; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garcia-Gonzalez A, 2002, RHEUMATOL INT, V22, P138, DOI 10.1007/s00296-002-0216-9; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Henson MC, 1998, OBSTET GYNECOL, V92, P1020, DOI 10.1016/S0029-7844(98)00299-3; Hoggard N, 2001, BIOCHEM SOC T, V29, P57, DOI 10.1042/0300-5127:0290057; Karakosta P, 2011, PAEDIATR PERINAT EP, V25, P150, DOI 10.1111/j.1365-3016.2010.01163.x; Landmann E, 2006, J MATERN-FETAL NEO M, V19, P157, DOI 10.1080/14767050600624786; Lepercq J, 1999, AM J OBSTET GYNECOL, V181, P621, DOI 10.1016/S0002-9378(99)70502-8; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; MADEJ T, 1995, FEBS LETT, V373, P13, DOI 10.1016/0014-5793(95)00977-H; Mahdi M, 2010, NEOREVIEWS, V11, P558; MANDEL MA, 1978, J IMMUNOL, V120, P1375; Martos-Moreno GA, 2009, EUR J ENDOCRINOL, V161, P381, DOI 10.1530/EJE-09-0193; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Matarese G, 2002, DIABETES, V51, P1356, DOI 10.2337/diabetes.51.5.1356; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Matarese G, 2001, EUR J IMMUNOL, V31, P1324, DOI 10.1002/1521-4141(200105)31:5<1324::AID-IMMU1324>3.0.CO;2-Y; Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89; Mattioli B, 2005, J IMMUNOL, V174, P6820, DOI 10.4049/jimmunol.174.11.6820; Mazaki-Tovi S, 2005, AM J OBSTET GYNECOL, V193, P1238, DOI 10.1016/j.ajog.2005.05.049; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mouzaki A, 2002, BLOOD, V100, P1774, DOI 10.1182/blood.V100.5.1774.h81702001774_1774_1779; Mouzaki A, 2009, CYTOKINE, V48, P203, DOI 10.1016/j.cyto.2009.07.006; Ong KKL, 1999, J CLIN ENDOCR METAB, V84, P1145, DOI 10.1210/jc.84.3.1145; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Page K, 1993, PHYSL HUMAN PLACENTA, P16; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Popa C, 2009, J RHEUMATOL, V36, P724, DOI 10.3899/jrheum.080626; Rey LK, 2011, MOL CELL PROBE, V25, P255, DOI 10.1016/j.mcp.2011.05.004; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Schubring C, 1996, EUR J PEDIATR, V155, P830, DOI 10.1007/BF02002918; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Simons PJ, 2005, CYTOKINE, V32, P94, DOI 10.1016/j.cyto.2005.08.003; Taleb S, 2007, ARTERIOSCL THROM VAS, V27, P2691, DOI 10.1161/ATVBAHA.107.149567; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; van den Biggelaar AHJ, 2010, CLIN EXP IMMUNOL, V160, P42, DOI 10.1111/j.1365-2249.2010.04137.x; Varvarigou AA, 2012, CYTOKINE, V58, P355, DOI 10.1016/j.cyto.2012.03.005; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Yura S, 1998, AM J OBSTET GYNECOL, V178, P926, DOI 10.1016/S0002-9378(98)70525-3; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	62	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40830	10.1371/journal.pone.0040830	http://dx.doi.org/10.1371/journal.pone.0040830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815836	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100078
J	Ring, M; Farahnak, P; Gustavsson, T; Nilsson, IL; Eriksson, MJ; Caidahl, K				Ring, Margareta; Farahnak, Parastou; Gustavsson, Tomas; Nilsson, Inga-Lena; Eriksson, Maria J.; Caidahl, Kenneth			Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; CAROTID-ARTERY; ULTRASOUND MEASUREMENT; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RADIAL ARTERY; D DEFICIENCY; MORTALITY	Objective: Elevated levels of calcium and parathyroid hormone (PTH), characteristics of primary hyperparathyroidism (PHPT), may be associated with cardiovascular morbidity and mortality in the general population. We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques. Design: A prospective case-control study. Subjects and Methods: Forty-eight patients with mild PHPT without any known cardiovascular risk factors were studied at baseline and at one year after parathyroidectomy (PTX) in comparison with 48 healthy age-and gender-matched controls. We measured biochemical variables, augmentation index (AIx), aortic pulse wave velocity (PWVao), radial (IMTrad) and common carotid artery (IMTcca) intima media thicknesses, and the grayscale median (IM-GSM) of the latter. Results: No significant differences were observed between PHPT patients and controls at baseline for AIx (28.6+/-12.2 vs. 27.7+/-12.8%), IMTrad (0.271+/-0.060 vs. 0.255+/-0.053 mm), IMTcca (0.688+/-0.113 vs. 0.680+/-0.135 mm), or IM-GSM (82.3+/-17.2 vs. 86.5+/-15.3), while PWVao was slightly higher in patients (8.68+/-1.50 vs. 8.13+/-1.55, p<0.05). Systolic blood pressure (SBP), calcium, and PTH were higher in patients compared with controls, and decreased after PTX, while vitamin D was lower in patients and increased after PTX. While AIx, PWVao, IMTrad, and IMTcca were related to SBP, neither correlated to vitamin D levels. Only PWVao correlated weakly to plasma PTH (r=0.29, p<0.01) and ionized calcium (r=0.22, p<0.05) but showed no relation when age and SBP were adjusted for. Conclusion: We found normal arterial function despite high calcium, PTH, and low vitamin D levels, in patients with mild PHPT without cardiovascular risk factors. The cardiovascular risk associated with low vitamin D and/or high PTH and calcium levels may be explained by their coupling to blood pressure and other risk factors rather than direct effects on arterial structure.	[Ring, Margareta; Nilsson, Inga-Lena; Eriksson, Maria J.; Caidahl, Kenneth] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Ring, Margareta; Nilsson, Inga-Lena; Eriksson, Maria J.; Caidahl, Kenneth] Karolinska Univ Hosp, Stockholm, Sweden; [Farahnak, Parastou] Karolinska Inst, Sect Surg, Dept Clin Sci & Educ, Stockholm, Sweden; [Gustavsson, Tomas] Chalmers Univ Technol, S-41296 Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Chalmers University of Technology	Ring, M (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	margareta.ring@ki.se	Caidahl, Kenneth/AAQ-2645-2021	Nilsson, Inga-Lena/0000-0002-8966-3729; Farahnak, Parastou/0000-0001-5659-6390	Stockholm County Council; Karolinska Institutet; Swedish Heart Lung Foundation; Swedish Medical Research Council; Capio Research Foundation; Fredrik and Ingrid Thuring Foundation	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Capio Research Foundation; Fredrik and Ingrid Thuring Foundation	This study was supported by grants from the Stockholm County Council, Karolinska Institutet, the Swedish Heart Lung Foundation, the Swedish Medical Research Council, Capio Research Foundation, and the Fredrik and Ingrid Thuring Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2009, ATHEROSCLEROSIS, V204, P612, DOI 10.1016/j.atherosclerosis.2008.10.038; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Brewer LC, 2011, CURR DRUG TARGETS, V12, P54; Burgaz A, 2011, J INTERN MED, V269, P211, DOI 10.1111/j.1365-2796.2010.02309.x; Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638; Christensen MHE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020481; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Fallo F, 2003, J CLIN ENDOCR METAB, V88, P2096, DOI 10.1210/jc.2002-021837; Farahnak P, 2010, EUR J ENDOCRINOL, V163, P461, DOI 10.1530/EJE-10-0201; Farahnak P, 2011, J CLIN ENDOCR METAB, V96, P2112, DOI 10.1210/jc.2011-0238; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; Hagstrom E, 2010, EUR J HEART FAIL, V12, P1186, DOI 10.1093/eurjhf/hfq134; Hedback G, 1998, EUR J CLIN INVEST, V28, P271; KARAMANOGLU M, 1993, EUR HEART J, V14, P160, DOI 10.1093/eurheartj/14.2.160; Kosch M, 2001, CLIN NEPHROL, V55, P303; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Liang Q, 2000, IEEE T MED IMAGING, V19, P127, DOI 10.1109/42.836372; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; Lind L, 2007, ATHEROSCLEROSIS, V195, P411, DOI 10.1016/j.atherosclerosis.2007.03.029; Lumachi F, 2006, IN VIVO, V20, P887; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Myredal A, 2010, ATHEROSCLEROSIS, V209, P147, DOI 10.1016/j.atherosclerosis.2009.09.017; Nilsson IL, 1999, SURGERY, V126, P1049, DOI 10.1067/msy.2099.101422; Nuzzo V, 2002, EUR J ENDOCRINOL, V147, P453, DOI 10.1530/eje.0.1470453; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OROURKE MF, 1971, AM HEART J, V82, P687, DOI 10.1016/0002-8703(71)90340-1; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Persson A, 2011, CLIN ENDOCRINOL, V74, P174, DOI 10.1111/j.1365-2265.2010.03909.x; Pilz S, 2010, EUR HEART J, V31, P1591, DOI 10.1093/eurheartj/ehq109; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Razuvaev A, 2008, ATHEROSCLEROSIS, V199, P310, DOI 10.1016/j.atherosclerosis.2007.11.035; Reis JP, 2009, ATHEROSCLEROSIS, V207, P585, DOI 10.1016/j.atherosclerosis.2009.05.030; Rosa J, 2011, HYPERTENS RES, V34, P296, DOI 10.1038/hr.2010.232; Rubin MR, 2005, J CLIN ENDOCR METAB, V90, P3326, DOI 10.1210/jc.2004-1400; Silverberg SJ, 2009, J CLIN ENDOCR METAB, V94, P351, DOI 10.1210/jc.2008-1760; Silverberg SJ, 1999, AM J MED, V107, P561, DOI 10.1016/S0002-9343(99)00294-6; Smith JC, 2000, J CLIN ENDOCR METAB, V85, P3515, DOI 10.1210/jc.85.10.3515; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Tordjman KM, 2010, EUR J ENDOCRINOL, V162, P925, DOI 10.1530/EJE-09-1067; Vermeersch SJ, 2009, J HYPERTENS, V27, P2377, DOI 10.1097/HJH.0b013e3283313a8a; Walker MD, 2009, J CLIN ENDOCR METAB, V94, P3849, DOI 10.1210/jc.2009-1086; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Weber T, 2009, J HYPERTENS, V27, P1624, DOI 10.1097/HJH.0b013e32832cb04e; Wendelhag I, 1997, STROKE, V28, P2195, DOI 10.1161/01.STR.28.11.2195; WENDELHAG I, 1991, CLIN PHYSIOL, V11, P565, DOI 10.1111/j.1475-097X.1991.tb00676.x; Williams DM, 2011, HEART, V97, P315, DOI 10.1136/hrt.2010.203224; Yu N, 2010, CLIN ENDOCRINOL, V73, P30, DOI 10.1111/j.1365-2265.2009.03766.x	50	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39519	10.1371/journal.pone.0039519	http://dx.doi.org/10.1371/journal.pone.0039519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815708	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100019
J	Vergara-Alert, J; Argilaguet, JM; Busquets, N; Ballester, M; Martin-Valls, GE; Rivas, R; Lopez-Soria, S; Solanes, D; Majo, N; Segales, J; Veljkovic, V; Rodriguez, F; Darji, A				Vergara-Alert, Julia; Argilaguet, Jordi M.; Busquets, Nuria; Ballester, Maria; Martin-Valls, Gerard E.; Rivas, Raquel; Lopez-Soria, Sergio; Solanes, David; Majo, Natalia; Segales, Joaquim; Veljkovic, Veljko; Rodriguez, Fernando; Darji, Ayub			Conserved Synthetic Peptides from the Hemagglutinin of Influenza Viruses Induce Broad Humoral and T-Cell Responses in a Pig Model	PLOS ONE			English	Article							A VIRUS; MATRIX PROTEIN-2; PROTECTION; VACCINATION; INFECTION	Outbreaks involving either H5N1 or H1N1 influenza viruses (IV) have recently become an increasing threat to cause potential pandemics. Pigs have an important role in this aspect. As reflected in the 2009 human H1N1 pandemia, they may act as a vehicle for mixing and generating new assortments of viruses potentially pathogenic to animals and humans. Lack of universal vaccines against the highly variable influenza virus forces scientists to continuously design vaccines a la carte, which is an expensive and risky practice overall when dealing with virulent strains. Therefore, we focused our efforts on developing a broadly protective influenza vaccine based on the Informational Spectrum Method (ISM). This theoretical prediction allows the selection of highly conserved peptide sequences from within the hemagglutinin subunit 1 protein (HA1) from either H5 or H1 viruses which are located in the flanking region of the HA binding site and with the potential to elicit broader immune responses than conventional vaccines. Confirming the theoretical predictions, immunization of conventional farm pigs with the synthetic peptides induced humoral responses in every single pig. The fact that the induced antibodies were able to recognize in vitro heterologous influenza viruses such as the pandemic H1N1 virus (pH1N1), two swine influenza field isolates (SwH1N1 and SwH3N2) and a H5N1 highly pathogenic avian virus, confirm the broad recognition of the antibodies induced. Unexpectedly, all pigs also showed T-cell responses that not only recognized the specific peptides, but also the pH1N1 virus. Finally, a partial effect on the kinetics of virus clearance was observed after the intranasal infection with the pH1N1 virus, setting forth the groundwork for the design of peptide-based vaccines against influenza viruses. Further insights into the understanding of the mechanisms involved in the protection afforded will be necessary to optimize future vaccine formulations.	[Vergara-Alert, Julia; Argilaguet, Jordi M.; Busquets, Nuria; Ballester, Maria; Martin-Valls, Gerard E.; Rivas, Raquel; Lopez-Soria, Sergio; Solanes, David; Majo, Natalia; Segales, Joaquim; Rodriguez, Fernando; Darji, Ayub] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, Inst Recerca & Tecnol Agroalimentaria, Bellaterra, Cerdanyola Del, Spain; [Majo, Natalia; Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Veljkovic, Veljko] Univ Belgrade, Inst Nucl Sci VINCA, Ctr Multidisciplinary Res, Belgrade, Serbia; [Darji, Ayub] Inst Recerca Tecnol Agroalimentaries, Barcelona, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; University of Belgrade; IRTA	Vergara-Alert, J (corresponding author), Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, Inst Recerca & Tecnol Agroalimentaria, Campus Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	julia.vergara@cresa.uab.cat	Rodriguez, Fernando/GLN-3947-2022; Busquets, Núria/T-8431-2017; Segalés, Joaquim/AAB-4815-2020; Devis, Maria Ballester/AAV-2467-2020; Lopez-Soria, Sergio/F-9858-2012; Vergara-Alert, Júlia/I-5010-2015; Argilaguet, Jordi/E-5109-2016; Ballester, Maria/H-7277-2013; Valls, Gerard Martin/AAB-1370-2019; Segalés, Joaquim/A-4933-2011; Ballester, Maria/E-7201-2016; Masferrer, Natàlia Majó/AAV-3696-2021	Rodriguez, Fernando/0000-0001-7361-8408; Segalés, Joaquim/0000-0002-1539-7261; Devis, Maria Ballester/0000-0002-5413-4640; Lopez-Soria, Sergio/0000-0001-7134-2014; Vergara-Alert, Júlia/0000-0001-7484-444X; Argilaguet, Jordi/0000-0001-5924-2774; Segalés, Joaquim/0000-0002-1539-7261; Ballester, Maria/0000-0002-5413-4640; Martin-Valls, Gerard/0000-0003-3302-0692; Majo, Natalia/0000-0003-0189-9751	Spanish Government [AGL2007-60434/GAN, AGL2010-22229-C03-01, RTA2010-00084-C02-02]; Ministry of Science and Technological Development of the Republic of Serbia [143001]; Spanish Ministry of Science and Innovation [BES-2008-00260]	Spanish Government(Spanish GovernmentEuropean Commission); Ministry of Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Spanish Government Grants AGL2007-60434/GAN and AGL2010-22229-C03-01 (Ministry of Science and Innovation) and RTA2010-00084-C02-02 (National Institute of Research and Food Technology). This work was also supported in part by the Ministry of Science and Technological Development of the Republic of Serbia, Grant no. 143001 (to VV). JVA was supported by a Research personnel in training program of the Spanish Ministry of Science and Innovation Training Grant: BES-2008-00260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argilaguet JM, 2011, VACCINE, V29, P5379, DOI 10.1016/j.vaccine.2011.05.084; Ballester M, 2011, J VIROL, V85, P8263, DOI 10.1128/JVI.00704-11; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Busquets N, 2010, VET RES, V41, DOI 10.1051/vetres/2010046; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Hillaire ML, 2011, J GEN VIROL; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kitikoon P, 2009, VACCINE, V28, P523, DOI 10.1016/j.vaccine.2009.09.130; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Molder T, 2009, VACCINE, V28, P293, DOI 10.1016/j.vaccine.2009.10.054; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; REED L. J., 1938, AMER JOUR HYG, V27, P493; Riberdy JM, 1999, J VIROL, V73, P1453, DOI 10.1128/JVI.73.2.1453-1459.1999; Rothkotter HJ, 2002, HUM EXP TOXICOL, V21, P533, DOI 10.1191/0960327102ht293oa; Sirskyj D, 2010, J VIROL METHODS, V163, P459, DOI 10.1016/j.jviromet.2009.11.014; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; World Organisation for Animal Health OIE, 2008, OIE, P1130	26	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40524	10.1371/journal.pone.0040524	http://dx.doi.org/10.1371/journal.pone.0040524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815759	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100041
J	Muehleisen, B; Jiang, SB; Gladsjo, JA; Gerber, M; Hata, T; Gallo, RL				Muehleisen, Beda; Jiang, Shang Brian; Gladsjo, Julie A.; Gerber, Monika; Hata, Tissa; Gallo, Richard L.			Distinct Innate Immune Gene Expression Profiles in Non-Melanoma Skin Cancer of Immunocompetent and Immunosuppressed Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ORGAN TRANSPLANT RECIPIENTS; ANTIMICROBIAL PEPTIDES; PSORIASIN S100A7; HUMAN BETA-DEFENSIN-2; BETA-DEFENSINS; MESSENGER-RNA; BREAST-CANCER; IN-SITU; DIFFERENTIATION	Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most frequent skin cancers in humans. An intact immune system is critical for protection against SCC since organ transplant recipients (OTR) have a 60- to 100-fold higher risk for developing these tumors. The role of the innate immune system in tumor immunosurveillance is unclear. Our aim was to determine the expression of selected innate immune genes in BCC and SCC arising in immunocompetent and OTR patients. Lesional and peri-lesional skin from 28 SCC and 19 BCC were evaluated for mRNA expression of toll-like receptors (TLR) 1-9, downstream TLR signaling molecules, and antimicrobial peptides. 11 SCC occurring in OTR patients were included in the analysis. We found that SCC but not BCC showed significantly elevated expression of TLRs 1-3, 5-8, TRIF and TRAF1. TNF was increased in SCC compared to normal skin. BCC showed increased IFN gamma. hBD1, hBD2 and psoriasin mRNA and protein expression were significantly higher in SCC than in normal skin and higher than in BCC. SCC from OTR showed only an increase in hBD2 but no increase in hBD1 or psoriasin. We conclude that innate immune gene expression in SCC is distinct from normal skin and BCC. BCC shows lesser induction of innate immune genes. SCC from OTR patients have depressed expression of hBD1 and psoriasin compared to SCC from immunocompetent patients.	[Muehleisen, Beda; Jiang, Shang Brian; Gladsjo, Julie A.; Gerber, Monika; Hata, Tissa; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA; [Gallo, Richard L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Muehleisen, Beda] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Gallo, Richard L.] Vet Adm San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Zurich; University Zurich Hospital	Muehleisen, B (corresponding author), Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Jiang, Shang I Brian/T-2052-2019; Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861	United States National Institutes of Health [R01 AR052728, R01 AI052453, R01 AI0833358]; Swiss National Science Foundation [PBZHP3-125571, PASMP3_140073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by United States National Institutes of Health grants R01 AR052728, R01 AI052453, R01 AI0833358, and the Swiss National Science Foundation (PBZHP3-125571, PASMP3_140073) to B.M. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Buchau AS, 2010, J IMMUNOL, V184, P369, DOI 10.4049/jimmunol.0902110; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Cumberland Lara, 2009, Facial Plast Surg Clin North Am, V17, P325, DOI 10.1016/j.fsc.2009.06.001; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Frye M, 2001, J MOL MED-JMM, V79, P275, DOI 10.1007/s001090100200; Gambichler T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-163; Glaser R, 2011, J DTSCH DERMATOL GES, V9, P897, DOI [10.1111/j.1610-0387.2011.07683.x, 10.1111/j.1610-0387.2011.07718_suppl.x]; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Hudson LG, 2010, MOL CARCINOGEN, V49, P619, DOI 10.1002/mc.20636; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010993; Kawsar HI, 2010, PEPTIDES, V31, P195, DOI 10.1016/j.peptides.2009.12.008; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kesting MR, 2009, ORAL ONCOL, V45, P731, DOI 10.1016/j.oraloncology.2008.11.012; Kisich KO, 2007, J INVEST DERMATOL, V127, P2368, DOI 10.1038/sj.jid.5700861; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Krynitz B, 2010, ACTA DERM-VENEREOL, V90, P379, DOI 10.2340/00015555-0876; Kuhns DB, 2007, INFLAMMATION, V30, P178, DOI 10.1007/s10753-007-9035-1; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lai Yuping, 2008, Infectious Disorders - Drug Targets, V8, P144; Lee JW, 2007, MOL CARCINOGEN, V46, P941, DOI 10.1002/mc.20325; Leygue E, 1996, CANCER RES, V56, P4606; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Lomas A, 2012, BR J DERMATOL; Mathew T, 2004, CLIN TRANSPLANT, V18, P446, DOI 10.1111/j.1399-0012.2004.00188.x; Mburu YK, 2011, CARCINOGENESIS, V32, P168, DOI 10.1093/carcin/bgq236; Morgan MR, 2011, ONCOGENE, V30, P1422, DOI 10.1038/onc.2010.535; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Muhleisen B, 2009, HISTOPATHOLOGY, V55, P67, DOI 10.1111/j.1365-2559.2009.03324.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Norval M, 2001, J PHOTOCH PHOTOBIO B, V63, P28, DOI 10.1016/S1011-1344(01)00200-7; ODELL BL, 1980, ARCH DERMATOL, V116, P559, DOI 10.1001/archderm.116.5.559; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Sawaki K, 2002, ANTICANCER RES, V22, P2103; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; STARNES CO, 1992, NATURE, V357, P11, DOI 10.1038/357011a0; Szczepanski M, 2007, EUR ARCH OTO-RHINO-L, V264, P525, DOI 10.1007/s00405-006-0215-7; Vahle AK, 2012, CANCER LETT, V317, P199, DOI 10.1016/j.canlet.2011.11.027; Wagstaff AJ, 2007, DRUGS, V67, P2187, DOI 10.2165/00003495-200767150-00006; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Yoshimoto T, 2003, ANTICANCER RES, V23, P4629; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179	55	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40754	10.1371/journal.pone.0040754	http://dx.doi.org/10.1371/journal.pone.0040754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808251	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700049
J	Phipps, MC; Xu, YY; Bellis, SL				Phipps, Matthew C.; Xu, Yuanyuan; Bellis, Susan L.			Delivery of Platelet-Derived Growth Factor as a Chemotactic Factor for Mesenchymal Stem Cells by Bone-Mimetic Electrospun Scaffolds	PLOS ONE			English	Article							NANOFIBROUS SCAFFOLDS; CONTROLLED-RELEASE; PDGF-BB; IN-VIVO; CHEMOKINE; EXPRESSION; MIGRATION; PROTEINS; BIOLOGY; REPAIR	The recruitment of mesenchymal stem cells (MSCs) is a vital step in the bone healing process, and hence the functionalization of osteogenic biomaterials with chemotactic factors constitutes an important effort in the tissue engineering field. Previously we determined that bone-mimetic electrospun scaffolds composed of polycaprolactone, collagen I and nanohydroxyapatite (PCL/col/HA) supported greater MSC adhesion, proliferation and activation of integrin-related signaling cascades than scaffolds composed of PCL or collagen I alone. In the current study we investigated the capacity of bone-mimetic scaffolds to serve as carriers for delivery of an MSC chemotactic factor. In initial studies, we compared MSC chemotaxis toward a variety of molecules including PDGF-AB, PDGF-BB, BMP2, and a mixture of the chemokines SDF-1 alpha, CXCL16, MIP-1 alpha, MIP-1 beta, and RANTES. Transwell migration assays indicated that, of these factors, PDGF-BB was the most effective in stimulating MSC migration. We next evaluated the capacity of PCL/col/HA scaffolds, compared with PCL scaffolds, to adsorb and release PDGF-BB. We found that significantly more PDGF- BB was adsorbed to, and subsequently released from, PCL/col/HA scaffolds, with sustained release extending over an 8-week interval. The PDGF-BB released was chemotactically active in transwell migration assays, indicating that bioactivity was not diminished by adsorption to the biomaterial. Complementing these studies, we developed a new type of migration assay in which the PDGF-BB-coated bone-mimetic substrates were placed 1.5 cm away from the cell migration front. These experiments confirmed the ability of PDGF-BB-coated PCL/col/HA scaffolds to induce significant MSC chemotaxis under more stringent conditions than standard types of migration assays. Our collective results substantiate the efficacy of PDGF-BB in stimulating MSC recruitment, and further show that the incorporation of native bone molecules, collagen I and nanoHA, into electrospun scaffolds not only enhances MSC adhesion and proliferation, but also increases the amount of PDGF-BB that can be delivered from scaffolds.	[Phipps, Matthew C.; Xu, Yuanyuan; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Phipps, MC (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA.	bellis@uab.edu			National Institutes of Health [R01AR51539, T32EB004312]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB004312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study received support from National Institutes of Health grants R01AR51539 (SLB), and T32EB004312 (MCP predoctoral fellowship) URL: www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; BETSHOLTZ C, 1986, P NATL ACAD SCI USA, V83, P6440, DOI 10.1073/pnas.83.17.6440; BOWENPOPE DF, 1984, BLOOD, V64, P458; CANALIS E, 1992, GROWTH REGULAT, V2, P151; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Chen L, 2009, BIOMACROMOLECULES, V10, P3193, DOI 10.1021/bm900850q; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Di Martino Alberto, 2011, Musculoskelet Surg, V95, P69, DOI 10.1007/s12306-011-0097-8; Distler JHW, 2003, Q J NUCL MED, V47, P149; Fujii H, 1999, HISTOCHEM CELL BIOL, V112, P131, DOI 10.1007/s004180050399; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607; Gruber R, 2003, J ORTHOPAED RES, V21, P941, DOI 10.1016/S0736-0266(03)00053-6; HART CE, 1990, BIOCHEMISTRY-US, V29, P166, DOI 10.1021/bi00453a022; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231; Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009; Homsi Jade, 2007, Cancer Control, V14, P285; Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008; Javed F, 2011, ARCH ORAL BIOL, V56, P1476, DOI 10.1016/j.archoralbio.2011.06.020; Jin QM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001729; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; KELLY JD, 1985, EMBO J, V4, P3399, DOI 10.1002/j.1460-2075.1985.tb04096.x; Krattinger N, 2011, EUR CELLS MATER, V21, P46, DOI 10.22203/eCM.v021a04; Liao IC, 2005, J CONTROL RELEASE, V104, P347, DOI 10.1016/j.jconrel.2005.02.013; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023; Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080; Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813; Prabhakaran MP, 2011, J NANOSCI NANOTECHNO, V11, P3039, DOI 10.1166/jnn.2011.3753; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Solchaga LA, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412442668; Solchaga LA, 2012, SPINE, V37, pE461, DOI 10.1097/BRS.0b013e31823b01dc; Trippel S B, 1997, Instr Course Lect, V46, P473; Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Young CS, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/246215	43	80	86	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40831	10.1371/journal.pone.0040831	http://dx.doi.org/10.1371/journal.pone.0040831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808271	Green Submitted, gold, Green Published			2022-12-27	WOS:000306366400060
J	Tapadia, MG; Verma, P				Tapadia, Madhu G.; Verma, Puja			Immune Response and Anti-Microbial Peptides Expression in Malpighian Tubules of Drosophila melanogaster Is under Developmental Regulation	PLOS ONE			English	Article							INSECT IMMUNITY; CECROPIN EXPRESSION; FLUID SECRETION; INNATE IMMUNITY; RENAL TUBULES; BLOOD-CELLS; GENE; ECDYSONE; PATHWAYS; HORMONE	Malpighian tubules (MT) of Drosophila melanogaster are osmoregulatory organs that maintain the ionic balance and remove toxic substances from the body. Additionally they act as autonomous immune sensing organs, which secrete antimicrobial peptides in response to invading microbial pathogens. We show that the antimicrobial peptides (AMP) diptericin, cecropinA, drosocin and attacinA are constitutively expressed and are regulated in developmental stage specific manner. Their developmental expression begins from 3rd instar larval stage and an immune challenge increases the expression several folds. Spatial variatons in the level of expression along the MT tissue are observed. The mortality of 3rd instar larvae fed on bacterial food is much less than that of the earlier larval stages, coinciding with the onset of innate immunity response in MT. Ectopic expression of AMP imparts better resistance to infection while, loss of function of one of the AMP through directed RNAi reduces host survival after immune challenge. The AMP secreted from the MT exhibit bactericidal activity. Expression of the NF-kappa B transcription factor, Relish, also coincides with activation of immune responsive genes in MT, demonstrating that immune regulation in MT is under developmental control and is governed by the Imd pathway.	[Tapadia, Madhu G.; Verma, Puja] Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Tapadia, MG (corresponding author), Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India.	madhu@bhu.ac.in			Department of Science and Technology, Department of Biotechnology, Government of India, New Delhi; University Grant Commission	Department of Science and Technology, Department of Biotechnology, Government of India, New Delhi; University Grant Commission(University Grants Commission, India)	This work is supported by grants from the Department of Science and Technology, Department of Biotechnology, Government of India, New Delhi, to M.G.T. DST is also acknowledged for its support for laser scanning Carl Zeiss 510 Meta Confocal Microscope Facility. P. V. was supported by a fellowship from the University Grant Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 1999, P NATL ACAD SCI USA, V96, P14795, DOI 10.1073/pnas.96.26.14795; Asano T, 2009, INSECT MOL BIOL, V18, P223, DOI 10.1111/j.1365-2583.2008.00858.x; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; CHERNYSH SI, 1995, EUR J ENTOMOL, V92, P203; Chow EKH, 2007, J LEUKOCYTE BIOL, V82, P187, DOI 10.1189/jlb.1206741; Davies SA, 2009, GEN COMP ENDOCR, V162, P113, DOI 10.1016/j.ygcen.2008.09.012; Denholm B, 2003, CURR BIOL, V13, P1052, DOI 10.1016/S0960-9822(03)00375-0; Dimarcq JL, 1997, INSECT BIOCHEM MOLEC, V27, P877, DOI 10.1016/S0965-1748(97)00072-6; DOW JAT, 1994, J EXP BIOL, V197, P421; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gautam NK, 2010, INT J DEV BIOL, V54, P635, DOI 10.1387/ijdb.092910ng; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hetru Charles, 1998, P40; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Martinelli C, 2005, J ENDOTOXIN RES, V11, P243, DOI 10.1179/09680510SX37411; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Meister M, 1996, INSECT BIOCHEM MOLEC, V26, P155, DOI 10.1016/0965-1748(95)00076-3; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; REICHHART JM, 1992, EMBO J, V11, P1469, DOI 10.1002/j.1460-2075.1992.tb05191.x; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Roxstrom Lindquist K, 2005, INSECT MOL BIOL, V14, P645; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Shukla A, 2011, EUR J CELL BIOL, V90, P72, DOI 10.1016/j.ejcb.2010.08.010; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; SKAER H, 1989, NATURE, V342, P566, DOI 10.1038/342566a0; Skaer H, 1993, DEV DROSOPHILA, P969; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Tingvall TO, 2001, EMBO REP, V2, P239; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Wagner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-446; WICKER C, 1990, J BIOL CHEM, V265, P22493; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	64	33	33	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40714	10.1371/journal.pone.0040714	http://dx.doi.org/10.1371/journal.pone.0040714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808242	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400051
J	Johnson, CA; Kleshchenko, YY; Ikejiani, AO; Udoko, AN; Cardenas, TC; Pratap, S; Duquette, MA; Lima, MF; Lawler, J; Villalta, F; Nde, PN				Johnson, Candice A.; Kleshchenko, Yulia Y.; Ikejiani, Adaeze O.; Udoko, Aniekanabasi N.; Cardenas, Tatiana C.; Pratap, Siddharth; Duquette, Mark A.; Lima, Maria F.; Lawler, Jack; Villalta, Fernando; Nde, Pius N.			Thrombospondin-1 Interacts with Trypanosoma cruzi Surface Calreticulin to Enhance Cellular Infection	PLOS ONE			English	Article							CHAGAS-DISEASE; BINDING; PROTEIN; ADHESION; DOMAIN; RECEPTOR; GENE; IDENTIFICATION; COMPONENT	Trypanosoma cruzi causes Chagas disease, which is a neglected tropical disease that produces severe pathology and mortality. The mechanisms by which the parasite invades cells are not well elucidated. We recently reported that T. cruzi up-regulates the expression of thrombospondin-1 (TSP-1) to enhance the process of cellular invasion. Here we characterize a novel TSP-1 interaction with T. cruzi that enhances cellular infection. We show that labeled TSP-1 interacts specifically with the surface of T. cruzi trypomastigotes. We used TSP-1 to pull down interacting parasite surface proteins that were identified by mass spectrometry. We also show that full length TSP-1 and the N-terminal domain of TSP-1 (NTSP) interact with T. cruzi surface calreticulin (TcCRT) and other surface proteins. Pre-exposure of recombinant NTSP or TSP-1 to T. cruzi significantly enhances cellular infection of wild type mouse embryo fibroblasts (MEF) compared to the C-terminal domain of TSP-1, E3T3C1. In addition, blocking TcCRT with antibodies significantly inhibits the enhancement of cellular infection mediated by the TcCRT-TSP-1 interaction. Taken together, our findings indicate that TSP-1 interacts with TcCRT on the surface of T. cruzi through the NTSP domain and that this interaction enhances cellular infection. Thus surface TcCRT is a virulent factor that enhances the pathogenesis of T. cruzi infection through TSP-1, which is up-regulated by the parasite.	[Johnson, Candice A.; Ikejiani, Adaeze O.; Udoko, Aniekanabasi N.; Cardenas, Tatiana C.; Pratap, Siddharth; Lima, Maria F.; Villalta, Fernando; Nde, Pius N.] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Kleshchenko, Yulia Y.] USN, US Mil Malaria Vaccine Program, Med Res Ctr, Silver Spring, MD USA; [Duquette, Mark A.; Lawler, Jack] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Meharry Medical College; United States Department of Defense; United States Navy; Harvard University; Beth Israel Deaconess Medical Center	Johnson, CA (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA.	pnde@mmc.edu	Lawler, Jack/AAJ-1379-2020	Villalta, Fernando/0000-0002-6232-0574; Pratap, Siddharth/0000-0003-2200-0848	National Institutes of Health [SC2AI083925, 5 U54 RR026140-03, AI080580, GM05999, G12RR003032];  [5T32 AI007281-23]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140, G12RR003032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080580, SC2AI083925, T32AI007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported, in whole or in part, by National Institutes of Health Grants SC2AI083925 and 5 U54 RR026140-03 (to PNN), AI080580 (to FV), GM05999 (to MFL), and G12RR003032 (to SP). CAJ and TCC are NIH fellows supported by grant 5T32 AI007281-23. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Aguilar L, 2005, BIOL RES, V38, P187, DOI 10.4067/S0716-97602005000200008; Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; Bornstein P, 2002, METHOD CELL BIOL, V69, P7, DOI 10.1016/S0091-679X(02)69003-X; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Conner D, 2000, CURRENT PROTOCOLS MO, P2321; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Ferreira V, 2005, TRENDS PARASITOL, V21, P169, DOI 10.1016/j.pt.2005.02.005; Ferreira V, 2004, MOL IMMUNOL, V40, P1279, DOI 10.1016/j.molimm.2003.11.018; GAO AG, 1994, J BIOL CHEM, V269, P29650; GIORDANO R, 1994, MOL BIOCHEM PARASIT, V65, P85, DOI 10.1016/0166-6851(94)90117-1; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Johnson RJ, 2001, NEUROBIOL AGING, V22, P387, DOI 10.1016/S0197-4580(00)00247-5; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Joshi M, 1996, MOL BIOCHEM PARASIT, V81, P53, DOI 10.1016/0166-6851(96)02676-X; Kleshchenko YY, 2004, INFECT IMMUN, V72, P6717, DOI 10.1128/IAI.72.11.6717-6721.2004; LAWLER J, 1989, BLOOD, V74, P2022; Lawler J, 2010, THROMBOSPONDIN; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; LIMA MF, 1989, MOL BIOCHEM PARASIT, V33, P159, DOI 10.1016/0166-6851(89)90030-3; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Moody TN, 2000, FEBS LETT, V470, P305, DOI 10.1016/S0014-5793(00)01347-8; Nakhasi HL, 1998, PARASITOL TODAY, V14, P157, DOI 10.1016/S0169-4758(97)01180-0; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; OUAISSI MA, 1984, NATURE, V308, P380, DOI 10.1038/308380a0; Santana JM, 1997, BIOCHEM J, V325, P129, DOI 10.1042/bj3250129; Simmons KJ, 2006, FEBS LETT, V580, P2365, DOI 10.1016/j.febslet.2006.03.054; Tanowitz HB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001136; VILLALTA F, 1990, BIOCHEM BIOPH RES CO, V172, P925, DOI 10.1016/0006-291X(90)90764-E; Xiao GQ, 1999, J NEUROSCI RES, V58, P652, DOI 10.1002/(SICI)1097-4547(19991201)58:5<652::AID-JNR6>3.0.CO;2-H; Yan Q, 2010, BIOCHEMISTRY-US, V49, P3685, DOI 10.1021/bi902067f; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	40	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40614	10.1371/journal.pone.0040614	http://dx.doi.org/10.1371/journal.pone.0040614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808206	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400084
J	Sorrentino, S; Bucciarelli, T; Corsaro, A; Tosatto, A; Thellung, S; Villa, V; Schinina, ME; Maras, B; Galeno, R; Scotti, L; Creati, F; Marrone, A; Re, N; Aceto, A; Florio, T; Mazzanti, M				Sorrentino, Sacha; Bucciarelli, Tonino; Corsaro, Alessandro; Tosatto, Alessio; Thellung, Stefano; Villa, Valentina; Schinina, M. Eugenia; Maras, Bruno; Galeno, Roberta; Scotti, Luca; Creati, Francesco; Marrone, Alessandro; Re, Nazzareno; Aceto, Antonio; Florio, Tullio; Mazzanti, Michele			Calcium Binding Promotes Prion Protein Fragment 90-231 Conformational Change toward a Membrane Destabilizing and Cytotoxic Structure	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; INTRACELLULAR ACCUMULATION; ION CHANNELS; FORCE-FIELD; CELL-DEATH; IDENTIFICATION; STABILITY; MECHANISM; CA2+; PRP	The pathological form of prion protein (PrPSc), as other amyloidogenic proteins, causes a marked increase of membrane permeability. PrPSc extracted from infected Syrian hamster brains induces a considerable change in membrane ionic conductance, although the contribution of this interaction to the molecular mechanism of neurodegeneration process is still controversial. We previously showed that the human PrP fragment 90-231 (hPrP(90-231)) increases ionic conductance across artificial lipid bilayer, in a calcium-dependent manner, producing an alteration similar to that observed for PrPSc. In the present study we demonstrate that hPrP(90-231), pre-incubated with 10 mM Ca++ and then re-suspended in physiological external solution increases not only membrane conductance but neurotoxicity as well. Furthermore we show the existence of a direct link between these two effects as demonstrated by a highly statistically significant correlation in several experimental conditions. A similar correlation between increased membrane conductance and cell degeneration has been observed assaying hPrP(90-231) bearing pathogenic mutations (D202N and E200K). We also report that Ca++ binding to hPrP(90-231) induces a conformational change based on an alteration of secondary structure characterized by loss of alpha-helix content causing hydrophobic amino acid exposure and proteinase K resistance. These features, either acquired after controlled thermal denaturation or induced by D202N and E200K mutations were previously identified as responsible for hPrP(90-231) cytotoxicity. Finally, by in silico structural analysis, we propose that Ca++ binding to hPrP(90-231) modifies amino acid orientation, in the same way induced by E200K mutation, thus suggesting a pathway for the structural alterations responsible of PrP neurotoxicity.	[Sorrentino, Sacha; Tosatto, Alessio; Mazzanti, Michele] Univ Milan, Dipartimento Biosci, Milan, Italy; [Corsaro, Alessandro; Thellung, Stefano; Villa, Valentina; Florio, Tullio] Univ Genoa, Dipartimento Med Interna, Sez Farmacol, Genoa, Italy; [Corsaro, Alessandro; Thellung, Stefano; Villa, Valentina; Florio, Tullio] Univ Genoa, Ctr Eccellenza Ric Biomed CEBR, Genoa, Italy; [Schinina, M. Eugenia; Maras, Bruno] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [Bucciarelli, Tonino; Scotti, Luca; Aceto, Antonio] Univ G dAnnunzio, Dipartimento Sci Biomed, Chieti, Italy; [Creati, Francesco; Marrone, Alessandro; Re, Nazzareno] Univ G dAnnunzio, Dipartimento Sci Farmaco, Chieti, Italy; [Galeno, Roberta] Ist Super Sanita, I-00161 Rome, Italy	University of Milan; University of Genoa; University of Genoa; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Istituto Superiore di Sanita (ISS)	Sorrentino, S (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	michele.mazzanti@unimi.it	Thellung, Stefano/L-8802-2015; Florio, Tullio/A-2211-2012; Scotti, Luca/J-4273-2012; FLORIO, TULLIO/ABG-3182-2020; Scotti, Luca/AAB-9197-2020	Thellung, Stefano/0000-0002-2010-331X; Florio, Tullio/0000-0002-2394-996X; Scotti, Luca/0000-0003-2662-8720; Marrone, Alessandro/0000-0002-8311-8172; Mazzanti, Michele/0000-0002-1819-3811; BUCCIARELLI, Tonino/0000-0002-5001-0165; Corsaro, Alessandro/0000-0003-4565-7914	Italian Ministry of University and Research; PRIN	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	We would like to thank Simona Gornati and Erica Pizzi for technical support. This work was supported by grants from Italian Ministry of University and Research to TF (PRIN 2008 and FIRB-Accordi di Programma 2011) and MM (PRIN 2007).	Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; CARBO R, 1980, INT J QUANTUM CHEM, V17, P1185, DOI 10.1002/qua.560170612; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chiovitti K, 2007, J NEUROCHEM, V103, P2597, DOI 10.1111/j.1471-4159.2007.04965.x; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Corsaro A, 2006, INT J IMMUNOPATH PH, V19, P339, DOI 10.1177/039463200601900211; Corsaro A, 2003, ANN NY ACAD SCI, V1010, P610, DOI 10.1196/annals.1299.114; Corsaro A, 2002, NEUROCHEM INT, V41, P55, DOI 10.1016/S0197-0186(01)00137-1; Corsaro A, 2010, J BIOL REG HOMEOS AG, V24, P27; Corsaro A, 2011, INT J BIOCHEM CELL B, V43, P372, DOI 10.1016/j.biocel.2010.11.007; Corsaro A, 2009, NEUROTOX RES, V15, P138, DOI 10.1007/s12640-009-9015-3; Florio T, 2003, J NEUROCHEM, V85, P62, DOI 10.1046/j.1471-4159.2003.01664.x; Gallo M, 2005, INT J IMMUNOPATH PH, V18, P95, DOI 10.1177/039463200501800111; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Haigh CL, 2010, FRONT BIOSCI-LANDMRK, V15, P1086, DOI 10.2741/3663; Henriques ST, 2010, CURR PROTEIN PEPT SC, V11, P326; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Keseru GM, 2001, J AM CHEM SOC, V123, P12708, DOI 10.1021/ja0160086; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kolossvary I, 2001, J COMPUT CHEM, V22, P21, DOI 10.1002/1096-987X(20010115)22:1<21::AID-JCC3>3.0.CO;2-I; Kourie JI, 2002, CELL BIOCHEM BIOPHYS, V36, P191, DOI 10.1385/CBB:36:2-3:191; Kourie JI, 2001, CAN J PHYSIOL PHARM, V79, P654, DOI 10.1139/cjpp-79-8-654; Kourie JI, 2001, CROAT MED J, V42, P359; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Paludi D, 2007, J NEUROCHEM, V103, P2291, DOI 10.1111/j.1471-4159.2007.04934.x; Paulis D, 2011, NEUROCHEM INT, V59, P168, DOI 10.1016/j.neuint.2011.04.008; Peggion C, 2011, BIOFACTORS, V37, P241, DOI 10.1002/biof.161; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Silvestrini MC, 1997, NAT MED, V3, P521, DOI 10.1038/nm0597-521; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Sonkina S, 2010, J PEPT SCI, V16, P342, DOI 10.1002/psc.1247; Sorgato MC, 2009, BIOCHEM BIOPH RES CO, V379, P171, DOI 10.1016/j.bbrc.2008.12.026; Stewart LA, 2008, NEUROLOGY, V70, P1272, DOI 10.1212/01.wnl.0000308955.25760.c2; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Thellung S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.21; Thellung S, 2002, NEUROBIOL DIS, V9, P69, DOI 10.1006/nbdi.2001.0461; Thellung S, 2007, ANN NY ACAD SCI, V1096, P258, DOI 10.1196/annals.1397.092; Thellung S, 2007, GLIA, V55, P1469, DOI 10.1002/glia.20559; Van Everbroeck B, 2004, ACTA NEUROPATHOL, V108, P194, DOI 10.1007/s00401-004-0879-2; Villa V, 2006, ANN NY ACAD SCI, V1090, P276, DOI 10.1196/annals.1378.030; Villa V, 2011, NEUROTOX RES, V19, P556, DOI 10.1007/s12640-010-9189-8; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Xiong J, 2002, J NEUROSCI, V22, P10761; Younan ND, 2011, J MOL BIOL, V410, P369, DOI 10.1016/j.jmb.2011.05.013; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	62	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38314	10.1371/journal.pone.0038314	http://dx.doi.org/10.1371/journal.pone.0038314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22811758	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400002
J	Niu, R; Yoshida, M; Ling, F				Niu, Rong; Yoshida, Minoru; Ling, Feng			Increases in Mitochondrial DNA Content and 4977-bp Deletion upon ATM/Chk2 Checkpoint Activation in HeLa Cells	PLOS ONE			English	Article							COPY NUMBER; RIBONUCLEOTIDE REDUCTASE; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; IN-VIVO; REPLICATION; RECOMBINATION; CYCLE; MUTATIONS; DAMAGE	Activation of the Mec1/Rad53 damage checkpoint pathway influences mitochondrial DNA (mtDNA) content and point mutagenesis in Saccharomyces cerevisiae. The effects of this conserved checkpoint pathway on mitochondrial genomes in human cells remain largely unknown. Here, we report that knockdown of the human DNA helicase RRM3 enhances phosphorylation of the cell cycle arrest kinase Chk2, indicating activation of the checkpoint via the ATM/Chk2 pathway, and increases mtDNA content independently of TFAM, a regulator of mtDNA copy number. Cell-cycle arrest did not have a consistent effect on mtDNA level: knockdown of cell cycle regulators PLK1 (polo-like kinase), MCM2, or MCM3 gave rise, respectively, to decreased, increased, or almost unchanged mtDNA levels. Therefore, we concluded that the mtDNA content increase upon RRM3 knockdown is not a response to delay of cell cycle progression. Also, we observed that RRM3 knockdown increased the levels of reactive oxygen species (ROS); two ROS scavengers, N-acetyl cysteine and vitamin C, suppressed the mtDNA content increase. On the other hand, in RRM3 knockdown cells, we detected an increase in the frequency of the common 4977-bp mtDNA deletion, a major mtDNA deletion that can be induced by abnormal ROS generation, and is associated with a decline in mitochondrial genome integrity, aging, and various mtDNA-related disorders in humans. These results suggest that increase of the mitochondrial genome by TFAM-independent mtDNA replication is connected, via oxidative stress, with the ATM/Chk2 checkpoint activation in response to DNA damage, and is accompanied by generation of the common 4977-bp deletion.	[Niu, Rong] RIKEN Adv Sci Inst, Chem Genet Lab, Wako, Saitama, Japan; JST, CREST, Wako, Saitama, Japan	RIKEN; Japan Science & Technology Agency (JST)	Niu, R (corresponding author), RIKEN Adv Sci Inst, Chem Genet Lab, Wako, Saitama, Japan.	ling@postman.riken.go.jp	Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674	Ministry of Education, Culture, Sports, Science and Technology of Japan [23510237]; JST-CREST	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (No.23510237) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to FL; and by a grant from the JST-CREST to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Aral C, 2010, GENET MOL BIOL, V33, P1, DOI 10.1590/S1415-47572009005000102; ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P; Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Enns GM, 2003, MOL GENET METAB, V80, P11, DOI 10.1016/j.ymgme.2003.08.009; Hori A, 2011, GENES CELLS, V16, P527, DOI 10.1111/j.1365-2443.2011.01504.x; Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Jahnke VE, 2009, AM J PHYSIOL-CELL PH, V296, pC1185, DOI 10.1152/ajpcell.00377.2008; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06; Ling F, 2009, J BIOL CHEM, V284, P9341, DOI 10.1074/jbc.M900023200; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; O'Rourke TW, 2005, GENE, V354, P86, DOI 10.1016/j.gene.2005.03.031; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Qiu JZ, 2001, J BIOL CHEM, V276, P4901, DOI 10.1074/jbc.M007825200; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SEKI S, 1987, CARCINOGENESIS, V8, P1391, DOI 10.1093/carcin/8.10.1391; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; WALLACE DC, 1994, EPILEPSIA, V35, pS43, DOI 10.1111/j.1528-1157.1994.tb05928.x; WALLACE DC, 1992, J INHERIT METAB DIS, V15, P472, DOI 10.1007/BF01799605; Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306; Xiong W, 2012, ACTA BIOCH BIOPH SIN, V44, P347, DOI 10.1093/abbs/gms006; Ylikallio E, 2010, NUCLEIC ACIDS RES, V38, P8208, DOI 10.1093/nar/gkq735; Zhou X, 2011, MITOCHONDRION, V11, P886, DOI 10.1016/j.mito.2011.07.005	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40572	10.1371/journal.pone.0040572	http://dx.doi.org/10.1371/journal.pone.0040572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808196	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500060
J	Inacio, A; Pinho, J; Pereira, PM; Comai, L; Coelho, MM				Inacio, Angela; Pinho, Joana; Pereira, Patricia Matos; Comai, Luca; Coelho, Maria Manuela			Global Analysis of the Small RNA Transcriptome in Different Ploidies and Genomic Combinations of a Vertebrate Complex - The Squalius alburnoides	PLOS ONE			English	Article							GENE-EXPRESSION; DOSAGE COMPENSATION; HYBRIDIZATION; MICRORNAS; EVOLUTION; BIOGENESIS; SENECIO; MODES; SHOCK; FISH	The Squalius alburnoides complex (Steindachner) is one of the most intricate hybrid polyploid systems known in vertebrates. In this complex, the constant switch of the genome composition in consecutive generations, very frequently involving a change on the ploidy level, promotes repetitive situations of potential genomic shock. Previously in this complex, it was showed that in response to the increase in genome dosage, triploids hybrids could regulate gene expression to a diploid state. In this work we compared the small RNA profiles in the different genomic compositions interacting in the complex in order to explore the miRNA involvement in gene expression regulation of triploids. Using high-throughput arrays and sequencing technologies we were able to verify that diploid and triploid hybrids shared most of their sequences and their miRNA expression profiles were high correlated. However, an overall view indicates an up-regulation of several miRNAs in triploids and a global miRNA expression in triploids higher than the predicted from an additive model. Those results point to a participation of miRNAs in the cellular functional stability needed when the ploidy change.	[Inacio, Angela; Pinho, Joana; Coelho, Maria Manuela] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal; [Pereira, Patricia Matos] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Pereira, Patricia Matos] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Comai, Luca] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Universidade de Lisboa; Universidade de Aveiro; Universidade de Aveiro; University of California System; University of California Davis; University of California System; University of California Davis	Inacio, A (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal.	mainacio@fc.ul.pt	Coelho, Maria M/B-8672-2009; Comai, Luca/F-4279-2010	Coelho, Maria M/0000-0003-3288-1693; Pereira, Patricia/0000-0002-4828-7632; Comai, Luca/0000-0003-2642-6619; Inacio, Angela/0000-0003-0396-6743	Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-BIC/110277/2009]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BIC/110277/2009] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by project PTDC/BIA-BIC/110277/2009 from Fundacao para a Ciencia e a Tecnologia-http://www.fct.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Crespo-Lopez ME, 2006, ZOOLOGY, V109, P277, DOI 10.1016/j.zool.2006.03.008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guo M, 1996, GENETICS, V142, P1349; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; Ha M, 2008, BBA-GENE REGUL MECH, V1779, P735, DOI 10.1016/j.bbagrm.2008.03.004; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Hegarty MJ, 2005, MOL ECOL, V14, P2493, DOI 10.1111/j.1365-294X.2005.02608.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inacio A, 2010, J FISH BIOL, V76, P1995, DOI 10.1111/j.1095-8649.2010.02637.x; Kenan-Eichler M, 2011, GENETICS, V188, P263, DOI 10.1534/genetics.111.128348; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Lu YL, 2010, BMB REP, V43, P635, DOI 10.3858/BMBRep.2010.43.9.635; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matos I, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-101; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Pala I, 2010, P ROY SOC B-BIOL SCI, V277, P3519, DOI 10.1098/rspb.2010.1071; Pala I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006401; Ribeiro F, 2003, ARCH HYDROBIOL, V156, P471, DOI 10.1127/0003-9136/2003/0156-0471; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Soares AR, 2012, TOXICOL SCI, V127, P18, DOI 10.1093/toxsci/kfs068; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711	34	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41158	10.1371/journal.pone.0041158	http://dx.doi.org/10.1371/journal.pone.0041158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815952	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900085
J	Sleimen-Malkoun, R; Temprado, JJ; Huys, R; Jirsa, V; Berton, E				Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Huys, Raoul; Jirsa, Viktor; Berton, Eric			Is Fitts' Law Continuous in Discrete Aiming?	PLOS ONE			English	Article							INFORMATION CAPACITY; TARGET WIDTH; MOVEMENT; DYNAMICS; COORDINATION; TASK; PERFORMANCE; MODEL	The lawful continuous linear relation between movement time and task difficulty (i.e., index of difficulty; ID) in a goal-directed rapid aiming task (Fitts' law) has been recently challenged in reciprocal performance. Specifically, a discontinuity was observed at critical ID and was attributed to a transition between two distinct dynamic regimes that occurs with increasing difficulty. In the present paper, we show that such a discontinuity is also present in discrete aiming when ID is manipulated via target width (experiment 1) but not via target distance (experiment 2). Fitts' law's discontinuity appears, therefore, to be a suitable indicator of the underlying functional adaptations of the neuro-muscular-skeletal system to task properties/requirements, independently of reciprocal or discrete nature of the task. These findings open new perspectives to the study of dynamic regimes involved in discrete aiming and sensori-motor mechanisms underlying the speed-accuracy trade-off.	[Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Berton, Eric] CNRS, UMR 7287, Inst Sci Mouvement EJ Marey, Marseille, France; [Sleimen-Malkoun, Rita; Temprado, Jean-Jacques; Berton, Eric] Aix Marseille Univ, Marseille, France; [Huys, Raoul; Jirsa, Viktor] Fac Med La Timone, INSERM, UMR 1106, Inst Neurosci Syst, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Sleimen-Malkoun, R (corresponding author), CNRS, UMR 7287, Inst Sci Mouvement EJ Marey, Marseille, France.	rita.sleimen-malkoun@univ-amu.fr	Jirsa, Viktor/M-4630-2016	Jirsa, Viktor/0000-0002-8251-8860; Sleimen-Malkoun, Rita/0000-0002-3508-3403	Aix-Marseille Universite	Aix-Marseille Universite	Support for this study was provided through a funded Ph.D. fellowship from Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIZZI E, 1992, BEHAV BRAIN SCI, V15, P808; Bootsma RJ, 2004, INT J HUM-COMPUT ST, V61, P811, DOI 10.1016/j.ijhcs.2004.09.004; Buchanan JJ, 2004, NEUROSCI LETT, V367, P317, DOI 10.1016/j.neulet.2004.06.028; Buchanan JJ, 2006, EXP BRAIN RES, V175, P710, DOI 10.1007/s00221-006-0589-1; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Davis NJ, 2008, EXP BRAIN RES, V188, P141, DOI 10.1007/s00221-008-1379-8; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; Fernandez L, 2008, ACTA PSYCHOL, V129, P217, DOI 10.1016/j.actpsy.2008.06.001; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Friedrich R, 1997, PHYS REV LETT, V78, P863, DOI 10.1103/PhysRevLett.78.863; Friedrich R, 1997, PHYSICA D, V102, P147, DOI 10.1016/S0167-2789(96)00235-7; GUIARD Y, 1993, ACTA PSYCHOL, V82, P139, DOI 10.1016/0001-6918(93)90009-G; Guiard Y, 1997, HUM MOVEMENT SCI, V16, P97, DOI 10.1016/S0167-9457(96)00045-0; Hoffmann E, 1981, P 9 NAT C I IND ENG, P34; Huys R, 2010, P ROY SOC B-BIOL SCI, V277, P1179, DOI 10.1098/rspb.2009.1954; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; LANGOLF GD, 1976, J MOTOR BEHAV, V8, P113, DOI 10.1080/00222895.1976.10735061; MacKenzie I. S., 1992, Human-Computer Interaction, V7, P91, DOI 10.1207/s15327051hci0701_3; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; Mottet D, 2001, J EXP PSYCHOL HUMAN, V27, P1275, DOI 10.1037//0096-1523.27.6.1275; Perdikis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016589; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; SALTZMAN E, 1987, PSYCHOL REV, V94, P84, DOI 10.1037/0033-295X.94.1.84; SCHONER G, 1990, BIOL CYBERN, V63, P257, DOI 10.1007/BF00203449; Shannon C. E., 1949, MATH THEORY COMMUNIC; TEASDALE N, 1993, J MOTOR BEHAV, V25, P97, DOI 10.1080/00222895.1993.9941644; van Mourik AM, 2006, BIOL CYBERN, V94, P233, DOI 10.1007/s00422-005-0041-9; Welford A.T., 1968, FUNDAMENTALS SKILL; Woodworth RS, 1988, PSYCHOL REV, V3, P1; Zaal FTJM, 2005, J EXP PSYCHOL HUMAN, V31, P1266, DOI 10.1037/0096-1523.31.6.1266; Zaal FTJM, 1999, J EXP PSYCHOL HUMAN, V25, P149, DOI 10.1037/0096-1523.25.1.149; Zaal FTJM, 1998, EXP BRAIN RES, V119, P427, DOI 10.1007/s002210050358	41	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41190	10.1371/journal.pone.0041190	http://dx.doi.org/10.1371/journal.pone.0041190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815965	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900093
J	Thomas, V; Gois, A; Ritts, B; Burke, P; Hanscheid, T; McDonnell, G				Thomas, Vincent; Gois, Ana; Ritts, Bruce; Burke, Peter; Haenscheid, Thomas; McDonnell, Gerald			A Novel Way to Grow Hemozoin-Like Crystals In Vitro and Its Use to Screen for Hemozoin Inhibiting Antimalarial Compounds	PLOS ONE			English	Article							PIGMENT BETA-HEMATIN; PLASMODIUM-FALCIPARUM; MALARIA PIGMENT; CREUTZFELDT-JAKOB; QUINOLINE DERIVATIVES; HEME CRYSTALLIZATION; MASS-SPECTROMETRY; DRUGS; ASSAY; POLYMERIZATION	Background: Hemozoin crystals are normally formed in vivo by Plasmodium parasites to detoxify free heme released after hemoglobin digestion during its intraerythrocytic stage. Inhibition of hemozoin formation by various drugs results in free heme concentration toxic for the parasites. As a consequence, in vitro assays have been developed to screen and select candidate antimalarial drugs based on their capacity to inhibit hemozoin formation. In this report we describe new ways to form hemozoin-like crystals that were incidentally discovered during research in the field of prion inactivation. Methods: We investigated the use of a new assay based on naturally occurring "self-replicating" particles and previously described as presenting resistance to decontamination comparable to prions. The nature of these particles was determined using electron microscopy, Maldi-Tof analysis and X-ray diffraction. They were compared to synthetic hemozoin and to hemozoin obtained from Plasmodium falciparum. We then used the assay to evaluate the capacity of various antimalarial and anti-prion compounds to inhibit "self-replication" (crystallisation) of these particles. Results: We identified these particles as being similar to ferriprotoporphyrin IX crystal and confirmed the ability of these particles to serve as nuclei for growth of new hemozoin-like crystals (HLC). HLC are morphologically similar to natural and synthetic hemozoin. Growth of HLC in a simple assay format confirmed inhibition by quinolines antimalarials at potencies described in the literature. Interestingly, artemisinins and tetracyclines also seemed to inhibit HLC growth. Conclusions: The described HLC assay is simple and easy to perform and may have the potential to be used as an additional tool to screen antimalarial drugs for their hemozoin inhibiting activity. As already described by others, drugs that inhibit hemozoin crystal formation have also the potential to inhibit misfolded proteins assemblies formation.	[Thomas, Vincent] STERIS SA R&D, Fontenay Aux Roses, France; [Gois, Ana; Haenscheid, Thomas] Fac Med Lisbon, Inst Med Mol, Unidade Microbiol Mol & Infeccao, Lisbon, Portugal; [Ritts, Bruce] STERIS Corp, St Louis, MO USA; [Burke, Peter] STERIS Corp, Mentor, OH USA; [McDonnell, Gerald] STERIS Ltd, Basingstoke, Hants, England	Universidade de Lisboa; Steris Corporation; Steris Corporation	Thomas, V (corresponding author), STERIS SA R&D, Fontenay Aux Roses, France.	peter_burke@steris.com	Thomas, Vincent/AAB-6394-2022; Thomas, Vincent/AAB-8982-2019; Thomas, Vincent/A-8941-2012; Hanscheid, Thomas/AAT-3639-2021	Thomas, Vincent/0000-0003-4034-9525; Thomas, Vincent/0000-0003-4034-9525; Hanscheid, Thomas/0000-0001-6353-9132; Gois, Ana/0000-0001-7527-0927	Direction Generale des Entreprises under the French competitiveness cluster Medicen Region Ile-de-France [072906389]; Fundacao para a Ciencia e Tecnologia [PIC/IC/83214/2007]	Direction Generale des Entreprises under the French competitiveness cluster Medicen Region Ile-de-France(Region Ile-de-France); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially funded by the Direction Generale des Entreprises (convention no 072906389) under the French competitiveness cluster Medicen Region Ile-de-France (web site: http://www.medicen.org). This work was partially funded (characterization of the different types of hemozoin) by the Fundacao para a Ciencia e Tecnologia (PIC/IC/83214/2007, web site: http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basilico N, 1998, J ANTIMICROB CHEMOTH, V42, P55, DOI 10.1093/jac/42.1.55; BURDON DW, 1989, J MED MICROBIOL, V29, P145, DOI 10.1099/00222615-29-2-145; Burdon DW, 1999, LANCET, V353, P1271, DOI 10.1016/S0140-6736(05)66945-0; Burdon DW, 1996, J MED MICROBIOL, V45, P10, DOI 10.1099/00222615-45-1-10; Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0; Coban C, 2002, INFECT IMMUN, V70, P3939, DOI 10.1128/IAI.70.7.3939-3943.2002; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Demirev PA, 2002, ANAL CHEM, V74, P3262, DOI 10.1021/ac025621k; Dolphin GT, 2008, CHEMBIOCHEM, V9, P952, DOI 10.1002/cbic.200700602; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; DYAS AC, 1990, J HOSP INFECT, V15, P265, DOI 10.1016/0195-6701(90)90034-L; European Parliament, 2008, REG EC 1272 2008 CLA; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Frita R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-74; Haynes RK, 2003, ANTIMICROB AGENTS CH, V47, P1175, DOI 10.1128/AAC.47.3.1175.2003; Huy NT, 2007, ANTIMICROB AGENTS CH, V51, P350, DOI 10.1128/AAC.00985-06; Jaramillo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006957; Klingenstein R, 2006, J MED CHEM, V49, P5300, DOI 10.1021/jm0602763; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Krishna S, 2010, TRENDS PARASITOL, V26, P517, DOI 10.1016/j.pt.2010.06.014; Larramendy-Gozalo C, 2007, J GEN VIROL, V88, P1062, DOI 10.1099/vir.0.82286-0; Mullie C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-65; Munoz-Durango K, 2012, ANAL CHEM, V84, P3324, DOI 10.1021/ac300065t; Murakami-Kubo I, 2004, J VIROL, V78, P1281, DOI 10.1128/JVI.78.3.1281-1288.2004; Ncokazi KK, 2005, ANAL BIOCHEM, V338, P306, DOI 10.1016/j.ab.2004.11.022; Niles JC, 2009, P NATL ACAD SCI USA, V106, P13266, DOI 10.1073/pnas.0906370106; Omodeo-Sale F, 2009, ANTIMICROB AGENTS CH, V53, P4339, DOI 10.1128/AAC.00536-09; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Parapini S, 2000, EXP PARASITOL, V96, P249, DOI 10.1006/expr.2000.4583; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Ramya TNC, 2007, ANTIMICROB AGENTS CH, V51, P307, DOI 10.1128/AAC.00808-06; Rodrigues JR, 2007, EXP PARASITOL, V115, P19, DOI 10.1016/j.exppara.2006.05.002; Sandlin RD, 2011, ANTIMICROB AGENTS CH, V55, P3363, DOI 10.1128/AAC.00121-11; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Solomonov I, 2007, J AM CHEM SOC, V129, P2615, DOI 10.1021/ja0674183; Thompson MJ, 2012, CHEMMEDCHEM, V7, P578, DOI 10.1002/cmdc.201200002; Trang DTX, 2006, ANAL BIOCHEM, V349, P292, DOI 10.1016/j.ab.2005.11.022; Vennerstrom JL, 1999, ANTIMICROB AGENTS CH, V43, P598, DOI 10.1128/AAC.43.3.598; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t	40	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41006	10.1371/journal.pone.0041006	http://dx.doi.org/10.1371/journal.pone.0041006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815894	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900066
J	Rocha, MGD; Faria, FL; Goncalves, L; Souza, MDM; Fernandes, PA; Fernandes, AP				de Lima Rocha, Maria Gabrielle; Faria, Fabio Lopes; Goncalves, Leonor; Souza, Maria do Carmo M.; Fernandes, Paula Avila; Fernandes, Ana Paula			Prevalence of DNA-HPV in Male Sexual Partners of HPV-Infected Women and Concordance of Viral Types in Infected Couples	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; POLYMERASE-CHAIN-REACTION; FLAT PENILE LESIONS; YOUNG-WOMEN; MEN; CYTOLOGY; EPIDEMIOLOGY; DISEASE; CANCER	Investigation of HPV infection in men remains important due to its association with genital warts and anorectal cancer, as well as to the role men play in HPV transmission to their female sexual partners. Asymptomatic men (n = 43), whose sexual partners had presented cervical HPV infection, were enrolled in this study. Among the 43 men, 23 had their female partner included and tested for HPV-DNA, totaling 23 couples. HPV-DNA was detected by PCR. Type specific PCR to detect HPV 16, 18, 31, 33, 45 and 6/11 was performed. At least one type of HPV was detected in 86.0% (37/43) of the male patients and more than one HPV type was identified in 39.5% (17/43) of the samples, including high and low risk HPV. HPV-16 proved to be the most prevalent viral type in both male and female samples. Concordance of at least one viral type was observed in 56.5% (13/23) of the couples. Among couples that have shown concordance of viral types, 84.6% (11/13) of the men had the same high risk viral type presented by the female sexual partner. These data suggest that HPV infected men is an important reservoir, contributing to a higher transmission to women and maintenance of infection, and consequently, a higher risk of developing cervical cancer. HPV vaccination in men will protect not only them but will also have implications for their sexual partners.	[de Lima Rocha, Maria Gabrielle; Faria, Fabio Lopes; Fernandes, Paula Avila; Fernandes, Ana Paula] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil; [Goncalves, Leonor; Souza, Maria do Carmo M.] Ctr Sexually Transmitted Dis Cent S Dist City Hal, Cent S Polyclin, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Rocha, MGD (corresponding author), Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil.	pavilafernandes@gmail.com	de Lima Rocha, Maria Gabrielle/F-6027-2013; de+Lima+Rocha, Maria Gabrielle/ABG-7667-2020	de+Lima+Rocha, Maria Gabrielle/0000-0002-8033-593X				Bleeker MCG, 2005, BRIT J CANCER, V92, P1388, DOI 10.1038/sj.bjc.6602524; Bleeker MCG, 2005, INT J CANCER, V113, P36, DOI 10.1002/ijc.20502; Bleeker MCG, 2002, J AM ACAD DERMATOL, V47, P351, DOI 10.1067/mjd.2002.122198; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; Rocha MGD, 2008, CANCER CYTOPATHOL, V114, P489, DOI 10.1002/cncr.23947; Depuydt CE, 2003, BRIT J CANCER, V88, P560, DOI 10.1038/sj.bjc.6600756; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194; Giraldo PC, 2008, EUR J OBSTET GYN R B, V137, P88, DOI 10.1016/j.ejogrb.2006.12.026; Giraldo Paulo C., 2006, Braz J Infect Dis, V10, P232, DOI 10.1590/S1413-86702006000400002; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Grce M, 1997, EUR J EPIDEMIOL, V13, P645, DOI 10.1023/A:1007323405069; Hernandez BY, 2008, EMERG INFECT DIS, V14, P888, DOI 10.3201/eid1406.070616; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Huang LW, 2004, J CLIN VIROL, V29, P271, DOI 10.1016/S1386-6532(03)00167-7; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Ishibashi MA, 2008, SALUD PUBLICA MEXICO, V50, P408, DOI 10.1590/s0036-36342008000500014; Jin FY, 2011, VACCINE, V29, P2322, DOI 10.1016/j.vaccine.2011.01.015; Munoz N, 1996, Bull Pan Am Health Organ, V30, P362; Nicolau SM, 2005, UROLOGY, V65, P251, DOI 10.1016/j.urology.2004.09.031; Parada R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-25; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Ramanakumar AV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-326; Reiter PL, 2010, CANCER EPIDEM BIOMAR, V19, P2916, DOI 10.1158/1055-9965.EPI-10-0576; Rombaldi RL, 2006, BRAZ J MED BIOL RES, V39, P177, DOI 10.1590/S0100-879X2006000200003; Rosenblatt C, 2004, INT J GYNECOL OBSTET, V84, P156, DOI 10.1016/j.ijgo.2003.08.008; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Taner MZ, 2006, INT J GYNECOL CANCER, V16, P791, DOI 10.1111/j.1525-1438.2006.00376.x; Teixeira Júlio César, 2002, Rev. Bras. Ginecol. Obstet., V24, P315, DOI 10.1590/S0100-72032002000500005; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Widdice LE, 2010, J ADOLESCENT HEALTH, V47, P151, DOI 10.1016/j.jadohealth.2010.01.006	34	28	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40988	10.1371/journal.pone.0040988	http://dx.doi.org/10.1371/journal.pone.0040988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815888	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000049
J	Yamaguchi, K; Shiozaki, K; Moriya, S; Koseki, K; Wada, T; Tateno, H; Sato, I; Asano, M; Iwakura, Y; Miyagi, T				Yamaguchi, Kazunori; Shiozaki, Kazuhiro; Moriya, Setsuko; Koseki, Koichi; Wada, Tadashi; Tateno, Hiroo; Sato, Ikuro; Asano, Masahide; Iwakura, Yoichiro; Miyagi, Taeko			Reduced Susceptibility to Colitis-Associated Colon Carcinogenesis in Mice Lacking Plasma Membrane-Associated Sialidase	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; NF-KAPPA-B; GANGLIOSIDE SIALIDASE; MOLECULAR-CLONING; CRUCIAL ROLE; EXPRESSION; CANCER; NEU3; CELLS; INFLAMMATION	Sialic acids are acidic monosaccharides that bind to the sugar chains of glycoconjugates and change their conformation, intermolecular interactions, and/or half-life. Thus, sialidases are believed to modulate the function of sialoglycoconjugates by desialylation. We previously reported that the membrane-associated mammalian sialidase NEU3, which preferentially acts on gangliosides, is involved in cell differentiation, motility, and tumorigenesis. The NEU3 gene expression is aberrantly elevated in several human cancers, including colon, renal, prostate, and ovarian cancers. The small interfering RNA-mediated knock-down of NEU3 in cancer cell lines, but not in normal cell-derived primary cultures, downregulates EGFR signaling and induces apoptosis. Here, to investigate the physiological role of NEU3 in tumorigenesis, we established Neu3-deficient mice and then subjected them to carcinogen-induced tumorigenesis, using a sporadic and a colitis-associated colon cancer models. The Neu3-deficient mice showed no conspicuous accumulation of gangliosides in the brain or colon mucosa, or overt abnormalities in their growth, development, behavior, or fertility. In dimethylhydrazine-induced colon carcinogenesis, there were no differences in the incidence or growth of tumors between the Neu3-deficient and wild-type mice. On the other hand, the Neu3-deficient mice were less susceptible than wild-type mice to the colitis-associated colon carcinogenesis induced by azoxymethane and dextran sodium sulfate. These results suggest that NEU3 plays an important role in inflammation-dependent tumor development.	[Yamaguchi, Kazunori; Koseki, Koichi] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Marine Biochem Lab, Kagoshima 890, Japan; [Moriya, Setsuko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Div Canc Glycosylat Res, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Wada, Tadashi; Sato, Ikuro] Miyagi Canc Ctr, Res Inst, Div Pathol, Natori, Miyagi 9811293, Japan; [Tateno, Hiroo] Surg Pathol Japan Inc, Sendai, Miyagi, Japan; [Asano, Masahide] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan	Miyagi Cancer Center; Kagoshima University; Tohoku Medical & Pharmaceutical University; Miyagi Cancer Center; Kanazawa University; University of Tokyo	Yamaguchi, K (corresponding author), Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, 47-1 Aza Nodayama, Natori, Miyagi 9811293, Japan.	kyamaguchi@med.tohoku.ac.jp	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology in Japan [21570122]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp) #21570122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1962, CANCER RES, V22, P525; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Auger KR, 2000, BIOCHEM BIOPH RES CO, V272, P822, DOI 10.1006/bbrc.2000.2806; Aureli M, 2011, J NEUROCHEM, V116, P891, DOI 10.1111/j.1471-4159.2010.07019.x; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bird RP, 2000, TOXICOL LETT, V112, P395, DOI 10.1016/S0378-4274(99)00261-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P583, DOI 10.1007/s10719-010-9302-5; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020859; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hata K, 1998, J BIOCHEM-TOKYO, V123, P899; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Katoh S, 1999, J IMMUNOL, V162, P5058; Katoh S, 2010, CLIN EXP IMMUNOL, V161, P233, DOI 10.1111/j.1365-2249.2010.04165.x; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2007, COMPREHENSIVE GLYCOS, P297; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Proshin S, 2002, NEUROCHEM RES, V27, P841, DOI 10.1023/A:1020269326825; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Schauer R, 1995, BIOL SIALIC ACIDS, DOI [10.1007/978-1-4757-9504-2, DOI 10.1007/978-1-4757-9504-2]; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; STEINMANN KE, 1991, P NATL ACAD SCI USA, V88, P6843, DOI 10.1073/pnas.88.15.6843; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; TUDEK B, 1989, CANCER RES, V49, P1236; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang P, 2004, BIOCHEM J, V380, P425, DOI 10.1042/BJ20031896; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Witz IP, 2008, ADV CANCER RES, V100, P203, DOI 10.1016/S0065-230X(08)00007-9; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531	61	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41132	10.1371/journal.pone.0041132	http://dx.doi.org/10.1371/journal.pone.0041132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815940	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000071
J	Yang, NW; Ji, LL; Lovei, GL; Wan, FH				Yang, Nian-Wan; Ji, Lu-Lu; Lovei, Gabor L.; Wan, Fang-Hao			Shifting Preference between Oviposition vs. Host-Feeding under Changing Host Densities in Two Aphelinid Parasitoids	PLOS ONE			English	Article							TABACI BIOTYPE-B; BEMISIA-TABACI; DIFFERENT INSTARS; HYMENOPTERA; BEHAVIOR; STRATEGIES; HOMOPTERA; SUITABILITY; EVOLUTION	Destructive host-feeding is common in hymenopteran parasitoids. Such feeding may be restricted to host stages not preferred for oviposition. However, whether this is a fixed strategy or can vary according to resource levels or parasitoid needs is less clear. We tested the trade-off between host feeding and oviposition on two whitefly parasitoids under varying host densities. Females of two aphelinid parasitoids, Eretmocerus hayati and Encarsia sophia were exposed to nine different densities of their whitefly host, Bemisia tabaci, in single-instar tests to identify their functional response. Mixed-instar host choice tests were also conducted by exposing whiteflies at four densities to the parasitoids. We hypothesized that the parasitoid females can detect different host densities, and decide on oviposition vs. host-feeding accordingly. The results showed that both Er. hayati and En. sophia females tended to increase both oviposition and host-feeding with increased host density within a certain range. Oviposition reached a plateau at lower host density than host-feeding in Er. hayati, while En. sophia reached its oviposition plateau at higher densities. At low densities, Er. hayati parasitized most on first and second (the optimal ones), and fed most on third nymphal instars (the suboptimal one) of the whitefly host as theory predicts, while at high densities, both parasitism and host-feeding occurred on first and second instars which are preferred for oviposition. En. sophia parasitized most on third and fourth (the optimal ones), while fed on first instars (the suboptimal one) at low densities, and utilized third and fourth instars for both at high densities. In conclusion, oviposition vs. host-feeding strategy of parasitoid females was found to vary at different host densities. The balance between reserving optimal hosts for oviposition or using them for host-feeding depended on parasitoid life history and the availability of host resources.	[Yang, Nian-Wan; Ji, Lu-Lu; Lovei, Gabor L.; Wan, Fang-Hao] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Lovei, Gabor L.] Aarhus Univ, Dept Agroecol, Flakkebjerg, Denmark	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Aarhus University	Yang, NW (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	wanfh@caas.net.cn	Yang, Nianwan/AAH-7371-2019; Lövei, Gabor L./B-7763-2008	Yang, Nianwan/0000-0002-6014-3383; Lövei, Gabor L./0000-0002-6467-9812	National Natural Science Foundation of China [30930062]; National Basic Research and Development Program of China [2009CB119200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	The research was financially supported by the National Natural Science Foundation of China (30930062) and the National Basic Research and Development Program of China (2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI B, 1990, ECOL ENTOMOL, V15, P9, DOI 10.1111/j.1365-2311.1990.tb00778.x; Burger JMS, 2004, OIKOS, V106, P117, DOI 10.1111/j.0030-1299.2004.12908.x; CHAN MS, 1993, EVOL ECOL, V7, P593, DOI 10.1007/BF01237823; COLLIER TR, 1995, ANN ENTOMOL SOC AM, V88, P206, DOI 10.1093/aesa/88.2.206; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Gerling D, 2004, ENTOMOL EXP APPL, V110, P87, DOI 10.1111/j.0013-8703.2004.00125.x; Gerling D, 2001, CROP PROT, V20, P779, DOI 10.1016/S0261-2194(01)00111-9; Giorgini M, 2004, BIOL CONTROL, V30, P25, DOI 10.1016/j.biocontrol.2003.09.013; Giron D, 2004, PHYSIOL ENTOMOL, V29, P436, DOI 10.1111/j.0307-6962.2004.00414.x; Heimpel GE, 1996, BIOL REV, V71, P373, DOI 10.1111/j.1469-185X.1996.tb01279.x; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; KIDD NAC, 1991, RES POPUL ECOL, V33, P87, DOI 10.1007/BF02514576; Lauziere I, 1999, ENTOMOL EXP APPL, V92, P21, DOI 10.1023/A:1003745606862; Le Lann C, 2011, FUNCT ECOL, V25, P641, DOI 10.1111/j.1365-2435.2010.01813.x; McAuslane HJ, 1996, ANN ENTOMOL SOC AM, V89, P686, DOI 10.1093/aesa/89.5.686; ROSENHEIM JA, 1992, ECOL ENTOMOL, V17, P263, DOI 10.1111/j.1365-2311.1992.tb01057.x; Tran TV, 2000, APPL ENTOMOL ZOOL, V35, P549, DOI 10.1303/aez.2000.549; Urbaneja A, 2004, BIOCONTROL, V49, P153, DOI 10.1023/B:BICO.0000017365.37010.e0; van Alphen JJM, 1976, B OILB SROP, V4, P165; Videllet P., 1997, IOBC-WPRS Bulletin, V20, P147; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Yang NW, 2011, BIOL CONTROL, V59, P313, DOI 10.1016/j.biocontrol.2011.07.019; Zang LS, 2008, ENTOMOL EXP APPL, V127, P55, DOI 10.1111/j.1570-7458.2008.00667.x; Zang LS, 2007, BIOL CONTROL, V41, P142, DOI 10.1016/j.biocontrol.2007.01.009; Zang LS, 2011, INSECT SCI, V18, P78, DOI 10.1111/j.1744-7917.2010.01382.x; Zang LS, 2009, BIOCONTROL SCI TECHN, V19, P573, DOI 10.1080/09583150902912673; Zolnerowich G, 1998, P ENTOMOL SOC WASH, V100, P310	28	24	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41189	10.1371/journal.pone.0041189	http://dx.doi.org/10.1371/journal.pone.0041189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815964	gold, Green Published			2022-12-27	WOS:000306507000077
J	Srivastava, MK; Zhu, L; Harris-White, M; Kar, U; Huang, M; Johnson, MF; Lee, JM; Elashoff, D; Strieter, R; Dubinett, S; Sharma, S				Srivastava, Minu K.; Zhu, Li; Harris-White, Marni; Kar, Upendra; Huang, Min; Johnson, Ming F.; Lee, Jay M.; Elashoff, David; Strieter, Robert; Dubinett, Steven; Sharma, Sherven			Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; MHC CLASS-I; BONE-MARROW; DENDRITIC CELLS; NK CELLS; ANTIGEN; TOLERANCE; INDUCTION; MECHANISM; ANERGY	Background: Myeloid derived suppressor cells (MDSC) are important regulators of immune responses. We evaluated the mechanistic role of MDSC depletion on antigen presenting cell (APC), NK, T cell activities and therapeutic vaccination responses in murine models of lung cancer. Principal Findings: Individual antibody mediated depletion of MDSC (anti-Gr1 or anti-Ly6G) enhanced the antitumor activity against lung cancer. In comparison to controls, MDSC depletion enhanced the APC activity and increased the frequency and activity of the NK and T cell effectors in the tumor. Compared to controls, the anti-Gr1 or anti-Ly6G treatment led to increased: (i) CD8 T cells, (ii) NK cells, (iii) CD8 T or NK intracytoplasmic expression of IFN gamma, perforin and granzyme (iv) CD3 T cells expressing the activation marker CD107a and CXCR3, (v) reduced CD8 T cell IL-10 production in the tumors (vi) reduced tumor angiogenic (VEGF, CXCL2, CXCL5, and Angiopoietin1& 2) but enhanced anti-angiogenic (CXCL9 and CXCL10) expression and (vii) reduced tumor staining of endothelial marker Meca 32. Immunocytochemistry of tumor sections showed reduced Gr1 expressing cells with increased CD3 T cell infiltrates in the anti-Gr1 or anti-Ly6G groups. MDSC depletion led to a marked inhibition in tumor growth, enhanced tumor cell apoptosis and reduced migration of the tumors from the primary site to the lung compared to controls. Therapeutic vaccination responses were enhanced in vivo following MDSC depletion with 50% of treated mice completely eradicating established tumors. Treated mice that rejected their primary tumors acquired immunological memory against a secondary tumor challenge. The remaining 50% of mice in this group had 20 fold reductions in tumor burden compared to controls. Significance: Our data demonstrate that targeting MDSC can improve antitumor immune responses suggesting a broad applicability of combined immune based approaches against cancer. This multifaceted approach may prove useful against tumors where MDSC play a role in tumor immune evasion.	[Srivastava, Minu K.; Zhu, Li; Lee, Jay M.; Elashoff, David; Dubinett, Steven; Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Lung Canc Res Program, Dept Med, Los Angeles, CA 90095 USA; [Lee, Jay M.; Elashoff, David; Dubinett, Steven; Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Kar, Upendra] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Srivastava, Minu K.; Zhu, Li; Harris-White, Marni; Huang, Min; Johnson, Ming F.; Dubinett, Steven; Sharma, Sherven] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Gene Med Lab, Los Angeles, CA USA; [Strieter, Robert] Univ Virginia, Dept Med, Charlottesville, VA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Virginia	Srivastava, MK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Lung Canc Res Program, Dept Med, Los Angeles, CA 90095 USA.	ssharma@mednet.ucla.edu	Kar, Upendra K/H-5250-2012	Kar, Upendra K/0000-0003-4065-0860	University of California Los Angeles Lung Cancer Program; Department of Veterans Affairs Medical Research Funds; National Institutes of Health (NIH) [RO1 CA95686, RO1 CA126944, P50 CA90388]; National Center for Advancing Translational Sciences [UL1TR000124]; Tobacco Related Disease Program Award Program of University of California [15RT-0207, 20FT0082]; NATIONAL CANCER INSTITUTE [P50CA090388, R01CA126944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	University of California Los Angeles Lung Cancer Program; Department of Veterans Affairs Medical Research Funds(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Tobacco Related Disease Program Award Program of University of California; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the University of California Los Angeles Lung Cancer Program, Department of Veterans Affairs Medical Research Funds, National Institutes of Health (NIH) Grants (RO1 CA95686, RO1 CA126944 and P50 CA90388), National Center for Advancing Translational Sciences, Grant UL1TR000124, and Tobacco Related Disease Program Award Program of University of California (15RT-0207 and 20FT0082). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; ANGULO L, 1995, J IMMUNOL, V155, P15; BEVAN MJ, 1995, J EXP MED, V182, P639, DOI 10.1084/jem.182.3.639; BROOKS JC, 1994, TRANSPLANTATION, V58, P1096, DOI 10.1097/00007890-199411270-00007; Butts C, 2005, J CLIN ONCOL, V23, P6674, DOI 10.1200/JCO.2005.13.011; Chouaib S, 1997, IMMUNOL TODAY, V18, P493, DOI 10.1016/S0167-5699(97)01115-8; Cuenca A, 2003, CANCER RES, V63, P9007; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich D, 2003, CURR DRUG TARGETS, V4, P525, DOI 10.2174/1389450033490849; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kusmartsev SA, 1998, ADV EXP MED BIOL, V451, P189; KUSMARTSEV SA, 1989, EKSP ONKOL, V11, P23; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; MCADAM AJ, 1995, CELL IMMUNOL, V165, P183, DOI 10.1006/cimm.1995.1204; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; SCHMIDTWOLF IGH, 1992, BLOOD, V80, P3242; SEUNG LP, 1995, P NATL ACAD SCI USA, V92, P6254, DOI 10.1073/pnas.92.14.6254; Sharma S, 1999, J IMMUNOL, V163, P5020; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shen ZH, 1997, J IMMUNOL, V158, P2723; Smyth MJ, 2001, TRENDS IMMUNOL, V22, P409, DOI 10.1016/S1471-4906(01)01977-9; Sotomayor EM, 2001, BLOOD, V98, P1070, DOI 10.1182/blood.V98.4.1070; Srivastava MK, 2012, IMMUNOTHERAPY-UK, V4, P291, DOI [10.2217/IMT.11.178, 10.2217/imt.11.178]; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; SUBIZA JL, 1989, INT J CANCER, V44, P307, DOI 10.1002/ijc.2910440220; SUGIURA K, 1988, P NATL ACAD SCI USA, V85, P4824, DOI 10.1073/pnas.85.13.4824; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Young MRI, 1997, J IMMUNOL, V159, P990; Young MRI, 1996, J IMMUNOL, V156, P1916; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	40	140	144	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40677	10.1371/journal.pone.0040677	http://dx.doi.org/10.1371/journal.pone.0040677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815789	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100054
J	Stampar, SN; Maronna, MM; Vermeij, MJA; Silveira, FLD; Morandini, AC				Stampar, Sergio N.; Maronna, Maximiliano M.; Vermeij, Mark J. A.; Silveira, Fabio L. D.; Morandini, Andre C.			Evolutionary Diversification of Banded Tube-Dwelling Anemones (Cnidaria; Ceriantharia; Isarachnanthus) in the Atlantic Ocean	PLOS ONE			English	Article							MOLECULAR EVIDENCE; SEQUENCE EVOLUTION; PHYLUM CNIDARIA; MITOCHONDRIAL; DISPERSAL; ANTHOZOA; MIOCENE; SPECIATION; PRIMERS; ISTHMUS	The use of molecular data for species delimitation in Anthozoa is still a very delicate issue. This is probably due to the low genetic variation found among the molecular markers (primarily mitochondrial) commonly used for Anthozoa. Ceriantharia is an anthozoan group that has not been tested for genetic divergence at the species level. Recently, all three Atlantic species described for the genus Isarachnanthus of Atlantic Ocean, were deemed synonyms based on morphological simmilarities of only one species: Isarachnanthus maderensis. Here, we aimed to verify whether genetic relationships (using COI, 16S, ITS1 and ITS2 molecular markers) confirmed morphological affinities among members of Isarachnanthus from different regions across the Atlantic Ocean. Results from four DNA markers were completely congruent and revealed that two different species exist in the Atlantic Ocean. The low identification success and substantial overlap between intra and interspecific COI distances render the Anthozoa unsuitable for DNA barcoding, which is not true for Ceriantharia. In addition, genetic divergence within and between Ceriantharia species is more similar to that found in Medusozoa (Hydrozoa and Scyphozoa) than Anthozoa and Porifera that have divergence rates similar to typical metazoans. The two genetic species could also be separated based on micromorphological characteristics of their cnidomes. Using a specimen of Isarachnanthus bandanensis from Pacific Ocean as an outgroup, it was possible to estimate the minimum date of divergence between the clades. The cladogenesis event that formed the species of the Atlantic Ocean is estimated to have occured around 8.5 million years ago (Miocene) and several possible speciation scenarios are discussed.	[Stampar, Sergio N.; Silveira, Fabio L. D.; Morandini, Andre C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Maronna, Maximiliano M.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Vermeij, Mark J. A.] Carmabi Fdn, Willemstad, Curacao, Netherlands; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Amsterdam	Stampar, SN (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	sergiostampar@gmail.com	Vermeij, Mark/B-2752-2013; Morandini, André Carrara/A-9892-2012; Vermeij, Mark/AAR-6757-2020; Fapesp, Biota/F-8655-2017; Morandini, Andre Carrara/AAC-2320-2020; Maronna, Maximiliano/AAY-6734-2020; Stampar, Sergio N/K-2334-2012; Stampar, Sergio N/C-3193-2014; Stampar, Sergio N/AAC-2019-2020; Maronna, Maximiliano M/G-9432-2016	Vermeij, Mark/0000-0001-9612-9527; Morandini, André Carrara/0000-0003-3747-8748; Vermeij, Mark/0000-0001-9612-9527; Fapesp, Biota/0000-0002-9887-8449; Morandini, Andre Carrara/0000-0003-3747-8748; Maronna, Maximiliano/0000-0002-2590-639X; Stampar, Sergio N/0000-0002-9782-1619; Stampar, Sergio N/0000-0002-9782-1619; Stampar, Sergio N/0000-0002-9782-1619; Maronna, Maximiliano M/0000-0002-2590-639X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia (Instituto de Biociencias Universidade de Sao Paulo (IBUSP); FAPESP [2012/01771-8, 2006/56211-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50174-7]; CAPES PROEX	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia (Instituto de Biociencias Universidade de Sao Paulo (IBUSP); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES PROEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SNS was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia (Instituto de Biociencias Universidade de Sao Paulo (IBUSP) and FAPESP 2012/01771-8. Part of this work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2010/50174-7 and CAPES PROEX to ACM, and FAPESP 2006/56211-6 to MMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna FH, 2003, ZOOL ANZ, V242, P75, DOI 10.1078/0044-5231-00088; [Anonymous], 1963, ANIMAL SPECIES EVOLU; ARNAULT S, 1987, J GEOPHYS RES-OCEANS, V92, P5076, DOI 10.1029/JC092iC05p05076; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; Bird CE, 2012, EVOL BIOL, V39, P158, DOI 10.1007/s11692-012-9183-6; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Bruun P, 2005, PORT COASTAL ENG DEV; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Carlgren O., 1924, Videnskabelige Meddelelser Nat For Kjobenhavn, V75, P169; Carlgren O, 1912, DANISH INGOLF EXPEDI, V5, P1; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Claremont M, 2011, J BIOGEOGR, V38, P1016, DOI 10.1111/j.1365-2699.2011.02482.x; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins Allen G., 2011, Zootaxa, V2753, P53; Coyne J.A., 2004, SPECIATION; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Daly M, 2010, INTEGR COMP BIOL, V50, P371, DOI 10.1093/icb/icq081; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; de Paula TS, 2012, MOL PHYLOGENET EVOL, V62, P529, DOI 10.1016/j.ympev.2011.11.001; den Hartog J.C., 1977, ZOOLOGISCHE MEDEDELI, V51, P211, DOI DOI 10.1016/B978-0-12-345320-4.50030-4; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dominguez J.M.L., 1983, REV BRASILEIRA GEOCI, V13, P98, DOI DOI 10.25249/0375-7536.198313298105; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2002, GENETICS, V161, P1307; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forster A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001349; Frey MA, 2010, J BIOGEOGR, V37, P1515, DOI 10.1111/j.1365-2699.2010.02283.x; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; GORDON ARNOLD L., 1966, DEEP SEA RES OCEANOGR ABSTR, V13, P1125, DOI 10.1016/0011-7471(66)90704-2; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; HEDGECOCK D, 1986, B MAR SCI, V39, P550; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; HODELL DA, 1986, NATURE, V320, P411, DOI 10.1038/320411a0; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lee KM, 2012, MARINE BIOL IN PRESS; Lunt DJ, 2008, CLIM DYNAM, V30, P1, DOI 10.1007/s00382-007-0265-6; Marshall LG, 1996, SCIENCE, V273, P123; Molnar P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001574; Molodtsova T.N., 2003, Zoologische Verhandelingen (Leiden), V345, P249; Molodtsova TN, 2011, AFR NAT HIST, V7, P1; Nei M., 2000, MOL EVOLUTION PHYLOG; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Norris RD, 2011, EVOLUTIONAR IN PRESS; Perez LM, 2010, MALACOLOGIA, V53, P61, DOI 10.4002/040.053.0104; Reimer JD, 2010, CAH BIOL MAR, V51, P451; Reimer JD, 2004, ZOOL SCI, V21, P517, DOI 10.2108/zsj.21.517; RKP KIKUCHI, 2002, SITIOS GEOLOGICOS PA, V1, P379; Rodriguez CS, 2011, ZOOTAXA, P49, DOI 10.11646/zootaxa.2971.1.5; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Soares MO, 2011, GEST COSTEIRA INTEG, V11, P149; Song JI, 1997, KOREAN J BIOL SCI, P43; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Beneden E, 1897, ERGEBNISSE PLANKTON, V2, P1; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh FP, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P421; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x	70	31	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41091	10.1371/journal.pone.0041091	http://dx.doi.org/10.1371/journal.pone.0041091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815928	Green Published, gold			2022-12-27	WOS:000306466100119
J	Hoenner, X; Whiting, SD; Hindell, MA; McMahon, CR				Hoenner, Xavier; Whiting, Scott D.; Hindell, Mark A.; McMahon, Clive R.			Enhancing the Use of Argos Satellite Data for Home Range and Long Distance Migration Studies of Marine Animals	PLOS ONE			English	Article							TURTLES ERETMOCHELYS-IMBRICATA; LOGGERHEAD SEA-TURTLES; STATE-SPACE MODELS; MEASUREMENT ERROR; SAMPLING REGIME; GREEN TURTLES; GPS TRACKING; TELEMETRY; MOVEMENT; LOCATION	Accurately quantifying animals' spatial utilisation is critical for conservation, but has long remained an elusive goal due to technological impediments. The Argos telemetry system has been extensively used to remotely track marine animals, however location estimates are characterised by substantial spatial error. State-space models (SSM) constitute a robust statistical approach to refine Argos tracking data by accounting for observation errors and stochasticity in animal movement. Despite their wide use in ecology, few studies have thoroughly quantified the error associated with SSM predicted locations and no research has assessed their validity for describing animal movement behaviour. We compared home ranges and migratory pathways of seven hawksbill sea turtles (Eretmochelys imbricata) estimated from (a) highly accurate Fastloc GPS data and (b) locations computed using common Argos data analytical approaches. Argos 68 th percentile error was <1 km for LC 1, 2, and 3 while markedly less accurate (>4 km) for LC <= 0. Argos error structure was highly longitudinally skewed and was, for all LC, adequately modelled by a Student's t distribution. Both habitat use and migration routes were best recreated using SSM locations post-processed by re-adding good Argos positions (LC 1, 2 and 3) and filtering terrestrial points (mean distance to migratory tracks +/- SD = 2.2 +/- 2.4 km; mean home range overlap and error ratio = 92.2% and 285.6 respectively). This parsimonious and objective statistical procedure however still markedly overestimated true home range sizes, especially for animals exhibiting restricted movements. Post-processing SSM locations nonetheless constitutes the best analytical technique for remotely sensed Argos tracking data and we therefore recommend using this approach to rework historical Argos datasets for better estimation of animal spatial utilisation for research and evidence-based conservation purposes.	[Hoenner, Xavier; McMahon, Clive R.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Whiting, Scott D.] No Terr Govt, Dept Nat Resources Environm Arts & Sport, Darwin, NT, Australia; [Whiting, Scott D.] Govt Western Australia, Dept Environm & Conservat, Kensington, NSW, Australia; [Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	Charles Darwin University; Northern Territory Government; University of Tasmania	Hoenner, X (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	xavier.hoenner@cdu.edu.au	Hoenner, Xavier/P-2676-2019; Hindell, Mark A/C-8368-2013; McMahon, Clive R/D-5713-2013; Patterson, Ruth/A-7540-2018; Hindell, Mark A/K-1131-2013	Hoenner, Xavier/0000-0001-5811-1166; McMahon, Clive R/0000-0001-5241-8917; Whiting, Scott/0000-0003-3339-9559; Hindell, Mark/0000-0002-7823-7185	Australian Government under the Caring for Country Initiative; Anindilyakwa Land Council; Northern Territory Government (Marine Biodiversity Group - Department of Natural Resources, Environment, the Arts and Sport); Charles Darwin University; ANZ Trustees Foundation - Holsworth Wildlife Research Endowment	Australian Government under the Caring for Country Initiative(Australian Government); Anindilyakwa Land Council; Northern Territory Government (Marine Biodiversity Group - Department of Natural Resources, Environment, the Arts and Sport); Charles Darwin University; ANZ Trustees Foundation - Holsworth Wildlife Research Endowment	The research was funded by the Australian Government under the Caring for Country Initiative (funder), the Anindilyakwa Land Council (funder and partner), the Northern Territory Government (Marine Biodiversity Group - Department of Natural Resources, Environment, the Arts and Sport) (funder and collaborator), Charles Darwin University (funder and collaborator), and the ANZ Trustees Foundation - Holsworth Wildlife Research Endowment (funder). URL of funders' websites: http://www.nrm.gov.au/, http://www.anindilyakwa.com.au/, http://www.nretas.nt.gov.au/, http://www.cdu.edu.au/, http://www.anz.com/personal/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Bolten AB, 1998, ECOL APPL, V8, P1; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Bradshaw CJA, 2002, ICES J MAR SCI, V59, P770, DOI 10.1006/jmsc.2002.1246; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00021.1; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Broderick AC, 2007, P R SOC B, V274, P3183, DOI 10.1098/rspb.2007.2001; Bryant E, 2007, TR01 WILDTR TEL SYST; Burnham KP., 2002, MODEL SELECTION MULT, P496; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Charrassin JB, 2004, DEEP-SEA RES PT I, V51, P2091, DOI 10.1016/j.dsr.2004.07.019; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Cracknell A. P., 1991, INTRO REMOTE SENSING; Cuevas Eduardo, 2010, Endangered Species Research, V10, P123, DOI 10.3354/esr00128; Dobbs Kirstin A., 1999, Chelonian Conservation and Biology, V3, P344; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Flemming JEM, 2006, ENVIRONMETRICS, V17, P351, DOI 10.1002/env.774; Gelman A., 2003, BAYESIAN DATA ANAL; Godley BJ, 2002, ECOGRAPHY, V25, P352, DOI 10.1034/j.1600-0587.2002.250312.x; Harless ML, 2010, HERPETOL CONSERV BIO, V5, P374; HARVEY AC, 1992, FORECASTING STRUCTUR; Hays GC, 2002, ANIM BEHAV, V64, P895, DOI 10.1006/anbe.2002.1975; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Katajisto J, 2006, ECOL MODEL, V194, P405, DOI 10.1016/j.ecolmodel.2005.11.001; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; Lonergan M, 2009, MAR MAMMAL SCI, V25, P275, DOI 10.1111/j.1748-7692.2008.00264.x; Lutz PL, 2002, BIOL SEA TURTLES, VII; Malarde J, 2011, IMPROVING ARGOS DOPP; McClellan CM, 2009, ECOL APPL, V19, P1660, DOI 10.1890/08-1091.1; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McMahon CR, 2007, MAR ECOL PROG SER, V329, P239, DOI 10.3354/meps329239; Meylan Anne B., 1999, Chelonian Conservation and Biology, V3, P200; Moorcroft P. R., 2006, MECHANISTIC HOME RAN; Moorcroft PR, 2006, P ROY SOC B-BIOL SCI, V273, P1651, DOI 10.1098/rspb.2005.3439; Nicholls D. G., 2007, Notornis, V54, P121; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; R Core Team, 2020, R LANG ENV STAT COMP; Royer F, 2008, J EXP MAR BIOL ECOL, V359, P1, DOI 10.1016/j.jembe.2008.01.026; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Schofield Gail, 2010, Endangered Species Research, V10, P191, DOI 10.3354/esr00137; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Service Argos, 2009, ARG US MAN; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Starbird Christopher H., 1999, Chelonian Conservation and Biology, V3, P237; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Togridou A, 2006, ENVIRON CONSERV, V33, P233, DOI 10.1017/S0376892906003171; Troeng S, 2005, MAR BIOL, V148, P435, DOI 10.1007/s00227-005-0076-4; Troeng S, 2005, ECOGRAPHY, V28, P394, DOI 10.1111/j.0906-7590.2005.04110.x; Turchin Peter, 1998; Van Dam Robert P., 2008, Endangered Species Research, V4, P85, DOI 10.3354/esr00044; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Visscher DR, 2006, ECOGRAPHY, V29, P458; Watson KP, 1998, J EXP BIOL, V201, P2497; Whiteway T. G., 2009, GEOSCI AUSTR REC; Wilson RR, 2010, J WILDLIFE MANAGE, V74, P1343, DOI 10.2193/2009-438; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zbinden JA, 2008, MAR BIOL, V153, P899, DOI 10.1007/s00227-007-0862-2; Zbinden JA, 2007, BIOL CONSERV, V137, P157, DOI 10.1016/j.biocon.2007.01.022	78	53	54	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40713	10.1371/journal.pone.0040713	http://dx.doi.org/10.1371/journal.pone.0040713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808241	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400050
J	Kaufman-Francis, K; Koffler, J; Weinberg, N; Dor, Y; Levenberg, S				Kaufman-Francis, Keren; Koffler, Jacob; Weinberg, Noa; Dor, Yuval; Levenberg, Shulamit			Engineered Vascular Beds Provide Key Signals to Pancreatic Hormone-Producing Cells	PLOS ONE			English	Article							ISLETS; TRANSPLANTATION; EXPRESSION; DIFFERENTIATION; MUSCLE; NICHE	The mechanisms underlying early islet graft failure are not entirely clear, but are thought to involve ischemic injury due to delayed vascularization. We hypothesize that blood vessels play an active role in cell-cell communications supporting islet survival and engraftment. To test this hypothesis and to uncouple endothelial cell (EC)-generated signaling stimuli from their nutritional and gas exchange functions, we developed three dimensional (3D) endothelial vessel networks in engineered pancreatic tissues prepared from islets, fibroblasts and ECs. The tri-culture setup, seeded on highly porous biocompatible polymeric scaffolds closely mimics the natural anatomical context of pancreatic vasculature. Enhanced islet survival correlating with formation of functional tube-like endothelial vessels was demonstrated. Addition of foreskin fibroblasts to islet-endothelial cultures promoted tube-like structure formation, which further supported islet survival as well as insulin secretion. Gene expression profiles of EC growth factors, extracellular matrix (ECM), morphogenes and differentiation markers were significantly different in 2D versus 3D culture systems and were further modified upon addition of fibroblasts. Implantation of prevascularized islets into diabetic mice promoted survival, integration and function of the engrafted engineered tissue, supporting the suggested role of ECs in islet survival. These findings present potential strategies for preparation of transplantable islets with increased survival prospects.	[Kaufman-Francis, Keren; Koffler, Jacob; Levenberg, Shulamit] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel; [Kaufman-Francis, Keren; Koffler, Jacob] Technion Israel Inst Technol, Biotechnol Interdisciplinary Unit, IL-32000 Haifa, Israel; [Weinberg, Noa; Dor, Yuval] Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Fac Med, Jerusalem, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Hebrew University of Jerusalem	Kaufman-Francis, K (corresponding author), Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel.	Shulamit@bm.technion.ac.il	Koffler, Yacov/K-7329-2012	Levenberg, Shulamit/0000-0001-5471-7339; koffler, jacob/0000-0002-8415-2938	Russell Berrie Nanotechnology Institute; Israel Ministry of Science; Juvenile Diabetes Research Foundation [9-2007-472]	Russell Berrie Nanotechnology Institute; Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The authors would like to thank the Russell Berrie Nanotechnology Institute for its support. K.K.F. and J.K. would like to thank the Israel Ministry of Science for its support.; This research was funded by the Juvenile Diabetes Research Foundation (Grant no.9-2007-472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Heart E, 2000, AM J PHYSIOL-ENDOC M, V278, pE103, DOI 10.1152/ajpendo.2000.278.1.E103; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; LUKINIUS A, 1995, AM J PATHOL, V146, P429; Mattsson G, 2005, UPSALA J MED SCI, V110, P1; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Menger MD, 2001, WORLD J SURG, V25, P509, DOI 10.1007/s002680020345; MENGER MD, 1989, DIABETES, V38, P199, DOI 10.2337/diab.38.1.S199; Mitchell TS, 2008, ANGIOGENESIS, V11, P141, DOI 10.1007/s10456-007-9085-x; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Pries A. R., 2006, V176, P1; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Yamada KM, 2002, NATURE, V419, P790, DOI 10.1038/419790a; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; Zaret KS, 2006, CELL METAB, V3, P148, DOI 10.1016/j.cmet.2006.02.006	26	42	46	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40741	10.1371/journal.pone.0040741	http://dx.doi.org/10.1371/journal.pone.0040741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808248	gold, Green Submitted, Green Published			2022-12-27	WOS:000306366400054
J	Jakubcakova, V; Flachskamm, C; Landgraf, R; Kimura, M				Jakubcakova, Vladimira; Flachskamm, Cornelia; Landgraf, Rainer; Kimura, Mayumi			Sleep Phenotyping in a Mouse Model of Extreme Trait Anxiety	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; SLOW-WAVE ACTIVITY; EEG POWER-DENSITY; PSYCHIATRIC-DISORDERS; GENERALIZED ANXIETY; DAYTIME SLEEPINESS; MOOD DISORDERS; ANIMAL-MODEL; CLOCK GENES	Background: There is accumulating evidence that anxiety impairs sleep. However, due to high sleep variability in anxiety disorders, it has been difficult to state particular changes in sleep parameters caused by anxiety. Sleep profiling in an animal model with extremely high vs. low levels of trait anxiety might serve to further define sleep patterns associated with this psychopathology. Methodology/Principal Findings: Sleep-wake behavior in mouse lines with high (HAB), low (LAB) and normal (NAB) anxiety-related behaviors was monitored for 24 h during baseline and recovery after 6 h sleep deprivation (SD). The amounts of each vigilance state, sleep architecture, and EEG spectral variations were compared between the mouse lines. In comparison to NAB mice, HAB mice slept more and exhibited consistently increased delta power during non-rapid eye movement (NREM) sleep. Their sleep patterns were characterized by heavy fragmentation, reduced maintenance of wakefulness, and frequent intrusions of rapid eye movement (REM) sleep. In contrast, LAB mice showed a robust sleep-wake rhythm with remarkably prolonged sleep latency and a long, persistent period of wakefulness. In addition, the accumulation of delta power after SD was impaired in the LAB line, as compared to HAB mice. Conclusions/Significance: Sleep-wake patterns were significantly different between HAB and LAB mice, indicating that the genetic predisposition to extremes in trait anxiety leaves a biological scar on sleep quality. The enhanced sleep demand observed in HAB mice, with a strong drive toward REM sleep, may resemble a unique phenotype reflecting not only elevated anxiety but also a depression-like attribute.	[Jakubcakova, Vladimira; Flachskamm, Cornelia; Landgraf, Rainer; Kimura, Mayumi] Max Planck Inst Psychiat, Munich, Germany	Max Planck Society	Jakubcakova, V (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	kimura@mpipsykl.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	This study was supported by the Max Planck Society. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; ADRIEN J, 1991, PHYSIOL BEHAV, V49, P257, DOI 10.1016/0031-9384(91)90041-L; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association Sleep disorders, 2000, DIAGN STAT MAN MENT; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; ANDERSON DJ, 1984, AM J PSYCHIAT, V141, P572; Baldwin DS, 2006, J CLIN PSYCHIAT, V67, P9; Baracchi F, 2008, BRAIN BEHAV IMMUN, V22, P982, DOI 10.1016/j.bbi.2008.02.001; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Benca R M, 1997, Sleep Med Rev, V1, P45, DOI 10.1016/S1087-0792(97)90005-8; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Besset A, 1998, ELECTROEN CLIN NEURO, V107, P122, DOI 10.1016/S0013-4694(98)00048-0; BONNET MH, 1985, PERCEPT MOTOR SKILL, V60, P323, DOI 10.2466/pms.1985.60.1.323; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brown CS, 2001, OBSTET GYN CLIN N AM, V28, P241, DOI 10.1016/S0889-8545(05)70199-6; BROWN TA, 1995, J CONSULT CLIN PSYCH, V63, P754, DOI 10.1037/0022-006X.63.5.754; Bruder GE, 2008, BIOL PSYCHIAT, V63, P1171, DOI 10.1016/j.biopsych.2007.10.009; Bunney JN, 2008, BRIT MED BULL, V86, P23, DOI 10.1093/bmb/ldn019; Buysse DJ, 1998, PSYCHIAT RES, V79, P105, DOI 10.1016/S0165-1781(98)00028-6; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Czibere L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023604; DIJK DJ, 1989, ELECTROEN CLIN NEURO, V72, P312, DOI 10.1016/0013-4694(89)90067-9; Ditzen C, 2006, MOL CELL PROTEOMICS, V5, P1914, DOI 10.1074/mcp.M600088-MCP200; Dugovic C, 2000, NEUROREPORT, V11, P627, DOI 10.1097/00001756-200002280-00038; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Fenzl T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-29; Filiou MD, 2011, BIOL PSYCHIAT, V70, P1074, DOI 10.1016/j.biopsych.2011.06.009; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; FRANKEN P, 1991, NEUROSCI LETT, V130, P141, DOI 10.1016/0304-3940(91)90382-4; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1999, SLEEP, V22, P155; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Friess E, 2008, EUR ARCH PSY CLIN N, V258, P285, DOI 10.1007/s00406-007-0795-2; Fuller KH, 1997, SLEEP, V20, P370, DOI 10.1093/sleep/20.5.370; Hasler G, 2005, J CLIN PSYCHIAT, V66, P521, DOI 10.4088/JCP.v66n0416; Jakubcakova V, 2011, BRAIN BEHAV IMMUN, V25, P1626, DOI 10.1016/j.bbi.2011.06.008; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; JONES D, 1987, PSYCHOPATHOLOGY, V20, P20, DOI 10.1159/000284520; Kimura M, 2007, CELL MOL LIFE SCI, V64, P1216, DOI 10.1007/s00018-007-6532-1; Kimura M, 2010, MOL PSYCHIATR, V15, P154, DOI 10.1038/mp.2009.46; Knoblauch V, 2002, CEREB CORTEX, V12, P1092, DOI 10.1093/cercor/12.10.1092; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Krystal AD, 2002, SLEEP, V25, P630; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; LAUER CJ, 1991, BIOL PSYCHIAT, V29, P979, DOI 10.1016/0006-3223(91)90355-P; Louis RP, 2004, J NEUROSCI METH, V133, P71, DOI 10.1016/j.jneumeth.2003.09.025; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Mendlewicz J, 2009, CNS DRUGS, V23, P15, DOI 10.2165/11318630-000000000-00000; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Monti JM, 2000, SLEEP MED REV, V4, P263, DOI 10.1053/smrv.1999.0096; Murck H, 2003, NEUROPSYCHOPHARMACOL, V28, P348, DOI 10.1038/sj.npp.1300029; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Neumann ID, 2011, PROG NEURO-PSYCHOPH, V35, P1357, DOI 10.1016/j.pnpbp.2010.11.028; Ohayon MM, 2008, SLEEP MED REV, V12, P129, DOI 10.1016/j.smrv.2008.01.001; Ohayon MM, 2000, COMPR PSYCHIAT, V41, P469, DOI 10.1053/comp.2000.16568; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Ohl F, 2001, BEHAV NEUROSCI, V115, P429, DOI 10.1037/0735-7044.115.2.429; Papadimitriou GN, 2005, INT REV PSYCHIATR, V17, P229, DOI 10.1080/09540260500104524; Perlis ML, 1997, BIOL PSYCHIAT, V42, P904, DOI 10.1016/S0006-3223(96)00439-8; Perlis ML, 1997, J AFFECT DISORDERS, V42, P209, DOI 10.1016/S0165-0327(96)01411-5; Pigeon WR, 2006, SLEEP MED REV, V10, P247, DOI 10.1016/j.smrv.2005.09.002; Popa D, 2006, NEUROPSYCHOPHARMACOL, V31, P1637, DOI 10.1038/sj.npp.1300948; Rao U, 2009, NEUROPSYCHOPHARMACOL, V34, P1936, DOI 10.1038/npp.2009.27; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sartori SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016849; Scott MM, 2011, BEHAV BRAIN RES, V222, P289, DOI 10.1016/j.bbr.2011.02.044; Shekhar A, 2001, PSYCHOPHARMACOLOGY, V157, P327; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; SHIROMANI PJ, 1988, NEUROPSYCHOPHARMACOL, V1, P127, DOI 10.1016/0893-133X(88)90004-8; Sipila T, 2010, BIOL PSYCHIAT, V67, P1163, DOI 10.1016/j.biopsych.2009.12.011; Staner Luc, 2003, Dialogues Clin Neurosci, V5, P249; Steiger A, 2010, J PSYCHIATR RES, V44, P242, DOI 10.1016/j.jpsychires.2009.08.013; STEPANSKI E, 1984, SLEEP, V7, P18, DOI 10.1093/sleep/7.1.18; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; Szelenberger Waldemar, 2005, World Psychiatry, V4, P186; TAN TL, 1984, AM J PSYCHIAT, V141, P357; Theorell-Haglow J, 2006, SLEEP, V29, P751, DOI 10.1093/sleep/29.6.751; TOBLER I, 1987, J COMP PHYSIOL A, V161, P449, DOI 10.1007/BF00603970; TOBLER I, 1990, BEHAV BRAIN RES, V36, P73, DOI 10.1016/0166-4328(90)90161-7; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Turek FW, 2007, INT CLIN PSYCHOPHARM, V22, pS1, DOI 10.1097/01.yic.0000277956.93777.6a; Uhde TW, 2009, CURR PSYCHIAT REP, V11, P269, DOI 10.1007/s11920-009-0039-4; Uys Joachim D K, 2003, Curr Psychiatry Rep, V5, P274; van Mill JG, 2010, J CLIN PSYCHIAT, V71, P239, DOI 10.4088/JCP.09m05218gry; Vgontzas AN, 2002, ENDOCRIN METAB CLIN, V31, P15, DOI 10.1016/S0889-8529(01)00005-6; VOGEL G, 1990, NEUROSCI BIOBEHAV R, V14, P77, DOI 10.1016/S0149-7634(05)80163-0; Wirz-Justice A, 2006, INT CLIN PSYCHOPHARM, V21, pS11, DOI 10.1097/01.yic.0000195660.37267.cf; Wong ML, 2004, NAT REV DRUG DISCOV, V3, P136, DOI 10.1038/nrd1303; Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10; Zhang Y., 2011, MOL CELL PROTEOMICS, V10	104	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40625	10.1371/journal.pone.0040625	http://dx.doi.org/10.1371/journal.pone.0040625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808211	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400088
J	Eskine, KJ; Kacinik, NA; Webster, GD				Eskine, Kendall J.; Kacinik, Natalie A.; Webster, Gregory D.			The Bitter Truth about Morality: Virtue, Not Vice, Makes a Bland Beverage Taste Nice	PLOS ONE			English	Article							BAD TASTE; DISGUST	To demonstrate that sensory and emotional states play an important role in moral processing, previous research has induced physical disgust in various sensory modalities (visual, tactile, gustatory, and olfactory modalities, among others) and measured its effects on moral judgment. To further assess the strength of the connection between embodied states and morality, we investigated whether the directionality of the effect could be reversed by exposing participants to different types of moral events prior to rating the same neutral tasting beverage. As expected, reading about moral transgressions, moral virtues, or control events resulted in inducing gustatory disgust, delight, or neutral taste experiences, respectively. Results are discussed in terms of the relation between embodied cognition and processing abstract conceptual representations.	[Eskine, Kendall J.] Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA; [Kacinik, Natalie A.] CUNY, Grad Ctr, Dept Psychol, New York, NY USA; [Kacinik, Natalie A.] CUNY Brooklyn Coll, New York, NY USA; [Webster, Gregory D.] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; State University System of Florida; University of Florida	Eskine, KJ (corresponding author), Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA.	kjeskine@loyno.edu						Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Damasio A.R., 2005, DESCARTES ERROR EMOT; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Eskine KJ, EMOT IN PRESS; Gray K, 2011, EMOT REV, V3, P258, DOI 10.1177/1754073911402388; Greene JD, 2011, EMOT REV, V3, P227, DOI 10.1177/1754073911409629; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Hume D, 2004, ENQUIRY HUMAN UNDERS; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George., 1999, PHILOS FLESH EMBODIE; Lee SWS, 2010, PSYCHOL SCI, V21, P1423, DOI 10.1177/0956797610382788; Lee SWS, 2012, EMB PREC SOC PERS SO; Liljenquist K, 2010, PSYCHOL SCI, V21, P381, DOI 10.1177/0956797610361426; Moretti L, 2010, EMOTION, V10, P169, DOI 10.1037/a0017826; Pizarro D, 2011, EMOT REV, V3, P267, DOI 10.1177/1754073911402394; Ritter RS, 2011, J EXP SOC PSYCHOL, V47, P1225, DOI 10.1016/j.jesp.2011.05.006; Royzman E, 2011, EMOT REV, V3, P274, DOI 10.1177/1754073911402402; Rozin P., 2009, DISGUST ITS DISORDER, P9, DOI DOI 10.1037/11856-001; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x; Schwarz N, 1998, AFFECT COGNITION SOC, P44; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	30	25	29	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41159	10.1371/journal.pone.0041159	http://dx.doi.org/10.1371/journal.pone.0041159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815953	gold, Green Published			2022-12-27	WOS:000306548900086
J	Kinde, I; Papadopoulos, N; Kinzler, KW; Vogelstein, B				Kinde, Isaac; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert			FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; GENOME BROWSER DATABASE; MATERNAL PLASMA; FETAL DNA; ALIGNMENT; IMPACT; BLOOD; AGE	Massively parallel sequencing of cell-free, maternal plasma DNA was recently demonstrated to be a safe and effective screening method for fetal chromosomal aneuploidies. Here, we report an improved sequencing method achieving significantly increased throughput and decreased cost by replacing laborious sequencing library preparation steps with PCR employing a single primer pair designed to amplify a discrete subset of repeated regions. Using this approach, samples containing as little as 4% trisomy 21 DNA could be readily distinguished from euploid samples.	[Kinde, Isaac] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Kinde, I (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA.	ik@jhmi.edu; kinzlke@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012		Virginia; D.K. Ludwig Fund for Cancer Research; National Institutes of Health [CA62924, CA43460, CA57345]; UNCF-Merck Graduate Fellowship; NATIONAL CANCER INSTITUTE [R37CA043460, P50CA062924, R01CA043460, R37CA057345, R01CA057345] Funding Source: NIH RePORTER	Virginia; D.K. Ludwig Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF-Merck Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Virginia and D.K. Ludwig Fund for Cancer Research, the National Institutes of Health (CA62924, CA43460, and CA57345), and by a UNCF-Merck Graduate Fellowship to I. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Bianchi DW, 2012, OBSTET GYNECOL; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hsu LYF, 1998, GENETIC DISORDERS FE, V4th, P179; Jones KL., 2006, SMITHS RECOGNIZABLE, V6th ed., P268; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Resta RG, 2005, AM J MED GENET A, V133A, P31, DOI 10.1002/ajmg.a.30553; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Sparks AB, 2012, PRENAT DIAGN; Staebler M, 2005, PRENATAL DIAG, V25, P567, DOI 10.1002/pd.1187; Tukey JW, 1977, EXPLORATORY DATA ANA; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	30	46	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41162	10.1371/journal.pone.0041162	http://dx.doi.org/10.1371/journal.pone.0041162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815955	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900087
J	Rabagliati, H; Senghas, A; Johnson, S; Marcus, GF				Rabagliati, Hugh; Senghas, Ann; Johnson, Scott; Marcus, Gary F.			Infant Rule Learning: Advantage Language, or Advantage Speech?	PLOS ONE			English	Article							PERCEPTION; SEQUENCES; CHILDREN	Infants appear to learn abstract rule-like regularities (e.g., la la da follows an AAB pattern) more easily from speech than from a variety of other auditory and visual stimuli (Marcus et al., 2007). We test if that facilitation reflects a specialization to learn from speech alone, or from modality-independent communicative stimuli more generally, by measuring 7.5-month-old infants' ability to learn abstract rules from sign language-like gestures. Whereas infants appear to easily learn many different rules from speech, we found that with sign-like stimuli, and under circumstances comparable to those of Marcus et al. (1999), hearing infants were able to learn an ABB rule, but not an AAB rule. This is consistent with results of studies that demonstrate lower levels of infant rule learning from a variety of other non-speech stimuli, and we discuss implications for accounts of speech-facilitation.	[Rabagliati, Hugh; Marcus, Gary F.] NYU, Dept Psychol, New York, NY 10003 USA; [Rabagliati, Hugh] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Senghas, Ann] Columbia Univ Barnard Coll, Dept Psychol, New York, NY 10027 USA; [Johnson, Scott] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	New York University; Harvard University; Columbia University; University of California System; University of California Los Angeles	Rabagliati, H (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	hugh@wjh.harvard.edu			NIH [R01-HD48733, R01-DC005407]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant R01-HD48733 (to SPJ and GFM) and NIH grant R01-DC005407 (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 2002, COGNITION, V85, pB43, DOI 10.1016/S0010-0277(02)00106-3; Baker SA, 2006, LANG LEARN DEV, V2, P147, DOI 10.1207/s15473341lld0203_1; Dawson C, 2009, COGNITION, V111, P378, DOI 10.1016/j.cognition.2009.02.010; Endress AD, 2007, COGNITION, V105, P577, DOI 10.1016/j.cognition.2006.12.014; Frank MC, 2009, DEVELOPMENTAL SCI, V12, P504, DOI 10.1111/j.1467-7687.2008.00794.x; Gerken L, 2006, COGNITION, V98, pB67, DOI 10.1016/j.cognition.2005.03.003; Gervain J, 2010, 17 BIENN INT C INF S; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Gomez RL, 1997, COGNITIVE PSYCHOL, V33, P154, DOI 10.1006/cogp.1997.0654; Johnson SP, 2009, INFANCY, V14, P2, DOI 10.1080/15250000802569611; JUSCZYK PW, 1977, PERCEPT PSYCHOPHYS, V21, P50, DOI 10.3758/BF03199467; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Klima E., 1979, SIGNS LANGUAGE; Marcus G, 2006, NAT NEUROSCI, V9, P1226, DOI 10.1038/nn1766; Marcus GF, 2007, PSYCHOL SCI, V18, P387, DOI 10.1111/j.1467-9280.2007.01910.x; Marcus GF, 2006, COGNITION, V101, P443, DOI 10.1016/j.cognition.2006.04.009; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Marcus GF, 2008, INFANT PATHWAYS LANG; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; Newport E.L., 1985, CROSS LINGUISTIC STU, VVol. 1, P881; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Petitto LA, 2001, NATURE, V413, P35, DOI 10.1038/35092613; Pollak SD, 2006, COGNITION; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Saffran JR, 2001, P NATL ACAD SCI USA, V98, P12874, DOI 10.1073/pnas.231498898; Tunney RJ, 2001, J EXP PSYCHOL LEARN, V27, P614, DOI 10.1037//0278-7393.27.3.614; Vouloumanos A, 2004, DEVELOPMENTAL SCI, V7, P270, DOI 10.1111/j.1467-7687.2004.00345.x; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	30	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40517	10.1371/journal.pone.0040517	http://dx.doi.org/10.1371/journal.pone.0040517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815756	gold, Green Submitted, Green Published			2022-12-27	WOS:000306548900029
J	Wei, CJ; Bhattaram, VK; Igwe, JC; Fleming, E; Tirnauer, JS				Wei, Chongjuan; Bhattaram, Varun Kumar; Igwe, John C.; Fleming, Elizabeth; Tirnauer, Jennifer S.			The LKB1 Tumor Suppressor Controls Spindle Orientation and Localization of Activated AMPK in Mitotic Epithelial Cells	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; PROTEIN-KINASE; DROSOPHILA LKB1; CANCER; POLARITY; GENE; DIVISION; LKB1/STK11; MUTATIONS; TIGHT	Orientation of mitotic spindles plays an integral role in determining the relative positions of daughter cells in a tissue. LKB1 is a tumor suppressor that controls cell polarity, metabolism, and microtubule stability. Here, we show that germline LKB1 mutation in mice impairs spindle orientation in cells of the upper gastrointestinal tract and causes dramatic mislocalization of the LKB1 substrate AMPK in mitotic cells. RNAi of LKB1 causes spindle misorientation in three-dimensional MDCK cell cysts. Maintaining proper spindle orientation, possibly mediated by effects on the downstream kinase AMPK, could be an important tumor suppressor function of LKB1.	[Wei, Chongjuan] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Bhattaram, Varun Kumar; Igwe, John C.; Fleming, Elizabeth; Tirnauer, Jennifer S.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Tirnauer, Jennifer S.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT USA	University of Texas System; UTMD Anderson Cancer Center; University of Connecticut; University of Connecticut	Wei, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	tirnauer@uchc.edu			Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center	Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center	Funded by the Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Chen XY, 2006, METHOD ENZYMOL, V406, P362, DOI 10.1016/S0076-6879(06)06026-5; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V48, P592; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; McCarthy A, 2009, J PATHOLOGY; Mehenni H, 1998, AM J HUM GENET, V63, P1641, DOI 10.1086/302159; Mian I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031583; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Miyoshi H, 2002, CANCER RES, V62, P2261; MORTON DG, 1992, GENETICS, V130, P771; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Nakau M, 2002, CANCER RES, V62, P4549; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Sebbagh M, 2011, FAMILAIL CANC; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shelly M, 2011, DEV NEUROBIOLOGY; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Spicer J, 2003, ONCOGENE, V22, P4752, DOI 10.1038/sj.onc.1206669; Su GH, 1999, AM J PATHOL, V154, P1835, DOI 10.1016/S0002-9440(10)65440-5; Thoma CR, 2009, NATURE CELL BIOL; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082; Vazquez-Martin A, 2009, CELL CYCLE, V8, P788, DOI 10.4161/cc.8.5.7787; Wang ZJ, 1999, J PATHOL, V188, P9, DOI 10.1002/(SICI)1096-9896(199905)188:1<9::AID-PATH326>3.0.CO;2-E; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wei CJ, 2005, CANCER RES, V65, P11297, DOI 10.1158/0008-5472.CAN-05-0716; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Ylikorkala A, 1999, HUM MOL GENET, V8, P45, DOI 10.1093/hmg/8.1.45; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	72	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41118	10.1371/journal.pone.0041118	http://dx.doi.org/10.1371/journal.pone.0041118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815934	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900075
J	Goyal, S; Gupta, G; Qin, HN; Upadya, MH; Tan, YJ; Chow, VTK; Song, JX				Goyal, Shaveta; Gupta, Garvita; Qin, Haina; Upadya, Megha Haridas; Tan, Yee Joo; Chow, Vincent T. K.; Song, Jianxing			VAPC, an Human Endogenous Inhibitor for Hepatitis C Virus (HCV) Infection, Is Intrinsically Unstructured but Forms a "Fuzzy Complex" with HCV NS5B	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; OXYSTEROL-BINDING-PROTEIN; RNA REPLICATION COMPLEX; NONSTRUCTURAL PROTEINS; NMR CHARACTERIZATION; MEMBRANE; IDENTIFICATION; INSIGHTS; POLYMERASE; HOMOLOGS	Nearly 200 million people are infected by hepatitis C virus (HCV) worldwide. For replicating the HCV genome, the membrane-associated machinery needs to be formed by both HCV non-structural proteins (including NS5B) and human host factors such as VAPB. Recently, the 99-residue VAPC, a splicing variant of VAPB, was demonstrated to inhibit HCV replication via binding to NS5B, thus acting as an endogenous inhibitor of HCV infection. So far, the structure of VAPC remains unknown, and its interaction with NS5B has not been biophysically characterized. In this study, we conducted extensive CD and NMR investigations on VAPC which led to several striking findings: 1) although the N-terminal 70 residues are identical in VAPC and VAPB, they constitute the characteristic beta-barrel MSP fold in VAPB, while VAPC is entirely unstructured in solution, only with helical-like conformations weakly populated. 2) VAPC is indeed capable of binding to NS5B, with an average dissociation constant (Kd) of similar to 20 mu M. Intriguingly, VAPC remains dynamic even in the complex, suggesting that the VAPC-NS5B is a "fuzzy complex". 3) NMR mapping revealed that the major binding region for NS5B is located over the C-terminal half of VAPC, which is composed of three discrete clusters, of which only the first contains the region identical in VAPC and VAPB. The second region containing similar to 12 residues appears to play a key role in binding since mutation of 4 residues within this region leads to almost complete loss of the binding activity. 4) A 14-residue mimetic, VAPC-14 containing the second region, only has a similar to 3-fold reduction of the affinity. Our study not only provides critical insights into how a human factor mediates the formation of the HCV replication machinery, but also leads to design of VAPC-14 which may be further used to explore the function of VAPC and to develop anti-HCV molecules.	[Goyal, Shaveta; Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Gupta, Garvita; Qin, Haina; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Upadya, Megha Haridas; Tan, Yee Joo; Chow, Vincent T. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Goyal, S (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchsj@nus.edu.sg	Song, Jianxing/H-8026-2012; Qin, Haina/AAB-7486-2020; Upadya, Megha/N-8554-2019; Upadya, Megha/N-2235-2016	Chow, Vincent/0000-0003-2634-6213; Haina, Qin/0000-0002-9175-8014; Tan, Yee-Joo/0000-0002-2278-4497; Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore [MOE2011-T2-1-096]; National Medical Research Council [R154-000-454-213]	Ministry of Education of Singapore(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is supported by Ministry of Education of Singapore Tier 2 Grant MOE2011-T2-1-096 and National Medical Research Council grant R154-000-454-213 to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hardy RW, 2003, J VIROL, V77, P2029, DOI 10.1128/JVI.77.3.2029-2037.2003; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kukihara H, 2009, J VIROL, V83, P7959, DOI 10.1128/JVI.00889-09; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Levin JM, 1997, PROTEIN ENG, V10, P771, DOI 10.1093/protein/10.7.771; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Liu JX, 2008, BIOPHYS J, V95, P4803, DOI 10.1529/biophysj.107.125641; Liu JX, 2008, BIOCHEM BIOPH RES CO, V366, P585, DOI 10.1016/j.bbrc.2007.12.022; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Liu JX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007805; Lohmann V, 1996, J HEPATOL, V24, P11; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Miao LL, 2011, FEBS LETT, V585, P3126, DOI 10.1016/j.febslet.2011.08.048; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; Moriishi Kohji, 2003, Antiviral Chemistry & Chemotherapy, V14, P285; Nachreiner T, 2010, BIOCHEM BIOPH RES CO, V394, P703, DOI 10.1016/j.bbrc.2010.03.055; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Rice Charles M, 2011, Top Antivir Med, V19, P117; Rosner HI, 2010, BIOCHEMISTRY-US, V49, P3246, DOI 10.1021/bi902125j; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Song JX, 1998, BIOCHEM CELL BIOL, V76, P177; Song JX, 2001, J BIOL CHEM, V276, P41205, DOI 10.1074/jbc.M103449200; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wen XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015967; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yamasaki LHT, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-14; Yang G, 2004, J VIROL, V78, P10202, DOI 10.1128/JVI.78.18.10202-10205.2004; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	74	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40341	10.1371/journal.pone.0040341	http://dx.doi.org/10.1371/journal.pone.0040341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815741	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000013
J	Liu, F; Guo, WB; Yu, DM; Gao, Q; Gao, KM; Xue, ZM; Du, HD; Zhang, JW; Tan, CL; Liu, ZN; Zhao, JP; Chen, HF				Liu, Feng; Guo, Wenbin; Yu, Dengmiao; Gao, Qing; Gao, Keming; Xue, Zhimin; Du, Handan; Zhang, Jianwei; Tan, Changlian; Liu, Zhening; Zhao, Jingping; Chen, Huafu			Classification of Different Therapeutic Responses of Major Depressive Disorder with Multivariate Pattern Analysis Method Based on Structural MR Scans	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; TREATMENT-RESISTANT DEPRESSION; FUNCTIONAL CONNECTIVITY; DISCRIMINATIVE ANALYSIS; HYPOTHALAMO-CEREBELLAR; BRAIN ACTIVATION; CINGULATE CORTEX; DEFAULT-MODE; ABNORMALITIES; 1ST-EPISODE	Background: Previous studies have found numerous brain changes in patients with major depressive disorder (MDD), but no neurological biomarker has been developed to diagnose depression or to predict responses to antidepressants. In the present study, we used multivariate pattern analysis (MVPA) to classify MDD patients with different therapeutic responses and healthy controls and to explore the diagnostic and prognostic value of structural neuroimaging data of MDD. Methodology/Principal Findings: Eighteen patients with treatment-resistant depression (TRD), 17 patients with treatment-sensitive depression (TSD) and 17 matched healthy controls were scanned using structural MRI. Voxel-based morphometry, together with a modified MVPA technique which combined searchlight algorithm and principal component analysis (PCA), was used to classify the subjects with TRD, those with TSD and healthy controls. The results revealed that both gray matter (GM) and white matter (WM) of frontal, temporal, parietal and occipital brain regions as well as cerebellum structures had a high classification power in patients with MDD. The accuracy of the GM and WM that correctly discriminated TRD patients from TSD patients was both 82.9%. Meanwhile, the accuracy of the GM that correctly discriminated TRD or TSD patients from healthy controls were 85.7% and 82.4%, respectively; and the WM that correctly discriminated TRD or TSD patients from healthy controls were 85.7% and 91.2%, respectively. Conclusions/Significance: These results suggest that structural MRI with MVPA might be a useful and reliable method to study the neuroanatomical changes to differentiate patients with MDD from healthy controls and patients with TRD from those with TSD. This method might also be useful to study potential brain regions associated with treatment response in patients with MDD.	[Liu, Feng; Yu, Dengmiao; Du, Handan; Zhang, Jianwei; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Sichuan, Peoples R China; [Guo, Wenbin; Xue, Zhimin; Liu, Zhening; Zhao, Jingping] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha 410083, Hunan, Peoples R China; [Guo, Wenbin] Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China; [Gao, Qing] Univ Elect Sci & Technol China, Sch Math Sci, Chengdu 610054, Sichuan, Peoples R China; [Gao, Keming] Case Western Reserve Univ, Sch Med, Dept Psychiat,Mood & Anxiety Clin, Univ Hosp Case Med Ctr,Mood Disorders Program, Cleveland, OH 44106 USA; [Tan, Changlian] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China	University of Electronic Science & Technology of China; Central South University; Guangxi Medical University; University of Electronic Science & Technology of China; Case Western Reserve University; Case Western Reserve University Hospital; Central South University	Liu, F (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Sichuan, Peoples R China.	zhaojingpingcsu@163.com; chenhf@uestc.edu.cn	zhao, jing/B-3868-2019; Gao, Keming/W-6017-2019; Liu, Feng/W-7572-2019	Liu, Feng/0000-0002-3570-4222; Liu, Zhening/0000-0001-6893-2427	973 project [2012CB517901]; Natural Science Foundation of China [61035006, 61125304, 30900483, 30971053]; Program for Changjiang Scholars and Innovative Research Team in University	973 project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the 973 project 2012CB517901 and Natural Science Foundation of China 61035006, 61125304, 30900483 and 30971053. This work was also supported by the Program for Changjiang Scholars and Innovative Research Team in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, DOI [10.1176/appi.books.9780890423349., DOI 10.1176/APPI.BOOKS.9780890423349]; ANDREZIK JA, 1984, NEUROSCIENCE, V11, P497, DOI 10.1016/0306-4522(84)90040-X; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bajbouj M, 2005, EXP NEUROL, V196, P332, DOI 10.1016/j.expneurol.2005.08.008; Bendfeldt K, 2012, NEUROIMAGE, V60, P400, DOI 10.1016/j.neuroimage.2011.12.070; Berlim MT, 2007, CAN J PSYCHIAT, V52, P46, DOI 10.1177/070674370705200108; Bonte FJ, 2001, J NUCL MED, V42, P1059; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Chen CH, 2007, BIOL PSYCHIAT, V62, P407, DOI 10.1016/j.biopsych.2006.09.018; Costafreda SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006353; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dean B, 2010, J AFFECT DISORDERS, V120, P245, DOI 10.1016/j.jad.2009.04.027; DIETRICHS E, 1984, ANAT EMBRYOL, V170, P313, DOI 10.1007/BF00318735; DIETRICHS E, 1984, BRAIN RES, V296, P225, DOI 10.1016/0006-8993(84)90060-X; DOLAN RJ, 1993, J NEUROL NEUROSUR PS, V56, P1290, DOI 10.1136/jnnp.56.12.1290; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fan Y, 2007, NEUROIMAGE, V36, P1189, DOI 10.1016/j.neuroimage.2007.04.009; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Furtado CP, 2008, PSYCHIAT RES-NEUROIM, V163, P133, DOI 10.1016/j.pscychresns.2007.11.005; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Hamilton M, 1967, BRIT J SOCIAL CLIN P; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Iidaka T, 1997, PSYCHIAT RES-NEUROIM, V68, P143, DOI 10.1016/S0925-4927(96)02969-1; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lacerda ALT, 2004, BIOL PSYCHIAT, V55, P353, DOI 10.1016/j.biopsych.2003.08.021; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Li LL, 2010, MAGN RESON IMAGING, V28, P380, DOI 10.1016/j.mri.2009.11.009; Liu MJ, 2012, NEUROREPORT, V23, P265, DOI 10.1097/WNR.0b013e32834f60a5; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; NIERENBERG A A, 1990, Journal of Clinical Psychiatry, V51, P39; NIERENBERG AA, 1991, J CLIN PSYCHIAT, V52, P40; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ojala M, 2009, IEEE DATA MINING, P908, DOI 10.1109/ICDM.2009.108; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Shah PJ, 2002, BRIT J PSYCHIAT, V180, P434, DOI 10.1192/bjp.180.5.434; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; STEIN JF, 1992, PHYSIOL REV, V72, P967, DOI 10.1152/physrev.1992.72.4.967; Stimpson N, 2002, BRIT J PSYCHIAT, V181, P284, DOI 10.1192/bjp.181.4.284; Stoodley C.J., 2011, CEREBELLUM; Sun DQ, 2009, BIOL PSYCHIAT, V66, P1055, DOI 10.1016/j.biopsych.2009.07.019; Teneback CC, 1999, J NEUROPSYCH CLIN N, V11, P426; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; VILENSKY JA, 1981, BRAIN RES, V205, P391, DOI 10.1016/0006-8993(81)90348-6; Wang LH, 2008, AM J PSYCHIAT, V165, P863, DOI 10.1176/appi.ajp.2008.07101590; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	66	111	113	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40968	10.1371/journal.pone.0040968	http://dx.doi.org/10.1371/journal.pone.0040968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815880	gold, Green Published			2022-12-27	WOS:000306507000046
J	Liu, SS; Kelvin, DJ; Leon, AJ; Jin, LQ; Farooqui, A				Liu, Shanshan; Kelvin, David J.; Leon, Alberto J.; Jin, Liqun; Farooqui, Amber			Induction of Fas Mediated Caspase-8 Independent Apoptosis in Immune Cells by Armigeres subalbatus Saliva	PLOS ONE			English	Article							AEDES-AEGYPTI; PATHOGEN TRANSMISSION; JAPANESE ENCEPHALITIS; VIRUS-INFECTION; GLAND EXTRACTS; MOSQUITO; CHINA; MODULATION; RESPONSES; DISEASE	Background: It is widely recognized that the introduction of saliva of bloodsucking arthropods at the site of pathogen transmission might play a central role in vector-borne infections. However, how the interaction between salivary components and the host immune system takes place and which physiological processes this leads to has yet to be investigated. Armigeres subalbatus is one of the prominent types of mosquitoes involved in the transmission of parasitic and viral diseases in humans and animals. Methodology/Principal Findings: Using murine peritoneal macrophages and lymphocytes, and human peripheral mononuclear cells (PBMCs), this study shows that saliva of the female Ar. subalbatus induces apoptosis via interaction with the Fas receptor within a few hours but without activating caspase-8. The process further activates downstream p38 MAPK signaling, a cascade that leads to the induction of apoptosis in capase-3 dependent manner. We further illustrate that Ar. subalbatus saliva suppresses proinflammatory cytokines without changing IL-10 levels, which might happen as a result of apoptosis. Conclusions: Our study shows for the first time that saliva-induced apoptosis is the leading phenomenon exerted by Ar. subalbatus that impede immune cells leading to the suppression of their effecter mechanism.	[Liu, Shanshan; Kelvin, David J.; Leon, Alberto J.; Farooqui, Amber] Shantou Univ, Coll Med, Div Immunol, Int Inst Infect & Immun, Shantou, Peoples R China; [Liu, Shanshan; Jin, Liqun] Shantou Univ, Coll Med, Dept Pathogen Biol, Shantou, Peoples R China; [Kelvin, David J.; Leon, Alberto J.; Farooqui, Amber] Univ Hlth Network, Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada; [Kelvin, David J.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy	Shantou University; Shantou University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Sassari	Liu, SS (corresponding author), Shantou Univ, Coll Med, Div Immunol, Int Inst Infect & Immun, Shantou, Peoples R China.	lqjin@stu.edu.cn; amberfarooqui@hotmail.com	Farooqui, Amber/D-1402-2009	Farooqui, Amber/0000-0002-6031-9561	Li Ka-Shing Foundation of Canada; Shantou University Medical College, China	Li Ka-Shing Foundation of Canada; Shantou University Medical College, China	The study is supported by the grants from the Li Ka-Shing Foundation of Canada and Shantou University Medical College, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliota MT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000666; Andersen JF, 2010, TOXICON, V56, P1120, DOI 10.1016/j.toxicon.2009.11.002; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arjona A, 2011, CELLULAR MICROBIOLOG; Belkin J.N., 1962, MOSQUITOES S PACIFIC, V2; Boppana VD, 2009, PARASITE IMMUNOL, V31, P287, DOI 10.1111/j.1365-3024.2009.01096.x; Cao MQ, 2010, TROP MED INT HEALTH, V15, P918, DOI 10.1111/j.1365-3156.2010.02563.x; Chu BK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000708; Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003; Daehnel K, 2007, PARASITE IMMUNOL, V29, P455, DOI 10.1111/j.1365-3024.2007.00962.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Espada-Murao LA, 2011, TROPICAL MED HLTH; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Gubler DJ, 2010, VECTOR BIOLOGY, ECOLOGY AND CONTROL, P39, DOI 10.1007/978-90-481-2458-9_4; Jin LQ, 2008, MED VET ENTOMOL, V22, P359, DOI 10.1111/j.1365-2915.2008.00758.x; Lee ACY, 2010, TRENDS PARASITOL, V26, P168, DOI 10.1016/j.pt.2010.01.003; Lee SE, 2007, VET PARASITOL, V148, P149, DOI 10.1016/j.vetpar.2007.04.015; Leitner WW, 2011, EUR J IMMUNOL, V41, P3396, DOI 10.1002/eji.201190075; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Lin W, 2005, J TROPICAL MED, V4; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Pan XL, 2011, J VIROL, V85, P9847, DOI 10.1128/JVI.00825-11; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Tsujimoto H, 2010, PARASITE IMMUNOL, V32, P275, DOI 10.1111/j.1365-3024.2009.01186.x; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; Zeidner N, 2009, COINOCULATION BORREL; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zieler H, 2000, J EXP BIOL, V203, P1599	35	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41145	10.1371/journal.pone.0041145	http://dx.doi.org/10.1371/journal.pone.0041145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815944	gold, Green Submitted, Green Published			2022-12-27	WOS:000306507000074
J	Ronsholt, FF; Ostrowski, SR; Katzenstein, TL; Ullum, H; Gerstoft, J				Ronsholt, Frederikke Falkencrone; Ostrowski, Sisse Rye; Katzenstein, Terese Lea; Ullum, Henrik; Gerstoft, Jan			T Cell Subsets in HIV Infected Patients after Successful Combination Antiretroviral Therapy: Impact on Survival after 12 Years	PLOS ONE			English	Article							IMMUNE ACTIVATION MARKERS; HIV-1-INFECTED PATIENTS; VIRAL LOAD; CD38 EXPRESSION; LOW-LEVEL; IMMUNODEFICIENCY; DISEASE; RECOVERY; ASSOCIATION; PROGRESSION	Objectives: Immune activation is decreased by combination antiretroviral therapy (cART) in patients infected with human immunodeficiency virus (HIV), but residual activation remains and has been proposed as a cause of premature aging and death, but data are lacking. We analyzed the relationship between T-cell subsets after 18 months of cART and overall survival during 12 years of follow up. Methods: A cohort of 101 HIV infected patients who had undetectable plasma HIV after starting cART was included in 1997-1998. T cell subsets were analyzed by flowcytometry after 18 months of cART. Relation to survival was calculated using Kaplan-Meier curves and multiple Cox regression. Results: Seventeen patients died during the observation period. The leading causes of death were non-AIDS cancer and cardiovascular disease. Higher levels of CD8 memory T cells (CD8+, CD45RO+, CD45RA-) showed a significant beneficiary effect on survival, HR of 0.95 (95% confidence interval 0.91-0.99, P = 0.016) when adjusted for age, nadir CD4 count, CD4 count, and AIDS and hepatitis C status. T cell activation was not associated with increased risk of death. Conclusions: Larger and longitudinal studies are needed to accurately establish prognostic factors, but overall results seem to suggest that prognostic information exists within the CD8 compartment.	[Ronsholt, Frederikke Falkencrone; Katzenstein, Terese Lea; Gerstoft, Jan] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Ostrowski, Sisse Rye; Ullum, Henrik] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Ronsholt, FF (corresponding author), Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	frederikkefr@gmail.com	Ostrowski, Sisse R/E-7423-2011	Ostrowski, Sisse R/0000-0001-5288-3851; Ronsholt, Frederikke/0000-0002-1170-5896; Katzenstein, Terese L/0000-0002-2233-500X; Ullum, Henrik/0000-0001-7306-9058	Danish Medical Research Council; Danish AIDS Foundation; A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme); Augustinus Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish AIDS Foundation; A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme); Augustinus Foundation	This work was supported by the Danish Medical Research Council; The Danish AIDS Foundation; A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme); and the Augustinus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Crawley AM, 2011, IMMUNOL CELL BIOL; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DEEKS SG, 2010, ANN REV MED; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Fahey JL, 1998, AIDS, V12, P1581, DOI 10.1097/00002030-199813000-00004; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Hunt PW, 2011, AIDS; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Katzenstein T L, 2003, HIV Med, V4, P53, DOI 10.1046/j.1468-1293.2003.00119.x; Lifson AR, 2008, HIV CLIN TRIALS, V9, P177, DOI 10.1310/hct0903-177; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Mens H, 2007, AIDS RES HUM RETROV, V23, P107, DOI 10.1089/aid.2006.0089; Mildvan D, 2004, J INFECT DIS, V189, P1811, DOI 10.1086/383277; Olsson J, 2000, MECH AGEING DEV, V121, P187; Ostrowski SR, 2008, SCAND J IMMUNOL, V68, P652, DOI 10.1111/j.1365-3083.2008.02184.x; Ostrowski SR, 2005, CLIN EXP IMMUNOL, V141, P526, DOI 10.1111/j.1365-2249.2005.02869.x; Ostrowski SR, 2005, J INFECT DIS, V191, P348, DOI 10.1086/427340; Ostrowski SR, 2003, J INFECT DIS, V187, P1726, DOI 10.1086/375239; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Steel A, 2008, HIV MED, V9, P118, DOI 10.1111/j.1468-1293.2007.00528.x	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e39356	10.1371/journal.pone.0039356	http://dx.doi.org/10.1371/journal.pone.0039356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815704	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000008
J	Shruster, A; Ben-Zur, T; Melamed, E; Offen, D				Shruster, Adi; Ben-Zur, Tali; Melamed, Eldad; Offen, Daniel			Wnt Signaling Enhances Neurogenesis and Improves Neurological Function after Focal Ischemic Injury	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; ADULT-RAT BRAIN; SUBVENTRICULAR ZONE; MULTIPLE-SCLEROSIS; CEREBRAL-ISCHEMIA; STROKE; CELLS; RECOVERY; NEURONS; NEUROPROTECTION	Stroke potently stimulates cell proliferation in the subventricular zone of the lateral ventricles with subsequent neuroblast migration to the injured striatum and cortex. However, most of the cells do not survive and mature. Extracellular Wnt proteins promote adult neurogenesis in the neurogenic niches. The aim of the study was to examine the efficacy of Wnt signaling on neurogenesis and functional outcome after focal ischemic injury. Lentivirus expressing Wnt3a-HA (LV-Wnt3a-HA) or GFP (LV-GFP) was injected into the striatum or subventricular zone of mice. Five days later, focal ischemic injury was induced by injection of the vasoconstrictor endothelin-1 into the striatum of the same hemisphere. Treatment with LV-Wnt3a-HA into the striatum significantly enhanced functional recovery after ischemic injury and increased the number of BrdU-positive cells that differentiated into mature neurons in the ischemic striatum by day 28. Treatment with LV-Wnt3a-HA into the subventricular zone significantly enhanced functional recovery from the second day after injury and increased the number of immature neurons in the striatum and subventricular zone. This was accompanied by reduced dissemination of the neuronal injury. Our data indicate that Wnt signaling appears to contribute to functional recovery after ischemic injury by increasing neurogenesis or neuronal survival in the striatum.	[Shruster, Adi; Ben-Zur, Tali; Melamed, Eldad; Offen, Daniel] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Neurosci Lab, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Shruster, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Neurosci Lab, Tel Aviv, Israel.	shruster@gmail.com			Tel Aviv University; Norma and Alan Aufzein chair of Research of Parkinson's Disease	Tel Aviv University; Norma and Alan Aufzein chair of Research of Parkinson's Disease	This work was supported, in part, by The Devora Eleonora Kirshman Fund for Research of Parkinson's Disease, Tel Aviv University and by the Norma and Alan Aufzein chair of Research of Parkinson's Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Gilmour G, 2004, BEHAV BRAIN RES, V150, P171, DOI 10.1016/j.bbr.2003.07.006; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Kametsu Y, 2003, J CEREBR BLOOD F MET, V23, P416, DOI 10.1097/01.WCB.0000052281.23292.7C; Kan I, 2011, STEM CELL REV REP, V7, P404, DOI 10.1007/s12015-010-9190-x; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lei ZN, 2008, NEUROSCI LETT, V435, P108, DOI 10.1016/j.neulet.2008.02.031; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Lev N, 2006, ANTIOXID REDOX SIGN, V8, P1987, DOI 10.1089/ars.2006.8.1987; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Matsuoka N, 2003, STROKE, V34, P1519, DOI 10.1161/01.STR.0000070840.56414.3B; Morris DC, 2007, NEUROSCI LETT, V418, P170, DOI 10.1016/j.neulet.2007.03.039; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Paxinos G. F, MOUSE BRAIN STEREOTA; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Seifert-Held T, 2011, ATHEROSCLEROSIS; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Tennant KA, 2009, J NEUROSCI METH, V181, P18, DOI 10.1016/j.jneumeth.2009.04.009; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006	31	65	101	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40843	10.1371/journal.pone.0040843	http://dx.doi.org/10.1371/journal.pone.0040843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815838	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000033
J	Zhang, LJ; Xue, YQ; Yang, C; Yang, WH; Chen, L; Zhang, QJ; Qu, TY; Huang, SL; Zhao, LR; Wang, XM; Duan, WM				Zhang, Li-Juan; Xue, Yue-Qiang; Yang, Chun; Yang, Wei-Hua; Chen, Long; Zhang, Qian-Jin; Qu, Ting-Yu; Huang, Shile; Zhao, Li-Ru; Wang, Xiao-Min; Duan, Wei-Ming			Human Albumin Prevents 6-Hydroxydopamine-Induced Loss of Tyrosine Hydroxylase in In Vitro and In Vivo	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; PROTECTS DOPAMINERGIC-NEURONS; SIGNAL-REGULATED KINASE; CYTOCHROME-C RELEASE; HUMAN SERUM-ALBUMIN; PARKINSONS-DISEASE; OXIDATIVE STRESS; INDUCED APOPTOSIS; MOLECULAR-MECHANISMS	Human albumin has recently been demonstrated to protect brain neurons from injury in rat ischemic brain. However, there is no information available about whether human albumin can prevent loss of tyrosine hydroxylase (TH) expression of dopaminergic (DA) neurons induced by 6-hydroxydopamine (6-OHDA) toxicity that is most commonly used to create a rat model of Parkinson's disease (PD). In the present study, two microliters of 1.25% human albumin were stereotaxically injected into the right striatum of rats one day before or 7 days after the 6-OHDA lesion in the same side. D-Amphetamine-induced rotational asymmetry was measured 7 days, 3 and 10 weeks after 6-OHDA lesion. We observed that intrastriatal administration of human albumin significantly reduced the degree of rotational asymmetry. The number of TH-immunoreactive neurons present in the substantia nigra was greater in 6-OHDA lesioned rats following human albumin-treatment than non-human albumin treatment. TH-immunoreactivity in the 6-OHDA-lesioned striatum was also significantly increased in the human albumin-treated rats. To examine the mechanisms underlying the effects of human albumin, we challenged PC12 cells with 6-OHDA as an in vitro model of PD. Incubation with human albumin prevented 6-OHDA-induced reduction of cell viability in PC12 cell cultures, as measured by MTT assay. Furthermore, human albumin reduced 6-OHDA-induced formation of reactive oxygen species (ROS) and apoptosis in cultured PC12 cells, as assessed by flow cytometry. Western blot analysis showed that human albumin inhibited 6-OHDA-induced activation of JNK, c-Jun, ERK, and p38 mitogen-activated protein kinases (MAPK) signaling in PC12 cultures challenged with 6-OHDA. Human albumin may protect against 6-OHDA toxicity by influencing MAPK pathway followed by anti-ROS formation and anti-apoptosis.	[Zhang, Li-Juan; Yang, Chun; Yang, Wei-Hua; Duan, Wei-Ming] Capital Med Univ, Dept Anat, Beijing, Peoples R China; [Zhang, Li-Juan; Wang, Xiao-Min] Capital Med Univ, Dept Physiol, Beijing, Peoples R China; [Xue, Yue-Qiang] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Chen, Long; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Zhang, Qian-Jin] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA; [Qu, Ting-Yu] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA	Capital Medical University; Capital Medical University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Xavier University of Louisiana; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Zhang, LJ (corresponding author), Capital Med Univ, Dept Anat, Beijing, Peoples R China.	xmwang@ccmu.edu.cn; duanwm08@yahoo.com	Zhang, Li/GWM-7501-2022; qu, tingyu/AGX-7752-2022; qu, tingyu/AHA-0840-2022; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072	Chinese Ministry of Science and Technology [2011CB504100]; Beijing Natural Science Foundation [11120087, 7112011]; Louisiana Board of Regents; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Louisiana Board of Regents; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB504100, WMD), Beijing Natural Science Foundation (11120087, WMD; 7112011, WMD), and the Louisiana Board of Regents (WMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bolitho C, 2007, J VASC RES, V44, P313, DOI 10.1159/000101777; Bowenkamp KE, 1996, EXP BRAIN RES, V111, P1; Bozyczko-Coyne D, 2002, CNS NEUROL DISORD-DR, V1, P31, DOI 10.2174/1568007023339472; Canals S, 2003, MOL CELL NEUROSCI, V24, P1012, DOI 10.1016/j.mcn.2003.08.004; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; de Bernardo S, 2004, J NEUROCHEM, V91, P667, DOI 10.1111/j.1471-4159.2004.02744.x; DUAN WM, 1995, EXP BRAIN RES, V104, P227; Duan WM, 1998, EUR J NEUROSCI, V10, P2595, DOI 10.1046/j.1460-9568.1998.t01-1-00279.x; EMERSON TE, 1989, CRIT CARE MED, V17, P690, DOI 10.1097/00003246-198907000-00020; Eminel S, 2004, J BIOL CHEM, V279, P55385, DOI 10.1074/jbc.M405858200; Gallego-Sandin S, 2005, EUR J PHARMACOL, V520, P1, DOI 10.1016/j.ejphar.2005.06.044; Ganguly A, 2004, J NEUROCHEM, V88, P469, DOI 10.1046/j.1471-4159.2003.02176.x; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Gum ET, 2004, STROKE, V35, P590, DOI 10.1161/01.STR.0000110790.05859.DA; Han BS, 2003, J NEUROSCI, V23, P5069; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; HANSON RW, 1968, J LIPID RES, V9, P667; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Jeohn GH, 2002, ANN NY ACAD SCI, V962, P332, DOI 10.1111/j.1749-6632.2002.tb04078.x; Jones RGA, 2011, J PHARMACEUT BIOMED, V54, P74, DOI 10.1016/j.jpba.2010.08.013; JUURLINK BHJ, 1990, BRAIN RES, V533, P73, DOI 10.1016/0006-8993(90)91797-K; Klintworth H, 2007, TOXICOL SCI, V97, P149, DOI 10.1093/toxsci/kfm029; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu YT, 2001, EUR J PHARMACOL, V428, P193, DOI 10.1016/S0014-2999(01)01255-9; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Moran EC, 2002, BRIT J HAEMATOL, V116, P316, DOI 10.1046/j.1365-2141.2002.03280.x; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Pan J, 2007, NEUROSCI LETT, V428, P82, DOI 10.1016/j.neulet.2007.09.032; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; Rodriguez-Blanco J, 2008, J NEUROCHEM, V107, P127, DOI 10.1111/j.1471-4159.2008.05588.x; Rodriguez-Pallares J, 2007, J NEUROCHEM, V103, P145, DOI 10.1111/j.1471-4159.2007.04699.x; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SCHNITZER JE, 1992, J BIOL CHEM, V267, P24544; Soto-Otero R, 2000, J NEUROCHEM, V74, P1605, DOI 10.1046/j.1471-4159.2000.0741605.x; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Tabernero A, 1999, GLIA, V25, P1; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wu SS, 2005, CNS DRUGS, V19, P723, DOI 10.2165/00023210-200519090-00001; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xue YQ, 2007, NEUROSCIENCE, V146, P1245, DOI 10.1016/j.neuroscience.2007.02.004; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zoellner H, 1996, J CELL SCI, V109, P2571	66	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41226	10.1371/journal.pone.0041226	http://dx.doi.org/10.1371/journal.pone.0041226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815976	Green Published, gold			2022-12-27	WOS:000306507000082
J	Suzuki, N; Suzuki, M; Hamajo, K; Murakami, K; Tsukamoto, T; Shimojo, M				Suzuki, Noriko; Suzuki, Motohisa; Hamajo, Kazuhiro; Murakami, Koji; Tsukamoto, Tetsuya; Shimojo, Masato			Contribution of Hypothermia and CB1 Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ISCHEMIC BRAIN-DAMAGE; MILD HYPOTHERMIA; INFARCT SIZE; ACUTE STROKE; NEUROPROTECTION; TEMPERATURE; RELEASE; AWAKE	Background: Cannabinoid (CB) receptor agonists are expected to alleviate ischemic brain damage by modulating neurotransmission and neuroinflammatory responses via CB1 and CB2 receptors, respectively. In a previous study, TAK-937, a novel potent and selective CB1 and CB2 receptor agonist, was shown to exert significant cerebroprotective effects accompanied by hypothermia after transient middle cerebral artery occlusion (MCAO) in rats. Sustained hypothermia itself induces significant neuroprotective effects. In the present studies, we examined the relative contribution of hypothermia and CB1 receptor activation to the cerebroprotective effects of TAK-937. Methodology/Principal Findings: Using a multichannel brain temperature controlling system we developed, the brain temperature of freely moving rats was telemetrically monitored and maintained between 37 and 38 degrees C during intravenous infusion of TAK-937 (100 mu g/kg/h) or vehicle for 24 h after 2 h MCAO. AM251, a selective CB1 receptor antagonist, was administered intraperitoneally at 30 mg/kg 30 min before starting intravenous infusion of TAK-937 (100 mu g/kg/h) for 24 h. Rats were sacrificed and their brains were isolated 26 h after MCAO in both experiments. When the hypothermic effect of TAK-937 was completely reversed by a brain temperature controlling system, the infarct-reducing effect of TAK-937 was attenuated in part, but remained significant. On the other hand, concomitant AM251 treatment with TAK-937 completely abolished the hypothermic and infarct-reducing effects of TAK-937. Conclusions/Significance: We conclude that the cerebroprotective effects of TAK-937 were at least in part mediated by induction of hypothermia, and mainly mediated by CB1 receptor activation.	[Suzuki, Noriko; Suzuki, Motohisa; Hamajo, Kazuhiro; Murakami, Koji; Tsukamoto, Tetsuya; Shimojo, Masato] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Murakami, Koji] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan	Takeda Pharmaceutical Company Ltd; Kanazawa University	Suzuki, N (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	Shimojo_Masato@takeda.co.jp	Tsukamoto, Tetsuya/ABD-4397-2020	Tsukamoto, Tetsuya/0000-0002-7502-8724	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceutical Company Limited. All authors were employees of Takeda Pharmaceutical Company Limited and were paid as such, therefore Takeda Pharmaceutical Company Limited had a role in study design, data collection and analysis, and decision to publish.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bonfils PK, 2006, NEUROCHEM INT, V49, P508, DOI 10.1016/j.neuint.2006.03.015; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hosohata K, 1997, LIFE SCI, V61, pPL115, DOI 10.1016/S0024-3205(97)00596-1; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; KIYOTA Y, 1993, EXP BRAIN RES, V95, P388; Koizumi JYY, 1986, JPN J STROKE, V8, P1, DOI [DOI 10.3995/JSTROKE.8.1, DOI 10.3995/jstroke.8.1]; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Leker RR, 2003, STROKE, V34, P2000, DOI 10.1161/01.STR.0000079817.68944.1E; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Ohta H, 2007, NEUROSCI RES, V57, P424, DOI 10.1016/j.neures.2006.12.002; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Suzuki N, 2012, BRAIN RES, V1430, P93, DOI 10.1016/j.brainres.2011.10.044; Waksman Y, 1999, J PHARMACOL EXP THER, V288, P1357; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhuang SY, 2005, NEUROPHARMACOLOGY, V48, P1086, DOI 10.1016/j.neuropharm.2005.01.005	25	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40889	10.1371/journal.pone.0040889	http://dx.doi.org/10.1371/journal.pone.0040889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815855	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100088
J	Verkhivker, GM				Verkhivker, Gennady M.			Simulating Molecular Mechanisms of the MDM2-Mediated Regulatory Interactions: A Conformational Selection Model of the MDM2 Lid Dynamics	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; N-TERMINAL DOMAIN; PROTEIN-PROTEIN INTERACTION; AMBER FORCE-FIELD; P53-MDM2 INTERACTION; DNA-DAMAGE; BINDING-SITE; POSTTRANSLATIONAL MODIFICATION; TRANSACTIVATION DOMAIN; PEPTIDE INHIBITION	Diversity and complexity of MDM2 mechanisms govern its principal function as the cellular antagonist of the p53 tumor suppressor. Structural and biophysical studies have demonstrated that MDM2 binding could be regulated by the dynamics of a pseudo-substrate lid motif. However, these experiments and subsequent computational studies have produced conflicting mechanistic models of MDM2 function and dynamics. We propose a unifying conformational selection model that can reconcile experimental findings and reveal a fundamental role of the lid as a dynamic regulator of MDM2-mediated binding. In this work, structure, dynamics and energetics of apo-MDM2 are studied as a function of posttranslational modifications and length of the lid. We found that the dynamic equilibrium between "closed" and "semi-closed" lid forms may be a fundamental characteristic of MDM2 regulatory interactions, which can be modulated by phosphorylation, phosphomimetic mutation as well as by the lid size. Our results revealed that these factors may regulate p53-MDM2 binding by fine-tuning the thermodynamic equilibrium between preexisting conformational states of apo-MDM2. In agreement with NMR studies, the effect of phosphorylation on MDM2 interactions was more pronounced with the truncated lid variant that favored the thermodynamically dominant closed form. The phosphomimetic mutation S17D may alter the lid dynamics by shifting the thermodynamic equilibrium towards the ensemble of "semi-closed" conformations. The dominant "semi-closed" lid form and weakened dependence on the phosphorylation seen in simulations with the complete lid can provide a rationale for binding of small p53-based mimetics and inhibitors without a direct competition with the lid dynamics. The results suggested that a conformational selection model of preexisting MDM2 states may provide a robust theoretical framework for understanding MDM2 dynamics. Probing biological functions and mechanisms of MDM2 regulation would require further integration of computational and experimental studies and may help to guide drug design of novel anti-cancer therapeutics.	[Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA USA; [Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Crean Sch Hlth & Life Sci, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Verkhivker, GM (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA USA.	gverkhiv@ucsd.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	funding from Chapman University	funding from Chapman University	This work is partly supported by funding from Chapman University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JG, 2009, J MED CHEM, V52, P7044, DOI 10.1021/jm900681h; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Arumugam M, 2009, CELL CYCLE, V8, P2828; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Barakat K, 2010, J MOL GRAPH MODEL, V28, P555, DOI 10.1016/j.jmgm.2009.12.003; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Bowman AL, 2007, J AM CHEM SOC, V129, P12809, DOI 10.1021/ja073687x; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Brown CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024122; Brown CJ, 2011, TRENDS PHARMACOL SCI, V32, P53, DOI 10.1016/j.tips.2010.11.004; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen JZ, 2012, INT J MOL SCI, V13, P2176, DOI 10.3390/ijms13022176; Chen JZ, 2011, J MOL GRAPH MODEL, V30, P46, DOI 10.1016/j.jmgm.2011.06.003; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Dastidar SG, 2011, CELL CYCLE, V10, P82, DOI 10.4161/cc.10.1.14345; Dastidar SG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S6; Ding Y, 2008, J PHYS CHEM B, V112, P11396, DOI 10.1021/jp8015886; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026071; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Espinoza-Fonseca LM, 2006, BIOPOLYMERS, V83, P365, DOI 10.1002/bip.20566; Espinoza-Fonseca LM, 2006, BIOCHEM BIOPH RES CO, V343, P110, DOI 10.1016/j.bbrc.2006.02.129; Fasan R, 2006, CHEMBIOCHEM, V7, P515, DOI 10.1002/cbic.200500452; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Freedman DA, 1997, MOL MED, V3, P248, DOI 10.1007/BF03401678; Fry DC, 2004, J BIOMOL NMR, V30, P163, DOI 10.1023/B:JNMR.0000048856.84603.9b; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Grasslin A, 2009, CHEMBIOCHEM, V10, P1360, DOI 10.1002/cbic.200900008; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hay TJ, 2000, FEBS LETT, V478, P183, DOI 10.1016/S0014-5793(00)01850-0; Henning W, 1997, J VIROL, V71, P7609, DOI 10.1128/JVI.71.10.7609-7618.1997; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu GD, 2010, J COMPUT AID MOL DES, V24, P687, DOI 10.1007/s10822-010-9366-0; Huang YJ, 2012, CHEMMEDCHEM, V7, P49, DOI 10.1002/cmdc.201100428; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Inuzuka H, 2010, ONCOTARGET, V1, P685; Jackson MW, 2004, ONCOGENE, V23, P4477, DOI 10.1038/sj.onc.1207575; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kalid O, 2009, J CHEM INF MODEL, V49, P865, DOI 10.1021/ci800352c; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lai ZH, 2000, ARCH BIOCHEM BIOPHYS, V381, P278, DOI 10.1006/abbi.2000.1998; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lauria A, 2010, CURR MED CHEM, V17, P3142, DOI 10.2174/092986710792232021; Lee HJ, 2007, CELL CYCLE, V6, P2604, DOI 10.4161/cc.6.21.4923; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li C, 2009, ANGEW CHEM INT EDIT, V48, P8712, DOI 10.1002/anie.200904550; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Liu M, 2010, ANGEW CHEM INT EDIT, V49, P3649, DOI 10.1002/anie.201000329; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lu F, 2006, J COMB CHEM, V8, P315, DOI 10.1021/cc050142v; Lu SY, 2011, J MOL GRAPH MODEL, V30, P167, DOI 10.1016/j.jmgm.2011.07.003; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacLaine NJ, 2011, CELL CYCLE, V10, P916, DOI 10.4161/cc.10.6.15076; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marrone TJ, 2000, PERSPECT DRUG DISCOV, V20, P209, DOI 10.1023/A:1008741308684; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mayo LD, 1997, CANCER RES, V57, P5013; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Meek DW, 2010, SEMIN CANCER BIOL, V20, P19, DOI 10.1016/j.semcancer.2009.10.005; Meek DW, 2003, MOL CANCER RES, V1, P1017; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Romer L, 2006, ANGEW CHEM INT EDIT, V45, P6440, DOI 10.1002/anie.200600611; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sakurai K, 2006, J AM CHEM SOC, V128, P11000, DOI 10.1021/ja063102j; Schaffer L, 1998, PROTEINS, V33, P295, DOI 10.1002/(SICI)1097-0134(19981101)33:2&lt;295::AID-PROT12&gt;3.0.CO;2-F; Schon O, 2004, J MOL BIOL, V336, P197, DOI 10.1016/j.jmb.2003.11.051; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shen H, 2011, CURR PHARM DESIGN, V17, P560, DOI 10.2174/138161211795222603; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; Sood VD, 2006, J MOL BIOL, V357, P917, DOI 10.1016/j.jmb.2006.01.045; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; STOUTEN PFW, 1993, MOL SIMULAT, V10, P97, DOI 10.1080/08927029308022161; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Verkhivker GM, 2003, PROTEINS, V53, P201, DOI 10.1002/prot.10456; Verkhivker GM, 2002, PROTEINS, V48, P539, DOI 10.1002/prot.10164; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang ZF, 2010, PROTEIN CELL, V1, P1063, DOI 10.1007/s13238-010-0140-9; WILLETT P, 1986, J CHEM INF COMP SCI, V26, P109, DOI 10.1021/ci00051a005; Worrall Erin G, 2009, J Chem Biol, V2, P113, DOI 10.1007/s12154-009-0019-5; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Zhan CY, 2012, J AM CHEM SOC, V134, P6855, DOI 10.1021/ja301255n; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275	136	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40897	10.1371/journal.pone.0040897	http://dx.doi.org/10.1371/journal.pone.0040897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815859	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100090
J	Hamad, I; Sokhna, C; Raoult, D; Bittar, F				Hamad, Ibrahim; Sokhna, Cheikh; Raoult, Didier; Bittar, Fadi			Molecular Detection of Eukaryotes in a Single Human Stool Sample from Senegal	PLOS ONE			English	Article							FECAL FUNGAL FLORA; HEALTHY-VOLUNTEERS; HUMAN INTESTINE; DIVERSITY; MICROBIOTA; TRICHOSPORON; INFECTIONS; BACTERIAL; DISEASES; GUT	Background: Microbial eukaryotes represent an important component of the human gut microbiome, with different beneficial or harmful roles; some species are commensal or mutualistic, whereas others are opportunistic or parasitic. The diversity of eukaryotes inhabiting humans remains relatively unexplored because of either the low abundance of these organisms in human gut or because they have received limited attention from a whole-community perspective. Methodology/Principal Finding: In this study, a single fecal sample from a healthy African male was studied using both culture-dependent methods and extended molecular methods targeting the 18S rRNA and ITS sequences. Our results revealed that very few fungi, including Candida spp., Galactomyces spp., and Trichosporon asahii, could be isolated using culture-based methods. In contrast, a relatively a high number of eukaryotic species could be identified in this fecal sample when culture-independent methods based on various primer sets were used. A total of 27 species from one sample were found among the 977 analyzed clones. The clone libraries were dominated by fungi (716 clones/977, 73.3%), corresponding to 16 different species. In addition, 187 sequences out of 977 (19.2%) corresponded to 9 different species of plants; 59 sequences (6%) belonged to other micro-eukaryotes in the gut, including Entamoeba hartmanni and Blastocystis sp; and only 15 clones/977 (1.5%) were related to human 18S rRNA sequences. Conclusion: Our results revealed a complex eukaryotic community in the volunteer's gut, with fungi being the most abundant species in the stool sample. Larger investigations are needed to assess the generality of these results and to understand their roles in human health and disease.	[Hamad, Ibrahim; Raoult, Didier; Bittar, Fadi] Aix Marseille Univ, IHU Mediterranee Infect, URMITE UMR IRD 198, Marseille, France; [Sokhna, Cheikh] IRD, UMR IRD 198, Dakar, Senegal	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Hamad, I (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, URMITE UMR IRD 198, Marseille, France.	fadi.bittar@univ-amu.fr	Bittar, Fadi/F-2037-2018; RAOULT, Didier/A-8434-2008	Bittar, Fadi/0000-0003-4052-344X; RAOULT, Didier/0000-0002-0633-5974	Chair of Excellence IRD, Institut de Recherche pour le Developpement	Chair of Excellence IRD, Institut de Recherche pour le Developpement	FB was supported by a Chair of Excellence IRD provided by the Institut de Recherche pour le Developpement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirbashi H, 2008, JPN J INFECT DIS, V61, P130; Agirbasli H, 2005, MYCOPATHOLOGIA, V159, P515, DOI 10.1007/s11046-005-3451-2; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Ashley FP, 2006, ORAL MICROBIOL IMMUN, V21, P61; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Chagas TC, 2008, MYCOPATHOLOGIA, V166, P121, DOI 10.1007/s11046-008-9136-x; Chen Y., 2010, DIAGN MICROBIOL INFE, V70, P492; Church C, 2010, J PARASITOL, V96, P194, DOI 10.1645/GE-2229; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Gonzalez GM, 2001, ANTIMICROB AGENTS CH, V45, P633, DOI 10.1128/AAC.45.2.633-635.2001; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Khatib R, 2001, MYCOSES, V44, P151, DOI 10.1046/j.1439-0507.2001.00639.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li Q, 2012, HUM PATHOL IN PRESS; Macura Anna B, 2010, Przegl Epidemiol, V64, P313; Marchesi JR, 2010, ADV APPL MICROBIOL, V72, P43, DOI 10.1016/S0065-2164(10)72002-5; Mueller MS, 2004, T ROY SOC TROP MED H, V98, P318, DOI 10.1016/j.trstmh.2003.09.001; Nam YD, 2008, J MICROBIOL, V46, P491, DOI 10.1007/s12275-008-0199-7; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; SONCK CE, 1969, ANTON VAN LEE J M S, V35, pE25; Stensvold CR, 2011, TRENDS PARASITOL, V27, P53, DOI 10.1016/j.pt.2010.11.005; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Vieira TO, 2009, REDOX REP, V14, P41, DOI 10.1179/135100009X392485; Waldman A, 2001, MYCOSES, V44, P77, DOI 10.1046/j.1439-0507.2001.00608.x; Weeks BS, 2009, MED SCI MONITOR, V15, pRA256; Yakoob J, 2010, PARASITOL RES, V107, P679, DOI 10.1007/s00436-010-1918-7	33	59	63	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40888	10.1371/journal.pone.0040888	http://dx.doi.org/10.1371/journal.pone.0040888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808282	Green Published, gold			2022-12-27	WOS:000306406700067
J	Zhang, JY; Diao, YF; Kim, HR; Jin, DI				Zhang, Jin Yu; Diao, Yun Fei; Kim, Hong Rye; Jin, Dong Il			Inhibition of Endoplasmic Reticulum Stress Improves Mouse Embryo Development	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PLASMA-CELL DIFFERENTIATION; HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR; ER STRESS; MESSENGER-RNA; SIGNALING PATHWAYS; OXIDATIVE STRESS; PORCINE OOCYTES; KINASE	X-box binding protein-1 (XBP-1) is an important regulator of a subset of genes during endoplasmic reticulum (ER) stress. In the current study, we analyzed endogenous XBP-1 expression and localization, with a view to determining the effects of ER stress on the developmental competency of preimplantation embryos in mice. Fluorescence staining revealed that functional XBP-1 is localized on mature oocyte spindles and abundant in the nucleus at the germinal vesicle (GV) stage. However, in preimplantation embryos, XBP-1 was solely detected in the cytoplasm at the one-cell stage. The density of XBP-1 was higher in the nucleus than the cytoplasm at the two-cell, four-cell, eight-cell, morula, and blastocyst stages. Furthermore, RT-PCR analysis confirmed active XBP-1 mRNA splicing at all preimplantation embryo stages, except the one-cell stage. Tunicamycin (TM), an ER stress inducer used as a positive control, promoted an increase in the density of nuclear XBP-1 at the one-cell and two-cell stages. Similarly, culture medium supplemented with 25 mM sorbitol displayed a remarkable increase active XBP-1 expression in the nuclei of 1-cell and 2-cell embryos. Conversely, high concentrations of TM or sorbitol led to reduced nuclear XBP-1 density and significant ER stress-induced apoptosis. Tauroursodeoxycholic acid (TUDCA), a known inhibitor of ER stress, improved the rate of two-cell embryo development to blastocysts by attenuating the expression of active XBP-1 protein in the nucleus at the two-cell stage. Our data collectively suggest that endogenous XBP-1 plays a role in normal preimplantation embryonic development. Moreover, XBP-1 splicing is activated to generate a functional form in mouse preimplantation embryos during culture stress. TUDCA inhibits hyperosmolar-induced ER stress as well as ER stress-induced apoptosis during mouse preimplantation embryo development.	[Zhang, Jin Yu; Diao, Yun Fei; Kim, Hong Rye; Jin, Dong Il] Chungnam Natl Univ, Res Ctr Transgen Cloned Pigs, Dept Anim Sci & Biotechnol, Taejon, South Korea	Chungnam National University	Zhang, JY (corresponding author), Chungnam Natl Univ, Res Ctr Transgen Cloned Pigs, Dept Anim Sci & Biotechnol, Taejon, South Korea.	dijin@cnu.ac.kr			BioGreen 21 Program of the Rural Development Administration [PJ009060]; National Research Foundation of Korea (NRF); Korean government (MEST) [2010-0022263]	BioGreen 21 Program of the Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the BioGreen 21 Program of the Rural Development Administration (grant no. PJ009060) and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (grant no. 2010-0022263).	Abraham T, 2011, MOL HUM REP IN PRESS; Blanco-Gelaz MA, 2010, STEM CELL REV REP, V6, P462, DOI 10.1007/s12015-010-9135-4; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cao Y, 2006, MECH DEVELOP, V123, P84, DOI 10.1016/j.mod.2005.09.003; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fong B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-2; Garmyn M, 2001, J INVEST DERMATOL, V117, P1290, DOI 10.1046/j.0022-202x.2001.01553.x; Gupta MK, 2007, MOL REPROD DEV, V74, P435, DOI 10.1002/mrd.20547; Hao LP, 2009, BIOL REPROD, V80, P944, DOI 10.1095/biolreprod.108.072546; Hosoi T, 2010, NEUROCHEM INT, V56, P216, DOI 10.1016/j.neuint.2009.12.005; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jia YW, 2010, FERTIL STERIL, V93, P2760, DOI 10.1016/j.fertnstert.2010.02.031; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; Kim NH, 1996, BIOL REPROD, V54, P1397, DOI 10.1095/biolreprod54.6.1397; LaRosa C, 2006, BIOL REPROD, V74, P585, DOI 10.1095/biolreprod.105.046524; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Maekawa M, 2005, DEVELOPMENT, V132, P1773, DOI 10.1242/dev.01729; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Miller SDW, 2007, HEPATOLOGY, V46, P496, DOI 10.1002/hep.21689; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Steeves CL, 2003, P NATL ACAD SCI USA, V100, P13982, DOI 10.1073/pnas.2334537100; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; URANO F, 2000, SCIENCE, V287, P664, DOI [DOI 10.1126/SCIENCE.287.5453.664, 10.1126/science.287.5453.664, DOI 10.1126/science.287.5453.664]; Wang YC, 2005, FERTIL STERIL, V83, P1144, DOI 10.1016/j.fertnstert.2004.08.038; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xie Y, 2007, MOL HUM REPROD, V13, P473, DOI 10.1093/molehr/gam027; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, CELL STRUCT FUNCT, V31, P117, DOI 10.1247/csf.06016; Zhang JY, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-25; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao H, 2003, DEV BIOL, V257, P278, DOI 10.1016/S0012-1606(03)00069-1	54	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40433	10.1371/journal.pone.0040433	http://dx.doi.org/10.1371/journal.pone.0040433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808162	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700029
J	Hong, JM; Stefanescu, E; Liang, P; Joshi, N; Xue, S; Litvinov, D; Khizroev, S				Hong, Jeongmin; Stefanescu, Eugenia; Liang, Ping; Joshi, Nikhil; Xue, Song; Litvinov, Dmitri; Khizroev, Sakhrat			Carbon Nanotubes Based 3-D Matrix for Enabling Three-Dimensional Nano-Magneto-Electronics	PLOS ONE			English	Article							ENHANCED MAGNETIZATION; TECHNOLOGY; CO	This letter describes the use of vertically aligned carbon nanotubes (CNT)-based arrays with estimated 2-nm thick cobalt (Co) nanoparticles deposited inside individual tubes to unravel the possibility of using the unique templates for ultra-high-density low-energy 3-D nano-magneto-electronic devices. The presence of oriented 2-nm thick Co layers within individual nanotubes in the CNT-based 3-D matrix is confirmed through VSM measurements as well as an energy-dispersive X-ray spectroscopy (EDS).	[Hong, Jeongmin; Stefanescu, Eugenia; Khizroev, Sakhrat] Florida Int Univ, Dept Elect & Comp Engn, Miami, FL 33199 USA; [Liang, Ping] Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA; [Joshi, Nikhil] Seagate Technol, Bloomington, MN USA; [Xue, Song] MultiDimension, San Jose, CA USA; [Litvinov, Dmitri] Univ Houston, Dept Elect Engn, Houston, TX USA	State University System of Florida; Florida International University; University of California System; University of California Riverside; Seagate Technology; University of Houston System; University of Houston	Hong, JM (corresponding author), Florida Int Univ, Dept Elect & Comp Engn, Miami, FL 33199 USA.	jehong@fiu.edu			National Science Foundation (NSF) [005084-002]; DARPA/Defense Microelectronics Activity (DMEA) [H94003-09-2-0904]; UC Discovery Grant [189573]; WDC; Motorola Corporation	National Science Foundation (NSF)(National Science Foundation (NSF)); DARPA/Defense Microelectronics Activity (DMEA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); UC Discovery Grant; WDC; Motorola Corporation	This study was funded by the National Science Foundation (NSF) under contract 005084-002, DARPA/Defense Microelectronics Activity (DMEA) under agreement number H94003-09-2-0904, and UC Discovery Grant (with WDC) under contract 189573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NJ is employed by Seagate Technology and SX by Multidimension. Support was provided by Motorola Corporation with discussion and help with the measurements. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abelmann L, 2000, J APPL PHYS, V87, P6636, DOI 10.1063/1.372795; Awano Y, 2010, P IEEE, V98, P2015, DOI 10.1109/JPROC.2010.2068030; Bom D, 2002, NANO LETT, V2, P615, DOI 10.1021/nl020297u; CHEN JP, 1995, PHYS REV B, V51, P11527, DOI 10.1103/PhysRevB.51.11527; CHILDRESS JR, 1991, PHYS REV B, V43, P8089, DOI 10.1103/PhysRevB.43.8089; Collins PG, 2001, PHYS REV LETT, V86, P3128, DOI 10.1103/PhysRevLett.86.3128; Emma PG, 2008, IBM J RES DEV, V52, P541, DOI 10.1147/JRD.2008.5388561; Falvo MR, 1997, NATURE, V389, P582, DOI 10.1038/39282; GONG W, 1991, J APPL PHYS, V69, P5119, DOI 10.1063/1.348144; Hone J, 1999, PHYS REV B, V59, pR2514, DOI 10.1103/PhysRevB.59.R2514; Hong J, 2006, MRS P, V963, P0963; IWASAKI S, 1977, IEEE T MAGN, V13, P1272, DOI 10.1109/TMAG.1977.1059695; Jiang H, 2004, J ENG MATER-T ASME, V126, P265, DOI 10.1115/1.1752925; Kikuchi H, 2008, JPN J APPL PHYS, V47, P2801, DOI 10.1143/JJAP.47.2801; Li J, 1998, CHEM MATER, V10, P1963, DOI 10.1021/cm980122e; Lu KH, 2010, P 60 EL COMP TECHN C; MATSUOKA M, 1989, PLAT SURF FINISH, V76, P54; MCHENRY ME, 1994, PHYS REV B, V49, P11358, DOI 10.1103/PhysRevB.49.11358; Newman M, 2006, P 56 EL COMP TECHN C; NISHIKAWA M, 1993, J MAGN MAGN MATER, V126, P303, DOI 10.1016/0304-8853(93)90609-6; Ragab T, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204971; Ramaswami S, 2009, IEEE T DEVICE MAT RE, V9, P524, DOI 10.1109/TDMR.2009.2034317; Ranganathan N, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/7/075018; Rimskog M, 2007, P 32 IEEE CPMT INT E; Shen L, 2008, P 58 EL COMP TECHN C; Tanaka N, 2005, P 55 EL COMP TECHN C; Tummala RR, 2006, IEEE SPECTRUM, V43, P44, DOI 10.1109/MSPEC.2006.1638044; Wei BQ, 2001, APPL PHYS LETT, V79, P1172, DOI 10.1063/1.1396632; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	29	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40554	10.1371/journal.pone.0040554	http://dx.doi.org/10.1371/journal.pone.0040554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808192	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400036
J	Montgomery, CM; Watts, C; Pool, R				Montgomery, Catherine M.; Watts, Charlotte; Pool, Robert			HIV and Dyadic Intervention: An Interdependence and Communal Coping Analysis	PLOS ONE			English	Article							DISCORDANT COUPLES; CONDOM USE; PREVENTION; AFRICA; ACCEPTABILITY; TRANSMISSION; PARTNERS; BEHAVIOR; RISK	Background: The most common form of HIV transmission in sub-Saharan Africa is heterosexual sex between two partners. While most HIV prevention interventions are aimed at the individual, there is mounting evidence of the feasibility, acceptability, and efficacy of dyadic interventions. However, the mechanisms through which dyadic-level interventions achieve success remain little explored. We address this gap by using Lewis et al's interdependence model of couple communal coping and behaviour change to analyse data from partners participating in an HIV prevention trial in Uganda and Zambia. Methods and Findings: We conducted a comparative qualitative study using in-depth interviews. Thirty-three interviews were conducted in total; ten with couples and twenty-three with staff members at the two sites. The Ugandan site recruited a sero-discordant couple cohort and the Zambian site recruited women alone. Spouses' transformation of motivation is strong where couples are recruited and both partners stand to gain considerably by participating in the research; it is weaker where this is not the case. As such, coping mechanisms differ in the two sites; among sero-discordant couples in Uganda, communal coping is evidenced through joint consent to participate, regular couple counselling and workshops, sharing of HIV test results, and strong spousal support for adherence and retention. By contrast, coping at the Zambian site is predominantly left to the individual woman and occurs against a backdrop of mutual mistrust and male disenfranchisement. We discuss these findings in light of practical and ethical considerations of recruiting couples to HIV research. Conclusions: We argue for the need to consider the broader context within which behaviour change occurs and propose that future dyadic research be situated within the framework of the 'risk environment'.	[Montgomery, Catherine M.] Univ Oxford, Inst Sci Innovat & Soc, Sch Anthropol & Museum Ethnog, Oxford, England; [Montgomery, Catherine M.] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Watts, Charlotte] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Pool, Robert] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	University of Oxford; University of Amsterdam; University of London; London School of Hygiene & Tropical Medicine; ISGlobal; CRESIB; University of Barcelona; University of Amsterdam	Montgomery, CM (corresponding author), Univ Oxford, Inst Sci Innovat & Soc, Sch Anthropol & Museum Ethnog, Oxford, England.	catherine.montgomery@insis.ox.ac.uk		Montgomery, Catherine/0000-0002-5829-6137	Microbicides Development Programme; London School of Hygiene & Tropical Medicine; British Government Department for International Development (DIFD); UK Medical Research Council; UK Economic and Social Research Council [PTA-026-27-2714]; MRC [G0100137] Funding Source: UKRI; Economic and Social Research Council [ES/I008179/1] Funding Source: researchfish; Medical Research Council [G0100137] Funding Source: researchfish	Microbicides Development Programme; London School of Hygiene & Tropical Medicine; British Government Department for International Development (DIFD); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Fieldwork for this research was supported by a small grant from the Microbicides Development Programme administered through Imperial College, London, and the London School of Hygiene & Tropical Medicine. The Microbicides Development Programme (MDP) is a partnership of African, UK and Spanish academic government/institutions and commercial organisations. MDP was funded by the British Government Department for International Development (DIFD) and the UK Medical Research Council. Analysis and manuscript writing was supported by the UK Economic and Social Research Council [Grant Ref. PTA-026-27-2714]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin D, 2010, AIDS BEHAV, V14, pS185, DOI 10.1007/s10461-010-9805-x; Allen S, 2010, AIDS RES HUM RETROV, V26, pA20; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Beaulieu R, 2011, J NURS SCHOLARSHIP, V43, P41, DOI 10.1111/j.1547-5069.2010.01381.x; Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; Bloor M., 1995, SOCIOLOGY HIV TRANSM; BLOOR MJ, 1993, MED ANTHROPOL Q, V7, P152, DOI 10.1525/maq.1993.7.2.02a00020; Boesten J., 2009, GENDER HIV AIDS CRIT; Burton J, 2010, AIDS BEHAV, V14, P1, DOI 10.1007/s10461-008-9471-4; Carlander I, 2011, QUAL HEALTH RES, V21, P683, DOI 10.1177/1049732310396102; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Conkling M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-10; De Walque D, 2007, POPUL DEV REV, V33, P501, DOI 10.1111/j.1728-4457.2007.00182.x; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; El-Bassel N, 2010, JAIDS-J ACQ IMM DEF, V55, pS98, DOI 10.1097/QAI.0b013e3181fbf407; El-Bassel N, 2010, AIDS BEHAV, V14, P1011, DOI 10.1007/s10461-010-9699-7; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gelmon L, 2009, KENYA HIV PREVENTION; HEISE LL, 1995, SOC SCI MED, V40, P931, DOI 10.1016/0277-9536(94)00165-P; Hislop J., 2007, SOCIOLOGICAL RES ONL, V12, P2, DOI [10.5153/sro.1621, DOI 10.5153/SR0.1621]; Johnson BT, 2010, AIDS BEHAV, V14, pS204, DOI 10.1007/s10461-010-9803-z; Kairania RM, 2010, AIDS CARE, V22, P1041, DOI 10.1080/09540121003602226; Karney BR, 2010, AIDS BEHAV, V14, pS189, DOI 10.1007/s10461-010-9802-0; Kebaabetswe P, 2010, PATIENT EDUC COUNS, V79, P120, DOI 10.1016/j.pec.2009.07.017; Kelley H. H, 1978, INTERPERSONAL RELATI; Khobotlo M, 2009, LESOTHO HIV PREVENTI; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Lyons RF, 1998, J SOC PERS RELAT, V15, P579, DOI 10.1177/0265407598155001; Marlow HM, 2010, CULT HEALTH SEX, V12, P899, DOI 10.1080/13691058.2010.508843; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; McGrath N, 2010, S AFR MED J, V100, P4280; McMahon James M, 2003, BMC Med Res Methodol, V3, P24, DOI 10.1186/1471-2288-3-24; McMahon JM, 2003, BMC MED RES METHODOL, P2; Mngadi S, 2009, SWAZILAND HIV PREVEN; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Montgomery CM, 2010, CULT HEALTH SEX, V12, P649, DOI 10.1080/13691051003736261; Noble S, 2004, 8 IAVI; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Orne-Gliemann J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-197; PADIAN NS, 1993, J ACQ IMMUN DEF SYND, V6, P1043; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Pappas-DeLuca KA, 2006, HEALTH EDUC RES, V21, P611, DOI 10.1093/her/cyl030; Peterson D.R., 1983, CLOSE RELATIONSHIPS; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011600; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011632; Racier F. E., 2000, J FAMILY NURSING, V6, P367, DOI DOI 10.1177/107484070000600404; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Rispel LC, 2011, REPROD HEALTH MATTER, V19, P184, DOI 10.1016/S0968-8080(11)37552-0; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Witte SS, 2004, J WOMENS HEALTH, V13, P1137, DOI 10.1089/jwh.2004.13.1137	58	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40661	10.1371/journal.pone.0040661	http://dx.doi.org/10.1371/journal.pone.0040661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973NH	22808227	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000306366400044
J	Chang, WC; Liu, KL; Hsu, FC; Jeng, ST; Cheng, YS				Chang, Wei-Chieh; Liu, Kai-Lun; Hsu, Fang-Ciao; Jeng, Shih-Tong; Cheng, Yi-Sheng			Ipomoelin, a Jacalin-Related Lectin with a Compact Tetrameric Association and Versatile Carbohydrate Binding Properties Regulated by Its N Terminus	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; WOUND-INDUCIBLE PROTEIN; BETA-PRISM FOLD; PLANT-LECTINS; CRYSTAL-STRUCTURE; SWEET-POTATO; QUATERNARY ARRANGEMENT; STRUCTURAL BASIS; ORYZA-SATIVA; X-RAY	Many proteins are induced in the plant defense response to biotic stress or mechanical wounding. One group is lectins. Ipomoelin (IPO) is one of the wound-inducible proteins of sweet potato (Ipomoea batatas cv. Tainung 57) and is a Jacalin-related lectin (JRL). In this study, we resolved the crystal structures of IPO in its apo form and in complex with carbohydrates such as methyl alpha-D-mannopyranoside (Me-Man), methyl alpha-D-glucopyranoside (Me-Glc), and methyl alpha-D-galactopyranoside (Me-Gal) in different space groups. The packing diagrams indicated that IPO might represent a compact tetrameric association in the JRL family. The protomer of IPO showed a canonical beta-prism fold with 12 strands of beta-sheets but with 2 additional short alpha-strands at the N terminus. A truncated IPO (Delta N10IPO) by removing the 2 short beta-strands of the N terminus was used to reveal its role in a tetrameric association. Gel filtration chromatography confirmed IPO as a tetrameric form in solution. Isothermal titration calorimetry determined the binding constants (K-A) of IPO and Delta N10IPO against various carbohydrates. IPO could bind to Me-Man, Me-Glc, and Me-Gal with similar binding constants. In contrast, Delta N10IPO showed high binding ability to Me-Man and Me-Glc but could not bind to Me-Gal. Our structural and functional analysis of IPO revealed that its compact tetrameric association and carbohydrate binding polyspecificity could be regulated by the 2 additional N-terminal beta-strands. The versatile carbohydrate binding properties of IPO might play a role in plant defense.	[Chang, Wei-Chieh; Liu, Kai-Lun; Jeng, Shih-Tong; Cheng, Yi-Sheng] Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 10764, Taiwan; [Jeng, Shih-Tong; Cheng, Yi-Sheng] Natl Taiwan Univ, Dept Life Sci, Coll Life Sci, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Chang, WC (corresponding author), Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 10764, Taiwan.	chengys@ntu.edu.tw		Cheng, Yi-Sheng/0000-0002-4423-4381; Jeng, Shih-Tong/0000-0002-3522-2792	National Science Council, Taiwan [98-2313-B-002-059-MY2, 99-2313-B-002-005-MY3]; National Science Council of Taiwan, ROC	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	Financial support was from the National Science Council, Taiwan, to Y. S. Cheng (98-2313-B-002-059-MY2) and S. T. Jeng (99-2313-B-002-005-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data collection and processing were performed at the National Synchrotron Radiation Research Center supported by the National Science Council of Taiwan, ROC. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Research Program for Genomic Medicine.	BALZARINI J, 1992, ANTIVIR RES, V18, P191, DOI 10.1016/0166-3542(92)90038-7; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Bourne Y, 1999, STRUCTURE, V7, P1473, DOI 10.1016/S0969-2126(00)88338-0; Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YC, 2005, PLANT CELL ENVIRON, V28, P251, DOI 10.1111/j.1365-3040.2005.01271.x; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; del Sol FG, 2005, J MOL BIOL, V353, P574, DOI 10.1016/j.jmb.2005.08.055; Delano WL., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hwang IS, 2011, PLANT PHYSIOL, V155, P447, DOI 10.1104/pp.110.164848; Imanishi S, 1997, PLANT CELL PHYSIOL, V38, P643, DOI 10.1093/oxfordjournals.pcp.a029216; Jeyaprakash AA, 2005, J MOL BIOL, V347, P181, DOI 10.1016/j.jmb.2005.01.015; Jeyaprakash AA, 2003, J MOL BIOL, V332, P217, DOI 10.1016/S0022-2836(03)00901-X; Jiang JF, 2006, TOXICON, V47, P133, DOI 10.1016/j.toxicon.2005.10.010; Jih PJ, 2003, PLANT PHYSIOL, V132, P381, DOI 10.1104/pp.102.015701; Kanagawa M, 2011, BIOCHEM BIOPH RES CO, V404, P201, DOI 10.1016/j.bbrc.2010.11.093; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Keyaerts E, 2007, ANTIVIR RES, V75, P179, DOI 10.1016/j.antiviral.2007.03.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; Ma QH, 2010, BIOCHIMIE, V92, P187, DOI 10.1016/j.biochi.2009.11.008; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Miyake K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000687; Mo HQ, 2001, EUR J BIOCHEM, V268, P2609, DOI 10.1046/j.1432-1327.2001.02148.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Peumans WJ, 2000, FEBS LETT, V477, P186, DOI 10.1016/S0014-5793(00)01801-9; PONSTEIN AS, 1994, PLANT PHYSIOL, V104, P109, DOI 10.1104/pp.104.1.109; Pratap JV, 2002, J MOL BIOL, V317, P237, DOI 10.1006/jmbi.2001.5432; Rabijns A, 2005, FEBS J, V272, P3725, DOI 10.1111/j.1742-4658.2005.04801.x; Rani PG, 1999, J BIOL CHEM, V274, P29694, DOI 10.1074/jbc.274.42.29694; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Schouppe D, 2011, PLANT PHYSIOL, V155, P1091, DOI 10.1104/pp.110.170134; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; Van Damme EJM, 2004, TRENDS PLANT SCI, V9, P484, DOI 10.1016/j.tplants.2004.08.003; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005; Wong JH, 2010, APPL MICROBIOL BIOT, V87, P1221, DOI 10.1007/s00253-010-2690-4; Zhang WL, 2000, PLANTA, V210, P970, DOI 10.1007/s004250050705; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40618	10.1371/journal.pone.0040618	http://dx.doi.org/10.1371/journal.pone.0040618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808208	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400086
J	Bello, M; Valderrama, B; Serrano-Posada, H; Rudino-Pinera, E				Bello, Martiniano; Valderrama, Brenda; Serrano-Posada, Hugo; Rudino-Pinera, Enrique			Molecular Dynamics of a Thermostable Multicopper Oxidase from Thermus thermophilus HB27: Structural Differences between the Apo and Holo Forms	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; COPPER PLASTOCYANIN; ELECTRON TRANSFERS; DISULFIDE BRIDGE; AZURIN; SIMULATION; MOTIONS; LACCASE; ION; STABILITY	Molecular dynamic (MD) simulations have been performed on Tth-MCO, a hyperthermophilic multicopper oxidase from thermus thermophilus HB27, in the apo as well as the holo form, with the aim of exploring the structural dynamic properties common to the two conformational states. According to structural comparison between this enzyme and other MCOs, the substrate in process to electron transfer in an outer-sphere event seems to transiently occupy a shallow and overall hydrophobic cavity near the Cu type 1 (T1Cu). The linker connecting the beta-strands 21 and 24 of the second domain (loop (beta 21-beta 24)(D2)) has the same conformation in both states, forming a flexible lid at the entrance of the electron-transfer cavity. Loop (beta 21-beta 24)(D2) has been tentatively assigned a role occluding the access to the electron-transfer site. The dynamic of the loop (beta 21-beta 24)(D2) has been investigated by MD simulation, and results show that the structures of both species have the same secondary and tertiary structure during almost all the MD simulations. In the simulation, loop (beta 21-beta 24)(D2) of the holo form undergoes a higher mobility than in the apo form. In fact, loop (beta 21-beta 24)(D2) of the holo form experiences a conformational change which enables exposure to the electron-transfer site (open conformation), while in the apo form the opposite effect takes place (closed conformation). To confirm the hypothesis that the open conformation might facilitate the transient electron-donor molecule occupation of the site, the simulation was extended another 40 ns with the electron-donor molecule docked into the protein cavity. Upon electron-donor molecule stabilization, loops near the cavity reduce their mobility. These findings show that coordination between the copper and the protein might play an important role in the general mobility of the enzyme, and that the open conformation seems to be required for the electron transfer process to T1Cu.	[Bello, Martiniano; Valderrama, Brenda; Serrano-Posada, Hugo; Rudino-Pinera, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Bello, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico.	bmartini@ibt.unam.mx; rudino@ibt.unam.mx	Bello, Martiniano/AAH-4134-2019	Bello Ramirez, Martiniano/0000-0002-9686-0755; Valderrama, Brenda/0000-0002-5510-9439; Rudino-Pinera, Enrique/0000-0001-8170-6379; Serrano-Posada, Hugo/0000-0002-7901-475X	Direccion General Asuntos del Personal Academico (DGAPA); Universidad nacional autonoma de Mexico (UNAM); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [204611]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [102370, 128156]; Program of Postdoctoral Scholarships from DGAPA (UNAM)	Direccion General Asuntos del Personal Academico (DGAPA); Universidad nacional autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Program of Postdoctoral Scholarships from DGAPA (UNAM)	This work was supported in part by Direccion General Asuntos del Personal Academico (DGAPA), Universidad nacional autonoma de Mexico (UNAM) [Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), grant 204611] and Consejo Nacional de Ciencia y Tecnologia (CONACyT) [Grant 102370 and 128156]. M.B. acknowledges the Program of Postdoctoral Scholarships from DGAPA (UNAM). Computer support and CPU time for the simulations were facilitated by Direccion General de Computo y de Tecnologias de Informacion y Comunicacion (DGTIC), UNAM and the cluster of the Instituto de Biotecnologia, UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arcangeli C, 2001, BIOPHYS CHEM, V92, P183, DOI 10.1016/S0301-4622(01)00199-5; Arcangeli C, 1999, BIOPHYS CHEM, V78, P247, DOI 10.1016/S0301-4622(99)00029-0; Arcangeli C, 2001, BIOPHYS CHEM, V90, P45, DOI 10.1016/S0301-4622(01)00128-4; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Auerbach G, 1998, STRUCTURE, V6, P769, DOI 10.1016/S0969-2126(98)00078-1; Augustine AJ, 2007, J AM CHEM SOC, V129, P13118, DOI 10.1021/ja073905m; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bello M, 2012, BIOPHYS CHE IN PRESS; Bello M, 2011, BIOCHEMISTRY-US, V50, P151, DOI 10.1021/bi1016155; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Chaboy J, 2011, CHEM BIOL, V18, P25, DOI 10.1016/j.chembiol.2010.12.006; Ciocchetti A, 1997, BIOPHYS CHEM, V69, P185, DOI 10.1016/S0301-4622(97)00089-6; Comba P, 2000, COORDIN CHEM REV, V200, P217, DOI 10.1016/S0010-8545(00)00265-4; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diaz-Vergara N, 2008, J PHYS CHEM B, V112, P3529, DOI 10.1021/jp7102275; Dick GJ, 2008, APPL ENVIRON MICROB, V74, P1527, DOI 10.1128/AEM.01240-07; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Enguita FJ, 2004, J BIOL CHEM, V279, P23472, DOI 10.1074/jbc.M314000200; Festa G, 2008, PROTEINS, V72, P25, DOI 10.1002/prot.21889; Glattli A, 2006, EUR BIOPHYS J BIOPHY, V35, P255, DOI 10.1007/s00249-005-0033-7; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; HARTE WE, 1990, P NATL ACAD SCI USA, V87, P8864, DOI 10.1073/pnas.87.22.8864; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Knapp S, 1997, J MOL BIOL, V267, P916, DOI 10.1006/jmbi.1996.0900; Korzhnev DM, 2003, PROTEIN SCI, V12, P56, DOI 10.1110/ps.0225403; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Milardi D, 2003, ARCH BIOCHEM BIOPHYS, V414, P121, DOI 10.1016/S0003-9861(03)00167-X; Missimer JH, 2007, PROTEIN SCI, V16, P1349, DOI 10.1110/ps.062542907; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Quintanar L, 2005, BIOCHEMISTRY-US, V44, P6081, DOI 10.1021/bi047379c; Quintanar L, 2007, ACCOUNTS CHEM RES, V40, P445, DOI 10.1021/ar600051a; Rizzuti B, 2004, J MOL MODEL, V10, P25, DOI 10.1007/s00894-003-0165-6; Rizzuti B, 2007, BIOPHYS CHEM, V125, P532, DOI 10.1016/j.bpc.2006.11.003; Rizzuti B, 2009, PROTEINS, V74, P961, DOI 10.1002/prot.22204; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Serrano-Posada H, 2011, ACTA CRYSTALLOGR F, V67, P1595, DOI 10.1107/S174430911103805X; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Tang L, 2007, J BIOMOL STRUCT DYN, V24, P379, DOI 10.1080/07391102.2007.10507127; van den Bosch M, 2006, THESIS LEIDEN U, P63; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zhuravleva AV, 2004, J MOL BIOL, V342, P1599, DOI 10.1016/j.jmb.2004.08.001	58	26	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40700	10.1371/journal.pone.0040700	http://dx.doi.org/10.1371/journal.pone.0040700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808237	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500072
J	Hytonen, MK; Arumilli, M; Lappalainen, AK; Kallio, H; Snellman, M; Sainio, K; Lohi, H				Hytonen, Marjo K.; Arumilli, Meharji; Lappalainen, Anu K.; Kallio, Heli; Snellman, Marjatta; Sainio, Kirsi; Lohi, Hannes			A Novel GUSB Mutation in Brazilian Terriers with Severe Skeletal Abnormalities Defines the Disease as Mucopolysaccharidosis VII	PLOS ONE			English	Article							BETA-GLUCURONIDASE DEFICIENCY; ENZYME REPLACEMENT THERAPY; L-IDURONIDASE LARONIDASE; MPS-VII; OSTEOBLAST DIFFERENTIATION; OSTEOGENESIS IMPERFECTA; IDENTIFICATION; MODEL; MOUSE; CDNA	Hundreds of different human skeletal disorders have been characterized at molecular level and a growing number of resembling dysplasias with orthologous genetic defects are being reported in dogs. This study describes a novel genetic defect in the Brazilian Terrier breed causing a congenital skeletal dysplasia. Affected puppies presented severe skeletal deformities observable within the first month of life. Clinical characterization using radiographic and histological methods identified delayed ossification and spondyloepiphyseal dysplasia. Pedigree analysis suggested an autosomal recessive disorder, and we performed a genome-wide association study to map the disease locus using Illumina's 22K SNP chip arrays in seven cases and eleven controls. A single association was observed near the centromeric end of chromosome 6 with a genome-wide significance after permutation (p(genome) = 0.033). The affected dogs shared a 13-Mb homozygous region including over 200 genes. A targeted next-generation sequencing of the entire locus revealed a fully segregating missense mutation (c.866C > T) causing a pathogenic p.P289L change in a conserved functional domain of beta-glucuronidase (GUSB). The mutation was confirmed in a population of 202 Brazilian terriers (p = 7,71 x 10(-29)). GUSB defects cause mucopolysaccharidosis VII (MPS VII) in several species and define the skeletal syndrome in Brazilian Terriers. Our results provide new information about the correlation of the GUSB genotype to phenotype and establish a novel canine model for MPS VII. Currently, MPS VII lacks an efficient treatment and this model could be utilized for the development and validation of therapeutic methods for better treatment of MPS VII patients. Finally, since almost one third of the Brazilian terrier population carries the mutation, breeders will benefit from a genetic test to eradicate the detrimental disease from the breed.	[Hytonen, Marjo K.; Arumilli, Meharji; Kallio, Heli; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland; [Hytonen, Marjo K.; Arumilli, Meharji; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Hytonen, Marjo K.; Sainio, Kirsi] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Lappalainen, Anu K.; Snellman, Marjatta] Univ Helsinki, Fac Vet Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Hytonen, MK (corresponding author), Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Arumilli, Meharji/0000-0003-4072-0996; Hytonen, Marjo/0000-0003-1976-5874	Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University of Helsinki Research Funds; Biocentrum Helsinki; European Comission [GA-201370]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; University of Helsinki Research Funds; Biocentrum Helsinki; European Comission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Academy of Finland (www.aka.fi), the Sigrid Juselius Foundation (www.sigridjuselius.fi), the Jane and Aatos Erkko Foundation (www.jaes.fi), The University of Helsinki Research Funds (/www.helsinki.fi/funds), Biocentrum Helsinki (www.helsinki.fi/biocentrum), and the European Comission (FP7-LUPA, GA-201370)(www.eurolupa.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldenboven M, 2008, BIOL BLOOD MARROW TR, V14, P485, DOI 10.1016/j.bbmt.2008.01.009; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; Campbell BG, 2000, ARCH BIOCHEM BIOPHYS, V384, P37, DOI 10.1006/abbi.2000.2099; Campbell BG, 2001, J BONE MINER RES, V16, P1147, DOI 10.1359/jbmr.2001.16.6.1147; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; DEJONG JGN, 1992, CLIN CHEM, V38, P803; Dombrowski DCS, 2004, JAVMA-J AM VET MED A, V224, P553, DOI 10.2460/javma.2004.224.553; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Fyfe JC, 1999, GENOMICS, V58, P121, DOI 10.1006/geno.1999.5825; GITZELMANN R, 1994, VET PATHOL, V31, P435, DOI 10.1177/030098589403100405; Gwynn B, 1998, MOL CELL BIOL, V18, P6474, DOI 10.1128/MCB.18.11.6474; HASKINS ME, 1984, PEDIATR RES, V18, P980, DOI 10.1203/00006450-198418100-00014; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; LOMBARDO A, 1980, CLIN CHIM ACTA, V108, P337, DOI 10.1016/0009-8981(80)90339-3; Muenzer J, 2004, J PEDIATR-US, V144, pS27, DOI 10.1016/j.jpeds.2004.01.052; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Ponder KP, 2002, P NATL ACAD SCI USA, V99, P13102, DOI 10.1073/pnas.192353499; Prasad VK, 2010, SEMIN HEMATOL, V47, P59, DOI 10.1053/j.seminhematol.2009.10.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ray J, 1998, GENOMICS, V48, P248, DOI 10.1006/geno.1997.5189; Schultheiss PC, 2000, VET PATHOL, V37, P502, DOI 10.1354/vp.37-5-502; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; Sly WS, 2001, P NATL ACAD SCI USA, V98, P2205, DOI 10.1073/pnas.051623698; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Tomatsu S, 2003, HUM MOL GENET, V12, P961, DOI 10.1093/hmg/ddg119; Tomatsu S, 2002, P NATL ACAD SCI USA, V99, P14982, DOI 10.1073/pnas.232570999; Tomatsu S, 2009, HUM MUTAT, V30, P511, DOI 10.1002/humu.20828; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wraith JE, 2007, PEDIATRICS, V120, pE37, DOI 10.1542/peds.2006-2156; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	39	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40281	10.1371/journal.pone.0040281	http://dx.doi.org/10.1371/journal.pone.0040281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22815736	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300044
J	Chen, WS; Hu, JY; Zhang, ZH; Chen, LL; Xie, H; Dong, N; Chen, YX; Liu, ZG				Chen, Wensheng; Hu, Jiaoyue; Zhang, Zhenhao; Chen, Lelei; Xie, Hui; Dong, Nuo; Chen, Yongxiong; Liu, Zuguo			Localization and Expression of Zonula Occludins-1 in the Rabbit Corneal Epithelium following Exposure to Benzalkonium Chloride	PLOS ONE			English	Article							END-POINT ANALYSIS; TIGHT JUNCTION; BARRIER FUNCTION; OCULAR SURFACE; PROTEIN; DISRUPTION; RESISTANCE; CELLS; ZO-1; ACTIN	Preservatives are a major component of the ophthalmic preparations in multi-dose bottles. The purpose of this study was to investigate the acute effect of benzalkonium chloride (BAC), a common preservative used in ophthalmic preparations, on the localization and expression of zonula occludens (ZO)-1 in the rabbit corneal epithelium in vivo. BAC at 0.005%, 0.01%, or 0.02% was topically applied to one eye each of albino rabbits at 5 min intervals for a total of 3 times. The contralateral untreated eyes served as controls. The following clinical indications were evaluated: Schirmer test, tear break-up time (BUT), fluorescein and rose Bengal staining. The structure of central cornea was examined by in vivo confocal microscopy, and the corneal barrier function was evaluated by measurement of corneal transepithelial electrical resistance and permeability to carboxy fluorescein. Whole mount corneas were analyzed by using fluorescence confocal microscopy for the presence of ZO-1, 2, occludin, claudin-1, Ki67 and cell apoptosis in the epithelium. The expression of ZO-1 in the corneal epithelium was also examined by western blot and reverse transcription-polymerase chain reaction analyses. Exposure to BAC resulted in higher rose Bengal staining scores while no significant changes in BUT, Schirmer and corneal florescein scores. It also induced corneal epithelial cell damage, dispersion of ZO-1 and ZO-2 from their normal locus at the superficial layer and disruption of epithelial barrier function. However, the amounts of ZO-1 mRNA and protein in the corneal epithelium were not affected by BAC treatment. Exposure to BAC can quickly impair the corneal epithelium without tear deficiency. BAC disrupts the tight junctions of corneal epithelium between superficial cells in the rabbit corneal epithelium in vivo.	[Chen, Wensheng] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Inst Eye, Fujian, Peoples R China; Xiamen Univ, Affiliated Xiamen Eye Ctr, Fujian, Peoples R China	Xiamen University; Xiamen University	Chen, WS (corresponding author), Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Inst Eye, Fujian, Peoples R China.	cwensheng@hotmail.com; zuguoliu@xmu.edu.cn			National Basic Research Program of China (Project 973) [2011CB504606]; National Natural Science Foundation of China, Beijing, China [30973249, 81100638]; Natural Science Foundation of Fujian Province, China [2009J01201]; Technological innovation platform program of Fujian Province, China [2009J1013]	National Basic Research Program of China (Project 973)(National Basic Research Program of China); National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Technological innovation platform program of Fujian Province, China	This work was supported by the National Basic Research Program of China (Project 973) Grant 2011CB504606; National Natural Science Foundation of China, Beijing, China (grant no: 30973249, 81100638); and Natural Science Foundation of Fujian Province, China (grant no: 2009J01201); Technological innovation platform program of Fujian Province, China (grant no: 2009J1013). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Champeau E, 1986, PREOCULAR TEAR FILM, P292; Chen WS, 2007, CORNEA, V26, P1101, DOI 10.1097/ICO.0b013e318123771e; Chen WS, 2007, EXP EYE RES, V84, P626, DOI 10.1016/j.exer.2006.11.006; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; FEENSTRA RPG, 1992, ARCH OPHTHALMOL-CHIC, V110, P984, DOI 10.1001/archopht.1992.01080190090035; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; Georgiev GA, 2011, INVEST OPHTH VIS SCI, V52, P4645, DOI 10.1167/iovs.10-6271; Guo Y, 2007, INVEST OPHTH VIS SCI, V48, P2001, DOI 10.1167/iovs.06-0613; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Jean MD, 1999, INVEST OPHTH VIS SCI, V40, P619; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Khan-Lim D, 2004, CURR EYE RES, V29, P311, DOI 10.1080/02713680490516864; Kimura K, 2009, INVEST OPHTH VIS SCI, V50, P597, DOI 10.1167/iovs.08-2606; Kusano M, 2010, CORNEA, V29, P80, DOI 10.1097/ICO.0b013e3181a3c3e6; Li Z., 2011, PLOS ONE, DOI [10.1371/journal.pone.0026103, DOI 10.1371/JOURNAL.PONE.0026103]; Mandell KJ, 2006, INVEST OPHTH VIS SCI, V47, P2408, DOI 10.1167/iovs.05-0745; MCLAUGHLIN BJ, 1985, CURR EYE RES, V4, P951, DOI 10.3109/02713689509000002; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Mokhtarzadeh M, 2011, INVEST OPHTH VIS SCI, V52, P2127, DOI 10.1167/iovs.10-6489; Nakamura T, 2010, BIOL PHARM BULL, V33, P107, DOI 10.1248/bpb.33.107; Pauly A, 2011, MOL VIS, V17, P745; Pauly A, 2007, INVEST OPHTH VIS SCI, V48, P5473, DOI 10.1167/iovs.06-0728; Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992; Petroll WM, 1996, CORNEA, V15, P525; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pisella PJ, 2000, OPHTHALMIC RES, V32, P3, DOI 10.1159/000055579; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Swan K. C., 1944, AM J OPHTHALMOL, V27, P1118; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Uematsu M, 2010, CORNEA, V29, P1296, DOI 10.1097/ICO.0b013e3181dc81b6; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Yanai R, 2009, INVEST OPHTH VIS SCI, V50, P4605, DOI 10.1167/iovs.09-3407; YOKOI N, 1995, CORNEA, V14, P485	42	26	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40893	10.1371/journal.pone.0040893	http://dx.doi.org/10.1371/journal.pone.0040893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815857	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900058
J	Hsieh, SH; Lin, CJ; Chen, P				Hsieh, Shu-Hua; Lin, Chun-Ju; Chen, Peichen			Sexual Compatibility among Different Host-Originated Isolates of Aphelenchoides besseyi and the Inheritance of the Parasitism	PLOS ONE			English	Article							MELOIDOGYNE	Nine isolates of Aphelenchoides besseyi from two different hosts were studied. The isolates were identified at the species level according to morphometrics and fine structures observed under a scanning electron microscope. Two fern-originated isolates, Fu, and Fm, one rice-originated isolate, Rl, were not able to reproduce from a single juvenile, based on at least 50 replicates. The other six isolates were able to develop into a small population when inoculated with a single juvenile, demonstrating parthenogenesis. Crosses between isolates were conducted. In a compatibility cross experiment, three fern-originated isolates were selfed and crossed reciprocally, and all nine crossings had viable offspring. When fern isolates were used as paternal lines, the only two successful crosses were with the Rd line, and as maternal lines, only the Ff x Re and Fu x Rn crosses had viable offspring. Rl was used as the maternal line and Fm as the paternal line to study the inheritance of the bird's-nest fern parasitism. Twenty of the 80 attempted crosses resulted in viable offspring and among these; six lines had the ability to parasitize on the bird's-nest fern. When the F-1 lines were back-crossed to the Rl maternal line, 20 viable offspring lines were obtained and among them 4 were able to parasitize bird's-nest fern. These results indicate that bird's-nest fern parasitism can be transferred to new generations by cross fertilization.	[Hsieh, Shu-Hua; Lin, Chun-Ju; Chen, Peichen] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan	National Chung Hsing University	Hsieh, SH (corresponding author), Panlabs Biol Inc, Taipei, Taiwan.	janetchen@nchu.edu.tw			National Science council [NSC 99-2815-C-005-014-B]	National Science council(Ministry of Science and Technology, Taiwan)	This work was partially supported by the National Science council, project number: NSC 99-2815-C-005-014-B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALLEN M. W., 1952, PROC HELMINTHOL SOC WASHINGTON, V19, P108; Baicheva O., 1998, Experimental Pathology and Parasitology, V1, P3; Bridge J., 1990, P69; Chen PC, 2003, NEMATOLOGY, V5, P687, DOI 10.1163/156854103322746869; De Waele D., 2002, P141, DOI 10.1079/9780851994666.0141; Franklin MT, 1972, DESCRIPTIONS PLANT P; Hesling JJ, 1977, DESCRIPTIONS PLANT P; Hooper DJ, 1975, DESCRIPTIONS PLANT P; HUANG CS, 1979, NEMATOLOGICA, V25, P255, DOI 10.1163/187529279X00271; Hugall A, 1999, MOL BIOL EVOL, V16, P157, DOI 10.1093/oxfordjournals.molbev.a026098; Hunt DJ, 1993, APHELENCHIDA LONGIDO; Janssen R, 1991, NEMATOLOGY, V14, P213; Lin Y. Y., 1992, Plant Protection Bulletin (Taichung), V34, P202; Riggs Robert D., 1991, P827; Siddiqi MR, 1975, DESCRIPTIONS PLANT P; Siddiqi MR, 1974, DESCRIPTIONS PLANT P; Siddiqui IA, 1976, DESCRIPTIONS PLANT P; Sturhan D, 1971, PLANT PARASIT NEMAT, VII, P51; Tamarin RH, 2002, PRINCIPLES GENETICS; Triantaphyllou AC, 1985, BIOL CONTROL, VII, P113; Tsay T. T., 1995, Plant Pathology Bulletin, V4, P180; Tsay T. T., 1998, Plant Protection Bulletin (Taichung), V40, P277; Tzeng C. Y., 2005, Plant Pathology Bulletin, V14, P67; Wang K. M., 1993, Plant Protection Bulletin (Taichung), V35, P14; Yu P. C., 2004, Plant Pathology Bulletin, V13, P35	25	7	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40886	10.1371/journal.pone.0040886	http://dx.doi.org/10.1371/journal.pone.0040886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815854	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900057
J	Huntjens, RJC; Verschuere, B; McNally, RJ				Huntjens, Rafaele J. C.; Verschuere, Bruno; McNally, Richard J.			Inter-Identity Autobiographical Amnesia in Patients with Dissociative Identity Disorder	PLOS ONE			English	Article							MULTIPLE PERSONALITY-DISORDER; MEMORY TRANSFER; ATTENTION; STATES	Background: A major symptom of Dissociative Identity Disorder (DID; formerly Multiple Personality Disorder) is dissociative amnesia, the inability to recall important personal information. Only two case studies have directly addressed autobiographical memory in DID. Both provided evidence suggestive of dissociative amnesia. The aim of the current study was to objectively assess transfer of autobiographical information between identities in a larger sample of DID patients. Methods: Using a concealed information task, we assessed recognition of autobiographical details in an amnesic identity. Eleven DID patients, 27 normal controls, and 23 controls simulating DID participated. Controls and simulators were matched to patients on age, education level, and type of autobiographical memory tested. Findings: Although patients subjectively reported amnesia for the autobiographical details included in the task, the results indicated transfer of information between identities. Conclusion: The results call for a revision of the DID definition. The amnesia criterion should be modified to emphasize its subjective nature.	[Huntjens, Rafaele J. C.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Verschuere, Bruno] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Verschuere, Bruno] Univ Ghent, Dept Psychol, B-9000 Ghent, Belgium; [Verschuere, Bruno] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands; [McNally, Richard J.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Groningen; University of Amsterdam; Ghent University; Maastricht University; Harvard University	Huntjens, RJC (corresponding author), Univ Groningen, Dept Clin Psychol, Groningen, Netherlands.	R.J.C.Huntjens@rug.nl	huntjens, rafaele/F-2403-2014	VERSCHUERE, BRUNO/0000-0002-6161-4415; Huntjens, Rafaele/0000-0001-6329-9810	Netherlands Organization for Scientific Research (NWO) [451-05-018]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by Innovative Research Veni grant 451-05-018 from the Netherlands Organization for Scientific Research (NWO) awarded to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJ, 2011, MEMORY DETECTION THE, P231; Allen JJB, 2000, INT J PSYCHOPHYSIOL, V38, P21, DOI 10.1016/S0167-8760(00)00128-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], COMPREHENSIVE HDB PS; Boon S., 1993, MULTIPLE PERSONALITY; BRYANT RA, 1995, J ABNORM PSYCHOL, V104, P625, DOI 10.1037/0021-843X.104.4.625; Cardena E, 2000, ENCY PSYCHOL, P55; Carlson EB, 1993, DISSOCIATION PROGR D, V6, P16, DOI DOI 10.1177/1073191116645904; Dorahy MJ, 2001, CLIN PSYCHOL REV, V21, P771, DOI 10.1016/S0272-7358(00)00068-4; Dorahy MJ, 2007, TRAUMATIC DISSOCIATI, P55; Eich E, 1997, PSYCHOL SCI, V8, P417, DOI 10.1111/j.1467-9280.1997.tb00454.x; Elzinga BM, 2003, J ABNORM PSYCHOL, V112, P237, DOI 10.1037/0021-843X.112.2.237; Giesbrecht T, 2008, PSYCHOL BULL, V134, P617, DOI 10.1037/0033-2909.134.5.617; Gronau N, 2003, J EXP PSYCHOL GEN, V132, P512, DOI 10.1037/0096-3445.132.4.512; Huntjens RJC, 2007, BEHAV RES THER, V45, P775, DOI 10.1016/j.brat.2006.07.001; Huntjens RJC, 2006, PSYCHOL MED, V36, P857, DOI 10.1017/S0033291706007100; Huntjens RJC, 2005, CONSCIOUS COGN, V14, P377, DOI 10.1016/j.concog.2004.10.001; Huntjens RJC, 2005, BEHAV RES THER, V43, P243, DOI 10.1016/j.brat.2004.01.007; Huntjens RJC, 2003, J ABNORM PSYCHOL, V112, P290, DOI 10.1037/0021-843X.112.2.290; Huntjens RJC, 2002, MEM COGNITION, V30, P1033, DOI 10.3758/BF03194321; Kihlstrom J. F., 1995, HDB MEMORY DISORDERS, P337; Kong LL, 2008, J ABNORM PSYCHOL, V117, P686, DOI 10.1037/0021-843X.117.3.686; LUDWIG AM, 1972, ARCH GEN PSYCHIAT, V26, P298; LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; McNally Richard J., 2003, REMEMBERING TRAUMA; Merckelbach H, 2001, CLIN PSYCHOL REV, V22, P1; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Nijenhuis Ellert R. S., 1999, SPLINTERED REFLECTIO, P39; Nijenhuis ERS, 1996, J NERV MENT DIS, V184, P688, DOI 10.1097/00005053-199611000-00006; NISSEN MJ, 1988, BRAIN COGNITION, V8, P117, DOI 10.1016/0278-2626(88)90043-7; Peters ML, 1998, CONSCIOUS COGN, V7, P27, DOI 10.1006/ccog.1997.0323; Putnam F. W., 1997, DISSOCIATION CHILDRE; Rosenfeld J.P., 2011, MEMORY DETECTION THE, P63, DOI [10.1017/CBO9780511975196.005, DOI 10.1017/CBO9780511975196.005]; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; SCHACTER DL, 1989, J ABNORM PSYCHOL, V98, P508, DOI 10.1037/0021-843X.98.4.508; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SILBERMAN EK, 1985, PSYCHIAT RES, V15, P253, DOI 10.1016/0165-1781(85)90062-9; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; SPIEGEL D, 1993, AM PSYCHIATRIC PRESS, V12, P747; Spiegel D, 2011, DEPRESS ANXIETY, V28, P824, DOI 10.1002/da.20874; Steinberg M., 1994, STRUCTURED CLIN INTE; Verhage F., 1964, INTELLIGENTIE LEEFTI	42	37	37	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40580	10.1371/journal.pone.0040580	http://dx.doi.org/10.1371/journal.pone.0040580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815769	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900034
J	Krakauer, NY; Krakauer, JC				Krakauer, Nir Y.; Krakauer, Jesse C.			A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; CARDIOMETABOLIC RISK; SCREENING TOOL; HEART-DISEASE; WEIGHT-LOSS; OBESITY; ADIPOSITY; FAT	Background: Obesity, typically quantified in terms of Body Mass Index (BMI) exceeding threshold values, is considered a leading cause of premature death worldwide. For given body size (BMI), it is recognized that risk is also affected by body shape, particularly as a marker of abdominal fat deposits. Waist circumference (WC) is used as a risk indicator supplementary to BMI, but the high correlation of WC with BMI makes it hard to isolate the added value of WC. Methods and Findings: We considered a USA population sample of 14,105 non-pregnant adults (age >= 18) from the National Health and Nutrition Examination Survey (NHANES) 1999-2004 with follow-up for mortality averaging 5 yr (828 deaths). We developed A Body Shape Index (ABSI) based on WC adjusted for height and weight: ABSI equivalent to WC/BMI(2/3)height(1/2). ABSI had little correlation with height, weight, or BMI. Death rates increased approximately exponentially with above average baseline ABSI (overall regression coefficient of +33% per standard deviation of ABSI [95% confidence interval: +20%-+48%]), whereas elevated death rates were found for both high and low values of BMI and WC. 22% (8%-41%) of the population mortality hazard was attributable to high ABSI, compared to 15% (3%-30%) for BMI and 15% (4%-29%) for WC. The association of death rate with ABSI held even when adjusted for other known risk factors including smoking, diabetes, blood pressure, and serum cholesterol. ABSI correlation with mortality hazard held across the range of age, sex, and BMI, and for both white and black ethnicities (but not for Mexican ethnicity), and was not weakened by excluding deaths from the first 3 yr of follow-up. Conclusions: Body shape, as measured by ABSI, appears to be a substantial risk factor for premature mortality in the general population derivable from basic clinical measurements. ABSI expresses the excess risk from high WC in a convenient form that is complementary to BMI and to other known risk factors.	[Krakauer, Nir Y.] CUNY, Dept Civil Engn, New York, NY 10021 USA; [Krakauer, Jesse C.] Middletown Med, Middletown, NY USA	City University of New York (CUNY) System	Krakauer, NY (corresponding author), CUNY, Dept Civil Engn, New York, NY 10021 USA.	nkrakauer@ccny.cuny.edu	Krakauer, Jesse/AAV-2692-2021					Allison DB, 1997, INT J OBESITY, V21, P424, DOI 10.1038/sj.ijo.0800423; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Atlantis E, 2010, AGE AGEING, V39, P643, DOI 10.1093/ageing/afq073; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Burton RF, 2010, MED HYPOTHESES, V75, P115, DOI 10.1016/j.mehy.2010.02.003; Cameron AJ, 2012, INT J EPIDEMIOLOGY; Campos P, 2006, INT J EPIDEMIOL, V35, P55, DOI 10.1093/ije/dyi254; Cepeda-Valery B, 2011, NAT REV CARDIOL, V8, P233, DOI 10.1038/nrcardio.2010.209; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Flegal KM, 2009, AM J CLIN NUTR, V89, P1213, DOI 10.3945/ajcn.2008.26698; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Gulsvik AK, 2009, EUR J EPIDEMIOL, V24, P683, DOI 10.1007/s10654-009-9390-3; Han TS, 1997, INT J OBESITY, V21, P127, DOI 10.1038/sj.ijo.0800377; Hansen P.C., 1998, RANK DEFICIENT DISCR; Heitmann BL, 2011, OBES REV, V12, P478, DOI 10.1111/j.1467-789X.2010.00794.x; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heymsfield SB, 2009, INT J OBESITY, V33, P1363, DOI 10.1038/ijo.2009.184; Heymsfield SB, 2011, AM J CLIN NUTR, V93, P302, DOI 10.3945/ajcn.110.005132; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Kang SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027694; Katzmarzyk PT, 2012, BONE, V50, P576, DOI 10.1016/j.bone.2011.04.012; Keele L, 2010, POLIT ANAL, V18, P189, DOI 10.1093/pan/mpp044; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; King NA, 2009, BRIT J SPORT MED, V43, P924, DOI 10.1136/bjsm.2009.065557; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kuh D, 2009, BRIT ACTUARIAL J, V15, P17, DOI DOI 10.1017/S135732170000550X; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Li WC, 2011, EUROPEAN J NUTR; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; MacKay NJ, 2010, J BIOMECH, V43, P764, DOI 10.1016/j.jbiomech.2009.10.038; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Moore SC, 2009, AM J CLIN NUTR, V89, P1003, DOI 10.3945/ajcn.2009.27598; National Center for Health Statistics (NCHS), 2011, NAT HLTH NUTR EX SUR; NCHS, 2006, INVESTIGATION CHANNE; Nevill AM, 2006, AM J PHYS ANTHROPOL, V129, P151, DOI 10.1002/ajpa.20262; NHANES, 2002, INVESTIGATION CHANNE; NHLBI, 1998, 984083  NAT HEART LU; Nilsson G, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000012; Petursson H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026621; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Ruhl CE, 2010, GASTROENTEROLOGY, V138, P1346, DOI 10.1053/j.gastro.2009.12.053; Seidell JC, 2010, EUR J CLIN NUTR, V64, P35, DOI 10.1038/ejcn.2009.71; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Therneau T.M., 2000, MODELING SURVIVAL DA; WHO, 2009, INVESTIGATION CHANNE; WHO, 2011, INVESTIGATION CHANNE; World Health Organization, 2000, WHO OB TECHN REP SER	55	486	509	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e39504	10.1371/journal.pone.0039504	http://dx.doi.org/10.1371/journal.pone.0039504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815707	gold, Green Published			2022-12-27	WOS:000306548900009
J	Musch, K; Engel, AK; Schneider, TR				Muesch, Kathrin; Engel, Andreas K.; Schneider, Till R.			On the Blink: The Importance of Target-Distractor Similarity in Eliciting an Attentional Blink with Faces	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; EMOTIONAL STIMULI; WORKING-MEMORY; HUMAN AMYGDALA; IDENTIFICATION; AWARENESS; CAPTURE; MASKING; TASK; EXPRESSIONS	Temporal allocation of attention is often investigated with a paradigm in which two relevant target items are presented in a rapid sequence of irrelevant distractors. The term Attentional Blink (AB) denotes a transient impairment of awareness for the second of these two target items when presented close in time. Experimental studies reported that the AB is reduced when the second target is emotionally significant, suggesting a modulation of attention allocation. The aim of the present study was to systematically investigate the influence of target-distractor similarity on AB magnitude for faces with emotional expressions under conditions of limited attention in a series of six rapid serial visual presentation experiments. The task on the first target was either to discriminate the gender of a neutral face (Experiments 1, 3-6) or an indoor/outdoor visual scene (Experiment 2). The task on the second target required either the detection of emotional expressions (Experiments 1-5) or the detection of a face (Experiment 6). The AB was minimal or absent when targets could be easily discriminated from each other. Three successive experiments revealed that insufficient masking and target-distractor similarity could account for the observed immunity of faces against the AB in the first two experiments. An AB was present but not increased when the facial expression was irrelevant to the task suggesting that target-distractor similarity plays a more important role in eliciting an AB than the attentional set demanded by the specific task. In line with previous work, emotional faces were less affected by the AB.	[Muesch, Kathrin; Engel, Andreas K.; Schneider, Till R.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Musch, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	k.muesch@uke.uni-hamburg.de	Engel, Andreas K/C-7781-2012; Engel, Andreas K./AAH-6384-2019; Schneider, Till/B-3751-2010	Engel, Andreas K/0000-0003-4899-8466; Engel, Andreas K./0000-0003-4899-8466; Schneider, Till/0000-0002-8889-6248	German Research Foundation [SFB TRR 58 B04]; European Union [ERC-2010-AdG-269716]	German Research Foundation(German Research Foundation (DFG)); European Union(European Commission)	This work has been supported by grants from the German Research Foundation (SFB TRR 58 B04) and the European Union (ERC-2010-AdG-269716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Amir N, 2009, J ANXIETY DISORD, V23, P1080, DOI 10.1016/j.janxdis.2009.07.010; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Arend I, 2002, PSICOTHEMA, V14, P209; Awh E, 2004, COGNITIVE PSYCHOL, V48, P95, DOI 10.1016/S0010-0285(03)00116-6; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chun MM, 1997, PERCEPT PSYCHOPHYS, V59, P1191, DOI 10.3758/BF03214207; Chun MM, 1997, J EXP PSYCHOL HUMAN, V23, P738, DOI 10.1037/0096-1523.23.3.738; Darque A, 2011, BRAIN TOPOGRAPHY; de Jong PJ, 2007, BEHAV RES THER, V45, P1285, DOI 10.1016/j.brat.2006.10.003; De Martino B, 2009, CEREB CORTEX, V19, P127, DOI 10.1093/cercor/bhn062; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Ferlazzo F, 2007, EXP PSYCHOL, V54, P89, DOI 10.1027/1618-3169.54.2.89; Fox E, 2005, COGN AFFECT BEHAV NE, V5, P396, DOI 10.3758/CABN.5.4.396; Giesbrecht B, 1998, J EXP PSYCHOL HUMAN, V24, P1454, DOI 10.1037/0096-1523.24.5.1454; Grandison TD, 1997, PERCEPT PSYCHOPHYS, V59, P266, DOI 10.3758/BF03211894; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Huang YM, 2008, J EXP PSYCHOL HUMAN, V34, P328, DOI 10.1037/0096-1523.34.2.328; Ishihara S., 1986, ISHIHARAS TESTS COLO; Jackson MC, 2006, PERCEPT PSYCHOPHYS, V68, P543, DOI 10.3758/BF03208757; Jannati A, 2011, PSYCHON B REV, V18, P70, DOI 10.3758/s13423-010-0015-3; Keil A, 2004, EMOTION, V4, P23, DOI 10.1037/1528-3542.4.1.23; Koster Ernst H W, 2009, Depress Anxiety, V26, pE16, DOI 10.1002/da.20420; Landau AN, 2008, J EXP PSYCHOL HUMAN, V34, P818, DOI 10.1037/0096-1523.34.4.818; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maratos FA, 2008, COGNITION EMOTION, V22, P1340, DOI 10.1080/02699930701774218; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Milders M, 2006, EMOTION, V6, P10, DOI 10.1037/1528-3542.6.1.10; Miyazawa S, 2010, EMOTION, V10, P712, DOI 10.1037/a0019348; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Nieuwenstein MR, 2006, PSYCHOL SCI, V17, P471, DOI 10.1111/j.1467-9280.2006.01730.x; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Reddy L, 2006, VISION RES, V46, P2336, DOI 10.1016/j.visres.2006.01.020; Reinecke A, 2008, J ANXIETY DISORD, V22, P655, DOI 10.1016/j.janxdis.2007.06.004; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; Serences J, 2009, VIS COGN, V17, P531, DOI 10.1080/13506280802102541; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Stein T, 2009, PSYCHON B REV, V16, P104, DOI 10.3758/PBR.16.1.104; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Trippe RH, 2007, BRAIN RES, V1148, P149, DOI 10.1016/j.brainres.2007.02.035; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vul E, 2008, PSYCHOL SCI, V19, P55, DOI 10.1111/j.1467-9280.2008.02046.x; Weaver MD, 2011, PSYCHOL RES-PSYCH FO, V75, P10, DOI 10.1007/s00426-010-0284-5; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	58	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41257	10.1371/journal.pone.0041257	http://dx.doi.org/10.1371/journal.pone.0041257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815982	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900102
J	Reishofer, G; Koschutnig, K; Enzinger, C; Ebner, F; Ahammer, H				Reishofer, Gernot; Koschutnig, Karl; Enzinger, Christian; Ebner, Franz; Ahammer, Helmut			Fractal Dimension and Vessel Complexity in Patients with Cerebral Arteriovenous Malformations	PLOS ONE			English	Article							GENERALIZED DIMENSIONS; MULTIFRACTAL ANALYSIS; CORTICAL SURFACE; SEGMENTATION; IMAGES; GEOMETRY; MATTER	The fractal dimension (FD) can be used as a measure for morphological complexity in biological systems. The aim of this study was to test the usefulness of this quantitative parameter in the context of cerebral vascular complexity. Fractal analysis was applied on ten patients with cerebral arteriovenous malformations (AVM) and ten healthy controls. Maximum intensity projections from Time-of-Flight MRI scans were analyzed using different measurements of FD, the Box-counting dimension, the Minkowski dimension and generalized dimensions evaluated by means of multifractal analysis. The physiological significance of this parameter was investigated by comparing values of FD first, with the maximum slope of contrast media transit obtained from dynamic contrast-enhanced MRI data and second, with the nidus size obtained from X-ray angiography data. We found that for all methods, the Box-counting dimension, the Minkowski dimension and the generalized dimensions FD was significantly higher in the hemisphere with AVM compared to the hemisphere without AVM indicating that FD is a sensitive parameter to capture vascular complexity. Furthermore we found a high correlation between FD and the maximum slope of contrast media transit and between FD and the size of the central nidus pointing out the physiological relevance of FD. The proposed method may therefore serve as an additional objective parameter, which can be assessed automatically and might assist in the complex workup of AVMs.	[Reishofer, Gernot] Med Univ Graz, MR Phys, Dept Radiol, Graz, Austria; [Koschutnig, Karl; Ebner, Franz] Med Univ Graz, Div Neuroradiol, Dept Radiol, Graz, Austria; [Koschutnig, Karl] Graz Univ, Dept Psychol, Graz, Austria; [Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Ahammer, Helmut] Med Univ Graz, Inst Biophys, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Graz; Medical University of Graz; Medical University of Graz	Reishofer, G (corresponding author), Med Univ Graz, MR Phys, Dept Radiol, Graz, Austria.	gernot.reishofer@medunigraz.at	Koschutnig, Karl/W-3106-2019; Reishofer, Gernot/E-9215-2011	Koschutnig, Karl/0000-0001-6234-0498; Reishofer, Gernot/0000-0002-3068-6475; Ahammer, Helmut/0000-0001-5400-294X				Ahammer H, 2004, CHAOS, V14, P183, DOI 10.1063/1.1638947; Ahammer H, 2011, CHAOS SOLITON FRACT, V44, P86, DOI 10.1016/j.chaos.2010.12.004; Ahammer H, 2003, PHYSICA D, V181, P147, DOI 10.1016/S0167-2789(03)00099-X; Azemin MZC, 2011, IEEE T MED IMAGING, V30, P243, DOI 10.1109/TMI.2010.2076322; Baish JW, 2000, CANCER RES, V60, P3683; Blackburn SL, 2011, J NEUROSURG; Bui A, 2009, MED BIOL ENG COMPUT, V47, P763, DOI 10.1007/s11517-009-0492-6; Cavallari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019150; Di Ieva A, 2010, MICROVASC RES, V80, P267, DOI 10.1016/j.mvr.2010.04.003; DUBUC B, 1989, PHYS REV A, V39, P1500, DOI 10.1103/PhysRevA.39.1500; Esteban FJ, 2007, NEUROIMAGE, V36, P543, DOI 10.1016/j.neuroimage.2007.03.057; Esteban FJ, 2009, J NEUROL SCI, V282, P67, DOI 10.1016/j.jns.2008.12.023; Falconer K. J., 2003, FRACTAL GEOMETRY MAT; Fernandez E, 2001, METHODS, V24, P309, DOI 10.1006/meth.2001.1201; Fleetwood IG, 2002, LANCET, V359, P863, DOI 10.1016/S0140-6736(02)07946-1; Gao X, 2011, J DIGIT IMAGING, V24, P609, DOI 10.1007/s10278-010-9326-1; Gould DJ, 2011, MICROCIRCULATION, V18, P136, DOI 10.1111/j.1549-8719.2010.00075.x; Ha TH, 2005, NEUROSCI LETT, V384, P172, DOI 10.1016/j.neulet.2005.04.078; HENTSCHEL HGE, 1983, PHYSICA D, V8, P435, DOI 10.1016/0167-2789(83)90235-X; Herman P, 2001, J CEREBR BLOOD F MET, V21, P741, DOI 10.1097/00004647-200106000-00012; Im K, 2006, HUM BRAIN MAPP, V27, P994, DOI 10.1002/hbm.20238; Jayaraman MV, 2008, AM J NEURORADIOL, V29, P242, DOI 10.3174/ajnr.A0793; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalda J, 1999, DISCRETE DYN NAT SOC, V3, P297, DOI 10.1155/S102602269900031X; KANMANI S, 1993, J MICROSC-OXFORD, V170, P81, DOI 10.1111/j.1365-2818.1993.tb03325.x; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Kiselev VG, 2003, NEUROIMAGE, V20, P1765, DOI 10.1016/S1053-8119(03)00380-X; Krings T, 2010, EUR RADIOL, V20, P2723, DOI 10.1007/s00330-010-1834-3; Lauwerier H. A., 1991, FRACTALS IMAGES CHAO; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Liu JZ, 2003, BIOPHYS J, V85, P4041, DOI 10.1016/S0006-3495(03)74817-6; Lopes R, 2011, MED PHYS, V38, P83, DOI 10.1118/1.3521470; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MEISEL LV, 1992, PHYS REV A, V45, P6989, DOI 10.1103/PhysRevA.45.6989; Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Ozsarlak O, 2004, NEURORADIOLOGY, V46, P955, DOI 10.1007/s00234-004-1297-9; Passat N, 2005, J MAGN RESON IMAGING, V21, P715, DOI 10.1002/jmri.20307; Peitgen H.O., 1988, SCI FRACTAL IMAGES; Perfect E, 2009, FRACTALS, V17, P351, DOI 10.1142/S0218348X09004302; PIETRONERO L, 1988, PHYSICA A, V151, P207, DOI 10.1016/0378-4371(88)90014-3; Pruess SA., 1995, FRACTALS EARTH SCI, P10; RUSSELL DA, 1980, PHYS REV LETT, V45, P1175, DOI 10.1103/PhysRevLett.45.1175; Soille P, 1996, J VIS COMMUN IMAGE R, V7, P217, DOI 10.1006/jvci.1996.0020; Stojic T, 2006, PHYSICA A, V367, P494, DOI 10.1016/j.physa.2005.11.030; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; VICSEK T, 1990, EUROPHYS LETT, V12, P217, DOI 10.1209/0295-5075/12/3/005; VICSEK T, 1990, PHYSICA A, V168, P490, DOI 10.1016/0378-4371(90)90401-D; Yampolsky M, 2008, PLACENTA, V29, P790, DOI 10.1016/j.placenta.2008.06.005; Zamir M, 2001, J THEOR BIOL, V212, P183, DOI 10.1006/jtbi.2001.2367	52	39	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41148	10.1371/journal.pone.0041148	http://dx.doi.org/10.1371/journal.pone.0041148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815946	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900081
J	Seita, J; Sahoo, D; Rossi, DJ; Bhattacharya, D; Serwold, T; Inlay, MA; Ehrlich, LIR; Fathman, JW; Dill, DL; Weissman, IL				Seita, Jun; Sahoo, Debashis; Rossi, Derrick J.; Bhattacharya, Deepta; Serwold, Thomas; Inlay, Matthew A.; Ehrlich, Lauren I. R.; Fathman, John W.; Dill, David L.; Weissman, Irving L.			Gene Expression Commons: An Open Platform for Absolute Gene Expression Profiling	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MICROARRAY DATA; DATABASE; PROGENITORS; SIGNATURE; NETWORKS; LEUKEMIA	Gene expression profiling using microarrays has been limited to comparisons of gene expression between small numbers of samples within individual experiments. However, the unknown and variable sensitivities of each probeset have rendered the absolute expression of any given gene nearly impossible to estimate. We have overcome this limitation by using a very large number (>10,000) of varied microarray data as a common reference, so that statistical attributes of each probeset, such as the dynamic range and threshold between low and high expression, can be reliably discovered through meta-anyalysis This strategy is implemented in a web-based platform named "Gene Expression Commons" (https://gexc.stanford.edu/) which contains data of 39 distinct highly purified mouse hematopoietic stem/progenitor/differentiated cell populations covering almost the entire hematopoietic system. Since the Gene Expression Commons is designed as an open platform, investigators can explore the expression level of any gene, search by expression patterns of interest, submit their own microarray data, and design their own working models representing biological relationship among samples.	[Seita, Jun; Sahoo, Debashis; Rossi, Derrick J.; Bhattacharya, Deepta; Serwold, Thomas; Inlay, Matthew A.; Ehrlich, Lauren I. R.; Fathman, John W.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Dill, David L.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Seita, J (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	jseita@stanford.edu; irv@stanford.edu	Seita, Jun/AAM-1478-2020	Seita, Jun/0000-0002-3008-3615; Ehrlich, Lauren/0000-0002-1697-1755	National Institutes of Health (NIH) [R01AI047457, R01AI047458, U01HL099999]; NIH/National Cancer Institute (NCI) [1U54 CA149145]; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; California Institute for Regenerative Medicine [T1-00001]; Public Health Service Grant [CA09151]; NCI; NATIONAL CANCER INSTITUTE [U54CA149145, R01CA086065, T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047457, R01AI047458] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation was supported by National Institutes of Health (NIH) Grants R01AI047457, R01AI047458, and U01HL099999 (to ILW) and NIH/National Cancer Institute (NCI) grant 1U54 CA149145 (to DLD), and a grant from Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation. JS was supported by a fellowship from the California Institute for Regenerative Medicine (T1-00001). MAI was supported by Public Health Service Grant CA09151, awarded by the NCI, and a fellowship from the California Institute for Regenerative Medicine (T1-00001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Barton G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-493; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Knudsen S., 2004, GUIDE ANAL DNA MICRO; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Miranda-Saavedra D, 2009, NUCLEIC ACIDS RES, V37, pD873, DOI 10.1093/nar/gkn854; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sahoo D, 2007, NUCLEIC ACIDS RES, V35, P3705, DOI 10.1093/nar/gkm284; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Tomlinson C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-379; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	28	175	176	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40321	10.1371/journal.pone.0040321	http://dx.doi.org/10.1371/journal.pone.0040321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815738	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900020
J	Coquery, N; Pannetier, N; Farion, R; Herbette, A; Azurmendi, L; Clarencon, D; Bauge, S; Josserand, V; Rome, C; Coll, JL; Sun, JS; Barbier, EL; Dutreix, M; Remy, CC				Coquery, Nicolas; Pannetier, Nicolas; Farion, Regine; Herbette, Aurelie; Azurmendi, Leire; Clarencon, Didier; Bauge, Stephane; Josserand, Veronique; Rome, Claire; Coll, Jean-Luc; Sun, Jian-Sheng; Barbier, Emmanuel L.; Dutreix, Marie; Remy, Chantal C.			Distribution and Radiosensitizing Effect of Cholesterol-Coupled Dbait Molecule in Rat Model of Glioblastoma	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; IN-VIVO; RADIATION-THERAPY; VESSEL SIZE; TUMOR VASCULATURE; GENE DELIVERY; GLIOMA-CELLS; BEARING RATS; MOUSE-BRAIN; PHASE-II	Background: Glioma is the most aggressive tumor of the brain and the most efficient treatments are based on radiotherapy. However, tumors are often resistant to radiotherapy due to an enhanced DNA repair activity. Short and stabilized DNA molecules (Dbait) have recently been proposed as an efficient strategy to inhibit DNA repair in tumor. Methodology/Principal Findings: The distribution of three formulations of Dbait, (i) Dbait alone, (ii) Dbait associated with polyethylenimine, and (iii) Dbait linked with cholesterol (coDbait), was evaluated one day after intratumoral delivery in an RG2 rat glioma model. Dbait molecule distribution was assessed in the whole organ with 2D-FRI and in brain sections. CoDbait was chosen for further studies given its good retention in the brain, cellular localization, and efficacy in inducing the activation of DNA repair effectors. The radiosensitizing effect of coDbait was studied in four groups of rats bearing RG2-glioma: no treatment, radiotherapy only, coDbait alone, and CoDbait with radiotherapy. Treatment started 7 days after tumor inoculation and consisted of two series of treatment in two weeks: coDbait injection followed by a selective 6-Gy irradiation of the head. We evaluated the radiosensitizing effect using animal survival, tumor volume, cell proliferation, and vasculature characteristics with multiparametric MRI. CoDbait with radiotherapy improved the survival of rats bearing RG2-glioma by reducing tumor growth and cell proliferation without altering tumor vasculature. Conclusion/Significance: coDbait is therefore a promising molecular therapy to sensitize glioma to radiotherapy.	[Coquery, Nicolas; Pannetier, Nicolas; Farion, Regine; Azurmendi, Leire; Barbier, Emmanuel L.; Remy, Chantal C.] INSERM, U836, Grenoble, France; [Coquery, Nicolas; Pannetier, Nicolas; Farion, Regine; Azurmendi, Leire; Barbier, Emmanuel L.; Remy, Chantal C.] Univ Grenoble 1, Grenoble Inst Neurosci, UMR S836, Grenoble, France; [Herbette, Aurelie; Sun, Jian-Sheng] DNA Therapeut, Evry, France; [Josserand, Veronique; Rome, Claire; Coll, Jean-Luc] INSERM, U823, Grenoble, France; [Josserand, Veronique; Rome, Claire; Coll, Jean-Luc] Univ Grenoble 1, Inst Albert Bonniot, UMR S823, Grenoble, France; [Josserand, Veronique; Rome, Claire; Coll, Jean-Luc] Museum Natl Hist Nat, USM503, F-75231 Paris, France; [Dutreix, Marie] Inst Curie Hosp, CNRS, INSERM, UMR3347,U2021, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay	Coquery, N (corresponding author), INSERM, U836, Grenoble, France.	nicolas.coquery@ujf-grenoble.fr	Coll, Jean-Luc/G-2520-2013; josserand, veronique/F-1773-2019; ROME, Claire/L-1724-2014; Barbier, Emmanuel/E-6302-2011; coquery, nicolas/N-9206-2019; Remy, Chantal/L-9459-2014; coquery, nicolas/GQP-5662-2022; josserand, veronique/M-2767-2013	Coll, Jean-Luc/0000-0002-2453-3552; josserand, veronique/0000-0001-6733-3801; ROME, Claire/0000-0002-3573-0543; Barbier, Emmanuel/0000-0002-4952-1240; coquery, nicolas/0000-0002-4687-5924; coquery, nicolas/0000-0002-4687-5924; 	Agence National de la Recherche [ANR-08-BiotechS-009]; Canceropole Lyon-Auvergne-Rhone-Alpes (CLARA); Association pour la Recherche sur le Cancer (ARC)	Agence National de la Recherche(French National Research Agency (ANR)); Canceropole Lyon-Auvergne-Rhone-Alpes (CLARA); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work is supported by the Agence National de la Recherche (ANR-08-BiotechS-009), and the Canceropole Lyon-Auvergne-Rhone-Alpes (CLARA). Dr. Nicolas Coquery benefited from a post-doctoral fellowship from Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; Berthault N, 2011, CANCER GENE THER, V18, P695, DOI 10.1038/cgt.2011.39; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Chen QM, 2010, J CONTROL RELEASE, V144, P227, DOI 10.1016/j.jconrel.2010.02.011; Combs Stephanie E, 2009, Recent Results Cancer Res, V171, P125, DOI 10.1007/978-3-540-31206-2_7; Dutreix M, 2010, MUTAT RES-REV MUTAT, V704, P182, DOI 10.1016/j.mrrev.2010.01.001; Han L, 2010, HUM GENE THER, V21, P417, DOI 10.1089/hum.2009.087; Hassani Z, 2005, J GENE MED, V7, P198, DOI 10.1002/jgm.659; Huang RQ, 2007, FASEB J, V21, P1117, DOI 10.1096/fj.06-7380com; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jorgensen TJ, 2009, CANCER BIOL THER, V8, P665, DOI 10.4161/cbt.8.8.8304; Kelley MR, 2008, ANTI-CANCER AGENT ME, V8, P417, DOI 10.2174/187152008784220294; Keramidas M, 2010, BRIT J SURG, V97, P737, DOI 10.1002/bjs.6986; Ko YT, 2009, J CONTROL RELEASE, V133, P230, DOI 10.1016/j.jconrel.2008.10.013; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Lemasson B, 2011, NMR BIOMED, V24, P473, DOI 10.1002/nbm.1611; Lemasson B, 2010, RADIOLOGY, V257, P342, DOI 10.1148/radiol.10092343; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Ng W. K., 2003, CURR DIAGN PATHOL, V9, P124, DOI DOI 10.1054/CDIP.2003.0164; OI S, 1990, Neurologia Medico-Chirurgica, V30, P36, DOI 10.2176/nmc.30.36; Palanichamy K, 2009, CURR OPIN NEUROL, V22, P625, DOI 10.1097/WCO.0b013e3283327d33; Pannetier N, 2012, NMR BIOMED, V25, P218, DOI 10.1002/nbm.1734; PEDERSEN PH, 1995, INT J CANCER, V62, P767, DOI 10.1002/ijc.2910620620; Quanz M, 2009, CLIN CANCER RES, V15, P1308, DOI 10.1158/1078-0432.CCR-08-2108; Quanz M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006298; REDGATE ES, 1991, LAB ANIM SCI, V41, P269; Rousseau J, 2009, INT J RADIAT ONCOL, V73, P530, DOI 10.1016/j.ijrobp.2008.09.018; Schlegel C, 2012, MOL THER NU IN PRESS; Schwartz B, 1996, GENE THER, V3, P405; Stukel JM, 2009, EXPERT OPIN DRUG DEL, V6, P705, DOI 10.1517/17425240902988470; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tihan T, 2006, HUM PATHOL, V37, P272, DOI 10.1016/j.humpath.2005.11.010; Tropres I, 2004, MAGN RESON MED, V51, P533, DOI 10.1002/mrm.20017; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Vredenburgh JJ, 2011, CLIN CANCER RES, V17, P4119, DOI 10.1158/1078-0432.CCR-11-0120; Zawaski JA, 2012, INT J RADIAT ONCOL, V82, P1075, DOI 10.1016/j.ijrobp.2011.06.1984; Zhang LH, 2011, EUR J PHARM BIOPHARM, V79, P232, DOI 10.1016/j.ejpb.2011.03.025; Zhang XH, 2003, J GENE MED, V5, P209, DOI 10.1002/jgm.340; Zhu YJ, 2009, CANCER TREAT REV, V35, P590, DOI 10.1016/j.ctrv.2009.06.005	42	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40567	10.1371/journal.pone.0040567	http://dx.doi.org/10.1371/journal.pone.0040567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815765	Green Published, gold			2022-12-27	WOS:000306507000019
J	Johansson, MEV				Johansson, Malin E. V.			Fast Renewal of the Distal Colonic Mucus Layers by the Surface Goblet Cells as Measured by In Vivo Labeling of Mucin Glycoproteins	PLOS ONE			English	Article							SECRETION; TERMINUS; COMPLEX; REGION; DIMERS	The enormous bacterial load and mechanical forces in colon create a special requirement for protection of the epithelium. In the distal colon, this problem is largely solved by separation of the bacteria from the epithelium by a firmly attached inner mucus layer. In addition, an outer mucus layer entraps bacteria to be cleared by distal transport. The mucus layers contain a network of Muc2 mucins as the main structural component. Here, the renewal rate of the inner protective mucus layer was studied as well as the production and secretion of Muc2 mucin in the distal colon. This was performed by intraperitoneal injection of N-azidoacetyl-galactosamine (GalNAz) that was in vivo incorporated during biosynthesis of O-glycosylated glycoproteins. The only gel-forming mucin produced in the colon is the Muc2 mucin and as it carries numerous O-glycans, the granulae of the goblet cells producing Muc2 mucin were intensely stained. The GalNAz-labeled glycoproteins were first observed in the Golgi apparatus of most cells. Goblet cells in the luminal surface epithelium had the fastest biosynthesis of Muc2 and secreted material already three hours after labeling. This secreted GalNAz-labeled Muc2 mucin formed the inner mucus layer. The goblet cells along the crypt epithelium accumulated labeled mucin vesicles for a longer period and secretion of labeled Muc2 mucin was first observed after 6 to 8 h. This study reveals a fast turnover (1 h) of the inner mucus layer in the distal colon mediated by goblet cells of the luminal surface epithelium.	Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden	University of Gothenburg	Johansson, MEV (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	malin.johansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022	Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council [7461, 21027, 342-2004-4434]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases [U01AI095473]; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 7461, 21027, and 342-2004-4434), The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation, IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUA-ALF), Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser, The Sahlgrenska Academy, National Institute of Allergy and Infectious Diseases (U01AI095473, the content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH), and The Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gaudier E, 2009, PHYSIOL RES, V58, P111, DOI 10.33549/physiolres.931271; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Grant TD, 1998, ANAT RECORD, V252, P41; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; HANSSON GC, 1994, BIOCHEM BIOPH RES CO, V198, P181, DOI 10.1006/bbrc.1994.1026; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; NEUTRA M, 1966, J CELL BIOL, V30, P137, DOI 10.1083/jcb.30.1.137; NEUTRA M, 1966, J CELL BIOL, V30, P119, DOI 10.1083/jcb.30.1.119; NEUTRA MR, 1982, AM J PHYSIOL, V242, pG380, DOI 10.1152/ajpgi.1982.242.4.G380; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; PHILLIPS TE, 1984, AM J PHYSIOL, V247, pG674, DOI 10.1152/ajpgi.1984.247.6.G674; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020	21	126	128	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41009	10.1371/journal.pone.0041009	http://dx.doi.org/10.1371/journal.pone.0041009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815896	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000051
J	Kipp, W; Konde-Lule, J; Saunders, LD; Alibhai, A; Houston, S; Rubaale, T; Senthilselvan, A; Okech-Ojony, J				Kipp, Walter; Konde-Lule, Joseph; Saunders, L. Duncan; Alibhai, Arif; Houston, Stan; Rubaale, Tom; Senthilselvan, Ambikaipakan; Okech-Ojony, Joa			Antiretroviral Treatment for HIV in Rural Uganda: Two-Year Treatment Outcomes of a Prospective Health Centre/Community-Based and Hospital-Based Cohort	PLOS ONE			English	Article							VIROLOGICAL FAILURE; DRUG-THERAPY; CARE MODEL; PROGRAM; PREDICTORS; HIV/AIDS; ADULTS	Background: In sub-Saharan Africa, a shortage of trained health professionals and limited geographical access to health facilities present major barriers to the expansion of antiretroviral therapy (ART). We tested the utility of a health centre (HC)/community-based approach in the provision of ART to persons living with HIV in a rural area in western Uganda. Methods: The HIV treatment outcomes of the HC/community-based ART program were evaluated and compared with those of an ART program at a best-practice regional hospital. The HC/community-based cohort comprised 185 treatment-naive patients enrolled in 2006. The hospital cohort comprised of 200 patients enrolled in the same time period. The HC/community-based program involved weekly home visits to patients by community volunteers who were trained to deliver antiretroviral drugs to monitor and support adherence to treatment, and to identify and report adverse reactions and other clinical symptoms. Treatment supporters in the homes also had the responsibility to remind patients to take their drugs regularly. ART treatment outcomes were measured by HIV-1 RNA viral load (VL) after two years of treatment. Adherence was determined through weekly pill counts. Results: Successful ART treatment outcomes in the HC/community-based cohort were equivalent to those in the hospital-based cohort after two years of treatment in on-treatment analysis (VL <= 400 copies/mL, 93.0% vs. 87.3%, p = 0.12), and in intention-to-treat analysis (VL <= 400 copies/mL, 64.9% and 62.0%, p = 0.560). In multivariate analysis patients in the HC/community-based cohort were more likely to have virologic suppression compared to hospital-based patients (adjusted OR = 2.47, 95% CI 1.01-6.04). Conclusion: Acceptable rates of virologic suppression were achieved using existing rural clinic and community resources in a HC/community-based ART program run by clinical officers and supported by lay volunteers and treatment supporters. The results were equivalent to those of a hospital-based ART program run primarily by doctors.	[Kipp, Walter; Saunders, L. Duncan; Alibhai, Arif; Senthilselvan, Ambikaipakan] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Konde-Lule, Joseph] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Kampala, Uganda; [Houston, Stan] Univ Alberta, Dept Med, Fac Med, Edmonton, AB, Canada; [Rubaale, Tom; Okech-Ojony, Joa] Kabarole Dist Hlth Dept, Ft Portal, Uganda	University of Alberta; Makerere University; University of Alberta	Kipp, W (corresponding author), Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada.	walter.kipp@ualberta.ca			Canadian Institutes of Health Research (CIHR) [MOP-74586]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The study was financed by the Canadian Institutes of Health Research (CIHR) through grant no. MOP-74586. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Chang LVW, 2009, JAIDS-J ACQ IMM DEF, V50, P276, DOI 10.1097/QAI.0b013e3181988375; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen J.E., 1988, STAT POWER ANAL BEHA; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Joint United Nations Programme on HIV/AIDS, 2008, AIDS SCOR UNAIDS REP; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kipp W, 2010, CURR HIV RES, V8, P179, DOI 10.2174/157016210790442722; Ministry of Health and ORC Macro, 2006, UG HIV AIDS SER SURV; Munoz M, 2010, AIDS BEHAV, V14, P721, DOI 10.1007/s10461-009-9559-5; Paris D, 1999, AIDS RES HUM RETROV, V15, P1631, DOI 10.1089/088922299309676; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; StataCorp, 2005, STAT SOFTW REL 9; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Wringe A, 2010, HEALTH POLICY PLANN, V25, P352, DOI 10.1093/heapol/czq005	20	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40902	10.1371/journal.pone.0040902	http://dx.doi.org/10.1371/journal.pone.0040902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JG	22815862	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000040
J	Huang, RL; Chang, CC; Su, PH; Chen, YC; Liao, YP; Wang, HC; Yo, YT; Chao, TK; Huang, HC; Lin, CY; Chu, TY; Lai, HC				Huang, Rui-Lan; Chang, Cheng-Chang; Su, Po-Hsuan; Chen, Yu-Chih; Liao, Yu-Ping; Wang, Hui-Chen; Yo, Yi-Te; Chao, Tai-Kuang; Huang, Hsuan-Cheng; Lin, Ching-Yu; Chu, Tang-Yuan; Lai, Hung-Cheng			Methylomic Analysis Identifies Frequent DNA Methylation of Zinc Finger Protein 582 (ZNF582) in Cervical Neoplasms	PLOS ONE			English	Article							TUMOR-SUPPRESSOR REGION; HUMAN-PAPILLOMAVIRUS; CANCER; HYPERMETHYLATION; GENES; WIDE; MARKERS; ADENOCARCINOMA; ABNORMALITIES; EPIGENETICS	Background: Despite of the trend that the application of DNA methylation as a biomarker for cancer detection is promising, clinically applicable genes are few. Therefore, we looked for novel hypermethylated genes for cervical cancer screening. Methods and Findings: At the discovery phase, we analyzed the methylation profiles of human cervical carcinomas and normal cervixes by methylated DNA immunoprecipitation coupled to promoter tiling arrays (MeDIP-on-chip). Methylation-specific PCR (MSP), quantitative MSP and bisulfite sequencing were used to verify the methylation status in cancer tissues and cervical scrapings from patients with different severities. Immunohistochemical staining of a cervical tissue microarray was used to confirm protein expression. We narrowed to three candidate genes: DBC1, PDE8B, and ZNF582; their methylation frequencies in tumors were 93%, 29%, and 100%, respectively. At the pre-validation phase, the methylation frequency of DBC1 and ZNF582 in cervical scraping correlated significantly with disease severity in an independent cohort (n = 330, both P < 0.001). For the detection of cervical intraepithelial neoplasia 3 (CIN3) and worse, the area under the receiver operating characteristic curve (AUC) of ZNF582 was 0.82 (95% confidence interval = 0.76-0.87). Conclusions: Our study shows ZNF582 is frequently methylated in CIN3 and worse lesions, and it is demonstrated as a potential biomarker for the molecular screening of cervical cancer.	[Huang, Rui-Lan; Chang, Cheng-Chang; Su, Po-Hsuan; Chen, Yu-Chih; Liao, Yu-Ping; Wang, Hui-Chen; Yo, Yi-Te; Lai, Hung-Cheng] Tri Serv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Huang, Rui-Lan; Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, Rui-Lan; Chang, Cheng-Chang; Wang, Hui-Chen; Yo, Yi-Te; Lai, Hung-Cheng] Natl Def Med Ctr, Lab Epigenet & Canc Stem Cells, Taipei, Taiwan; [Chang, Cheng-Chang; Su, Po-Hsuan; Chen, Yu-Chih; Lai, Hung-Cheng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Liao, Yu-Ping; Lai, Hung-Cheng] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chao, Tai-Kuang] Tri Serv Gen Hosp, Dept Pathol, Taipei, Taiwan; [Lin, Ching-Yu] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Coll Med Sci & Technol, Taipei, Taiwan; [Chu, Tang-Yuan] Tzu Chi Univ, Ctr Cerv Canc Prevent, Dept Obstet & Gynecol, Grad Inst Clin Med,Tzu Chi Med Ctr, Hualien, Taiwan	Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Buddhist Tzu Chi General Hospital; Tzu Chi University	Huang, RL (corresponding author), Tri Serv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	hclai@ndmctsgh.edu.tw	Huang, Hsuan-Cheng/C-7266-2011; Lai, Hung Cheng/F-6426-2012	Huang, Hsuan-Cheng/0000-0002-3386-0934; Huang, Rui Lan/0000-0001-6458-4672; Chu, Tang-Yuan/0000-0003-2717-2681; Lin, Ching-Yu/0000-0001-8269-797X; Chang, Cheng-Chang/0000-0002-7356-446X	National Sciene Council [NSC-99-3113-P-016-001, NSC98-2314-B-016-030-MY3]; Tri-Service General Hospital, Taiwan, Republic of China [TSGH-C101-005-010-014-S01, TSGH-C101-005-010-014-S02, TSGH-C97-6-S03, TSGH-C96-2-S03, TSGH-C95-7-S03]	National Sciene Council; Tri-Service General Hospital, Taiwan, Republic of China	This work was supported by grants (NSC-99-3113-P-016-001, NSC98-2314-B-016-030-MY3) from the National Sciene Council (to HCL), and (TSGH-C101-005-010-014-S01, TSGH-C101-005-010-014-S02, TSGH-C97-6-S03, TSGH-C96-2-S03 and TSGH-C95-7-S03) from Tri-Service General Hospital (to CCC) Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2010, WIRES SYST BIOL MED, V2, P210, DOI 10.1002/wsbm.35; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BRINTON LA, 1987, J NATL CANCER I, V79, P23; Chao TK, 2011, DIAGN CYTOPATHOL; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cottrell SE, 2004, CLIN BIOCHEM, V37, P595, DOI 10.1016/j.clinbiochem.2004.05.010; Cottrell SE, 2003, ANN NY ACAD SCI, V983, P120, DOI 10.1111/j.1749-6632.2003.tb05967.x; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eijsink JJ, 2011, INT J CANC; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gronbaek K, 2008, MODERN PATHOL, V21, P632, DOI 10.1038/modpathol.2008.27; Habuchi T, 1998, GENOMICS, V48, P277, DOI 10.1006/geno.1997.5165; Habuchi T, 2001, ONCOGENE, V20, P531, DOI 10.1038/sj.onc.1204122; Hellberg D, 2005, ANTICANCER RES, V25, P3041; Hesselink AT, 2011, CLIN CANCER RES, V17, P2459, DOI 10.1158/1078-0432.CCR-10-2548; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Koliopoulos G, 2012, ACTA OBSTET GYNECOL; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; Lai HC, 2007, GYNECOL ONCOL, V104, P629, DOI 10.1016/j.ygyno.2006.10.003; Lai HC, 2010, CANCER-AM CANCER SOC, V116, P4266, DOI 10.1002/cncr.25252; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lim EH, 2010, GYNECOL ONCOL, V119, P225, DOI 10.1016/j.ygyno.2010.07.028; Liu CY, 2009, J PATHOL, V219, P222, DOI 10.1002/path.2589; Lynge E, 2009, NAT REV CLIN ONCOL, V6, P699, DOI 10.1038/nrclinonc.2009.167; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Negri G, 2011, INT J GYNECOL PATHOL, V30, P407, DOI 10.1097/PGP.0b013e31820a79b0; Overmeer RM, 2011, INT J CANCER, V129, P2218, DOI 10.1002/ijc.25890; Peng HZ, 2007, J MOL BIOL, V370, P269, DOI 10.1016/j.jmb.2007.03.047; Reesink-Peters N, 2004, MOL CANCER RES, V2, P289; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Silling S, 2012, J CLIN VIROL, V53, P325, DOI 10.1016/j.jcv.2011.12.029; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Sorbye SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012724; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Tsimplaki E, 2012, J ONCOL, V2012, DOI 10.1155/2012/893275; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; van der Meide WF, 2011, GYNECOL ONCOL, V123, P116, DOI 10.1016/j.ygyno.2011.06.015; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang SS, 2008, CANCER RES, V68, P2489, DOI 10.1158/0008-5472.CAN-07-3194; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Wright KO, 2004, ONCOGENE, V23, P82, DOI 10.1038/sj.onc.1206642; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Ziegler RG, 2002, J NUTR, V132, p2345S, DOI 10.1093/jn/132.8.2345S	55	59	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41060	10.1371/journal.pone.0041060	http://dx.doi.org/10.1371/journal.pone.0041060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815913	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100113
J	Liu, TR; Xu, LH; Yang, AK; Zhong, Q; Song, M; Li, MZ; Hu, LJ; Chen, FJ; Hu, ZD; Han, P; Zeng, MS				Liu, Tian-Run; Xu, Li-Hua; Yang, An-Kui; Zhong, Qian; Song, Ming; Li, Man-Zhi; Hu, Li-Juan; Chen, Fu-Jin; Hu, Ze-Dong; Han, Ping; Zeng, Mu-Sheng			Decreased Expression of SATB2: A Novel Independent Prognostic Marker of Worse Outcome in Laryngeal Carcinoma Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BINDING PROTEIN; CANCER STATISTICS; GENE-EXPRESSION; DETERMINANT; METASTASIS; SURVIVAL	Background: To investigate the expression and role of special AT-rich sequence-binding protein-2 (SATB2) in laryngeal squamous cell carcinoma (LSCC) tissue and cell line (HEp2), and to evaluate the clinical and prognostic significance of SATB2 protein in patients with LSCC. Methods: The expression of SATB2 was examined in LSCC tissue and HEp2 cells by Western-blotting, Real-time PCR and immunohistochemical staining. Cell growth curve assay and colony formation assay were used to verify the effect of SATB2 on the proliferation and tumor progression ability of HEp2 cells. Tumor formation assay in nude mice was used to analyze the effect of SATB2 on the tumorigenicity of HEp2 cells. Results: The status of SATB2 protein in carcinoma tissues is much lower than that in paracarcinoma tissues. The overall survival of the patients with high SATB2 expression was significantly higher than the low SATB2 expression group. Lower or negative SATB2 expression was significantly correlated with advanced clinical staging, histological grade and tumor recurrence. In vitro experiments demonstrated that over-expression of SATB2 in HEp2 cells inhibited cell proliferation and tumor progression ability, and down-regulation of SATB2 showed the opposite effects. Over-expression of SATB2 repressed the tumorigenicity of HEp2 cells by in vivo experiments. Moreover, multivariate analysis suggested that SATB2 expression might be an independent prognostic indicator for the survival of LSCC patients after curative surgery. Conclusions: SATB2 might involve in the development and progression of LSCC as a tumor suppressor, and thereby may be a valuable prognostic marker for LSCC patients.	[Liu, Tian-Run; Xu, Li-Hua; Yang, An-Kui; Zhong, Qian; Song, Ming; Li, Man-Zhi; Hu, Li-Juan; Chen, Fu-Jin; Zeng, Mu-Sheng] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Liu, Tian-Run] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Otorinolaryngol Head & Neck Surg, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Li-Hua; Zhong, Qian; Li, Man-Zhi; Hu, Li-Juan; Zeng, Mu-Sheng] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yang, An-Kui; Song, Ming; Chen, Fu-Jin] Sun Yat Sen Univ, Dept Head & Neck Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Ze-Dong] Kunming Med Univ, Affiliated Hosp 3, Dept Head & Neck Surg, Kunming, Peoples R China; [Han, Ping] Sun Yat Sen Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Kunming Medical University; Sun Yat Sen University	Liu, TR (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	zengmsh@sysucc.org.cn	xu, li/GNH-3667-2022		National Natural Science Foundation of China [81025014, 91019015, 81161120408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant number: 81025014, 91019015 and 81161120408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2006, Acta Otorhinolaryngol Ital, V26, P326; Almadori G, 2005, EUR J CANCER, V41, P683, DOI 10.1016/j.ejca.2004.10.031; Alvarez JD, 2000, GENE DEV, V14, P521; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Gourin CG, 2009, LARYNGOSCOPE, V119, P1312, DOI 10.1002/lary.20477; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hoffman HT, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236095.97947.26; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johansen LV, 2003, ACTA ONCOL, V42, P771, DOI 10.1080/02841860310017595; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Liu JH, 2008, J SURG ONCOL, V97, P267, DOI 10.1002/jso.20934; Lohynska R, 2005, NEOPLASMA, V52, P483; Magnusson K, 2011, AM J SURG PATHOL, V35, P937, DOI 10.1097/PAS.0b013e31821c3dae; Marioni G, 2006, CANCER TREAT REV, V32, P504, DOI 10.1016/j.ctrv.2006.07.002; Nakayama Y, 2005, CELL CYCLE, V4, P1099; Nguyen-Tan PF, 2001, INT J RADIAT ONCOL, V50, P1172, DOI 10.1016/S0360-3016(01)01538-3; Nie H, 2005, J IMMUNOL, V174, P4745, DOI 10.4049/jimmunol.174.8.4745; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575	25	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40704	10.1371/journal.pone.0040704	http://dx.doi.org/10.1371/journal.pone.0040704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815795	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100058
J	Chen, YT; Cassone, BJ; Bai, XD; Redinbaugh, MG; Michel, AP				Chen, Yuting; Cassone, Bryan J.; Bai, Xiaodong; Redinbaugh, Margaret G.; Michel, Andrew P.			Transcriptome of the Plant Virus Vector Graminella nigrifrons, and the Molecular Interactions of Maize fine streak rhabdovirus Transmission	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; REAL-TIME PCR; IMMUNE-RESPONSE; INNATE IMMUNITY; LEAFHOPPER TRANSMISSION; TRIPEPTIDYL-PEPTIDASE; RNA INTERFERENCE; INSECT IMMUNITY; HOST-PLANT; CORN STUNT	Background: Leafhoppers (Hemiptera: Cicadellidae) are plant-phloem feeders that are known for their ability to vector plant pathogens. The black-faced leafhopper (Graminella nigrifrons) has been identified as the only known vector for the Maize fine streak virus (MFSV), an emerging plant pathogen in the Rhabdoviridae. Within G. nigrifrons populations, individuals can be experimentally separated into three classes based on their capacity for viral transmission: transmitters, acquirers and non-acquirers. Understanding the molecular interactions between vector and virus can reveal important insights in virus immune defense and vector transmission. Results: RNA sequencing (RNA-Seq) was performed to characterize the transcriptome of G. nigrifrons. A total of 38,240 ESTs of a minimum 100 bp were generated from two separate cDNA libraries consisting of virus transmitters and acquirers. More than 60% of known D. melanogaster, A. gambiae, T. castaneum immune response genes mapped to our G. nigrifrons EST database. Real time quantitative PCR (RT-qPCR) showed significant down-regulation of three genes for peptidoglycan recognition proteins (PGRP - SB1, SD, and LC) in G. nigrifrons transmitters versus control leafhoppers. Conclusions: Our study is the first to characterize the transcriptome of a leafhopper vector species. Significant sequence similarity in immune defense genes existed between G. nigrifrons and other well characterized insects. The down-regulation of PGRPs in MFSV transmitters suggested a possible role in rhabdovirus transmission. The results provide a framework for future studies aimed at elucidating the molecular mechanisms of plant virus vector competence.	[Chen, Yuting; Bai, Xiaodong; Michel, Andrew P.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Cassone, Bryan J.; Redinbaugh, Margaret G.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA; [Cassone, Bryan J.; Redinbaugh, Margaret G.] ARS, USDA, Wooster, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Agriculture (USDA)	Chen, YT (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	michel.70@osu.edu	Redinbaugh, Margaret/A-3611-2013		Department of Entomology, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University; United States Department of Agriculture-Agricultural Resarch Service	Department of Entomology, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University; United States Department of Agriculture-Agricultural Resarch Service	Funding was provided by the Department of Entomology, Ohio Agricultural Research and Development Center (OARDC), The Ohio State University, an OARDC-Graduate Research Award (YC), and United States Department of Agriculture-Agricultural Resarch Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Ammar ED, 2002, ADV BOT RES, V36, P141, DOI 10.1016/S0065-2296(02)36062-2; Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Baton LA, 2008, INSECT SCI, V15, P15, DOI 10.1111/j.1744-7917.2008.00184.x; BOYD FJ, 1969, J ECON ENTOMOL, V62, P126, DOI 10.1093/jee/62.1.126; Carpenter J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006838; Carpenter JA, 2007, MOL ECOL, V16, P3947, DOI 10.1111/j.1365-294X.2007.03460.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Douglas AE, 2011, P ROY SOC B-BIOL SCI, V278, P333, DOI 10.1098/rspb.2010.1563; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; HOFFMANN JA, 1992, IMMUNOL TODAY, V13, P411, DOI 10.1016/0167-5699(92)90092-L; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Kim CH, 2008, BMB REP, V41, P93, DOI 10.5483/BMBRep.2008.41.2.093; Kurtz S., 2011, CENT BIOINFORM, V170, P391; LAMBERT J, 1989, P NATL ACAD SCI USA, V86, P262, DOI 10.1073/pnas.86.1.262; LARSEN KJ, 1990, ENTOMOL EXP APPL, V55, P285, DOI 10.1111/j.1570-7458.1990.tb01373.x; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; NAULT LR, 1980, PHYTOPATHOLOGY, V70, P709, DOI 10.1094/Phyto-70-709; NAULT LR, 1980, PHYTOPATHOLOGY, V70, P659, DOI 10.1094/Phyto-70-659; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Redinbaugh MG, 2005, CURR TOP MICROBIOL, V292, P143; Redinbaugh MG, 2002, PHYTOPATHOLOGY, V92, P1167, DOI 10.1094/PHYTO.2002.92.11.1167; Rosinski-Chupin I, 2007, CELL MICROBIOL, V9, P708, DOI 10.1111/j.1462-5822.2006.00822.x; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Sim C, 2005, INSECT MOL BIOL, V14, P475, DOI 10.1111/j.1365-2583.2005.00578.x; Stewart L.R., 2011, WAIKAVIRUSES STUDIED; STONER WN, 1967, ANN ENTOMOL SOC AM, V60, P496, DOI 10.1093/aesa/60.3.496; Todd JC, 2010, PHYTOPATHOLOGY, V100, P1138, DOI 10.1094/PHYTO-05-10-0144; Tomkinson B, 2005, INT J BIOCHEM CELL B, V37, P1933, DOI 10.1016/j.biocel.2005.02.009; Tsai CW, 2008, APPL ENVIRON MICROB, V74, P3251, DOI 10.1128/AEM.02248-07; Tsai CW, 2005, J VIROL, V79, P5304, DOI 10.1128/JVI.79.9.5304-5314.2005; Ursic-Bedoya RJ, 2007, DEV COMP IMMUNOL, V31, P109, DOI 10.1016/j.dci.2006.05.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Whitfield AE, 2011, INSECT MOL BIOL, V20, P225, DOI 10.1111/j.1365-2583.2010.01060.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	61	22	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40613	10.1371/journal.pone.0040613	http://dx.doi.org/10.1371/journal.pone.0040613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808205	gold, Green Published, Green Submitted			2022-12-27	WOS:000306366400041
J	Trusca, VG; Florea, IC; Kardassis, D; Gafencu, AV				Trusca, Violeta G.; Florea, Irina C.; Kardassis, Dimitris; Gafencu, Anca V.			STAT1 Interacts with RXR alpha to Upregulate ApoCII Gene Expression in Macrophages	PLOS ONE			English	Article							APOLIPOPROTEIN-C-II; HORMONE RESPONSE ELEMENTS; HEPATIC CONTROL REGION-1; TRANSGENIC MICE; TRANSCRIPTION FACTORS; NUCLEOTIDE-SEQUENCE; NUCLEAR RECEPTORS; MESSENGER-RNA; X-RECEPTOR; PROMOTER	Apolipoprotein CII (apoCII) is a specific activator of lipoprotein lipase and plays an important role in triglyceride metabolism. The aim of our work was to elucidate the regulatory mechanisms involved in apoCII gene modulation in macrophages. Using Chromosome Conformation Capture we demonstrated that multienhancer 2 (ME. 2) physically interacts with the apoCII promoter and this interaction facilitates the transcriptional enhancement of the apoCII promoter by the transcription factors bound on ME.2. We revealed that the transcription factor STAT1, previously shown to bind to its specific site on ME. 2, is functional for apoCII gene upregulation. We found that siRNA-mediated inhibition of STAT1 gene expression significantly decreased the apoCII levels, while STAT1 overexpression in RAW 264.7 macrophages increased apoCII gene expression. Using transient transfections, DNA pull down and chromatin immunoprecipitation assays, we revealed a novel STAT1 binding site in the -500/-493 region of the apoCII promoter, which mediates apoCII promoter upregulation by STAT1. Interestingly, STAT1 could not exert its upregulatory effect when the RXR alpha/T3R beta binding site located on the apoCII promoter was mutated, suggesting physical and functional interactions between these factors. Using GST pull-down and co-immunoprecipitation assays, we demonstrated that STAT1 physically interacts with RXR alpha. Taken together, these data revealed that STAT1 bound on ME.2 cooperates with RXR alpha located on apoCII promoter and upregulates apoCII expression only in macrophages, due to the specificity of the long-range interactions between the proximal and distal regulatory elements. Moreover, we showed for the first time that STAT1 and RXR alpha physically interact to exert their regulatory function.	[Trusca, Violeta G.; Florea, Irina C.; Gafencu, Anca V.] Nicolae Simionescu Romanian Acad, Inst Cellular Biol & Pathol, Bucharest, Romania; [Kardassis, Dimitris] Univ Crete, Sch Med, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; Foundation for Research & Technology - Hellas (FORTH); University of Crete	Trusca, VG (corresponding author), Nicolae Simionescu Romanian Acad, Inst Cellular Biol & Pathol, Bucharest, Romania.	anca.gafencu@icbp.ro	Gafencu, Anca/AAP-8707-2020; Trusca, Violeta Georgeta I/H-5562-2013; Trusca, Violeta/AAS-9472-2021; Gafencu, Anca/C-3323-2011	Gafencu, Anca/0000-0002-1290-1346; Bivol (Trusca), Violeta Georgeta/0000-0003-2980-3811	Romanian National Authority for Scientific Research; National Research Council Executive Agency for Higher Education, Research, Development and Innovation Funding (CNCS - UEFISCDI) [PNII-IDEI 1307/2008, PN-II-ID-PCE-2011-3-0591]; Romanian Academy; European Cooperation in Science and Technology (COST) Action [BM0904]; European Union - European Regional Development Fund; Romanian National Authority for Scientific Research [143/2009 - CARDIOPRO]	Romanian National Authority for Scientific Research; National Research Council Executive Agency for Higher Education, Research, Development and Innovation Funding (CNCS - UEFISCDI)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Romanian Academy(Romanian Academy of Sciences); European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); European Union - European Regional Development Fund(European Commission); Romanian National Authority for Scientific Research	This work was supported by the grants of the Romanian National Authority for Scientific Research, National Research Council Executive Agency for Higher Education, Research, Development and Innovation Funding (CNCS - UEFISCDI, http://uefiscdi.gov.ro), project PNII-IDEI 1307/2008 and PN-II-ID-PCE-2011-3-0591 (grants to Dr. Gafencu), by the Romanian Academy (http://www.acad.ro), and by the European Cooperation in Science and Technology (COST) Action BM0904 (http://www.cost.eu/domains_actions/bmbs/Actions/BM0904, and by the European Union - European Regional Development Fund (http://www.fonduri-ue.ro), and the Romanian National Authority for Scientific Research (http://www.ancs.ro) co-financed Project No. 143/2009 - CARDIOPRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN CM, 1995, J BIOL CHEM, V270, P26278, DOI 10.1074/jbc.270.44.26278; ALLAN CM, 1995, GENOMICS, V28, P291, DOI 10.1006/geno.1995.1144; Andersson Y, 1999, ARTERIOSCL THROM VAS, V19, P115, DOI 10.1161/01.ATV.19.1.115; BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; CONNELLY PW, 1987, P NATL ACAD SCI USA, V84, P270, DOI 10.1073/pnas.84.1.270; DANG Q, 1995, J BIOL CHEM, V270, P22577, DOI 10.1074/jbc.270.38.22577; Gafencu AV, 2007, J BIOL CHEM, V282, P21776, DOI 10.1074/jbc.M611422200; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Goulielmos GN, 2010, BIOCHEM BIOPH RES CO, V402, P141, DOI 10.1016/j.bbrc.2010.10.004; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; Jong MC, 2000, INT J TISSUE REACT, V22, P59; Kardassis D, 2003, BIOCHEM J, V372, P291, DOI 10.1042/BJ20021532; Kardassis D, 1998, J BIOL CHEM, V273, P17810, DOI 10.1074/jbc.273.28.17810; LAUER SJ, 1988, J BIOL CHEM, V263, P7277; LENICH C, 1988, J LIPID RES, V29, P755; LUSIS AJ, 1986, P NATL ACAD SCI USA, V83, P3929, DOI 10.1073/pnas.83.11.3929; Mak PA, 2002, J BIOL CHEM, V277, P31900, DOI 10.1074/jbc.M202993200; MILLER AL, 1973, J BIOL CHEM, V248, P3359; Mosialou I, 2011, J BIOL CHEM, V286, P17259, DOI 10.1074/jbc.M110.200659; MYKLEBOST O, 1984, J BIOL CHEM, V259, P4401; NILSSONEHLE P, 1980, ANNU REV BIOCHEM, V49, P667, DOI 10.1146/annurev.bi.49.070180.003315; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; SHACHTER NS, 1994, J CLIN INVEST, V93, P1683, DOI 10.1172/JCI117151; Shih SJ, 2000, J BIOL CHEM, V275, P31567, DOI 10.1074/jbc.M005468200; SIMONET WS, 1991, J BIOL CHEM, V266, P8651; Streicher R, 1996, J LIPID RES, V37, P2599; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; Trusca VG, 2011, J BIOL CHEM, V286, P13891, DOI 10.1074/jbc.M110.179572; Tsatsanis C, 2006, J IMMUNOL, V176, P1869, DOI 10.4049/jimmunol.176.3.1869; Vorgia P, 1998, J BIOL CHEM, V273, P4188, DOI 10.1074/jbc.273.7.4188; WEI CF, 1985, J BIOL CHEM, V260, P5211; ZANNIS VI, 1993, ADV HUM GENET, V21, P145; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028	34	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40463	10.1371/journal.pone.0040463	http://dx.doi.org/10.1371/journal.pone.0040463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808166	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400025
J	Jiang, GM; Sun, DM; Kaplan, HJ; Shao, H				Jiang, Guomin; Sun, Deming; Kaplan, Henry J.; Shao, Hui			Retinal Astrocytes Pretreated with NOD2 and TLR2 Ligands Activate Uveitogenic T Cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; CENTRAL-NERVOUS-SYSTEM; BACTERIAL PEPTIDOGLYCAN; DENDRITIC CELLS; UVEITIS; RECEPTOR; RECOGNITION; EXPRESSION; RESIDENT; MICE	On entering the tissues, infiltrating autoreactive T cells must be reactivated locally to gain pathogenic activity. We have previously reported that, when activated by Toll-like receptor 3 (TLR3) and TLR4 ligands, retinal astrocytes (RACs) are able to function as antigen-presenting cells to re-activate uveitogenic T cells and allow responder T cells to induce uveitis in mice. In the present study, we found that, although the triggering of TLR2 or nucleotide-binding oligomerization domain receptor 2 (NOD2) alone did not activate RACs, their combined triggering induced RACs with the phenotypes required to efficiently reactivate interphotoreceptor retinoid-binding protein (IRBP)-specific T cells. The synergistic effect of TLR2 and NOD2 ligands on RAC activation might be explained by the observations that bacterial lipoprotein (BLP, a TLR2 ligand) was able to upregulate NOD2 expression and the combination of BLP and muramyldipeptide (MDP, a NOD2 ligand) enhanced the expression of RICK (Rip2), the signaling molecule of NOD2. Moreover, the synergistic effect of MDP and BLP on RACs was lost when the RACs were derived from NOD2 knockout mice or were pre-treated with Rip2 antagonist. Thus, our data suggest that exogenous or endogenous molecules acting on both TLR2 and NOD2 on RACs might have an enhancing effect on susceptibility to autoimmune uveitis.	[Jiang, Guomin; Kaplan, Henry J.; Shao, Hui] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40292 USA; [Sun, Deming] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA	University of Louisville; Doheny Eye Institute; University of Southern California	Jiang, GM (corresponding author), Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40292 USA.	h0shao01@louisville.edu			National Institutes of Health [NEI EY12974]; Commonwealth of Kentucky Research Challenge Trust Fund; RPB, New York, NY; RPB Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE [R01EY012974, R01EY022403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky Research Challenge Trust Fund; RPB, New York, NY; RPB Lew R. Wasserman Merit Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by National Institutes of Health grant NEI EY12974 (grants.nih.gov/), an RPB Lew R. Wasserman Merit Award (HS, http://www.rpbusa.org/rpb/grants/current_grants/), the Commonwealth of Kentucky Research Challenge Trust Fund (HK), and an unrestricted grant from RPB, New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; Butler TL, 1996, INVEST OPHTH VIS SCI, V37, P2195; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Conforti-Andreoni C, 2010, J LEUKOCYTE BIOL, V88, P1207, DOI 10.1189/jlb.1009652; Cortes LM, 2008, INVEST OPHTH VIS SCI, V49, P1946, DOI 10.1167/iovs.07-0868; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; FORRESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P64; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; GILBART J, 1987, INFECT IMMUN, V55, P1526, DOI 10.1128/IAI.55.6.1526-1528.1987; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Iwanaga Y, 2003, INFLAMM RES, V52, P272, DOI 10.1007/s00011-003-1170-z; Jiang GM, 2008, INVEST OPHTH VIS SCI, V49, P282, DOI 10.1167/iovs.07-0371; Jiang GM, 2009, INVEST OPHTH VIS SCI, V50, P4769, DOI 10.1167/iovs.08-3303; Jiang GM, 2009, INVEST OPHTH VIS SCI, V50, P2245, DOI 10.1167/iovs.08-1949; Ke Y, 2010, J LEUKOCYTE BIOL, V88, P1241, DOI 10.1189/jlb.0610332; Ke Y, 2009, J LEUKOCYTE BIOL, V86, P1377, DOI 10.1189/jlb.0409237; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Liao TJ, 2006, INVEST OPHTH VIS SCI, V47, P1543, DOI 10.1167/iovs.05-1238; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Pennesi Giuseppina, 2002, Int Rev Immunol, V21, P67, DOI 10.1080/08830180212059; PERCOPO CM, 1990, J IMMUNOL, V145, P4101; Robertson MJ, 2002, INVEST OPHTH VIS SCI, V43, P2250; Rosenbaum JT, 2008, OPHTHAL RES, V40, P165, DOI 10.1159/000119870; Rosenzweig HL, 2008, INVEST OPHTH VIS SCI, V49, P1518, DOI 10.1167/iovs.07-1174; Rosenzweig HL, 2009, INVEST OPHTH VIS SCI, V50, P1746, DOI 10.1167/iovs.08-2852; Rosenzweig HL, 2009, INVEST OPHTH VIS SCI, V50, P1739, DOI 10.1167/iovs.08-2756; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Schrijver IA, 1999, J INFECT DIS, V179, P1459, DOI 10.1086/314761; Schrijver IA, 2001, RHEUMATOLOGY, V40, P438, DOI 10.1093/rheumatology/40.4.438; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Shao H, 2003, J IMMUNOL, V171, P5624, DOI 10.4049/jimmunol.171.10.5624; Shao H, 2003, EUR J IMMUNOL, V33, P1736, DOI 10.1002/eji.200323745; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Silver PB, 1999, INVEST OPHTH VIS SCI, V40, P2898; Sterka D, 2006, GLIA, V53, P322, DOI 10.1002/glia.20286; Sun D, 1996, J NEUROSCI RES, V45, P400, DOI 10.1002/(SICI)1097-4547(19960815)45:4<400::AID-JNR9>3.0.CO;2-D; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Visser L, 2005, J IMMUNOL, V174, P808, DOI 10.4049/jimmunol.174.2.808; Visser L, 2006, AM J PATHOL, V169, P1671, DOI 10.2353/ajpath.2006.060143; Walcott JC, 2003, CLIN EXP OPHTHALMOL, V31, P246, DOI 10.1046/j.1442-9071.2003.00638.x; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235; Xu HP, 2003, J NEUROIMMUNOL, V142, P47, DOI 10.1016/S0165-5728(03)00258-3	49	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40510	10.1371/journal.pone.0040510	http://dx.doi.org/10.1371/journal.pone.0040510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808176	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500049
J	Romao, JM; Jin, WW; He, ML; McAllister, T; Guan, LL				Romao, Josue Moura; Jin, Weiwu; He, Maolong; McAllister, Tim; Guan, Le Luo			Altered MicroRNA Expression in Bovine Subcutaneous and Visceral Adipose Tissues from Cattle under Different Diet	PLOS ONE			English	Article							GENE-EXPRESSION; ADIPOCYTE DIFFERENTIATION; FAT; IDENTIFICATION; ADIPOGENESIS; METABOLISM; MECHANISM; APOPTOSIS; OBESITY; RNAS	Background: MicroRNAs (miRNAs) are a class of molecular regulators found to participate in numerous biological processes, including adipogenesis in mammals. This study aimed to evaluate the differences of miRNA expression between bovine subcutaneous (backfat) and visceral fat depots (perirenal fat) and the dietary effect on miRNA expression in these fat tissues. Methodology/Principal Findings: Fat tissues were collected from 16 Hereford x Aberdeen Angus cross bred steers (15.5 month old) fed a high-fat diet (5.85% fat, n = 8) or control diet (1.95% fat, n = 8). Total RNA from each animal was subjected to miRNA microarray analysis using a customized Agilent miRNA microarray containing 672 bovine miRNA probes. Expression of miRNAs was not equal between fat depots as well as diets: 207 miRNAs were detected in both fat depots, while 37 of these were found to be tissue specific; and 169 miRNAs were commonly expressed under two diets while 75 were diet specific. The number of miRNAs detected per animal fed the high fat diet was higher than those fed control diet (p = 0.037 in subcutaneous fat and p = 0.002 visceral fat). Further qRT-PCR analysis confirmed that the expression of some miRNAs was highly influenced by diet (miR-19a, -92a, -92b, -101, -103, -106, -142-5p, and 296) or fat depot (miR-196a and -2454). Conclusions/Significance: Our results revealed that the miRNA may differ among adipose depots and level of fat in the diet, suggesting that miRNAs may play a role in the regulation of bovine adipogenesis.	[Romao, Josue Moura; Jin, Weiwu; Guan, Le Luo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [He, Maolong; McAllister, Tim] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	University of Alberta; Agriculture & Agri Food Canada	Romao, JM (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca	; McAllister, Tim A./R-9201-2017	Romao, Josue/0000-0002-9308-2177; McAllister, Tim A./0000-0002-8266-6513	Alberta Livestock Meat Agency [2010R033R]; Alberta Biosolutions [2010F110R]; Alberta Innovates-Technology Futures PhD student scholarship	Alberta Livestock Meat Agency; Alberta Biosolutions; Alberta Innovates-Technology Futures PhD student scholarship	The authors thank the funding support provided by Alberta Livestock Meat Agency (2010R033R), Alberta Biosolutions (2010F110R) for L. L. Guan and Alberta Innovates-Technology Futures PhD student scholarship for J. M. Romao.; This work was supported by Alberta Livestock Meat Agency (2010R033R) and Alberta Biosolutions (2010F110R). J.M.R. was supported by a PhD graduate student scholarship from Alberta Innovates-Technology Futures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Bong JJ, 2010, CELL BIOL INT, V34, P125, DOI 10.1042/CBI20090046; Cartwright AL, 1987, BIOL ADIPOCYTE, P229; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dodson MV, 2010, INT J BIOL SCI, V6, P691; Ferland-McCollough D, 2012, CELL DEATH DIFFER, V19, P1003, DOI 10.1038/cdd.2011.183; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He ML, 2010, NUTR RES, V30, P125, DOI 10.1016/j.nutres.2009.09.009; He ML, 2012, J ANIMAL S IN PRESS, V90, P600; He ML, 2011, J ANIMAL SCI S1, V89; Hishikawa D, 2005, PHYSIOL GENOMICS, V21, P343, DOI 10.1152/physiolgenomics.00184.2004; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Jin W, 2012, J ANIM SCI, V90, P171, DOI 10.2527/jas.2011-4229; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Joseph SJ, 2010, GENE REGUL SYST BIO, V4, P91, DOI 10.4137/GRSB.S5831; Joseph SJ, 2010, BIOINFORM BIOL INSIG, V4, P19; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Mortarino M, 2010, LEUKEMIA RES, V34, P1070, DOI 10.1016/j.leukres.2009.10.023; Neville MJ, 2011, OBESITY, V19, P888, DOI 10.1038/oby.2010.257; O'Rourke Jason R., 2006, Birth Defects Research, V78, P172, DOI 10.1002/bdrc.20071; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Romao JM, 2011, EXP BIOL MED, V236, P997, DOI 10.1258/ebm.2011.011101; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Taniguchi M, 2008, BIOCHEM BIOPH RES CO, V366, P346, DOI 10.1016/j.bbrc.2007.11.111; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	62	42	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40605	10.1371/journal.pone.0040605	http://dx.doi.org/10.1371/journal.pone.0040605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22815773	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500063
J	Yi, ZZ; Katz, LA; Song, WB				Yi, Zhenzhen; Katz, Laura A.; Song, Weibo			Assessing Whether Alpha-Tubulin Sequences Are Suitable for Phylogenetic Reconstruction of Ciliophora with Insights into Its Evolution in Euplotids	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; MOLECULAR PHYLOGENY; CILIATES CILIOPHORA; GENE SEQUENCE; MULTIGENE ANALYSES; N. SP.; SPIROTRICHEA; MORPHOLOGY; PROTOZOA; POSITION	The current understanding of ciliate phylogeny is mainly based on analyses of a single gene, the small subunit ribosomal RNA (SSU-rDNA). However, phylogenetic trees based on single gene sequence are not reliable estimators of species trees, and SSU-rDNA genealogies are not useful for resolution of some branches within Ciliophora. Since congruence between multiple loci is the best tool to determine evolutionary history, we assessed the usefulness of alpha-tubulin gene, a proteincoding gene that is frequently sequenced, for ciliate phylogeny. Here, we generate alpha-tubulin gene sequences of 12 genera and 30 species within the order Euplotida, one of the most frequently encountered ciliate clades with numerous apparently cosmopolitan species, as well as four genera within its putative sister order Discocephalida. Analyses of the resulting data reveal that: 1) the alpha-tubulin gene is suitable phylogenetic marker for euplotids at the family level, since both nucleotide and amino acid phylogenies recover all monophyletic euplotid families as defined by both morphological criteria and SSU-rDNA trees; however, alpha-tubulin gene is not a good marker for defining species, order and subclass; 2) for seven out of nine euplotid species for which paralogs are detected, gene duplication appears recent as paralogs are monophyletic; 3) the order Euplotida is non-monophyletic, and the family Uronychiidae with sequences from four genera, is non-monophyletic; and 4) there is more genetic diversity within the family Euplotidae than is evident from dargyrome (geometrical pattern of dorsal "silverline system'' in ciliates) patterns, habit and SSU-rDNA phylogeny, which indicates the urgent need for taxonomic revision in this area.	[Yi, Zhenzhen; Song, Weibo] S China Normal Univ, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Yi, Zhenzhen; Song, Weibo] Ocean Univ China, Lab Protozool, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Katz, Laura A.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA	South China Normal University; Ocean University of China; Smith College	Yi, ZZ (corresponding author), S China Normal Univ, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	wsong@ouc.edu.cn	Katz, Laura A/AAF-4802-2019	Katz, Laura/0000-0002-9138-4702	The Natural Science Foundation of China [31030059, 41006098]; China Postdoctoral Science Foundation [20110491623]; National Science Foundation [DEB 0816828, DEB RUI:0919152]; Direct For Biological Sciences [0919152] Funding Source: National Science Foundation	The Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the 'The Natural Science Foundation of China' (Project No. 31030059, 41006098) to W.S. and Z.Y., China Postdoctoral Science Foundation (20110491623) to Z.Y., and two National Science Foundation awards (DEB 0816828 and DEB RUI:0919152) to L.A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Berger H., 2006, MONOGR BIOL, V85, P1, DOI DOI 10.1007/1-4020-5273-1_1; Bernhard D, 2001, MOL PHYLOGENET EVOL, V21, P86, DOI 10.1006/mpev.2001.0997; BORROR AC, 1995, J EUKARYOT MICROBIOL, V42, P457, DOI 10.1111/j.1550-7408.1995.tb05891.x; Budin K, 1998, MOL BIOL EVOL, V15, P943, DOI 10.1093/oxfordjournals.molbev.a026010; Chen ZG, 2002, ACTA PROTOZOOL, V41, P1; Chen ZG, 2001, EUR J PROTISTOL, V37, P291, DOI 10.1078/0932-4739-00827; Cho BC, 2008, J EUKARYOT MICROBIOL, V55, P417, DOI 10.1111/j.1550-7408.2008.00340.x; CORLISS J O, 1979, P455; Curds RC, 1975, B BR MUS NAT HIS Z, V28, P3; Dalby AB, 2004, CHROMOSOMA, V112, P247, DOI 10.1007/s00412-003-0270-4; DEPUYTORAC P, 1993, CR ACAD SCI III-VIE, V316, P716; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fitch WM, 1970, SYST ZOOL, V28, P132; Foissner W, 2008, ACTA PROTOZOOL, V47, P1; GALTIER N, 1995, P NATL ACAD SCI USA, V92, P11317, DOI 10.1073/pnas.92.24.11317; Gates M.A., 1979, Bulletin of the British Museum (Natural History) Zoology, V35, P127; Gong YC, 2010, J EUKARYOT MICROBIOL, V57, P265, DOI 10.1111/j.1550-7408.2010.00472.x; Goodman M, 1979, SYST ZOOL, V19, P99; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1993, NATURE, V361, P23, DOI 10.1038/361023b0; Hewitt EA, 2003, MOL PHYLOGENET EVOL, V29, P258, DOI 10.1016/S1055-7903(03)00097-6; Hoffman DC, 1997, J MOL EVOL, V45, P301, DOI 10.1007/PL00006234; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Israel RL, 2002, EVOLUTION, V56, P1110; Jankowski A., 1979, T ZOOL I LENINGR, V86, P48; Jiang JM, 2010, J EUKARYOT MICROBIOL, V57, P354, DOI 10.1111/j.1550-7408.2010.00482.x; Jiang JM, 2010, EUR J PROTISTOL, V46, P121, DOI 10.1016/j.ejop.2009.11.003; Jiang JM, 2010, INT J SYST EVOL MICR, V60, P1241, DOI 10.1099/ijs.0.012120-0; Katz LA, 2004, MOL BIOL EVOL, V21, P555, DOI 10.1093/molbev/msh048; LEIPE DD, 1993, MOL BIOCHEM PARASIT, V59, P41, DOI 10.1016/0166-6851(93)90005-I; Li LF, 2010, SCI CHINA LIFE SCI, V53, P131, DOI 10.1007/s11427-010-0012-9; Li LF, 2009, INT J SYST EVOL MICR, V59, P439, DOI 10.1099/ijs.0.65801-0; Lynn D.H., 2008, CILIATED PROTOZOA; Lynn DH, 2002, J EUKARYOT MICROBIOL, V49, P460, DOI 10.1111/j.1550-7408.2002.tb00229.x; LYNN DH, 1988, BIOSYSTEMS, V21, P249, DOI 10.1016/0303-2647(88)90020-2; Lynn DH, 1997, REV SOC MEX HIST NAT, V47, P65; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mia M, 2007, J EUKARYOT MICROBIOL, V54, P371, DOI 10.1111/j.1550-7408.2007.00271.x; Miao M, 2008, PROTIST, V159, P519, DOI 10.1016/j.protis.2008.05.002; Miao M, 2011, SCI CHINA LIFE SCI, V54, P634, DOI 10.1007/s11427-011-4192-8; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Nylander J.A.A, 2004, MRMODELTEST V2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Petroni G, 2002, MOL PHYLOGENET EVOL, V22, P118, DOI 10.1006/mpev.2001.1030; Riley JL, 2001, MOL BIOL EVOL, V18, P1372, DOI 10.1093/oxfordjournals.molbev.a003921; SCHLEGEL M, 1988, EUR J PROTISTOL, V24, P22, DOI 10.1016/S0932-4739(88)80005-1; Schmidt SL, 2007, J EUKARYOT MICROBIOL, V54, P201, DOI 10.1111/j.1550-7408.2007.00250.x; Schwarz MVJ, 2007, J EUKARYOT MICROBIOL, V54, P125, DOI 10.1111/j.1550-7408.2007.00243x; Shao C, 2008, INT J SYST EVOL MICR, V58, P2962, DOI 10.1099/ijs.0.65781-0; Shen Z, 2011, J EUKARYOT MICROBIOL, V58, P242, DOI 10.1111/j.1550-7408.2011.00536.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Small E.B., 1985, P393; Snoeyenbos-West OLO, 2002, INT J SYST EVOL MICR, V52, P1901, DOI 10.1099/00207713-52-5-1901; Song WB, 2007, J EUKARYOT MICROBIOL, V54, P283, DOI 10.1111/j.1550-7408.2007.00266.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stoeck T, 2007, J EUKARYOT MICROBIOL, V54, P436, DOI 10.1111/j.1550-7408.2007.00283.x; Struder-Kypke MC, 2006, PROTIST, V157, P261, DOI 10.1016/j.protis.2006.03.003; Sun P, 2010, MOL PHYLOGENET EVOL, V56, P242, DOI 10.1016/j.ympev.2010.02.030; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tekle YI, 2008, MOL PHYLOGENET EVOL, V47, P339, DOI 10.1016/j.ympev.2007.11.015; Tourancheau AB, 1998, MOL PHYLOGENET EVOL, V10, P299, DOI 10.1006/mpev.1998.0534; Tuffrau M., 1994, TRAIT ZOOLOGIE INFUS, P83; WICKLOW BJ, 1982, PROTISTOLOGICA, V18, P299; Yi ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017471; Yi ZZ, 2010, MOL PHYLOGENET EVOL, V57, P937, DOI 10.1016/j.ympev.2010.08.001; Yi ZZ, 2010, SYST BIODIVERS, V8, P149, DOI 10.1080/14772000903523493; Yi ZZ, 2009, ZOOL J LINN SOC-LOND, V157, P227, DOI 10.1111/j.1096-3642.2008.00524.x; Yi ZZ, 2009, MOL PHYLOGENET EVOL, V50, P599, DOI 10.1016/j.ympev.2008.12.006; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14; Zufall RA, 2007, J EUKARYOT MICROBIOL, V54, P275, DOI 10.1111/j.1550-7408.2007.00267.x; Zufall RA, 2006, MOL BIOL EVOL, V23, P1681, DOI 10.1093/molbev/msl032	75	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40635	10.1371/journal.pone.0040635	http://dx.doi.org/10.1371/journal.pone.0040635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808216	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500065
J	El Shamieh, S; Ndiaye, NC; Stathopoulou, MG; Murray, HA; Masson, C; Lamont, JV; Fitzgerald, P; Benetos, A; Visvikis-Siest, S				El Shamieh, Said; Ndiaye, Ndeye Coumba; Stathopoulou, Maria G.; Murray, Helena A.; Masson, Christine; Lamont, John V.; Fitzgerald, Peter; Benetos, Athanase; Visvikis-Siest, Sophie			Functional Epistatic Interaction between rs6046G > A in F7 and rs5355C > T in SELE Modifies Systolic Blood Pressure Levels	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; KAPPA-B ACTIVATION; FACTOR-VII GENE; STANISLAS COHORT; FOLLOW-UP; RISK; POLYMORPHISMS; EXPRESSION; HYPERTENSION; CELLS	Background: Although numerous genetic studies have been performed, only 0.9% of blood pressure phenotypic variance has been elucidated. This phenomenon could be partially due to epistatic interactions. Our aim was to identify epistatic interaction(s) associated with blood pressure levels in a pre-planned two-phase approach. Methods and Results: In a discovery cohort composed of 3,600 French individuals, we found rs6046A allele in F7 associated with decreased blood pressure levels (P <= 3.7x10(-3)) and rs5355T allele in SELE associated with decreased diastolic blood pressure levels (P = 5x10 (-3)). Both variants interacted in order to influence blood pressure levels (P <= 0.048). This interaction was replicated with systolic blood pressure in 4,620 additional European individuals (P = 0.03). Similarly, in this replication cohort, rs6046A was associated with decreased blood pressure levels (P <= 8.5x10(-4)). Furthermore, in peripheral blood mononuclear cells of a subsample of 90 supposed healthy individuals, we found rs6046A positively associated with NAMPT mRNA levels (P <= 9.1x10(-5)), suggesting an eventual involvement of NAMPT expression in blood pressure regulation. Confirming this hypothesis, further transcriptomic analyses showed that increased NAMPT mRNA levels were positively correlated with ICAM1, SELL, FPR1, DEFA1-3, and LL-37 genes expression (P <= 5x10(-3)). The last two mRNA levels were positively associated with systolic blood pressure levels (P <= 0.01) and explained 4% of its phenotypic variation. Conclusion: These findings reveal the importance of epistatic interactions in blood pressure genetics and give new insights for the role of inflammation in its complex regulation.	[El Shamieh, Said; Ndiaye, Ndeye Coumba; Stathopoulou, Maria G.; Masson, Christine; Visvikis-Siest, Sophie] Univ Lorraine, EA 4373, Nancy, France; [Murray, Helena A.; Lamont, John V.; Fitzgerald, Peter] Randox Labs Ltd, Crumlin, Antrim, North Ireland; [Benetos, Athanase] Univ Lorraine, INSERM, U961, Nancy, France; [Benetos, Athanase; Visvikis-Siest, Sophie] CHU Nancy, Serv Geriatr, Nancy, France	Universite de Lorraine; Randox Laboratories; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy	El Shamieh, S (corresponding author), Univ Lorraine, EA 4373, Nancy, France.	Sophie.Visvikis-Siest@inserm.fr	Stathopoulou, Maria/H-7324-2016; Shamieh, Said El/J-6343-2019; Visvikis-Siest, Sophie/H-2324-2014	Stathopoulou, Maria/0000-0003-4376-2083; Shamieh, Said El/0000-0002-8522-0445; Visvikis-Siest, Sophie/0000-0001-8104-8425; MASSON, Christine/0000-0001-5804-3722	"Institut national de la sante et de la recherche medicale" (INSERM); Region Lorraine; communaute Urbaine de Grand Nancy; Universite de Lorraine	"Institut national de la sante et de la recherche medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Lorraine(Region Grand-Est); communaute Urbaine de Grand Nancy; Universite de Lorraine	This project was realized thanks to the Bio-Intelligence project. We also thank the "Institut national de la sante et de la recherche medicale" (INSERM), the "Region Lorraine", the "communaute Urbaine de Grand Nancy'' and the "Universite de Lorraine" for supporting this work. Samples and data used for this study are part of the Biological Resources Center (BRC): "Interactions Gene-Environnement en Physiopathologie Cardio-Vasculaire" (IGE-PCV) in Nancy, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Hamza, 2007, Genomic Med, V1, P105, DOI 10.1007/s11568-008-9017-x; Benachour H, 2009, NUTR METAB CARDIOVAS, V19, P720, DOI 10.1016/j.numecd.2009.01.001; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DASBERG H, 1962, BRIT HEART J, V24, P214; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ehret GB, 2010, CURR HYPERTENS REP, V12, P17, DOI 10.1007/s11906-009-0086-6; Ehret GB, 2009, EUR J HUM GENET, V17, P1650, DOI 10.1038/ejhg.2009.94; El Shamieh S, 2012, CLIN CHIM ACTA, V413, P34, DOI 10.1016/j.cca.2010.11.038; Faruque MU, 2011, J HYPERTENS, V29, P1906, DOI 10.1097/HJH.0b013e32834b000d; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Girelli D, 2000, NEW ENGL J MED, V343, P774, DOI 10.1056/NEJM200009143431104; Harrap SB, 2003, LANCET, V361, P2149, DOI 10.1016/S0140-6736(03)13694-X; Harrap SB, 2009, J AM SOC HYPERTENS, V3, P231, DOI 10.1016/j.jash.2009.06.001; Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Joehanes R, 2011, PHYSL GENOMICS; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Kontaraki JE, 2011, J HYPERTENS, V29, P791, DOI 10.1097/HJH.0b013e3283424bc4; Leamy LJ, 2002, EVOLUTION, V56, P642, DOI 10.1111/j.0014-3820.2002.tb01373.x; Lee WJ, 2009, INT J OBESITY, V33, P465, DOI 10.1038/ijo.2009.24; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Marteau JB, 2005, CLIN CHEM, V51, P1250, DOI 10.1373/clinchem.2005.048546; Marteau JB, 2004, J HYPERTENS, V22, P305, DOI 10.1097/00004872-200402000-00014; Maumus S, 2007, ATHEROSCLEROSIS, V191, P369, DOI 10.1016/j.atherosclerosis.2006.04.003; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Misono M, 2009, J HYPERTENS, V27, P1377, DOI 10.1097/HJH.0b013e32832b7ead; Ndiaye NC, 2011, CLIN CHIM ACTA, V412, P1697, DOI 10.1016/j.cca.2011.05.035; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sass C, 2000, HUM GENET, V107, P58, DOI 10.1007/s004390050011; Sass C, 2004, J HYPERTENS, V22, P297, DOI 10.1097/00004872-200402000-00013; Sass C, 2004, HYPERTENSION, V44, P674, DOI 10.1161/01.HYP.0000144799.41945.a5; Sass G, 2000, J HYPERTENS, V18, P1775, DOI 10.1097/00004872-200018120-00011; Taal HR, 2011, HYPERTENSION, V111; Tomaszewski M, 2011, J AM SOC NEPHROL, V22, P947, DOI 10.1681/ASN.2010080829; VanderWeele TJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1517; Visvikis-Siest S, 2008, CLIN CHEM LAB MED, V46, P733, DOI 10.1515/CCLM.2008.178; Visvikis-Siest S, 2007, CLIN CHEM LAB MED, V45, P1154, DOI 10.1515/CCLM.2007.255; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Wang P, 2010, J PHYSIOL SCI, V60, P317, DOI 10.1007/s12576-010-0103-1; Zee RYL, 2006, CIRCULATION, V113, P2193, DOI 10.1161/CIRCULATIONAHA.106.615401	47	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40777	10.1371/journal.pone.0040777	http://dx.doi.org/10.1371/journal.pone.0040777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815813	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900046
J	Zhang, H; Guo, CF; Wu, DJ; Zhang, AA; Gu, T; Wang, LS; Wang, CQ				Zhang, Huili; Guo, Changfa; Wu, Duojiao; Zhang, Alian; Gu, Ting; Wang, Liansheng; Wang, Changqian			Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; LESION FORMATION; CECAL LIGATION; MICE REVEALS; NITRIC-OXIDE; CELL-LINE; KAPPA-B; FRACTALKINE; CHEMOKINES; CCR2	Hydrogen sulfide, as a novel gaseous mediator, has been suggested to play a key role in atherogenesis. However, the precise mechanisms by which H2S affects atherosclerosis remain unclear. Therefore, the present study aimed to investigate the potential role of H2S in atherosclerosis and the underlying mechanism with respect to chemokines (CCL2, CCL5 and CX3CL1) and chemokine receptors (CCR2, CCR5, and CX3CR1) in macrophages. Mouse macrophage cell line RAW 264.7 or mouse peritoneal macrophages were pre-incubated with saline or NaHS (50 mu M, 100 mu M, 200 mu M), an H2S donor, and then stimulated with interferon-gamma (IFN-gamma) or lipopolysaccharide (LPS). It was found that NaHS dose-dependently inhibited IFN-gamma or LPS-induced CX3CR1 and CX3CL1 expression, as well as CX3CR1-mediated chemotaxis in macrophages. Overexpression of cystathionine gamma-lyase (CSE), an enzyme that catalyzes H2S biosynthesis resulted in a significant reduction in CX3CR1 and CX3CL1 expression as well as CX3CR1-mediated chemotaxis in stimulated macrophages. The inhibitory effect of H2S on CX3CR1 and CX3CL1 expression was mediated by modulation of proliferators-activated receptor-gamma (PPAR-gamma) and NF-kappa B pathway. Furthermore, male apoE(-/-) mice were fed a high-fat diet and then randomly given NaHS (1 mg/kg, i.p., daily) or DL-propargylglycine (PAG, 10 mg/kg, i.p., daily). NaHS significantly inhibited aortic CX3CR1 and CX3CL1 expression and impeded aortic plaque development. NaHS had a better anti-atherogenic benefit when it was applied at the early stage of atherosclerosis. However, inhibition of H2S formation by PAG increased aortic CX3CR1 and CX3CL1 expression and exacerbated the extent of atherosclerosis. In addition, H2S had minimal effect on the expression of CCL2, CCL5, CCR2 and CCR5 in vitro and in vivo. In conclusion, these data indicate that H2S hampers the progression of atherosclerosis in fat-fed apoE(-/-) mice and downregulates CX3CR1 and CX3CL1 expression on macrophages and in lesion plaques.	[Zhang, Huili; Zhang, Alian; Wang, Changqian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China; [Guo, Changfa] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China; [Wu, Duojiao] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200433, Peoples R China; [Gu, Ting] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Oral & Maxillofacial Pathol, Shanghai 200030, Peoples R China; [Wang, Liansheng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Clin Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	changqianw@gmail.com	Gu, Tingyi/M-6505-2019	Gu, Tingyi/0000-0003-0414-6333	National Natural Science Foundation of China [30900522]; Shanghai Pujiang Program [09PJ1407000]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by the National Natural Science Foundation of China grant (Grant No. 30900522) www.nsfc.gov.cn, the Shanghai Pujiang Program (Grant No. 09PJ1407000) www.stcsm.gov.cn, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China www.cscse.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlic J, 2007, TRENDS CARDIOVAS MED, V17, P269, DOI 10.1016/j.tcm.2007.09.004; Barlic J, 2006, CIRCULATION, V114, P807, DOI 10.1161/CIRCULATIONAHA.105.602359; Bhavsar PK, 2008, FASEB J, V22, P1807, DOI 10.1096/fj.07-094235; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Elsey DJ, 2010, CELL BIOCHEM FUNCT, V28, P95, DOI 10.1002/cbf.1618; Gan LM, 2007, ATHEROSCLEROSIS, V190, P313, DOI 10.1016/j.atherosclerosis.2006.03.035; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Meng QH, 2007, AM J PATHOL, V170, P1406, DOI 10.2353/ajpath.2007.060939; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Renga Barbara, 2011, Inflammation & Allergy Drug Targets, V10, P85; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Shibuya A, 2002, FEBS LETT, V525, P43, DOI 10.1016/S0014-5793(02)03059-4; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Wan YH, 2010, J MOL ENDOCRINOL, V44, P135, DOI 10.1677/JME-09-0090; Wang QA, 2010, BIOCHEM BIOPH RES CO, V396, P182, DOI 10.1016/j.bbrc.2010.04.061; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2006, BIOCHEM BIOPH RES CO, V343, P303, DOI 10.1016/j.bbrc.2006.02.154; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Wu DJ, 2009, ATHEROSCLEROSIS, V207, P68, DOI 10.1016/j.atherosclerosis.2009.04.025; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhang HL, 2007, J LEUKOCYTE BIOL, V82, P894, DOI 10.1189/jlb.0407237; Zhao QH, 2010, J LEUKOCYTE BIOL, V88, P41, DOI 10.1189/jlb.1009671; Zhao ZZ, 2011, EXP BIOL MED, V236, P169, DOI 10.1258/ebm.2010.010308; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599	38	51	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41147	10.1371/journal.pone.0041147	http://dx.doi.org/10.1371/journal.pone.0041147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815945	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900080
J	Mishellany-Dutour, A; Woda, A; Laboure, H; Bourdiol, P; Lachaze, P; Guichard, E; Feron, G				Mishellany-Dutour, Anne; Woda, Alain; Laboure, Helene; Bourdiol, Pierre; Lachaze, Pauline; Guichard, Elisabeth; Feron, Gilles			Retro-Nasal Aroma Release Is Correlated with Variations in the In-Mouth Air Cavity Volume after Empty Deglutition	PLOS ONE			English	Article							FLAVOR PERCEPTION; ACOUSTIC REFLECTION; SWALLOWING PROCESS; SOFT PALATE; SOLID FOOD; AREA; RESPIRATION; MASTICATION; CONSEQUENCES; CHEESE	We hypothesized that interindividual differences in motor activities during chewing and/or swallowing were determining factors for the transfer of volatile aroma from the in-mouth air cavity (IMAC) toward the olfactory mucosa. In our first experiment, we looked for changes in IMAC volume after saliva deglutition in 12 healthy subjects. The mean IMAC volume was measured after empty deglutition using an acoustic pharyngometer device. Based on the time course of the IMAC volume after swallowing, we discerned two groups of subjects. The first group displayed a small, constant IMAC volume (2.26 mL +/- 0.62) that corresponded to a high tongue position. The second group displayed a progressive increase in IMAC (from 6.82 mL +/- 2.37 to 22.82 mL +/- 3.04) that corresponded to a progressive lowering of the tongue to its resting position. In our second experiment, we investigated the relationship between IMAC volume changes after deglutition and the level of aroma release at the nostril. For this purpose, the release of menthone was measured at the nostril level in 25 subjects who consumed similar amounts of a mint tablet. The subjects were separated into two groups corresponding to two levels of menthone release: high (H) and low (L). The mean volume of IMAC was measured during and after empty deglutition. Group H displayed a small, constant amplitude of IMAC volume change after deglutition, while Group L displayed a progressive increase in IMAC. It is likely that Group H continuously released the aroma through the veloglossal isthmus as the mint was consumed, while Group L trapped the aroma in the oral cavity and then released it into the nasal cavity upon swallowing. These results show that the in vivo aroma release profile in humans depends closely on the different motor patterns at work during empty deglutition.	[Mishellany-Dutour, Anne; Woda, Alain; Bourdiol, Pierre; Lachaze, Pauline] Ctr Rech Odontol Clin, Fac Dent, Equipe Accueil 3847, Clermont Ferrand, France; [Laboure, Helene; Guichard, Elisabeth; Feron, Gilles] Univ Bourgogne, CNRS, UMR 6265, Ctr Sci Gout & Alimentat,UMR 1324,Inst Natl Rech, Dijon, France; [Woda, Alain; Bourdiol, Pierre] Ctr Hosp Univ, Serv Odontol, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Clermont Ferrand	Mishellany-Dutour, A (corresponding author), Ctr Rech Odontol Clin, Fac Dent, Equipe Accueil 3847, Clermont Ferrand, France.	alain.woda@u-clermont1.fr	Laboure, Helene/S-3006-2016; FERON, Gilles/AAW-8714-2020	Laboure, Helene/0000-0002-8173-6145; Feron, Gilles/0000-0002-9522-9654	French National Research Agency [ANR 07-PNRA-014]; Burgundy region	French National Research Agency(French National Research Agency (ANR)); Burgundy region(Region Bourgogne-Franche-Comte)	This work was supported by the French National Research Agency [grant SensInMouth, ANR 07-PNRA-014] and by the Burgundy region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blissett A, 2006, J TEXTURE STUD, V37, P476, DOI 10.1111/j.1745-4603.2006.00064.x; Bourdiol P, 2010, J ORAL REHABIL, V37, P100, DOI 10.1111/j.1365-2842.2009.02024.x; BROOKS LJ, 1989, J APPL PHYSIOL, V66, P2901, DOI 10.1152/jappl.1989.66.6.2901; Buettner A, 2002, FOOD QUAL PREFER, V13, P497, DOI 10.1016/S0950-3293(02)00052-6; Buettner A, 2001, CHEM SENSES, V26, P1211, DOI 10.1093/chemse/26.9.1211; Buettner A, 2000, LEBENSM-WISS TECHNOL, V33, P553, DOI 10.1006/fstl.2000.0708; Buettner A, 2000, FOOD CHEM, V71, P347, DOI 10.1016/S0308-8146(00)00199-0; COLLINS LMC, 1987, J DENT RES, V66, P285; Eckmann DM, 1996, ANESTH ANALG, V83, P1084, DOI 10.1097/00000539-199611000-00033; FREDBERG JJ, 1980, J APPL PHYSIOL, V48, P749, DOI 10.1152/jappl.1980.48.5.749; Gavião Maria Beatriz Duarte, 2004, J. Appl. Oral Sci., V12, P159, DOI 10.1590/S1678-77572004000200015; Gierczynski I, 2008, J AGR FOOD CHEM, V56, P1697, DOI 10.1021/jf0728505; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; Hodgson M, 2003, J AGR FOOD CHEM, V51, P5052, DOI 10.1021/jf030118+; Hodgson MD, 2005, J AGR FOOD CHEM, V53, P1700, DOI 10.1021/jf040316g; INGHAM KE, 1995, FOOD SCI TECHNOL-LEB, V28, P105; Kamal I, 2001, OTOLARYNG HEAD NECK, V124, P323, DOI 10.1067/mhn.2001.113136; Land DG, 1996, ACS SYM SER, V633, P2; Le Quere Jean-Luc, 2006, V43, P589; LOUIS B, 1994, J APPL PHYSIOL, V76, P2234, DOI 10.1152/jappl.1994.76.5.2234; Matsuo K, 2005, J DENT RES, V84, P39, DOI 10.1177/154405910508400106; Matsuo K, 2010, J DENT RES, V89, P1401, DOI 10.1177/0022034510377336; Matsuo K, 2008, J APPL PHYSIOL, V104, P674, DOI 10.1152/japplphysiol.00527.2007; Normand V, 2004, CHEM SENSES, V29, P235, DOI 10.1093/chemse/bjh028; Ovejero-Lopez I, 2004, J AGR FOOD CHEM, V52, P8119, DOI 10.1021/jf048716r; Palmer JB, 2003, DYSPHAGIA, V18, P169, DOI 10.1007/s00455-002-0097-9; Pionnier E, 2005, ROY SOC CH, P13; Pionnier E, 2004, J AGR FOOD CHEM, V52, P557, DOI 10.1021/jf030544v; Repoux M, 2012, FLAVOUR FRAG J, V27, P40, DOI 10.1002/ffj.2077; Ruijschop RMAJ, 2009, CHEM SENSES, V34, P395, DOI 10.1093/chemse/bjp011; Salles C, 2011, CRIT REV FOOD SCI, V51, P67, DOI 10.1080/10408390903044693; Semon E, 2003, ADV MASS SPECTROME S, P324; Singh GD, 2007, SLEEP BREATH, V11, P209, DOI 10.1007/s11325-007-0104-3	33	26	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41276	10.1371/journal.pone.0041276	http://dx.doi.org/10.1371/journal.pone.0041276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815986	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000085
J	Paffett, ML; Hesterman, J; Candelaria, G; Lucas, S; Anderson, T; Irwin, D; Hoppin, J; Norenberg, J; Campen, MJ				Paffett, Michael L.; Hesterman, Jacob; Candelaria, Gabriel; Lucas, Selita; Anderson, Tamara; Irwin, Daniel; Hoppin, Jack; Norenberg, Jeffrey; Campen, Matthew J.			Longitudinal In Vivo SPECT/CT Imaging Reveals Morphological Changes and Cardiopulmonary Apoptosis in a Rodent Model of Pulmonary Arterial Hypertension	PLOS ONE			English	Article							RIGHT-VENTRICULAR HYPERTROPHY; MONOCROTALINE; DYSFUNCTION; SURVIVAL; PREVENTS; IMPROVES; DISEASE	Pulmonary arterial hypertension (PAH) has a complex pathogenesis involving both heart and lungs. Animal models can reflect aspects of the human pathology and provide insights into the development and underlying mechanisms of disease. Because of the variability of most animal models of PAH, serial in vivo measurements of cardiopulmonary function, morphology, and markers of pathology can enhance the value of such studies. Therefore, quantitative in vivo SPECT/CT imaging was performed to assess cardiac function, morphology and cardiac perfusion utilizing (201)Thallium (Tl-201) in control and monocrotaline-treated rats. In addition, lung and heart apoptosis was examined with Tc-99m-Annexin V (Tc-99m-Annexin) in these cohorts. Following baseline imaging, rats were injected with saline or monocrotaline (50 mg/kg, i.p.) and imaged weekly for 6 weeks. To assess a therapeutic response in an established pulmonary hypertensive state, a cohort of rats received resveratrol in drinking water (3 mg/kg/day) on days 28-42 post-monocrotaline injection to monitor regression of cardiopulmonary apoptosis. PAH in monocrotaline-treated rats was verified by conventional hemodynamic techniques on day 42 (right ventricular systolic pressure (RSVP) = 66.2 mmHg in monocrotaline vs 28.8 mmHg in controls) and in terms of right ventricular hypertrophy (RV/LVS = 0.70 in monocrotaline vs 0.32 in controls). Resveratrol partially reversed both RVSP (41.4 mmHg) and RV/LVS (0.46), as well as lung edema and RV contractility +dP/dt(max). Serial Tc-99m-Annexin V imaging showed clear increases in pulmonary and cardiac apoptosis when compared to baseline, which regressed following resveratrol treatment. Monocrotaline induced modest changes in whole-heart perfusion as assessed by Tl-201 imaging and cardiac morphological changes consistent with septal deviation and enlarged RV. This study demonstrates the utility of functional in vivo SPECT/CT imaging in rodent models of PAH and further confirms the efficacy of resveratrol in reversing established monocrotaline-induced PAH presumably by attenuation of cardiopulmonary apoptosis.	[Paffett, Michael L.; Lucas, Selita; Campen, Matthew J.] Univ New Mexico, Hlth Sci Ctr, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Hesterman, Jacob; Hoppin, Jack] InviCRO, Boston, MA USA; [Candelaria, Gabriel; Anderson, Tamara; Irwin, Daniel; Norenberg, Jeffrey] Univ New Mexico, Coll Pharm, Radiopharmaceut Sci Program, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Candelaria, Gabriel; Anderson, Tamara; Irwin, Daniel; Norenberg, Jeffrey] Univ New Mexico, Hlth Sci Ctr, Keck UNM Small Anim Imaging Resource, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Paffett, ML (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	mpaffett@salud.unm.edu	Norenberg, Jeffrey/AAL-1725-2021		Translational Cardiopulmonary Functional Assessment in a Rat Model of Pulmonary Arterial Hypertension [CMDP2010]; National Institutes of Health [ES014369]; W.M. Keck Foundation; NCI-designated University of New Mexico Cancer Center [P30CA118100-06]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER	Translational Cardiopulmonary Functional Assessment in a Rat Model of Pulmonary Arterial Hypertension; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NCI-designated University of New Mexico Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by an internally funded pilot project, Translational Cardiopulmonary Functional Assessment in a Rat Model of Pulmonary Arterial Hypertension (CMDP2010), by a grant from the National Institutes of Health (ES014369), and Small-Animal SPECT/CT images in this article were generated at the Keck-University of New Mexico Small-Animal Imaging Resource (KUSAIR) established through a grant from the W.M. Keck Foundation, and supported by the NCI-designated University of New Mexico Cancer Center Support Grant (P30CA118100-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campian ME, 2009, J NUCL MED, V50, P1371, DOI 10.2967/jnumed.108.061366; Chan V, 2011, CURR PHARM BIOTECHNO, V12, P429, DOI 10.2174/138920111794480552; Chen YR, 2008, CARDIOVASC DRUG THER, V22, P479, DOI 10.1007/s10557-008-6141-8; Correia-Pinto J, 2009, BASIC RES CARDIOL, V104, P535, DOI 10.1007/s00395-009-0017-3; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Guerard P, 2006, N-S ARCH PHARMACOL, V373, P401, DOI 10.1007/s00210-006-0082-1; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Jian BX, 2012, MOL MED, V18, P209, DOI 10.2119/molmed.2011.00365; Lamberts RR, 2007, AM J PHYSIOL-HEART C, V293, pH1869, DOI 10.1152/ajpheart.00294.2007; Laufer EM, 2008, BASIC RES CARDIOL, V103, P95, DOI 10.1007/s00395-008-0701-8; Louis XL, 2011, J NUTR BIOCH; Marsboom G, 2012, AM J RESP CRIT CARE, V185, P670, DOI 10.1164/rccm.201108-1562OC; Morrell NW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-88; Paffett ML, 2012, VASC PHARMACOL, V56, P64, DOI 10.1016/j.vph.2011.11.002; Price LC, 2011, EUR RESPIR J, V37, P813, DOI 10.1183/09031936.00028310; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Santamore WP, 1998, PROG CARDIOVASC DIS, V40, P289, DOI 10.1016/S0033-0620(98)80049-2; Vizza CD, 1998, CHEST, V113, P576, DOI 10.1378/chest.113.3.576; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wang W, 2011, MOL BIOL REP, V38, P3277, DOI 10.1007/s11033-010-0390-x; Yang DL, 2010, CLIN EXP PHARMACOL P, V37, P150, DOI 10.1111/j.1440-1681.2009.05231.x; Zaiman AL, 2008, AM J RESP CRIT CARE, V177, P896, DOI 10.1164/rccm.200707-1083OC; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022	24	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40910	10.1371/journal.pone.0040910	http://dx.doi.org/10.1371/journal.pone.0040910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815866	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000042
J	Rao, LL; Li, S; Jiang, TZ; Zhou, Y				Rao, Li-Lin; Li, Shu; Jiang, Tianzi; Zhou, Yuan			Is Payoff Necessarily Weighted by Probability When Making a Risky Choice? Evidence from Functional Connectivity Analysis	PLOS ONE			English	Article							HUMAN DECISION-MAKING; PREFRONTAL CORTEX; WORKING-MEMORY; HUMAN BRAIN; PROSPECT-THEORY; BASAL GANGLIA; NEURAL RESPONSES; REWARD; UNCERTAINTY; FMRI	How people make decisions under risk remains an as-yet-unresolved but fundamental question. Mainstream theories about risky decision making assume that the core processes involved in reaching a risky decision include weighting each payoff or reward magnitude by its probability and then summing the outcomes. However, recently developed theories question whether payoffs are necessarily weighted by probability when making a risky choice. Using functional connectivity analysis, we aimed to provide neural evidence to answer whether this key assumption of computing expectations holds when making a risky choice. We contrasted a trade-off instruction choice that required participants to integrate probability and payoff information with a preferential choice that did not. Based on the functional connectivity patterns between regions in which activity was detected during both of the decision-making tasks, we classified the regions into two networks. One network includes primarily the left and right lateral prefrontal cortices and posterior parietal cortices, which were found to be related to probability in previous reports, and the other network is composed of the bilateral basal ganglia, which have been implicated in payoff. We also found that connectivity between the payoff network and some regions in the probability network (including the left lateral prefrontal cortices and bilateral inferior parietal lobes) were stronger during the trade-off instruction choice task than during the preferential choice task. This indicates that the functional integration between the probability and payoff networks during preferential choice was not as strong as the integration during trade-off instruction choice. Our results provide neural evidence that the weighting process uniformly predicted by the mainstream theory is unnecessary during preferential choice. Thus, our functional integration findings can provide a new direction for the investigation of the principles of risky decision making.	[Rao, Li-Lin; Li, Shu; Zhou, Yuan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China; [Jiang, Tianzi] Chinese Acad Sci, LIAMA Ctr Computat Med, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; University of Queensland	Rao, LL (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China.	zhouyuan@psych.ac.cn	Zhou, Yuan/N-5569-2017; Zhou, Yuan/AAI-6570-2021; Jiang, Tianzi/I-4256-2012	Zhou, Yuan/0000-0001-6378-1711; Zhou, Yuan/0000-0001-6378-1711; Jiang, Tianzi/0000-0001-9531-291X; li, shu/0000-0003-4402-1674	National Basic Research Program of China (973 Program) [2011CB711000]; National Natural Science Foundation of China [31170976]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; Project for Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences [Y0CX163S01]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Project for Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences	This research was partially supported by the National Basic Research Program of China (973 Program, No. 2011CB711000), National Natural Science Foundation of China (No. 31170976), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-8), and Project for Young Scientists Fund, Institute of Psychology, Chinese Academy of Sciences (Y0CX163S01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abler B, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-154; Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Berns GS, 2008, NEUROIMAGE, V39, P2047, DOI 10.1016/j.neuroimage.2007.10.028; Brandstatter E, 2008, PSYCHOL REV, V115, P281, DOI 10.1037/0033-295X.115.1.281; Brandstatter E, 2006, PSYCHOL REV, V113, P409, DOI 10.1037/0033-295X.113.2.409; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cohen MX, 2008, NEUROIMAGE, V39, P1396, DOI 10.1016/j.neuroimage.2007.10.004; Cohen MX, 2005, COGNITIVE BRAIN RES, V23, P61, DOI 10.1016/j.cogbrainres.2005.01.010; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; EDWARDS W, 1954, PSYCHOL BULL, V51, P380, DOI 10.1037/h0053870; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Engelmann JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004957; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fennema H, 1998, J RISK UNCERTAINTY, V17, P277, DOI 10.1023/A:1007739018615; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gigerenzer G.E., 2011, HEURISTICS FDN ADAPT; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Huettel SA, 2006, COGN AFFECT BEHAV NE, V6, P141, DOI 10.3758/CABN.6.2.141; Ino T, 2009, CORTEX; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kang SS, 2011, NEUROPSYCHOLOGIA, V49, P2836, DOI 10.1016/j.neuropsychologia.2011.06.009; Knight FH., 1921, RISKS UNCERTAINTY PR; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Li S, 2004, APPL INTELL, V20, P147, DOI 10.1023/B:APIN.0000013337.01711.c7; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lopes L. L., 1990, THEORY DECISION LIBR, P267; LOPES LL, 1984, J EXP PSYCHOL HUMAN, V10, P465, DOI 10.1037/0096-1523.10.4.465; LOPES LL, 1987, ADV EXP SOC PSYCHOL, V20, P255, DOI 10.1016/S0065-2601(08)60416-5; LUCE RD, 1991, J RISK UNCERTAINTY, V4, P29, DOI 10.1007/BF00057885; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Payne J. W., 1993, ADAPTIVE DECISION MA; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; QUIGGIN J, 1982, J ECON BEHAV ORGAN, V3, P323, DOI 10.1016/0167-2681(82)90008-7; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Rao LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014756; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Satterthwaite TD, 2007, NEUROIMAGE, V37, P1017, DOI 10.1016/j.neuroimage.2007.04.066; Savage L.J., 1954, FDN STAT; Schmidt U, 2008, J RISK UNCERTAINTY, V36, P203, DOI 10.1007/s11166-008-9040-2; Smith BW, 2009, NEUROIMAGE, V44, P600, DOI 10.1016/j.neuroimage.2008.08.016; THURSTON DL, 1993, STRUCT OPTIMIZATION, V5, P240, DOI 10.1007/BF01743586; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1990, AM ECON REV, V80, P204; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Waltz JA, 1999, PSYCHOL SCI, V10, P119, DOI 10.1111/1467-9280.00118; Xue G, 2009, CEREB CORTEX, V19, P1019, DOI 10.1093/cercor/bhn147; YAARI ME, 1987, ECONOMETRICA, V55, P95, DOI 10.2307/1911158; Zheng H, NEUROPSYCHOLOGIA, V48, P3198	88	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41048	10.1371/journal.pone.0041048	http://dx.doi.org/10.1371/journal.pone.0041048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JG	22815908	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000056
J	Bodinham, CL; Smith, L; Wright, J; Frost, GS; Robertson, MD				Bodinham, Caroline L.; Smith, Leanne; Wright, John; Frost, Gary S.; Robertson, M. Denise			Dietary Fibre Improves First-phase Insulin Secretion in Overweight Individuals	PLOS ONE			English	Article							RESISTANT STARCH; SENSITIVITY; GLUCOSE; FERMENTATION	Previous work has shown increased insulin sensitivity, increased hepatic insulin clearance and lower postprandial insulin responses following treatment with resistant starch, a type of dietary fibre. The objective of this study was to further explore the effects of resistant starch on insulin secretion. Twelve overweight (BMI 28.2 +/- 0.4 kg/m(2)) individuals participated in this randomized, subject-blind crossover study. Participants consumed either 40 g type 2 resistant starch or the energy and carbohydrate-matched placebo daily for four weeks. Assessment of the effect on insulin secretion was made at the end of each intervention using an insulin-modified frequently sampled intravenous glucose tolerance test (FSIVGTT). Insulin and C-peptide concentrations were significantly higher during the FSIVGTT following the resistant starch compared with the placebo. Modelling of the data showed significantly improved first-phase insulin secretion with resistant starch. These effects were observed without any changes to either body weight or habitual food intake. This study showed that just four weeks of resistant starch intake significantly increased the first-phase insulin secretion in individuals at risk of developing type 2 diabetes. Further studies exploring this effect in individuals with type 2 diabetes are required.	[Bodinham, Caroline L.; Smith, Leanne; Wright, John; Robertson, M. Denise] Univ Surrey, Dept Nutr & Metab, Guildford GU2 5XH, Surrey, England; [Frost, Gary S.] Univ London Imperial Coll Sci Technol & Med, Nutr & Dietet Res Grp, London, England	University of Surrey; Imperial College London	Bodinham, CL (corresponding author), Univ Surrey, Dept Nutr & Metab, Guildford GU2 5XH, Surrey, England.	caroline.bodinham@surrey.ac.uk			educational fellowship from Premier Foods; Diabetes United Kingdom	educational fellowship from Premier Foods; Diabetes United Kingdom(Diabetes UK)	The study was funded jointly by an educational fellowship from Premier Foods for Caroline Bodinham and Diabetes United Kingdom. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CLB received an educational fellowship from Premier Foods; this fellowship was independent to the research and was not involved in the study design, collection, analysis and interpretation of data, writing of the paper and/or decisions to submit the publication. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Balkau B, 1999, DIABETIC MED, V16, P442; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bodinham CL, 2010, BRIT J NUTR, V103, P917, DOI 10.1017/S0007114509992534; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Freeland KR, 2010, BRIT J NUTR, V103, P82, DOI 10.1017/S0007114509991462; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; HOSKER JP, 1985, DIABETOLOGIA, V28, P809, DOI 10.1007/BF00291069; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Johnston KL, 2010, DIABETIC MED, V27, P391, DOI 10.1111/j.1464-5491.2010.02923.x; Juntunen KS, 2003, AM J CLIN NUTR, V77, P385; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Polyzogopoulou EV, 2003, DIABETES, V52, P1098, DOI 10.2337/diabetes.52.5.1098; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Robertson MD, 2003, DIABETOLOGIA, V46, P659, DOI 10.1007/s00125-003-1081-0; Shen L, 2009, OBESITY, V17, P40, DOI 10.1038/oby.2008.483; Shen L, 2011, MOL NUTR FOOD RES, V55, P1499, DOI 10.1002/mnfr.201000605; Strazzullo P, 2008, METABOLISM, V57, P355, DOI 10.1016/j.metabol.2007.10.010; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	21	55	58	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40834	10.1371/journal.pone.0040834	http://dx.doi.org/10.1371/journal.pone.0040834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815837	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100079
J	de-Oliveira-Pinto, LM; Marinho, CF; Povoa, TF; de Azeredo, EL; de Souza, LA; Barbosa, LDR; Motta-Castro, ARC; Alves, AMB; Avila, CAL; de Souza, LJ; da Cunha, RV; Damasco, PV; Paes, MV; Kubelka, CF				de-Oliveira-Pinto, Luzia Maria; Marinho, Cintia Ferreira; Povoa, Tiago Fajardo; de Azeredo, Elzinandes Leal; de Souza, Luiza Assed; Ribeiro Barbosa, Luiza Damian; Motta-Castro, Ana Rita C.; Alves, Ada M. B.; Lins Avila, Carlos Andre; de Souza, Luiz Jose; da Cunha, Rivaldo Venancio; Damasco, Paulo Vieira; Paes, Marciano Viana; Kubelka, Claire Fernandes			Regulation of Inflammatory Chemokine Receptors on Blood T Cells Associated to the Circulating Versus Liver Chemokines in Dengue Fever	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; VIRUS-INFECTION; HEMORRHAGIC-FEVER; ADHESION RECEPTORS; DENDRITIC CELLS; FUNCTIONAL-CHARACTERIZATION; SELECTIVE EXPRESSION; CYTOKINE PRODUCTION; HEPATITIS-C; IFN-GAMMA	Little is known about the role of chemokines/chemokines receptors on T cells in natural DENV infection. Patients from DENV-2 and -3-outbreaks were studied prospectively during the acute or convalescent phases. Expression of chemokine receptor and activation markers on lymphocyte subpopulations were determined by flow cytometry analysis, plasma chemokine ligands concentrations were measured by ELISA and quantification of CCL5/RANTES(+) cells in liver tissues from fatal dengue cases was performed by immunochemistry. In the acute DENV-infection, T-helper/T-cytotoxic type-1 cell (Th1/Tc1)-related CCR5 is significantly higher expressed on both CD4 and CD8 T cells. The Th1-related CXCR3 is up-regulated among CD4 T cells and Tc2-related CCR4 is up-regulated among CD8 T cells. In the convalescent phase, all chemokine receptor or chemokine ligand expression tends to reestablish control healthy levels. Increased CCL2/MCP-1 and CCL4/MIP-1 beta but decreased CCL5/RANTES levels were observed in DENV-patients during acute infection. Moreover, we showed an increased CD107a expression on CCR5 or CXCR3-expressing T cells and higher expression of CD29, CD44(HIGH) and CD127(LOW) markers on CCR4-expressing CD8 T cells in DENV-patients when compared to controls. Finally, liver from dengue fatal patients showed increased number of cells expressing CCL5/RANTES in three out of four cases compared to three death from a non-dengue patient. In conclusion, both Th1-related CCR5 and CXCR3 among CD4 T cells have a potential ability to exert cytotoxicity function. Moreover, Tc1-related CCR5 and Tc2-related CCR4 among CD8 T cells have a potential ability to exert effector function and migration based on cell markers evaluated. The CCR5 expression would be promoting an enhanced T cell recruitment into liver, a hypothesis that is corroborated by the CCL5/RANTES increase detected in hepatic tissue from dengue fatal cases. The balance between protective and pathogenic immune response mediated by chemokines during dengue fever will be discussed.	[de-Oliveira-Pinto, Luzia Maria; Marinho, Cintia Ferreira; de Azeredo, Elzinandes Leal; Kubelka, Claire Fernandes] Fiocruz MS, Lab Imunol Viral, IOC, BR-21045900 Rio De Janeiro, Brazil; [Povoa, Tiago Fajardo; Alves, Ada M. B.; Paes, Marciano Viana] Fiocruz MS, IOC, Lab Biotecnol & Fisiol Infecces Virais, BR-21045900 Rio De Janeiro, Brazil; [de Souza, Luiza Assed; Ribeiro Barbosa, Luiza Damian; de Souza, Luiz Jose] Ctr Reg Referencia Dengue, Rio De Janeiro, Brazil; [Motta-Castro, Ana Rita C.; da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Setor Hemonucleo, Mato Grosso, Brazil; [Lins Avila, Carlos Andre; Damasco, Paulo Vieira] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso do Sul; Universidade do Estado do Rio de Janeiro	de-Oliveira-Pinto, LM (corresponding author), Fiocruz MS, Lab Imunol Viral, IOC, BR-21045900 Rio De Janeiro, Brazil.	lpinto@ioc.fiocruz.br	Cunha, Rivaldo Venancio/I-7737-2014; Kubelka, Claire F/C-5558-2009; /AAD-2097-2020; de-Oliveira-Pinto, Luzia/AAX-6421-2021; motta-castro, ana rita c/O-2075-2017	Cunha, Rivaldo Venancio/0000-0002-6622-7043; Motta-Castro, Ana Rita/0000-0003-3070-1337; Paes, Marciano/0000-0002-2266-2801	Brazilian Research Council; Oswaldo Cruz Foundation	Brazilian Research Council; Oswaldo Cruz Foundation	This work was supported by the Brazilian Research Council and the Oswaldo Cruz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2005, BLOOD, V105, P2384, DOI 10.1182/blood-2004-09-3422; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Aplin AE, 1998, PHARMACOL REV, V50, P197; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; Arai K, 2002, CELL IMMUNOL, V219, P48, DOI 10.1016/S0008-8749(02)00584-1; Araujo LM, 2004, EUR J IMMUNOL, V34, P327, DOI 10.1002/eji.200324151; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Azeredo EL, 2006, MEM I OSWALDO CRUZ, V101, P437, DOI 10.1590/S0074-02762006000400016; Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; Chen RF, 2007, T ROY SOC TROP MED H, V101, P1106, DOI 10.1016/j.trstmh.2007.06.019; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192; Drillenburg P, 2000, BLOOD, V95, P1900, DOI 10.1182/blood.V95.6.1900; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012; Gao P, 2003, J LEUKOCYTE BIOL, V73, P273, DOI 10.1189/jlb.0602269; Guabiraba R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015680; Gulzar N, 2011, HUM IMMUNOL; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Heydtmann M, 2002, GUT, V50, P150, DOI 10.1136/gut.50.2.150; Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Ip PP, 2010, J IMMUNOL, V184, P5705, DOI 10.4049/jimmunol.0903484; Kadhiravan T, 2010, IMMUNE NETW, V10, P164; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Khanna R, 1997, J IMMUNOL, V158, P3619; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Kobayashi N, 2006, J LEUKOCYTE BIOL, V80, P320, DOI 10.1189/jlb.1205725; Kondo T, 2009, INT IMMUNOL, V21, P523, DOI 10.1093/intimm/dxp019; Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Maggi E, 1997, BLOOD, V89, P3672, DOI 10.1182/blood.V89.10.3672.3672_3672_3681; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Nightingale ZD, 2008, J LEUKOCYTE BIOL, V84, P1028, DOI 10.1189/jlb.0208105; PALIARD X, 1988, J IMMUNOL, V141, P849; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Rabin RL, 1999, J IMMUNOL, V162, P3840; Rabin RL, 2003, J IMMUNOL, V171, P2812, DOI 10.4049/jimmunol.171.6.2812; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Schluns KS, 2005, INT J BIOCHEM CELL B, V37, P1567, DOI 10.1016/j.biocel.2005.02.017; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Seneviratne SL, 2007, QJM-INT J MED, V100, P19, DOI 10.1093/qjmed/hcl132; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagner C, 2001, EUR J IMMUNOL, V31, P1173, DOI 10.1002/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9; Whitehorn J, 2011, VACCINE; Zhou W, 2007, VIRAL IMMUNOL, V20, P379, DOI 10.1089/vim.2007.0030	70	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e38527	10.1371/journal.pone.0038527	http://dx.doi.org/10.1371/journal.pone.0038527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815692	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100011
J	He, MA; Workalemahu, T; Manson, JE; Hu, FB; Qi, L				He, Meian; Workalemahu, Tsegaselassie; Manson, JoAnn E.; Hu, Frank B.; Qi, Lu			Genetic Determinants for Body Iron Store and Type 2 Diabetes Risk in US Men and Women	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; NURSES HEALTH; TRANSFERRIN; FERRITIN; MELLITUS; DISEASE; ONSET; REPRODUCIBILITY; VALIDITY	Background: High body iron store has been associated with an increased risk of type 2 diabetes (T2D); it remains unknown whether the genetic variants related to body iron status affect T2D risk. We aimed at comprehensively investigating the associations between the genetic variants related to body iron status and the T2D risk. Methodology/Principal Findings: Six common SNPs related to body iron status from recent genome-wide association (GWA) studies were determined in the Nurses' Health Study (NHS; 1,467 diabetic cases and 1,754 controls) and the Health Professionals Follow-up Study (HPFS; 1,124, diabetic cases and 1,298 controls). Plasma levels of ferritin, soluble transferrin receptor (sTfR), and transferrin were measured in NHS. Significant associations were observed for loci in TPMRSS6 with sTfR (P = 3.47 x 10(-6)), TF with transferrin (P = 0.0002 to 1.72 x 10(-10)); and HFE with ferritin (P = 0.017 to 1.6 x 10(-8)), sTfR (P = 0.007 to 7.9 x 10(-6)), and transferrin (P = 0.006 to 0.0007). The six SNPs together explained 5.7%, 2.7%, and 13.3% of the variation in plasma levels of ferritin, sTfR, and transferrin. After adjustment for the conventional risk factors, the T allele of SNP rs855791 in the TPMRSS6 gene was significantly associated with a 19% decreased risk of T2D (OR = 0.81; 95% CI = 0.66-0.98; P = 0.03) in men. Multiple tests attenuated this significant association to null. No associations were observed in women. SNPs at HFE and TF were not associated with diabetes risk in either sex. Dietary iron intake did not modify the associations of the newly identified loci with diabetes risk. Conclusions/Significance: The newly identified iron-related SNP rs855791 in TPMRSS6 was nominally associated with a decreased risk of T2D in men but not in women. The apparent differences by gender warrant further study.	[He, Meian; Workalemahu, Tsegaselassie; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [He, Meian] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Occupat Med, Wuhan 430074, Hubei, Peoples R China; [Manson, JoAnn E.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Manson, JoAnn E.; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Med, Boston, MA USA; [Manson, JoAnn E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	He, MA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	nhlqi@channing.harvard.edu	Hu, Frank/C-1919-2013	Workalemahu, Tsegaselassie/0000-0003-4571-9740	National Institutes of Health [DK58845, HL34594, HL71981]; American Heart Association Scientist Development Award; Boston Obesity Nutrition Research Center [DK46200]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Award(American Heart Association); Boston Obesity Nutrition Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (DK58845, HL34594, and HL71981), American Heart Association Scientist Development Award and the Boston Obesity Nutrition Research Center (DK46200 to LQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 2009, CIRC-CARDIOVASC GENE, V2, P34, DOI 10.1161/CIRCGENETICS.108.813089; Altman D, 1991, PRACTICAL STAT MED R, P211; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; Gavin JR, 1997, DIABETES CARE, V20, P1183; Green A, 2006, METABOLISM, V55, P1042, DOI 10.1016/j.metabol.2006.03.015; Group NDD, 1997, DIABETES, V28, P1039; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; LEGGETT BA, 1993, J GASTROEN HEPATOL, V8, P21, DOI 10.1111/j.1440-1746.1993.tb01170.x; Liu JM, 2003, AM J CLIN NUTR, V78, P1160, DOI 10.1093/ajcn/78.6.1160; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Fernandez-Real JM, 2010, EUR J CLIN INVEST, V40, P600, DOI 10.1111/j.1365-2362.2010.02306.x; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Qi L, 2005, DIABETES, V54, P3567, DOI 10.2337/diabetes.54.12.3567; Qi L, 2006, HUM MOL GENET, V15, P1914, DOI 10.1093/hmg/ddl113; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Reddy MB, 2004, NUTR REV, V62, P120, DOI 10.1301/nr.2004.mar.120-124; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; SEISER C, 1993, J BIOL CHEM, V268, P13074; Whitfield JB, 2003, BRIT J HAEMATOL, V120, P860, DOI 10.1046/j.1365-2141.2003.04224.x; Willett W., 2012, NUTR EPIDEMIOLOGY; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637	39	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40919	10.1371/journal.pone.0040919	http://dx.doi.org/10.1371/journal.pone.0040919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815867	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100094
J	Thillai, M; Eberhardt, C; Lewin, AM; Potiphar, L; Hingley-Wilson, S; Sridhar, S; Macintyre, J; Kon, OM; Wickremasinghe, M; Wells, A; Weeks, ME; Mitchell, D; Lalvani, A				Thillai, Muhunthan; Eberhardt, Christian; Lewin, Alex M.; Potiphar, Lee; Hingley-Wilson, Suzie; Sridhar, Saranya; Macintyre, Jonathan; Kon, Onn Min; Wickremasinghe, Melissa; Wells, Athol; Weeks, Mark E.; Mitchell, Donald; Lalvani, Ajit			Sarcoidosis and Tuberculosis Cytokine Profiles: Indistinguishable in Bronchoalveolar Lavage but Different in Blood	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PULMONARY TUBERCULOSIS; LUNG-DISEASE; T-CELLS; SERUM; MYCOBACTERIAL; EXPRESSION; RESPONSES; CD4(+); ALPHA	Background: The clinical, radiological and pathological similarities between sarcoidosis and tuberculosis can make disease differentiation challenging. A complicating factor is that some cases of sarcoidosis may be initiated by mycobacteria. We hypothesised that immunological profiling might provide insight into a possible relationship between the diseases or allow us to distinguish between them. Methods: We analysed bronchoalveolar lavage (BAL) fluid in sarcoidosis (n = 18), tuberculosis (n = 12) and healthy volunteers (n = 16). We further investigated serum samples in the same groups; sarcoidosis (n = 40), tuberculosis (n = 15) and healthy volunteers (n = 40). A cross-sectional analysis of multiple cytokine profiles was performed and data used to discriminate between samples. Results: We found that BAL profiles were indistinguishable between both diseases and significantly different from healthy volunteers. In sera, tuberculosis patients had significantly lower levels of the Th2 cytokine interleukin-4 (IL-4) than those with sarcoidosis (p = 0.004). Additional serum differences allowed us to create a linear regression model for disease differentiation (within-sample accuracy 91%, cross-validation accuracy 73%). Conclusions: These data warrant replication in independent cohorts to further develop and validate a serum cytokine signature that may be able to distinguish sarcoidosis from tuberculosis. Systemic Th2 cytokine differences between sarcoidosis and tuberculosis may also underly different disease outcomes to similar respiratory stimuli.	[Thillai, Muhunthan; Eberhardt, Christian; Potiphar, Lee; Hingley-Wilson, Suzie; Sridhar, Saranya; Macintyre, Jonathan; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, London, England; [Lewin, Alex M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Biostat Grp, London, England; [Kon, Onn Min; Wickremasinghe, Melissa] St Marys Hosp, Dept Resp Med, London, England; [Wells, Athol; Mitchell, Donald] Imperial Coll London NHS Healthcare Trust, Royal Brompton Hosp, Interstitial Lung Unit, London, England; [Weeks, Mark E.] UCL Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England	Imperial College London; Imperial College London; Imperial College London; Royal Brompton Hospital; University of London; University College London	Thillai, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, London, England.	a.lalvani@imperial.ac.uk	weeks, Mark/AAT-7258-2021; /C-2531-2011	/0000-0002-6576-8809; Kon, Onn Min/0000-0003-2647-4688; Sridhar, Saranya/0000-0002-4267-3102; Lalvani, Ajit/0000-0002-2396-246X; Hingley-Wilson, Suzie/0000-0002-6514-1424; Lewin, Alexandra/0000-0003-0081-7582	Wellcome Trust [WT085275MA]; Medical Research Council [G0801620]; Biotechnology and Biological Sciences Research Council [BB/G000352/1] Funding Source: researchfish; BBSRC [BB/G000352/1] Funding Source: UKRI; MRC [G0801620] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the Wellcome Trust (grant code WT085275MA) and the Medical Research Council (grant code G0801620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, SCAND J IMMUNOL, V70, P300, DOI 10.1111/j.1365-3083.2009.02294.x; Balboni I, 2006, ANNU REV IMMUNOL, V24, P391, DOI 10.1146/annurev.immunol.24.021605.090709; BAUGHMAN RP, 1990, J LAB CLIN MED, V115, P36; Bergeron A, 1997, J IMMUNOL, V159, P3034; Biglino A, 1996, CLIN IMMUNOL IMMUNOP, V78, P61, DOI 10.1006/clin.1996.0009; Boin F, 2008, ARTHRITIS RHEUM-US, V58, P1165, DOI 10.1002/art.23406; BRICE EAW, 1995, CHEST, V107, P706, DOI 10.1378/chest.107.3.706; Carlsson A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005033; Chen ES, 2008, J IMMUNOL, V181, P8784, DOI 10.4049/jimmunol.181.12.8784; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Christensen E, 2009, CLIN CANCER RES, V15, P5576, DOI 10.1158/1078-0432.CCR-09-0245; DEWIT D, 1993, J IMMUNOL, V150, P361; Hauber HP, 2003, THORAX, V58, P519, DOI 10.1136/thorax.58.6.519; Horster R, 2009, CLIN RESPIR J, V3, P229, DOI 10.1111/j.1752-699X.2009.00136.x; HOSHINO T, 1995, CLIN EXP IMMUNOL, V102, P399; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Inui N, 2008, RESP MED, V102, P313, DOI 10.1016/j.rmed.2007.09.013; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Levy H, 1998, CHEST, V94, P1254; MIKHAIL JR, 1970, AM REV RESPIR DIS, V102, P636; Moller DR, 1999, SARCOIDOSIS VASC DIF, V16, P24; Popper HH, 1997, HUM PATHOL, V28, P796, DOI 10.1016/S0046-8177(97)90152-0; Ricci M, 1997, J INVEST ALLERG CLIN, V7, P144; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SCOTT P, 1989, IMMUNOL REV, V112, P161, DOI 10.1111/j.1600-065X.1989.tb00557.x; SELROOS O, 1980, J CLIN LAB IMMUNOL, V3, P129; Taha RA, 1997, AM J RESP CRIT CARE, V155, P1135, DOI 10.1164/ajrccm.155.3.9116999; Tsao TCY, 2002, INT J TUBERC LUNG D, V6, P720; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325	31	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e38083	10.1371/journal.pone.0038083	http://dx.doi.org/10.1371/journal.pone.0038083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815689	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306466100008
J	Heustis, RJ; Ng, HK; Brand, KJ; Rogers, MC; Le, LT; Specht, CA; Fuhrman, JA				Heustis, Ronald J.; Ng, Hong K.; Brand, Kenneth J.; Rogers, Meredith C.; Le, Linda T.; Specht, Charles A.; Fuhrman, Juliet A.			Pharyngeal Polysaccharide Deacetylases Affect Development in the Nematode C. elegans and Deacetylate Chitin In Vitro	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODE; CAENORHABDITIS-ELEGANS; CRYPTOCOCCUS-NEOFORMANS; CARBOHYDRATE ESTERASE; PROTEIN; EXPRESSION; CHITOSAN; SYNTHASE; RNAI; WALL	Chitin (beta-1,4-linked-N-acetylglucosamine) provides structural integrity to the nematode eggshell and pharyngeal lining. Chitin is synthesized in nematodes, but not in plants and vertebrates, which are often hosts to parasitic roundworms; hence, the chitin metabolism pathway is considered a potential target for selective interventions. Polysaccharide deacetylases (PDAs), including those that convert chitin to chitosan, have been previously demonstrated in protists, fungi and insects. We show that genes encoding PDAs are distributed throughout the phylum Nematoda, with the two paralogs F48E3.8 and C54G7.3 found in C. elegans. We confirm that the genes are somatically expressed and show that RNAi knockdown of these genes retards C. elegans development. Additionally, we show that proteins from the nematode deacetylate chitin in vitro, we quantify the substrate available in vivo as targets of these enzymes, and we show that Eosin Y (which specifically stains chitosan in fungal cells walls) stains the C. elegans pharynx. Our results suggest that one function of PDAs in nematodes may be deacetylation of the chitinous pharyngeal lining.	[Heustis, Ronald J.; Ng, Hong K.; Brand, Kenneth J.; Rogers, Meredith C.; Le, Linda T.; Fuhrman, Juliet A.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Specht, Charles A.] Univ Massachusetts, Dept Med, Worcester, MA USA	Tufts University; University of Massachusetts System; University of Massachusetts Worcester	Heustis, RJ (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	ronald.heustis@tufts.edu	Heustis, Ronald/AAW-4582-2020	Heustis, Ronald/0000-0003-1359-666X; Brand, Kenneth/0000-0002-5102-3208; Rogers, Meredith/0000-0003-1798-6294				Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Bennuru S, 2011, P NATL ACAD SCI USA, V108, P9649, DOI 10.1073/pnas.1011481108; Berninsone P, 1998, J BIOL CHEM, V273, P25556, DOI 10.1074/jbc.273.40.25556; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; Das S, 2006, MOL BIOCHEM PARASIT, V148, P86, DOI 10.1016/j.molbiopara.2006.03.002; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Fanelli E, 2005, GENE, V349, P87, DOI 10.1016/j.gene.2004.11.045; Franks DM, 2006, DEV BIOL, V296, P409, DOI 10.1016/j.ydbio.2006.06.008; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; JOHN M, 1993, P NATL ACAD SCI USA, V90, P625, DOI 10.1073/pnas.90.2.625; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; TRUDEL J, 1990, ANAL BIOCHEM, V189, P249, DOI 10.1016/0003-2697(90)90116-Q; Veronico P, 2001, MOL GENET GENOMICS, V266, P28, DOI 10.1007/s004380100513; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wood WB, 1988, NEMATODE CAENORHABDI; Zhang YH, 2005, DEV BIOL, V285, P330, DOI 10.1016/j.ydbio.2005.06.037	30	15	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40426	10.1371/journal.pone.0040426	http://dx.doi.org/10.1371/journal.pone.0040426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808160	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700027
J	Kasaoka, M; Ma, J; Lashkari, K				Kasaoka, Masataka; Ma, Jie; Lashkari, Kameran			c-Met Modulates RPE Migratory Response to Laser-Induced Retinal Injury	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; SCATTER FACTOR EXPRESSION; TYROSINE KINASE; EYE INJURIES; PROLIFERATIVE VITREORETINOPATHY; FACTOR RECEPTOR; IN-VIVO; MOTILITY; MORPHOGENESIS	Retinal laser injuries are often associated with aberrant migration of the retinal pigment epithelium (RPE), which can cause expansion of the scar beyond the confines of the original laser burn. In this study, we devised a novel method of laser-induced injury to the RPE layer in mouse models and began to dissect the mechanisms associated with pathogenesis and progression of laser-induced RPE injury. We have hypothesized that the proto-oncogene receptor, c-Met, is intimately involved with migration of RPE cells, and may be an early responder to injury. Using transgenic mouse models, we show that constitutive activation of c-Met induces more robust RPE migration into the outer retina of laser-injured eyes, while abrogation of the receptor using a cre-lox method reduces these responses. We also demonstrate that retinal laser injury increases expression of both HGF and c-Met, and activation of c-Met after injury is correlated with RPE cell migration. RPE migration may be responsible for clinically significant anatomic changes observed after laser injury. Abrogation of c-Met activity may be a therapeutic target to minimize retinal damage from aberrant RPE cell migration.	[Kasaoka, Masataka; Ma, Jie; Lashkari, Kameran] Harvard Univ, Sch Med, Schepens Eye Res Inst Massachusetts Eye & Ear Inf, Dept Ophthalmol, Boston, MA 02115 USA; [Kasaoka, Masataka] Kurume Univ, Sch Med, Dept Ophthalmol, Kurume, Fukuoka 830, Japan	Harvard University; Harvard Medical School; Kurume University	Lashkari, K (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst Massachusetts Eye & Ear Inf, Dept Ophthalmol, Boston, MA 02115 USA.	kameran.lashkari@schepens.harvard.edu		Lashkari, Kameran/0000-0003-3855-0246	Department of Defense [W81XWH-04-1-0892-P00001]	Department of Defense(United States Department of Defense)	The study was supported by a grant (W81XWH-04-1-0892-P00001) from the Department of Defense and no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1972, SCIENCE, V177, P58, DOI 10.1126/science.177.4043.58; ALHALEL A, 1993, RETINA-J RET VIT DIS, V13, P152, DOI 10.1097/00006982-199313020-00012; Barkana Y, 2000, SURV OPHTHALMOL, V44, P459, DOI 10.1016/S0039-6257(00)00112-0; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; BIRCHMEIER C, 1993, BIOESSAYS, V15, P185, DOI 10.1002/bies.950150307; BIRCHMEIER C, 1995, INT REV CYTOL, V160, P221, DOI 10.1016/S0074-7696(08)61556-9; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOROS P, 1995, LANCET, V345, P293, DOI 10.1016/S0140-6736(95)90279-1; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; CAI YS, 1989, HEALTH PHYS, V56, P643, DOI 10.1097/00004032-198905000-00007; CAMPOCHIARO PA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1685, DOI 10.1001/archopht.1986.01050230123046; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; FRISCH GD, 1974, NATURE, V248, P433, DOI 10.1038/248433a0; Furge KA, 2001, P NATL ACAD SCI USA, V98, P10722, DOI 10.1073/pnas.191067898; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Harris MD, 2003, AVIAT SPACE ENVIR MD, V74, P947; Hudson SJ, 1998, AVIAT SPACE ENVIR MD, V69, P519; KIRCHHOF B, 1989, INVEST OPHTH VIS SCI, V30, P1951; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; Koochekpour S, 1997, CANCER RES, V57, P5391; Lashkari K, 1999, INVEST OPHTH VIS SCI, V40, P149; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mishima K, 1999, INVEST OPHTH VIS SCI, V40, P1590; MODARRESZAHEH M, 1995, RETINA-J RET VIT DIS, V15, P356, DOI 10.1097/00006982-199515040-00016; Nabeshima K, 1997, HISTOPATHOLOGY, V31, P436, DOI 10.1046/j.1365-2559.1997.3010889.x; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Park M, 1987, P NATL ACAD SCI USA, V84, P6879; REH TA, 1987, NATURE, V330, P68, DOI 10.1038/330068a0; Rosen E M, 1997, EXS, V79, P193; Rosen EM, 1996, INT J CANCER, V67, P248, DOI 10.1002/(SICI)1097-0215(19960717)67:2<248::AID-IJC16>3.0.CO;2-7; ROSEN EM, 1991, EXP SUPPL, V59, P76; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0	41	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40771	10.1371/journal.pone.0040771	http://dx.doi.org/10.1371/journal.pone.0040771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808260	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700052
J	Roustit, M; Blaise, S; Arnaud, C; Hellmann, M; Millet, C; Godin-Ribuot, D; Dufournet, B; Boutonnat, J; Ribuot, C; Cracowski, JL				Roustit, Matthieu; Blaise, Sophie; Arnaud, Claire; Hellmann, Marcin; Millet, Claire; Godin-Ribuot, Diane; Dufournet, Boris; Boutonnat, Jean; Ribuot, Christophe; Cracowski, Jean-Luc			Iontophoresis of Endothelin Receptor Antagonists in Rats and Men	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; SYSTEMIC-SCLEROSIS; VASODILATOR IONTOPHORESIS; RAYNAUDS-PHENOMENON; DRUG-DELIVERY; SKIN; BOSENTAN; MICROVASCULATURE; THERAPY; HUMANS	Introduction: The treatment of scleroderma-related digital ulcers is challenging. The oral endothelin receptor antagonist (ERA) bosentan has been approved but it may induce liver toxicity. The objective of this study was to test whether ERAs bosentan and sitaxentan could be locally delivered using iontophoresis. Methods: Cathodal and anodal iontophoresis of bosentan and sitaxentan were performed on anaesthetized rat hindquarters without and during endothelin-1 infusion. Skin blood flow was quantified using laser-Doppler imaging and cutaneous tolerability was assessed. Iontophoresis of sitaxentan (20 min, 20 or 100 mu A) was subsequently performed on the forearm skin of healthy men (n = 5). Results: In rats neither bosentan nor sitaxentan increased skin blood flux compared to NaCl. When simultaneously infusing endothelin-1, cathodal iontophoresis of sitaxentan increased skin blood flux compared to NaCl (AUC(0-20) were 44032.2 +/- 12277 and 14957.5 +/- 23818.8 %BLs, respectively; P = 0.01). In humans, sitaxentan did not significantly increase skin blood flux as compared to NaCl. Iontophoresis of ERAs was well tolerated both in animals and humans. Conclusions: This study shows that cathodal iontophoresis of sitaxentan but not bosentan partially reverses endothelin-induced skin vasoconstriction in rats, suggesting that sitaxentan diffuses into the dermis. However, sitaxentan does not influence basal skin microvascular tone in rats or in humans.	[Roustit, Matthieu; Hellmann, Marcin; Millet, Claire; Dufournet, Boris; Cracowski, Jean-Luc] Grenoble Univ Hosp, Inserm CIC03, Clin Pharmacol Unit, Grenoble, France; [Roustit, Matthieu; Blaise, Sophie; Arnaud, Claire; Millet, Claire; Godin-Ribuot, Diane; Ribuot, Christophe; Cracowski, Jean-Luc] Inserm, U1042, Lab HP2, Grenoble, France; [Roustit, Matthieu; Blaise, Sophie; Arnaud, Claire; Hellmann, Marcin; Millet, Claire; Godin-Ribuot, Diane; Boutonnat, Jean; Ribuot, Christophe; Cracowski, Jean-Luc] Univ Grenoble 1, Grenoble, France; [Blaise, Sophie] Grenoble Univ Hosp, Vasc Med Dept, Grenoble, France; [Boutonnat, Jean] CNRS, UMR 5525, TIMC, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Roustit, M (corresponding author), Grenoble Univ Hosp, Inserm CIC03, Clin Pharmacol Unit, Grenoble, France.	MRoustit@chu-grenoble.fr	, CRACOWSKI/M-6946-2014; Roustit, Matthieu/M-6927-2014; Christophe, Ribuot/M-7105-2014; Godin-Ribuot, Diane/B-6945-2014; Blaise, Sophie/AAS-2389-2020; Arnaud, Claire/D-4698-2014; Blaise, Sophie/AAD-4476-2019	, CRACOWSKI/0000-0003-0787-1469; Roustit, Matthieu/0000-0003-4475-1626; Christophe, Ribuot/0000-0003-4425-6203; Godin-Ribuot, Diane/0000-0001-7589-932X; Blaise, Sophie/0000-0001-7238-112X; Arnaud, Claire/0000-0003-0964-9423; Blaise, Sophie/0000-0001-7238-112X; Hellmann, Marcin/0000-0003-0403-805X	patients' association "Association des Sclerodermiques de France''; Groupe Francais de Recherche sur la Sclerodermie; Pfizer; Actelion; GlaxoSmithKline	patients' association "Association des Sclerodermiques de France''; Groupe Francais de Recherche sur la Sclerodermie; Pfizer(Pfizer); Actelion; GlaxoSmithKline(GlaxoSmithKline)	This work was funded by the patients' association "Association des Sclerodermiques de France'' and the "Groupe Francais de Recherche sur la Sclerodermie''. Actelion Pharmaceuticals and Pfizer Inc provided the drugs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MR and JLC received unrestricted research grants from Pfizer, Actelion, and GlaxoSmithKline for other studies. JLC reports being a consultant for Actelion. Actelion Pharmaceuticals and Pfizer Inc provided the drugs for the present study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. None of the sponsors have any involvement in the design and conduct of the present study; nor in the preparation, review, or approval of the present manuscript.	Blaise S, 2011, BRIT J PHARMACOL, V162, P557, DOI 10.1111/j.1476-5381.2010.01045.x; Blaise S, 2010, BRIT J PHARMACOL, V160, P1128, DOI 10.1111/j.1476-5381.2010.00778.x; Blaise S, 2012, J CLIN PHARM; Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Dixit Nitin, 2007, Current Drug Delivery, V4, P1, DOI 10.2174/156720107779314802; Durand S, 2002, J VASC RES, V39, P59, DOI 10.1159/000048994; Fregert S., 1981, MANUAL CONTACT DERMA, V2nd ed.; Galie N, 2011, EUR RESPIR J, V37, P475, DOI 10.1183/09031936.00194810; Herrick AL, 2000, CURR OPIN RHEUMATOL, V12, P527, DOI 10.1097/00002281-200011000-00009; Hettema ME, 2007, ANN RHEUM DIS, V66, P1398, DOI 10.1136/ard.2007.073684; Hettema ME, 2009, CLIN RHEUMATOL, V28, P825, DOI 10.1007/s10067-009-1157-4; Humbert M, 2007, EUR RESPIR J, V30, P338, DOI 10.1183/09031936.00138706; Kalia YN, 2004, ADV DRUG DELIVER REV, V56, P619, DOI 10.1016/j.addr.2003.10.026; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; LAWRENCE E, 1994, EUR J PHARMACOL, V260, P103, DOI 10.1016/0014-2999(94)90017-5; LAWRENCE E, 1995, BRIT J PHARMACOL, V115, P840, DOI 10.1111/j.1476-5381.1995.tb15009.x; Leslie SJ, 2004, BRIT J CLIN PHARMACO, V57, P720, DOI 10.1111/j.1365-2125.2004.02074.x; Murray AK, 2008, RHEUMATOLOGY, V47, P76, DOI 10.1093/rheumatology/kem314; Murray AK, 2005, MICROVASC RES, V69, P89, DOI 10.1016/j.mvr.2005.01.005; OLEARY DS, 1991, AM J PHYSIOL, V260, pH632, DOI 10.1152/ajpheart.1991.260.2.H632; Rosato E, 2010, J RHEUMATOL, V37, P2531, DOI 10.3899/jrheum.100358; Roustit M, 2012, MICROCIRCULATION, V19, P47, DOI 10.1111/j.1549-8719.2011.00129.x; WIGLEY FM, 1992, J RHEUMATOL, V19, P1407	24	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40792	10.1371/journal.pone.0040792	http://dx.doi.org/10.1371/journal.pone.0040792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808263	Green Submitted, gold, Green Published			2022-12-27	WOS:000306406700053
J	Santamaria-Hernando, S; Krell, T; Ramos-Gonzalez, MI				Santamaria-Hernando, Saray; Krell, Tino; Ramos-Gonzalez, Maria-Isabel			Identification of a Novel Calcium Binding Motif Based on the Detection of Sequence Insertions in the Animal Peroxidase Domain of Bacterial Proteins	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; LIGNIN PEROXIDASE; MN(II) OXIDATION; NODULATION	Proteins of the animal heme peroxidase (ANP) superfamily differ greatly in size since they have either one or two catalytic domains that match profile PS50292. The orf PP_2561 of Pseudomonas putida KT2440 that we have called PepA encodes a two-domain ANP. The alignment of these domains with those of PepA homologues revealed a variable number of insertions with the consensus G-x-D-G-x-x-[GN]-[TN]-x-D-D. This motif has also been detected in the structure of pseudopilin (pdb 3G20), where it was found to be involved in Ca2+ coordination although a sequence analysis did not reveal the presence of any known calcium binding motifs in this protein. Isothermal titration calorimetry revealed that a peptide containing this consensus motif bound specifically calcium ions with affinities ranging between 33-79 mu M depending on the pH. Microcalorimetric titrations of the purified N-terminal ANP-like domain of PepA revealed Ca2+ binding with a K-D of 12 mu M and stoichiometry of 1.25 calcium ions per protein monomer. This domain exhibited peroxidase activity after its reconstitution with heme. These data led to the definition of a novel calcium binding motif that we have termed PERCAL and which was abundantly present in animal peroxidase-like domains of bacterial proteins. Bacterial heme peroxidases thus possess two different types of calcium binding motifs, namely PERCAL and the related hemolysin type calcium binding motif, with the latter being located outside the catalytic domains and in their C-terminal end. A phylogenetic tree of ANP-like catalytic domains of bacterial proteins with PERCAL motifs, including single domain peroxidases, was divided into two major clusters, representing domains with and without PERCAL motif containing insertions. We have verified that the recently reported classification of bacterial heme peroxidases in two families (cd09819 and cd09821) is unrelated to these insertions. Sequences matching PERCAL were detected in all kingdoms of life.	[Santamaria-Hernando, Saray; Krell, Tino; Ramos-Gonzalez, Maria-Isabel] Estac Expt Zaidin Consejo Super Invest CSIC, Environm Protect Dept, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Santamaria-Hernando, S (corresponding author), Estac Expt Zaidin Consejo Super Invest CSIC, Environm Protect Dept, Granada, Spain.	maribel.ramos@eez.csic.es	Ramos-González, María-Isabel/F-3082-2016; Hernando, Saray Santamaría/G-9662-2015; Krell, Tino/G-7296-2015	Ramos-González, María-Isabel/0000-0001-8380-807X; Hernando, Saray Santamaría/0000-0001-6763-3839; Krell, Tino/0000-0002-9040-3166	Junta de Andalucia [P07-CVI-03156]; EDFR; Plan Nacional de I+D+I [BFU2010-17946]	Junta de Andalucia(Junta de Andalucia); EDFR; Plan Nacional de I+D+I	S.S.H. was granted with a predoctoral fellowship from Junta de Andalucia. This work was supported by grants P07-CVI-03156 from Junta de Andalucia http://www.juntadeandalucia.es/organismos/economiainnovacionyciencia/ and EDFR, and BFU2010-17946 from the Plan Nacional de I+D+I http://www.idi.mineco.gob.es/portal/site/MICINN/ and EDFR to M.I.R.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2009, APPL ENVIRON MICROB, V75, P4130, DOI 10.1128/AEM.02890-08; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Blodig W, 2001, J MOL BIOL, V305, P851, DOI 10.1006/jmbi.2000.4346; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; ECONOMOU A, 1990, EMBO J, V9, P349, DOI 10.1002/j.1460-2075.1990.tb08117.x; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Finnie C, 1997, MOL MICROBIOL, V25, P135, DOI 10.1046/j.1365-2958.1997.4471803.x; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Korotkov KV, 2009, J BIOL CHEM, V284, P25466, DOI 10.1074/jbc.C109.037655; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; Le TQ, 2006, EUR J ORAL SCI, V114, P320, DOI 10.1111/j.1600-0722.2006.00313.x; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matilla MA, 2010, ENV MICROBIOL REP, V2, P381, DOI 10.1111/j.1758-2229.2009.00091.x; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Miron S, 2011, BIOCHEMISTRY-US, V50, P6409, DOI 10.1021/bi200518d; Moffet DA, 2000, J AM CHEM SOC, V122, P7612, DOI 10.1021/ja001198q; Nakazawa T, 2002, ENVIRON MICROBIOL, V4, P782, DOI 10.1046/j.1462-2920.2002.00310.x; Nicodeme P, 2001, J COMPUT BIOL, V8, P235, DOI 10.1089/10665270152530836; Nie GJ, 1997, ARCH BIOCHEM BIOPHYS, V337, P225, DOI 10.1006/abbi.1996.9770; Nie GJ, 1997, BIOCHEMISTRY-US, V36, P5113, DOI 10.1021/bi962583o; Onweremadu E. U., 2011, NJAFE, V7, P24; Palma C, 2000, J BIOTECHNOL, V77, P235, DOI 10.1016/S0168-1656(99)00218-7; Rad AM, 2007, ANAL BIOCHEM, V362, P38, DOI 10.1016/j.ab.2006.11.035; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P112, DOI 10.1016/0003-9861(91)90171-E; Ridgen DJ, 2011, PLOS ONE, V6; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Smith R J, 1995, Adv Microb Physiol, V37, P83, DOI 10.1016/S0065-2911(08)60144-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TRINDER P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158; Wei C-C, 2012, CHEM CENTRA IN PRESS; Worthington K, 2011, WORTHINGTON ENZYEM M; Yousef F, 2007, RES MICROBIOL, V158, P545, DOI 10.1016/j.resmic.2007.04.006; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902	40	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40698	10.1371/journal.pone.0040698	http://dx.doi.org/10.1371/journal.pone.0040698			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808235	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700045
J	Bridle, AR; Koop, BF; Nowak, BF				Bridle, Andrew R.; Koop, Ben F.; Nowak, Barbara F.			Identification of Surrogates of Protection against Yersiniosis in Immersion Vaccinated Atlantic Salmon	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; FLOUNDER PARALICHTHYS-OLIVACEUS; RAINBOW-TROUT; JAPANESE FLOUNDER; GENE-EXPRESSION; IMMUNE-RESPONSE; RUCKERI INFECTION; ADAPTIVE IMMUNITY; MECHANISMS; DISEASE	Simple cost-effective bacterins are the earliest and most successfully used commercial vaccines in fish. In particular, those prepared from Yersinia ruckeri have proven effective at controlling Enteric Red Mouth Disease (ERM) and yersiniosis in rainbow trout and Atlantic salmon, respectively. However, the emergence of outbreaks of ERM caused by atypical biotypes of Y. ruckeri and reports of vaccine failure resulting in mass mortality of hatchery Atlantic salmon has reinvigorated interest in vaccines against fish bacterial diseases. Therefore the objective of this study was to identify surrogates of protection against yersiniosis using cDNA microarray to characterise the response of host genes in the gills of unvaccinated and vaccinated Atlantic salmon challenged with Y. ruckeri. Differentially expressed genes were identified using two-way ANOVA and restricted to those with >2.5-fold change at P<0.05. Using cDNA microarray we identified the expression of 6 genes in response to infection and 4 genes associated with the protective host response to yersiniosis. Analysis by real-time PCR confirmed that three immunologically relevant genes, namely a cathelicidin (47-fold) and a C-type lectin (19-fold) increased in response to yersiniosis. Including collagenase (17-fold increase), an important tissue remodelling and repair enzyme, these genes represent 3 of 6 non-protective and/or pathological responses to yersiniosis. Genes associated with the protective host response included an immunoglobulin gene and a selenoprotein that showed significant fold changes (15-fold increases each), highlighting the importance of antibody-mediated protection against yersiniosis. These findings provide much needed knowledge of the host-pathogen interaction in response to bacterial infection and immunisation in fish. Significantly, we identified a transcriptional biosignature consisting of predominantly immune-relevant genes (14 up and 3 down-regulated) in the gills of Atlantic salmon after immersion vaccination and before bacterial challenge. This biosignature may be used as a surrogate of protection and therefore as a predictor of vaccine success against yersiniosis.	[Bridle, Andrew R.; Nowak, Barbara F.] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Hobart, Tas 7001, Australia; [Koop, Ben F.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada	University of Tasmania; University of Victoria	Bridle, AR (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Hobart, Tas 7001, Australia.	Andrew.Bridle@utas.edu.au	Nowak, Barbara/J-7261-2014; Bridle, Andrew/B-4117-2013; Koop, Ben F./A-8151-2008	Nowak, Barbara/0000-0002-0347-643X; Koop, Ben F./0000-0003-0045-5200; Bridle, Andrew/0000-0002-5788-1297	Australian Research Council [LP0883880]; Tasmanian salmonid growers association (TSGA)	Australian Research Council(Australian Research Council); Tasmanian salmonid growers association (TSGA)	This research was supported under Australian Research Council's Linkage Projects funding scheme (project number LP0883880). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Jeremy Carson (DPIPWE) for the provision of bacterial isolates and bacterin. We also acknowledge the technical contributions Stephen Hindrum, Philip Crosbie, Dan Sanderson, Ben Sutherland, Glenn Cooper, Jong Leong and Stuart Jantzen. Thank you also to the Tasmanian salmonid growers association (TSGA) and Ridley aquafeed for their support and provision of fish and feed.	Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Bridle A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023417; BUSCH RA, 1978, MAR FISH REV, V40, P42; Byon JY, 2006, VACCINE, V24, P921, DOI 10.1016/j.vaccine.2005.08.087; Carson J, 2008, AUSTR NZ STANDARD DI, P1; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; Cortes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011319; Costa AA, 2011, AQUACULTURE, V315, P201, DOI 10.1016/j.aquaculture.2011.02.031; Degen WGJ, 2006, VACCINE, V24, P6096, DOI 10.1016/j.vaccine.2006.05.027; Dumrongphol Y, 2009, FISH SHELLFISH IMMUN, V26, P197, DOI 10.1016/j.fsi.2008.03.014; EGIDIUS EC, 1979, J FISH DIS, V2, P405, DOI 10.1111/j.1365-2761.1979.tb00392.x; Evenhuis JP, 2012, VET IMMUNOL IMMUNOP, V146, P8, DOI 10.1016/j.vetimm.2012.01.008; Frank M, 2000, PROG NEUROBIOL, V60, P531, DOI 10.1016/S0301-0082(99)00039-8; Galindo RC, 2009, VACCINE, V27, P3039, DOI 10.1016/j.vaccine.2009.03.046; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Haig SJ, 2011, VET MICROBIOL, V147, P155, DOI 10.1016/j.vetmic.2010.06.022; Harun NO, 2011, VACCINE, V29, P4388, DOI 10.1016/j.vaccine.2011.04.003; Haugarvoll E, 2008, J ANAT, V213, P202, DOI 10.1111/j.1469-7580.2008.00943.x; Hoffmann PR, 2007, ARCH IMMUNOL THER EX, V55, P289, DOI 10.1007/s00005-007-0036-4; Kano R, 2009, J VET MED SCI, V71, P603, DOI 10.1292/jvms.71.603; Komatsu K, 2009, DEV COMP IMMUNOL, V33, P499, DOI 10.1016/j.dci.2008.09.012; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Kurobe T, 2005, DEV COMP IMMUNOL, V29, P515, DOI 10.1016/j.dci.2004.10.005; Leong J, 2010, IDENTIFICATION ANNOT; MacKenzie S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-141; Matsuyama T, 2007, FISH SHELLFISH IMMUN, V22, P598, DOI 10.1016/j.fsi.2006.08.006; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; OLESEN NJ, 1991, J APPL ICHTHYOL, V7, P36, DOI 10.1111/j.1439-0426.1991.tb00592.x; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pridgeon JW, 2010, VET IMMUNOL IMMUNOP, V138, P25, DOI 10.1016/j.vetimm.2010.06.011; Raida MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018832; Raida MK, 2011, FISH SHELLFISH IMMUN, V30, P1257, DOI 10.1016/j.fsi.2011.03.022; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ramanathan B, 2002, MICROBES INFECT, V4, P361, DOI 10.1016/S1286-4579(02)01549-6; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Ruckner R. R., 1966, Bulletin Office International des Epizooties, V65, P825; Ryckaert J, 2010, FISH SHELLFISH IMMUN, V29, P648, DOI 10.1016/j.fsi.2010.06.009; Saraiva TC, 2011, INT IMMUNOPHARMACOL, V11, P1546, DOI 10.1016/j.intimp.2011.05.012; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Skugor S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-503; Soanes KHH, 2004, IMMUNOGENETICS, V56, P572, DOI 10.1007/s00251-004-0719-5; Stokes WS, 2011, PROCEDIA VACCINOL, V5, P84, DOI 10.1016/j.provac.2011.10.006; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Wheeler RW, 2009, DIS AQUAT ORGAN, V84, P25, DOI 10.3354/dao02039; Wiens GD, 2010, FISH SHELLFISH IMMUN, V29, P639, DOI 10.1016/j.fsi.2010.06.010; Yasuike M, 2007, FISH SHELLFISH IMMUN, V23, P531, DOI 10.1016/j.fsi.2006.12.006; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P103, DOI 10.1016/j.cimid.2010.03.001	52	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40841	10.1371/journal.pone.0040841	http://dx.doi.org/10.1371/journal.pone.0040841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808275	Green Published, gold			2022-12-27	WOS:000306366400062
J	Proud, D; Hudy, MH; Wiehler, S; Zaheer, RS; Amin, MA; Pelikan, JB; Tacon, CE; Tonsaker, TO; Walker, BL; Kooi, C; Traves, SL; Leigh, R				Proud, David; Hudy, Magdalena H.; Wiehler, Shahina; Zaheer, Raza S.; Amin, Minaa A.; Pelikan, Jonathan B.; Tacon, Claire E.; Tonsaker, Tabitha O.; Walker, Brandie L.; Kooi, Cora; Traves, Suzanne L.; Leigh, Richard			Cigarette Smoke Modulates Expression of Human Rhinovirus-Induced Airway Epithelial Host Defense Genes	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; IN-VITRO; CELLS; INFECTION; ASTHMA; EXACERBATIONS; SUSCEPTIBILITY; INDUCTION; VIVO	Human rhinovirus (HRV) infections trigger acute exacerbations of chronic obstructive pulmonary disease (COPD) and asthma. The human airway epithelial cell is the primary site of HRV infection and responds to infection with altered expression of multiple genes, the products of which could regulate the outcome to infection. Cigarette smoking aggravates asthma symptoms, and is also the predominant risk factor for the development and progression of COPD. We, therefore, examined whether cigarette smoke extract (CSE) modulates viral responses by altering HRV-induced epithelial gene expression. Primary cultures of human bronchial epithelial cells were exposed to medium alone, CSE alone, purified HRV-16 alone or to HRV-16+ CSE. After 24 h, supernatants were collected and total cellular RNA was isolated. Gene array analysis was performed to examine mRNA expression. Additional experiments, using real-time RT-PCR, ELISA and/or western blotting, validated altered expression of selected gene products. CSE and HRV-16 each induced groups of genes that were largely independent of each other. When compared to gene expression in response to CSE alone, cells treated with HRV+CSE showed no obvious differences in CSE-induced gene expression. By contrast, compared to gene induction in response to HRV-16 alone, cells exposed to HRV+CSE showed marked suppression of expression of a number of HRV-induced genes associated with various functions, including antiviral defenses, inflammation, viral signaling and airway remodeling. These changes were not associated with altered expression of type I or type III interferons. Thus, CSE alters epithelial responses to HRV infection in a manner that may negatively impact antiviral and host defense outcomes.	[Proud, David; Hudy, Magdalena H.; Wiehler, Shahina; Zaheer, Raza S.; Amin, Minaa A.; Pelikan, Jonathan B.; Tacon, Claire E.; Tonsaker, Tabitha O.; Kooi, Cora; Traves, Suzanne L.; Leigh, Richard] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol,Airway Inflammat Res Grp, Calgary, AB, Canada; [Walker, Brandie L.; Kooi, Cora; Leigh, Richard] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Airway Inflammat Res Grp,Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Proud, D (corresponding author), Univ Calgary, Fac Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol,Airway Inflammat Res Grp, Calgary, AB, Canada.	dproud@ucalgary.ca			Canadian Institutes of Health Research [43923]; Lung Association of Alberta and Northwest Territories; GlaxoSmithKline/Canadian Institutes of Health; Alberta Innovates-Health Solutions; AllerGen/Canadian Thoracic Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta and Northwest Territories; GlaxoSmithKline/Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; AllerGen/Canadian Thoracic Society	This work was supported by grant number 43923 from the Canadian Institutes of Health Research and by a grant from the Lung Association of Alberta and Northwest Territories. D. Proud holds a Canada Research Chair in Inflammatory Airway Diseases. R. Leigh holds the GlaxoSmithKline/Canadian Institutes of Health Research Professorship in Inflammatory Lung Diseases. M. Hudy and C. Tacon are recipients of studentships from Alberta Innovates-Health Solutions. J. Pelikan and M. Amin are recipents of studentships from the Lung Association of Alberta and Northwest Territories. B. Walker is the recipient of an AllerGen/Canadian Thoracic Society Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; CHURCHILL L, 1989, AM REV RESPIR DIS, V140, P449, DOI 10.1164/ajrccm/140.2.449; COHEN S, 1993, AM J PUBLIC HEALTH, V83, P1277, DOI 10.2105/AJPH.83.9.1277; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Eddleston J, 2011, AM J RESP CELL MOL, V44, P118, DOI 10.1165/rcmb.2009-0266OC; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Gelbman BD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-10; Gern JE, 1996, J IMMUNOL, V156, P621; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Leigh R, 2011, FUTURE VIROL, V6, P375, DOI 10.2217/FVL.11.9; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mcleish AC, 2010, J ASTHMA, V47, P345, DOI 10.3109/02770900903556413; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nickel R, 1999, J ALLERGY CLIN IMMUN, V104, P723, DOI 10.1016/S0091-6749(99)70281-2; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Pickett G, 2010, TOXICOL SCI, V114, P79, DOI 10.1093/toxsci/kfp298; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Schneider D, 2010, AM J RESP CRIT CARE, V182, P332, DOI 10.1164/rccm.200911-1673OC; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Teran LM, 1999, J INFECT DIS, V179, P677, DOI 10.1086/314618; Traves SL, 2007, CURR OPIN PHARMACOL, V7, P252, DOI 10.1016/j.coph.2006.11.010; Trifilo MJ, 2004, J VIROL, V78, P585, DOI 10.1128/JVI.78.2.585-594.2004; Venarske DL, 2006, J INFECT DIS, V193, P1536, DOI 10.1086/503809; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Wirtz HRW, 1996, EUR RESPIR J, V9, P24, DOI 10.1183/09031936.96.09010024	38	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40762	10.1371/journal.pone.0040762	http://dx.doi.org/10.1371/journal.pone.0040762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808255	gold, Green Published, Green Submitted			2022-12-27	WOS:000306366400056
J	Rogers, I; Kerr, F; Martinez, P; Hardy, J; Lovestone, S; Partridge, L				Rogers, Iain; Kerr, Fiona; Martinez, Pedro; Hardy, John; Lovestone, Simon; Partridge, Linda			Ageing Increases Vulnerability to A beta 42 Toxicity in Drosophila	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; A-BETA; ALZHEIMERS-DISEASE; MODEL; TURNOVER; BRAIN; EXPRESSION; GLUTAMATE; PEPTIDE; SYSTEM	Age is the major risk factor for many neurodegenerative diseases, including Alzheimer's Disease (AD), for reasons that are not clear. The association could indicate that the duration or degree of exposure to toxic proteins is important for pathology, or that age itself increases susceptibility to protein toxicity. Using an inducible Drosophila model of AD, we investigated these possibilities by varying the expression of an A beta 42 transgene in neurons at different adult ages and measuring the effects on A beta 42 levels and associated pathological phenotypes. Acute induction of Arctic A beta 42 in young adult flies resulted in rapid expression and clearance of mRNA and soluble Arctic A beta 42 protein, but in irreversible expression of insoluble Arctic A beta 42 peptide. Arctic A beta 42 peptide levels accumulated with longer durations of induction, and this led to a dose-dependent reduction in negative geotaxis and lifespan. For a standardised level of mRNA expression, older flies had higher levels of Arctic A beta 42 peptide and associated toxicity, and this correlated with an age-dependent reduction in proteasome activity. Equalising A beta 42 protein at different ages shortened lifespan in correlation with the duration of exposure to the peptide, suggesting that A beta 42 expression accumulates damage over time. However, the relative reduction in lifespan compared to controls was greater in flies first exposed to the peptide at older ages, suggesting that ageing itself also increases susceptibility to A beta 42 toxicity. Indeed older flies were more vulnerable to chronic A beta 42 toxicity even with a much lower lifetime exposure to the peptide. Finally, the persistence of insoluble A beta 42 in both young and old induced flies suggests that aggregated forms of the peptide cause toxicity in later life. Our results suggest that reduced protein turnover, increased duration of exposure and increased vulnerability to protein toxicity at later ages in combination could explain the late age-of-onset of neurodegenerative phenotypes.	[Rogers, Iain; Kerr, Fiona; Martinez, Pedro; Partridge, Linda] UCL, Inst Healthy Ageing, London, England; [Rogers, Iain; Kerr, Fiona; Martinez, Pedro; Partridge, Linda] UCL, GEE, London, England; [Hardy, John] UCL, Dept Neurol, London, England; [Lovestone, Simon] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England; [Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany	University of London; University College London; University of London; University College London; University of London; University College London; University of London; King's College London; Max Planck Society	Rogers, I (corresponding author), UCL, Inst Healthy Ageing, London, England.	l.partridge@ucl.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010; Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Partridge, Linda/0000-0001-9615-0094; Lovestone, Simon/0000-0003-0473-4565; Kerr, Fiona/0000-0003-3097-1951	Eisai London Research Laboratories (UK); Wellcome Trust; Alzheimer's Research UK; Alzheimers Research UK [ART-PPG2011A-14, ART-PG2009-4] Funding Source: researchfish; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	Eisai London Research Laboratories (UK)(Eisai Co Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Eisai London Research Laboratories (UK), the Wellcome Trust and Alzheimer's Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2011, ALZHEIMERS DEMENT, V7, P208, DOI 10.1016/j.jalz.2011.02.004; AMADUCCI L, 1994, CURR OPIN NEUROL, V7, P283, DOI 10.1097/00019052-199408000-00001; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Brewer GJ, 1998, NEUROBIOL AGING, V19, P561, DOI 10.1016/S0197-4580(98)00091-8; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Bulteau AL, 2002, FREE RADICAL BIO MED, V32, P1157, DOI 10.1016/S0891-5849(02)00816-X; Burns M, 2003, J NEUROSCI, V23, P5645; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Latouche M, 2007, J NEUROSCI, V27, P2483, DOI 10.1523/JNEUROSCI.5453-06.2007; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; NIEDZWIECKI A, 1990, MECH AGEING DEV, V52, P295, DOI 10.1016/0047-6374(90)90133-Z; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Ryazanov AG, 2002, MECH AGEING DEV, V123, P207, DOI 10.1016/S0047-6374(01)00337-2; Sofola O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001087; Tucker SMF, 2008, J NEUROPATH EXP NEUR, V67, P30; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063	42	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40569	10.1371/journal.pone.0040569	http://dx.doi.org/10.1371/journal.pone.0040569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808195	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400037
J	Xin, Z; Yuan, MX; Li, HX; Hua, L; Feng, JP; Shi, J; Zhu, XR; Cao, X; Yang, JK				Xin, Zhong; Yuan, Ming-Xia; Li, Hong-Xing; Hua, Lin; Feng, Jian-Ping; Shi, Jing; Zhu, Xiao-Rong; Cao, Xi; Yang, Jin-Kui			Evaluation for Fasting and 2-hour Glucose and HbA(1)c for Diagnosing Diabetes Based on Prevalence of Retinopathy in a Chinese Population	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; EXPERT COMMITTEE; MELLITUS; CRITERIA; A1C; THRESHOLDS; RISK	Background: The glycemic thresholds for diabetes diagnosis have long been at the forefront of discussion. However, no information about glycemic cutoff points has been made available for the Chinese population. The aim of the present study was to examine the association of fasting plasma glucose (FPG), 2-h plasma glucose (2-h PG) and HbA(1)c levels with diabetic retinopathy (DR) and determine the associated cutoff levels in a Chinese population. Methodology and Principal Findings: In a cross-sectional population-based sample of 2551 Chinese (representing a population of 1,660,500 in a Beijing district) between 18-79 years of age, the three glycemic measures were measured in a 75 g oral glucose tolerance test, and DR was assessed by two 45 degrees color digital retinal images. The prevalence of DR increased in the ninth decile of each variable, corresponding to an FPG of >= 7.2 mmol/l, a 2-h PG of >= 10.7 mmol/l, and HbA(1)c of >= 6.4%, according to the Joinpoint regression method. After excluding individuals receiving antihyperglycemic medication, the prevalence significantly increased at an FPG of >= 6.8 mmol/l, a 2-h PG of >= 12.0 mmol/l, and HbA(1)c of >= 6.7%. The area under the ROC curve for all three measures showed no significant differences for detecting DR. After excluding individuals receiving antihyperglycemic medication, the three measures also showed no significant differences. Conclusions and Significance: A significant increase in retinopathy prevalence occurs among individuals with FPG >= 7.2 mmol/l, 2-h PG >= 10.5 mmol/and HbA(1)c >= 6.4%; and measuring FPG or HbA1c are equally reliable methods as measuring 2-h PG for the diagnosis of diabetes in the Chinese population.	[Xin, Zhong; Yuan, Ming-Xia; Li, Hong-Xing; Feng, Jian-Ping; Shi, Jing; Zhu, Xiao-Rong; Cao, Xi; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China; [Hua, Lin] Capital Med Univ, Sch Biomed Engn, Dept Math, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Xin, Z (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China.	jinkui.yang@gmail.com		Yang, Jin-Kui/0000-0002-5430-2149	Capital Medical Development Foundation [2009-Z-SQ03]; Expert Promotion Program of Beijing Health Systems [2009-3-34]	Capital Medical Development Foundation; Expert Promotion Program of Beijing Health Systems	This work was supported by the Capital Medical Development Foundation (http://www.bjhb.gov.cn/ggtz/200903/t20090327_13055.htm) (http://www.bjhbkj.com/)(No. 2009-Z-SQ03) and Expert Promotion Program of Beijing Health Systems (No. 2009-3-34) to Professor Jin-Kui Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; DOWSE GK, 1994, MED J AUSTRALIA, V160, P767, DOI 10.5694/j.1326-5377.1994.tb125945.x; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Gavin JR, 1997, DIABETES CARE, V20, P1183; Harris EL, 1999, DIABETES CARE, V22, P779, DOI 10.2337/diacare.22.5.779; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; MCCANCE DR, 1995, DIABETES CARE, V18, P1042, DOI 10.2337/diacare.18.7.1042; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; McCance DR, 1997, DIABETOLOGIA, V40, P247, DOI 10.1007/s001250050671; Miyazaki M, 2004, DIABETOLOGIA, V47, P1411, DOI 10.1007/s00125-004-1466-8; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; OMAR MAK, 1994, DIABETES CARE, V17, P70, DOI 10.2337/diacare.17.1.70; West SK, 2001, DIABETES CARE, V24, P1204, DOI 10.2337/diacare.24.7.1204; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	18	22	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40610	10.1371/journal.pone.0040610	http://dx.doi.org/10.1371/journal.pone.0040610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808204	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400039
J	Okereke, OI; Prescott, J; Wong, JYY; Han, JL; Rexrode, KM; De Vivo, I				Okereke, Olivia I.; Prescott, Jennifer; Wong, Jason Y. Y.; Han, Jiali; Rexrode, Kathryn M.; De Vivo, Immaculata			High Phobic Anxiety Is Related to Lower Leukocyte Telomere Length in Women	PLOS ONE			English	Article							CIGARETTE-SMOKING; OXIDATIVE STRESS; PANIC DISORDER; PATERNAL AGE; DNA-DAMAGE; RISK; DISEASE; CANCER; COMORBIDITY; ASSOCIATION	Background: Chronic psychological distress has been linked to shorter telomeres, an indication of accelerated aging. Yet, little is known about relations of anxiety to telomeres. We examined whether a typically chronic form of anxiety - phobic anxiety - is related to telomere length. Methodology/Principal Findings: Relative telomere lengths (RTLs) in peripheral blood leukocytes were measured by quantitative real-time polymerase chain reaction among 5,243 women (aged 42-69 years) who: were participants in the Nurses' Health Study; were controls in prior case-control studies of telomeres and disease, or randomly selected healthy participants in a cognitive function sub-study; had completed the Crown-Crisp phobic index proximal to blood collection. Adjusted least-squares mean RTLs (z-scores) were calculated across phobic categories. Higher phobic anxiety was generally associated with lower RTLs (age-adjusted p-trend = 0.09); this association was similar after adjustment for confounders - paternal age-at-birth, smoking, body mass index (BMI) and physical activity (p-trend = 0.15). Notably, a threshold was identified. Among women with Crown-Crisp<6 points, the multivariable-adjusted least-squares mean RTL z-score = 0.02 standard units; however, among the most phobic women (Crown-Crisp >= 6), the multivariable-adjusted least-squares mean RTL z-score = -0.09 standard units (mean difference = -0.10 standard units; p = 0.02). The magnitude of this difference was comparable to that for women 6 years apart in age. Finally, effect modification by BMI, smoking and paternal age was observed: associations were stronger among highly phobic women with BMI >= 25 kg/m(2), without smoking history, or born to fathers aged >= 40 years. Conclusions/Significance: In this large, cross-sectional study high phobic anxiety was associated with shorter telomeres. These results point toward prospective investigations relating anxiety to telomere length change.	[Okereke, Olivia I.; Prescott, Jennifer; Wong, Jason Y. Y.; Han, Jiali; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Okereke, Olivia I.; Prescott, Jennifer; Wong, Jason Y. Y.; Han, Jiali; Rexrode, Kathryn M.; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Okereke, Olivia I.; Prescott, Jennifer; Wong, Jason Y. Y.; Han, Jiali; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer; Wong, Jason Y. Y.; Han, Jiali; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Han, Jiali] Brigham & Womens Hosp, Dept Dermatol, Clin Res Program, Boston, MA 02115 USA; [Okereke, Olivia I.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Okereke, OI (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	olivia.okereke@channing.harvard.edu	Rexrode, Kathryn M/I-1177-2018; Okereke, Olivia I/R-9934-2016; Okereke, Olivia/AAF-7031-2021	Rexrode, Kathryn/0000-0003-3387-8429; Wong, Jason/0000-0002-8167-540X; De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health (NIH) [R01 CA082838, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, R01 CA065725, R03 CA132190, R03 CA139586, K07 CA140790, K08 AG029813]; Harvard Medical School; NATIONAL CANCER INSTITUTE [R01CA049449, R01CA082838, R03CA139586, K07CA140790, R03CA132190, R01CA065725, P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088521, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG029813] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R01 CA082838, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, R01 CA065725, R03 CA132190, R03 CA139586 and K07 CA140790. Dr. Okereke was supported by the Harvard Medical School Eleanor and Miles Shore Fellowship and NIH Career Development Award K08 AG029813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brennan AM, 2009, DIABETES CARE, V32, P926, DOI 10.2337/dc08-1979; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; BURGESS PM, 1987, BRIT J MED PSYCHOL, V60, P61; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chartier M J, 1998, Depress Anxiety, V7, P113, DOI 10.1002/(SICI)1520-6394(1998)7:3<113::AID-DA3>3.0.CO;2-C; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; CROWN S, 1966, BRIT J PSYCHIAT, V112, P917, DOI 10.1192/bjp.112.490.917; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; Drury SS, 2011, MOL PSYCHIAT; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; GOLDBERG R, 1990, PSYCHOSOMATICS, V31, P168, DOI 10.1016/S0033-3182(90)72190-1; Haines H, 2001, HEART, V85, P385, DOI 10.1136/heart.85.4.385; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Hartmann N, 2010, DEPRESS ANXIETY, V27, P1111, DOI 10.1002/da.20749; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Irie M, 2001, JPN J CANCER RES, V92, P367, DOI 10.1111/j.1349-7006.2001.tb01104.x; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kessler R. C., 2011, Textbook in psychiatric epidemiology, P221; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2010, CURR TOP BEHAV NEURO, V2, P21, DOI 10.1007/7854_2009_9; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lecrubier Y, 1998, J CLIN PSYCHIAT, V59, P11; Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x; Liu K, 2011, J OBSTET GYNAECOL CA, V33, P1165, DOI 10.1016/S1701-2163(16)35087-3; Lung FW, 2007, PSYCHIAT GENET, V17, P195, DOI 10.1097/YPG.0b013e32808374f6; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; McGrath M, 2004, AM J PSYCHIAT, V161, P1703, DOI 10.1176/appi.ajp.161.9.1703; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Nunez MJ, 2011, LIFE SCI, V89, P650, DOI 10.1016/j.lfs.2011.07.027; Parks CG, 2011, OCCUP ENVIRON MED, V68, P582, DOI 10.1136/oem.2010.063214; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Spitzer C, 2011, J PSYCHOSOM RES, V71, P174, DOI 10.1016/j.jpsychores.2011.03.005; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Streiner E.L., 1989, HLTH MEASUREMENT SCA, P39; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van Dijk APM, 1998, EUR J CLIN INVEST, V28, P664; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986	80	53	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40516	10.1371/journal.pone.0040516	http://dx.doi.org/10.1371/journal.pone.0040516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808180	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400066
J	Tejada, J; Arisi, GM; Garcia-Cairasco, N; Roque, AC				Tejada, Julian; Arisi, Gabriel M.; Garcia-Cairasco, Norberto; Roque, Antonio C.			Morphological Alterations in Newly Born Dentate Gyrus Granule Cells That Emerge after Status Epilepticus Contribute to Make Them Less Excitable	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CA3 PYRAMIDAL CELLS; NEURONAL MORPHOLOGIES; SEIZURES; NEUROGENESIS; HIPPOCAMPUS; PLASTICITY; MODEL; ELECTROPHYSIOLOGY; REORGANIZATION	Computer simulations of external current stimulations of dentate gyrus granule cells of rats with Status Epilepticus induced by pilocarpine and control rats were used to evaluate whether morphological differences alone between these cells have an impact on their electrophysiological behavior. The cell models were constructed using morphological information from tridimensional reconstructions with Neurolucida software. To evaluate the effect of morphology differences alone, ion channel conductances, densities and distributions over the dendritic trees of dentate gyrus granule cells were the same for all models. External simulated currents were injected in randomly chosen dendrites belonging to one of three different areas of dentate gyrus granule cell molecular layer: inner molecular layer, medial molecular layer and outer molecular layer. Somatic membrane potentials were recorded to determine firing frequencies and inter-spike intervals. The results show that morphologically altered granule cells from pilocarpine-induced epileptic rats are less excitable than control cells, especially when they are stimulated in the inner molecular layer, which is the target area for mossy fibers that sprout after pilocarpine-induced cell degeneration. This suggests that morphological alterations may act as a protective mechanism to allow dentate gyrus granule cells to cope with the increase of stimulation caused by mossy fiber sprouting.	[Tejada, Julian; Roque, Antonio C.] Univ Sao Paulo, Dept Fis, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [Tejada, Julian; Arisi, Gabriel M.; Garcia-Cairasco, Norberto] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Fisiol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Tejada, J (corresponding author), Univ Sao Paulo, Dept Fis, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.	ngcairas@fmrp.usp.br; antonior@ffclrp.usp.br	Tejada, Julian/G-7326-2012; Tejada, Julian/U-7746-2019; Arisi, Gabriel/J-8714-2012; Cairasco, Norberto Garcia/E-3250-2015; Roque, Antonio C./C-2316-2011; Tejada, Julian/B-4000-2011	Arisi, Gabriel/0000-0002-6832-3389; Cairasco, Norberto Garcia/0000-0001-8857-3775; Roque, Antonio C./0000-0003-1260-4840; Tejada, Julian/0000-0003-0275-3578	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - "National Counsel of Technological and Scientific Development" (CNPq) -Brazil [156597/2101-1]; CNPq Fellowship; CNPq; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - "Foundation for Research Support of the State of Sao Paulo" (FAPESP); Cooperacao Interinstitucional de Apoio a Pesquisas sobre o Cerebro da FAPESP "Inter-institutional Cooperation in Support of Brain Research Program of FAPESP" (FAPESP-Cinapce); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - "Federal Agency of Support and Evaluation of Postgraduate Education" (CAPES); CAPES program of Academic Excellence (CAPES-PROEX), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - "National Counsel of Technological and Scientific Development" (CNPq) -Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - "Foundation for Research Support of the State of Sao Paulo" (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cooperacao Interinstitucional de Apoio a Pesquisas sobre o Cerebro da FAPESP "Inter-institutional Cooperation in Support of Brain Research Program of FAPESP" (FAPESP-Cinapce)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - "Federal Agency of Support and Evaluation of Postgraduate Education" (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES program of Academic Excellence (CAPES-PROEX), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JT has a Postdoctoral fellowships of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - "National Counsel of Technological and Scientific Development" (CNPq) -Brazil, process number 156597/2101-1. GMA was the recipient of a PhD CNPq Fellowship. NGC and AR are recipients of grants from CNPq, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - "Foundation for Research Support of the State of Sao Paulo" (FAPESP), Cooperacao Interinstitucional de Apoio a Pesquisas sobre o Cerebro da FAPESP "Inter-institutional Cooperation in Support of Brain Research Program of FAPESP" (FAPESP-Cinapce), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - "Federal Agency of Support and Evaluation of Postgraduate Education" (CAPES) and the CAPES program of Academic Excellence (CAPES-PROEX), Brazil. NGC and AR are also recipients of CNPq-Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Aradi I, 2002, J PHYSIOL-LONDON, V538, P227, DOI 10.1113/jphysiol.2001.013054; Aradi I, 1999, J COMPUT NEUROSCI, V6, P215, DOI 10.1023/A:1008801821784; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Dayan P, 2001, COMPUTATIONAL NEUROS; Dietrich D, 2005, BRAIN RES, V1032, P123, DOI 10.1016/j.brainres.2004.10.060; Fang M, 2011, MED HYPOTHESES, V76, P871, DOI 10.1016/j.mehy.2011.02.039; Garcia-Cairasco N, 2009, EPILEPSY BEHAV, V14, P54, DOI 10.1016/j.yebeh.2008.09.010; Gordon-Weeks P. R., 2000, NEURONAL GROWTH CONE; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Maloney MT, 2011, DEV NEUROBIOLOGY; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Murphy BL, 2011, J NEUROSCI, V31, P2959, DOI 10.1523/JNEUROSCI.3381-10.2011; Murphy BL, 2011, J NEUROSCI, V31, P105, DOI 10.1523/JNEUROSCI.2728-10.2011; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Santos VR, 2011, NEUROSCIENCE, V197, P348, DOI 10.1016/j.neuroscience.2011.09.034; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Scorcioni R, 2008, NAT PROTOC, V3, P866, DOI 10.1038/nprot.2008.51; Shapiro LA, 2006, EPILEPSY RES, V69, P53, DOI 10.1016/j.eplepsyres.2005.12.003; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; Thomas EA, 2010, EPILEPSIA, V51, P136, DOI 10.1111/j.1528-1167.2009.02202.x; van Elburg RAJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000781; Varodayan FP, 2009, EPILEPSIA, V50, P2638, DOI 10.1111/j.1528-1167.2009.02244.x; Walter C, 2007, J NEUROSCI, V27, P7541, DOI 10.1523/JNEUROSCI.0431-07.2007; Washington SD, 2000, NEUROCOMPUTING, V32, P261, DOI 10.1016/S0925-2312(00)00173-9; Weaver CM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040011; Weisz VI, COGNITION, V112, P229; Young CC, 2009, J PHYSIOL-LONDON, V587, P4213, DOI 10.1113/jphysiol.2009.170746; YUEN GLF, 1991, NEUROSCIENCE, V41, P411, DOI 10.1016/0306-4522(91)90337-N	40	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40726	10.1371/journal.pone.0040726	http://dx.doi.org/10.1371/journal.pone.0040726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22811762	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400096
J	FitzGerald, L; Macey, PM; Brecht, ML				FitzGerald, Leah; Macey, Paul M.; Brecht, Mary-Lynn			Pathways to Interleukin-6 in Healthy Males and Serious Leisure Male Athletes: Physical Activity, Body Composition and Age	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SKELETAL-MUSCLE; WEIGHT-LOSS; EXERCISE; RISK; INFLAMMATION; ASSOCIATION; MARKERS; IL-6; MASS	Physical activity (PA) is beneficial to overall health, in part due to physiological changes that lower risk factors for cardiovascular disease, including reduced inflammation. However, the mechanism by which PA reduces inflammation is unclear. One possible pathway is that PA improves body composition which in turn reduces inflammation. To test this hypothesis, we used structural equation modeling (SEM) to assess PA-body composition -inflammation pathways, as well as influences of age. In a sample of 72 healthy males with a range of PA profiles (age 18-65, mean +/- sd = ), we measured PA as metabolic equivalent tasks (as per the International PA Questionnaire), body composition as percent body fat, lean mass, and fat mass, and inflammation as plasma interleukin-6 (IL-6). We treated body composition in the SEM analysis as a latent variable indicated by the three measures. We performed statistical corrections for missing values and one outlier. The model demonstrated significant effects of PA on IL-6 both directly and through body composition. Percent body fat, fat mass, and lean mass were significant indicators of the body composition latent variable. Additionally, age showed an indirect effect on IL-6 through body composition, but no direct effect. The findings suggest that PA does improve inflammatory profile through improving body composition, but that other pathways also exist.	[FitzGerald, Leah; Macey, Paul M.; Brecht, Mary-Lynn] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Brecht, Mary-Lynn] Univ Calif Los Angeles, Sch Med, Semel Inst, Integrated Subst Abuse Programs, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	FitzGerald, L (corresponding author), Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA.	lfitzger@sonnet.ucla.edu	Macey, Paul M./B-5037-2008	Macey, Paul M./0000-0003-4093-7458	Sigma Theta Tau, Gamma Tau at Large Chapter; Cousins Center for Psychoneuroimmunology at the UCLA Semel Institute for Neuroscience; GCRC [MO1RR00865]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER	Sigma Theta Tau, Gamma Tau at Large Chapter; Cousins Center for Psychoneuroimmunology at the UCLA Semel Institute for Neuroscience; GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding support for this work was provided by Sigma Theta Tau, Gamma Tau at Large Chapter and the Cousins Center for Psychoneuroimmunology at the UCLA Semel Institute for Neuroscience. In addition, the authors would like to acknowledge the support of GCRC grant # MO1RR00865. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Bentler PM, 1999, MULTIVAR BEHAV RES, V34, P181, DOI 10.1207/S15327906Mb340203; Blake GJ, 2003, J AM COLL CARDIOL, V41, p37S, DOI 10.1016/S0735-1097(02)02953-4; Buhi ER, 2007, AM J HEALTH BEHAV, V31, P74, DOI 10.5993/AJHB.31.1.8; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Dod HS, 2010, AM J CARDIOL, V105, P362, DOI 10.1016/j.amjcard.2009.09.038; Edwards KM, 2006, J SPORT SCI, V24, P855, DOI 10.1080/02640410500245645; Elosua R, 2005, J GERONTOL A-BIOL, V60, P760, DOI 10.1093/gerona/60.6.760; Empana JP, 2010, ARTERIOSCL THROM VAS, V30, P2047, DOI 10.1161/ATVBAHA.110.208785; Eyre H, 2004, DIABETES CARE, V27, P1812, DOI 10.2337/diacare.27.7.1812; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; FitzGerald L, 2007, J CLIN DENSITOM, V13, P256; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Graham JE, 2006, BRAIN BEHAV IMMUN, V20, P389, DOI 10.1016/j.bbi.2005.11.002; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herzog W, 2009, STRUCT EQU MODELING, V16, P1, DOI 10.1080/10705510802561279; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jankord R, 2004, MED SCI SPORTS EXERC, V36; Kelly AS, 2007, METABOLISM, V56, P1005, DOI 10.1016/j.metabol.2007.03.009; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Lambert CP, 2008, J APPL PHYSIOL, V105, P473, DOI 10.1152/japplphysiol.00006.2008; Little R. J. A., 1987, STAT ANAL MISSING DA; Oberbach A, 2008, EUR J ENDOCRINOL, V159, P129, DOI 10.1530/EJE-08-0220; Olsson UH, 2000, STRUCT EQU MODELING, V7, P557, DOI 10.1207/S15328007SEM0704_3; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Pedersen M, 2003, MECH AGEING DEV, V124, P495, DOI 10.1016/S0047-6374(03)00027-7; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Plaisance EP, 2006, SPORTS MED, V36, P443, DOI 10.2165/00007256-200636050-00006; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Sacheck JM, 2006, AM J PHYSIOL-ENDOC M, V291, pE340, DOI 10.1152/ajpendo.00052.2005; Scharhag J, 2005, BRIT J SPORT MED, V39, P171, DOI 10.1136/bjsm.2004.013060; Sivo SA, 2006, J EXP EDUC, V74, P267, DOI 10.3200/JEXE.74.3.267-288; Silva TSE, 2010, HORM RES PAEDIAT, V74, P6, DOI 10.1159/000313586; Timmons BW, 2005, J APPL PHYSIOL, V99, P979, DOI 10.1152/japplphysiol.00171.2005; Ullman JB, 2006, J PERS ASSESS, V87, P35, DOI 10.1207/s15327752jpa8701_03	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40513	10.1371/journal.pone.0040513	http://dx.doi.org/10.1371/journal.pone.0040513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808178	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500050
J	Clark, TJW; Houck, SA; Clark, JI				Clark, Tyler J. W.; Houck, Scott A.; Clark, John I.			Hemoglobin Interactions with alpha B Crystallin: A Direct Test of Sensitivity to Protein Instability	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; EXPRESSION; CATARACT; STABILITY	As a small stress response protein, human alpha B crystallin, detects protein destabilization that can alter structure and function to cause self assembly of fibrils or aggregates in diseases of aging. The sensitivity of alpha B crystallin to protein instability was evaluated using wild-type hemoglobin (HbA) and hemoglobin S (HbS), the glutamate-6-valine mutant that forms elongated, filamentous aggregates in sickling red blood cells. The progressive thermal unfolding and aggregation of HbA and HbS in solution at 37 degrees C, 50 degrees C and 55 degrees C was measured as increased light scattering. UV circular dichroism (UVCD) was used to evaluate conformational changes in HbA and HbS with time at the selected temperatures. The changes in interactions between alpha B crystallin and HbA or HbS with temperature were analyzed using differential centrifugation and SDS PAGE at 37 degrees C, 50 degrees C and 55 degrees C. After only 5 minutes at the selected temperatures, differences in the aggregation or conformation of HbA and HbS were not observed, but alpha B crystallin bound approximately 6% and 25% more HbS than HbA at 37 degrees C, and 50 degrees C respectively. The results confirmed (a) the remarkable sensitivity of alpha B crystallin to structural instabilities at the very earliest stages of thermal unfolding and (b) an ability to distinguish the self assembling mutant form of HbS from the wild type HbA in solution.	[Clark, Tyler J. W.; Clark, John I.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; [Houck, Scott A.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Clark, John I.] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Clark, TJW (corresponding author), Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA.	clarkji@uw.edu			N.E.I. (National Eye Institute of the National Institutes of Health (NIH)) [RO1 EY04542]; NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER	N.E.I. (National Eye Institute of the National Institutes of Health (NIH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding is from RO1 EY04542 from the N.E.I. (National Eye Institute of the National Institutes of Health (NIH)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Andley UP, 2009, CURR MOL MED, V9, P887, DOI 10.2174/156652409789105598; Arrigo AP, 2010, CURR MOL MED, V10, P776, DOI 10.2174/156652410793937804; Banerjee PR, 2011, P NATL ACAD SCI USA, V108, P574, DOI 10.1073/pnas.1014653107; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CHATTERJEE R, 1986, J BIOL CHEM, V261, P9929; Chen KJ, 2004, BIOPHYS J, V87, P4113, DOI 10.1529/biophysj.104.046482; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; EATON WA, 1987, BLOOD, V70, P1245; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Ferrer I, 2011, J ALZHEIMERS DIS, V23, P537, DOI 10.3233/JAD-2010-101485; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Hawse J, 2003, MOL VIS, V9, P515; Houck SA, 2010, PROTEIN SCI ENG, P417; KINDERLERER J, 1973, BIOCHEM J, V135, P805, DOI 10.1042/bj1350805; Mansergh FC, 2008, INT J DEV BIOL, V52, P873, DOI 10.1387/ijdb.082597fm; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Simon S, 2010, PROTEIN SCI ENG; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Vaiana SM, 2005, PROTEINS, V58, P426, DOI 10.1002/prot.20339; WELLEMS TE, 1980, J MOL BIOL, V137, P443, DOI 10.1016/0022-2836(80)90169-2; WILSON SM, 1980, P NATL ACAD SCI-BIOL, V77, P944, DOI 10.1073/pnas.77.2.944	27	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40486	10.1371/journal.pone.0040486	http://dx.doi.org/10.1371/journal.pone.0040486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815750	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900026
J	Minetti, AE; Ivanenko, YP; Cappellini, G; Dominici, N; Lacquaniti, F				Minetti, Alberto E.; Ivanenko, Yuri P.; Cappellini, Germana; Dominici, Nadia; Lacquaniti, Francesco			Humans Running in Place on Water at Simulated Reduced Gravity	PLOS ONE			English	Article							HUMAN LOCOMOTION; WALKING; MODEL	Background: On Earth only a few legged species, such as water strider insects, some aquatic birds and lizards, can run on water. For most other species, including humans, this is precluded by body size and proportions, lack of appropriate appendages, and limited muscle power. However, if gravity is reduced to less than Earth's gravity, running on water should require less muscle power. Here we use a hydrodynamic model to predict the gravity levels at which humans should be able to run on water. We test these predictions in the laboratory using a reduced gravity simulator. Methodology/Principal Findings: We adapted a model equation, previously used by Glasheen and McMahon to explain the dynamics of Basilisk lizard, to predict the body mass, stride frequency and gravity necessary for a person to run on water. Progressive body-weight unloading of a person running in place on a wading pool confirmed the theoretical predictions that a person could run on water, at lunar (or lower) gravity levels using relatively small rigid fins. Three-dimensional motion capture of reflective markers on major joint centers showed that humans, similarly to the Basilisk Lizard and to the Western Grebe, keep the head-trunk segment at a nearly constant height, despite the high stride frequency and the intensive locomotor effort. Trunk stabilization at a nearly constant height differentiates running on water from other, more usual human gaits. Conclusions/Significance: The results showed that a hydrodynamic model of lizards running on water can also be applied to humans, despite the enormous difference in body size and morphology.	[Minetti, Alberto E.] Univ Milan, Dept Human Physiol, Milan, Italy; [Ivanenko, Yuri P.; Cappellini, Germana; Dominici, Nadia; Lacquaniti, Francesco] IRCCS, Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Dominici, Nadia; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space BioMed, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Neurosci Sect, Dept Syst Med, Rome, Italy	University of Milan; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Minetti, AE (corresponding author), Univ Milan, Dept Human Physiol, Milan, Italy.	y.ivanenko@hsantalucia.it	Lacquaniti, Francesco/J-9842-2016; Minetti, Alberto Enrico/P-2320-2017; Cappellini, Germana/AAA-7754-2019; Ivanenko, Yury/L-1599-2018	Lacquaniti, Francesco/0000-0003-0896-7315; Minetti, Alberto Enrico/0000-0002-0120-4406; Ivanenko, Yury/0000-0001-9363-9548; Dominici, Nadia/0000-0003-2312-915X; Cappellini, Germana/0000-0001-9110-3870	Italian Ministry of Health; Italian Ministry of University and Research; Italian Space Agency; European Union [248311]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); European Union(European Commission)	This work was supported by the Italian Ministry of Health, Italian Ministry of University and Research (PRIN grant), Italian Space Agency (DCMC and CRUSOE grants) and European Union FP7-ICT program (AMARSi grant #248311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; Denny M. W., 1993, AIR WATER BIOL PHYS; Donelan JM, 2000, J EXP BIOL, V203, P2405; Floyd S, 2008, IEEE T ROBOT, V24, P698, DOI 10.1109/TRO.2008.924258; Gazzani F, 2000, IEEE T REHABIL ENG, V8, P506, DOI 10.1109/86.895954; Glasheen JW, 1996, NATURE, V380, P340, DOI 10.1038/380340a0; Glasheen JW, 1996, J EXP BIOL, V199, P2611; Glasheen JW, 1996, PHYS FLUIDS, V8, P2078, DOI 10.1063/1.869010; Hsieh ST, 2004, P NATL ACAD SCI USA, V101, P16784, DOI 10.1073/pnas.0405736101; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Ivanenko YP, 2011, J APPL PHYSIOL, V110, P781, DOI 10.1152/japplphysiol.00799.2010; MARGARIA R, 1964, AEROSPACE MED, V35, P1140; Minetti AE, 2001, NATURE, V409, P467, DOI 10.1038/35054166; Minetti AE, 2004, J EXP BIOL, V207, P1265, DOI 10.1242/jeb.00886; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113	16	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e37300	10.1371/journal.pone.0037300	http://dx.doi.org/10.1371/journal.pone.0037300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815681	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900004
J	Churches, O; Callahan, R; Michalski, D; Brewer, N; Turner, E; Keage, HAD; Thomas, NA; Nicholls, MER				Churches, Owen; Callahan, Rebecca; Michalski, Dana; Brewer, Nicola; Turner, Emma; Keage, Hannah Amy Diane; Thomas, Nicole Annette; Nicholls, Mike Elmo Richard			How Academics Face the World: A Study of 5829 Homepage Pictures	PLOS ONE			English	Article							FACIAL EMOTION; RIGHT POSES; CHEEK; LATERALITY; EXPRESSION; SCIENCE	It is now standard practice, at Universities around the world, for academics to place pictures of themselves on a personal profile page maintained as part of their University's web-site. Here we investigated what these pictures reveal about the way academics see themselves. Since there is an asymmetry in the degree to which emotional information is conveyed by the face, with the left side being more expressive than the right, we hypothesised that academics in the sciences would seek to pose as non-emotional rationalists and put their right cheek forward, while academics in the arts would express their emotionality and pose with the left cheek forward. We sourced 5829 pictures of academics from their University websites and found that, consistent with the hypotheses, there was a significant difference in the direction of face posing between science academics and English academics with English academics showing a more leftward orientation. Academics in the Fine Arts and Performing Arts however, did not show the expected left cheek forward bias. We also analysed profile pictures of psychology academics and found a greater bias toward presenting the left check compared to science academics which makes psychologists appear more like arts academics than scientists. These findings indicate that the personal website pictures of academics mirror the cultural perceptions of emotional expressiveness across disciplines.	[Churches, Owen; Callahan, Rebecca; Michalski, Dana; Brewer, Nicola; Turner, Emma; Keage, Hannah Amy Diane] Univ S Australia, Sch Psychol Social Work & Social Policy, Cognit Neurosci Lab, Adelaide, SA 5001, Australia; [Churches, Owen] Univ S Australia, Hawke Res Inst, Adelaide, SA 5001, Australia; [Thomas, Nicole Annette; Nicholls, Mike Elmo Richard] Flinders Univ S Australia, Sch Psychol, Brain & Cognit Lab, Adelaide, SA 5001, Australia	University of South Australia; University of South Australia; Flinders University South Australia	Churches, O (corresponding author), Univ S Australia, Sch Psychol Social Work & Social Policy, Cognit Neurosci Lab, Adelaide, SA 5001, Australia.	Owen.Churches@UniSA.edu.au	Callahan, Rebecca A/G-8904-2012; Keage, Hannah/C-6470-2011	Callahan, Rebecca A/0000-0003-0975-2180; Keage, Hannah/0000-0002-6814-4997; Thomas, Nicole/0000-0002-1112-9024; Churches, Owen/0000-0002-2571-4849; Nicholls, Mike/0000-0002-7072-3744	Australian National Health and Medical Research Council [568890]; Natural Sciences and Engineering Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	During the period of this work Hannah Keage was funded by an Australian National Health and Medical Research Council Training Award (568890) and Nicole Thomas was supported by the Natural Sciences and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWERS D, 1991, BRAIN, V114, P2593, DOI 10.1093/brain/114.6.2593; CROSBY EC, 1963, ANN OTO RHINOL LARYN, V72, P735, DOI 10.1177/000348946307200310; Darwin C, 1872, EXPERSSION EMOTIONS; Gergen KJ, 2010, THEOR PSYCHOL, V20, P795, DOI 10.1177/0959354310370906; Lindell AK, 2010, LATERALITY, V15, P639, DOI 10.1080/13576500903201784; Lunn M, 2008, INT J SCI EDUC, V30, P793, DOI 10.1080/09500690701264750; MCMANUS IC, 1973, NATURE, V243, P271, DOI 10.1038/243271a0; Nicholls MER, 2002, BRAIN COGNITION, V48, P480, DOI 10.1006/brcg.2001.1402; Nicholls MER, 2002, NEUROPSYCHOLOGIA, V40, P1662, DOI 10.1016/S0028-3932(02)00024-6; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Rose N, 2009, SOCIOL REV, V57, P66, DOI 10.1111/j.1467-954X.2010.01886.x; SACKEIM HA, 1978, SCIENCE, V202, P434, DOI 10.1126/science.705335; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; ten Cate C, 2002, J NONVERBAL BEHAV, V26, P175, DOI 10.1023/A:1020713416442; Zhou RL, 2006, PERCEPT MOTOR SKILL, V102, P430, DOI 10.2466/PMS.102.2.430-434	15	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e38940	10.1371/journal.pone.0038940	http://dx.doi.org/10.1371/journal.pone.0038940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JG	22815695	Green Published, Green Accepted, gold			2022-12-27	WOS:000306507000005
J	Gonzalez-Montalban, N; Baskakov, IV				Gonzalez-Montalban, Nuria; Baskakov, Ilia V.			Assessment of Strain-Specific PrPSc Elongation Rates Revealed a Transformation of PrPSc Properties during Protein Misfolding Cyclic Amplification	PLOS ONE			English	Article							PRION PROTEIN; CONFORMATIONAL STABILITY; MOLECULES	Prion replication is believed to consist of two components, a growth or elongation of infectious isoform of the prion protein (PrPSc) particles and their fragmentation, a process that provides new replication centers. The current study introduced an experimental approach that employs Protein Misfolding Cyclic Amplification with beads (PMCAb) and relies on a series of kinetic experiments for assessing elongation rates of PrPSc particles. Four prion strains including two strains with short incubation times to disease (263K and Hyper) and two strains with very long incubation times (SSLOW and LOTSS) were tested. The elongation rate of brain-derived PrPSc was found to be strain-specific. Strains with short incubation times had higher rates than strains with long incubation times. Surprisingly, the strain-specific elongation rates increased substantially for all four strains after they were subjected to six rounds of serial PMCAb. In parallel to an increase in elongation rates, the percentages of diglycosylated PrP glycoforms increased in PMCAb-derived PrPSc comparing to those of brain-derived PrPSc. These results suggest that PMCAb selects the same molecular features regardless of strain initial characteristics and that convergent evolution of PrPSc properties occurred during in vitro amplification. These results are consistent with the hypothesis that each prion strain is comprised of a variety of conformers or 'quasi-species' and that change in the prion replication environment gives selective advantage to those conformers that replicate most effectively under specific environment.	[Gonzalez-Montalban, Nuria; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gonzalez-Montalban, N (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu			National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant NS045585 to Ilia V. Baskakov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Gonzalez-Montalban N, 2011, BIOCHEMISTRY-US, V50, P7933, DOI 10.1021/bi200950v; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Klingeborn M, 2011, PROCACADNAT IN PRESS; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2012, NATURE COMM IN PRESS; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mays CE, 2010, FASEB J, V24, P5102, DOI 10.1096/fj.10-163600; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; Prusiner S. B., 1998, LES PRIX NOBEL, P268; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Shikiya RA, 2011, J VIROL, V85, P13439, DOI 10.1128/JVI.06134-11; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Tattum MH, 2010, TRANSFUSION, V50, P2619, DOI 10.1111/j.1537-2995.2010.02731.x; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748	39	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41210	10.1371/journal.pone.0041210	http://dx.doi.org/10.1371/journal.pone.0041210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815972	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000079
J	Hill, KS; Gaziova, I; Harrigal, L; Guerra, YA; Qiu, SM; Sastry, SK; Arumugam, T; Logsdon, CD; Elferink, LA				Hill, Kristen S.; Gaziova, Ivana; Harrigal, Lindsay; Guerra, Yvette A.; Qiu, Suimin; Sastry, Sarita K.; Arumugam, Thiruvengadam; Logsdon, Craig D.; Elferink, Lisa A.			Met Receptor Tyrosine Kinase Signaling Induces Secretion of the Angiogenic Chemokine Interleukin-8/CXCL8 in Pancreatic Cancer	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; INTRAEPITHELIAL NEOPLASIA; LIVER METASTASIS; STROMAL CELLS; MOUSE MODEL; EXPRESSION; INHIBITOR; CARCINOMA; PROGRESSION	At diagnosis, the majority of pancreatic cancer patients present with advanced disease when curative resection is no longer feasible and current therapeutic treatments are largely ineffective. An improved understanding of molecular targets for effective intervention of pancreatic cancer is thus urgent. The Met receptor tyrosine kinase is one candidate implicated in pancreatic cancer. Notably, Met is over expressed in up to 80% of invasive pancreatic cancers but not in normal ductal cells correlating with poor overall patient survival and increased recurrence rates following surgical resection. However the functional role of Met signaling in pancreatic cancer remains poorly understood. Here we used RNA interference to directly examine the pathobiological importance of increased Met signaling for pancreatic cancer. We show that Met knockdown in pancreatic tumor cells results in decreased cell survival, cell invasion, and migration on collagen I in vitro. Using an orthotopic model for pancreatic cancer, we provide in vivo evidence that Met knockdown reduced tumor burden correlating with decreased cell survival and tumor angiogenesis, with minimal effect on cell growth. Notably, we report that Met signaling regulates the secretion of the pro-angiogenic chemokine interleukin-8/CXCL8. Our data showing that the interleukin-8 receptors CXCR1 and CXCR2 are not expressed on pancreatic tumor cells, suggests a paracrine mechanism by which Met signaling regulates interleukin-8 secretion to remodel the tumor microenvironment, a novel finding that could have important clinical implications for improving the effectiveness of treatments for pancreatic cancer.	[Hill, Kristen S.; Gaziova, Ivana; Harrigal, Lindsay; Guerra, Yvette A.; Elferink, Lisa A.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Qiu, Suimin] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Sastry, Sarita K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Qiu, Suimin; Sastry, Sarita K.; Elferink, Lisa A.] Univ Texas Med Branch, UTMB Canc Ctr, Galveston, TX USA; [Arumugam, Thiruvengadam; Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center	Hill, KS (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	lisa.elferink@utmb.edu	Sastry, Sarita/A-1291-2013	Hill, Kristen/0000-0003-3757-2822	National Institutes of Health [CA-119075, DK-052067, CA-118405]; NIH/NCI Multidisciplinary Training in Cancer Research [T32 (CA117834-03)]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA118405, T32CA117834, R01CA119075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Multidisciplinary Training in Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health CA-119075 to L. A. E., DK-052067 to C. D. L., and CA-118405 to S. K. S. K. S. H. was supported by training grant NIH/NCI Multidisciplinary Training in Cancer Research, T32 (CA117834-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; DIRENZO MF, 1995, CANCER RES, V55, P1129; EBERT M, 1994, CANCER RES, V54, P5775; FURUKAWA T, 1995, AM J PATHOL, V147, P889; Goggins M, 2000, AM J PATHOL, V156, P1767, DOI 10.1016/S0002-9440(10)65047-X; Hill Kristen S, 2010, J Exp Ther Oncol, V8, P297; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ide T, 2007, ANN SURG ONCOL, V14, P2600, DOI 10.1245/s10434-007-9435-3; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Ko AH, 2010, CANCER CHEMOTH PHARM, V66, P1051, DOI 10.1007/s00280-010-1257-5; Kopantzev E P, 2009, Dokl Biol Sci, V429, P583; Kuwada Y, 2003, INT J ONCOL, V22, P765; La Rosa S, 2000, ENDOCR PATHOL, V11, P315, DOI 10.1385/EP:11:4:315; Logan-Collins J, 2010, CANCER RES, V70, P1130, DOI 10.1158/0008-5472.CAN-09-0761; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Qazi BS, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/908468; Sattler M, 2003, CANCER RES, V63, P5462; Seo Y, 2000, CANCER, V88, P2239, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Shi Q, 1999, CLIN CANCER RES, V5, P3711; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singh S, 2009, CANCER RES, V69, P411, DOI 10.1158/0008-5472.CAN-08-3378; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Tomioka D, 2001, CANCER RES, V61, P7518; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wen JH, 2004, CANCER GENE THER, V11, P419, DOI 10.1038/sj.cgt.7700705; Wilentz RE, 2000, CANCER RES, V60, P2002; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Xu DH, 2010, J SURG ONCOL, V102, P469, DOI 10.1002/jso.21530; Yokoi K, 2005, NEOPLASIA, V7, P696, DOI 10.1593/neo.05193; Yu J, 2006, WORLD J GASTROENTERO, V12, P3878, DOI 10.3748/wjg.v12.i24.3878; Zeng HM, 2011, PANCREAS, V40, P657, DOI 10.1097/MPA.0b013e31821268d1; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100; Zhu GH, 2011, DIGEST DIS SCI, V56, P1090, DOI 10.1007/s10620-010-1416-x; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	49	22	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40420	10.1371/journal.pone.0040420	http://dx.doi.org/10.1371/journal.pone.0040420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815748	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000015
J	Huang, XY; Chen, LL; Song, WL; Chen, L; Niu, JM; Han, X; Feng, GY; He, L; Qin, SY				Huang, Xunyi; Chen, Lili; Song, Wenlong; Chen, Ling; Niu, Jiamin; Han, Xia; Feng, Guoyin; He, Lin; Qin, Shengying			Systematic Functional Characterization of Cytochrome P450 2E1 Promoter Variants in the Chinese Han Population	PLOS ONE			English	Article							TANDEM REPEAT POLYMORPHISM; GENETIC-POLYMORPHISM; 5'-FLANKING REGION; CYP2E1; 2E1; IDENTIFICATION; EXPRESSION; OXIDATION; P4502E1; CANCER	CYP2E1 promoter polymorphisms can lead to significant interindividual differences in expression of CYP2E1. Using a database of CYP2E1 gene polymorphisms established in 2010, our study aimed to functionally characterize the single nucleotide polymorphisms (SNPs) of the promoter region and corresponding haplotypes in the Chinese Han population. Six novel SNPs and seven haplotypes with a frequency equal to or greater than 0.01 were constructed on a luciferase reporter system on the basis of site-directed mutagenesis. Dual luciferase reporter systems were used to analyze regulatory activity. The constructs including single novel SNP mutations exhibited insignificant change in luciferase activity, whereas, the activity produced by Haplo1(GTTGCTATAT), Haplo2 (CTTGCTATAT) and Haplo7 (GAGCTCACAT), containing a -333T>A polymorphism was significantly greater than for the wild type in Hep G2 cells (p<0.05), being 1.5-, 2.0- and 1.4- times greater respectively. These findings suggest the possibility of significant clinical prediction of adverse drug reaction and the facilitation of personalized medicine.	[Huang, Xunyi; Chen, Lili; Song, Wenlong; Feng, Guoyin; He, Lin; Qin, Shengying] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Huang, Xunyi; Chen, Lili; Song, Wenlong; Feng, Guoyin; He, Lin; Qin, Shengying] Shanghai GenomePilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [Chen, Ling] Shanghai Jiao Tong Univ, Sch Life Sci & Technol, Shanghai 200030, Peoples R China; [Niu, Jiamin; Han, Xia] Laiwu Hosp, Laiwu, Shandong, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University	Huang, XY (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	helin@bio-x.cn; chinsir@sjtu.edu.cn			863 Program [2012AA02A515]; 973 Program [2010CB529600]; National Key Technology RD Program [2006BAI05A09, 2012BAI01B09]; National Nature Science Foundation of China [81121001, 30900799, 30972823]; Shanghai Municipal Commission of Science and Technology Program [11DZ1950300, 09DJ1400601]; Shanghai Jiaotong University Med-X Fund [YG2010MS61]; Public Science and Technology Research Funds [201210056]; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project [B205]	863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Shanghai Jiaotong University Med-X Fund; Public Science and Technology Research Funds; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the 863 Program (2012AA02A515), the 973 Program (2010CB529600), the National Key Technology R&D Program (2006BAI05A09, 2012BAI01B09), the National Nature Science Foundation of China (81121001, 30900799, 30972823), the Shanghai Municipal Commission of Science and Technology Program (11DZ1950300, 09DJ1400601), the Shanghai Jiaotong University Med-X Fund (YG2010MS61), Public Science and Technology Research Funds (201210056), the Shanghai Jiaotong University Interdisciplinary Research fund, and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; Cederbaum AI, 2006, MT SINAI J MED, V73, P657; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P689, DOI 10.1016/0006-2952(89)90217-7; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hasler J A, 1999, Mol Aspects Med, V20, P12; Hu Y, 1999, BIOCHEM BIOPH RES CO, V263, P286, DOI 10.1006/bbrc.1999.1362; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; INGELMANSUNDBERG M, 1993, ALCOHOL, V10, P447, DOI 10.1016/0741-8329(93)90063-T; Itoga S, 2002, ALCOHOL CLIN EXP RES, V26, p15S, DOI 10.1097/01.ALC.0000026828.13868.B5; Johnsrud EK, 2003, J PHARMACOL EXP THER, V307, P402, DOI 10.1124/jpet.102.053124; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; KHARASCH ED, 1993, ANESTHESIOLOGY, V79, P795, DOI 10.1097/00000542-199310000-00023; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; LIU SY, 1995, DNA CELL BIOL, V14, P285, DOI 10.1089/dna.1995.14.285; Nomura F, 2003, ALCOHOL CLIN EXP RES, V27, p42S, DOI 10.1097/01.ALC.0000078612.01626.96; Peng HM, 2000, ARCH BIOCHEM BIOPHYS, V382, P129, DOI 10.1006/abbi.2000.2001; PETER R, 1990, CHEM RES TOXICOL, V3, P566, DOI 10.1021/tx00018a012; Tang KF, 2010, GENOMICS, V95, P224, DOI 10.1016/j.ygeno.2010.01.005; UENO T, 1990, MOL CELL BIOL, V10, P4495, DOI 10.1128/MCB.10.9.4495; WRIGHTON SA, 1986, BIOCHEMISTRY-US, V25, P6731, DOI 10.1021/bi00370a001; Zhukov A, 1999, BIOCHEM J, V340, P453, DOI 10.1042/0264-6021:3400453	21	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40883	10.1371/journal.pone.0040883	http://dx.doi.org/10.1371/journal.pone.0040883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815852	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000038
J	Tabara, K; Kanda, R; Sonoda, K; Kubo, T; Murakami, Y; Kawahara, A; Azuma, K; Abe, H; Kage, M; Yoshinaga, A; Tahira, T; Hayashi, K; Arao, T; Nishio, K; Rosell, R; Kuwano, M; Ono, M				Tabara, Keisuke; Kanda, Rina; Sonoda, Kahori; Kubo, Takuya; Murakami, Yuichi; Kawahara, Akihiko; Azuma, Koichi; Abe, Hideyuki; Kage, Masayoshi; Yoshinaga, Aki; Tahira, Tomoko; Hayashi, Kenshi; Arao, Tokuzo; Nishio, Kazuto; Rosell, Rafael; Kuwano, Michihiko; Ono, Mayumi			Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells	PLOS ONE			English	Article							FACTOR RECEPTOR GENE; QUANTITATIVE-ANALYSIS; GEFITINIB RESISTANCE; PIK3CA GENE; PHASE-II; MUTATIONS; SENSITIVITY; ERLOTINIB; AMPLIFICATION; EXPRESSION	Non-small-cell lung cancer harboring epidermal growth factor receptor (EGFR) mutations attains a meaningful response to EGFR-tyrosine kinase inhibitors (TKIs). However, acquired resistance to EGFR-TKIs could affect long-term outcome in almost all patients. To identify the potential mechanisms of resistance, we established cell lines resistant to EGFR-TKIs from the human lung cancer cell lines PC9 and11-18, which harbored activating EGFR mutations. One erlotinib-resistant cell line from PC9 and two erlotinib-resistant cell lines and two gefitinib-resistant cell lines from 11-18 were independently established. Almost complete loss of mutant delE746-A750 EGFR gene was observed in the erlotinib-resistant cells isolated from PC9, and partial loss of the mutant L858R EGFR gene copy was specifically observed in the erlotinib- and gefitinib-resistant cells from 11-18. However, constitutive activation of EGFR downstream signaling, PI3K/Akt, was observed even after loss of the mutated EGFR gene in all resistant cell lines even in the presence of the drug. In the erlotinib-resistant cells from PC9, constitutive PI3K/Akt activation was effectively inhibited by lapatinib (a dual TKI of EGFR and HER2) or BIBW2992 (pan-TKI of EGFR family proteins). Furthermore, erlotinib with either HER2 or HER3 knockdown by their cognate siRNAs also inhibited PI3K/Akt activation. Transfection of activating mutant EGFR complementary DNA restored drug sensitivity in the erlotinib-resistant cell line. Our study indicates that loss of addiction to mutant EGFR resulted in gain of addiction to both HER2/HER3 and PI3K/Akt signaling to acquire EGFR-TKI resistance.	[Tabara, Keisuke; Kanda, Rina; Sonoda, Kahori; Kubo, Takuya; Murakami, Yuichi; Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan; [Murakami, Yuichi] St Marys Hosp, Kurume, Fukuoka, Japan; [Kawahara, Akihiko; Abe, Hideyuki; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Azuma, Koichi] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Yoshinaga, Aki; Tahira, Tomoko; Hayashi, Kenshi] Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal, Fukuoka 812, Japan; [Arao, Tokuzo; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan; [Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain; [Rosell, Rafael] USP Dexeus Univ, Pangaea Biotech SL, Inst Barcelona, Barcelona, Spain; [Kuwano, Michihiko] Kyushu Univ, Lab Mol Canc Biol, Dept Clin Pharmaceut, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan	Kyushu University; Kurume University; Kurume University; Kyushu University; Kindai University (Kinki University); Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Kyushu University	Tabara, K (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan.	mono@phar.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research [23790425] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-aid for Scientific Research on Priority Areas (Cancer) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2003, BIOTECHNIQUES, V34, P746, DOI 10.2144/03344st03; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hammerman PS, 2009, CLIN CANCER RES, V15, P7502, DOI 10.1158/1078-0432.CCR-09-0189; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kawahara A, 2011, LUNG CANCER, V74, P35, DOI 10.1016/j.lungcan.2011.02.002; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kukita Y, 2002, ELECTROPHORESIS, V23, P2259, DOI 10.1002/1522-2683(200207)23:14<2259::AID-ELPS2259>3.0.CO;2-8; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Ono M, 2004, MOL CANCER THER, V3, P465; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, CLIN CANCER RES, V10, p4238S, DOI 10.1158/1078-0432.CCR-040017; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Tahira T, 2005, HUM MUTAT, V26, P69, DOI 10.1002/humu.20196; Tahira T, 2006, ELECTROPHORESIS, V27, P3869, DOI 10.1002/elps.200600098; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643	39	61	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41017	10.1371/journal.pone.0041017	http://dx.doi.org/10.1371/journal.pone.0041017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815900	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000053
J	Fukuhara, S; Akizawa, T; Morita, S; Tsubakihara, Y				Fukuhara, Shunichi; Akizawa, Tadao; Morita, Satoshi; Tsubakihara, Yoshiharu			Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities	PLOS ONE			English	Article							HEALTH-STATUS	Background: Many patients with chronic kidney disease (CKD) suffer from fatigue caused by anemia, but that anemia can be reversed. Successful treatment can be measured as a decrease in fatigue and an increase in energy or vitality, particularly on the vitality (VT) subscale of the SF-36. Changes in VT scores are most commonly interpreted in terms of minimally important differences or standardized effect sizes, but neither a minimally important difference nor a standardized effect size provides information about how patients' activities are affected. Therefore, we analyzed the association between differences in VT scores and a variable that is meaningful to patients and to society the frequency of going out. Study Design: Questionnaire survey. Analyses of differences among participants at bseline, and analyses of differences within participants over time. Setting and Participants: CKD patients who were not on dialysis and were involved in a study of anti-anemia therapy. Predictor: VT scores. Outcome: Frequency of going out. Measurements: VT scores and the frequency of going out. Results: At baseline, higher VT scores and younger age were associated with going out more often, while sex and the presence of diabetic nephropathy were not associated with the frequency of going out. Greater changes in VT scores over time were associated with greater changes in the frequency of going out, in univariate and multivariate analyses. Conclusions: At baseline, VT was associated with the frequency of going out. Increases in VT were also associated with increases in the frequency of going out. These results show how VT scores can be linked to daily activities that are important to individual patients and to society.	[Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Epidemiol, Kyoto, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Morita, Satoshi] Yokohama City Univ, Sch Med, Univ Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Tsubakihara, Yoshiharu] Osaka Gen Med Ctr, Dept Kidney Dis & Hypertens, Osaka, Japan	Kyoto University; Showa University; Yokohama City University	Fukuhara, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Epidemiol, Kyoto, Japan.	fukuhara.shunichi.6m@kyoto-u.ac.jp		Tsubakihara, Yoshiharu/0000-0001-9703-9443	Kyowa Hakko Kirin Co., Ltd (Tokyo, Japan); Kyowa Hakko Kirin Co., Ltd.	Kyowa Hakko Kirin Co., Ltd (Tokyo, Japan); Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd)	This study is not a Randomized Controlled Trial. However, the data used in this study were collected as part of such a trial, which was sponsored by Kyowa Hakko Kirin Co., Ltd (Tokyo, Japan). Registration of Clinical Trials: The Cochrane Renal Group registry: autoid 121, crg_id CRG030600049. The authors participated in that trial as advisers and received consultation fees from Kyowa Hakko Kirin Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizawa T, 2011, THER APHER DIAL, V15, P431, DOI 10.1111/j.1744-9987.2011.00931.x; Bjorner JB, 2007, CURR MED RES OPIN, V23, P731, DOI 10.1185/030079907X178757; Cohen J.E., 1988, STAT POWER ANAL BEHA; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Gandra SR, 2010, AM J KIDNEY DIS, V55, P519, DOI 10.1053/j.ajkd.2009.09.019; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Sato D, 2007, QUAL LIFE RES, V16, P1577, DOI 10.1007/s11136-007-9269-2; Shibayama T, 2007, DIABETES RES CLIN PR, V76, P265, DOI 10.1016/j.diabres.2006.09.017; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485	14	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40455	10.1371/journal.pone.0040455	http://dx.doi.org/10.1371/journal.pone.0040455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973NH	22808164	Green Submitted, gold, Green Published			2022-12-27	WOS:000306366400024
J	Rangel, HR; Maes, M; Villalba, J; Sulbaran, Y; de Waard, JH; Bello, G; Pujol, FH				Rangel, Hector R.; Maes, Mailis; Villalba, Julian; Sulbaran, Yoneira; de Waard, Jacobus H.; Bello, Gonzalo; Pujol, Flor H.			Evidence of at Least Two Introductions of HIV-1 in the Amerindian Warao Population from Venezuela	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MAXIMUM-LIKELIHOOD; PERUVIAN AMAZON; SUBTYPE-B; TUBERCULOSIS; COMMUNITIES; PREVENTION; DIVERSITY; SEQUENCES; INFERENCE	Background: The Venezuelan Amerindians were, until recently, free of human immunodeficiency virus (HIV) infection. However, in 2007, HIV-1 infection was detected for the first time in the Warao Amerindian population living in the Eastern part of Venezuela, in the delta of the Orinoco river. The aim of this study was to analyze the genetic diversity of the HIV-1 circulating in this population. Methodology/Principal Findings: The pol genomic region was sequenced for 16 HIV-1 isolates and for some of them, sequences from env, vif and nef genomic regions were obtained. All HIV-1 isolates were classified as subtype B, with exception of one that was classified as subtype C. The 15 subtype B isolates exhibited a high degree of genetic similarity and formed a highly supported monophyletic cluster in each genomic region analyzed. Evolutionary analyses of the pol genomic region indicated that the date of the most recent common ancestor of the Waraos subtype B clade dates back to the late 1990s. Conclusions/Significance: At least two independent introductions of HIV-1 have occurred in the Warao Amerindians from Venezuela. The HIV-1 subtype B was successfully established and got disseminated in the community, while no evidence of local dissemination of the HIV-1 subtype C was detected in this study. These results warrant further surveys to evaluate the burden of this disease, which can be particularly devastating in this Amerindian population, with a high prevalence of tuberculosis, hepatitis B, among other infectious diseases, and with limited access to primary health care.	[Rangel, Hector R.; Sulbaran, Yoneira; Pujol, Flor H.] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Virol Mol, Caracas, Venezuela; [Maes, Mailis; Villalba, Julian; de Waard, Jacobus H.] Cent Univ Venezuela, Inst Biomed, Lab TB, Caracas, Venezuela; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil	Venezuelan Institute Science Research; University of Central Venezuela; Fundacao Oswaldo Cruz	Rangel, HR (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Virol Mol, Caracas, Venezuela.	fhpujol@gmail.com	Villalba, Julian/AAK-4222-2020; Rangel, Hector R/E-5575-2010; Bentancor, Gonzalo Jose Bello/N-7377-2019; de Waard, Jacobus/AGM-8709-2022; Bello, Gonzalo/E-6842-2013; Pujol, Flor H/E-5687-2010	Villalba, Julian/0000-0001-9230-8747; Rangel, Hector R/0000-0001-5937-9690; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Pujol, Flor H/0000-0001-6086-6883; Maes, Mailis/0000-0002-0266-6557; de Waard, Jacobus H./0000-0003-4118-1015	Grant Ley Organica de Ciencia, Tecnologia e Innovacion from Fondo Nacional de Ciencia y Tecnologia, Venezuela	Grant Ley Organica de Ciencia, Tecnologia e Innovacion from Fondo Nacional de Ciencia y Tecnologia, Venezuela	This work was supported by Grant Ley Organica de Ciencia, Tecnologia e Innovacion from Fondo Nacional de Ciencia y Tecnologia, Venezuela. The authors wish to thank Shell SA de Venezuela for the operational part in the Delta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2014, TRACER V1 6; Bartlett EC, 2008, INT J INFECT DIS, V12, pE89, DOI 10.1016/j.ijid.2008.03.036; Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Burks DJ, 2011, CULT HEALTH SEX, V13, P283, DOI 10.1080/13691058.2010.525666; Centers for Disease Control and Prevention, 1992, MMWR RECOMM REP, V41, P1; Devesa M, 2004, J MED VIROL, V72, P377, DOI 10.1002/jmv.20015; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fernández de Larrea Carlos, 2002, Invest. clín, V43, P35; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halpern M, 2010, REV PANAM SALUD PUBL, V28, P107, DOI 10.1590/S1020-49892010000800006; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Lavandero J, 2010, DELTA AMACURO C ARTI; Maes M, 2008, TUBERCULOSIS, V88, P490, DOI 10.1016/j.tube.2008.04.003; Mazin R., 2011, DESACATOS, V35, P87; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Rangel HR, 2009, INTERCIENCIA, V34, P163; Rangel HR, 2009, AIDS RES HUM RETROV, V25, P347, DOI 10.1089/aid.2008.0241; Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UNAIDS, 2010, GLOB REP UNAIDS REP; Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120; Vernon IS, 2002, PUBLIC HEALTH REP, V117, pS96; Wilbert J, 1993, MYSTIC ENDOWNMENT RE; Zavaleta C, 2007, AM J TROP MED HYG, V76, P703, DOI 10.4269/ajtmh.2007.76.703	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40626	10.1371/journal.pone.0040626	http://dx.doi.org/10.1371/journal.pone.0040626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808212	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400042
J	Huang, ZC; Fu, FJ; Zhong, ZH; Zhang, L; Xu, R; Zhao, XK				Huang, Zhichao; Fu, Fajun; Zhong, Zhaohui; Zhang, Lei; Xu, Ran; Zhao, Xiaokun			Chinese Minimally Invasive Percutaneous Nephrolithotomy for Intrarenal Stones in Patients with Solitary Kidney: A Single-Center Experience	PLOS ONE			English	Article							STAGHORN CALCULI; RENAL-CALCULI; MANAGEMENT; TRACT; SURGERY; NEPHROSTOLITHOTOMY; HEMORRHAGE; EXTRACTION; STANDARD; MINIPERC	Objective: To report our experience with Chinese minimally invasive percutaneous nephrolithotomy (Chinese MPCNL) to manage patients with intrarenal stones in solitary kidney, and evaluate the safety, efficiency and feasibility of this technique. Methods: Forty-one patients with intrarenal stones in solitary kidney underwent Chinese MPCNL in our department from March 2009 to February 2011. Demographic characteristics, operative parameters, number of tracts, stone-free rates (SFRs), stone analyses, hemoglobin levels, nephrostomy tube removal time, hospitalization time, and complications were evaluated. Serum creatinine (Scr) and glomerular filtration rate (GFR) were measured preoperatively, postoperatively at 1 month, and each follow-up visit. The 5-stage classification of chronic kidney disease (CKD) was used according to the National Kidney Foundation guidelines. Results: The initial stone-free status was achieved in 35 (85.4%) patients after Chinese MPCNL. The mean follow- up time was 16.9 +/- 4.7 months (range: 12-24), and the final SFR improved to 97.6% after auxiliary procedures. Among all patients, complex stones were detected in 26 (63.4%) patients, and 9 (22.0%) required multiple tracts. The mean operative time and mean hospitalization time were 71.3 +/- 23.5 min (range: 40-139) and 6.1 +/- 0.5 days (range: 5-11), respectively. During preoperative period and postoperative period (1 month), Scr were 132.1 +/- 41.3 umol/L (range: 78.2-231.4) and 108.9 +/- 30.7 umol/L (range: 71.6-136.9), respectively (P < 0.05), while GFR were 74.9 +/- 24.2 ml/min (range: 35-110) and 83.9 +/- 27.4 ml/min (range: 65-110), respectively (P < 0.05). According to CKD classification, the renal function was stable, improved, and worse in 29 (70.7%), 11 (26.8%), and 1 (2.5%) patients, compared with the preoperative levels. No patient progressed to end-stage renal disease requiring dialysis. Conclusions: Our experience with Chinese MPCNL demonstrates that it is safe, feasible and efficient for managing the intrarenal calculi in solitary kidney with a low complication rate. At long-term follow-up, renal function stabilized or even improved in the majority of patients with solitary kidney.	[Huang, Zhichao; Zhong, Zhaohui; Zhang, Lei; Xu, Ran; Zhao, Xiaokun] Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Fu, Fajun] Changsha Cent Hosp, Dept Urol, Changsha, Hunan, Peoples R China	Central South University	Zhao, XK (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	hzc0305@163.com						Akman T, 2011, UROLOGY, V78, P272, DOI 10.1016/j.urology.2010.12.029; Akman T, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.06.060; Aron M, 2005, UROL INT, V75, P327, DOI 10.1159/000089168; Borges CF, 2010, J ENDOUROL, V24, P1739, DOI 10.1089/end.2010.0231; Canes D, 2009, J UROLOGY, V181, P154, DOI 10.1016/j.juro.2008.09.023; Chandhoke PS, 1996, J UROLOGY, V156, P1567, DOI 10.1016/S0022-5347(01)65448-X; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Desai M, 2009, BJU INT, V104, P542, DOI 10.1111/j.1464-410X.2009.08472.x; El-Nahas AR, 2007, J UROLOGY, V177, P576, DOI 10.1016/j.juro.2006.09.048; FERNSTROM I, 1976, SCAND J UROL NEPHROL, V10, P257, DOI 10.1080/21681805.1976.11882084; Ganpule AP, 2008, CURR OPIN UROL, V18, P220, DOI 10.1097/MOU.0b013e3282f3e6e4; Giusti G, 2007, EUR UROL, V51, P810, DOI 10.1016/j.eururo.2006.07.047; He ZH, 2007, BJU INT, V99, P1467, DOI 10.1111/j.1464-410X.2007.06768.x; Jackman SV, 1998, WORLD J UROL, V16, P371, DOI 10.1007/s003450050083; KESSARIS DN, 1995, J UROLOGY, V153, P604, DOI 10.1016/S0022-5347(01)67659-6; Lahme S, 2001, EUR UROL, V40, P619, DOI 10.1159/000049847; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li X, 1998, CHINA J UROL, V19, P469; Li Xun, 2004, Beijing Da Xue Xue Bao Yi Xue Ban, V36, P124; Marguet CG, 2005, BJU INT, V96, P1097, DOI 10.1111/j.1464-410X.2005.05808.x; Matlaga BR, 2004, J UROLOGY, V172, P1351, DOI 10.1097/01.ju.0000138286.91104.2c; Michel MS, 2007, EUR UROL, V51, P899, DOI 10.1016/j.eururo.2006.10.020; Mishra S, 2011, BJU INT, V108, P896, DOI 10.1111/j.1464-410X.2010.09936.x; Monga M, 2000, J ENDOUROL, V14, P419, DOI 10.1089/end.2000.14.419; Preminger GM, 2005, J UROLOGY, V173, P1991, DOI 10.1097/01.ju.0000161171.67806.2a; Rassweiler JJ, 2000, BJU INT, V86, P919, DOI 10.1046/j.1464-410x.2000.00906.x; Shoma AM, 2012, UROLOGY, V79, P771, DOI 10.1016/j.urology.2011.09.042; Singla M, 2008, UROLOGY, V71, P1039, DOI 10.1016/j.urology.2007.11.072; STOLLER ML, 1994, J UROLOGY, V152, P1977, DOI 10.1016/S0022-5347(17)32283-8; STREEM SB, 1986, UROLOGY, V27, P247, DOI 10.1016/0090-4295(86)90283-9; Tiselius HG., 2008, EUR ASS UROL; Traxer O, 2001, J UROLOGY, V165, P1693, DOI 10.1016/S0022-5347(05)66395-1; WEBB DR, 1986, BRIT J UROL, V58, P1, DOI 10.1111/j.1464-410X.1986.tb05416.x; Zeng GH, 2007, SURG LAPARO ENDO PER, V17, P124, DOI 10.1097/SLE.0b013e318038faa4; Zhong W, 2008, J ENDOUROL, V22, P2147, DOI 10.1089/end.2008.0001; Zhong W, 2011, UROL RES, V39, P117, DOI 10.1007/s00240-010-0308-z	36	9	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40577	10.1371/journal.pone.0040577	http://dx.doi.org/10.1371/journal.pone.0040577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808197	gold, Green Submitted, Green Published			2022-12-27	WOS:000306355500061
J	Carmichael, RH; Graham, WM; Aven, A; Worthy, G; Howden, S				Carmichael, Ruth H.; Graham, William M.; Aven, Allen; Worthy, Graham; Howden, Stephan			Were Multiple Stressors a 'Perfect Storm' for Northern Gulf of Mexico Bottlenose Dolphins (Tursiops truncatus) in 2011?	PLOS ONE			English	Article							HEAT-LOSS; BLUBBER; MECHANISMS; INFECTION	An unusual number of near term and neonatal bottlenose dolphin (Tursiops truncatus) mortalities occurred in the northern Gulf of Mexico (nGOM) in 2011, during the first calving season after two well documented environmental perturbations; sustained cold weather in 2010 and the Deepwater Horizon oil spill (DWHOS). Preceding the stranding event, large volumes of cold freshwater entered the nGOM due to unusually large snowmelt on the adjacent watershed, providing a third potential stressor. We consider the possibility that this extreme cold and freshwater event contributed to the pattern of perinatal dolphin strandings along the nGOM coast. During the 4-month period starting January 2011, 186 bottlenose dolphins, including 46% perinatal calves (nearly double the percentage for the same time period from 2003-2010) washed ashore from Louisiana to western Florida. Comparison of the frequency distribution of strandings to flow rates and water temperature at a monitoring buoy outside Mobile Bay, Alabama (the 4th largest freshwater drainage in the U. S.) and along the nGOM coast showed that dolphin strandings peaked in Julian weeks 5, 8, and 12 (February and March), following water temperature minima by 2-3 weeks. If dolphin condition was already poor due to depleted food resources, bacterial infection, or other factors, it is plausible that the spring freshet contributed to the timing and location of the unique stranding event in early 2011. These data provide strong observational evidence to assess links between the timing of the DWHOS, other local environmental stressors, and mortality of a top local predator. Targeted analyses of tissues from stranded dolphins will be essential to define a cause of death, and our findings highlight the importance of considering environmental data along with biological samples to interpret stranding patterns during and after an unusual mortality event.	[Carmichael, Ruth H.; Graham, William M.; Aven, Allen] Dauphin Isl Sea Lab, Univ Programs, Dauphin Isl, AL USA; [Carmichael, Ruth H.; Graham, William M.; Aven, Allen] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Howden, Stephan] Univ So Mississippi, Dept Marine Sci, Stennis Space Ctr, MS USA; [Worthy, Graham] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	Dauphin Island Sea Lab; University of South Alabama; University of Southern Mississippi; State University System of Florida; University of Central Florida	Carmichael, RH (corresponding author), Dauphin Isl Sea Lab, Univ Programs, Dauphin Isl, AL USA.	rcarmichael@disl.org		Carmichael, Ruth/0000-0002-6033-3777; Howden, Stephan/0000-0002-7690-6365	Dauphin Island Sea Lab; National Fish and Wildlife Foundation [26321]	Dauphin Island Sea Lab; National Fish and Wildlife Foundation	This work was funded by the Dauphin Island Sea Lab and The National Fish and Wildlife Foundation, project #26321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2001, COAST ESTUAR STUD, V57, P119; Barros NB, 2010, MAR MAMMAL SCI, V26, P324, DOI 10.1111/j.1748-7692.2009.00315.x; Carvan MJ, 2003, N P TOX ENV, P429; Clark S, 2008, FOREST WISDOM, V12, P4; Dunkin RC, 2005, J EXP BIOL, V208, P1469, DOI 10.1242/jeb.01559; El-Tras WF, 2010, VET MICROBIOL, V141, P321, DOI 10.1016/j.vetmic.2009.09.017; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Florida Fish and Wildlife Conservation Commission, 2011, COLD REL MORT EV WIN; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Gutman M, 2011, ABC NEWS; Meagher EM, 2008, J COMP PHYSIOL B, V178, P529, DOI 10.1007/s00360-007-0245-5; MILLER WG, 1992, FISH B-NOAA, V90, P791; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Mitra S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049505; MMC, 1999, P MAR MAMM COMM WORK; Mobile Bay National Estuary Program, 2012, ENV MON DAUPH ISL; Murphy S., 2010, J NORTHWEST ATL FISH, V42, P153, DOI [10.2960/J.v42.m658, DOI 10.2960/J.V42.M658]; NOAA, 2011, NAT MAR MAMM HLTH ST; NOAA Fisheries Office of Protected Resources, 2011, NOAA FINDS BACT INF; NOAA Fisheries Office of Protected Resources, 2012, MAR MAMM UN MORT EV; NOAA Fisheries Office of Protected Resources, 2011, 2010 2011 CET UN MOR; NOAA Fisheries Office of Protected Resources, 2011, BRUC 2010 2011 CET U; Noren SR, 2009, J MAMMAL, V90, P629, DOI 10.1644/08-MAMM-A-138R.1; NRDA, 2012, NAT RES DAM ASS STAT, P53; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Quinlan P, 2010, PALM BEACH POST; SCHROEDER WW, 1990, ESTUARIES, V13, P145, DOI 10.2307/1351583; Scott M.D., 1990, P235; Semansky P, 2011, NATL GEOGRAPHIC; Slater GF, 2006, ORG GEOCHEM, V37, P981, DOI 10.1016/j.orggeochem.2006.06.014; Smultea Mari Ann, 1995, Aquatic Mammals, V21, P171; Struntz DJ, 2004, J MORPHOL, V259, P7, DOI 10.1002/jmor.10154; Tachibana M, 2006, J WILDLIFE DIS, V42, P412, DOI 10.7589/0090-3558-42.2.412; USGS, 2012, NAT WAT INF SYST WEB; Whitehead A, 2011, P NATL ACAD SCI USA, V108, P6193, DOI 10.1073/pnas.1017542108; Wilson B, 1999, P ROY SOC B-BIOL SCI, V266, P1077, DOI 10.1098/rspb.1999.0746; Worthy G, 1998, CHARACTERISTICS CAUS, V143, P47; Worthy G, 2006, HARBOR BRANCH OCEANO, V93, P27; Worthy G, 1992, 40WCNF202988 SE FISH; WORTHY GAJ, 1990, PHYSIOL ZOOL, V63, P432, DOI 10.1086/physzool.63.2.30158506; Yeates LC, 2008, J EXP BIOL, V211, P3249, DOI 10.1242/jeb.020610	41	45	47	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41155	10.1371/journal.pone.0041155	http://dx.doi.org/10.1371/journal.pone.0041155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815950	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900084
J	Elfstrom, KM; Stephenson, R				Elfstrom, K. Miriam; Stephenson, Rob			The Role of Place in Shaping Contraceptive Use among Women in Africa	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; CONTEXTUAL INFLUENCES; DOMESTIC VIOLENCE; MULTILEVEL MODELS; UTTAR-PRADESH; EASTERN CAPE; COMMUNITY; FAMILY; HOUSEHOLD; CHOICE	Background: Contraceptive prevalence is low in the African region despite considerable family planning programmatic efforts. This study is the first to examine how community factors shape contraceptive use for married women in an entire region, comparing results across 21 African countries with a DHS in the last 5 years. The analysis builds on previous studies through an examination of the individual, household and community level factors that shape contraceptive use. Methods: The data used in this analysis were from nationally representative Demographic and Health Surveys completed between 2005 and 2009. A separate multi-level logistic model was fitted for the outcome of current modern contraceptive use in each country. Results: After controlling for individual and household level factors, community level factors of demographics and fertility norms, gender norms and inequalities, and health knowledge remain significantly associated with contraceptive use, although the magnitude and direction of these community effects varied significantly across countries. Conclusions: The results highlight the importance of harnessing community level factors in planning interventions for increasing access to and utilization of modern contraceptive methods.	[Elfstrom, K. Miriam; Stephenson, Rob] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Elfstrom, KM (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	rbsteph@sph.emory.edu	Stephenson, Rob/J-9876-2012					Barnett B, 1999, NETWORK, V19, P4; Beyeza-Kashesy Jolly, 2010, Afr J Reprod Health, V14, P71; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Burgard SA, 2009, J HEALTH SOC BEHAV, V50, P293, DOI 10.1177/002214650905000304; Cammack M, 2001, POPUL RES POLICY REV, V20, P565, DOI 10.1023/A:1015659123964; Chacko E, 2001, HEALTH PLACE, V7, P197, DOI 10.1016/S1353-8292(01)00009-0; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Dinkelman T, 2007, AIDS, V21, pS49, DOI 10.1097/01.aids.0000300535.05226.a9; Diop-Sidibe N, 2006, SOC SCI MED, V62, P1260, DOI 10.1016/j.socscimed.2005.07.022; DIPRETE TA, 1994, ANNU REV SOCIOL, V20, P331, DOI 10.1146/annurev.so.20.080194.001555; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Entwisle B, 1996, DEMOGRAPHY, V33, P1, DOI 10.2307/2061709; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; Habibov NN, 2008, HEALTH POLICY PLANN, V23, P443, DOI 10.1093/heapol/czn032; Hong R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-79; Kaggwa EB, 2008, INT FAM PLAN PERSPEC, V34, P79, DOI 10.1363/ifpp.34.079.08; Kaye DK, 2006, QUAL HEALTH RES, V16, P1120, DOI 10.1177/1049732306292172; Kayembe PK, 2006, CONTRACEPTION, V74, P400, DOI 10.1016/j.contraception.2006.06.006; Mace R, 2009, AM J HUM BIOL, V21, P472, DOI 10.1002/ajhb.20940; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Magnani RJ, 1999, STUD FAMILY PLANN, V30, P120, DOI 10.1111/j.1728-4465.1999.00120.x; Omokhodion FO, 2007, J OBSTET GYNAECOL, V27, P612, DOI 10.1080/01443610701497785; Oye-Adeniran Boniface A, 2006, Afr J Reprod Health, V10, P90; Paek HJ, 2008, HEALTH EDUC BEHAV, V35, P461, DOI 10.1177/1090198106296769; Pebley AR, 1996, DEMOGRAPHY, V33, P231, DOI 10.2307/2061874; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Rutenberg N, 1997, STUD FAMILY PLANN, V28, P290, DOI 10.2307/2137860; Smith R, 2009, FAMILY PLANNING SAVE, V4th; Stephenson R, 2003, AM J PUBLIC HEALTH, V93, P1820, DOI 10.2105/AJPH.93.11.1820; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; Stephenson R, 2008, HEALTH PLACE, V14, P841, DOI 10.1016/j.healthplace.2008.01.005; Stephenson R, 2008, INT FAM PLAN PERSPEC, V34, P62, DOI 10.1363/ifpp.34.062.08; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; Stephenson R, 2006, STUD FAMILY PLANN, V37, P75, DOI 10.1111/j.1728-4465.2006.00087.x; *UN MILL PROJ, 2006, PUBL CHOIC PRIV DEC; United Nations Population Division, 2007, WORLD CONTR US 2007; Weldegerima B, 2008, RES SOC ADMIN PHARM, V4, P302, DOI 10.1016/j.sapharm.2007.10.001	43	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40670	10.1371/journal.pone.0040670	http://dx.doi.org/10.1371/journal.pone.0040670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815784	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900036
J	Kishore, D; Talat, M; Srivastava, ON; Kayastha, AM				Kishore, Devesh; Talat, Mahe; Srivastava, Onkar Nath; Kayastha, Arvind M.			Immobilization of beta-Galactosidase onto Functionalized Graphene Nano-sheets Using Response Surface Methodology and Its Analytical Applications	PLOS ONE			English	Article							NONDIGESTIBLE OLIGOSACCHARIDES; BIOCHEMICAL-PROPERTIES; ENZYME IMMOBILIZATION; LACTOSE; OXIDE; OPTIMIZATION; PURIFICATION; PERFORMANCE; OXIDATION	Background: beta-Galactosidase is a vital enzyme with diverse application in molecular biology and industries. It was covalently attached onto functionalized graphene nano-sheets for various analytical applications based on lactose reduction. Methodology/Principal Findings: Response surface methodology based on Box-Behnken design of experiment was used for determination of optimal immobilization conditions, which resulted in 84.2% immobilization efficiency. Native and immobilized functionalized graphene was characterized with the help of transmission and scanning electron microscopy, followed by Fourier transform infrared (FTIR) spectroscopy. Functionalized graphene sheets decorated with islands of immobilized enzyme were evidently visualized under both transmission and scanning electron microscopy after immobilization. FTIR spectra provided insight on various chemical interactions and bonding, involved during and after immobilization. Optimum temperature and energy of activation (E-a) remains unchanged whereas optimum pH and K-m were changed after immobilization. Increased thermal stability of enzyme was observed after conjugating the enzyme with functionalized graphene. Significance: Immobilized beta-galactosidase showed excellent reusability with a retention of more than 92% enzymatic activity after 10 reuses and an ideal performance at broad ranges of industrial environment.	[Kishore, Devesh; Kayastha, Arvind M.] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India; [Talat, Mahe; Srivastava, Onkar Nath] Banaras Hindu Univ, Dept Phys, Nanosci & Nanotechnol Unit, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Kishore, D (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	kayasthabhu@gmail.com		Kayastha, Arvind M./0000-0002-5090-7159	Department of Biotechnology (DBT), New Delhi, India	Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India)	(DK) would like to acknowledge the financial assistance from Department of Biotechnology (DBT), New Delhi, India, in the form of Junior and Senior research fellowships to carry out this work. The authors also thank Mr. H. Raghuvanshi for helping with graphene synthesis. The funding agency (DBT) had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Betancor L, 2008, BIOTECHNOL BIOENG, V99, P261, DOI 10.1002/bit.21570; Bielecka M, 2002, FOOD RES INT, V35, P139, DOI 10.1016/S0963-9969(01)00175-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown JN, 2012, BIORESOURCE TECHNOL, V103, P405, DOI 10.1016/j.biortech.2011.09.117; Chen CW, 2003, ENZYME MICROB TECH, V33, P497, DOI 10.1016/S0141-0229(03)00155-8; Cho YJ, 2003, BIOTECHNOL LETT, V25, P2107, DOI 10.1023/B:BILE.0000007077.58019.bb; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Dwevedi A, 2009, BIOSENS BIOELECTRON, V25, P784, DOI 10.1016/j.bios.2009.08.029; Dwevedi A, 2009, BIORESOURCE TECHNOL, V100, P2667, DOI 10.1016/j.biortech.2008.12.048; Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; Fogler H, 1999, ELEMENTS CHEM REACTI, V705; Gaur R, 2006, FOOD CHEM, V97, P426, DOI 10.1016/j.foodchem.2005.05.020; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Grbavcic S, 2011, BIORESOURCE TECHNOL, V102, P11226, DOI 10.1016/j.biortech.2011.09.076; Gu H, 2012, BIOSENS BIOELECTRON, V32, P118, DOI 10.1016/j.bios.2011.11.044; Ji ES, 2005, WORLD J MICROB BIOT, V21, P759, DOI 10.1007/s11274-004-5487-8; Kishore D, 2012, FOOD CHEM, V134, P1650, DOI 10.1016/j.foodchem.2012.03.055; Kishore D, 2012, FOOD CHEM, V134, P1113, DOI 10.1016/j.foodchem.2012.03.032; Kumari A, 2011, J MOL CATAL B-ENZYM, V69, P8, DOI 10.1016/j.molcatb.2010.12.003; Li ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015168; Maischberger T, 2008, CARBOHYD RES, V343, P2140, DOI 10.1016/j.carres.2008.01.040; McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800; Mussatto SI, 2007, CARBOHYD POLYM, V68, P587, DOI 10.1016/j.carbpol.2006.12.011; NAKAJIMA M, 1993, BIOPROCESS ENG, V9, P31, DOI 10.1007/BF00389537; Novalin S, 2005, J BIOTECHNOL, V119, P212, DOI 10.1016/j.jbiotec.2005.03.018; Park AR, 2010, APPL MICROBIOL BIOT, V85, P1279, DOI 10.1007/s00253-009-2356-2; Rivero-Urgell M, 2001, EARLY HUM DEV, V65, pS43, DOI 10.1016/S0378-3782(01)00202-X; Sako T, 1999, INT DAIRY J, V9, P69, DOI 10.1016/S0958-6946(99)00046-1; Sardar M, 2005, ENZYME MICROB TECH, V37, P355, DOI 10.1016/j.enzmictec.2005.03.007; Sassolas A, 2012, BIOTECHNOL ADV, V30, P489, DOI 10.1016/j.biotechadv.2011.09.003; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Song YS, 2010, FOOD CHEM, V123, P1, DOI 10.1016/j.foodchem.2010.04.043; Stankovich S, 2006, CARBON, V44, P3342, DOI 10.1016/j.carbon.2006.06.004; Staudenmaier L., 1898, EUR J INORG CHEM, V31, P1481, DOI 10.1002/cber.18980310237; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; TOMOMATSU H, 1994, FOOD TECHNOL-CHICAGO, V48, P61; Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6; Zhang F, 2010, J PHYS CHEM C, V114, P8469, DOI 10.1021/jp101073b; Zhang JL, 2010, LANGMUIR, V26, P6083, DOI 10.1021/la904014z; Zhang ST, 2010, APPL BIOCHEM BIOTECH, V160, P1386, DOI 10.1007/s12010-009-8600-5; Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005; Zhang YH, 2010, ACS NANO, V4, P7303, DOI 10.1021/nn1024219; Zhou QZK, 2001, BIOCHEM ENG J, V9, P33, DOI 10.1016/S1369-703X(01)00118-8	43	51	51	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40708	10.1371/journal.pone.0040708	http://dx.doi.org/10.1371/journal.pone.0040708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815797	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900039
J	Milner, DA; Pochet, N; Krupka, M; Williams, C; Seydel, K; Taylor, TE; Van de Peer, Y; Regev, A; Wirth, D; Daily, JP; Mesirov, JP				Milner, Danny A., Jr.; Pochet, Nathalie; Krupka, Malkie; Williams, Chris; Seydel, Karl; Taylor, Terrie E.; Van de Peer, Yves; Regev, Aviv; Wirth, Dyann; Daily, Johanna P.; Mesirov, Jill P.			Transcriptional Profiling of Plasmodium falciparum Parasites from Patients with Severe Malaria Identifies Distinct Low vs. High Parasitemic Clusters	PLOS ONE			English	Article							OCULAR FUNDUS FINDINGS; CEREBRAL MALARIA; CHILDREN; TRANSMISSION; DISCOVERY; NORMALIZATION; RETINOPATHY; INFECTION; REVEALS; STRESS	Background: In the past decade, estimates of malaria infections have dropped from 500 million to 225 million per year; likewise, mortality rates have dropped from 3 million to 791,000 per year. However, approximately 90% of these deaths continue to occur in sub-Saharan Africa, and 85% involve children less than 5 years of age. Malaria mortality in children generally results from one or more of the following clinical syndromes: severe anemia, acidosis, and cerebral malaria. Although much is known about the clinical and pathological manifestations of CM, insights into the biology of the malaria parasite, specifically transcription during this manifestation of severe infection, are lacking. Methods and Findings: We collected peripheral blood from children meeting the clinical case definition of cerebral malaria from a cohort in Malawi, examined the patients for the presence or absence of malaria retinopathy, and performed whole genome transcriptional profiling for Plasmodium falciparum using a custom designed Affymetrix array. We identified two distinct physiological states that showed highly significant association with the level of parasitemia. We compared both groups of Malawi expression profiles with our previously acquired ex vivo expression profiles of parasites derived from infected patients with mild disease; a large collection of in vitro Plasmodium falciparum life cycle gene expression profiles; and an extensively annotated compendium of expression data from Saccharomyces cerevisiae. The high parasitemia patient group demonstrated a unique biology with elevated expression of Hrd1, a member of endoplasmic reticulum-associated protein degradation system. Conclusions: The presence of a unique high parasitemia state may be indicative of the parasite biology of the clinically recognized hyperparasitemic severe disease syndrome.	[Milner, Danny A., Jr.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Milner, Danny A., Jr.; Wirth, Dyann] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Milner, Danny A., Jr.; Pochet, Nathalie; Williams, Chris; Regev, Aviv; Wirth, Dyann; Mesirov, Jill P.] Broad Inst, Infect Dis Initiat, Cambridge, MA USA; [Milner, Danny A., Jr.; Seydel, Karl; Taylor, Terrie E.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Pochet, Nathalie; Van de Peer, Yves] Univ Ghent, Dept Plant Syst Biol, B-9000 Ghent, Belgium; [Krupka, Malkie; Taylor, Terrie E.; Daily, Johanna P.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Krupka, Malkie; Taylor, Terrie E.; Daily, Johanna P.] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Seydel, Karl] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Malawi; Ghent University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Michigan State University; Michigan State University College of Osteopathic Medicine	Milner, DA (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	dmilner@partners.org	Mesirov, Jill/AGF-7626-2022; Milner, Danny/K-3568-2019; Van de Peer, Yves/D-4388-2009; Van de Peer, Yves/AAE-7666-2019; Pochet, Nathalie/Q-1322-2017	Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Pochet, Nathalie/0000-0003-1820-5656; Milner, Jr, Danny Arnold/0000-0002-6685-8208	The Broad Institute; National Institutes of Health (NIH) [5K23AI072033-05, 5R01AI077623-05, 5R01AI034969-14, K23AI079402, R01GM074024-07, R01CA121941]; Bill and Melinda Gates Foundation; Burroughs Wellcome Fund; Howard Hughes Medical Institute; Fund for Scientific Research - Flanders (FWO Vlaanderen), Belgium; NATIONAL CANCER INSTITUTE [R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI079402, R01AI077623, K23AI072033, R01AI034969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024] Funding Source: NIH RePORTER	The Broad Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fund for Scientific Research - Flanders (FWO Vlaanderen), Belgium(FWO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Broad Institute generously provided funding to AR, JPM, CW, and NP via internal competitive initiatives. The following individuals were supported by funds from National Institutes of Health (NIH): (DAM (5K23AI072033-05), JPD (5R01AI077623-05), TET (5R01AI034969-14), KBS (K23AI079402), JPM & CW (R01GM074024-07), JPM (R01CA121941), AR (NIH Director's Pioneer Award). Funding provided by the Bill and Melinda Gates Foundation supports the work of CW, DAM, and DFW. Additional funding is provided by the Burroughs Wellcome Fund to AR (Career Award at the Scientific Interface) and the Howard Hughes Medical Institute to AR. NP is supported by the Fund for Scientific Research - Flanders (FWO Vlaanderen), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of he mansuscript.	[Anonymous], GEN PATT SOFTW; Bahl A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-603; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1141, DOI 10.1001/archopht.122.8.1141; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brasseur P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-203; Bruce MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002775; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Gadiaga L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-312; Habluetzel A, 1999, TROP MED INT HEALTH, V4, P557, DOI 10.1046/j.1365-3156.1999.00455.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kikkert M, 2005, CURR TOP MICROBIOL, V300, P57; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lewallen S, 1999, T ROY SOC TROP MED H, V93, P619, DOI 10.1016/S0035-9203(99)90071-8; LEWALLEN S, 1993, OPHTHALMOLOGY, V100, P857, DOI 10.1016/S0161-6420(93)31563-0; Lewallen S, 2000, ARCH OPHTHALMOL-CHIC, V118, P924; Liu LJ, 2011, CELL RES, V21, P957, DOI 10.1038/cr.2010.181; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Mabunda S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-216; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Qi X, 2004, MOL BRAIN RES, V130, P30, DOI 10.1016/j.molbrainres.2004.07.013; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosenberg E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006991; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; White VA, 2001, T ROY SOC TROP MED H, V95, P618, DOI 10.1016/S0035-9203(01)90097-5; White VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004317; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Young JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-70; Zhang M, 2002, J EXP MED, V207, P1465; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40739	10.1371/journal.pone.0040739	http://dx.doi.org/10.1371/journal.pone.0040739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815802	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900040
J	Moholdt, T; Vold, MB; Grimsmo, J; Slordahl, SA; Wisloff, U				Moholdt, Trine; Vold, Mona Bekken; Grimsmo, Jostein; Slordahl, Stig Arild; Wisloff, Ulrik			Home-Based Aerobic Interval Training Improves Peak Oxygen Uptake Equal to Residential Cardiac Rehabilitation: A Randomized, Controlled Trial	PLOS ONE			English	Article							HEART-RATE RECOVERY; MYOCARDIAL-INFARCTION; FOLLOW-UP; EXERCISE; INTENSITY; SUPERIOR	Aerobic capacity, measured as the peak oxygen uptake, is a strong predictor of survival in cardiac patients. Aerobic interval training (AIT), walking/running four times four minutes at 85-95% of peak heart rate, has proven to be effective in increasing peak oxygen uptake in coronary heart disease patients. As some patients do not attend organized rehabilitation programs, home-based exercise should be an alternative. We investigated whether AIT could be performed effectively at home, and compared the effects on peak oxygen uptake with that observed after a standard care, four-week residential rehabilitation. Thirty patients undergoing coronary artery bypass surgery were randomized to residential rehabilitation or home-based AIT. At six months follow-up, peak oxygen uptake increased 4.6 (+/- 2.7) and 3.9 (+/- 3.6) mL.kg(-1) min(-1) (both p<0.005, non-significant between-group difference) after residential rehabilitation and AIT, respectively. Quality of life increased significantly in both groups, with no statistical significant difference between groups. We found no evidence for a different treatment effect between patients randomized to home-based AIT compared to patients attending organized rehabilitation (95% confidence interval -1.8, 3.5). AIT patients reported good adherence to exercise training. Even though these first data indicate positive effects of home-based AIT in patients undergoing coronary artery bypass surgery, more studies are needed to provide supporting evidence for the application of this rehabilitation strategy.	[Moholdt, Trine; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Moholdt, Trine] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Vold, Mona Bekken; Grimsmo, Jostein] Feiring Heart Clin, Feiringklinikken, Dept Cardiac Rehabil, Feiring, Norway; [Slordahl, Stig Arild] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Slordahl, Stig Arild] St Olavs Hosp, Dept Cardiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moholdt, T (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	trine.moholdt@ntnu.no	Moholdt, Trine/J-5884-2014; Wisloff, Ulrik/K-2899-2012; Moholdt, Trine/ABC-8674-2021	Moholdt, Trine/0000-0003-1024-8088; Wisloff, Ulrik/0000-0002-7211-3587	EXTRA funds from the Norwegian Foundation for Health and Rehabilitation	EXTRA funds from the Norwegian Foundation for Health and Rehabilitation	This study was financed with the aid of EXTRA funds from the Norwegian Foundation for Health and Rehabilitation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur HM, 2002, MED SCI SPORT EXER, V34, P1544, DOI 10.1097/00005768-200210000-00003; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Dalal HM, 2007, INT J CARDIOL, V119, P202, DOI 10.1016/j.ijcard.2006.11.018; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gormley SE, 2008, MED SCI SPORT EXER, V40, P1336, DOI 10.1249/MSS.0b013e31816c4839; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hofer S, 2006, EUR J CARDIOV PREV R, V13, P398, DOI 10.1097/01.hjr.0000201514.51461.64; Moholdt T, 2012, CLIN REHABIL, V26, P33, DOI 10.1177/0269215511405229; Moholdt T, 2011, INT J CARDIOL, V152, P388, DOI 10.1016/j.ijcard.2011.08.025; Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Vanhees Lucas, 2002, J Cardiopulm Rehabil, V22, P264, DOI 10.1097/00008483-200207000-00009; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Warburton DER, 2005, AM J CARDIOL, V95, P1080, DOI 10.1016/j.amjcard.2004.12.063; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041	20	63	66	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41199	10.1371/journal.pone.0041199	http://dx.doi.org/10.1371/journal.pone.0041199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815970	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900098
J	Song, YG; Ji, DD; Li, S; Wang, P; Li, Q; Xiang, FN				Song, Yuguang; Ji, Dandan; Li, Shuo; Wang, Peng; Li, Qiang; Xiang, Fengning			The Dynamic Changes of DNA Methylation and Histone Modifications of Salt Responsive Transcription Factor Genes in Soybean	PLOS ONE			English	Article							H3 LYSINE-9; STRESS TOLERANCE; CPG METHYLATION; ARABIDOPSIS; PROTEIN; ACETYLATION; PATTERNS; EXPRESSION; DROUGHT; ABA	Epigenetic modification contributes to the regulation of gene expression and plant development under salinity stress. Here we describe the identification of 49 soybean transcription factors by microarray analysis as being inducible by salinity stress. A semi-quantitative RT-PCR-based expression assay confirmed the salinity stress inducibility of 45 of these 49 transcription factors, and showed that ten of them were up-regulated when seedlings were exposed to the demethylation agent 5-aza-2-deoxycytidine. Salinity stress was shown to affect the methylation status of four of these ten transcription factors (one MYB, one b-ZIP and two AP2/DREB family members) using a combination of bisulfite sequencing and DNA methylation-sensitive DNA gel blot analysis. ChIP analysis indicated that the activation of three of the four DNA methylated transcription factors was correlated with an increased level of histone H3K4 trimethylation and H3K9 acetylation, and/or a reduced level of H3K9 demethylation in various parts of the promoter or coding regions. Our results suggest a critical role for some transcription factors' activation/repression by DNA methylation and/or histone modifications in soybean tolerance to salinity stress.	[Song, Yuguang; Ji, Dandan; Li, Shuo; Wang, Peng; Li, Qiang; Xiang, Fengning] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China	Shandong University	Song, YG (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China.	xfn0990@sdu.edu.cn	WANG, Peng/GSN-5263-2022		National Special Science Research Program of China [2007CB948203]; National Natural Science Foundation of China [30970243, 30771116]; Excellent Youth Foundation of Shandong Province of China [JQ200810]; Science & Technology Plan of Shandong Province [2009GG10002001]; Chinese Natural Education Ministry Doctor Station Foundation Fellowship [913111006]	National Special Science Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Shandong Province of China; Science & Technology Plan of Shandong Province; Chinese Natural Education Ministry Doctor Station Foundation Fellowship	This work was supported by the National Special Science Research Program of China (grant no. 2007CB948203) http://www.973.gov.cn/AreaMana.aspx; the National Natural Science Foundation of China (grant nos. 30970243 and 30771116) http://www.nsfc.gov.cn; Excellent Youth Foundation of Shandong Province of China (grant no. JQ200810) http://www.sdnsf.gov.cn/portal/; Science & Technology Plan of Shandong Province (grant 2009GG10002001) http://www.sdstc.gov.cn/index.jsp and the Chinese Natural Education Ministry Doctor Station Foundation Fellowship (grant no. 913111006) http://std.nankai.edu.cn/kyjh-bsd/1.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Chen M, 2009, J EXP BOT, V60, P121, DOI 10.1093/jxb/ern269; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Chinnusamy V, 2008, J INTEGR PLANT BIOL, V50, P1187, DOI 10.1111/j.1744-7909.2008.00727.x; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fahrner JA, 2002, CANCER RES, V62, P7213; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; Phang TH, 2008, J INTEGR PLANT BIOL, V50, P1196, DOI 10.1111/j.1744-7909.2008.00760.x; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shibukawa T, 2009, GENE, V437, P22, DOI 10.1016/j.gene.2009.02.011; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Xia R, 2006, PLANT CELL, V18, P85, DOI 10.1105/tpc.105.037507; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhu JK, 2008, CELL, V133, P395, DOI 10.1016/j.cell.2008.04.016; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	53	138	161	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41274	10.1371/journal.pone.0041274	http://dx.doi.org/10.1371/journal.pone.0041274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815985	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900105
J	Strug, LJ; Addis, L; Chiang, T; Baskurt, Z; Li, WL; Clarke, T; Hardison, H; Kugler, SL; Mandelbaum, DE; Novotny, EJ; Wolf, SM; Pal, DK				Strug, Lisa J.; Addis, Laura; Chiang, Theodore; Baskurt, Zeynep; Li, Weili; Clarke, Tara; Hardison, Huntley; Kugler, Steven L.; Mandelbaum, David E.; Novotny, Edward J.; Wolf, Steven M.; Pal, Deb K.			The Genetics of Reading Disability in an Often Excluded Sample: Novel Loci Suggested for Reading Disability in Rolandic Epilepsy	PLOS ONE			English	Article							SPEECH-SOUND DISORDER; LOD-SCORE; LINKAGE ANALYSIS; I ERROR; DYSLEXIA; RISK; SCHIZOPHRENIA; DISC1; EEG; HETEROGENEITY	Background: Reading disability (RD) is a common neurodevelopmental disorder with genetic basis established in families segregating "pure" dyslexia. RD commonly occurs in neurodevelopmental disorders including Rolandic Epilepsy (RE), a complex genetic disorder. We performed genomewide linkage analysis of RD in RE families, testing the hypotheses that RD in RE families is genetically heterogenenous to pure dyslexia, and shares genetic influences with other sub-phenotypes of RE. Methods: We initially performed genome-wide linkage analysis using 1000 STR markers in 38 US families ascertained through a RE proband; most of these families were multiplex for RD. We analyzed the data by two-point and multipoint parametric LOD score methods. We then confirmed the linkage evidence in a second US dataset of 20 RE families. We also resequenced the SEMA3C gene at the 7q21 linkage locus in members of one multiplex RE/RD pedigree and the DISC1 gene in affected pedigrees at the 1q42 locus. Results: In the discovery dataset there was suggestive evidence of linkage for RD to chromosome 7q21 (two-point LOD score 3.05, multipoint LOD 3.08) and at 1q42 (two-point LOD 2.87, multipoint LOD 3.03). Much of the linkage evidence at 7q21 derived from families of French-Canadian origin, whereas the linkage evidence at 1q42 was well distributed across all the families. There was little evidence for linkage at known dyslexia loci. Combining the discovery and confirmation datasets increased the evidence at 1q42 (two-point LOD = 3.49, multipoint HLOD = 4.70), but decreased evidence at 7q21 (two-point LOD = 2.28, multipoint HLOD = 1.81), possibly because the replication sample did not have French Canadian representation. Discussion: Reading disability in rolandic epilepsy has a genetic basis and may be influenced by loci at 1q42 and, in some populations, at 7q21; there is little evidence of a role for known DYX loci discovered in "pure" dyslexia pedigrees. 1q42 and 7q21 are candidate novel dyslexia loci.	[Strug, Lisa J.; Chiang, Theodore; Baskurt, Zeynep; Li, Weili] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Strug, Lisa J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Addis, Laura; Pal, Deb K.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England; [Clarke, Tara] Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Hardison, Huntley] St Christophers Hosp Children, Philadelphia, PA 19133 USA; [Kugler, Steven L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kugler, Steven L.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Mandelbaum, David E.] Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Mandelbaum, David E.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Novotny, Edward J.] Yale Univ, Med Ctr, New Haven, CT USA; [Wolf, Steven M.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Pal, Deb K.] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of London; King's College London; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Brown University; Hasbro Children's Hospital; Brown University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Columbia University	Strug, LJ (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deb.pal@kcl.ac.uk	Addis, Laura/R-1385-2016; Novotny, Edward J./ABG-9577-2021	Addis, Laura/0000-0001-8455-4278; Strug, Lisa/0000-0003-0503-9740; Novotny, Edward/0000-0001-9726-0447	American Epilepsy Society; Epilepsy Foundation; Anna and Jim Fantaci; Fight Against Childhood Epilepsy and Seizures (f.a.c.e.s); Neurotherapy Ventures Charitable Research Fund; Parents Against Childhood Epilepsy (P.A.C.E.); National Institutes of Health [NS27941, NS047530]; Human Genome Research Institute [HG004314]; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation; European Union Marie Curie Reintegration Award; Waterloo Foundation; Charles Sykes Epilepsy Research Trust; National Institute of Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health of South London and Maudsley; National Health Service (NHS) Foundation Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG004314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047530, R01NS027941] Funding Source: NIH RePORTER	American Epilepsy Society; Epilepsy Foundation; Anna and Jim Fantaci; Fight Against Childhood Epilepsy and Seizures (f.a.c.e.s); Neurotherapy Ventures Charitable Research Fund; Parents Against Childhood Epilepsy (P.A.C.E.); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Genome Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); European Union Marie Curie Reintegration Award; Waterloo Foundation; Charles Sykes Epilepsy Research Trust; National Institute of Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health of South London and Maudsley(National Institute for Health Research (NIHR)); National Health Service (NHS) Foundation Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Partnership for Pediatric Epilepsy Research, which includes the American Epilepsy Society, the Epilepsy Foundation, Anna and Jim Fantaci, Fight Against Childhood Epilepsy and Seizures (f.a.c.e.s), Neurotherapy Ventures Charitable Research Fund, and Parents Against Childhood Epilepsy (P.A.C.E.) (DKP); the Epilepsy Foundation through the generous support of the Charles L. Shor Foundation for Epilepsy Research, Inc (DKP); National Institutes of Health grants NS27941 (DAG), NS047530 (DKP); and HG004314 (LJS) from the Human Genome Research Institute (LJS); Natural Sciences and Engineering Research Council of Canada and the Ontario Ministry of Research and Innovation Early Researcher Award program (LJS); European Union Marie Curie Reintegration Award (DKP); Waterloo Foundation (DKP); Charles Sykes Epilepsy Research Trust (DKP); National Institute of Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health of South London and Maudsley National Health Service (NHS) Foundation Trust (DKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu PC, 2002, GENET EPIDEMIOL, V22, P156, DOI 10.1002/gepi.0155; Bali B, 2005, ANN NEUROL, V57, P464, DOI 10.1002/ana.20399; Burdick KE, 2005, NEUROREPORT, V16, P1399, DOI 10.1097/01.wnr.0000175248.25535.f6; Burke MS, 1997, J CHILD NEUROL, V12, P148; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Clarke T, 2007, EPILEPSIA, V48, P2258; Clarke T, 2009, EPILEPSIA, V50, P2428, DOI 10.1111/j.1528-1167.2009.02240.x; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; Gayan J, 2005, J CHILD PSYCHOL PSYC, V46, P1045, DOI 10.1111/j.1469-7610.2005.01447.x; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hinshelwood J., 1907, BMJ-BRIT MED J, V1, P608; Hodge SE, 1997, AM J HUM GENET, V60, P217; Kaplan E, 2001, BOSTON NAMING TEST; Kavros PM, 2008, EPILEPSIA, V49, P1570, DOI 10.1111/j.1528-1167.2008.01610.x; Kilpinen H, 2007, MOL PSYCHIAT; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Pal DK, 2010, GENES BRAIN BEHAV, V9, P1004, DOI 10.1111/j.1601-183X.2010.00648.x; Pal DK, 2011, CURR OPIN NEUROL, V24, P126, DOI 10.1097/WCO.0b013e328344634a; Pal DK, 2001, EUR J HUM GENET, V9, P855, DOI 10.1038/sj.ejhg.5200724; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; PENNINGTON BF, 1990, J CHILD PSYCHOL PSYC, V31, P193, DOI 10.1111/j.1469-7610.1990.tb01561.x; Roberts RC, 2007, SCHIZOPHRENIA BULL, V33, P11, DOI 10.1093/schbul/sbl063; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Smith AB, 2012, EPILEPSIA, V53, P705, DOI 10.1111/j.1528-1167.2011.03371.x; Smith SD, 2005, J CHILD PSYCHOL PSYC, V46, P1057, DOI 10.1111/j.1469-7610.2005.01534.x; Staden U, 1998, NEUROPEDIATRICS, V29, P242, DOI 10.1055/s-2007-973569; Stein CM, 2006, BEHAV GENET, V36, P858, DOI 10.1007/s10519-006-9090-7; Stein CM, 2004, AM J HUM GENET, V74, P283, DOI 10.1086/381562; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; Strug LJ, 2009, EUR J HUM GENET, V17, P1171, DOI 10.1038/ejhg.2008.267; Torgesen J.K., 1999, TOWRE TEST WORD READ; Vaughn BV, 1996, PEDIATR NEUROL, V15, P261, DOI 10.1016/S0887-8994(96)00175-0; VOGLER GP, 1985, J LEARN DISABIL, V18, P419, DOI 10.1177/002221948501800711; Wiederholt J.L., 2001, GRAY ORAL READING TE; Woodcock R, 2001, WOODCOCK JOHNSON 3 E; Yale W, 1975, J CHILD PSYCHOL PSYC, V16, P181	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40696	10.1371/journal.pone.0040696	http://dx.doi.org/10.1371/journal.pone.0040696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815793	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900038
J	Andersson, R; Johnston, A; Fisahn, A				Andersson, Richard; Johnston, April; Fisahn, Andre			Dopamine D4 Receptor Activation Increases Hippocampal Gamma Oscillations by Enhancing Synchronization of Fast-Spiking Interneurons	PLOS ONE			English	Article							IN-VITRO; WORKING-MEMORY; D-4 RECEPTORS; FREQUENCY OSCILLATIONS; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; NMDA RECEPTORS; SCHIZOPHRENIA; MECHANISMS	Background: Gamma oscillations are electric activity patterns of the mammalian brain hypothesized to serve attention, sensory perception, working memory and memory encoding. They are disrupted or altered in schizophrenic patients with associated cognitive deficits, which persist in spite of treatment with antipsychotics. Because cognitive symptoms are a core feature of schizophrenia it is relevant to explore signaling pathways that potentially regulate gamma oscillations. Dopamine has been reported to decrease gamma oscillation power via D1-like receptors. Based on the expression pattern of D4 receptors (D4R) in hippocampus, and pharmacological effects of D4R ligands in animals, we hypothesize that they are in a position to regulate gamma oscillations as well. Methodology/Principal Findings: To address this hypothesis we use rat hippocampal slices and kainate-induced gamma oscillations. Local field potential recordings as well as intracellular recordings of pyramidal cells, fast-spiking and non-fast-spiking interneurons were carried out. We show that D4R activation with the selective ligand PD168077 increases gamma oscillation power, which can be blocked by the D4R-specific antagonist L745,870 as well as by the antipsychotic drug Clozapine. Pyramidal cells did not exhibit changes in excitatory or inhibitory synaptic current amplitudes, but inhibitory currents became more coherent with the oscillations after application of PD168077. Fast-spiking, but not non-fast spiking, interneurons, increase their action potential phase-coupling and coherence with regard to ongoing gamma oscillations in response to D4R activation. Among several possible mechanisms we found that the NMDA receptor antagonist AP5 also blocks the D4R mediated increase in gamma oscillation power. Conclusions/Significance: We conclude that D4R activation affects fast-spiking interneuron synchronization and thereby increases gamma power by an NMDA receptor-dependent mechanism. This suggests that converging deficits on fast-spiking interneurons may lead to decreased network function and thus aberrant gamma oscillations and cognitive decline in schizophrenia.	[Andersson, Richard; Johnston, April; Fisahn, Andre] Karolinska Inst, Dept Neurobiol Care Sci & Soc, KI Alzheimer Dis Res Ctr, Neuronal Oscillat Lab, Stockholm, Sweden	Karolinska Institutet	Andersson, R (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, KI Alzheimer Dis Res Ctr, Neuronal Oscillat Lab, Stockholm, Sweden.	andre.fisahn@ki.se	Andersson, Richard/C-1579-2013	Andersson, Richard/0000-0003-1108-8397	Karolinska Institute; Sweden-Japan Foundation; Swedish Society for Medical Research (Svenska Sallskapet for Medicinsk Forskning); Karolinska Institute/NIH Graduate Partnerships Program; Swedish Research Council (Vetenskapsradet); Swedish Medical Association (Svenska Lakaresallskapet); Brain Fund (Hjarnfonden); KI-Strategic Program in Neurosciences	Karolinska Institute(Karolinska Institutet); Sweden-Japan Foundation; Swedish Society for Medical Research (Svenska Sallskapet for Medicinsk Forskning); Karolinska Institute/NIH Graduate Partnerships Program; Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Medical Association (Svenska Lakaresallskapet); Brain Fund (Hjarnfonden); KI-Strategic Program in Neurosciences	This research was supported by a KID PhD studentship from the Karolinska Institute, the Sweden-Japan Foundation, the Swedish Society for Medical Research (Svenska Sallskapet for Medicinsk Forskning) (R. A.), the Karolinska Institute/NIH Graduate Partnerships Program (A. J.), and grants from the Swedish Research Council (Vetenskapsradet), the Swedish Medical Association (Svenska Lakaresallskapet), the Brain Fund (Hjarnfonden), the KI-Strategic Program in Neurosciences and the Karolinska Institute (A. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2010, J PHYSIOL-LONDON, V588, P1241, DOI 10.1113/jphysiol.2009.180984; Ariano MA, 1997, BRAIN RES, V752, P26, DOI 10.1016/S0006-8993(96)01422-9; Barr MS, 2010, SCHIZOPHR RES, V121, P146, DOI 10.1016/j.schres.2010.05.023; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Berens P., 2009, J STAT SOFTWARE, V31; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Corrigan MH, 2004, BIOL PSYCHIAT, V55, P445, DOI 10.1016/j.biopsych.2003.10.004; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Defagot MC, 1997, MOL BRAIN RES, V45, P1, DOI 10.1016/S0169-328X(96)00235-5; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Faulkner HJ, 1998, BRIT J PHARMACOL, V125, P483, DOI 10.1038/sj.bjp.0702113; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fisher N., 1995, STAT ANAL CIRCULAR D; Flynn G, 2008, SCHIZOPHR RES, V105, P262, DOI 10.1016/j.schres.2008.05.029; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Gisabella B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032483; Gouwens NW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000951; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Graziane NM, 2009, J BIOL CHEM, V284, P8329, DOI 10.1074/jbc.M807387200; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Herwerth M, 2011, CEREB CORTE IN PRESS; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Konradi C, 2011, SCHIZOPHR RES, V131, P165, DOI 10.1016/j.schres.2011.06.007; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Kramer MS, 1997, ARCH GEN PSYCHIAT, V54, P567; Leao RN, 2009, J NEUROSCI, V29, P13353, DOI 10.1523/JNEUROSCI.1463-09.2009; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; Oren I, 2010, J PHYSIOL-LONDON, V588, P785, DOI 10.1113/jphysiol.2009.180851; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Rivera A, 2008, NEUROSCIENCE, V155, P997, DOI 10.1016/j.neuroscience.2008.05.060; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Shin RM, 2003, J NEUROSCI, V23, P11662; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sood P, 2011, J PSYCHOPHARMACOL, V25, P792, DOI 10.1177/0269881110387840; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Truffinet P, 1999, AM J PSYCHIAT, V156, P419; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Van Drongelen W., 2018, SIGNAL PROCESSING NE, DOI 10.1016/B978-0-12-370867-0.X5000-1; van Vugt MK, 2010, J NEUROSCI, V30, P2694, DOI 10.1523/JNEUROSCI.0567-09.2010; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Wang X, 2003, J NEUROSCI, V23, P9852; Weiss T, 2003, EUR J NEUROSCI, V18, P2573, DOI 10.1046/j.1460-9568.2003.02970.x; Wojtowicz AM, 2009, HIPPOCAMPUS, V19, P273, DOI 10.1002/hipo.20508; Wong AHC, 2003, PROG NEURO-PSYCHOPH, V27, P1091, DOI 10.1016/j.pnpbp.2003.09.005; Woo TUW, 2010, HARVARD REV PSYCHIAT, V18, P173, DOI 10.3109/10673221003747609; Yuen EY, 2009, J NEUROSCI, V29, P550, DOI 10.1523/JNEUROSCI.5050-08.2009	58	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40906	10.1371/journal.pone.0040906	http://dx.doi.org/10.1371/journal.pone.0040906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815864	gold, Green Published			2022-12-27	WOS:000306507000041
J	Koole, O; Kalenga, L; Kiumbu, M; Menten, J; Ryder, RW; Mukumbi, H; Colebunders, R				Koole, Olivier; Kalenga, Lucien; Kiumbu, Modeste; Menten, Joris; Ryder, Robert W.; Mukumbi, Henri; Colebunders, Robert			Retention in a NGO Supported Antiretroviral Program in the Democratic Republic of Congo	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; THERAPY PROGRAMS; FOLLOW-UP; SCALE-UP; LOW-INCOME; OUTCOMES; MORTALITY; SURVIVAL; CARE	Background: Retention of patients in ART care is a major challenge in sub-Saharan programs. Retention is also one of the key indicators to evaluate the success of ART programs. Methods and Findings: A retrospective review of 1500 randomly selected medical charts of adult ART patients from a local non-governmental (NGO) supported ART program in the Democratic Republic of Congo (DRC). Retention was defined as any visit to the clinic in the 4 months prior to the abstraction date. Retention over time and across different sites was described. The relationship between patient characteristics and retention rates at 1 year was also examined. 1450 patients were included in the analysis. The overall retention rates were 81.4% (95% CI: 79.3-83.4), 75.2% (95% CI: 72.8-77.3), 65.0% (95% CI: 62.3-67.6) and 57.2% (95% CI: 54.0-60.3) at 6 months, 1 year, 2 years and 3 years respectively. The retention rates between sites varied between 62.1% and 90.6% at 6 months and between 55.5% and 86.2% at 1 year. During multivariable analysis weight below 50 kg (aHR: 1.33, 95% CI: 1.05-1.69), higher WHO stage at initiation (aHR: 1.22, 95% CI 0.85-1.76 for stage 3 and aHR: 2.98, 95% CI: 1.93-4.59 for stage 4), and male sex (aHR: 1.32, 95% CI: 1.05-1.65) remained as significant risk factors for attrition during the first year after ART initiation. Other independent risk factors were year of initiation (aHR: 1.73, 95% CI: 1.26-2.38 for the year 2007 and aHR: 3.06, 95% CI: 2.26-4.14 for the period 2008-2009), and site. Conclusions: Retention is a major problem in DRC, while coverage of patients on ART is still very low. With the flattening of funding for HIV care and treatment in sub-Saharan Africa, and with decreasing funding worldwide, maximizing retention during the much needed scaling-up will even be more important.	[Koole, Olivier; Menten, Joris; Colebunders, Robert] Inst Trop Med, B-2000 Antwerp, Belgium; [Kalenga, Lucien; Mukumbi, Henri] AmoCongo, Lubumbashi, DEM REP CONGO; [Kalenga, Lucien; Kiumbu, Modeste; Mukumbi, Henri] Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Ryder, Robert W.] Univ Calif San Diego, Div Hosp Med, San Diego, CA 92103 USA; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of California System; University of California San Diego; University of Antwerp	Koole, O (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	olivierkoole@yahoo.com		Koole, Olivier/0000-0002-1122-5382	Flemish Interuniversity Council [ZRDC 2007 MP037]	Flemish Interuniversity Council	The study was funded by the Flemish Interuniversity Council (ZRDC 2007 MP037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Boyles TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019201; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Ministere du plan et Macro International, 2007, ENQ DEM SANT; MSF Campaign for access to essential medicines, 2009, PUN SUCC EARLY SIGNS; MSF Campaign for access to essential medicines, 2010, 10 CONS AIDS TREATM; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Programme National Multisectoriel de Lutte contre le SIDA (PNMLS), 2010, RAPP NAT SUIV DECL E; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2011, TREATM 2 0 FRAM ACT; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	28	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40971	10.1371/journal.pone.0040971	http://dx.doi.org/10.1371/journal.pone.0040971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815883	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000306507000047
J	Stoddard, MC; Fayet, AL; Kilner, RM; Hinde, CA				Stoddard, Mary Caswell; Fayet, Annette L.; Kilner, Rebecca M.; Hinde, Camilla A.			Egg Speckling Patterns Do Not Advertise Offspring Quality or Influence Male Provisioning in Great Tits	PLOS ONE			English	Article							MUTUAL MATE CHOICE; SEXUAL SELECTION; EGGSHELL COLORATION; PATERNAL INVESTMENT; FICEDULA-HYPOLEUCA; PIED FLYCATCHERS; CUCULUS-CANORUS; COMMON CUCKOO; AVIAN EGGS; BLUE	Many passerine birds lay white eggs with reddish brown speckles produced by protoporphyrin pigment. However, the function of these spots is contested. Recently, the sexually selected eggshell coloration (SSEC) hypothesis proposed that eggshell color is a sexually selected signal through which a female advertises her quality (and hence the potential quality of her future young) to her male partner, thereby encouraging him to contribute more to breeding attempts. We performed a test of the SSEC hypothesis in a common passerine, the great tit Parus major. We used a double cross-fostering design to determine whether males change their provisioning behavior based on eggshell patterns they observe at the nest. We also tested the assumption that egg patterning reflects female and/or offspring quality. Because birds differ from humans in their color and pattern perception, we used digital photography and models of bird vision to quantify egg patterns objectively. Neither male provisioning nor chick growth was related to the pattern of eggs males observed during incubation. Although heavy females laid paler, less speckled eggs, these eggs did not produce chicks that grew faster. Therefore, we conclude that the SSEC hypothesis is an unlikely explanation for the evolution of egg speckling in great tits.	[Stoddard, Mary Caswell; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Cambridge, England; [Fayet, Annette L.] Univ Oxford, Dept Zool, Oxford Nav Grp, Oxford OX1 3PS, England; [Hinde, Camilla A.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Cambridge; University of Oxford; University of Oxford	Stoddard, MC (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	mcs66@cam.ac.uk	Hinde, Camilla/G-4023-2012; Kilner, Rebecca/B-2867-2012; Hinde, Camilla/AAF-1597-2019	Hinde, Camilla/0000-0001-9376-4023; Kilner, Rebecca/0000-0003-1159-0758; Hinde, Camilla/0000-0001-9376-4023; Fayet, Annette/0000-0001-6373-0500	Environmental Protection Agency; Gonville and Caius College, Cambridge; National Science Foundation; Hanne and Torkel Weis-Fogh Fund; Erasmus Scholarship for European Internships; Newnham College, Cambridge; ERC [ADG 250164]	Environmental Protection Agency(United States Environmental Protection Agency); Gonville and Caius College, Cambridge; National Science Foundation(National Science Foundation (NSF)); Hanne and Torkel Weis-Fogh Fund; Erasmus Scholarship for European Internships; Newnham College, Cambridge; ERC(European Research Council (ERC)European Commission)	MCS was supported by a Marshall Scholarship, the Marshall Scholar-Environmental Protection Agency Partnership, Gonville and Caius College, Cambridge, a National Science Foundation Graduate Research Fellowship, and the Hanne and Torkel Weis-Fogh Fund. ALF was supported by an Erasmus Scholarship for European Internships. CAH was supported by a Junior Research Fellowship at Newnham College, Cambridge, and an ERC grant (ADG 250164) awarded to Ben Sheldon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles JM, 2008, P ROY SOC B-BIOL SCI, V275, P2345, DOI 10.1098/rspb.2008.0720; Aviles JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P1721, DOI 10.1007/s00265-011-1180-8; BAIRD T, 1975, BRIT POULTRY SCI, V16, P201, DOI 10.1080/00071667508416177; BAKKEN GS, 1978, SCIENCE, V200, P321, DOI 10.1126/science.200.4339.321; Berg EC, 2009, J AVIAN BIOL, V40, P448, DOI 10.1111/j.1600-048X.2008.04632.x; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Bruce V., 2003, VISUAL PERCEPTION PH, V4th; Bulla M, 2012, AUK, V129, P26, DOI 10.1525/auk.2012.11090; Cassey P, 2008, BIOL LETTERS, V4, P515, DOI 10.1098/rsbl.2008.0279; Cassey P, 2009, CURR BIOL, V19, pR1083, DOI 10.1016/j.cub.2009.10.014; Cassey P, 2009, IBIS, V151, P689, DOI 10.1111/j.1474-919X.2009.00953.x; Cherry MI, 2010, BIOL J LINN SOC, V100, P753, DOI 10.1111/j.1095-8312.2010.01457.x; Chiao CC, 2009, VISION RES, V49, P1647, DOI 10.1016/j.visres.2009.04.002; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; De Coster G, 2012, OECOLOGIA, V170, P297, DOI 10.1007/s00442-012-2304-1; English PA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1029, DOI 10.1007/s00265-010-1107-9; Garcia-Navas V, 2011, J ORNITHOL, V152, P71, DOI 10.1007/s10336-010-0551-7; GOSLER A, 1987, ARDEA, V75, P91; Gosler A, 1993, GREAT TIT; GOSLER AG, 1987, IBIS, V129, P451, DOI 10.1111/j.1474-919X.1987.tb08234.x; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Gosler AG, 2011, AVIAN BIOL RES, V4, P214, DOI 10.3184/175815511X13207833399666; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hanley D, 2009, BEHAV ECOL SOCIOBIOL, V63, P719, DOI 10.1007/s00265-008-0705-2; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Heeb P, 2003, ANIM BEHAV, V66, P637, DOI 10.1006/anbe.2003.2238; Higham JP, 2006, OECOLOGIA, V149, P561, DOI 10.1007/s00442-006-0484-2; Hinde CA, 2006, BEHAV ECOL, V17, P6, DOI 10.1093/beheco/ari092; Hinde CA, 2007, P ROY SOC B-BIOL SCI, V274, P53, DOI 10.1098/rspb.2006.3692; Holveck MJ, 2010, BIOL LETTERS, V6, P453, DOI 10.1098/rsbl.2009.1044; Honza M, 2011, NATURWISSENSCHAFTEN, V98, P493, DOI 10.1007/s00114-011-0790-3; Ishikawa S, 2010, FEBS LETT, V584, P770, DOI 10.1016/j.febslet.2009.12.041; Jagannath A, 2008, J APPL ECOL, V45, P133, DOI 10.1111/j.1365-2664.2007.01386.x; Johnsen A, 2011, ETHOLOGY, V117, P309, DOI 10.1111/j.1439-0310.2011.01876.x; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jones CD, 2004, VISION RES, V44, P83, DOI 10.1016/j.visres.2003.08.014; Sanz JJ, 2009, J ANIM ECOL, V78, P31, DOI 10.1111/j.1365-2656.2008.01465.x; Jourdie V, 2004, NATURE, V431, P262, DOI 10.1038/431262a; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; Krist M, 2007, BEHAV ECOL SOCIOBIOL, V61, P863, DOI 10.1007/s00265-006-0315-9; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Langmore NE, 2005, BEHAV ECOL, V16, P686, DOI 10.1093/beheco/ari041; Lind O, 2009, J EXP BIOL, V212, P3693, DOI 10.1242/jeb.035477; Lind O, 2009, VISION RES, V49, P1939, DOI 10.1016/j.visres.2009.05.003; de Hierro MDGL, 2010, J ORNITHOL, V151, P833, DOI 10.1007/s10336-010-0520-1; Magi M, 2012, J ORNITHOL, V153, P645, DOI 10.1007/s10336-011-0782-2; Martinez-de la Puente J, 2007, J AVIAN BIOL, V38, P377, DOI 10.1111/j.0908-8857.2007.03877.x; Maurer G, 2011, J ZOOL, V285, P194, DOI 10.1111/j.1469-7998.2011.00830.x; MCCOMB WC, 1981, J WILDLIFE MANAGE, V45, P284, DOI 10.2307/3807906; Michler SPM, 2010, BEHAVIOUR, V147, P1355, DOI 10.1163/000579510X517208; Moreno J, 2005, BEHAV ECOL, V16, P931, DOI 10.1093/beheco/ari072; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; Moreno J, 2008, ETHOLOGY, V114, P1078, DOI 10.1111/j.1439-0310.2008.01551.x; Moreno J, 2006, J AVIAN BIOL, V37, P555, DOI 10.1111/j.2006.0908-8857.03915.x; Naef-Daenzer L, 2000, J AVIAN BIOL, V31, P206, DOI 10.1034/j.1600-048X.2000.310212.x; Pike TW, 2011, AVIAN BIOL RES, V4, P231, DOI 10.3184/175815511X13228268534598; Reynolds SJ, 2009, ANIM BEHAV, V78, P209, DOI 10.1016/j.anbehav.2009.03.003; Riehl C, 2011, AUK, V128, P175, DOI 10.1525/auk.2011.10171; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; Soler JJ, 2005, EVOLUTION, V59, P636; Soler JJ, 2008, AM NAT, V171, P183, DOI 10.1086/524958; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stoddard MC, 2011, AVIAN BIOL RES, V4, P196, DOI 10.3184/175815511X13207484398647; Stoddard MC, 2011, EVOLUTION, V65, P2004, DOI 10.1111/j.1558-5646.2011.01262.x; Stoddard MC, 2010, P ROY SOC B-BIOL SCI, V277, P1387, DOI 10.1098/rspb.2009.2018; Underwood T.J., 2002, AVIAN INCUBATION BEH; Verhulst S, 1996, J EVOLUTION BIOL, V9, P771, DOI 10.1046/j.1420-9101.1996.9060771.x; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P1271, DOI 10.1098/rspb.2001.1661; Walters LA, 2010, J FIELD ORNITHOL, V81, P155, DOI 10.1111/j.1557-9263.2010.00273.x; Westmoreland D, 2008, J FIELD ORNITHOL, V79, P263, DOI 10.1111/j.1557-9263.2008.00172.x	74	34	34	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40211	10.1371/journal.pone.0040211	http://dx.doi.org/10.1371/journal.pone.0040211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815730	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000012
J	Tang, XS; Freitak, D; Vogel, H; Ping, LY; Shao, YQ; Cordero, EA; Andersen, G; Westermann, M; Heckel, DG; Boland, W				Tang, Xiaoshu; Freitak, Dalial; Vogel, Heiko; Ping, Liyan; Shao, Yongqi; Cordero, Erika Arias; Andersen, Gary; Westermann, Martin; Heckel, David G.; Boland, Wilhelm			Complexity and Variability of Gut Commensal Microbiota in Polyphagous Lepidopteran Larvae	PLOS ONE			English	Article							BACTERIAL ENDOSYMBIONTS; ANTIBIOTIC-TREATMENT; IMMUNE HOMEOSTASIS; DIGESTIVE-TRACT; MANDUCA-SEXTA; DIVERSITY; INSECT; DROSOPHILA; COMMUNITY; MICROARRAY	Background: The gut of most insects harbours nonpathogenic microorganisms. Recent work suggests that gut microbiota not only provide nutrients, but also involve in the development and maintenance of the host immune system. However, the complexity, dynamics and types of interactions between the insect hosts and their gut microbiota are far from being well understood. Methods/Principal Findings: To determine the composition of the gut microbiota of two lepidopteran pests, Spodoptera littoralis and Helicoverpa armigera, we applied cultivation-independent techniques based on 16S rRNA gene sequencing and microarray. The two insect species were very similar regarding high abundant bacterial families. Different bacteria colonize different niches within the gut. A core community, consisting of Enterococci, Lactobacilli, Clostridia, etc. was revealed in the insect larvae. These bacteria are constantly present in the digestion tract at relatively high frequency despite that developmental stage and diet had a great impact on shaping the bacterial communities. Some low-abundant species might become dominant upon loading external disturbances; the core community, however, did not change significantly. Clearly the insect gut selects for particular bacterial phylotypes. Conclusions: Because of their importance as agricultural pests, phytophagous Lepidopterans are widely used as experimental models in ecological and physiological studies. Our results demonstrated that a core microbial community exists in the insect gut, which may contribute to the host physiology. Host physiology and food, nevertheless, significantly influence some fringe bacterial species in the gut. The gut microbiota might also serve as a reservoir of microorganisms for ever-changing environments. Understanding these interactions might pave the way for developing novel pest control strategies.	[Tang, Xiaoshu; Ping, Liyan; Shao, Yongqi; Cordero, Erika Arias; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Freitak, Dalial; Vogel, Heiko; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Andersen, Gary] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Ctr Environm Biol & Mol Microbial Ecol, Berkeley, CA 94720 USA; [Westermann, Martin] Univ Jena, Univ Hosp, Ctr Electron Microscopy, Jena, Germany	Max Planck Society; Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Friedrich Schiller University of Jena	Tang, XS (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	hvogel@ice.mpg.de; lping@ice.mpg.de; boland@ice.mpg.de	Freitak, Dalial/H-4904-2012; Heckel, David G/K-2138-2013; Boland, Wilhelm/K-7762-2012; Andersen, Gary/G-2792-2015	Heckel, David G/0000-0001-8991-2150; Boland, Wilhelm/0000-0001-6784-2534; Andersen, Gary/0000-0002-1618-9827; Freitak, Dalial/0000-0001-8574-0531	Max Planck Society; excellence graduate school "Jena School of Microbial Communication"	Max Planck Society(Max Planck Society); excellence graduate school "Jena School of Microbial Communication"	This research was supported by the Max Planck Society and the excellence graduate school "Jena School of Microbial Communication". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; BRAUMAN A, 1992, SCIENCE, V257, P1384, DOI 10.1126/science.257.5075.1384; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; CARTER D.J., 1984, PEST LEPIDOPTERA EUR; Chen DQ, 1997, CURR MICROBIOL, V34, P220, DOI 10.1007/s002849900172; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Daly H.V., 1998, INTRO INSECT BIOL DI; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2000, NATURE, V403, P851, DOI 10.1038/35002669; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; Funke M, 2008, CHEMBIOCHEM, V9, P1953, DOI 10.1002/cbic.200700781; Garcia ES, 2010, MEM I OSWALDO CRUZ, V105, P605, DOI 10.1590/S0074-02762010000500001; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; HUNT J, 1981, J INVERTEBR PATHOL, V38, P378, DOI 10.1016/0022-2011(81)90105-1; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Morrison M, 2009, CURR OPIN BIOTECH, V20, P358, DOI 10.1016/j.copbio.2009.05.004; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Ping LY, 2008, FEMS MICROBIOL LETT, V287, P192, DOI 10.1111/j.1574-6968.2008.01311.x; Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x; Pinto-Tomas A, 2007, REV BIOL TROP, V55, P401; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Santo Domingo JW, 1998, MOL ECOL, V7, P761, DOI 10.1046/j.1365-294x.1998.00390.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shao YQ, 2011, INSECT BIOCHEM MOLEC, V41, P273, DOI 10.1016/j.ibmb.2011.01.004; Sleator RD, 2008, LETT APPL MICROBIOL, V47, P361, DOI 10.1111/j.1472-765X.2008.02444.x; Spiteller D, 2000, BIOL CHEM, V381, P755, DOI 10.1515/BC.2000.096; Svec P, 2006, INT J SYST EVOL MICR, V56, P577, DOI 10.1099/ijs.0.63937-0; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; van der Hoeven R, 2008, FEMS MICROBIOL LETT, V286, P249, DOI 10.1111/j.1574-6968.2008.01277.x; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Zaspel JM, 2008, ANN ENTOMOL SOC AM, V101, P1050, DOI 10.1603/0013-8746-101.6.1050	45	129	135	4	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e36978	10.1371/journal.pone.0036978	http://dx.doi.org/10.1371/journal.pone.0036978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815679	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000001
J	Yang, X; Wang, F; Su, J; Lu, BR				Yang, Xiao; Wang, Feng; Su, Jun; Lu, Bao-Rong			Limited Fitness Advantages of Crop-Weed Hybrid Progeny Containing Insect-Resistant Transgenes (Bt/CpTI) in Transgenic Rice Field	PLOS ONE			English	Article							GENETICALLY-MODIFIED CROPS; GENE FLOW; WILD RELATIVES; BRASSICA-RAPA; ORYZA-SATIVA; CULTIVATED RICE; RISK-ASSESSMENT; RED RICE; PLANTS; FECUNDITY	Background: The spread of insect-resistance transgenes from genetically engineered (GE) rice to its coexisting weedy rice (O. sativa f. spontanea) populations via gene flow creates a major concern for commercial GE rice cultivation. Transgene flow to weedy rice seems unavoidable. Therefore, characterization of potential fitness effect brought by the transgenes is essential to assess environmental consequences caused by crop-weed transgene flow. Methodology/Principal Findings: Field performance of fitness-related traits was assessed in advanced hybrid progeny of F-4 generation derived from a cross between an insect-resistant transgenic (Bt/CpTI) rice line and a weedy strain. The performance of transgene-positive hybrid progeny was compared with the transgene-negative progeny and weedy parent in pure and mixed planting of transgenic and nontransgenic plants under environmental conditions with natural vs. low insect pressure. Results showed that under natural insect pressure the insect-resistant transgenes could effectively suppress target insects and bring significantly increased fitness to transgenic plants in pure planting, compared with nontransgenic plants (including weedy parent). In contrast, no significant differences in fitness were detected under low insect pressure. However, such increase in fitness was not detected in the mixed planting of transgenic and nontransgenic plants due to significantly reduced insect pressure. Conclusions/Significance: Insect-resistance transgenes may have limited fitness advantages to hybrid progeny resulted from crop-weed transgene flow owning to the significantly reduced ambient target insect pressure when an insect-resistant GE crop is grown. Given that the extensive cultivation of an insect-resistant GE crop will ultimately reduce the target insect pressure, the rapid spread of insect-resistance transgenes in weedy populations in commercial GE crop fields may be not likely to happen.	[Yang, Xiao; Lu, Bao-Rong] Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China; [Wang, Feng; Su, Jun] Fujian Acad Agr Sci, Fujian Prov Key Lab Genet Engn Agr, Fuzhou, Peoples R China	Fudan University; Fujian Academy of Agricultural Sciences	Yang, X (corresponding author), Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	yang, xiao/K-8509-2013; Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390; Yang, Xiao/0000-0002-2351-4827	Natural Science Foundation of China [30730066, 30871503]; National Program of Development of Transgenic New Species of China [2011ZX08011-006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Development of Transgenic New Species of China	This research was supported by the Natural Science Foundation of China (Grant no. 30730066 and 30871503), and National Program of Development of Transgenic New Species of China 2011ZX08011-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Cao QJ, 2009, J INTEGR PLANT BIOL, V51, P1138, DOI 10.1111/j.1744-7909.2009.00877.x; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Chen LY, 2006, AM J BOT, V93, P94, DOI 10.3732/ajb.93.1.94; Chen YH, 2002, ENVIRON ENTOMOL, V31, P626, DOI 10.1603/0046-225X-31.4.626; Cohen Michael B., 2008, Environmental Biosafety Research, V7, P73, DOI 10.1051/ebr:2008011; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Delouche JC, 2007, FOOD AGR ORG UN PLAN, P144; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; FAO, 2004, AGR BIOT M NEEDS POO; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Hails RS, 2005, TRENDS ECOL EVOL, V20, P245, DOI 10.1016/j.tree.2005.02.006; Halfhill MD, 2005, MOL ECOL, V14, P3177, DOI 10.1111/j.1365-294X.2005.02649.x; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Haygood R, 2003, P ROY SOC B-BIOL SCI, V270, P1879, DOI 10.1098/rspb.2003.2426; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Jenczewski E, 2002, ENV BIOSAF RESERV, V2, P9; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Mason Peter, 2003, Environmental Biosafety Research, V2, P263, DOI 10.1051/ebr:2003016; MOA (Ministry of Agriculture China), 2009, 2 BATCH GEN MOD ORG; RAYBOULD AF, 1993, J APPL ECOL, V30, P199, DOI 10.2307/2404623; Rong J, 2005, NEW PHYTOL, V168, P559, DOI 10.1111/j.1469-8137.2005.01539.x; Snow AA, 1997, BIOSCIENCE, V47, P86, DOI 10.2307/1313019; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Vacher C, 2004, THEOR APPL GENET, V109, P806, DOI 10.1007/s00122-004-1696-7; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xia H, 2010, FIELD CROP RES, V118, P215, DOI 10.1016/j.fcr.2010.05.008; Yang X, 2011, EVOL APPL, V4, P672, DOI 10.1111/j.1752-4571.2011.00190.x	33	21	28	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41220	10.1371/journal.pone.0041220	http://dx.doi.org/10.1371/journal.pone.0041220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815975	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000081
J	Burke, SM; Veltman, DJ; Gerber, J; Hummel, T; Bakker, J				Burke, Sarah M.; Veltman, Dick J.; Gerber, Johannes; Hummel, Thomas; Bakker, Julie			Heterosexual Men and Women Both Show a Hypothalamic Response to the Chemo-Signal Androstadienone	PLOS ONE			English	Article							ODOR IDENTIFICATION; PUTATIVE PHEROMONES; BRAIN RESPONSE; AXILLARY ODOR; BODY POSITION; MOOD; HUMANS; 4,16-ANDROSTADIEN-3-ONE; 16-ANDROSTENES; CHEMOSIGNALS	The odorous steroid compound 4,16-androstadien-3-one (androstadienone), found in axillary sweat, was previously reported to evoke hypothalamic activation in heterosexual women, but not in heterosexual men. However, subjects were exposed to the pure crystalline form of androstadienone, which raised the question whether the observed hypothalamic response is physiologically relevant. Therefore, in the present study, we asked whether sexually dimorphic hypothalamic responses could be measured when subjects were exposed to lower, more physiologically relevant concentrations of androstadienone. A total of 21 women and 16 men, all heterosexual, participated in our functional magnetic resonance imaging study (fMRI). Three different concentrations of androstadienone diluted in propylene glycol (10 mM "high," 0.1 mM "medium" and 0.001 mM "low") were delivered to the subjects' nostrils using a computer-controlled stimulator. When exposed to the "high" androstadienone concentration, women showed stronger hypothalamic activation than men. By contrast, men showed more hypothalamic activation when exposed to the "medium" androstadienone concentrations in comparison to women. Thus, we replicated that smelling the chemo-signal androstadienone elicits a hypothalamic activation. However, this effect does not seem to be gender-specific, because androstadienone activated the hypothalamus in both men and women, suggesting that androstadienone exerts specific effects in heterosexual individuals of both sexes.	[Burke, Sarah M.; Bakker, Julie] Vrije Univ Amsterdam, Dept Med Psychol, Med Ctr, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands; [Gerber, Johannes] Univ Dresden, Dept Neuroradiol, Sch Med, Dresden, Germany; [Hummel, Thomas] Univ Dresden, Dept Otorhinolaryngol, Sch Med, Dresden, Germany; [Bakker, Julie] Univ Liege, GIGA Neurosci, Liege, Belgium; [Bakker, Julie] Netherlands Inst Neurosci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Technische Universitat Dresden; Technische Universitat Dresden; University of Liege; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Burke, SM (corresponding author), Vrije Univ Amsterdam, Dept Med Psychol, Med Ctr, Amsterdam, Netherlands.	jbakker@ulg.ac.be	Gerber, Johannes/U-4918-2019; Burke, Sarah/J-6635-2019	Gerber, Johannes/0000-0001-7465-8700; Burke, Sarah/0000-0001-7172-491X	Dutch Science Foundation Nederlandse Organisatie voor Wetenschappelijk Onderzoek [453-08-003]; Centre National de la Recherche Scientifique	Dutch Science Foundation Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This study was funded by a VICI grant (453-08-003) from the Dutch Science Foundation Nederlandse Organisatie voor Wetenschappelijk Onderzoek) to JB. JB is a research associate of the Belgian Fonds National de la Recherche Scientifique. Furthermore, this research was supported by a grant from the Centre National de la Recherche Scientifique to TH (European associated laboratory; EAL 549, CNRS-TUD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; Bensafi M, 2004, PSYCHONEUROENDOCRINO, V29, P1290, DOI 10.1016/j.psyneuen.2004.03.007; Bensafi M, 2003, BEHAV NEUROSCI, V117, P1125, DOI 10.1037/0735-7044.117.6.1125; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Brunetti M, 2008, EUR J NEUROSCI, V27, P2922, DOI 10.1111/j.1460-9568.2008.06241.x; DOTY RL, 1978, BEHAV BIOL, V23, P373, DOI 10.1016/S0091-6773(78)91393-7; Ferdenzi C, 2009, CHEM SENSES, V34, P565, DOI 10.1093/chemse/bjp037; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grabenhorst F, 2010, CEREB CORTEX, V20, P1082, DOI 10.1093/cercor/bhp169; HUMMEL T, 1991, EXPERIENTIA, V47, P712, DOI 10.1007/BF01958823; Hummer TA, 2009, HORM BEHAV, V55, P548, DOI 10.1016/j.yhbeh.2009.01.002; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Kang N, 2011, NEUROSCIENCE, V172, P196, DOI 10.1016/j.neuroscience.2010.11.003; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Lundstrom JN, 2006, NEUROIMAGE, V30, P1340, DOI 10.1016/j.neuroimage.2005.10.040; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Lundstrom JN, 2009, HORM BEHAV, V55, P280, DOI 10.1016/j.yhbeh.2008.11.009; Lundstrom JN, 2006, CHEM SENSES, V31, P249, DOI 10.1093/chemse/bjj025; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; Lundstrom JN, 2008, CHEM SENSES, V33, P23, DOI 10.1093/chemse/bjm059; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MESTER AF, 1988, AVIAT SPACE ENVIR MD, V59, P734; NIXON A, 1988, J STEROID BIOCHEM, V29, P505, DOI 10.1016/0022-4731(88)90185-9; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Savic I, 2000, NEUROIMAGE, V11, ps751; Savic I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008651; Savic I, 2009, HUM BRAIN MAPP, V30, P3057, DOI 10.1002/hbm.20727; Schaal B, 2009, BEHAV BRAIN RES, V200, P346, DOI 10.1016/j.bbr.2009.02.008; Sewards TV, 2003, BRAIN RES BULL, V61, P25, DOI 10.1016/S0361-9230(03)00069-8; Sommer JU, 2011, ANN C ASS CHEM SCI A; Villemure C, 2007, EUR J PAIN, V11, P181, DOI 10.1016/j.ejpain.2006.02.005; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a	41	41	42	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40993	10.1371/journal.pone.0040993	http://dx.doi.org/10.1371/journal.pone.0040993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815889	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100104
J	De Martino, A; De Martino, D; Mulet, R; Uguzzoni, G				De Martino, Andrea; De Martino, Daniele; Mulet, Roberto; Uguzzoni, Guido			Reaction Networks as Systems for Resource Allocation: A Variational Principle for Their Non-Equilibrium Steady States	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; ESCHERICHIA-COLI; BIOCHEMICAL NETWORKS; METABOLIC NETWORK; THERMODYNAMICS; RECONSTRUCTION; PATHWAYS; DYNAMICS	Within a fully microscopic setting, we derive a variational principle for the non-equilibrium steady states of chemical reaction networks, valid for time-scales over which chemical potentials can be taken to be slowly varying: at stationarity the system minimizes a global function of the reaction fluxes with the form of a Hopfield Hamiltonian with Hebbian couplings, that is explicitly seen to correspond to the rate of decay of entropy production over time. Guided by this analogy, we show that reaction networks can be formally re-cast as systems of interacting reactions that optimize the use of the available compounds by competing for substrates, akin to agents competing for a limited resource in an optimal allocation problem. As an illustration, we analyze the scenario that emerges in two simple cases: that of toy (random) reaction networks and that of a metabolic network model of the human red blood cell.	[De Martino, Andrea] Univ Roma La Sapienza, Dipartimento Fis, IPCF CNR, Rome, Italy; [Mulet, Roberto] Univ Havana, Fac Phys, Dept Theoret Phys, Grp Complex Syst, Havana, Cuba; [Uguzzoni, Guido] Univ Parma, Dipartimento Fis, I-43100 Parma, Italy; [Uguzzoni, Guido] Ist Nazl Fis Nucl, Sez Parma, Parma, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Sapienza University Rome; Universidad de la Habana; University of Parma; Istituto Nazionale di Fisica Nucleare (INFN)	De Martino, A (corresponding author), Univ Roma La Sapienza, Dipartimento Fis, IPCF CNR, Rome, Italy.	andrea.demartino@roma1.infn.it	de martino, daniele/L-6519-2017; De Martino, Daniele/GQA-9589-2022; De Martino, Andrea/AAY-4120-2020	Mulet, Roberto/0000-0001-5168-5116; De Martino, Daniele/0000-0002-5214-4706; De Martino, Andrea/0000-0001-7590-6542	Seed Project DREAM of the Italian Institute of Technology (IIT); IIT/Sapienza Nanomedicine Lab; FIRB (Futuro In Ricerca di Base) from the Italian MIUR [RBFR08EKEV]	Seed Project DREAM of the Italian Institute of Technology (IIT); IIT/Sapienza Nanomedicine Lab; FIRB (Futuro In Ricerca di Base) from the Italian MIUR	This work is supported by the Seed Project DREAM of the Italian Institute of Technology (IIT) and by the joint IIT/Sapienza Nanomedicine Lab. GU is supported by the FIRB (Futuro In Ricerca di Base) grant Nr. RBFR08EKEV from the Italian MIUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2009, EUR J CONTROL, V15, P398, DOI 10.3166/EJC.15.398-406; Beard D. A., 2008, CHEM BIOPHYSICS; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; CHALLET D., 2005, MINORITY GAMES; Coolen ACC., 2005, MATH THEORY MINORITY; De Martino A, 2010, J PHYS CONF SER, V233, DOI 10.1088/1742-6596/233/1/012019; De Martino A, 2006, J PHYS A-MATH GEN, V39, pR465, DOI 10.1088/0305-4470/39/43/R01; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fleming RMT, 2012, J THEOR BIOL, V292, P71, DOI 10.1016/j.jtbi.2011.09.029; Galla T, 2005, EUR PHYS J B, V46, P153, DOI 10.1140/epjb/e2005-00242-0; Gaspard P, 2004, J CHEM PHYS, V120, P8898, DOI 10.1063/1.1688758; Ge H, 2012, PHYS REP, V510, P87, DOI 10.1016/j.physrep.2011.09.001; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Imielinski M, 2006, BIOPHYS J, V90, P2659, DOI 10.1529/biophysj.105.069278; Jamshidi N, 2001, BIOINFORMATICS, V17, P286, DOI 10.1093/bioinformatics/17.3.286; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kondepudi D, 1998, MODERN THERMODYNAMIC; Kschischo M, 2010, EUR PHYS J-SPEC TOP, V187, P255, DOI 10.1140/epjst/e2010-01290-3; Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104; Marsili M, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056138; Martelli C, 2009, P NATL ACAD SCI USA, V106, P2607, DOI 10.1073/pnas.0813229106; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; OSTER G, 1971, NATURE, V234, P393, DOI 10.1038/234393a0; OSTER GF, 1974, ARCH RATION MECH AN, V55, P230, DOI 10.1007/BF00281751; OSTER GF, 1973, Q REV BIOPHYS, V6, P1, DOI 10.1017/S0033583500000081; OSTER GF, 1974, ARCH RATIONAL MECH A, V57, P31; PERELSON AS, 1975, BIOPHYS J, V15, P667, DOI 10.1016/S0006-3495(75)85847-4; Price ND, 2002, BIOPHYS J, V83, P2879, DOI 10.1016/S0006-3495(02)75297-1; Prigogine I., 1961, INTRO THERMODYNAMICS; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schmiedl T, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2428297; Sengupta AM, 1999, PHYS REV E, V60, P3389, DOI 10.1103/PhysRevE.60.3389; Solodovnikov Aleksandr, 1980, SYSTEMS LINEAR INEQU; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Zhang XJ, 2012, PHYS REP, V510, P1, DOI 10.1016/j.physrep.2011.09.002	39	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39849	10.1371/journal.pone.0039849	http://dx.doi.org/10.1371/journal.pone.0039849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815715	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100023
J	Glynn, LH; Hallgren, KA; Houck, JM; Moyers, TB				Glynn, Lisa H.; Hallgren, Kevin A.; Houck, Jon M.; Moyers, Theresa B.			CACTI: Free, Open-Source Software for the Sequential Coding of Behavioral Interactions	PLOS ONE			English	Article							PSYCHOTHERAPY; RELIABILITY; LANGUAGE	The sequential analysis of client and clinician speech in psychotherapy sessions can help to identify and characterize potential mechanisms of treatment and behavior change. Previous studies required coding systems that were time-consuming, expensive, and error-prone. Existing software can be expensive and inflexible, and furthermore, no single package allows for pre-parsing, sequential coding, and assignment of global ratings. We developed a free, open-source, and adaptable program to meet these needs: The CASAA Application for Coding Treatment Interactions (CACTI). Without transcripts, CACTI facilitates the real-time sequential coding of behavioral interactions using WAV-format audio files. Most elements of the interface are user-modifiable through a simple XML file, and can be further adapted using Java through the terms of the GNU Public License. Coding with this software yields interrater reliabilities comparable to previous methods, but at greatly reduced time and expense. CACTI is a flexible research tool that can simplify psychotherapy process research, and has the potential to contribute to the improvement of treatment content and delivery.	[Glynn, Lisa H.; Hallgren, Kevin A.; Houck, Jon M.; Moyers, Theresa B.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	University of New Mexico	Glynn, LH (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	lglynn@unm.edu	Houck, Jon M/G-1016-2011	Houck, Jon M/0000-0002-6565-4481	Project ELICIT; National Institute on Drug Abuse [R01-DA02122]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021227] Funding Source: NIH RePORTER	Project ELICIT; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Project ELICIT, which was funded by the National Institute on Drug Abuse R01-DA02122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas.ti Scientific Software Development, 2012, ATL TI QUAL DAT AN; Audacity, 2011, FREE CROSS PLATF SOU; AULD F, 1959, J ABNORM SOC PSYCH, V58, P100, DOI 10.1037/h0043325; AULD F, 1955, PSYCHOL BULL, V52, P377, DOI 10.1037/h0039358; BAKEMAN R, 1992, BEHAV RES METH INSTR, V24, P554, DOI 10.3758/BF03203604; Bakeman R, 2011, GSEQ SOFTWARE ANAL I; Bertholet N, 2010, ADDICTION, V105, P2106, DOI 10.1111/j.1360-0443.2010.03081.x; Carroll KM, 2000, DRUG ALCOHOL DEPEN, V57, P225, DOI 10.1016/S0376-8716(99)00049-6; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crutcher RJ, 2007, BEHAV RES METHODS, V39, P167, DOI 10.3758/BF03193145; Dartfish, 2009, DARTF PROSUITE; Fassnacht C, 2009, TRANSANA; GOTTMAN J, 1977, J MARRIAGE FAM, V39, P461, DOI 10.2307/350902; HALL SM, 1991, J CONSULT CLIN PSYCH, V59, P526, DOI 10.1037/0022-006X.59.4.526; Hallgren KA, 2011, MANUAL CASAA A UNPUB; Hanninen L, 2009, BEHAV RES METHODS, V41, P472, DOI 10.3758/BRM.41.2.472; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; HILL CE, 1990, J CONSULT CLIN PSYCH, V58, P288, DOI 10.1037/0022-006X.58.3.288; Houck JM, 2011, GETCASAA V 1 01; Houck JM, 2010, ELICIT MISC 2 UNPUB; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Kieren DK, 1985, 143 U ALB DEP FAM ST; KRIPPEND.K, 1970, EDUC PSYCHOL MEAS, V30, P61, DOI 10.1177/001316447003000105; LAPADAT JC, 1999, QUALITATIVE INQUIRY, V0005; Lasswell HD, 1938, PSYCHIATR, V1, P197; Long S., 2000, COMPUTERIZED PROFILI; Long SH, 2008, CP PROGRAM INFORM; MacLin OH, 2005, BEHAV RES METHODS, V37, P224, DOI 10.3758/BF03192690; Manuel JK, 2012, BEHAV COGN PSYCHOTH, V40, P297, DOI 10.1017/S1352465811000592; Martin T., 2005, MOTIVATIONAL INTERVI; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; Miller WR, 2004, J CONSULT CLIN PSYCH, V72, P1050, DOI 10.1037/0022-006X.72.6.1050; Moyers T. B., 2010, REVISED GLOBAL SCALE; Moyers T. B., 2011, ALCOHOLISM CLIN EXPT, V35, P296; Moyers TB, 2006, J SUBST ABUSE TREAT, V30, P245, DOI 10.1016/j.jsat.2005.12.003; Moyers T, 2003, BEHAV COGN PSYCHOTH, V31, P177, DOI 10.1017/S1352465803002054; Moyers TB, 2009, J CONSULT CLIN PSYCH, V77, P1113, DOI 10.1037/a0017189; National Centre for e-Social Science, 2009, DIG REPL SYST DRS; Noldus Information Technology, 2011, OBS XT OBS MAD SIMPL; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; Norcross JC, 2011, PSYCHOTHERAPY, V48, P98, DOI 10.1037/a0022161; Oracle, 2011, FREE JAV DOWNL; QSR International, 2011, NVIVO 9; RUSSELL RL, 1986, J CONSULT CLIN PSYCH, V54, P16, DOI 10.1037/0022-006X.54.1.16; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Staaf CC, 2010, CACTI USER CONFIGURA; TRUAX CB, 1966, J ABNORM PSYCHOL, V71, P1, DOI 10.1037/h0022912	48	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39740	10.1371/journal.pone.0039740	http://dx.doi.org/10.1371/journal.pone.0039740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974VS	22815713	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100021
J	Ogasawara, J; Sakurai, T; Kizaki, T; Ishibashi, Y; Izawa, T; Sumitani, Y; Ishida, H; Radak, Z; Haga, S; Ohno, H				Ogasawara, Junetsu; Sakurai, Takuya; Kizaki, Takako; Ishibashi, Yoshinaga; Izawa, Tetsuya; Sumitani, Yoshikazu; Ishida, Hitoshi; Radak, Zsolt; Haga, Shukoh; Ohno, Hideki			Higher Levels of ATGL Are Associated with Exercise-Induced Enhancement of Lipolysis in Rat Epididymal Adipocytes	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; ACTIVATED RECEPTOR-GAMMA; ISOLATED FAT-CELLS; LIPID DROPLETS; PPAR-GAMMA; ADENYLATE-CYCLASE; KEY ROLE; TISSUE; PERILIPIN	Background: In adipose cells, adipose triglyceride lipase (ATGL) catalyzes the first step in adipocyte triacylglyceride hydrolysis, thereby regulating both basal and hormone-stimulated lipolysis. However, little is known about the molecular mechanism(s) underlying habitual exercise-induced adaptive modulation of ATGL in white adipocytes via alteration in transcription regulator and lipolytic cofactors. Methodology/Principal Results: Male Wistar rats were randomly divided into 2 groups a sedentary control group (CG) and a habitual exercise group (EG). The EG was subjected to running on a treadmill set at 5 days per week for 9 weeks. The CG was not subjected to running on a treadmill. In the EG, levels of ATGL mRNA and protein were elevated with a significant increase in lipolysis compared with the CG, accompanied by a significant increase in associations of CGI-58 with ATGL protein. Under these conditions, an upregulation of peroxisome proliferation-activated receptorg-2 (PPARg-2) was observed. In the EG, the addition of rosiglitazone further significantly increased the levels of ATGL protein compared with the CG. However, attenuated levels of the ATGL protein in adipocytes were obtained by the addition of insulin, which is known to inhibit the expression of ATGL, in both types of groups. Actually, levels of plasma insulin were significantly reduced in the EG compared with the CG. Conclusions: These data suggest that elevated levels of ATGL are involved in the exercise-induced enhancement of lipolysis in primary adipocytes. The exact mechanism(s) underlying this phenomenon is associated, at least in part, with upregulated transcriptional activation of PPARg-2. In addition, exercise-induced lower circulation levels of insulin also correlate with habitual exercise-induced higher levels of ATGL in primary adipocytes.	[Ogasawara, Junetsu; Sakurai, Takuya; Kizaki, Takako; Ishibashi, Yoshinaga; Ohno, Hideki] Kyorin Univ, Sch Med, Dept Mol Predict Med & Sport Sci, Tokyo, Japan; [Izawa, Tetsuya] Doshisha Univ, Grad Sch Hlth & Sports Sci, Kyoto 602, Japan; [Sumitani, Yoshikazu; Ishida, Hitoshi] Kyorin Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan; [Radak, Zsolt] Semmelweis Univ, Fac Phys Educ & Sports Sci, Res Inst Sports Sci, H-1085 Budapest, Hungary; [Haga, Shukoh] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Kyorin University; Doshisha University; Kyorin University; Semmelweis University; University of Tsukuba	Ogasawara, J (corresponding author), Kyorin Univ, Sch Med, Dept Mol Predict Med & Sport Sci, Tokyo, Japan.	junetsu@ks.kyorin-u.ac.jp		Radak, Zsolt/0000-0003-1297-6804; Izawa, Tetsuya/0000-0001-5197-9085	Japan Ministry of Education, Culture, Sports, Science and Technology [20700528]; Grants-in-Aid for Scientific Research [22590993, 23300242] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Ministry of Education, Culture, Sports, Science and Technology (No. 20700528). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Bergman BC, 1999, AM J PHYSIOL-ENDOC M, V276, pE106, DOI 10.1152/ajpendo.1999.276.1.E106; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Enevoldsen LH, 2000, AM J PHYSIOL-ENDOC M, V279, pE585, DOI 10.1152/ajpendo.2000.279.3.E585; Enevoldsen LH, 2001, J PHYSIOL-LONDON, V536, P871, DOI 10.1111/j.1469-7793.2001.t01-1-00871.x; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Ghanbari-Niaki A, 2011, HORM METAB RES, V43, P112, DOI 10.1055/s-0030-1267998; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; GYNTELBERG F, 1977, J APPL PHYSIOL, V43, P302, DOI 10.1152/jappl.1977.43.2.302; HIRSCH AH, 1984, J LIPID RES, V25, P665; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; IZAWA T, 1988, BIOCHEM BIOPH RES CO, V151, P1262, DOI 10.1016/S0006-291X(88)80502-3; IZAWA T, 1991, J APPL PHYSIOL, V71, P23, DOI 10.1152/jappl.1991.71.1.23; Izawa T, 2000, LIFE SCI, V66, pPL359; Karanth J, 2009, INDIAN J EXP BIOL, V47, P748; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Lira FS, 2009, CYTOKINE, V45, P80, DOI 10.1016/j.cyto.2008.10.018; Liu LF, 2009, DIABETES OBES METAB, V11, P131, DOI 10.1111/j.1463-1326.2008.00916.x; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002; Nielsen TS, 2011, J CLIN ENDOCR METAB, V96, pE1293, DOI 10.1210/jc.2011-0149; Nomura S, 2002, BIOCHEM BIOPH RES CO, V295, P236, DOI 10.1016/S0006-291X(02)00664-2; Ogasawara J, 2004, BIOCHEM BIOPH RES CO, V323, P1109, DOI 10.1016/j.bbrc.2004.08.202; Ogasawara J, 2006, FASEB J, V20, P350, DOI 10.1096/fj.05-4688fje; Ogasawara J, 2010, BIOCHEM BIOPH RES CO, V400, P134, DOI 10.1016/j.bbrc.2010.08.026; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Petridou A, 2007, METABOLISM, V56, P1029, DOI 10.1016/j.metabol.2007.03.011; REARDON MF, 1973, J LIPID RES, V14, P319; RODBELL M, 1964, J BIOL CHEM, V239, P375; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; VAUGHAN M, 1963, J LIPID RES, V4, P193; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yao-Borengasser A, 2011, METABOLISM, V60, P1012, DOI 10.1016/j.metabol.2010.10.005; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	46	31	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40876	10.1371/journal.pone.0040876	http://dx.doi.org/10.1371/journal.pone.0040876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815850	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100086
J	Strong, JA; Xie, WR; Coyle, DE; Zhang, JM				Strong, Judith A.; Xie, Wenrui; Coyle, Dennis E.; Zhang, Jun-Ming			Microarray Analysis of Rat Sensory Ganglia after Local Inflammation Implicates Novel Cytokines in Pain	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; NEUROPATHIC PAIN; GENE-EXPRESSION; UP-REGULATION; INTERNATIONAL UNION; NOCICEPTIVE NEURONS; QUANTITATIVE PCR; TARGET GENES; NERVE INJURY; MODEL	Inflammation plays a role in neuropathic pain conditions as well as in pain induced solely by an inflammatory stimulus. Robust mechanical hyperalgesia and allodynia can be induced by locally inflaming the L5 dorsal root ganglion (DRG) in rat. This model allows investigation of the contribution of inflammation per se to chronic pain conditions. Most previous microarray studies of DRG gene expression have investigated neuropathic pain models. To examine the role of inflammation, we used microarray methods to examine gene expression 3 days after local inflammation of the L5 DRG in rat. We observed significant regulation in a large number of genes (23% of observed transcripts), and examined 221 (3%) with a fold-change of 1.5-fold or more in more detail. Immune-related genes were the largest category in this group and included members of the complement system as well as several pro-inflammatory cytokines. However, these upregulated cytokines had no prior links to peripheral pain in the literature other than through microarray studies, though most had previously described roles in CNS (especially neuroinflammatory conditions) as well as in immune responses. To confirm an association to pain, qPCR studies examined these cytokines at a later time (day 14), as well as in two different versions of the spinal nerve ligation pain model including a version without any foreign immunogenic material (suture). Cxcl11, Cxcl13, and Cxcl14 were found to be significantly upregulated in all these conditions, while Cxcl9, Cxcl10, and Cxcl16 were upregulated in at least two of these conditions.	[Strong, Judith A.; Xie, Wenrui; Coyle, Dennis E.; Zhang, Jun-Ming] Univ Cincinnati, Coll Med, Dept Anesthesiol, Pain Res Ctr, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Strong, JA (corresponding author), Univ Cincinnati, Coll Med, Dept Anesthesiol, Pain Res Ctr, Cincinnati, OH 45221 USA.	Judith.strong@uc.edu; Jun-Ming.Zhang@uc.edu		Strong, Judith/0000-0001-9363-0551	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [NS045594, NS055860]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055860, R01NS045594] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grants NS045594 and NS055860 to J-MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2008, EXP NEUROL, V210, P368, DOI 10.1016/j.expneurol.2007.11.018; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Chang M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-56; Cho J, 2009, J NEUROIMMUNOL, V207, P92, DOI 10.1016/j.jneuroim.2008.12.007; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Davis-Taber RA, 2006, DRUG DEVELOP RES, V67, P308, DOI 10.1002/ddr.20096; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Dong F, 2012, NEUROSCI BULL, V28, P155, DOI 10.1007/s12264-012-1208-8; Hammer P, 2010, GENOME RES, V20, P847, DOI 10.1101/gr.101204.109; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Kleinschnitz C, 2004, J NEUROIMMUNOL, V149, P77, DOI 10.1016/j.jneuroim.2003.12.013; Kuo LT, 2011, J MOL NEUROSCI, V43, P503, DOI 10.1007/s12031-010-9473-3; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Levin ME, 2008, PAIN, V137, P182, DOI 10.1016/j.pain.2007.11.005; Li JY, 2011, REGION ANESTH PAIN M, V36, P56, DOI 10.1097/AAP.0b013e318203087f; Liu LP, 2005, CURR TOP DEV BIOL, V68, P149, DOI 10.1016/S0070-2153(05)68006-4; Maratou K, 2009, EUR J PAIN, V13, P387, DOI 10.1016/j.ejpain.2008.05.011; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2002, PHARMACOL REV, V54, P227, DOI 10.1124/pr.54.2.227; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Nishida K, 2008, CANCER SCI, V99, P1618, DOI 10.1111/j.1349-7006.2008.00877.x; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Steain M, 2011, J VIROL, V85, P626, DOI 10.1128/JVI.01816-10; Tanaka T, 2004, NEUROSCI RES, V48, P463, DOI 10.1016/j.neures.2004.01.004; Taskinen HS, 2000, J PERIPHER NERV SYST, V5, P75, DOI 10.1046/j.1529-8027.2000.00009.x; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Vega-Avelaira D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-70; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wang JG, 2007, ANESTHESIOLOGY, V107, P322, DOI 10.1097/01.anes.0000270761.99469.a7; Xie W, 2012, NEUROSCIENCE, V206, P212, DOI 10.1016/j.neuroscience.2012.01.007; Xie WR, 2006, NEUROSCIENCE, V142, P809, DOI 10.1016/j.neuroscience.2006.06.045; Xie WR, 2010, PAIN, V151, P447, DOI 10.1016/j.pain.2010.08.006; Xu QH, 2011, CURR OPIN ANESTHESIO, V24, P400, DOI 10.1097/ACO.0b013e32834871df; Yamamoto T, 2011, NEUROSCI LETT, V487, P335, DOI 10.1016/j.neulet.2010.10.051; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	47	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40779	10.1371/journal.pone.0040779	http://dx.doi.org/10.1371/journal.pone.0040779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815815	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100066
J	van Hoek, AJ; Andrews, N; Waight, PA; George, R; Miller, E				van Hoek, Albert Jan; Andrews, Nick; Waight, Pauline A.; George, Robert; Miller, Elizabeth			Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CARRIAGE; CHILDREN; ASSOCIATIONS; ADULTS	Background: Differences in pathogenicity between pneumococcal serotypes are important when assessing the potential benefit of different valency vaccines. We investigated the effect of serotype on clinical presentation, outcome, and quality of life lost from invasive pneumococcal disease (IPD) in the context of the 7, 10, and 13 valent pneumococcal conjugate vaccines (PCV7, PCV10, PCV13). Method: Serotyped IPD cases in England were linked to the national dataset of hospital admissions for April 2002 to March 2011. Based on patients' diagnostic codes and vital status at the end of the admission, disease focus (meningitis, empyema, sepsis, or respiratory disease) and case fatality rates by serotype and age group (5, 5-64, and 65 years and over) were obtained. Using these data the quality adjusted life years (QALY) lost from the IPD remaining when use of PCV7 stopped in 2010 was estimated for the serotypes covered by higher valency vaccines. Results: The linked dataset contained 23,688 cases with information on diagnosis, mortality, and serotype. There were significant differences between serotypes in the propensity to cause meningitis, death, and QALY loss in each of the investigated age groups. As a result, vaccines' coverage of disease burden differed by endpoint. For example, in children under 5 years in 2009/10, PCV10 covered 39% of meningitis, 19% of deaths and 28% of the QALY loss of attributable to IPD, whereas the respective percentages for PCV13 were 65%, 67%, and 66%. The highest QALY loss per serotype in this age group was for 6A. Non-PCV serotypes causing the highest QALY loss were 22F and 33F in <5 year olds and 31 in older individuals. Conclusion: Marked differences exist between serotypes in clinical presentation and outcome, and these should be considered when evaluating the potential impact of higher valency vaccines on overall disease burden and associated QALY loss.	[van Hoek, Albert Jan; Waight, Pauline A.; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England; [Andrews, Nick] Hlth Protect Agcy, Hlth Protect Serv, Stat Unit, London, England; [George, Robert] Hlth Protect Agcy, Microbiol Serv Div, Resp & Syst Infect Lab, London, England	Health Protection Agency; Health Protection Agency; Health Protection Agency	van Hoek, AJ (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England.	albertjan.vanhoek@hpa.org.uk			UK Department of Health Policy Research Programme [039/0031]; Wyeth (Pfizer); GlaxoSmithKline	UK Department of Health Policy Research Programme; Wyeth (Pfizer)(WyethPfizer); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by the UK Department of Health Policy Research Programme, grant number: 039/0031 to AJvH. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RG has received assistance to attend scientific meetings from Wyeth (Pfizer) and GlaxoSmithKline, and his laboratory has received research funding from Wyeth (Pfizer) and GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; [Anonymous], 2008, GUID METH TECHN APPR; Bennett JE, 2000, ARCH PEDIAT ADOL MED, V154, P43; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Burgos J, 2011, CLIN INFECT DIS, V53, P254, DOI 10.1093/cid/cir354; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Department for Communities and Local Government, 2011, ENGL IND DEPR; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; GlaxoSmithKline Biologicals, 2011, PACK INS SYNFL, P9; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Healthcare cost and Utilization Project, 2012, CLIN CLASS; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; National Office for Statistics, 2011, INT LIF TABL 2008 20; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Sawicki GS, 2008, EUR RESPIR J, V31, P1285, DOI 10.1183/09031936.00099807; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; World Health Organisation, 2011, REV SER REPL SETT PC	26	77	86	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39150	10.1371/journal.pone.0039150	http://dx.doi.org/10.1371/journal.pone.0039150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815698	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100014
J	Hughes, JM; Real, KM; Marshall, JC; Schmidt, DJ				Hughes, Jane M.; Real, Kathryn M.; Marshall, Jonathan C.; Schmidt, Daniel J.			Extreme Genetic Structure in a Small-Bodied Freshwater Fish, the Purple Spotted Gudgeon, Mogurnda adspersa (Eleotridae)	PLOS ONE			English	Article							EFFECTIVE POPULATION SIZES; DRYLAND RIVER; COMPUTER-PROGRAM; INFERENCE; CONTEMPORARY; AUSTRALIA; SOFTWARE; PATTERNS; FLOW; DIFFERENTIATION	Freshwater fish are a group that is especially susceptible to biodiversity loss as they often exist naturally in small, fragmented populations that are vulnerable to habitat degradation, pollution and introduction of exotic species. Relatively little is known about spatial dynamics of unperturbed populations of small-bodied freshwater fish species. This study examined population genetic structure of the purple spotted gudgeon (Mogurnda adspersa, Eleotridae), a small-bodied freshwater fish that is widely distributed in eastern Australia. The species is threatened in parts of its range but is common in coastal streams of central Queensland where this study took place. Microsatellite (msat) and mitochondrial DNA (mtDNA) variation was assessed for nine sites from four stream sections in two drainage basins. Very high levels of among population structure were observed (msat F-ST = 0.18; mtDNA Phi(ST) = 0.85) and evidence for contemporary migration among populations was rare and limited to sites within the same section of stream. Hierarchical structuring of variation was best explained by stream section rather than by drainage basin. Estimates of contemporary effective population size for each site was low (range 28 - 63, Sibship method), but compared favorably with similar estimates for other freshwater fish species, and there was no genetic evidence for inbreeding or recent population bottlenecks. In conclusion, within a stable part of its range, M adspersa exists as a series of small, demographically stable populations that are highly isolated from one another. Complimentary patterns in microsatellites and mtDNA indicate this structuring is the result of long-term processes that have developed over a remarkably small spatial scale. High population structure and limited dispersal mean that recolonisation of locally extinct populations is only likely to occur from closely situated populations within stream sections. Limited potential for recolonisation should be considered as an important factor in conservation and management of this species.	[Hughes, Jane M.; Real, Kathryn M.; Schmidt, Daniel J.] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Marshall, Jonathan C.] Queensland Dept Sci IT Innovat & Arts, Environm & Resource Sci Div, Brisbane, Qld, Australia	Griffith University	Hughes, JM (corresponding author), Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia.	jane.hughes@griffith.edu.au	Schmidt, Daniel/I-9289-2014; hughes, jane m/C-5321-2008	Schmidt, Daniel/0000-0001-5638-497X; Marshall, Jonathan/0000-0002-7177-4543	Queensland Department of Environment and Resource Management	Queensland Department of Environment and Resource Management	Funding was provided by the Queensland Department of Environment and Resource Management as part of its Environmental Flows Assessment Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; Allendorf F.W., 2006, CONSERVATION GENETIC; Araguas RM, 2012, FRESHWATER BIOL, V57, P143, DOI 10.1111/j.1365-2427.2011.02705.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Benjamini Y, 2001, ANN STAT, V29, P1165; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Boxall GD, 2002, MAR FRESHWATER RES, V53, P909, DOI 10.1071/MF01039; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coleman RA, 2010, CONSERV GENET, V11, P1911, DOI 10.1007/s10592-010-0082-z; Cook BD, 2011, FRESHWATER BIOL, V56, P812, DOI 10.1111/j.1365-2427.2010.02527.x; Cornuet JM, 1996, GENETICS, V144, P2001; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Faulks LK, 2008, MAR FRESHWATER RES, V59, P89, DOI 10.1071/MF07167; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HARRIS JH, 1997, FISH RIVERS STRESS; Horreo JL, 2011, FRESHWATER BIOL, V56, P2567, DOI 10.1111/j.1365-2427.2011.02682.x; Huey JA, 2006, BIOL J LINN SOC, V87, P457, DOI 10.1111/j.1095-8312.2006.00590.x; Huey JA, 2011, FRESHWATER BIOL, V56, P2378, DOI 10.1111/j.1365-2427.2011.02666.x; Huey JA, 2010, J N AM BENTHOL SOC, V29, P1148, DOI 10.1899/09-093.1; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; Hurwood DA, 1998, MOL ECOL, V7, P1507, DOI 10.1046/j.1365-294x.1998.00469.x; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kubota H, 2010, CONSERV GENET, V11, P2343, DOI 10.1007/s10592-010-0120-x; Langen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024689; Larsen LK, 2011, J EVOLUTION BIOL, V24, P823, DOI 10.1111/j.1420-9101.2010.02224.x; Larson HK, 1996, FRESHWATER FISHES S, P200; Lintermans M., 2007, FISHES MURRAY DARLIN; Llewellyn L, 1983, DISTRIBUTION FISH NS; McGlashan DJ, 2000, MOL ECOL, V9, P1737, DOI 10.1046/j.1365-294x.2000.01054.x; McGlashan DJ, 2001, HEREDITY, V86, P222, DOI 10.1046/j.1365-2540.2001.00824.x; MEFFE G K, 1988, Conservation Biology, V2, P157, DOI 10.1111/j.1523-1739.1988.tb00167.x; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Palstra FP, 2011, HEREDITY, V107, P444, DOI 10.1038/hdy.2011.31; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pujolar JM, 2011, PLOS ONE, V6; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Pusey BJ, 1998, ENVIRON BIOL FISH, V53, P303, DOI 10.1023/A:1007468417947; Real KM, 2009, CONSERV GENET RESOUR, V1, P411, DOI 10.1007/s12686-009-9095-7; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanz N, 2011, HYDROBIOLOGIA, V671, P105, DOI 10.1007/s10750-011-0708-2; Schmidt DJ, 2011, J FISH BIOL, V78, P98, DOI 10.1111/j.1095-8649.2010.02844.x; Sheldon F, 2010, MAR FRESHWATER RES, V61, P885, DOI 10.1071/MF09239; Thoms MC, 2000, J HYDROL, V228, P10, DOI 10.1016/S0022-1694(99)00191-2; Tweed S, 2009, J HYDROL, V379, P41, DOI 10.1016/j.jhydrol.2009.09.043; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wager R, 1993, ACTION PLAN AUSTR FR; WALKER KF, 1995, REGUL RIVER, V11, P85, DOI 10.1002/rrr.3450110108; Walter RP, 2011, MOL ECOL, V20, P601, DOI 10.1111/j.1365-294X.2010.04968.x; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wilson GA, 2003, GENETICS, V163, P1177; Woods RJ, 2010, CAN J FISH AQUAT SCI, V67, P1098, DOI 10.1139/F10-043; Young W.J., 2001, RIVERS ECOLOGICAL SY	67	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40546	10.1371/journal.pone.0040546	http://dx.doi.org/10.1371/journal.pone.0040546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808190	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400035
J	Ren, YF; Li, GL; Wu, JM; Xue, YF; Song, YJ; Lv, L; Zhang, XJ; Tang, KF				Ren, Yong-Feng; Li, Guiling; Wu, Jianmin; Xue, Yong-Feng; Song, Yi-Jiang; Lv, Lu; Zhang, Xue-Jiao; Tang, Kai-Fu			Dicer-Dependent Biogenesis of Small RNAs Derived from 7SL RNA	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; VIRUS-LIKE PARTICLES; MESSENGER-RNA; MOUSE OOCYTES; UP-REGULATION; PROTEIN; CELLS; HIV-1; INTERFERENCE; EXPRESSION	It has been reported that decreased Dicer expression leads to Alu RNAs accumulation in human retinal pigmented epithelium cells, and Dicer may process the endogenous SINE/B1 RNAs (the rodent equivalent of the primate Alu RNAs) into small interfering RNAs (siRNAs). In this study, we aimed to address whether Dicer can process Alu RNAs and their common ancestor, 7SL RNA. Using Solexa sequencing technology, we showed that Alu-derived small RNAs accounted for 0.6% of the total cellular small RNAs in HepG2.2.15 cells, and the abundance decreased when Dicer was knocked down. However, Alu-derived small RNAs showed different characteristics from miRNAs and siRNAs, the classic Dicer-processed products. Interestingly, we found that small RNAs derived from 7SL RNA accounted for 3.1% of the total cellular small RNAs in the control cells, and the abundance dropped about 3.4 folds in Dicer knockdown cells. Dicer-dependent biogenesis of 7SL RNA-derived small RNAs was validated by northern blotting. In vitro cleavage assay using the recombinant human Dicer protein also showed that synthetic 7SL RNA was processed by Dicer into fragments of different lengths. Further functional analysis suggested that 7SL RNA-derived small RNAs do not function like miRNAs, neither do they regulate the expression of 7SL RNA. In conclusion, the current study demonstrated that Dicer can process 7SL RNA, however, the biological significance remains to be elucidated.	[Ren, Yong-Feng; Li, Guiling; Wu, Jianmin; Xue, Yong-Feng; Song, Yi-Jiang; Lv, Lu; Zhang, Xue-Jiao; Tang, Kai-Fu] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China	Wenzhou Medical University	Ren, YF (corresponding author), Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China.	tang_kaifu@yahoo.com.cn		Tang, Kai-Fu/0000-0002-2657-4163; Tang, Kai-Fu/0000-0002-6892-1207; Wu, Jianmin/0000-0002-8223-1667	National Natural Science Foundation of China [30700708, 30971621, 81171967]; Zhejiang Provincial Natural Science Foundation [R2110503, Y2101210]; Wenzhou Science and Technology Foundation [Y20100202, Y20100203]; Chongqing Medical Science Foundation [09-1-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Wenzhou Science and Technology Foundation; Chongqing Medical Science Foundation	This work was supported by National Natural Science Foundation of China (30700708, 30971621 and 81171967 to KFT); Zhejiang Provincial Natural Science Foundation (R2110503 to KFT, Y2101210 to JW); Wenzhou Science and Technology Foundation (Y20100202 to KFT, Y20100203 to JW) and the key project of Chongqing Medical Science Foundation (09-1-17 to KFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BISHOP JM, 1970, VIROLOGY, V42, P927, DOI 10.1016/0042-6822(70)90341-7; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Keene SE, 2010, J VIROL, V84, P9070, DOI 10.1128/JVI.00714-10; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Ohnishi Y, 2012, MOL BIOL REP, V39, P903, DOI 10.1007/s11033-011-0815-1; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; Perron MP, 2011, METHODS MOL BIOL, V725, P121, DOI 10.1007/978-1-61779-046-1_9; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Portnoy V, 2011, WIRES RNA, V2, P748, DOI 10.1002/wrna.90; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Ritchie W, 2007, RNA, V13, P457, DOI 10.1261/rna.366507; Rother S, 2011, BIOCHIMIE, V93, P1905, DOI 10.1016/j.biochi.2011.07.032; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tang KF, 2008, J CELL BIOL, V182, P233, DOI 10.1083/jcb.200801169; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	37	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40705	10.1371/journal.pone.0040705	http://dx.doi.org/10.1371/journal.pone.0040705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808238	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400049
J	Stearns, NA; Lee, J; Leong, KW; Sullenger, BA; Pisetsky, DS				Stearns, Nancy A.; Lee, Jaewoo; Leong, Kam W.; Sullenger, Bruce A.; Pisetsky, David S.			The Inhibition of Anti-DNA Binding to DNA by Nucleic Acid Binding Polymers	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIBODIES; DELIVERY; AUTOANTIBODIES; ACTIVATION; PEPTIDE	Antibodies to DNA (anti-DNA) are the serological hallmark of systemic lupus erythematosus (SLE) and can mediate disease pathogenesis by the formation of immune complexes. Since blocking immune complex formation can attenuate disease manifestations, the effects of nucleic acid binding polymers (NABPs) on anti-DNA binding in vitro were investigated. The compounds tested included polyamidoamine dendrimer, 1,4-diaminobutane core, generation 3.0 (PAMAM-G3), hexadimethrine bromide, and a beta-cylodextrin-containing polycation. As shown with plasma from patients with SLE, NABPs can inhibit anti-DNA antibody binding in ELISA assays. The inhibition was specific since the NABPs did not affect binding to tetanus toxoid or the Sm protein, another lupus autoantigen. Furthermore, the polymers could displace antibody from preformed complexes. Together, these results indicate that NABPs can inhibit the formation of immune complexes and may represent a new approach to treatment.	[Stearns, Nancy A.; Pisetsky, David S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Pisetsky, David S.] Durham Vet Adm Med Ctr, Med Res Serv, Durham, NC USA; [Lee, Jaewoo; Sullenger, Bruce A.] Duke Translat Res Inst, Durham, NC USA; [Lee, Jaewoo; Leong, Kam W.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University; Duke University	Stearns, NA (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	dpiset@acpub.duke.edu	Leong, Kam/O-9302-2019; Leong, Kam W/A-7270-2009	Leong, Kam/0000-0002-8133-4955; Leong, Kam W/0000-0002-8133-4955	VA Merit Review grant; Alliance for Lupus Research Grant; National Institutes of Health (NIH) [AI093960, HL089764]; Wallace H. Coulter Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093960] Funding Source: NIH RePORTER	VA Merit Review grant(US Department of Veterans Affairs); Alliance for Lupus Research Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wallace H. Coulter Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a VA Merit Review grant, an Alliance for Lupus Research Grant, National Institutes of Health (NIH) AI093960, NIH HL089764, and a Wallace H. Coulter Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardoin SP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2488; Aubin R, 1991, Methods Mol Biol, V7, P35, DOI 10.1385/0-89603-178-0:35; Aubin Remy A., 1994, Molecular Biotechnology, V1, P29, DOI 10.1007/BF02821509; Blatt NB, 1999, PHARMACOL THERAPEUT, V83, P125, DOI 10.1016/S0163-7258(99)00022-4; Bloom O, 2011, P NATL ACAD SCI USA, V108, P10255, DOI 10.1073/pnas.1103555108; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Cardiel MH, 2008, ARTHRITIS RHEUM, V58, P2470, DOI 10.1002/art.23673; Dall'Era M, 2011, CURR RHEUMATOL REP, V13, P308, DOI 10.1007/s11926-011-0186-6; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179; Gonzalez H, 1999, BIOCONJUGATE CHEM, V10, P1068, DOI 10.1021/bc990072j; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Grigsby CL, 2010, J R SOC INTERFACE, V7, pS67, DOI 10.1098/rsif.2009.0260; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Han LA, 2010, MOL PHARMACEUT, V7, P2156, DOI 10.1021/mp100185f; Hwang SJ, 2001, BIOCONJUGATE CHEM, V12, P280, DOI 10.1021/bc0001084; Iking-Konert C, 2004, ANN RHEUM DIS, V63, P1104, DOI 10.1136/ard.2003.016691; Ippolito A, 2011, LUPUS, V20, P250, DOI 10.1177/0961203310385738; Jang YJ, 2003, CELL MOL LIFE SCI, V60, P309, DOI 10.1007/s000180300026; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Lee J, 2011, P NATL ACAD SCI USA, V108, P14055, DOI 10.1073/pnas.1105777108; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Medina-Kauwe LK, 2005, GENE THER, V12, P1734, DOI 10.1038/sj.gt.3302592; MONESTIER M, 1994, EUR J IMMUNOL, V24, P723, DOI 10.1002/eji.1830240335; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; Mortensen ES, 2009, J AM SOC NEPHROL, V20, P696, DOI 10.1681/ASN.2008010112; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; Mellet CO, 2011, CHEM SOC REV, V40, P1586, DOI 10.1039/c0cs00019a; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; PAPALIAN M, 1980, J CLIN INVEST, V65, P469, DOI 10.1172/JCI109690; PISETSKY DS, 1994, CLIN IMMUNOL IMMUNOP, V72, P350, DOI 10.1006/clin.1994.1152; Pisetsky DS, 1998, MOL IMMUNOL, V35, P1161, DOI 10.1016/S0161-5890(98)00108-4; Shlomchik MJ, 2009, CURR OPIN IMMUNOL, V21, P626, DOI 10.1016/j.coi.2009.08.005; Skaggs BJ, 2011, LUPUS, V20, P912, DOI 10.1177/0961203311398509; STOLLAR BD, 1980, J CLIN INVEST, V66, P210, DOI 10.1172/JCI109846; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Vallin H, 1999, J IMMUNOL, V163, P6306; Voynova E, 2008, IMMUNOL LETT, V116, P168, DOI 10.1016/j.imlet.2007.12.016; Xu QX, 2010, CURR PHARM DESIGN, V16, P2350, DOI 10.2174/138161210791920469	41	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40862	10.1371/journal.pone.0040862	http://dx.doi.org/10.1371/journal.pone.0040862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808279	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400105
J	Wang, JJ; Sun, YP; Xu, Q; Tan, YY; Pu, J; Yang, HC; Brown, EG; Liu, JH				Wang, Jingjing; Sun, Yipeng; Xu, Qi; Tan, Yuanyuan; Pu, Juan; Yang, Hanchun; Brown, Earl G.; Liu, Jinhua			Mouse-Adapted H9N2 Influenza A Virus PB2 Protein M147L and E627K Mutations Are Critical for High Virulence	PLOS ONE			English	Article							SINGLE AMINO-ACID; AVIAN INFLUENZA; MOLECULAR-BASIS; PANDEMIC H1N1; HONG-KONG; H5N1 VIRUSES; HOST-RANGE; ADAPTATION; REPLICATION; POULTRY	H9N2 influenza viruses have been circulating worldwide in multiple avian species and have repeatedly infected humans to cause typical disease. The continued avian-to-human interspecies transmission of H9N2 viruses raises concerns about the possibility of viral adaption with increased virulence for humans. To investigate the genetic basis of H9N2 influenza virus host range and pathogenicity in mammals, we generated a mouse-adapted H9N2 virus (SD16-MA) that possessed significantly higher virulence than wide-type virus (SD16). Increased virulence was detectable after 8 sequential lung passages in mice. Five amino acid substitutions were found in the genome of SD16-MA compared with SD16 virus: PB2 (M147L, V250G and E627K), HA (L226Q) and M1 (R210K). Assessments of replication in mice showed that all of the SD16-MA PB2, HA and M1 genome segments increased virus replication; however, only the mouse-adapted PB2 significantly increased virulence. Although the PB2 E627K amino acid substitution enhanced viral polymerase activity and replication, none of the single mutations of mouse adapted PB2 could confer increased virulence on the SD16 backbone. The combination of M147L and E627K significantly enhanced viral replication ability and virulence in mice. Thus, our results show that the combination of PB2 amino acids at position 147 and 627 is critical for the increased pathogenicity of H9N2 influenza virus in mammalian host.	[Wang, Jingjing; Sun, Yipeng; Xu, Qi; Tan, Yuanyuan; Pu, Juan; Yang, Hanchun; Liu, Jinhua] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China; [Brown, Earl G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Brown, Earl G.] Univ Ottawa, Fac Med, Emerging Pathogens Res Ctr, Ottawa, ON, Canada; [Liu, Jinhua] Shandong Anim Dis Control Ctr, Jinan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; University of Ottawa; University of Ottawa	Liu, JH (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China.	ljh@cau.edu.cn			National Basic Research Program (973 Program) [2011CB504702]; National Natural Science Foundation of China [30901072]; Taishan Scholar Foundation	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Foundation	This work was supported by the National Basic Research Program (973 Program) (No. 2011CB504702) and the National Natural Science Foundation of China (No. 30901072). Jinhua Liu was also funded by the Taishan Scholar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2010, AVIAN DIS, V54, P313, DOI 10.1637/8781-040109-Reg.1; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Bi JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013063; Bogs J, 2011, J VIROL, V85, P10691, DOI 10.1128/JVI.00786-11; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; HIRST GK, 1947, J EXP MED, V86, P357, DOI 10.1084/jem.86.5.357; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; KAVERIN NV, 1989, ARCH VIROL, V105, P29, DOI 10.1007/BF01311114; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu QF, 2012, J VIROL, V86, P1233, DOI 10.1128/JVI.05699-11; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Panshin A, 2010, VIRUS GENES, V41, P396, DOI 10.1007/s11262-010-0522-3; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; RAUT S, 1975, J MED MICROBIOL, V8, P127, DOI 10.1099/00222615-8-1-127; Rolling T, 2009, J VIROL, V83, P6673, DOI 10.1128/JVI.00212-09; RUDNEVA IA, 1986, ARCH VIROL, V90, P237, DOI 10.1007/BF01317373; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun Y, 2010, VET MICROBIOL; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; WYDE PR, 1977, INFECT IMMUN, V15, P221, DOI 10.1128/IAI.15.1.221-229.1977; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Yu H, 2011, VET MICROBIOL, V149, P254, DOI 10.1016/j.vetmic.2010.11.008; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10	64	53	57	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40752	10.1371/journal.pone.0040752	http://dx.doi.org/10.1371/journal.pone.0040752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808250	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500077
J	Deleon, O; Puglise, JM; Liu, FM; Smits, J; ter Beest, MB; Zegers, MM				Deleon, Orlando; Puglise, Jason M.; Liu, Fengming; Smits, Jos; ter Beest, Martin B.; Zegers, Mirjam M.			Pak1 Regulates the Orientation of Apical Polarization and Lumen Formation by Distinct Pathways	PLOS ONE			English	Article							CELL-POLARITY; EXTRACELLULAR-MATRIX; SPINDLE ORIENTATION; MYOSIN-II; KINASE; PHOSPHORYLATION; PROTEIN; CDC42; RAC1; MORPHOGENESIS	The development of the basic architecture of branching tubules enclosing a central lumen that characterizes most epithelial organs crucially depends on the apico-basolateral polarization of epithelial cells. Signals from the extracellular matrix control the orientation of the apical surface, so that it faces the lumen interior, opposite to cell-matrix adhesion sites. This orientation of the apical surface is thought to be intrinsically linked to the formation of single lumens. We previously demonstrated in three-dimensional cyst cultures of Madin-Darby canine kidney (MDCK) cells that signaling by beta 1 integrins regulates the orientation of the apical surface, via a mechanism that depends on the activity of the small GTPase Rac1. Here, we investigated whether the Rac1 effector Pak1 is a downstream effector in this pathway. Expression of constitutive active Pak1 phenocopies the effect of beta 1 integrin inhibition in that it misorients the apical surface and induces a multilumen phenotype. The misorientation of apical surfaces depends on the interaction of active Pak1 with PIX proteins and is linked to defects in basement membrane assembly. In contrast, the multilumen phenotype was independent of PIX and the basement membrane. Therefore, Pak1 likely regulates apical polarization and lumen formation by two distinct pathways.	[Deleon, Orlando; Puglise, Jason M.; Liu, Fengming; ter Beest, Martin B.; Zegers, Mirjam M.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Zegers, Mirjam M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Smits, Jos; Zegers, Mirjam M.] Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Cell Biol, NL-6525 GA Nijmegen, Netherlands	University of Chicago; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen	Deleon, O (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	m.zegers@ncmls.ru.nl	Zegers, Mirjam/L-3160-2019; Smits, Jos P.H./P-5044-2015; Zegers, Mirjam M P/B-6818-2012	Zegers, Mirjam/0000-0002-1190-4094; Smits, Jos P.H./0000-0003-0915-8624; Zegers, Mirjam M P/0000-0002-1190-4094	NICHD; National Institutes of Health [GM076363, R01 GM076363]; Concern Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076363] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Concern Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Jonathan Chernoff provided the Pak1-L107F construct. Ann-Marie Thompson-Baine and Kaitlin Swanson are acknowledged for excellent technical support. The rat-anti beta 1-integrin monoclonal antibody developed by Caroline Damsky was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, 52242. M.M.Z. was supported by the National Institutes of Health (GM076363) and the Concern Foundation.; M.Z. was supported by funds of the Concern Foundation and the National Institutes of Health (R01 GM076363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gudjonsson T, 2002, J CELL SCI, V115, P39; Guo QS, 2008, EUR J CELL BIOL, V87, P251, DOI 10.1016/j.ejcb.2007.11.004; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Hunter MP, 2010, AM J PHYSIOL-CELL PH, V299, pC21, DOI 10.1152/ajpcell.00543.2009; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Liu FM, 2010, MOL CELL BIOL, V30, P1971, DOI 10.1128/MCB.01247-09; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Ng YW, 2010, STRUCTURE, V18, P879, DOI 10.1016/j.str.2010.04.011; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Ojakian GK, 2001, J CELL SCI, V114, P941; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pirraglia C, 2010, DEVELOPMENT, V137, P4177, DOI 10.1242/dev.048827; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Schluter MA, 2009, J AM SOC NEPHROL, V20, P1444, DOI 10.1681/ASN.2008090949; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; SCHWIMMER R, 1995, J CELL SCI, V108, P2487; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; VEGASALAS DE, 1987, J CELL BIOL, V104, P905, DOI 10.1083/jcb.104.4.905; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zegers M, 2008, INT REV CEL MOL BIO, V267, P253, DOI 10.1016/S1937-6448(08)00606-0; Zegers MMP, 2003, EMBO J, V22, P4155, DOI 10.1093/emboj/cdg398; Zeng DH, 2006, BIOPHYS J, V90, P4380, DOI 10.1529/biophysj.105.073494; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zuk A, 1996, J CELL SCI, V109, P1875	58	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41039	10.1371/journal.pone.0041039	http://dx.doi.org/10.1371/journal.pone.0041039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815903	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900069
J	Khanna, R; Flanagan, JJ; Feng, J; Soska, R; Frascella, M; Pellegrino, LJ; Lun, Y; Guillen, D; Lockhart, DJ; Valenzano, KJ				Khanna, Richie; Flanagan, John J.; Feng, Jessie; Soska, Rebecca; Frascella, Michelle; Pellegrino, Lee J.; Lun, Yi; Guillen, Darlene; Lockhart, David J.; Valenzano, Kenneth J.			The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid alpha-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; LONG-TERM; ALGLUCOSIDASE ALPHA; MUSCLE-CELLS; STORAGE; MICE; STABILITY; FIBROBLASTS; DEFICIENCIES; INDUCTION	Pompe disease is an inherited lysosomal storage disease that results from a deficiency in the enzyme acid alpha-glucosidase (GAA), and is characterized by progressive accumulation of lysosomal glycogen primarily in heart and skeletal muscles. Recombinant human GAA (rhGAA) is the only approved enzyme replacement therapy (ERT) available for the treatment of Pompe disease. Although rhGAA has been shown to slow disease progression and improve some of the pathophysiogical manifestations, the infused enzyme tends to be unstable at neutral pH and body temperature, shows low uptake into some key target tissues, and may elicit immune responses that adversely affect tolerability and efficacy. We hypothesized that co-administration of the orally-available, small molecule pharmacological chaperone AT2220 (1-deoxynojirimycin hydrochloride, duvoglustat hydrochloride) may improve the pharmacological properties of rhGAA via binding and stabilization. AT2220 co-incubation prevented rhGAA denaturation and loss of activity in vitro at neutral pH and 37 degrees C in both buffer and blood. In addition, oral pre-administration of AT2220 to rats led to a greater than two-fold increase in the circulating half-life of intravenous rhGAA. Importantly, co-administration of AT2220 and rhGAA to GAA knock-out (KO) mice resulted in significantly greater rhGAA levels in plasma, and greater uptake and glycogen reduction in heart and skeletal muscles, compared to administration of rhGAA alone. Collectively, these preclinical data highlight the potentially beneficial effects of AT2220 on rhGAA in vitro and in vivo. As such, a Phase 2 clinical study has been initiated to investigate the effects of co-administered AT2220 on rhGAA in Pompe patients.	[Khanna, Richie; Flanagan, John J.; Feng, Jessie; Soska, Rebecca; Frascella, Michelle; Pellegrino, Lee J.; Lun, Yi; Guillen, Darlene; Lockhart, David J.; Valenzano, Kenneth J.] Amicus Therapeut Inc, Cranbury, NJ USA		Khanna, R (corresponding author), Amicus Therapeut Inc, Cranbury, NJ USA.	rkhanna@amicusrx.com						Adera M, 2011, MOL GENET METAB, V102, pS4, DOI 10.1016/j.ymgme.2010.11.011; Amalfitano A, 1999, P NATL ACAD SCI USA, V96, P8861, DOI 10.1073/pnas.96.16.8861; Benjamin ER, 2012, MOL THER, V20, P717, DOI 10.1038/mt.2011.271; Bijvoet AGA, 1998, HUM MOL GENET, V7, P53, DOI 10.1093/hmg/7.1.53; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Chen LR, 2009, J PEDIATR-US, V155, P271, DOI 10.1016/j.jpeds.2009.03.015; de Vries JM, 2010, MOL GENET METAB, V101, P338, DOI 10.1016/j.ymgme.2010.08.009; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Douillard-Guilloux G, 2009, BIOCHEM BIOPH RES CO, V388, P333, DOI 10.1016/j.bbrc.2009.08.006; Drost MR, 2008, MUSCLE NERVE, V37, P251, DOI 10.1002/mus.20896; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Flanagan JJ, 2009, HUM MUTAT, V30, P1683, DOI 10.1002/humu.21121; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; Joseph A, 2008, CLIN EXP IMMUNOL, V152, P138, DOI 10.1111/j.1365-2249.2008.03602.x; Khanna R, 2009, NEUROMUSCULAR DISORD, V19, P592, DOI 10.1016/j.nmd.2009.06.155; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Kishnani PS, 2004, J PEDIATR-US, V144, pS35, DOI 10.1016/j.jpeds.2004.01.053; Koeberl DD, 2011, MOL GENET METAB, V103, P107, DOI 10.1016/j.ymgme.2011.02.006; Lee CJ, 2011, J CARDIOL, V57, P115, DOI 10.1016/j.jjcc.2010.08.003; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Mendelsohn NJ, 2009, NEW ENGL J MED, V360, P194, DOI 10.1056/NEJMc0806809; Myozyme package insert, 2006, MYOZ PACK INS; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Okumiya T, 2007, MOL GENET METAB, V90, P49, DOI 10.1016/j.ymgme.2006.09.010; Parenti G, 2007, MOL THER, V15, P508, DOI 10.1038/sj.mt.6300074; Porto C, 2012, J INHERIT METAB DIS, V35, P513, DOI 10.1007/s10545-011-9424-3; Porto C, 2009, MOL THER, V17, P964, DOI 10.1038/mt.2009.53; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2003, TRANSGENIC RES, V12, P171, DOI 10.1023/A:1022998010833; REUSER AJJ, 1984, EXP CELL RES, V155, P178, DOI 10.1016/0014-4827(84)90779-1; Schoser B, 2008, NEUROTHERAPEUTICS, V5, P569, DOI 10.1016/j.nurt.2008.08.009; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Sidman RL, 2008, J NEUROPATH EXP NEUR, V67, P803, DOI 10.1097/NEN.0b013e3181815994; Strothotte S, 2010, J NEUROL, V257, P91, DOI 10.1007/s00415-009-5275-3; Sun BD, 2010, MOL THER, V18, P353, DOI 10.1038/mt.2009.195; Thai R, 2004, J BIOL CHEM, V279, P50257, DOI 10.1074/jbc.M405738200; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; Van den Hout H, 2000, LANCET, V356, P397, DOI 10.1016/S0140-6736(00)02533-2; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; van Til NP, 2010, BLOOD, V115, P5329, DOI 10.1182/blood-2009-11-252874; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364	50	59	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40776	10.1371/journal.pone.0040776	http://dx.doi.org/10.1371/journal.pone.0040776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815812	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900045
J	van Hoogmoed, AH; van den Brink, D; Janzen, G				van Hoogmoed, Anne H.; van den Brink, Danielle; Janzen, Gabriele			Electrophysiological Correlates of Object Location and Object Identity Processing in Spatial Scenes	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TOP-DOWN FACILITATION; WORKING-MEMORY; RECOGNITION MEMORY; VISUAL AWARENESS; CHANGE BLINDNESS; MACAQUE MONKEY; HUMAN BRAIN; CORTEX; ATTENTION	The ability to quickly detect changes in our surroundings has been crucial to human adaption and survival. In everyday life we often need to identify whether an object is new and if an object has changed its location. In the current event-related potential (ERP) study we investigated the electrophysiological correlates and the time course in detecting different types of changes of an object's location and identity. In a delayed match-to-sample task participants had to indicate whether two consecutive scenes containing a road, a house, and two objects, were either the same or different. In six randomly intermixed conditions the second scene was identical, one of the objects had changed its identity, one of the objects had changed its location, or the objects had switched locations. The results reveal different time courses for the processing of identity and location changes in spatial scenes. Whereas location changes elicited a posterior N2 effect, indicating early mismatch detection, followed by a P3 effect reflecting post-perceptual processing, identity changes elicited an anterior N3 effect, which was delayed and functionally distinct from the N2 effect found for the location changes. The condition in which two objects switched position elicited a late ERP effect, reflected by a P3 effect similar to that obtained for the location changes. In sum, this study is the first to cohesively show different time courses for the processing of location changes, identity changes, and object switches in spatial scenes, which manifest themselves in different electrophysiological correlates.	[van Hoogmoed, Anne H.; van den Brink, Danielle; Janzen, Gabriele] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van Hoogmoed, Anne H.; van den Brink, Danielle; Janzen, Gabriele] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Hoogmoed, AH (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	anne.vanhoogmoed@donders.ru.nl	van den Brink, Danielle/D-6485-2012; Janzen, Gabriele/G-2058-2012	van Hoogmoed, Anne/0000-0001-9038-9993	Netherlands Organization for Scientific Research [452-07-015]; European Commission (ERC) [204643]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission (ERC)(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC))	This work was supported by the Netherlands Organization for Scientific Research (Vidi Grant no. 452-07-015) and by the European Commission (ERC Starting Independent Researcher Grant no. 204643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bornstein MH, 2011, INFANT BEHAV DEV, V34, P206, DOI 10.1016/j.infbeh.2010.12.010; Busch NA, 2010, J COGNITIVE NEUROSCI, V22, P1852, DOI 10.1162/jocn.2009.21294; Cichy RM, 2011, NEUROIMAGE, V54, P2297, DOI 10.1016/j.neuroimage.2010.09.044; CZIGLER I, 1990, PSYCHOPHYSIOLOGY, V27, P669, DOI 10.1111/j.1469-8986.1990.tb03191.x; De Cesarei A, 2011, PSYCHON B REV, V18, P840, DOI 10.3758/s13423-011-0133-6; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Eddy M, 2006, PSYCHOPHYSIOLOGY, V43, P564, DOI 10.1111/j.1469-8986.2006.00455.x; Eimer M, 2005, PSYCHOPHYSIOLOGY, V42, P328, DOI 10.1111/j.1469-8986.2005.00285.x; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Haxby JV, 1994, J NEUROSCI, V14, P6226; Huang TR, 2010, PSYCHOL REV, V117, P1080, DOI 10.1037/a0020664; Jackson MC, 2011, HUM BRAIN MAPP, V32, P1330, DOI 10.1002/hbm.21112; Jellema T, 2004, CEREB CORTEX, V14, P781, DOI 10.1093/cercor/bhh038; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Koivisto M, 2003, PSYCHOPHYSIOLOGY, V40, P423, DOI 10.1111/1469-8986.00044; Koivisto M, 2010, NEUROSCI BIOBEHAV R, V34, P922, DOI 10.1016/j.neubiorev.2009.12.002; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; MacEvoy SP, 2011, NAT NEUROSCI, V14, P1323, DOI 10.1038/nn.2903; Mazza V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017453; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Mecklinger A, 1996, J COGNITIVE NEUROSCI, V8, P453, DOI 10.1162/jocn.1996.8.5.453; Mecklinger A, 1996, COGNITIVE BRAIN RES, V4, P211, DOI 10.1016/S0926-6410(96)00034-1; Mecklinger A, 1998, MEM COGNITION, V26, P1068, DOI 10.3758/BF03201184; Mecklinger A, 1998, NEUROPSYCHOLOGIA, V36, P441, DOI 10.1016/S0028-3932(97)00128-0; Munk MHJ, 2002, CEREB CORTEX, V12, P866, DOI 10.1093/cercor/12.8.866; Murphy JS, 2009, BIOL PSYCHOL, V82, P234, DOI 10.1016/j.biopsycho.2009.08.002; Oostenveld R, 2011, COMP INTELLIGENCE NE, DOI 10.1155/2011/156869; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Pihlajamaki M, 2005, EUR J NEUROSCI, V22, P2095, DOI 10.1111/j.1460-9568.2005.04380.x; Potts GF, 1996, BRAIN TOPOGR, V9, P3, DOI 10.1007/BF01191637; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Simon-Thomas ER, 2003, COGNITIVE BRAIN RES, V16, P457, DOI 10.1016/S0926-6410(03)00060-0; Singhal A, 2006, INT J NEUROSCI, V116, P1457, DOI 10.1080/00207450500514342; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsivilis D, 2001, NEURON, V31, P497, DOI 10.1016/S0896-6273(01)00376-2; Underleider LG, 1982, ANAL VISUAL BEHAV, P549; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; van der Ham IJM, 2010, INT J PSYCHOPHYSIOL, V77, P83, DOI 10.1016/j.ijpsycho.2010.04.008; van der Lubbe RHJ, 2006, NEUROPSYCHOLOGIA, V44, P1547, DOI 10.1016/j.neuropsychologia.2006.01.019; Wu CT, 2011, J COGNITIVE NEUROSCI, V23, P4094, DOI 10.1162/jocn_a_00045	45	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41180	10.1371/journal.pone.0041180	http://dx.doi.org/10.1371/journal.pone.0041180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815960	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900090
J	McCullough, C; Wang, MX; Rong, LJ; Caffrey, M				McCullough, Christopher; Wang, Minxiu; Rong, Lijun; Caffrey, Michael			Characterization of Influenza Hemagglutinin Interactions with Receptor by NMR	PLOS ONE			English	Article							TRANSFER DIFFERENCE NMR; VIRUS; SPECIFICITY; BINDING; H5N1; TROPISM; LIGAND; ENTRY	In influenza, the envelope protein hemagglutinin (HA) plays a critical role in viral entry by first binding to sialic acid receptors on the cell surface and subsequently mediating fusion of the viral and target membranes. In this work, the receptor binding properties of influenza A HA from different subtypes (H1 A/California/04/09, H5 A/Vietnam/1205/04, H5 A/bar-headed goose/Qinghai/1A/05, and H9 A/Hong Kong/1073/99) have been characterized by NMR spectroscopy. Using saturation transfer difference (STD) NMR, we find that all HAs bind to the receptor analogs 2,3-sialyllactose and 2,6-sialyllactose, with subtle differences in the binding mode. Using competition STD NMR, we determine the receptor preferences for the HA subtypes. We find that H5-Qinghai and H9-Hong Kong HA bind to both receptor analogs with similar affinity. On the other hand, H1 exhibits a clear preference for 2,6-sialyllactose while H5-Vietnam exhibits a clear preference for 2,3-sialyllactose. Together, these results are interpreted within the context of differences in both the amino acid sequence and structures of HA from the different subtypes in determining receptor preference.	[McCullough, Christopher; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60680 USA; [Wang, Minxiu; Rong, Lijun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	McCullough, C (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60680 USA.	caffrey@uic.edu			University of Illinois at Chicago Center for Structural Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101676] Funding Source: NIH RePORTER	University of Illinois at Chicago Center for Structural Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by the University of Illinois at Chicago Center for Structural Biology. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Celigoy J, 2011, J BIOL CHEM, V286, P23975, DOI 10.1074/jbc.M111.251025; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guo Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-39; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Haselhorst T, 2008, ANGEW CHEM INT EDIT, V47, P1910, DOI 10.1002/anie.200704872; Jiang SK, 2004, BIOCHEMISTRY-US, V43, P1847, DOI 10.1021/bi035490x; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kovacova A, 2002, VIRUS GENES, V24, P57, DOI 10.1023/A:1014038120979; Lagoja IM, 2008, MED RES REV, V28, P1, DOI 10.1002/med.20096; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Liao HY, 2010, J AM CHEM SOC, V132, P14849, DOI 10.1021/ja104657b; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Rumschlag-Booms E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-76; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1	35	34	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e33958	10.1371/journal.pone.0033958	http://dx.doi.org/10.1371/journal.pone.0033958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815674	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100001
J	Steiert, B; Raue, A; Timmer, J; Kreutz, C				Steiert, Bernhard; Raue, Andreas; Timmer, Jens; Kreutz, Clemens			Experimental Design for Parameter Estimation of Gene Regulatory Networks	PLOS ONE			English	Article							RECEPTOR; RANGE	Systems biology aims for building quantitative models to address unresolved issues in molecular biology. In order to describe the behavior of biological cells adequately, gene regulatory networks (GRNs) are intensively investigated. As the validity of models built for GRNs depends crucially on the kinetic rates, various methods have been developed to estimate these parameters from experimental data. For this purpose, it is favorable to choose the experimental conditions yielding maximal information. However, existing experimental design principles often rely on unfulfilled mathematical assumptions or become computationally demanding with growing model complexity. To solve this problem, we combined advanced methods for parameter and uncertainty estimation with experimental design considerations. As a showcase, we optimized three simulated GRNs in one of the challenges from the Dialogue for Reverse Engineering Assessment and Methods (DREAM). This article presents our approach, which was awarded the best performing procedure at the DREAM6 Estimation of Model Parameters challenge. For fast and reliable parameter estimation, local deterministic optimization of the likelihood was applied. We analyzed identifiability and precision of the estimates by calculating the profile likelihood. Furthermore, the profiles provided a way to uncover a selection of most informative experiments, from which the optimal one was chosen using additional criteria at every step of the design process. In conclusion, we provide a strategy for optimal experimental design and show its successful application on three highly nonlinear dynamic models. Although presented in the context of the GRNs to be inferred for the DREAM6 challenge, the approach is generic and applicable to most types of quantitative models in systems biology and other disciplines.	[Steiert, Bernhard; Raue, Andreas; Timmer, Jens; Kreutz, Clemens] Univ Freiburg, Inst Phys, D-79106 Freiburg, Germany; [Steiert, Bernhard; Raue, Andreas; Timmer, Jens; Kreutz, Clemens] Univ Freiburg, Freiburg Ctr Syst Biol, D-79106 Freiburg, Germany; [Steiert, Bernhard; Timmer, Jens] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Timmer, Jens] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Linkoping University	Steiert, B (corresponding author), Univ Freiburg, Inst Phys, Hugstetter Str 55, D-79106 Freiburg, Germany.	bernhard.steiert@frias.uni-freiburg.de	Kreutz, Clemens/ABC-9732-2020	Kreutz, Clemens/0000-0002-8796-5766	German Federal Ministry of Education and Research [0315766-VirtualLiver, 0313921-FRISYS]; FP7 EU project CancerSys [HEALTH-F4-2008-223188]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); FP7 EU project CancerSys	The authors acknowledge financial support by the grants [0315766-VirtualLiver] (http://www.virtual-liver.de/) and [0313921-FRISYS] (http://www.frisys.biologie.uni-freiburg.de/) provided by the German Federal Ministry of Education and Research, as well as the FP7 EU project CancerSys [HEALTH-F4-2008-223188] (http://www.ifado.de/cancersys/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Conn A. R., 2009, MPS SIAM SERIES OPTI; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Kreutz C., 2011, 11070013 ARXIV; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Kurien BT, 2006, METHODS, V38, P283, DOI 10.1016/j.ymeth.2005.11.007; LEIS JR, 1988, ACM T MATH SOFTWARE, V14, P45, DOI 10.1145/42288.46156; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Raue A, 2010, CHAOS, V20, DOI 10.1063/1.3528102; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]	16	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40052	10.1371/journal.pone.0040052	http://dx.doi.org/10.1371/journal.pone.0040052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815723	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100026
J	Stryjek, R; Modlinska, K; Pisula, W				Stryjek, Rafal; Modlinska, Klaudia; Pisula, Wojciech			Species Specific Behavioural Patterns (Digging and Swimming) and Reaction to Novel Objects in Wild Type, Wistar, Sprague-Dawley and Brown Norway Rats	PLOS ONE			English	Article							RATTUS-NORVEGICUS; SOCIAL INTERACTIONS; LABORATORY RATS; ALBINO-RATS; DOMESTICATION; PLACE; NEOPHOBIA; CONSEQUENCES; ENVIRONMENT; EXPERIENCE	Background: The purpose of the present study was to analyse species-specific forms of behaviour (digging and swimming) and response to novelty in laboratory rats and their wild type counterparts at a very early stage of laboratorization. Three behavioural phenomena were taken into account: burrowing, spontaneous swimming, and neophobic behaviour. Principal Findings: Wild-type rats and three strains of laboratory rats were involved in experiments: Warsaw-Wild-Captive-Pisula-Stryjek (WWCPS), Wistar, Sprague-Dawley, and Brown Norway rats were compared in spontaneous swimming test, while WWCPS and Wistar rats were studied in burrowing and neophobia experiments. Wild rats were found to be faster at building tunnels than Wistar rats and at constructing more complex burrow systems. The experiment on neophobia showed that Wistar rats exhibited less neophobic responses and were more often trapped. WWCPS rats showed highly neophobic behaviour and were rarely trapped in this experiment. The experiment on swimming showed that WWCPS rats showed more complex water tank related activity than their laboratory counterparts. They swam and explored under surface environment. Conclusions: The three experiments showed profound behavioural differences in quasi-natural forms of behaviour between wild type rats (WWCPS) and three laboratory strains frequently used in behavioural studies.	[Stryjek, Rafal; Pisula, Wojciech] Polish Acad Sci, Inst Psychol, Warsaw, Poland; [Stryjek, Rafal; Modlinska, Klaudia] Helena Chodkowska Univ Management & Law, Warsaw, Poland	Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences	Stryjek, R (corresponding author), Polish Acad Sci, Inst Psychol, Warsaw, Poland.	wojciech.pisula@wp.pl	Pisula, Wojciech/AAR-3618-2020	Pisula, Wojciech/0000-0001-5777-0549; Modlinska, Klaudia/0000-0002-2161-9019; Stryjek, Rafal/0000-0003-3889-9341	Polish Ministry of Science [UMO-2011/01/B/HS6/02458]	Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This research project was funded by the Polish Ministry of Science #UMO-2011/01/B/HS6/02458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1992, PHYSIOL BEHAV, V52, P781, DOI 10.1016/0031-9384(92)90414-W; Aguilar R, 2002, BEHAV GENET, V32, P127, DOI 10.1023/A:1015253807488; Barker DJ, 2010, BEHAV BRAIN RES, V214, P402, DOI 10.1016/j.bbr.2010.06.020; BARNETT SA, 1981, AGGRESSIVE BEHAV, V7, P259, DOI 10.1002/1098-2337(1981)7:3<259::AID-AB2480070309>3.0.CO;2-V; BARNETT SA, 1979, AGGRESSIVE BEHAV, V5, P105, DOI 10.1002/1098-2337(1979)5:2<105::AID-AB2480050202>3.0.CO;2-U; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Barnett SA, 2009, RAT STUDY BEHAV; Beach FA, 1950, AM PSYCHOL, V5, P115, DOI 10.1037/h0056510; Benhamou S, 1998, J COMP PSYCHOL, V112, P317, DOI 10.1037/0735-7036.112.3.317; BLANCHARD RJ, 1986, J COMP PSYCHOL, V100, P101, DOI 10.1037/0735-7036.100.2.101; BOICE R, 1977, J COMP PHYSIOL PSYCH, V91, P649, DOI 10.1037/h0077338; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; CASTLE WE, 1947, P NATL ACAD SCI USA, V33, P109, DOI 10.1073/pnas.33.5.109; CLUTTONBROCK J, 1977, SCIENCE, V197, P1340, DOI 10.1126/science.197.4311.1340; COTTAM C, 1948, J MAMMAL, V29, P299, DOI 10.1093/jmammal/29.3.299; COWAN PE, 1977, J COMP PHYSIOL PSYCH, V91, P63, DOI 10.1037/h0077297; Deacon RMJ, 2009, BEHAV BRAIN RES, V200, P128, DOI 10.1016/j.bbr.2009.01.007; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DODWELL PC, 1960, J COMP PHYSIOL PSYCH, V53, P422, DOI 10.1037/h0048587; FRANK H, 1982, APPL ANIM ETHOL, V8, P507, DOI 10.1016/0304-3762(82)90215-2; GALEF BG, 1980, J COMP PHYSIOL PSYCH, V94, P416, DOI 10.1037/h0077678; Hamilton DA, 2009, J EXP PSYCHOL-ANIM B, V35, P271, DOI 10.1037/a0013260; Harker KT, 2002, BEHAV BRAIN RES, V134, P467; HUCK UW, 1975, J COMP PHYSIOL PSYCH, V89, P892, DOI 10.1037/h0077160; HUCK UW, 1976, ANIM BEHAV, V24, P364; Jensen P, 2010, ANIM WELFARE, V19, P7; Keeler CE, 1947, J TENN ACAD SCI, V22, P202; KING HELEN DEAN, 1939, AMER ANAT MEMOIR, V17, P1; KITAOKA A, 1994, BEHAV PROCESS, V31, P13, DOI 10.1016/0376-6357(94)90034-5; Kunzl C, 1999, HORM BEHAV, V35, P28, DOI 10.1006/hbeh.1998.1493; LICKLITER R, 1990, J COMP PSYCHOL, V104, P211, DOI 10.1037/0735-7036.104.3.211; LOCKARD RB, 1968, AM PSYCHOL, V23, P734, DOI 10.1037/h0026726; MASON WA, 1953, J COMP PHYSIOL PSYCH, V46, P159, DOI 10.1037/h0059146; MILLAR RD, 1975, J COMP PHYSIOL PSYCH, V89, P913, DOI 10.1037/h0077161; MITCHELL D, 1976, J COMP PHYSIOL PSYCH, V90, P190, DOI 10.1037/h0077196; Pisula W., 2004, POL PSYCHOL BULL, V35, P99; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRICE EO, 1972, J COMP PHYSIOL PSYCH, V79, P51, DOI 10.1037/h0032552; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; RICHTER CP, 1959, AM PSYCHOL, V14, P18, DOI 10.1037/h0043834; Robinson R., 1965, GENETICS NORWAY RAT; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Sachs BD, 1996, PHYSIOL BEHAV, V60, P803, DOI 10.1016/S0031-9384(96)00158-8; Stryjek R, 2008, POL PSYCHOL BULL, V39, P6770; Stryjek R, 2008, ACTA NEUROBIOL EXP, V68, P407; Stryjek R, 2010, LAB ANIMAL, V39, P279, DOI 10.1038/laban0910-279; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813	49	31	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40642	10.1371/journal.pone.0040642	http://dx.doi.org/10.1371/journal.pone.0040642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815778	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100048
J	Virtanen, JK; Laukkanen, JA; Mursu, J; Voutilainen, S; Tuomainen, TP				Virtanen, Jyrki K.; Laukkanen, Jari A.; Mursu, Jaakko; Voutilainen, Sari; Tuomainen, Tomi-Pekka			Serum Long-Chain n-3 Polyunsaturated Fatty Acids, Mercury, and Risk of Sudden Cardiac Death in Men: A Prospective Population-Based Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ACUTE CORONARY EVENTS; EASTERN FINNISH MEN; MYOCARDIAL-INFARCTION; FISH CONSUMPTION; DOCOSAHEXAENOIC ACID; CARDIOVASCULAR-DISEASE; EICOSAPENTAENOIC ACID; LIPID-PEROXIDATION; CONTROLLED-TRIAL	Objectives: Fish consumption has been associated with reduced risk of cardiovascular diseases (CVD), especially sudden cardiac death (SCD). Fish is the major source of long-chain n-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic acid and docosahexaenoic acid. It is also a major source of methylmercury, which was associated with increased risk of CVD in this study population. Impact of interaction between long-chain n-3 PUFA and methylmercury on the SCD risk is unknown. Methods: A total of 1857 men from the prospective, population-based Kuopio Ischaemic Heart Disease Risk Factor study, aged 42-60 years and free of CVD at baseline in 1984-1989, were studied. Serum long-chain n-3 PUFA was used as the marker for long-chain n-3 PUFA intake and hair mercury as the marker for mercury exposure. Results: During the mean follow-up of 20.1 years, 91 SCD events occurred. In the multivariate Cox proportional hazards regression models, serum long-chain n-3 PUFA concentration was not associated with the risk of SCD until hair mercury was accounted for; then the hazard ratio (HR) in the highest vs. lowest tertile was 0.54 [95% confidence interval (CI) 0.32 to 0.91, p for trend = 0.046]. When the analyses were stratified by hair mercury content, among those with lower hair mercury, each 0.5 percentage unit increase in the serum long-chain n-3 PUFA was associated with HR of 0.77 (95% CI 0.64 to 0.93), whereas no association was seen among those with higher hair mercury (p for interaction = 0.01). Among the individual long-chain n-3 PUFA, docosahexaenoic acid was most strongly associated with the risk. Conclusion: High exposure to mercury may reduce the benefits of long-chain n-3 PUFA on SCD.	[Virtanen, Jyrki K.; Laukkanen, Jari A.; Mursu, Jaakko; Voutilainen, Sari; Tuomainen, Tomi-Pekka] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland	University of Eastern Finland	Virtanen, JK (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	jyrki.virtanen@uef.fi	Virtanen, Jyrki/G-5149-2013; Laukkanen, Jari Antero/N-2196-2019; Laukkanen, Jari A/I-4528-2017; Virtanen, Jyrki/AAC-8945-2020	Virtanen, Jyrki/0000-0002-0648-999X; Laukkanen, Jari Antero/0000-0002-3738-1586; Laukkanen, Jari A/0000-0002-3738-1586; Virtanen, Jyrki/0000-0002-0648-999X	Juho Vainio Foundation; Finnish Cultural Foundation; Academy of Finland [121206]	Juho Vainio Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland)	The work was supported by the Juho Vainio Foundation (www.juhovainionsaatio.fi), North Savo Regional Fund of the Finnish Cultural Foundation (www.skr.fi), and by the Academy of Finland grant #121206 (www.aka.fi) to JKV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; Brouwer IA, 2009, EUR HEART J, V30, P820, DOI 10.1093/eurheartj/ehp003; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Christensen JH, 1996, BMJ-BRIT MED J, V312, P677, DOI 10.1136/bmj.312.7032.677; Christensen JH, 1999, AM J CLIN NUTR, V70, P331; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Engstrom KS, 2008, ENVIRON HEALTH PERSP, V116, P734, DOI 10.1289/ehp.10804; Fukuda K, 2005, CIRC RES, V97, P1262, DOI 10.1161/01.RES.0000195844.31466.e9; Grimsgaard S, 1998, AM J CLIN NUTR, V68, P52, DOI 10.1093/ajcn/68.1.52; Groth E, 2010, ENVIRON RES, V110, P226, DOI 10.1016/j.envres.2009.12.006; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hallgren CG, 2001, BRIT J NUTR, V86, P397, DOI 10.1079/BJN2001415; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Hunter D, 1998, NUTR EPIDEMIOLOGY, P174, DOI DOI 10.1093/ACPR0F:OSO/9780195122978.003.09; IPCS, 1990, ENV HLTH CRIT 101 ME; KANG JX, 1994, P NATL ACAD SCI USA, V91, P9886, DOI 10.1073/pnas.91.21.9886; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; McLennan P, 1996, EUR J PHARMACOL, V300, P83, DOI 10.1016/0014-2999(95)00861-6; McLennan PL, 2001, LIPIDS, V36, pS111, DOI 10.1007/s11745-001-0692-x; Mori TA, 1999, HYPERTENSION, V34, P253, DOI 10.1161/01.HYP.34.2.253; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2008, CIRCULATION, V117, P1130, DOI 10.1161/CIRCULATIONAHA.107.732826; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2011, NEW ENGL J MED, V364, P1116, DOI 10.1056/NEJMoa1006876; NIKKARI T, 1995, ANN MED, V27, P491, DOI 10.3109/07853899709002458; Roman HA, 2011, ENVIRON HEALTH PERSP, V119, P607, DOI 10.1289/ehp.1003012; SALONEN JT, 1995, CIRCULATION, V91, P645, DOI 10.1161/01.CIR.91.3.645; SALONEN JT, 1988, ANN CLIN RES, V20, P46; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Streppel MT, 2008, EUR HEART J, V29, P2024, DOI 10.1093/eurheartj/ehn294; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Virtanen JK, 2007, J NUTR BIOCHEM, V18, P75, DOI 10.1016/j.jnutbio.2006.05.001; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; Wennberg M, 2011, AM J CLIN NUTR, V93, P27, DOI 10.3945/ajcn.2010.29408	47	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41046	10.1371/journal.pone.0041046	http://dx.doi.org/10.1371/journal.pone.0041046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815906	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100111
J	Vrljicak, P; Cullum, R; Xu, E; Chang, ACY; Wederell, ED; Bilenky, M; Jones, SJM; Marra, MA; Karsan, A; Hoodless, PA				Vrljicak, Pavle; Cullum, Rebecca; Xu, Eric; Chang, Alex C. Y.; Wederell, Elizabeth D.; Bilenky, Mikhail; Jones, Steven J. M.; Marra, Marco A.; Karsan, Aly; Hoodless, Pamela A.			Twist1 Transcriptional Targets in the Developing Atrio-Ventricular Canal of the Mouse	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CUSHION CELL-PROLIFERATION; HEART-VALVE DEVELOPMENT; CARDIAC NEURAL CREST; SNAIL FAMILY GENES; EXPRESSION ANALYSIS; BETA-CATENIN; BHLH PROTEIN; SOX9; DIFFERENTIATION	Malformations of the cardiovascular system are the most common type of birth defect in humans, frequently affecting the formation of valves and septa. During heart valve and septa formation, cells from the atrio-ventricular canal (AVC) and outflow tract (OFT) regions of the heart undergo an epithelial-to-mesenchymal transformation (EMT) and invade the underlying extracellular matrix to give rise to endocardial cushions. Subsequent maturation of newly formed mesenchyme cells leads to thin stress-resistant leaflets. TWIST1 is a basic helix-loop-helix transcription factor expressed in newly formed mesenchyme cells of the AVC and OFT that has been shown to play roles in cell survival, cell proliferation and differentiation. However, the downstream targets of TWIST1 during heart valve formation remain unclear. To identify genes important for heart valve development downstream of TWIST1, we performed global gene expression profiling of AVC, OFT, atria and ventricles of the embryonic day 10.5 mouse heart by tag-sequencing (Tag-seq). Using this resource we identified a novel set of 939 genes, including 123 regulators of transcription, enriched in the valve forming regions of the heart. We compared these genes to a Tag-seq library from the Twist1 null developing valves revealing significant gene expression changes. These changes were consistent with a role of TWIST1 in controlling differentiation of mesenchymal cells following their transformation from endothelium in the mouse. To study the role of TWIST1 at the DNA level we performed chromatin immunoprecipitation and identified novel direct targets of TWIST1 in the developing heart valves. Our findings support a role for TWIST1 in the differentiation of AVC mesenchyme post-EMT in the mouse, and suggest that TWIST1 can exert its function by direct DNA binding to activate valve specific gene expression.	[Vrljicak, Pavle; Cullum, Rebecca; Xu, Eric; Wederell, Elizabeth D.; Hoodless, Pamela A.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Vrljicak, Pavle; Jones, Steven J. M.; Marra, Marco A.; Hoodless, Pamela A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Chang, Alex C. Y.; Bilenky, Mikhail; Jones, Steven J. M.; Marra, Marco A.; Karsan, Aly] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Karsan, Aly] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Vrljicak, P (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	hoodless@bccrc.ca	Jones, Steven J/C-3621-2009; Karsan, Aly/K-2067-2015; Marra, Marco A/B-5987-2008	Jones, Steven J/0000-0003-3394-2208; Marra, Marco A/0000-0001-7146-7175; Chang, Alex Chia Yu/0000-0001-9441-4033; Xu, Eric/0000-0003-3399-2184; Hoodless, Pamela/0000-0003-1371-0725	Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Genome Canada; Genome British Columbia	Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Genome Canada(Genome Canada); Genome British Columbia	This research was supported by funding to PH and AK from the Heart and Stroke Foundation of British Columbia and Yukon (www.heartandstroke.bc.ca), and to AK, PH and MM from Genome Canada (www.genomecanada.ca) and Genome British Columbia (www.genomebc.ca). AK, PH and MM are Senior Scholars of the Michael Smith Foundation for Health Research (www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; ANDRESS DL, 1992, J BIOL CHEM, V267, P22467; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Chakraborty S, 2010, DEV BIOL, V347, P167, DOI 10.1016/j.ydbio.2010.08.021; Chakraborty S, 2008, PHYSIOL GENOMICS, V35, P75, DOI 10.1152/physiolgenomics.90212.2008; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng MY, 2009, CLIN EXP METASTAS, V26, P1013, DOI 10.1007/s10585-009-9291-6; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Krawchuk D, 2010, DEV BIOL, V347, P133, DOI 10.1016/j.ydbio.2010.08.015; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Laursen KB, 2007, J BIOL CHEM, V282, P34623, DOI 10.1074/jbc.M707085200; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Loebel DAF, 2005, GENOMICS, V85, P782, DOI 10.1016/j.ygeno.2005.02.001; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MARKWALD RR, 1975, DEV BIOL, V42, P160, DOI 10.1016/0012-1606(75)90321-8; McKnight KD, 2007, DEV DYNAM, V236, P2909, DOI 10.1002/dvdy.21313; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Oram KF, 2005, GENETICS, V170, P971, DOI 10.1534/genetics.105.041277; Oshima A, 2002, J CELL BIOCHEM, V86, P792, DOI 10.1002/jcb.10272; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Raid R, 2009, MECH DEVELOP, V126, P80, DOI 10.1016/j.mod.2008.10.001; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schweickert A, 2008, DEV DYNAM, V237, P3557, DOI 10.1002/dvdy.21638; Shelton EL, 2008, DEV BIOL, V317, P282, DOI 10.1016/j.ydbio.2008.02.037; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Takahashi E, 2004, BIOCHEM BIOPH RES CO, V325, P1136, DOI 10.1016/j.bbrc.2004.10.148; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vincentz JW, 2008, DEV BIOL, V320, P131, DOI 10.1016/j.ydbio.2008.04.037; Vrljicak P, 2010, PHYSIOL GENOMICS, V40, P150, DOI 10.1152/physiolgenomics.00142.2009; Watanabe Y, 2006, DEVELOPMENT, V133, P1625, DOI 10.1242/dev.02344; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Zhao ZY, 2000, DEV DYNAM, V217, P388, DOI 10.1002/(SICI)1097-0177(200004)217:4<388::AID-DVDY6>3.0.CO;2-N; Zhou CJ, 2011, DIAGN CYTOPATHOL, V39, P105, DOI 10.1002/dc.21348	69	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40815	10.1371/journal.pone.0040815	http://dx.doi.org/10.1371/journal.pone.0040815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815831	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100074
J	Waters, JS; Fewell, JH				Waters, James S.; Fewell, Jennifer H.			Information Processing in Social Insect Networks	PLOS ONE			English	Article							ANT; ORGANIZATION; TRANSPORT; EMERGENCE; MOTIFS; TOOL	Investigating local-scale interactions within a network makes it possible to test hypotheses about the mechanisms of global network connectivity and to ask whether there are general rules underlying network function across systems. Here we use motif analysis to determine whether the interactions within social insect colonies resemble the patterns exhibited by other animal associations or if they exhibit characteristics of biological regulatory systems. Colonies exhibit a predominance of feed-forward interaction motifs, in contrast to the densely interconnected clique patterns that characterize human interaction and animal social networks. The regulatory motif signature supports the hypothesis that social insect colonies are shaped by selection for network patterns that integrate colony functionality at the group rather than individual level, and demonstrates the utility of this approach for analysis of selection effects on complex systems across biological levels of organization.	[Waters, James S.; Fewell, Jennifer H.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Waters, JS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	james.waters@asu.edu		Waters, James/0000-0001-7077-9441	National Science Foundation (NSF) [IOS-0446415, IOS-1110796, IOS-0938047]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research is funded by National Science Foundation (NSF) IOS-0446415, IOS-1110796, and IOS-0938047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollazzi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017667; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dubroca L, 2011, PLFIT R; Feigenbaum C, 2010, INSECT SOC, V57, P217, DOI 10.1007/s00040-010-0073-6; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Holbrook CT, 2011, BEHAV ECOL, V22, P960, DOI 10.1093/beheco/arr075; Holldobler B, 2009, SUPERORGANISM BEAUTY, Vxxi; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaluza P, 2008, CHAOS, V18; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moses ME, 2008, J R SOC INTERFACE, V5, P1469, DOI 10.1098/rsif.2008.0091; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Penick CA, 2008, INSECT SOC, V55, P176, DOI 10.1007/s00040-008-0987-4; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; R Core Team, 2016, R FDN STAT COMP; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Sasaki T, 2011, BEHAV ECOL, V22, P276, DOI 10.1093/beheco/arq198; Sendova-Franks AB, 2010, ANIM BEHAV, V79, P473, DOI 10.1016/j.anbehav.2009.11.035; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Waters JS, 2010, AM NAT, V176, P501, DOI 10.1086/656266; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; WILSON EO, 1988, TRENDS ECOL EVOL, V3, P65, DOI 10.1016/0169-5347(88)90018-3	34	45	45	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40337	10.1371/journal.pone.0040337	http://dx.doi.org/10.1371/journal.pone.0040337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815740	Green Published, gold			2022-12-27	WOS:000306466100034
J	Eapen, SA; Netherton, SJ; Sarker, KP; Deng, LL; Chan, A; Riabowol, K; Bonni, S				Eapen, Shawn A.; Netherton, Stuart J.; Sarker, Krishna P.; Deng, Lili; Chan, Angela; Riabowol, Karl; Bonni, Shirin			Identification of a Novel Function for the Chromatin Remodeling Protein ING2 in Muscle Differentiation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P33(ING1); MYOGENIC DIFFERENTIATION; PLANT HOMEODOMAIN; GENE FAMILY; PHD; EXPRESSION; ACTIVATION; RESPONSES; MEDIATOR; FINGER	The inhibitor of growth (ING) family of zinc-finger plant homeodomain (PHD)-containing chromatin remodeling protein controls gene expression and has been implicated in the regulation of cell proliferation and death. However, the role of ING proteins in cell differentiation remains largely unexplored. Here, we identify an essential function for ING2 in muscle differentiation. We find that knockdown of ING2 by RNA interference (RNAi) blocks the differentiation of C2C12 cells into myotubes, suggesting that ING2 regulates the myogenic differentiation program. We also characterize a mechanism by which ING2 drives muscle differentiation. In structure-function analyses, we find that the leucine zipper motif of ING2 contributes to ING2-dependent muscle differentiation. By contrast, the PHD domain, which recognizes the histone H3K4me3 epigenetic mark, inhibits the ability of ING2 to induce muscle differentiation. We also find that the Sin3A-HDAC1 chromatin remodeling complex, which interacts with ING2, plays a critical role in ING2-dependent muscle differentiation. These findings define a novel function for ING2 in muscle differentiation and bear significant implications for our understanding of the role of the ING protein family in cell differentiation and tumor suppression.	[Eapen, Shawn A.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, So Alberta Canc Res Inst, Calgary, AB, Canada; Univ Calgary, Fac Med, Dept Oncol, So Alberta Canc Res Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Eapen, SA (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, So Alberta Canc Res Inst, Calgary, AB, Canada.	sbonni@ucalgary.ca			Alberta Cancer Foundation (ACF); Canadian Institutes of Health Research	Alberta Cancer Foundation (ACF); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by grants from the Alberta Cancer Foundation (ACF), and the Canadian Institutes of Health Research to SB and KR. SJN is an ACB Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Gong W, 2005, INT J BIOCHEM CELL B, V37, P1054, DOI 10.1016/j.biocel.2004.09.008; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Larrieu D, 2010, CELL CYCLE, V9, P3984, DOI 10.4161/cc.9.19.13208; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Netherton SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013971; Paulino AC, 2008, CURR PROB CANCER, V32, P7, DOI 10.1016/j.currproblcancer.2007.11.001; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Russell MW, 2008, BIOCHEM BIOPH RES CO, V374, P490, DOI 10.1016/j.bbrc.2008.07.076; Saito M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015541; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sarker KP, 2008, J BIOL CHEM, V283, P13269, DOI 10.1074/jbc.M708834200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Thalappilly S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021065; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang YM, 2006, FEBS LETT, V580, P3787, DOI 10.1016/j.febslet.2006.05.065; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; Weston AD, 2003, J CELL SCI, V116, P2885, DOI 10.1242/jcs.00525; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790	32	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40684	10.1371/journal.pone.0040684	http://dx.doi.org/10.1371/journal.pone.0040684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808232	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400046
J	Ishikawa, Y; Nishiuchi, H; Hayashi, H; Viswanath, K				Ishikawa, Yoshiki; Nishiuchi, Hiromu; Hayashi, Hana; Viswanath, Kasisomayajula			Socioeconomic Status and Health Communication Inequalities in Japan: A Nationwide Cross-Sectional Survey	PLOS ONE			English	Article							INFORMATION-SEEKING; SOCIAL DETERMINANTS	Background: Considerable evidence suggests that communication inequality is one potential mechanism linking social determinants, particularly socioeconomic status, and health inequalities. This study aimed to examine how dimensions of health communication outcomes (health information seeking, self-efficacy, exposure, and trust) are patterned by socioeconomic status in Japan. Methods: Data of a nationally representative cross-sectional survey of 2,455 people aged 15-75 years in Japan were used for secondary analysis. Measures included socio-demographic characteristics, subjective health, recent health information seeking, self-efficacy in seeking health information, and exposure to and trust in health information from different media. Results: A total of 1,311 participants completed the questionnaire, giving a response rate of 53.6%. Multivariate logistic regression revealed that education and household income, but not employment, were significantly associated with health information seeking and self-efficacy. Socioeconomic status was not associated with exposure to and trust in health information from mass media, but was significantly associated with health information from healthcare providers and the Internet. Conclusion: Health communication outcomes were patterned by socioeconomic status in Japan thus demonstrating the prevalence of health communication inequalities. Providing customized exposure to and enhancing the quality of health information by considering social determinants may contribute to addressing social disparities in health in Japan.	[Ishikawa, Yoshiki] Jichi Med Univ, Dept Publ Hlth, Shimotuke, Tochigi, Japan; [Nishiuchi, Hiromu] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan; [Hayashi, Hana; Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Hayashi, Hana] McCann Healthcare Worldwide Japan Inc, Dept Publ Hlth, Minato Ku, Tokyo, Japan; [Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA	Jichi Medical University; Keio University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Ishikawa, Y (corresponding author), Jichi Med Univ, Dept Publ Hlth, Shimotuke, Tochigi, Japan.	ishikun@gmail.com			Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	The authors would like to acknowledge the financial support from Japanese Ministry of Health, Labour and Welfare (National Healthy Lifestyle Project 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerson LK, 2009, PREV CHRONIC DIS, V6; Beaudoin CE, 2011, INT J MED INFORM, V80, P586, DOI 10.1016/j.ijmedinf.2011.04.003; Benjamin-Garner Ruby, 2002, Ethnicity and Disease, V12, P124; Hay J, 2009, J AM ACAD DERMATOL, V61, P783, DOI 10.1016/j.jaad.2009.04.023; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Lahelma E, 2010, HEALTH PLACE, V16, P61, DOI 10.1016/j.healthplace.2009.08.004; Lewis N, 2011, HLTH COMMUN IN PRESS; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Ministry of Health Labour and Welfare, 2010, INC ITS DISTR SURV; Rutten LJF, 2009, NICOTINE TOB RES, V11, P190, DOI 10.1093/ntr/ntn019; Science Council of Japan, 2011, UND ADDR HLTH DISP J; Viswanath K, 2006, J HEALTH COMMUN, V11, P1, DOI 10.1080/10810730600637426; Viswanath K., 2006, EXAMINING HLTH DISPA; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550	15	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40664	10.1371/journal.pone.0040664	http://dx.doi.org/10.1371/journal.pone.0040664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973NH	22808229	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400045
J	Salomon, C; Westermeier, F; Puebla, C; Arroyo, P; Guzman-Gutierrez, E; Pardo, F; Leiva, A; Casanello, P; Sobrevia, L				Salomon, Carlos; Westermeier, Francisco; Puebla, Carlos; Arroyo, Pablo; Guzman-Gutierrez, Enrique; Pardo, Fabian; Leiva, Andrea; Casanello, Paola; Sobrevia, Luis			Gestational Diabetes Reduces Adenosine Transport in Human Placental Microvascular Endothelium, an Effect Reversed by Insulin	PLOS ONE			English	Article							RECEPTOR ISOFORMS; GLUCOSE; RESISTANCE; MELLITUS; DYSFUNCTION; EXPRESSION; PROTEIN-1; CELLS	Gestational diabetes mellitus (GDM) courses with increased fetal plasma adenosine concentration and reduced adenosine transport in placental macrovascular endothelium. Since insulin modulates human equilibrative nucleoside transporters (hENTs) expression/activity, we hypothesize that GDM will alter hENT2-mediated transport in human placental microvascular endothelium (hPMEC), and that insulin will restore GDM to a normal phenotype involving insulin receptors A (IR-A) and B (IR-B). GDM effect on hENTs expression and transport activity, and IR-A/IR-B expression and associated cell signalling cascades (p42/44 mitogen-activated protein kinases (p42/44(mapk)) and Akt) role in hPMEC primary cultures was assayed. GDM associates with elevated umbilical whole and vein, but not arteries blood adenosine, and reduced hENTs adenosine transport and expression. IR-A/IR-B mRNA expression and p42/44(mapk)/Akt ratios ('metabolic phenotype') were lower in GDM. Insulin reversed GDM-reduced hENT2 expression/activity, IR-A/IR-B mRNA expression and p42/44(mapk)/Akt ratios to normal pregnancies ('mitogenic phenotype'). It is suggested that insulin effects required IR-A and IR-B expression leading to differential modulation of signalling pathways restoring GDM-metabolic to a normal-mitogenic like phenotype. Insulin could be acting as protecting factor for placental microvascular endothelial dysfunction in GDM.	[Salomon, Carlos] Pontificia Univ Catolica Chile, Fac Med, CMPL, Alameda 340, Santiago, Chile; Pontificia Univ Catolica Chile, Fac Med, PRL, CIM,Div Obstet & Gynaecol,Sch Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Salomon, C (corresponding author), Pontificia Univ Catolica Chile, Fac Med, CMPL, Alameda 340, Santiago, Chile.	sobrevia@med.puc.cl	Westermeier, Francisco/D-2551-2012; Salomon, Carlos F/L-2167-2013; Westermeier, Francisco/AAL-4145-2021; Sobrevia, Luis/H-9608-2016; Casanello, Paola/X-7443-2019; Guzman-Gutierrez, Enrique/H-3536-2016	Salomon, Carlos F/0000-0003-4474-0046; Westermeier, Francisco/0000-0002-4476-4198; Casanello, Paola/0000-0002-2355-1476; Guzman-Gutierrez, Enrique/0000-0001-6589-5667; Puebla, Carlos/0000-0001-6648-2135; Sobrevia, Luis/0000-0001-5802-2243	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 1120928, 11110059]; Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) [PIA Anillos ACT-73]; Pontificia Universidad Catolica de Chile (PUC), Chile [PMD 03/10]; CONICYT-PhD (Chile) fellowships; PUC-PhD fellowship	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Pontificia Universidad Catolica de Chile (PUC), Chile; CONICYT-PhD (Chile) fellowships; PUC-PhD fellowship	This research was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1110977, 1120928, 11110059), Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT, PIA Anillos ACT-73) and Pontificia Universidad Catolica de Chile (PUC) (PMD 03/10), Chile. CS, FW, PA and EG-G hold CONICYT-PhD (Chile) fellowships. CS and PA hold a PUC-PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Escudero C, 2008, PLACENTA, V29, P816, DOI 10.1016/j.placenta.2008.06.014; Giudice J, 2011, J CELL SCI, V124, P801, DOI 10.1242/jcs.076869; Gunderson EP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-952; Guzman-Gutierrez E, 2011, CURR VASC PHARMACOL, V9, P750, DOI 10.2174/157016111797484062; Hiden U, 2009, CURR VASC PHARMACOL, V7, P460, DOI 10.2174/157016109789043973; KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Lindsay RS, 2007, CLIN ENDOCRINOL, V66, P322, DOI 10.1111/j.1365-2265.2006.02719.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Munoz G, 2006, J CELL PHYSIOL, V209, P826, DOI 10.1002/jcp.20769; Puebla C, 2008, J CELL PHYSIOL, V215, P645, DOI 10.1002/jcp.21347; Saito H, 1999, AM J RESP CRIT CARE, V159, P1014, DOI 10.1164/ajrccm.159.3.9803100; Sakowicz M, 2005, INT IMMUNOL, V17, P145, DOI 10.1093/intimm/dxh195; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Sesti G, 2011, DIABETES-METAB RES, V17, P363; SOBREVIA L, 1994, AM J PHYSIOL, V267, pC39, DOI 10.1152/ajpcell.1994.267.1.C39; Sobrevia L, 2011, PLACENTA, V32, pS159, DOI 10.1016/j.placenta.2010.12.011; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Westgate JA, 2006, DIABETES CARE, V29, P1345, DOI 10.2337/dc05-1677	26	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40578	10.1371/journal.pone.0040578	http://dx.doi.org/10.1371/journal.pone.0040578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808198	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400038
J	Wang, B; Chen, J				Wang, Bo; Chen, Jin			Effects of Fat and Protein Levels on Foraging Preferences of Tannin in Scatter-Hoarding Rodents	PLOS ONE			English	Article							SEED PREDATION; GRAY SQUIRRELS; WOOD MOUSE; DISPERSAL; ACORNS; ENERGY; DIET; SELECTION; REMOVAL; CHOICE	Both as consumers and dispersers of seeds, scatter-hoarding rodents often play an important role in the reproductive ecology of many plant species. However, the seeds of many plant species contain tannins, which are a diverse group of water-soluble phenolic compounds that have a high affinity for proteins. The amount of tannins in seeds is expected to affect rodent foraging preferences because of their major impact on rodent physiology and survival. However, variable results have been obtained in studies that evaluated the effects of tannin on rodent foraging behavior. Hence, in this study, we aimed to explain these inconsistent results and proposed that a combination of seed traits might be important in rodent foraging behavior, because it is difficult to distinguish between the effects of individual traits on rodent foraging behavior and the interactions among them. By using a novel artificial seed system, we manipulated seed tannin and fat/protein levels to examine directly the univariate effects of each component on the seed preferences of free-ranging forest rats (Apodemus latronum and Apodemus chevrieri) during the behavioral process of scatter hoarding. Our results showed that both tannin and fat/protein had significant effects on rodent foraging behavior. Although only a few interactive effects of tannin and fat/protein were recorded, higher concentrations of both fat and protein could attenuate the exclusion of seeds with higher tannin concentrations by rodents, thus influencing seed fate. Furthermore, aside from the concentrations of tannin, fat, and protein, numerous other traits of plant seeds may also influence rodent foraging behavior. We suggest that by clarifying rodent foraging preferences, a better understanding of the evolution of plant seed traits may be obtained because of their strong potential for selective pressure.	[Wang, Bo; Chen, Jin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Wang, Bo] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, B (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	yangblue@xtbg.org.cn			National Natural Science Foundation of China [31100315]; National Basic Research Program of China (973 Program) [2007CB411603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (31100315) and the National Basic Research Program of China (973 Program-2007CB411603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelmess EL, 2001, ETHOL ECOL EVOL, V13, P115; Bensaid A, 2002, PHYSIOL BEHAV, V75, P577, DOI 10.1016/S0031-9384(02)00646-7; Cameron GN, 1996, J MAMMAL, V77, P220, DOI 10.2307/1382723; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032890; ChungMacCoubrey AL, 1997, PHYSIOL ZOOL, V70, P270, DOI 10.1086/639595; DeMattia EA, 2004, ECOLOGY, V85, P2161, DOI 10.1890/03-0254; Downs CT, 2003, J CHEM ECOL, V29, P845, DOI 10.1023/A:1022975531372; EDOZIEN JC, 1978, J NUTR, V108, P282, DOI 10.1093/jn/108.2.282; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; KARASOV WH, 1982, PHYSIOL ZOOL, V55, P378, DOI 10.1086/physzool.55.4.30155865; KERLEY GIH, 1991, OECOLOGIA, V86, P261, DOI 10.1007/BF00317539; Kollmann J, 1998, FUNCT ECOL, V12, P683, DOI 10.1046/j.1365-2435.1998.00239.x; LEWIS AR, 1980, ECOLOGY, V61, P1371, DOI 10.2307/1939046; LEWIS AR, 1982, AM MIDL NAT, V107, P250, DOI 10.2307/2425376; Lewis CE, 2001, CAN J ZOOL, V79, P562, DOI 10.1139/cjz-79-4-562; Li HJ, 2007, FOREST ECOL MANAG, V242, P511, DOI 10.1016/j.foreco.2007.01.063; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; SHENK JS, 1970, J NUTR, V100, P1437, DOI 10.1093/jn/100.12.1437; Shimada T, 2003, POPUL ECOL, V45, P7, DOI 10.1007/s10144-002-0134-4; Shimada T, 2001, ECOL RES, V16, P127, DOI 10.1046/j.1440-1703.2001.00378.x; Smallwood PD, 2001, AM ZOOL, V41, P840, DOI 10.1668/0003-1569(2001)041[0840:TUBOTC]2.0.CO;2; SMALLWOOD PD, 1986, ECOLOGY, V67, P168, DOI 10.2307/1938515; Takahashi A, 2008, ECOL RES, V23, P1033, DOI 10.1007/s11284-008-0473-5; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; VICKERY WL, 1994, ANIM BEHAV, V47, P55, DOI 10.1006/anbe.1994.1007; Wall SBV, 2010, PHILOS T R SOC B, V365, P989, DOI 10.1098/rstb.2009.0205; Wang B, 2008, ACTA OECOL, V34, P379, DOI 10.1016/j.actao.2008.07.001; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026424; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Wood MD, 2005, NORTHEAST NAT, V12, P463, DOI 10.1656/1092-6194(2005)012[0463:TALCOA]2.0.CO;2; Xiao ZS, 2008, ANIM BEHAV, V75, P1235, DOI 10.1016/j.anbehav.2007.08.017; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020	34	24	28	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40640	10.1371/journal.pone.0040640	http://dx.doi.org/10.1371/journal.pone.0040640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808217	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500066
J	Kasper, MR; Lescano, AG; Lucas, C; Gilles, D; Biese, BJ; Stolovitz, G; Reaves, EJ				Kasper, Matthew R.; Lescano, Andres G.; Lucas, Carmen; Gilles, Duncan; Biese, Brian J.; Stolovitz, Gary; Reaves, Erik J.			Diarrhea Outbreak during US Military Training in El Salvador	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; OPERATIONS IRAQI FREEDOM; TRAVELERS DIARRHEA; SOUTH-AMERICA; ENDURING FREEDOM; MULTIPLEX PCR; WEST-AFRICA; PERSONNEL; EPIDEMIOLOGY; EGYPT	Infectious diarrhea remains a major risk to deployed military units worldwide in addition to their impact on travelers and populations living in the developing world. This report describes an outbreak of diarrheal illness in the U.S. military's 130th Maneuver Enhancement Brigade deployed in San Vicente, El Salvador during a training and humanitarian assistance mission. An outbreak investigation team from U.S. Naval Medical Research Unit - Six conducted an epidemiologic survey and environmental assessment, patient interviews, and collected stool samples for analysis in an at risk population of 287 personnel from May 31st to June 3rd, 2011. Personnel (n = 241) completed an epidemiological survey (87% response rate) and 67 (27%) reported diarrhea and/or vomiting during the past two weeks. The median duration of illness was reported to be 3 days (IQR 2-4 days) and abdominal pain was reported among 30 (49%) individuals. Presentation to the medical aid station was sought by (62%) individuals and 9 (15%) had to stop or significantly reduce work for at least one day. Microscopy and PCR analysis of 14 stool samples collected from previously symptomatic patients, Shigella (7), Cryptosporidium (5), and Cyclospora (4) were the most prevalent pathogens detected. Consumption of food from on-base local vendors (RR = 4.01, 95% CI = 1.53-10.5, p-value <0.001) and arriving on base within the past two weeks (RR = 2.79, 95% confidence [CI] = 1.35-5.76, p-value = 0.001) were associated with increased risk of developing diarrheal disease. The risk of infectious diarrhea is great among reserve military personnel during two week training exercises. The consumption of local food, prepared without proper monitoring, is a risk factor for deployed personnel developing diarrheal illness. Additional information is needed to better understand disease risks to personnel conducting humanitarian assistance activities in the Latin America Region.	[Kasper, Matthew R.; Lescano, Andres G.; Lucas, Carmen; Reaves, Erik J.] USN, Med Res Unit 6, Lima, Peru; [Gilles, Duncan] Madigan Healthcare Syst, Tacoma, WA USA; [Biese, Brian J.; Stolovitz, Gary] US Army Reserve, Combat Support Hosp 452, Milwaukee, WI USA; [Lescano, Andres G.] Univ Peruana Cayetano Heredia, Lima, Peru	United States Department of Defense; United States Army; Universidad Peruana Cayetano Heredia	Kasper, MR (corresponding author), USN, Med Res Unit 6, Lima, Peru.	Matthew.kasper@med.navy.mil	Lescano, Andres G/B-8479-2008; Lescano, Andres G./M-9849-2019	Lescano, Andres G/0000-0001-9779-633X; Lescano, Andres G./0000-0001-9779-633X	U.S. Department of Defense Global Emerging Infectious Systems (DoD-GEIS), a division of the Armed Forces Health Surveillance Center; National Institutes of Health/Fogarty International Center [2D43 TW0007393]; FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER	U.S. Department of Defense Global Emerging Infectious Systems (DoD-GEIS), a division of the Armed Forces Health Surveillance Center; National Institutes of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by the U.S. Department of Defense Global Emerging Infectious Systems (DoD-GEIS), a division of the Armed Forces Health Surveillance Center. The participation of Dr. Lescano in this activity was partially funded by the National Institutes of Health/Fogarty International Center training grant 2D43 TW0007393 "Peru Infectious Diseases Epidemiology Research Training Consortium". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURGEOIS AL, 1993, AM J TROP MED HYG, V48, P243, DOI 10.4269/ajtmh.1993.48.243; Castelli F, 2001, J TRAVEL MED, V8, pS26, DOI 10.1111/j.1708-8305.2001.tb00543.x; de Boer RF, 2010, J CLIN MICROBIOL, V48, P4140, DOI 10.1128/JCM.01124-10; Fotedar R, 2007, J CLIN MICROBIOL, V45, P1035, DOI 10.1128/JCM.02144-06; HABERBERGER RL, 1991, MIL MED, V156, P27, DOI 10.1093/milmed/156.1.27; Hoge CW, 1996, JAMA-J AM MED ASSOC, V275, P533, DOI 10.1001/jama.275.7.533; HYAMS KC, 1991, NEW ENGL J MED, V325, P1423, DOI 10.1056/NEJM199111143252006; Klena JD, 2004, J CLIN MICROBIOL, V42, P5549, DOI 10.1128/JCM.42.12.5549-5557.2004; McKenzie R, 2011, J INFECT DIS, V204, P60, DOI 10.1093/infdis/jir220; Minvielle MC, 2008, MEM I OSWALDO CRUZ, V103, P98, DOI 10.1590/S0074-02762008000100015; Ochoa TJ, 2009, CLIN INFECT DIS, V49, P1694, DOI 10.1086/648069; Orlandi PA, 2003, APPL ENVIRON MICROB, V69, P4806, DOI 10.1128/AEM.69.8.4806-4813.2003; Porter CK, 2011, VACCINE, V29, P5869, DOI 10.1016/j.vaccine.2011.05.021; Putnam SD, 2006, J TRAVEL MED, V13, P92, DOI 10.1111/j.1708-8305.2006.00020.x; Redman CA, 2006, J TRAVEL MED, V13, P203, DOI 10.1111/j.1708-8305.2006.00046.x; Riddle MS, 2008, VACCINE, V26, P2490, DOI 10.1016/j.vaccine.2008.03.008; Riddle MS, 2007, J TRAVEL MED, V14, P392, DOI 10.1111/j.1708-8305.2007.00159.x; Riddle MS, 2011, VACCINE, V29, P7009, DOI 10.1016/j.vaccine.2011.07.033; Riddle MS, 2011, AM J TROP MED HYG, V84, P59, DOI 10.4269/ajtmh.2011.10-0093; Riddle MS, 2005, MIL MED, V170, P492, DOI 10.7205/MILMED.170.6.492; Sanchez JL, 1998, AM J TROP MED HYG, V58, P299, DOI 10.4269/ajtmh.1998.58.299; Sanders JW, 2005, DIAGN MICR INFEC DIS, V52, P85, DOI 10.1016/j.diagmicrobio.2005.02.005; Sanders JW, 2004, DIAGN MICR INFEC DIS, V50, P89, DOI 10.1016/j.diagmicrobio.2004.06.008; Sanders JW, 2002, AM J TROP MED HYG, V67, P533, DOI 10.4269/ajtmh.2002.67.533; Sturbaum GD, 2001, APPL ENVIRON MICROB, V67, P2665, DOI 10.1128/AEM.67.6.2665-2668.2001; Thiem VD, 2004, J CLIN MICROBIOL, V42, P2031, DOI 10.1128/JCM.42.5.2031-2035.2004; THORNTON SA, 1992, MIL MED, V157, P55, DOI 10.1093/milmed/157.2.55; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; World Health Organization, 2005, GUIDELINES CONTROL S	30	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40404	10.1371/journal.pone.0040404	http://dx.doi.org/10.1371/journal.pone.0040404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815747	gold, Green Submitted, Green Published			2022-12-27	WOS:000306548900025
J	Vasilyev, A; Liu, Y; Hellman, N; Pathak, N; Drummond, IA				Vasilyev, Aleksandr; Liu, Yan; Hellman, Nathan; Pathak, Narendra; Drummond, Iain A.			Mechanical Stretch and PI3K Signaling Link Cell Migration and Proliferation to Coordinate Epithelial Tubule Morphogenesis in the Zebrafish Pronephros	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; FORCES; DIFFERENTIATION; ACTIVATION; GROWTH; TRPV4; FLOW	Organ development leads to the emergence of organ function, which in turn can impact developmental processes. Here we show that fluid flow-induced collective epithelial migration during kidney nephron morphogenesis induces cell stretch that in turn signals epithelial proliferation. Increased cell proliferation was dependent on PI3K signaling. Inhibiting epithelial proliferation by blocking PI3K or CDK4/Cyclin D1 activity arrested cell migration prematurely and caused a marked overstretching of the distal nephron tubule. Computational modeling of the involved cell processes predicted major morphological and kinetic outcomes observed experimentally under a variety of conditions. Overall, our findings suggest that kidney development is a recursive process where emerging organ function "feeds back" to the developmental program to influence fundamental cellular events such as cell migration and proliferation, thus defining final organ morphology.	[Vasilyev, Aleksandr] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA USA; [Vasilyev, Aleksandr; Liu, Yan; Hellman, Nathan; Pathak, Narendra; Drummond, Iain A.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Drummond, Iain A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Vasilyev, A (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA USA.	avasilyev@partners.org; idrummon@receptor.mgh.harvard.edu			National Institutes of Heatlh/NIDDK [K08DK082782, DK053093, DK071041, DK070263]; HSCI [DP-0074-10-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK082782, R01DK071041, R01DK053093, R01DK070263] Funding Source: NIH RePORTER	National Institutes of Heatlh/NIDDK; HSCI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Heatlh/NIDDK(http://www2.niddk.nih.gov/): K08DK082782, DK053093, DK071041, DK070263; HSCI(http://www.hsci.harvard.edu/): DP-0074-10-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; CHEVALIER RL, 1995, SEMIN NEPHROL, V15, P353; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Inanlou MR, 2003, INT J DEV BIOL, V47, P363; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; Kubo A, 1999, CLIN CANCER RES, V5, P4279; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mangos S, 2007, GENE EXPR PATTERNS, V7, P480, DOI 10.1016/j.modgep.2006.10.011; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Pankow S, 2006, J CELL SCI, V119, P4033, DOI 10.1242/jcs.03175; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Stokes Ian, 2002, Stud Health Technol Inform, V91, P314; Tang MJ, 2002, DEV BIOL, V243, P128, DOI 10.1006/dbio.2001.0557; TANNER GA, 1995, J AM SOC NEPHROL, V6, P1230; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Vasilyev A, 2010, CELL ADHES MIGR, V4, P353, DOI 10.4161/cam.4.3.11428; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015	33	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e39992	10.1371/journal.pone.0039992	http://dx.doi.org/10.1371/journal.pone.0039992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815719	Green Published, gold			2022-12-27	WOS:000306548900014
J	Ritchie, HH; Yee, CT; Tang, XN; Dong, ZH; Fuller, RS				Ritchie, Helena H.; Yee, Colin T.; Tang, Xu-na; Dong, Zhihong; Fuller, Robert S.			DSP-PP Precursor Protein Cleavage by Tolloid-Related-1 Protein and by Bone Morphogenetic Protein-1	PLOS ONE			English	Article							DENTIN SIALOPHOSPHOPROTEIN DSPP; MATRIX PROTEIN-1; C-PROTEINASE; IN-VIVO; PHOSPHOPHORYN; METALLOPROTEINASES; SIALOPROTEIN; MOUSE; EXPRESSION; DENTINOGENESIS	Dentin sialoprotein (DSP) and phosphophoryn (PP), acidic proteins critical to dentin mineralization, are translated from a single transcript as a DSP-PP precursor that undergoes specific proteolytic processing to generate DSP and PP. The cleavage mechanism continues to be controversial, in part because of the difficulty of obtaining DSP-PP from mammalian cells and dentin matrix. We have infected Sf9 cells with a recombinant baculovirus to produce large amounts of secreted DSP-PP240, a variant form of rat DSP-PP. Mass spectrometric analysis shows that DSP-PP240 secreted by Sf9 cells undergoes specific cleavage at the site predicted from the N-terminal sequence of PP extracted from dentin matrix: SMQG(447) down arrow (DDPN)-D-448. DSP-PP240 is cleaved after secretion by a zinc-dependent activity secreted by Sf9 cells, generating DSP430 and PP240 products that are stable in the medium. DSP-PP processing activity is constitutively secreted by Sf9 cells, but secretion is diminished 3 days after infection. Using primers corresponding to the highly conserved catalytic domain of Drosophila melanogaster tolloid (a mammalian BMP1 homolog), we isolated a partial cDNA for a Spodopotera frugiperda tolloid-related-1 protein (TLR1) that is 78% identical to Drosophila TLR1 but only 65% identical to Drosophila tolloid. Tlr1 mRNA decreased rapidly in Sf9 cells after baculovirus infection and was undetectable 4d after infection, paralleling the observed decrease in secretion of the DSP-PP240 processing activity after infection. Human BMP1 is more similar to Sf9 and Drosophila TLR1 than to tolloid, and Sf9 TLR1 is more similar to BMP1 than to other mammalian homologs. Recombinant human BMP1 correctly processed baculovirus-expressed DSP-PP240 in a dose-dependent manner. Together, these data suggest that the physiologically accurate cleavage of mammalian DSP-PP240 in the Sf9 cell system represents the action of a conserved processing enzyme and support the proposed role of BMP1 in processing DSP-PP in dentin matrix.	[Ritchie, Helena H.; Yee, Colin T.; Tang, Xu-na; Dong, Zhihong] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Fuller, Robert S.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Tang, Xu-na] Nanjing Univ, Med Ctr, Sch Stomatol, Dept Endodontol, Nanjing, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Nanjing University	Ritchie, HH (corresponding author), Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.	helenar@umich.edu			National Institutes of Health NIDCR [DE18901]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011442] Funding Source: NIH RePORTER	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health NIDCR DE18901 to HHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Godovikova V, 2006, DEV BIOL, V289, P507, DOI 10.1016/j.ydbio.2005.10.002; Godovikova V, 2007, J BIOL CHEM, V282, P31341, DOI 10.1074/jbc.M702605200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Li JH, 2009, CELLS TISSUES ORGANS, V189, P252, DOI 10.1159/000158571; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Qin CL, 2001, J BIOL CHEM, V276, P904, DOI 10.1074/jbc.M006271200; Salvesen G. S., 2001, PROTEOLYTIC ENZYMES, P105; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Tang XN, 2011, J DERMATOL SCI, V64, P92, DOI 10.1016/j.jdermsci.2011.08.009; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	27	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41110	10.1371/journal.pone.0041110	http://dx.doi.org/10.1371/journal.pone.0041110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815932	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000068
J	Savvatis, K; van Linthout, S; Miteva, K; Pappritz, K; Westermann, D; Schefold, JC; Fusch, G; Weithauser, A; Rauch, U; Becher, PM; Klingel, K; Ringe, J; Kurtz, A; Schultheiss, HP; Tschope, C				Savvatis, Konstantinos; van Linthout, Sophie; Miteva, Kapka; Pappritz, Kathleen; Westermann, Dirk; Schefold, Joerg C.; Fusch, Gerhard; Weithaeuser, Alice; Rauch, Ursula; Becher, Peter-Moritz; Klingel, Karin; Ringe, Jochen; Kurtz, Andreas; Schultheiss, Heinz-Peter; Tschoepe, Carsten			Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental Myocarditis	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITION; STEM-CELLS; IFN-GAMMA; INTERFERON-GAMMA; AUTOIMMUNE MYOCARDITIS; GROWTH-FACTOR; MICE; EXPRESSION; MURINE; INJURY	Systemic application of mesenchymal stromal cells (MSCs) in inflammatory cardiomyopathy exerts cardiobeneficial effects. The mode of action is unclear since a sufficient and long-acting cardiac homing of MSCs is unlikely. We therefore investigated the regulation of the immune response in coxsackievirus B3 (CVB3)-induced acute myocarditis after intravenous application of MSCs. Wildtype mice were infected with CVB3 and treated with either PBS, human MSCs or human cardiac fibroblasts intravenously 1 day after infection. Seven days after infection, MSCs could be detected in the spleen, heart, pancreas, liver, lung and kidney, whereby the highest presence was observed in the lung. MSCs increased significantly the myocardial expression of HGF and decreased the expression of the proinflammatory cytokines TNF alpha, IL1 beta and IL6 as well as the severity of myocarditis and ameliorated the left ventricular dysfunction measured by conductance catheter. MSCs upregulated the production of IFN gamma in CD4+ and CD8+ cells, the number of IL10-producing regulatory T cells and the apoptosis rate of T cells in the spleen. An increased number of CD4+CD25+FoxP3 could be found in the spleen as well as in the circulation. In contrast, application of human cardiac fibroblasts had no effect on the severity of myocarditis and the systemic immune response observed after MSCs-administration. In conclusion, modulation of the immune response in extracardiac organs is associated with cardiobeneficial effects in experimental inflammatory cardiomyopathy after systemic application of MSCs.	[Savvatis, Konstantinos; van Linthout, Sophie; Pappritz, Kathleen; Westermann, Dirk; Weithaeuser, Alice; Rauch, Ursula; Becher, Peter-Moritz; Schultheiss, Heinz-Peter; Tschoepe, Carsten] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany; [Savvatis, Konstantinos; van Linthout, Sophie; Miteva, Kapka; Ringe, Jochen; Kurtz, Andreas; Tschoepe, Carsten] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Schefold, Joerg C.] Charite, Dept Nephrol & Intens Care Med, D-13353 Berlin, Germany; [Fusch, Gerhard] Univ Hosp, Dept Pediat, Greifswald, Germany; [Fusch, Gerhard] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Klingel, Karin] Univ Tubingen Hosp, Dept Mol Pathol, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McMaster University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Savvatis, K (corresponding author), Charite, Dept Cardiol & Pneumol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	carsten.tschoepe@charite.de	Savvatis, Konstantinos/AAJ-9012-2020; Westermann, Dirk/D-1344-2011; /GPG-3365-2022; Fusch, Gerhard/ABG-1096-2021	Fusch, Gerhard/0000-0003-4026-3211; Westermann, Dirk/0000-0002-7542-1956; Kurtz, Andreas/0000-0003-3301-6546; Schefold, Joerg C./0000-0001-9162-5724; Tschope, Carsten/0000-0001-5243-8985	Deutsche Forschungsgemeinschaft [SFB/TR 19]; Berlin-Brandenburg Center for Regenerative Therapies (Platform F); Deutsches Zentrum fur Herzkreislaufforschung (Working package 2); Deutsches Zentrum fur Herzkreislaufforschung (Working package 3)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berlin-Brandenburg Center for Regenerative Therapies (Platform F); Deutsches Zentrum fur Herzkreislaufforschung (Working package 2); Deutsches Zentrum fur Herzkreislaufforschung (Working package 3)	This study was supported by the "Deutsche Forschungsgemeinschaft" (SFB/TR 19, Project Z3 and B5 to C. T.), the Berlin-Brandenburg Center for Regenerative Therapies (Platform F to C. T.) and the "Deutsches Zentrum fur Herzkreislaufforschung" (Working package 2 and 3 to C. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 1996, J VIROL, V70, P4632, DOI 10.1128/JVI.70.7.4632-4645.1996; Bock C, 2010, NEW ENGL J MED, V362, P1248, DOI 10.1056/NEJMc0911362; Bopegamage S, 2005, J GEN VIROL, V86, P3271, DOI 10.1099/vir.0.81249-0; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Ding Q, 2006, J IMMUNOL, V177, P3606, DOI 10.4049/jimmunol.177.6.3606; DRORY Y, 1991, AM J CARDIOL, V68, P1388, DOI 10.1016/0002-9149(91)90251-F; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Eriksson U, 2001, CIRCULATION, V103, P18; ESFANDIAREI M, 2007, ANN REV PATHOL; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Gupta S, 2008, NAT CLIN PRACT CARD, V5, P693, DOI 10.1038/ncpcardio1331; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Isobe M, 2006, TRENDS CARDIOVAS MED, V16, P188, DOI 10.1016/j.tcm.2006.03.007; Jui HY, 2012, CELL TRANSPLANT, V21, P971, DOI 10.3727/096368911X627525; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Maccario R, 2005, HAEMATOLOGICA, V90, P516; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Miteva K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028513; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Okada H, 2007, INT HEART J, V48, P649, DOI 10.1536/ihj.48.649; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pauschinger M, 2005, EUR J HEART FAIL, V7, P444, DOI 10.1016/j.ejheart.2004.07.002; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Rameshwar P, 2008, CELL RES, V18, P805, DOI 10.1038/cr.2008.90; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Schefold JC, 2010, SCAND J INFECT DIS, V42, P164, DOI 10.3109/00365540903405768; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Staal EM, 2004, PHYSIOL MEAS, V25, P565, DOI 10.1088/0967-3334/25/2/013; Szalay G, 2006, AM J PATHOL, V169, P2085, DOI 10.2353/ajpath.2006.060350; Tschope C, 2011, CURR PHARM DESIGN, V17, P3295, DOI 10.2174/138161211797904136; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Van Linthout S, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/757154; Van Linthout S, 2011, EUR HEART J, V32, P2168, DOI 10.1093/eurheartj/ehq467; Van Linthout S, 2002, GENE THER, V9, P1520, DOI 10.1038/sj.gt.3301824; Wang W, 2011, REGEN MED, V6, P179, DOI [10.2217/rme.10.104, 10.2217/RME.10.104]; Westermann D, 2007, DIABETES, V56, P1834, DOI 10.2337/db06-1662; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Yamamoto K, 2003, J AM COLL CARDIOL, V42, P2000, DOI 10.1016/j.jacc.2003.07.021	53	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41047	10.1371/journal.pone.0041047	http://dx.doi.org/10.1371/journal.pone.0041047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815907	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000055
J	Baba, T; Badr, ME; Tomaru, U; Ishizu, A; Mukaida, N				Baba, Tomohisa; Badr, Mohamed El Sherif; Tomaru, Utano; Ishizu, Akihiro; Mukaida, Naofumi			Novel Process of Intrathymic Tumor-Immune Tolerance through CCR2-Mediated Recruitment of Sirp alpha(+) Dendritic Cells: A Murine Model	PLOS ONE			English	Article							HUMAN THYMIC CORTEX; REGULATORY T-CELLS; NEGATIVE SELECTION; ESCAPE MECHANISM; CLONAL DELETION; THYMOCYTES; RECEPTOR; ANTIGEN; PROTEIN; MICE	Immune surveillance system can detect more efficiently secretory tumor-specific antigens, which are superior as a target for cancer immunotherapy. On the contrary, immune tolerance can be induced in the thymus when a tumor antigen is massively secreted into circulation. Thus, the secretion of tumor-specific antigen may have contradictory roles in tumor immunity in a context-dependent manner. However, it remains elusive on the precise cellular mechanism of intrathymic immune tolerance against tumor antigens. We previously demonstrated that a minor thymic conventional dendritic cell (cDC) subset, CD8 alpha(-)Sirp alpha(+) cDCs, but not the major subset, CD8 alpha(+)Sirp alpha(-) cDCs can selectively capture blood-borne antigens and crucially contribute to the self-tolerance. In the present study, we further demonstrated that Sirp alpha(+) cDCs can capture a blood-borne antigen leaking inside the interlobular vascular-rich regions (IVRs). Blood-borne antigen selectively captured by Sirp alpha(+) cDCs can induce antigen-specific Treg generation or negative selection, depending on the immunogenicity of the presented antigen. Furthermore, CCR2 expression by thymic Sirp alpha(+) cDCs and abundant expression of its ligands, particularly, CCL2 by tumor-bearing mice prompted us to examine the function of thymic Sirp alpha(+) cDCs in tumor-bearing mice. Interestingly, tumor-bearing mice deposited CCL2 inside IVRs in the thymus. Moreover, tumor formation induced the accumulation of Sirp alpha(+) cDCs in IVRs under the control of CCR2-CCL2 axis and enhanced their capacity to take up antigens, resulting in the shift from Treg differentiation to negative selection. Finally, intrathymic negative selection similarly ensued in CCR2-competent mice once the tumor-specific antigen was secreted into bloodstream. Thus, we demonstrated that thymic Sirp alpha(+) cDCs crucially contribute to this novel process of intrathymic tumor immune tolerance.	[Baba, Tomohisa; Badr, Mohamed El Sherif; Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan; [Tomaru, Utano] Hokkaido Univ, Dept Pathol Pathophysiol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan	Kanazawa University; Hokkaido University; Hokkaido University	Baba, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan.	sergenti@staff.kanazawa-u.ac.jp	Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851	 [23790532]		This work was supported by Grant-in-aid for scientific research in Japan (23790532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Atibalentja DF, 2009, J IMMUNOL, V183, P7909, DOI 10.4049/jimmunol.0902632; Azakami H, 2005, J AGR FOOD CHEM, V53, P1254, DOI 10.1021/jf049325f; Baba T, 2009, J IMMUNOL, V183, P3053, DOI 10.4049/jimmunol.0900438; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; BOELAERT JR, 1989, PERITON DIALYSIS INT, V9, P95; Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Bubanovic IV, 2003, MED HYPOTHESES, V60, P315, DOI 10.1016/S0306-9877(02)00450-4; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; CORBETT TH, 1975, CANCER RES, V35, P2434; Corthay A, 2011, SCAND J IMMUNOL, V73, P527, DOI 10.1111/j.1365-3083.2011.02558.x; Corthay A, 2009, CANCER RES, V69, P5901, DOI 10.1158/0008-5472.CAN-08-4816; Croguennec T, 2007, J COLLOID INTERF SCI, V315, P627, DOI 10.1016/j.jcis.2007.07.041; Fujii H, 2011, ARTHRITIS RHEUM-US, V63, P96, DOI 10.1002/art.30106; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Kyewski B, CELL, V140, P24; Lauritzsen GF, 1998, INT J CANCER, V78, P216, DOI 10.1002/(SICI)1097-0215(19981005)78:2<216::AID-IJC16>3.3.CO;2-E; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Paessens LC, 2008, J PATHOL, V214, P96, DOI 10.1002/path.2260; Paessens LC, 2007, IMMUNOL LETT, V110, P65, DOI 10.1016/j.imlet.2007.03.005; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41154	10.1371/journal.pone.0041154	http://dx.doi.org/10.1371/journal.pone.0041154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815949	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100122
J	Blanco, FC; Soria, M; Bianco, MV; Bigi, F				Carlos Blanco, Federico; Soria, Marcelo; Veronica Bianco, Maria; Bigi, Fabiana			Transcriptional Response of Peripheral Blood Mononuclear Cells from Cattle Infected with Mycobacterium bovis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TUBERCULOUS GRANULOMA; MATRIX-METALLOPROTEINASE-9; PATHOGENESIS; EXPRESSION; SIGNATURE; PROTEIN	Mycobacterium bovis is the causative agent of most cases of bovine tuberculosis. The identification of bTB biomarkers in specific stages of the disease will contribute to a better understanding of the immunopathology associated with tuberculosis and will enable their use in disease diagnosis and prognosis. The aim of this study was to evaluate the gene expression profile induced after specific stimulation of bovine peripheral blood mononuclear cells from cattle infected with M. bovis using the Affymetrix (R) GeneChip (R) Bovine Genome Array. A total of 172 genes showed differential expression profile that was statistically significant with log2-fold change >2.5 and <-22.5. Twenty-four out of these genes were upregulated and 148 were downregulated in bovine peripheral blood mononuclear cells of M. bovis-infected cattle. The highest differentially-expressed genes were related to immune and inflammatory responses, apoptosis, endocytosis, cellular trafficking and genes encoding proteins involved in cellular matrix degradation. Microarray results were confirmed in another group of infected cattle by RT-qPCR for the CD14, IL-1R, THBS1, MMP9 and FYVE genes. This study confirms previous findings that have shown that M. bovis infection in cattle results in the downregulation of immune response-related genes. Moreover, it validates the use of microarray platforms in combination with RT-qPCR to identify biomarkers of bovine tuberculosis. In addition, we propose CD14, IL-1R, THBS1, MMP9 and FYVE as potential biomarkers of bovine tuberculosis.	[Carlos Blanco, Federico; Veronica Bianco, Maria; Bigi, Fabiana] Inst Nacl Tecnol Agropecuaria, Inst Biotecnol CICVyA, Buenos Aires, DF, Argentina; [Soria, Marcelo] Univ Buenos Aires, Sch Agron, INBA, Consejo Nacl Invest Cient1 & Tecn, Buenos Aires, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Buenos Aires	Blanco, FC (corresponding author), Inst Nacl Tecnol Agropecuaria, Inst Biotecnol CICVyA, Buenos Aires, DF, Argentina.	fbigi@cnia.inta.gov.ar			National Institute of Agricultural Technology [PE AEBIO243512]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2324]	National Institute of Agricultural Technology; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was funded by National Institute of Agricultural Technology grant PE AEBIO243512 and Agencia Nacional de Promocion Cientifica y Tecnologica grant PICT 2324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranday-Cortes E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030626; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Blanco FC, 2009, MICROBIOL IMMUNOL, V53, P460, DOI 10.1111/j.1348-0421.2009.00141.x; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Buddle BM, 2010, EXPERT REV VACCINES, V9, P1121, DOI [10.1586/erv.10.112, 10.1586/ERV.10.112]; CORNER LA, 1994, VET MICROBIOL, V40, P53, DOI 10.1016/0378-1135(94)90046-9; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Killick KE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-611; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Magee DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032034; Matsuura E, 2000, J NEUROL SCI, V173, P45, DOI 10.1016/S0022-510X(99)00303-2; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; NEILL SD, 1994, VET MICROBIOL, V40, P41, DOI 10.1016/0378-1135(94)90045-0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Price NM, 2003, J IMMUNOL, V171, P5579, DOI 10.4049/jimmunol.171.10.5579; Rhodes SG, 2000, IMMUNOLOGY, V99, P195, DOI 10.1046/j.1365-2567.2000.00944.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Smit van Dixhoorn MGA, 2008, MOL IMMUNOL, V45, P1573, DOI 10.1016/j.molimm.2007.10.022; Smyth G, 2005, LIMMA LINEAR MODELS; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wedlock DN, 2008, CLIN VACCINE IMMUNOL, V15, P765, DOI 10.1128/CVI.00034-08; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312	31	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41066	10.1371/journal.pone.0041066	http://dx.doi.org/10.1371/journal.pone.0041066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815916	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100115
J	Wang, C; Guo, XJ; Xu, JF; Wu, C; Sun, YL; Ye, XF; Qian, W; Ma, XQ; Du, WM; He, J				Wang, Chao; Guo, Xiao-Jing; Xu, Jin-Fang; Wu, Cheng; Sun, Ya-Lin; Ye, Xiao-Fei; Qian, Wei; Ma, Xiu-Qiang; Du, Wen-Min; He, Jia			Exploration of the Association Rules Mining Technique for the Signal Detection of Adverse Drug Events in Spontaneous Reporting Systems	PLOS ONE			English	Article							GENERATION	Background: The detection of signals of adverse drug events (ADEs) has increased because of the use of data mining algorithms in spontaneous reporting systems (SRSs). However, different data mining algorithms have different traits and conditions for application. The objective of our study was to explore the application of association rule (AR) mining in ADE signal detection and to compare its performance with that of other algorithms. Methodology/Principal Findings: Monte Carlo simulation was applied to generate drug-ADE reports randomly according to the characteristics of SRS datasets. Thousand simulated datasets were mined by AR and other algorithms. On average, 108,337 reports were generated by the Monte Carlo simulation. Based on the predefined criterion that 10% of the drug-ADE combinations were true signals, with RR equaling to 10, 4.9, 1.5, and 1.2, AR detected, on average, 284 suspected associations with a minimum support of 3 and a minimum lift of 1.2. The area under the receiver operating characteristic (ROC) curve of the AR was 0.788, which was equivalent to that shown for other algorithms. Additionally, AR was applied to reports submitted to the Shanghai SRS in 2009. Five hundred seventy combinations were detected using AR from 24,297 SRS reports, and they were compared with recognized ADEs identified by clinical experts and various other sources. Conclusions/Significance: AR appears to be an effective method for ADE signal detection, both in simulated and real SRS datasets. The limitations of this method exposed in our study, i.e., a non-uniform thresholds setting and redundant rules, require further research.	[Wang, Chao; Guo, Xiao-Jing; Xu, Jin-Fang; Wu, Cheng; Sun, Ya-Lin; Ye, Xiao-Fei; Qian, Wei; Ma, Xiu-Qiang; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Du, Wen-Min] Adverse Drug React Monitoring Ctr Shanghai, Shanghai, Peoples R China	Naval Medical University	Wang, C (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com	guo, xiaojing/GYJ-0885-2022	ye, xiaofei/0000-0003-3692-1285; He, Jia/0000-0002-2338-9501; Wei, Qian/0000-0001-5753-7579	National Natural Science Foundation of China [30872186, 81072388]; Studying of Data Mining Method for ADE Signals [09XD1405500]; Leading Talents of Science in Shanghai [2010(022)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Studying of Data Mining Method for ADE Signals; Leading Talents of Science in Shanghai	This study was funded by the National Natural Science Foundation of China (grant 30872186, grant 81072388), the Studying of Data Mining Method for ADE Signals (grant 09XD1405500) and Leading Talents of Science in Shanghai 2010(022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P VLDB; [Anonymous], 2010, ADVERSE REACTION TER; Avery AJ, 2011, EVALUATION PATIENT R; Bate A, 2002, DRUG SAFETY, V25, P393, DOI 10.2165/00002018-200225060-00002; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Davidson MH, 1997, AM J CARDIOL, V79, P38, DOI 10.1016/S0002-9149(96)00742-4; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Gould AL, 2003, PHARMACOEPIDEM DR S, V12, P559, DOI 10.1002/pds.771; Griffin Marie R., 1998, American Journal of Medicine, V104, p23S, DOI 10.1016/S0002-9343(97)00207-6; Han J, 2000, SIGMOD 00 DALL TX MA, P11; Harpaz R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S7; Hauben Manfred, 2005, Expert Opin Drug Saf, V4, P929, DOI 10.1517/14740338.4.5.929; Kuo MH, 2009, STUD HEALTH TECHNOL, V148, P95, DOI 10.3233/978-1-60750-043-8-95; Molokhia Mariam, 2009, Clin Epidemiol, V1, P75; National Adverse Drug Reaction Monitoring Centre, 2003, WHO ADV REACT TERM; Ordonez C, 2006, KNOWL INF SYST, V9, P259, DOI 10.1007/s10115-005-0226-5; Orlando S., 2001, Data Warehousing and Knowledge Discovery. Third International Conference, DaWaK 2001. Proceedings (Lecture Notes in Computer Science Vol.2114), P71; Roux E, 2005, IEEE T INF TECHNOL B, V9, P518, DOI [10.1109/TITB.2005.855566A, 10.1109/TITB.2005.855566]; Roux E, 2003, INT DAT AN MED PHARM; Shichao Z, 2002, ASS RULES MINING MOD, P25; Stephenson WP, 2007, PHARMACOEPIDEM DR S, V16, P359, DOI 10.1002/pds.1323; Szarfman A, 2002, DRUG SAFETY, V25, P381, DOI 10.2165/00002018-200225060-00001; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; WHO Collaborating Centre for International Drug Monitoring, 2002, IMP PHARM	26	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40561	10.1371/journal.pone.0040561	http://dx.doi.org/10.1371/journal.pone.0040561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815764	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100042
J	Charlson, FJ; Steel, Z; Degenhardt, L; Chey, T; Silove, D; Marnane, C; Whiteford, HA				Charlson, Fiona J.; Steel, Zachary; Degenhardt, Louisa; Chey, Tien; Silove, Derrick; Marnane, Claire; Whiteford, Harvey A.			Predicting the Impact of the 2011 Conflict in Libya on Population Mental Health: PTSD and Depression Prevalence and Mental Health Service Requirements	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MIDDLE-INCOME COUNTRIES; TRAUMATIC EVENTS; EPIDEMIOLOGY; METAANALYSIS; EMERGENCIES; SYMPTOMS; CARE; WAR	Background: Mental disorders are likely to be elevated in the Libyan population during the post-conflict period. We estimated cases of severe PTSD and depression and related health service requirements using modelling from existing epidemiological data and current recommended mental health service targets in low and middle income countries (LMIC's). Methods: Post-conflict prevalence estimates were derived from models based on a previously conducted systematic review and meta-regression analysis of mental health among populations living in conflict. Political terror ratings and intensity of exposure to traumatic events were used in predictive models. Prevalence of severe cases was applied to chosen populations along with uncertainty ranges. Six populations deemed to be affected by the conflict were chosen for modelling: Misrata (population of 444,812), Benghazi (pop. 674,094), Zintan (pop. 40,000), displaced people within Tripoli/Zlitan (pop. 49,000), displaced people within Misrata (pop. 25,000) and Ras Jdir camps (pop. 3,700). Proposed targets for service coverage, resource utilisation and full-time equivalent staffing for management of severe cases of major depression and post-traumatic stress disorder (PTSD) are based on a published model for LMIC's. Findings: Severe PTSD prevalence in populations exposed to a high level of political terror and traumatic events was estimated at 12.4% (95% CI 8.5-16.7) and was 19.8% (95% CI 14.0-26.3) for severe depression. Across all six populations (total population 1,236,600), the conflict could be associated with 123,200 (71,600-182,400) cases of severe PTSD and 228,100 (134,000-344,200) cases of severe depression; 50% of PTSD cases were estimated to co-occur with severe depression. Based upon service coverage targets, approximately 154 full-time equivalent staff would be required to respond to these cases sufficiently which is substantially below the current level of resource estimates for these regions. Discussion: This is the first attempt to predict the mental health burden and consequent service response needs of such a conflict, and is crucially timed for Libya.	[Charlson, Fiona J.; Whiteford, Harvey A.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Steel, Zachary; Chey, Tien; Silove, Derrick; Marnane, Claire] Univ New S Wales, Prince Wales Hosp, Sch Psychiat, Randwick, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Carlton, Vic 3053, Australia; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Randwick, NSW, Australia	University of Queensland; University of New South Wales Sydney; University of Melbourne; University of New South Wales Sydney	Charlson, FJ (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	h.whiteford@uq.edu.au	Whiteford, Harvey A/A-4840-2009; Charlson, Fiona J/F-5290-2011; Degenhardt, Louisa J/D-4515-2012; Charlson, Fiona/R-8963-2019	Whiteford, Harvey A/0000-0003-4667-6623; Charlson, Fiona J/0000-0003-2876-5040; Degenhardt, Louisa J/0000-0002-8513-2218; Charlson, Fiona/0000-0003-2876-5040; Steel, Zachary/0000-0002-5048-2920	Queensland Department of Health	Queensland Department of Health	Core funding for the Queensland Centre of Mental Health Research is provided by the Queensland Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amnesty International, 2012, LIB DEATHS DET AM WI; Amnesty International, 2011, LIB DIS BES NAF MOUN; [Anonymous], 2011, BBC NEWS AFRICA 0220; [Anonymous], 2008, WHO WORLD MENTAL HLT; [Anonymous], 2002, SAS SOFTW; Arie S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5653; Attanayake Vindya, 2009, Med Confl Surviv, V25, P4, DOI 10.1080/13623690802568913; Baxter AJ, 2011, COMMUNICATION   0125; Bradley Lloyd, 2006, Torture, V16, P41; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; Bryant R, 2011, COMMUNICATION   0125; Central Intelligence Agency, 2011, WORLD FACTB LIB; Chapman C, 2011, REMISSION P IN PRESS; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Dahl S, 1998, J TRAUMA STRESS, V11, P137, DOI 10.1023/A:1024417401973; Doney A, 1997, SCARRED MINDS PSYCHO, P259; EpiGear, 2011, METAXL; Ferrari AJ, 2011, COMMUNICATION   0125; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; Globalsecurity.org, 2011, CIT 100 000 MOR INH; Hathaway O, 2004, CHARACTERIZING MEASU; Human Rights Watch, 2011, LIB ROCK ATT W MOUNT; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; International Medical Corps, 2011, WHO IS DOING WHAT MN; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Levy BS, 2009, ANNU REV PUBL HEALTH, V30, P123, DOI 10.1146/annurev.publhealth.031308.100147; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MSF, 2011, LIB PSYCH SERV MISR; Musisi Seggane, 2004, Afr Health Sci, V4, P80; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Roberts B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-38; Rodin D, 2009, INT J EPIDEMIOL, V38, P1045, DOI 10.1093/ije/dyp203; Salguero JM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-96; Silove D, 2005, B WORLD HEALTH ORGAN, V83, P75; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Summerfield D, 2000, BRIT MED J, V321, P232, DOI 10.1136/bmj.321.7255.232; The Sphere Project, 2004, HUM CHART MIN STAND; UN News Service, 2011, UN NEWS SERVICE; UNHCR, 2011, UN MISS FIND DISPL L; UNHCR, 2011, UPD 27 HUM SIT LIB N; United States Congressional Research Service, 2011, LIB BACKGR US REL; van Ommeren M, 2005, B WORLD HEALTH ORGAN, V83, P71; WHO, 2001, WORLD HLTH REPORT 20; WHO, 2008, MHGAP MENTAL HLTH GA; WHO, 2003, PLANN BUDG DEL SERV; Wilczynski Nancy L, 2006, Ann Gen Psychiatry, V5, P4, DOI 10.1186/1744-859X-5-4; World Health Organization, 2011, PROJ ATL RES MENT HL; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2011, LIB CRIS AUG 2011 UP; Zarocostas J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4326; Zeiton M, 2011, LANCET, V378, P756, DOI 10.1016/S0140-6736(11)61360-3	55	31	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40593	10.1371/journal.pone.0040593	http://dx.doi.org/10.1371/journal.pone.0040593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808201	Green Published, gold			2022-12-27	WOS:000306406700036
J	Moreno-Aguirre, AJ; Santiago-Rodriguez, E; Harmony, T; Fernandez-Bouzas, A				Janeth Moreno-Aguirre, Alma; Santiago-Rodriguez, Efrain; Harmony, Thalia; Fernandez-Bouzas, Antonio			Effect of Hearing Aids on Auditory Function in Infants with Perinatal Brain Injury and Severe Hearing Loss	PLOS ONE			English	Article							STEADY-STATE RESPONSES; EVOKED-POTENTIALS; IMPLANTED CHILDREN; COCHLEAR NUCLEUS; RISK-FACTORS; INTERVENTION; MATURATION; COMPONENTS; PROGRAMS; NEURONS	Background: Approximately 2-4% of newborns with perinatal risk factors present with hearing loss. Our aim was to analyze the effect of hearing aid use on auditory function evaluated based on otoacoustic emissions (OAEs), auditory brain responses (ABRs) and auditory steady state responses (ASSRs) in infants with perinatal brain injury and profound hearing loss. Methodology/Principal Findings: A prospective, longitudinal study of auditory function in infants with profound hearing loss. Right side hearing before and after hearing aid use was compared with left side hearing (not stimulated and used as control). All infants were subjected to OAE, ABR and ASSR evaluations before and after hearing aid use. The average ABR threshold decreased from 90.0 to 80.0 dB (p = 0.003) after six months of hearing aid use. In the left ear, which was used as a control, the ABR threshold decreased from 94.6 to 87.6 dB, which was not significant (p > 0.05). In addition, the ASSR threshold in the 4000-Hz frequency decreased from 89 dB to 72 dB (p = 0.013) after six months of right ear hearing aid use; the other frequencies in the right ear and all frequencies in the left ear did not show significant differences in any of the measured parameters (p > 0.05). OAEs were absent in the baseline test and showed no changes after hearing aid use in the right ear (p > 0.05). Conclusions/Significance: This study provides evidence that early hearing aid use decreases the hearing threshold in ABR and ASSR assessments with no functional modifications in the auditory receptor, as evaluated by OAEs.	[Janeth Moreno-Aguirre, Alma; Santiago-Rodriguez, Efrain; Harmony, Thalia; Fernandez-Bouzas, Antonio] Univ Nacl Autonoma Mexico, Inst Neurobiol, Unidad Invest Neurodesarrollo Dr Augusto Fernande, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Moreno-Aguirre, AJ (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Unidad Invest Neurodesarrollo Dr Augusto Fernande, Campus Juriquilla, Queretaro, Mexico.	santiagorode@unam.mx	SANTIAGO-RODRIGUEZ, EFRAIN/N-5243-2017	SANTIAGO-RODRIGUEZ, EFRAIN/0000-0003-3590-6825	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico (UNAM), Mexico [IN205006-17]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico (UNAM), Mexico	This work was sponsored by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))IN205006-17, Universidad Nacional Autonoma de Mexico (UNAM),Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borg E, 1997, SCAND AUDIOL, V26, P77, DOI 10.3109/01050399709074979; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Cone-Wesson Barbara, 2002, J Am Acad Audiol, V13, P260; DAVIDSON J, 1989, INT J PEDIATR OTORHI, V17, P239, DOI 10.1016/0165-5876(89)90051-7; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; du Plessis AJ, 2002, CURR OPIN NEUROL, V15, P151, DOI 10.1097/00019052-200204000-00005; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Erenberg A, 1999, PEDIATRICS, V103, P527; Hardie NA, 1998, NEUROREPORT, V9, P2019, DOI 10.1097/00001756-199806220-00020; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; Hyde M L, 1990, J Am Acad Audiol, V1, P59; Moreno-Aguirre AJ, 2010, INT J AUDIOL, V49, P110, DOI 10.3109/14992020903311370; JEWETT DL, 1970, SCIENCE, V167, P1517, DOI 10.1126/science.167.3924.1517; John M Sasha, 2002, J Am Acad Audiol, V13, P246; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; KEMP DT, 1991, ACTA OTO-LARYNGOL, P73; Margolis Robert H, 2003, J Am Acad Audiol, V14, P383; Martinez-Cruz CF, 2008, ARCH MED RES, V39, P686, DOI 10.1016/j.arcmed.2008.06.004; McAlpine D, 1997, J NEUROPHYSIOL, V78, P767, DOI 10.1152/jn.1997.78.2.767; Meyer C, 1999, PEDIATRICS, V104, P900, DOI 10.1542/peds.104.4.900; Norton SJ, 2000, EAR HEARING, V21, P529, DOI 10.1097/00003446-200010000-00014; Ozdek A, 2010, EUR ARCH OTO-RHINO-L, V267, P43, DOI 10.1007/s00405-009-1014-8; Pantev C, 2006, CEREB CORTEX, V16, P31, DOI 10.1093/cercor/bhi081; PASIC TR, 1994, J COMP NEUROL, V348, P111, DOI 10.1002/cne.903480106; Perez-Abalo MC, 2001, EAR HEARING, V22, P200, DOI 10.1097/00003446-200106000-00004; Picton T W, 1998, J Am Acad Audiol, V9, P315; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Poblano A, 2003, J PERINAT MED, V31, P237, DOI 10.1515/JPM.2003.032; POWELL TPS, 1962, J ANAT, V96, P249; Santiago-Rodriguez E, 2005, PEDIATR NEUROL, V32, P236, DOI 10.1016/j.pediatrneurol.2004.12.005; Savio G, 2006, INT J AUDIOL, V45, P109, DOI 10.1080/14992020500377980; Savio G, 2001, AUDIOL NEURO-OTOL, V6, P279, DOI 10.1159/000046133; Thai-Van H, 2007, CLIN NEUROPHYSIOL, V118, P676, DOI 10.1016/j.clinph.2006.11.010; Tierney TS, 1997, J COMP NEUROL, V378, P295, DOI 10.1002/(SICI)1096-9861(19970210)378:2<295::AID-CNE11>3.0.CO;2-R; Valdes JL, 1997, EAR HEARING, V18, P420, DOI 10.1097/00003446-199710000-00007; Volpe JJ, 1997, CLIN PERINATOL, V24, P567, DOI 10.1016/S0095-5108(18)30159-3; Yoshinaga-Itano C, 2003, MENT RETARD DEV D R, V9, P252, DOI 10.1002/mrdd.10088	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e41002	10.1371/journal.pone.0041002	http://dx.doi.org/10.1371/journal.pone.0041002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808289	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700073
J	Liu, ZW; Ren, GL; Shangguan, CY; Guo, LJ; Dong, ZX; Li, YY; Zhang, WN; Zhao, L; Hou, PF; Zhang, Y; Wang, XL; Lu, J; Huang, BQ				Liu, Zhiwei; Ren, Guoling; Shangguan, Chenyan; Guo, Lijing; Dong, Zhixiong; Li, Yueyang; Zhang, Weina; Zhao, Li; Hou, Pingfu; Zhang, Yu; Wang, Xiuli; Lu, Jun; Huang, Baiqu			ATRA Inhibits the Proliferation of DU145 Prostate Cancer Cells through Reducing the Methylation Level of HOXB13 Gene	PLOS ONE			English	Article							TRANS-RETINOIC ACID; GROUP PROTEIN EZH2; DNA METHYLATION; DOWN-REGULATION; LEUKEMIA-CELLS; HOMEOBOX GENES; GROWTH; DIFFERENTIATION; DNMT3B; EXPRESSION	All-trans retinoic acid (ATRA) has been widely investigated for treatments of many cancers including prostate cancer. HOXB13, silenced in androgen receptor-negative (AR(-)) prostate cancer cells, plays a role in AR(-) prostate cancer cell growth arrest. In this study we intended to elucidate the mechanisms that are involved in the proliferation inhibition of AR(-) prostate cancer cells triggered by ATRA. We discovered that ATRA was able to induce the growth arrest and to increase HOXB13 expression in AR(-) prostate cancer cells. Both EZH2 and DNMT3b participated in the repression of HOXB13 expression through an epigenetic mechanism involving DNA and histone methylation modifications. Specifically, EZH2 recruited DNMT3b to HOXB13 promoter to form a repression complex. Moreover, ATRA could upregulate HOXB13 through decreasing EZH2 and DNMT3b expressions and reducing their interactions with the HOXB13 promoter. Concurrently, the methylation level of the HOXB13 promoter was reduced upon the treatment of ATRA. Results from this study implicated a novel effect of ATRA in inhibition of the growth of AR(-) resistant human prostate cancer cells through alteration of HOXB13 expression as a result of epigenetic modifications.	[Liu, Zhiwei; Shangguan, Chenyan; Guo, Lijing; Li, Yueyang; Zhang, Yu; Wang, Xiuli; Huang, Baiqu] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Ren, Guoling] Daqing Normal Univ, Coll Life Sci, Daqing, Heilongjiang, Peoples R China; [Dong, Zhixiong] Tianjin Normal Univ, Coll Life Sci, Tianjin, Peoples R China; [Zhang, Weina; Zhao, Li; Hou, Pingfu; Lu, Jun] NE Normal Univ, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China	Northeast Normal University - China; Daqing Normal University; Tianjin Normal University; Northeast Normal University - China	Liu, ZW (corresponding author), NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China.	ycsuo@nenu.edu.cn; huangbq705@nenu.edu.cn			The National Natural Science Foundation of China [30971613, 31071149, 91019011, 30800557]; Fundamental Research Funds for the Central Universities [09ZDQD01]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from The National Natural Science Foundation of China (30971613, 31071149, 91019011, 30800557), and The Fundamental Research Funds for the Central Universities (09ZDQD01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovska OP, 2006, CELL CYCLE, V5, P1886; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bryant RJ, 2007, PROSTATE, V67, P547, DOI 10.1002/pros.20550; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chi HT, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-165; DRACH J, 1993, CANCER RES, V53, P2100; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Fan T, 2011, MOL CANC RES; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Hagiwara Y, 2010, INT J HEMATOL, V92, P136, DOI 10.1007/s12185-010-0627-4; Hammond LA, 2001, BRIT J CANCER, V85, P453, DOI 10.1054/bjoc.2001.1939; Han SY, 2006, BIOCHEM J, V400, P439, DOI 10.1042/BJ20061085; Hoffmann MJ, 2007, CANCER BIOL THER, V6, P1403, DOI 10.4161/cbt.6.9.4542; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Jung CY, 2004, CANCER RES, V64, P3046, DOI 10.1158/0008-5472.CAN-03-2614; Kahlem P, 2004, J CLIN INVEST, V113, P169, DOI 10.1172/JCI200420784; Karabulut B, 2011, MOL BIOL REP, V38, P249, DOI 10.1007/s11033-010-0102-6; Kim YR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-124; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kucukzeybek Y, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-37; Lewis MT, 2000, BREAST CANCER RES, V2, P158, DOI 10.1186/bcr49; Li L, 2011, BREAST CANC RES TREA; Li LC, 2004, BBA-REV CANCER, V1704, P87, DOI 10.1016/j.bbcan.2004.06.001; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Lu J, 2005, CYTOKINE, V31, P46, DOI 10.1016/j.cyto.2005.03.001; Mack JA, 2005, J BIOL CHEM, V280, P29904, DOI 10.1074/jbc.M505262200; Miao J, 2007, P NATL ACAD SCI USA, V104, P17093, DOI 10.1073/pnas.0707938104; Miyauchi J, 1999, LEUKEMIA LYMPHOMA, V33, P267, DOI 10.3109/10428199909058426; Okuda H, 2006, ONCOGENE, V25, P1733, DOI 10.1038/sj.onc.1209200; Qi HL, 2006, CANCER RES, V66, P5875, DOI 10.1158/0008-5472.CAN-05-4048; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; Schlemmer HP, 2008, RADIOLOGE, V48, P45, DOI 10.1007/s00117-007-1555-z; Siddikuzzaman Guruvayoorappan C, 2010, IMMUNOPHARMACOL IMMU; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sowinska A, 2007, CANCER LETT, V255, P153, DOI 10.1016/j.canlet.2007.04.004; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang H, 2011, UROL ONCOL; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wu XD, 2008, NUCLEIC ACIDS RES, V36, P3590, DOI 10.1093/nar/gkn243; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13; Zhang XK, 2002, ENDOCR-RELAT CANCER, V9, DOI 10.1677/erc.0.0090087	49	20	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40943	10.1371/journal.pone.0040943	http://dx.doi.org/10.1371/journal.pone.0040943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808286	gold, Green Submitted, Green Published			2022-12-27	WOS:000306406700071
J	Dinh, MH; Hirbod, T; Kigozi, G; Okocha, EA; Cianci, GC; Kong, XR; Prodger, JL; Broliden, K; Kaul, R; Serwadda, D; Wawer, MJ; Gray, RH; Hope, TJ				Dinh, Minh H.; Hirbod, Taha; Kigozi, Godfrey; Okocha, Eneniziaogochukwu A.; Cianci, Gianguido C.; Kong, Xiangrong; Prodger, Jessica L.; Broliden, Kristina; Kaul, Rupert; Serwadda, David; Wawer, Maria J.; Gray, Ronald H.; Hope, Thomas J.			No Difference in Keratin Thickness between Inner and Outer Foreskins from Elective Male Circumcisions in Rakai, Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADULT MALE FORESKIN; BARRIER FUNCTION; HIV PREVENTION; TARGET-CELLS; YOUNG MEN; TISSUE; SKIN; INFECTIONS; INVOLUCRIN	It has been hypothesized that increased HIV acquisition in uncircumcised men may relate to a more thinly keratinized inner foreskin. However, published data are contradictory and potentially confounded by medical indications for circumcision. We tested the hypothesis that the inner foreskin was more thinly keratinized than the outer foreskin using tissues from 19 healthy, HIV-uninfected men undergoing routine prophylactic circumcision in Rakai, Uganda. Sections from 3 foreskin anatomic sites (inner, outer, and frenar band) were snap-frozen separately. Two independent laboratories each separately stained, imaged, and measured keratin thicknesses in a blinded fashion. There was no significant difference in keratin thickness between the inner (mean = 14.67 +/- 7.48 mu m) and outer (mean = 13.30 +/- 8.49 mu m) foreskin, or between the inner foreskin and the frenar band (mean = 16.91 +/- 12.42 mu m). While the frenar band showed the greatest intra-individual heterogeneity in keratin thickness, there was substantial inter-individual variation seen in all regions. Measurements made by the two laboratories showed high correlation (r = 0.741, 95% CI, 0.533-0.864). We conclude that, despite inter-and intra-individual variability, keratin thickness was similar in the inner and outer foreskin of healthy Ugandan men, and that reduced keratin thickness is not likely to make the inner foreskin more susceptible to HIV acquisition.	[Dinh, Minh H.; Okocha, Eneniziaogochukwu A.; Cianci, Gianguido C.; Hope, Thomas J.] Northwestern Univ, Dept Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [Dinh, Minh H.; Okocha, Eneniziaogochukwu A.; Cianci, Gianguido C.; Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hirbod, Taha; Broliden, Kristina] Karolinska Inst, Dept Med Solna, Ctr Mol Med, Stockholm, Sweden; [Kigozi, Godfrey] Rakai Hlth Sci Program, Entebbe, Uganda; [Prodger, Jessica L.; Kaul, Rupert; Wawer, Maria J.; Gray, Ronald H.] Univ Toronto, Dept Med, Toronto, ON, Canada; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kong, Xiangrong; Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kong, Xiangrong; Serwadda, David] Makerere Univ, Sch Publ Hlth, Rakai, Uganda	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Karolinska Institutet; Rakai Health Sciences Program; University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Makerere University	Dinh, MH (corresponding author), Northwestern Univ, Dept Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA.	m-dinh@northwestern.edu		Kaul, Rupert/0000-0002-1586-4093; Prodger, Jessica/0000-0003-0805-4196	National Institutes of Health [5R33AI076968, 5K08HD060451-02, U01AI075115, R01AI087409]; Bill and Melinda Gates Foundation Grant [22006.03]; FIC AITRP and Pop Health, Anaerobes [D43TW01508, D43TW000010, PEPFAR USGPS000971]; Swedish Research Council; SIDA/SAREC; Canadian Institutes of Health Research [HBF-115704]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD060451] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001508, D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI076968, R01AI087409, U01AI075115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK096989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Grant(Bill & Melinda Gates Foundation); FIC AITRP and Pop Health, Anaerobes; Swedish Research Council(Swedish Research CouncilEuropean Commission); SIDA/SAREC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by: National Institutes of Health 5R33AI076968 (TJH), 5K08HD060451-02 (MD), U01AI075115 (RG), and R01AI087409 (RG), Bill and Melinda Gates Foundation Grant 22006.03 (RG), FIC AITRP and Pop Health, Anaerobes D43TW01508 (RG), D43TW000010 (RG), and PEPFAR USGPS000971 (RG), the Swedish Research Council (KB, TH), SIDA/SAREC (KB, TH), and Canadian Institutes of Health Research HBF-115704 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SAS STAT 9 2 USERS G; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Dinh MH, 2011, BIOL REPROD; Dinh MH, 2010, AIDS, V24, P899, DOI 10.1097/QAD.0b013e3283367779; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Ganor Yonatan, 2011, Am J Reprod Immunol, V65, P284, DOI 10.1111/j.1600-0897.2010.00933.x; Gray RH, 2010, AIDS, V24, P1381, DOI 10.1097/QAD.0b013e3283392555; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hirbod T, 2010, AM J PATHOL, V176, P2798, DOI 10.2353/ajpath.2010.090926; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; Johnson KE, 2009, AIDS, V23, P1807, DOI 10.1097/QAD.0b013e32832efdf1; Jordan GH, 2007, WEIN CAMPBELL WALSH; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Presland RB, 2004, J INVEST DERMATOL, V123, P603, DOI 10.1111/j.0022-202X.2004.23226.x; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Prodger JL, 2011, MUCOSAL IMMUNOL; Qin Q, 2009, INT UROL NEPHROL, V41, P747, DOI 10.1007/s11255-008-9521-x; Taylor SC, 2002, J AM ACAD DERMATOL, V46, pS41, DOI 10.1067/mjd.2002.120790; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Weiss HA, 2007, CURR OPIN INFECT DIS, V20, P66, DOI 10.1097/QCO.0b013e328011ab73	27	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41271	10.1371/journal.pone.0041271	http://dx.doi.org/10.1371/journal.pone.0041271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815984	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900104
J	Liu, FH; Tang, Y; Sun, JW; Yuan, ZN; Li, SS; Sheng, J; Ren, H; Hao, JH				Liu, Fenghua; Tang, Yong; Sun, Junwei; Yuan, Zhanna; Li, Shasha; Sheng, Jun; Ren, He; Hao, Jihui			Regional Intra-Arterial vs. Systemic Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							ARTERIAL INFUSION CHEMOTHERAPY; PHASE-III TRIAL; GEMCITABINE; THERAPY; PHARMACOKINETICS; COMBINATION; CARCINOMA	Objective: To investigate the efficacy and safety of regional intra-arterial chemotherapy (RIAC) versus systemic chemotherapy for stage III/IV pancreatic cancer. Methods: Randomized controlled trials of patients with advanced pancreatic cancer treated by regional intra-arterial or systemic chemotherapy were identified using PubMed, ISI, EMBASE, Cochrane Library, Google, Chinese Scientific Journals Database (VIP), and China National Knowledge Infrastructure (CNKI) electronic databases, for all publications dated between 1960 and December 31, 2010. Data was independently extracted by two reviewers. Odds ratios and relative risks were pooled using either fixed-or random-effects models, depending on I-2 statistic and Q test assessments of heterogeneity. Statistical analysis was performed using RevMan 5.0. Results: Six randomized controlled trials comprised of 298 patients met the standards for inclusion in the meta-analysis, among 492 articles that were identified. Eight patients achieved complete remission (CR) with regional intra-arterial chemotherapy (RIAC), whereas no patients achieved CR with systemic chemotherapy. Compared with systemic chemotherapy, patients receiving RIAC had superior partial remissions (RR = 1.99, 95% CI: 1.50, 2.65; 58.06% with RIAC and 29.37% with systemic treatment), clinical benefits (RR = 2.34, 95% CI: 1.84, 2.97; 78.06% with RAIC and 29.37% with systemic treatment), total complication rates (RR = 0.72, 95% CI: 0.60, 0.87; 49.03% with RIAC and 71.33% with systemic treatment), and hematological side effects (RR = 0.76, 95% CI: 0.63, 0.91; 60.87% with RIAC and 85.71% with systemic treatment). The median survival time with RIAC (5-21 months) was longer than for systemic chemotherapy (2.7-14 months). Similarly, one year survival rates with RIAC (28.6%-241.2%) were higher than with systemic chemotherapy (0%-212.9%.). Conclusion: Regional intra-arterial chemotherapy is more effective and has fewer complications than systemic chemotherapy for treating advanced pancreatic cancer.	[Liu, Fenghua; Tang, Yong; Sun, Junwei; Yuan, Zhanna; Li, Shasha; Sheng, Jun; Ren, He; Hao, Jihui] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Dept Pancreat Canc, Tianjin, Peoples R China	Tianjin Medical University	Liu, FH (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Dept Pancreat Canc, Tianjin, Peoples R China.	jihuihao@yahoo.com			National Natural Science Foundation of China (NSFC) [30973490]; Tianjin education committee foundation [10JCZDJC202000, 20101202110002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin education committee foundation	This study was supported by the National Natural Science Foundation of China (NSFC) 30973490, and Tianjin education committee foundation 10JCZDJC202000, 20101202110002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner KR, 2005, ANTICANCER RES, V25, P4407; Aigner KR, 1998, HEPATO-GASTROENTEROL, V45, P1125; Arshad A, 2011, BRIT J NUTR, V106, P795, DOI 10.1017/S0007114511003060; Bayraktar S, 2010, MT SINAI J MED, V77, P606, DOI 10.1002/msj.20217; Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Bouchahda M, 2009, CANCER-AM CANCER SOC, V115, P4990, DOI 10.1002/cncr.24549; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Colucci G, 2010, J CLIN ONCOL, V28, P1645, DOI 10.1200/JCO.2009.25.4433; Friess H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-285; Fu Deliang, 2002, Zhonghua Yi Xue Za Zhi, V82, P371; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Han Guo Hong, 2006, Chin J Dig Dis, V7, P45, DOI 10.1111/j.1443-9573.2006.00243.x; Haramoto M, 2010, ONCOL REP, V23, P365, DOI 10.3892/or_00000644; Homma H, 2000, CANCER, V89, P303, DOI 10.1002/1097-0142(20000715)89:2<303::AID-CNCR15>3.3.CO;2-T; [洪国斌 HONG Guobin], 2007, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V34, P54; Ji ZZ, 2003, CHINESE MED J-PEKING, V116, P89; Kingham TP, 2010, J SURG ONCOL, V102, P988, DOI 10.1002/jso.21753; [李强 LI Qiang], 2009, [中华放射学杂志, Chinese Journal of Radiology], V43, P191; [李强 LI Qiang], 2009, [介入放射学杂志, Journal of Interventional Radiology], V18, P275; Liu HQ, 2008, JOF BAS CLIN ONCOL, V21, P479; Lorenz M, 1998, EUR J SURG ONCOL, V24, P542, DOI 10.1016/S0748-7983(98)93572-7; Mitsutsuji M, 2003, ANN SURG ONCOL, V10, P546, DOI 10.1245/ASO.2003.07.018; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakchbandi W, 2008, J GASTROINTEST LIVER, V17, P285; Philip PA, 2011, J CLIN ONCOL, V29, P4066, DOI 10.1200/JCO.2011.37.2532; Shamseddine AI, 2005, CLIN PHARMACOKINET, V44, P957, DOI 10.2165/00003088-200544090-00005; Tanaka T, 2010, J VASC INTERV RADIOL, V21, P116, DOI 10.1016/j.jvir.2009.09.027; Xie DR, 2006, WORLD J GASTROENTERO, V12, P6973, DOI 10.3748/wjg.v12.i43.6973; Xie Yi-bin, 2010, Zhonghua Yi Xue Za Zhi, V90, P2126; [杨梅 YANG Mei], 2010, [中国药学杂志, Chinese Pharmaceutical Journal], V45, P295	30	24	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40847	10.1371/journal.pone.0040847	http://dx.doi.org/10.1371/journal.pone.0040847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815840	gold, Green Submitted, Green Published			2022-12-27	WOS:000306548900055
J	Schrauf, C; Call, J; Fuwa, K; Hirata, S				Schrauf, Cornelia; Call, Josep; Fuwa, Koki; Hirata, Satoshi			Do Chimpanzees Use Weight to Select Hammer Tools?	PLOS ONE			English	Article							NUT-CRACKING BEHAVIOR; MONKEYS CEBUS-LIBIDINOSUS; WILD CHIMPANZEES; STONE HAMMERS; ANVILS	The extent to which tool-using animals take into account relevant task parameters is poorly understood. Nut cracking is one of the most complex forms of tool use, the choice of an adequate hammer being a critical aspect in success. Several properties make a hammer suitable for nut cracking, with weight being a key factor in determining the impact of a strike; in general, the greater the weight the fewer strikes required. This study experimentally investigated whether chimpanzees are able to encode the relevance of weight as a property of hammers to crack open nuts. By presenting chimpanzees with three hammers that differed solely in weight, we assessed their ability to relate the weight of the different tools with their effectiveness and thus select the most effective one(s). Our results show that chimpanzees use weight alone in selecting tools to crack open nuts and that experience clearly affects the subjects' attentiveness to the tool properties that are relevant for the task at hand. Chimpanzees can encode the requirements that a nut-cracking tool should meet (in terms of weight) to be effective.	[Schrauf, Cornelia] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Fuwa, Koki; Hirata, Satoshi] Hayashibara Biochem Labs Inc, Great Ape Res Inst, Okayama, Japan	University of Vienna; Max Planck Society; Hayashibara Biochemical Laboratories, Inc.	Schrauf, C (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	connyschrauf@chello.at		Call Balaguer, Josep/0000-0002-8597-8336	Japan Society for the Promotion of Science Predoc Grant	Japan Society for the Promotion of Science Predoc Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by a Japan Society for the Promotion of Science Predoc Grant (http://www.jsps.go.jp/english/e-summer/index.html) to Cornelia Schrauf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J R, 1983, Primates, V24, P594, DOI 10.1007/BF02381692; BEATTY H, 1951, J MAMMAL, V32, P118, DOI 10.1093/jmammal/32.1.118; Biro D, 2011, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P476; BOESCH C, 1984, INT J PRIMATOL, V5, P323; BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; BOESCH C, 1990, FOLIA PRIMATOL, V54, P86, DOI 10.1159/000156428; BOESCH C, 1991, INT J PRIMATOL, V12, P541, DOI 10.1007/BF02547669; Boesch C, 2000, CHIMPANZEES TAI FORE; Bril B., 2000, PERLES CAMBAY PRACTI, P211; Bril B, 2009, ANIM COGN, V12, P217, DOI 10.1007/s10071-008-0184-x; Brosnan SF, 2009, CURR BIOL, V19, pR124, DOI 10.1016/j.cub.2008.12.001; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Fragaszy DM, 2010, ANIM BEHAV, V80, P205, DOI 10.1016/j.anbehav.2010.04.018; FUSHIMI T, 1991, PRIMATOLOGY TODAY, P695; Goodall J., 1986, CHIMPANZEES GOMBE PA; HANNAH AC, 1987, PRIMATES, V28, P31, DOI 10.1007/BF02382181; Hanus D, 2008, CURR BIOL, V18, pR370, DOI 10.1016/j.cub.2008.02.039; Hayashi M, 2005, PRIMATES, V46, P91, DOI 10.1007/s10329-004-0110-z; Hirata S, 2009, ANIM COGN, V12, pS87, DOI 10.1007/s10071-009-0275-3; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Liu Q, 2009, AM J PHYS ANTHROPOL, V138, P210, DOI 10.1002/ajpa.20920; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; Matsuzawa Tetsuro, 1996, P196, DOI 10.1017/CBO9780511752414.017; Matsuzawa Tetsuro, 1994, P351; McGrew WC, 1997, INT J PRIMATOL, V18, P353, DOI 10.1023/A:1026382316131; Morgan BJ, 2006, CURR BIOL, V16, pR632, DOI 10.1016/j.cub.2006.07.045; Nishida T., 1990, CHIMPANZEES MAHALE M; Ross SR, 2010, FOLIA PRIMATOL, V81, P224, DOI 10.1159/000322118; SAKURA O, 1991, ETHOLOGY, V87, P237; Schrauf C, 2008, ANIM COGN, V11, P413, DOI 10.1007/s10071-007-0131-2; Schrauf C, 2011, AM J PRIMATOL, V73, P323, DOI 10.1002/ajp.20899; STRUHSAKER TT, 1971, FOLIA PRIMATOL, V15, P212, DOI 10.1159/000155380; SUGIYAMA Y, 1981, Primates, V22, P435, DOI 10.1007/BF02381236; SUGIYAMA Y, 1979, Primates, V20, P323, DOI 10.1007/BF02373387; Sugiyama Yukimaru, 1993, P175; SUMITA K, 1985, Primates, V26, P168, DOI 10.1007/BF02382016; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whitesides G.H., 1985, Primates, V26, P91, DOI 10.1007/BF02389050	40	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41044	10.1371/journal.pone.0041044	http://dx.doi.org/10.1371/journal.pone.0041044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815905	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900070
J	Shaw, CN; Hofmann, CL; Petraglia, MD; Stock, JT; Gottschall, JS				Shaw, Colin N.; Hofmann, Cory L.; Petraglia, Michael D.; Stock, Jay T.; Gottschall, Jinger S.			Neandertal Humeri May Reflect Adaptation to Scraping Tasks, but Not Spear Thrusting	PLOS ONE			English	Article							BILATERAL ASYMMETRY; BONE; ROBUSTICITY; MIDDLE; HANDEDNESS; BEHAVIOR; SHAPE; HOMO	Unique compared with recent and prehistoric Homo sapiens, Neandertal humeri are characterised by a pronounced right-dominant bilateral strength asymmetry and an anteroposteriorly strengthened diaphyseal shape. Remodeling in response to asymmetric forces imposed during regular underhanded spear thrusting is the most influential explanatory hypothesis. The core tenet of the "Spear Thrusting Hypothesis", that underhand thrusting requires greater muscle activity on the right side of the body compared to the left, remains untested. It is unclear whether alternative subsistence behaviours, such as hide processing, might better explain this morphology. To test this, electromyography was used to measure muscle activity at the primary movers of the humerus (pectoralis major (PM), anterior (AD) and posterior deltoid (PD)) during three distinct spear-thrusting tasks and four separate scraping tasks. Contrary to predictions, maximum muscle activity (MAX) and total muscle activity (TOT) were significantly higher (all values, p<.05) at the left (non-dominant) AD, PD and PM compared to the right side of the body during spear thrusting tasks. Thus, the muscle activity required during underhanded spearing tasks does not lend itself to explaining the pronounced right dominant strength asymmetry found in Neandertal humeri. In contrast, during the performance of all three unimanual scraping tasks, right side MAX and TOT were significantly greater at the AD (all values, p<.01) and PM (all values, p<.02) compared to the left. The consistency of the results provides evidence that scraping activities, such as hide preparation, may be a key behaviour in determining the unusual pattern of Neandertal arm morphology. Overall, these results yield important insight into the Neandertal behavioural repertoire that aided survival throughout Pleistocene Eurasia.	[Shaw, Colin N.; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, PAVE Res Grp, Cambridge, England; [Hofmann, Cory L.; Gottschall, Jinger S.] Penn State Univ, Dept Kinesiol, Neuromot Lab, University Pk, PA 16802 USA; [Petraglia, Michael D.] Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford, England; [Shaw, Colin N.] Univ Cambridge, Dept Archaeol & Anthropol, McDonald Inst Archaeol Res, Cambridge, England	University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Oxford; University of Cambridge	Shaw, CN (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, PAVE Res Grp, Cambridge, England.	cns30@cam.ac.uk	Petraglia, Michael/ABA-9748-2021; Stock, Jay T/B-6453-2011	Stock, Jay T/0000-0003-0147-8631; Petraglia, Michael/0000-0003-2522-5727	Cushing Anthropological Research Fund	Cushing Anthropological Research Fund	The authors wish to thank Tim Ryan, Neil Sharkey, John Challis and Nori Okita, Sylvie Beyries, Jill Oakes and Sarah Beam (Bata Shoe Museum) for their support and helpful suggestions during the course of this project, to Stefano Benazzi, Brigitte Holt, Asier Gomez-Olivencia, Steven Churchill and Eric Trinkaus for commenting on versions of this manuscript, to all participants, without whom this research would have remained theoretical, and to Bruce Bradley and John Lord for very generously knapping and donating the replica Mousterian side-scrapers used in this study. CNS wishes to also acknowledge the benevolence of the Cushing Anthropological Research Fund for its ongoing financial support.	Albright A, 1984, TAHLTAN ETHNOARCHAEO; Anderson-Gerfaud P., 1990, EMERGENCE MODERN HUM, P389; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; BENITZHAK S, 1988, AM J PHYS ANTHROPOL, V77, P231, DOI 10.1002/ajpa.1330770211; Beyries S, 1987, BRIT ARCHAEOLOGICAL; Beyries S, 2000, LIVING SKIN MY REIND; Bordes F., 1961, TYPOLOGIE PALEOLITHI; CENA K, 1978, PHYS MED BIOL, V23, P565, DOI 10.1088/0031-9155/23/4/001; Churchill S.E., 1998, Quaternaria Nova, V6, P413; Churchill S.E., 1994, THESIS U NEW MEXICO; Churchill SE, 2002, EVOL ANTHROPOL, V11, P185, DOI 10.1002/evan.10027; CHURCHILL SE, 1990, AM J PHYS ANTHROPOL, V83, P147, DOI 10.1002/ajpa.1330830203; Churchill SE, 2009, VERTEBR PALEOBIOL PA, P201, DOI 10.1007/978-1-4020-9699-0_15; Clark J. D., 1981, MODERN MAT CULTURE A, P303; Clement AF, 2012, J HUM EVOL, V62, P367, DOI 10.1016/j.jhevol.2011.11.014; Cram J, 1998, ELECTRODE PLACEMENT; Currey J., 1984, MECH ADAPTATION BONE; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; EWERS JC, 1930, BLACKFEET CRAFTS; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Faurie C, 2003, P ROY SOC LOND B BIO, V271, pS43; Frayer D, 2012, LATERALITY, V17; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Gurven M, 2009, CURR ANTHROPOL, V50, P51, DOI 10.1086/595620; Haaland R, 1987, SOCIOECONOMIC DIFFER; HAMMEL HT, 1955, AM J PHYSIOL, V182, P369, DOI 10.1152/ajplegacy.1955.182.2.369; Hardy BL, 2004, ANTIQUITY, V78, P547, DOI 10.1017/S0003598X00113213; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; HAYDEN B., 1990, INTERPRETATIVE POSSI, P89; Judex S, 2009, MED SCI SPORT EXER, V41, P2037, DOI 10.1249/MSS.0b013e3181a8c6e5; Keeley L.H., 1980, EXPT DETERMINATION S; Kennedy KAR, 2004, EVOL ANTHROPOL, V13, P127, DOI 10.1002/evan.20007; LANYON LE, 1992, J BONE MINER RES, V7, pS369, DOI 10.1002/jbmr.5650071403; LANYON LE, 1975, ACTA ORTHOP SCAND, V46, P256, DOI 10.3109/17453677508989216; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Liapunova R, 1975, ESSAYS ETHNOGRAPHY A; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; Martin RB., 1989, STRUCTURE FUNCTION; Mellars P.A., 1996, NEANDERTAL LEGACY; Moote I., 1955, TEXT RES J, V25, P832; Oakes J, 1991, SKIN PREPARATION TEC, P102; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Qin YX, 1998, J ORTHOPAED RES, V16, P482, DOI 10.1002/jor.1100160414; Raymond M, 2004, LATERALITY, V9, P35, DOI 10.1080/13576500244000274; Rhodes JA, 2005, AM J PHYS ANTHROPOL, V128, P536, DOI 10.1002/ajpa.20147; Rhodes JA, 2009, J HUM EVOL, V56, P1, DOI 10.1016/j.jhevol.2008.08.022; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Rios-Garaizar J, 2010, ZEPHYRUS, VLXV, P15; Rots V., 2009, QUARTAR, V56, P37; RUBIN CT, 1990, J BIOMECH, V23, P43, DOI 10.1016/0021-9290(90)90040-A; RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165; Ruff C. B., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P202; Schmitt D, 2003, J ARCHAEOL SCI, V30, P103, DOI 10.1006/jasc.2001.0814; Semenov S., 1964, PREHISTORIC TECHNOLO; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P160, DOI 10.1002/ajpa.21063; Shea J., 1992, EVOL ANTHROPOL, V1, P143, DOI DOI 10.1002/EVAN.1360010407; Shipman P, 2008, P NATL ACAD SCI USA, V105, P14241, DOI 10.1073/pnas.0807931105; Snodgrass J. Josh, 2009, Paleoanthropology, V2009, P220; Sorensen MV, 2001, J HUM EVOL, V40, P483, DOI 10.1006/jhev.2001.0472; Steegmann AT, 2002, AM J HUM BIOL, V14, P566, DOI 10.1002/ajhb.10070; Stock JT, 2004, J ARCHAEOL SCI, V31, P999, DOI 10.1016/j.jas.2003.12.012; Takase K, 2004, MAT CULTURE, V77, P57; TOTH N, 1985, J HUM EVOL, V14, P607, DOI 10.1016/S0047-2484(85)80087-7; Trinkaus E, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P391; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P753, DOI 10.1006/jasc.1998.0345; Trinkaus E, 1997, P NATL ACAD SCI USA, V94, P13367, DOI 10.1073/pnas.94.24.13367; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; TRINKAUS E, 1991, J ANTHROPOL SOC NIP, V99, P257; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P173, DOI 10.1006/jasc.1998.0314; Trinkaus E, 2010, TEXAS A M U ANTHR SE, P96; Trinkaus E, 2008, ANN ROUM ANTHR, V45, P27; TRINKAUS E, 2005, EARLY MODERN HUMAN E, P327; Trinkaus E, 2008, ANTHROPOL SCI, V116, P231, DOI 10.1537/ase.071221; Turner L, 1894, ETHNOLOGY UNGAVA DIS; Uomini NT, 2009, J HUM EVOL, V57, P411, DOI 10.1016/j.jhevol.2009.02.012; Waguespack NM, 2009, ANTIQUITY, V83, P786, DOI 10.1017/S0003598X00098999; Walker A., 1993, NARIOKOTOME HOMO ERE; Watkins SM., 1984, CLOTHING PORTABLE EN, V1st ed; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Wheeler P, 2003, NEANDERTHALS MODERN, P147; White MJ, 2006, WORLD ARCHAEOL, V38, P547, DOI 10.1080/00438240600963031; Williams EM, 2010, AM J PHYS ANTHROPOL, V143, P134, DOI 10.1002/ajpa.21302; Williams EMS, 2012, AM J PHYS ANTHROPOL, V147, P303; Wolpoff M. H., 1999, PALEOANTHROPOLOGY	85	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40349	10.1371/journal.pone.0040349	http://dx.doi.org/10.1371/journal.pone.0040349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815742	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900022
J	Yan, C; Cao, Y; Zhang, Y; Song, LL; Cheung, EFC; Chan, RCK				Yan, Chao; Cao, Yuan; Zhang, Yang; Song, Li-Ling; Cheung, Eric F. C.; Chan, Raymond C. K.			Trait and State Positive Emotional Experience in Schizophrenia: A Meta-Analysis	PLOS ONE			English	Article							STRIATAL REWARD PREDICTION; FILE-DRAWER PROBLEM; SOCIAL ANHEDONIA; PARANOID SCHIZOPHRENIA; NEURAL RESPONSE; NEGATIVE AFFECT; FACIAL EMOTION; MEMORY; AROUSAL; DYSFUNCTION	Background: Prior meta-analyses indicated that people with schizophrenia show impairment in trait hedonic capacity but retain their state hedonic experience (valence) in laboratory-based assessments. Little is known about what is the extent of differences for state positive emotional experience (especially arousal) between people with schizophrenia and healthy controls. It is also not clear whether negative symptoms and gender effect contribute to the variance of positive affect. Methods and Findings: The current meta-analysis examined 21 studies assessing state arousal experience, 40 studies measuring state valence experience, and 47studies assessing trait hedonic capacity in schizophrenia. Patients with schizophrenia demonstrated significant impairment in trait hedonic capacity (Cohen's d = 0.81). However, patients and controls did not statistically differ in state hedonic (valence) as well as exciting (arousal) experience to positive stimuli (Cohen's d = -20.24 to 0.06). They also reported experiencing relatively robust state aversion and calmness to positive stimuli compared with controls (Cohen's d = 0.75, 0.56, respectively). Negative symptoms and gender contributed to the variance of findings in positive affect, especially trait hedonic capacity in schizophrenia. Conclusions: Our findings suggest that schizophrenia patients have no deficit in state positive emotional experience but impairment in "noncurrent" hedonic capacity, which may be mediated by negative symptoms and gender effect.	[Yan, Chao; Song, Li-Ling; Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Yan, Chao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cao, Yuan] City Univ Hong Kong, Dept Appl Social Studies, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Cheung, Eric F. C.] Castle Peak Hosp, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; City University of Hong Kong; Beijing University of Technology	Yan, C (corresponding author), Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Cao, Yuan/AAF-4860-2020; Chan, Raymond CK/B-6717-2009	Cao, Yuan/0000-0002-5635-9253; Chan, Raymond CK/0000-0002-3414-450X	National Science Fund China [81088001, 91132701]; Chinese Academy of Sciences [KSCX2-EW-J-8]	National Science Fund China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the grants from the National Science Fund China (81088001 and 91132701), and the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff SR, 2011, PSYCHIAT RES, V185, P309, DOI 10.1016/j.psychres.2010.07.026; An SK, 2006, YONSEI MED J, V47, P343, DOI 10.3349/ymj.2006.47.3.343; Andreason NC, 1983, SCALE ASSESSMENT POS; Bach D. M., 2010, SCHIZOPHR B, V36, P919; BERENBAUM H, 1992, J ABNORM PSYCHOL, V101, P37, DOI 10.1037/0021-843X.101.1.37; BERENBAUM H, 1994, J ABNORM PSYCHOL, V103, P148, DOI 10.1037/0021-843X.103.1.148; Blanchard JJ, 2011, SCHIZOPHRENIA BULL, V37, P291, DOI 10.1093/schbul/sbq104; Blanchard JJ, 1998, SCHIZOPHRENIA BULL, V24, P413, DOI 10.1093/oxfordjournals.schbul.a033336; Blanchard JJ, 2001, J ABNORM PSYCHOL, V110, P363, DOI 10.1037//0021-843X.110.3.363; Bleuler E., 1950, DEMENTIA PRAECOX; Borenstein M., 2005, COMPREHENSIVE META A; Burbridge JA, 2007, J ABNORM PSYCHOL, V116, P30, DOI 10.1037/0021-843X.116.1.30; Cavenett T, 2006, BEHAV RES THER, V44, P1461, DOI 10.1016/j.brat.2005.11.002; Chan RCK, 2010, PSYCHIAT RES, V175, P181, DOI 10.1016/j.psychres.2009.01.020; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Chapman LJ, 1978, REV PHYS ANHEDONIA S; Cohen AS, 2011, CLIN PSYCHOL REV, V31, P440, DOI 10.1016/j.cpr.2010.11.001; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Crespo-Facorro B, 2001, JAMA-J AM MED ASSOC, V286, P427, DOI 10.1001/jama.286.4.427; Dowd EC, 2010, BIOL PSYCHIAT, V67, P902, DOI 10.1016/j.biopsych.2009.10.020; Earnst KS, 1999, PSYCHIAT RES, V88, P191, DOI 10.1016/S0165-1781(99)00083-9; Gold JM, 2008, SCHIZOPHRENIA BULL, V34, P835, DOI 10.1093/schbul/sbn068; Goldstein JM, 2006, HORM BEHAV, V50, P612, DOI 10.1016/j.yhbeh.2006.06.029; Gooding DC, 2005, PSYCHIAT RES, V133, P173, DOI 10.1016/j.psychres.2003.12.029; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Habel U, 2000, SCHIZOPHR RES, V42, P57, DOI 10.1016/S0920-9964(99)00093-6; Haralanova E, 2012, EUR ARCH PSY CLIN N, V262, P59, DOI 10.1007/s00406-011-0227-1; Harvey PO, 2010, J PSYCHIATR RES, V44, P707, DOI 10.1016/j.jpsychires.2009.12.008; Heerey EA, 2007, J ABNORM PSYCHOL, V116, P268, DOI 10.1037/0021-843X.116.2.268; Hempel RJ, 2005, J PSYCHIATR RES, V39, P509, DOI 10.1016/j.jpsychires.2004.11.004; Hempel RJ, 2007, INT J PSYCHOPHYSIOL, V64, P174, DOI 10.1016/j.ijpsycho.2007.01.008; Herbener ES, 2008, SCHIZOPHRENIA BULL, V34, P875, DOI 10.1093/schbul/sbn081; Herbener ES, 2007, J ABNORM PSYCHOL, V116, P43, DOI 10.1037/0021-843X.116.1.43; Horan WP, 2008, SCHIZOPHRENIA BULL, V34, P856, DOI 10.1093/schbul/sbn083; Horan WP, 2006, J ABNORM PSYCHOL, V115, P496, DOI 10.1037/0021-843X.115.3.496; Horan WP, 2006, SCHIZOPHRENIA BULL, V32, P259, DOI 10.1093/schbul/sbj009; Horan WP, 2003, SCHIZOPHR RES, V65, P125, DOI 10.1016/S0920-9964(02)00410-3; Hudry J, 2002, CHEM SENSES, V27, P407, DOI 10.1093/chemse/27.5.407; Irani F, 2012, SCHIZOPHR RES, V137, P203, DOI 10.1016/j.schres.2012.01.023; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Juckel G, 2006, PSYCHOPHARMACOLOGY, V187, P222, DOI 10.1007/s00213-006-0405-4; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Kring AM, 1996, J ABNORM PSYCHOL, V105, P249, DOI 10.1037/0021-843X.105.2.249; Kring AM, 2003, PSYCHOL SCI, V14, P207, DOI 10.1111/1467-9280.02433; KRING AM, 1993, J ABNORM PSYCHOL, V102, P507, DOI 10.1037/0021-843X.102.4.507; Kring AM, 2008, SCHIZOPHRENIA BULL, V34, P819, DOI 10.1093/schbul/sbn071; Kring AM, 2010, CURR DIR PSYCHOL SCI, V19, P255, DOI 10.1177/0963721410377599; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Lakis N, 2011, PSYCHIAT RES-NEUROIM, V194, P245, DOI 10.1016/j.pscychresns.2011.05.010; Li HJ, 2011, SCHIZOPHR RES; Lipsey MW, 2001, EVAL HEALTH PROF, V24, P236, DOI 10.1177/01632780122034902; Mathews JR, 2004, COGNITION EMOTION, V18, P721, DOI 10.1080/02699930341000284; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Meehl PE., 1990, J PERS DISORD, V4, P1, DOI [10.1521/pedi.1990.4.1.1, DOI 10.1521/PEDI.1990.4.1.1]; Moberg PJ, 2003, AM J PSYCHIAT, V160, P1784, DOI 10.1176/appi.ajp.160.10.1784; Mulholland C, 2000, ADV PSYCHIAT TREAT, V6, P169, DOI [10.1192/apt.6.3.169, DOI 10.1192/APT.6.3.169]; Pelizza Lorenzo, 2009, Ann Gen Psychiatry, V8, P22, DOI 10.1186/1744-859X-8-22; Rauch AV, 2010, PSYCHIAT RES-NEUROIM, V182, P200, DOI 10.1016/j.pscychresns.2010.03.005; Reich JW, 2002, MOTIV EMOTION, V26, P209, DOI 10.1023/A:1021773013487; Ritsner MS, 2011, J NERV MENT DIS, V199, P845, DOI 10.1097/NMD.0b013e3182349ce6; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rupp CI, 2005, SCHIZOPHR RES, V74, P149, DOI 10.1016/j.schres.2004.07.010; Schlagenhauf F, 2008, PSYCHOPHARMACOLOGY, V196, P673, DOI 10.1007/s00213-007-1016-4; SCHLENKER R, 1995, EUR ARCH PSY CLIN N, V245, P309, DOI 10.1007/BF02191873; SCHNEIDER F, 1995, SCHIZOPHR RES, V17, P67, DOI 10.1016/0920-9964(95)00031-G; Seubert J, 2010, J PSYCHIATR NEUROSCI, V35, P185, DOI 10.1503/jpn.090094; Simon JJ, 2010, SCHIZOPHR RES, V118, P154, DOI 10.1016/j.schres.2009.11.007; Strauss GP, 2012, AM J PSYCHIAT, V169, P364, DOI 10.1176/appi.ajp.2011.11030447; Suslow T, 2003, EUR ARCH PSY CLIN N, V253, P292, DOI 10.1007/s00406-003-0443-4; Suslow T, 2003, PSYCHIAT RES, V120, P131, DOI 10.1016/S0165-1781(03)00173-2; Taylor SF, 2005, NEUROPSYCHOPHARMACOL, V30, P984, DOI 10.1038/sj.npp.1300679; Tremeau F, 2009, SCHIZOPHR RES, V107, P223, DOI 10.1016/j.schres.2008.09.020; Ursu S, 2011, AM J PSYCHIAT, V168, P276, DOI 10.1176/appi.ajp.2010.09081215; Volz M, 2003, INT J PSYCHOPHYSIOL, V49, P123, DOI 10.1016/S0167-8760(03)00100-4; Walter H, 2009, PSYCHOPHARMACOLOGY, V206, P121, DOI 10.1007/s00213-009-1586-4; Waltz JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1567, DOI 10.1038/npp.2008.214; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Wynn JK, 2010, INT J PSYCHOPHYSIOL, V77, P141, DOI 10.1016/j.ijpsycho.2010.05.009; Yik MSM, 1999, J PERS SOC PSYCHOL, V77, P600, DOI 10.1037/0022-3514.77.3.600	84	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40672	10.1371/journal.pone.0040672	http://dx.doi.org/10.1371/journal.pone.0040672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815785	Green Published, gold, Green Submitted			2022-12-27	WOS:000306548900037
J	Abdala-Valencia, H; Berdnikovs, S; Cook-Mills, JM				Abdala-Valencia, Hiam; Berdnikovs, Sergejs; Cook-Mills, Joan M.			Vitamin E Isoforms Differentially Regulate Intercellular Adhesion Molecule-1 Activation of PKC alpha in Human Microvascular Endothelial Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; BIOMECHANICAL PROPERTIES; INTRACELLULAR DOMAIN; LYMPHOCYTE MIGRATION; XANTHINE-OXIDASE; HUMAN MONOCYTES; IN-VIVO; TOCOPHEROL; INHIBITION	Aims: ICAM-1-dependent leukocyte recruitment in vivo is inhibited by the vitamin E isoform d-alpha-tocopherol and elevated by d-gamma-tocopherol. ICAM-1 is reported to activate endothelial cell signals including protein kinase C (PKC), but the PKC isoform and the mechanism for ICAM-1 activation of PKC are not known. It is also not known whether ICAM-1 signaling in endothelial cells is regulated by tocopherol isoforms. We hypothesized that d-alpha-tocopherol and d-gamma-tocopherol differentially regulate ICAM-1 activation of endothelial cell PKC. Results: ICAM-1 crosslinking activated the PKC isoform PKC alpha but not PKC beta in TNF alpha-pretreated human microvascular endothelial cells. ICAM-1 activation of PKC alpha was blocked by the PLC inhibitor U73122, ERK1/2 inhibitor PD98059, and xanthine oxidase inhibitor allopurinol. ERK1/2 activation was blocked by inhibition of XO and PLC but not by inhibition of PKC alpha, indicating that ERK1/2 is downstream of XO and upstream of PKC alpha during ICAM-1 signaling. During ICAM-1 activation of PKC alpha, the XO-generated ROS did not oxidize PKC alpha. Interestingly, d-alpha-tocopherol inhibited ICAM-1 activation of PKC alpha but not the upstream signal ERK1/2. The d-alpha-tocopherol inhibition of PKC alpha was ablated by the addition of d-gamma-tocopherol. Conclusions: Crosslinking ICAM-1 stimulated XO/ROS which activated ERK1/2 that then activated PKC alpha. ICAM-1 activation of PKC alpha was inhibited by d-alpha-tocopherol and this inhibition was ablated by the addition of d-gamma-tocopherol. These tocopherols regulated ICAM-1 activation of PKC alpha without altering the upstream signal ERK1/2. Thus, we identified a mechanism for ICAM-1 activation of PKC and determined that d-alpha-tocopherol and d-gamma-tocopherol have opposing regulatory functions for ICAM-1-activated PKC alpha in endothelial cells.	[Abdala-Valencia, Hiam; Berdnikovs, Sergejs; Cook-Mills, Joan M.] NW Univ Feinberg, Sch Med, Div Allergy Immunol, Chicago, IL USA	Northwestern University; Feinberg School of Medicine	Abdala-Valencia, H (corresponding author), NW Univ Feinberg, Sch Med, Div Allergy Immunol, Chicago, IL USA.	j-cook-mills@northwestern.edu		Abdala Valencia, Hiam/0000-0003-3384-5299	National Institutes of Health [R01 AT004837]; American Heart Association [0855583G]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	These studies were supported by National Institutes of Health Grant R01 AT004837 (J.M.C-M) and by American Heart Association 0855583G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Valencia H, 2006, J IMMUNOL, V177, P6379, DOI 10.4049/jimmunol.177.9.6379; Abdala-Valencia H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026706; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Anfuso CD, 2007, J LIPID RES, V48, P782, DOI 10.1194/jlr.M600489-JLR200; Azzi A, 2001, J NUTR, V131, p378S, DOI 10.1093/jn/131.2.378S; Berdnikovs S, 2009, J IMMUNOL, V182, P4395, DOI 10.4049/jimmunol.0803659; BOSCOBOINIK D, 1991, ARCH BIOCHEM BIOPHYS, V286, P264, DOI 10.1016/0003-9861(91)90039-L; BOSCOBOINIK D, 1991, J BIOL CHEM, V266, P6188; Broide DH, 1998, BLOOD, V91, P2847, DOI 10.1182/blood.V91.8.2847.2847_2847_2856; Cachia O, 1998, J BIOL CHEM, V273, P32801, DOI 10.1074/jbc.273.49.32801; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; CAZAUBON SM, 1993, J BIOL CHEM, V268, P17559; Chin JE, 1997, AM J PHYSIOL-LUNG C, V272, pL219, DOI 10.1152/ajplung.1997.272.2.L219; Clayton A, 1998, J CELL SCI, V111, P443; Cominacini L, 1997, FREE RADICAL BIO MED, V22, P117, DOI 10.1016/S0891-5849(96)00271-7; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Cook-Mills Joan M., 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P348; Dasgupta B, 2008, EUR J IMMUNOL, V38, P3499, DOI 10.1002/eji.200838605; Devaraj S, 1996, J CLIN INVEST, V98, P756, DOI 10.1172/JCI118848; Du CL, 2010, EXP LUNG RES, V36, P201, DOI 10.3109/01902140903290022; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; FARUQI R, 1994, J CLIN INVEST, V94, P592, DOI 10.1172/JCI117374; Freedman JE, 1996, CIRCULATION, V94, P2434, DOI 10.1161/01.CIR.94.10.2434; FUJITA H, 1994, ARCH BIOCHEM BIOPHYS, V309, P62, DOI 10.1006/abbi.1994.1085; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Jimenez B, 2001, ONCOGENE, V20, P3443, DOI 10.1038/sj.onc.1204464; Kaminuma O, 2001, EUR J IMMUNOL, V31, P2669, DOI 10.1002/1521-4141(200109)31:9<2669::AID-IMMU2669>3.0.CO;2-Y; Kanno T, 1996, FREE RADICAL RES, V24, P281, DOI 10.3109/10715769609088025; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; LABERGE S, 1995, AM J RESP CRIT CARE, V151, P822; Lawson C, 1999, J IMMUNOL, V162, P2990; Martin A, 1997, ARTERIOSCL THROM VAS, V17, P429, DOI 10.1161/01.ATV.17.3.429; Martin-Nizard F, 1998, J Cardiovasc Risk, V5, P339, DOI 10.1097/00043798-199810000-00010; Martinelli R, 2009, MOL BIOL CELL, V20, P995, DOI 10.1091/mbc.E08-06-0636; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; McCary CA, 2012, BIOCHEM J, V441, P189, DOI 10.1042/BJ20111318; Meydani SN, 1997, JAMA-J AM MED ASSOC, V277, P1380, DOI 10.1001/jama.277.17.1380; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Peng HH, 2005, FRONT BIOSCI-LANDMRK, V10, P1597, DOI 10.2741/1643; PHAN SH, 1989, AM J PATHOL, V134, P1201; Redlich CA, 1996, AM J RESP CRIT CARE, V154, P1436, DOI 10.1164/ajrccm.154.5.8912761; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; Sano H, 1998, BIOCHEM BIOPH RES CO, V250, P694, DOI 10.1006/bbrc.1998.9385; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Sukumaran SK, 2002, J BIOL CHEM, V277, P12253, DOI 10.1074/jbc.M110740200; Sumagin R, 2010, J IMMUNOL, V184, P5242, DOI 10.4049/jimmunol.0903319; Sylvester PW, 2001, CELL PROLIFERAT, V34, P347, DOI 10.1046/j.1365-2184.2001.00221.x; Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190; Tsakadze NL, 2002, TRENDS CARDIOVAS MED, V12, P101, DOI 10.1016/S1050-1738(01)00157-8; Venugopal SK, 2002, DIABETES, V51, P3049, DOI 10.2337/diabetes.51.10.3049; WAKABAYASHI Y, 1995, BBA-MOL CELL RES, V1265, P103, DOI 10.1016/0167-4889(94)00202-P; Walker VG, 2007, AM J PHYSIOL-CELL PH, V293, pC119, DOI 10.1152/ajpcell.00525.2006; Wang Q, 2000, J IMMUNOL, V164, P6487, DOI 10.4049/jimmunol.164.12.6487; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Wang Q, 2002, AM J RESP CRIT CARE, V166, P872, DOI 10.1164/rccm.2201007; Wang Q, 2001, BLOOD, V97, P660, DOI 10.1182/blood.V97.3.660; Wolf G, 2006, NUTR REV, V64, P295, DOI [10.1111/j.1753-4887.2006.tb00213.x, 10.1301/nr.2006.jun.295-299]; Wolyniec WW, 1998, AM J RESP CELL MOL, V18, P777, DOI 10.1165/ajrcmb.18.6.3056; Yoshikawa T, 1998, BIOFACTORS, V7, P15, DOI 10.1002/biof.5520070103	65	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41054	10.1371/journal.pone.0041054	http://dx.doi.org/10.1371/journal.pone.0041054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815910	Green Submitted, gold, Green Published			2022-12-27	WOS:000306507000057
J	Govatati, S; Tipirisetti, NR; Perugu, S; Kodati, VL; Deenadayal, M; Satti, V; Bhanoori, M; Shivaji, S				Govatati, Suresh; Tipirisetti, Nageswara Rao; Perugu, Shyam; Kodati, Vijaya Lakshmi; Deenadayal, Mamata; Satti, Vishnupriya; Bhanoori, Manjula; Shivaji, S.			Mitochondrial Genome Variations in Advanced Stage Endometriosis: A Study in South Indian Population	PLOS ONE			English	Article							DNA MUTATIONS; OXIDATIVE STRESS; REGION POLYMORPHISM; LARGE DELETIONS; INCREASED RISK; NITRIC-OXIDE; WOMEN; CANCER; ASSOCIATION; INSTABILITY	Background: Endometriosis is a chronic gynecological benign disease that shares several features similar to malignancy. Mitochondrial DNA (mtDNA) mutations have been reported in all most all types of tumors. However, it is not known as to whether mtDNA mutations are associated with endometriosis. Methodology: We sequenced the entire mitochondrial genome of analogous ectopic and eutopic endometrial tissues along with blood samples from 32 advanced stage endometriosis patients to analyze the role of somatic and germ-line mtDNA variations in pathogenesis of endometriosis. All ectopic tissues were screened for tumor-specific mtDNA deletions and microsatellite instability (MSI). We also performed mtDNA haplogrouping in 128 patients and 90 controls to identify its possible association with endometriosis risk. Principal Findings: We identified 51 somatic (novel: 31; reported: 20) and 583 germ-line mtDNA variations (novel: 53; reported: 530) in endometriosis patients. The A13603G, a novel missense mutation which leads to a substitution from serine to glycine at the codon 423 of ND5 gene showed 100% incidence in ectopic tissues. Interestingly, eutopic endometrium and peripheral leukocytes of all the patients showed heteroplasmy (A/G; 40-80%) at this locus, while their ectopic endometrium showed homoplasmic mutant allele (G/G). Superimposition of native and mutant structures of ND5 generated by homology modeling revealed no structural differences. Tumor-specific deletions and MSI were not observed in any of the ectopic tissues. Haplogrouping analysis showed a significant association between haplogroup M5 and endometriosis risk (P: 0.00069) after bonferroni correction. Conclusions: Our findings substantiate the rationale for exploring the mitochondrial genome as a biomarker for the diagnosis of endometriosis.	[Govatati, Suresh; Perugu, Shyam; Bhanoori, Manjula] Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India; [Tipirisetti, Nageswara Rao; Satti, Vishnupriya] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Kodati, Vijaya Lakshmi] Vasavi Med & Res Ctr, Hyderabad, Andhra Pradesh, India; [Deenadayal, Mamata] Infertil Inst & Res Ctr, Secundrabad, Andhra Pradesh, India; [Shivaji, S.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Osmania University; Osmania University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Govatati, S (corresponding author), Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India.	bhanoorim@yahoo.co.in; shivas@ccmb.res.in	govatati, suresh/M-9418-2019; Bhanoori, Manjula/ACH-9333-2022	govatati, suresh/0000-0001-8587-4388; shivaji, sisinthy/0000-0003-0376-4658	OU-DST PURSE; Council of Scientific and Industrial Research (CSIR), India	OU-DST PURSE; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Dr. Manjula Bhanoori would like to thank OU-DST PURSE for financial support. Suresh Govatati would like to thank Council of Scientific and Industrial Research (CSIR), India for JRF (NET) and SRF (NET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bhanoori M, 2005, J SOC GYNECOL INVEST, V12, P365, DOI 10.1016/j.jsgi.2005.03.005; Bhanoori M, 2005, HUM REPROD, V20, P1844, DOI 10.1093/humrep/deh852; Bhanoori M, 2008, EUR J OBSTET GYN R B, V139, P53, DOI 10.1016/j.ejogrb.2008.01.006; Bhanoori M, 2007, HUM REPROD, V22, P1026, DOI 10.1093/humrep/del486; Canis M, 1997, FERTIL STERIL, V67, P817; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chen JJZ, 2003, CARCINOGENESIS, V24, P1481, DOI 10.1093/carcin/bgg102; Cho S, 2011, DNA CELL BIOL, V17; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Govatati S, 2012, GENET TEST MOL BIOMA, V16, P865, DOI 10.1089/gtmb.2011.0295; Govatati S, 2012, MOL HUM REPROD, V18, P280, DOI 10.1093/molehr/gar079; Ho HN, 1997, HUM REPROD, V12, P2810, DOI 10.1093/humrep/12.12.2810; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kao SH, 2005, ANN NY ACAD SCI, V1042, P186, DOI 10.1196/annals.1338.021; Koks CAM, 2000, GYNECOL OBSTET INVES, V50, P13, DOI 10.1159/000010271; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurent A, 2005, CANCER RES, V65, P948; Liu VWS, 2003, BRIT J CANCER, V89, P697, DOI 10.1038/sj.bjc.6601110; Maji S, 2009, J GENET, V88, P127, DOI 10.1007/s12041-009-0020-3; Maximo V, 2001, GENE CHROMOSOME CANC, V32, P136, DOI 10.1002/gcc.1175; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mithani SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008493; Murphy AA, 1998, FERTIL STERIL, V69, P1092, DOI 10.1016/S0015-0282(98)00087-9; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; Oner-Iyidogan Y, 2004, GYNECOL OBSTET INVES, V57, P214, DOI 10.1159/000076691; PORTZ DM, 1991, INT J FERTIL, V36, P39; Rani DS, 2010, MITOCHONDRION, V10, P166, DOI 10.1016/j.mito.2009.12.146; Rogounovitch TI, 2002, CANCER RES, V62, P7031; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Shanti A, 1999, FERTIL STERIL, V71, P1115, DOI 10.1016/S0015-0282(99)00145-4; SPUIJBROEK MDEH, 1992, FERTIL STERIL, V58, P929; Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8; Tempfer CB, 2009, HUM REPROD UPDATE, V15, P97, DOI 10.1093/humupd/dmn040; Van Langendonckt A, 2002, FERTIL STERIL, V77, P861, DOI 10.1016/S0015-0282(02)02959-X; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang YJ, 1997, FERTIL STERIL, V68, P826, DOI 10.1016/S0015-0282(97)00343-9; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a; Zondervan KT, 2002, HUM REPROD, V17, P1415, DOI 10.1093/humrep/17.6.1415	52	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40668	10.1371/journal.pone.0040668	http://dx.doi.org/10.1371/journal.pone.0040668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815783	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000024
J	Pommerenke, C; Wilk, E; Srivastava, B; Schulze, A; Novoselova, N; Geffers, R; Schughart, K				Pommerenke, Claudia; Wilk, Esther; Srivastava, Barkha; Schulze, Annika; Novoselova, Natalia; Geffers, Robert; Schughart, Klaus			Global Transcriptome Analysis in Influenza-Infected Mouse Lungs Reveals the Kinetics of Innate and Adaptive Host Immune Responses	PLOS ONE			English	Article							GENE-EXPRESSION; EPITHELIAL-CELLS; VIRUS; MICE; PATHOGENESIS; RECOGNITION; MACAQUES; DEATH	An infection represents a highly dynamic process involving complex biological responses of the host at many levels. To describe such processes at a global level, we recorded gene expression changes in mouse lungs after a non-lethal infection with influenza A virus over a period of 60 days. Global analysis of the large data set identified distinct phases of the host response. The increase in interferon genes and up-regulation of a defined NK-specific gene set revealed the initiation of the early innate immune response phase. Subsequently, infiltration and activation of T and B cells could be observed by an augmentation of T and B cell specific signature gene expression. The changes in B cell gene expression and preceding chemokine subsets were associated with the formation of bronchus-associated lymphoid tissue. In addition, we compared the gene expression profiles from wild type mice with Rag2 mutant mice. This analysis readily demonstrated that the deficiency in the T and B cell responses in Rag2 mutants could be detected by changes in the global gene expression patterns of the whole lung. In conclusion, our comprehensive gene expression study describes for the first time the entire host response and its kinetics to an acute influenza A infection at the transcriptome level.	[Pommerenke, Claudia; Wilk, Esther; Srivastava, Barkha; Schulze, Annika; Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany; [Pommerenke, Claudia; Wilk, Esther; Srivastava, Barkha; Schulze, Annika; Schughart, Klaus] Univ Vet Med Hannover, Braunschweig, Germany; [Novoselova, Natalia] Natl Acad Sci Belarus, United Inst Informat Problems, Minsk, BELARUS; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; National Academy of Sciences of Belarus (NASB); United Institute of Informatics Problems of the National Academy of Sciences of Belarus; Helmholtz Association; Helmholtz-Center for Infection Research	Pommerenke, C (corresponding author), Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany.	klaus.schughart@helmholtz-hzi.de	Novoselova, Natalia/AAC-4216-2021	Schughart, Klaus/0000-0002-6824-7523	Helmholtz-Association (Program Infection and Immunity); German Ministry of Education and Research [01KI07137]	Helmholtz-Association (Program Infection and Immunity)(Helmholtz Association); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by intramural grants from the Helmholtz-Association (Program Infection and Immunity) and a research grant FluResearchNet (No. 01KI07137) from the German Ministry of Education and Research to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-61; Alberts R, 2010, MICROBES INFECT, V12, P309, DOI 10.1016/j.micinf.2010.01.008; Baskin CR, 2004, J VIROL, V78, P10420, DOI 10.1128/JVI.78.19.10420-10432.2004; Blazejewska P, 2011, VIROLOGY, V412, P36, DOI 10.1016/j.virol.2010.12.047; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Chung S., 2004, P ACM INT C INF KNOW, P150; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Dimitrakopoulou Konstantina, 2011, J Clin Bioinforma, V1, P27, DOI 10.1186/2043-9113-1-27; Ding M, 2008, GENES BRAIN BEHAV, V7, P173, DOI 10.1111/j.1601-183X.2007.00335.x; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Haller O, 2009, Verh K Acad Geneeskd Belg, V71, P73; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosseau S, 2007, IMMUNOLOGY, V120, P380, DOI 10.1111/j.1365-2567.2006.02514.x; Seki M, 2009, JPN J INFECT DIS, V62, P6; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Toapanta FR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-112; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van Iterson M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-439; Viemann D, 2010, J IMMUNOL; Wang J, 2011, AM J RESP CELL MOL B; Wu HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-172; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang MS, 2004, IEEE T PATTERN ANAL, V26, P434, DOI 10.1109/TPAMI.2004.1265860; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhang H, 2006, MICROBES INFECT, V8, P2172, DOI 10.1016/j.micinf.2006.04.018	51	83	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41169	10.1371/journal.pone.0041169	http://dx.doi.org/10.1371/journal.pone.0041169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815957	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000075
J	Vaes, AW; Franssen, FME; Meijer, K; Cuijpers, MWJ; Wouters, EFM; Rutten, EPA; Spruit, MA				Vaes, Anouk W.; Franssen, Frits M. E.; Meijer, Kenneth; Cuijpers, Martijn W. J.; Wouters, Emiel F. M.; Rutten, Erica P. A.; Spruit, Martijn A.			Effects of Body Mass Index on Task-Related Oxygen Uptake and Dyspnea during Activities of Daily Life in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DYNAMIC HYPERINFLATION; EXERCISE; OBESITY; REHABILITATION; VALIDATION; RESPONSES	Background: Patients with COPD use a higher proportion of their peak aerobic capacity during the performance of domestic activities of daily life (ADLs) compared to healthy peers, accompanied by a higher degree of task-related symptoms. To date, the influence of body mass index (BMI) on the task-related metabolic demands remains unknown in patients with COPD. Therefore, the aim of our study was to determine the effects of BMI on metabolic load during the performance of 5 consecutive domestic ADLs in patients with COPD. Methodology: Ninety-four COPD patients and 20 healhty peers performed 5 consecutive, self-paced domestic ADLs putting on socks, shoes and vest; folding 8 towels; putting away groceries; washing up 4 dishes, cups and saucers; and sweeping the floor for 4 min. Task-related oxygen uptake and ventilation were assessed using a mobile oxycon, while Borg scores were used to assess task-related dyspnea and fatigue. Principal Findings: 1. Relative task-related oxygen uptake after the performance of domestic ADLs was increased in patients with COPD compared to healthy elderly, whereas absolute oxygen uptake is similar between groups; 2. Relative oxygen uptake and oxygen uptake per kilogram fat-free mass were comparable between BMI groups; and 3. Borg symptom scores for dyspnea en fatigue were comparable between BMI groups. Conclusion: Patients with COPD in different BMI groups perform self-paced domestic ADLs at the same relative metabolic load, accompanied by comparable Borg symptom scores for dyspnea and fatigue.	[Vaes, Anouk W.; Franssen, Frits M. E.; Cuijpers, Martijn W. J.; Wouters, Emiel F. M.; Rutten, Erica P. A.; Spruit, Martijn A.] CIRO, Program Dev Ctr, Horn, Netherlands; [Meijer, Kenneth] MUMC, Sch Nutr Toxicol & Metab, Dept Human Movement Sci, Maastricht, Netherlands	Maastricht University	Vaes, AW (corresponding author), CIRO, Program Dev Ctr, Horn, Netherlands.	anoukvaes@ciro-horn.nl	Meijer, Kenneth/A-8573-2014; Wouters, Emiel/ABD-6200-2021; Franssen, Frits M.E./L-3334-2019; Franssen, Frits M.E./B-6988-2018	Meijer, Kenneth/0000-0001-8236-8754; Franssen, Frits M.E./0000-0002-1633-6356; Franssen, Frits M.E./0000-0002-1633-6356	Foundation 'De Weijerhorst'	Foundation 'De Weijerhorst'	This work was supported by Foundation 'De Weijerhorst'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annegarn J, 2011, J AM MED DIR ASS; Baarends EM, 1997, EUR RESPIR J, V10, P2807, DOI 10.1183/09031936.97.10122807; Bautista J, 2011, RESP MED, V105, P1189, DOI 10.1016/j.rmed.2011.02.019; Cecere LM, 2011, COPD; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Franssen FME, 2008, THORAX, V63, P1110, DOI 10.1136/thx.2007.086827; Graat-Verboom L, 2009, EUR RESPIR J, V34, P209, DOI 10.1183/09031936.50130408; Guenette JA, 2010, CURR OPIN CLIN NUTR, V13, P618, DOI 10.1097/MCO.0b013e32833e3453; Hannink JDC, 2010, CHEST, V137, P1116, DOI 10.1378/chest.09-1847; Jeng C, 2003, HEART LUNG, V32, P121, DOI 10.1067/mhl.2003.20; Katz P, 2010, J CARDIOPULM REHABIL; Lahaije AJMC, 2010, RESP MED, V104, P1152, DOI 10.1016/j.rmed.2010.02.011; Laviolette L, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-33; Monteiro F, 2012, LUNG; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; Ofir D, 2007, J APPL PHYSIOL, V102, P2217, DOI 10.1152/japplphysiol.00898.2006; Ora J, 2011, J APPL PHYSIOL, V111, P10, DOI 10.1152/japplphysiol.01131.2010; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Sandland CJ, 2008, CHEST, V134, P753, DOI 10.1378/chest.07-1848; Sava F, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-55; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Sillen MJH, 2008, RESP MED, V102, P786, DOI 10.1016/j.rmed.2008.01.013; Spruit MA, 2011, REV BRAS FI IN PRESS; Spruit MA, 2008, LANCET, V371, P12, DOI 10.1016/S0140-6736(08)60048-3; Spruit MA, 2007, RESP MED, V101, P2454, DOI 10.1016/j.rmed.2007.07.003; Spruit MA, 2011, EUR J APPL PHYSIOL, V111, P1679, DOI 10.1007/s00421-010-1794-y; Spruit MA, 2010, RESP MED, V104, P849, DOI 10.1016/j.rmed.2009.12.007; Steuten Lotte M G, 2006, Prim Care Respir J, V15, P84, DOI 10.1016/j.pcrj.2005.09.001; Vaes AW, 2011, CHEST, V140, P970, DOI 10.1378/chest.10-3005; Velloso M, 2003, CHEST, V123, P1047, DOI 10.1378/chest.123.4.1047; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41078	10.1371/journal.pone.0041078	http://dx.doi.org/10.1371/journal.pone.0041078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815922	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000061
J	Das, P; Thomas, A; Mahantshetty, U; Shrivastava, SK; Deodhar, K; Mulherkar, R				Das, Poulami; Thomas, Asha; Mahantshetty, Umesh; Shrivastava, Shyam K.; Deodhar, Kedar; Mulherkar, Rita			HPV Genotyping and Site of Viral Integration in Cervical Cancers in Indian Women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CELLULAR FUSION TRANSCRIPTS; INTRAEPITHELIAL NEOPLASIA; ANOGENITAL LESIONS; READING FRAMES; E2 GENE; CARCINOMA; DNA; AMPLIFICATION; PREVALENCE	Persistent HPV infection plays a major role in cervical cancer. This study was undertaken to identify HPV types in a cohort of Indian women with locally advanced cervical cancer as well as to determine the physical state and/or site of viral integration in the host genome. Pretreatment biopsies (n = 270) from patients were screened for HPV infection by a high throughput HPV genotyping assay based on luminex xMAP technology as well as MY09/11 PCR and SPF1/2 PCR. Overall HPV positivity was observed to be 95%, with HPV16 being most common (63%) followed by infection with HPV18. Integration status of the virus was identified using Amplification of Papillomavirus Oncogene Transcripts (APOT) assay in a subset of samples positive for HPV16 and/or HPV18 (n = 86) and with an adequate follow-up. The data was correlated with clinical outcome of the patients. Integration of the viral genome was observed in 79% of the cases and a preference for integration into the chromosomal loci 1p, 3q, 6q, 11q, 13q and 20q was seen. Clinical data revealed that the physical state of the virus (integrated or episomal) could be an important prognostic marker for cervical cancer.	[Das, Poulami; Thomas, Asha; Mulherkar, Rita] Tata Mem Hosp, Mulherkar Lab, ACTREC, Navi Mumbai, India; [Mahantshetty, Umesh; Shrivastava, Shyam K.] Tata Mem Hosp, Dept Radiat Oncol, Tata Mem Ctr, Bombay 400012, Maharashtra, India; [Deodhar, Kedar] Tata Mem Hosp, Dept Pathol, Tata Mem Ctr, Bombay 400012, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	Das, P (corresponding author), Tata Mem Hosp, Mulherkar Lab, ACTREC, Navi Mumbai, India.	rmulherkar@actrec.gov.in	DAS, POULAMI/ABC-6544-2020	Thomas, Asha/0000-0002-0293-5403; DAS, POULAMI/0000-0002-8100-7962	Women's Cancer Initiative IRG [634]	Women's Cancer Initiative IRG	The authors wish to express their gratitude for the financial support from Women's Cancer Initiative IRG#634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Basu P, 2011, J CLIN MICROBIOL, V49, P3537, DOI 10.1128/JCM.00354-11; Basu P, 2009, ASIAN PAC J CANCER P, V10, P27; Bechtold V, 2003, J VIROL, V77, P2021, DOI 10.1128/JVI.77.3.2021-2028.2003; Bellanger S, 2010, J VIROL, V84, P437, DOI 10.1128/JVI.01162-09; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Chatterjee Ramdas, 2003, Indian J Pathol Microbiol, V46, P596; CHOO KB, 1987, VIROLOGY, V161, P259, DOI 10.1016/0042-6822(87)90195-4; Corden SA, 1999, J CLIN PATHOL-MOL PA, V52, P275, DOI 10.1136/mp.52.5.275; COUTURIER J, 1991, J VIROL, V65, P4534, DOI 10.1128/JVI.65.8.4534-4538.1991; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Deodhar K, 2012, J MED VIROL, V84, P1054, DOI 10.1002/jmv.23310; DILUCA D, 1986, J GEN VIROL, V67, P583, DOI 10.1099/0022-1317-67-3-583; Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gray E, 2010, CANCER RES, V70, P4081, DOI 10.1158/0008-5472.CAN-09-3335; Hamid NA, 2009, CELL MOL LIFE SCI, V66, P1700, DOI 10.1007/s00018-009-8631-7; Holm Ruth, 2008, Open Virol J, V2, P74, DOI 10.2174/1874357900802010074; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Klaes R, 1999, CANCER RES, V59, P6132; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Koopman LA, 1999, CANCER RES, V59, P5615; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Matovina M, 2009, GYNECOL ONCOL, V113, P120, DOI 10.1016/j.ygyno.2008.12.004; Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nambaru L, 2009, ASIAN PAC J CANCER P, V10, P355; Nirmala JG, 2011, ASIAN PAC J CANCER P, V12, P2689; Peedicayil A, 2006, INT J GYNECOL CANCER, V16, P1591, DOI 10.1111/j.1525-1438.2006.00631.x; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pett MR, 2006, P NATL ACAD SCI USA, V103, P3822, DOI 10.1073/pnas.0600078103; Pillai RM, 2010, INT J GYNECOL CANCER, V20, P1046, DOI 10.1111/IGC.0b013e3181e02fe0; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; Saranath D, 2002, GYNECOL ONCOL, V86, P157, DOI 10.1006/gyno.2002.6735; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Singh A, 2009, INT J GYNECOL CANCER, V19, P1642, DOI 10.1111/IGC.0b013e3181a83555; Sowjanya AP, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-116; Thorland EC, 2000, CANCER RES, V60, P5916; Travasso CM, 2008, J BIOSCIENCES, V33, P73, DOI 10.1007/s12038-008-0023-x; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789; Yu TX, 2005, CANCER GENET CYTOGEN, V158, P27, DOI 10.1016/j.cancergencyto.2004.08.021; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629	52	43	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41012	10.1371/journal.pone.0041012	http://dx.doi.org/10.1371/journal.pone.0041012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815898	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100108
J	Hill, ES; Vasireddi, SK; Bruno, AM; Wang, J; Frost, WN				Hill, Evan S.; Vasireddi, Sunil K.; Bruno, Angela M.; Wang, Jean; Frost, William N.			Variable Neuronal Participation in Stereotypic Motor Programs	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; MOLLUSK TRITONIA-DIOMEDEA; INDEPENDENT COMPONENT ANALYSIS; FIXED ACTION PATTERN; PREPULSE INHIBITION; SPINAL INTERNEURONS; NEURAL CONTROL; ESCAPE SWIM; NETWORK; BEHAVIOR	To what extent are motor networks underlying rhythmic behaviors rigidly hard-wired versus fluid and dynamic entities? Do the members of motor networks change from moment-to-moment or from motor program episode-to-episode? These are questions that can only be addressed in systems where it is possible to monitor the spiking activity of networks of neurons during the production of motor programs. We used large-scale voltage-sensitive dye (VSD) imaging followed by Independent Component Analysis spike-sorting to examine the extent to which the neuronal network underlying the escape swim behavior of Tritonia diomedea is hard-wired versus fluid from a moment-to-moment perspective. We found that while most neurons were dedicated to the swim network, a small but significant proportion of neurons participated in a surprisingly variable manner. These neurons joined the swim motor program late, left early, burst only on some cycles or skipped cycles of the motor program. We confirmed that this variable neuronal participation was not due to effects of the VSD by finding such neurons with intracellular recording in dye-free saline. Further, these neurons markedly varied their level of participation in the network from swim episode-to-episode. The generality of such unreliably bursting neurons was confirmed by their presence in the rhythmic escape networks of two other molluscan species, Tritonia festiva and Aplysia californica. Our observations support a view that neuronal networks, even those underlying rhythmic and stereotyped motor programs, may be more variable in structure than widely appreciated.	[Hill, Evan S.; Vasireddi, Sunil K.; Bruno, Angela M.; Wang, Jean; Frost, William N.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA; [Bruno, Angela M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Neurosci, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	Hill, ES (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA.	evan.hill@rosalindfranklin.edu	Vasireddi, Sunil/AAL-5104-2021	Vasireddi, Sunil/0000-0001-7950-6140	National Institute of Neurological Disorders and Stroke [NS-060921]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060921] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by grant number NS-060921; a grant from the National Institute of Neurological Disorders and Stroke to WNF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY D, 1978, ANNU REV NEUROSCI, V1, P35, DOI 10.1146/annurev.ne.01.030178.000343; Berkowitz A, 2008, J NEUROPHYSIOL, V99, P2887, DOI 10.1152/jn.90235.2008; Blitz DM, 1999, J NEUROSCI, V19, P5449; Briggman KL, 2006, J NEUROSCI, V26, P10925, DOI 10.1523/JNEUROSCI.3265-06.2006; Brown GD, 1996, BEHAV NEUROSCI, V110, P478; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; Butefisch CM, 2004, NEUROSCIENTIST, V10, P163, DOI 10.1177/1073858403262152; Calabrese RL, 2007, CURR BIOL, V17, pR139, DOI 10.1016/j.cub.2006.12.007; Carmena JM, 2005, J NEUROSCI, V25, P10712, DOI 10.1523/JNEUROSCI.2772-05.2005; DORSETT DA, 1973, J NEUROBIOL, V4, P287, DOI 10.1002/neu.480040309; Eugenin J, 2006, NEUROSCIENCE, V137, P1221, DOI 10.1016/j.neuroscience.2005.10.053; Frost WN, 2006, BIOL BULL-US, V210, P230, DOI 10.2307/4134560; Frost WN, 2003, NEURON, V40, P991, DOI 10.1016/S0896-6273(03)00731-1; Frost WN, 1996, NEUROBIOL LEARN MEM, V65, P125, DOI 10.1006/nlme.1996.0015; GETTING PA, 1980, J NEUROPHYSIOL, V44, P151, DOI 10.1152/jn.1980.44.1.151; GETTING PA, 1981, J NEUROPHYSIOL, V46, P65, DOI 10.1152/jn.1981.46.1.65; GETTING PA, 1983, SYM SOC EXP BIOL, P89; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; Hill ES, 2010, SOC NEUR ANN M SAN D; Hill ES, 2010, J NEUROPHYSIOL, V104, P3721, DOI 10.1152/jn.00691.2010; Horn CC, 2004, J NEUROPHYSIOL, V92, P157, DOI 10.1152/jn.01190.2003; HUME RI, 1982, J NEUROPHYSIOL, V47, P60, DOI 10.1152/jn.1982.47.1.60; Jing J, 2003, J NEUROSCI, V23, P3039; Jing J, 1999, J NEUROPHYSIOL, V81, P654, DOI 10.1152/jn.1999.81.2.654; KATZ PS, 1994, NATURE, V367, P729, DOI 10.1038/367729a0; LENNARD PR, 1980, J NEUROPHYSIOL, V44, P165, DOI 10.1152/jn.1980.44.1.165; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; MCPHERSON DR, 1991, J NEUROPHYSIOL, V66, P1352, DOI 10.1152/jn.1991.66.4.1352; Mennerick S, 2010, J NEUROSCI, V30, P2871, DOI 10.1523/JNEUROSCI.5607-09.2010; Mongeluzi DL, 1998, J NEUROSCI, V18, P8467; Mongeluzi DL, 2000, LEARN MEMORY, V7, P43, DOI 10.1101/lm.7.1.43; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; Romanova EV, 2007, J NEUROPHYSIOL, V97, P481, DOI 10.1152/jn.00581.2006; Stein PSG, 2004, J NEUROPHYSIOL, V91, P2380, DOI 10.1152/jn.01184.2003; Stein W, 2010, J NEUROSCI METH, V188, P290, DOI 10.1016/j.jneumeth.2010.03.003; Walloe S, 2011, J NEUROSCI, V31, P2431, DOI 10.1523/JNEUROSCI.3938-10.2011; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; WILLOWS AOD, 1973, J NEUROBIOL, V4, P255, DOI 10.1002/neu.480040308; Xin YP, 1996, J NEUROSCI, V16, P5266	44	27	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40579	10.1371/journal.pone.0040579	http://dx.doi.org/10.1371/journal.pone.0040579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815768	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100043
J	Hung, TH; Chen, SF; Lo, LM; Li, MJ; Yeh, YL; Hsieh, TT				Hung, Tai-Ho; Chen, Szu-Fu; Lo, Liang-Ming; Li, Meng-Jen; Yeh, Yi-Lin; Hsieh, T'sang-T'ang			Increased Autophagy in Placentas of Intrauterine Growth-Restricted Pregnancies	PLOS ONE			English	Article							TROPHOBLAST APOPTOSIS; CELL-DEATH; ABNORMAL PREGNANCIES; VILLOUS TROPHOBLAST; PREECLAMPSIA; EXPRESSION; P53; MECHANISMS; PROTEINS; HYPOXIA	Background: Unexplained intrauterine growth restriction (IUGR) may be a consequence of placental insufficiency; however, its etiology is not fully understood. We surmised that defective placentation in IUGR dysregulates cellular bioenergic homeostasis, leading to increased autophagy in the villous trophoblast. The aims of this work were (1) to compare the differences in autophagy, p53 expression, and apoptosis between placentas of women with normal or IUGR pregnancies; (2) to study the effects of hypoxia and the role of p53 in regulating trophoblast autophagy; and (3) to investigate the relationship between autophagy and apoptosis in hypoxic trophoblasts. Methodology/Principal Findings: Compared with normal pregnant women, women with IUGR had higher placental levels of autophagy-related proteins LC3B-II, beclin-1, and damage-regulated autophagy modulator (DRAM), with increased p53 and caspase-cleaved cytokeratin 18 (M30). Furthermore, cytotrophoblasts cultured under hypoxia (2% oxygen) in the presence or absence of nutlin-3 (a p53 activity stimulator) had higher levels of LC3B-II, DRAM, and M30 proteins and increased Bax mRNA expression compared with controls cultured under standard conditions. In contrast, administration of pifithrin-alpha (a p53 activity inhibitor) during hypoxia resulted in protein levels that were similar to those of the control groups. Moreover, cytotrophoblasts transfected with LC3B, beclin-1, or DRAM siRNA had higher levels of M30 compared with the controls under hypoxia. However, transfection with Bcl-2 or Bax siRNA did not cause any significant change in the levels of LC3B-II in hypoxic cytotrophoblasts. Conclusions/Significance: Together, these results suggest that there is a crosstalk between autophagy and apoptosis in IUGR and that p53 plays a pivotal and complex role in regulating trophoblast cell turnover in response to hypoxic stress.	[Hung, Tai-Ho; Lo, Liang-Ming; Li, Meng-Jen; Yeh, Yi-Lin; Hsieh, T'sang-T'ang] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Dept Chinese Med, Tao Yuan, Taiwan; [Chen, Szu-Fu] Cheng Hsin Rehabil Med Ctr, Dept Phys Med & Rehabil, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, TH (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	thh20@adm.cgmh.org.tw	Sánchez-Margalet, Victor/AAB-9986-2021; Hung, Tai-Ho/ABD-1800-2020; Chen, Szu-Fu/K-5040-2012; Hung, Tai-Ho/C-7584-2011	Sánchez-Margalet, Victor/0000-0001-8638-8680; Hung, Tai-Ho/0000-0003-2354-7060	Chang Gung Memorial Hospital [CMRPG100021]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by Chang Gung Memorial Hospital (CMRPG100021) to THH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Heazell AEP, 2008, PLACENTA, V29, P772, DOI 10.1016/j.placenta.2008.07.003; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Hsieh Wu-Shiun, 2006, Acta Paediatrica Taiwanica, V47, P25; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; Hung TH, 2008, REPROD SCI, V15, P195, DOI 10.1177/1933719107310709; Hung TH, 2011, REPROD TOXICOL, V31, P144, DOI 10.1016/j.reprotox.2010.11.009; Hung TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012202; Hunga TH, 2012, PLACENTA, V33, P294, DOI 10.1016/j.placenta.2012.01.004; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Kadyrov M, 2001, PLACENTA, V22, P44, DOI 10.1053/plac.2000.0616; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Levy R, 2000, AM J PHYSIOL-CELL PH, V278, pC982, DOI 10.1152/ajpcell.2000.278.5.C982; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Mayhew TM, 2009, J ANAT, V215, P77, DOI 10.1111/j.1469-7580.2008.00994.x; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Shen ZY, 2008, PLACENTA, V29, P956, DOI 10.1016/j.placenta.2008.09.001; Signorelli P, 2011, PLACENTA, V32, P482, DOI 10.1016/j.placenta.2011.03.005; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; Wu BX, 2006, MOL VIS, V12, P1292; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193	35	92	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40957	10.1371/journal.pone.0040957	http://dx.doi.org/10.1371/journal.pone.0040957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815878	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100099
J	Ruffner, H; Sprunger, J; Charlat, O; Leighton-Davies, J; Grosshans, B; Salathe, A; Zietzling, S; Beck, V; Therier, M; Isken, A; Xie, Y; Zhang, Y; Hao, HX; Shi, XY; Liu, D; Song, QH; Clay, I; Hintzen, G; Tchorz, J; Bouchez, LC; Michaud, G; Finan, P; Myer, VE; Bouwmeester, T; Porter, J; Hild, M; Bassilana, F; Parker, CN; Cong, F				Ruffner, Heinz; Sprunger, Joelle; Charlat, Olga; Leighton-Davies, Juliet; Grosshans, Bianka; Salathe, Adrian; Zietzling, Svenja; Beck, Valerie; Therier, Maxime; Isken, Andrea; Xie, Yang; Zhang, Yue; Hao, Huaixiang; Shi, Xiaoying; Liu, Dong; Song, Qinhui; Clay, Ieuan; Hintzen, Gabriele; Tchorz, Jan; Bouchez, Laure C.; Michaud, Gregory; Finan, Peter; Myer, Vic E.; Bouwmeester, Tewis; Porter, Jeff; Hild, Marc; Bassilana, Fred; Parker, Christian N.; Cong, Feng			R-Spondin Potentiates Wnt/beta-Catenin Signaling through Orphan Receptors LGR4 and LGR5	PLOS ONE			English	Article							PANETH CELL-DIFFERENTIATION; STEM-CELLS; IN-VITRO; REDUCED EXPRESSION; DOWN-REGULATION; HAIR FOLLICLE; NULL MICE; R-SPONDIN1; PATHWAY; LRP6	The Wnt/beta-catenin signaling pathbway controls many important biological processes. R-Spondin (RSPO) proteins are a family of secreted molecules that strongly potentiate Wnt/beta-catenin signaling, however, the molecular mechanism of RSPO action is not yet fully understood. We performed an unbiased siRNA screen to identify molecules specifically required for RSPO, but not Wnt, induced beta-catenin signaling. From this screen, we identified LGR4, then an orphan G protein-coupled receptor (GPCR), as the cognate receptor of RSPO. Depletion of LGR4 completely abolished RSPO-induced beta-catenin signaling. The loss of LGR4 could be compensated by overexpression of LGR5, suggesting that LGR4 and LGR5 are functional homologs. We further demonstrated that RSPO binds to the extracellular domain of LGR4 and LGR5, and that overexpression of LGR4 strongly sensitizes cells to RSPO-activated beta-catenin signaling. Supporting the physiological significance of RSPO-LGR4 interaction, Lgr4(-/-) crypt cultures failed to grow in RSPO-containing intestinal crypt culture medium. No coupling between LGR4 and heterotrimeric G proteins could be detected in RSPO-treated cells, suggesting that LGR4 mediates RSPO signaling through a novel mechanism. Identification of LGR4 and its relative LGR5, an adult stem cell marker, as the receptors of RSPO will facilitate the further characterization of these receptor/ligand pairs in regenerative medicine applications.	[Ruffner, Heinz; Sprunger, Joelle; Leighton-Davies, Juliet; Grosshans, Bianka; Salathe, Adrian; Zietzling, Svenja; Beck, Valerie; Therier, Maxime; Isken, Andrea; Clay, Ieuan; Hintzen, Gabriele; Tchorz, Jan; Bouchez, Laure C.; Bouwmeester, Tewis; Bassilana, Fred; Parker, Christian N.] Novartis Pharma AG, Dev & Mol Pathways, Novartis Inst Biomed Res, Basel, Switzerland; [Charlat, Olga; Xie, Yang; Zhang, Yue; Hao, Huaixiang; Shi, Xiaoying; Liu, Dong; Song, Qinhui; Michaud, Gregory; Finan, Peter; Myer, Vic E.; Porter, Jeff; Hild, Marc; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA USA	Novartis; Novartis	Ruffner, H (corresponding author), Novartis Pharma AG, Dev & Mol Pathways, Novartis Inst Biomed Res, Basel, Switzerland.	heinz.ruffner@novartis.com; feng.cong@novartis.com		bouchez, laure/0000-0003-4583-6760				Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Gao Y, 2006, HOKKAIDO IGAKU ZASSH, V81, P109; Gao Y, 2006, HOKKAIDO IGAKU ZASSH, V81, P107; Gao Yun, 2006, Hokkaido Igaku Zasshi, V81, P101; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2008, DEV DYNAM, V237, P2235, DOI 10.1002/dvdy.21639; Mohri Y, 2011, DEV DYNAM, V240, P1626, DOI 10.1002/dvdy.22651; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SEUWEN K, 1988, EMBO J, V7, P161, DOI 10.1002/j.1460-2075.1988.tb02796.x; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	42	128	135	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40976	10.1371/journal.pone.0040976	http://dx.doi.org/10.1371/journal.pone.0040976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815884	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100101
J	Semchenko, EA; Day, CJ; Moutin, M; Wilson, JC; Tiralongo, J; Korolik, V				Semchenko, Evgeny A.; Day, Christopher J.; Moutin, Marc; Wilson, Jennifer C.; Tiralongo, Joe; Korolik, Victoria			Structural Heterogeneity of Terminal Glycans in Campylobacter jejuni Lipooligosaccharides	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; PHASE VARIATION; LIPO-OLIGOSACCHARIDE; GANGLIOSIDE MIMICS; IDENTIFICATION; BIOSYNTHESIS; TEMPERATURE; GENE; MECHANISM; PATHOGEN	Lipooligosaccharides of the gastrointestinal pathogen Campylobacter jejuni are regarded as a major virulence factor and are implicated in the production of cross-reactive antibodies against host gangliosides, which leads to the development of autoimmune neuropathies such as Guillain-Barre and Fisher Syndromes. C. jejuni strains are known to produce diverse LOS structures encoded by more than 19 types of LOS biosynthesis clusters. This study demonstrates that the final C. jejuni LOS structure cannot always be predicted from the genetic composition of the LOS biosynthesis cluster, as determined by novel lectin array analysis of the terminal LOS glycans. The differences were shown to be partially facilitated by the differential on/off status of three genes wlaN, cst and cj1144-45. The on/off status of these genes was also analysed in C. jejuni strains grown in vitro and in vivo, isolated directly from the host animal without passaging, using immunoseparation. Importantly, C. jejuni strains 331, 421 and 520 encoding cluster type C were shown to produce different LOS, mimicking asialo GM1, asialo GM2 and a heterogeneous mix of gangliosides and other glycoconjugates respectively. In addition, individual C. jejuni colonies were shown to consistently produce heterogeneous LOS structures, irrespective of the cluster type and the status of phase variable genes. Furthermore we describe C. jejuni strains (351 and 375) with LOS clusters that do not match any of the previously described LOS clusters, yet are able to produce LOS with asialo GM2-like mimicries. The LOS biosynthesis clusters of these strains are likely to contain genes that code for LOS biosynthesis machinery previously not identified, yet capable of synthesising LOS mimicking gangliosides.	[Semchenko, Evgeny A.; Day, Christopher J.; Moutin, Marc; Wilson, Jennifer C.; Tiralongo, Joe; Korolik, Victoria] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia	Griffith University	Semchenko, EA (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	v.korolik@griffith.edu.au	Wilson, Jennifer/H-5297-2013	Tiralongo, Joe/0000-0002-3529-6310; Korolik, Victoria/0000-0002-5535-4151; Semchenko, Evgeny/0000-0002-5188-7946; Day, Christopher/0000-0001-7953-4408	Australian Postgraduate Award; Griffith University Postdoctoral Research Fellowship	Australian Postgraduate Award(Australian Government); Griffith University Postdoctoral Research Fellowship	This study was funded by an Australian Postgraduate Award (to EAS) and a Griffith University Postdoctoral Research Fellowship (to CJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; BLASER MJ, 1979, ANN INTERN MED, V91, P179, DOI 10.7326/0003-4819-91-2-179; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; Day CJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00009; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; Fujikawa K, 2011, CHEM-EUR J, V17, P5641, DOI 10.1002/chem.201003357; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; HAGIWARA K, 1988, MOL IMMUNOL, V25, P69, DOI 10.1016/0161-5890(88)90092-2; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Holden N, 2007, INFECT IMMUN, V75, P3325, DOI 10.1128/IAI.01989-06; Houliston RS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181750; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; King RM, J BASIC MICROBIOLOGY; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Linton D, 2000, MOL MICROBIOL, V37, P501, DOI 10.1046/j.1365-2958.2000.02020.x; LIS H, 1987, METHOD ENZYMOL, V138, P544; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Moran AP, 2005, J NEUROIMMUNOL, V165, P179, DOI 10.1016/j.jneuroim.2005.04.013; Muller J, 2007, J MED MICROBIOL, V56, P1589, DOI 10.1099/jmm.0.47305-0; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Prendergast MM, 2000, J ENDOTOXIN RES, V6, P341, DOI 10.1179/096805100101532270; Semchenko EA, 2011, J GLYCOMICS LIPIDOMI, V1, P5; Semchenko EA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-305; Shahrizaila N, 2011, EXPERT OPIN PHARMACO, V12, P1551, DOI 10.1517/14656566.2011.564160; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; WEISER JN, 1989, CELL, V59, P657, DOI 10.1016/0092-8674(89)90011-1; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Yuki N, 2010, METHODS MOL BIOL, V600, P51, DOI 10.1007/978-1-60761-454-8_4	40	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40920	10.1371/journal.pone.0040920	http://dx.doi.org/10.1371/journal.pone.0040920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815868	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100095
J	Suda, Y; Okazaki, F; Hasegawa, Y; Adachi, S; Fukase, K; Kokubo, S; Kuramitsu, S; Kusumoto, S				Suda, Yasuo; Okazaki, Fumiaki; Hasegawa, Yushi; Adachi, Seiji; Fukase, Koichi; Kokubo, Susumu; Kuramitsu, Seiki; Kusumoto, Shoichi			Structural Characterization of Neutral and Acidic Glycolipids from Thermus thermophilus HB8	PLOS ONE			English	Article							PURIFICATION	The structural characterization of glycolipids from Thermus thermophilus HB8 was performed in this study. Two neutral and one acidic glycolipids were extracted and purified by the modified TLC-blotting method, after which their chemical structures were determined by chemical composition analysis, mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. The structure of one of the neutral glycolipids, NGL-A, was Galp(alpha 1-6)GlcpNacyl(beta 1-2)Glcp(alpha 1-)acyl(2)Gro, and the other, NGL-C, was Galf(beta 1-2)Galp(alpha 1-6)GlcpNacyl(beta 1-2)Glcp(alpha 1-)acyl(2)Gro. The structure of NGL-C was identical to that reported previously [Oshima, M. and Ariga, T. (1976) FEBS Lett. 64, 440]. Both neutral glycolipids shared a common structural unit found in the Thermus species. The acyl groups found in NGL-A and NGL-C, iso-type pentadecanoxy and heptadecanoxy fatty acid, were also the same as those found in this species. In contrast, the acidic glycolipid, AGL-B, possessed the structure of N-(((GlcpNAc(alpha 1-)acyl(2)Gro)P-2)GroA)alkylamine. The alkyl group in AGL-B was an iso-type heptadecanyl, suggesting that the iso-type structure of the long alkyl chain is responsible for the thermal stability of the bacteria.	[Suda, Yasuo; Kokubo, Susumu] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 890, Japan; [Suda, Yasuo; Kuramitsu, Seiki] RIKEN, Harima Inst SPring 8, Hyogo, Japan; [Okazaki, Fumiaki; Hasegawa, Yushi; Adachi, Seiji; Fukase, Koichi; Kusumoto, Shoichi] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 560, Japan; [Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 560, Japan	Kagoshima University; RIKEN; Osaka University; Osaka University	Suda, Y (corresponding author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 890, Japan.	ysuda@eng.kagoshima-u.ac.jp						ANDERSON R, 1985, J BIOL CHEM, V260, P2219; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Boone DR, 2001, BERGEYS MANUAL SYSTE, V1, P396; DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P103, DOI 10.1016/0005-2744(68)90248-9; FUJINAGA M, 1993, J MOL BIOL, V234, P222, DOI 10.1006/jmbi.1993.1576; Hashimoto M, 2001, EUR J BIOCHEM, V268, P3139, DOI 10.1046/j.1432-1327.2001.02147.x; HUANG Y, 1991, J BACTERIOL, V173, P457, DOI 10.1128/jb.173.2.457-462.1991; IKEMOTO S, 1978, J GEN APPL MICROBIOL, V24, P41, DOI 10.2323/jgam.24.41; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; Kuramitsu S, 1995, PROTEIN ENG, V8, P40; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; OSHIMA M, 1976, FEBS LETT, V64, P440, DOI 10.1016/0014-5793(76)80345-6; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; PASKHUGHES RA, 1982, J BACTERIOL, V149, P54, DOI 10.1128/JB.149.1.54-58.1982; Prado A, 1988, Adv Exp Med Biol, V238, P47; RAY PH, 1971, J BACTERIOL, V108, P227, DOI 10.1128/JB.108.1.227-235.1971; STALLINGS WC, 1985, J BIOL CHEM, V260, P6424; SUDA Y, 1995, FEMS IMMUNOL MED MIC, V12, P97, DOI 10.1111/j.1574-695X.1995.tb00181.x; TAKI T, 1994, ANAL BIOCHEM, V223, P232, DOI 10.1006/abio.1994.1579; TORELLO LA, 1980, J CHROMATOGR, V202, P195, DOI 10.1016/S0021-9673(00)81728-8; Wait R, 1997, J BACTERIOL, V179, P6154, DOI 10.1128/jb.179.19.6154-6162.1997; YAN H, 1989, J BIOL CHEM, V264, P18667; Yokoyama S, 2000, PROG BIOPHYS MOL BIO, V73, P363, DOI 10.1016/S0079-6107(00)00012-2	24	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e35067	10.1371/journal.pone.0035067	http://dx.doi.org/10.1371/journal.pone.0035067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815675	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100002
J	Gorostiaga, EM; Navarro-Amezqueta, I; Calbet, JAL; Hellsten, Y; Cusso, R; Guerrero, M; Granados, C; Gonzalez-Izal, M; Ibanez, J; Izquierdo, M				Gorostiaga, Esteban M.; Navarro-Amezqueta, Ion; Calbet, Jose A. L.; Hellsten, Ylva; Cusso, Roser; Guerrero, Mario; Granados, Cristina; Gonzalez-Izal, Miriam; Ibanez, Javier; Izquierdo, Mikel			Energy Metabolism during Repeated Sets of Leg Press Exercise Leading to Failure or Not	PLOS ONE			English	Article							MUSCLE GLYCOGEN-PHOSPHORYLASE; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; RESISTANCE EXERCISE; MAXIMAL EXERCISE; RESPONSES; FIBERS; POWER; ATP; PHOSPHOCREATINE	This investigation examined the influence of the number of repetitions per set on power output and muscle metabolism during leg press exercise. Six trained men (age 34 +/- 6 yr) randomly performed either 5 sets of 10 repetitions (10REP), or 10 sets of 5 repetitions (5REP) of bilateral leg press exercise, with the same initial load and rest intervals between sets. Muscle biopsies (vastus lateralis) were taken before the first set, and after the first and the final sets. Compared with 5REP, 10REP resulted in a markedly greater decrease (P<0.05) of the power output, muscle PCr and ATP content, and markedly higher (P<0.05) levels of muscle lactate and IMP. Significant correlations (P<0.01) were observed between changes in muscle PCr and muscle lactate (R-2 = 0.46), between changes in muscle PCr and IMP (R-2 = 0.44) as well as between changes in power output and changes in muscle ATP (R-2 = 0.59) and lactate (R-2 = 0.64) levels. Reducing the number of repetitions per set by 50% causes a lower disruption to the energy balance in the muscle. The correlations suggest that the changes in PCr and muscle lactate mainly occur simultaneously during exercise, whereas IMP only accumulates when PCr levels are low. The decrease in ATP stores may contribute to fatigue.	[Gorostiaga, Esteban M.; Navarro-Amezqueta, Ion; Granados, Cristina; Gonzalez-Izal, Miriam; Ibanez, Javier; Izquierdo, Mikel] Govt Navarre, Studies Res & Sport Med Ctr, Pamplona, Spain; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Hellsten, Ylva] Univ Copenhagen, Mol Physiol Grp, Copenhagen Muscle Res Ctr, Dept Exercise & Sport Sci,Sect Human Physiol, Copenhagen, Denmark; [Cusso, Roser; Guerrero, Mario] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIAPS, Dept Physiol Sci 1, Barcelona, Spain	Universidad de Las Palmas de Gran Canaria; University of Copenhagen; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Gorostiaga, EM (corresponding author), Govt Navarre, Studies Res & Sport Med Ctr, Pamplona, Spain.	egorosta@cfnavarra.es	Izquierdo, Mikel/A-4894-2010; Izquierdo, Mikel/O-8049-2019; Calbet, Jose A L/H-6693-2015; Hellsten, Ylva/B-3420-2015	Izquierdo, Mikel/0000-0002-1506-4272; Calbet, Jose A L/0000-0002-9215-6234; Granados, Cristina/0000-0002-8366-8932; Hellsten, Ylva/0000-0002-2435-9558; antunez, Ariel/0000-0002-2548-7885; Marisol, Izquierdo/0000-0003-4297-210X; Guerrero, Mario/0000-0002-9912-661X	Spanish Ministry of Education [DEP2006-56076]	Spanish Ministry of Education(Spanish Government)	This study was supported by the Spanish Ministry of Education (National Plan of R&D+I 2004-2007, Key action "Sport and Physical Activity" DEP2006-56076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; BROOKE MH, 1969, J HISTOCHEM CYTOCHEM, V17, P431, DOI 10.1177/17.6.431; Burd NA, 2012, J PHYSIOL-LONDON, V590, P351, DOI 10.1113/jphysiol.2011.221200; Casey A, 1996, AM J PHYSIOL-ENDOC M, V271, pE38, DOI 10.1152/ajpendo.1996.271.1.E38; CHEETHAM ME, 1986, J APPL PHYSIOL, V61, P54, DOI 10.1152/jappl.1986.61.1.54; Edwards R H, 1981, Ciba Found Symp, V82, P1; EDWARDS RHT, 1972, J PHYSIOL-LONDON, V220, P335, DOI 10.1113/jphysiol.1972.sp009710; Gollnick P D, 1973, Exerc Sport Sci Rev, V1, P1; Hancock CR, 2006, J PHYSIOL PHARMACOL, V57, P17; Hancock CR, 2006, J APPL PHYSIOL, V100, P406, DOI 10.1152/japplphysiol.00885.2005; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HARRIS RC, 1977, J APPL PHYSIOL, V43, P852, DOI 10.1152/jappl.1977.43.5.852; Hellsten Y, 1998, AM J PHYSIOL-ENDOC M, V274, pE600, DOI 10.1152/ajpendo.1998.274.4.E600; Howlett RA, 1998, AM J PHYSIOL-REG I, V275, pR418, DOI 10.1152/ajpregu.1998.275.2.R418; HULTMAN E, 1991, SCI PROG, V75, P361; HULTMAN E, 1967, SCAND J CLIN LAB INV, VS 19, P11; Izquierdo M, 2006, INT J SPORTS MED, V27, P718, DOI 10.1055/s-2005-872825; Izquierdo M, 2006, J APPL PHYSIOL, V100, P1647, DOI 10.1152/japplphysiol.01400.2005; JANSSON E, 1987, CLIN PHYSIOL, V7, P337, DOI 10.1111/j.1475-097X.1987.tb00177.x; JUEL C, 1988, MUSCLE NERVE, V11, P714, DOI 10.1002/mus.880110707; Karatzaferi C, 2001, PFLUG ARCH EUR J PHY, V442, P467, DOI 10.1007/s004240100552; KARLSSON J, 1970, SCAND J CLIN LAB INV, V26, P385, DOI 10.3109/00365517009046250; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; KRAEMER WJ, 1987, INT J SPORTS MED, V8, P247, DOI 10.1055/s-2008-1025663; Kramer JB, 1997, J STRENGTH COND RES, V11, P143; Lowry O H, 1971, Curr Probl Clin Biochem, V3, P63; MCCARTNEY N, 1986, J APPL PHYSIOL, V60, P1164, DOI 10.1152/jappl.1986.60.4.1164; NAKAMARU Y, 1972, J GEN PHYSIOL, V59, P22, DOI 10.1085/jgp.59.1.22; NORMAN B, 1991, CLIN PHYSIOL, V11, P375, DOI 10.1111/j.1475-097X.1991.tb00666.x; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; SAHLIN K, 1990, INT J SPORTS MED, V11, pS62, DOI 10.1055/s-2007-1024856; SAHLIN K, 1975, BIOCHEM J, V152, P173, DOI 10.1042/bj1520173; Saltin B, 1971, MUSCLE METABOLISM EX, P419; Sanborn K, 2000, J STRENGTH COND RES, V14, P328; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; SPRIET LL, 1987, J APPL PHYSIOL, V62, P611, DOI 10.1152/jappl.1987.62.2.611; SPRIET LL, 1989, J APPL PHYSIOL, V66, P8, DOI 10.1152/jappl.1989.66.1.8; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; TESCH PA, 1986, EUR J APPL PHYSIOL, V55, P362, DOI 10.1007/BF00422734; Tullson P C, 1991, Exerc Sport Sci Rev, V19, P507; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	44	105	106	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40621	10.1371/journal.pone.0040621	http://dx.doi.org/10.1371/journal.pone.0040621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808209	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700038
J	Jembere, N; Campitelli, MA; Sherman, M; Feld, JJ; Lou, WD; Peacock, S; Yoshida, E; Krahn, MD; Earle, C; Thein, HH				Jembere, Nathaniel; Campitelli, Michael A.; Sherman, Morris; Feld, Jordan J.; Lou, Wendy; Peacock, Stuart; Yoshida, Eric; Krahn, Murray D.; Earle, Craig; Thein, Hla-Hla			Influence of Socioeconomic Status on Survival of Hepatocellular Carcinoma in the Ontario Population; A Population-Based Study, 1990-2009	PLOS ONE			English	Article							BREAST-CANCER SURVIVAL; UNITED-STATES; DIAGNOSIS; CANADA; CALIFORNIA; COMORBIDITY; VALIDATION; MORTALITY; INCOME; STAGE	Background: Research has shown that people from higher socioeconomic status (SES) have better hepatocellular carcinoma (HCC) survival outcomes, although no such research has been carried out in Canada. We aimed to assess if an association between SES and HCC survival existed in the Canadian context. Methodology/Prinicpal Findings: We conducted a population-based cohort study linking HCC cases identified in the Ontario Cancer Registry between 1990 and 2009 to administrative and hospital data. Logistic regression and chi-squared tests were used to evaluate associations between SES (income quintile) and covariates. The Kaplan-Meier method was used to estimate survival. Sequential analysis of the proportional-hazards models were used to determine the association between SES and HCC survival controlling for potential prognostic covariates. During the period 1990-2009, 5,481 cases of HCC were identified. A significant association was found between SES and curative treatment (p = 0.0003), but no association was found between SES and non-curative treatment (p = 0.064), palliative treatment (p = 0.680), or ultrasound screening (p = 0.615). The median survival for the lowest SES was 8.5 months, compared to 8.8 months for the highest SES group. The age-and sex-adjusted proportional-hazards model showed statistically significant difference in HCC survival among the SES groups, with hazard ratio 0.905 (95% confidence intervals 0.821, 0.998) when comparing highest to lowest SES group. Further adjustments indicated that potentially curative treatment was the likely explanation for the association between SES and HCC survival. Conclusions/Significance: Our findings suggest that a 10% HCC survival advantage exists for the higher SES groups. This association between SES and HCC survival is most likely a reflection of lack of access to care for low SES groups, revealing inequities in the Canadian healthcare system.	[Jembere, Nathaniel; Campitelli, Michael A.; Lou, Wendy; Thein, Hla-Hla] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Campitelli, Michael A.; Earle, Craig] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Sherman, Morris; Krahn, Murray D.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Feld, Jordan J.] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Peacock, Stuart] Univ British Columbia, Canadian Ctr Appl Res Canc Control ARCC, Vancouver, BC V5Z 1M9, Canada; [Krahn, Murray D.] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Krahn, Murray D.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Krahn, Murray D.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Krahn, Murray D.] Univ Toronto, Fac Pharm, Toronto, ON, Canada; [Earle, Craig; Thein, Hla-Hla] Canc Care Ontario, Ontario Inst Canc Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia; University of Toronto; University of Toronto; University of Toronto; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Jembere, N (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	rosie.thein@utoronto.ca	Peacock, Stuart J/P-2437-2018; Feld, Jordan/AAH-5628-2020	Peacock, Stuart J/0000-0002-8243-8721; Feld, Jordan/0000-0003-2640-2211; Krahn, Murray/0000-0001-5836-397X; Thein, Hla-Hla/0000-0003-4950-187X	Ministry of Health and Long-Term Care (MOHLTC); Ontario Institute for Cancer Research Health Services Research Program New Investigator Award; F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto; Toronto Health Economics and Technology Assessment (THETA) Collaborative through Ontario Ministry of Health and Long-Term Care	Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Ontario Institute for Cancer Research Health Services Research Program New Investigator Award; F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto; Toronto Health Economics and Technology Assessment (THETA) Collaborative through Ontario Ministry of Health and Long-Term Care	This study was supported through provision of data by the Institute for Clinical Evaluative Sciences (ICES) and Cancer Care Ontario (CCO) and through funding support to ICES from an annual grant by the Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors. No endorsement by ICES, CCO, or the MOHLTC is intended or should be inferred. HHT is supported through the Ontario Institute for Cancer Research Health Services Research Program New Investigator Award. MDK is supported by the F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto and in part by the Toronto Health Economics and Technology Assessment (THETA) Collaborative through the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alibhai SMH, 2005, JNCI-J NATL CANCER I, V97, P1525, DOI 10.1093/jnci/dji313; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; Booth CM, 2010, CANCER-AM CANCER SOC, V116, P4160, DOI 10.1002/cncr.25427; Boyd C, 1999, J CLIN ONCOL, V17, P2244, DOI 10.1200/JCO.1999.17.7.2244; Bradley CJ, 2002, J NATL CANCER I, V94, P490; Cagnoni C, 2000, HEPATO-GASTROENTEROL, V47, P199; CELLA DF, 1991, J CLIN ONCOL, V9, P1500, DOI 10.1200/JCO.1991.9.8.1500; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarke EA, 1991, IARC SCI PUBL, P246; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dyer Z, 2005, ALIMENT PHARM THER, V22, P17, DOI 10.1111/j.1365-2036.2005.02504.x; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Gorey KM, 2011, AM J PUBLIC HEALTH, V101, P112, DOI 10.2105/AJPH.2009.173112; Gorey KM, 2010, BREAST J, V16, P416, DOI 10.1111/j.1524-4741.2010.00922.x; Gorey KM, 2010, HEALTH PLACE, V16, P156, DOI 10.1016/j.healthplace.2009.09.011; Gorey KM, 2009, ANN EPIDEMIOL, V19, P121, DOI 10.1016/j.annepidem.2008.10.010; Gorey KM, 2003, ANN EPIDEMIOL, V13, P32, DOI 10.1016/S1047-2797(02)00259-4; Groome PA, 2006, CLIN ONCOL-UK, V18, P283, DOI 10.1016/j.clon.2005.12.010; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Joshi S, 2008, PUBLIC HEALTH, V122, P1144, DOI 10.1016/j.puhe.2008.04.003; KOGEVINAS M, 1991, J EPIDEMIOL COMMUN H, V45, P216, DOI 10.1136/jech.45.3.216; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kwong SL, 2010, CANCER EPIDEM BIOMAR, V19, P2747, DOI 10.1158/1055-9965.EPI-10-0477; Mackillop WJ, 1997, J CLIN ONCOL, V15, P1680, DOI 10.1200/JCO.1997.15.4.1680; Match Ware Technologies INC, 1998, AUTOMATCH GEN REC LI; Mustard CA, 1999, HEALTH PLACE, V5, P157, DOI 10.1016/S1353-8292(99)00008-8; Pocobelli G, 2008, LIVER INT, V28, P1272, DOI 10.1111/j.1478-3231.2008.01704.x; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; SCHRIJVERS CTM, 1995, INT J CANCER, V63, P324, DOI 10.1002/ijc.2910630303; Statistics Canada Agriculture Division, 2002, AGR RUR WORK PAP SER; Wilkins R., 2004, AUTOMATED GEOGRAPHIC; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; Yim J, 2010, J EPIDEMIOL COMMUNIT, V66, P37; Yun EH, 2010, BRIT J CANCER, V103, P741, DOI 10.1038/sj.bjc.6605803; Zak Y, 2011, ARCH SURG-CHICAGO, V146, P778, DOI 10.1001/archsurg.2011.37	36	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40917	10.1371/journal.pone.0040917	http://dx.doi.org/10.1371/journal.pone.0040917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808283	Green Published, gold			2022-12-27	WOS:000306406700068
J	Kato, TA; Watabe, M; Tsuboi, S; Ishikawa, K; Hashiya, K; Monji, A; Utsumi, H; Kanba, S				Kato, Takahiro A.; Watabe, Motoki; Tsuboi, Sho; Ishikawa, Katsuhiko; Hashiya, Kazuhide; Monji, Akira; Utsumi, Hideo; Kanba, Shigenobu			Minocycline Modulates Human Social Decision-Making: Possible Impact of Microglia on Personality-Oriented Social Behaviors	PLOS ONE			English	Article							IN-VITRO; PREFRONTAL CORTEX; OPEN-LABEL; ACTIVATION; BRAIN; SCHIZOPHRENIA; TRUST; STRESS; ARIPIPRAZOLE; INFLAMMATION	Background: Microglia, one of the glial cells, play important roles in various brain pathologies including psychiatric disorders. In addition, microglia have recently been proved to monitor synaptic reactions via direct-touching even in normal brain. Human microglia may modulate various social/mental functions, while microglial social/mental roles remain unresolved especially in healthy humans. There is no known drug with the specific effect of modulating microglia. Therefore, using minocycline, a tetracycline antibiotic and the most famous microglial inhibitor, is one of the best alternative approaches to clarify microglial functions on human social/mental activities. Methodology/Principal Findings: We conducted a double-blind randomized trial of trust game, a monetary decision-making experiment, with ninety-nine human adult males who decided how much to trust an anonymous partner after a four-day administration of minocycline. Our previous pilot trial indicated a positive effect of minocycline, while the underlying mechanisms were not clarified. Therefore, in this trial with larger samples, we additionally measured the effects of anxiety and personality. The monetary score in trust game was significantly lower in the minocycline group. Interestingly, participants' ways of decision-making were significantly shifted; cooperativeness, one component of personality, proved to be the main modulating factor of decision-making in the placebo group, on the other hand, the minocycline group was mainly modulated by state anxiety and trustworthiness. Conclusions/Significance: Our results suggest that minocycline led to more situation-oriented decision-making, possibly by suppressing the effects of personality traits, and furthermore that personality and social behaviors might be modulated by microglia. Early-life events may activate human microglia, establish a certain neuro-synaptic connection, and this formation may determine each human's personality and personality-oriented social behaviors in later life. To explore these mechanisms, further translational research is needed.	[Kato, Takahiro A.; Monji, Akira; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan; [Kato, Takahiro A.; Utsumi, Hideo] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka, Japan; [Tsuboi, Sho] Kyoto Univ, Dept Psychol, Grad Sch Letters, Kyoto, Japan; [Ishikawa, Katsuhiko; Hashiya, Kazuhide] Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyoto University; Kyushu University	Kato, TA (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan.	takahiro@npsych.med.kyushu-u.ac.jp; motokiw@gmail.com	Watabe, Motoki/H-2094-2018; Kato, Takahiro/R-7665-2019	Kato, Takahiro/0000-0001-5169-2930	Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [19046002] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) to Dr. Kato, Dr. Watabe, Dr. Hashiya, Dr. Monji, Dr. Utsumi and Dr. Kanba, and a JSPS Research Fellow Grant to Dr. Tsuboi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabori H, 2010, SHOCK, V33, P43, DOI 10.1097/SHK.0b013e3181b0ebcb; Barraza JA, 2011, HORM BEHAV, V60, P148, DOI 10.1016/j.yhbeh.2011.04.008; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bjork JM, 2009, BIOL PSYCHIAT, V65, P710, DOI 10.1016/j.biopsych.2008.11.023; Cloninger RC., 1994, TEMPERAMENT CHARACTE; Converse AK, 2011, J NUCL MED, V52, P257, DOI 10.2967/jnumed.110.082743; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Gheorghiu MA, 2009, SOC PSYCHOL QUART, V72, P365, DOI 10.1177/019027250907200408; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hashimoto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015430; Hinwood M, 2012, CEREB CORTEX, V22, P1442, DOI 10.1093/cercor/bhr229; Horikawa H, 2010, PROG NEURO-PSYCHOPH, V34, P1306, DOI 10.1016/j.pnpbp.2010.07.015; JONAS M, 1982, THER DRUG MONIT, V4, P137; Kato TA, 2011, MINI-REV MED CHEM, V11, P565; Kato T, 2008, J NEUROCHEM, V106, P815, DOI 10.1111/j.1471-4159.2008.05435.x; Kato T, 2007, SCHIZOPHR RES, V92, P108, DOI 10.1016/j.schres.2007.01.019; Kato TA, 2011, SCHIZOPHR RES, V129, P172, DOI 10.1016/j.schres.2011.03.019; Kijima N, 2000, PSYCHOL REP, V86, P1050, DOI 10.2466/PR0.86.3.1050-1058; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; Loughland CM, 2002, BIOL PSYCHIAT, V52, P338, DOI 10.1016/S0006-3223(02)01356-2; Miyaoka T, 2008, CLIN NEUROPHARMACOL, V31, P287, DOI 10.1097/wnf.0b013e3181593d45; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Neigh GN, 2009, STROKE, V40, P3601, DOI 10.1161/STROKEAHA.109.564146; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Purisai MG, 2007, NEUROBIOL DIS, V25, P392, DOI 10.1016/j.nbd.2006.10.008; Ransohoff RM, 2011, SCIENCE, V333, P1391, DOI 10.1126/science.1212112; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rogers RD, 2011, NEUROPSYCHOPHARMACOL, V36, P114, DOI 10.1038/npp.2010.165; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Schiavone S, 2009, BIOL PSYCHIAT, V66, P384, DOI 10.1016/j.biopsych.2009.04.033; Sofuoglu M, 2011, PSYCHOPHARMACOLOGY, V213, P61, DOI 10.1007/s00213-010-2014-5; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Sugama S, 2009, J NEUROIMMUNOL, V207, P24, DOI 10.1016/j.jneuroim.2008.11.007; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Uban KA, 2012, NEUROPSYCHOPHARMACOL, V37, P390, DOI 10.1038/npp.2011.176; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Vilares I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017113; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Watabe Motoki, 2012, Psychopharmacology (Berl), V220, P551, DOI 10.1007/s00213-011-2509-8; Wei L, 2012, NEUROPSYCHOPHARMACOL, V37, P567, DOI 10.1038/npp.2011.239; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Yamagishi T, 1994, MOTIV EMOTION, V18, P9; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zhong SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013765	58	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40461	10.1371/journal.pone.0040461	http://dx.doi.org/10.1371/journal.pone.0040461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808165	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700030
J	Ljungberg, K; McBrayer, A; Camp, JV; Chu, YK; Tapp, R; Noah, DL; Grimes, S; Proctor, ML; Liljestrom, P; Jonsson, CB; Bruder, CE				Ljungberg, Karl; McBrayer, Alexis; Camp, Jeremy V.; Chu, Yong-Kyu; Tapp, Ronald; Noah, Diana L.; Grimes, Sheila; Proctor, Mary L.; Liljestrom, Peter; Jonsson, Colleen B.; Bruder, Carl E.			Host Gene Expression Signatures Discriminate between Ferrets Infected with Genetically Similar H1N1 Strains	PLOS ONE			English	Article							INFLUENZA-A H1N1; MICROARRAY DATA; VIRUS; RESPONSES; DEATH; MODEL	Different respiratory viruses induce virus-specific gene expression in the host. Recent evidence, including those presented here, suggests that genetically related isolates of influenza virus induce strain-specific host gene regulation in several animal models. Here, we identified systemic strain-specific gene expression signatures in ferrets infected with pandemic influenza A/California/07/2009, A/Mexico/4482/2009 or seasonal influenza A/Brisbane/59/2007. Using uncorrelated shrunken centroid classification, we were able to accurately identify the infecting influenza strain with a combined gene expression profile of 10 selected genes, independent of the severity of disease. Another gene signature, consisting of 7 genes, could classify samples based on lung pathology. Furthermore, we identified a gene expression profile consisting of 31 probes that could classify samples based on both strain and severity of disease. Thus, we show that expression-based analysis of non-infected tissue enables distinction between genetically related influenza viruses as well as lung pathology. These results open for development of alternative tools for influenza diagnostics.	[Ljungberg, Karl; Liljestrom, Peter; Bruder, Carl E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [McBrayer, Alexis; Tapp, Ronald; Noah, Diana L.; Grimes, Sheila] So Res Inst, Birmingham, AL 35255 USA; [Camp, Jeremy V.; Chu, Yong-Kyu; Jonsson, Colleen B.; Bruder, Carl E.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA	Karolinska Institutet; University of Louisville	Ljungberg, K (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	carl.bruder@ki.se	Jonsson, Colleen/GPC-4424-2022; Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/X-2360-2019	Jonsson, Colleen/0000-0002-2640-7672; Camp, Jeremy V./0000-0002-9040-5786; Liljestrom, Peter/0000-0002-2132-0981; Ljungberg, Karl/0000-0001-7192-6204	National Institute of Allergy and Infectious Diseases (NIAID) [N01-AI-30063]; European Research Council [FP-PEOPLE-2009-IIF, 251456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the contract N01-AI-30063 from the National Institute of Allergy and Infectious Diseases (NIAID). CEB is a recipient of a Marie Curie IIF grant from the European Research Council (FP-PEOPLE-2009-IIF, contract 251456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Bar-Or C, 2007, TRENDS GENET, V23, P200, DOI 10.1016/j.tig.2007.02.003; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Bruder CE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-251; Buckley BA, 2007, J EXP BIOL, V210, P1602, DOI 10.1242/jeb.002402; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Fang YA, 2010, J VIROL, V84, P8369, DOI 10.1128/JVI.02305-09; HEYWARD JT, 1977, ARCH VIROL, V55, P107, DOI 10.1007/BF01314484; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kim HS, 2011, J KOREAN MED SCI, V26, P22, DOI 10.3346/jkms.2011.26.1.22; Liu L, 2011, CHINESE MED J-PEKING, V124, P1662, DOI 10.3760/cma.j.issn.0366-6999.2011.11.011; Liu WX, 2008, J BIOMED INFORM, V41, P602, DOI 10.1016/j.jbi.2007.12.003; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Matesanz-Isabel J, 2011, IMMUNOL LETT, V134, P104, DOI 10.1016/j.imlet.2010.09.019; McBrayer A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-149; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Suk K, 2010, CELL ADHES MIGR, V4, P207, DOI 10.4161/cam.4.2.11073; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wang YG, 2009, IMMUNOL REV, V229, P232, DOI 10.1111/j.1600-065X.2009.00762.x; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020698; Yang IV, 2009, GENETICS, V183, P1535, DOI 10.1534/genetics.109.107540; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r83; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40743	10.1371/journal.pone.0040743	http://dx.doi.org/10.1371/journal.pone.0040743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808249	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700048
J	Tani, A; Sahin, N; Matsuyama, Y; Enomoto, T; Nishimura, N; Yokota, A; Kimbara, K				Tani, Akio; Sahin, Nurettin; Matsuyama, Yumiko; Enomoto, Takashi; Nishimura, Naoki; Yokota, Akira; Kimbara, Kazuhide			High-Throughput Identification and Screening of Novel Methylobacterium Species Using Whole-Cell MALDI-TOF/MS Analysis	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION IONIZATION-TIME; SP-NOV.; FLOWERING PLANTS; SP. NOV.; PHYLLOSPHERE; EXTORQUENS; METHANOL; PINK; MICROBIOLOGY	Methylobacterium species are ubiquitous alpha-proteobacteria that reside in the phyllosphere and are fed by methanol that is emitted from plants. In this study, we applied whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis (WC-MS) to evaluate the diversity of Methylobacterium species collected from a variety of plants. The WC-MS spectrum was reproducible through two weeks of cultivation on different media. WC-MS spectrum peaks of M. extorquens strain AM1 cells were attributed to ribosomal proteins, but those were not were also found. We developed a simple method for rapid identification based on spectra similarity. Using all available type strains of Methylobacterium species, the method provided a certain threshold similarity value for species-level discrimination, although the genus contains some type strains that could not be easily discriminated solely by 16S rRNA gene sequence similarity. Next, we evaluated the WC-MS data of approximately 200 methylotrophs isolated from various plants with MALDI Biotyper software (Bruker Daltonics). Isolates representing each cluster were further identified by 16S rRNA gene sequencing. In most cases, the identification by WC-MS matched that by sequencing, and isolates with unique spectra represented possible novel species. The strains belonging to M. extorquens, M. adhaesivum, M. marchantiae, M. komagatae, M. brachiatum, M. radiotolerans, and novel lineages close to M. adhaesivum, many of which were isolated from bryophytes, were found to be the most frequent phyllospheric colonizers. The WC-MS technique provides emerging high-throughputness in the identification of known/novel species of bacteria, enabling the selection of novel species in a library and identification without 16S rRNA gene sequencing.	[Tani, Akio; Enomoto, Takashi] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Sahin, Nurettin] Mugla Sitki Kocman Univ, Fac Educ, TR-48170 Kotekli, Mugla, Turkey; [Matsuyama, Yumiko] Bruker Daltonics Inc, KK, Yokohama, Kanagawa, Japan; [Nishimura, Naoki] Okayama Univ Sci Japan, Bot Garden, Okayama, Japan; [Yokota, Akira] Univ Indonesia, Fac Math & Nat Sci, Depok, Indonesia; [Kimbara, Kazuhide] Shizuoka Univ, Fac Engn, Kita Ku, Hamamatsu, Shizuoka 4328561, Japan	Okayama University; Mugla Sitki Kocman University; University of Indonesia; Shizuoka University	Tani, A (corresponding author), Okayama Univ, Inst Plant Sci & Resources, 2-20-1 Chuo, Kurashiki, Okayama, Japan.	atani@rib.okayama-u.ac.jp	SAHIN, Nurettin/A-5068-2009; TANI, Akio/B-2516-2011; Yokota, Akira/R-1109-2019	SAHIN, Nurettin/0000-0002-1049-6180; Yokota, Akira/0000-0002-4722-527X; Tani, Akio/0000-0001-7685-9063	Japan Science and Technology Agency; Sekisui Chemical Co.; Institute of Fermentation, Osaka (IFO); Ryobi Tei-en Memorial Foundation	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sekisui Chemical Co.; Institute of Fermentation, Osaka (IFO); Ryobi Tei-en Memorial Foundation	This work was supported by a grant for Research for Promoting Technological Seeds from the Japan Science and Technology Agency and grants from Sekisui Chemical Co., the Institute of Fermentation, Osaka (IFO), and the Ryobi Tei-en Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; Burgmann H, 2004, APPL ENVIRON MICROB, V70, P240, DOI 10.1128/AEM.70.1.240-247.2004; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Fedorov DN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1435, DOI 10.1134/S0006297910120035; Galbally IE, 2002, J ATMOS CHEM, V43, P195, DOI 10.1023/A:1020684815474; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Han SH, 2008, FEMS MICROBIOL LETT, V282, P140, DOI 10.1111/j.1574-6968.2008.01120.x; Hoppe T, 2011, SYST APPL MICROBIOL, V34, P482, DOI 10.1016/j.syapm.2010.12.005; Hornschuh M, 2006, NATURWISSENSCHAFTEN, V93, P480, DOI 10.1007/s00114-006-0137-7; Idris R, 2004, APPL ENVIRON MICROB, V70, P2667, DOI 10.1128/AEM.70.5.2667-2677.2004; Idris R, 2006, SYST APPL MICROBIOL, V29, P634, DOI 10.1016/j.syapm.2006.01.011; Ivanova EG, 2000, MICROBIOLOGY+, V69, P646, DOI 10.1023/A:1026693805653; Iwatsuki Z, 2001, MOSSES LIVERWORTS JA; Jarman KH, 2000, ANAL CHEM, V72, P1217, DOI 10.1021/ac990832j; Jayashree S, 2011, ARCH MICROBIOL, V193, P543, DOI 10.1007/s00203-011-0691-z; Jourand P, 2005, MOL PLANT MICROBE IN, V18, P1061, DOI 10.1094/MPMI-18-1061; Kato Y, 2005, J GEN APPL MICROBIOL, V51, P287, DOI 10.2323/jgam.51.287; Kato Y, 2008, INT J SYST EVOL MICR, V58, P1134, DOI 10.1099/ijs.0.65583-0; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2012, ANTON LEEUW INT J G, V101, P169, DOI 10.1007/s10482-011-9650-6; Knief C, 2010, MICROB ECOL, V60, P440, DOI 10.1007/s00248-010-9725-3; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Kolb S, 2009, FEMS MICROBIOL LETT, V300, P1, DOI 10.1111/j.1574-6968.2009.01681.x; Kurland CG, 1971, METHODS ENZYMOLOGY C, V20, P379, DOI [10.1016/S0076-6879(71)20041- 0, DOI 10.1016/S0076-6879(71)20041-0]; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lidstrom ME, 2002, J BACTERIOL, V184, P1818, DOI 10.1128/JB.184.7.1818.2002; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Madhaiyan M, 2009, INT J SYST EVOL MICR, V59, P22, DOI 10.1099/ijs.0.001693-0; Madhaiyan M, 2007, PLANTA, V226, P867, DOI 10.1007/s00425-007-0532-0; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rezzonico F, 2010, APPL ENVIRON MICROB, V76, P4497, DOI 10.1128/AEM.03112-09; Saenz AJ, 1999, RAPID COMMUN MASS SP, V13, P1580, DOI 10.1002/(SICI)1097-0231(19990815)13:15<1580::AID-RCM679>3.0.CO;2-V; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schauer S, 2011, PLANT SIGNAL BEHAV, V6, P510, DOI 10.4161/psb.6.4.14335; Schauer S, 2011, INT J SYST EVOL MICR, V61, P870, DOI 10.1099/ijs.0.021915-0; Schmidt S, 2010, MICROBIOL-SGM, V156, P2575, DOI 10.1099/mic.0.038570-0; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Senthilkumar M, 2009, MICROBIOL RES, V164, P92, DOI 10.1016/j.micres.2006.10.007; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Soung GY, 2009, J PROTEOME RES, V8, P3390, DOI 10.1021/pr900042e; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tani A, 2011, INT J SYST IN PRESS; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033800; Van Aken B, 2004, INT J SYST EVOL MICR, V54, P1191, DOI 10.1099/ijs.0.02796-0; Verroken A, 2010, J CLIN MICROBIOL, V48, P4015, DOI 10.1128/JCM.01234-10; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wellner S, 2012, INT J SYST EVOL MICR, V62, P917, DOI 10.1099/ijs.0.030767-0; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300	62	38	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40784	10.1371/journal.pone.0040784	http://dx.doi.org/10.1371/journal.pone.0040784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808262	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400059
J	Toju, H; Tanabe, AS; Yamamoto, S; Sato, H				Toju, Hirokazu; Tanabe, Akifumi S.; Yamamoto, Satoshi; Sato, Hirotoshi			High-Coverage ITS Primers for the DNA-Based Identification of Ascomycetes and Basidiomycetes in Environmental Samples	PLOS ONE			English	Article							ECTOMYCORRHIZAL GENUS STROBILOMYCES; FUNGAL COMMUNITIES; SPECIFICITY; ENDOPHYTES; DIVERSITY; ABUNDANCE; BARCODE; REVEAL; MARKER; REGION	The kingdom Fungi is estimated to include 1.5 million or more species, playing key roles as decomposers, mutualists, and parasites in every biome on the earth. To comprehensively understand the diversity and ecology of this huge kingdom, DNA barcoding targeting the internal transcribed spacer (ITS) region of the nuclear ribosomal repeat has been regarded as a prerequisite procedure. By extensively surveying ITS sequences in public databases, we designed new ITS primers with improved coverage across diverse taxonomic groups of fungi compared to existing primers. An in silico analysis based on public sequence databases indicated that the newly designed primers matched 99% of ascomycete and basidiomycete ITS taxa (species, subspecies or varieties), causing little taxonomic bias toward either fungal group. Two of the newly designed primers could inhibit the amplification of plant sequences and would enable the selective investigation of fungal communities in mycorrhizal associations, soil, and other types of environmental samples. Optimal PCR conditions for the primers were explored in an in vitro investigation. The new primers developed in this study will provide a basis for ecological studies on the diversity and community structures of fungi in the era of massive DNA sequencing.	[Toju, Hirokazu] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto, Japan; [Toju, Hirokazu; Tanabe, Akifumi S.; Yamamoto, Satoshi] Kyoto Univ, Div Biol Sci, Grad Sch Sci, Sakyo Ku, Kyoto, Japan; [Sato, Hirotoshi] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Fushimi Ku, Kyoto, Japan	Kyoto University; Kyoto University; Forestry & Forest Products Research Institute - Japan	Toju, H (corresponding author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto, Japan.	toju.hirokazu.4c@kyoto-u.ac.jp	Sato, Hirotoshi/A-2429-2015; Toju, Hirokazu/S-7307-2017; Toju, Hirokazu/T-7355-2019; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Japan Society for the Promotion of Science [GS014]; Hakubi Project by Kyoto University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hakubi Project by Kyoto University	This work was supported by grant-in-aid by Funding Program for Next Generation World-Leading Researchers (GS014) by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-jisedai/index.html) and the Hakubi Project by Kyoto University (http://www.hakubi.kyoto-u.ac.jp/eng/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M.F., 1991, ECOLOGY MYCORRHIZAE; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Arfi Y, 2012, FEMS MICROBIOL ECOL, V79, P433, DOI 10.1111/j.1574-6941.2011.01236.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Berg B, 2003, PLANT LITTER DECOMPO; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Cardoso IM, 2006, AGR ECOSYST ENVIRON, V116, P72, DOI 10.1016/j.agee.2006.03.011; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; EGGER KN, 1995, CAN J BOT, V73, pS1415, DOI 10.1139/b95-405; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kayser O, 2003, PARASITOL RES, V90, pS55, DOI 10.1007/s00436-002-0768-3; Kelly LJ, 2011, NEW PHYTOL, V191, P288, DOI 10.1111/j.1469-8137.2011.03677.x; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Moora M, 2011, J BIOGEOGR, V38, P1305, DOI 10.1111/j.1365-2699.2011.02478.x; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Nilsson RH, 2011, NEW PHYTOL, V191, P314, DOI 10.1111/j.1469-8137.2011.03755.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Robinson CH, 2001, NEW PHYTOL, V151, P341, DOI 10.1046/j.1469-8137.2001.00177.x; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Sato H, 2008, MOL PHYLOGENET EVOL, V48, P326, DOI 10.1016/j.ympev.2008.01.033; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Sawers RJH, 2008, TRENDS PLANT SCI, V13, P93, DOI 10.1016/j.tplants.2007.11.006; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vega Fernando E., 2005, P211; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wang JL, 2006, BIOTECHNOL ADV, V24, P427, DOI 10.1016/j.biotechadv.2006.03.001; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zjawiony JK, 2004, J NAT PROD, V67, P300, DOI 10.1021/np030372w	54	529	553	16	223	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40863	10.1371/journal.pone.0040863	http://dx.doi.org/10.1371/journal.pone.0040863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808280	gold, Green Submitted, Green Published			2022-12-27	WOS:000306366400063
J	Zhang, XL; Torcasio, A; Vandamme, K; Ogawa, T; van Lenthe, GH; Naert, I; Duyck, J				Zhang, Xiaolei; Torcasio, Antonia; Vandamme, Katleen; Ogawa, Toru; van Lenthe, G. Harry; Naert, Ignace; Duyck, Joke			Enhancement of Implant Osseointegration by High-Frequency Low-Magnitude Loading	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; MECHANICAL SIGNALS; BONE-FORMATION; TITANIUM IMPLANTS; STRAIN MAGNITUDE; TISSUE DIFFERENTIATION; SURFACE-ROUGHNESS; LOW-LEVEL; MODEL; MECHANOTRANSDUCTION	Background: Mechanical loading is known to play an important role in bone remodelling. This study aimed to evaluate the effect of high- and low-frequency axial loading, applied directly to the implant, on peri-implant bone healing and implant osseointegration. Methodology: Titanium implants were bilaterally installed in rat tibiae. For every animal, one implant was loaded (test) while the other one was not (control). The test implants were randomly divided into 8 groups according to 4 loading regimes and 2 experimental periods (1 and 4 weeks). The loaded implants were subject to an axial displacement. Within the high- (HF, 40 Hz) or low-frequency (LF, 8 Hz) loading category, the displacements varied 2-fold and were ranked as low- or high-magnitude (LM, HM), respectively. The strain rate amplitudes were kept constant between the two frequency groups. This resulted in the following 4 loading regimes: 1) HF-LM, 40 Hz-8 mu m; 2) HF-HM, 40 Hz-16 mu m; 3) LF-LM, 8 Hz-41 mu m; 4) LF-HM, 8 Hz-82 mu m. The tissue samples were processed for resin embedding and subjected to histological and histomorphometrical analyses. Data were analyzed statistically with the significance set at p<0.05. Principal Findings: After loading for 4 weeks, HF-LM loading (40 Hz-8 mu m) induced more bone-to-implant contact (BIC) at the level of the cortex compared to its unloaded control. No significant effect of the four loading regimes on the peri-implant bone fraction (BF) was found in the 2 experimental periods. Conclusions: The stimulatory effect of immediate implant loading on bone-to-implant contact was only observed in case of high-frequency (40 Hz) low-magnitude (8 mu m) loading. The applied load regimes failed to influence the peri-implant bone mass.	[Zhang, Xiaolei; Vandamme, Katleen; Ogawa, Toru; Naert, Ignace; Duyck, Joke] Univ Louvain, BIOMAT Res Cluster, Dept Prosthet Dent, Louvain, Belgium; [Torcasio, Antonia; van Lenthe, G. Harry] Univ Louvain, Dept Mech Engn, Div Biomech & Engn Design, Louvain, Belgium; [Ogawa, Toru] Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Sendai, Miyagi 980, Japan; [van Lenthe, G. Harry] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	Tohoku University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zhang, XL (corresponding author), Univ Louvain, BIOMAT Res Cluster, Dept Prosthet Dent, Louvain, Belgium.	Joke.Duyck@uz.kuleuven.ac.be	van Lenthe, Harry (GH)/C-1030-2008	van Lenthe, Harry (GH)/0000-0001-8303-4959; OGAWA, Toru/0000-0002-5578-7766; Vandamme, Katleen/0000-0002-5766-2254; Naert, Ignace/0000-0001-7007-1443	Research Council of University of Leuven [OT/07/059]	Research Council of University of Leuven	This study was supported by the Research Council of University of Leuven (OT/07/059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akca Kivanc, 2007, Head Face Med, V3, P28, DOI 10.1186/1746-160X-3-28; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Cullen DM, 2001, J APPL PHYSIOL, V91, P1971, DOI 10.1152/jappl.2001.91.5.1971; De Smet E, 2007, J CLIN PERIODONTOL, V34, P618, DOI 10.1111/j.1600-051X.2007.01082.x; De Smet E, 2005, CLIN ORAL IMPLAN RES, V16, P402, DOI 10.1111/j.1600-0501.2005.01156.x; De Smet E, 2011, CLIN IMPLANT DENT RE; De Smet E, 2008, CLIN ORAL IMPLAN RES, V19, P733, DOI [10.1111/j.1600-0501.2008.01474.x, 10.1111/j.1600-0501.2008.01528_19_8.x]; De Smet E, 2006, EUR J ORAL SCI, V114, P232, DOI 10.1111/j.1600-0722.2006.00355.x; Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003; Duyck J, 2004, J BIOMECH, V37, P1819, DOI 10.1016/j.jbiomech.2004.02.044; Duyck J, 2007, J CLIN PERIODONTOL, V34, P998, DOI 10.1111/j.1600-051X.2007.01135.x; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Goodship AE, 1998, CLIN ORTHOP RELAT R, pS105; Goodship AE, 2009, J ORTHOP RES, V27, P922, DOI 10.1002/jor.20824; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Isidor F, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2006.01360.x; Jemt T, 2011, INT J PROSTHODONT, V24, P345; Judex S, 2010, J MUSCULOSKEL NEURON, V10, P3; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005; LaMothe JM, 2005, MED ENG PHYS, V27, P277, DOI 10.1016/j.medengphy.2004.04.012; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; Ogawa T, 2011, CLIN ORAL IMPLAN RES, V22, P302, DOI 10.1111/j.1600-0501.2010.02020.x; Ogawa T, 2011, J CLIN PERIODONTOL, V38, P180, DOI 10.1111/j.1600-051X.2010.01637.x; Omar H, 2008, J ORAL MAXIL SURG, V66, P1104, DOI 10.1016/j.joms.2008.01.048; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Qin YX, 1996, J ORTHOPAED RES, V14, P862, DOI 10.1002/jor.1100140604; Rittweger J, 2010, BONE, V46, P137, DOI 10.1016/j.bone.2009.08.051; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Torcasio A, 2011, BIOMECH MODEL MECHAN; Torcasio A, 2012, BIOMECH MODEL MECHAN, V11, P403, DOI 10.1007/s10237-011-0320-4; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686; Vandamme K, 2008, J PERIODONTOL, V79, P150, DOI 10.1902/jop.2008.060413 ; Vandamme K, 2007, EUR J ORAL SCI, V115, P21, DOI 10.1111/j.1600-0722.2007.00416.x; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012; You LD, 2001, J BIOMECH, V34, P1375, DOI 10.1016/S0021-9290(01)00107-5; Zhang X, 2012, J R SOC INTERFACE; Zhang X, 2010, CLIN IMPLANT DENT RE	45	11	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40488	10.1371/journal.pone.0040488	http://dx.doi.org/10.1371/journal.pone.0040488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808172	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500047
J	Bill, A; Schmitz, A; Konig, K; Heukamp, LC; Hannam, JS; Famulok, M				Bill, Anke; Schmitz, Anton; Koenig, Katharina; Heukamp, Lukas C.; Hannam, Jeffrey S.; Famulok, Michael			Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; KINASE INHIBITORS; RNA INTERFERENCE; EGFR MUTATION; INSULIN; ACTIVATION; PATHWAY; ADENOCARCINOMAS; AMPLIFICATION	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), such as gefitinib, have been proven to efficiently inhibit the proliferation of a subset of non small-cell lung cancers (NSCLC). Unfortunately, the majority of NSCLC expressing wild type EGFR is primarily resistant to EGFR-TKI treatment. Here, we show that the proliferation of the gefitinib-resistant NSCLC cell lines H460 and A549 is reduced by the small molecule SecinH3 which indirectly attenuates EGFR activation by inhibition of cytohesins, a class of recently discovered cytoplasmic EGFR activators. SecinH3 and gefitinib showed a synergistic antiproliferative effect, which correlated with a profound inhibition of Akt activation and survivin expression. Treating mice bearing H460 xenografts with SecinH3 showed the antiproliferative and pro-apoptotic effect of SecinH3 in vivo. Our data suggest that targeting the EGFR indirectly by inhibiting its cytoplasmic activators, the cytohesins, has the potential to improve the treatment of primarily EGFR-TKI resistant lung cancers.	[Bill, Anke; Schmitz, Anton; Hannam, Jeffrey S.; Famulok, Michael] Univ Bonn, Chem Biol & Med Chem Unit, Life & Med Sci LIMES Inst, Bonn, Germany; [Koenig, Katharina; Heukamp, Lukas C.] Univ Cologne, Inst Pathol, Cologne, Germany	University of Bonn; University of Cologne	Bill, A (corresponding author), Univ Bonn, Chem Biol & Med Chem Unit, Life & Med Sci LIMES Inst, Bonn, Germany.	m.famulok@uni-bonn.de	Heukamp, Lukas C/A-8338-2013; Heukamp, Lukas/G-9967-2012	Hannam, Jeffrey/0000-0001-9827-3143; Bill, Anke/0000-0003-1244-7574; Heukamp, Lukas/0000-0002-3388-3482	Deutsche Forschungsgemeinschaft; Collaborative Reseach Center 645 [SFB 645]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Reseach Center 645	This work was funded by the Deutsche Forschungsgemeinschaft and the Collaborative Reseach Center 645 (SFB 645). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bi XH, 2008, ANGEW CHEM INT EDIT, V47, P9565, DOI 10.1002/anie.200803962; Bill A, 2011, J AM CHEM SOC, V133, P8372, DOI 10.1021/ja202513s; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Bodzin AS, 2012, J CELL PHYSIOL, V227, P2947, DOI 10.1002/jcp.23041; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Chakravarti A, 2002, CANCER RES, V62, P200; Chen G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-28; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fidler MJ, 2012, THER ADV MED ONCOL, V4, P51, DOI 10.1177/1758834011427576; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; GRECO WR, 1995, PHARMACOL REV, V47, P331; Habben K, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7584; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Li SD, 2008, MOL THER, V16, P163, DOI 10.1038/sj.mt.6300323; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Stumpfe D, 2010, ACS CHEM BIOL, V5, P839, DOI 10.1021/cb100171c; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Yamanaka S, 2008, PATHOBIOLOGY, V75, P2, DOI 10.1159/000113789; Zhang M, 2004, ACTA PHARMACOL SIN, V25, P61; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	36	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41179	10.1371/journal.pone.0041179	http://dx.doi.org/10.1371/journal.pone.0041179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815959	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900089
J	da Costa, BR; Rutjes, AWS; Mendy, A; Freund-Heritage, R; Vieira, ER				da Costa, Bruno Roza; Rutjes, Anne Wilhelmina Saskia; Mendy, Angelico; Freund-Heritage, Rosalie; Vieira, Edgar Ramos			Can Falls Risk Prediction Tools Correctly Identify Fall-Prone Elderly Rehabilitation Inpatients? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HOSPITALS; STRATIFY	Background: Falls of elderly people may cause permanent disability or death. Particularly susceptible are elderly patients in rehabilitation hospitals. We systematically reviewed the literature to identify falls prediction tools available for assessing elderly inpatients in rehabilitation hospitals. Methods and Findings: We searched six electronic databases using comprehensive search strategies developed for each database. Estimates of sensitivity and specificity were plotted in ROC space graphs and pooled across studies. Our search identified three studies which assessed the prediction properties of falls prediction tools in a total of 754 elderly inpatients in rehabilitation hospitals. Only the STRATIFY tool was assessed in all three studies; the other identified tools (PJC-FRAT and DOWNTON) were assessed by a single study. For a STRATIFY cut-score of two, pooled sensitivity was 73% (95% CI 63 to 81%) and pooled specificity was 42% (95% CI 34 to 51%). An indirect comparison of the tools across studies indicated that the DOWNTON tool has the highest sensitivity (92%), while the PJC-FRAT offers the best balance between sensitivity and specificity (73% and 75%, respectively). All studies presented major methodological limitations. Conclusions: We did not identify any tool which had an optimal balance between sensitivity and specificity, or which were clearly better than a simple clinical judgment of risk of falling. The limited number of identified studies with major methodological limitations impairs sound conclusions on the usefulness of falls risk prediction tools in geriatric rehabilitation hospitals.	[da Costa, Bruno Roza; Rutjes, Anne Wilhelmina Saskia] Univ Bern, Inst Social & Prevent Med, Div Clin Epidemiol & Biostat, Bern, Switzerland; [Mendy, Angelico] Florida Int Univ, Dept Epidemiol & Biostat, Robert Stempel Sch Publ Hlth, Miami, FL 33199 USA; [Freund-Heritage, Rosalie; Vieira, Edgar Ramos] Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Vieira, Edgar Ramos] Florida Int Univ, Dept Phys Therapy, Miami, FL 33199 USA	University of Bern; State University System of Florida; Florida International University; State University System of Florida; Florida International University	da Costa, BR (corresponding author), Univ Bern, Inst Social & Prevent Med, Div Clin Epidemiol & Biostat, Bern, Switzerland.	evieira@fiu.edu	Rutjes, Anne/L-8750-2017; Vieira, Edgar Ramos/I-7609-2013	Rutjes, Anne/0000-0001-9782-779X; Vieira, Edgar Ramos/0000-0002-1011-5077; Mendy, Angelico/0000-0002-8227-6830	Alberta Health Services; College of Nursing and Health Sciences, Florida International University, Miami	Alberta Health Services; College of Nursing and Health Sciences, Florida International University, Miami	This work was supported by the Alberta Health Services. Funding for publishing this paper was provided by the College of Nursing and Health Sciences, Florida International University, Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Centers for Disease Control and Prevention, 2007, PREV FALLS OLD AD; Coker E, 2003, OUTCOMES MANAG, V7, P15; Coker Esther, 2003, Outcomes Manag, V7, P8; Evans D., 1998, FALLS ACUTE HOSP SYS; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; Haines TP, 2006, J CLIN EPIDEMIOL, V59, P168, DOI 10.1016/j.jclinepi.2005.07.017; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Healey F, 2008, QUAL SAF HEALTH CARE, V17, P424, DOI 10.1136/qshc.2007.024695; Higgins J., 2009, COCHRANE HDB SYSTEMA; Macaskill P, 2010, COCHRANE HDB SYSTEMA; Morse JM, 2006, CAN J NURS RES, V38, P74; National Patient Safety Agency, 2007, SLIPS TRIPS FALLS HO; Oliver D, 1997, BMJ-BRIT MED J, V315, P1049, DOI 10.1136/bmj.315.7115.1049; Oliver D, 2008, AGE AGEING, V37, P621, DOI 10.1093/ageing/afn203; Oliver D, 2006, CAN J NURS RES, V38, P89; PHAC-Public Health Agency of Canada. Division of Aging and Seniors, 2005, REP SEN FALLS CAN; Rousseau P, 1993, Arch Fam Med, V2, P169, DOI 10.1001/archfami.2.2.169; Rousseau P, 1993, ARCH FAM MED, V2, P166; Saverino A, 2006, Eura Medicophys, V42, P179; UDEN G, 1985, J AM GERIATR SOC, V33, P833, DOI 10.1111/j.1532-5415.1985.tb05435.x; Vassallo M, 2003, AGE AGEING, V32, P338, DOI 10.1093/ageing/32.3.338; Vassallo M, 2008, AGE AGEING, V37, P277, DOI 10.1093/ageing/afn062; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; Vieira ER, 2011, CLIN REHABIL, V25, P788, DOI 10.1177/0269215511400639; VLAHOV D, 1990, ARCH PHYS MED REHAB, V71, P8	28	63	65	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41061	10.1371/journal.pone.0041061	http://dx.doi.org/10.1371/journal.pone.0041061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815914	gold, Green Published			2022-12-27	WOS:000306507000060
J	Engelmann, JC; Spang, R				Engelmann, Julia C.; Spang, Rainer			A Least Angle Regression Model for the Prediction of Canonical and Non-Canonical miRNA-mRNA Interactions	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; TARGET RECOGNITION; MECHANISMS; GENE; IDENTIFICATION; REPRESSION	microRNAs (miRNAs) are short non-coding RNAs with regulatory functions in various biological processes including cell differentiation, development and oncogenic transformation. They can bind to mRNA transcripts of protein-coding genes and repress their translation or lead to mRNA degradation. Conversely, the transcription of miRNAs is regulated by proteins including transcription factors, co-factors, and messenger molecules in signaling pathways, yielding a bidirectional regulatory network of gene and miRNA expression. We describe here a least angle regression approach for uncovering the functional interplay of gene and miRNA regulation based on paired gene and miRNA expression profiles. First, we show that gene expression profiles can indeed be reconstructed from the expression profiles of miRNAs predicted to be regulating the specific gene. Second, we propose a two-step model where in the first step, sequence information is used to constrain the possible set of regulating miRNAs and in the second step, this constraint is relaxed to find regulating miRNAs that do not rely on perfect seed binding. Finally, a bidirectional network comprised of miRNAs regulating genes and genes regulating miRNAs is built from our previous regulatory predictions. After applying the method to a human cancer cell line data set, an analysis of the underlying network reveals miRNAs known to be associated with cancer when dysregulated are predictors of genes with functions in apoptosis. Among the predicted and newly identified targets that lack a classical miRNA seed binding site of a specific oncomir, miR-19b-1, we found an over-representation of genes with functions in apoptosis, which is in accordance with the previous finding that this miRNA is the key oncogenic factor in the mir-17-92 cluster. In addition, we found genes involved in DNA recombination and repair that underline its importance in maintaining the integrity of the cell.	[Engelmann, Julia C.; Spang, Rainer] Univ Regensburg, Dept Stat Bioinformat, Inst Funct Genom, Regensburg, Germany	University of Regensburg	Engelmann, JC (corresponding author), Univ Regensburg, Dept Stat Bioinformat, Inst Funct Genom, Regensburg, Germany.	julia.engelmann@ur.de	Engelmann, Julia Catherine/AAF-5049-2021	Engelmann, Julia Catherine/0000-0002-4160-5474; Spang, Rainer/0000-0002-1326-4297	Bavarian Genome Network BAYGENE	Bavarian Genome Network BAYGENE	This work was funded by the Bavarian Genome Network BAYGENE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brambillasca F, 1999, LEUKEMIA, V13, P369, DOI 10.1038/sj.leu.2401338; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dugan KA, 2002, ONCOGENE, V21, P5835, DOI 10.1038/sj.onc.1205763; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elefant N, 2011, BIOINFORMATICS, V27, P3093, DOI 10.1093/bioinformatics/btr534; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HASTIE T, 2007, LARS LEAST ANGLE REG; Huang J C, 2008, Pac Symp Biocomput, P52; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; R Core Team, 2020, R LANG ENV STAT COMP; Radfar MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019312; Ritchie W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000513; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Slawski M, 2009, UNIFIED TRISERVICES; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stanhope SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000516; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218	52	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40634	10.1371/journal.pone.0040634	http://dx.doi.org/10.1371/journal.pone.0040634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815777	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000021
J	Hammerschmidt, K; Radyushkin, K; Ehrenreich, H; Fischer, J				Hammerschmidt, Kurt; Radyushkin, Konstantin; Ehrenreich, Hannelore; Fischer, Julia			The Structure and Usage of Female and Male Mouse Ultrasonic Vocalizations Reveal only Minor Differences	PLOS ONE			English	Article							MICE MUS-MUSCULUS; COMMUNICATION; SONGS; CALLS; EXPERIENCE; DISORDERS; EVOLUTION; MODELS; AUTISM; INDEX	Ultrasonic vocalizations (USV) of mice are increasingly recognized as informative dependent variables in studies using mouse models of human diseases. While pup vocalizations primarily serve to re-establish contact with the mother, adult male "songs" were considered to be courtship signals. Alternatively, mouse USVs may generally function as territorial signals. To distinguish between these two hypotheses, we compared the structure and usage of adult male and female USVs in staged resident-intruder encounters. If calls function primarily as courtship signals, males should respond stronger than females, specifically when presented with a female intruder. Refuting this hypothesis, we found that in response to female intruders, females called more than males (228 +/- 32 calls/min vs. 71 +/- 15 calls/min), and males called more to female than to male intruders (14 +/- 7.5 calls/min). There were no significant differences in the acoustic characteristics of the calls given by females and males. To control for the influence of the intruder's behavior on calling, we repeated the experiments using anaesthetized intruders. Again, females produced more calls to female than male intruders (173 +/- 17 calls/min vs. 71 +/- 15 calls/min), while males called more in response to female than male intruders (39 +/- 17 calls/min), and there were no acoustic differences in female and male calls. The vocal activity did not differ significantly with regard to intruder state (awake or anaesthetized), while the acoustic structure exhibited significant differences. Taken together, our findings support the view that calls do not mainly function as courtship signals, although they might serve both a territorial (sex-independent) and a courtship function. The comparison of responses to awake vs. anaesthetized intruders suggests that the latter are sufficient to elicit vocal activity. The subtle acoustic differences, however, indicate that the subject differentiates between intruder states.	[Hammerschmidt, Kurt; Fischer, Julia] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Radyushkin, Konstantin; Ehrenreich, Hannelore] Max Planck Inst Expt Med, Div Clin Neurosci, D-37075 Gottingen, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Mouse Behav Outcome Unit, Mainz, Germany	Deutsches Primatenzentrum (DPZ); Max Planck Society; Johannes Gutenberg University of Mainz	Hammerschmidt, K (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	hammerschmidt@cog-ethol.de	Fischer, Julia/B-6674-2008	Fischer, Julia/0000-0002-5807-0074; Ehrenreich, Hannelore/0000-0001-8371-5711				Briggs JR, 2011, ANIM BEHAV, V82, P1263, DOI 10.1016/j.anbehav.2011.09.003; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; D'Amato FR, 2001, BEHAV NEUROSCI, V115, P834, DOI 10.1037//0735-7044.115.4.834; DIZINNO G, 1978, BEHAV BIOL, V22, P104, DOI 10.1016/S0091-6773(78)92094-1; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Guo ZS, 2007, CHEM SENSES, V32, P463, DOI 10.1093/chemse/bjm015; Hahn EM, 2005, BEHAV GENET, V32, P267; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; NUNEZ AA, 1984, PHYSIOL BEHAV, V32, P717, DOI 10.1016/0031-9384(84)90184-7; NYBY J, 1976, BEHAV BIOL, V18, P285, DOI 10.1016/S0091-6773(76)92198-2; Nyby J, 1977, ANIM BEHAV, V25, P3; Nyby JG, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P3; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; SALES G D, 1972, Journal of Zoology (London), V168, P149; SALES GD, 1978, DEV PSYCHOBIOL, V11, P595, DOI 10.1002/dev.420110609; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Shepard KN, 2011, GENES BRAIN BEHAV, V10, P28, DOI 10.1111/j.1601-183X.2010.00580.x	34	83	85	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41133	10.1371/journal.pone.0041133	http://dx.doi.org/10.1371/journal.pone.0041133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815941	gold, Green Published			2022-12-27	WOS:000306507000072
J	Williams, AS; Kasahara, DI; Verbout, NG; Fedulov, AV; Zhu, M; Si, HQ; Wurmbrand, AP; Hug, C; Ranscht, B; Shore, SA				Williams, Alison S.; Kasahara, David I.; Verbout, Norah G.; Fedulov, Alexey V.; Zhu, Ming; Si, Huiqing; Wurmbrand, Allison P.; Hug, Christopher; Ranscht, Barbara; Shore, Stephanie A.			Role of the Adiponectin Binding Protein, T-Cadherin (Cdh13), in Allergic Airways Responses in Mice	PLOS ONE			English	Article							BODY-MASS INDEX; TARGETED DISRUPTION; DEFICIENT MICE; IN-VITRO; ASTHMA; INFLAMMATION; ASSOCIATION; OBESITY; HYPERRESPONSIVENESS; RISK	Adiponectin is an adipose derived hormone that declines in obesity. We have previously shown that exogenous administration of adiponectin reduces allergic airways responses in mice. T-cadherin (T-cad; Cdh13) is a binding protein for the high molecular weight isoforms of adiponectin. To determine whether the beneficial effects of adiponectin on allergic airways responses require T-cad, we sensitized wildtype (WT), T-cadherin deficient (T-cad(-/-)) and adiponectin and T-cad bideficient mice to ovalbumin (OVA) and challenged the mice with aerosolized OVA or PBS. Compared to WT, T-cad(-/-) mice were protected against OVA-induced airway hyperresponsiveness, increases in BAL inflammatory cells, and induction of IL-13, IL-17, and eotaxin expression. Histological analysis of the lungs of OVA-challenged T-cad(-/-) versus WT mice indicated reduced inflammation around the airways, and reduced mucous cell hyperplasia. Combined adiponectin and T-cad deficiency reversed the effects of T-cad deficiency alone, indicating that the observed effects of T-cad deficiency require adiponectin. Compared to WT, serum adiponectin was markedly increased in T-cad(-/-) mice, likely because adiponectin that is normally sequestered by endothelial T-cad remains free in the circulation. In conclusion, T-cad does not mediate the protective effects of adiponectin. Instead, mice lacking T-cad have reduced allergic airways disease, likely because elevated serum adiponectin levels act on other adiponectin signaling pathways.	[Williams, Alison S.; Kasahara, David I.; Verbout, Norah G.; Zhu, Ming; Si, Huiqing; Wurmbrand, Allison P.; Shore, Stephanie A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA; [Ranscht, Barbara] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Hug, Christopher] Childrens Hosp, Boston, MA 02115 USA; [Fedulov, Alexey V.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Williams, AS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.	sshore@hsph.harvard.edu		Verbout, Norah/0000-0002-8170-9331	National Heart, Lung, and Blood Institute [HL-084044, HL102680]; National Institute of Environmental Health Sciences [ES-013307, ES-00002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084044, R21HL102680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES013307] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Heart, Lung, and Blood Institute grant HL-084044 and HL102680, National Institute of Environmental Health Sciences grants ES-013307 and ES-00002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Arif AA, 2003, EUR RESPIR J, V21, P827, DOI 10.1183/09031936.03.00054103a; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Fedulov AV, 2011, AM J RESP CELL MOL, V44, P285, DOI 10.1165/rcmb.2009-0400OC; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Folco EJ, 2009, J BIOL CHEM     1224; Gove ME, 2009, CYTOKINE, V47, P119, DOI 10.1016/j.cyto.2009.05.010; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ionescu LI, 2011, AM J RESP CELL MOL B; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Ivanov D, 2004, EXP CELL RES, V293, P207, DOI 10.1016/j.yexcr.2003.09.030; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Johnston RA, 2010, J APPL PHYSL; Joshi MB, 2005, FASEB J; Kasahara DI, 2012, J IMMUNOL, V188, P4558, DOI 10.4049/jimmunol.1102363; Kim S, 2003, ANN EPIDEMIOL, V13, P666, DOI 10.1016/S1047-2797(03)00054-1; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Litonjua AA, 2002, THORAX, V57, P581, DOI 10.1136/thorax.57.7.581; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Maillet I, 2011, AM J RESP CELL MOL, V45, P731, DOI 10.1165/rcmb.2010-0512OC; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Matsuzawa Y, 2005, ATHEROSCLEROSIS SUPP, V6, P7, DOI 10.1016/j.atherosclerosissup.2005.02.003; Medoff BD, 2009, AM J RESP CELL MOL B; Miller M, 2010, AM J PHYSIOL-LUNG C, V299, pL834, DOI 10.1152/ajplung.00326.2009; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Pillow JJ, 2001, J APPL PHYSIOL, V91, P2730, DOI 10.1152/jappl.2001.91.6.2730; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Sood A, 2008, THORAX, V63, P877, DOI 10.1136/thx.2007.090803; Summer R, 2008, AM J PHYSIOL-LUNG C, V294, pL1035, DOI 10.1152/ajplung.00397.2007; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Takeuchi T, 2001, VIRCHOWS ARCH, V438, P370, DOI 10.1007/s004280000385; Tian L, 2011, ATHEROSCLEROSIS; Tian L, 2009, ATHEROSCLEROSIS, V202, P152, DOI 10.1016/j.atherosclerosis.2008.04.011; Tomioka S, 2002, J APPL PHYSIOL, V93, P263, DOI 10.1152/japplphysiol.01129.2001; Tsang JYS, 2011, INT IMMUNOP IN PRESS; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Wang Y, 2005, J BIOL CHEM     1224; Wilk S, 2011, EUR J IMMUNOL, V41, P2323, DOI 10.1002/eji.201041349; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhu M, 2009, AM J RESP CELL MOL B; Zhu M, 2011, EUROPEAN RESP J	61	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41088	10.1371/journal.pone.0041088	http://dx.doi.org/10.1371/journal.pone.0041088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815927	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000064
J	Gallardo, CM; Gunapala, KM; King, OD; Steele, AD				Gallardo, Christian M.; Gunapala, Keith M.; King, Oliver D.; Steele, Andrew D.			Daily Scheduled High Fat Meals Moderately Entrain Behavioral Anticipatory Activity, Body Temperature, and Hypothalamic c-Fos Activation	PLOS ONE			English	Article							AMYLOID-PRECURSOR PROTEIN; CIRCADIAN-RHYTHMS; PALATABLE MEAL; FEEDING SCHEDULES; LIMBIC FOREBRAIN; PERIOD2 PROTEIN; FOOD; RATS; EXPRESSION; MICE	When fed in restricted amounts, rodents show robust activity in the hours preceding expected meal delivery. This process, termed food anticipatory activity (FAA), is independent of the light-entrained clock, the suprachiasmatic nucleus, yet beyond this basic observation there is little agreement on the neuronal underpinnings of FAA. One complication in studying FAA using a calorie restriction model is that much of the brain is activated in response to this strong hunger signal. Thus, daily timed access to palatable meals in the presence of continuous access to standard chow has been employed as a model to study FAA in rats. In order to exploit the extensive genetic resources available in the murine system we extended this model to mice, which will anticipate rodent high fat diet but not chocolate or other sweet daily meals (Hsu, Patton, Mistlberger, and Steele; 2010, PLoS ONE e12903). In this study we test additional fatty meals, including peanut butter and cheese, both of which induced modest FAA. Measurement of core body temperature revealed a moderate preprandial increase in temperature in mice fed high fat diet but entrainment due to handling complicated interpretation of these results. Finally, we examined activation patterns of neurons by immunostaining for the immediate early gene c-Fos and observed a modest amount of entrainment of gene expression in the hypothalamus of mice fed a daily fatty palatable meal.	[Gallardo, Christian M.; Gunapala, Keith M.; Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [King, Oliver D.] Boston Biomed Res Inst, Watertown, MA USA	California Institute of Technology; Boston Biomedical Research Institute	Gallardo, CM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	steelea@caltech.edu		Gallardo, Christian/0000-0001-5702-0852	Klarman Family Foundation	Klarman Family Foundation	Funding was provided by the Broad Fellows Program in Brain Circuitry at Caltech, an Ellison Medical Foundation New Scholar Award, and a Grants Program in Eating Disorders Research from the Klarman Family Foundation to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Angeles-Castellanos M, 2005, AM J PHYSIOL-REG I, V288, pR678, DOI 10.1152/ajpregu.00590.2004; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; BOLLES RC, 1974, BEHAV BIOL, V11, P365, DOI 10.1016/S0091-6773(74)90633-6; BOLLES RC, 1969, PHYSIOL BEHAV, V4, P87, DOI 10.1016/0031-9384(69)90018-3; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Minana-Solis MD, 2011, NUTR NEUROSCI, V14, P72, DOI 10.1179/1476830511Y.0000000003; EIKELBOOM R, 1986, PHYSIOL BEHAV, V37, P649, DOI 10.1016/0031-9384(86)90299-4; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Escobar C, 2011, PHYSIOL BEHAV, V104, P555, DOI 10.1016/j.physbeh.2011.05.001; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Gunapala KM, 2010, PRION, V4, P302, DOI 10.4161/pri.4.4.13721; Hsu CT, 2010, PLOS ONE IN PRESS; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Kalueff AV, 2005, BEHAV BRAIN RES, V160, P1, DOI 10.1016/j.bbr.2004.11.010; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; Merkestein M, 2012, OBESITY, V20, P963, DOI 10.1038/oby.2011.389; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; MISTLBERGER RE, 1992, BEHAV NEUROSCI, V106, P192, DOI 10.1037/0735-7044.106.1.192; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mohawk JA, 2011, TRENDS NEUROSCI; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Steele AD, 2008, P NATL ACAD SCI USA, V105, P13626, DOI 10.1073/pnas.0806319105; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Wolfer DP, 1997, BRAIN RES, V771, P1, DOI 10.1016/S0006-8993(97)00673-2	43	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41161	10.1371/journal.pone.0041161	http://dx.doi.org/10.1371/journal.pone.0041161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815954	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000306466100124
J	Hlavaty, J; Petznek, H; Holzmuller, H; Url, A; Jandl, G; Berger, A; Salmons, B; Gunzburg, WH; Renner, M				Hlavaty, Juraj; Petznek, Helga; Holzmueller, Harry; Url, Angelika; Jandl, Gerrit; Berger, Andre; Salmons, Brian; Guenzburg, Walter H.; Renner, Matthias			Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer	PLOS ONE			English	Article							ENCAPSULATED CELLS; ORTHOTOPIC MODEL; STELLATE CELL; MOUSE MODELS; K-RAS; IFOSFAMIDE; CARCINOMA; CHEMOTHERAPY; GEMCITABINE; ADENOCARCINOMA	Background: Gene-directed enzyme prodrug therapy (GDEPT) is a two-step treatment protocol for solid tumors that involves the transfer of a gene encoding a prodrug-activating enzyme followed by administration of the inactive prodrug that is subsequently activated by the enzyme to its tumor toxic form. However, the establishment of such novel treatment regimes to combat pancreatic cancer requires defined and robust animal model systems. Methods: Here, we comprehensively compared six human pancreatic cancer cell lines (PaCa-44, PANC-1, MIA PaCa-2, Hs-766T, Capan-2, and BxPc-3) in subcutaneous and orthotopical mouse models as well as in their susceptibility to different GDEPTs. Results: Tumor uptake was 83% to 100% in the subcutaneous model and 60% to 100% in the orthotopical mouse model, except for Hs-766T cells, which did not grow orthotopically. Pathohistological analyses of the orthotopical models revealed an infiltrative growth of almost all tumors into the pancreas; however, the different cell lines gave rise to tumors with different morphological characteristics. All of the resultant tumors were positive for MUC-1 staining indicating their origin from glandular or ductal epithelium, but revealed scattered pan-cytokeratin staining. Transfer of the cytochrome P450 and cytosine deaminase suicide gene, respectively, into the pancreatic cancer cell lines using retroviral vector technology revealed high level infectibility of these cell lines and allowed the analysis of the sensitivity of these cells to the chemotherapeutic drugs ifosfamide and 5-fluorocytosine, respectively. Conclusion: These data qualify the cell lines as part of valuable in vitro and in vivo models for the use in defined preclinical studies for pancreas tumor therapy.	[Hlavaty, Juraj; Petznek, Helga; Holzmueller, Harry; Jandl, Gerrit; Guenzburg, Walter H.; Renner, Matthias] Univ Vet Med, Dept Pathobiol, Inst Virol, Vienna, Austria; [Hlavaty, Juraj] Christian Doppler Lab Innovat Immunotherapy, Vienna, Austria; [Url, Angelika] Univ Vet Med, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria; [Berger, Andre; Renner, Matthias] Paul Ehrlich Inst, Div Med Biotechnol, D-6070 Langen, Germany; [Salmons, Brian; Guenzburg, Walter H.] Austrianova Singapore Pte Ltd, Singapore, Singapore	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Paul Ehrlich Institute	Hlavaty, J (corresponding author), Univ Vet Med, Dept Pathobiol, Inst Virol, Vienna, Austria.	Matthias.Renner@pei.de	Salmons, Brian/E-3001-2010; Hlavaty, Juraj/J-8735-2019; Gunzburg, Walter/ABI-6076-2020	Salmons, Brian/0000-0002-9490-9447; Hlavaty, Juraj/0000-0003-3050-5176; Gunzburg, Walter/0000-0001-8907-1021	Austrian Industrial Research Promotion Fund program; Christian Doppler Laboratory for Gene Therapeutic Vector Development	Austrian Industrial Research Promotion Fund program; Christian Doppler Laboratory for Gene Therapeutic Vector Development	This work was financed in part by The Austrian Industrial Research Promotion Fund program as well as by the Christian Doppler Laboratory for Gene Therapeutic Vector Development. The funders had no role in in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCK ER, 1972, ANTIMICROB AGENTS CH, V1, P476, DOI 10.1128/AAC.1.6.476; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Breslin TM, 2001, ANN SURG ONCOL, V8, P123, DOI 10.1007/s10434-001-0123-4; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cascinu S, 1999, BRIT J CANCER, V80, P1595, DOI 10.1038/sj.bjc.6690568; CERNY T, 1991, J CANCER RES CLIN, V117, pS135, DOI 10.1007/BF01613218; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Ding YZ, 2010, PANCREAS, V39, P283, DOI 10.1097/MPA.0b013e3181c15619; EINHORN LH, 1986, CANCER CHEMOTH PHARM, V18, pS51, DOI 10.1007/BF00647452; GADELMAWLA N, 1986, CANCER CHEMOTH PHARM, V18, pS55, DOI 10.1007/BF00647453; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gunzburg WH, 2002, EXPERT OPIN INV DRUG, V11, P1; Hamilton SR, 2000, WHO CLASSIFICATION T, P221; Hess V, 2003, J CLIN ONCOL, V21, P66, DOI 10.1200/JCO.2003.04.029; Hlavaty J, 2004, VIROLOGY, V330, P351, DOI 10.1016/j.virol.2004.09.012; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karle P, 1998, ADV EXP MED BIOL, V451, P97; Katz MH, 2004, CLIN EXP METASTAS, V21, P7, DOI 10.1023/B:CLIN.0000017160.93812.3b; KEIZER HJ, 1995, J CANCER RES CLIN, V121, P297, DOI 10.1007/BF01209597; KYRIAZIS AA, 1986, CANCER RES, V46, P5810; Leach SD, 2004, CANCER CELL, V5, P7, DOI 10.1016/S1535-6108(03)00337-4; Levi F, 2003, PANCREAS, V27, P139, DOI 10.1097/00006676-200308000-00006; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lockhart AC, 2005, GASTROENTEROLOGY, V128, P1642, DOI 10.1053/j.gastro.2005.03.039; Lohr M, 1998, GENE THER, V5, P1070, DOI 10.1038/sj.gt.3300671; Lohr M, 2001, LANCET, V357, P1591, DOI 10.1016/S0140-6736(00)04749-8; LOHR M, 1994, BRIT J CANCER, V69, P144, DOI 10.1038/bjc.1994.24; Lohr M, 2003, CANC THER, V1, P121; Macdonald JS, 2004, CANCER CHEMOTH PHARM, V54, pS4, DOI 10.1007/s00280-004-0880-4; Mohammad RM, 1998, CLIN CANCER RES, V4, P887; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Owens RB, 1976, J NATL CANCER I, V56, P483; Oya Natsuo, 2004, Int J Clin Oncol, V9, P451, DOI 10.1007/s10147-004-0449-6; Pambalk K, 2002, BIOCHEM BIOPH RES CO, V293, P239, DOI 10.1016/S0006-291X(02)00207-3; Portsmouth D, 2007, MOL ASPECTS MED, V28, P4, DOI 10.1016/j.mam.2006.12.001; Regiba S, 2009, NEOPLASIA, V11, P637, DOI 10.1593/neo.81686; Salek C, 2007, WORLD J GASTROENTERO, V13, P3714; Salmons B, 2010, CURR OPIN MOL THER, V12, P450; Solcia E, 1995, ATLAS TUMOR PATHOL, P64; Summers KK, 1997, J ANTIMICROB CHEMOTH, V40, P753, DOI 10.1093/jac/40.6.753; Tai CK, 2008, FRONT BIOSCI-LANDMRK, V13, P3083, DOI 10.2741/2910; Tamada K, 2005, WORLD J SURG, V29, P325, DOI 10.1007/s00268-004-7821-6; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118	50	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40611	10.1371/journal.pone.0040611	http://dx.doi.org/10.1371/journal.pone.0040611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815775	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100046
J	Poirel, N; Borst, G; Simon, G; Rossi, S; Cassotti, M; Pineau, A; Houde, O				Poirel, Nicolas; Borst, Gregoire; Simon, Gregory; Rossi, Sandrine; Cassotti, Mathieu; Pineau, Arlette; Houde, Olivier			Number Conservation is Related to Children's Prefrontal Inhibitory Control: An fMRI Study of a Piagetian Task	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; EXECUTIVE FUNCTIONS; UNIQUE COMPONENTS; YOUNG-ADULTS; COMMON; NUMEROSITY; MAGNITUDE; METAANALYSIS; PRESCHOOL; MEMORY	Although young children can accurately determine that two rows contain the same number of coins when they are placed in a one-to-one correspondence, children younger than 7 years of age erroneously think that the longer row contains more coins when the coins in one of the rows are spread apart. To demonstrate that prefrontal inhibitory control is necessary to succeed at this task (Piaget's conservation-of-number task), we studied the relationship between the percentage of BOLD signal changes in the brain areas activated in this developmental task and behavioral performance on a Stroop task and a Backward Digit Span task. The level of activation in the right insula/inferior frontal gyrus was selectively related to inhibitory control efficiency (i.e., the Stroop task), whereas the activation in the left intraparietal sulcus (IPS) was selectively related to the ability to manipulate numerical information in working memory (i.e., the Backward Digit Span task). Taken together, the results indicate that to acquire number conservation, children's brains must not only activate the reversibility of cognitive operations (supported by the IPS) but also inhibit a misleading length-equal-number strategy (supported by the right insula/inferior frontal gyrus).	[Poirel, Nicolas; Borst, Gregoire; Simon, Gregory; Rossi, Sandrine; Cassotti, Mathieu; Pineau, Arlette; Houde, Olivier] Univ Paris 05, LaPsyDE, Unite CNRS 3521, Paris, France; [Poirel, Nicolas; Borst, Gregoire; Simon, Gregory; Rossi, Sandrine; Cassotti, Mathieu; Pineau, Arlette; Houde, Olivier] Univ Caen, LaPsyDE, Unite CNRS 3521, F-14032 Caen, France; [Poirel, Nicolas; Houde, Olivier] IUF, Paris, France; [Cassotti, Mathieu] Mines ParisTech, Ctr Gest Sci, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Poirel, N (corresponding author), Univ Paris 05, LaPsyDE, Unite CNRS 3521, Paris, France.	nicolas.poirel@parisdescartes.fr	simon, gregory/B-7275-2008; Rossi, Sandrine/B-8667-2008	simon, gregory/0000-0001-6506-9349; Rossi, Sandrine/0000-0001-9285-2152; Garbui, Maria Cristina/0000-0003-2100-9461; Poirel, Nicolas/0000-0002-3972-2575; Cassotti, Mathieu/0000-0003-4837-4442				Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Beratis IN, 2010, LATERALITY, V15, P597, DOI 10.1080/13576500903071104; Daurignac E, 2006, J COGNITIVE NEUROSCI, V18, P730, DOI 10.1162/jocn.2006.18.5.730; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; de Hevia MD, 2006, EXP BRAIN RES, V168, P254, DOI 10.1007/s00221-005-0084-0; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Dehaene Stanislas, 2011, SPACE TIME NUMBER BR; Dempster Frank N., 1995, P3, DOI 10.1016/B978-012208930-5/50002-7; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Dormal V, 2010, NEUROIMAGE, V52, P1677, DOI 10.1016/j.neuroimage.2010.04.254; Dormal V, 2009, HUM BRAIN MAPP, V30, P2466, DOI 10.1002/hbm.20677; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Ganis G., 2006, CASE MENTAL IMAGERY; Goldberg MC, 2011, DEV COGN NEUROS-NETH, V1, P47, DOI 10.1016/j.dcn.2010.07.002; Houde O, 2000, COGNITIVE DEV, V15, P63, DOI 10.1016/S0885-2014(00)00015-0; Houde O, 2001, DEVELOPMENTAL SCI, V4, P119, DOI 10.1111/1467-7687.00156; Houde O, 2011, J EXP CHILD PSYCHOL, V110, P332, DOI 10.1016/j.jecp.2011.04.008; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Kawashima R, 2004, COGNITIVE BRAIN RES, V18, P227, DOI 10.1016/j.cogbrainres.2003.10.009; Leroux G, 2006, HUM BRAIN MAPP, V27, P498, DOI 10.1002/hbm.20194; Leroux G, 2009, DEVELOPMENTAL SCI, V12, P326, DOI 10.1111/j.1467-7687.2008.00785.x; Lourenco SF, 2011, ATTENTION PERFORM, P225, DOI 10.1016/B978-0-12-385948-8.00015-3; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Piaget J, 1984, HDB CHILD PSYCHOL; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Ping RM, 2008, DEV PSYCHOL, V44, P1277, DOI 10.1037/0012-1649.44.5.1277; Poirel N, 2011, EXP PSYCHOL, V58, P142, DOI 10.1027/1618-3169/a000079; Strang NM, 2011, DEV COGN NEUROS-NETH, V1, P560, DOI 10.1016/j.dcn.2011.06.006; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wechsler D, 1974, WECHSLER INTELLIGENC; Wright I, 2003, J CHILD PSYCHOL PSYC, V44, P561, DOI 10.1111/1469-7610.00145; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zhang Q, 2008, NEUROSCI LETT, V431, P17, DOI 10.1016/j.neulet.2007.11.011	39	23	23	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40802	10.1371/journal.pone.0040802	http://dx.doi.org/10.1371/journal.pone.0040802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815825	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100070
J	Sassoli, C; Pini, A; Chellini, F; Mazzanti, B; Nistri, S; Nosi, D; Saccardi, R; Quercioli, F; Zecchi-Orlandini, S; Formigli, L				Sassoli, Chiara; Pini, Alessandro; Chellini, Flaminia; Mazzanti, Benedetta; Nistri, Silvia; Nosi, Daniele; Saccardi, Riccardo; Quercioli, Franco; Zecchi-Orlandini, Sandra; Formigli, Lucia			Bone Marrow Mesenchymal Stromal Cells Stimulate Skeletal Myoblast Proliferation through the Paracrine Release of VEGF	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MUSCLE SATELLITE CELLS; STEM-CELLS; MYOCARDIAL-INFARCTION; REGENERATION; EXPRESSION; REPAIR; MICE; ANGIOGENESIS; ENGRAFTMENT	Mesenchymal stromal cells (MSCs) are the leading cell candidates in the field of regenerative medicine. These cells have also been successfully used to improve skeletal muscle repair/regeneration; however, the mechanisms responsible for their beneficial effects remain to be clarified. On this basis, in the present study, we evaluated in a co-culture system, the ability of bone-marrow MSCs to influence C2C12 myoblast behavior and analyzed the cross-talk between the two cell types at the cellular and molecular level. We found that myoblast proliferation was greatly enhanced in the co-culture as judged by time lapse videomicroscopy, cyclin A expression and EdU incorporation. Moreover, myoblasts immunomagnetically separated from MSCs after co-culture expressed higher mRNA and protein levels of Notch-1, a key determinant of myoblast activation and proliferation, as compared with the single culture. Notch-1 intracellular domain and nuclear localization of Hes-1, a Notch-1 target gene, were also increased in the co-culture. Interestingly, the myoblastic response was mainly dependent on the paracrine release of vascular endothelial growth factor (VEGF) by MSCs. Indeed, the addition of MSC-derived conditioned medium (CM) to C2C12 cells yielded similar results as those observed in the co-culture and increased the phosphorylation and expression levels of VEGFR. The treatment with the selective pharmacological VEGFR inhibitor, KRN633, resulted in a marked attenuation of the receptor activation and concomitantly inhibited the effects of MSC-CM on C2C12 cell growth and Notch-1 signaling. In conclusion, this study provides novel evidence for a role of MSCs in stimulating myoblast cell proliferation and suggests that the functional interaction between the two cell types may be exploited for the development of new and more efficient cell-based skeletal muscle repair strategies.	[Sassoli, Chiara; Pini, Alessandro; Chellini, Flaminia; Nistri, Silvia; Nosi, Daniele; Zecchi-Orlandini, Sandra; Formigli, Lucia] Univ Florence, Dept Human Anat Histol & Forens Med, Florence, Italy; [Mazzanti, Benedetta; Saccardi, Riccardo] Univ Florence, Careggi Hosp, Dept Hematol, Cord Blood Bank, Florence, Italy; [Quercioli, Franco] Natl Res Council CNR, Natl Inst Opt INO, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Sassoli, C (corresponding author), Univ Florence, Dept Human Anat Histol & Forens Med, Florence, Italy.	formigli@unifi.it	SASSOLI, CHIARA/AAC-4023-2019	SASSOLI, CHIARA/0000-0002-1337-0938; Pini, Alessandro/0000-0001-9828-2082; Saccardi, Riccardo/0000-0002-5763-5467; QUERCIOLI, FRANCO/0000-0002-7844-4686	University of Florence; Italian Ministry of University and Research (MIUR-PRIN)	University of Florence; Italian Ministry of University and Research (MIUR-PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by funds from the University of Florence (to LF, SZO, CS) and Italian Ministry of University and Research (MIUR-PRIN 2008 to SZO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2010, CELL CYCLE, V9, P892, DOI 10.4161/cc.9.5.10851; Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P164, DOI 10.1038/bmt.2011.81; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; de la Garza-Rodea AS, 2011, CELL TRANSPLANT, V20, P217, DOI 10.3727/096368910X522117; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Gang EJ, 2009, EXP CELL RES, V315, P2624, DOI 10.1016/j.yexcr.2009.05.009; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Herve MAJ, 2006, J ENDOCRINOL, V188, P91, DOI 10.1677/joe.1.06184; Hoffmann J, 2010, THORAC CARDIOV SURG, V58, P136, DOI 10.1055/s-0029-1240758; Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Kiec-Wilk B, 2010, J PHYSIOL PHARMACOL, V61, P217; Kuraitis D, 2010, CURR OPIN CARDIOL, V25, P575, DOI 10.1097/HCO.0b013e32833f0318; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lorenzi B, 2008, DIS COLON RECTUM, V51, P411, DOI 10.1007/s10350-007-9153-8; Manetti M, 2011, CIRC RES, V109, pE14, DOI 10.1161/CIRCRESAHA.111.242057; Mezey E, 2011, J CELL BIOCHEM, V112, P2683, DOI 10.1002/jcb.23216; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mounier R, 2010, EXP PHYSIOL, V95, P899, DOI 10.1113/expphysiol.2010.052928; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Parvaresh KC, 2010, EXP PHYSIOL, V95, P1098, DOI 10.1113/expphysiol.2010.053959; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Popescu LM, 2011, J CELL MOL MED, V15, P1379, DOI 10.1111/j.1582-4934.2011.01330.x; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7; Sassoli C, 2011, J CELL MOL MED, V15, P2498, DOI 10.1111/j.1582-4934.2010.01250.x; Sassoli C, 2011, J MOL CELL CARDIOL, V51, P399, DOI 10.1016/j.yjmcc.2011.06.004; Stemberger S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019808; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7	41	74	83	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e37512	10.1371/journal.pone.0037512	http://dx.doi.org/10.1371/journal.pone.0037512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815682	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100005
J	Scharinger, M; Bendixen, A; Trujillo-Barreto, NJ; Obleser, J				Scharinger, Mathias; Bendixen, Alexandra; Trujillo-Barreto, Nelson J.; Obleser, Jonas			A Sparse Neural Code for Some Speech Sounds but Not for Others	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; MEMORY TRACES; AUDITORY-CORTEX; MENTAL LEXICON; REPRESENTATIONS; RECOGNITION; PERCEPTION; WORDS; EEG; UNDERSPECIFICATION	The precise neural mechanisms underlying speech sound representations are still a matter of debate. Proponents of 'sparse representations' assume that on the level of speech sounds, only contrastive or otherwise not predictable information is stored in long-term memory. Here, in a passive oddball paradigm, we challenge the neural foundations of such a 'sparse' representation; we use words that differ only in their penultimate consonant ("coronal" [t] vs. "dorsal" [k] place of articulation) and for example distinguish between the German nouns Latz ([lats]; bib) and Lachs ([laks]; salmon). Changes from standard [t] to deviant [k] and vice versa elicited a discernible Mismatch Negativity (MMN) response. Crucially, however, the MMN for the deviant [lats] was stronger than the MMN for the deviant [laks]. Source localization showed this difference to be due to enhanced brain activity in right superior temporal cortex. These findings reflect a difference in phonological 'sparsity': Coronal [t] segments, but not dorsal [k] segments, are based on more sparse representations and elicit less specific neural predictions; sensory deviations from this prediction are more readily 'tolerated' and accordingly trigger weaker MMNs. The results foster the neurocomputational reality of 'representationally sparse' models of speech perception that are compatible with more general predictive mechanisms in auditory perception.	[Scharinger, Mathias; Obleser, Jonas] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany; [Bendixen, Alexandra] Univ Leipzig, Inst Psychol, Leipzig, Germany; [Trujillo-Barreto, Nelson J.] Cuban Neurosci Ctr, Havana, Cuba	Max Planck Society; Leipzig University	Scharinger, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany.	mscharinger@cbs.mpg.de	Bendixen, Alexandra/B-3922-2010; Obleser, Jonas/C-9891-2011; Trujillo-Barreto, Nelson J/G-3764-2013	Obleser, Jonas/0000-0002-7619-0459; Trujillo-Barreto, Nelson J/0000-0001-6581-7503; Bendixen, Alexandra/0000-0001-8211-9619	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	MS and JO are funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN O, 1993, BRAIN LANG, V44, P139, DOI 10.1006/brln.1993.1009; Alexandrov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022999; AULANKO R, 1993, NEUROREPORT, V4, P1356, DOI 10.1097/00001756-199309150-00018; Baayen H. R., 1995, CELEX LEXICAL DATABA; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Bendixen A, 2008, BIOL PSYCHOL, V78, P231, DOI 10.1016/j.biopsycho.2008.03.005; Bendixen A, 2008, NEUROIMAGE, V41, P1111, DOI 10.1016/j.neuroimage.2008.03.040; Bendixen A, 2013, CLIN NEUROPHYSIOL, V124, P928, DOI 10.1016/j.clinph.2012.11.012; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Boersma P., 2020, PRAAT DOING PHONETIC; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; CHATRIAN GE, 1988, J CLIN NEUROPHYSIOL, V5, P183, DOI 10.1097/00004691-198804000-00005; Cornell SA, 2011, BRAIN RES, V1394, P79, DOI 10.1016/j.brainres.2011.04.001; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P635, DOI 10.1162/089892900562390; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; EGAN JP, 1961, J ACOUST SOC AM, V33, P993, DOI 10.1121/1.1908935; Eisner F, 2006, J ACOUST SOC AM, V119, P1950, DOI 10.1121/1.2178721; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; EVANS AC, 1993, 3D STAT NEUROANATOMI, P1813; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Garrido MI, 2009, J NEUROPHYSIOL, V101, P2620, DOI 10.1152/jn.90291.2008; Green DM, 1966, SIGNAL DETECTION THE; Grimm S, 2007, RESTOR NEUROL NEUROS, V25, P241; Hawkins J, 2009, PHILOS T R SOC B, V364, P1203, DOI 10.1098/rstb.2008.0322; Hwang SOK, 2010, PHONOLOGY, V27, P205, DOI 10.1017/S0952675710000102; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jacobsen T, 2005, J COGNITIVE NEUROSCI, V17, P1704, DOI 10.1162/089892905774589262; Jacobsen T, 2004, BRAIN LANG, V88, P54, DOI 10.1016/S0093-934X(03)00156-1; Johnson Keith, 1997, TALKER VARIABILITY S, P145, DOI DOI 10.1017/S1366728914000790; Kilian-Hutten N, 2011, J NEUROSCI, V31, P1715, DOI 10.1523/JNEUROSCI.4572-10.2011; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; KRAUS N, 1992, EAR HEARING, V13, P158, DOI 10.1097/00003446-199206000-00004; Ladefoged Peter, 2001, COURSE PHONETICS; Lahiri A, 2002, PHONOL PHONET, V4-1, P637; Lahiri A, 2010, J PHONETICS, V38, P44, DOI 10.1016/j.wocn.2010.01.002; Li GP, 2012, INT J AUDIOL, V51, P75, DOI 10.3109/14992027.2011.625984; Macmillan NA, 2005, DETECTION THEORY USE; Mitterer H, 2011, J EXP PSYCHOL HUMAN, V37, P496, DOI 10.1037/a0020989; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Nousak JMK, 1996, COGNITIVE BRAIN RES, V4, P305, DOI 10.1016/S0926-6410(96)00068-7; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; Paavilainen P, 2007, NEUROREPORT, V18, P159, DOI 10.1097/WNR.0b013e328010e2ac; Peltola MS, 2003, NEUROSCI LETT, V352, P25, DOI 10.1016/j.neulet.2003.08.013; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peter V, 2010, NEUROSCI LETT, V482, P71, DOI 10.1016/j.neulet.2010.07.010; Pettigrew Catharine M, 2004, J Am Acad Audiol, V15, P47, DOI 10.3766/jaaa.15.1.6; Pettigrew CM, 2004, EAR HEARING, V25, P284, DOI 10.1097/01.AUD.0000130800.88987.03; Pierrehumbert J., 2001, FREQUENCY EFFECTS EM, P137, DOI DOI 10.1075/TSL.45.08PIE; PISONI DB, 1993, SPEECH COMMUN, V13, P109, DOI 10.1016/0167-6393(93)90063-Q; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Pulvermuller F, 2006, NEUROIMAGE, V31, P1297, DOI 10.1016/j.neuroimage.2006.01.030; Pulvermuller F, 2004, PSYCHOPHYSIOLOGY, V41, P106, DOI 10.1111/j.1469-8986.2003.00135.x; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Rivera-Gaxiola M, 2000, BEHAV BRAIN RES, V111, P13, DOI 10.1016/S0166-4328(00)00139-X; Rivera-Gaxiola M, 2000, BEHAV BRAIN RES, V112, P1, DOI 10.1016/S0166-4328(00)00218-7; SAMS M, 1984, PSYCHOPHYSIOLOGY, V21, P434, DOI 10.1111/j.1469-8986.1984.tb00223.x; Sams M, 1990, J Cogn Neurosci, V2, P344, DOI 10.1162/jocn.1990.2.4.344; Scharinger M, 2011, J LAB PHONOLOGY, V2, P99; Scharinger M, 2011, BRAIN LANG, V116, P71, DOI 10.1016/j.bandl.2010.11.002; Scharinger M, 2010, LANG SPEECH, V53, P245, DOI 10.1177/0023830909357154; Scharinger M, 2010, J NEUROLINGUIST, V23, P383, DOI 10.1016/j.jneuroling.2010.02.005; Schroger E, 2005, ACTA ACUST UNITED AC, V91, P490; Sharma A, 2000, J ACOUST SOC AM, V107, P2697, DOI 10.1121/1.428655; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Shtyrov Y, 2002, NEUROREPORT, V13, P521, DOI 10.1097/00001756-200203250-00033; Shtyrov Y, 2002, EUR J NEUROSCI, V15, P1085, DOI 10.1046/j.1460-9568.2002.01941.x; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Song JH, 2011, J COGNITIVE NEUROSCI, V23, P2268, DOI 10.1162/jocn.2010.21556; Srinivasan R., 2005, EVENT RELATED POTENT, P167; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Steriade Donca., 1995, HDB PHONOLOGICAL THE, P114, DOI 10.1111/b.9780631201267.1996.00006.x; Tampas JW, 2005, J SPEECH LANG HEAR R, V48, P1147, DOI 10.1044/1092-4388(2005/081); TENPENNY PL, 1995, PSYCHON B REV, V2, P339, DOI 10.3758/BF03210972; Tervaniemi M, 1999, NEUROIMAGE, V9, P330, DOI 10.1006/nimg.1999.0405; Thompson SandraA., 2001, FREQUENCY EMERGENCE, P27, DOI [10.1075/tsl.45.03tho, DOI 10.1075/TSL.45.03THO]; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Valdes-Sosa P, 2000, BIOMAG 96: PROCEEDINGS OF THE TENTH INTERNATIONAL CONFERENCE ON BIOMAGNETISM, VOLS I & II, P373; Wheeldon L, 2004, BRAIN LANG, V90, P401, DOI 10.1016/S0093-934X(03)00451-6; Winkler I, 1999, COGNITIVE BRAIN RES, V7, P357, DOI 10.1016/S0926-6410(98)00039-1; Winkler I, 1999, PSYCHOPHYSIOLOGY, V36, P638, DOI 10.1111/1469-8986.3650638; Winkler I, 1998, NEUROREPORT, V9, P3809, DOI 10.1097/00001756-199812010-00008; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	97	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40953	10.1371/journal.pone.0040953	http://dx.doi.org/10.1371/journal.pone.0040953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815876	Green Published, gold			2022-12-27	WOS:000306466100098
J	Uhlik, O; Wald, J; Strejcek, M; Musilova, L; Ridl, J; Hroudova, M; Vlcek, C; Cardenas, E; Mackova, M; Macek, T				Uhlik, Ondrej; Wald, Jiri; Strejcek, Michal; Musilova, Lucie; Ridl, Jakub; Hroudova, Miluse; Vlcek, Cestmir; Cardenas, Erick; Mackova, Martina; Macek, Tomas			Identification of Bacteria Utilizing Biphenyl, Benzoate, and Naphthalene in Long-Term Contaminated Soil	PLOS ONE			English	Article							ISOTOPE PROBING REVEALS; POLYCHLORINATED-BIPHENYLS; AEROBIC DEGRADATION; DIOXYGENASE GENES; COMPLETE GENOME; RARE BIOSPHERE; SP-NOV.; DIVERSITY; STRAIN; METABOLISM	Bacteria were identified associated with biodegradation of aromatic pollutants biphenyl, benzoate, and naphthalene in a long-term polychlorinated biphenyl- and polyaromatic hydrocarbon-contaminated soil. In order to avoid biases of culture-based approaches, stable isotope probing was applied in combination with sequence analysis of 16 S rRNA gene pyrotags amplified from C-13-enriched DNA fractions. Special attention was paid to pyrosequencing data analysis in order to eliminate the errors caused by either generation of amplicons (random errors caused by DNA polymerase, formation of chimeric sequences) or sequencing itself. Therefore, sample DNA was amplified, sequenced, and analyzed along with the DNA of a mock community constructed out of 8 bacterial strains. This warranted that appropriate tools and parameters were chosen for sequence data processing. C-13-labeled metagenomes isolated after the incubation of soil samples with all three studied aromatics were largely dominated by Proteobacteria, namely sequences clustering with the genera Rhodanobacter Burkholderia, Pandoraea, Dyella as well as some Rudaea- and Skermanella-related ones. Pseudomonads were mostly labeled by C-13 from naphthalene and benzoate. The results of this study show that many biphenyl/benzoate-assimilating bacteria derive carbon also from naphthalene, pointing out broader biodegradation abilities of some soil microbiota. The results also demonstrate that, in addition to traditionally isolated genera of degradative bacteria, yet-to-be cultured bacteria are important players in bioremediation. Overall, the study contributes to our understanding of biodegradation processes in contaminated soil. At the same time our results show the importance of sequencing and analyzing a mock community in order to more correctly process and analyze sequence data.	[Uhlik, Ondrej; Wald, Jiri; Strejcek, Michal; Musilova, Lucie; Mackova, Martina; Macek, Tomas] Prague Inst Chem Technol, Fac Food & Biochem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Ridl, Jakub; Hroudova, Miluse; Vlcek, Cestmir] Czech Acad Sci, Inst Mol Genet, Dept Genom & Bioinformat, Prague, Czech Republic; [Cardenas, Erick] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Michigan State University	Uhlik, O (corresponding author), Prague Inst Chem Technol, Fac Food & Biochem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic.	tomas.macek@vscht.cz	Musilová, Lucie/J-4522-2012; Uhlik, Ondrej/D-3672-2010; Hradilova, Miluse/G-3829-2014; Musilová, Lucie/AAL-6331-2020; Strejcek, Michal/F-7319-2014; Wald, Jiri/AAX-1215-2021; Vlcek, Cestmir/I-8820-2014; Macek, Tomas/K-1843-2012	Musilová, Lucie/0000-0002-8244-8006; Uhlik, Ondrej/0000-0002-0506-202X; Hradilova, Miluse/0000-0001-6615-0149; Musilová, Lucie/0000-0002-8244-8006; Macek, Tomas/0000-0002-7281-9512; Cardenas, Erick/0000-0002-5456-013X; Wald, Jiri/0000-0002-1539-6488	EU [265946]; Ministry of Education, Youth and Sports of the Czech Republic [2B08031, ME 09024]; Czech Science Foundation [525/09/1058]	EU(European Commission); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by EU project MINOTAURUS within the 7th Framework Programme (project no: 265946), the Ministry of Education, Youth and Sports of the Czech Republic projects 2B08031 and ME 09024), and Czech Science Foundation (project 525/09/1058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanderud ZT, 2011, APPL ENVIRON MICROB, V77, P4589, DOI 10.1128/AEM.02735-10; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Bernard L, 2012, ISME J, V6, P213, DOI 10.1038/ismej.2011.87; BOPP LH, 1986, J IND MICROBIOL, V1, P23, DOI 10.1007/BF01569413; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; Chen Y, 2010, TRENDS MICROBIOL, V18, P157, DOI 10.1016/j.tim.2010.02.002; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FURUKAWA K, 1989, J BACTERIOL, V171, P5467, DOI 10.1128/jb.171.10.5467-5472.1989; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Gentry TJ, 2004, MICROBIAL ECOL, V48, P90, DOI 10.1007/s00248-003-1048-1; Ginard M, 1997, INT J SYST BACTERIOL, V47, P132, DOI 10.1099/00207713-47-1-132; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gutierrez-Zamora ML, 2010, REV ENVIRON SCI BIO, V9, P153, DOI 10.1007/s11157-010-9205-8; Habe H, 2003, BIOSCI BIOTECH BIOCH, V67, P225, DOI 10.1271/bbb.67.225; HARDISSO.C, 1969, J GEN MICROBIOL, V59, P1; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; HURTUBISE Y, 1995, J BACTERIOL, V177, P6610, DOI 10.1128/jb.177.22.6610-6618.1995; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Hutchens E, 2004, ENVIRON MICROBIOL, V6, P111, DOI 10.1046/j.1462-2920.2003.00543.x; Ionescu M, 2009, INT BIODETER BIODEGR, V63, P667, DOI 10.1016/j.ibiod.2009.03.009; Jeon CO, 2003, P NATL ACAD SCI USA, V100, P13591, DOI 10.1073/pnas.1735529100; Johnsen AR, 2005, ENVIRON POLLUT, V133, P71, DOI 10.1016/j.envpol.2004.04.015; Jones MD, 2011, ENVIRON MICROBIOL, V13, P2623, DOI 10.1111/j.1462-2920.2011.02501.x; Kanaly RA, 2002, APPL ENVIRON MICROB, V68, P5826, DOI 10.1128/AEM.68.12.5826-5833.2002; Kiemer P, 1996, BIOL FERT SOILS, V23, P307, DOI 10.1007/BF00335959; Kim S, 2001, APPL ENVIRON MICROB, V67, P1953, DOI 10.1128/AEM.67.4.1953-1955.2001; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Langenheder S, 2008, ENVIRON MICROBIOL, V10, P2245, DOI 10.1111/j.1462-2920.2008.01647.x; Lee TK, 2011, APPL ENVIRON MICROB, V77, P3888, DOI 10.1128/AEM.00023-11; Leigh MB, 2007, ISME J, V1, P134, DOI 10.1038/ismej.2007.26; Li A, 2009, APPL BIOCHEM BIOTECH, V159, P687, DOI 10.1007/s12010-008-8513-8; Link L, 2004, MICROB ECOL, V47, P159, DOI 10.1007/s00248-003-1029-4; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Luo W, 2008, CHEMOSPHERE, V70, P364, DOI 10.1016/j.chemosphere.2007.07.022; Mackova M, 2009, ENVIRON SCI POLLUT R, V16, P817, DOI 10.1007/s11356-009-0240-3; Madsen EL, 2011, STABLE ISOTOPE PROBING AND RELATED TECHNOLOGIES, P165; Manoli E, 1999, TRAC-TREND ANAL CHEM, V18, P417, DOI 10.1016/S0165-9936(99)00111-9; McGuinness M, 2009, INT J ENV RES PUB HE, V6, P2226, DOI 10.3390/ijerph6082226; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Nalin R, 1999, INT J SYST BACTERIOL, V49, P19, DOI 10.1099/00207713-49-1-19; Novakova H, 2002, INT BIODETER BIODEGR, V50, P47, DOI 10.1016/S0964-8305(02)00058-6; Padmanabhan P, 2003, APPL ENVIRON MICROB, V69, P1614, DOI 10.1128/AEM.69.3.1614-1622.2003; Pavlikova D, 2007, INT J PHYTOREMEDIAT, V9, P71, DOI 10.1080/15226510601139433; Pieper DH, 2005, APPL MICROBIOL BIOT, V67, P170, DOI 10.1007/s00253-004-1810-4; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; Pilloni G, 2011, FEMS MICROBIOL ECOL, V78, P165, DOI 10.1111/j.1574-6941.2011.01083.x; Pumphrey GM, 2008, APPL ENVIRON MICROB, V74, P4111, DOI 10.1128/AEM.00464-08; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Radajewski S, 2002, MICROBIOL-SGM, V148, P2331, DOI 10.1099/00221287-148-8-2331; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rokem JS, 2011, BIOTECHNOL BIOENG, V108, P2770, DOI 10.1002/bit.23212; Ryslava E, 2003, FRESEN ENVIRON BULL, V12, P296; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHNOOR JL, 1995, ENVIRON SCI TECHNOL, V29, pA318, DOI [10.1021/es00007a002, 10.1021/es00007a747]; Singer AC, 2002, APPL ENVIRON MICROB, V68, P5756, DOI 10.1128/AEM.68.11.5756-5759.2002; Singleton DR, 2006, ENVIRON MICROBIOL, V8, P1736, DOI 10.1111/j.1462-2920.2006.01112.x; Singleton DR, 2011, BIODEGRADATION, V22, P1061, DOI 10.1007/s10532-011-9463-3; Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005; Strnad H, 2011, J BACTERIOL, V193, P791, DOI 10.1128/JB.01299-10; Strnad H, 2010, J BACTERIOL, V192, P3545, DOI 10.1128/JB.00366-10; SUESS M J, 1976, Science of the Total Environment, V6, P239, DOI 10.1016/0048-9697(76)90033-4; Sul WJ, 2009, APPL ENVIRON MICROB, V75, P5501, DOI 10.1128/AEM.00121-09; SYLVESTRE M, 1980, APPL ENVIRON MICROB, V39, P1223, DOI 10.1128/AEM.39.6.1223-1224.1980; TAIRA K, 1992, J BIOL CHEM, V267, P4844; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Tillmann S, 2005, FEMS MICROBIOL ECOL, V52, P207, DOI 10.1016/j.femsec.2004.11.014; Uhlik O, 2011, APPL ENVIRON MICROB, V77, P6858, DOI 10.1128/AEM.05465-11; Uhlik O, 2009, APPL ENVIRON MICROB, V75, P6471, DOI 10.1128/AEM.00466-09; Uhlik O, 2009, SCI TOTAL ENVIRON, V407, P3611, DOI 10.1016/j.scitotenv.2008.05.012; Vezina J, 2008, J MOL MICROB BIOTECH, V15, P139, DOI 10.1159/000121326; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westerberg K, 2000, INT J SYST EVOL MICR, V50, P2083, DOI 10.1099/00207713-50-6-2083; White DC, 1996, CURR OPIN BIOTECH, V7, P301, DOI 10.1016/S0958-1669(96)80034-6; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Yu CP, 2005, ENVIRON SCI TECHNOL, V39, P9611, DOI 10.1021/es051024e; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhang L, 2008, J SOIL SEDIMENT, V8, P379, DOI 10.1007/s11368-008-0043-z	85	91	93	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40653	10.1371/journal.pone.0040653	http://dx.doi.org/10.1371/journal.pone.0040653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808223	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700042
J	Banu, S; Mahmud, AM; Rahman, MT; Hossain, A; Uddin, MKM; Ahmed, T; Khatun, R; Akhanda, W; Brosch, R				Banu, Sayera; Mahmud, Asif Mujtaba; Rahman, Md Toufiq; Hossain, Arman; Uddin, Mohammad Khaja Mafij; Ahmed, Tahmeed; Khatun, Razia; Akhanda, Wahiduzzaman; Brosch, Roland			Multidrug-Resistant Tuberculosis in Admitted Patients at a Tertiary Referral Hospital of Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; STRAIN DIFFERENTIATION; MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; IDENTIFICATION; DIAGNOSIS; GENOTYPE; ELEMENTS; PCR	Background: This study was set out to investigate the magnitude, patterns and molecular characterization of drug-resistant Mycobacterium tuberculosis strains at a tertiary referral hospital in Bangladesh. Methods: Pulmonary tuberculosis (TB) patients admitted at National Institute of Diseases of the Chest and Hospital from February 2002 to September 2005 with or without previous history of TB and/or other complications were randomly interviewed. Among 265 participants enrolled, M. tuberculosis isolates from 189 patients were finally tested for susceptibility to rifampicin (RMP), isoniazid (INH), ethambutol (ETM) and streptomycin (STM). Genotyping of M. tuberculosis was done using deletion analysis and spoligotyping. Results: Eighty-eight percent (n = 167) of the patients had history of previous anti-TB treatment while the remaining 12% were new TB cases. Of the 189 isolates, 9% were fully susceptible to the first line anti-TB drugs and 73.5% were multi-drug resistant TB. Other susceptibility results showed 79.4%, 77.2%, 76.7% and 78.8% resistance to INH, RMP, ETM and STM respectively. Multi-drug resistance was significantly higher among the 130 (78%) patients with previous history of anti-tuberculosis treatment (95% confidence interval, p = 0.001). Among the 189 analyzed isolates, 69% were classified as "modern" M. tuberculosis strains (i.e. TbD1-strains, lacking the M. tuberculosis-deletion region TbD1), whereas the remaining 31% were found to belong to the "ancestal" TbD1+ M. tuberculosis lineages. One hundred and five different spoligotype patterns were identified in which 16 clusters contained 100 strains and 89 strains had unique pattern. Strains with a spoligotype characteristic for the "Beijing" cluster were predominant (19%) and most of these strains (75%) were multi-drug resistant (MDR). Conclusions: A high level of drug resistance observed among the re-treatment patients poses a threat of transmission of resistant strains to susceptible persons in the community. Proper counseling of patients and attention towards the completion of the anti-TB treatment is needed.	[Banu, Sayera; Rahman, Md Toufiq; Hossain, Arman; Uddin, Mohammad Khaja Mafij; Ahmed, Tahmeed; Khatun, Razia] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Mahmud, Asif Mujtaba; Akhanda, Wahiduzzaman] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh; [Brosch, Roland] Inst Pasteur, Integrated Mycobacterial Pathogen Unit, Paris, France	International Centre for Diarrhoeal Disease Research (ICDDR); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	sbanu@icddrb.org	Brosch, Roland/ABB-4108-2021; Brosch, Roland/AAZ-3850-2021	Brosch, Roland/0000-0003-2587-3863; Banu, Sayera/0000-0002-5121-1962	United Nations Development Programme/World Bank/World Health Organization special program for Research and Training in Tropical Diseases; Ellison Medical Foundation - International Nutrition Foundation; Tuberculosis Laboratory of International Centre for Diarrheal Diseases and Research, Bangladesh;  [GR-00278]	United Nations Development Programme/World Bank/World Health Organization special program for Research and Training in Tropical Diseases; Ellison Medical Foundation - International Nutrition Foundation(Lawrence Ellison Foundation); Tuberculosis Laboratory of International Centre for Diarrheal Diseases and Research, Bangladesh; 	This work was supported in part by grants from the United Nations Development Programme/World Bank/World Health Organization special program for Research and Training in Tropical Diseases, Ellison Medical Foundation - International Nutrition Foundation and the Tuberculosis Laboratory of International Centre for Diarrheal Diseases and Research, Bangladesh. The grant number was GR-00278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2000, EMERG INFECT DIS, V6, P302; [Anonymous], 2009, OP MAN MAN MULT RES; [Anonymous], 2008, WHOHTMTB2008394 ANT; [Anonymous], 2010, WHOHTMTB20103; [Anonymous], 2009, NAT GUID OP MAN TUB; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Banu S, 2012, INT J TUBERC LUNG D, V16, P319, DOI 10.5588/ijtld.11.0426; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chadha VK, 1997, GLOBAL TRENDS TUBERC, V33, P11; Chan ED, 2002, BMJ-BRIT MED J, V325, P1282, DOI 10.1136/bmj.325.7375.1282; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Diaz R, 1998, INT J TUBERC LUNG D, V2, P743; Djuretic T, 2002, THORAX, V57, P477, DOI 10.1136/thorax.57.6.477; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; HERMANS PWM, 1991, INFECT IMMUN, V59, P2695, DOI 10.1128/IAI.59.8.2695-2705.1991; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kim SJ, 1997, INT J TUBERC LUNG D, V1, P302; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Kordy FNS, 2004, INT J TUBERC LUNG D, V8, P1007; KOX LFF, 1994, J CLIN MICROBIOL, V32, P672, DOI 10.1128/JCM.32.3.672-678.1994; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Miah M R, 2000, Bangladesh Med Res Counc Bull, V26, P33; Mistry NF, 2002, J CLIN MICROBIOL, V40, P2677, DOI 10.1128/JCM.40.7.2677-2680.2002; Mostafizur Rahman, 2009, Journal of Medicine, V10, P45; Mostofa Kamal SM, 2009, BANGLADESH J MED MIC, P23; Organization WH, 2008, GLOB TUB CONTR SURV; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Saltini C, 2006, RESP MED, V100, P2085, DOI 10.1016/j.rmed.2006.09.015; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Sola C, 2001, EMERG INFECT DIS, V7, P390; Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2; The World Health Organization, 2008, WHOHTMTB2008393; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; World Health Organization, 2007, WHOHTMTB2007387; World Health Organization (WHO), 2003, WHOCDSTB2003320; Zaman K, 2005, SCAND J INFECT DIS, V37, P21, DOI 10.1080/00365540410026095	41	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40545	10.1371/journal.pone.0040545	http://dx.doi.org/10.1371/journal.pone.0040545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808189	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400069
J	Ho, AL; Musi, E; Ambrosini, G; Nair, JS; Vasudeva, SD; de Stanchina, E; Schwartz, GK				Ho, Alan L.; Musi, Elgilda; Ambrosini, Grazia; Nair, Jayasree S.; Vasudeva, Shyamprasad Deraje; de Stanchina, Elisa; Schwartz, Gary K.			Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype	PLOS ONE			English	Article							VIVO ANTITUMOR-ACTIVITY; IN-VIVO; BRAF GENE; TRANSLATIONAL CONTROL; MEDIATES RESISTANCE; CELL SUSCEPTIBILITY; KINASE INHIBITOR; REGULATED KINASE; B-RAF; PATHWAY	Uveal melanomas possess activation of the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT/mammalian Target of Rapamycin (mTOR) pathways. MAPK activation occurs via somatic mutations in the heterotrimeric G protein subunits GNAQ and GNA11 for over 70% of tumors and less frequently via V600E BRAF mutations. In this report, we describe the impact of dual pathway inhibition upon uveal melanoma cell lines with the MEK inhibitor selumetinib (AZD6244/ARRY-142886) and the ATP-competitive mTOR kinase inhibitor AZD8055. While synergistic reductions in cell viability were observed with AZD8055/selumetinib in both BRAF and GNAQ mutant cell lines, apoptosis was preferentially induced in BRAF mutant cells only. In vitro apoptosis assay results were predictive of in vivo drug efficacy as tumor regressions were observed only in a BRAF mutant xenograft model, but not GNAQ mutant model. We went on to discover that GNAQ promotes relative resistance to AZD8055/selumetinib-induced apoptosis in GNAQ mutant cells. For BRAF mutant cells, both AKT and 4E-BP1 phosphorylation were modulated by the combination; however, decreasing AKT phosphorylation alone was not sufficient and decreasing 4E-BP1 phosphorylation was not required for apoptosis. Instead, cooperative mTOR complex 2 (mTORC2) and MEK inhibition resulting in downregulation of the pro-survival protein MCL-1 was found to be critical for combination-induced apoptosis. These results suggest that the clinical efficacy of combined MEK and mTOR kinase inhibition will be determined by tumor genotype, and that BRAF mutant malignancies will be particularly susceptible to this strategy.	[Ho, Alan L.; Musi, Elgilda; Ambrosini, Grazia; Nair, Jayasree S.; Vasudeva, Shyamprasad Deraje; Schwartz, Gary K.] Mem Sloan Kettering Canc Ctr, Lab New Drug Dev, New York, NY 10021 USA; [de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY USA; [Ho, Alan L.; Schwartz, Gary K.] Cornell Univ, Dept Med, Weill Med Coll, Ithaca, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Ho, AL (corresponding author), Mem Sloan Kettering Canc Ctr, Lab New Drug Dev, 1275 York Ave, New York, NY 10021 USA.	hoa@mskcc.org			AstraZeneca	AstraZeneca(AstraZeneca)	The authors have read the journal's policy and have the following conflicts: one-time paid consultancy (AstraZeneca), research funding (AstraZeneca) was provided to Alan Ho. To clarify, funding in both instances were not used or applicable to the study described in this submission, but instead to other, unrelated clinical research. Selumetinib and AZD8055 were supplied by AstraZeneca for this study. There are no other patents, products in development or other marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abdel-Rahman MH, 2006, J CLIN ONCOL, V24, P288, DOI 10.1200/JCO.2005.02.2418; Ambrosini G, 2008, MOL CANCER THER, V7, P890, DOI 10.1158/1535-7163.MCT-07-0518; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Braun RD, 2006, INVEST OPHTH VIS SCI, V47, P7, DOI 10.1167/iovs.04-0882; Calipel A, 2006, J BIOL CHEM, V281, P9238, DOI 10.1074/jbc.M600228200; Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Dummer R, 2008, J CLIN ONCOL S, V26; Edmunds SC, 2003, BRIT J CANCER, V88, P1403, DOI 10.1038/sj.bjc.6600919; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Janssen CS, 2008, BRIT J CANCER, V99, P1673, DOI 10.1038/sj.bjc.6604731; Kilic E, 2004, MELANOMA RES, V14, P203, DOI 10.1097/cmr.0000130006.46885.a0; Lefevre G, 2004, J BIOL CHEM, V279, P31769, DOI 10.1074/jbc.M403907200; LUYTEN GPM, 1993, BIOCHEM BIOPH RES CO, V192, P22, DOI 10.1006/bbrc.1993.1376; MA D, 1995, INVEST OPHTH VIS SCI, V36, P435; Maat W, 2008, INVEST OPHTH VIS SCI, V49, P23, DOI 10.1167/iovs.07-0722; Malaponte G, 2006, CANCER BIOL THER, V5, P225, DOI 10.4161/cbt.5.2.2429; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014124; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013026; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Motwani M, 1999, CLIN CANCER RES, V5, P1876; Nair JS, 2009, CLIN CANCER RES, V15, P2022, DOI 10.1158/1078-0432.CCR-08-1826; Naus NC, 2000, INT J CANCER, V87, P151, DOI 10.1002/1097-0215(20000701)87:1<151::AID-IJC23>3.0.CO;2-1; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Patel M, 2011, CLIN CANC RES; Rimoldi D, 2003, CANCER RES, V63, P5712; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Sun Y, 2005, INVEST OPHTH VIS SCI, V46, P1561, DOI 10.1167/iovs.04-1362; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Weber A, 2003, LAB INVEST, V83, P1771, DOI 10.1097/01.LAB.0000101732.89463.29; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yu K, 2008, CANCER BIOL THER, V7, P307; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	53	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40439	10.1371/journal.pone.0040439	http://dx.doi.org/10.1371/journal.pone.0040439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808163	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500042
J	Zhao, YO; Kurscheid, S; Zhang, Y; Liu, L; Zhang, LL; Loeliger, K; Fikrig, E				Zhao, Yang O.; Kurscheid, Sebastian; Zhang, Yue; Liu, Lei; Zhang, Lili; Loeliger, Kelsey; Fikrig, Erol			Enhanced Survival of Plasmodium-Infected Mosquitoes during Starvation	PLOS ONE			English	Article							ANOPHELES-STEPHENSI MOSQUITOS; MALARIA PARASITES; FALCIPARUM INFECTION; INSULIN; GAMBIAE; EXPRESSION; RESISTANCE; DROSOPHILA; HEMOLYMPH; FECUNDITY	Plasmodium spp. are pathogenic to their vertebrate hosts and also apparently, impose a fitness cost on their insect vectors. We show here, however, that Plasmodium-infected mosquitoes survive starvation significantly better than uninfected mosquitoes. This survival advantage during starvation is associated with higher energy resource storage that infected mosquitoes accumulate during period of Plasmodium oocyst development. Microarray analysis revealed that the metabolism of sated mosquitoes is altered in the presence of rapidly growing oocysts, including the down-regulation of several enzymes involved in carbohydrate catabolism. In addition, enhanced expression of several insulin-like peptides was observed in Plasmodium-infected mosquitoes. Blocking insulin-like signaling pathway resulted in impaired Plasmodium development. We conclude that Plasmodium infection alters metabolic pathways in mosquitoes, epitomized by enhanced insulin-like signaling - thereby conferring a survival advantage to the insects during periods of starvation. Manipulation of this pathway might provide new strategies to influence the ability of mosquitoes to survive and transmit the protozoa that cause malaria.	[Zhao, Yang O.; Kurscheid, Sebastian; Zhang, Yue; Liu, Lei; Zhang, Lili; Loeliger, Kelsey; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Zhao, Yang O.; Zhang, Yue; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Zhao, YO (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	yang.zhao@yale.edu; erol.fikrig@yale.edu	Liu, Lei/C-2725-2012; Kurscheid, Sebastian/A-5758-2009	Kurscheid, Sebastian/0000-0002-4887-7480; Loeliger, Kelsey B/0000-0002-1193-4357	Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-243; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hogg JC, 1997, PARASITOLOGY, V114, P325, DOI 10.1017/S0031182096008542; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Krieger MJB, 2004, INSECT MOL BIOL, V13, P305, DOI 10.1111/j.0962-1075.2004.00489.x; Lambrechts L, 2006, P ROY SOC B-BIOL SCI, V273, P1501, DOI 10.1098/rspb.2006.3483; Luckhart S, 2007, DEV COMP IMMUNOL, V31, P647, DOI 10.1016/j.dci.2006.10.005; MACK SR, 1979, J PARASITOL, V65, P217, DOI 10.2307/3280149; MACK SR, 1979, J PARASITOL, V65, P130, DOI 10.2307/3280217; MAIER WA, 1987, PARASITOL TODAY, V3, P216, DOI 10.1016/0169-4758(87)90063-9; Marquez AG, 2011, GEN COMP ENDOCR, V173, P303, DOI 10.1016/j.ygcen.2011.06.005; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Rivero A, 2003, P ROY SOC B-BIOL SCI, V270, P1365, DOI 10.1098/rspb.2003.2389; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; SCHIEFER BA, 1977, EXP PARASITOL, V41, P397, DOI 10.1016/0014-4894(77)90111-4; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Tripet F, 2008, TRENDS PARASITOL, V24, P219, DOI 10.1016/j.pt.2008.02.008; Vernick KD, 2005, CURR TOP MICROBIOL, V295, P383	33	23	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40556	10.1371/journal.pone.0040556	http://dx.doi.org/10.1371/journal.pone.0040556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808193	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500056
J	Yamaguchi, T; Hamanaka, S; Kamiya, A; Okabe, M; Kawarai, M; Wakiyama, Y; Umino, A; Hayama, T; Sato, H; Lee, YS; Kato-Itoh, M; Masaki, H; Kobayashi, T; Yamazaki, S; Nakauchi, H				Yamaguchi, Tomoyuki; Hamanaka, Sanae; Kamiya, Akihide; Okabe, Motohito; Kawarai, Mami; Wakiyama, Yukiko; Umino, Ayumi; Hayama, Tomonari; Sato, Hideyuki; Lee, Youn-Su; Kato-Itoh, Megumi; Masaki, Hideki; Kobayashi, Toshihiro; Yamazaki, Satoshi; Nakauchi, Hiromitsu			Development of an All-in-One Inducible Lentiviral Vector for Gene Specific Analysis of Reprogramming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; C-MYC; HUMAN FIBROBLASTS; SOMATIC-CELLS; SENDAI-VIRUS; INDUCTION; GENERATION; MOUSE; DIFFERENTIATION; MURINE	Fair comparison of reprogramming efficiencies and in vitro differentiation capabilities among induced pluripotent stem cell (iPSC) lines has been hampered by the cellular and genetic heterogeneity of de novo infected somatic cells. In order to address this problem, we constructed a single cassette all-in-one inducible lentiviral vector (Ai-LV) for the expression of three reprogramming factors (Oct3/4, Klf4 and Sox2). To obtain multiple types of somatic cells having the same genetic background, we generated reprogrammable chimeric mice using iPSCs derived from Ai-LV infected somatic cells. Then, hepatic cells, hematopoietic cells and fibroblasts were isolated at different developmental stages from the chimeric mice, and reprogrammed again to generate 2nd iPSCs. The results revealed that somatic cells, especially fetal hepatoblasts were reprogrammed 1200 times more efficiently than adult hepatocytes with maximum reprogramming efficiency reaching 12.5%. However, we found that forced expression of c-Myc compensated for the reduced reprogramming efficiency in aged somatic cells without affecting cell proliferation. All these findings suggest that the Ai-LV system enables us to generate a panel of iPSC clones derived from various tissues with the same genetic background, and thus provides an invaluable tool for iPSC research.	[Yamaguchi, Tomoyuki; Hamanaka, Sanae; Kawarai, Mami; Wakiyama, Yukiko; Umino, Ayumi; Hayama, Tomonari; Sato, Hideyuki; Lee, Youn-Su; Kato-Itoh, Megumi; Masaki, Hideki; Kobayashi, Toshihiro; Yamazaki, Satoshi; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan; [Yamaguchi, Tomoyuki; Hamanaka, Sanae; Kamiya, Akihide; Okabe, Motohito; Hayama, Tomonari; Lee, Youn-Su; Masaki, Hideki; Kobayashi, Toshihiro; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Yamaguchi, T (corresponding author), Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan.	tomoyama@ims.u-tokyo.ac.jp; nakauchi@ims.u-tokyo.ac.jp		Kobayashi, Toshihiro/0000-0001-8019-0008	Japan Science and Technology Agency (JST), the Ministry of Education, Culture, Sport, Science	Japan Science and Technology Agency (JST), the Ministry of Education, Culture, Sport, Science	This work was supported by grants from Japan Science and Technology Agency (JST), the Ministry of Education, Culture, Sport, Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hamanaka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022008; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kleger A, 2012, GASTROENTEROLOGY; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Marion RM, 2010, ADV EXP MED BIOL, V695, P118, DOI 10.1007/978-1-4419-7037-4_9; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Matsumoto K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004820; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	36	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41007	10.1371/journal.pone.0041007	http://dx.doi.org/10.1371/journal.pone.0041007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815895	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900067
J	Yuan, XG; Zhang, JY; Yang, LY; Zhang, SL; Chen, BD; Geng, YJ; Wang, Y				Yuan, Xiguo; Zhang, Junying; Yang, Liying; Zhang, Shengli; Chen, Baodi; Geng, Yaojun; Wang, Yue			TAGCNA: A Method to Identify Significant Consensus Events of Copy Number Alterations in Cancer	PLOS ONE			English	Article							ARRAY CGH DATA; CIRCULAR BINARY SEGMENTATION; GENE-EXPRESSION; PROSTATE-CANCER; LUNG-CANCER; ABERRATIONS; TUMORS; IDENTIFICATION; CARCINOMAS; MUTATIONS	Somatic copy number alteration (CNA) is a common phenomenon in cancer genome. Distinguishing significant consensus events (SCEs) from random background CNAs in a set of subjects has been proven to be a valuable tool to study cancer. In order to identify SCEs with an acceptable type I error rate, better computational approaches should be developed based on reasonable statistics and null distributions. In this article, we propose a new approach named TAGCNA for identifying SCEs in somatic CNAs that may encompass cancer driver genes. TAGCNA employs a peel-off permutation scheme to generate a reasonable null distribution based on a prior step of selecting tag CNA markers from the genome being considered. We demonstrate the statistical power of TAGCNA on simulated ground truth data, and validate its applicability using two publicly available cancer datasets: lung and prostate adenocarcinoma. TAGCNA identifies SCEs that are known to be involved with proto-oncogenes (e.g. EGFR, CDK4) and tumor suppressor genes (e.g. CDKN2A, CDKN2B), and provides many additional SCEs with potential biological relevance in these data. TAGCNA can be used to analyze the significance of CNAs in various cancers. It is implemented in R and is freely available at http://tagcna.sourceforge.net/.	[Yuan, Xiguo; Zhang, Junying; Yang, Liying; Chen, Baodi; Geng, Yaojun] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Wang, Yue] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp, Arlington, VA USA; [Zhang, Shengli] Xidian Univ, Dept Math, Xian, Peoples R China	Xidian University; Virginia Polytechnic Institute & State University; Xidian University	Yuan, XG (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	jyzhang@mail.xidian.edu.cn; yuewang@vt.edu			Natural Science Foundation of China [61070137, 91130006, 60933009]; US National Institutes of Health [CA160036, CA149147, GM085665]; Natural Science Basic Research Plan in Shaanxi Province of China [2012JQ8027]; Science and Technology Research Development Program in Shaanxi province of China [2009K01-56]; Fundamental Research Funds for the Central Universities [K50511030002]; NATIONAL CANCER INSTITUTE [U54CA149147, U24CA160036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM085665] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Basic Research Plan in Shaanxi Province of China; Science and Technology Research Development Program in Shaanxi province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Natural Science Foundation of China under Grants 61070137, 91130006, and 60933009; the US National Institutes of Health under Grants CA160036, CA149147, and GM085665; and the Project Supported by Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2012JQ8027); the Science and Technology Research Development Program in Shaanxi province of China (No. 2009K01-56), and the Fundamental Research Funds for the Central Universities (No. K50511030002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Choi HW, 2010, J COMPUT BIOL, V17, P121, DOI 10.1089/cmb.2009.0019; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Goransson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006057; Guttman M, 2007, PLOS GENET, V3, P1464, DOI 10.1371/journal.pgen.0030143; Houlden H, 2009, NEUROLOGY, V72, P617, DOI 10.1212/01.wnl.0000342463.35089.cc; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kim Jihoon, 2010, THESIS; Klijn C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1143; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nof E, 2007, CIRCULATION, V116, P463, DOI 10.1161/CIRCULATIONAHA.107.706887; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Outi S, 2006, GENE COPY NUMBER ALT; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Rose AE, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-70; Rueda OM, 2010, CURR BIOINFORM, V5, P1; Sawasaki T, 2004, TUMOR BIOL, V25, P141, DOI 10.1159/000079146; Shah SP, 2008, CYTOGENET GENOME RES, V123, P343, DOI 10.1159/000184726; Shah SP, 2007, BIOINFORMATICS, V23, pI450, DOI 10.1093/bioinformatics/btm221; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Treutlein J, 2009, SCHIZOPHR RES, V111, P123, DOI 10.1016/j.schres.2009.03.011; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vocke CD, 1996, CANCER RES, V56, P2411; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Yu GQ, 2011, BIOINFORMATICS, V27, P1473, DOI 10.1093/bioinformatics/btr183; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708	34	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41082	10.1371/journal.pone.0041082	http://dx.doi.org/10.1371/journal.pone.0041082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815924	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900073
J	Angelo, JR; Guerrero-Zayas, MI; Tremblay, KD				Angelo, Jesse R.; Guerrero-Zayas, Mara-Isel; Tremblay, Kimberly D.			A Fate Map of the Murine Pancreas Buds Reveals a Multipotent Ventral Foregut Organ Progenitor	PLOS ONE			English	Article							DORSAL PANCREAS; MOUSE EMBRYO; TRANSCRIPTION FACTOR; ENDODERM; MORPHOGENESIS; MICE; LIVER; DIFFERENTIATION; AGENESIS; CELLS	The definitive endoderm is the embryonic germ layer that gives rise to the budding endodermal organs including the thyroid, lung, liver and pancreas as well as the remainder of the gut tube. DiI fate mapping and whole embryo culture were used to determine the endodermal origin of the 9.5 days post coitum (dpc) dorsal and ventral pancreas buds. Our results demonstrate that the progenitors of each bud occupy distinct endodermal territories. Dorsal bud progenitors are located in the medial endoderm overlying somites 2-4 between the 2 and 11 somite stage (SS). The endoderm forming the ventral pancreas bud is found in 2 distinct regions. One territory originates from the left and right lateral endoderm caudal to the anterior intestinal portal by the 6 SS and the second domain is derived from the ventral midline of the endoderm lip (VMEL). Unlike the laterally located ventral foregut progenitors, the VMEL population harbors a multipotent progenitor that contributes to the thyroid bud, the rostral cap of the liver bud, ventral midline of the liver bud and the midline of the ventral pancreas bud in a temporally restricted manner. This data suggests that the midline of the 9.5 dpc thyroid, liver and ventral pancreas buds originates from the same progenitor population, demonstrating a developmental link between all three ventral foregut buds. Taken together, these data define the location of the dorsal and ventral pancreas progenitors in the prespecified endodermal sheet and should lead to insights into the inductive events required for pancreas specification.	[Angelo, Jesse R.; Guerrero-Zayas, Mara-Isel; Tremblay, Kimberly D.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Angelo, JR (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	kdtrembl@vasci.umass.edu		Tremblay, Kimberly/0000-0002-3059-9910	American Diabetes Association [1-10-BS-178, R01DK087753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087753] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the American Diabetes Association (1-10-BS-178) and R01DK087753 to KDT. No additional external money was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Deutsch G, 2001, DEVELOPMENT, V128, P871; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Franklin V, 2008, MECH DEVELOP, V125, P587, DOI 10.1016/j.mod.2008.04.001; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Galan-Gomez E, 2007, EUR J MED GENET, V50, P144, DOI 10.1016/j.ejmg.2006.12.001; Gannon M, 1999, ENDODERMAL PATTERNIN, P583; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; GUZ Y, 1995, DEVELOPMENT, V121, P11; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kirby ML, 2003, DEV BIOL, V253, P175, DOI 10.1016/S0012-1606(02)00024-6; LEDOUARIN NM, 1975, MED BIOL, V53, P427; Li H, 1999, NAT GENET, V23, P67; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; MARTINEZFRIAS ML, 1992, AM J MED GENET, V44, P352, DOI 10.1002/ajmg.1320440316; Matsuura K, 2009, MECH DEVELOP, V126, P817, DOI 10.1016/j.mod.2009.07.009; Miki R, 2012, MECH DEV; Offield MF, 1996, DEVELOPMENT, V122, P983; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Tam PPL, 2007, DEVELOPMENT, V134, P251, DOI 10.1242/dev.02724; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Uemura M, 2010, BIOCHEM BIOPH RES CO, V391, P357, DOI 10.1016/j.bbrc.2009.11.063; Ward AB, 2007, DEV DYNAM, V236, P1558, DOI 10.1002/dvdy.21168; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	32	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40707	10.1371/journal.pone.0040707	http://dx.doi.org/10.1371/journal.pone.0040707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815796	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000027
J	Conde, C; Rambout, X; Lebrun, M; Lecat, A; Di Valentin, E; Dequiedt, F; Piette, J; Gloire, G; Legrand, S				Conde, Claude; Rambout, Xavier; Lebrun, Marielle; Lecat, Aurore; Di Valentin, Emmanuel; Dequiedt, Franck; Piette, Jacques; Gloire, Geoffrey; Legrand, Sylvie			The Inositol Phosphatase SHIP-1 Inhibits NOD2-Induced NF-kappa B Activation by Disturbing the Interaction of XIAP with RIP2	PLOS ONE			English	Article							X-LINKED INHIBITOR; FC-GAMMA-RIIB; CROHNS-DISEASE; SIGNAL-TRANSDUCTION; BINDING DOMAIN; PROTEIN; NOD2; RECEPTOR; APOPTOSIS; INNATE	SHIP-1 is an inositol phosphatase predominantly expressed in hematopoietic cells. Over the ten past years, SHIP-1 has been described as an important regulator of immune functions. Here, we characterize a new inhibitory function for SHIP-1 in NOD2 signaling. NOD2 is a crucial cytoplasmic bacterial sensor that activates proinflammatory and antimicrobial responses upon bacterial invasion. We observed that SHIP-1 decreases NOD2-induced NF-kappa B activation in macrophages. This negative regulation relies on its interaction with XIAP. Indeed, we observed that XIAP is an essential mediator of the NOD2 signaling pathway that enables proper NF-kappa B activation in macrophages. Upon NOD2 activation, SHIP-1 C-terminal proline rich domain (PRD) interacts with XIAP, thereby disturbing the interaction between XIAP and RIP2 in order to decrease NF-kappa B signaling.	[Conde, Claude; Lebrun, Marielle; Lecat, Aurore; Piette, Jacques; Legrand, Sylvie] Univ Liege, Lab Virol & Immunol, Signal Transduct Unit, GIGA R, Liege, Belgium; [Rambout, Xavier; Dequiedt, Franck] Univ Liege, Signal Transduct Unit, GIGA R, Lab Prot Signaling & Interact, Liege, Belgium; [Di Valentin, Emmanuel] Univ Liege, GIGA Viral Vector Platform, GIGA R, Liege, Belgium; [Gloire, Geoffrey] Interface Entreprises Univ Liege Sci Pk, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Conde, C (corresponding author), Univ Liege, Lab Virol & Immunol, Signal Transduct Unit, GIGA R, Liege, Belgium.	s.legrand@ulg.ac.be	Lebrun, Marielle/GVT-8895-2022	Rambout, Xavier/0000-0002-5147-2863; Dequiedt, Franck/0000-0003-1234-7477	Fond National de la Recherche Scientifique (FNRS, Brussels, Belgium) [3.4543.08]; Televie program (FNRS, Brussels, Belgium) [7.4568.09, 7.4533.11F]; Interuniversity Attraction Poles, Bruxelles, Belgium [IAP6/18, 6/18]; Fond de la Recherche Industrielle et Agricole (FRIA - FNRS, Brussels, Belgium)	Fond National de la Recherche Scientifique (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Televie program (FNRS, Brussels, Belgium); Interuniversity Attraction Poles, Bruxelles, Belgium; Fond de la Recherche Industrielle et Agricole (FRIA - FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work is supported by the Fond National de la Recherche Scientifique (FNRS, Brussels, Belgium) [grant number 3.4543.08], The Televie program (FNRS, Brussels, Belgium) [grant number 7.4568.09 and 7.4533.11F] and by the Interuniversity Attraction Poles (IAP6/18, Bruxelles, Belgium) [grant number 6/18]. CC is supported by the Televie program (FNRS, Brussels, Belgium) [grant number 7.4568.09 and 7.4533.11F]; XR is a Research Fellow of the FNRS (Brussels, Belgium); AL is supported by supported by the Fond de la Recherche Industrielle et Agricole (FRIA - FNRS, Brussels, Belgium) and by the Televie program (FNRS, Brussels, Belgium); EDV is a first GIGA Associate (Groupe Interdisciplimanire de Genoproteomique Appliquee, Liege, Belgium) paid by the Interuniversity Attraction Poles (IAP6/18, Bruxelles, Belgium) [grant number 6/18]; FDQ is a associate Researcher from the FNRS (FNRS, Brussels, Belgium); JP and SL are Research Director and Associate Researcher from the FNRS (FNRS, Brussels, Belgium), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Buchse T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006239; Conde C, 2011, BIOCHEM PHARMACOL, V82, P1320, DOI 10.1016/j.bcp.2011.05.031; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Damen JE, 2001, BLOOD, V97, P1343, DOI 10.1182/blood.V97.5.1343; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Galandrini R, 2002, BLOOD, V100, P4581, DOI 10.1182/blood-2002-04-1058; Galandrini R, 2001, EUR J IMMUNOL, V31, P2016, DOI 10.1002/1521-4141(200107)31:7<2016::AID-IMMU2016>3.0.CO;2-W; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kalesnikoff J, 2002, MOL IMMUNOL, V38, P1201, DOI 10.1016/S0161-5890(02)00064-0; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kerr WG, 2011, GUT, V60, P177, DOI 10.1136/gut.2009.202283; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; McLarren KW, 2011, AM J PATHOL, V179, P180, DOI 10.1016/j.ajpath.2011.03.018; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Prakash H, 2010, J BIOL CHEM, V285, P20291, DOI 10.1074/jbc.M109.096297; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tridandapani S, 1998, MOL IMMUNOL, V35, P1135, DOI 10.1016/S0161-5890(98)00097-2; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	54	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41005	10.1371/journal.pone.0041005	http://dx.doi.org/10.1371/journal.pone.0041005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815893	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000050
J	Forsythe, P; Wang, BX; Khambati, I; Kunze, WA				Forsythe, Paul; Wang, Binxiang; Khambati, Ibrahim; Kunze, Wolfgang A.			Systemic Effects of Ingested Lactobacillus Rhamnosus: Inhibition of Mast Cell Membrane Potassium (IKCa) Current and Degranulation	PLOS ONE			English	Article							K+ CHANNEL K(CA)3.1; PASSIVE CUTANEOUS ANAPHYLAXIS; ORAL TREATMENT; IMMUNOMODULATION; EXPRESSION; BACTERIA; REUTERI; MODEL; MICE; MIGRATION	Exposure of the intestine to certain strains lactobacillus can have systemic immune effects that include the attenuation of allergic responses. Despite the central role of mast cells in allergic disease little is known about the effect of lactobacilli on the function of these cells. To address this we assessed changes in rat mast cell activation following oral treatment with a strain of Lactobacillus known to attenuate allergic responses in animal models. Sprague Dawley rats were fed with L.rhamnosus JB-1 (1x10(9)) or vehicle control for 9 days. Mediator release from peritoneal mast cells (RPMC) was determined in response to a range of stimuli. Passive cutaneous anaphylaxis (PCA) was used to assess mast cell responses in vivo. The Ca2+ activated K+ channel (KCa3.1) current, identified as critical to mast cell degranulation, was monitored by whole cell patch-clamp. L.rhamnosus JB-1 treatment lead to significant inhibition of mast cell mediator release in response to a range of stimuli including IgE mediated activation. Furthermore, the PCA response was significantly reduced in treated rats. Patch-clamp studies revealed that RPMC from treated animals were much less responsive to the KCa3.1 opener, DCEBIO. These studies demonstrate that Ingestion of L. rhamnosus JB-1 leads to mast cell stabilization in rats and identify KCa3.1 as an immunomodulatory target for certain lactobacilli. Thus the systemic effects of certain candidate probiotics may include mast cell stabilization and such actions could contribute to the beneficial effect of these organisms in allergic and other inflammatory disorders.	[Forsythe, Paul; Wang, Binxiang; Khambati, Ibrahim; Kunze, Wolfgang A.] McMaster Univ, Brain Body Inst, Hamilton, ON, Canada; [Forsythe, Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat, Hamilton, ON, Canada; [Wang, Binxiang] McMaster Univ, Ctr Simulat Based Learning, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Forsythe, P (corresponding author), McMaster Univ, Brain Body Inst, Hamilton, ON, Canada.	forsytp@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada [371513-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada, grant number 371513-2009 (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba N, 2009, IMMUNOLOGY, V128, pe523, DOI 10.1111/j.1365-2567.2008.03022.x; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; BISSONNETTE EY, 1990, J IMMUNOL, V145, P3385; Bradding P, 2005, CHEM IMMUNOL ALLERGY, V87, P163, DOI 10.1159/000087643; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Duffy SM, 2008, EUR J IMMUNOL, V38, P2548, DOI 10.1002/eji.200738106; Duffy SM, 2007, EUR J IMMUNOL, V37, P1653, DOI 10.1002/eji.200637024; Duffy SM, 2005, FASEB J, V19, P1006, DOI 10.1096/fj.04-3439fje; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Eisenhut M, 2011, PFLUG ARCH EUR J PHY, V461, P401, DOI 10.1007/s00424-010-0917-y; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Forsythe P, 2010, IMMUNOL INVEST, V39, P429, DOI 10.3109/08820131003667978; Hille B, 1984, IONIC CHANNELS EXCIT; Hisbergues M, 2007, CLIN EXP ALLERGY, V37, P1286, DOI 10.1111/j.1365-2222.2007.02792.x; Inoue R, 2007, BRIT J DERMATOL, V156, P499, DOI 10.1111/j.1365-2133.2006.07695.x; Iwabuchi N, 2009, FEMS IMMUNOL MED MIC, V55, P324, DOI 10.1111/j.1574-695X.2008.00510.x; Kamiya T, 2006, GUT, V55, P191, DOI 10.1136/gut.2005.070987; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; KATAYAMA S, 1978, MICROBIOL IMMUNOL, V22, P89, DOI 10.1111/j.1348-0421.1978.tb00352.x; Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x; Kim JY, 2008, J MICROBIOL BIOTECHN, V18, P1393; KNUDSEN T, 1995, DAN MED BULL, V42, P441; KODA A, 1990, INT ARCH ALLER A IMM, V92, P209, DOI 10.1159/000235179; Kunze WA, 2007, SCIENCE UNPUB; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Kwon HK, P NATL ACAD SCI US, V107, P2159; Lyons A, CLIN EXP ALLERGY, V40, P811; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Magerl M, 2008, EXP DERMATOL, V17, P427, DOI 10.1111/j.1600-0625.2008.00704.x; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; Maurer M, 2003, EXP DERMATOL, V12, P886, DOI 10.1111/j.0906-6705.2003.0109a.x; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; NEMETH A, 1990, AGENTS ACTIONS, V30, P143; Oksaharju A, 2011, WORLD J GASTROENTERO, V17, P750, DOI 10.3748/wjg.v17.i6.750; OSKERITZIAN C, 1993, INT ARCH ALLERGY IMM, V100, P56; Rivera J, 2008, CURR ALLERGY ASTHM R, V8, P14, DOI 10.1007/s11882-008-0004-z; Rugiero F, 2002, J PHYSIOL-LONDON, V538, P447, DOI 10.1113/jphysiol.2001.013051; Schiffer C, 2011, J IMMUNOL, V187, P2646, DOI 10.4049/jimmunol.1002415; SCHWARTZ LB, 1980, J INVEST DERMATOL, V74, P349, DOI 10.1111/1523-1747.ep12543620; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Vancanneyt M, 2006, APPL ENVIRON MICROB, V72, P5376, DOI 10.1128/AEM.00091-06; Vliagoftis H, 2005, IMMUNOL REV, V206, P190, DOI 10.1111/j.0105-2896.2005.00279.x; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640	48	29	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41234	10.1371/journal.pone.0041234	http://dx.doi.org/10.1371/journal.pone.0041234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815978	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000084
J	Blohm, G				Blohm, Gunnar			Simulating the Cortical 3D Visuomotor Transformation of Reach Depth	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; EYE-HAND COORDINATION; PRIMARY MOTOR CORTEX; CAT STRIATE CORTEX; INTERSTITIAL NUCLEUS; VISUAL-CORTEX; RETINAL DISPARITY; BINOCULAR VISION; REFERENCE FRAME; CYCLOPEAN EYE	We effortlessly perform reach movements to objects in different directions and depths. However, how networks of cortical neurons compute reach depth from binocular visual inputs remains largely unknown. To bridge the gap between behavior and neurophysiology, we trained a feed-forward artificial neural network to uncover potential mechanisms that might underlie the 3D transformation of reach depth. Our physiologically-inspired 4-layer network receives distributed 3D visual inputs (1st layer) along with eye, head and vergence signals. The desired motor plan was coded in a population (3rd layer) that we read out (4th layer) using an optimal linear estimator. After training, our network was able to reproduce all known single-unit recording evidence on depth coding in the parietal cortex. Network analyses predict the presence of eye/head and vergence changes of depth tuning, pointing towards a gain-modulation mechanism of depth transformation. In addition, reach depth was computed directly from eye-centered (relative) visual distances, without explicit absolute depth coding. We suggest that these effects should be observable in parietal and pre-motor areas.	Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada	Queens University - Canada	Blohm, G (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.	gunnar.blohm@queensu.ca		Blohm, Gunnar/0000-0002-2297-3271	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Ontario Research Fund (Canada); Botterell Foundation (Queen's University, Kingston, Ontario, Canada)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund (Canada); Botterell Foundation (Queen's University, Kingston, Ontario, Canada)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Foundation for Innovation, the Ontario Research Fund (Canada) and the Botterell Foundation (Queen's University, Kingston, Ontario, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Baraduc P, 2001, CEREB CORTEX, V11, P906, DOI 10.1093/cercor/11.10.906; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Batista AP, 2007, J NEUROPHYSIOL; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Bhattacharyya R, 2009, J NEUROPHYSIOL, V102, P805, DOI 10.1152/jn.90359.2008; Blohm G, 2009, NEURON, V64, P598, DOI 10.1016/j.neuron.2009.11.022; Blohm G, 2007, J VISION, V7, DOI 10.1167/7.5.4; Blohm G, 2008, J VISION, V8, DOI 10.1167/8.16.3; Blohm G, 2009, CEREB CORTEX, V19, P1372, DOI 10.1093/cercor/bhn177; Bockisch CJ, 2001, VISION RES, V41, P2127, DOI 10.1016/S0042-6989(01)00094-3; Brotchie PR, 2003, NEUROIMAGE, V18, P178, DOI 10.1006/nimg.2002.1294; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2005, NEUROPSYCHOLOGIA; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Burns JK, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00221; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; CRAWFORD JD, 1994, J NEUROSCI, V14, P6911; CRAWFORD JD, 1992, J NEUROPHYSIOL, V68, P432, DOI 10.1152/jn.1992.68.2.432; CRAWFORD JD, 1991, SCIENCE, V252, P1551, DOI 10.1126/science.2047862; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Ferraina S, 2009, J NEUROSCI, V29, P11461, DOI 10.1523/JNEUROSCI.1305-09.2009; Ferraina S, 2009, NEUROPSYCHOLOGIA, V47, P1409, DOI 10.1016/j.neuropsychologia.2008.12.028; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; FUKUSHIMA K, 1992, NEUROSCI RES, V13, P301, DOI 10.1016/0168-0102(92)90041-A; FUKUSHIMA K, 1990, EXP BRAIN RES, V79, P25; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; Genovesio A, 2007, J NEUROSCI, V27, P3268, DOI 10.1523/JNEUROSCI.5415-06.2007; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Gnadt JW, 1998, NEUROREPORT, V9, P233, DOI 10.1097/00001756-199801260-00011; Hadjidimitrakis K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023335; Hager WW, 2005, SIAM J OPTIMIZ, V16, P170, DOI 10.1137/030601880; HASLWANTER T, 1992, VISION RES, V32, P1341, DOI 10.1016/0042-6989(92)90226-9; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2003, EXP BRAIN RES, V152, P70, DOI 10.1007/s00221-003-1523-4; Henriques DYP, 2002, ANN NY ACAD SCI, V956, P515, DOI 10.1111/j.1749-6632.2002.tb02870.x; HEPP K, 1995, VISION RES, V35, P3237, DOI 10.1016/0042-6989(95)00104-M; Hermundstad AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002063; Howard I. P., 2008, SEEING DEPTH; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Keith GP, 2007, J COMPUT NEUROSCI; Khokhotva M, 2005, VISION RES, V45, P2339, DOI 10.1016/j.visres.2005.04.007; KING WM, 1981, J NEUROPHYSIOL, V46, P549, DOI 10.1152/jn.1981.46.3.549; Krug K, 2011, J NEUROSCI, V31, P17892, DOI 10.1523/JNEUROSCI.2658-11.2011; LEHKY SR, 1990, PROC R SOC SER B-BIO, V240, P251, DOI 10.1098/rspb.1990.0037; MARSAGLIA G, 1972, ANN MATH STAT, V43, P645, DOI 10.1214/aoms/1177692644; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; Merriam ER, 2005, NEUROSCIENTIST, V11, P484, DOI 10.1177/1073858405276871; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; MULLER ME, 1959, COMMUN ACM, V2, P19, DOI 10.1145/377939.377946; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P556, DOI 10.1113/jphysiol.1966.sp008002; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; NIKARA T, 1968, EXP BRAIN RES, V6, P353; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; Ono H, 2002, VISION RES, V42, P1307, DOI 10.1016/S0042-6989(01)00281-4; ONO H, 1982, PERCEPT PSYCHOPHYS, V32, P201, DOI 10.3758/BF03206224; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P391; POGGIO GF, 1995, CEREB CORTEX, V5, P193, DOI 10.1093/cercor/5.3.193; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; POLAK E, 1969, REV FR INFORM RECH O, V3, P35; Polyak BT., 1969, USSR COMP MATH MATH, V9, P94, DOI [10.1016/0041-5553(69)90035-4, DOI 10.1016/0041-5553(69)90035-4]; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; POUGET A, 1994, CEREB CORTEX, V4, P314, DOI 10.1093/cercor/4.3.314; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Read J, 2005, PROG BIOPHYS MOL BIO, V87, P77, DOI 10.1016/j.pbiomolbio.2004.06.005; Read JCA, 2006, J VISION, V6, P1323, DOI 10.1167/6.12.1; Roe AW, 2007, J NEUROSCI, V27, P11820, DOI 10.1523/JNEUROSCI.4164-07.2007; Rushworth MFS, 2006, NEUROPSYCHOLOGIA, V44, P2700, DOI 10.1016/j.neuropsychologia.2005.12.007; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SALINAS E, 1995, J NEUROSCI, V15, P6461; Salinas E, 2001, Prog Brain Res, V130, P175; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; Scott SH, 2001, NAT NEUROSCI, V4, P969, DOI 10.1038/nn1001-969; Smith MA, 2005, J NEUROPHYSIOL, V93, P1742, DOI 10.1152/jn.00306.2004; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Soechting J F, 1990, J Cogn Neurosci, V2, P32, DOI 10.1162/jocn.1990.2.1.32; Somani RAB, 1998, VISION RES, V38, P911, DOI 10.1016/S0042-6989(97)00228-9; SUZUKI Y, 1995, EXP BRAIN RES, V106, P215; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tsutsui KI, 2005, NEUROSCI RES, V51, P221, DOI 10.1016/j.neures.2004.11.006; Tweed D, 1997, J NEUROPHYSIOL, V77, P654, DOI 10.1152/jn.1997.77.2.654; Uka T, 2002, CURR BIOL, V12, pR764, DOI 10.1016/S0960-9822(02)01287-3; VANRIJN LJ, 1993, VISION RES, V33, P691, DOI 10.1016/0042-6989(93)90189-4; Westheimer G, 2009, J PHYSIOL-LONDON, V587, P2807, DOI 10.1113/jphysiol.2009.170175; Wilcox LM, 2009, VISION RES, V49, P2653, DOI 10.1016/j.visres.2009.06.004; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Yang Y, 2011, J NEUROSCI, V31, P17905, DOI 10.1523/JNEUROSCI.4032-11.2011; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	103	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41241	10.1371/journal.pone.0041241	http://dx.doi.org/10.1371/journal.pone.0041241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815979	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100126
J	Chen, AD; Xiong, XQ; Gan, XB; Zhang, F; Zhou, YB; Gao, XY; Han, Y				Chen, Ai-Dong; Xiong, Xiao-Qing; Gan, Xian-Bing; Zhang, Feng; Zhou, Ye-Bo; Gao, Xing-Ya; Han, Ying			Endothelin-1 in Paraventricular Nucleus Modulates Cardiac Sympathetic Afferent Reflex and Sympathetic Activity in Rats	PLOS ONE			English	Article							RENOVASCULAR HYPERTENSIVE-RATS; ARTERIAL-PRESSURE; NAD(P)H OXIDASE; SUPEROXIDE ANION; ANGIOTENSIN-II; BINDING-SITES; VASOPRESSIN; BRAIN; RELEASE; MEDIATE	Background: Cardiac sympathetic afferent reflex (CSAR) is a positive-feedback, sympathoexcitatory reflex. Paraventricular nucleus (PVN) is an important component of the central neurocircuitry of the CSAR. The present study is designed to determine whether endothelin-1 (ET-1) in the PVN modulates the CSAR and sympathetic activity, and whether superoxide anions are involved in modulating the effects of ET-1 in the PVN in rats. Methodology/Principal Findings: In anaesthetized Sprague-Dawley rats with cervical vagotomy and sinoaortic denervation, renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were recorded. The CSAR was evaluated by the responses of the RSNA and MAP to epicardial application of capsaicin. Microinjection of ET-1 into the bilateral PVN dose-dependently enhanced the CSAR, increased the baseline RSNA and MAP. The effects of ET-1 were blocked by PVN pretreatment with the ETA receptor antagonist BQ-123. However, BQ-123 alone had no significant effects on the CSAR, the baseline RSNA and MAP. Bilateral PVN pretreatment with either superoxide anion scavenger tempol or polyethylene glycol-superoxide dismutase (PEG-SOD) inhibited the effects of ET-1 on the CSAR, RSNA and MAP. Microinjection of ET-1 into the PVN increased the superoxide anion level in the PVN, which was abolished by PVN pretreatment with BQ-123. Epicardial application of capsaicin increased superoxide anion level in PVN which was further enhanced by PVN pretreatment with ET-1. Conclusions: Exogenous activation of ETA receptors with ET-1 in the PVN enhances the CSAR, increases RSNA and MAP. Superoxide anions in PVN are involved in the effects of ET-1 in the PVN.	[Chen, Ai-Dong; Xiong, Xiao-Qing; Gan, Xian-Bing; Zhang, Feng; Zhou, Ye-Bo; Gao, Xing-Ya; Han, Ying] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Chen, Ai-Dong] Wannan Med Coll, Yijishan Hosp, Dept Clin Pharm, Wuhu, Peoples R China	Nanjing Medical University; Wannan Medical College	Chen, AD (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	yhancn@njmu.edu.cn		Han, Ying/0000-0001-8591-7894	Natural Science Fund of Nanjing Medical University [2010NJMUZ23]; Natural Science Fund of Jiangsu Provincial Department of Education [11KJB310002]; Chinese National Natural Science Fund [81100182]	Natural Science Fund of Nanjing Medical University; Natural Science Fund of Jiangsu Provincial Department of Education; Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Fund of Nanjing Medical University (2010NJMUZ23), Natural Science Fund of Jiangsu Provincial Department of Education (11KJB310002), and Chinese National Natural Science Fund (81100182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnier M, 2012, NEPHROL DIAL TRANSPL, V27, P865, DOI 10.1093/ndt/gfr704; Dammanahalli KJ, 2008, CLIN EXP PHARMACOL P, V35, P2, DOI 10.1111/j.1440-1681.2007.04830.x; De Giusti VC, 2008, LIFE SCI, V83, P264, DOI 10.1016/j.lfs.2008.06.008; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; FUXE K, 1989, ACTA PHYSIOL SCAND, V137, P563, DOI 10.1111/j.1748-1716.1989.tb08802.x; Gan XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025784; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Gu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014633; Gulati A, 1997, AM J PHYSIOL-HEART C, V273, pH1177, DOI 10.1152/ajpheart.1997.273.3.H1177; Han Y, 2005, BRAIN RES, V1058, P82, DOI 10.1016/j.brainres.2005.07.055; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Han Y, 2011, J APPL PHYSIOL, V110, P646, DOI 10.1152/japplphysiol.00908.2010; Han Y, 2011, PFLUG ARCH EUR J PHY, V461, P437, DOI 10.1007/s00424-011-0932-7; He JJ, 2008, NEUROSCIENCE, V152, P1006, DOI 10.1016/j.neuroscience.2007.11.051; HOROWITZ MJ, 1994, BRAIN RES, V648, P59, DOI 10.1016/0006-8993(94)91905-4; JONES CR, 1989, NEUROSCI LETT, V97, P276, DOI 10.1016/0304-3940(89)90610-1; Just A, 2008, AM J PHYSIOL-RENAL, V294, pF719, DOI 10.1152/ajprenal.00506.2007; KUWAKI T, 1994, JPN J PHYSIOL, V44, P1, DOI 10.2170/jjphysiol.44.1; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; LIU TH, 1989, AM J PHYSIOL, V256, pH589, DOI 10.1152/ajpheart.1989.256.2.H589; Lund AK, 2005, TOXICOL SCI, V88, P265, DOI 10.1093/toxsci/kfi284; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; Meimaridou E, 2005, FREE RADICAL BIO MED, V38, P1553, DOI 10.1016/j.freeradbiomed.2005.02.020; Nakamura K, 1999, J CARDIOVASC PHARM, V33, P876, DOI 10.1097/00005344-199906000-00007; NISHIMURA M, 1991, J HYPERTENS, V9, P71, DOI 10.1097/00004872-199101000-00011; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rossi NF, 1997, AM J PHYSIOL-ENDOC M, V272, pE126, DOI 10.1152/ajpendo.1997.272.1.E126; Rossi NF, 2000, AM J PHYSIOL-ENDOC M, V279, pE18, DOI 10.1152/ajpendo.2000.279.1.E18; Rossi NF, 2001, AM J PHYSIOL-ENDOC M, V280, pE349, DOI 10.1152/ajpendo.2001.280.2.E349; Rossi NF, 2006, EXP BIOL MED, V231, P1075; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Tai MH, 2005, FREE RADICAL BIO MED, V38, P450, DOI 10.1016/j.freeradbiomed.2004.11.015; Wang W, 2000, Heart Fail Rev, V5, P57; YAMAMOTO T, 1991, J CARDIOVASC PHARM, V17, pS316, DOI 10.1097/00005344-199100177-00090; Yao L, 2004, HYPERTENS RES, V27, P493, DOI 10.1291/hypres.27.493; Zahner MR, 2005, AM J PHYSIOL-REG I, V288, pR420, DOI 10.1152/ajpregu.00563.2004; Zeng QH, 2008, J PHARMACOL EXP THER, V326, P732, DOI 10.1124/jpet.108.140301; Zhang Y, 2006, BRAIN RES, V1082, P132, DOI 10.1016/j.brainres.2006.01.113; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhu GQ, 2009, EXP PHYSIOL, V94, P785, DOI 10.1113/expphysiol.2008.046565; Zucker Irving H, 2002, Heart Fail Monit, V3, P2	43	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40748	10.1371/journal.pone.0040748	http://dx.doi.org/10.1371/journal.pone.0040748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815806	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100062
J	Dunn, SR; Pernice, M; Green, K; Hoegh-Guldberg, O; Dove, SG				Dunn, Simon R.; Pernice, Mathieu; Green, Kathryn; Hoegh-Guldberg, Ove; Dove, Sophie G.			Thermal Stress Promotes Host Mitochondrial Degradation in Symbiotic Cnidarians: Are the Batteries of the Reef Going to Run Out?	PLOS ONE			English	Article							CYTOCHROME-C; SEA-ANEMONE; CELL-DEATH; OXIDATIVE STRESS; DIFFERENT FORMS; CLIMATE-CHANGE; NITRIC-OXIDE; PRIMARY SITE; HEAT-STRESS; APOPTOSIS	The symbiotic relationship between cnidarians and their dinoflagellate symbionts, Symbiodinium spp, which underpins the formation of tropical coral reefs, can be destabilized by rapid changes to environmental conditions. Although some studies have concluded that a breakdown in the symbiosis begins with increased reactive oxygen species (ROS) generation within the symbiont due to a decoupling of photosynthesis, others have reported the release of viable symbionts via a variety of host cell derived mechanisms. We explored an alternative model focused upon changes in host cnidarian mitochondrial integrity in response to thermal stress. Mitochondria are often likened to being batteries of the cell, providing energy in the form of ATP, and controlling cellular pathway activation and ROS generation. The overall morphology of host mitochondria was compared to that of associated symbionts under an experimental thermal stress using confocal and electron microscopy. The results demonstrate that hyperthermic stress induces the degradation of cnidarian host mitochondria that is independent of symbiont cellular deterioration. The potential sites of host mitochondrial disruption were also assessed by measuring changes in the expression of genes associated with electron transport and ATP synthesis using quantitative RT-PCR. The primary site of degradation appeared to be downstream of complex III of the electron transport chain with a significant reduction in host cytochrome c and ATP synthase expression. The consequences of reduced expression could limit the capacity of the host to mitigate ROS generation and maintain both organelle integrity and cellular energy supplies. The disruption of host mitochondria, cellular homeostasis, and subsequent cell death irrespective of symbiont integrity highlights the importance of the host response to thermal stress and in symbiosis dysfunction that has substantial implications for understanding how coral reefs will survive in the face of climate change.	[Dunn, Simon R.; Pernice, Mathieu; Hoegh-Guldberg, Ove; Dove, Sophie G.] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Pernice, Mathieu] Ecole Polytech Fed Lausanne, Lab Biol Geochem, Sch Architecture Civil & Environm Engn, Lausanne, Switzerland; [Green, Kathryn] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia	University of Queensland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Queensland; University of Queensland	Dunn, SR (corresponding author), Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia.	s.dunn2@uq.edu.au	Pernice, Mathieu/AAU-9285-2020; Hoegh-Guldberg, Ove/ABA-5420-2020; Hoegh-Guldberg, Ove/H-6169-2011; Dove, Sophie/I-7873-2013	Pernice, Mathieu/0000-0002-3431-2104; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Dove, Sophie/0000-0003-1823-8634	Australian Research Council [CE0561435, LP110100566]	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council through CE0561435 and LP110100566 grant funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Blackstone N, 2009, SEMIN CELL DEV BIOL, V20, P330, DOI 10.1016/j.semcdb.2008.12.006; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buxton L, 2012, J PHYCOL, V48, P117, DOI 10.1111/j.1529-8817.2011.01099.x; Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206; CHALKER BE, 1975, P ROY SOC LOND B BIO, V201, P179; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Donepudi M, 2002, BIOPHYS CHEM, V101, P145, DOI 10.1016/S0301-4622(02)00151-5; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Dunn SR, 2002, J EXP MAR BIOL ECOL, V272, P29, DOI 10.1016/S0022-0981(02)00036-9; DYKENS JA, 1992, J EXP BIOL, V168, P219; Eguchi Y, 1997, CANCER RES, V57, P1835; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Furla P, 2005, INTEGR COMP BIOL, V45, P595, DOI 10.1093/icb/45.4.595; Giddings TH, 2003, J MICROSC-OXFORD, V212, P53, DOI 10.1046/j.1365-2818.2003.01228.x; GILKEY JC, 1986, J ELECTRON MICR TECH, V3, P177, DOI 10.1002/jemt.1060030206; Giorgi C, 2008, CURR MOL MED, V8, P119; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Huang SP, 1998, ZOOL STUD, V37, P89; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iglesias-Prieto R., 1997, P1313; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; Kowaltowski AJ, 2005, ANTIOXID REDOX SIGN, V7, P508, DOI 10.1089/ars.2005.7.508; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; Lane N., 2002, OXYGEN MOL MADE WORL; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Martinou JC, 1999, NATURE, V399, P411, DOI 10.1038/20804; Matsubara S, 2004, P NATL ACAD SCI USA, V101, P18234, DOI 10.1073/pnas.0403857102; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Min L, 2007, MITOCHONDRION, V7, P13, DOI 10.1016/j.mito.2006.11.011; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Muscatine L., 1990, P75; Nii CM, 1997, BIOL BULL, V192, P444, DOI 10.2307/1542753; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ralph PJ, 2001, MAR ECOL PROG SER, V220, P163, DOI 10.3354/meps220163; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Richier S, 2003, BBA-GEN SUBJECTS, V1621, P84, DOI 10.1016/S0304-4165(03)00049-7; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Rozen S, 2000, Methods Mol Biol, V132, P365; Samudio I, 2006, MOL PHARMACOL, V69, P1182, DOI 10.1124/mol.105.018051; Sanchez-Alcazar JA, 2001, CANCER RES, V61, P1038; Saragosti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012508; Sawyer SJ, 2001, J EXP BIOL, V204, P3443; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Thomason JC, 2000, P 9 INT COR REEF S, P145; Trapido-Rosenthal HG, 2001, AM ZOOL, V41, P247, DOI 10.1668/0003-1569(2001)041[0247:NOACDS]2.0.CO;2; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2008, ENV MICROBI IN PRESS; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	79	63	63	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39024	10.1371/journal.pone.0039024	http://dx.doi.org/10.1371/journal.pone.0039024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815696	gold, Green Published			2022-12-27	WOS:000306466100013
J	Forno, E; Cloutier, MM; Datta, S; Paul, K; Sylvia, J; Calvert, D; Thornton-Thompson, S; Wakefield, DB; Brehm, J; Hamilton, RG; Alvarez, M; Colon-Semidey, A; Acosta-Perez, E; Canino, G; Celedon, JC				Forno, Erick; Cloutier, Michelle M.; Datta, Soma; Paul, Kathryn; Sylvia, Jody; Calvert, Deanna; Thornton-Thompson, Sherell; Wakefield, Dorothy B.; Brehm, John; Hamilton, Robert G.; Alvarez, Maria; Colon-Semidey, Angel; Acosta-Perez, Edna; Canino, Glorisa; Celedon, Juan C.			Mouse Allergen, Lung Function, and Atopy in Puerto Rican Children	PLOS ONE			English	Article							INNER-CITY CHILDREN; ASTHMATIC-CHILDREN; EXPOSURE; PREDICTORS; MORBIDITY; HOMES; COCKROACH; SUBURBAN; WHEEZE; BOSTON	Objective: To examine the relation between mouse allergen exposure and asthma in Puerto Rican children. Methods: Mus m 1, Der p 1, Bla g 2, and Fel d 1 allergens were measured in dust samples from homes of Puerto Rican children with (cases) and without (controls) asthma in Hartford, CT (n = 449) and San Juan (SJ), Puerto Rico (n = 678). Linear or logistic regression was used for the multivariate analysis of mouse allergen (Mus m 1) and lung function (FEV1 and FEV1/FVC) and allergy (total IgE and skin test reactivity (STR) to >= 1 allergen) measures. Results: associated with higher FEV1 in cases in Hartford (+70.6 ml, 95% confidence interval (CI) = 8.6-132.7 ml, P = 0.03) and SJ (+45.1 ml, 95% CI = -0.5 to 90.6 ml, P = 0.05). In multivariate analyses of controls, mouse allergen was inversely associated with STR to >= 1 allergen in non-sensitized children (odds ratio [ OR] for each log-unit increment in Mus m 1 = 0.7, 95% CI = 0.5-0.9, P<0.01). In a multivariate analysis including all children at both study sites, each log-increment in mouse allergen was positively associated with FEV1 (+28.3 ml, 95% CI = 1.4-55.2 ml, P = 0.04) and inversely associated with STR to >= 1 allergen (OR for each log-unit increment in Mus m 1 = 0.8, 95% CI = 0.6-0.9, P<0.01). Conclusions: Mouse allergen is associated with a higher FEV1 and lower odds of STR to >= 1 allergen in Puerto Rican children. This may be explained by the allergen itself or correlated microbial exposures.	[Forno, Erick] Univ Miami, Dept Pediat, Div Pediat Pulmonol, Miami, FL 33152 USA; [Cloutier, Michelle M.; Wakefield, Dorothy B.] Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT USA; [Datta, Soma; Paul, Kathryn; Sylvia, Jody] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Calvert, Deanna; Thornton-Thompson, Sherell] Connecticut Childrens Med Ctr, Hartford, CT USA; [Brehm, John; Celedon, Juan C.] Univ Pittsburgh, Sch Med, Dept Pediat,Childrens Hosp Pittsburgh, Div Pediat Pulm Med Allergy & Immunol,UPMC, Pittsburgh, PA 15261 USA; [Hamilton, Robert G.] Johns Hopkins Univ, Sch Med, Div Allergy & Immunol, Baltimore, MD USA; [Alvarez, Maria; Colon-Semidey, Angel; Acosta-Perez, Edna; Canino, Glorisa] Univ Puerto Rico, Behav Sci Res Inst, San Juan, PR 00936 USA	University of Miami; University of Connecticut; Harvard University; Brigham & Women's Hospital; Connecticut Children's Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Forno, E (corresponding author), Univ Miami, Dept Pediat, Div Pediat Pulmonol, Miami, FL 33152 USA.	juan.celedon@chp.edu	Pérez, Edna Acosta/AAW-6672-2021; Forno, Erick/I-1476-2019; Alvarez, Maria/GZH-1345-2022	Forno, Erick/0000-0001-6497-9885; Brehm, John/0000-0003-3138-6615; acosta, edna/0000-0001-7101-3157	U.S. National Institutes of Health [HL079966]; General Clinical Research Center at University of Connecticut Health Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079966] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center at University of Connecticut Health Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant HL079966 from the U.S. National Institutes of Health and General Clinical Research Center at the University of Connecticut Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird HR, 2006, J AM ACAD CHILD PSY, V45, P1032, DOI 10.1097/01.chi.0000227879.65651.cf; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chew GL, 2003, ENVIRON HEALTH PERSP, V111, P1348, DOI 10.1289/ehp.6124; Cohen RT, 2007, CHEST, V131, P1331, DOI 10.1378/chest.06-1917; Forno E, 2009, CURR OPIN ALLERGY CL, V9, P154, DOI 10.1097/ACI.0b013e3283292207; Gent JF, 2009, ENVIRON RES, V109, P768, DOI 10.1016/j.envres.2009.04.010; Hunninghake GM, 2006, AM J RESP CRIT CARE, V173, P143, DOI 10.1164/rccm.200508-1232SO; Kitch BT, 2000, ENVIRON HEALTH PERSP, V108, P301, DOI 10.2307/3454347; Leaderer BP, 2002, ENVIRON HEALTH PERSP, V110, P419, DOI 10.1289/ehp.02110419; Matsui EC, 2004, J ALLERGY CLIN IMMUN, V113, P910, DOI 10.1016/j.jaci.2004.02.034; Matsui EC, 2007, J ALLERGY CLIN IMMUN, V119, P910, DOI 10.1016/j.jaci.2006.12.663; Matsui EC, 2006, ANN ALLERG ASTHMA IM, V97, P514, DOI 10.1016/S1081-1206(10)60943-X; Montealegre F, 2004, J ASTHMA, V41, P485, DOI 10.1081/JAS-120033993; Phipatanakul W, 2008, ALLERGY, V63, P1512, DOI 10.1111/j.1398-9995.2008.01679.x; Phipatanakul W, 2005, ANN ALLERG ASTHMA IM, V94, P593, DOI 10.1016/S1081-1206(10)61139-8; Phipatanakul W, 2005, ALLERGY, V60, P697, DOI 10.1111/j.1398-9995.2005.00825.x; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1075, DOI 10.1067/mai.2000.110795; Ramsey CD, 2005, PEDIATR PULM, V39, P268, DOI 10.1002/ppul.20177; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Salo PW, 2009, ENVIRON HEALTH PERSP, V117, P387, DOI 10.1289/ehp.11847; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; Wood RA, 2011, J ALLERGY CLIN IMMUN, V127, P913, DOI 10.1016/j.jaci.2010.12.1122	22	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40383	10.1371/journal.pone.0040383	http://dx.doi.org/10.1371/journal.pone.0040383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815744	Green Published, gold			2022-12-27	WOS:000306466100035
J	Huang, YZ; Cai, B; Xu, M; Qiu, ZQ; Tao, YH; Zhang, Y; Wang, J; Xu, YL; Zhou, YH; Yang, J; Han, XF; Gao, Q				Huang, Yuzheng; Cai, Bing; Xu, Ming; Qiu, Zhiqin; Tao, Yonghui; Zhang, Ying; Wang, Jie; Xu, Yongliang; Zhou, Yonghua; Yang, Jing; Han, Xiaofeng; Gao, Qi			Gene Silencing of Toll-Like Receptor 2 Inhibits Proliferation of Human Liver Cancer Cells and Secretion of Inflammatory Cytokines	PLOS ONE			English	Article							PROMOTES TUMOR-GROWTH; IN-VITRO; HEPATITIS-B; EXPRESSION; TLR2; LIPOPOLYSACCHARIDE; METASTASIS; CARCINOMA; APOPTOSIS; INVASION	Background: Toll-like receptors (TLRs) are key factors in the innate immune system and initiate the inflammatory response to foreign pathogens such as bacteria, fungi and viruses. In the microenvironment of tumorigenesis, TLRs can promote inflammation and cell survival. Toll-like receptor 2/6 (TLR2/6) signaling in tumor cells is regarded as one of the mechanisms of chronic inflammation but it can also mediate tumor cell immune escape and tumor progression. However, the expression of TLR2 and its biological function in the development and progression of hepatocarcinoma have not been investigated. This study aimed to determine the expression of TLRs 1-10 in the established human hepatocellular carcinoma cell line BLE-7402, to investigate the biological effect of TLR2 on cell growth and survival. Methods: TLR expression in BLE-7402 cells was assayed by RT-PCR, real-time PCR and flow cytometry (FCM). To further investigate the function of TLR2 in hepatocarcinoma growth, BLE-7402 cells were transfected with recombinant plasmids expressing one of three forms of TLR2 siRNA (sh-TLR2 RNAi(A, B and C)). TLR2 knockdown was confirmed using RT-PCR, real-time PCR and fluorescence microscopy. Tumor cell proliferation was monitored by MTT assay and secreted cytokines in the supernatant of transfected cells were measured by bead-based FCM, the function of TLR2 siRNA was also investigated in vivo. Results: The BLE-7402 cell line expressed TLRs 2 to 10 at both mRNA and protein levels. TLR2 was the most highly expressed TLR. While all the three siRNAs inhibited TLR2 mRNA and protein expression, sh-TLR2 RNAi(B) had the strongest knockdown effect. TLR2 knockdown with sh-TLR2 RNAi(B) reduced cell proliferation. Furthermore, secretion of IL-6 and IL-8 was also reduced. The result showed a drastic reduction in tumor volume in mice treated with sh-TLR2 RNAi(B). Discussion: These results suggest that TLR2 knockdown inhibit proliferation of cultured hepatocarcinoma cells and decrease the secretion of cytokines. It is suggested that TLR2 silencing may worth further investigations for siRNA based gene therapy in treatment of hepatocarcinoma.	[Huang, Yuzheng; Xu, Ming; Tao, Yonghui; Zhang, Ying; Wang, Jie; Xu, Yongliang; Zhou, Yonghua; Yang, Jing; Gao, Qi] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China; [Cai, Bing] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Qiu, Zhiqin; Han, Xiaofeng] Nanjing Med Univ, Wuxi Secondly Peoples Hosp, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Nanjing Medical University; Nanjing Medical University	Huang, YZ (corresponding author), Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China.	xfenghan@hotmail.com; gaoqi54@hotmail.com	Huang, Yuzheng/AAW-2130-2021		Jiangsu Provincial Natural Science Foundation [BK2011175, BK2011164]; Health Research Program of Jiangsu Province [X200736, X201110]	Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Health Research Program of Jiangsu Province	This study was supported by grants from the Jiangsu Provincial Natural Science Foundation (BK2011175). YZH is supported by Jiangsu Provincial Natural Science Foundation (BK2011164), Health Research Program of Jiangsu Province (X200736, X201110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; Hassan F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-281; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hise AG, 2007, J IMMUNOL, V178, P1068, DOI 10.4049/jimmunol.178.2.1068; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Hua D, 2009, MOL IMMUNOL, V46, P2876, DOI 10.1016/j.molimm.2009.06.016; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Huang YZ, 2011, INT J MASS SPECTROM, V299, P191, DOI 10.1016/j.ijms.2010.10.013; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Molteni M, 2006, CANCER LETT, V235, P75, DOI 10.1016/j.canlet.2005.04.006; MOTYKA B, 1991, EUR J IMMUNOL, V21, P1951, DOI 10.1002/eji.1830210825; Muccioli M, 2012, ISRN ONCOL, V2012; Orihara K, 2007, CLIN EXP IMMUNOL, V148, P260, DOI 10.1111/j.1365-2249.2007.03352.x; Ren T, 2007, CANCER BIOL THER, V6, P1704, DOI 10.4161/cbt.6.11.4826; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Testro AG, 2009, J GASTROEN HEPATOL, V24, P943, DOI 10.1111/j.1440-1746.2009.05854.x; Thompson AJ, 2009, ANTIVIR THER, V14, P797, DOI 10.3851/IMP1294; Xu N, 2008, ACTA PHARMACOL SIN, V29, P239, DOI 10.1111/j.1745-7254.2008.00711.x; Yang HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006520	27	29	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e38890	10.1371/journal.pone.0038890	http://dx.doi.org/10.1371/journal.pone.0038890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815694	Green Submitted, gold, Green Published			2022-12-27	WOS:000306466100012
J	Lipka, DB; Wagner, MC; Dziadosz, M; Schnoder, T; Heidel, F; Schemionek, M; Melo, JV; Kindler, T; Muller-Tidow, C; Koschmieder, S; Fischer, T				Lipka, Daniel B.; Wagner, Marie-Christine; Dziadosz, Marek; Schnoeder, Tina; Heidel, Florian; Schemionek, Mirle; Melo, Junia V.; Kindler, Thomas; Mueller-Tidow, Carsten; Koschmieder, Steffen; Fischer, Thomas			Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR/ABL-POSITIVE LEUKEMIA; BCR-ABL; IMATINIB MESYLATE; TYROSINE KINASE; DOSE IMATINIB; STEM-CELLS; C-ABL; RESISTANCE	Clinical development of imatinib in CML established continuous target inhibition as a paradigm for successful tyrosine kinase inhibitor (TKI) therapy. However, recent reports suggested that transient potent target inhibition of BCR-ABL by high-dose TKI (HD-TKI) pulse-exposure is sufficient to irreversibly commit cells to apoptosis. Here, we report a novel mechanism of prolonged intracellular TKI activity upon HD-TKI pulse-exposure (imatinib, dasatinib) in BCR-ABL-positive cells. Comprehensive mechanistic exploration revealed dramatic intracellular accumulation of TKIs which closely correlated with induction of apoptosis. Cells were rescued from apoptosis upon HD-TKI pulse either by repetitive drug wash-out or by overexpression of ABC-family drug transporters. Inhibition of ABCB1 restored sensitivity to HD-TKI pulse-exposure. Thus, our data provide evidence that intracellular drug retention crucially determines biological activity of imatinib and dasatinib. These studies may refine our current thinking on critical requirements of TKI dose and duration of target inhibition for biological activity of TKIs.	[Lipka, Daniel B.; Wagner, Marie-Christine; Schnoeder, Tina; Heidel, Florian; Fischer, Thomas] Otto Von Guericke Univ, Univ Med Ctr, Dept Hematol & Oncol, Magdeburg, Germany; [Lipka, Daniel B.] German Canc Res Ctr, Div Epigenom & Canc Risk Factors, D-6900 Heidelberg, Germany; [Dziadosz, Marek] Otto Von Guericke Univ, Univ Med Ctr, Inst Forens Med, Magdeburg, Germany; [Schemionek, Mirle; Mueller-Tidow, Carsten; Koschmieder, Steffen] Univ Munster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany; [Schemionek, Mirle; Koschmieder, Steffen] Rhein Westfal TH Aachen, Dept Oncol Hematol & Stem Cell Transplantat, Univ Med Ctr, D-52062 Aachen, Germany; [Melo, Junia V.] Univ Adelaide, Dept Haematol, Ctr Canc Biol, Adelaide, SA, Australia; [Melo, Junia V.] Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London, England; [Kindler, Thomas] Johannes Gutenberg Univ Mainz, Dept Med 3, Univ Med Ctr, Mainz, Germany	Otto von Guericke University; Helmholtz Association; German Cancer Research Center (DKFZ); Otto von Guericke University; University of Munster; RWTH Aachen University; RWTH Aachen University Hospital; Centre for Cancer Biology; University of Adelaide; Imperial College London; Johannes Gutenberg University of Mainz	Lipka, DB (corresponding author), Otto Von Guericke Univ, Univ Med Ctr, Dept Hematol & Oncol, Magdeburg, Germany.	thomas.fischer@med.ovgu.de	Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014; Kindler, Thomas/K-5995-2013	Müller-Tidow, Carsten/0000-0002-7166-5232; Koschmieder, Steffen/0000-0002-1011-8171; Heidel, Florian/0000-0003-2438-1955	Wilhelm-Sander-Stiftung [2011.079.1]; Deutsche Forschungsgemeinschaft [GRK-1167, P17-2, SFB-854/1, TP20]; SA Pathology (Australia); National Institute for Health Research (NIHR) Biomedical Research Centre, UK funding scheme; Medical Research Council [G0600782] Funding Source: researchfish; MRC [G0600782] Funding Source: UKRI	Wilhelm-Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SA Pathology (Australia); National Institute for Health Research (NIHR) Biomedical Research Centre, UK funding scheme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by research funds granted by the "Wilhelm-Sander-Stiftung'' (No 2011.079.1 to FH, DL, and TF) and by the "Deutsche Forschungsgemeinschaft'' (GRK-1167, P17-2 to TF and SFB-854/1, TP20 to TF), and by SA Pathology (Australia) and the National Institute for Health Research (NIHR) Biomedical Research Centre, UK funding scheme (to JVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Chu S, 2007, CANCER RES, V67, P7045, DOI 10.1158/0008-5472.CAN-06-4312; Davies A, 2009, LEUKEMIA, V23, P1999, DOI 10.1038/leu.2009.166; Deenik W, 2010, BLOOD, V116, P6144, DOI 10.1182/blood-2010-07-296954; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Giannoudis A, 2008, BLOOD, V112, P3348, DOI 10.1182/blood-2007-10-116236; Heidel FH, 2012, ANN HEMATOL, V91, P331, DOI 10.1007/s00277-011-1311-3; Hiwase DK, 2009, LEUKEMIA, V23, P1205, DOI 10.1038/leu.2009.45; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jordanides NE, 2006, BLOOD, V108, P1370, DOI 10.1182/blood-2006-02-003145; Kindler T, 2003, LEUKEMIA, V17, P999, DOI 10.1038/sj.leu.2402940; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; le Coutre P, 2004, CANCER CHEMOTH PHARM, V53, P313, DOI 10.1007/s00280-003-0741-6; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; MARIE JP, 1993, LEUKEMIA, V7, P825; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Ni LN, 2011, MED ONCOL, V28, P265, DOI 10.1007/s12032-010-9456-9; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Samanta A, 2011, LEUKEMIA, V25, P463, DOI 10.1038/leu.2010.287; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Shah NP, 2008, J CLIN ONCOL, V26, P3204, DOI 10.1200/JCO.2007.14.9260; Shah NP, 2010, HAEMATOL-HEMATOL J, V95, P232, DOI 10.3324/haematol.2009.011452; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Snead JL, 2009, BLOOD, V114, P3459, DOI 10.1182/blood-2007-10-113969; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Walz C, 2012, BLOOD; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; White DL, 2011, HAEMATOLOGICA; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	47	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40853	10.1371/journal.pone.0040853	http://dx.doi.org/10.1371/journal.pone.0040853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815843	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100083
J	Rahman, MS; Thomas, P				Rahman, Md. Saydur; Thomas, Peter			Effects of Hypoxia Exposure on Hepatic Cytochrome P450 1A (CYP1A) Expression in Atlantic Croaker: Molecular Mechanisms of CYP1A Down-Regulation	PLOS ONE			English	Article							INDUCED GENE-EXPRESSION; NITRIC-OXIDE; UP-REGULATION; EROD ACTIVITY; CLONING; LIVER; FISH; METABOLISM; INHIBITION; SEQUENCE	Hypoxia-inducible factor-alpha (HIF-alpha) and cytochrome P450 1A (CYP1A) are biomarkers of environmental exposure to hypoxia and organic xenobiotic chemicals that act through the aryl hydrocarbon receptor, respectively. Many aquatic environments heavily contaminated with organic chemicals, such as harbors, are also hypoxic. Recently, we and other scientists reported HIF-alpha genes are upregulated by hypoxia exposure in aquatic organisms, but the molecular mechanisms of hypoxia regulation of CYP1A expression have not been investigated in teleost fishes. As a first step in understanding the molecular mechanisms of hypoxia modulation of CYP1A expression in fish, we characterized CYP1A cDNA from croaker liver. Hypoxia exposure (dissolved oxygen, DO: 1.7 mg/ L for 2 to 4 weeks) caused significant decreases in hepatic CYP1A mRNA and protein levels compared to CYP1A levels in fish held in normoxic conditions. In vivo studies showed that the nitric oxide (NO)-donor, S-nitroso-N-acetyl-DL-penicillamine, significantly decreased CYP1A expression in croaker livers, whereas the competitive inhibitor of NO synthase (NOS), N-omega-nitro-L-arginine methyl ester, restored CYP1A mRNA and protein levels in hypoxia-exposed (1.7 mg DO/L for 4 weeks) fish. In vivo hypoxia exposure also markedly increased interleukin-1 beta (IL-1 beta, a cytokine), HIF-2 alpha mRNA and endothelial NOS (eNOS) protein levels in croaker livers. Pharmacological treatment with vitamin E, an antioxidant, lowered the IL-1 beta, HIF-2 alpha mRNA and eNOS protein levels in hypoxia-exposed fish and completely reversed the down-regulation of hepatic CYP1A mRNA and protein levels in response to hypoxia exposure. These results suggest that hypoxia-induced down-regulation of CYP1A is due to alterations of NO and oxidant status, and cellular IL-1 beta and HIF-alpha levels. Moreover, the present study provides the first evidence of a role for antioxidants in hepatic eNOS and IL-1 beta regulation in aquatic vertebrates during hypoxic stress.	[Rahman, Md. Saydur; Thomas, Peter] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA	University of Texas System; University of Texas Austin	Rahman, MS (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	rahman@mail.utexas.edu	Thomas, Peter/U-9908-2019; Rahman, Mohammad Saifur/GZM-5483-2022; Rahman, Mohammad Sohelur/AAJ-7376-2020	Thomas, Peter/0000-0001-6656-4907; Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Mohammad Sohelur/0000-0002-4489-2202	National Oceanic and Atmospheric Administration Coastal Ocean Program Gulf of Mexico GOMEX [NA09NOS4780179]; National Science Foundation [IOS-1119242]	National Oceanic and Atmospheric Administration Coastal Ocean Program Gulf of Mexico GOMEX; National Science Foundation(National Science Foundation (NSF))	This study was supported by a grant from the National Oceanic and Atmospheric Administration Coastal Ocean Program Gulf of Mexico GOMEX, grant no. NA09NOS4780179 to PT, publication no. NGOMEX 1**, and National Science Foundation, grant no. IOS-1119242 to PT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agvald P, 2002, BRIT J PHARMACOL, V135, P373, DOI 10.1038/sj.bjp.0704489; BARKER CW, 1994, J BIOL CHEM, V269, P3985; BERNDTSON AK, 1994, ARCH BIOCHEM BIOPHYS, V310, P187, DOI 10.1006/abbi.1994.1156; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; Cavanagh JE, 2000, MAR POLLUT BULL, V41, P377, DOI 10.1016/S0025-326X(00)00135-1; El-Kadi AOS, 2000, DRUG METAB DISPOS, V28, P1112; Eum HA, 2006, NITRIC OXIDE-BIOL CH, V15, P423, DOI 10.1016/j.niox.2006.06.004; Fleming CR, 2011, ECOTOXICOLOGY, V20, P1300, DOI 10.1007/s10646-011-0686-1; Fleming CR, 2009, COMP BIOCHEM PHYS C, V150, P383, DOI 10.1016/j.cbpc.2009.06.003; FLOWERS NL, 1991, TOXICOLOGY, V68, P259; Fradette C, 2004, CURR DRUG METAB, V5, P257, DOI 10.2174/1389200043335577; Fradette C, 2007, DRUG METAB DISPOS, V35, P765, DOI 10.1124/dmd.106.013508; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Fujita Y, 1999, ARCH BIOCHEM BIOPHYS, V371, P24, DOI 10.1006/abbi.1999.1425; Galal A, 1999, BRIT J PHARMACOL, V128, P374, DOI 10.1038/sj.bjp.0702796; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; Goldstone JV, 2007, MOL BIOL EVOL, V24, P2619, DOI 10.1093/molbev/msm200; GOTOH O, 1992, J BIOL CHEM, V267, P83; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; GROVER SK, 1987, INT J VITAM NUTR RES, V57, P115; Haddad JJ, 2005, INT IMMUNOPHARMACOL, V5, P461, DOI 10.1016/j.intimp.2004.11.009; Hinton David E., 2008, P327, DOI 10.1201/9780203647295.ch7; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jonsson M, 2003, COMP BIOCHEM PHYS C, V136, P235, DOI 10.1016/j.cca.2003.09.005; Kavanagh RJ, 2001, BRIT J ANAESTH, V86, P110, DOI 10.1093/bja/86.1.110; Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1; KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147; Kim JH, 2008, MAR POLLUT BULL, V57, P433, DOI 10.1016/j.marpolbul.2008.01.005; Kraemer LD, 2004, COMP BIOCHEM PHYS C, V139, P23, DOI 10.1016/j.cca.2004.08.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CM, 2008, J BIOL CHEM, V283, P889, DOI 10.1074/jbc.M708821200; Lewis DFV, 1998, MUTAT RES-REV MUTAT, V410, P245, DOI 10.1016/S1383-5742(97)00040-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin A, 1996, FREE RADICAL BIO MED, V20, P99, DOI 10.1016/0891-5849(95)02010-1; Martinez ML, 2006, J EXP BIOL, V209, P3851, DOI 10.1242/jeb.02437; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; McNeill B, 2006, J EXP BIOL, V209, P4214, DOI 10.1242/jeb.02519; MORRISON HG, 1995, BIOCHEM J, V308, P97, DOI 10.1042/bj3080097; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Nikinmaa M, 2002, COMP BIOCHEM PHYS A, V133, P1, DOI 10.1016/S1095-6433(02)00132-0; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; Ockaili R, 1999, AM J PHYSIOL-HEART C, V277, pH2425, DOI 10.1152/ajpheart.1999.277.6.H2425; Olsvik PA, 2006, J EXP BIOL, V209, P2893, DOI 10.1242/jeb.02320; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Rahman MS, 2009, NEUROSCIENCE, V158, P751, DOI 10.1016/j.neuroscience.2008.10.029; Rahman MS, 2011, AM J PHYSIOL-ENDOC M, V301, pE637, DOI 10.1152/ajpendo.00168.2011; Rees CB, 2005, AQUACULTURE, V246, P11, DOI 10.1016/j.aquaculture.2004.12.025; Rice CD, 1998, MAR ENVIRON RES, V46, P87, DOI 10.1016/S0141-1136(97)00122-0; Richards JG, 2009, FISH PHYSIOL, V27, P443, DOI 10.1016/S1546-5098(08)00010-1; Ryu J, 2004, ENVIRON TOXICOL CHEM, V23, P1004, DOI 10.1897/03-27; Schild L, 2003, FASEB J, V17, P2194, DOI 10.1096/fj.02-1170com; Schlenk Daniel, 2008, P153, DOI 10.1201/9780203647295.ch4; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; STADLER J, 1994, P NATL ACAD SCI USA, V91, P3559, DOI 10.1073/pnas.91.9.3559; Stegeman John J., 1994, P87; Sullivan C, 2007, SCI TOTAL ENVIRON, V384, P221, DOI 10.1016/j.scitotenv.2007.06.006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas P, 2009, J EXP MAR BIOL ECOL, V381, pS38, DOI 10.1016/j.jembe.2009.07.008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi V, 2008, J ENDOCRINOL, V199, P307, DOI 10.1677/JOE-07-0509; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; WINK DA, 1993, ARCH BIOCHEM BIOPHYS, V300, P115, DOI 10.1006/abbi.1993.1016; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; YAMAZAKI S, 1993, J BIOCHEM-TOKYO, V114, P652, DOI 10.1093/oxfordjournals.jbchem.a124232; Yawetz A, 1998, ENVIRON TOXICOL PHAR, V6, P13, DOI 10.1016/S1382-6689(98)00014-3; Yu RMK, 2008, AQUAT TOXICOL, V90, P235, DOI 10.1016/j.aquatox.2008.09.004	78	46	51	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40825	10.1371/journal.pone.0040825	http://dx.doi.org/10.1371/journal.pone.0040825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815834	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100076
J	Rodriguez-Serrano, E; Inostroza-Michael, O; Avaria-Llautureo, J; Hernandez, CE				Rodriguez-Serrano, Enrique; Inostroza-Michael, Oscar; Avaria-Llautureo, Jorge; Hernandez, Cristian E.			Colony Size Evolution and the Origin of Eusociality in Corbiculate Bees (Hymenoptera: Apinae)	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; KIN SELECTION; MODEL; PHYLOGENY; MONOGAMY; SEQUENCE; BIOLOGY; SINGLE; ANTS	Recently, it has been proposed that the one of the main determinants of complex societies in Hymenoptera is colony size, since the existence of large colonies reduces the direct reproductive success of an average individual, given a decreased chance of being part of the reproductive caste. In this study, we evaluate colony size evolution in corbiculate bees and their relationship with the sociality level shown by these bees. Specifically i) the correlation between colony size and level of sociality considering the phylogenetic relationship to evaluate a general evolutionary tendency, and ii) the hypothetical ancestral forms of several clades within a phylogeny of corbiculate bees, to address idiosyncratic process occurring at important nodes. We found that the level of social complexity in corbiculate bees is phylogenetically correlated with colony size. Additionally, another process is invoked to propose why colony size evolved concurrently with the level of social complexity. The study of this trait improves the understanding of the evolutionary transition from simple to complex societies, and highlights the importance of explicit probabilistic models to test the evolution of other important characters involved in the origin of eusociality.	[Rodriguez-Serrano, Enrique; Inostroza-Michael, Oscar; Avaria-Llautureo, Jorge; Hernandez, Cristian E.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Lab Ecol Mol & Filoinformat, Concepcion, Chile	Universidad de Concepcion	Rodriguez-Serrano, E (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Lab Ecol Mol & Filoinformat, Concepcion, Chile.	enrodriguez@udec.cl	Hernández, Cristián E./GLS-1111-2022; Hernández, Cristián E./AAS-1286-2020; Hernández, Cristián E./C-4414-2012	Hernández, Cristián E./0000-0002-9811-2881; Hernández, Cristián E./0000-0002-9811-2881; Avaria-Llautureo, Jorge/0000-0002-8610-7428; Rodriguez-Serrano, Enrique/0000-0002-5049-8500	FONDECYT from the Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile [11080110]	FONDECYT from the Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported in part by FONDECYT 11080110 from the Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile http://www.conicyt.cl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexander R.D., 1991, P3; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; BREED MD, 1976, EVOLUTION, V30, P234, DOI [10.2307/2407698, 10.1111/j.1558-5646.1976.tb00906.x]; Cameron SA, 2001, SYST BIOL, V50, P194, DOI 10.1080/10635150151125851; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; Dew RM, 2012, INSECT SOC, V59, P207, DOI 10.1007/s00040-011-0206-6; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Harvey P, 1991, OXFORD SERIES ECOLOG; Heinrich B., 1979, BUMBLEBEE EC; Holbrook CT, 2011, BEHAV ECOL, V22, P960, DOI 10.1093/beheco/arr075; HOUSTON T F, 1976, Transactions of the Royal Society of South Australia, V100, P15; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; JEANNE RL, 1980, ANNU REV ENTOMOL, V25, P371, DOI 10.1146/annurev.en.25.010180.002103; Karsai I, 1998, P NATL ACAD SCI USA, V95, P8665, DOI 10.1073/pnas.95.15.8665; KUKUK PF, 1994, ANIM BEHAV, V47, P1475, DOI 10.1006/anbe.1994.1198; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison WP, 2019, MESQUITE MODULAR SYS; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Oster G.F., 1978, Monographs in Population Biology, pi; Otero JT, 2008, INSECT SOC, V55, P320, DOI 10.1007/s00040-008-1009-2; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M., 2007, BAYESTRAITS VERSION; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PAMILO P, 1991, AM NAT, V138, P412, DOI 10.1086/285224; RATNIEKS FLW, 1990, BEHAV ECOL SOCIOBIOL, V26, P343, DOI 10.1007/BF00171100; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Richards MH, 2003, P NATL ACAD SCI USA, V100, P7175, DOI 10.1073/pnas.1030738100; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Thompson GJ, 2000, J EVOLUTION BIOL, V13, P869, DOI 10.1046/j.1420-9101.2000.00237.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VILLET M, 1990, J NAT HIST, V24, P1321, DOI 10.1080/00222939000770791; WILLE A, 1983, ANNU REV ENTOMOL, V28, P41, DOI 10.1146/annurev.en.28.010183.000353; Williams P, 2007, BIOL J LINN SOC, V92, P97, DOI 10.1111/j.1095-8312.2007.00878.x; WILSON EO, 1959, ECOLOGY, V40, P437, DOI 10.2307/1929761	45	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40838	10.1371/journal.pone.0040838	http://dx.doi.org/10.1371/journal.pone.0040838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808274	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700062
J	Dougherty, JD; Zhang, J; Feng, HF; Gong, SC; Heintz, N				Dougherty, Joseph D.; Zhang, Juliet; Feng, Huifen; Gong, Shiaoching; Heintz, Nathaniel			Mouse Transgenesis in a Single Locus with Independent Regulation for Multiple Fluorophores	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; BACTERIAL ARTIFICIAL CHROMOSOME; CNS CELL-TYPES; FLUORESCENT PROTEIN; IN-VIVO; NERVOUS-SYSTEM; MICE; EXPRESSION; GENE; BAC	A major barrier to complex experimental design in mouse genetics is the allele problem: combining three or more alleles is time-consuming and inefficient. Here, we solve this problem for transgenic animals with a simple modification of existing BAC transgenesis protocols, and generate triple-colored 'prism' mice in which the major cell types of the brain: neurons, astrocytes, and oligodendrocytes, are each labeled with a distinct fluorophore. All three fluorophores are expressed from the same locus, yet each fluorophore is expressed in an independent temporal and spatial pattern. All three transgenes are generally co-inherited across multiple generations with stable genomic copy number and expression patterns. This generic solution should permit more sophisticated experimental manipulations to assess functional interactions amongst populations of cell types in vivo in a more rapid and efficient manner.	[Dougherty, Joseph D.; Zhang, Juliet; Heintz, Nathaniel] Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA; [Dougherty, Joseph D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Dougherty, Joseph D.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Feng, Huifen; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10021 USA; [Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Washington University (WUSTL); Washington University (WUSTL); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Dougherty, JD (corresponding author), Rockefeller Univ, Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	jdougherty@genetics.wustl.edu		Dougherty, Joseph/0000-0002-6385-3997	Howard Hughes Medical Institute; Simons Foundation; National Institute of Neurological Disorders and Stroke [1K99NS067239-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS067239] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Howard Hughes Medical Institute, the Simons Foundation, and the National Institute of Neurological Disorders and Stroke (1K99NS067239-01 to JDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Holz A, 1996, J NEUROSCI, V16, P467; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; Ma X, 2008, DRUG METAB DISPOS, V36, P2506, DOI 10.1124/dmd.108.022723; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Semprini S, 2009, MOL ENDOCRINOL, V23, P529, DOI 10.1210/me.2008-0399; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	31	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40511	10.1371/journal.pone.0040511	http://dx.doi.org/10.1371/journal.pone.0040511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808177	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400029
J	Clause, KC; Tchao, J; Powell, MC; Liu, LJ; Huard, J; Keller, BB; Tobita, K				Clause, Kelly C.; Tchao, Jason; Powell, Mary C.; Liu, Li J.; Huard, Johnny; Keller, Bradley B.; Tobita, Kimimasa			Developing Cardiac and Skeletal Muscle Share Fast-Skeletal Myosin Heavy Chain and Cardiac Troponin-I Expression	PLOS ONE			English	Article							C-PROTEIN; DEVELOPING HEART; STRIATED-MUSCLE; MESSENGER-RNA; MOUSE HEART; CELLS; CONTRACTION; ISOFORMS; FIBERS; EMBRYO	Skeletal muscle derived stem cells (MDSCs) transplanted into injured myocardium can differentiate into fast skeletal muscle specific myosin heavy chain (sk-fMHC) and cardiac specific troponin-I (cTn-I) positive cells sustaining recipient myocardial function. We have recently found that MDSCs differentiate into a cardiomyocyte phenotype within a three-dimensional gel bioreactor. It is generally accepted that terminally differentiated myocardium or skeletal muscle only express cTn-I or sk-fMHC, respectively. Studies have shown the presence of non-cardiac muscle proteins in the developing myocardium or cardiac proteins in pathological skeletal muscle. In the current study, we tested the hypothesis that normal developing myocardium and skeletal muscle transiently share both sk-fMHC and cTn-I proteins. Immunohistochemistry, western blot, and RT-PCR analyses were carried out in embryonic day 13 (ED13) and 20 (ED20), neonatal day 0 (ND0) and 4 (ND4), postnatal day 10 (PND10), and 8 week-old adult female Lewis rat ventricular myocardium and gastrocnemius muscle. Confocal laser microscopy revealed that sk-fMHC was expressed as a typical striated muscle pattern within ED13 ventricular myocardium, and the striated sk-fMHC expression was lost by ND4 and became negative in adult myocardium. cTn-I was not expressed as a typical striated muscle pattern throughout the myocardium until PND10. Western blot and RT-PCR analyses revealed that gene and protein expression patterns of cardiac and skeletal muscle transcription factors and sk-fMHC within ventricular myocardium and skeletal muscle were similar at ED20, and the expression patterns became cardiac or skeletal muscle specific during postnatal development. These findings provide new insight into cardiac muscle development and highlight previously unknown common developmental features of cardiac and skeletal muscle.	[Clause, Kelly C.; Tchao, Jason; Powell, Mary C.; Liu, Li J.; Tobita, Kimimasa] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Cardiovasc Dev Res Program, Pittsburgh, PA 15213 USA; [Clause, Kelly C.; Tchao, Jason; Tobita, Kimimasa] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Liu, Li J.; Tobita, Kimimasa] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Huard, Johnny] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA USA; [Huard, Johnny; Tobita, Kimimasa] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Keller, Bradley B.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Louisville	Clause, KC (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Cardiovasc Dev Res Program, Pittsburgh, PA 15213 USA.	kit3@pitt.edu		Tobita, Kimimasa/0000-0001-5435-8436	National Institutes of Health (NIH) [RO1 HL085777, R21 HL094402]; NIH [T32-HL76124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094402, R01HL085777, T32HL076124] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) RO1 HL085777, R21 HL094402, and NIH T32-HL76124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple FS, 1999, CLIN CHIM ACTA, V284, P151, DOI 10.1016/S0009-8981(99)00077-7; BAHLER M, 1985, DEV BIOL, V112, P345, DOI 10.1016/0012-1606(85)90405-1; Bortolotto SK, 2000, AM J PHYSIOL-CELL PH, V279, pC1564, DOI 10.1152/ajpcell.2000.279.5.C1564; CAMORETTIMERCADO B, 1993, CELL MOL BIOL RES, V39, P425; Clause KC, 2010, TISSUE ENG PART C-ME, V16, P375, DOI [10.1089/ten.tec.2009.0098, 10.1089/ten.TEC.2009.0098]; COGNARD C, 1992, PFLUG ARCH EUR J PHY, V422, P207, DOI 10.1007/BF00370424; Di Lisi R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-78; Du AP, 2008, DEV BIOL, V318, P236, DOI 10.1016/j.ydbio.2008.03.011; Fougerousse F, 1998, CIRC RES, V82, P130; Fredericks S, 2007, CLIN BIOCHEM, V40, P423, DOI 10.1016/j.clinbiochem.2006.12.008; Hamalainen N, 1997, J MUSCLE RES CELL M, V18, P401; Haufe V, 2005, J PHYSIOL-LONDON, V564, P683, DOI 10.1113/jphysiol.2004.079681; Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x; KAWASHIMA M, 1986, J BIOCHEM-TOKYO, V99, P1037, DOI 10.1093/oxfordjournals.jbchem.a135567; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Messner B, 2000, AM J CLIN PATHOL, V114, P544, DOI 10.1309/8KCL-UQRF-6EEL-36XK; Okada M, 2008, J AM COLL CARDIOL, V52, P1869, DOI 10.1016/j.jacc.2008.07.064; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; PEDROSADOMELLOF F, 1992, EXPERIENTIA, V48, P491, DOI 10.1007/BF01928171; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; Rutland CS, 2011, DEVELOPMENT, V138, P3955, DOI 10.1242/dev.059063; SAGGIN L, 1990, DEVELOPMENT, V110, P547; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; SARTORE S, 1978, NATURE, V274, P82, DOI 10.1038/274082a0; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; SUTHERLAND CJ, 1991, DEV BIOL, V146, P167, DOI 10.1016/0012-1606(91)90457-E; SWEENEY LJ, 1984, P NATL ACAD SCI-BIOL, V81, P797, DOI 10.1073/pnas.81.3.797; Tobita K, 2005, ANAT REC PART A, V283A, P193, DOI 10.1002/ar.a.20133; YASUDA M, 1995, J MOL CELL CARDIOL, V27, P2275, DOI 10.1016/S0022-2828(95)91731-4	32	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40725	10.1371/journal.pone.0040725	http://dx.doi.org/10.1371/journal.pone.0040725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808244	Green Published, gold, Green Accepted			2022-12-27	WOS:000306355500074
J	Li, YH; Guo, XW; Cao, XJ; Deng, W; Luo, W; Wang, WM				Li, Yanhe; Guo, Xianwu; Cao, Xiaojuan; Deng, Wei; Luo, Wei; Wang, Weimin			Population Genetic Structure and Post-Establishment Dispersal Patterns of the Red Swamp Crayfish Procambarus Clarkii in China	PLOS ONE			English	Article							RAPID EVOLUTION; SOFTWARE; DIVERSITY; VARIABILITY; BOTTLENECK; CRUSTACEAN; INVASION; DISTANCE; HISTORY; SUCCESS	The red swamp crayfish (Procambarus clarkii) was introduced to China in the early 20th century. It has been spread to almost all forms of fresh water bodies including lakes, rivers and even paddyfields in most provinces of China. To clarify issues such as the initial entry point(s), dispersal pattern, genetic diversity and genetic structure of Procambarus clarkii in China, the genetic structure and diversity of P. clarkii populations at 37 sampling sites (35 from China, one from the USA and one from Japan) were analyzed using both mitochondrial gene sequences (COI and 16S rRNA) and 12 nuclear microsatellites. Multiple tests including phylogenetic analyses, Bayesian assignment and analysis of isolation by distance showed that (i) the population from Japan and those collected from China, particularly from NanJing (BGt and XG) and its some neighboring sites (CJr, NT and NB), have similar genetic composition, (ii) relatively high genetic diversity was detected in Chinese populations, (iii) the P. clarkii populations in China did not experience significant population expansions. Taken together, Nanjing, Jiangsu province is the presumed initial entry point, and human-mediated dispersal and adaptive variation are likely responsible for the observed genetic pattern of P. clarkii in China.	[Li, Yanhe; Cao, Xiaojuan; Deng, Wei; Luo, Wei; Wang, Weimin] Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Li, Yanhe] Anhui Acad Agr Sci, Inst Fisheries, Hefei, Peoples R China; [Guo, Xianwu] Inst Politecn Nacl, Ctr Biotecnol Genom, Lab Biomed Mol, Colonia Narciso Mendoza, Tamaulipas, Mexico	Huazhong Agricultural University; Anhui Academy of Agricultural Sciences; Instituto Politecnico Nacional - Mexico	Li, YH (corresponding author), Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	wangwm@mail.hzau.edu.cn	Guo, Xianwu/D-6709-2018	Li, Yanhe/0000-0001-6451-4527	US Agency for International Development (USAID)	US Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is a component of the Aquafish-ACRSP (Aquaculture Collaborative Research Support Program), supported by the US Agency for International Development (USAID). The funders had no role in study design, data collcetion and analysis, decision to publish,or preparation of the manuscript.	ADAO H, 1993, CRUSTACEANA, V65, P336, DOI 10.1163/156854093X00766; Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Anastacio PM, 2005, FRESHWATER BIOL, V50, P697, DOI 10.1111/j.1365-2427.2005.01343.x; Arignon JCV, 1999, CRUSTACEAN ISS, V11, P129; Barbaresi S, 2003, BIOL INVASIONS, V5, P269, DOI 10.1023/A:1026133519707; Barbaresi Silvia, 2007, V2, P381; Belfiore NM, 2000, MOL ECOL, V9, P2231, DOI 10.1046/j.1365-294X.2000.105339.x; Bi K, 2008, EUR FOOD RES TECHNOL, V227, P1733, DOI 10.1007/s00217-008-0903-1; Cao Lingliang, 2010, Shengwu Duoyangxing, V18, P398, DOI 10.3724/SP.J.1003.2010.398; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crandall KA, 1995, FRESHWATER CRAYFISH, V10, P18; Cruz MJ, 2007, HYDROBIOLOGIA, V575, P191, DOI 10.1007/s10750-006-0376-9; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer OM., 1994, MOL MAR BIOL BIOTECH, V5, P304; Friar EA, 2000, MOL ECOL, V9, P2027, DOI 10.1046/j.1365-294X.2000.01111.x; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Habsburgo-Lorena AS, 1983, FRESHWATER CRAYFISH, V5, P552; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Huner J.V., 1988, P239; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kolbe JJ, 2007, MOL ECOL, V16, P1579, DOI 10.1111/j.1365-294X.2006.03135.x; Larson ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1114, DOI 10.1111/j.1466-8238.2012.00758.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Li J.L., 2007, INVASIVE AQUATIC SPE; Li S., 2005, CHIN AGR SCI B, V21, P156, DOI [10.3969/j.issn.1000-6850.2005.06.045, DOI 10.3969/J.ISSN.1000-6850.2005.06.045]; Li YH, 2011, INDIAN J EXP BIOL, V49, P953; Li Z., 2002, INVASIVE ALIEN SPECI; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Mayr E., 1965, P29; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vellend M, 2007, TRENDS ECOL EVOL, V22, P481, DOI 10.1016/j.tree.2007.02.017; Wang Changzhong, 2009, Shengwu Duoyangxing, V17, P518, DOI 10.3724/SP.J.1003.2009.09017; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yue GH, 2010, BIOL INVASIONS, V12, P2697, DOI 10.1007/s10530-009-9675-1; Zhan A, 2012, BIODIVERSITY DISTRIB, DOI [10.1111/j.1472-4642.2012.00894.x, DOI 10.1111/J.1472-4642.2012.00894.X]; Zhan AB, 2012, ECOL EVOL, V2, P1331, DOI 10.1002/ece3.258; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zhu ZY, 2008, MOL ECOL RESOUR, V8, P796, DOI 10.1111/j.1755-0998.2007.02067.x	53	42	48	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40652	10.1371/journal.pone.0040652	http://dx.doi.org/10.1371/journal.pone.0040652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808222	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500067
J	Grugni, V; Battaglia, V; Kashani, BH; Parolo, S; Al-Zahery, N; Achilli, A; Olivieri, A; Gandini, F; Houshmand, M; Sanati, MH; Torroni, A; Semino, O				Grugni, Viola; Battaglia, Vincenza; Kashani, Baharak Hooshiar; Parolo, Silvia; Al-Zahery, Nadia; Achilli, Alessandro; Olivieri, Anna; Gandini, Francesca; Houshmand, Massoud; Sanati, Mohammad Hossein; Torroni, Antonio; Semino, Ornella			Ancient Migratory Events in the Middle East: New Clues from the Y-Chromosome Variation of Modern Iranians	PLOS ONE			English	Article							SEQUENCE VARIATION; MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; HUMAN MIGRATIONS; MTDNA; HAPLOTYPES; ORIGIN; POLYMORPHISMS; DIVERSITY; DIFFUSION	Knowledge of high resolution Y-chromosome haplogroup diversification within Iran provides important geographic context regarding the spread and compartmentalization of male lineages in the Middle East and southwestern Asia. At present, the Iranian population is characterized by an extraordinary mix of different ethnic groups speaking a variety of Indo-Iranian, Semitic and Turkic languages. Despite these features, only few studies have investigated the multiethnic components of the Iranian gene pool. In this survey 938 Iranian male DNAs belonging to 15 ethnic groups from 14 Iranian provinces were analyzed for 84 Y-chromosome biallelic markers and 10 STRs. The results show an autochthonous but non-homogeneous ancient background mainly composed by J2a sub-clades with different external contributions. The phylogeography of the main haplogroups allowed identifying post-glacial and Neolithic expansions toward western Eurasia but also recent movements towards the Iranian region from western Eurasia (R1b-L23), Central Asia (Q-M25), Asia Minor (J2a-M92) and southern Mesopotamia (J1-Page08). In spite of the presence of important geographic barriers (Zagros and Alborz mountain ranges, and the Dasht-e Kavir and Dash-e Lut deserts) which may have limited gene flow, AMOVA analysis revealed that language, in addition to geography, has played an important role in shaping the nowadays Iranian gene pool. Overall, this study provides a portrait of the Y-chromosomal variation in Iran, useful for depicting a more comprehensive history of the peoples of this area as well as for reconstructing ancient migration routes. In addition, our results evidence the important role of the Iranian plateau as source and recipient of gene flow between culturally and genetically distinct populations.	[Grugni, Viola; Battaglia, Vincenza; Kashani, Baharak Hooshiar; Parolo, Silvia; Al-Zahery, Nadia; Olivieri, Anna; Gandini, Francesca; Torroni, Antonio; Semino, Ornella] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Houshmand, Massoud; Sanati, Mohammad Hossein] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran; [Semino, Ornella] Univ Pavia, Ctr Interdipartimentale Studi Genere, I-27100 Pavia, Italy	University of Pavia; University of Perugia; University of Pavia	Grugni, V (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol, Via Palestro 3, I-27100 Pavia, Italy.	ornella.semino@unipv.it	Achilli, Alessandro/I-9236-2012; OLIVIERI, ANNA/I-9235-2012; Al-Zahery, Nadia/AAV-5878-2020; Houshmand, Massoud/AEG-9909-2022; Battaglia, Vincenza/F-6950-2017; Gandini, Francesca/H-8936-2015; Torroni, Antonio/E-1557-2011	Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Gandini, Francesca/0000-0001-8930-8295; Torroni, Antonio/0000-0002-4163-4478; Houshmand, Massoud/0000-0002-2198-223X; Parolo, Silvia/0000-0002-3671-5353; , Masoud/0000-0001-7687-7464; SEMINO, Ornella/0000-0002-9675-9403; sanati, Mohammad Hossein/0000-0002-0292-7673	Fondazione Alma Mater Ticinensis; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca	Fondazione Alma Mater Ticinensis; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This research received support from Fondazione Alma Mater Ticinensis (to O.S. and A.T.), the Italian Ministry of the University: Progetti Ricerca Interesse Nazionale 2009 (to A.A., O.S. and A.T.) and FIRB-Futuro in Ricerca 2008 (to A.A. and A.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-59; AKBARI MT, 1986, AM J HUM GENET, V38, P84; Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Amanollahi-Baharvand S, 1992, LURS INVESTIGATION T; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Bosch E, 2003, HUM GENET, V112, P353, DOI 10.1007/s00439-003-0913-9; Briant P., 2006, CYRUS ALEXANDER HIST; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cruciani F, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9445; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Farjadian S, 2007, INT J IMMUNOGENET, V34, P457, DOI 10.1111/j.1744-313X.2007.00723.x; Farjadian Shirin, 2006, Iran J Immunol, V3, P106, DOI IJIv3i3A2; Flores C, 2003, ANN HUM GENET, V67, P138, DOI 10.1046/j.1469-1809.2003.00015.x; Ghirshman Roman, 1961, IRAN EARLIEST TIMES; Gimbutas M, 1970, PROTOINDOEUROPEAN CU; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gusmao A, 2008, ANN HUM GENET, V72, P215, DOI 10.1111/j.1469-1809.2007.00421.x; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; King RJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-69; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Lacau H, 2012, EUR J HUM G IN PRESS; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lamberg-Karlovsky CC, 2002, CURR ANTHROPOL, V43, P63, DOI 10.1086/324130; Lashgary Z, 2011, ANN HUM BIOL, V38, P364, DOI 10.3109/03014460.2010.535562; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nasidze I, 2006, CURR BIOL, V16, P668, DOI 10.1016/j.cub.2006.02.021; Nasidze I, 2005, ANN HUM GENET, V69, P401, DOI 10.1046/j.1529-8817.2005.00174.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Pala M, 2012, AM J HUM GE IN PRESS; Passarino G, 2001, HUM IMMUNOL, V62, P922, DOI 10.1016/S0198-8859(01)00291-9; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Rootsi S, 2012, EUR J HUM G IN PRESS; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Terreros MC, 2011, J HUM GENET, V56, P235, DOI 10.1038/jhg.2010.174; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	68	66	67	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41252	10.1371/journal.pone.0041252	http://dx.doi.org/10.1371/journal.pone.0041252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815981	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900101
J	Hersmus, R; van der Zwan, YG; Stoop, H; Bernard, P; Sreenivasan, R; Oosterhuis, W; Brueggenwirth, HT; de Boer, S; White, S; Wolffenbuttel, KP; Alders, M; McElreavy, K; Drop, SLS; Harley, VR; Looijenga, LHJ				Hersmus, Remko; van der Zwan, Yvonne G.; Stoop, Hans; Bernard, Pascal; Sreenivasan, Rajini; Oosterhuis, Wolter; Brueggenwirth, Hennie T.; de Boer, Suzan; White, Stefan; Wolffenbuttel, Katja P.; Alders, Marielle; McElreavy, Kenneth; Drop, Stenvert L. S.; Harley, Vincent R.; Looijenga, Leendert H. J.			A 46,XY Female DSD Patient with Bilateral Gonadoblastoma, a Novel SRY Missense Mutation Combined with a WT1 KTS Splice-Site Mutation	PLOS ONE			English	Article							GERM-CELL TUMORS; TESTICULAR DYSGENESIS SYNDROME; MALE SEXUAL DEVELOPMENT; FRASIER-SYNDROME; NUCLEAR IMPORT; MOSAIC FATHER; SOX9; EXPRESSION; DISORDERS; DIFFERENTIATION	Patients with Disorders of Sex Development (DSD), especially those with gonadal dysgenesis and hypovirilization are at risk of developing malignant type II germ cell tumors/cancer (GCC) (seminoma/dysgerminoma and nonseminoma), with either carcinoma in situ (CIS) or gonadoblastoma (GB) as precursor lesion. In 10-15% of 46,XY gonadal dysgenesis cases (i.e., Swyer syndrome), SRY mutations, residing in the HMG (High Mobility Group) domain, are found to affect nuclear transport or binding to and bending of DNA. Frasier syndrome (FS) is characterized by gonadal dysgenesis with a high risk for development of GB as well as chronic renal failure in early adulthood, and is known to arise from a splice site mutation in intron 9 of the Wilms' tumor 1 gene (WT1). Mutations in SRY as well as WT1 can lead to diminished expression and function of SRY, resulting in sub-optimal SOX9 expression, Sertoli cell formation and subsequent lack of proper testicular development. Embryonic germ cells residing in this unfavourable micro-environment have an increased risk for malignant transformation. Here a unique case of a phenotypically normal female (age 22 years) is reported, presenting with primary amenorrhoea, later diagnosed as hypergonadotropic hypogonadism on the basis of 46,XY gonadal dygenesis with a novel missense mutation in SRY. Functional in vitro studies showed no convincing protein malfunctioning. Laparoscopic examination revealed streak ovaries and a normal, but small, uterus. Pathological examination demonstrated bilateral GB and dysgerminoma, confirmed by immunohistochemistry. Occurrence of a delayed progressive kidney failure (focal segmental glomerular sclerosis) triggered analysis of WT1, revealing a pathogenic splice-site mutation in intron 9. Analysis of the SRY gene in an additional five FS cases did not reveal any mutations. The case presented shows the importance of multi-gene based diagnosis of DSD patients, allowing early diagnosis and treatment, thus preventing putative development of an invasive cancer.	[Hersmus, Remko; van der Zwan, Yvonne G.; Stoop, Hans; Oosterhuis, Wolter; Looijenga, Leendert H. J.] Erasmus MC Univ, Med Ctr, Josephine Nefkens Inst, Daniel den Hoed Canc Ctr,Dept Pathol, Rotterdam, Netherlands; [Bernard, Pascal; Sreenivasan, Rajini; Harley, Vincent R.] Prince Henrys Inst Med Res, Mol Genet & Dev Div, Clayton, Vic, Australia; [Sreenivasan, Rajini; McElreavy, Kenneth] Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic, Australia; [Brueggenwirth, Hennie T.] Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [de Boer, Suzan; White, Stefan] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Wolffenbuttel, Katja P.] Erasmus MC Univ, Med Ctr, Dept Pediat Urol, Rotterdam, Netherlands; [Alders, Marielle] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [McElreavy, Kenneth] Inst Pasteur, Human Dev Genet Unit, Paris, France; [van der Zwan, Yvonne G.; Drop, Stenvert L. S.] Erasmus MC Univ, Med Ctr, Dept Pediat Endocrinol, Sophia Childrens Hosp, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Prince Henry's Institute of Medical Research; University of Melbourne; Erasmus University Rotterdam; Erasmus MC; Monash University; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Hersmus, R (corresponding author), Erasmus MC Univ, Med Ctr, Josephine Nefkens Inst, Daniel den Hoed Canc Ctr,Dept Pathol, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Harley, Vincent/B-8092-2018; Hersmus, Remko/AAE-9953-2019; Sreenivasan, Rajini/G-6930-2019; Looijenga, Leendert/B-8145-2019	Harley, Vincent/0000-0002-2405-1262; Sreenivasan, Rajini/0000-0002-6357-5392; Looijenga, Leendert/0000-0002-8146-1911; Hersmus, Remko/0000-0001-5250-3572	Translational Research grant Erasmus MC; Erasmus MC and European Society for Pediatric Endocrinology Research Fellowship; Australian National Health and Medical Research Council [546517, 441102, 546478, 491293]	Translational Research grant Erasmus MC; Erasmus MC and European Society for Pediatric Endocrinology Research Fellowship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was financially supported by Translational Research grant Erasmus MC 2006 (to RH), Erasmus MC and European Society for Pediatric Endocrinology Research Fellowship (to YvdZ), the Australian National Health and Medical Research Council Program Grant 546517 and Fellowship 441102 (to VH), Grant 546478 and Fellowship 491293 (to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Cameron FJ, 1997, HUM MUTAT, V9, P388; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; de Jong J, 2005, J PATHOL, V206, P242, DOI 10.1002/path.1766; Filges I, 2011, FERTIL STERIL; GIESE K, 1994, P NATL ACAD SCI USA, V91, P3368, DOI 10.1073/pnas.91.8.3368; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Hersmus R, 2008, J PATHOL, V215, P31, DOI 10.1002/path.2335; Hersmus R, 2008, MOL CELL ENDOCRINOL, V291, P1, DOI 10.1016/j.mce.2008.02.028; Hersmus R, 2009, EUR J HUM GENET, V17, P1642, DOI 10.1038/ejhg.2009.96; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Isidor B, 2009, J CLIN ENDOCR METAB, V94, P3467, DOI 10.1210/jc.2009-0226; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Koopman P, 2001, J EXP ZOOL, V290, P463, DOI 10.1002/jez.1089; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Ottolenghi C, 2007, BIOESSAYS, V29, P15, DOI 10.1002/bies.20515; Park SY, 2005, ENDOCRINOLOGY, V146, P1035, DOI 10.1210/en.2004-1454; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; Schumacher V, 2008, MOL REPROD DEV, V75, P1484, DOI 10.1002/mrd.20889; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shahid M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-131; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Stoop H, 2008, J PATHOL, V216, P43, DOI 10.1002/path.2378; Thevenet L, 2004, EMBO J, V23, P3336, DOI 10.1038/sj.emboj.7600352; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; WOODWARD PJ, 2004, WHO CLASSIFICATION T, P217	35	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40858	10.1371/journal.pone.0040858	http://dx.doi.org/10.1371/journal.pone.0040858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815844	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900056
J	Ryan, TM; Shaw, CN				Ryan, Timothy M.; Shaw, Colin N.			Unique Suites of Trabecular Bone Features Characterize Locomotor Behavior in Human and Non-Human Anthropoid Primates	PLOS ONE			English	Article							OLD-WORLD MONKEYS; FEMORAL-HEAD; CANCELLOUS BONE; MICROSTRUCTURAL PROPERTIES; DIAPHYSEAL STRUCTURE; PHYLOGENETIC SIGNAL; ELASTIC PROPERTIES; BODY-MASS; MU-CT; ARCHITECTURE	Understanding the mechanically-mediated response of trabecular bone to locomotion-specific loading patterns would be of great benefit to comparative mammalian evolutionary morphology. Unfortunately, assessments of the correspondence between individual trabecular bone features and inferred behavior patterns have failed to reveal a strong locomotion-specific signal. This study assesses the relationship between inferred locomotor activity and a suite of trabecular bone structural features that characterize bone architecture. High-resolution computed tomography images were collected from the humeral and femoral heads of 115 individuals from eight anthropoid primate genera (Alouatta, Homo, Macaca, Pan, Papio, Pongo, Trachypithecus, Symphalangus). Discriminant function analyses reveal that subarticular trabecular bone in the femoral and humeral heads is significantly different among most locomotor groups. The results indicate that when a suite of femoral head trabecular features is considered, trabecular number and connectivity density, together with fabric anisotropy and the relative proportion of rods and plates, differentiate locomotor groups reasonably well. A similar, yet weaker, relationship is also evident in the trabecular architecture of the humeral head. The application of this multivariate approach to analyses of trabecular bone morphology in recent and fossil primates may enhance our ability to reconstruct locomotor behavior in the fossil record.	[Ryan, Timothy M.; Shaw, Colin N.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Ryan, Timothy M.; Shaw, Colin N.] Penn State Univ, Ctr Quantitat Imaging, EMS Energy Inst, University Pk, PA 16802 USA; [Shaw, Colin N.] Univ Cambridge, PAVE Res Grp, Cambridge, England; [Shaw, Colin N.] Univ Cambridge, McDonald Inst Archaeol Res, Dept Archaeol & Anthropol, Cambridge, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cambridge; University of Cambridge	Ryan, TM (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	tmr21@psu.edu			National Science Foundation [BCS-0617097]	National Science Foundation(National Science Foundation (NSF))	This project was supported by National Science Foundation grant number BCS-0617097 (to TMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Begun DR, 2007, SCIENCE, V318, DOI 10.1126/science.1146446; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cotter MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026658; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; COWIN SC, 1986, J BIOMECH ENG-T ASME, V108, P83, DOI 10.1115/1.3138584; Crompton RH, 2007, J ANAT, V210, P770; Doube M, 2011, P ROY SOC B-BIOL SCI, V278, P3067, DOI 10.1098/rspb.2011.0069; Eizirik Eduardo, 2004, P45; Fajardo RJ, 2000, AM J PHYS ANTHROPOL, P147; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Fajardo RJ, 2007, ANAT REC, V290, P422, DOI 10.1002/ar.20493; Fox JC, 2001, J THEOR BIOL, V212, P211, DOI 10.1006/jtbi.2001.2371; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Gosman JH, 2011, YEARB PHYS ANTHROPOL, V54, P86; Gosman JH, 2009, AM J PHYS ANTHROPOL, V138, P318, DOI 10.1002/ajpa.20931; Griffin NL, 2008, J HUM EVOL, V54, P162, DOI 10.1016/j.jhevol.2007.09.008; Griffin NL, 2010, J HUM EVOL, V59, P202, DOI 10.1016/j.jhevol.2010.06.006; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; HARRIGAN TP, 1988, J BIOMECH, V21, P269, DOI 10.1016/0021-9290(88)90257-6; Havill LM, 2010, BONE, V46, P835, DOI 10.1016/j.bone.2009.11.002; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hodgskinson R, 1990, Proc Inst Mech Eng H, V204, P43, DOI 10.1243/PIME_PROC_1990_204_227_02; Hodgskinson R, 1990, Proc Inst Mech Eng H, V204, P115, DOI 10.1243/PIME_PROC_1990_204_240_02; Judex S, 2004, J BONE MINER RES, V19, P600, DOI 10.1359/JBMR.040101; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Kabel J, 1999, BONE, V25, P481, DOI 10.1016/S8756-3282(99)00190-8; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; Kim DG, 2004, BONE, V35, P1375, DOI 10.1016/j.bone.2004.09.007; Lazenby RA, 2008, J ANAT, V213, P698, DOI 10.1111/j.1469-7580.2008.00991.x; MacLatchy L, 2002, J HUM EVOL, V43, P89, DOI 10.1006/jhev.2002.0559; Maga M, 2006, AM J PHYS ANTHROPOL, V129, P410, DOI 10.1002/ajpa.20276; Mittra E, 2005, J BIOMECH, V38, P1229, DOI 10.1016/j.jbiomech.2004.06.007; Mittra E, 2008, J BIOMECH, V41, P368, DOI 10.1016/j.jbiomech.2007.09.003; O'Neill MC, 2008, J HUM EVOL, V54, P309, DOI 10.1016/j.jhevol.2007.08.008; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Odgaard A, 1997, J BIOMECH, V30, P487, DOI 10.1016/S0021-9290(96)00177-7; Payseur BA, 1999, AM J PHYS ANTHROPOL, V109, P41, DOI 10.1002/(SICI)1096-8644(199905)109:1<41::AID-AJPA5>3.0.CO;2-X; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; Porter CA, 1997, INT J PRIMATOL, V18, P261, DOI 10.1023/A:1026328804319; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; RUFF C, 1988, J HUM EVOL, V17, P687, DOI 10.1016/0047-2484(88)90025-5; RUFF C, 1987, J HUM EVOL, V16, P391, DOI 10.1016/0047-2484(87)90069-8; Ruff CB, 2003, AM J PHYS ANTHROPOL, V120, P16, DOI 10.1002/ajpa.10118; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; RUFF CB, 1991, AM J PHYS ANTHROPOL, V86, P397, DOI 10.1002/ajpa.1330860306; Ruff C, 2008, J HUM EVOL, V54, P383, DOI 10.1016/j.jhevol.2007.09.001; Ruff C, 2009, AM J PHYS ANTHROPOL, V138, P90, DOI 10.1002/ajpa.20907; Ryan TM, 2006, J HUM EVOL, V51, P591, DOI 10.1016/j.jhevol.2006.06.004; Ryan TM, 2010, ANAT REC, V293, P719, DOI 10.1002/ar.21139; Ryan TM, 2005, J MORPHOL, V265, P249, DOI 10.1002/jmor.10315; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Ryan TM, 2002, J HUM EVOL, V43, P241, DOI 10.1006/jhev.2002.0575; Saparin P, 2009, BONE, V44, pS63, DOI 10.1016/j.bone.2009.01.031; Scherf H, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P39, DOI 10.1007/978-4-431-76933-0_4; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Shaw CN, 2011, AM J PHYS ANTHROPOL, V144, P22, DOI 10.1002/ajpa.21363; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P160, DOI 10.1002/ajpa.21063; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P149, DOI 10.1002/ajpa.21064; Smuts J.C, 1927, HOLISM EVOLUTION; Stauffer RL, 2001, J HERED, V92, P469, DOI 10.1093/jhered/92.6.469; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Tosi AJ, 2003, MOL PHYLOGENET EVOL, V27, P510, DOI 10.1016/S1055-7903(03)00024-1; TRUSSELL HJ, 1979, IEEE T SYST MAN CYB, V9, P311, DOI 10.1109/TSMC.1979.4310204; TURNER CH, 1990, J BIOMECH, V23, P549, DOI 10.1016/0021-9290(90)90048-8; Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8; Van Rietbergen B, 1998, J ORTHOPAED RES, V16, P23, DOI 10.1002/jor.1100160105; VanRietbergen B, 1996, J BIOMECH, V29, P1653, DOI 10.1016/0021-9290(96)00093-0; VIOLA TB, 2002, THESIS U VIENNA VIEN; Wallace IJ, 2010, AM J PHYS ANTHROPOL, V143, P21, DOI 10.1002/ajpa.21286; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; [No title captured]	77	69	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41037	10.1371/journal.pone.0041037	http://dx.doi.org/10.1371/journal.pone.0041037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975YY	22815902	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900068
J	Sugimoto, M; Watanabe, T; Sugimoto, Y				Sugimoto, Mayumi; Watanabe, Toshio; Sugimoto, Yoshikazu			The Molecular Effects of a Polymorphism in the 5 ' UTR of Solute Carrier Family 44, Member 5 that Is Associated with Birth Weight in Holsteins	PLOS ONE			English	Article							CHOLINE TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; EMBRYONIC-DEVELOPMENT; EXPRESSION; IDENTIFICATION; FERTILITY; EFFLUX; GROWTH; CATTLE; CELLS	Dystocia is a major problem for the dairy cattle industry, and the observed high rates of this condition stem from genetic selection to increase subsequent milk production of the calving female. Because smaller birth size does not adversely affect subsequent milk production, selecting for cows with a smaller birth size would reduce dystocia rates and be beneficial for both the cattle and the farmers. To identify genes that regulate birth weight, we conducted a genome-wide association study using 1151 microsatellite markers and identified a single nucleotide polymorphism (SNP) associated with birth weight: A-326G in the 59 untranslated region (UTR) of solute carrier family 44, member 5 (SLC44A5). Cows with higher birth weights carried the A polymorphism in the SLC44A5 59 UTR, and the presence of the A polymorphism correlated with a high rate of dystocia. Luciferase assays and quantitative polymerase chain reaction (QPCR) assays revealed that SLC44A5 transcripts with the A polymorphism are expressed at lower levels than those carrying the G polymorphism. SLC44A5 encodes a choline transporter-like protein, and choline is a component of the major phospholipids of cell membranes. Uptake studies in HeLa cells demonstrated that SLC44A5 knockdown reduces choline efflux, whereas SLC44A5 overexpression resulted in the opposite effect. Furthermore, cell viability assays indicated that SLC44A5 knockdown increased cell proliferation, whereas SLC44A5 overexpression repressed proliferation. Taken together, our results suggest that calves with reduced SLC44A5 expression are larger due to enhanced cell proliferation. This study provides novel insights into the molecular mechanisms that control birth weight in Holsteins and suggests that SLC44A5 may serve as a potential target for preventing dystocia.	[Sugimoto, Mayumi] Natl Livestock Breeding Ctr, Nishigo, Japan; [Watanabe, Toshio; Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Nishigo, Japan		Sugimoto, M (corresponding author), Natl Livestock Breeding Ctr, Nishigo, Japan.	m0komats@nlbc.go.jp			Japan Racing and Livestock Promotion Foundation	Japan Racing and Livestock Promotion Foundation	This work was supported by the Japan Racing and Livestock Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardalan M, 2010, J ANIM PHYSIOL AN N, V94, pE259, DOI 10.1111/j.1439-0396.2009.00966.x; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Cheng KR, 2008, AM J PHYSIOL-GASTR L, V295, pG591, DOI 10.1152/ajpgi.00055.2008; Coffey MP, 2006, J DAIRY SCI, V89, P322, DOI 10.3168/jds.S0022-0302(06)72097-5; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Kouji H, 2009, ARCH BIOCHEM BIOPHYS, V483, P90, DOI 10.1016/j.abb.2008.12.008; Li YL, 1997, J CLIN INVEST, V100, P2873, DOI 10.1172/JCI119836; Maltecca C, 2009, ANIM GENET, V40, P27, DOI 10.1111/j.1365-2052.2008.01793.x; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Mee I, 2008, VET J, V176, P93, DOI 10.1016/j.tvjl.2007.12.032; Miakotina OL, 2005, AM J PHYSIOL-LUNG C, V288, pL93, DOI 10.1152/ajplung.00184.2004; Michel V, 2006, EXP BIOL MED, V231, P490; Pritchard JK, 2000, GENETICS, V155, P945; Sanchez X, 1998, J IMMUNOL, V160, P906; Sugimoto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013817; Swali A, 2006, THERIOGENOLOGY, V66, P1173, DOI 10.1016/j.theriogenology.2006.03.028; Thomasen JR, 2008, J DAIRY SCI, V91, P2098, DOI 10.3168/jds.2007-0602; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; Uchida Y, 2009, J PHARMACOL SCI, V109, P102, DOI 10.1254/jphs.08291FP; Wang T, 2007, ACTA BIOCH BIOPH SIN, V39, P668, DOI 10.1111/j.1745-7270.2007.00323.x; Watanabe T, 2008, ANIM GENET, V39, P374, DOI 10.1111/j.1365-2052.2008.01742.x; WONG TY, 1982, NEUROSCI LETT, V29, P293, DOI 10.1016/0304-3940(82)90332-9; YAVIN E, 1976, J BIOL CHEM, V251, P1392; Yuan ZF, 2004, GENE, V341, P305, DOI 10.1016/j.gene.2004.07.042; ZEISEL SH, 1992, J AM COLL NUTR, V11, P473; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zufferey R, 2004, NEUROCHEM RES, V29, P461, DOI 10.1023/B:NERE.0000013752.43906.e5	36	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41267	10.1371/journal.pone.0041267	http://dx.doi.org/10.1371/journal.pone.0041267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815983	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900103
J	Bukowski, R; Chlebowski, RT; Thune, I; Furberg, AS; Hankins, GDV; Malone, FD; D'Alton, ME				Bukowski, Radek; Chlebowski, Rowan T.; Thune, Inger; Furberg, Anne-Sofie; Hankins, Gary D. V.; Malone, Fergal D.; D'Alton, Mary E.			Birth Weight, Breast Cancer and the Potential Mediating Hormonal Environment	PLOS ONE			English	Article							PLASMA PROTEIN-A; HUMAN CHORIONIC-GONADOTROPIN; ALPHA-FETOPROTEIN; PREGNANCY CHARACTERISTICS; COLLABORATIVE REANALYSIS; FRACTIONAL POLYNOMIALS; ESTROGEN-RECEPTOR; INDIVIDUAL DATA; MATERNAL SERUM; PAPP-A	Background: Previous studies have shown that woman's risk of breast cancer in later life is associated with her infants birth weights. The objective of this study was to determine if this association is independent of breast cancer risk factors, mother's own birth weight and to evaluate association between infants birth weight and hormonal environment during pregnancy. Independent association would have implications for understanding the mechanism, but also for prediction and prevention of breast cancer. Methods and Findings: Risk of breast cancer in relation to a first infant's birth weight, mother's own birth weight and breast cancer risk factors were evaluated in a prospective cohort of 410 women in the Framingham Study. Serum concentrations of estriol (E3), anti-estrogen alpha-fetoprotein (AFP), and pregnancy-associated plasma protein-A (PAPP-A) were measured in 23,824 pregnant women from a separate prospective cohort, the FASTER trial. During follow-up (median, 14 years) 31 women (7.6 %) were diagnosed with breast cancer. Women with large birth weight infants (in the top quintile) had a higher breast cancer risk compared to other women (hazard ratio (HR), 2.5; 95% confidence interval (CI), 1.2-5.2; P = 0.012). The finding was not affected by adjustment for birth weight of the mother and traditional breast cancer risk factors (adjusted HR, 2.5; 95% CI, 1.2-5.6; P = 0.021). An infant's birth weight had a strong positive relationship with the mother's serum E3/AFP ratio and PAPP-A concentration during pregnancy. Adjustment for breast cancer risk factors did not have a material effect on these relationships. Conclusions: Giving birth to an infant with high birth weight was associated with increased breast cancer risk in later life, independently of mother's own birth weight and breast cancer risk factors and was also associated with a hormonal environment during pregnancy favoring future breast cancer development and progression.	[Bukowski, Radek; Hankins, Gary D. V.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Thune, Inger] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Thune, Inger; Furberg, Anne-Sofie] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Malone, Fergal D.] Royal Coll Surgeons Ireland, Dept Obstet & Gynecol, Dublin 2, Ireland; [D'Alton, Mary E.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA	University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Oslo; UiT The Arctic University of Tromso; Royal College of Surgeons - Ireland; Columbia University	Bukowski, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.	rkbukows@utmb.edu			National Heart, Lung, and Blood Institute; Boston University [N01-HC-25195]; National Institutes of Health and National Institute of Child Health and Human Development [RO1 HD 38625]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; National Institutes of Health and National Institute of Child Health and Human Development; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or National Heart, Lung, and Blood Institute. FASTER trial was supported by grant from National Institutes of Health and National Institute of Child Health and Human Development (RO1 HD 38625). The funders did not have any involvement in the design of the study; the collection, analysis, and interpretation of the data; the writing of the article; or the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Framingham Heart Study, Boston University, National Heart, Lung, and Blood Institute, National Institute of Child Health and Human Development or the National Institutes of Health.	Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Benn PA, 2002, CLIN CHIM ACTA, V323, P1, DOI 10.1016/S0009-8981(02)00186-9; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Bukowski R, 2008, OBSTET GYNECOL, V111, P1065, DOI 10.1097/AOG.0b013e3181704e48; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Catov JM, 2006, ANN EPIDEMIOL, V16, P429, DOI 10.1016/j.annepidem.2005.09.004; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chen WY, 2004, CANCER, V101, P1490, DOI 10.1002/cncr.20499; Chlebowski R, 2007, J NUTR, V137, p233S, DOI 10.1093/jn/137.1.233S; Cnattingius S, 2005, JAMA-J AM MED ASSOC, V294, P2474, DOI 10.1001/jama.294.19.2474; Cresswell JL, 1997, EARLY HUM DEV, V49, P143, DOI 10.1016/S0378-3782(97)00028-5; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hill M, 2010, J STEROID BIOCHEM, V121, P594, DOI 10.1016/j.jsbmb.2009.10.012; Joy JE, 2005, SAVING WOMENS LIVES; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P493, DOI 10.1002/uog.5332; KUHAJDA FP, 1985, AM J PATHOL, V121, P342; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIN TM, 1974, J CLIN INVEST, V54, P576, DOI 10.1172/JCI107794; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Melbye M, 2000, JNCI-J NATL CANCER I, V92, P1001, DOI 10.1093/jnci/92.12.1001; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; SEPPALA M, 1972, LANCET, V1, P375; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; Tehranifar P, 2009, AM J EPIDEMIOL, V170, P910, DOI 10.1093/aje/kwp205; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Vakharia D, 2000, BREAST CANCER RES TR, V63, P41, DOI 10.1023/A:1006484223325; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; WESTERGAARD JG, 1983, ARCH GYNECOL, V233, P211, DOI 10.1007/BF02114602; Whiteman MK, 2003, OBSTET GYNECOL, V101, P264, DOI 10.1016/S0029-7844(02)02593-0; Wohlfahrt J, 1999, EPIDEMIOLOGY, V10, P441, DOI 10.1097/00001648-199907000-00017; Xu XH, 2009, J WOMENS HEALTH, V18, P1169, DOI 10.1089/jwh.2008.1034; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yaron Y, 1999, AM J OBSTET GYNECOL, V181, P968, DOI 10.1016/S0002-9378(99)70334-0; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	47	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40199	10.1371/journal.pone.0040199	http://dx.doi.org/10.1371/journal.pone.0040199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815728	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000011
J	Ahmed, SSSJ; Ramakrishnan, V				Ahmed, Shiek S. S. J.; Ramakrishnan, V.			Systems Biological Approach of Molecular Descriptors Connectivity: Optimal Descriptors for Oral Bioavailability Prediction	PLOS ONE			English	Article							HUMAN INTESTINAL-ABSORPTION; ADME EVALUATION; DRUG DISCOVERY; FEATURE-SELECTION; PROTEIN-BINDING; QSAR MODEL; ANALOGS; HUMANS	Background: Poor oral bioavailability is an important parameter accounting for the failure of the drug candidates. Approximately, 50% of developing drugs fail because of unfavorable oral bioavailability. In silico prediction of oral bioavailability (%F) based on physiochemical properties are highly needed. Although many computational models have been developed to predict oral bioavailability, their accuracy remains low with a significant number of false positives. In this study, we present an oral bioavailability model based on systems biological approach, using a machine learning algorithm coupled with an optimal discriminative set of physiochemical properties. Results: The models were developed based on computationally derived 247 physicochemical descriptors from 2279 molecules, among which 969, 605 and 705 molecules were corresponds to oral bioavailability, intestinal absorption (HIA) and caco-2 permeability data set, respectively. The partial least squares discriminate analysis showed 49 descriptors of HIA and 50 descriptors of caco-2 are the major contributing descriptors in classifying into groups. Of these descriptors, 47 descriptors were commonly associated to HIA and caco-2, which suggests to play a vital role in classifying oral bioavailability. To determine the best machine learning algorithm, 21 classifiers were compared using a bioavailability data set of 969 molecules with 47 descriptors. Each molecule in the data set was represented by a set of 47 physiochemical properties with the functional relevance labeled as (+bioavailability/2bioavailability) to indicate good-bioavailability/poor-bioavailability molecules. The best-performing algorithm was the logistic algorithm. The correlation based feature selection (CFS) algorithm was implemented, which confirms that these 47 descriptors are the fundamental descriptors for oral bioavailability prediction. Conclusion: The logistic algorithm with 47 selected descriptors correctly predicted the oral bioavailability, with a predictive accuracy of more than 71%. Overall, the method captures the fundamental molecular descriptors, that can be used as an entity to facilitate prediction of oral bioavailability.	[Ahmed, Shiek S. S. J.] Chettinad Univ, Dept Computat Biol, Kelambakkam, Tamil Nadu, India; [Ramakrishnan, V.] Chettinad Univ, Dept Genet, Kelambakkam, Tamil Nadu, India		Ahmed, SSSJ (corresponding author), Chettinad Univ, Dept Computat Biol, Kelambakkam, Tamil Nadu, India.	bioinfoshiek@gmail.com	Ramakrishnan, Veerabathiran/HGU-7117-2022	Ramakrishnan, Veerabathiran/0000-0002-9307-5428	council of scientific & industrial research, government of India; Council of Scientific & Industrial Research (CSIR), India	council of scientific & industrial research, government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by council of scientific & industrial research, government of India. The funding agency has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professors RM. Pitchappan and R. Murugesan for their intellectual input. This work was supported by the Council of Scientific & Industrial Research (CSIR), India.	Ahmed SSSJ, 2010, J THEOR COMPUT CHEM, V9, P975, DOI 10.1142/S0219633610006146; Ahmed SSSJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-6; Andrews CW, 2000, PHARM RES-DORDR, V17, P639, DOI 10.1023/A:1007556711109; Caldwell G W, 2000, Curr Opin Drug Discov Devel, V3, P30; Fujiwara S, 2002, INT J PHARMACEUT, V237, P95, DOI 10.1016/S0378-5173(02)00045-5; Gayathri P, 2001, BIOORGAN MED CHEM, V9, P3059, DOI 10.1016/S0968-0896(01)00210-3; Gupta MK, 2006, J CHEM INF MODEL, V46, P93, DOI 10.1021/ci0501140; The HP, 2011, MOL INFORM, V30, P376, DOI 10.1002/minf.201000118; Han V, 1998, DRUG BIOAVAILABILITY; Hou TJ, 2007, J CHEM INF MODEL, V47, P2408, DOI 10.1021/ci7002076; Hou TJ, 2007, J CHEM INF MODEL, V47, P460, DOI 10.1021/ci6003515; Hou TJ, 2007, J CHEM INF MODEL, V47, P208, DOI 10.1021/ci600343x; Hou TJ, 2004, J CHEM INF COMP SCI, V44, P1585, DOI 10.1021/ci049884m; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Jang GR, 2001, MED RES REV, V21, P382, DOI 10.1002/med.1015; Kennedy T, 1997, DRUG DISCOV TODAY, V2, P436, DOI 10.1016/S1359-6446(97)01099-4; Li J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000450; Ma CY, 2008, J PHARMACEUT BIOMED, V47, P677, DOI 10.1016/j.jpba.2008.03.023; Moda TL, 2007, BIOORGAN MED CHEM, V15, P7738, DOI 10.1016/j.bmc.2007.08.060; Nassar AEF, 2004, DRUG DISCOV TODAY, V9, P1020, DOI 10.1016/S1359-6446(04)03280-5; Ooi CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-320; Paixao P, 2010, EUR J PHARM SCI, V41, P107, DOI 10.1016/j.ejps.2010.05.014; Reddy AS, 2010, J MOL GRAPH MODEL, V28, P852, DOI 10.1016/j.jmgm.2010.03.005; Ruiz-Garcia A, 2011, ORAL BIOAVAILABILITY; Subramanian G, 2006, J MOL MODEL, V12, P577, DOI 10.1007/s00894-005-0065-z; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Tian S, 2011, MOL PHARMACEUT, V8, P841, DOI 10.1021/mp100444g; Turner JV, 2003, ANAL CHIM ACTA, V485, P89, DOI 10.1016/S0003-2670(03)00406-9; Varma MVS, 2010, J MED CHEM, V53, P1098, DOI 10.1021/jm901371v; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang JM, 2006, J CHEM INF MODEL, V46, P2674, DOI 10.1021/ci060087t; Yan AX, 2008, INT J MOL SCI, V9, P1961, DOI 10.3390/ijms9101961; Yoshida F, 2000, J MED CHEM, V43, P2575, DOI 10.1021/jm0000564; Zhou W, 2012, INT J MOL SCI, V13, P1161, DOI 10.3390/ijms13011161; Zhu JY, 2011, COMB CHEM HIGH T SCR, V14, P362, DOI 10.2174/138620711795508368	35	27	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40654	10.1371/journal.pone.0040654	http://dx.doi.org/10.1371/journal.pone.0040654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815781	gold, Green Submitted, Green Published			2022-12-27	WOS:000306466100050
J	Brass, DM; Spencer, JC; Li, ZW; Potts-Kant, E; Reilly, SM; Dunkel, MK; Latoche, JD; Auten, RL; Hollingsworth, JW; Fattman, CL				Brass, David M.; Spencer, Jennifer C.; Li, Zhuowei; Potts-Kant, Erin; Reilly, Sarah M.; Dunkel, Mary K.; Latoche, Joseph D.; Auten, Richard L.; Hollingsworth, John W.; Fattman, Cheryl L.			RETRACTED: Innate Immune Activation by Inhaled Lipopolysaccharide, Independent of Oxidative Stress, Exacerbates Silica-Induced Pulmonary Fibrosis in Mice (Retracted article. See vol. 11, e0155388, 2016)	PLOS ONE			English	Article; Retracted Publication							NALP3 INFLAMMASOME; LUNG INFLAMMATION; GENE-EXPRESSION; MODEL; PROGRESSION; PARTICLES; APOPTOSIS; INJURY	Acute exacerbations of pulmonary fibrosis are characterized by rapid decrements in lung function. Environmental factors that may contribute to acute exacerbations remain poorly understood. We have previously demonstrated that exposure to inhaled lipopolysaccharide (LPS) induces expression of genes associated with fibrosis. To address whether exposure to LPS could exacerbate fibrosis, we exposed male C57BL/6 mice to crystalline silica, or vehicle, followed 28 days later by LPS or saline inhalation. We observed that mice receiving both silica and LPS had significantly more total inflammatory cells, more whole lung lavage MCP-1, MIP-2, KC and IL-1 beta, more evidence of oxidative stress and more total lung hydroxyproline than mice receiving either LPS alone, or silica alone. Blocking oxidative stress with N-acetylcysteine attenuated whole lung inflammation but had no effect on total lung hydroxyproline. These observations suggest that exposure to innate immune stimuli, such as LPS in the environment, may exacerbate stable pulmonary fibrosis via mechanisms that are independent of inflammation and oxidative stress.	[Brass, David M.; Spencer, Jennifer C.; Auten, Richard L.] Duke Univ, Med Ctr, Dept Pediat, Neonatol Div,Neonatal Perinatal Res Inst, Durham, NC 27710 USA; [Li, Zhuowei; Potts-Kant, Erin; Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Med, Pulm Allergy & Crit Care Div, Durham, NC 27710 USA; [Reilly, Sarah M.; Dunkel, Mary K.; Latoche, Joseph D.; Fattman, Cheryl L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Hollingsworth, John W.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University	Brass, DM (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Neonatol Div,Neonatal Perinatal Res Inst, Durham, NC 27710 USA.	david.brass@duke.edu		Latoche, Joseph/0000-0002-4800-5623	March of Dimes [ES016126, ES016000, AI 081672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126, R01ES016000] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the March of Dimes, ES016126, ES016000, AI 081672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamer CA, 2005, AM J PHYSIOL-LUNG C, V289, pL186, DOI 10.1152/ajplung.00474.2004; Beamer CA, 2012, TOXICOL SCI, V126, P554, DOI 10.1093/toxsci/kfs024; Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Brass DM, 2008, IMMUNOGENETICS, V60, P353, DOI 10.1007/s00251-008-0293-3; Brass DM, 2010, AM J PHYSIOL-LUNG C, V299, pL664, DOI 10.1152/ajplung.00389.2009; Brass DM, 2003, AM J PHYSIOL-LUNG C, V285, pL755, DOI 10.1152/ajplung.00001.2003; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Corbel M, 2001, INFLAMM RES, V50, P129, DOI 10.1007/s000110050736; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; GHIO AJ, 1994, AM J PHYSIOL-LUNG C, V267, pL686, DOI 10.1152/ajplung.1994.267.6.L686; Gilberti RM, 2008, AM J RESP CELL MOL, V39, P619, DOI 10.1165/rcmb.2008-0046OC; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; HEPPLESTON AG, 1975, AM J PATHOL, V78, P171; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/09031936.06.00114004; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Kornum Jette B, 2008, BMC Pulm Med, V8, P24, DOI 10.1186/1471-2466-8-24; Langley RJ, 2011, J TOXICOL ENV HEAL A, V74, P1261, DOI 10.1080/15287394.2011.595669; Li H, 2009, INNATE IMMUN-LONDON, V15, P143, DOI 10.1177/1753425908101509; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lo Re S, 2011, AM J RESP CRIT CARE, V184, P1270, DOI 10.1164/rccm.201103-0516OC; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McMillan TR, 2008, AM J RESP CRIT CARE, V177, P771, DOI 10.1164/rccm.200708-1184OC; Papanikolaou IC, 2010, CURR OPIN PULM MED, V16, P480, DOI 10.1097/MCP.0b013e32833ae49d; Park IN, 2007, CHEST, V132, P214, DOI 10.1378/chest.07-0323; Peters JM., 1986, SILICOSIS, V86, P219; Porter DW, 2004, TOXICOL SCI, V79, P370, DOI 10.1093/toxsci/kfh110; Potts-Kant EN, 2011, FREE RADIC BIOL MED; Rabolli V, 2011, TOXICOL LETT, V203, P127, DOI 10.1016/j.toxlet.2011.03.009; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; SARIH M, 1993, J LEUKOCYTE BIOL, V54, P407, DOI 10.1002/jlb.54.5.407; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Shimbori C, 2012, INT ARCH ALLERGY IMM, V158, P241, DOI 10.1159/000331439; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Srivastava KD, 2002, AM J RESP CRIT CARE, V165, P527, DOI 10.1164/ajrccm.165.4.2106009; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wohlford-Lenane CL, 1999, AM J PHYSIOL-LUNG C, V276, pL736, DOI 10.1152/ajplung.1999.276.5.L736; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Yucesoy B, 2001, AM J IND MED, V39, P286, DOI 10.1002/1097-0274(200103)39:3<286::AID-AJIM1016>3.0.CO;2-7	45	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40789	10.1371/journal.pone.0040789	http://dx.doi.org/10.1371/journal.pone.0040789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815821	Green Published, Green Accepted, gold			2022-12-27	WOS:000306466100068
J	Chakraborti, A; Allen, A; Allen, B; Rosi, S; Fike, JR				Chakraborti, Ayanabha; Allen, Antino; Allen, Barrett; Rosi, Susanna; Fike, John R.			Cranial Irradiation Alters Dendritic Spine Density and Morphology in the Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IN-VIVO; PREFRONTAL CORTEX; SPATIAL MEMORY; COGNITIVE IMPAIRMENT; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; PYRAMIDAL CELLS; RAT HIPPOCAMPUS	Therapeutic irradiation of the brain is a common treatment modality for brain tumors, but can lead to impairment of cognitive function. Dendritic spines are sites of excitatory synaptic transmission and changes in spine structure and number are thought to represent a morphological correlate of altered brain functions associated with hippocampal dependent learning and memory. To gain some insight into the temporal and sub region specific cellular changes in the hippocampus following brain irradiation, we investigated the effects of 10 Gy cranial irradiation on dendritic spines in young adult mice. One week or 1 month post irradiation, changes in spine density and morphology in dentate gyrus (DG) granule and CA1 pyramidal neurons were quantified using Golgi staining. Our results showed that in the DG, there were significant reductions in spine density at both 1 week (11.9%) and 1 month (26.9%) after irradiation. In contrast, in the basal dendrites of CA1 pyramidal neurons, irradiation resulted in a significant reduction (18.7%) in spine density only at 1 week post irradiation. Analysis of spine morphology showed that irradiation led to significant decreases in the proportion of mushroom spines at both time points in the DG as well as CA1 basal dendrites. The proportions of stubby spines were significantly increased in both the areas at 1 month post irradiation. Irradiation did not alter spine density in the CA1 apical dendrites, but there were significant changes in the proportion of thin and mushroom spines at both time points post irradiation. Although the mechanisms involved are not clear, these findings are the first to show that brain irradiation of young adult animals leads to alterations in dendritic spine density and morphology in the hippocampus in a time dependent and region specific manner.	[Chakraborti, Ayanabha; Allen, Antino; Allen, Barrett; Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Chakraborti, Ayanabha; Allen, Antino; Allen, Barrett; Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chakraborti, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	john.fike@ucsf.edu	Chakraborti, Ayanabha/N-1898-2019	Chakraborti, Ayanabha/0000-0003-2060-8200	National Institutes of Health (NIH) grant [R01 NS046051, R01 CA133216]; NATIONAL CANCER INSTITUTE [R01CA133216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046051] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant R01 NS046051 and R01 CA133216. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffret A, 2009, J NEUROSCI, V29, P10144, DOI 10.1523/JNEUROSCI.1856-09.2009; Babus LW, 2011, BRAIN RES, V1415, P96, DOI 10.1016/j.brainres.2011.07.059; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Bock J, 2011, NEUROSCIENCE, V193, P34, DOI 10.1016/j.neuroscience.2011.07.048; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; BROCK JW, 1992, DEV BRAIN RES, V66, P266, DOI 10.1016/0165-3806(92)90090-J; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; DAWIRS RR, 1991, NEUROPHARMACOLOGY, V30, P275, DOI 10.1016/0028-3908(91)90155-5; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Dimberg Y, 1997, TOXICOL LETT, V90, P35, DOI 10.1016/S0378-4274(96)03827-1; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Ferre S, 2007, BRAIN RES REV, V55, P55, DOI 10.1016/j.brainresrev.2007.01.007; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Gonzalez-Burgos I, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/309494; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; KING MA, 1988, BRAIN RES, V459, P381, DOI 10.1016/0006-8993(88)90656-7; Kitanishi T, 2009, CEREB CORTEX, V19, P2572, DOI 10.1093/cercor/bhp012; Kondo S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-27; Kramar EA, 2003, NEUROSCIENCE, V118, P387, DOI 10.1016/S0306-4522(02)00916-8; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; MARTIN C, 1993, NEUROSCI LETT, V155, P77, DOI 10.1016/0304-3940(93)90677-D; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Maul B, 2008, J MOL MED, V86, P563, DOI 10.1007/s00109-008-0316-4; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje M, 2008, DEV DISABIL RES REV, V14, P238, DOI 10.1002/ddrr.26; Nakamura JL, 2011, CANCER RES, V71, P106, DOI 10.1158/0008-5472.CAN-10-2732; Norrholm SD, 2001, SYNAPSE, V42, P151, DOI 10.1002/syn.10006; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Raber J, 2010, TOXICOL PATHOL, V38, P198, DOI 10.1177/0192623309352003; Rao AAN, 2011, J NEURO-ONCOL, V105, P191, DOI 10.1007/s11060-011-0582-9; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Sajikumar S, 2011, LEARN MEMORY, V18, P327, DOI 10.1101/lm.2095811; Santos HR, 2004, NEUROTOXICOLOGY, V25, P481, DOI 10.1016/j.neuro.2004.01.007; Schultz SR, 1999, HIPPOCAMPUS, V9, P582, DOI 10.1002/(SICI)1098-1063(1999)9:5<582::AID-HIPO12>3.0.CO;2-P; Scoccianti S, 2012, J NEUROONCOL; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Segal M, 2010, EUR J NEUROSCI, V31, P2178, DOI 10.1111/j.1460-9568.2010.07270.x; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Shimizu H, 1996, NEUROSCI LETT, V203, P195, DOI 10.1016/0304-3940(95)12293-1; Soussain C, 2009, LANCET, V374, P1639, DOI 10.1016/S0140-6736(09)61299-X; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Spires-Jones TL, 2011, NEUROSCI LETT, V487, P260, DOI 10.1016/j.neulet.2010.10.033; Staffend N.A., 2011, CURR PROTOC NEUROSCI, V55; Stranahan AM, 2011, NEUROSCI LETT, V495, P60, DOI 10.1016/j.neulet.2011.03.037; SUNANDA, 1995, BRAIN RES, V694, P312, DOI 10.1016/0006-8993(95)00822-8; Taupin P, 2008, HIPPOCAMPUS NEUROTRA; Titus ADJ, 2007, NEUROSCIENCE, V145, P265, DOI 10.1016/j.neuroscience.2006.11.037; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Yazlovitskaya EM, 2006, CANCER RES, V66, P11179, DOI 10.1158/0008-5472.CAN-06-2740; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	69	85	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40844	10.1371/journal.pone.0040844	http://dx.doi.org/10.1371/journal.pone.0040844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815839	Green Published, gold			2022-12-27	WOS:000306466100080
J	Jash, A; Yun, K; Sahoo, A; So, JS; Im, SH				Jash, Arijita; Yun, Kangsun; Sahoo, Anupama; So, Jae-Seon; Im, Sin-Hyeog			Looping Mediated Interaction between the Promoter and 3 ' UTR Regulates Type II Collagen Expression in Chondrocytes	PLOS ONE			English	Article							ENHANCER FACTOR-I; BETA-CATENIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CARTILAGE; PHENOTYPE; INHIBITION; FAMILY; DOMAIN; LEF1	Type II collagen is the major component of articular cartilage and is mainly synthesized by chondrocytes. Repeated sub-culturing of primary chondrocytes leads to reduction of type II collagen gene (Col2a1) expression, which mimics the process of chondrocyte dedifferentiation. Although the functional importance of Col2a1 expression has been extensively investigated, mechanism of transcriptional regulation during chondrocyte dedifferentiation is still unclear. In this study, we have investigated the crosstalk between cis-acting DNA element and transcription factor on Col2a1 expression in primary chondrocytes. Bioinformatic analysis revealed the potential regulatory regions in the Col2a1 genomic locus. Among them, promoter and 3' untranslated region (UTR) showed highly accessible chromatin architecture with enriched recruitment of active chromatin markers in primary chondrocytes. 3' UTR has a potent enhancer function which recruits Lef1 (Lymphoid enhancer binding factor 1) transcription factor, leading to juxtaposition of the 39 UTR with the promoter through gene looping resulting in up-regulation of Col2a1 gene transcription. Knock-down of endogenous Lef1 level significantly reduced the gene looping and subsequently down-regulated Col2a1 expression. However, these regulatory loci become inaccessible due to condensed chromatin architecture as chondrocytes dedifferentiate which was accompanied by a reduction of gene looping and down-regulation of Col2a1 expression. Our results indicate that Lef1 mediated looping between promoter and 3' UTR under the permissive chromatin architecture upregulates Col2a1 expression in primary chondrocytes.	[Jash, Arijita] Gwangju Inst Sci & Technol GIST, Sch Life Sci, Kwangju, South Korea; Gwangju Inst Sci & Technol GIST, Immune Synapse Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Jash, A (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Life Sci, Kwangju, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/E-6811-2013; So, Jae-Seon/ABG-4245-2020; Im, Sin-Hyeog/AAM-9586-2021	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Sahoo, Anupama/0000-0002-0928-958X; So, Jae-Seon/0000-0002-5423-7148	National Research Foundation grant; Korea government (MEST) [2011-0028529]; Research Program for Agricultural Science & Technology Development, National Academy of Agricultural Science, Rural Development Administration, Republic of Korea [PJ907153]	National Research Foundation grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Research Program for Agricultural Science & Technology Development, National Academy of Agricultural Science, Rural Development Administration, Republic of Korea	This work was supported by grants from National Research Foundation grant funded by the Korea government (MEST) (No. 2011-0028529) and by the Research Program for Agricultural Science & Technology Development (Project No.: PJ907153)'', National Academy of Agricultural Science, Rural Development Administration, Republic of Korea.	AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; [Anonymous], EXAMINATION EXPRESSI; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BENYA PD, 1979, ARCH BIOCHEM BIOPHYS, V192, P327, DOI 10.1016/0003-9861(79)90100-0; BOGAERT R, 1994, AM J HUM GENET, V55, P1128; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Cormier Stephania A, 2003, BMC Dev Biol, V3, P4, DOI 10.1186/1471-213X-3-4; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Furumatsu T, 2010, ACTA MED OKAYAMA, V64, P155; Ghayor C, 2000, J BIOL CHEM, V275, P27421; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Huang Y, 2012, J ORTHOP RES, V30, P304, DOI 10.1002/jor.21505; Huh YH, 2007, J BIOL CHEM, V282, P17123, DOI 10.1074/jbc.M700599200; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002; Krebsbach PH, 1996, J BIOL CHEM, V271, P4298, DOI 10.1074/jbc.271.8.4298; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Levy S, 2001, BIOINFORMATICS, V17, P871, DOI 10.1093/bioinformatics/17.10.871; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; LUI VCH, 1995, BIOCHEM J, V311, P511, DOI 10.1042/bj3110511; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Ning B, 2012, INT ORTHOP, V36, P655, DOI 10.1007/s00264-011-1315-6; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Rodriguez RR, 2004, OSTEOARTHR CARTILAGE, V12, P314, DOI 10.1016/j.joca.2003.12.002; RYAN MC, 1990, GENOMICS, V8, P41, DOI 10.1016/0888-7543(90)90224-I; SAVAGNER P, 1995, DNA CELL BIOL, V14, P501, DOI 10.1089/dna.1995.14.501; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; TILLER GE, 1995, AM J HUM GENET, V56, P388; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; VISSING H, 1989, J BIOL CHEM, V264, P18265; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Yang CL, 1997, EXP CELL RES, V235, P370, DOI 10.1006/excr.1997.3692; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Yoon SW, 2008, OSTEOARTHR CARTILAGE, V16, P115, DOI 10.1016/j.joca.2007.05.026; YOSHIOKA H, 1995, DEV DYNAM, V204, P41, DOI 10.1002/aja.1002040106; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Yun K, 2007, BIOCHEM BIOPH RES CO, V357, P589, DOI 10.1016/j.bbrc.2007.03.170; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614	65	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40828	10.1371/journal.pone.0040828	http://dx.doi.org/10.1371/journal.pone.0040828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815835	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100077
J	Liu, JF; Li, J; Wu, ZF; Pei, HD; Zhou, J; Xiang, H				Liu, Jingfang; Li, Jie; Wu, Zhenfang; Pei, Huadong; Zhou, Jian; Xiang, Hua			Identification and Characterization of the Cognate Anti-Sigma Factor and Specific Promoter Elements of a T. tengcongensis ECF Sigma Factor	PLOS ONE			English	Article							BACILLUS-SUBTILIS SIGMA(W); ESCHERICHIA-COLI SIGMA(E); TARGET PROMOTERS; RNA-POLYMERASE; MUTATIONAL ANALYSIS; COMPLETE SEQUENCE; CRYSTAL-STRUCTURE; RECOGNITION; BINDING; DNA	Extracytoplasmic function (ECF) sigma factors, the largest group of alternative s factors, play important roles in response to environmental stresses. Tt-RpoE1 is annotated as an ECF sigma factor in Thermoanaerobacter tengcongensis. In this study, we revealed that the Tt-tolB gene located downstream of the Tt-rpoE1 gene encoded the cognate anti-sigma factor, which could inhibit the transcription activity of Tt-RpoE1 by direct interaction with Tt-RpoE1 via its N-terminal domain. By in vitro transcription assay, the auto-regulation ability of Tt-RpoE1 was determined, and band shift assay showed that Tt-RpoE1 preferred to bind a fork-junction promoter DNA. With truncation or base-specific scanning mutations, the contribution of the nucleotides in -35 and -10 regions to interaction between Tt-RpoE1 and promoter DNA was explored. The promoter recognition pattern of Tt-RpoE1 was determined as 5' tGTTACN(16)CGTC 3', which was further confirmed by in vitro transcription assays. This result showed that the Tt-RpoE1-recognized promoter possessed a distinct -10 motif (-13CGTC-10) as the recognition determinant, which is distinguished from the -10 element recognized by sigma(70). Site-directed mutagenesis in Region 2.4 of Tt-RpoE1 indicated that the "D" residue of DXXR motif was responsible for recognizing the -12G nucleotide. Our results suggested that distinct -10 motif may be an efficient and general strategy used by ECF sigma factors in adaptive response regulation of the related genes.	[Liu, Jingfang; Li, Jie; Wu, Zhenfang; Pei, Huadong; Zhou, Jian; Xiang, Hua] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, JF (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	xiangh@sun.im.ac.cn	Pei, Huadong/C-9625-2013	li, jie/0000-0002-2773-6806	National Natural Science Foundation of China [30621005, 30925001, 31100893]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by grants (Grant Nos. 30621005, 30925001, 31100893) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades SE, 2004, CURR OPIN MICROBIOL, V7, P157, DOI 10.1016/j.mib.2004.02.010; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Cao M, 2002, J MOL BIOL, V316, P443, DOI 10.1006/jmbi.2001.5372; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Feklistov A, 2009, GENE DEV, V23, P2371, DOI 10.1101/gad.1862609; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Huang XJ, 1998, J BACTERIOL, V180, P3765, DOI 10.1128/JB.180.15.3765-3770.1998; Huang XJ, 1998, J MOL BIOL, V279, P165, DOI 10.1006/jmbi.1998.1765; Huang XJ, 1997, J BACTERIOL, V179, P2915, DOI 10.1128/jb.179.9.2915-2921.1997; Huang XJ, 1999, MOL MICROBIOL, V31, P361, DOI 10.1046/j.1365-2958.1999.01180.x; Koo BM, 2009, GENE DEV, V23, P2426, DOI 10.1101/gad.1843709; Koo BM, 2009, MOL MICROBIOL, V72, P830, DOI 10.1111/j.1365-2958.2009.06691.x; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Liu JF, 2008, BIOCHEM BIOPH RES CO, V371, P573, DOI 10.1016/j.bbrc.2008.04.131; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Roberts CW, 1996, CELL, V86, P495; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Wilson MJ, 2006, J BACTERIOL, V188, P1935, DOI 10.1128/JB.188.5.1935-1942.2006; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555; Zhou MX, 2004, EXTREMOPHILES, V8, P91, DOI 10.1007/s00792-003-0366-z	36	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40885	10.1371/journal.pone.0040885	http://dx.doi.org/10.1371/journal.pone.0040885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815853	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100087
J	Londhe, KB; Borlak, J				Londhe, Kishor Bapu; Borlak, Juergen			A Cross-Platform Comparison of Genome-Wide Expression Changes of Laser Microdissected Lung Tissue of C-Raf Transgenic Mice Using 3 ' IVT and Exon Array	PLOS ONE			English	Article							GENE-EXPRESSION; AFFYMETRIX EXON; C-RAF-1; CANCER; MICROARRAYS; DYSPLASIA	Microarrays are widely used to study genome-wide gene expression changes in different conditions most notably disease, growth, or to investigate the effects of drugs on entire genomes. While the number and gene probe sequences to investigate individual gene expression changes differs amongst manufactures, the design for all of the probes is biased towards the 39 region. With the advent of exon arrays, transcripts of any known or predicted exon can be investigated to facilitate the study of genome-wide alternative splicing events. Thus, the use of exon arrays provides unprecedented opportunities in gene expression studies. However, it remains a major challenge to directly compare gene expression data derived from oligonucleotide to exon arrays. In the present study, genome-wide expression profiling of Laser Microdissected Pressure Catapulted (LMPC) samples of c-Raf mouse lung adenocarcinoma, dysplasia, unaltered transgenic and non-transgenic tissues was performed using the Affymetrix GeneChip Mouse Genome 430 2.0 Array and whole genome Mouse Exon 1.0 ST Array. Based on individual group comparisons 52 to 83% of regulated genes were similar in direction, but fold changes of regulated genes disagreed when data amongst the two platforms were compared. Furthermore, for 27 regulated genes opposite direction of gene expression was observed when the two platforms were compared pointing to the need to assess alternative splicing events at the 3' end. Taken collectively, exon arrays can be performed even with laser microdissected samples but fold change gene expression changes differ considerably between 3'IVT array and exon arrays with alternative splicing events contributing to apparent differences in gene expression changes.	[Londhe, Kishor Bapu; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany	Hannover Medical School	Londhe, KB (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany.	Borlak.Juergen@mh-hannover.de			DFG REBIRTH excellence cluster program; Lower Saxony Ministry of Culture and Sciences; Volkswagen foundation, Germany [25A.5-7251-99-3/00]	DFG REBIRTH excellence cluster program; Lower Saxony Ministry of Culture and Sciences; Volkswagen foundation, Germany(Volkswagen)	Part of the PhD stipend for Kishor Londhe was supported by the DFG REBIRTH excellence cluster program and by the Lower Saxony Ministry of Culture and Sciences and the Volkswagen foundation, Germany to JB. Grant number: 25A.5-7251-99-3/00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000913; Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; *AFF, 2005, GEN SIGN EST EX ARR; Affymetrix, 2005, GENECHIP EX ARR DES; Affymetrix, AFF EX ARR AN FREQ A; Affymetrix, 2004, GENECHIP MOUS GEN AR; Affymetrix, 2007, APPL FOC WHOL TRANSC; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Frantz S, 2005, NAT REV DRUG DISCOV, V4, P362, DOI 10.1038/nrd1746; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kumar V, 2007, ROBBINS BASIC PATHOL; Miklos GLG, 2004, NAT BIOTECHNOL, V22, P615, DOI 10.1038/nbt965; NIYAZ Y, 2005, MED LASER APPL, V20, P223; Niyaz Y, 2005, HDB IMMUNOHISTOCHEMI, P55; Niyaz Y, 2005, METH MOLEC MED, V114, P1; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-449; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007315; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005637; Schutze K, 2007, METHOD CELL BIOL, V82, P649, DOI 10.1016/S0091-679X(06)82023-6; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang XL, 2007, GENOME INFORM SER, V18, P247	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40778	10.1371/journal.pone.0040778	http://dx.doi.org/10.1371/journal.pone.0040778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815814	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100065
J	Michel, J; Cuchillo, R				Michel, Julien; Cuchillo, Remi			The Impact of Small Molecule Binding on the Energy Landscape of the Intrinsically Disordered Protein C-Myc	PLOS ONE			English	Article							SECONDARY STRUCTURE; CONFORMATIONAL SELECTION; TRANSCRIPTION FACTORS; EFFICIENT GENERATION; COUPLED BINDING; AM1-BCC MODEL; MAX; DYNAMICS; METADYNAMICS; SIMULATIONS	Intrinsically disordered proteins are attractive therapeutic targets owing to their prevalence in several diseases. Yet their lack of well-defined structure renders ligand discovery a challenging task. An intriguing example is provided by the oncoprotein c-Myc, a transcription factor that is over expressed in a broad range of cancers. Transcriptional activity of c-Myc is dependent on heterodimerization with partner protein Max. This protein-protein interaction is disrupted by the small molecule 10058-F4 (1), that binds to monomeric and disordered c-Myc. To rationalize the mechanism of inhibition, structural ensembles for the segment of the c-Myc domain that binds to 1 were computed in the absence and presence of the ligand using classical force fields and explicit solvent metadynamics molecular simulations. The accuracy of the computed structural ensembles was assessed by comparison of predicted and measured NMR chemical shifts. The small molecule 1 was found to perturb the composition of the apo equilibrium ensemble and to bind weakly to multiple distinct c-Myc conformations. Comparison of the apo and holo equilibrium ensembles reveals that the c-Myc conformations binding 1 are already partially formed in the apo ensemble, suggesting that 1 binds to c-Myc through an extended conformational selection mechanism. The present results have important implications for rational ligand design efforts targeting intrinsically disordered proteins.	[Michel, Julien; Cuchillo, Remi] Univ Edinburgh, EastCHEM Sch Chem, Edinburgh, Midlothian, Scotland	University of Edinburgh	Michel, J (corresponding author), Univ Edinburgh, EastCHEM Sch Chem, Edinburgh, Midlothian, Scotland.	mail@julienmichel.net			Royal Society University Research Fellowship; European Commission [PIRG-GA-2010-276785]	Royal Society University Research Fellowship(Royal Society of London); European Commission(European CommissionEuropean Commission Joint Research Centre)	JM is supported by a Royal Society University Research Fellowship. This research was also supported by a Marie Curie International re-integration grant from the European Commission (PIRG-GA-2010-276785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Berg T, 2011, CURR TOP MICROBIOL, V348, P139, DOI 10.1007/82_2010_90; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Biarnes X, 2012, COMPUT PHYS COMMUN, V183, P203, DOI 10.1016/j.cpc.2011.08.020; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Camilloni C, 2012, BIOPHYS J, V102, P158, DOI 10.1016/j.bpj.2011.12.003; Case DA, 2010, AMBER11; Chen JH, 2009, J AM CHEM SOC, V131, P2088, DOI 10.1021/ja809547p; Cino EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027371; Click TH, 2010, INT J MOL SCI, V11, P5293, DOI 10.3390/ijms11125292; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; De Sancho D, 2012, MOL BIOSYST, V8, P256, DOI 10.1039/c1mb05252g; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Ganguly D, 2012, MOL BIOSYST, V8, P198, DOI 10.1039/c1mb05156c; Ganguly D, 2009, J AM CHEM SOC, V131, P5214, DOI 10.1021/ja808999m; Guo JX, 2009, CANCER CHEMOTH PHARM, V63, P615, DOI 10.1007/s00280-008-0774-y; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Higo J, 2011, J AM CHEM SOC, V133, P10448, DOI 10.1021/ja110338e; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Leone V, 2010, CURR OPIN STRUC BIOL, V20, P148, DOI 10.1016/j.sbi.2010.01.011; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Marinelli F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000452; Mendgen T, 2012, J MED CHEM, V55, P743, DOI 10.1021/jm201243p; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mobley DL, 2012, J COMPUT AID MOL DES, V26, P93, DOI 10.1007/s10822-011-9497-y; Mustata G, 2009, J MED CHEM, V52, P1247, DOI 10.1021/jm801278g; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Pande VS, 2010, METHODS, V52, P99, DOI 10.1016/j.ymeth.2010.06.002; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Piana S, 2007, J PHYS CHEM B, V111, P4553, DOI 10.1021/jp067873l; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]; Schrodinger LLC, 2011, MAESTR VERS 9 2; Shi J, 2009, BIOORG MED CHEM LETT, V19, P6038, DOI 10.1016/j.bmcl.2009.09.044; Shirts MR, 2007, J PHYS CHEM B, V111, P13052, DOI 10.1021/jp0735987; Sigalov AB, 2008, BIOCHEMISTRY-US, V47, P12942, DOI 10.1021/bi801602p; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sousa Da Silva AW, VRANKEN WF ACPYPE; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Staneva I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002131; Todorova N, 2009, J PHYS CHEM B, V113, P3556, DOI 10.1021/jp809776v; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vymetal J, 2011, J PHYS CHEM A, V115, P11455, DOI 10.1021/jp2065612; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001118; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Y, 2012, ACS CHEM NEUROSCIENC; Wostenberg C, 2011, J PHYS CHEM B, V115, P13731, DOI 10.1021/jp208008m; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	80	54	54	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41070	10.1371/journal.pone.0041070	http://dx.doi.org/10.1371/journal.pone.0041070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815918	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100117
J	Pan, CE; Wei, XB; Ye, JQ; Liu, GD; Zhang, S; Zhang, Y; Du, HG; Ding, ZR				Pan, ChangE; Wei, Xunbin; Ye, Jianqin; Liu, Guangda; Zhang, Si; Zhang, Yan; Du, Hongguang; Ding, Zhongren			BF066, a Novel Dual Target Antiplatelet Agent without Significant Bleeding	PLOS ONE			English	Article							P2Y(12) RECEPTOR; PLATELET-AGGREGATION; IN-VIVO; THERAPY; PHOSPHODIESTERASE; INHIBITION; DRUGS; PHOSPHORYLATION; ACTIVATION; CILOSTAZOL	In this study, we report BF066, a novel adenine derivative, inhibits platelet activation and thrombosis via the adenosine receptor (A(2A)) activation and phosphodiesterase (PDE) inhibition. BF066 inhibits platelet aggregation and ATP releasing induced by multiple platelet agonists in a dose-dependent manner. The inhibition of BF066 on ADP-induced aggregation is potentiated by adenosine and can be dramatically antagonized by the A(2A) antagonist SCH58261. BF066 also inhibits the PDE activity and platelet spreading on fibrinogen. In FeCl3-injured mouse mesenteric arterial thrombosis model, BF066 prevents thrombus formation effectively, similar to clopidogrel. Intriguingly, at dose achieving similar antithrombotic effect compared to clopidogrel, BF066 does not increase bleeding significantly. Taken together, these results suggest that BF066 may be an effective and safe antiplatelet agent targeting both PDE and A(2A). Considering the successful use of combined antiplatelet therapy, BF066 may be further developed as a novel dual target antiplatelet agent.	[Pan, ChangE] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Pan, ChangE; Wei, Xunbin; Liu, Guangda] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wei, Xunbin] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Wei, Xunbin] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Ye, Jianqin; Zhang, Si; Zhang, Yan; Ding, Zhongren] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Ye, Jianqin; Zhang, Si; Zhang, Yan; Ding, Zhongren] Fudan Univ, Minist Educ, Key Lab Mol Med, Shanghai 200433, Peoples R China; [Du, Hongguang] Beijing Univ Chem Technol, Coll Sci, Beijing, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Fudan University; Beijing University of Chemical Technology	Pan, CE (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	xwei01@sjtu.edu.cn; dingzr@fudan.edu.cn	zhang, si/AAG-9094-2021	zhang, Si/0000-0002-5682-4995	National Basic Research Program of China (973 Program) [2011CB910400, 2012CB966800]; China National Key Sci-Tech Special Project [2008ZX10002-025]; China National Natural Science Foundation [30901432, 30972949, 20975027]; Chinese Ministry of Education [109056]; Program for New Century Excellent Talents in University Award [NCET-08-0131]; Shanghai Science and Technology Committee [11DZ2211000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); China National Key Sci-Tech Special Project; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in University Award(Program for New Century Excellent Talents in University (NCET)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work is supported by the National Basic Research Program of China (973 Program, 2011CB910400 and 2012CB966800), China National Key Sci-Tech Special Project (2008ZX10002-025), China National Natural Science Foundation (30901432, 30972949 and 20975027), the Chinese Ministry of Education (109056), Program for New Century Excellent Talents in University Award (NCET-08-0131) and Shanghai Science and Technology Committee (11DZ2211000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno F, 2009, BLOOD, V113, P5323, DOI 10.1182/blood-2008-07-169359; Biscetti F, 2012, INT J CARDIOL; Capranzano P, 2012, CATHETER CARDIOVASC; Cattaneo M, 2007, J THROMB HAEMOST, V5, P577, DOI 10.1111/j.1538-7836.2007.02356.x; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791; Dickinson NT, 1997, BIOCHEM J, V323, P371, DOI 10.1042/bj3230371; Ding Z, 2009, J THROMB HAEMOST, V7, P232, DOI 10.1111/j.1538-7836.2008.03202.x; FUSTER V, 1981, MAYO CLIN PROC, V56, P102; Gao GX, 2009, BIOCHEM BIOPH RES CO, V385, P439, DOI 10.1016/j.bbrc.2009.05.090; Gessi S, 2000, BRIT J PHARMACOL, V129, P2, DOI 10.1038/sj.bjp.0703045; Gresele P, 2011, BRIT J CLIN PHARMACO, V72, P634, DOI 10.1111/j.1365-2125.2011.04034.x; Hayashi H, 2009, THROMB HAEMOSTASIS, V102, P327, DOI 10.1160/TH08-12-0781; Herman AG, 1998, THROMB RES, V92, pS17, DOI 10.1016/S0049-3848(98)00100-5; Hu L, 2011, THROMB HAEMOSTASIS, V106, P1203, DOI 10.1160/TH11-06-0400; Ishii H, 2009, THROMB HAEMOSTASIS, V102, P1204, DOI 10.1160/TH09-03-0194; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Lee K, 2010, J THROMB HAEMOST, V8, P2578, DOI 10.1111/j.1538-7836.2010.04019.x; Li ZY, 2003, BLOOD, V101, P4423, DOI 10.1182/blood-2002-10-3210; Liu J, 2004, J THROMB HAEMOST, V2, P2213, DOI 10.1111/j.1538-7836.2004.01023.x; Mahla E, 2012, CIRC CARDIOVASC INTE; MARCUS AJ, 1993, FASEB J, V7, P516, DOI 10.1096/fasebj.7.6.8472890; Orlowski E, 2009, J THROMB HAEMOST, V7, P2074, DOI 10.1111/j.1538-7836.2009.03612.x; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Shankar H, 2004, BLOOD, V104, P1335, DOI 10.1182/blood-2004-01-0069; Stolla M, 2011, BLOOD, V117, P1005, DOI 10.1182/blood-2010-07-297713; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Tendera M, 2003, THROMB RES, V110, P355, DOI 10.1016/j.thromres.2003.08.003; Valgimigli M, 2012, CIRCULATION; Yang D, 2010, J THROMB HAEMOST, V8, P817, DOI 10.1111/j.1538-7836.2010.03769.x; Zhang S, 2010, THROMB HAEMOSTASIS, V104, P845, DOI 10.1160/TH10-05-0285; Zhao L, 2001, BRIT J PHARMACOL, V134, P353, DOI 10.1038/sj.bjp.0704248	32	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40451	10.1371/journal.pone.0040451	http://dx.doi.org/10.1371/journal.pone.0040451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815749	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100036
J	Guo, L; Qi, ST; Miao, DQ; Liang, XW; Li, H; Ou, XH; Huang, X; Yang, CR; Ouyang, YC; Hou, Y; Sun, QY; Han, ZM				Guo, Lei; Qi, Shu-Tao; Miao, De-Qiang; Liang, Xing-Wei; Li, Hui; Ou, Xiang-Hong; Huang, Xin; Yang, Cai-Rong; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan; Han, Zhiming			The Roles of Parathyroid Hormone-Like Hormone during Mouse Preimplantation Embryonic Development	PLOS ONE			English	Article							IN-VITRO; EXPRESSION; PEPTIDE; PROTEIN; PTHRP; TRANSCRIPTION; GENE; NANOG; CELLS	Parathyroid hormone-like hormone (PTHLH) was first identified as a parathyroid hormone (PTH)-like factor responsible for humoral hypercalcemia in malignancies in the 1980s. Previous studies demonstrated that PTHLH is expressed in multiple tissues and is an important regulator of cellular and organ growth, development, migration, differentiation, and survival. However, there is a lack of data on the expression and function of PTHLH during preimplantation embryonic development. In this study, we investigated the expression characteristics and functions of PTHLH during mouse preimplantation embryonic development. The results show that Pthlh is expressed in mouse oocytes and preimplantation embryos at all developmental stages, with the highest expression at the MII stage of the oocytes and the lowest expression at the blastocyst stage of the preimplantation embryos. The siRNA-mediated depletion of Pthlh at the MII stage oocytes or the 1-cell stage embryos significantly decreased the blastocyst formation rate, while this effect could be corrected by culturing the Pthlh depleted embryos in the medium containing PTHLH protein. Moreover, expression of the pluripotency-related genes Nanog and Pou5f1 was significantly reduced in Pthlh-depleted embryos at the morula stage. Additionally, histone acetylation patterns were altered by Pthlh depletion. These results suggest that PTHLH plays important roles during mouse preimplantation embryonic development.	[Guo, Lei; Qi, Shu-Tao; Miao, De-Qiang; Liang, Xing-Wei; Li, Hui; Ou, Xiang-Hong; Huang, Xin; Yang, Cai-Rong; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan; Han, Zhiming] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Qi, Shu-Tao; Miao, De-Qiang; Li, Hui] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Guo, Lei; Ou, Xiang-Hong] So Med Univ, Nanfang Hosp, Ctr Reprod Med, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southern Medical University - China	Guo, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	hanzm@ioz.ac.cn	Miao, Deqiang/F-1226-2015; Yang, Cairong/AAB-1440-2021	Miao, Deqiang/0000-0001-9731-9322; Yang, Cairong/0000-0001-9594-0529; Qi, Shutao/0000-0002-4073-1161	National Natural Science Foundation of China [30770245]; Knowledge Innovation Project of Chinese Academy of Sciences [KSCX3-IOZ-1003]; High-Tech Research and Development Program of China [2008AA101006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); High-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 30770245), the Knowledge Innovation Project of Chinese Academy of Sciences (Grant No. KSCX3-IOZ-1003), and the High-Tech Research and Development Program of China (Grant No. 2008AA101006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Datta NS, 2005, J BONE MINER RES, V20, P1051, DOI 10.1359/JBMR.050106; Duranthon V, 2008, REPRODUCTION, V135, P141, DOI 10.1530/REP-07-0324; Escande B, 2001, SEMIN PERINATOL, V25, P76, DOI 10.1053/sper.2001.23194; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Han ZM, 2008, BIOL REPROD, V79, P638, DOI 10.1095/biolreprod.108.069096; Han ZM, 2010, AM J PHYSIOL-CELL PH, V298, pC1235, DOI 10.1152/ajpcell.00393.2009; Han ZM, 2005, BIOL REPROD, V72, P612, DOI 10.1095/biolreprod.104.035444; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kartsogiannis V, 1997, BONE, V21, P385, DOI 10.1016/S8756-3282(97)00180-4; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MONIZ C, 1990, J MOL ENDOCRINOL, V5, P259, DOI 10.1677/jme.0.0050259; Nowak RA, 1999, BIOL REPROD, V60, P85, DOI 10.1095/biolreprod60.1.85; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shi LH, 2008, J ANIM SCI, V86, P1106, DOI 10.2527/jas.2007-0718; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Tong GQ, 2006, CELL TISSUE RES, V325, P231, DOI 10.1007/s00441-006-0189-1; VANDESTOLPE A, 1993, J CELL BIOL, V120, P235, DOI 10.1083/jcb.120.1.235; Watson PH, 2001, ANAT EMBRYOL, V203, P175, DOI 10.1007/s004290000145; Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431; Yang JF, 2007, BIOL REPROD, V76, P36, DOI 10.1095/biolreprod.106.051383; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	25	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40528	10.1371/journal.pone.0040528	http://dx.doi.org/10.1371/journal.pone.0040528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808183	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700033
J	Yang, NC; Inaki, M; Cliffe, A; Rorth, P				Yang, Nachen; Inaki, Mikiko; Cliffe, Adam; Rorth, Pernille			Microtubules and Lis-1/NudE/Dynein Regulate Invasive Cell-on-Cell Migration in Drosophila	PLOS ONE			English	Article							NEURONAL MIGRATION; BORDER CELLS; COLLECTIVE MIGRATION; LISSENCEPHALY GENE; CYTOPLASMIC DYNEIN; DE-CADHERIN; RHO-GTPASES; LIS1; POLARITY; MOTILITY	The environment through which cells migrate in vivo differs considerably from the in vitro environment where cell migration is often studied. In vivo many cells migrate in crowded and complex 3-dimensional tissues and may use other cells as the substratum on which they move. This includes neurons, glia and their progenitors in the brain. Here we use a Drosophila model of invasive, collective migration in a cellular environment to investigate the roles of microtubules and microtubule regulators in this type of cell movement. Border cells are of epithelial origin and have no visible microtubule organizing center (MTOC). Interestingly, microtubule plus-end growth was biased away from the leading edge. General perturbation of the microtubule cytoskeleton and analysis by live imaging showed that microtubules in both the migrating cells and the substrate cells affect movement. Also, whole-tissue and cell autonomous deletion of the microtubule regulator Stathmin had distinct effects. A screen of 67 genes encoding microtubule interacting proteins uncovered cell autonomous requirements for Lis-1, NudE and Dynein in border cell migration. Net cluster migration was decreased, with initiation of migration and formation of dominant front cell protrusion being most dramatically affected. Organization of cells within the cluster and localization of cell-cell adhesion molecules were also abnormal. Given the established role of Lis-1 in migrating neurons, this could indicate a general role of Lis-1/NudE, Dynein and microtubules, in cell-on-cell migration. Spatial regulation of cell-cell adhesion may be a common theme, consistent with observing both cell autonomous and non-autonomous requirements in both systems.	[Yang, Nachen; Inaki, Mikiko; Cliffe, Adam; Rorth, Pernille] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Yang, Nachen; Rorth, Pernille] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Yang, NC (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	prorth@imcb.a-star.edu.sg	Rørth, Pernille/H-3020-2011; Inaki, Mikiko/AAG-5450-2019	Inaki, Mikiko/0000-0002-1448-5462	A*STAR - Agency for Science, Technology and Research - Singapore	A*STAR - Agency for Science, Technology and Research - Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by A*STAR - Agency for Science, Technology and Research - Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004; Borghese L, 2009, DEV CELL, V17, P299, DOI 10.1016/j.devcel.2009.08.001; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Doerflinger H, 2003, DEVELOPMENT, V130, P3965, DOI 10.1242/dev.00616; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mathieu J, 2007, GENETICS, V176, P1579, DOI 10.1534/genetics.107.071282; McDonald JA, 2008, CURR BIOL, V18, P1659, DOI 10.1016/j.cub.2008.09.041; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Poukkula M, 2011, J CELL BIOL, V192, P513, DOI 10.1083/jcb.201010003; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Szafranski P, 2004, DEVELOPMENT, V131, P2023, DOI 10.1242/dev.01097; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Van de Bor V, 2011, DEVELOPMENT, V138, P1383, DOI 10.1242/dev.056184; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Wittmann T, 2001, J CELL SCI, V114, P3795; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Youn YH, 2009, J NEUROSCI, V29, P15520, DOI 10.1523/JNEUROSCI.4630-09.2009	53	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40632	10.1371/journal.pone.0040632	http://dx.doi.org/10.1371/journal.pone.0040632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808215	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700040
J	Yokoyama, S; Maki, H; Hashimoto, Y; Toma, M; Kawashima, R				Yokoyama, Satoru; Maki, Hideki; Hashimoto, Yosuke; Toma, Masahiko; Kawashima, Ryuta			Mechanism of Case Processing in the Brain: An fMRI Study	PLOS ONE			English	Article							EVENT-RELATED FMRI; SENTENCE COMPREHENSION; PASSIVE SENTENCES; WORKING-MEMORY; BROCAS AREA; ACTIVATION; LANGUAGE; JAPANESE; FACULTY; CORTEX	In sentence comprehension research, the case system, which is one of the subsystems of the language processing system, has been assumed to play a crucial role in signifying relationships in sentences between noun phrases (NPs) and other elements, such as verbs, prepositions, nouns, and tense. However, so far, less attention has been paid to the question of how cases are processed in our brain. To this end, the current study used fMRI and scanned the brain activity of 15 native English speakers during an English-case processing task. The results showed that, while the processing of all cases activates the left inferior frontal gyrus and posterior part of the middle temporal gyrus, genitive case processing activates these two regions more than nominative and accusative case processing. Since the effect of the difference in behavioral performance among these three cases is excluded from brain activation data, the observed different brain activations would be due to the different processing patterns among the cases, indicating that cases are processed differently in our brains. The different brain activations between genitive case processing and nominative/accusative case processing may be due to the difference in structural complexity between them.	[Yokoyama, Satoru; Hashimoto, Yosuke; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Maki, Hideki] Gifu Univ, Fac Reg Studies, Gifu, Japan; [Hashimoto, Yosuke; Toma, Masahiko] Akita Int Univ, Akita, Japan	Tohoku University; Gifu University; Akita International University	Yokoyama, S (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	yokoyama@idac.tohoku.ac.jp			Tohoku University Exploratory Research Program for Young Scientists; Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University	Tohoku University Exploratory Research Program for Young Scientists; Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University	This study was supported by a grant to S.Y. from the Tohoku University Exploratory Research Program for Young Scientists, and a part of this work was carried out through a grant to H. M. from the Cooperative Research Project Program of the Institute of Development, Aging and Cancer, Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caplan D, 2002, HUM BRAIN MAPP, V15, P26, DOI 10.1002/hbm.1059; Caplan D, 1999, NEUROIMAGE, V9, P343, DOI 10.1006/nimg.1998.0412; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam, 1981, LECT GOVT BINDING DO; Cutting LE, 2006, NEUROIMAGE, V29, P429, DOI 10.1016/j.neuroimage.2005.07.057; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Harada Shinichi, 1971, GENGO KENKYU, V60, P25; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Hashimoto Y, OPEN MED IMAGING J; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Inui T, 1998, NEUROREPORT, V9, P3325, DOI 10.1097/00001756-199810050-00032; Inui T, 2007, NEUROREPORT, V18, P431, DOI 10.1097/WNR.0b013e32805dfb7e; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kang AM, 1999, NEUROIMAGE, V10, P555, DOI 10.1006/nimg.1999.0493; Kuperberg GR, 2003, J COGNITIVE NEUROSCI, V15, P272, DOI 10.1162/089892903321208204; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Meltzer JA, 2010, CEREB CORTEX, V20, P1853, DOI 10.1093/cercor/bhp249; Miyagawa S, 1993, MITWPL 19, P213; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Yokoyama S, 2006, NEUROIMAGE, V30, P570, DOI 10.1016/j.neuroimage.2005.09.066; Yokoyama S, PARTIAL INC IN PRESS, P159; Yokoyama S, 2007, NEUROPSYCHOLOGIA, V45, P989, DOI 10.1016/j.neuropsychologia.2006.09.003	26	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40474	10.1371/journal.pone.0040474	http://dx.doi.org/10.1371/journal.pone.0040474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808169	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400027
J	Kantermann, T; Forstner, S; Halle, M; Schlangen, L; Roenneberg, T; Schmidt-Trucksass, A				Kantermann, Thomas; Forstner, Sebastian; Halle, Martin; Schlangen, Luc; Roenneberg, Till; Schmidt-Trucksaess, Arno			The Stimulating Effect of Bright Light on Physical Performance Depends on Internal Time	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; CYCLING PERFORMANCE; DARK PHASE; SHIFT-WORK; HUMANS; PULSES; ENTRAINMENT; MELATONIN; EXERCISE; STRESS	The human circadian clock regulates the daily timing of sleep, alertness and performance and is synchronized to the 24-h day by the environmental light-dark cycle. Bright light exposure has been shown to positively affect sleepiness and alertness, yet little is known about its effects on physical performance, especially in relation to chronotype. We, therefore, exposed 43 male participants (mean age 24.5 yrs +/- SD 2.3 yrs) in a randomized crossover study to 160 minutes of bright (BL: approximate to 4.420 lx) and dim light (DL: approximate to 230 lx). During the last 40 minutes of these exposures, participants performed a bicycle ergometer test. Time-of-day of the exercise sessions did not differ between the BL and DL condition. Chronotype (MSFsc, mid-sleep time on free days corrected for oversleep due to sleep debt on workdays) was assessed by the Munich ChronoType Questionnaire (MCTQ). Total work was significantly higher in BL (median 548.4 kJ, min 411.82 kJ, max 875.20 kJ) than in DL (median 521.5 kJ, min 384.33 kJ, max 861.23 kJ) (p = 0.004) going along with increased exhaustion levels in BL (blood lactate (+12.7%, p = 0.009), heart rate (+1.8%, p = 0.031), and Borg scale ratings (+2.6%, p = 0.005)) in all participants. The differences between total work levels in BL and DL were significantly higher (p = 0.004) if participants were tested at a respectively later time point after their individual mid-sleep (chronotype). These novel results demonstrate, that timed BL exposure enhances physical performance with concomitant increase in individual strain, and is related not only to local (external) time, but also to an individual's internal time.	[Kantermann, Thomas] Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands; [Forstner, Sebastian] Cty Hosp Schrobenhausen, Schrobenhausen, Germany; [Halle, Martin] Tech Univ Munich, Dept Prevent & Sports Med, Munich, Germany; [Schlangen, Luc] Philips Lighting, Eindhoven, Netherlands; [Roenneberg, Till] Univ Munich, Inst Med Psychol, D-8000 Munich, Germany; [Schmidt-Trucksaess, Arno] Univ Basel, Inst Exercise & Hlth Sci, Basel, Switzerland	University of Groningen; Technical University of Munich; Philips; University of Munich; University of Basel	Kantermann, T (corresponding author), Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands.	Arno.Schmidt-Trucksaess@unibas.ch	Kantermann, Thomas/AAW-8613-2020; Schmidt-Trucksäss, Arno/I-7673-2015	Kantermann, Thomas/0000-0002-5536-1263; Schmidt-Trucksäss, Arno/0000-0002-4662-3911; Schlangen, Luc/0000-0002-8424-7240; Halle, Martin/0000-0003-3065-530X; Roenneberg, Till/0000-0003-2939-0332	DFG (German Research Foundation)	DFG (German Research Foundation)(German Research Foundation (DFG))	Thomas Kantermann was funded by the DFG (German Research Foundation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; BEERSMA DGM, 1993, J BIOL RHYTHM, V8, P340, DOI 10.1177/074873049300800407; Boivin DB, 2005, IND HEALTH, V43, P34, DOI 10.2486/indhealth.43.34; Borbely A A, 1982, Hum Neurobiol, V1, P195; Cain SW, 2007, J BIOL RHYTHM, V22, P534, DOI 10.1177/0748730407306884; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; Dalton B, 1997, INT J SPORTS MED, V18, P538, DOI 10.1055/s-2007-972678; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Guay F, 2000, MOTIV EMOTION, V24, P175, DOI 10.1023/A:1005614228250; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; HONMA K, 1987, EXPERIENTIA, V43, P1205, DOI 10.1007/BF01945525; Kantermann T, 2007, CURR BIOL, V17, P1996, DOI 10.1016/j.cub.2007.10.025; Kantermann T, 2010, SLEEP BIOL RHYTHMS, V8, P95, DOI 10.1111/j.1479-8425.2010.00432.x; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Lollgen H, 2004, DTSCH Z SPORTMEDIZIN, V55, P299; MONTELEONE P, 1993, J NEURAL TRANSM-GEN, V92, P25, DOI 10.1007/BF01245159; MONTELEONE P, 1992, NEUROENDOCRINOLOGY, V55, P367, DOI 10.1159/000126146; O'Brien PM, 2000, MED SCI SPORT EXER, V32, P439, DOI 10.1097/00005768-200002000-00027; Ohkuwa T., 2001, Archives of Physiology and Biochemistry, V109, P430, DOI 10.1076/apab.109.5.430.8034; Reilly T, 2009, EUR J APPL PHYSIOL, V106, P321, DOI 10.1007/s00421-009-1066-x; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roenneberg T, 2010, J BIOL RHYTHM, V25, P329, DOI 10.1177/0748730410379082; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107	26	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40655	10.1371/journal.pone.0040655	http://dx.doi.org/10.1371/journal.pone.0040655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808224	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400091
J	Rottschaefer, SM; Lazzaro, BP				Rottschaefer, Susan M.; Lazzaro, Brian P.			No Effect of Wolbachia on Resistance to Intracellular Infection by Pathogenic Bacteria in Drosophila melanogaster	PLOS ONE			English	Article							HOST	Multiple studies have shown that infection with the endosymbiotic bacterium Wolbachia pipientis confers Drosophila melanogaster and other insects with resistance to infection by RNA viruses. Studies investigating whether Wolbachia infection induces the immune system or confers protection against secondary bacterial infection have not shown any effect. These studies, however, have emphasized resistance against extracellular pathogens. Since Wolbachia lives inside the host cell, we hypothesized that Wolbachia might confer resistance to pathogens that establish infection by invading host cells. We therefore tested whether Wolbachia-infected D. melanogaster are protected against infection by the intracellular pathogenic bacteria Listeria monocytogenes and Salmonella typhimurium, as well as the extracellular pathogenic bacterium Providencia rettgeri. We evaluated the ability of flies infected with Wolbachia to suppress secondary infection by pathogenic bacteria relative to genetically matched controls that had been cured of Wolbachia by treatment with tetracycline. We found no evidence that Wolbachia alters host ability to suppress proliferation of any of the three pathogenic bacteria. Our results indicate that Wolbachia-induced antiviral protection does not result from a generalized response to intracellular pathogens.	[Rottschaefer, Susan M.; Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University	Rottschaefer, SM (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	smr53@cornell.edu			National Institutes of Health [R01 AI083932]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI083932. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard JWO, 2007, INSECT MOL BIOL, V16, P799, DOI 10.1111/j.1365-2583.2007.00760.x; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	21	29	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40500	10.1371/journal.pone.0040500	http://dx.doi.org/10.1371/journal.pone.0040500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808174	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400064
J	Boily-Larouche, G; Milev, MP; Zijenah, LS; Labbe, AC; Zannou, DM; Humphrey, JH; Ward, BJ; Poudrier, J; Mouland, AJ; Cohen, EA; Roger, M				Boily-Larouche, Genevieve; Milev, Miroslav P.; Zijenah, Lynn S.; Labbe, Annie-Claude; Zannou, Djimon M.; Humphrey, Jean H.; Ward, Brian J.; Poudrier, Johanne; Mouland, Andrew J.; Cohen, Eric A.; Roger, Michel			Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother-To-Child Transmission	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NECROSIS-FACTOR-ALPHA; VERTICAL TRANSMISSION; PROMOTER POLYMORPHISM; PRODUCTIVE INFECTION; AIDS PROGRESSION; DENDRITIC CELLS; IN-UTERO; RECEPTOR; CD209	Background: Mother-to-child transmission (MTCT) is the main cause of HIV-1 infection in children worldwide. Dendritic cell-specific ICAM-3 grabbing-nonintegrin (DC-SIGN, also known as CD209) is an HIV-1 receptor that enhances its transmission to T cells and is expressed on placental macrophages. Methods and Findings: We have investigated the association between DC-SIGN genetic variants and risk of MTCT of HIV-1 among Zimbabwean infants and characterized the impact of the associated mutations on DC-SIGN expression and interaction with HIV-1. DC-SIGN promoter (p-336C and p-201A) and exon 4 (198Q and 242V) variants were all significantly associated with increased risk of intrauterine (IU) HIV-1 infection. Promoter variants decreased DC-SIGN expression both in vitro and in placental CD163(+) macrophages (Hofbauer cells) of HIV-1 unexposed infants but not of HIV-1 exposed infants. The exon 4 protein-modifying mutations increased HIV-1 capture and transmission to T cells in vitro. Conclusion: This study provides compelling evidence to support an important role of DC-SIGN in IU HIV-1 infection.	[Boily-Larouche, Genevieve; Poudrier, Johanne; Roger, Michel] CRCHUM, Immunogenet Lab, Montreal, PQ, Canada; [Boily-Larouche, Genevieve; Labbe, Annie-Claude; Poudrier, Johanne; Cohen, Eric A.; Roger, Michel] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Milev, Miroslav P.; Mouland, Andrew J.] McGill Univ, Dept Med, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Milev, Miroslav P.; Mouland, Andrew J.] McGill AIDS Ctr, Montreal, PQ, Canada; [Zijenah, Lynn S.] Univ Zimbabwe, Coll Hlth Sci, Dept Immunol, Harare, Zimbabwe; [Labbe, Annie-Claude] Hop Maison Neuve Rosemont, Dept Microbiol, Montreal, PQ H1T 2M4, Canada; [Zannou, Djimon M.] Univ Abomey Calavi, Ctr Natl Hosp Univ, Cotonou, Benin; [Humphrey, Jean H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Ward, Brian J.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Cohen, Eric A.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Universite de Montreal; Universite de Montreal; Lady Davis Institute; McGill University; McGill University; University of Zimbabwe; Universite de Montreal; University of Abomey Calavi; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Boily-Larouche, G (corresponding author), CRCHUM, Immunogenet Lab, Montreal, PQ, Canada.	michel.roger.chum@ssss.gouv.qc.ca		Milev, Miroslav/0000-0002-3354-1634	Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante du Quebec (FRSQ) and a Fraser Monat and MacPherson Scholarship; Canada research; Reseau SIDA FRSQ; CIHR [MOP-38111]; Canadian International Development Agency (CIDA) (R/C) [690/M3688]; United States Agency for International Development (USAID) [HRN-A-00-97-00015-00]; Bill and Melinda Gates Foundation, Seattle, Washington, United States of America; Rockefeller Foundation (New York, NY); BASF (Ludwigshafen Germany); BASF for the ZVITAMBO project	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ) and a Fraser Monat and MacPherson Scholarship; Canada research; Reseau SIDA FRSQ; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian International Development Agency (CIDA) (R/C); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Bill and Melinda Gates Foundation, Seattle, Washington, United States of America; Rockefeller Foundation (New York, NY); BASF (Ludwigshafen Germany)(BASF); BASF for the ZVITAMBO project(BASF)	Dr. Boily-Larouche holds a Doctoral Research Award from the Canadian Institutes of Health Research (CIHR), Dr. Roger and Dr. Mouland are supported by careers award from the Fonds de la Recherche en Sante du Quebec (FRSQ) and a Fraser Monat and MacPherson Scholarship, respectively, while Dr. Cohen is recipient of the Canada research chair in human retrovirology. This work was supported by a grant from Reseau SIDA FRSQ to Dr. Roger and grants from the CIHR to Dr. Mouland (MOP-38111) and Dr. Cohen. The ZVITAMBO project was supported by the Canadian International Development Agency (CIDA) (R/C Project 690/M3688), United States Agency for International Development (USAID) (cooperative agreement number HRN-A-00-97-00015-00 between Johns Hopkins University and the Office of Health and Nutrition - USAID) and a grant from the Bill and Melinda Gates Foundation, Seattle, Washington, United States of America. Additional funding was received from the Rockefeller Foundation (New York, NY) and BASF (Ludwigshafen Germany). It is a collaborative project of The University of Zimbabwe, The Harare City Health Department, The Johns Hopkins Bloomberg School of Public Health and the Research Institute of McGill University Health Centres. Dr. Humphrey received an operating grant from BASF for the ZVITAMBO project. The BASF and other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarasu K, 2009, INDIAN J MED RES, V130, P444; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003; Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002; Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211; Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Chan KYK, 2010, HUM IMMUNOL, V71, P702, DOI 10.1016/j.humimm.2010.03.006; Chaudhary O, 2008, J CLIN VIROL, V43, P196, DOI 10.1016/j.jcv.2008.06.005; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Humphrey JH, 2006, J INFECT DIS, V193, P960; Humphrey JH, 2010, BRIT MED J, V341, pc6580; Joerink M, 2011, PLACENTA, V32, P380, DOI 10.1016/j.placenta.2011.02.003; Kfutwah AKW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-36; Kourtis AP, 2010, CLIN PERINATOL, V37, P721, DOI 10.1016/j.clp.2010.08.004; Kumar SB, 2011, J VIROL, V85, P7142, DOI 10.1128/JVI.01955-10; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LAIRMORE MD, 1993, J IMMUNOL, V151, P1673; Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997; Liu HB, 2003, GENE, V313, P149, DOI 10.1016/S0378-1119(03)00674-7; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; Luciano-Montalvo C, 2008, PLACENTA, V29, P1016, DOI 10.1016/j.placenta.2008.09.005; MacDonald KS, 2001, J INFECT DIS, V183, P503, DOI 10.1086/318092; Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528; Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; MCGANN KA, 1994, J INFECT DIS, V169, P746, DOI 10.1093/infdis/169.4.746; Parry S, 2006, J GEN VIROL, V87, P2269, DOI 10.1099/vir.0.81071-0; Pedersen BR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000838; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Rathore A, 2008, CLIN CHIM ACTA, V391, P1, DOI 10.1016/j.cca.2007.12.019; Reuben JM, 1996, J INTERF CYTOK RES, V16, P963, DOI 10.1089/jir.1996.16.963; Ricci E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-49; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Schramm DB, 2006, JAIDS-J ACQ IMM DEF, V42, P545, DOI 10.1097/01.qai.0000225009.30698.ce; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Sheikh AU, 2000, AM J OBSTET GYNECOL, V182, P207, DOI 10.1016/S0002-9378(00)70514-X; Singh KK, 2008, JAIDS-J ACQ IMM DEF, V49, P259, DOI 10.1097/QAI.0b013e318186eaa4; Singh KK, 2009, PEDIATR RES, V65, p55R, DOI 10.1203/PDR.0b013e31819dca03; Soilleux EJ, 2003, INT J BIOCHEM CELL B, V35, P283, DOI 10.1016/S1357-2725(02)00132-2; Soilleux EJ, 2001, J PATHOL, V195, P586, DOI 10.1002/path.1026; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Tsegaye TS, 2010, CELL MICROBIOL, V12, P1553, DOI 10.1111/j.1462-5822.2010.01519.x; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; UNAIDS, 2012, GLOBAL HIV AIDS RESP; Wang L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000934; Zhang J, 2008, J INFECT DIS, V198, P68, DOI 10.1086/588710; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	54	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40706	10.1371/journal.pone.0040706	http://dx.doi.org/10.1371/journal.pone.0040706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808239	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500073
J	Keppler, SJ; Rosenits, K; Koegl, T; Vucikuja, S; Aichele, P				Keppler, Selina Jessica; Rosenits, Kerstin; Koegl, Tamara; Vucikuja, Smiljka; Aichele, Peter			Signal 3 Cytokines as Modulators of Primary Immune Responses during Infections: The Interplay of Type I IFN and IL-12 in CD8 T Cell Responses	PLOS ONE			English	Article							CLONAL EXPANSION; CUTTING EDGE; VIRAL-INFECTION; INTERFERON-ALPHA/BETA; TRANSCRIPTION FACTOR; MEMORY FORMATION; GAMMA PRODUCTION; 3RD SIGNAL; EFFECTOR; DIFFERENTIATION	Signal 3 cytokines, such as IL-12 or type I IFN, support expansion and differentiation of CD8 T cells in vivo. If and how these two signal 3 cytokines compensate each other in T cell activation during different infections is so far unknown. Using CD8 T cells lacking receptors for IL-12, type I IFN or both, we show that the expansion of CD8 T cells depends on type I IFN (LCMV infection), type I IFN and IL-12 (Listeria and vesicular stomatitis virus infection) or is largely independent of the two cytokines (vaccinia virus infection). Furthermore, we show that CD8 T cells lacking IL-12 and type I IFN signals are impaired in cytokine production and cytolytic activity in the context of VSV and Listeria infection. These effector CD8 T cells fail to express KLRG1, thereby exhibiting a memory-like phenotype which correlated with lower expression of the transcription factor T-bet and higher expression of Eomes. This indicates that the variable interplay of both signal 3 cytokines is mandatory for cell fate decision of CD8 T cells in the context of different infections. Furthermore our results demonstrate that the pathogen-induced overall inflammatory milieu and not the antigen load and/or the quality of antigen presentation critically determine the signal 3 dependence of CD8 T cells.	[Keppler, Selina Jessica; Rosenits, Kerstin; Koegl, Tamara; Vucikuja, Smiljka; Aichele, Peter] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Immunol, D-79106 Freiburg, Germany; [Keppler, Selina Jessica; Rosenits, Kerstin; Koegl, Tamara] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Keppler, SJ (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Dept Immunol, Hugstetter Str 55, D-79106 Freiburg, Germany.	peter.aichele@uniklinik-freiburg.de		Keppler, Selina Jessica/0000-0002-9010-8044; Tripp, Ralph/0000-0002-2924-9956	Deutsche Forschungsgemeinschaft [AI 34/2-1]; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by Deutsche Forschungsgemeinschaft grant AI 34/2-1 (P. A.) and the Boehringer Ingelheim Fonds (S.J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; Frenz T, EUR J IMMUNOL, V40, P2769; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, IMMUNITY, V32, P91; Keppler SJ, 2009, EUR J IMMUNOL, V39, P1774, DOI 10.1002/eji.200839093; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pinschewer DD, 2004, J CLIN INVEST, V114, P988, DOI 10.1172/JCI200422374; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Roth E, 2002, J IMMUNOL, V168, P5124, DOI 10.4049/jimmunol.168.10.5124; Sanchez PJ, 2012, VACCINE, V30, P1154, DOI 10.1016/j.vaccine.2011.12.017; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; VOGEL SN, 1982, INFECT IMMUN, V38, P681, DOI 10.1128/IAI.38.2.681-685.1982; Wiesel M, J IMMUNOL, V186, P754; Wiesel M, J IMMUNOL, V185, P5188; Wiesel M, 2012, EUR J IMMUNOL, V42, P320, DOI 10.1002/eji.201142091; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Zenewicz LA, 2002, J IMMUNOL, V169, P5805, DOI 10.4049/jimmunol.169.10.5805	39	66	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40865	10.1371/journal.pone.0040865	http://dx.doi.org/10.1371/journal.pone.0040865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815848	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000035
J	Loos, M; Geens, M; Schauvliege, S; Gasthuys, F; van der Meulen, J; Dubreuil, JD; Goddeeris, BM; Niewold, T; Cox, E				Loos, Michaela; Geens, Marisa; Schauvliege, Stijn; Gasthuys, Frank; van der Meulen, Jan; Dubreuil, J. Daniel; Goddeeris, Bruno M.; Niewold, Theo; Cox, Eric			Role of Heat-Stable Enterotoxins in the Induction of Early Immune Responses in Piglets after Infection with Enterotoxigenic Escherichia coli	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR; PANCREATITIS-ASSOCIATED PROTEIN; INTESTINAL EPITHELIAL-CELLS; POSTWEANING DIARRHEA; LABILE ENTEROTOXIN; GENE-EXPRESSION; DENDRITIC CELLS; CYTOKINE EXPRESSION; HUMAN MONOCYTES; NET ABSORPTION	Enterotoxigenic Escherichia coli (ETEC) strains that produce heat-stable (ST) and/or heat - labile (LT) enterotoxins are cause of post - weaning diarrhea in piglets. However, the relative importance of the different enterotoxins in host immune responses against ETEC infection has been poorly defined. In the present study, several isogenic mutant strains of an O149:F4ac(+), LT+ STa+ STb+ ETEC strain were constructed that lack the expression of LT in combination with one or both types of ST enterotoxins (STa and/or STb). The small intestinal segment perfusion (SISP) technique and microarray analysis were used to study host early immune responses induced by these mutant strains 4 h after infection in comparison to the wild type strain and a PBS control. Simultaneously, net fluid absorption of pig small intestinal mucosa was measured 4 h after infection, allowing us to correlate enterotoxin secretion with gene regulation. Microarray analysis showed on the one hand a non-toxin related general antibacterial response comprising genes such as PAP, MMP1 and IL8. On the other hand, results suggest a dominant role for STb in small intestinal secretion early after post-weaning infection, as well as in the induced innate immune response through differential regulation of immune mediators like interleukin 1 and interleukin 17.	[Loos, Michaela; Goddeeris, Bruno M.; Cox, Eric] Univ Ghent, Fac Vet Med, Lab Vet Immunol, Merelbeke, Belgium; [Geens, Marisa; Goddeeris, Bruno M.; Niewold, Theo] Katholieke Univ Leuven, Lab Livestock Physiol Immunol & Genet, Dept Biosyst, Fac Biosci Engn, Louvain, Belgium; [Schauvliege, Stijn; Gasthuys, Frank] Univ Ghent, Dept Surg & Anaesthesia Domest Anim, Fac Vet Med, Merelbeke, Belgium; [van der Meulen, Jan] Wageningen UR Livestock Res, Dept Anim Nutr, Lelystad, Netherlands; [Dubreuil, J. Daniel] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, Montreal, PQ H3C 3J7, Canada	Ghent University; KU Leuven; Ghent University; Wageningen University & Research; Universite de Montreal	Loos, M (corresponding author), Univ Ghent, Fac Vet Med, Lab Vet Immunol, Merelbeke, Belgium.	michaela.loos@ugent.be	Goddeeris, Bruno Maria/L-2440-2015; Dubreuil, Jean-Daniel/A-5929-2015	Goddeeris, Bruno Maria/0000-0003-3729-7592; Niewold, Theo/0000-0001-8838-750X; Schauvliege, Stijn/0000-0002-7105-6517; Cox, Eric/0000-0003-4281-2990	Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen - Belgium) [G026307N]	Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen - Belgium)(FWO)	This work is supported by the Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen - Belgium), grant G026307N (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x; Chapman TA, 2006, APPL ENVIRON MICROB, V72, P4782, DOI 10.1128/AEM.02885-05; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; CORCORAN ML, 1994, ARCH BIOCHEM BIOPHYS, V310, P481, DOI 10.1006/abbi.1994.1196; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desjeux A, 2002, GASTROEN CLIN BIOL, V26, P23; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; Dong C, 2008, J IMMUNOTOXICOL, V5, P43, DOI 10.1080/15476910801897953; Dubreuil JD, 2008, FEMS MICROBIOL LETT, V278, P137, DOI 10.1111/j.1574-6968.2007.00967.x; Dubreuil JD, 1997, MICROBIOL-SGM, V143, P1783, DOI 10.1099/00221287-143-6-1783; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erume J, 2008, INFECT IMMUN, V76, P3141, DOI 10.1128/IAI.01743-07; Flach CF, 2007, INFECT IMMUN, V75, P2343, DOI 10.1128/IAI.01900-06; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Geenen PL, 2005, EPIDEMIOL INFECT, V133, P459, DOI 10.1017/S0950268804003292; Geens MM, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/469583; Giannella RA, 2003, T AM CLIN CLIMAT ASS, V114, P85; Giannella Ralph A, 2003, Trans Am Clin Climatol Assoc, V114, P67; Gosset M, 2010, J IMMUNOL, V185, P6244, DOI 10.4049/jimmunol.0903315; Grange PA, 2006, VET RES COMMUN, V30, P57, DOI 10.1007/s11259-005-3225-9; Gross G, 2008, FEMS IMMUNOL MED MIC, V54, P215, DOI 10.1111/j.1574-695X.2008.00466.x; Guerrant RL, 2005, CLIN INFECT DIS, V41, pS524, DOI 10.1086/432946; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; HITOTSUBASHI S, 1992, INFECT IMMUN, V60, P4468, DOI 10.1128/IAI.60.11.4468-4474.1992; Huang DB, 2004, CLIN DIAGN LAB IMMUN, V11, P548, DOI 10.1128/CDLI.11.3.548-551.2004; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; IMBERECHTS H, 1994, VET MICROBIOL, V40, P219, DOI 10.1016/0378-1135(94)90111-2; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Lamprecht G, 2009, ANN NY ACAD SCI, V1165, P261, DOI 10.1111/j.1749-6632.2009.04044.x; LECCE JG, 1982, J CLIN MICROBIOL, V16, P715, DOI 10.1128/JCM.16.4.715-723.1982; Lee J, 2011, MOL CELL ENDOCRINOL, V332, P306, DOI 10.1016/j.mce.2010.11.022; Li CKF, 2004, J IMMUNOL, V173, P5171, DOI 10.4049/jimmunol.173.8.5171; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long KZ, 2010, INFECT IMMUN, V78, P1221, DOI 10.1128/IAI.00767-09; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; MOON HW, 1986, AM J VET RES, V47, P210; Moucadel V, 2001, EUR J CELL BIOL, V80, P156, DOI 10.1078/0171-9335-00148; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; NABUURS MJA, 1993, RES VET SCI, V55, P108, DOI 10.1016/0034-5288(93)90043-F; NABUURS MJA, 1994, RES VET SCI, V56, P379, DOI 10.1016/0034-5288(94)90156-2; NAGY B, 1990, J CLIN MICROBIOL, V28, P651, DOI 10.1128/JCM.28.4.651-653.1990; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nandakumar NS, 2009, INDIAN J MED RES, V130, P170; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; Niewold TA, 2005, VET IMMUNOL IMMUNOP, V105, P317, DOI 10.1016/j.vetimm.2005.02.010; Niewold TA, 2007, MOL IMMUNOL, V44, P1316, DOI 10.1016/j.molimm.2006.05.013; Niewold TA, 2010, VET MICROBIOL, V141, P110, DOI 10.1016/j.vetmic.2009.08.014; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; Raymond CR, 2005, VET IMMUNOL IMMUNOP, V107, P235, DOI 10.1016/j.vetimm.2005.05.008; SALAJKA E, 1992, VET MICROBIOL, V32, P163, DOI 10.1016/0378-1135(92)90103-Z; SHAPIRO SD, 1993, J BIOL CHEM, V268, P8170; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; TAKEDA T, 1993, INFECT IMMUN, V61, P289, DOI 10.1128/IAI.61.1.289-294.1993; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; TZIPORI S, 1980, AUST VET J, V56, P279, DOI 10.1111/j.1751-0813.1980.tb05724.x; Van den Broeck W, 1999, VET MICROBIOL, V68, P255, DOI 10.1016/S0378-1135(99)00076-0; van der Meulen J, 2010, BENEF MICROBES, V1, P439, DOI 10.3920/BM2010.0025; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Verdonck F, 2002, VACCINE, V20, P2995, DOI 10.1016/S0264-410X(02)00220-7; Verhelst R, 2010, LIVEST SCI, V133, P101, DOI 10.1016/j.livsci.2010.06.035; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wintero AK, 1996, MAMM GENOME, V7, P509, DOI 10.1007/s003359900153; Zhang WP, 2008, APPL ENVIRON MICROB, V74, P5832, DOI 10.1128/AEM.00893-08; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	81	55	62	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41041	10.1371/journal.pone.0041041	http://dx.doi.org/10.1371/journal.pone.0041041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815904	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000054
J	Mila, B; Tavares, ES; Saldana, AM; Karubian, J; Smith, TB; Baker, AJ				Mila, Borja; Tavares, Erika S.; Munoz Saldana, Alberto; Karubian, Jordan; Smith, Thomas B.; Baker, Allan J.			A Trans-Amazonian Screening of mtDNA Reveals Deep Intraspecific Divergence in Forest Birds and Suggests a Vast Underestimation of Species Diversity	PLOS ONE			English	Article							POSTGLACIAL POPULATION EXPANSION; MITOCHONDRIAL-DNA; HISTORICAL DIVERSIFICATION; MOLECULAR PHYLOGENETICS; PHYLOGEOGRAPHIC PATTERNS; GENETIC DIFFERENTIATION; LATITUDINAL GRADIENT; GEOGRAPHIC-VARIATION; MAXIMUM-LIKELIHOOD; COMPLEX AVES	The Amazonian avifauna remains severely understudied relative to that of the temperate zone, and its species richness is thought to be underestimated by current taxonomy. Recent molecular systematic studies using mtDNA sequence reveal that traditionally accepted species-level taxa often conceal genetically divergent subspecific lineages found to represent new species upon close taxonomic scrutiny, suggesting that intraspecific mtDNA variation could be useful in species discovery. Surveys of mtDNA variation in Holarctic species have revealed patterns of variation that are largely congruent with species boundaries. However, little information exists on intraspecific divergence in most Amazonian species. Here we screen intraspecific mtDNA genetic variation in 41 Amazonian forest understory species belonging to 36 genera and 17 families in 6 orders, using 758 individual samples from Ecuador and French Guiana. For 13 of these species, we also analyzed trans-Andean populations from the Ecuadorian Choco. A consistent pattern of deep intraspecific divergence among trans-Amazonian haplogroups was found for 33 of the 41 taxa, and genetic differentiation and genetic diversity among them was highly variable, suggesting a complex range of evolutionary histories. Mean sequence divergence within families was the same as that found in North American birds (13%), yet mean intraspecific divergence in Neotropical species was an order of magnitude larger (2.13% vs. 0.23%), with mean distance between intraspecific lineages reaching 3.56%. We found no clear relationship between genetic distances and differentiation in plumage color. Our results identify numerous genetically and phenotypically divergent lineages which may result in new species-level designations upon closer taxonomic scrutiny and thorough sampling, although lineages in the tropical region could be older than those in the temperate zone without necessarily representing separate species. In-depth phylogeographic surveys are urgently needed to avoid underestimating tropical diversity, and the use of mtDNA markers can be instrumental in identifying and prioritizing taxa for species discovery.	[Mila, Borja; Munoz Saldana, Alberto] Spanish Res Council CSIC, Natl Museum Nat Sci, Madrid, Spain; [Mila, Borja; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA USA; [Tavares, Erika S.; Baker, Allan J.] Royal Ontario Museum, Toronto, ON M5S 2C6, Canada; [Karubian, Jordan] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of California System; University of California Los Angeles; Royal Ontario Museum; Tulane University; University of California System; University of California Los Angeles	Mila, B (corresponding author), Spanish Res Council CSIC, Natl Museum Nat Sci, Madrid, Spain.	b.mila@csic.es	Tavares, Erika/ABB-9701-2020; Karubian, Jordan/A-4364-2015; Mila, Borja/L-4867-2014	Karubian, Jordan/0000-0001-8201-9992; Mila, Borja/0000-0002-6446-0079	Centre National de la Recherche Scientifique (France); NSF (National Science Foundation) [IRCEB9977072]; NASA (National Aeronautics and Space Administration) [IDS/03-0169-0347]; Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, Natural Sciences and Engineering Research Council of Canada (NSERC); ROM Governors' Fund	Centre National de la Recherche Scientifique (France)(Centre National de la Recherche Scientifique (CNRS)); NSF (National Science Foundation)(National Science Foundation (NSF)); NASA (National Aeronautics and Space Administration)(National Aeronautics & Space Administration (NASA)); Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); ROM Governors' Fund	Field work was funded through grants from the Centre National de la Recherche Scientifique (France) to BM, and grants from NSF (National Science Foundation) (IRCEB9977072) and NASA (National Aeronautics and Space Administration) (IDS/03-0169-0347) to TBS. Laboratory work was supported by funding through the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, Natural Sciences and Engineering Research Council of Canada (NSERC), and other sponsors (listed on http://www.barcodinglife.org), and the ROM Governors' Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleixo A, 2004, EVOLUTION, V58, P1303, DOI 10.1111/j.0014-3820.2004.tb01709.x; Aleixo A, 2002, AUK, V119, P621, DOI 10.1642/0004-8038(2002)119[0621:MSATRO]2.0.CO;2; Aleixo A, 2006, BIOL J LINN SOC, V89, P383, DOI 10.1111/j.1095-8312.2006.00703.x; Armenta JK, 2005, CONDOR, V107, P527, DOI 10.1650/0010-5422(2005)107[0527:GVIMDS]2.0.CO;2; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bates JM, 1999, AUK, V116, P1093, DOI 10.2307/4089688; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; BEVEN S, 1984, J BIOGEOGR, V11, P383, DOI 10.2307/2844803; Blackburn TM, 1996, PHILOS T R SOC B, V351, P897, DOI 10.1098/rstb.1996.0083; Bleiweiss R, 2004, P NATL ACAD SCI USA, V101, P16561, DOI 10.1073/pnas.0406386101; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Braun MJ, 2005, CONDOR, V107, P327, DOI 10.1650/7647; Brumfield RT, 2007, EVOLUTION, V61, P346, DOI 10.1111/j.1558-5646.2007.00039.x; Brumfield RT, 2005, AUK, V122, P414, DOI 10.1642/0004-8038(2005)122[0414:MVIBPO]2.0.CO;2; Brumfield RT, 1996, EVOLUTION, V50, P1607, DOI 10.1111/j.1558-5646.1996.tb03933.x; Buerkle CA, 1999, EVOLUTION, V53, P1915, DOI 10.1111/j.1558-5646.1999.tb04572.x; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Burns KJ, 2004, MOL PHYLOGENET EVOL, V32, P838, DOI 10.1016/j.ympev.2004.02.013; Cabanne GS, 2011, BIOL J LINN SOC, V103, P801, DOI 10.1111/j.1095-8312.2011.01678.x; Cadena CD, 2007, MOL PHYLOGENET EVOL, V44, P993, DOI 10.1016/j.ympev.2006.12.012; Campagna L, 2011, MOL PHYLOGENET EVOL, V61, P521, DOI 10.1016/j.ympev.2011.07.011; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; CRACRAFT J, 1988, EVOLUTION, V42, P603, DOI 10.1111/j.1558-5646.1988.tb04164.x; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Dacosta JM, 2008, MOL ECOL, V17, P1328, DOI 10.1111/j.1365-294X.2007.03647.x; Cadena CD, 2011, MOL PHYLOGENET EVOL, V58, P540, DOI 10.1016/j.ympev.2010.12.014; DEAN AD, 1995, BIOTECHNIQUES, V18, P980; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; Eberhard JR, 2005, MOL PHYLOGENET EVOL, V36, P288, DOI 10.1016/j.ympev.2005.01.022; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAITH DP, 1994, BIOL CONSERV, V68, P69, DOI 10.1016/0006-3207(94)90548-7; Faith DP, 2004, CONSERV BIOL, V18, P255, DOI 10.1111/j.1523-1739.2004.00330.x; Fu YX, 1997, GENETICS, V147, P915; HACKETT SJ, 1990, AUK, V107, P473; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Isler ML, 2007, AUK, V124, P11, DOI 10.1642/0004-8038(2007)124[11:SLIATT]2.0.CO;2; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kimura M, 2002, MOL ECOL, V11, P1605, DOI 10.1046/j.1365-294X.2002.01551.x; Lijtmaer DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020744; Lovette IJ, 2004, MOL PHYLOGENET EVOL, V32, P512, DOI 10.1016/j.ympev.2004.01.007; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; Marks BD, 2002, MOL PHYLOGENET EVOL, V24, P153, DOI 10.1016/S1055-7903(02)00233-6; Martin PR, 2010, EVOLUTION, V64, P336, DOI 10.1111/j.1558-5646.2009.00831.x; McCormack JE, 2008, MOL ECOL, V17, P2505, DOI 10.1111/j.1365-294X.2008.03776.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; Merila J, 1997, EVOLUTION, V51, P946, DOI 10.1111/j.1558-5646.1997.tb03675.x; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Mila B, 2006, EVOLUTION, V60, P2403; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Mila B, 2011, BIOL J LINN SOC, V103, P696, DOI 10.1111/j.1095-8312.2011.01661.x; Miller MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1133, DOI 10.1098/rspb.2008.0015; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Moore WS, 2006, BIOL J LINN SOC, V87, P611, DOI 10.1111/j.1095-8312.2006.00586.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Navarro-Sigüenza Adolfo G., 2004, Biota Neotrop., V4, P1, DOI 10.1590/S1676-06032004000200013; Nyari AS, 2007, MOL PHYLOGENET EVOL, V44, P154, DOI 10.1016/j.ympev.2007.02.020; Omland KE, 2000, EVOLUTION, V54, P2119; Padial JM, 2010, BIOL J LINN SOC, V101, P747, DOI 10.1111/j.1095-8312.2010.01528.x; Pavlova A, 2003, AUK, V120, P744, DOI 10.1642/0004-8038(2003)120[0744:PPIMFA]2.0.CO;2; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Puebla-Olivares F, 2008, AUK, V125, P39, DOI 10.1525/auk.2008.125.1.39; Restall R, 2006, BIRDS NO S AM IDENTI; Ribas CC, 2006, AUK, V123, P660, DOI 10.1642/0004-8038(2006)123[660:MSAPOD]2.0.CO;2; Ribas CC, 2005, J BIOGEOGR, V32, P1409, DOI 10.1111/j.1365-2699.2005.01289.x; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russello MA, 2004, MOL PHYLOGENET EVOL, V30, P421, DOI 10.1016/S1055-7903(03)00192-1; Sangster G, 2009, P ROY SOC B-BIOL SCI, V276, P3185, DOI 10.1098/rspb.2009.0582; SEUTIN G, 1995, EVOLUTION, V49, P962, DOI 10.1111/j.1558-5646.1995.tb02331.x; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Tavares ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028543; Thomassen HA, 2009, EVOLUTIONARY APPL, V3, P1; Tobias JA, 2008, SCIENCE, V319, DOI 10.1126/science.1150568; Toews DPL, 2008, MOL ECOL, V17, P2691, DOI 10.1111/j.1365-294X.2008.03769.x; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Voelker G, 2007, MOL PHYLOGENET EVOL, V42, P422, DOI 10.1016/j.ympev.2006.07.016; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2011, MOL ECOL, V20, P4550, DOI 10.1111/j.1365-294X.2011.05294.x; Weir JT, 2011, P ROY SOC B-BIOL SCI, V278, P1713, DOI 10.1098/rspb.2010.2037; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910; Yoo HS, 2006, MOL CELLS, V22, P323; ZINK RM, 1993, EVOLUTION, V47, P717, DOI 10.1111/j.1558-5646.1993.tb01228.x; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zink Robert M., 1997, P301, DOI 10.1016/B978-012498315-1/50017-0	102	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40541	10.1371/journal.pone.0040541	http://dx.doi.org/10.1371/journal.pone.0040541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815761	Green Submitted, Green Published, gold			2022-12-27	WOS:000306507000018
J	de Azevedo, MF; Gilson, PR; Gabriel, HB; Simoes, RF; Angrisano, F; Baum, J; Crabb, BS; Wunderlich, G				de Azevedo, Mauro Ferreira; Gilson, Paul R.; Gabriel, Heloisa B.; Simoes, Roseli F.; Angrisano, Fiona; Baum, Jacob; Crabb, Brendan S.; Wunderlich, Gerhard			Systematic Analysis of FKBP Inducible Degradation Domain Tagging Strategies for the Human Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							RED-BLOOD-CELLS; TRANSFECTION; PROTEINS; GENE; EXPRESSION; REVEALS; RECOMBINATION; VIRULENCE; INVASION	Targeted regulation of protein levels is an important tool to gain insights into the role of proteins essential to cell function and development. In recent years, a method based on mutated forms of the human FKBP12 has been established and used to great effect in various cell types to explore protein function. The mutated FKBP protein, referred to as destabilization domain (DD) tag when fused with a native protein at the N- or C-terminus targets the protein for proteosomal degradation. Regulated expression is achieved via addition of a compound, Shld-1, that stabilizes the protein and prevents degradation. A limited number of studies have used this system to provide powerful insight into protein function in the human malaria parasite Plasmodium falciparum. In order to better understand the DD inducible system in P. falciparum, we studied the effect of Shld-1 on parasite growth, demonstrating that although development is not impaired, it is delayed, requiring the appropriate controls for phenotype interpretation. We explored the quantified regulation of reporter Green Fluorescent Protein (GFP) and luciferase constructs fused to three DD variants in parasite cells either via transient or stable transfection. The regulation obtained with the original FKBP derived DD domain was compared to two triple mutants DD24 and DD29, which had been described to provide better regulation for C-terminal tagging in other cell types. When cloned to the C-terminal of reporter proteins, DD24 provided the strongest regulation allowing reporter activity to be reduced to lower levels than DD and to restore the activity of stabilised proteins to higher levels than DD29. Importantly, DD24 has not previously been applied to regulate proteins in P. falciparum. The possibility of regulating an exported protein was addressed by targeting the Ring-Infected Erythrocyte Surface Antigen (RESA) at its C-terminus. The tagged protein demonstrated an important modulation of its expression.	[de Azevedo, Mauro Ferreira; Gabriel, Heloisa B.; Simoes, Roseli F.; Wunderlich, Gerhard] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [de Azevedo, Mauro Ferreira; Gilson, Paul R.; Crabb, Brendan S.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Gilson, Paul R.] Monash Univ, Melbourne, Vic 3004, Australia; [Angrisano, Fiona; Baum, Jacob] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Angrisano, Fiona; Baum, Jacob; Crabb, Brendan S.] Univ Melbourne, Melbourne, Vic 3010, Australia	Universidade de Sao Paulo; Burnet Institute; Monash University; Walter & Eliza Hall Institute; University of Melbourne	de Azevedo, MF (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	gwunder@usp.br	Crabb, Brendan/F-5287-2013; Wunderlich, Gerhard/G-8245-2012; Gabriel, Heloisa B/D-6424-2015; Azevedo, Mauro/H-6180-2012	Wunderlich, Gerhard/0000-0003-1724-0337; Azevedo, Mauro/0000-0002-5233-2037; Angrisano, Fiona/0000-0002-0457-5982; Baum, Jake/0000-0002-0275-352X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Council for Scientific and Technological Development (CNPq); National Health and Medical Research Council of Australia	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), by The National Council for Scientific and Technological Development (CNPq) and by the National Health and Medical Research Council of Australia. MFA is a former postdoctoral fellow from FAPESP (Process No: 09/51026-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Balu B, 2007, INT J PARASITOL, V37, P1, DOI 10.1016/j.ijpara.2006.10.001; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Bullen H. E., 2012, J BIOL CHEM; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 2010, INT J PARASITOL, V40, P509, DOI 10.1016/j.ijpara.2010.02.002; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; de Koning-Ward TF, 2009, TRENDS PARASITOL, V25, P4, DOI 10.1016/j.pt.2008.09.009; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Dvorin JD, SCIENCE, V328, P910; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungstr?m I., 2004, METHODS MALARIA RES; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Militello KT, 2003, PARASITOL RES, V89, P154, DOI 10.1007/s00436-002-0721-5; Monaghan P, 2005, MOL BIOCHEM PARASIT, V139, P185, DOI 10.1016/j.molbiopara.2004.10.007; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Neelam S, 2011, EXP BIOL MED, V236, P580, DOI 10.1258/ebm.2011.010394; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Wilson DW, MALAR J, V9, P152; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	33	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40981	10.1371/journal.pone.0040981	http://dx.doi.org/10.1371/journal.pone.0040981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815885	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100102
J	Hol, J; Otterdal, K; Breland, UM; Stang, E; Pedersen, TM; Hagelsteen, K; Ranheim, T; Kasprzycka, M; Halvorsen, B; Haraldsen, G; Aukrust, P				Hol, Johanna; Otterdal, Kari; Breland, Unni M.; Stang, Espen; Pedersen, Turid M.; Hagelsteen, Kathrine; Ranheim, Trine; Kasprzycka, Monika; Halvorsen, Bente; Haraldsen, Guttorm; Aukrust, Pal			Statins Affect the Presentation of Endothelial Chemokines by Targeting to Multivesicular Bodies	PLOS ONE			English	Article							HMG-COA REDUCTASE; MEDIATED HISTONE MODIFICATIONS; GENE-EXPRESSION; E-SELECTIN; GRO-ALPHA; CELLS; ATORVASTATIN; ADHESION; IDENTIFICATION; EXOCYTOSIS	Background: In addition to lowering cholesterol, statins are thought to beneficially modulate inflammation. Several chemokines including CXCL1/growth-related oncogene (GRO)-alpha, CXCL8/interleukin (IL)-8 and CCL2/monocyte chemoattractant protein (MCP)-1 are important in the pathogenesis of atherosclerosis and can be influenced by statin-treatment. Recently, we observed that atorvastatin-treatment alters the intracellular content and subcellular distribution of GRO-alpha in cultured human umbilical vein endothelial cells (HUVECs). The objective of this study was to investigate the mechanisms involved in this phenomenon. Methodology/Principal Findings: The effect of atorvastatin on secretion levels and subcellular distribution of GRO-alpha, IL-8 and MCP-1 in HUVECs activated by interleukin (IL)-1 beta were evaluated by ELISA, confocal microscopy and immunoelectron microscopy. Atorvastatin increased the intracellular contents of GRO-alpha, IL-8, and MCP-1 and induced colocalization with E-selectin in multivesicular bodies. This effect was prevented by adding the isoprenylation substrate GGPP, but not the cholesterol precursor squalene, indicating that atorvastatin exerts these effects by inhibiting isoprenylation rather than depleting the cells of cholesterol. Conclusions/Significance: Atorvastatin targets inflammatory chemokines to the endocytic pathway and multivesicular bodies and may contribute to explain the anti-inflammatory effect of statins at the level of endothelial cell function.	[Hol, Johanna; Stang, Espen; Hagelsteen, Kathrine; Kasprzycka, Monika; Haraldsen, Guttorm] Oslo Univ Hosp, Div Pathol, Oslo, Norway; [Otterdal, Kari; Breland, Unni M.; Pedersen, Turid M.; Ranheim, Trine; Halvorsen, Bente; Aukrust, Pal] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway	University of Oslo; University of Oslo	Hol, J (corresponding author), Oslo Univ Hosp, Div Pathol, Oslo, Norway.	guttorm.haraldsen@rr-research.no	Haraldsen, Guttorm/W-4359-2019; Haraldsen, Guttorm/I-2680-2013; Hol, Johanna/AAJ-8586-2020	Hol, Johanna/0000-0001-5837-5006; Haraldsen, Guttorm/0000-0002-0064-9665	Norwegian Research Council; South-Eastern Norway Regional Health Authority	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority	This study has been funded by grants from The Norwegian Research Council and South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breland UM, 2008, ARTERIOSCL THROM VAS, V28, P1005, DOI 10.1161/ATVBAHA.108.162305; Chansrichavala P, 2010, INT IMMUNOPHARMACOL, V10, P892, DOI 10.1016/j.intimp.2010.04.027; Cowled PA, 2007, J SURG RES, V141, P267, DOI 10.1016/j.jss.2006.11.021; Eccles KA, 2008, ATHEROSCLEROSIS, V200, P69, DOI 10.1016/j.atherosclerosis.2007.12.018; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Hol J, 2009, J BIOL CHEM, V284, P23532, DOI 10.1074/jbc.M900874200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kluger MS, 2002, J IMMUNOL, V168, P2091, DOI 10.4049/jimmunol.168.5.2091; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Kruger PS, 2009, INTENS CARE MED, V35, P717, DOI 10.1007/s00134-008-1358-3; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu PY, 2009, CIRCULATION, V119, P131, DOI 10.1161/CIRCULATIONAHA.108.813311; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; N'Guessan PD, 2009, ARTERIOSCL THROM VAS, V29, P380, DOI 10.1161/ATVBAHA.108.178319; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Papadopoulou C, 2008, CYTOKINE, V43, P181, DOI 10.1016/j.cyto.2008.05.009; Posvar EL, 1996, J CLIN PHARMACOL, V36, P728, DOI 10.1002/j.1552-4604.1996.tb04242.x; Rao AD, 2010, CRIT CARE, V14, DOI 10.1186/cc9006; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Schmeck B, 2008, CIRC RES, V102, P888, DOI 10.1161/CIRCRESAHA.107.161307; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shaw SM, 2009, CARDIOLOGY, V112, P4, DOI 10.1159/000137692; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; SUBRAMANIAM M, 1993, MOL BIOL CELL, V4, P791, DOI 10.1091/mbc.4.8.791; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	31	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40673	10.1371/journal.pone.0040673	http://dx.doi.org/10.1371/journal.pone.0040673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815786	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100051
J	Nene, NR; Zaikin, A				Nene, Nuno R.; Zaikin, Alexey			Interplay between Path and Speed in Decision Making by High-Dimensional Stochastic Gene Regulatory Networks	PLOS ONE			English	Article							NOISE; EXPRESSION; DIFFERENTIATION; BIFURCATION; SPECIFICITY; FRAMEWORK; MODEL; STATE	Induction of a specific transcriptional program by external signaling inputs is a crucial aspect of intracellular network functioning. The theoretical concept of coexisting attractors representing particular genetic programs is reasonably adapted to experimental observations of "genome-wide" expression profiles or phenotypes. Attractors can be associated either with developmental outcomes such as differentiation into specific types of cells, or maintenance of cell functioning such as proliferation or apoptosis. Here we review a mechanism known as speed-dependent cellular decision making (SdCDM) in a small epigenetic switch and generalize the concept to high-dimensional space. We demonstrate that high-dimensional network clustering capacity is dependent on the level of intrinsic noise and the speed at which external signals operate on the transcriptional landscape.	[Nene, Nuno R.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Zaikin, Alexey] UCL, Dept Math, London, England; [Zaikin, Alexey] UCL, Inst Womens Hlth, London, England	Imperial College London; University of London; University College London; University of London; University College London	Nene, NR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	n.nene@imperial.ac.uk	Zaikin, Alexey/K-6581-2017; Zaikin, Alexey/T-7171-2019	Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130	Engineering and Physical Sciences Research Council at CoMPLEX, University College London	Engineering and Physical Sciences Research Council at CoMPLEX, University College London	NRN acknowledges financial support from the Engineering and Physical Sciences Research Council at CoMPLEX, University College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Andrecut M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/148; Ashwin P, 2012, PHILOS T R SOC A, V370, P1166, DOI 10.1098/rsta.2011.0306; Berg J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.188101; Berglund N, 2006, PROB APPL S; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; Cinquin O, 2002, J THEOR BIOL, V216, P229, DOI 10.1006/jtbi.2002.2544; Cinquin O, 2007, B MATH BIOL, V69, P483, DOI 10.1007/s11538-006-9114-8; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; GARCAOJALVO J, 1999, NOISE SPATIALLY EXTE; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Ge H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148103; Guantes R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000235; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kaneko K, 1998, PHYSICA D, V124, P322, DOI 10.1016/S0167-2789(98)00205-X; Kloeden P.E., 1999, NUMERICAL SOLUTION S; Kobayashi TJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.228101; KONDEPUDI DK, 1986, PHYSICA D, V21, P296, DOI 10.1016/0167-2789(86)90006-0; Koseska A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004872; Kuchina A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.88; Kuehn C, 2011, PHYSICA D, V240, P1020, DOI 10.1016/j.physd.2011.02.012; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nene NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032779; Nicolis C, 2000, PHYS REV E, V62, P197, DOI 10.1103/PhysRevE.62.197; Nicolis G, 2005, PHYSICA A, V351, P22, DOI 10.1016/j.physa.2004.12.006; Sen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025102; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vangelov B, 2011, EXP HEMATOL, V39, pS89; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	45	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40085	10.1371/journal.pone.0040085	http://dx.doi.org/10.1371/journal.pone.0040085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815725	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100028
J	Ramos, R; Granadeiro, JP; Nevoux, M; Mougin, JL; Dias, MP; Catry, P				Ramos, Rauel; Granadeiro, Jose Pedro; Nevoux, Marie; Mougin, Jean-Louis; Dias, Maria Peixe; Catry, Paulo			Combined Spatio-Temporal Impacts of Climate and Longline Fisheries on the Survival of a Trans-Equatorial Marine Migrant	PLOS ONE			English	Article							SHEARWATER CALONECTRIS-DIOMEDEA; SELVAGEM-GRANDE 30-DEGREES-09'N; SOUTHERN-OCEAN; SEABIRD BYCATCH; POPULATION-DYNAMICS; MODELING SURVIVAL; WORLD FISHERIES; TOP PREDATORS; MORTALITY; TRENDS	Predicting the impact of human activities and their derivable consequences, such as global warming or direct wildlife mortality, is increasingly relevant in our changing world. Due to their particular life history traits, long-lived migrants are amongst the most endangered and sensitive group of animals to these harming effects. Our ability to identify and quantify such anthropogenic threats in both breeding and wintering grounds is, therefore, of key importance in the field of conservation biology. Using long-term capture-recapture data (34 years, 4557 individuals) and year-round tracking data (4 years, 100 individuals) of a trans-equatorial migrant, the Cory's shearwater (Calonectris diomedea), we investigated the impact of longline fisheries and climatic variables in both breeding and wintering areas on the most important demographic trait of this seabird, i.e. adult survival. Annual adult survival probability was estimated at 0.914+/-0.022 on average, declining throughout 1978-1999 but recovering during the last decade (2005-2011). Our results suggest that both the incidental bycatch associated with longline fisheries and high sea surface temperatures (indirectly linked to food availability; SST) increased mortality rates during the long breeding season (March-October). Shearwater survival was also negatively affected during the short non-breeding season (December-February) by positive episodes of the Southern Oscillation Index (SOI). Indirect negative effects of climate at both breeding (SST) and wintering grounds (SOI) had a greater impact on survival than longliner activity, and indeed these climatic factors are those which are expected to present more unfavourable trends in the future. Our work underlines the importance of considering both breeding and wintering habitats as well as precise schedules/phenology when assessing the global role of the local impacts on the dynamics of migratory species.	[Ramos, Rauel; Dias, Maria Peixe; Catry, Paulo] Inst Super Psicol Aplicada, Ecoethol Res Unit, Lisbon, Portugal; [Granadeiro, Jose Pedro] Univ Lisbon, Ctr Environm & Marine Studies, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal; [Nevoux, Marie] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, Hatfield, South Africa; [Mougin, Jean-Louis] Museum Natl Hist Nat, Zool Lab, F-75231 Paris, France	Instituto Superior Psicologia Aplicada (ISPA); Universidade de Lisboa; University of Pretoria; Museum National d'Histoire Naturelle (MNHN)	Ramos, R (corresponding author), Inst Super Psicol Aplicada, Ecoethol Res Unit, Lisbon, Portugal.	ramos@ub.edu	Catry, Paulo/I-5408-2013; Dias, Maria/AAK-1171-2021; Ramos, Raül/S-3112-2016; Granadeiro, José Pedro/E-8060-2011	Catry, Paulo/0000-0003-3000-0522; Dias, Maria/0000-0002-7281-4391; Ramos, Raül/0000-0002-0551-8605; Granadeiro, José Pedro/0000-0002-7207-3474	Fundacao para a Ciencia e a Tecnologia [PTDC/MAR/71927/2006, BPD/46827/08]; Programa Plurianual [UID 331/94]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Plurianual	This study was financed by Fundacao para a Ciencia e a Tecnologia (www.fct.mctes.pt, Portugal) through Project PTDC/MAR/71927/2006 and as part of the Programa Plurianual (UI&D 331/94). MAD benefited from a fellowship from Fundacao para a Ciencia e a Tecnologia (BPD/46827/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Arcos JM, 2009, IMPORTANT AREAS CONS; arra P. P., 2006, CONNECTIVITY CONSERV, P157, DOI [10.1017/CBO9780511754821.008, DOI 10.1017/CBO9780511754821.008]; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barbraud C, 2008, J APPL ECOL, V45, P1460, DOI 10.1111/j.1365-2664.2008.01537.x; Barbraud C, 2011, J ANIM ECOL, V80, P89, DOI 10.1111/j.1365-2656.2010.01752.x; Bearzi G, 2006, BIOL CONSERV, V127, P373, DOI 10.1016/j.biocon.2005.08.017; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Benjamins Steven, 2008, Endangered Species Research, V5, P149, DOI 10.3354/esr00094; Berrow SD, 1993, IRISH BIRDS, V5, P78; BirdLife International, 2008, STAT WORLDS BIRDS IN; Boano G, 2010, ITAL J ZOOL, V77, P460, DOI 10.1080/11250000903469017; Brichetti P, 2000, WATERBIRDS, V23, P147; British Antarctic Survey, 2008, BAS RES INSTR TECHN; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Bunce A, 2002, MAR BIOL, V141, P263, DOI 10.1007/s00227-002-0838-1; Burnham K. P., 1998, MODEL SELECTION MODE; Camphuysen CJ, 2005, AFR J MAR SCI, V27, P427, DOI 10.2989/18142320509504101; Choquet R., 2006, M SURGE MULTISTATE S; Choquet R, 2005, U CARE UTILITIES CAP; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Cooper J, 2003, SCI MAR, V67, P57, DOI 10.3989/scimar.2003.67s257; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; Croxall JP., 1987, SEABIRDS FEEDING ECO; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Duffy D.C., 1990, Elsevier Oceanography Series, V52, P395; Fontaine R, 2011, BIOL CONSERV, V144, P1998, DOI 10.1016/j.biocon.2011.04.022; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Gaston A. J., 2004, SEABIRDS NATURAL HIS, P162; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Granadeiro JP, 2006, WATERBIRDS, V29, P56, DOI 10.1675/1524-4695(2006)29[56:NAPTOC]2.0.CO;2; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Grosbois V, 2009, ECOLOGY, V90, P2922, DOI 10.1890/08-1657.1; Guinet C, 1996, ANTARCT SCI, V8, P23, DOI 10.1017/S0954102096000053; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hjermann DO, 2004, MAR ECOL PROG SER, V273, P229, DOI 10.3354/meps273229; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2003, J ANIM ECOL, V72, P576, DOI 10.1046/j.1365-2656.2003.00727.x; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jenouvrier S, 2009, GLOBAL CHANGE BIOL, V15, P268, DOI 10.1111/j.1365-2486.2008.01715.x; LACOCK GD, 1986, CLIMATIC CHANGE, V8, P173, DOI 10.1007/BF00139753; Laneri K, 2010, MAR ECOL PROG SER, V420, P241, DOI 10.3354/meps08847; Le Bohec C, 2008, P NATL ACAD SCI USA, V105, P2493, DOI 10.1073/pnas.0712031105; Lebreton J-D, 2011, BIOMETRICS IN PRESS; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Llewellin EW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015697; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Luczak C, 2011, BIOL LETTERS, V7, P702, DOI 10.1098/rsbl.2011.0225; Machu E, 2009, FISH OCEANOGR, V18, P287, DOI 10.1111/j.1365-2419.2009.00511.x; Martin A., 1991, Boletim do Museu Municipal do Funchal, V43, P107; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Mougin J.-L., 2000, Boletim do Museu Municipal do Funchal, V52, P45; Mougin J-L, 1996, B MUSEU MUNINCIPAL F, V269, P171; Mougin JL, 2000, REV ECOL-TERRE VIE, V55, P275; Mougin JL, 1997, CR ACAD SCI III-VIE, V320, P825, DOI 10.1016/S0764-4469(97)85019-6; Nevoux M, 2007, J ANIM ECOL, V76, P159, DOI 10.1111/j.1365-2656.2006.01191.x; Olmos F, 1997, IBIS, V139, P685, DOI 10.1111/j.1474-919X.1997.tb04692.x; ORO D, 1994, OSTRICH, V65, P225, DOI 10.1080/00306525.1994.9639686; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Pradel R., 2005, Animal Biodiversity and Conservation, V28, P189; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R., 1993, P29; Quilifeldt P, 2007, J AVIAN BIOL, V38, P298, DOI 10.1111/j.2007.0908-8857.03846.x; Ramirez I, 2008, IMPORTANT AREAS SEAB; Rando JC, 1997, INT J OSTEOARCHAEOL, V7, P298, DOI 10.1002/(SICI)1099-1212(199707/08)7:4<298::AID-OA384>3.0.CO;2-L; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Ristow D, 2000, CONDOR, V102, P696, DOI 10.1650/0010-5422(2000)102[0696:STOCSS]2.0.CO;2; RISTOW D, 1990, Vogelwelt, V111, P172; Roy C, 2003, LAR MAR ECOSYST, V12, P255; Santos AMP, 2005, J MAR RES, V63, P359, DOI 10.1357/0022240053693671; Sanz-Aguilar A, 2011, ECOL APPL, V21, P555, DOI 10.1890/09-2339.1; Shackell NL, 2012, ICES J MAR SCI, V69, P151, DOI 10.1093/icesjms/fsr195; Skalski JR, 1996, CAN J FISH AQUAT SCI, V53, P196, DOI 10.1139/cjfas-53-1-196; Solomon S., 2007, PHYS SCI BASIS WORKI; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Veran S, 2007, J APPL ECOL, V44, P942, DOI 10.1111/j.1365-2664.2007.01346.x; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Weimerskirch H, 2000, POLAR BIOL, V23, P236, DOI 10.1007/s003000050440; Wells BK, 2008, MAR ECOL PROG SER, V364, P15, DOI 10.3354/meps07486; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y; Wynn Russell B., 2004, British Birds, V97, P323; Zino PA, 1985, MUSEU MUNICIPAL FUNC, V84, P1	97	26	26	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40822	10.1371/journal.pone.0040822	http://dx.doi.org/10.1371/journal.pone.0040822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815833	Green Published, Green Submitted, gold			2022-12-27	WOS:000306466100075
J	Vanderwel, MC; Malcolm, JR; Caspersen, JP				Vanderwel, Mark C.; Malcolm, Jay R.; Caspersen, John P.			Using a Data-Constrained Model of Home Range Establishment to Predict Abundance in Spatially Heterogeneous Habitats	PLOS ONE			English	Article							GREEN-TREE RETENTION; SMALL MAMMALS; FOREST; PATTERNS; RESPONSES; POPULATIONS; SELECTION; DYNAMICS; AVAILABILITY; REGENERATION	Mechanistic modelling approaches that explicitly translate from individual-scale resource selection to the distribution and abundance of a larger population may be better suited to predicting responses to spatially heterogeneous habitat alteration than commonly-used regression models. We developed an individual-based model of home range establishment that, given a mapped distribution of local habitat values, estimates species abundance by simulating the number and position of viable home ranges that can be maintained across a spatially heterogeneous area. We estimated parameters for this model from data on red-backed vole (Myodes gapperi) abundances in 31 boreal forest sites in Ontario, Canada. The home range model had considerably more support from these data than both non-spatial regression models based on the same original habitat variables and a mean-abundance null model. It had nearly equivalent support to a non-spatial regression model that, like the home range model, scaled an aggregate measure of habitat value from local associations with habitat resources. The home range and habitat-value regression models gave similar predictions for vole abundance under simulations of light-and moderate-intensity partial forest harvesting, but the home range model predicted lower abundances than the regression model under high-intensity disturbance. Empirical regression-based approaches for predicting species abundance may overlook processes that affect habitat use by individuals, and often extrapolate poorly to novel habitat conditions. Mechanistic home range models that can be parameterized against abundance data from different habitats permit appropriate scaling from individual-to population-level habitat relationships, and can potentially provide better insights into responses to disturbance.	[Vanderwel, Mark C.; Malcolm, Jay R.; Caspersen, John P.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Vanderwel, Mark C.] Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England	University of Toronto; Microsoft	Vanderwel, MC (corresponding author), Univ Toronto, Fac Forestry, Toronto, ON, Canada.	mark.vanderwel@utoronto.ca			Sustainable Forest Management Network [malcolmjdyna11]; Natural Sciences and Engineering Research Council of Canada; Forestry Futures Trust [035-2-R1]; Ontario Ministry of Natural Resources; Tembec Inc.; Lake Abitibi Model Forest; University of Toronto Faculty of Forestry	Sustainable Forest Management Network; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Forestry Futures Trust; Ontario Ministry of Natural Resources; Tembec Inc.; Lake Abitibi Model Forest; University of Toronto Faculty of Forestry(University of Toronto)	This work was supported by the Sustainable Forest Management Network (malcolmjdyna11), Natural Sciences and Engineering Research Council of Canada (Discovery Grant to JRM; http://www.nserc-crsng.gc.ca/), Forestry Futures Trust (035-2-R1; http://www.forestryfutures.ca), Ontario Ministry of Natural Resources (http://www.mnr.gov.on.ca), Tembec Inc. (http://tembec.com), Lake Abitibi Model Forest (http://www.modelforest.net), and University of Toronto Faculty of Forestry (http://www.forestry.utoronto.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry Keith B., 2004, Forest Snow and Landscape Research, V78, P119; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; BONDRUPNIELSEN S, 1985, ANN ZOOL FENN, V22, P385; Buchmann CM, 2011, OIKOS, V120, P106, DOI 10.1111/j.1600-0706.2010.18556.x; Butler SJ, 2010, J APPL ECOL, V47, P67, DOI 10.1111/j.1365-2664.2009.01750.x; Coates KD, 1997, FOREST ECOL MANAG, V99, P337, DOI 10.1016/S0378-1127(97)00113-8; Cumming SG, 2000, ECOL APPL, V10, P744; Franklin JF, 2004, J FOREST, V102, P22; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gagne N, 1999, CAN J FOREST RES, V29, P1128, DOI 10.1139/cjfr-29-7-1128; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gautestad AO, 2005, AM NAT, V165, P44, DOI 10.1086/426673; Gitzen RA, 2007, FOREST ECOL MANAG, V251, P142, DOI 10.1016/j.foreco.2007.05.028; Guenette JS, 2005, CONSERV BIOL, V19, P1168, DOI 10.1111/j.1523-1739.2005.00085.x; Gunn JS, 2000, FOREST ECOL MANAG, V126, P1, DOI 10.1016/S0378-1127(99)00078-X; Haeussler S, 2007, CAN J BOT, V85, P1158, DOI 10.1139/B07-108; Halpern CB, 2005, ECOL APPL, V15, P175, DOI 10.1890/03-6000; Harvey BD, 2007, CAN J FOREST RES, V37, P1525, DOI 10.1139/X07-090; Hilborn Ray, 1997, V28; Hinam HL, 2008, BIOL CONSERV, V141, P524, DOI 10.1016/j.biocon.2007.11.011; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kramer-Schadt S, 2007, ECOL MODEL, V204, P553, DOI 10.1016/j.ecolmodel.2007.01.018; Le Blanc ML, 2010, ECOSCIENCE, V17, P334, DOI 10.2980/17-3-3340; MacDonald GB, 2003, FOREST ECOL MANAG, V182, P213, DOI 10.1016/S0378-1127(03)00047-1; Macdonald SE, 2007, FOREST ECOL MANAG, V242, P34, DOI 10.1016/j.foreco.2007.01.029; Manly B.F.J., 2002, RESOURCE SELECTION A; McCarthy John, 2001, Environmental Reviews, V9, P1, DOI 10.1139/a00-012; Messier C, 2008, RAPPORT PARAMETRISAT; Mitchell MS, 2007, ANIM BEHAV, V74, P219, DOI 10.1016/j.anbehav.2006.11.017; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; Moorcroft PR, 2008, ECOLOGY, V89, P1112, DOI 10.1890/06-1985.1; Morris DW, 2011, P ROY SOC B-BIOL SCI, V278, P2401, DOI 10.1098/rspb.2011.0604; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Moses RA, 2001, CAN J FOREST RES, V31, P483, DOI 10.1139/cjfr-31-3-483; Murphy LE, 2009, SORTIE ND USER MANUA; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; OSTFELD RS, 1985, AM NAT, V126, P1, DOI 10.1086/284391; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pearce J, 2005, FOREST ECOL MANAG, V208, P153, DOI 10.1016/j.foreco.2004.11.024; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Stamps J., 2009, PRINCETON GUIDE ECOL, P38; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Vanderwel MC, 2009, FOREST CHRON, V85, P91, DOI 10.5558/tfc85091-1; Vanderwel MC, 2010, J WILDLIFE MANAGE, V74, P1492, DOI 10.2193/2009-426; Wang M, 2007, ECOL MODEL, V205, P397, DOI 10.1016/j.ecolmodel.2007.03.003	47	5	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40599	10.1371/journal.pone.0040599	http://dx.doi.org/10.1371/journal.pone.0040599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815772	gold, Green Published, Green Submitted			2022-12-27	WOS:000306466100044
J	Oberbach, A; Schlichting, N; Heinrich, M; Till, H; Stolzenburg, JU; Neuhaus, J				Oberbach, Andreas; Schlichting, Nadine; Heinrich, Marco; Till, Holger; Stolzenburg, Jens-Uwe; Neuhaus, Jochen			Free Fatty Acid Palmitate Impairs the Vitality and Function of Cultured Human Bladder Smooth Muscle Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; N-TERMINAL KINASE; FACTOR-KAPPA-B; SIGNALING PATHWAY; IL-6-INDUCED ACTIVATION; HUMAN DETRUSOR; COLON-CANCER; INTERLEUKIN-6; EXPRESSION; PROLIFERATION	Background: Incidence of urinary tract infections is elevated in patients with diabetes mellitus. Those patients show increased levels of the saturated free fatty acid palmitate. As recently shown metabolic alterations induced by palmitate include production and secretion of the pro-inflammatory cytokine interleukine-6 (IL-6) in cultured human bladder smooth muscle cells (hBSMC). Here we studied the influence of palmitate on vital cell properties, for example, regulation of cell proliferation, mitochondrial enzyme activity and antioxidant capacity in hBSMC, and analyzed the involvement of major cytokine signaling pathways. Methodology/Principal Findings: HBSMC cultures were set up from bladder tissue of patients undergoing cystectomy and stimulated with palmitate. We analyzed cell proliferation, mitochondrial enzyme activity, and antioxidant capacity by ELISA and confocal immunofluorescence. In signal transduction inhibition experiments we evaluated the involvement of NF-kappa B, JAK/STAT, MEK1, PI3K, and JNK in major cytokine signaling pathway regulation. We found: (i) palmitate decreased cell proliferation, increased mitochondrial enzyme activity and antioxidant capacity; (ii) direct inhibition of cytokine receptor by AG490 even more strongly suppressed cell proliferation in palmitate-stimulated cells, while counteracting palmitate-induced increase of antioxidant capacity; (iii) in contrast knockdown of the STAT3 inhibitor SOCS3 increased cell proliferation and antioxidant capacity; (iv) further downstream JAK/STAT3 signaling cascade the inhibition of PI3K or JNK enhanced palmitate induced suppression of cell proliferation; (v) increase of mitochondrial enzyme activity by palmitate was enhanced by inhibition of PI3K but counteracted by inhibition of MEK1. Conclusions/Significance: Saturated free fatty acids (e.g., palmitate) cause massive alterations in vital cell functions of cultured hBSMC involving distinct major cytokine signaling pathways. Thereby, certain cytokines might counteract the palmitate-induced downregulation of cell proliferation and vitality. This could be an important link to clinical findings of increased risk of metabolic related bladder diseases such as overactive bladder (OAB) and bladder pain syndrome/interstitial cystitis (BPS/IC).	[Oberbach, Andreas; Schlichting, Nadine; Heinrich, Marco; Till, Holger] Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany; [Oberbach, Andreas; Schlichting, Nadine; Till, Holger] Univ Leipzig, Med Ctr, IFB Adipos Dis, Leipzig, Germany; [Heinrich, Marco; Stolzenburg, Jens-Uwe; Neuhaus, Jochen] Univ Leipzig, Dept Urol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Oberbach, A (corresponding author), Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de						ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bahillo-Curieses MP, 2012, ENDOCRINE, V41, P289, DOI 10.1007/s12020-011-9540-8; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Bruce CR, 2004, AM J PHYSIOL-ENDOC M, V287, pE616, DOI 10.1152/ajpendo.00150.2004; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chang MC, 2004, J BIOL CHEM, V279, P50676, DOI 10.1074/jbc.M404465200; Chang S, 2009, LAB INVEST, V89, P823, DOI 10.1038/labinvest.2009.38; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gasbarro G, 2010, AM J PHYSIOL-RENAL, V298, pF72, DOI 10.1152/ajprenal.00309.2009; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; Heo SK, 2008, J CELL BIOCHEM, V105, P70, DOI 10.1002/jcb.21805; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; LaRosa Christopher, 2010, J Med Liban, V58, P132; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; McGrother CW, 2006, AGE AGEING, V35, P16, DOI 10.1093/ageing/afi205; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Neuhaus J, 2007, UROLOGE, V46, P1193, DOI 10.1007/s00120-007-1479-2; Neuhaus J, 2009, EUR UROL, V55, P491, DOI 10.1016/j.eururo.2008.03.090; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Sabin MA, 2007, PEDIATRICS, V120, pE1426, DOI 10.1542/peds.2007-0189; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Seo IA, 2009, KOREAN J PHYSIOL PHA, V13, P131, DOI 10.4196/kjpp.2009.13.2.131; Shao CH, 2010, BIOCHEM PHARMACOL, V80, P205, DOI 10.1016/j.bcp.2010.03.024; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; Stapleton A, 2002, AM J MED, V113, p80S; Tao QS, 2012, MOL BIOL REP, V39, P4201, DOI 10.1007/s11033-011-1205-4; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang ZP, 2009, EXP MOL MED, V41, P717, DOI 10.3858/emm.2009.41.10.078; Watanabe S, 2004, AM J NEPHROL, V24, P387, DOI 10.1159/000079706; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yu JH, 2008, INT J BIOCHEM CELL B, V40, P677, DOI 10.1016/j.biocel.2007.10.007; ZHENG CF, 1993, J BIOL CHEM, V268, P23933	52	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e41026	10.1371/journal.pone.0041026	http://dx.doi.org/10.1371/journal.pone.0041026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808290	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700074
J	Rodrigo, G; Carrera, J; Ruiz-Ferrer, V; del Toro, FJ; Llave, C; Voinnet, O; Elena, SF				Rodrigo, Guillermo; Carrera, Javier; Ruiz-Ferrer, Virgina; del Toro, Francisco J.; Llave, Cesar; Voinnet, Olivier; Elena, Santiago F.			A Meta-Analysis Reveals the Commonalities and Differences in Arabidopsis thaliana Response to Different Viral Pathogens	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; GENE-EXPRESSION PROFILE; SYSTEMS BIOLOGY; FUNCTIONAL ANNOTATION; SCALE-FREE; VIRUS; NETWORKS; MICROARRAY; TOOL; INTERACTOME	Understanding the mechanisms by which plants trigger host defenses in response to viruses has been a challenging problem owing to the multiplicity of factors and complexity of interactions involved. The advent of genomic techniques, however, has opened the possibility to grasp a global picture of the interaction. Here, we used Arabidopsis thaliana to identify and compare genes that are differentially regulated upon infection with seven distinct (+)ssRNA and one ssDNA plant viruses. In the first approach, we established lists of genes differentially affected by each virus and compared their involvement in biological functions and metabolic processes. We found that phylogenetically related viruses significantly alter the expression of similar genes and that viruses naturally infecting Brassicaceae display a greater overlap in the plant response. In the second approach, virus-regulated genes were contextualized using models of transcriptional and protein-protein interaction networks of A. thaliana. Our results confirm that host cells undergo significant reprogramming of their transcriptome during infection, which is possibly a central requirement for the mounting of host defenses. We uncovered a general mode of action in which perturbations preferentially affect genes that are highly connected, central and organized in modules.	[Rodrigo, Guillermo; Carrera, Javier; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Carrera, Javier] Univ Politecn Valencia, Inst ITACA, E-46071 Valencia, Spain; [Ruiz-Ferrer, Virgina; Voinnet, Olivier] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [del Toro, Francisco J.; Llave, Cesar] CSIC, Ctr Invest Biol, Madrid, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universitat Politecnica de Valencia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); The Santa Fe Institute	Rodrigo, G (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	santiago.elena@csic.es	Llave, Cesar/ABF-5827-2021; Elena, Santiago F./A-4191-2011; Rodrigo, Guillermo/K-9207-2014	Elena, Santiago F./0000-0001-8249-5593; Ruiz-Ferrer, Virginia/0000-0002-7840-297X; Voinnet, Olivier/0000-0001-6982-9544; Rodrigo, Guillermo/0000-0002-1871-9617	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2009-06993, BIO2006-13107]; Generalitat Valenciana [PROMETEO2010/016, BFPI2007-160]; MICINN [TIN2006-12860]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN) grants BFU2009-06993 (S. F. E.) and BIO2006-13107 (C. L.) and by Generalitat Valenciana grant PROMETEO2010/016 (S. F. E.). G. R. is supported by a graduate fellowship from the Generalitat Valenciana (BFPI2007-160) and J.C. by a contract from MICINN grant TIN2006-12860. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Agudelo-Romero P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002397; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allemeersch J, 2005, PLANT PHYSIOL, V137, P588, DOI 10.1104/pp.104.051300; Andeweg AC, 2008, CURR OPIN MICROBIOL, V11, P461, DOI 10.1016/j.mib.2008.09.010; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Bailer SM, 2009, CURR OPIN MICROBIOL, V12, P453, DOI 10.1016/j.mib.2009.06.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Carrera J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r96; Choi IR, 2000, VIROLOGY, V267, P185, DOI 10.1006/viro.1999.0117; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Daudin JJ, 2008, STAT COMPUT, V18, P173, DOI 10.1007/s11222-007-9046-7; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Elena SF, 2011, CURR OPIN PLANT BIOL, V14, P372, DOI 10.1016/j.pbi.2011.03.013; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Guo DY, 2001, J GEN VIROL, V82, P935, DOI 10.1099/0022-1317-82-4-935; Handford MG, 2007, J GEN VIROL, V88, P337, DOI 10.1099/vir.0.82376-0; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishihara T, 2004, PLANT CELL PHYSIOL, V45, P470, DOI 10.1093/pcp/pch057; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kang SH, 2004, MOL CELLS, V18, P122; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Lin L, 2009, VIRUS RES, V142, P36, DOI 10.1016/j.virusres.2009.01.006; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Maule A, 2002, CURR OPIN PLANT BIOL, V5, P279, DOI 10.1016/S1369-5266(02)00272-8; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Pagan I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000124; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Redner S, 2008, NATURE, V453, P47, DOI 10.1038/453047a; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shen WT, 2010, ACTA VIROL, V54, P49, DOI 10.4149/av_2010_01_49; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stumpf MPH, 2005, EUROPHYS LETT, V71, P152, DOI 10.1209/epl/i2004-10531-8; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Tarraga J, 2008, NUCLEIC ACIDS RES, V36, pW308, DOI 10.1093/nar/gkn303; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	62	56	56	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40526	10.1371/journal.pone.0040526	http://dx.doi.org/10.1371/journal.pone.0040526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808182	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400031
J	Sun, Y; Yu, S; Sun, P; Wu, HY; Zhu, WD; Liu, W; Zhang, J; Fang, J; Li, RY				Sun, Yi; Yu, Shuang; Sun, Peng; Wu, Haiyan; Zhu, Weidong; Liu, Wei; Zhang, Jue; Fang, Jing; Li, Ruoyu			Inactivation of Candida Biofilms by Non-Thermal Plasma and Its Enhancement for Fungistatic Effect of Antifungal Drugs	PLOS ONE			English	Article							PRESSURE AIR PLASMA; HYDROGEN-PEROXIDE; SINGLET OXYGEN; COAGULATION; RESISTANCE; EPIDEMIOLOGY; DAMAGE	We investigated the antifungal effect of non-thermal plasma, as well as its combination with common antifungal drugs, against Candida biofilms. A direct current atmospheric pressure He/O-2 (2%) plasma microjet (PMJ) was used to treat Candida biofilms in a 96-well plate. Inactivation efficacies of the biofilms were evaluated by XTT assay and counting colony forming units (CFUs). Morphological properties of the biofilms were evaluated by Scanning Electron Microscope (SEM). The sessile minimal inhibitory concentrations (SMICs) of fluconazole, amphotericin B, and caspofungin for the biofilms were also tested. Electron Spin Resonance (ESR) spectroscopy was used to detect the reactive oxygen species (ROS) generated directly and indirectly by PMJ. The Candida biofilms were completely inactivated after 1 min PMJ treatment, where severely deformed fungal elements were observed in SEM images. The SMICs of the tested antifungal drugs for the plasma-treated biofilms were decreased by 2-6 folds of dilution, compared to those of the untreated controls. ROS such as hydroxyl radical ((OH)-O-center dot), superoxide anion radical (O-center dot(2)) and singlet molecular oxygen (O-1(2)) were detected by ESR. We hence conclude that He/O-2 (2%) plasma alone, as well as in combination with common antifungal drugs, is able to inactivate Candida biofilms rapidly. The generation of ROS is believed to be one of the underlying mechanisms for the fungicidal activity	[Sun, Yi; Liu, Wei; Li, Ruoyu] Peking Univ, Dept Dermatol & Venereolgy, Hosp 1, Res Ctr Med Mycol, Beijing 100871, Peoples R China; [Yu, Shuang; Zhang, Jue; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Sun, Peng; Wu, Haiyan; Zhang, Jue; Fang, Jing] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Zhu, Weidong] St Peters Coll, Dept Appl Sci & Technol, Jersey City, NJ USA	Peking University; Peking University; Peking University	Sun, Y (corresponding author), Peking Univ, Dept Dermatol & Venereolgy, Hosp 1, Res Ctr Med Mycol, Beijing 100871, Peoples R China.	liuwei@bjmu.edu.cn; zhangjue@pku.edu.cn	Zhang, Jue/E-2067-2014; Zhang, Jue/N-7594-2013; Sun, Peter P/H-8154-2013; Sun, Peter P./AAG-9200-2019	Sun, Peter P/0000-0001-5681-6621; Sun, Peter P./0000-0001-5681-6621	National Natural Science Foundation of China [30970131]; Program for New Century Excellent Talents in University [NCET-10-0198]; Beijing Natural Science Foundation [7102149]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research was supported by the National Natural Science Foundation of China (30970131), the Program for New Century Excellent Talents in University (NCET-10-0198), and the Beijing Natural Science Foundation (7102149) to Dr. Wei Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Baillie GS, 2000, J ANTIMICROB CHEMOTH, V46, P397, DOI 10.1093/jac/46.3.397; Bryers JD, 2004, ASM NEWS, V70, P232; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Buonocore G, 2010, SEMIN FETAL NEONAT M, V15, P186, DOI 10.1016/j.siny.2010.04.003; Cauda R, 2009, DRUGS, V69, P33, DOI 10.2165/11315520-000000000-00000; CLSI, 1908, M27A3 CLSI; Concia E, 2009, DRUGS, V69, P5, DOI 10.2165/11315500-000000000-00000; d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458; Dasgupta MK, 2002, SEMIN DIALYSIS, V15, P338, DOI 10.1046/j.1525-139X.2002.00084.x; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Feng HQ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491180; Feng HQ, 2009, IEEE T PLASMA SCI, V37, P121, DOI 10.1109/TPS.2008.2008438; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; GORMAN AA, 1978, CHEM PHYS LETT, V55, P52, DOI 10.1016/0009-2614(78)85130-6; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hasan F, 2009, MICROBES INFECT, V11, P753, DOI 10.1016/j.micinf.2009.04.018; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Kim SJ, 2009, APPL PHYS LETT, V94; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Koppenol WH, 2001, REDOX REP, V6, P229, DOI 10.1179/135100001101536373; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Lee HW, 2009, J ENDODONT, V35, P587, DOI 10.1016/j.joen.2009.01.008; Liu FX, 2010, PLASMA PROCESS POLYM, V7, P231, DOI 10.1002/ppap.200900070; Ma RN, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3693165; Malick KJ, 2006, GASTROENTEROL NURS, V29, P386, DOI 10.1097/00001610-200609000-00006; Morfill GE, 2009, NEW J PHYS, V11; Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002; Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Raiser J, 2006, J PHYS D APPL PHYS, V39, P3520, DOI 10.1088/0022-3727/39/16/S10; Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002; Ramage G, 2001, Am Clin Lab, V20, P42; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Rowen JL, 2003, SEMIN PERINATOL, V27, P406, DOI 10.1016/S0146-0005(03)00066-1; Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; Schulz H, 2000, GASTROINTEST ENDOSC, V51, P659, DOI 10.1016/S0016-5107(00)33002-4; Seneviratne CJ, 2008, ANTIMICROB AGENTS CH, V52, P3259, DOI 10.1128/AAC.00541-08; Sun P, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530434; Sun P, 2010, IEEE T PLASMA SCI, V38, P1892, DOI 10.1109/TPS.2009.2039585; Tobudic S, 2010, J ANTIMICROB CHEMOTH, V65, P271, DOI 10.1093/jac/dkp429; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; VENKATADRI R, 1993, HAZARD WASTE HAZARD, V10, P107, DOI 10.1089/hwm.1993.10.107	46	25	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40629	10.1371/journal.pone.0040629	http://dx.doi.org/10.1371/journal.pone.0040629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808213	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500064
J	Haaber, J; Cohn, MT; Frees, D; Andersen, TJ; Ingmer, H				Haaber, Jakob; Cohn, Marianne Thorup; Frees, Dorte; Andersen, Thorbjorn Joest; Ingmer, Hanne			Planktonic Aggregates of Staphylococcus aureus Protect against Common Antibiotics	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; BACTERIAL BIOFILMS; INTERCELLULAR-ADHESION; CAMPYLOBACTER-JEJUNI; CYSTIC-FIBROSIS; ICA LOCUS; RESISTANCE; VIRULENCE; EPIDERMIDIS; TOLERANCE	Bacterial cells are mostly studied during planktonic growth although in their natural habitats they are often found in communities such as biofilms with dramatically different physiological properties. We have examined another type of community namely cellular aggregates observed in strains of the human pathogen Staphylococcus aureus. By laser-diffraction particle-size analysis (LDA) we show, for strains forming visible aggregates, that the aggregation starts already in the early exponential growth phase and proceeds until post-exponential phase where more than 90% of the population is part of the aggregate community. Similar to some types of biofilm, the structural component of S. aureus aggregates is the polysaccharide intercellular adhesin (PIA). Importantly, PIA production correlates with the level of aggregation whether altered through mutations or exposure to sub-inhibitory concentrations of selected antibiotics. While some properties of aggregates resemble those of biofilms including increased mutation frequency and survival during antibiotic treatment, aggregated cells displayed higher metabolic activity than planktonic cells or cells in biofilm. Thus, our data indicate that the properties of cells in aggregates differ in some aspects from those in biofilms. It is generally accepted that the biofilm life style protects pathogens against antibiotics and the hostile environment of the host. We speculate that in aggregate communities S. aureus increases its tolerance to hazardous environments and that the combination of a biofilm-like environment with mobility has substantial practical and clinical importance.	[Haaber, Jakob; Cohn, Marianne Thorup; Frees, Dorte; Ingmer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Andersen, Thorbjorn Joest] Univ Copenhagen, Dept Geog & Geol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Haaber, J (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	hi@life.ku.dk	Andersen, Thorbjorn/I-7083-2012; Andersen, Thorbjørn/N-7560-2014	Andersen, Thorbjørn/0000-0001-5032-9945; Ingmer, Hanne/0000-0002-8350-5631; Krause Haaber, Jakob/0000-0001-6984-7515; Frees, Dorte/0000-0003-4946-2890	Danish Reserch Council for Independent Research [274-08-0531]; Lundbeck foundation [R31-A2472]	Danish Reserch Council for Independent Research; Lundbeck foundation(Lundbeckfonden)	This work was supported by the Danish Reserch Council for Independent Research, grant number 274-08-0531, and the Lundbeck foundation, grant number R31-A2472. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2002, J CLIN MICROBIOL, V40, P4172, DOI 10.1128/JCM.40.11.4172-4179.2002; Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Andersen JB, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-86; Andersen MT, 2005, MICROBIOL-SGM, V151, P905, DOI 10.1099/mic.0.27513-0; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Chander Y, 2005, J ENVIRON QUAL, V34, P1952, DOI 10.2134/jeq2005.0017; Cohn MT, 2007, APPL ENVIRON MICROB, V73, P7803, DOI 10.1128/AEM.00698-07; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hoyle B D, 1991, Prog Drug Res, V37, P91; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Mirani Z.A., 2010, J BASIC MICROBIOL; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; QVORTRUP K, 1995, ANN OTO RHINOL LARYN, V104, P120, DOI 10.1177/000348949510400207; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Resch A, 2005, FEMS MICROBIOL LETT, V252, P89, DOI 10.1016/j.femsle.2005.08.048; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Smith K, 2009, INT J ANTIMICROB AG, V33, P374, DOI 10.1016/j.ijantimicag.2008.08.029; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Tunney MM, 2004, ANTIMICROB AGENTS CH, V48, P1879, DOI 10.1128/AAC.48.5.1879-1881.2004; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; van Gennip M, 2012, INFECT IMMUN, V80, P2601, DOI 10.1128/IAI.06215-11; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035	64	102	102	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41075	10.1371/journal.pone.0041075	http://dx.doi.org/10.1371/journal.pone.0041075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815921	gold, Green Published			2022-12-27	WOS:000306548900072
J	Tambor, V; Kacerovsky, M; Andrys, C; Musilova, I; Hornychova, H; Pliskova, L; Link, M; Stulik, J; Lenco, J				Tambor, Vojtech; Kacerovsky, Marian; Andrys, Ctirad; Musilova, Ivana; Hornychova, Helena; Pliskova, Lenka; Link, Marek; Stulik, Jiri; Lenco, Juraj			Amniotic Fluid Cathelicidin in PPROM Pregnancies: From Proteomic Discovery to Assessing Its Potential in Inflammatory Complications Diagnosis	PLOS ONE			English	Article							PRETERM PREMATURE RUPTURE; ANTIMICROBIAL PEPTIDE LL-37; VITAMIN-D; INTRAAMNIOTIC INFECTION; 1ST YEAR; MEMBRANES; RISK; EXPRESSION; MANAGEMENT; CELLS	Background: Preterm prelabor rupture of membranes (PPROM) complicated by microbial invasion of the amniotic cavity (MIAC) leading to histological chorioamnionitis (HCA) significantly impacts perinatal morbidity. Unfortunately, no well-established tool for identifying PPROM patients threatened by these disorders is available. Methodology/Principal Findings: We performed an unbiased exploratory analysis of amniotic fluid proteome changes due to MIAC and HCA. From among the top five proteins that showed the most profound and significant change, we sought to confirm results concerning cathelicidin (P49913, CAMP_HUMAN), since an ELISA kit was readily available for this protein. In our exploratory proteomic study, cathelicidin showed a similar to 6-fold higher concentration in PPROM patients with confirmed MIAC and HCA. We verified significantly higher levels of cathelicidin in exploratory samples (women without both MIAC and HCA: median 1.4 ng/ml; women with both conditions confirmed: median 3.6 ng/ml; p = 0.0003). A prospective replication cohort was used for independent validation and for assessment of cathelicidin potential to stratify women with MIAC leading to HCA from women in whom at least one of these conditions was ruled out. We confirmed the association of higher amniotic fluid cathelicidin levels with MIAC leading to HCA (the presence of both MIAC and HCA: median 3.1 ng/ml; other women: median 1.4 ng/ml; p < 0.0001). A cathelicidin concentration of 4.0 ng/ml was found to be the best cut-off point for identifying PPROM women with both MIAC and HCA. When tested on the validation cohort, a sensitivity of 48%, a specificity of 90%, a likelihood ratio of 5.0, and an area under receiver-operating characteristic curve of 71% were achieved for identification of women with MIAC leading to HCA. Conclusions: Our multi-stage study suggests cathelicidin as a candidate marker that should be considered for a panel of amniotic fluid proteins permitting identification of PPROM women with MIAC leading to HCA.	[Tambor, Vojtech; Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Kacerovsky, Marian; Musilova, Ivana] Charles Univ Prague, Fac Med Hradec Kralove, Dept Obstet & Gynecol, Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Andrys, Ctirad] Charles Univ Prague, Fac Med Hradec Kralove, Dept Allergy & Clin Immunol, Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Musilova, Ivana] Pardubice Univ, Hosp Pardubice, Dept Obstet & Gynecol, Fac Hlth Studies, Pardubice, Czech Republic; [Hornychova, Helena] Charles Univ Prague, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Fingerlands Dept Pathol, Hradec Kralove, Czech Republic; [Pliskova, Lenka] Charles Univ Prague, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Link, Marek; Stulik, Jiri; Lenco, Juraj] Univ Def, Fac Mil Hlth Sci, Inst Mol Pathol, Hradec Kralove, Czech Republic	University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University of Pardubice; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University of Defence - Czech Republic	Tambor, V (corresponding author), Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic.	lenco@pmfhk.cz	Lenčo, Juraj/AAL-4281-2020; Kacerovsky, Marian/ABE-3437-2020; Hornychová, Helena/M-9470-2017; Musilová, Ivana Kacerovská/I-6204-2017; Kacerovsky, Marian/A-7586-2011	Hornychová, Helena/0000-0002-2487-1754; Musilová, Ivana Kacerovská/0000-0002-6960-8319; Kacerovsky, Marian/0000-0001-9858-7900; Lenco, Juraj/0000-0002-8526-9249; Stulik, Jiri/0000-0002-4790-2365; Andrys, Ctirad/0000-0001-6489-8786; Link, Marek/0000-0003-4601-4523	Ministry of Health of the Czech Republic [NS 10382-3/2009]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was fully supported by a grant received from the Ministry of Health of the Czech Republic (NS 10382-3/2009, http://www.mzcr.cz/Odbornik/obsah/veda-a-vyzkum_977_3.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Amatngalim GD, 2011, INFLAMMATION, V34, P412, DOI 10.1007/s10753-010-9248-6; Ananth C V, 1996, Obstet Gynecol Surv, V51, P324, DOI 10.1097/00006254-199605000-00024; Arora Chander P., 2010, Biopolymers and Cell, V26, P97; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7; Doyle LW, 2012, CURR OPIN PEDIATR, V24, P154, DOI 10.1097/MOP.0b013e3283504da1; Edmondson N, 2009, PEDIATR DEVEL PATHOL, V12, P16, DOI 10.2350/07-04-0270.1; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gopalani S, 2004, AM J PERINAT, V21, P183, DOI 10.1055/s-2004-828609; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Havelka AM, 2010, ACTA PAEDIATR, V99, P836, DOI 10.1111/j.1651-2227.2010.01726.x; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; Klaffenbach D, 2011, PLACENTA, V32, P830, DOI 10.1016/j.placenta.2011.08.004; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; Mercer BM, 2000, AM J OBSTET GYNECOL, V183, P738, DOI 10.1067/mob.2000.106766; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Porreco RP, 2008, J MATERN-FETAL NEO M, V21, P573, DOI 10.1080/14767050802178011; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Reeves SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.014; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P661, DOI 10.1016/S0002-9378(88)80030-9; Romero R, 2010, J MATERN-FETAL NEO M, V23, P261, DOI 10.3109/14767050903067386; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Shand AW, 2010, BJOG-INT J OBSTET GY, V117, P1593, DOI 10.1111/j.1471-0528.2010.02742.x; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simhan HN, 2005, BJOG-INT J OBSTET GY, V112, P32, DOI 10.1111/j.1471-0528.2005.00582.x; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Tambor V, 2010, PHYSIOL RES, V59, P471, DOI 10.33549/physiolres.931758; Tambor V, 2012, J PROTEOMICS, V75, P857, DOI 10.1016/j.jprot.2011.09.027; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; The czech society of obstetrics and gynecology, 2007, CLIN GUID OBST; Tjabringa GS, 2006, INT ARCH ALLERGY IMM, V140, P103, DOI 10.1159/000092305; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang YH, 2003, LEUKEMIA RES, V27, P947, DOI 10.1016/S0145-2126(03)00020-1; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; Zanardo V, 2008, PEDIATR DEVEL PATHOL, V11, P350, DOI 10.2350/07-08-0324.1; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17	56	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41164	10.1371/journal.pone.0041164	http://dx.doi.org/10.1371/journal.pone.0041164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815956	Green Submitted, Green Published, gold			2022-12-27	WOS:000306548900088
J	Wolfe, BE; Tulloss, RE; Pringle, A				Wolfe, Benjamin E.; Tulloss, Rodham E.; Pringle, Anne			The Irreversible Loss of a Decomposition Pathway Marks the Single Origin of an Ectomycorrhizal Symbiosis	PLOS ONE			English	Article							EDIBLE STRAW MUSHROOM; EVOLUTIONARY TRANSITIONS; VOLVARIELLA-VOLVACEA; FUNGI; CLONING; GENOME; PLANTS; RADIOCARBON; EXPRESSION; INSIGHTS	Microbial symbioses have evolved repeatedly across the tree of life, but the genetic changes underlying transitions to symbiosis are largely unknown, especially for eukaryotic microbial symbionts. We used the genus Amanita, an iconic group of mushroom-forming fungi engaged in ectomycorrhizal symbioses with plants, to identify both the origins and potential genetic changes maintaining the stability of this mutualism. A multi-gene phylogeny reveals one origin of the symbiosis within Amanita, with a single transition from saprotrophic decomposition of dead organic matter to biotrophic dependence on host plants for carbon. Associated with this transition are the losses of two cellulase genes, each of which plays a critical role in extracellular decomposition of organic matter. However a third gene, which acts at later stages in cellulose decomposition, is retained by many, but not all, ectomycorrhizal species. Experiments confirm that symbiotic Amanita species have lost the ability to grow on complex organic matter and have therefore lost the capacity to live in forest soils without carbon supplied by a host plant. Irreversible losses of decomposition pathways are likely to play key roles in the evolutionary stability of these ubiquitous mutualisms.	[Wolfe, Benjamin E.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Tulloss, Rodham E.] Herbarium Rooseveltensis Amanitarum, Roosevelt, NJ USA; [Tulloss, Rodham E.] Honorary Res Associate, New York Bot Garden, Bronx, NY USA; [Pringle, Anne] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; New York Botanical Garden; Harvard University	Wolfe, BE (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	bewolfe@fas.harvard.edu			NSF Dissertation Improvement Grant (DEB) [0808404]; New England Botanical Club Graduate Student Research Fellowship; Harvard University	NSF Dissertation Improvement Grant (DEB); New England Botanical Club Graduate Student Research Fellowship; Harvard University	This work was funded by an NSF Dissertation Improvement Grant (DEB #0808404), a New England Botanical Club Graduate Student Research Fellowship, and by faculty startup funds provided to the last author (Anne Pringle) by Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUZINADAH RA, 1989, NEW PHYTOL, V112, P55, DOI 10.1111/j.1469-8137.1989.tb00308.x; Baldrian P, 2008, BR MYCOL SY, V28, P19; Baldrian P, 2009, OECOLOGIA, V161, P657, DOI 10.1007/s00442-009-1433-7; Bas C, 1969, PERSOONIA, V5, P285, DOI DOI 10.3852/09-288; Bas C, 2000, B GRUPPO MICOLOGICO, V43, P9; Bas K, 2001, FIELD MYCOLOGY, V2, P40; Baxter JW, 2005, MYCORRHIZA, V15, P513, DOI 10.1007/s00572-005-0359-0; Bruns TD, 2004, CAN J BOT, V82, P1122, DOI [10.1139/B04-021, 10.1139/b04-021]; BURGESS TI, 1993, PLANT SOIL, V153, P155, DOI 10.1007/BF00012988; Chapela IH, 2001, SOIL BIOL BIOCHEM, V33, P1733, DOI 10.1016/S0038-0717(01)00098-0; Cullings K, 2009, OECOLOGIA, V161, P661, DOI 10.1007/s00442-009-1434-6; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Ding SJ, 2007, FEMS MICROBIOL LETT, V267, P221, DOI 10.1111/j.1574-6968.2006.00550.x; Ding SJ, 2006, FEMS MICROBIOL LETT, V263, P207, DOI 10.1111/j.1574-6968.2006.00433.x; Ding SJ, 2001, EUR J BIOCHEM, V268, P5687, DOI 10.1046/j.0014-2956.2001.02503.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Drehmel D, 1999, MYCOLOGIA, V91, P610, DOI 10.2307/3761246; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Hobbie EA, 2002, NEW PHYTOL, V156, P129, DOI 10.1046/j.1469-8137.2002.00496.x; Jia J, 1999, MOL GEN GENET, V261, P985, DOI 10.1007/s004380051047; Karst J, 2008, ECOLOGY, V89, P1032, DOI 10.1890/07-0823.1; Kibby G, 2005, FIELD MYCOLOGY, V6, P31; Letcher A., 2007, SHROOM CULTURAL HIST; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martins A, 1996, MYCORRHIZA, V6, P265, DOI 10.1007/s005720050135; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; McFall-Ngai M, 2008, NAT REV MICROBIOL, V6, P789, DOI 10.1038/nrmicro1982; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Nagendran S, 2009, FUNGAL GENET BIOL, V46, P427, DOI 10.1016/j.fgb.2009.02.001; Nehls U, 2001, PLANT CELL ENVIRON, V24, P741, DOI 10.1046/j.1365-3040.2001.00717.x; Nygren CMR, 2007, MYCORRHIZA, V17, P241, DOI 10.1007/s00572-006-0100-7; Pande V, 2007, SYMBIOSIS, V44, P115; Plett JM, 2011, TRENDS GENET, V27, P14, DOI 10.1016/j.tig.2010.10.005; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Somogyi M., 1952, J BIOL CHEM, V200, P245; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Talbot JM, 2008, FUNCT ECOL, V22, P955, DOI 10.1111/j.1365-2435.2008.01402.x; Talbot JM, 2010, PEDOBIOLOGIA, V53, P169, DOI 10.1016/j.pedobi.2009.12.001; Treseder KK, 2006, SOIL BIOL BIOCHEM, V38, P1077, DOI 10.1016/j.soilbio.2005.09.006; Tulloss RE, 2000, B GRUPPO MICOL G BRE, V43, P13; Weber CF, 2011, ENVIRON MICROBIOL, V13, P2778, DOI 10.1111/j.1462-2920.2011.02548.x; Weiss M, 1998, CAN J BOT, V76, P1170, DOI 10.1139/cjb-76-7-1170; Weyl EG, 2010, P NATL ACAD SCI USA, V107, P15712, DOI 10.1073/pnas.1005294107; Wolfe BE, 2012, MYCOLOGIA, V104, P22, DOI 10.3852/11-056; Yang ZL, 1999, ECTOMYCORRHIZAL FUNGI: KEY GENERA IN PROFILE, P201	58	86	96	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e39597	10.1371/journal.pone.0039597	http://dx.doi.org/10.1371/journal.pone.0039597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815710	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900010
J	Doufas, AG; Panagiotou, OA; Ioannidis, JPA				Doufas, Anthony G.; Panagiotou, Orestis A.; Ioannidis, John P. A.			Concordance of Sleep and Pain Outcomes of Diverse Interventions: An Umbrella Review	PLOS ONE			English	Review							CHRONIC WIDESPREAD PAIN; MUSCULOSKELETAL PAIN; INSOMNIA SYMPTOMS; DISTURBANCE; ASSOCIATION; CONTRIBUTES; POPULATION; PREVALENCE; HEADACHE; DISEASE	Background/Objective: Pain influences sleep and vice versa. We performed an umbrella review of meta-analyses on treatments for diverse conditions in order to examine whether diverse medical treatments for different conditions have similar or divergent effects on pain and sleep. Methods: We searched published systematic reviews with meta-analyses in the Cochrane Database of Systematic Reviews until October 20, 2011. We identified randomized trials (or meta-analyses thereof, when >1 trial was available) where both pain and sleep outcomes were examined. Pain outcomes were categorized as headache, musculoskeletal, abdominal, pelvic, generic or other pain. Sleep outcomes included insomnia, sleep disruption, and sleep disturbance. We estimated odds ratios for all outcomes and evaluated the concordance in the direction of effects between sleep and various types of pain and the correlation of treatment effects between sleep and pain outcomes. Results: 151 comparisons with 385 different trials met our eligibility criteria. 96 comparisons had concordant direction of effects between each pain outcome and sleep, while in 55 the effect estimates were in opposite directions (P<0.0001). In the 20 comparisons with largest amount of evidence, the experimental drug always had worse sleep outcomes and tended to have worse pain outcomes in 17/20 cases. For headache and musculoskeletal pain, 69 comparisons showed concordant direction of effects with sleep outcomes and 36 showed discordant direction (P<0.0001). For the other 4 pain types there were overall 27 vs. 19 pairs with concordant vs. discordant direction of effects (P = 0.095). There was a weak correlation of the treatment effect sizes for sleep vs. headache/musculoskeletal pain (r = 0.17, P = 0.092). Conclusions: Medical interventions tend to have effects in the same direction for pain and sleep outcomes, but exceptions occur. Concordance is primarily seen for sleep and headache or musculoskeletal pain where many drugs may both disturb sleep and cause pain.	[Doufas, Anthony G.] Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA; [Doufas, Anthony G.] Outcomes Res Consortium, Cleveland, OH USA; [Panagiotou, Orestis A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; University of Ioannina; Stanford University; Stanford University; Stanford University	Doufas, AG (corresponding author), Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Panagiotou, Orestis A/I-5934-2015; Panagiotou, Orestis/AAI-1268-2021; Doufas, Anthony G/L-9297-2019	Panagiotou, Orestis A/0000-0001-9604-8380; 				Alattar M, 2007, J AM BOARD FAM MED, V20, P365, DOI 10.3122/jabfm.2007.04.060153; Bigatti SM, 2008, ARTHRIT RHEUM-ARTHR, V59, P961, DOI 10.1002/art.23828; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Brown J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008475.pub2; Cipriani A., 2010, COCHRANE DATABASE SY; Ciraulo DA, 2003, PSYCHIAT CLIN N AM, V26, P381, DOI 10.1016/S0193-953X(02)00106-5; Daley M, 2009, SLEEP, V32, P55; Davies KA, 2008, RHEUMATOLOGY, V47, P1809, DOI 10.1093/rheumatology/ken389; Davis L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001019.pub2; Edwards RR, 2009, EUR J PAIN, V13, P1043, DOI 10.1016/j.ejpain.2008.12.007; Edwards RR, 2008, PAIN, V137, P202, DOI 10.1016/j.pain.2008.01.025; Fine PG, 2011, PAIN MED, V12, P996, DOI 10.1111/j.1526-4637.2011.01187.x; Haack M, 2009, PAIN, V145, P136, DOI 10.1016/j.pain.2009.05.029; [Institute of Medicine (US) Forum on Advancing Pain Research Care and Education Policy BoHS], 2011, REL PAIN AM BLUEPR T; [Institute of Medicine (US) Forum on Sleep Medicine and Research Policy BoHS], 2006, SLEEP DIS SLEEP DEPR; Kelman L, 2005, HEADACHE, V45, P904, DOI 10.1111/j.1526-4610.2005.05159.x; Lateef T, 2011, CEPHALALGIA, V31, P648, DOI 10.1177/0333102410390395; Latham J, 1994, Disabil Rehabil, V16, P39; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lavigne GJ, 2011, CURR RHEUMATOL REP, V13, P535, DOI 10.1007/s11926-011-0209-3; Marin R, 2006, AM J PHYS MED REHAB, V85, P430, DOI 10.1097/01.phm.0000214259.06380.79; Marty M, 2008, EUR SPINE J, V17, P839, DOI 10.1007/s00586-008-0660-7; McCracken Lance M, 2002, Pain Res Manag, V7, P75; Menefee LA, 2000, PAIN MED, V1, P156, DOI 10.1046/j.1526-4637.2000.00022.x; Mork PJ, 2012, ARTHRITIS RHEUM-US, V64, P281, DOI 10.1002/art.33346; [National Library of Medicine U.S. National Library of Medicine National Institutes of Health], 2008, DAILYMED CURR MED IN; National Sleep Foundation, 2000, OMN SLEEP AM POLL; National Sleep Foundation, 2000, 1997 SURV SLEEPL PAI; O'Brien EM, 2011, CLIN J PAIN, V27, P425, DOI 10.1097/AJP.0b013e318208c8e4; Okifuji A, 2011, CURR RHEUMATOL REP, V13, P528, DOI 10.1007/s11926-011-0204-8; Okura K, 2008, SLEEP MED, V9, P352, DOI 10.1016/j.sleep.2007.07.007; Osei-Akoto A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004529.pub2; Pennick VE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001139.pub2; PILOWSKY I, 1985, PAIN, V23, P27, DOI 10.1016/0304-3959(85)90227-1; Rains JC, 2010, CURR TREAT OPTION NE, V12, P1, DOI 10.1007/s11940-009-0056-y; RASMUSSEN BK, 1993, PAIN, V53, P65, DOI 10.1016/0304-3959(93)90057-V; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rohrbeck J, 2007, BRIT J GEN PRACT, V57, P109; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Sivertsen B, 2009, J PSYCHOSOM RES, V67, P109, DOI 10.1016/j.jpsychores.2009.05.001; Smith MT, 2008, PAIN, V138, P497, DOI 10.1016/j.pain.2008.01.028; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith MT, 2009, CURR PAIN HEADACHE R, V13, P447, DOI 10.1007/s11916-009-0073-2; Smith MT, 2009, SLEEP, V32, P779, DOI 10.1093/sleep/32.6.779; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Tang NKY, 2007, J SLEEP RES, V16, P85, DOI 10.1111/j.1365-2869.2007.00571.x; Theadom A, 2007, J PSYCHOSOM RES, V62, P145, DOI 10.1016/j.jpsychores.2006.09.013; Wilson KG, 1998, PAIN, V75, P75, DOI 10.1016/S0304-3959(97)00207-8; WITTIG RM, 1982, J NERV MENT DIS, V170, P429, DOI 10.1097/00005053-198207000-00011	49	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40891	10.1371/journal.pone.0040891	http://dx.doi.org/10.1371/journal.pone.0040891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815856	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000039
J	Ellingson, L; Zhang, JF				Ellingson, Leif; Zhang, Jinfeng			Protein Surface Matching by Combining Local and Global Geometric Information	PLOS ONE			English	Article							BINDING-SITE SIMILARITY; RELATE 2 SETS; STRUCTURAL GENOMICS; FUNCTIONAL-RELATIONSHIPS; ACTIVE-SITES; 3D TEMPLATES; SHAPE; ALGORITHM; EVOLUTIONARY; RECOGNITION	Comparison of the binding sites of proteins is an effective means for predicting protein functions based on their structure information. Despite the importance of this problem and much research in the past, it is still very challenging to predict the binding ligands from the atomic structures of protein binding sites. Here, we designed a new algorithm, TIPSA (Triangulation-based Iterative-closest-point for Protein Surface Alignment), based on the iterative closest point (ICP) algorithm. TIPSA aims to find the maximum number of atoms that can be superposed between two protein binding sites, where any pair of superposed atoms has a distance smaller than a given threshold. The search starts from similar tetrahedra between two binding sites obtained from 3D Delaunay triangulation and uses the Hungarian algorithm to find additional matched atoms. We found that, due to the plasticity of protein binding sites, matching the rigid body of point clouds of protein binding sites is not adequate for satisfactory binding ligand prediction. We further incorporated global geometric information, the radius of gyration of binding site atoms, and used nearest neighbor classification for binding site prediction. Tested on benchmark data, our method achieved a performance comparable to the best methods in the literature, while simultaneously providing the common atom set and atom correspondences.	[Ellingson, Leif] Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA; [Zhang, Jinfeng] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA	Texas Tech University System; Texas Tech University; State University System of Florida; Florida State University	Ellingson, L (corresponding author), Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA.	jinfeng@stat.fsu.edu		Ellingson, Leif/0000-0003-0474-0383	National Science Foundation [DMS-0805977]; National Institutes of Health [1R21GM101552-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM101552] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LE was partially funded by grant no. DMS-0805977 from the National Science Foundation and JZ was partially supported by grant no. 1R21GM101552-01 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Binkowski TA, 2004, NUCLEIC ACIDS RES, V32, pW555, DOI 10.1093/nar/gkh390; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Binkowski TA, 2003, J MOL BIOL, V332, P505, DOI 10.1016/S0022-2836(03)00882-9; Buehren M, 2009, FUNCTIONS RECTANGULA; Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697; Chen BY, 2007, J COMPUT BIOL, V14, P791, DOI 10.1089/cmb.2007.R017; Chen BY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000881; Chen LN, 2005, BIOINFORMATICS, V21, P51, DOI 10.1093/bioinformatics/bth467; CHEN Y, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P2724, DOI 10.1109/ROBOT.1991.132043; Chruszcz M, 2010, CURR OPIN STRUC BIOL, V20, P587, DOI 10.1016/j.sbi.2010.08.001; Das S, 2009, J CHEM INF MODEL, V49, P2863, DOI 10.1021/ci900317x; Davies JR, 2007, BIOINFORMATICS, V23, P3001, DOI 10.1093/bioinformatics/btm470; Dundas J, 2011, J MOL BIOL, V406, P713, DOI 10.1016/j.jmb.2010.12.005; Ellingson L, 2011, EFFICIENT ALGORITHM, P289; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Gold ND, 2006, NUCLEIC ACIDS RES, V34, pD231, DOI 10.1093/nar/gkj062; Hoffmann B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-99; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Kristensen DM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-17; Kristensen DM, 2006, PROTEIN SCI, V15, P1530, DOI 10.1110/ps.062152706; Kuhn D, 2006, J MOL BIOL, V359, P1023, DOI 10.1016/j.jmb.2006.04.024; La D, 2009, BIOINFORMATICS, V25, P2843, DOI 10.1093/bioinformatics/btp542; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liang J, 1998, PROTEINS, V33, P1; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Montelione GT, 2001, P NATL ACAD SCI USA, V98, P13488, DOI 10.1073/pnas.261549098; Morris RJ, 2005, BIOINFORMATICS, V21, P2347, DOI 10.1093/bioinformatics/bti337; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Najmanovich RJ, 2007, BIOINFORMATICS, V23, pE104, DOI 10.1093/bioinformatics/btl292; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; Ren JY, 2010, NUCLEIC ACIDS RES, V38, pW441, DOI 10.1093/nar/gkq400; Rosen M, 1998, PROTEIN ENG, V11, P263, DOI 10.1093/protein/11.4.263; Sael L, 2008, PROTEINS, V72, P1259, DOI 10.1002/prot.22030; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; SCHONEMA.PH, 1966, PSYCHOMETRIKA, V31, P1, DOI 10.1007/BF02289451; Shulman-Peleg A, 2005, NUCLEIC ACIDS RES, V33, pW337, DOI 10.1093/nar/gki482; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011; Tanimoto T.T., 1958, ELEMENTARY MATH THEO; Tseng YY, 2009, J MOL BIOL, V387, P451, DOI 10.1016/j.jmb.2008.12.072; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Weskamp N, 2004, BIOINFORMATICS, V20, P1522, DOI 10.1093/bioinformatics/bth113; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Xiong B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-47	54	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40540	10.1371/journal.pone.0040540	http://dx.doi.org/10.1371/journal.pone.0040540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815760	Green Published, gold			2022-12-27	WOS:000306507000017
J	Garcia, M; Leonardi, R; Zhang, YM; Rehg, JE; Jackowski, S				Garcia, Matthew; Leonardi, Roberta; Zhang, Yong-Mei; Rehg, Jerold E.; Jackowski, Suzanne			Germline Deletion of Pantothenate Kinases 1 and 2 Reveals the Key Roles for CoA in Postnatal Metabolism	PLOS ONE			English	Article							PEROXISOMAL NUDIX HYDROLASE; COENZYME-A; OXIDATIVE-METABOLISM; IRON ACCUMULATION; GENE-EXPRESSION; MOUSE MODEL; IDENTIFICATION; ENCODES; PANK2; BRAIN	Pantothenate kinase (PanK) phosphorylates pantothenic acid (vitamin B-5) and controls the overall rate of coenzyme A (CoA) biosynthesis. Pank1 gene deletion in mice results in a metabolic phenotype where fatty acid oxidation and gluconeogenesis are impaired in the fasted state, leading to mild hypoglycemia. Inactivating mutations in the human PANK2 gene lead to childhood neurodegeneration, but Pank2 gene inactivation in mice does not elicit a phenotype indicative of the neuromuscular symptoms or brain iron accumulation that accompany the human disease. Pank1/Pank2 double knockout (dKO) mice were derived to determine if the mild phenotypes of the single knockout mice are due to the ability of the two isoforms to compensate for each other in CoA biosynthesis. Postnatal development was severely affected in the dKO mice. The dKO pups developed progressively severe hypoglycemia and hyperketonemia by postnatal day 10 leading to death by day 17. Hyperketonemia arose from impaired whole-body ketone utilization illustrating the requirement for CoA in energy generation from ketones. dKO pups had reduced CoA and decreased fatty acid oxidation coupled with triglyceride accumulation in liver. dKO hepatocytes could not maintain the NADH levels compared to wild-type hepatocytes. These results revealed an important link between CoA and NADH levels, which was reflected by deficiencies in hepatic oleate synthesis and gluconeogenesis. The data indicate that PanK1 and PanK2 can compensate for each other to supply tissue CoA, but PanK1 is more important to CoA levels in liver whereas PanK2 contributes more to CoA synthesis in the brain.	[Garcia, Matthew; Leonardi, Roberta; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Zhang, Yong-Mei] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Medical University of South Carolina; St Jude Children's Research Hospital	Garcia, M (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018; Rehg, Jerold E/N-8111-2018	Jackowski, Suzanne/0000-0002-6855-1429; 	National Institutes of Health [GM062896]; American Lebanese Syrian Associated Charities - ALSAC; St. Jude Transgenic Core Facility; Veterinary Pathology Core Facility; Hartwell Center for Bioinformatics and Biotechnology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities - ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Transgenic Core Facility; Veterinary Pathology Core Facility; Hartwell Center for Bioinformatics and Biotechnology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health [www.nih.gov]GM062896 (SJ) and American Lebanese Syrian Associated Charities - ALSAC [www.stjude.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Katie Wells, Jina Wang, Karen Miller, and Lois Richmond for expert technical assistance. We also thank the St. Jude Transgenic Core Facility, the Veterinary Pathology Core Facility and the Hartwell Center for Bioinformatics and Biotechnology for their technical contributions and support. We thank Charles Rock for critical reading of the manuscript.	Adams SH, 1997, AM J PHYSIOL-REG I, V272, pR1641, DOI 10.1152/ajpregu.1997.272.5.R1641; Afshar K, 2001, GENETICS, V157, P1267; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Arisi I, 2011, J ALZHEIMERS DIS, V24, P721, DOI 10.3233/JAD-2011-101881; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai L, 2011, COLD SPRING IN PRESS; Calder RB, 1999, J BIOL CHEM, V274, P2014, DOI 10.1074/jbc.274.4.2014; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; DENNE SC, 1986, AM J PHYSIOL, V251, pE71, DOI 10.1152/ajpendo.1986.251.1.E71; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Ghosh S, 2010, BBA-GENE REGUL MECH, V1799, P681, DOI 10.1016/j.bbagrm.2010.08.002; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Hertz L, 2002, INT REV NEUROBIOL, V51, P1, DOI 10.1016/S0074-7742(02)51003-5; Hirschey MD, 2011, AGING-US, V3, P635, DOI 10.18632/aging.100339; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Ibdah JA, 1998, J CLIN INVEST, V102, P1193, DOI 10.1172/JCI2091; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Johnson MA, 2004, ANN NY ACAD SCI, V1012, P282, DOI 10.1196/annals.1306.023; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kuo YM, 2007, J INHERIT METAB DIS, V30, P310, DOI 10.1007/s10545-007-0560-8; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1; PETTIT FH, 1975, BIOCHEM BIOPH RES CO, V65, P575, DOI 10.1016/S0006-291X(75)80185-9; Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhang YM, 2006, J BIOL CHEM, V281, P107, DOI 10.1074/jbc.M508825200; Zhang YM, 2005, J BIOL CHEM, V280, P32594, DOI 10.1074/jbc.M506275200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	42	46	52	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e40871	10.1371/journal.pone.0040871	http://dx.doi.org/10.1371/journal.pone.0040871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815849	Green Published, gold, Green Submitted			2022-12-27	WOS:000306507000036
J	Hu, CF; Wei, WB; Chen, XY; Woodman, CB; Yao, YH; Nicholls, JM; Joab, I; Sihota, SK; Shao, JY; Derkaoui, KD; Amari, A; Maloney, SL; Bell, AI; Murray, PG; Dawson, CW; Young, LS; Arrand, JR				Hu, Chunfang; Wei, Wenbin; Chen, Xiaoyi; Woodman, Ciaran B.; Yao, Yunhong; Nicholls, John M.; Joab, Irene; Sihota, Sim K.; Shao, Jian-Yong; Derkaoui, K. Dalia; Amari, Aicha; Maloney, Stephanie L.; Bell, Andrew I.; Murray, Paul G.; Dawson, Christopher W.; Young, Lawrence S.; Arrand, John R.			A Global View of the Oncogenic Landscape in Nasopharyngeal Carcinoma: An Integrated Analysis at the Genetic and Expression Levels	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; TUMOR-SUPPRESSOR GENE; EPITHELIAL-CELLS; POOR-PROGNOSIS; BREAST-CANCER; TGF-BETA; PROTEIN; DNA; CHINA; LUNG	Previous studies have reported that the tumour cells of nasopharyngeal carcinoma (NPC) exhibit recurrent chromosome abnormalities. These genetic changes are broadly assumed to lead to changes in gene expression which are important for the pathogenesis of this tumour. However, this assumption has yet to be formally tested at a global level. Therefore a genome wide analysis of chromosome copy number and gene expression was performed in tumour cells micro-dissected from the same NPC biopsies. Cellular tumour suppressor and tumour-promoting genes (TSG, TPG) and Epstein-Barr Virus (EBV)-encoded oncogenes were examined. The EBV-encoded genome maintenance protein EBNA1, along with the putative oncogenes LMP1, LMP2 and BARF1 were expressed in the majority of NPCs that were analysed. Significant downregulation of expression in an average of 76 cellular TSGs per tumour was found, whilst a per-tumour average of 88 significantly upregulated, TPGs occurred. The expression of around 60% of putative TPGs and TSGs was both up-and down-regulated in different types of cancer, suggesting that the simplistic classification of genes as TSGs or TPGs may not be entirely appropriate and that the concept of context-dependent onco-suppressors may be more extensive than previously recognised. No significant enrichment of TPGs within regions of frequent genomic gain was seen but TSGs were significantly enriched within regions of frequent genomic loss. It is suggested that loss of the FHIT gene may be a driver of NPC tumourigenesis. Notwithstanding the association of TSGs with regions of genomic loss, on a gene by gene basis and excepting homozygous deletions and high-level amplification, there is very little correlation between chromosomal copy number aberrations and expression levels of TSGs and TPGs in NPC.	[Hu, Chunfang; Wei, Wenbin; Chen, Xiaoyi; Woodman, Ciaran B.; Yao, Yunhong; Sihota, Sim K.; Maloney, Stephanie L.; Bell, Andrew I.; Murray, Paul G.; Dawson, Christopher W.; Young, Lawrence S.; Arrand, John R.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Chen, Xiaoyi; Yao, Yunhong] Guangdong Med Coll, Dept Pathol, Zhanjiang, Guangdong, Peoples R China; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Joab, Irene] Univ Paris Sud, UMR542, INSERM, Villejuif, France; [Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, Guangzhou 510275, Guangdong, Peoples R China; [Derkaoui, K. Dalia] Univ Oran, Fac Sci, Lab Biol Dev & Differeciat, Oran, Algeria; [Amari, Aicha] ORL Ctr Hosp & Univ, Oran, Algeria	University of Birmingham; Guangdong Medical University; University of Hong Kong; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Sun Yat Sen University; Universite d'Oran	Hu, CF (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England.	j.r.arrand@bham.ac.uk	Young, Lawrence S/B-7213-2009; Bell, Andrew J/A-1731-2008; Nicholls, John Malcolm/C-4375-2009	Young, Lawrence S/0000-0003-3919-4298; Bell, Andrew J/0000-0002-2061-3862; Bell, Andrew/0000-0001-9520-4417; Nicholls, John Malcolm/0000-0001-7217-7444; Wei, Wenbin/0000-0003-1288-6999	Cancer Research UK; Dorothy Hodgkin Fellowship	Cancer Research UK(Cancer Research UK); Dorothy Hodgkin Fellowship	This work was funded by Cancer Research UK (http://www.cancerresearchuk.org) and a Dorothy Hodgkin Fellowship to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2008, CANCER METAST REV, V27, P205, DOI 10.1007/s10555-008-9114-2; Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Chan ASC, 2000, CANCER RES, V60, P5365; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Cheung AKL, 2008, CANCER RES, V68, P8137, DOI 10.1158/0008-5472.CAN-08-0904; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chow LSN, 2004, INT J CANCER, V109, P839, DOI 10.1002/ijc.20079; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Decaussin G, 2000, CANCER RES, V60, P5584; Dodd LE, 2006, CANCER EPIDEM BIOMAR, V15, P2216, DOI 10.1158/1055-9965.EPI-06-0455; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Ferguson S, 2011, PEDIATR BLOOD CANCER, V56, P349, DOI 10.1002/pbc.22679; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Hill CE, 2006, AM J CLIN PATHOL, V125, P665, DOI 10.1309/ABEYV2VKE6DHXAAA; HUANG DP, 1994, CANCER RES, V54, P4003; Hui ABY, 2005, CANCER RES, V65, P8125, DOI 10.1158/0008-5472.CAN-05-0648; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; Ko JY, 2002, CANCER-AM CANCER SOC, V94, P1987, DOI 10.1002/cncr.10406; Kotliarov Y, 2009, CANCER RES, V69, P1596, DOI 10.1158/0008-5472.CAN-08-2496; Kouzarides Y, 2011, CELL, V128, P693; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li X, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-4; Li YH, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-1; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazzarelli P, 2009, ADV CANCER RES, V105, P45, DOI 10.1016/S0065-230X(09)05003-9; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mok SC, 1996, ONCOGENE, V12, P1895; Mori A, 2009, MOL CANCER RES, V7, P1390, DOI 10.1158/1541-7786.MCR-08-0525; Morris MA, 2008, J GEN VIROL, V89, P2806, DOI 10.1099/vir.0.2008/003970-0; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Nicholls JM, 1997, ADV ANAT PATHOL, V4, P71; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Or YYY, 2010, J PATHOL, V220, P97, DOI 10.1002/path.2609; Owen TJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-241; POIRIER S, 1987, INT J CANCER, V39, P293, DOI 10.1002/ijc.2910390305; Reynolds GM, 2000, J PATHOL, V190, p51A; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Seto E, 2008, CANCER RES, V68, P1030, DOI 10.1158/0008-5472.CAN-07-5252; Shi W, 2006, INT J CANCER, V119, P2467, DOI 10.1002/ijc.22107; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Sriuranpong V, 2004, CLIN CANCER RES, V10, P4944, DOI 10.1158/1078-0432.CCR-03-0757; Strockbine LD, 1998, J VIROL, V72, P4015, DOI 10.1128/JVI.72.5.4015-4021.1998; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang GL, 1999, BRIT J CANCER, V81, P1122, DOI 10.1038/sj.bjc.6690818; Wang HY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-27; WILSON G, 1979, VIROLOGY, V95, P351, DOI 10.1016/0042-6822(79)90490-2; Xian J, 2004, CANCER RES, V64, P6432, DOI 10.1158/0008-5472.CAN-04-2561; Xie LQ, 2010, ANN SURG ONCOL, V17, P1927, DOI 10.1245/s10434-010-0922-6; Yau WL, 2006, INT J CANCER, V119, P2821, DOI 10.1002/ijc.22232; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zanesi N, 2005, MUTAT RES-FUND MOL M, V591, P103, DOI 10.1016/j.mrfmmm.2005.05.016; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zhang WL, 2009, ACTA BIOCH BIOPH SIN, V41, P414, DOI 10.1093/abbs/gmp025; Zhang Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-538; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; ZHENG YM, 1994, BRIT J CANCER, V69, P508, DOI 10.1038/bjc.1994.92	69	40	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41055	10.1371/journal.pone.0041055	http://dx.doi.org/10.1371/journal.pone.0041055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815911	gold, Green Published, Green Accepted			2022-12-27	WOS:000306507000058
J	Pereira, LVB; Shimizu, MHM; Rodrigues, LPMR; Leite, CC; Andrade, L; Seguro, AC				Barbosa Pereira, Leonardo Victor; Massola Shimizu, Maria Heloisa; Miranda Ruiz Rodrigues, Lina Paola; Leite, Claudia Costa; Andrade, Lucia; Seguro, Antonio Carlos			N-Acetylcysteine Protects Rats with Chronic Renal Failure from Gadolinium-Chelate Nephrotoxicity	PLOS ONE			English	Article							CONTRAST AGENTS; SAFETY; MEDIA; NEPHROPATHY	The aim of this study was to evaluate the effect of Gd-chelate on renal function, iron parameters and oxidative stress in rats with CRF and a possible protective effect of the antioxidant N-Acetylcysteine (NAC). Male Wistar rats were submitted to 5/6 nephrectomy (Nx) to induced CRF. An ionic - cyclic Gd (Gadoterate Meglumine) was administrated (1.5 mM/KgBW, intravenously) 21 days after Nx. Clearance studies were performed in 4 groups of anesthetized animals 48 hours following Gd-chelate administration: 1 - Nx (n = 7); 2 - Nx+NAC (n = 6); 3 - Nx+Gd (n = 7); 4 - Nx+NAC+Gd (4.8 g/L in drinking water), initiated 2 days before Gd-chelate administration and maintained during 4 days (n = 6). This group was compared with a control. We measured glomerular filtration rate, GFR (inulin clearance, ml/min/kg BW), proteinuria (mg/24 hs), serum iron (mu g/dL); serum ferritin (ng/mL); transferrin saturation (%), TIBC (mu g/dL) and TBARS (nmles/ml). Normal rats treated with the same dose of Gd-chelate presented similar GFR and proteinuria when compared with normal controls, indicating that at this dose Gd-chelate is not nephrotoxic to normal rats. Gd-chelate administration to Nx-rats results in a decrease of GFR and increased proteinuria associated with a decrease in TIBC, elevation of ferritin serum levels, transferrin oversaturation and plasmatic TBARS compared with Nx-rats. The prophylactic treatment with NAC reversed the decrease in GFR and the increase in proteinuria and all alterations in iron parameters and TBARS induced by Gd-chelate. NAC administration to Nx rat did not modify the inulin clearance and iron kinetics, indicating that the ameliorating effect of NAC was specific to Gd-chelate. These results suggest that NAC can prevent Gd-chelate nephrotoxicity in patients with chronic renal failure.	[Barbosa Pereira, Leonardo Victor; Massola Shimizu, Maria Heloisa; Miranda Ruiz Rodrigues, Lina Paola; Andrade, Lucia; Seguro, Antonio Carlos] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil; [Leite, Claudia Costa] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pereira, LVB (corresponding author), Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil.	trulu@usp.br	Shimizu, Maria/B-7887-2013; Andrade, Lucia C/C-5223-2014; Leite, Claudia C/B-6036-2013	Andrade, Lucia C/0000-0002-3078-8957; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Laboratorios de Investigacao Medica of the Faculdade de Medicina da Universidade de Sao Paulo Hospital das Clinicas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309947/2009-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorios de Investigacao Medica of the Faculdade de Medicina da Universidade de Sao Paulo Hospital das Clinicas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support for this study was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and by the Laboratorios de Investigacao Medica of the Faculdade de Medicina da Universidade de Sao Paulo Hospital das Clinicas. ACS is a recipient of a grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Grant 309947/2009-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briguori C, 2006, CATHETER CARDIO INTE, V67, P175, DOI 10.1002/ccd.20592; BRILLET G, 1994, INVEST RADIOL, V29, P352, DOI 10.1097/00004424-199403000-00016; Buhaescu I, 2008, INT J CLIN PRACT, V62, P1113, DOI 10.1111/j.1742-1241.2007.01582.x; Cvetkovic T, 2009, J DIABETES COMPLICAT, V23, P337, DOI 10.1016/j.jdiacomp.2008.01.005; Danilovic A, 2011, TRANSPL P, V43, P1443, DOI 10.1016/j.transproceed.2011.02.020; de Araujo M, 2005, J AM SOC NEPHROL, V16, P3339, DOI 10.1681/ASN.2004100832; Drager LF, 2004, NEPHROL DIAL TRANSPL, V19, P1803, DOI 10.1093/ndt/gfh261; Erley CM, 2004, NEPHROL DIAL TRANSPL, V19, P2526, DOI 10.1093/ndt/gfh272; Ersoy H, 2007, J MAGN RESON IMAGING, V26, P1190, DOI 10.1002/jmri.21135; Fretellier N, 2011, INVEST RADIOL, V46, P85, DOI 10.1097/RLI.0b013e3181f54044; Fujisaki K, 2011, CLIN NEPHROL, V75, P251, DOI 10.5414/CNP75251; Haylor J, 2010, INVEST RADIOL, V45, P507, DOI 10.1097/RLI.0b013e3181eb51f2; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; HEYMAN SN, 1992, J AM SOC NEPHROL, V3, P58; Idee JM, 2006, FUND CLIN PHARMACOL, V20, P563, DOI 10.1111/j.1472-8206.2006.00447.x; Ishiguchi Tsuneo, 2010, Drugs R D, V10, P133, DOI 10.2165/11539140-000000000-00000; Lauffer RB, 1998, RADIOLOGY, V207, P529, DOI 10.1148/radiology.207.2.9577506; Ledneva E, 2009, RADIOLOGY, V250, P618, DOI 10.1148/radiol.2503080253; Romeu Marta, 2010, BMC Res Notes, V3, P20, DOI 10.1186/1756-0500-3-20; Sambol EB, 2011, ANN VASC SURG, V25, P366, DOI 10.1016/j.avsg.2010.09.012; Shimizu MHM, 2005, KIDNEY INT, V68, P2208, DOI 10.1111/j.1523-1755.2005.00677.x; Swaminathan S, 2007, J AM SOC NEPHROL, V18, P2636, DOI 10.1681/ASN.2007060645; Swaminathan S, 2007, NEW ENGL J MED, V357, P720, DOI 10.1056/NEJMc070248; Swan SK, 1999, INVEST RADIOL, V34, P443, DOI 10.1097/00004424-199907000-00001; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Yao KZ, 2001, EUR J PHARMACOL, V414, P99, DOI 10.1016/S0014-2999(01)00764-6; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	27	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39528	10.1371/journal.pone.0039528	http://dx.doi.org/10.1371/journal.pone.0039528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815709	Green Submitted, Green Published, gold			2022-12-27	WOS:000306466100020
J	Kohler, PL; Greenwood, SD; Nookala, S; Kotb, M; Kranz, DM; Schlievert, PM				Kohler, Petra L.; Greenwood, Seth D.; Nookala, Suba; Kotb, Malak; Kranz, David M.; Schlievert, Patrick M.			Staphylococcus aureus Isolates Encode Variant Staphylococcal Enterotoxin B Proteins That Are Diverse in Superantigenicity and Lethality	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; 3-DIMENSIONAL STRUCTURE; METHICILLIN-RESISTANT; ATOPIC-DERMATITIS; CRYSTAL-STRUCTURE; MINNESOTA; EXOTOXIN; SITE; C2	Staphylococcus aureus produces superantigens (SAgs) that bind and cross-link T cells and APCs, leading to activation and proliferation of immune cells. SAgs bind to variable regions of the beta-chains of T cell receptors (V beta-TCRs), and each SAg binds a unique subset of V beta-TCRs. This binding leads to massive cytokine production and can result in toxic shock syndrome (TSS). The most abundantly produced staphylococcal SAgs and the most common causes of staphylococcal TSS are TSS toxin-1 (TSST-1), and staphylococcal enterotoxins B and C (SEB and SEC, respectively). There are several characterized variants of humans SECs, designated SEC1-4, but only one variant of SEB has been described. Sequencing the seb genes from over 20 S. aureus isolates show there are at least five different alleles of seb, encoding forms of SEB with predicted amino acid substitutions outside of the predicted immune-cell binding regions of the SAgs. Examination of purified, variant SEBs indicates that these amino acid substitutions cause differences in proliferation of rabbit splenocytes in vitro. Additionally, the SEBs varied in lethality in a rabbit model of TSS. The SEBs were diverse in their abilities to cause proliferation of human peripheral blood mononuclear cells, and differed in their activation of subsets of T cells. A soluble, high-affinity V beta-TCR, designed to neutralize the previously characterized variant of SEB (SEB1), was able to neutralize the variant SEBs, indicating that this high-affinity peptide may be useful in treating a variety of SEB-mediated illnesses.	[Kohler, Petra L.; Greenwood, Seth D.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Nookala, Suba; Kotb, Malak] Univ Cincinnati, Sch Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Kranz, David M.] Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, Urbana, IL 61801 USA; [Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa	Kohler, PL (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	patrick-schlievert@uiowa.edu		Schlievert, Patrick/0000-0001-8314-9369	United States Public Health Service from Great Lakes Regional Center of Excellence [R01-AI074283, U54-AI57153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI074283] Funding Source: NIH RePORTER	United States Public Health Service from Great Lakes Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service grants R01-AI074283 awarded to PMS, and U54-AI57153 awarded to PMS and DMK from the Great Lakes Regional Center of Excellence of which PMS and DMK are members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MD, 2002, J BIOL CHEM, V277, P2756, DOI 10.1074/jbc.M109369200; BERGDOLL MS, 1981, LANCET, V1, P1017; Briggs C, 1997, IMMUNOLOGY, V90, P169, DOI 10.1046/j.1365-2567.1997.00151.x; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Buonpane RA, 2007, NAT MED, V13, P725, DOI 10.1038/nm1584; Chi YI, 2002, J BIOL CHEM, V277, P22839, DOI 10.1074/jbc.M201932200; CRASS BA, 1986, J CLIN MICROBIOL, V23, P1138, DOI 10.1128/JCM.23.6.1138-1139.1986; Garcia C, 1998, IMMUNOLOGY, V94, P160, DOI 10.1046/j.1365-2567.1998.00493.x; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; KOMISAR JL, 1994, INFECT IMMUN, V62, P4775, DOI 10.1128/IAI.62.11.4775-4780.1994; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; LEE PK, 1992, J INFECT DIS, V165, P1056, DOI 10.1093/infdis/165.6.1056; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; MARRACK P, 1990, SCIENCE, V248, P1066; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Neill RJ, 1996, INFECT IMMUN, V64, P3007, DOI 10.1128/IAI.64.8.3007-3015.1996; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; POINDEXTER NJ, 1985, J INFECT DIS, V151, P65, DOI 10.1093/infdis/151.1.65; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schlievert PM, 2008, CLIN INFECT DIS, V46, P1562, DOI 10.1086/586746; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; SCHLIEVERT PM, 1986, LANCET, V1, P1149; Schlievert PM, 2004, J CLIN MICROBIOL, V42, P2875, DOI 10.1128/JCM.42.6.2875-2876.2004; Thomas D, 2009, INFECT IMMUN, V77, P2043, DOI 10.1128/IAI.01388-08; Wang XG, 2009, MICROBIOL-SGM, V155, P680, DOI 10.1099/mic.0.025254-0; Yarwood JM, 2002, J BIOL CHEM, V277, P13138, DOI 10.1074/jbc.M111661200	33	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e41157	10.1371/journal.pone.0041157	http://dx.doi.org/10.1371/journal.pone.0041157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815951	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100123
J	Marcucci, L; Yanagida, T				Marcucci, Lorenzo; Yanagida, Toshio			From Single Molecule Fluctuations to Muscle Contraction: A Brownian Model of AF Huxley's Hypotheses	PLOS ONE			English	Article							SKELETAL-MUSCLE; WORKING STROKE; MYOSIN HEAD; FORCE GENERATION; ACTIN-FILAMENT; MECHANISM; MOTORS; STEPS; MOTION; SPEED	Muscular force generation in response to external stimuli is the result of thermally fluctuating, cyclical interactions between myosin and actin, which together form the actomyosin complex. Normally, these fluctuations are modelled using transition rate functions that are based on muscle fiber behaviour, in a phenomenological fashion. However, such a basis reduces the predictive power of these models. As an alternative, we propose a model which uses direct single molecule observations of actomyosin fluctuations reported in the literature. We precisely estimate the actomyosin potential bias and use diffusion theory to obtain a Brownian ratchet model that reproduces the complete cross-bridge cycle. The model is validated by simulating several macroscopic experimental conditions, while its interpretation is compatible with two different force-generating scenarios.	[Marcucci, Lorenzo] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Yanagida, Toshio] Ctr Informat & Neural Network, Suita, Osaka, Japan; [Yanagida, Toshio] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan	Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; RIKEN	Marcucci, L (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	lorenzo.marcucci@gmail.com	Marcucci, Lorenzo/AAD-5771-2020	Marcucci, Lorenzo/0000-0002-9542-4417	Global COE Program System Dynamics of Biological Function, Ministry of Education, Culture, Sports, Science and Technology, Japan	Global COE Program System Dynamics of Biological Function, Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by Global COE Program System Dynamics of Biological Function, Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barclay CJ, 1998, J MUSCLE RES CELL M, V19, P855, DOI 10.1023/A:1005409708838; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P2770, DOI 10.1073/pnas.96.6.2770; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Gardiner C., 2004, QUANTUM NOISE HDB MA; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Huxley AF, 1996, J MUSCLE RES CELL M, V17, P507, DOI 10.1007/BF00123366; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; ISHIJIMA A, 1991, NATURE, V352, P301, DOI 10.1038/352301a0; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Kitamura Kazuo, 2005, Biophysics (Nagoya-shi), V1, P1, DOI 10.2142/biophysics.1.1; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Magnasco OM, 1993, PHYS REV LETT, V71, P1477; Mansson A, 2010, BIOPHYS J, V98, P1237, DOI 10.1016/j.bpj.2009.12.4285; Marcucci L, 2010, EUR PHYS J E, V32, P411, DOI 10.1140/epje/i2010-10641-0; Marcucci L, 2011, ANAL DWELL TIME BIDI; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Parmeggiani A, 1999, PHYS REV E, V60, P2127, DOI 10.1103/PhysRevE.60.2127; PATE E, 1989, J MUSCLE RES CELL M, V10, P181, DOI 10.1007/BF01739809; PIAZZESI G, 1995, BIOPHYS J, V68, P1966, DOI 10.1016/S0006-3495(95)80374-7; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; Piazzesi G, 1996, J MUSCLE RES CELL M, V17, P45, DOI 10.1007/BF00140323; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; PROST J, 1994, PHYS REV LETT, V72, P2652, DOI 10.1103/PhysRevLett.72.2652; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reconditi M, 2011, P NATL ACAD SCI USA, V108, P7236, DOI 10.1073/pnas.1018330108; Sekimoto K, 1997, J PHYS SOC JPN, V66, P1234, DOI 10.1143/JPSJ.66.1234; Smith DA, 2008, ANN BIOMED ENG, V36, P1624, DOI 10.1007/s10439-008-9536-6; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Takano M, 2010, P NATL ACAD SCI USA, V107, P7769, DOI 10.1073/pnas.0911830107; Thomas DD, 2009, ANNU REV BIOPHYS, V38, P347, DOI 10.1146/annurev.biophys.35.040405.102118	42	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40042	10.1371/journal.pone.0040042	http://dx.doi.org/10.1371/journal.pone.0040042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815722	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100025
J	Raak-van Den Berg, CL; De Lange, HJ; Van Lenteren, JC				Raak-van den Berg, C. Lidwien; De Lange, Hendrika J.; Van Lenteren, Joop C.			Intraguild Predation Behaviour of Ladybirds in Semi-Field Experiments Explains Invasion Success of Harmonia axyridis	PLOS ONE			English	Article							COCCINELLA-SEPTEMPUNCTATA L; APHIDOPHAGOUS LADYBIRDS; ADALIA-BIPUNCTATA; SEARCHING BEHAVIOR; LARVAL TRACKS; COLEOPTERA; CANNIBALISM; BEETLE; PREY; ECOLOGY	Harmonia axyridis has been introduced as a biological control agent in Europe and the USA. Since its introduction, it has established and spread, and it is now regarded as an invasive alien species. It has been suggested that intraguild predation is especially important for the invasion success of H. axyridis. The aim of this study was to compare the intraguild predation behaviour of three ladybird species (Coccinella septempunctata, Adalia bipunctata, and H. axyridis). Predation behaviour was investigated in semi-field experiments on small lime trees (Tilia platyphyllos). Two fourth-instar larvae placed on a tree rarely made contact during 3-hour observations. When placed together on a single leaf in 23%-43% of the observations at least one contact was made. Of those contacts 0%-27% resulted in an attack. Harmonia axyridis attacked mostly heterospecifics, while A. bipunctata and C. septempunctata attacked heterospecifics as often as conspecifics. In comparison with A. bipunctata and C. septempunctata, H. axyridis was the most successful intraguild predator as it won 86% and 44% of heterospecific battles against A. bipunctata and C. septempunctata respectively, whilst A. bipunctata won none of the heterospecific battles and C. septempunctata won only the heterospecific battles against A. bipunctata. Coccinella septempunctata dropped from a leaf earlier and more often than the other two species but was in some cases able to return to the tree, especially under cloudy conditions. The frequency with which a species dropped did not depend on the species the larva was paired with. The results of these semi-field experiments confirm that H. axyridis is a strong intraguild predator as a consequence of its aggressiveness and good defence against predation from heterospecific species. The fact that H. axyridis is such a strong intraguild predator helps to explain its successful establishment as invasive alien species in Europe and the USA.	[Raak-van den Berg, C. Lidwien; Van Lenteren, Joop C.] Wageningen Univ, Entomol Lab, Wageningen, Netherlands; [De Lange, Hendrika J.] Wageningen UR, Alterra, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Raak-van Den Berg, CL (corresponding author), Wageningen Univ, Entomol Lab, Wageningen, Netherlands.	Lidwien.Raak-vandenBerg@wur.nl	van Lenteren, Joop/J-1748-2014; Raak-van den Berg, Lidwien/A-3383-2013	van Lenteren, Joop/0000-0003-3620-1392; 	Strategic Research Funds Alterra, Wageningen UR; Stichting Integratie Landbouw	Strategic Research Funds Alterra, Wageningen UR; Stichting Integratie Landbouw	The following sources of funding have supported the work: Strategic Research Funds Alterra, Wageningen UR to H. J. De Lange. Stichting Integratie Landbouw to C. L. Raak-van den Berg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWALA BK, 1992, ECOL ENTOMOL, V17, P303, DOI 10.1111/j.1365-2311.1992.tb01062.x; Alhmedi A, 2010, BIOTECHNOL AGRON SOC, V14, P187; Alyokhin A, 2004, BIOL INVASIONS, V6, P463, DOI 10.1023/B:BINV.0000041554.14539.74; Brown PMJ, 2008, BIOCONTROL, V53, P5, DOI 10.1007/s10526-007-9132-y; CARTER MC, 1984, OECOLOGIA, V63, P394, DOI 10.1007/BF00390671; Crowder DW, 2010, BIOL INVASIONS, V12, P2857, DOI 10.1007/s10530-010-9733-8; Denno RF, 2006, TROPHIC GUILD INTERA; Dixon A.F.G., 2000, INSECT PREDATOR PREY; Felix S, 2004, EUR J ENTOMOL, V101, P237, DOI 10.14411/eje.2004.032; FERRAN A, 1991, ENTOMOPHAGA, V36, P213, DOI 10.1007/BF02374557; FERRAN A, 1993, EUR J ENTOMOL, V90, P383; FERRAN A, 1992, J INSECT BEHAV, V5, P147, DOI 10.1007/BF01049286; Gagnon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028061; Hall RJ, 2011, ECOLOGY, V92, P352, DOI 10.1890/09-2314.1; Hautier L., 2010, IOBC WPRS B, V58, P45; Hautier L, 2003, THESIS U LIBRE BRUXE; Hautier L, 2008, CHEMOECOLOGY, V18, P191, DOI 10.1007/s00049-008-0405-4; Hautier L, 2011, BIOL INVASIONS, V13, P1805, DOI 10.1007/s10530-010-9935-0; Hemptinne JL, 2001, CHEMOECOLOGY, V11, P43, DOI 10.1007/PL00001831; Hemptinne JL, 1996, ECOL ENTOMOL, V21, P165, DOI 10.1111/j.1365-2311.1996.tb01183.x; Hemptinne JL, 2000, CHEMOECOLOGY, V10, P149, DOI 10.1007/PL00001817; Hodek I., 1996, ECOLOGY COCCINELLIDA; Hodek I., 1973, BIOL COCCINELLIDAE K; Jansen JP, 2008, BIOCONTROL, V53, P223, DOI 10.1007/s10526-007-9134-9; Janssen A, 2007, ECOLOGY, V88, P2713, DOI 10.1890/06-1408.1; Kajita Y, 2006, ECOL ENTOMOL, V31, P58, DOI 10.1111/j.0307-6946.2006.00753.x; Katsanis A, 2010, PATCH EXPLOITATION B; KAWAI A, 1976, Researches on Population Ecology (Tokyo), V18, P123, DOI 10.1007/BF02754087; Kesten U., 1969, Zeitschrift fuer Angewandte Entomologie, V63, P412; Kindlmann P., 2010, IOBC/WPRS Bulletin, V58, P61; King AG, 1996, CHEM REV, V96, P1105; Koch RL, 2008, BIOCONTROL, V53, P23, DOI 10.1007/s10526-007-9121-1; Lucas E, 2005, EUR J ENTOMOL, V102, P351, DOI 10.14411/eje.2005.052; Lucas E, 2011, BIOL CONTROL, V59, P61, DOI 10.1016/j.biocontrol.2011.05.010; MARKS RJ, 1977, B ENTOMOL RES, V67, P235, DOI 10.1017/S0007485300011044; Meisner MH, 2011, ENVIRON ENTOMOL, V40, P103, DOI 10.1603/EN10211; Michaud JP, 2002, ENVIRON ENTOMOL, V31, P827, DOI 10.1603/0046-225X-31.5.827; Moser SE, 2010, J INSECT BEHAV, V23, P45, DOI 10.1007/s10905-009-9194-z; Osawa N, 2011, BIOCONTROL, V56, P613, DOI 10.1007/s10526-011-9382-6; Pell JK, 2008, BIOCONTROL, V53, P147, DOI 10.1007/s10526-007-9125-x; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; Raak-van den Berg CL, 2012, BIOCONTROL, V57, P71, DOI 10.1007/s10526-011-9394-2; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Ruzicka Z, 2002, EUR J ENTOMOL, V99, P471, DOI 10.14411/eje.2002.061; Sato S, 2004, AGR FOREST ENTOMOL, V6, P21, DOI 10.1111/j.1461-9555.2004.00197.x; Sato S, 2005, ECOL ENTOMOL, V30, P220, DOI 10.1111/j.0307-6946.2005.00688.x; Sato S, 2003, ECOL ENTOMOL, V28, P628, DOI 10.1046/j.1365-2311.2003.00542.x; Sato S, 2008, APPL ENTOMOL ZOOL, V43, P143, DOI 10.1303/aez.2008.143; Sato S, 2009, ENTOMOL SCI, V12, P111, DOI 10.1111/j.1479-8298.2009.00312.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sloggett JJ, 2011, BIOCONTROL, V56, P643, DOI 10.1007/s10526-011-9376-4; Snyder WE, 2009, BIOL CONTROL, V51, P323, DOI 10.1016/j.biocontrol.2009.05.010; STUBBS M, 1980, ECOL ENTOMOL, V5, P179, DOI 10.1111/j.1365-2311.1980.tb01139.x; TAKAHASHI K, 1989, Japanese Journal of Entomology, V57, P199; van Lenteren JC, 2008, BIOCONTROL, V53, P37, DOI 10.1007/s10526-007-9120-2; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1; Ware RL, 2008, BIOCONTROL, V53, P169, DOI 10.1007/s10526-007-9135-8; Weber DC, 2009, BIOL CONTROL, V51, P199, DOI 10.1016/j.biocontrol.2009.05.013; WRATTEN SD, 1973, J ANIM ECOL, V42, P785, DOI 10.2307/3139; Yasuda H, 2004, OECOLOGIA, V141, P722, DOI 10.1007/s00442-004-1680-6; Yasuda H, 2001, J INSECT BEHAV, V14, P373, DOI 10.1023/A:1011175430247; YASUDA H, 1997, ENTOMOPHAGA, V42, P153	62	29	32	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40681	10.1371/journal.pone.0040681	http://dx.doi.org/10.1371/journal.pone.0040681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815790	gold, Green Published			2022-12-27	WOS:000306466100055
J	Shulman, LM; Hindiyeh, M; Muhsen, K; Cohen, D; Mendelson, E; Sofer, D				Shulman, Lester M.; Hindiyeh, Musa; Muhsen, Khitam; Cohen, Dani; Mendelson, Ella; Sofer, Danit			Evaluation of Four Different Systems for Extraction of RNA from Stool Suspensions Using MS-2 Coliphage as an Exogenous Control for RT-PCR Inhibition	PLOS ONE			English	Article							NUCLEIC-ACID EXTRACTION; RESPIRATORY SYNDROME CORONAVIRUS; REAL-TIME PCR; NUCLISENS EASYMAG; ENTEROVIRUS RNA; SPECIMENS; SAMPLES; VIRUSES; ASSAYS; AMPLIFICATION	Knowing when, and to what extent co-extracted inhibitors interfere with molecular RNA diagnostic assays is of utmost importance. The QIAamp Viral RNA Mini Kit (A); MagNA Pure LC2.0 Automatic extractor (B); KingFisher (C); and NucliSENS EasyMag (D) RNA extraction systems were evaluated for extraction efficiency and co-purification of inhibitors from stool suspensions. Real-Time Reverse Transcriptase Polymerase Chain Reaction (rRT-PCR) of MS-2 coliphage spiked into each system's lysis buffer served as an external control for both. Cycle thresholds (Cts) of the MS2 were determined for RNA extracted from stool suspensions containing unknown (n = 93) or varying amounts of inhibitors (n = 92). Stool suspensions from the latter group were also used to determine whether MS-2 and enterovirus rRT-PCR inhibitions were correlated. Specifically 23 RNA extracts from stool suspensions were spiked with enterovirus RNA after extraction and 13 of these stool suspension were spiked with intact enterovirus before extraction. MS2 rRT-PCR inhibition varied for RNAs extracted by the different systems. Inhibition was noted in 12 (13.0%), 26 (28.3%), 7 (7.6%), and 7 (7.6%) of the first 93 RNA extracts, and 58 (63.0%), 55 (59.8%), 37 (40.2%) and 30 (32.6%) of the second 92 extracts for A, B, C, and D, respectively. Furthermore, enterovirus rRT-PCR inhibition correlated with MS2 rRT-PCR inhibition for added enterovirus RNA or virus particles. In conclusion, rRT-PCR for MS-2 RNA is a good predictor of inhibition of enterovirus RNA extracted from stool suspensions. EasyMag performed the best, however all four extraction methods were suitable provided that external controls identified problematic samples.	[Shulman, Lester M.; Hindiyeh, Musa; Mendelson, Ella; Sofer, Danit] Sheba Med Ctr, Israel Minist Hlth, Publ Hlth Serv, Cent Virol Lab, Tel Hashomer, Israel; [Shulman, Lester M.; Muhsen, Khitam; Cohen, Dani; Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shulman, LM (corresponding author), Sheba Med Ctr, Israel Minist Hlth, Publ Hlth Serv, Cent Virol Lab, Tel Hashomer, Israel.	lester.shulman@sheba.health.gov.il	Shulman, Lester M./AAU-4372-2021	Shulman, Lester M./0000-0002-6385-894X; Cohen, Daniel/0000-0003-2664-2303				Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Anwar A, 2009, J MOL DIAGN, V11, P537, DOI 10.2353/jmoldx.2009.080164; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Chan KH, 2008, J CLIN MICROBIOL, V46, P2195, DOI 10.1128/JCM.00315-08; Cheng YJ, 2006, J CLIN MICROBIOL, V44, P3557, DOI 10.1128/JCM.00713-06; Chidlow G, 2010, J CLIN MICROBIOL, V48, P862, DOI 10.1128/JCM.01435-09; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Dreier J, 2006, J CLIN MICROBIOL, V44, P2714, DOI 10.1128/JCM.00443-06; Dundas N, 2008, J MOL DIAGN, V10, P311, DOI 10.2353/jmoldx.2008.070149; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0; Ginocchio CC, 2008, J CLIN MICROBIOL, V46, P1274, DOI 10.1128/JCM.01567-07; Gregory JB, 2006, APPL ENVIRON MICROB, V72, P3960, DOI 10.1128/AEM.02291-05; Hale AD, 1996, J VIROL METHODS, V57, P195, DOI 10.1016/0166-0934(95)01966-9; Hata A, 2011, APPL ENVIRON MICROB, V77, P4336, DOI 10.1128/AEM.00077-11; Kern M, 2009, J MICROBIOL METH, V79, P189, DOI 10.1016/j.mimet.2009.08.020; Knepp JH, 2003, J CLIN MICROBIOL, V41, P3532, DOI 10.1128/JCM.41.8.3532-3536.2003; Lieu D, 2010, MOL DETECTION HUMAN; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Oikarinen S, 2009, J CLIN VIROL, V44, P211, DOI 10.1016/j.jcv.2008.12.017; Petrich A, 2006, J CLIN MICROBIOL, V44, P2681, DOI 10.1128/JCM.02460-05; Schlaurman T, 2007, J MICROBIOL METH, V71, P238, DOI 10.1016/j.mimet.2007.09.003; Sofer D, 2010, MOL DETECTION HUMAN, P37; Valentine-Thon E, 2002, J CLIN VIROL, V25, pS13; Verstrepen WA, 2002, J CLIN VIROL, V25, pS39, DOI 10.1016/S1386-6532(02)00032-X; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	30	35	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e39455	10.1371/journal.pone.0039455	http://dx.doi.org/10.1371/journal.pone.0039455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815706	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100018
J	Cheng, K; Delghingaro-Augusto, V; Nolan, CJ; Turner, N; Hallahan, N; Andrikopoulos, S; Gunton, JE				Cheng, Kim; Delghingaro-Augusto, Viviane; Nolan, Christopher J.; Turner, Nigel; Hallahan, Nicole; Andrikopoulos, Sofianos; Gunton, Jenny E.			High Passage MIN6 Cells Have Impaired Insulin Secretion with Impaired Glucose and Lipid Oxidation	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; MITOCHONDRIAL UNCOUPLING PROTEINS; DIFFERENTIAL GENE-EXPRESSION; DIABETES-MELLITUS; LACTATE-DEHYDROGENASE; B-CELLS; UCP2; METABOLISM; PATHWAYS; RELEASE	Type 2 diabetes is a metabolic disorder characterized by the inability of beta-cells to secrete enough insulin to maintain glucose homeostasis. MIN6 cells secrete insulin in response to glucose and other secretagogues, but high passage (HP) MIN6 cells lose their ability to secrete insulin in response to glucose. We hypothesized that metabolism of glucose and lipids were defective in HP MIN6 cells causing impaired glucose stimulated insulin secretion (GSIS). HP MIN6 cells had no first phase and impaired second phase GSIS indicative of global functional impairment. This was coupled with a markedly reduced ATP content at basal and glucose stimulated states. Glucose uptake and oxidation were higher at basal glucose but ATP content failed to increase with glucose. HP MIN6 cells had decreased basal lipid oxidation. This was accompanied by reduced expressions of Glut1, Gck, Pfk, Srebp1c, Ucp2, Sirt3, Nampt. MIN6 cells represent an important model of beta cells which, as passage numbers increased lost first phase but retained partial second phase GSIS, similar to patients early in type 2 diabetes onset. We believe a number of gene expression changes occurred to produce this defect, with emphasis on Sirt3 and Nampt, two genes that have been implicated in maintenance of glucose homeostasis.	[Cheng, Kim; Gunton, Jenny E.] GIMR, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Delghingaro-Augusto, Viviane; Nolan, Christopher J.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Turner, Nigel; Hallahan, Nicole] GIMR, Diabet & Obes Program, Sydney, NSW, Australia; [Andrikopoulos, Sofianos] Univ Melbourne, Dept Med AH NH, Melbourne, Vic, Australia; [Gunton, Jenny E.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Gunton, Jenny E.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia	Australian National University; University of Melbourne; University of Sydney; University of New South Wales Sydney; University of Sydney	Cheng, K (corresponding author), GIMR, Diabet & Transcript Factors Grp, Sydney, NSW, Australia.	j.gunton@garvan.org.au	Delghingaro-Augusto, Viviane/AAG-8696-2019; Gunton, Jenny E/AAH-7719-2021; Nolan, Christopher J/B-2026-2008; Turner, Nigel/H-7176-2013	Delghingaro-Augusto, Viviane/0000-0002-5107-2384; Nolan, Christopher J/0000-0002-6964-3819; Turner, Nigel/0000-0002-0119-9328; Hallahan, Nicole/0000-0001-5975-0971				Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Akerfeldt MC, 2011, DIABETES, V60, P2506, DOI 10.2337/db11-0083; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cheng G, 2003, BIOCHEM BIOPH RES CO, V308, P573, DOI 10.1016/S0006-291X(03)01409-8; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; DAVIES MJ, 1994, DIABETIC MED, V11, P432, DOI 10.1111/j.1464-5491.1994.tb00302.x; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; EFRAT S, 1994, TRENDS BIOCHEM SCI, V19, P535, DOI 10.1016/0968-0004(94)90056-6; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; KELLY RP, 1991, J PHYSIOL-LONDON, V443, P175, DOI 10.1113/jphysiol.1991.sp018829; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Laffranchi R, 1995, BIOCHEM BIOPH RES CO, V217, P584, DOI 10.1006/bbrc.1995.2815; Liang Y, 1996, AM J PHYSIOL-ENDOC M, V270, pE846, DOI 10.1152/ajpendo.1996.270.5.E846; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; MATSCHINSKY FM, 1973, BIOCHEM BIOPH RES CO, V50, P193, DOI 10.1016/0006-291X(73)90826-7; Mertz RJ, 1996, J BIOL CHEM, V271, P4838, DOI 10.1074/jbc.271.9.4838; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; O'Driscoll L, 2004, TRANSPL P, V36, P1159, DOI 10.1016/j.transproceed.2004.04.011; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; Pi J, 2010, DIABETES OBES METAB, V12, P141, DOI 10.1111/j.1463-1326.2010.01269.x; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; ROBERTSON RP, 1992, J CLIN INVEST, V90, P320, DOI 10.1172/JCI115865; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; SCHMIDT HHHW, 1992, SCIENCE, V255, P721, DOI 10.1126/science.1371193; SEKINE N, 1994, J BIOL CHEM, V269, P4895; SENER A, 1987, BIOCHEM J, V246, P89, DOI 10.1042/bj2460089; SENER A, 1978, BIOCHEM J, V176, P217, DOI 10.1042/bj1760217; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yechoor VK, 2004, P NATL ACAD SCI USA, V101, P16525, DOI 10.1073/pnas.0407574101; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0	58	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40868	10.1371/journal.pone.0040868	http://dx.doi.org/10.1371/journal.pone.0040868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808281	Green Submitted, gold, Green Published			2022-12-27	WOS:000306406700066
J	Xiao, B; Lin, ZB; Zhang, LZ; Huang, YS; Wang, GF				Xiao, Bin; Lin, Zhoubin; Zhang, Lizhen; Huang, Yisheng; Wang, Guofu			Growth, Thermal and Spectral Properties of Er3+-Doped and Er3+/Yb3+-Codoped Li3Ba2La3(WO4)(8) Crystals	PLOS ONE			English	Article							UP-CONVERSION LUMINESCENCE; DIODE-PUMPED ER; SPECTROSCOPIC CHARACTERIZATION; LASER PERFORMANCE; LANTHANIDE; IONS; FLUORESCENCE; NAY(WO4)(2); KLU(WO4)(2); INTENSITIES	This paper reports the growth and spectral properties of Er3+-doped and Er3+/Yb3+-codoped Li3Ba2La3(WO4)(8) crystals. The Er3+: Li3Ba2La3(WO4)(8) crystal with dimensions of 56 mmx28 mmx9 mm and Er3+/Yb3+: Li3Ba2La3(WO4)(8) crystal with dimensions of 52 mmx24 mmx8 mm were obtained by the top-seeded solution growth (TSSG) method. Thermal expansion coefficients and thermal conductivity of both crystals were measured. The spectroscopic characterizations of both crystals were investigated. The spectroscopic analysis reveals that the Er3+/Yb3+: Li3Ba2La3(WO4)(8) crystal has much better optical properties than the Er3+: Li3Ba2La3(WO4)(8) crystal, thus it may become a potential candidate for solid-state laser gain medium material.	[Xiao, Bin; Lin, Zhoubin; Zhang, Lizhen; Huang, Yisheng; Wang, Guofu] Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fujian, Peoples R China; [Xiao, Bin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, B (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fujian, Peoples R China.	wgf@ms.fjirsm.ac.cn		Xiao, Bin/0000-0001-8512-0340	National Natural Science Foundation of China [61108054]; National Natural Science Foundation of Fujian Province [2011J01376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work is supported by the National Natural Science Foundation of China (No. 61108054) and the National Natural Science Foundation of Fujian Province (No. 2011J01376), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RL, 2005, J APPL PHYS, V98, DOI 10.1063/1.2128696; AULL BF, 1982, IEEE J QUANTUM ELECT, V18, P925, DOI 10.1109/JQE.1982.1071611; Burns PA, 2004, IEEE J QUANTUM ELECT, V40, P1575, DOI 10.1109/JQE.2004.834935; Buse G, 2009, AIP CONF PROC, V1131, P131, DOI 10.1063/1.3153434; CARNALL WT, 1968, J CHEM PHYS, V49, P4424, DOI 10.1063/1.1669893; Chen GY, 2011, ACS NANO, V5, P4981, DOI 10.1021/nn201083j; Chen YJ, 2007, OPT LETT, V32, P2759, DOI 10.1364/OL.32.002759; Denker B, 2004, APPL PHYS B-LASERS O, V79, P577, DOI 10.1007/s00340-004-1605-4; DHANARAJ G, 1992, J APPL PHYS, V72, P3464, DOI 10.1063/1.351421; Fan JD, 2006, J PHYS D APPL PHYS, V39, P1034, DOI 10.1088/0022-3727/39/6/007; Gallis S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2730583; Ge WW, 2007, J APPL CRYSTALLOGR, V40, P125, DOI 10.1107/S0021889806045407; Georgobiani AN, 2009, INORG MATER+, V45, P1032, DOI 10.1134/S0020168509090167; Guo WJ, 2008, J APPL PHYS, V104, DOI 10.1063/1.2973657; Han XM, 2002, J CRYST GROWTH, V242, P412, DOI 10.1016/S0022-0248(02)01450-1; Huang JH, 2012, LASER PHYS, V22, P146, DOI 10.1134/S1054660X12010069; Jaque D, 2004, OPT MATER, V25, P9, DOI 10.1016/S0925-3467(03)00184-8; Jiang HD, 2002, CHEM PHYS LETT, V357, P15, DOI 10.1016/S0009-2614(02)00409-8; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; Li H, 2010, CRYSTENGCOMM, V12, P1307, DOI 10.1039/b914641e; Li H, 2009, J ALLOY COMPD, V478, P484, DOI 10.1016/j.jallcom.2008.11.079; Li LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030327; Lisiecki R, 2009, J LUMIN, V129, P521, DOI 10.1016/j.jlumin.2008.12.006; Macalik L, 2000, J MOL STRUCT, V555, P289, DOI 10.1016/S0022-2860(00)00612-8; MASON SF, 1975, MOL PHYS, V30, P1829, DOI 10.1080/00268977500103321; Mateos X, 2006, OPT MATER, V28, P423, DOI 10.1016/j.optmat.2004.12.024; Mateos X, 2005, J LUMIN, V115, P131, DOI 10.1016/j.jlumin.2005.01.015; Mateos X, 2002, PHYS REV B, V66; Nieboer E, 1975, INTENSITIES LANTHANI, P83; Nii H, 1998, J LUMIN, V76-7, P116, DOI 10.1016/S0022-2313(97)00271-8; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; OHTA K, 1993, J APPL PHYS, V73, P3149, DOI 10.1063/1.353005; Pan Y, 2012, CRYSTENGCOMM, V14, P3930, DOI 10.1039/c2ce25190f; Petrov V, 2007, LASER PHOTONICS REV, V1, P179, DOI 10.1002/lpor.200710010; Pollnau M, 2000, PHYS REV B, V61, P3337, DOI 10.1103/PhysRevB.61.3337; Pujol MC, 2001, MATER SCI FORUM, V378-3, P710, DOI 10.4028/www.scientific.net/MSF.378-381.710; Sani E, 2005, J APPL PHYS, V97, DOI 10.1063/1.1938276; Sato Y, 2005, IEEE J SEL TOP QUANT, V11, P613, DOI 10.1109/JSTQE.2005.850569; Scheps R, 1996, PROG QUANT ELECTRON, V20, P271, DOI 10.1016/0079-6727(95)00007-0; SCHWEIZER T, 1995, OPT COMMUN, V118, P557, DOI 10.1016/0030-4018(95)00284-F; SILVERSMITH A, 1994, J LUMIN, V60-1, P636, DOI 10.1016/0022-2313(94)90237-2; Silvestre O, 2008, OPT EXPRESS, V16, P5022, DOI 10.1364/OE.16.005022; Sokolska I, 2000, APPL PHYS B-LASERS O, V71, P893, DOI 10.1007/s003400000458; Song F, 2006, OPT COMMUN, V259, P179, DOI 10.1016/j.optcom.2005.08.049; Song MJ, 2010, OPT MATER, V33, P36, DOI 10.1016/j.optmat.2010.07.027; Sudmeyer T, 2009, APPL PHYS B-LASERS O, V97, P281, DOI 10.1007/s00340-009-3700-z; Tolstik NA, 2007, OPT LETT, V32, P3233, DOI 10.1364/OL.32.003233; Wang P, 2002, OPT MATER, V19, P383, DOI 10.1016/S0925-3467(01)00241-5; WEBER MJ, 1967, PHYS REV, V157, P262, DOI 10.1103/PhysRev.157.262; Wei B, 2007, MATER RES INNOV, V11, P154, DOI 10.1179/143307507X225605; Zhang HJ, 1999, PHYS STATUS SOLIDI A, V175, P705, DOI 10.1002/(SICI)1521-396X(199910)175:2<705::AID-PSSA705>3.0.CO;2-N; Zhao D, 2005, J CRYST GROWTH, V277, P401, DOI 10.1016/j.jcrysgro.2005.01.081; Zhao D, 2010, J LUMIN, V130, P424, DOI 10.1016/j.jlumin.2009.10.007	53	6	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40631	10.1371/journal.pone.0040631	http://dx.doi.org/10.1371/journal.pone.0040631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808214	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700039
J	Danhier, F; Danhier, P; Magotteaux, N; De Preter, G; Ucakar, B; Karroum, O; Jordan, B; Gallez, B; Preat, V				Danhier, Fabienne; Danhier, Pierre; Magotteaux, Nicolas; De Preter, Geraldine; Ucakar, Bernard; Karroum, Oussama; Jordan, Benedicte; Gallez, Bernard; Preat, Veronique			Electron Paramagnetic Resonance Highlights That the Oxygen Effect Contributes to the Radiosensitizing Effect of Paclitaxel	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; EPR OXIMETRY; IN-VIVO; REOXYGENATION; RADIORESPONSE; RADIOTHERAPY; ENHANCEMENT; CONSUMPTION; CELLS	Background: Paclitaxel (PTX) is a potent anti-cancer chemotherapeutic agent and is widely used in the treatments of solid tumors, particularly of the breast and ovaries. An effective and safe micellar formulation of PTX was used to administer higher doses of PTX than Taxol (R) (the current commercialized drug). We hypothesize that PTX-loaded micelles (M-PTX) may enhance tumor radiosensitivity by increasing the tumor oxygenation (pO(2)). Our goals were (i) to evaluate the contribution of the "oxygen effect'' to the radiosensitizing effect of PTX; (ii) to demonstrate the therapeutic relevance of the combination of M-PTX and irradiation and (iii) to investigate the underlying mechanisms of the observed oxygen effect. Methodology and Principal Findings: We used (PEG-p-(CL-co-TMC)) polymeric micelles to solubilize PTX. pO(2) was measured on TLT tumor-bearing mice treated with M-PTX (80 mg/kg) using electron paramagnetic resonance (EPR) oximetry. The regrowth delay following 10 Gy irradiation 24 h after M-PTX treatment was measured. The tumor perfusion was assessed by the patent blue staining. The oxygen consumption rate and the apoptosis were evaluated by EPR oximetry and the TUNEL assay, respectively. EPR oximetry experiments showed that M-PTX dramatically increases the pO(2) 24 h post treatment. Regrowth delay assays demonstrated a synergy between M-PTX and irradiation. M-PTX increased the tumor blood flow while cells treated with M-PTX consumed less oxygen and presented more apoptosis. Conclusions: M-PTX improved the tumor oxygenation which leads to synergy between this treatment and irradiation. This increased pO(2) can be explained both by an increased blood flow and an inhibition of O-2 consumption.	[Danhier, Fabienne; Danhier, Pierre; De Preter, Geraldine; Karroum, Oussama; Jordan, Benedicte; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Lab Biomed Magnet Resonance, B-1200 Brussels, Belgium	Universite Catholique Louvain	Danhier, F (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Lab Biomed Magnet Resonance, B-1200 Brussels, Belgium.	veronique.preat@uclouvain.be		Danhier, Pierre/0000-0002-9028-8399	FNRS; Fonds Joseph Maisin; Belgian Foundation against Cancer; Actions de Recherches Concertees-Communaute Francaise de Belgique; Pole d'attraction Interuniversitaire	FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Joseph Maisin; Belgian Foundation against Cancer; Actions de Recherches Concertees-Communaute Francaise de Belgique; Pole d'attraction Interuniversitaire	This work is supported by grants from the FNRS, the Fonds Joseph Maisin, the Belgian Foundation against Cancer, the "Actions de Recherches Concertees-Communaute Francaise de Belgique'', and the "Pole d'attraction Interuniversitaire". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J D, 1993, J Natl Cancer Inst Monogr, P141; Ansiaux R, 2006, CLIN CANCER RES, V12, P1276, DOI 10.1158/1078-0432.CCR-05-1222; Ansiaux R, 2005, CLIN CANCER RES, V11, P743; Crokart N, 2005, INT J RADIAT ONCOL, V63, P901, DOI 10.1016/j.ijrobp.2005.02.038; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Danhier F, 2009, EUR J PHARM BIOPHARM, V73, P230, DOI 10.1016/j.ejpb.2009.06.015; Diepart C, 2012, CANCER RES, V72, P482, DOI 10.1158/0008-5472.CAN-11-1755; Gallez B, 1999, MAGN RESON MED, V42, P627, DOI 10.1002/(SICI)1522-2594(199910)42:4<627::AID-MRM2>3.0.CO;2-M; Gallez B, 2004, NMR BIOMED, V17, P240, DOI 10.1002/nbm.900; JAMES PE, 1995, FREE RADICAL BIO MED, V18, P641, DOI 10.1016/0891-5849(94)00179-N; Jordan BF, 2003, INT J RADIAT ONCOL, V55, P1066, DOI 10.1016/S0360-3016(02)04505-4; Jordan BF, 2000, INT J RADIAT ONCOL, V48, P565, DOI 10.1016/S0360-3016(00)00694-5; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; MILAS L, 1995, ACTA ONCOL, V34, P409, DOI 10.3109/02841869509093999; MILAS L, 1995, CANCER RES, V55, P3564; Milross CG, 1997, EUR J CANCER, V33, P1299, DOI 10.1016/S0959-8049(97)00107-X; Negishi T, 2006, BRIT J CANCER, V95, P601, DOI 10.1038/sj.bjc.6603311; Ould-Ouali L, 2004, PHARM RES-DORDR, V21, P1581, DOI 10.1023/B:PHAM.0000041452.08005.b0; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; TAPER HS, 1966, CANCER RES, V26, P143; TISHLER RB, 1992, CANCER RES, V52, P3495; Vaupel P, 1998, INT J RADIAT ONCOL, V42, P843, DOI 10.1016/S0360-3016(98)00324-1	23	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40772	10.1371/journal.pone.0040772	http://dx.doi.org/10.1371/journal.pone.0040772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808261	Green Published, gold			2022-12-27	WOS:000306366400058
J	Zhong, WJ; Sumita, Y; Ohba, S; Kawasaki, T; Nagai, K; Ma, GW; Asahina, I				Zhong, Weijian; Sumita, Yoshinori; Ohba, Seigo; Kawasaki, Takako; Nagai, Kazuhiro; Ma, Guowu; Asahina, Izumi			In Vivo Comparison of the Bone Regeneration Capability of Human Bone Marrow Concentrates vs. Platelet-Rich Plasma	PLOS ONE			English	Article							MONONUCLEAR-CELL IMPLANTATION; PERIODONTAL INTRABONY DEFECTS; AUTOGENOUS BONE; STEM-CELLS; LIMB ISCHEMIA; RECONSTRUCTION; COMBINATION; GRAFTS; REPAIR; TRANSPLANTATION	Background: Bone marrow aspirate concentrate (BMAC) including high densities of stem cells and progenitor cells may possess a stronger bone regenerative capability compared with Platelet-rich plasma (PRP), which contains enriched growth factors. The objective of this study was to evaluate the effects of human BMAC and PRP in combination with beta-tricalcium phosphate (beta-TCP) on promoting initial bone augmentation in an immunodeficient mouse model. Methodology/Principal Findings: BMAC and PRP were concentrated with an automated blood separator from the bone marrow and peripheral blood aspirates. beta-TCP particles were employed as a scaffold to carry cells. After cell counting and FACS characterization, three groups of nude mice (BMAC+TCP, PRP+TCP, and a TCP control) were implanted with graft materials for onlay placement on the cranium. Samples were harvested after 4 weeks, and serial sections were prepared. We observed the new bone on light microscopy and performed histomorphometric analysis. After centrifugation, the concentrations of nucleated cells and platelets in BMAC were increased by factors of 2.8 +/- 0.8 and 5.3 +/- 2.4, respectively, whereas leucocytes and platelets in PRP were increased by factors of 4.1 +/- 1.8 and 4.4 +/- 1.9, respectively. The concentrations of CD34-, CD271-, CD90-, CD105-, and CD146-positive cells were markedly increased in both BMAC and PRP. The percentage of new bone in the BMAC group (7.6 +/- 3.9%) and the PRP group (7.2 +/- 3.8%) were significantly higher than that of TCP group (2.7 +/- 1.4%). Significantly more bone cells in the new bone occurred in sites transplanted with BMAC (552 +/- 257) and PRP (491 +/- 211) compared to TCP alone (187 +/- 94). But the difference between the treatment groups was not significant. Conclusions/Significance: Both human BMACs and PRP may provide therapeutic benefits in bone tissue engineering applications. These fractions possess a similar ability to enhance early-phase bone regeneration.	[Zhong, Weijian; Sumita, Yoshinori; Ohba, Seigo; Kawasaki, Takako; Asahina, Izumi] Nagasaki Univ, Dept Regenerat Oral Surg, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Zhong, Weijian; Ma, Guowu] Dalian Med Univ, Coll Stomatol, Dept Oral & Maxillofacial Surg, Dalian, Liaoning, Peoples R China; [Nagai, Kazuhiro] Nagasaki Univ Hosp, Transfus & Cell Therapy Unit, Nagasaki, Japan	Nagasaki University; Dalian Medical University; Nagasaki University	Zhong, WJ (corresponding author), Nagasaki Univ, Dept Regenerat Oral Surg, Grad Sch Biomed Sci, Nagasaki 852, Japan.	asahina@nagasaki-u.ac.jp	Ohba, Seigo/ABE-3239-2020		Japan Society for the Promotion of Science [22390387]; Grants-in-Aid for Scientific Research [22390387, 22390375] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study has been partially supported by the Grant-in-Aid for Scientific Research (22390387) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Arora NS, 2010, IMPLANT DENT, V19, P145, DOI 10.1097/ID.0b013e3181cd706d; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; Chang F, 2008, J ORTHOP RES, V26, P18, DOI 10.1002/jor.20470; Dori F, 2008, J PERIODONTOL, V79, P660, DOI [10.1902/jop.2008.070473, 10.1902/jop.2008.070473 ]; El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302; Hanna R, 2004, J PERIODONTOL, V75, P1668, DOI 10.1902/jop.2004.75.12.1668; Hernandez P, 2007, ATHEROSCLEROSIS, V194, pE52, DOI 10.1016/j.atherosclerosis.2006.08.025; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hibi H, 2006, INT J ORAL MAX SURG, V35, P551, DOI 10.1016/j.ijom.2005.12.007; Higashi Y, 2004, CIRCULATION, V109, P1215, DOI 10.1161/01.CIR.0000121427.53291.78; Hisatome T, 2005, BIOMATERIALS, V26, P4550, DOI 10.1016/j.biomaterials.2004.11.032; Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055; Jakse N, 2003, CLIN ORAL IMPLAN RES, V14, P578, DOI 10.1034/j.1600-0501.2003.00928.x; Kao RT, 2009, PERIODONTOL 2000, V50, P127, DOI 10.1111/j.1600-0757.2008.00287.x; Kassolis JD, 2005, J CRANIOFAC SURG, V16, P280, DOI 10.1097/00001665-200503000-00015; Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471; Lee J, 2010, J ORAL MAXIL SURG, V68, P188, DOI 10.1016/j.joms.2009.08.031; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Ouyang XY, 2006, CHINESE MED J-PEKING, V119, P1511, DOI 10.1097/00029330-200609020-00003; Piemontese M, 2008, J PERIODONTOL, V79, P802, DOI [10.1902/jop.2008.070436, 10.1902/jop.2008.070436 ]; Pieri F, 2008, J CLIN PERIODONTOL, V35, P539, DOI 10.1111/j.1600-051X.2008.01220.x; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rickert D, 2011, CLIN ORAL IMPLAN RES, V22, P251, DOI 10.1111/j.1600-0501.2010.01981.x; Sauerbier S, 2011, TISSUE ENG PT A, V17, P2187, DOI [10.1089/ten.tea.2010.0516, 10.1089/ten.TEA.2010.0516]; Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009; Schlegel KA, 2004, BIOMATERIALS, V25, P5387, DOI 10.1016/j.biomaterials.2003.12.043; Smiler D, 2007, IMPLANT DENT, V16, P42, DOI 10.1097/ID.0b013e3180335934; Soltan Muna, 2005, Implant Dent, V14, P322; Stenport VF, 2011, J ORAL MAXIL SURG, V69, P1079, DOI 10.1016/j.joms.2010.11.027; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Thor A, 2005, CLIN IMPLANT DENT R, V7, P209, DOI 10.1111/j.1708-8208.2005.tb00066.x; Umemura T, 2006, CIRC J, V70, P1362, DOI 10.1253/circj.70.1362; Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x; Wojtowicz Andrzej, 2007, N Y State Dent J, V73, P41; Yasuhara S, 2010, ARTIF ORGANS, V34, P594, DOI 10.1111/j.1525-1594.2009.00980.x	39	55	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40833	10.1371/journal.pone.0040833	http://dx.doi.org/10.1371/journal.pone.0040833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808272	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400061
J	Niu, DF; Kondo, T; Nakazawa, T; Kawasaki, T; Yamane, T; Mochizuki, K; Kato, Y; Matsuzaki, T; Takata, K; Katoh, R				Niu, Dongfeng; Kondo, Tetsuo; Nakazawa, Tadao; Kawasaki, Tomonori; Yamane, Tetsu; Mochizuki, Kunio; Kato, Yohichiro; Matsuzaki, Toshiyuki; Takata, Kuniaki; Katoh, Ryohei			Differential Expression of Aquaporins and Its Diagnostic Utility in Thyroid Cancer	PLOS ONE			English	Article							KIDNEY COLLECTING DUCT; WATER-CHANNEL; MESSENGER-RNA; CELL-MIGRATION; RAT; AQP3; GLYCEROL; PROTEIN; CLONING; LOCALIZATION	Background: Aquaporin3 (AQP3) and Aquaporin4 (AQP4) play a major role in transcellular and transepithelial water movement as water channel membrane proteins. Little is known of their expression and significance in human thyroid tissues. Thus, we examined the expression of AQP3 and AQP4 in normal, hyperplastic and neoplastic thyroid tissues in conjunction with human thyroid cancer cell lines. Methods and Results: Immunohistochemical analyses demonstrated AQP3 in the cytoplasmic membrane of normal C cells, but not in follicular cells. In contrast, AQP4 was not found in C cells but was identified in normal follicular cells. AQP4 was positive in 92% of Graves' disease thyroids and 97% of multinodular goiters, and we failed to demonstrate AQP3 in these hyperplastic tissues. In neoplastic thyroid lesions, we observed AQP3 in 91% of medullary thyroid carcinomas but in no other follicular cell tumors. AQP4 was demonstrated in 100% of follicular adenomas, 90% of follicular carcinomas, and 85% of papillary carcinomas, while it was negative in all medullary carcinomas and undifferentiated carcinomas. Reverse transcriptase polymerase chain reaction (RT-PCR) analyses revealed AQP3 mRNA expression only in medullary carcinomas and AQP4 mRNA expression in follicular cell-derived tumors except for undifferentiated carcinomas. In thyroid cancer cell lines, using RT-PCR and western blotting, AQP3 mRNA and protein were only identified in the TT cell line (human medullary carcinoma cell line) and AQP4 in the other cell lines. In addition, AQP3 mRNA expression was up-regulated by FBS and calcium administration in both a dose and time dependent manner in TT cells. Conclusion: The differential expressions of AQP3 and AQP4 may reflect the biological nature and/or function of normal, hyperplastic, and neoplastic thyroid cells and additionally may have value in determining differential diagnoses of thyroid tumors.	[Niu, Dongfeng; Kondo, Tetsuo; Nakazawa, Tadao; Kawasaki, Tomonori; Yamane, Tetsu; Mochizuki, Kunio; Katoh, Ryohei] Univ Yamanashi, Dept Human Pathol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Matsuzaki, Toshiyuki; Takata, Kuniaki] Gunma Univ, Dept Anat & Cell Biol, Grad Sch Med, Maebashi, Gunma 371, Japan; [Kato, Yohichiro] Tokyo Womens Med Univ, Dept Pathol, Grad Sch Med, Tokyo, Japan	University of Yamanashi; Gunma University; Tokyo Women's Medical University	Niu, DF (corresponding author), Univ Yamanashi, Dept Human Pathol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan.	rkatoh@yamanashi.ac.jp		Niu, Dongfeng/0000-0003-0389-6239				Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; De Lellis R.A., 2004, WHO CLASSIFICATION T, V3rd; Ding T, 2010, J CLIN NEUROSCI, V17, P1359, DOI 10.1016/j.jocn.2010.02.014; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Fernandez-Santos JM, 2001, HISTOL HISTOPATHOL, V16, P407, DOI 10.14670/HH-16.407; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hara-Chikuma M, 2008, J INVEST DERMATOL, V128, P2145, DOI 10.1038/jid.2008.70; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Ishibashi Kenichi, 2009, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-540-79885-9_13; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kafe H, 2004, VIRCHOWS ARCH, V445, P637, DOI 10.1007/s00428-004-1124-z; Kakigi A, 2009, AURIS NASUS LARYNX, V36, P135, DOI 10.1016/j.anl.2008.04.012; Katoh R, 2000, HUM PATHOL, V31, P386, DOI 10.1016/S0046-8177(00)80255-5; Kim H, 2010, MOL BIOL REP, V37, P3593, DOI 10.1007/s11033-010-0008-3; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kondo T, 2003, J HISTOCHEM CYTOCHEM, V51, P167, DOI 10.1177/002215540305100205; Kondo T, 2007, HUM PATHOL, V38, P1810, DOI 10.1016/j.humpath.2007.04.014; Kondo T, 2009, LAB INVEST, V89, P791, DOI 10.1038/labinvest.2009.50; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Loreto C, 2010, CURR NEUROPHARMACOL, V8, P105, DOI 10.2174/157015910791233196; Ma DF, 2010, HUM PATHOL, V41, P1550, DOI 10.1016/j.humpath.2010.04.008; Ma TH, 2002, J BIOL CHEM, V277, P17147, DOI 10.1074/jbc.M200925200; MA TH, 1994, J BIOL CHEM, V269, P21845; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Matsuzaki T, 1999, J HISTOCHEM CYTOCHEM, V47, P1275, DOI 10.1177/002215549904701007; Matsuzaki T, 2005, HISTOCHEM CELL BIOL, V123, P501, DOI 10.1007/s00418-005-0753-x; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Mou Ke-Jie, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P651; Ng WH, 2009, J CLIN NEUROSCI, V16, P441, DOI 10.1016/j.jocn.2008.04.028; Nico B, 2011, EXP CELL RES, V317, P2391, DOI 10.1016/j.yexcr.2011.07.006; Nico B, 2009, EUR J CANCER, V45, P3315, DOI 10.1016/j.ejca.2009.09.023; Niu DF, 2012, LAB INVESTIGAT UNPUB; Niu DF, 2012, HISTOPATHOLOGY UNPUB; Ramirez-Lorca R, 1999, PFLUG ARCH EUR J PHY, V438, P94, DOI 10.1007/s004240050884; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; Spector DA, 2002, AM J PHYSIOL-RENAL, V282, pF1034, DOI 10.1152/ajprenal.00136.2001; Tanaka M, 1997, AM J PHYSIOL-LUNG C, V273, pL1090, DOI 10.1152/ajplung.1997.273.5.L1090; Umenishi F, 1996, DNA CELL BIOL, V15, P475, DOI 10.1089/dna.1996.15.475; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Verkman AS, 1996, AM J PHYSIOL-CELL PH, V270, pC12, DOI 10.1152/ajpcell.1996.270.1.C12; Xie YP, 2012, CLIN LAB, V58, P75; Xu H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-86; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200	49	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40770	10.1371/journal.pone.0040770	http://dx.doi.org/10.1371/journal.pone.0040770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808259	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500080
J	Chen, MJ; Lin, CY; Wu, YT; Wu, PC; Lung, SC; Su, HJ				Chen, Mu-Jean; Lin, Chuan-Yao; Wu, Yi-Ting; Wu, Pei-Chih; Lung, Shih-Chun; Su, Huey-Jen			Effects of Extreme Precipitation to the Distribution of Infectious Diseases in Taiwan, 1994-2008	PLOS ONE			English	Article							CLIMATE-CHANGE; BACILLARY DYSENTERY; POTENTIAL IMPACTS; UNITED-STATES; RAINFALL; MELIOIDOSIS; VARIABILITY; OUTBREAK; HEALTH; LEPTOSPIROSIS	The incidence of extreme precipitation has increased with the exacerbation of worldwide climate disruption. We hypothesize an association between precipitation and the distribution patterns that would affect the endemic burden of 8 infectious diseases in Taiwan, including water- and vector-borne infectious diseases. A database integrating daily precipitation and temperature, along with the infectious disease case registry for all 352 townships in the main island of Taiwan was analysed for the period from 1994 to 2008. Four precipitation levels, <130 mm, 130-200 mm, 200-350 mm and >350 mm, were categorized to represent quantitative differences, and their associations with each specific disease was investigated using the Generalized Additive Mixed Model and afterwards mapped on to the Geographical Information System. Daily precipitation levels were significantly correlated with all 8 mandatory-notified infectious diseases in Taiwan. For water-borne infections, extreme torrential precipitation (>350 mm/day) was found to result in the highest relative risk for bacillary dysentery and enterovirus infections when compared to ordinary rain (<130 mm/day). Yet, for vector-borne diseases, the relative risk of dengue fever and Japanese encephalitis increased with greater precipitation only up to 350 mm. Differential lag effects following precipitation were statistically associated with increased risk for contracting individual infectious diseases. This study's findings can help health resource sector management better allocate medical resources and be better prepared to deal with infectious disease outbreaks following future extreme precipitation events.	[Chen, Mu-Jean; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Lin, Chuan-Yao; Lung, Shih-Chun] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; [Wu, Yi-Ting] Fdn Taiwan Ind Serv, Dept Occupat Safety, Taipei, Taiwan; [Wu, Pei-Chih] Chang Jung Christian Univ, Dept Occupat Safety & Hlth, Tainan, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; Chang Jung Christian University	Chen, MJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw	Lung, Shih-Chun Candice/ABA-1011-2020; Lung, Shih-Chun Candice/GYD-5623-2022; Lin, CY/K-6503-2014; lin, chuan/HHD-2571-2022	Lung, Shih-Chun Candice/0000-0002-4227-0469; Lung, Shih-Chun Candice/0000-0002-4227-0469; Lin, CY/0000-0002-0005-7088; Su, Huey-Jen/0000-0003-3589-9987	Taiwan National Science Council [NSC95-2625-Z-006-018, NSC96-2625-Z-006-016, NSC97-2625-Z-006-016, NSC99-2621-M-006-008]; Taiwan's Centers for Diseases Control [DOH98-DC-1002]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taiwan's Centers for Diseases Control	This supplement received financial support from the Taiwan National Science Council [http://web1.nsc.gov.tw/] (NSC95-2625-Z-006-018, NSC96-2625-Z-006-016, NSC97-2625-Z-006-016, NSC99-2621-M-006-008) and Taiwan's Centers for Diseases Control [http://www.cdc.gov.tw/mp.asp?mp=1] (DOH98-DC-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar R, 1996, LANCET, V348, P1457, DOI 10.1016/S0140-6736(04)70109-9; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Benitez MA, 2009, LANCET, V373, P1070, DOI 10.1016/S0140-6736(09)60634-6; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; Bi P, 2003, VECTOR-BORNE ZOONOT, V3, P111, DOI 10.1089/153036603768395807; Brockmann S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-91; Centers for Disease Control (CDC) Taiwan, TAIW SURV SYST; Chen VYJ, 2010, SCI TOTAL ENVIRON, V408, P2042, DOI 10.1016/j.scitotenv.2009.11.044; Chou DW, 2007, J FORMOS MED ASSOC, V106, P1013, DOI 10.1016/S0929-6646(08)60077-7; Corkeron ML, 2010, EPIDEMIOL INFECT, V138, P1346, DOI 10.1017/S0950268809991634; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Davis J.C., 1986, STAT DATA ANAL GEOLO; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Dura G, 2010, J WATER HEALTH, V8, P513, DOI 10.2166/wh.2010.099; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; ECHEVERRIA P, 1983, DIAGN MICR INFEC DIS, V1, P193, DOI 10.1016/0732-8893(83)90018-4; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Ge XY, 2010, ATMOS SCI LETT, V11, P46, DOI 10.1002/asl.255; Greenough G, 2001, ENVIRON HEALTH PERSP, V109, P191, DOI 10.2307/3435009; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hong CC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042761; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Hung MN, 2009, TAIWAN EPIDEMIOL B, V25, P625; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Islam MS, 2009, T ROY SOC TROP MED H, V103, P1165, DOI 10.1016/j.trstmh.2009.04.016; Jean JS, 2006, J APPL MICROBIOL, V101, P1224, DOI 10.1111/j.1365-2672.2006.03025.x; Lai SK, 2010, TAIWAN EPIDEMIOL B, V26, P178; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Liu SC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040218; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Majani BS, 2007, ANAL EXTERNAL DRIFT; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Pappachan MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1054, DOI 10.1136/jech.2003.018556; Patz JA, 2008, AM J PREV MED, V35, P451, DOI 10.1016/j.amepre.2008.08.026; Qin Juan, 2009, Wei Sheng Yan Jiu, V38, P762; Robertson J, 2010, AM J TROP MED HYG, V82, P88, DOI 10.4269/ajtmh.2010.09-0226; Sam IC, 2007, J INFECTION, V54, P519, DOI 10.1016/j.jinf.2006.07.007; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Shiu CJ, 2009, J CLIMATE, V22, P5635, DOI 10.1175/2009JCLI2514.1; Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931; Slack AT, 2006, EPIDEMIOL INFECT, V134, P1217, DOI 10.1017/S0950268806006352; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Su HP, 2007, EMERG INFECT DIS, V13, P1795, DOI 10.3201/eid1311.061461; SUPUTTAMONGKOL Y, 1994, INT J EPIDEMIOL, V23, P1082, DOI 10.1093/ije/23.5.1082; The Taiwan Central Weather Bureau, PREC CLASS; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; Vecchi GA, 2007, NATURE, V450, P1066, DOI 10.1038/nature06423; WENIGER BG, 1983, AM J PUBLIC HEALTH, V73, P868, DOI 10.2105/AJPH.73.8.868; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu PC, 2011, OCCUP ENVIRON MED, V68, P525, DOI 10.1136/oem.2010.056168; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002	60	185	204	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e34651	10.1371/journal.pone.0034651	http://dx.doi.org/10.1371/journal.pone.0034651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737206	Green Submitted, gold, Green Published			2022-12-27	WOS:000305695100001
J	Chen, JB; Yang, YH; Lee, WC; Liou, CW; Lin, TK; Chung, YH; Chuang, LY; Yang, CH; Chang, HW				Chen, Jin-Bor; Yang, Yi-Hsin; Lee, Wen-Chin; Liou, Chia-Wei; Lin, Tsu-Kung; Chung, Yueh-Hua; Chuang, Li-Yeh; Yang, Cheng-Hong; Chang, Hsueh-Wei			Sequence-Based Polymorphisms in the Mitochondrial D-Loop and Potential SNP Predictors for Chronic Dialysis	PLOS ONE			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; STAGE RENAL-DISEASE; DNA MUTATIONS; BREAST-CANCER; CONTROL REGION; OXIDATIVE STRESS; POINT MUTATIONS; PROSTATE-CANCER; ORAL-CANCER; COMBINATIONAL POLYMORPHISMS	Background: The mitochondrial (mt) displacement loop (D-loop) is known to accumulate structural alterations and mutations. The aim of this study was to investigate the prevalence of single nucleotide polymorphisms (SNPs) within the D-loop among chronic dialysis patients and healthy controls. Methodology and Principal Findings: We enrolled 193 chronic dialysis patients and 704 healthy controls. SNPs were identified by large scale D-loop sequencing and bioinformatic analysis. Chronic dialysis patients had lower body mass index, blood thiols, and cholesterol levels than controls. A total of 77 SNPs matched with the positions in reference of the Revised Cambridge Reference Sequence (CRS) were found in the study population. Chronic dialysis patients had a significantly higher incidence of 9 SNPs compared to controls. These include SNP5 (16108Y), SNP17 (16172Y), SNP21 (16223Y), SNP34 (16274R), SNP35 (16278Y), SNP55 (16463R), SNP56 (16519Y), SNP64 (185R), and SNP65 (189R) in D-loop of CRS. Among these SNPs with genotypes, SNP55-G, SNP56-C, and SNP64-A were 4.78, 1.47, and 5.15 times more frequent in dialysis patients compared to controls (P<0.05), respectively. When adjusting the covariates of demographics and comorbidities, SNP64-A was 5.13 times more frequent in dialysis patients compared to controls (P<0.01). Furthermore, SNP64-A was found to be 35.80, 3.48, 4.69, 5,55, and 4.67 times higher in female patients and in patients without diabetes, coronary artery disease, smoking, and hypertension in an independent significance manner (P<0.05), respectively. In patients older than 50 years or with hypertension, SNP34-A and SNP17-C were found to be 7.97 and 3.71 times more frequent (P<0.05) compared to patients younger than 50 years or those without hypertension, respectively. Conclusions and Significance: The results of large-scale sequencing suggest that specific SNPs in the mtDNA D-loop are significantly associated with chronic dialysis. These SNPs can be considered as potential predictors for chronic dialysis.	[Chen, Jin-Bor; Lee, Wen-Chin] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Nephrol,Dept Internal Med,Mitochondrial Res U, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Liou, Chia-Wei; Lin, Tsu-Kung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Liou, Chia-Wei; Lin, Tsu-Kung] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chung, Yueh-Hua] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Yang, Cheng-Hong] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Ctr Canc, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung University; Chang Gung Memorial Hospital; National Sun Yat Sen University; I Shou University; I Shou University; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, JB (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Nephrol,Dept Internal Med,Mitochondrial Res U, Kaohsiung, Taiwan.	chyang@cc.kuas.edu.tw; changhw@kmu.edu.tw	LEE, Wen-Chin/AAQ-8466-2021; Chang, Hsueh-Wei/C-9654-2009; Yang, Cheng-Hong/K-2438-2019; Yang, Yi-Hsin/D-6471-2012; Yang, Cheng-Hong/M-7984-2013	LEE, Wen-Chin/0000-0001-6172-1483; Chang, Hsueh-Wei/0000-0003-0068-2366; Yang, Yi-Hsin/0000-0002-9581-2778; Yang, Cheng-Hong/0000-0002-2741-0072; Arcelus, Jon/0000-0002-3805-0180; Guo, Boliang/0000-0002-1844-705X	Kaohsiung Chang Gung Memorial Hospital [CMRPG850271, CMRPG850272, CMRPG850242, CMRPG850252]; Department of Health, Executive Yuan, Republic of China [DOH101-TD-C-111-002]; Kaohsiung Medical University Research Foundation [KMUER014, KMU-M110001]; National Sun Yat-sen University-KMU Joint Research Project [NSYSUKMU 101-006]	Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Department of Health, Executive Yuan, Republic of China; Kaohsiung Medical University Research Foundation; National Sun Yat-sen University-KMU Joint Research Project	This study was partly supported by grants from Kaohsiung Chang Gung Memorial Hospital under contract nos. CMRPG850271, CMRPG850272, CMRPG850242, and CMRPG850252, the Department of Health, Executive Yuan, Republic of China (DOH101-TD-C-111-002), and the Kaohsiung Medical University Research Foundation (KMUER014 and KMU-M110001) and the National Sun Yat-sen University-KMU Joint Research Project (#NSYSUKMU 101-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022332; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Boles RG, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01305.x; Bostrom MA, 2011, AM J KIDNEY IN PRESS; Briollais L, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-22; Chen JB, 2008, AM J NEPHROL, V28, P853, DOI 10.1159/000139638; Chen JB, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-10; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; Chuang LY, 2012, EUR J CANCER PREV, V21, P336, DOI 10.1097/CEJ.0b013e32834e31f6; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Marinho AND, 2011, GENET MOL BIOL, V34, P31, DOI 10.1590/S1415-47572010005000106; Ebner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027192; Goia-Rusanu Cristina D, 2011, Roum Arch Microbiol Immunol, V70, P5; Ha PK, 2002, CLIN CANCER RES, V8, P2260; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Kalousova M, 2008, ANN NY ACAD SCI, V1126, P268, DOI 10.1196/annals.1433.012; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kim W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002211; Lenz O, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-30; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Lin GT, 2008, CHINESE J PHYSIOL, V51, P32; Lin GT, 2009, OMICS, V13, P165, DOI 10.1089/omi.2008.0050; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Liu SA, 2011, EUR ARCH OT IN PRESS; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Nagy A, 2003, J PATHOL, V199, P237, DOI 10.1002/path.1273; Nomoto S, 2002, CLIN CANCER RES, V8, P481; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parrella P, 2001, CANCER RES, V61, P7623; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Reiner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014359; Rose G, 2002, INT J BIOCHEM CELL B, V34, P1449, DOI 10.1016/S1357-2725(02)00042-0; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sigrist MK, 2008, NEPHRON CLIN PRACT, V108, pC121, DOI 10.1159/000114202; Sotgia F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-62; Sperati CJ, 2009, AM J KIDNEY DIS, V53, P845, DOI 10.1053/j.ajkd.2008.12.025; Suzuki M, 2003, CLIN CANCER RES, V9, P5636; Tan DJ, 2003, GENE CHROMOSOME CANC, V37, P186, DOI 10.1002/gcc.10217; Wada T, 2006, ANTICANCER RES, V26, P3403; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Wang QX, 2006, MITOCHONDRION, V6, P37, DOI 10.1016/j.mito.2005.11.002; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Wang YC, 2011, J NEPHROL, V24, P351, DOI 10.5301/JN.2010.5816; Wetmore JB, 2006, HUM GENET, V120, P201, DOI 10.1007/s00439-006-0191-4; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yang CH, 2012, KAOHSIUNG J MED SCI, V28, P362, DOI 10.1016/j.kjms.2012.02.002; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yao Li, 2009, BMC Proc, V3 Suppl 7, pS83; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Zaki E A, 2009, Cephalalgia, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng ZL, 2009, NEPHRON CLIN PRACT, V113, pC104, DOI 10.1159/000228542	62	166	171	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e41125	10.1371/journal.pone.0041125	http://dx.doi.org/10.1371/journal.pone.0041125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22815937	Green Published, Green Submitted, gold			2022-12-27	WOS:000306548900077
J	Wu, SG; Wang, GT; Angert, ER; Wang, WW; Li, WX; Zou, H				Wu, Shangong; Wang, Guitang; Angert, Esther R.; Wang, Weiwei; Li, Wenxiang; Zou, Hong			Composition, Diversity, and Origin of the Bacterial Community in Grass Carp Intestine	PLOS ONE			English	Article							GUT MICROBIOTA; AEROMONAS-SALMONICIDA; PROBIOTIC ACTIVITY; RAINBOW-TROUT; MICROFLORA; RUMEN; FISH; IDENTIFICATION; AMPLIFICATION; FURUNCULOSIS	Gut microbiota has become an integral component of the host, and received increasing attention. However, for many domestic animals, information on the microbiota is insufficient and more effort should be exerted to manage the gastrointestinal bacterial community. Understanding the factors that influence the composition of microbial community in the host alimentary canal is essential to manage or improve the microbial community composition. In the present study, 16S rRNA gene sequence-based comparisons of the bacterial communities in the grass carp (Ctenopharyngodon idellus) intestinal contents and fish culture-associated environments are performed. The results show that the fish intestinal microbiota harbors many cellulose-decomposing bacteria, including sequences related to Anoxybacillus, Leuconostoc, Clostridium, Actinomyces, and Citrobacter. The most abundant bacterial operational taxonomic units (OTUs) in the grass carp intestinal content are those related to feed digestion. In addition, the potential pathogens and probiotics are important members of the intestinal microbiota. Further analyses show that grass carp intestine holds a core microbiota composed of Proteobacteria, Firmicutes, and Actinobacteria. The comparison analyses reveal that the bacterial community in the intestinal contents is most similar to those from the culture water and sediment. However, feed also plays significant influence on the composition of gut microbiota.	[Wu, Shangong; Wang, Guitang; Wang, Weiwei; Li, Wenxiang; Zou, Hong] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wu, Shangong; Wang, Guitang; Wang, Weiwei; Li, Wenxiang; Zou, Hong] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China; [Angert, Esther R.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Cornell University	Wu, SG (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	gtwang@ihb.ac.cn		Kuo, Ping-Chung/0000-0003-3019-1138; TENG, CHE-MING/0000-0002-9719-7334	National Basic Research Program of China [2009CB118705]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FB07]; earmarked fund for China Agriculture Research System [CARS-46-08]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); earmarked fund for China Agriculture Research System	The research was financially supported by grants from National Basic Research Program of China (No. 2009CB118705), the Open Fund of State Key Laboratory of Freshwater Ecology and Biotechnology (No. 2011FB07), and the earmarked fund for China Agriculture Research System (No. CARS-46-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; [Anonymous], 2008, FRESHWATER FISHERY; [Anonymous], [No title captured]; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Berg R. D., 1992, Probiotics: the scientific basis., P55; Bjorksten B, 2006, CLIN EXP ALLERGY, V36, P1215, DOI 10.1111/j.1365-2222.2006.02579.x; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Cui Y., 1991, PROGR NATURAL SCI, V1, P449; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gibson LF, 1998, AQUACULTURE, V169, P111, DOI 10.1016/S0044-8486(98)00369-X; Gibson LF, 1999, J APPL MICROBIOL, V85, p243S, DOI 10.1111/j.1365-2672.1998.tb05304.x; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; He Li, 2009, Chinese Journal of Applied and Environmental Biology, V15, P414, DOI 10.3724/SP.J.1145.2009.00414; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; HINEY MP, 1994, DIS AQUAT ORGAN, V19, P161, DOI 10.3354/dao019161; Irianto A, 2002, J FISH DIS, V25, P333, DOI 10.1046/j.1365-2761.2002.00375.x; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Kovach W., 1999, MVSP A MULTIVARIATE; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li J.H., 2010, CHINA FISHERY STAT Y; Li SF, 1980, J FISH CHINA, V4, P275; Lodemel JB, 2001, AQUAC RES, V32, P935, DOI 10.1046/j.1365-2109.2001.00621.x; Luo Lin, 2001, Journal of Fisheries of China, V25, P232; MACKIE RI, 1990, J DAIRY SCI, V73, P2971, DOI 10.3168/jds.S0022-0302(90)78986-2; Ni D S, 1999, BIOL DIS GRASS CARP; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pankratov T A, 2006, Dokl Biol Sci, V410, P428, DOI 10.1134/S0012496606050243; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Perumbakkam S, 2011, ANTON LEEUW INT J G, V99, P231, DOI 10.1007/s10482-010-9481-x; Pond MJ, 2006, AQUACULTURE, V261, P194, DOI 10.1016/j.aquaculture.2006.06.037; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu Y, 2010, CHINA FOOD, V19, P34; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Ringo E, 1999, AQUAC RES, V30, P73, DOI 10.1046/j.1365-2109.1999.00302.x; Ringo E, 2003, AQUACULTURE, V227, P395, DOI 10.1016/j.aquaculture.2003.05.001; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Roeselers G, 2011, ISME J, DOI [10.1038/ismej.2011.1038, DOI 10.1038/ISMEJ.2011.1038]; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; RUSSELL JB, 1981, J ANIM SCI, V53, P242, DOI 10.2527/jas1981.531242x; Saha S, 2006, AQUAC RES, V37, P380, DOI 10.1111/j.1365-2109.2006.01442.x; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Song Xiao, 2009, Acta Hydrobiologica Sinica, V33, P709, DOI 10.3724/SP.J.1035.2009.40709; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x; Tomsic B, 2007, CARBOHYD POLYM, V69, P478, DOI 10.1016/j.carbpol.2007.01.003; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu SG, 2010, AQUACULTURE, V303, P1, DOI 10.1016/j.aquaculture.2009.12.025; XU BH, 1988, ACTA HYDROBIOL SIN, V12, P308; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yang WM, 2010, THESIS CAS WUHAN; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou W., 1998, J HUAZHONG AGRIC UNI, V17, P252; Zu G, 2000, FRESHW FISH, V30, P35	63	431	489	19	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30440	10.1371/journal.pone.0030440	http://dx.doi.org/10.1371/journal.pone.0030440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22815798	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500008
J	Chen, MN; Li, X; Yang, QL; Chi, XY; Pan, LJ; Chen, N; Yang, Z; Wang, T; Wang, MA; Yu, SL				Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin			Soil Eukaryotic Microorganism Succession as Affected by Continuous Cropping of Peanut - Pathogenic and Beneficial Fungi were Selected	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; SOILBORNE DISEASES; MYCORRHIZAL FUNGI; ENZYME-ACTIVITIES; PLANT-PATHOGENS; YIELD DECLINE; BIOCONTROL; DIVERSITY; TRICHODERMA; POPULATIONS	Peanut is an important oil crop worldwide and shows considerable adaptability but growth and yield are negatively affected by continuous cropping. Soil micro-organisms are efficient bio-indicators of soil quality and plant health and are critical to the sustainability of soil-based ecosystem function and to successful plant growth. In this study, 18S rRNA gene clone library analyses were employed to study the succession progress of soil eukaryotic micro-organisms under continuous peanut cultivation. Eight libraries were constructed for peanut over three continuous cropping cycles and its representative growth stages. Cluster analyses indicated that soil micro-eukaryotic assemblages obtained from the same peanut cropping cycle were similar, regardless of growth period. Six eukaryotic groups were found and fungi predominated in all libraries. The fungal populations showed significant dynamic change and overall diversity increased over time under continuous peanut cropping. The abundance and/or diversity of clones affiliated with Eurotiales, Hypocreales, Glomerales, Orbiliales, Mucorales and Tremellales showed an increasing trend with continuous cropping but clones affiliated with Agaricales, Cantharellales, Pezizales and Pyxidiophorales decreased in abundance and/or diversity over time. The current data, along with data from previous studies, demonstrated that the soil microbial community was affected by continuous cropping, in particular, the pathogenic and beneficial fungi that were positively selected over time, which is commonplace in agro-ecosystems. The trend towards an increase in fungal pathogens and simplification of the beneficial fungal community could be important factors contributing to the decline in peanut growth and yield over many years of continuous cropping.	[Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China		Chen, MN (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	yshanlin1956@163.com	Lung, Shih-Chun Candice/ABA-1011-2020; Lung, Shih-Chun Candice/GYD-5623-2022; Lin, CY/K-6503-2014; lin, chuan/HHD-2571-2022	Lung, Shih-Chun Candice/0000-0002-4227-0469; Lung, Shih-Chun Candice/0000-0002-4227-0469; Lin, CY/0000-0002-0005-7088; Su, Huey-Jen/0000-0003-3589-9987	China Agriculture Research System [CARS-14]; National Natural Science Foundation of China [31000728, 31100205]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province [BS2010NY023]; Qingdao Municipal Science and Technology Plan Project [11-2-4-9-(3)-jch, 11-2-3-26-nsh]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shangdong Province; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from China Agriculture Research System (CARS-14), the National Natural Science Foundation of China (31000728; 31100205), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), the Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province (BS2010NY023), Qingdao Municipal Science and Technology Plan Project (11-2-4-9-(3)-jch; 11-2-3-26-nsh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2008, CROP PROT, V27, P410, DOI 10.1016/j.cropro.2007.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anaissie EJ, 2002, CLIN INFECT DIS, V34, P780, DOI 10.1086/338958; Avidano L, 2005, APPL SOIL ECOL, V30, P21, DOI 10.1016/j.apsoil.2005.01.003; Benhamou N, 2004, PHYTOPATHOLOGY, V94, P693, DOI 10.1094/PHYTO.2004.94.7.693; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Blakney AJC, 2011, FEMS MICROBIOL ECOL, V77, P546, DOI 10.1111/j.1574-6941.2011.01136.x; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bruehl GW., 1987, SOILBORNE PLANT PATH; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Budi SW, 1999, APPL ENVIRON MICROB, V65, P5148; Caesar-TonThat T, 2010, EUR J SOIL BIOL, V46, P119, DOI 10.1016/j.ejsobi.2009.12.004; Cizkova D, 2005, FOLIA MICROBIOL, V50, P59, DOI 10.1007/BF02931294; Cotxarrera L, 2002, SOIL BIOL BIOCHEM, V34, P467, DOI 10.1016/S0038-0717(01)00205-X; CURL EA, 1988, CRIT REV PLANT SCI, V7, P175, DOI 10.1080/07352688809382263; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; DELEIJ FAAM, 1995, APPL ENVIRON MICROB, V61, P3443, DOI 10.1128/AEM.61.9.3443-3453.1995; Dobermann A, 2000, AGRON J, V92, P633, DOI 10.2134/agronj2000.924633x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Heydari A., 2010, Journal of Biological Sciences, V10, P273; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3378, DOI 10.1128/AEM.02715-09; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; JOHNSON NC, 1992, AGRON J, V84, P387, DOI 10.2134/agronj1992.00021962008400030007x; Kandeler E, 2006, SOIL BIOL BIOCHEM, V38, P2448, DOI 10.1016/j.soilbio.2006.02.021; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Kubicek C. P., 2001, Journal of Plant Pathology, V83, P11; Larkin RP, 2008, SOIL BIOL BIOCHEM, V40, P1341, DOI 10.1016/j.soilbio.2007.03.005; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Lithourgidis AS, 2006, EUR J AGRON, V25, P208, DOI 10.1016/j.eja.2006.05.003; Lutz MP, 2003, APPL ENVIRON MICROB, V69, P3077, DOI 10.1128/AEM.69.6.3077-3084.2003; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; Morace Giulia, 2012, Int J Microbiol, V2012, P349278, DOI 10.1155/2012/349278; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nayyar A, 2009, APPL SOIL ECOL, V43, P115, DOI 10.1016/j.apsoil.2009.06.008; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pankhurst CE, 1996, BIODIVERS CONSERV, V5, P197, DOI 10.1007/BF00055830; Pliego C, 2011, PLANT SOIL, V340, P505, DOI 10.1007/s11104-010-0615-8; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Reichardt W, 1997, APPL ENVIRON MICROB, V63, P233, DOI 10.1128/AEM.63.1.233-238.1997; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sharma KK, 2006, METH MOL B, V343, P347; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Sudini H, 2011, PHYTOPATHOLOGY, V101, P819, DOI 10.1094/PHYTO-11-10-0310; Tedersoo L, 2006, NEW PHYTOL, V170, P581, DOI 10.1111/j.1469-8137.2006.01678.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Elsas JD., 2006, MODERN SOIL MICROBIO, DOI [10.1201/9781420015201, DOI 10.1201/9781420015201]; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027381; Wehner J, 2010, PEDOBIOLOGIA, V53, P197, DOI 10.1016/j.pedobi.2009.10.002; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2; Ying SH, 2004, J APPL MICROBIOL, V97, P323, DOI 10.1111/j.1365-2672.2004.02311.x	64	185	204	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40659	10.1371/journal.pone.0040659	http://dx.doi.org/10.1371/journal.pone.0040659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22737206	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500068
J	Shen, K; Rice, SD; Gingrich, DA; Wang, DK; Mi, ZB; Tian, CQ; Ding, ZY; Brower, SL; Ervin, PR; Gabrin, MJ; Tseng, G; Song, N				Shen, Kui; Rice, Shara D.; Gingrich, David A.; Wang, Dakun; Mi, Zhibao; Tian, Chunqiao; Ding, Zhenyu; Brower, Stacey L.; Ervin, Paul R., Jr.; Gabrin, Michael J.; Tseng, George; Song, Nan			Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; ANTICANCER DRUGS; NEOADJUVANT CHEMOTHERAPY; EXPRESSION PROFILES; MOLECULAR PORTRAITS; SUBTYPES; SENSITIVITY; DOXORUBICIN; CYCLOPHOSPHAMIDE; CHEMOSENSITIVITY	Breast cancer patients have different responses to chemotherapeutic treatments. Genes associated with drug response can provide insight to understand the mechanisms of drug resistance, identify promising therapeutic opportunities, and facilitate personalized treatment. Estrogen receptor (ER) positive and ER negative breast cancer have distinct clinical behavior and molecular properties. However, to date, few studies have rigorously assessed drug response genes in them. In this study, our goal was to systematically identify genes associated with multidrug response in ER positive and ER negative breast cancer cell lines. We tested 27 human breast cell lines for response to seven chemotherapeutic agents (cyclophosphamide, docetaxel, doxorubicin, epirubicin, fluorouracil, gemcitabine, and paclitaxel). We integrated publicly available gene expression profiles of these cell lines with their in vitro drug response patterns, then applied meta-analysis to identify genes related to multidrug response in ER positive and ER negative cells separately. One hundred eighty-eight genes were identified as related to multidrug response in ER positive and 32 genes in ER negative breast cell lines. Of these, only three genes (DBI, TOP2A, and PMVK) were common to both cell types. TOP2A was positively associated with drug response, and DBI was negatively associated with drug response. Interestingly, PMVK was positively associated with drug response in ER positive cells and negatively in ER negative cells. Functional analysis showed that while cell cycle affects drug response in both ER positive and negative cells, most biological processes that are involved in drug response are distinct. A number of signaling pathways that are uniquely enriched in ER positive cells have complex cross talk with ER signaling, while in ER negative cells, enriched pathways are related to metabolic functions. Taken together, our analysis indicates that distinct mechanisms are involved in multidrug response in ER positive and ER negative breast cells.	[Shen, Kui; Rice, Shara D.; Gingrich, David A.; Wang, Dakun; Tian, Chunqiao; Ding, Zhenyu; Brower, Stacey L.; Ervin, Paul R., Jr.; Gabrin, Michael J.; Song, Nan] Precis Therapeut Inc, Pittsburgh, PA USA; [Tseng, George] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Mi, Zhibao] VA Maryland Hlth Care Syst, Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shen, K (corresponding author), Precis Therapeut Inc, Pittsburgh, PA USA.	nsong@ptilabs.com	Shen, Kui/E-2764-2015		Precision Therapeutics, Inc.	Precision Therapeutics, Inc.	KS, SR, CT, DG, DW, ZD, SB, PE, MG and NS were employees of Precision Therapeutics, Inc., and received salary from Precision Therapeutics, Inc. Zhibao Mi and George Tseng are consultants of Precision Therapeutics, Inc. A provisional patent application (# 61/265,588) related to the content of the manuscript has been filed. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andre F, 2008, J CLIN ONCOL, V26, P2636, DOI 10.1200/JCO.2007.14.9146; Andre F, 2006, NAT CLIN PRACT ONCOL, V3, P621, DOI 10.1038/ncponc0636; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Council NR, 1992, COMB INF STAT ISS OP; Dan S, 2002, CANCER RES, V62, P1139; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Iwamoto T, 2011, BREAST CANC RES TREA; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Jarvinen TAH, 2000, AM J PATHOL, V156, P839, DOI 10.1016/S0002-9440(10)64952-8; Knoop AS, 2005, J CLIN ONCOL, V23, P7483, DOI 10.1200/JCO.2005.11.007; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Liedtke C, 2009, J CLIN ONCOL, V27, P3185, DOI 10.1200/JCO.2008.18.5934; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Mi ZB, 2008, ANTICANCER RES, V28, P1733; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pollard C, 2009, AM J PATHOL, V175, P1824, DOI 10.2353/ajpath.2009.090155; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Rustici G. R., 2008, CURR PROTOC BIOINFOR; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; Tanner M, 2006, J CLIN ONCOL, V24, P2428, DOI 10.1200/JCO.2005.02.9264; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WERMUTH B, 1986, BIOCHEM PHARMACOL, V35, P1277, DOI 10.1016/0006-2952(86)90271-6; Zembutsu H, 2002, CANCER RES, V62, P518	38	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40900	10.1371/journal.pone.0040900	http://dx.doi.org/10.1371/journal.pone.0040900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815861	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000306466100092
J	Dakos, V; Carpenter, SR; Brock, WA; Ellison, AM; Guttal, V; Ives, AR; Kefi, S; Livina, V; Seekell, DA; van Nes, EH; Scheffer, M				Dakos, Vasilis; Carpenter, Stephen R.; Brock, William A.; Ellison, Aaron M.; Guttal, Vishwesha; Ives, Anthony R.; Kefi, Sonia; Livina, Valerie; Seekell, David A.; van Nes, Egbert H.; Scheffer, Marten			Methods for Detecting Early Warnings of Critical Transitions in Time Series Illustrated Using Simulated Ecological Data	PLOS ONE			English	Article							CRITICAL SLOWING-DOWN; REGIME SHIFTS; CATASTROPHIC SHIFTS; LEADING INDICATOR; STATES; DESERTIFICATION; ECOSYSTEMS; ESTIMATORS; VEGETATION; STABILITY	Many dynamical systems, including lakes, organisms, ocean circulation patterns, or financial markets, are now thought to have tipping points where critical transitions to a contrasting state can happen. Because critical transitions can occur unexpectedly and are difficult to manage, there is a need for methods that can be used to identify when a critical transition is approaching. Recent theory shows that we can identify the proximity of a system to a critical transition using a variety of so-called 'early warning signals', and successful empirical examples suggest a potential for practical applicability. However, while the range of proposed methods for predicting critical transitions is rapidly expanding, opinions on their practical use differ widely, and there is no comparative study that tests the limitations of the different methods to identify approaching critical transitions using time-series data. Here, we summarize a range of currently available early warning methods and apply them to two simulated time series that are typical of systems undergoing a critical transition. In addition to a methodological guide, our work offers a practical toolbox that may be used in a wide range of fields to help detect early warning signals of critical transitions in time series data.	[Dakos, Vasilis; van Nes, Egbert H.; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Dakos, Vasilis] Estn Biol Donana, Integrat Ecol Grp, Seville, Spain; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Brock, William A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Guttal, Vishwesha] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Kefi, Sonia] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Livina, Valerie] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Seekell, David A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Indian Institute of Science (IISC) - Bangalore; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of East Anglia; University of Virginia	Dakos, V (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands.	vasilis.dakos@gmail.com	van Nes, Egbert H/F-2681-2011; Scheffer, Marten/C-1852-2012; Leite-Moreira, Adelino F./A-1463-2018; Guttal, Vishwesha/A-3007-2008; Livina, Valerie N/C-7636-2011; Carpenter, Stephen/AAQ-6404-2020; Ives, Anthony/A-5698-2008	Leite-Moreira, Adelino F./0000-0001-7808-3596; Guttal, Vishwesha/0000-0002-2677-857X; Livina, Valerie N/0000-0003-3759-9013; Ives, Anthony/0000-0001-9375-9523; Dakos, Vasilis/0000-0001-8862-718X; van Nes, Egbert/0000-0002-6345-104X; Kefi, Sonia/0000-0002-9678-7770; Ellison, Aaron/0000-0003-4151-6081	Spinoza Award; European Research Council; Vilas Trust; Center for Robust Decision Making in Climate and Energy Policy; National Science Foundation (NSF) through the Decision Making Under Uncertainty Program; NSF; Hilldale Fund of UW-Madison; Natural Environment Research Council [NE/F005474/1]; AXA Research Fund; US National Science Foundation (GRFP); US National Science Foundation through its LTER program [DEB 06-20443]; Santa Fe Institute; Arizona State University; NERC [NE/F005474/1] Funding Source: UKRI	Spinoza Award; European Research Council(European Research Council (ERC)European Commission); Vilas Trust; Center for Robust Decision Making in Climate and Energy Policy; National Science Foundation (NSF) through the Decision Making Under Uncertainty Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Hilldale Fund of UW-Madison; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); AXA Research Fund(AXA Research Fund); US National Science Foundation (GRFP)(National Science Foundation (NSF)); US National Science Foundation through its LTER program; Santa Fe Institute; Arizona State University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	VD, EHvN and MS are supported by a Spinoza Award and a European Research Council Advanced Grant both awarded to MS. WAB is grateful for financial and scientific support from the Vilas Trust and the Center for Robust Decision Making in Climate and Energy Policy funded by the National Science Foundation (NSF) through the Decision Making Under Uncertainty Program. SRC's work is supported by the NSF and the Hilldale Fund of UW-Madison. VNL was supported by the Natural Environment Research Council project 'Detecting and classifying bifurcations in the climate system' (NE/F005474/1) and by the AXA Research Fund through a postdoctoral fellowship. VNL's research was carried out on the High Performance Computing Cluster at the University of East Anglia. DS is supported by the US National Science Foundation (GRFP). AME's work on critical transitions is supported by the US National Science Foundation through its LTER program (DEB 06-20443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was based on the workshop 'Practical Methods for Analysis of Early Warnings for Regime Shifts' organized by VD, SRC and MS in the Santa Fe Institute, in Santa Fe, New Mexico, USA, from 10 to 12 of October 2011. We are grateful to the Santa Fe Institute and the Arizona State University for the financial support, and in particular to Sander van der Leeuw for the invitation to organize the workshop as part of the Complex Adaptive Systems Initiative. We are also grateful to Marty Anderies serving as our critical observer during the workshop. We thank Tim Cline for writing the R code for the Conditional Heteroskedasticity.	[Anonymous], 1991, FRACTALS CHAOS POWER; Bandi FM, 2003, J ECONOMETRICS, V116, P293, DOI 10.1016/S0304-4076(03)00110-6; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Broock W.A., 1996, ECONOMET REV, V15, P197, DOI [10.1080/07474939608800353, DOI 10.1080/07474939608800353]; Carpenter SR, 2011, ECOLOGY, V92, P2196, DOI 10.1890/11-0716.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2002, REGIME SHIFTS LAKE E; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, ECOLOGY, V93, P264, DOI 10.1890/11-0889.1; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; ENGLE RF, 1985, CAN J ECON, V18, P66, DOI 10.2307/135114; ENGLE RF, 1982, J ECONOMETRICS, V20, P83, DOI 10.1016/0304-4076(82)90104-X; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Halley JM, 2011, CLIMATIC CHANGE, V109, P549, DOI 10.1007/s10584-011-0053-5; Hardle W., 1990, APPL NONPARAMETRIC R; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Horsthemke W, 2006, NOISE INDUCED TRANSI; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Ives AR, ECOSPHERE IN PRESS; Johannes M, 2004, J FINANC, V59, P227, DOI 10.1111/j.1540-6321.2004.00632.x; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; KRAMER J, 1985, J CHEM PHYS, V83, P6234, DOI 10.1063/1.449571; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Lenton TM, 2012, PHILOS T R SOC A, V370, P1185, DOI 10.1098/rsta.2011.0304; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; Livina VN, 2012, PHYSICA A, V391, P485, DOI 10.1016/j.physa.2011.08.025; Livina VN, 2011, CLIM DYNAM, V37, P2437, DOI 10.1007/s00382-010-0980-2; Livina VN, 2010, CLIM PAST, V6, P77, DOI 10.5194/cp-6-77-2010; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Maestre FT, 2009, ECOLOGY, V90, P1729, DOI 10.1890/08-2096.1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Oborny B, 2005, OIKOS, V109, P291; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seekell DA, 2011, AM NAT, V178, P442, DOI 10.1086/661898; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thompson JMT, 2011, INT J BIFURCAT CHAOS, V21, P399, DOI 10.1142/S0218127411028519; Tredicce JR, 2004, AM J PHYS, V72, P799, DOI 10.1119/1.1688783; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	63	473	489	13	321	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e41010	10.1371/journal.pone.0041010	http://dx.doi.org/10.1371/journal.pone.0041010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22815897	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000306507000052
J	Wang, HK; Yan, YH; Wang, JM; Zhang, HP; Qi, W				Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Zhang, HePing; Qi, Wei			Production and Characterization of Antifungal Compounds Produced by Lactobacillus plantarum IMAU10014	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTICS; SPOILAGE; BREAD; FOOD	Lactobacillus plantarum IMAU10014 was isolated from koumiss that produces a broad spectrum of antifungal compounds, all of which were active against plant pathogenic fungi in an agar plate assay. Two major antifungal compounds were extracted from the cell-free supernatant broth of L. plantarum IMAU10014. 3-phenyllactic acid and Benzeneacetic acid, 2-propenyl ester were carried out by HPLC, LC-MS, GC-MS, NMR analysis. It is the first report that lactic acid bacteria produce antifungal Benzeneacetic acid, 2-propenyl ester. Of these, the antifungal products also have a broad spectrum of antifungal activity, namely against Botrytis cinerea, Glomerella cingulate, Phytophthora drechsleri Tucker, Penicillium citrinum, Penicillium digitatum and Fusarium oxysporum, which was identified by the overlay and well-diffusion assay. F. oxysporum, P. citrinum and P. drechsleri Tucker were the most sensitive among molds.	[Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Qi, Wei] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China; [Zhang, HePing] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Minist Educ, Hohhot, Peoples R China	Tianjin University Science & Technology; Inner Mongolia Agricultural University	Wang, HK (corresponding author), Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China.	haikuanwangcn@yahoo.com.cn; hepingdd@vip.sina.com	Zhang, He/GXN-0028-2022		National Natural Science Foundation of China [30900961, 20876116]; Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	This work was supported by the National Natural Science Foundation of China (No. 30900961 and No. 20876116), the Key Laboratory of Dairy Biotechnology, the Engineering, Ministry of Education, the Inner Mongolia Agricultural University for helpful contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2008, LETT APPL MICROBIOL, V47, P180, DOI 10.1111/j.1472-765X.2008.02412.x; Coloretti F, 2007, FEMS MICROBIOL LETT, V271, P245, DOI 10.1111/j.1574-6968.2007.00723.x; Dal Bello F, 2007, J CEREAL SCI, V45, P309, DOI 10.1016/j.jcs.2006.09.004; Dalie DKD, 2010, FOOD CONTROL, V21, P370, DOI 10.1016/j.foodcont.2009.07.011; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V87, P149; Gerez CL, 2009, FOOD CONTROL, V20, P144, DOI 10.1016/j.foodcont.2008.03.005; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; MATSUDA T, 1994, J JPN SOC FOOD SCI, V41, P687; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Niku-Paavola ML, 1999, J APPL MICROBIOL, V86, P29, DOI 10.1046/j.1365-2672.1999.00632.x; Prema P, 2010, FOOD BIOPROCESS TECH, V3, P379, DOI 10.1007/s11947-008-0127-1; Rouse S, 2008, J APPL MICROBIOL, V104, P915, DOI 10.1111/j.1365-2672.2007.03619.x; Schnurer J, 2005, TRENDS FOOD SCI TECH, V16, P70, DOI 10.1016/j.tifs.2004.02.014; Schwenninger SM, 2008, J FOOD PROTECT, V71, P2481, DOI 10.4315/0362-028X-71.12.2481; Sjogren J, 2003, APPL ENVIRON MICROB, V69, P7554, DOI 10.1128/AEM.69.12.7554-7557.2003; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Sun TS, 2009, EUR FOOD RES TECHNOL, V228, P607, DOI 10.1007/s00217-008-0969-9; Vermeulen N, 2006, J AGR FOOD CHEM, V54, P3832, DOI 10.1021/jf052733e; Wang HK, 2011, ANN MICROBIOL, V61, P879, DOI 10.1007/s13213-011-0209-6; Yang LP, 2008, WORLD J MICROB BIOT, V24, P909, DOI 10.1007/s11274-007-9626-x	22	374	401	7	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29452	10.1371/journal.pone.0029452	http://dx.doi.org/10.1371/journal.pone.0029452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22844460	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200014
